{
  "file_name": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
  "total_pages": 75,
  "pdf_type": "normal",
  "font_analysis": {
    "font_sizes_frequency": {
      "27.959999084472656": 2,
      "24.0": 1,
      "15.0": 5,
      "11.039999961853027": 909,
      "17.03999900817871": 2,
      "12.960000038146973": 38,
      "14.039999961853027": 11,
      "15.960000038146973": 1,
      "20.03999900817871": 1,
      "12.0": 108,
      "9.960000038146973": 1512,
      "7.679999828338623": 3,
      "9.0": 131,
      "6.359999656677246": 37,
      "7.079999923706055": 14,
      "8.039999961853027": 9,
      "18.0": 2,
      "9.719964981079102": 1,
      "9.588688850402832": 1,
      "9.828072547912598": 2,
      "6.231501579284668": 1,
      "37.864219665527344": 2,
      "6.721034049987793": 4,
      "8.279999732971191": 2,
      "11.256997108459473": 11
    },
    "heading_sizes": [
      37.864219665527344,
      27.959999084472656,
      18.0,
      17.03999900817871,
      15.0,
      14.039999961853027,
      12.960000038146973,
      12.0,
      11.256997108459473,
      11.039999961853027
    ]
  },
  "table_analysis": {
    "total_tables": 15,
    "tables_info": [
      {
        "bbox": [
          76.43999481201172,
          153.7042999267578,
          525.1611938476562,
          587.9083251953125
        ],
        "num_rows": 7,
        "num_cols": 2
      },
      {
        "bbox": [
          64.55999755859375,
          193.2797393798828,
          508.58154296875,
          275.5273132324219
        ],
        "num_rows": 3,
        "num_cols": 2
      },
      {
        "bbox": [
          112.68000030517578,
          220.63973999023438,
          502.22149658203125,
          282.8473205566406
        ],
        "num_rows": 4,
        "num_cols": 3
      },
      {
        "bbox": [
          108.47999572753906,
          212.83973693847656,
          515.3015747070312,
          250.08731079101562
        ],
        "num_rows": 3,
        "num_cols": 4
      },
      {
        "bbox": [
          89.75999450683594,
          361.2797546386719,
          504.4795227050781,
          731.0362548828125
        ],
        "num_rows": 4,
        "num_cols": 4
      },
      {
        "bbox": [
          75.83999633789062,
          101.23973846435547,
          496.7010803222656,
          284.2873229980469
        ],
        "num_rows": 3,
        "num_cols": 2
      },
      {
        "bbox": [
          95.63999938964844,
          250.2797393798828,
          508.94189453125,
          713.0473022460938
        ],
        "num_rows": 9,
        "num_cols": 4
      },
      {
        "bbox": [
          107.39999389648438,
          129.07974243164062,
          501.92578125,
          634.0762329101562
        ],
        "num_rows": 6,
        "num_cols": 6
      },
      {
        "bbox": [
          104.39999389648438,
          505.9997253417969,
          500.69110107421875,
          620.4073486328125
        ],
        "num_rows": 3,
        "num_cols": 3
      },
      {
        "bbox": [
          110.27999877929688,
          148.87974548339844,
          506.48577880859375,
          644.7562255859375
        ],
        "num_rows": 5,
        "num_cols": 6
      },
      {
        "bbox": [
          63.119998931884766,
          175.63973999023438,
          727.461669921875,
          406.4472961425781
        ],
        "num_rows": 6,
        "num_cols": 2
      },
      {
        "bbox": [
          63.119998931884766,
          235.51974487304688,
          723.9595336914062,
          500.7673034667969
        ],
        "num_rows": 7,
        "num_cols": 2
      },
      {
        "bbox": [
          63.119998931884766,
          94.51974487304688,
          732.5008544921875,
          345.3673095703125
        ],
        "num_rows": 5,
        "num_cols": 2
      },
      {
        "bbox": [
          80.75999450683594,
          325.9125061035156,
          489.6601867675781,
          646.916259765625
        ],
        "num_rows": 4,
        "num_cols": 3
      },
      {
        "bbox": [
          65.04000091552734,
          597.7645874023438,
          502.1649475097656,
          633.2552490234375
        ],
        "num_rows": 3,
        "num_cols": 4
      }
    ]
  },
  "text_blocks": [
    {
      "text": "화장품 위해평가",
      "font_size": 27.959999084472656,
      "font_name": "H2hdrM",
      "bbox": [
        192.59999084472656,
        320.1591796875,
        411.911376953125,
        348.1191711425781
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드라인(민원인 안내서)",
      "font_size": 27.959999084472656,
      "font_name": "H2hdrM",
      "bbox": [
        128.39999389648438,
        364.9191589355469,
        466.65679931640625,
        392.879150390625
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2023. 11.",
      "font_size": 24.0,
      "font_name": "T3",
      "bbox": [
        249.72000122070312,
        507.47998046875,
        345.4319763183594,
        536.2559814453125
      ],
      "page_num": 1,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료제품연구부 화장품연구과",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        188.87998962402344,
        742.2693481445312,
        406.3199768066406,
        758.0896606445312
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발간등록번호",
      "font_size": 11.039999961853027,
      "font_name": "GulimChe",
      "bbox": [
        99.95999908447266,
        123.72328186035156,
        165.95932006835938,
        134.76327514648438
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안내서-0747-02",
      "font_size": 11.039999961853027,
      "font_name": "GulimChe",
      "bbox": [
        94.31999969482422,
        142.20327758789062,
        171.47999572753906,
        153.24327087402344
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침서ᆞ안내서 제ᆞ개정 점검표",
      "font_size": 17.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        170.16000366210938,
        81.37289428710938,
        425.1600036621094,
        98.41288757324219
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명칭",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        90.95999908447266,
        113.38429260253906,
        438.9637145996094,
        128.068359375
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화장품 위해평가 가이드라인(민원인 안내서)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        90.95999908447266,
        113.38429260253906,
        438.9637145996094,
        128.068359375
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아래에 해당하는 사항에 체크하여 주시기 바랍니다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        167.16000366210938,
        136.06430053710938,
        428.52935791015625,
        150.7483673095703
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등록대상",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        79.19999694824219,
        292.9042663574219,
        123.23966217041016,
        307.5883483886719
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여부",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        90.23999786376953,
        310.5442810058594,
        112.19966125488281,
        325.2283630371094
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        153.7042999267578,
        430.00091552734375,
        168.38836669921875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서가 있습니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        157.44000244140625,
        170.144287109375,
        303.8810119628906,
        184.82835388183594
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        154.18429565429688,
        503.7596435546875,
        184.34835815429688
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        154.18429565429688,
        503.7596435546875,
        184.34835815429688
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        186.8242950439453,
        522.719970703125,
        201.50836181640625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "선적으로 고려하시기 바랍니다. 그럼에도 불구하고 동 지침서ㆍ안내서의",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        156.72000122070312,
        203.38429260253906,
        526.721923828125,
        234.50836181640625
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제정이 필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        156.72000122070312,
        203.38429260253906,
        526.721923828125,
        234.50836181640625
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(사유 :                                                                 )",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        236.38429260253906,
        518.7637329101562,
        251.068359375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 법령(법ㆍ시행령ㆍ시행규칙) 또는",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        253.0642852783203,
        322.24102783203125,
        267.74835205078125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        157.44000244140625,
        269.5042724609375,
        423.281005859375,
        300.74835205078125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나열한 것입니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        157.44000244140625,
        269.5042724609375,
        423.281005859375,
        300.74835205078125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        261.82427978515625,
        503.7596435546875,
        291.9883728027344
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        261.82427978515625,
        503.7596435546875,
        291.9883728027344
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        299.8642883300781,
        503.7596435546875,
        330.0283508300781
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        299.8642883300781,
        503.7596435546875,
        330.0283508300781
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        299.8642883300781,
        503.7596435546875,
        330.0283508300781
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        329.144287109375,
        408.5205993652344,
        343.828369140625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당하는 내용입니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        156.72000122070312,
        344.5042724609375,
        266.3179626464844,
        359.1883544921875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        329.144287109375,
        503.7596435546875,
        359.1883544921875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        329.144287109375,
        503.7596435546875,
        359.1883544921875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 외국 규정을 번역하거나 설명하는 내용입니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        358.30426025390625,
        503.7596435546875,
        388.4683532714844
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        358.30426025390625,
        503.7596435546875,
        388.4683532714844
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        358.30426025390625,
        503.7596435546875,
        388.4683532714844
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        387.58428955078125,
        446.44091796875,
        402.26837158203125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정리한 자료입니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        156.72000122070312,
        402.94427490234375,
        259.1210021972656,
        417.62835693359375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        387.58428955078125,
        503.7596435546875,
        417.62835693359375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        387.58428955078125,
        503.7596435546875,
        417.62835693359375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        416.7442626953125,
        522.8392944335938,
        431.4283447265625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        154.8000030517578,
        433.30426025390625,
        169.9613494873047,
        447.98834228515625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        449.8642883300781,
        442.93499755859375,
        464.5483703613281
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        75.5999984741211,
        485.7442626953125,
        126.84215545654297,
        500.4283447265625
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서 구분",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        85.68000030517578,
        503.2642517089844,
        116.76042938232422,
        517.9483032226562
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 행정사무의 통일을 기하기 위하여 내부적으로 행정사무의",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        464.5042724609375,
        447.881591796875,
        479.1883544921875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세부기준이나 절차를 제시하는 것입니까? (공무원용)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        156.83999633789062,
        479.8642578125,
        413.88372802734375,
        494.54833984375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예(☞지침서)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        464.5042724609375,
        525.1611938476562,
        494.54833984375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        464.5042724609375,
        525.1611938476562,
        494.54833984375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        494.624267578125,
        447.8814392089844,
        509.308349609375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        156.83999633789062,
        509.9842834472656,
        447.8812561035156,
        540.0283203125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입장을 기술하는 것입니까? (민원인용)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        156.83999633789062,
        509.9842834472656,
        447.8812561035156,
        540.0283203125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 예(☞안내서)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        502.3042907714844,
        524.9207153320312,
        532.3483276367188
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        502.3042907714844,
        524.9207153320312,
        532.3483276367188
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기타 확인",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        76.43999481201172,
        555.5842895507812,
        126.0,
        570.268310546875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사항",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        90.23999786376953,
        573.2243041992188,
        112.19966125488281,
        587.9083251953125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        541.5443115234375,
        441.040283203125,
        556.2283325195312
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민원인을 구속하는 내용이 있습니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        156.83999633789062,
        556.904296875,
        343.35797119140625,
        571.5883178710938
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        541.5443115234375,
        503.7596435546875,
        571.5883178710938
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        454.1999816894531,
        541.5443115234375,
        503.7596435546875,
        571.5883178710938
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        140.27999877929688,
        573.1043090820312,
        522.841064453125,
        587.788330078125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ㆍ안내서 제ㆍ개정 절차를 진행하시기 바랍니다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        156.72000122070312,
        589.5443115234375,
        388.81500244140625,
        604.2283325195312
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상기 사항에 대하여 확인하였음.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        215.39999389648438,
        606.1043090820312,
        381.2493591308594,
        620.788330078125
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2023년 11월",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        247.0800018310547,
        639.1043090820312,
        342.041259765625,
        653.788330078125
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "담당자",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        332.03997802734375,
        673.184326171875,
        406.91131591796875,
        702.1483154296875
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확  인(부서장)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        332.03997802734375,
        673.184326171875,
        406.91131591796875,
        702.1483154296875
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "박은재",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        482.03997802734375,
        671.5042724609375,
        515.0396118164062,
        686.1882934570312
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "송영미",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        481.55999755859375,
        689.144287109375,
        515.0399169921875,
        703.8283081054688
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        65.76000213623047,
        420.74249267578125,
        538.4390869140625,
        434.4112548828125
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가원 화장품연구과에 문의하시기 바랍니다.",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.15999603271484,
        446.782470703125,
        309.8531188964844,
        460.45123291015625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전화번호: 043-719-4852",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.79999542236328,
        472.8224792480469,
        228.6027374267578,
        486.4912414550781
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "팩스번호: 043-719-4850",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.79999542236328,
        498.7424621582031,
        228.6027374267578,
        512.4112548828125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 안내서는 화장품 위해평가에 대하여 알기 쉽게 설명하거나 식품의약",
      "font_size": 14.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        88.0391616821289,
        513.4806518554688,
        106.71345520019531
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품안전처의 입장을 기술한 것입니다.",
      "font_size": 14.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        117.43916320800781,
        301.5756530761719,
        136.11346435546875
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술",
      "font_size": 14.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        156.79916381835938,
        513.600341796875,
        175.4734649658203
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방식(‘∼하여야 한다’ 등)에도 불구하고 참고로만 활용하시기 바랍니다. 또한,",
      "font_size": 14.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        186.19915771484375,
        518.416259765625,
        204.8734588623047
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 안내서는 2023년 11월 현재의 과학적ㆍ기술적 사실 및 유효한 법규를",
      "font_size": 14.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        215.59915161132812,
        518.4158935546875,
        234.27345275878906
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계",
      "font_size": 14.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        244.99916076660156,
        518.4153442382812,
        263.6734619140625
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등에 따라 달리 적용될 수 있음을 알려드립니다.",
      "font_size": 14.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        274.3991394042969,
        355.9356384277344,
        293.0734558105469
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ “민원인 안내서”란 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        326.5746154785156,
        518.03564453125,
        343.8124084472656
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 입장을 기술하는",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        88.43999481201172,
        343.49462890625,
        518.034912109375,
        377.65240478515625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        88.43999481201172,
        343.49462890625,
        518.034912109375,
        377.65240478515625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개정 이력서",
      "font_size": 17.03999900817871,
      "font_name": "H2gtrE",
      "bbox": [
        250.79998779296875,
        106.45288848876953,
        344.3999938964844,
        123.49288177490234
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화장품 위해평가 가이드라인",
      "font_size": 15.960000038146973,
      "font_name": "T8",
      "bbox": [
        191.87998962402344,
        171.239990234375,
        402.48150634765625,
        190.39199829101562
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제․개정번호",
      "font_size": 14.039999961853027,
      "font_name": "T8",
      "bbox": [
        86.4000015258789,
        227.52000427246094,
        429.8396911621094,
        244.3679962158203
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "승인일자",
      "font_size": 14.039999961853027,
      "font_name": "T8",
      "bbox": [
        86.4000015258789,
        227.52000427246094,
        429.8396911621094,
        244.3679962158203
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주요 내용",
      "font_size": 14.039999961853027,
      "font_name": "T8",
      "bbox": [
        86.4000015258789,
        227.52000427246094,
        429.8396911621094,
        244.3679962158203
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B2-2011-4-005",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        87.0,
        269.1600036621094,
        494.6396789550781,
        284.7120056152344
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2011.08.",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        87.0,
        269.1600036621094,
        494.6396789550781,
        284.7120056152344
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 위해평가 가이드라인 제정",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        87.0,
        269.1600036621094,
        494.6396789550781,
        284.7120056152344
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B1-2013-4-002",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        87.0,
        314.2799987792969,
        494.6396789550781,
        329.8320007324219
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2013.10.",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        87.0,
        314.2799987792969,
        494.6396789550781,
        329.8320007324219
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 위해평가 가이드라인 개정",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        87.0,
        314.2799987792969,
        494.6396789550781,
        329.8320007324219
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B1-2016-4-001",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        87.0,
        359.3999938964844,
        494.6396789550781,
        374.9519958496094
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2016.02.",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        87.0,
        359.3999938964844,
        494.6396789550781,
        374.9519958496094
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 위해평가 가이드라인 개정",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        87.0,
        359.3999938964844,
        494.6396789550781,
        374.9519958496094
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B1-2016-4-002",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        87.0,
        404.5199890136719,
        494.6396789550781,
        420.0719909667969
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2016.11.",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        87.0,
        404.5199890136719,
        494.6396789550781,
        420.0719909667969
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 위해평가 가이드라인 개정",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        87.0,
        404.5199890136719,
        494.6396789550781,
        420.0719909667969
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안내서-0747-01",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        84.5999984741211,
        449.6399841308594,
        494.6396789550781,
        465.1919860839844
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2017.03.",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        84.5999984741211,
        449.6399841308594,
        494.6396789550781,
        465.1919860839844
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 위해평가 가이드라인 개정",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        84.5999984741211,
        449.6399841308594,
        494.6396789550781,
        465.1919860839844
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안내서-0747-02",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        84.5999984741211,
        494.760009765625,
        494.6396789550781,
        510.31201171875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2023.11.",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        84.5999984741211,
        494.760009765625,
        494.6396789550781,
        510.31201171875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 위해평가 가이드라인 개정",
      "font_size": 12.960000038146973,
      "font_name": "T9",
      "bbox": [
        84.5999984741211,
        494.760009765625,
        494.6396789550781,
        510.31201171875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목차",
      "font_size": 20.03999900817871,
      "font_name": "MalgunGothicBold",
      "bbox": [
        277.55999755859375,
        70.10888671875,
        317.6400146484375,
        96.7636489868164
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제1장 화장품 위해평가 가이드라인의 목적 ························································· 1",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        120.89460754394531,
        511.1514587402344,
        138.13241577148438
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 목적 ·································································································································· 1",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        66.5999984741211,
        145.81944274902344,
        510.849365234375,
        161.78038024902344
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 관련 규정 ························································································································ 2",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        66.5999984741211,
        169.0994415283203,
        510.849365234375,
        185.0603790283203
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제2장 화장품 안전의 일반사항 ··············································································· 4",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        207.65460205078125,
        511.1514587402344,
        224.8924102783203
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 일반사항 ·························································································································· 4",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        66.5999984741211,
        232.69944763183594,
        510.849365234375,
        248.66038513183594
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 화장품 성분 ···················································································································· 4",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        66.5999984741211,
        255.85943603515625,
        510.849365234375,
        271.82037353515625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제3장 화장품 위해평가 ····························································································· 5",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        293.2146301269531,
        511.1514587402344,
        310.4524230957031
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 위해평가 절차 및 수행에 필요한 일반사항 ···························································· 5",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        66.5999984741211,
        318.1394348144531,
        510.849365234375,
        334.1003723144531
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1-1. 위해평가 단계 ········································································································· 5",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        76.68000030517578,
        341.41943359375,
        510.849365234375,
        357.38037109375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1-2. 위해평가 수행에 필요한 일반사항 ····································································· 6",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        76.68000030517578,
        364.5794372558594,
        510.849365234375,
        380.5403747558594
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1-3. 위해평가 대상 ········································································································· 6",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        76.68000030517578,
        387.73944091796875,
        510.849365234375,
        403.70037841796875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1-4. 위해요소별 위해평가 유형 ··················································································· 7",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        76.68000030517578,
        411.0194396972656,
        510.849365234375,
        426.9803771972656
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 위해평가 방법 ················································································································ 8",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        66.5999984741211,
        434.179443359375,
        510.849365234375,
        450.140380859375
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2-1. 위해평가 사전 검토사항 ······················································································· 8",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        76.68000030517578,
        457.3394470214844,
        510.849365234375,
        473.3003845214844
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2-2. 위해평가 세부 수행절차 ······················································································· 9",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        76.68000030517578,
        480.61944580078125,
        510.849365234375,
        496.58038330078125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2-2-1. 위험성 확인 ······································································································ 9",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        86.63999938964844,
        503.7794189453125,
        510.849365234375,
        519.7403564453125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2-2-2. 위험성 결정 ···································································································· 12",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        86.63999938964844,
        526.939453125,
        510.849365234375,
        542.900390625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2-2-3. 노출평가 ·········································································································· 14",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        86.63999938964844,
        550.2194213867188,
        510.849365234375,
        566.1803588867188
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2-2-3-1. 피부 노출평가 ························································································ 17",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        86.63999938964844,
        573.3794555664062,
        510.849365234375,
        589.3403930664062
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2-2-3-2. 흡입 노출평가 ························································································ 19",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        86.63999938964844,
        596.5394287109375,
        510.849365234375,
        612.5003662109375
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2-2-4. 위해도 결정 ···································································································· 21",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        86.63999938964844,
        619.8194580078125,
        510.849365234375,
        635.7803955078125
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 위해평가 보고서 ········································································································ 23",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        66.5999984741211,
        642.9794311523438,
        510.849365234375,
        658.9403686523438
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제4장 참고문헌 ········································································································· 24",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        682.8545532226562,
        511.15203857421875,
        700.0924072265625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[붙임 자료]",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        264.3599853515625,
        71.81460571289062,
        331.5185241699219,
        89.05242156982422
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 1. 화장품 위해평가 관련 용어집(Glossary) ·························································· 26",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        121.69944763183594,
        510.849365234375,
        137.66038513183594
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 2. 화장품 위해평가 보고서 양식 ········································································· 30",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        144.8594512939453,
        510.849365234375,
        160.8203887939453
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 3. OECD 독성시험 종류 ························································································· 33",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        168.0194549560547,
        510.849365234375,
        183.9803924560547
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 4. 화장품 노출 피부 표면적 ················································································· 35",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        191.29945373535156,
        510.849365234375,
        207.26039123535156
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 5. 한국인의 화장품 사용량 ····················································································· 37",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        214.45944213867188,
        510.849365234375,
        230.42037963867188
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 6. 유럽의 화장품 사용량 ························································································· 39",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        237.61944580078125,
        510.849365234375,
        253.58038330078125
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 7. 흡입 노출평가 방법 및 기본 정보 ··································································· 41",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        260.8994445800781,
        510.849365234375,
        276.8603820800781
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 8. 피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시 ················ 49",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        284.0594482421875,
        510.849365234375,
        300.0203857421875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 9. 화장품 유형별 평가 예시 ··················································································· 53",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        307.2194519042969,
        510.849365234375,
        323.1803894042969
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 10. 화장품 성분 위해평가를 위한 정보 수집 ····················································· 57",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        330.49945068359375,
        510.849365234375,
        346.46038818359375
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[참고 자료]",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        264.3599853515625,
        423.05462646484375,
        331.5185241699219,
        440.29241943359375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "참고 1. 발암물질 위해평가 및 예시 ··············································································· 62",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        472.8194274902344,
        510.849365234375,
        488.7803649902344
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고 2. TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정 ············ 67",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        496.0994567871094,
        510.849365234375,
        512.0604248046875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 1 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        285.1199951171875,
        786.5027465820312,
        310.0413513183594,
        799.4507446289062
      ],
      "page_num": 7,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제1장 화장품 위해평가 가이드라인의 목적",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        71.39431762695312,
        349.79998779296875,
        91.34548950195312
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 목적",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        121.85459899902344,
        99.12052154541016,
        139.0924072265625
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 가이드라인에는 화장품 위해평가를 수행함에 있어 일반적으로 고려되어야 할 사",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        167.04750061035156,
        538.4400024414062,
        179.70375061035156
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항, 절차 및 관련 용어 등을 기술하였다. 본 가이드라인은 화장품의 안전을 확보하기",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        188.64749145507812,
        544.4400024414062,
        201.30374145507812
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위하여 「화장품법」, 「화장품법 시행규칙」에 따른 화장품 위해평가 업무에 활용한다.",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        208.67999267578125,
        531.8399658203125,
        223.5
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 2 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        285.1199951171875,
        786.5027465820312,
        310.0413513183594,
        799.4507446289062
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 관련 규정",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        71.81460571289062,
        131.52000427246094,
        89.05242156982422
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "⌜화장품법⌟",
      "font_size": 7.679999828338623,
      "font_name": "Haansoft Batang",
      "bbox": [
        83.04000091552734,
        128.16749572753906,
        146.39999389648438,
        142.56748962402344
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제2조(정의) 1. “화장품”이란 인체를 청결ㆍ미화하여 매력을 더하고 용모를 밝게 변",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        156.3524932861328,
        512.1599731445312,
        167.99624633789062
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화시키거나 피부ㆍ모발의 건강을 유지 또는 증진하기 위하여 인체에 바르고 문지르",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        176.15249633789062,
        512.1593017578125,
        187.79624938964844
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거나 뿌리는 등 이와 유사한 방법으로 사용되는 물품으로서 인체에 대한 작용이 경",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        195.95249938964844,
        512.1599731445312,
        207.59625244140625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미한 것을 말한다. 다만, 「약사법」제2조제4호의 의약품에 해당하는 물품은 제외한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        214.23561096191406,
        508.4156188964844,
        227.94281005859375
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제8조(화장품 안전기준 등) ① 식품의약품안전처장은 화장품의 제조 등에 사용할 수",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        240.4724884033203,
        517.5599975585938,
        252.11624145507812
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "없는 원료를 지정하여 고시하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        260.2724914550781,
        281.8556213378906,
        271.9162292480469
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 식품의약품안전처장은 보존제, 색소, 자외선차단제 등과 같이 특별히 사용상의 제한",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        280.072509765625,
        512.1600952148438,
        291.71624755859375
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 필요한 원료에 대하여는 그 사용기준을 지정하여 고시하여야 하며, 사용기준이 지",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        299.87249755859375,
        512.1599731445312,
        311.5162353515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정·고시된 원료 외의 보존제, 색소, 자외선차단제 등은 사용할 수 없다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        319.6725158691406,
        438.69561767578125,
        331.3162536621094
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 식품의약품안전처장은 국내외에서 유해물질이 포함되어 있는 것으로 알려지는 등",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        339.4725036621094,
        517.6799926757812,
        351.1162414550781
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국민보건상 위해 우려가 제기되는 화장품 원료 등의 경우에는 총리령으로 정하는 바",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        359.2724914550781,
        512.1599731445312,
        370.9162292480469
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 따라 위해요소를 신속히 평가하여 그 위해 여부를 결정하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        379.072509765625,
        440.9995422363281,
        390.71624755859375
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "④ 식품의약품안전처장은 제3항에 따라 위해평가가 완료된 경우에는 해당 화장품의",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        398.87249755859375,
        517.5606079101562,
        410.5162353515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료 등을 화장품의 제조에 사용할 수 없는 원료로 지정하거나 그 사용기준을 지정하",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        418.6725158691406,
        512.1605224609375,
        430.3162536621094
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        438.4725036621094,
        134.37562561035156,
        450.1162414550781
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑤ 식품의약품안전처장은 제2항에 따라 지정ㆍ고시된 원료의 사용기준의 안전성을 정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        458.2724914550781,
        512.1599731445312,
        469.9162292480469
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기적으로 검토하여야 하고, 그 결과에 따라 지정ㆍ고시된 원료의 사용기준을 변경할",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        478.072509765625,
        517.6805419921875,
        489.71624755859375
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수 있다. 이 경우 안전성 검토의 주기 및 절차 등에 관한 사항은 총리령으로 정한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        497.87249755859375,
        502.8955993652344,
        509.5162353515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 3 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        285.1199951171875,
        786.5027465820312,
        310.0413513183594,
        799.4507446289062
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "⌜화장품법 시행규칙⌟",
      "font_size": 7.679999828338623,
      "font_name": "Haansoft Batang",
      "bbox": [
        83.04000091552734,
        82.32749938964844,
        200.39999389648438,
        96.72750091552734
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제17조(화장품 원료 등의 위해평가) ① 법 제8조제3항에 따른 위해평가는 다음 각",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        110.39249420166016,
        517.5596313476562,
        122.03624725341797
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "호의 확인·결정·평가 등의 과정을 거쳐 실시한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        130.19248962402344,
        344.3756103515625,
        141.83624267578125
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 위해요소의 인체 내 독성을 확인하는 위험성 확인과정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        149.99249267578125,
        377.3996887207031,
        161.63624572753906
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 위해요소의 인체노출 허용량을 산출하는 위험성 결정과정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        169.79249572753906,
        393.8396911621094,
        181.43624877929688
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 위해요소가 인체에 노출된 양을 산출하는 노출평가과정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        189.59249877929688,
        382.919677734375,
        201.2362518310547
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 제1호부터 제3호까지의 결과를 종합하여 인체에 미치는 위해 영향을 판단하는",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        209.39248657226562,
        517.559326171875,
        221.03623962402344
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위해도 결정과정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        229.19248962402344,
        186.4796600341797,
        240.83624267578125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 식품의약품안전처장은 제1항에 따른 결과를 근거로 식품의약품안전처장이 정하는",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        248.9924774169922,
        517.5596313476562,
        260.63623046875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준에 따라 위해여부를 결정한다. 다만, 해당화장품 원료 등에 대하여 국내외의 연",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        268.7925109863281,
        512.1599731445312,
        280.4362487792969
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구·검사기관에서 이미 위해평가를 실시하였거나 위해요소에 대한 과학적 시험·분",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        288.5924987792969,
        512.1599731445312,
        300.2362365722656
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "석 자료가 있는 경우에는 그 자료를 근거로 위해 여부를 결정할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        308.39251708984375,
        454.29559326171875,
        320.0362548828125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 제1항 및 제2항에 따른 위해평가의 기준, 방법 등에 관한 세부 사항은 식품의약",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        328.1925048828125,
        512.0396118164062,
        339.83624267578125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품안전처장이 정하여 고시한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        347.99249267578125,
        239.9756317138672,
        359.63623046875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제17조의2(지정·고시된 원료의 사용기준의 안전성 검토) ① 법 제8조제5항에 따른",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        372.8324890136719,
        517.5596313476562,
        384.4762268066406
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지정·고시된 원료의 사용기준의 안전성 검토 주기는 5년으로 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        392.63250732421875,
        426.81561279296875,
        404.2762451171875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 식품의약품안전처장은 법 제8조제5항에 따라 지정·고시된 원료의 사용기준의 안",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        412.4324951171875,
        512.1599731445312,
        424.07623291015625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전성을 검토할 때에는 사전에 안전성 검토 대상을 선정하여 실시해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.04000091552734,
        432.2325134277344,
        465.3356018066406,
        443.8762512207031
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 4 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        285.1199951171875,
        786.5027465820312,
        310.0413513183594,
        799.4507446289062
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제2장 화장품 안전의 일반사항",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        71.39431762695312,
        267.3599853515625,
        91.34548950195312
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 일반사항",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        115.85459899902344,
        125.04052734375,
        133.0924072265625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 화장품은 제품 설명서, 표시사항 등에 따라 정상적으로 사용하거나 또는 예측가능한 사용",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        151.19248962402344,
        543.9596557617188,
        162.83624267578125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조건에 따라 사용하였을 때 인체에 안전하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        170.99249267578125,
        345.4555969238281,
        182.63624572753906
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 화장품은 일반 소비자뿐만 아니라 화장품을 직업적으로 사용하는 전문가(예, 미용사, 피부",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        194.7524871826172,
        538.5599365234375,
        206.396240234375
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미용사 등)에게 안전해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        214.552490234375,
        239.03958129882812,
        226.1962432861328
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 화장품의 안전성은 화장품 성분의 안전성에 기반하며, 화장품 성분의 안전성은 독성시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        238.4324951171875,
        543.9592895507812,
        250.0762481689453
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과 등을 통해 평가한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        258.2325134277344,
        208.05563354492188,
        269.8762512207031
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 화장품 성분",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        299.0946044921875,
        144.60052490234375,
        316.3323974609375
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 화장품 성분은 화학물질 또는 천연물 등이며, 경우에 따라 단일 또는 혼합물일 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        334.4324951171875,
        543.9595947265625,
        346.07623291015625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최종 제품의 안전성을 확보하기 위해서는 성분의 안전성이 확보되어야 한다. 원료 성분의",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        354.2325134277344,
        544.0796508789062,
        365.8762512207031
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해 우려가 제기되는 경우 위해평가를 통해 안전성을 확보할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        374.0325012207031,
        438.93560791015625,
        385.6762390136719
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 화장품 성분은 식약처장이 화장품의 제조에 사용할 수 없는 원료로 지정·고시한 것이 아",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        397.7925109863281,
        538.43994140625,
        409.4362487792969
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "니어야 한다. 또한, 지정·고시된 사용 목적 및 사용한도에 적합하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        417.5924987792969,
        472.3203430175781,
        429.2362365722656
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 미량의 중금속 등 불순물, 제조공정이나 보관 중에 생길 수 있는 비의도적 오염물질을 가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        441.3525085449219,
        538.43994140625,
        452.9962463378906
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "능한 줄이기 위한 충분한 조치를 취하여야 한다. 그럼에도 오염물질이 존재할 경우, 그 안",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        461.1524963378906,
        538.43994140625,
        472.7962341308594
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전성은 노출량 등을 고려하여 사례별(case-by-case)로 검토되어야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        480.9525146484375,
        444.95953369140625,
        492.59625244140625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 화장품 성분의 화학구조에 따라 물리․화학적 반응 및 생물학적 반응이 결정되며 화학적 순",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        504.83251953125,
        538.43994140625,
        516.4762573242188
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "도, 조성 내의 다른 성분들과의 상호작용 및 피부투과 등은 효능과 안전성 및 안정성에 영",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        524.6325073242188,
        538.5599365234375,
        536.2762451171875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "향을 미칠 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        544.4324951171875,
        180.59957885742188,
        556.0762329101562
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 화장품 성분의 상호작용으로 인해 유해물질 발생(예를 들면, 니트로소아민 형성) 가능성과",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        568.1925048828125,
        543.9596557617188,
        579.8362426757812
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식물유래 및 동물에서 추출한 성분에 농약, 살충제, 금속물질 및 생물학적 유해물질이 함",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        587.9924926757812,
        538.43994140625,
        599.63623046875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유되어 있을 가능성에 특별한 주의를 기울여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        607.79248046875,
        345.4555969238281,
        619.4362182617188
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6) 피부를 투과한 화장품 성분은 국소 및 전신작용에 영향을 미칠 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        631.552490234375,
        443.8556213378906,
        643.1962280273438
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7) 화장품의 안전성은 각 성분의 독성학적 특징과 유사한 조성의 제품을 사용한 경험, 신물질",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        655.4324951171875,
        538.5596313476562,
        667.0762329101562
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 함유 여부 등을 참고하여 전반적으로 검토한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        675.2324829101562,
        334.5356140136719,
        686.876220703125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8) 화장품에 대한 안전성은 특정 소비자(영유아, 민감성 피부 등) 대상 여부, 피부 투과 혹은",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        698.9924926757812,
        543.9596557617188,
        710.63623046875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부 자극을 증가시킬 수 있는 특정 성분(피부투과 강화제, 유기 용제, 산성 성분 등) 존재",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.23999786376953,
        718.79248046875,
        543.9596557617188,
        730.4362182617188
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여부, 독성학적 우려가 예측되는 성분 간의 화학반응 유무 등 추가 정보를 고려하여 평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.23999786376953,
        738.5924682617188,
        538.5599365234375,
        750.2362060546875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.23999786376953,
        758.3925170898438,
        108.71955871582031,
        770.0362548828125
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 5 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        285.1199951171875,
        786.5027465820312,
        310.0413513183594,
        799.4507446289062
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제3장 화장품 위해평가",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        71.39431762695312,
        214.9199981689453,
        91.34548950195312
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 위해평가 절차 및 수행에 필요한 일반사항",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        125.45460510253906,
        326.5205078125,
        142.69241333007812
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1-1. 위해평가 절차",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        175.0994415283203,
        161.39999389648438,
        191.0603790283203
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할 수 있는 위해 영향과 발생확",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        218.15249633789062,
        538.5599365234375,
        229.79624938964844
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "률을 과학적으로 예측하는 위해평가는 위험성 확인, 위험성 결정, 노출평가, 위해도 결정의 4",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        237.95248413085938,
        538.5599975585938,
        249.5962371826172
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단계의 과정을 거쳐 실시한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        257.75250244140625,
        215.015625,
        269.396240234375
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 위험성 확인(Hazard Identification) : 위해요소에 노출됨에 따라 인체 건강에 위해한 영향",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        295.552490234375,
        538.5599365234375,
        307.19622802734375
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 미칠 가능성에 대하여 물질의 고유한 물리화학적 특성, 독성의 정도 및 그 영향 등을",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        82.08000183105469,
        315.3525085449219,
        543.9600219726562,
        326.9962463378906
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "파악하는 과정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        82.08000183105469,
        335.1524963378906,
        153.59999084472656,
        346.7962341308594
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 위험성 결정(Hazard Characterization) : 노출과 독성반응에 대한 관계를 평가하는 단계로 주",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        359.0325012207031,
        538.43994140625,
        370.6762390136719
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 실험동물을 이용한 독성시험 결과 등으로부터 독성기준값을 결정하는 과정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.47999572753906,
        378.8324890136719,
        468.96044921875,
        390.4762268066406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 노출평가(Exposure Assessment) : 화장품의 사용으로 인해 위해요소에 노출되는 양 또는",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        402.5924987792969,
        543.9596557617188,
        414.2362365722656
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "노출 수준을 정량적 산출하는 과정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        82.31999969482422,
        422.39251708984375,
        258.3599853515625,
        434.0362548828125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 위해도 결정(Risk Characterization) : 위해요소 및 이를 함유한 화장품의 사용에 따라 독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        446.1524963378906,
        538.5599365234375,
        457.7962341308594
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준값 및 노출량을 고려하여 사람에게 미칠 수 있는 위해의 정도 등을 정량적으로 예측",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.1199951171875,
        465.9525146484375,
        538.5599365234375,
        477.59625244140625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 과정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.1199951171875,
        485.75250244140625,
        136.1999969482422,
        497.396240234375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 6 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        285.1199951171875,
        786.5027465820312,
        310.0413513183594,
        799.4507446289062
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1-2. 위해평가 수행에 필요한 일반사항",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        269.3999938964844,
        87.98039245605469
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해평가 수행에 필요한 일반사항은 다음과 같으며, 위해요소 특성에 따라 예외가 있을 수",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        115.19249725341797,
        543.9596557617188,
        126.83625030517578
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        134.99249267578125,
        94.08032989501953,
        146.63624572753906
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 위해평가 시 본 가이드라인을 체크리스트로 간주할 수 없으며, 화장품 성분의 특성에 따",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        168.83248901367188,
        538.43994140625,
        180.4762420654297
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라 사례별(case-by-case)로 평가하는 것이 바람직하다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.83999633789062,
        188.6324920654297,
        354.57562255859375,
        200.2762451171875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 독성자료는 OECD 가이드라인 등 국제적으로 인정된 프로토콜에 따른 시험을 우선적으로",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        212.39248657226562,
        543.9609985351562,
        224.03623962402344
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려할 수 있으며, 과학적으로 타당한 방법으로 수행된 자료인 경우에 활용 가능하다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.83999633789062,
        232.19248962402344,
        507.0956115722656,
        243.83624267578125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 반복투여독성시험, 생식독성시험 등 독성시험 자료가 충분하지 않거나 시험결과의 신뢰성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        255.95249938964844,
        543.9596557617188,
        267.59625244140625
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확인 등 독성시험 자료가 제한적인 경우, 위험성 확인 단계에서 자료 부족임을 명시하고",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.83999633789062,
        275.75250244140625,
        544.0796508789062,
        287.396240234375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전역 산출을 하지 않을 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.83999633789062,
        295.552490234375,
        255.2156219482422,
        307.19622802734375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 평가성분은 화장품 중 다른 성분에 의해 피부투과에 영향을 받을 수 있으므로 피부흡수",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        319.4324951171875,
        538.5596313476562,
        331.07623291015625
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "율, 감작성 등을 평가할 때, 성분 자체만이 아니라 매질 등의 영향도 고려해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.1199951171875,
        339.2325134277344,
        507.69561767578125,
        350.8762512207031
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 노출평가는 여러 상황을 고려하여 현실적인 노출시나리오를 작성한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        362.99249267578125,
        441.47955322265625,
        374.63623046875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6) 결과보고서는 관련 자료의 불확실성 등을 고려하여 정량적 또는 정성적으로 표현할 수 있",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        386.75250244140625,
        538.43994140625,
        398.396240234375
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으나 과학적으로 가능한 범위 내에서 정량화한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.72000122070312,
        406.552490234375,
        337.5595397949219,
        418.19622802734375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 위해평가 결과는 새로운 독성시험 결과가 보고되는 등 새로운 과학적 사실이 밝혀지는 경",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        430.4324951171875,
        538.43994140625,
        442.07623291015625
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우, 재평가할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.1199951171875,
        450.2325134277344,
        191.49562072753906,
        461.8762512207031
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1-3. 위해평가 대상",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        492.85943603515625,
        161.39999389648438,
        508.82037353515625
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 관련 규정에 따라 국민보건상 위해 우려가 제기되는 화장품 원료, 화장품 사용한도 원료",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        535.4324951171875,
        543.9596557617188,
        547.0762329101562
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 위해평가 대상으로 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.95999908447266,
        555.2324829101562,
        238.91957092285156,
        566.876220703125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 비의도적 오염물질의 검출허용한도 설정이 필요한 경우에 위해평가를 수행할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        578.9924926757812,
        507.93560791015625,
        590.63623046875
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 7 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        285.1199951171875,
        786.5027465820312,
        310.0413513183594,
        799.4507446289062
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1-4. 위해요소별 위해평가 유형",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        227.39999389648438,
        87.98039245605469
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 위해평가는 위해요소의 용도(화장품 성분 등 의도적 사용물질, 중금속 등 비의도적 오염물",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        115.19249725341797,
        538.5596313476562,
        126.83625030517578
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질)에 따라 구분하여 평가한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.1199951171875,
        134.99249267578125,
        241.44033813476562,
        146.63624572753906
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 의도적 사용물질로 유전독성 등이 확인되는 경우, 위험성 확인에서 위해평가를 종료하며,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        158.7524871826172,
        544.07958984375,
        170.396240234375
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비발암물질, 비유전독성 발암물질과 같이 독성영향이 역치를 가진다고 추정되는 경우에는",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.72000122070312,
        178.552490234375,
        543.9592895507812,
        190.1962432861328
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해도를 결정한다(그림 1).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.72000122070312,
        198.3524932861328,
        223.55905151367188,
        209.99624633789062
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 비의도적 오염물질과 같이 완전히 제거할 수 없는 경우에는 오염도를 측정하여 노출량을",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        222.2324981689453,
        543.9592895507812,
        233.87625122070312
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산출하고 위해평가를 수행한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.95999908447266,
        242.03248596191406,
        238.8956298828125,
        253.67623901367188
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그림 1. 화장품 성분(의도적 사용물질)의 위해성평가 흐름도",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.87999725341797,
        568.1925048828125,
        415.1996765136719,
        579.8362426757812
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 8 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        285.1199951171875,
        786.5027465820312,
        310.0413513183594,
        799.4507446289062
      ],
      "page_num": 14,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 위해평가 방법",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        71.81460571289062,
        157.55999755859375,
        89.05242156982422
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2-1. 위해평가 사전 검토사항",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        119.179443359375,
        215.39999389648438,
        135.140380859375
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 위해평가를 수행하기 전, 관련 평가 이력 등 배경을 충분히 검토한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        160.552490234375,
        430.29559326171875,
        172.1962432861328
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 위해평가 시 요구되는 관련 자료 등에 대해 검토한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        184.3125,
        350.3756103515625,
        195.9562530517578
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 화장품 사용량은 위해요소의 특성과 위해평가의 목적, 평가대상에 적합한 자료를 활용한",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        208.07249450683594,
        538.4396362304688,
        219.71624755859375
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다(붙임 5 참고).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.68000030517578,
        226.79249572753906,
        170.01510620117188,
        238.43624877929688
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 유해물질 모니터링 자료를 사용하는 경우, 위해평가를 목적으로 수행된 시험자료를 활용하",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        249.5924835205078,
        538.5599365234375,
        261.2362365722656
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 것이 가장 좋으나 기존의 자료들도 활용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        269.39251708984375,
        356.3756103515625,
        281.0362548828125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 개별적으로 실시한 여러 시험결과를 하나의 위해평가에 활용할 경우에는 시험목적, 시료채",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        293.1524963378906,
        538.4404907226562,
        304.7962341308594
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "취범위, 전처리방법, 분석기기, 정량한계 등을 고려하여 동질성이 인정된 값을 활용한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.31999969482422,
        311.87249755859375,
        524.8556518554688,
        323.5162353515625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 정량한계(Limit of Quantification, LOQ) 이하 값인 경우 시료 수와 LOQ 이하 값의 분포",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        334.552490234375,
        538.4396362304688,
        346.19622802734375
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 따라 0 또는 LOQ/2로 처리한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.79999542236328,
        353.2724914550781,
        265.4156188964844,
        364.9162292480469
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 특정 목적으로 수행된 분석 자료는 일반적인 노출평가를 위한 자료에서 제외한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        376.072509765625,
        503.3756103515625,
        387.71624755859375
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 9 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        285.1199951171875,
        786.5027465820312,
        310.0413513183594,
        799.4507446289062
      ],
      "page_num": 15,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2-2. 위해평가 단계별 수행절차",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        227.39999389648438,
        87.98039245605469
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2-2-1. 위험성 확인",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        118.30429077148438,
        152.15965270996094,
        132.9883575439453
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 위험성 확인은 평가대상 물질에 대하여 최근까지 보고된 국내외 자료들을 조사·분석하여",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        155.99249267578125,
        544.0797119140625,
        167.63624572753906
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질이 인체 건강에 유해한 영향을 미칠 가능성이 있는지 확인하는 단계이다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.95999908447266,
        175.79249572753906,
        468.2156066894531,
        187.43624877929688
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "① 물질의 식별정보, 물리화학적 특성 및 고유한 독성학적 특성을 고려하여 in vitro 및  in",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        199.552490234375,
        547.2388305664062,
        211.1962432861328
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "vivo, 임상자료, 역학자료 등 현재 이용할 수 있는 모든 독성자료를 종합적으로 검토한",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        89.1619644165039,
        219.3524932861328,
        538.5596313476562,
        230.99624633789062
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        89.87999725341797,
        239.15249633789062,
        109.31956481933594,
        250.79624938964844
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 독성정보는 해외 화장품 위해평가 기관(유럽 소비자안전과학위원회(Scientific Committee",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        263.0325012207031,
        543.9605102539062,
        274.6762390136719
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "on Consumer Safety, SCCS) 등에서 발간한 보고서나 평가원에서 생산된 자료를 활용할",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.23999786376953,
        282.83251953125,
        543.9596557617188,
        294.47625732421875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있으며, 붙임 10의 사이트를 참고하여 수집할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.23999786376953,
        302.63250732421875,
        387.59954833984375,
        314.2762451171875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 독성자료의 경우, OECD 등 국제적 인정기관에서 독성시험 설계 및 수행에 필요한 최소",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        326.39251708984375,
        538.5599365234375,
        338.0362548828125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준에 관한 표준지침을 제공하고 있으므로 이를 참조하여 검토한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.79999542236328,
        346.1925048828125,
        438.0956115722656,
        357.83624267578125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 독성영향은 인체에서의 생물학적 영향과의 연관성이 있는지를 판단한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        369.9525146484375,
        449.40032958984375,
        381.59625244140625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 위험성 확인에서 전신영향(Systemic effect) 또는 국소영향(Local effect)(예: 피부, 눈 자극,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        393.8324890136719,
        544.07958984375,
        405.4762268066406
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부 과민성, 폐 영향)을 검토한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        413.63250732421875,
        258.47955322265625,
        425.2762451171875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 위험성 확인에 필요한 자료는 다음과 같다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        437.39251708984375,
        295.4156188964844,
        449.0362548828125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "① 물리화학적 성질 : 검토 대상 성분의 물리화학적 특성은 물질의 독성을 예측할 수 있는",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        461.1524963378906,
        543.9596557617188,
        472.7962341308594
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중요한 정보이다. 검토 대상 성분의 물질명(INCI명, IUPAC명), CAS 번호, 화학식, 분자량,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        89.15999603271484,
        480.9525146484375,
        543.9603881835938,
        492.59625244140625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구조식, 물리화학적 성질(성상, 녹는점, 끓는점, 밀도, 증기압, pH, 용해도, Log Pow)과",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        89.15999603271484,
        500.75250244140625,
        543.9596557617188,
        512.396240234375
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "같은 정보가 포함된다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        89.15999603271484,
        520.552490234375,
        202.05563354492188,
        532.1962280273438
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 흡수·분포·대사·배설(ADME) : 체내에서 검토 대상 성분의 안전성에 대해 설명하기",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        544.4324951171875,
        543.9592895507812,
        556.0762329101562
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해 독성동태학 자료(OECD 417)를 이용할 수 있다. 검토 대상 성분의 체내 흡수, 분포,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.91999816894531,
        564.2324829101562,
        543.9603881835938,
        575.876220703125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대사, 배설에 대한 정보는 독성 가능성을 예측할 수 있으며 독성연구 해석에 도움을 줄",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.91999816894531,
        584.032470703125,
        543.9600219726562,
        595.6762084960938
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.91999816894531,
        603.83251953125,
        135.83956909179688,
        615.4762573242188
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "③ 피부흡수 : 화장품 성분의 피부흡수는 통과(penetration), 침투(permeation), 흡수",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        627.5924682617188,
        538.5599365234375,
        639.2362060546875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(resorption) 세 단계의 과정으로 이루어진다. 화장품 성분은 혈관과 림프관에 도달하기",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.79999542236328,
        647.3925170898438,
        543.9596557617188,
        659.0362548828125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해서 여러 층의 피부조직을 통과하게 되며, 이때 물질의 피부흡수율을 결정하는 층",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.79999542236328,
        667.1925048828125,
        538.5599365234375,
        678.8362426757812
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(rate-determining layer)은 각질층이다. 화장품 성분에 대한 피부흡수 연구는 화장품의",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.79999542236328,
        686.9924926757812,
        544.0796508789062,
        698.63623046875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용조건에서 인체의 전신 구획(systemic compartment)으로 들어가는 화합물의 정성적",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.79999542236328,
        706.79248046875,
        544.0796508789062,
        718.4362182617188
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 정량적 정보를 얻는 목적으로 수행되며 안전역(margin of safety) 산출에 반영된다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.79999542236328,
        726.5924682617188,
        528.7196044921875,
        738.2362060546875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "④ 독성자료 : 검토 대상 성분의 독성연구를 기반으로 화장품 성분의 독성 가능성을 확인할",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        750.3524780273438,
        544.0796508789062,
        761.9962158203125
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 10 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있다. 사람과 동일한 노출경로(국소, 경구, 흡입 경로)에 해당하는 독성 데이터를 조",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        89.4000015258789,
        70.79249572753906,
        538.43994140625,
        82.43624877929688
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사하여 수집한다. 독성자료에는 다음과 같은 독성연구가 포함된다(SCCS/1628/21, 2021).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        89.4000015258789,
        90.59249114990234,
        527.615478515625,
        102.23624420166016
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(a) 단회투여독성 : 경구, 피부, 흡입 경로를 통해 물질에 1회 노출됨에 따라 건강과 관련",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        114.35249328613281,
        538.5599365234375,
        125.99624633789062
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여 발생할 수 있는 이상반응을 설명하는데 사용되며, LD50 값을 결정하기 위한 목적",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        98.87999725341797,
        134.15249633789062,
        538.5599365234375,
        146.34280395507812
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 개발되었다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        98.87999725341797,
        153.95249938964844,
        189.83956909179688,
        165.59625244140625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(b) 반복투여독성 : 물질을 장기간(28일/90일/24개월)에 걸쳐 매일 반복하여 투여하거나 노",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        177.83248901367188,
        538.5599365234375,
        189.4762420654297
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "출됨에 따라 나타나는 일반적인 독성영향(생식독성, 유전독성, 발암성 효과 제외)을 말",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        98.75999450683594,
        197.6324920654297,
        538.43994140625,
        209.2762451171875
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        98.75999450683594,
        217.4324951171875,
        123.81562042236328,
        229.0762481689453
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(c) 피부부식성, 피부자극성, 안점막자극성, 피부감작성 : 검토 대상 성분이 피부 또는 안",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        241.19248962402344,
        538.5599365234375,
        252.83624267578125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "점막에 노출되어 표피 또는 진피 내부, 각막에 나타나는 손상으로 피부에 나타나는 독",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.23999786376953,
        260.99249267578125,
        538.5599365234375,
        272.63623046875
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성 영향을 말한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.23999786376953,
        280.7925109863281,
        190.17562866210938,
        292.4362487792969
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(d) 생식발생독성 : 물질로 인해 포유류 생식의 모든 측면에 발생하는 유해 영향으로 남성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        304.552490234375,
        538.5599365234375,
        316.19622802734375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/여성의 생식기능 장애, 자손에 유전되지 않는 유해영향 발생(예: 사망, 성장지연, 구조",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.23999786376953,
        324.3525085449219,
        543.9596557617188,
        335.9962463378906
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 기능적 영향)을 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.23999786376953,
        344.1524963378906,
        248.6395721435547,
        355.7962341308594
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(e) 유전독성 : DNA의 구조나 정보, 분리의 변화를 일으키는 과정으로 물질에 의해 정상",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        368.0325012207031,
        538.4396362304688,
        379.6762390136719
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적인 복제과정이 방해되어 DNA 손상을 일으키거나 비생리적 방식으로 복제를 변경하",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.23999786376953,
        387.8324890136719,
        538.5596313476562,
        399.4762268066406
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 경우를 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.23999786376953,
        407.63250732421875,
        206.6403350830078,
        419.2762451171875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(f) 발암성 : 흡입, 경구, 피부 도포, 주사(injection)를 통해 종양(양성 또는 악성)을 유발하",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        431.39251708984375,
        538.5596313476562,
        443.0362548828125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거나 종양의 발생률과 악성도 증가, 종양 발생 시간을 단축하는 물질을 발암물질로 정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.23999786376953,
        451.1925048828125,
        538.5599365234375,
        462.83624267578125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의한다. 발암물질은 DNA와의 상호작용과 돌연변이 유발을 통해 암을 발생시키는 유전",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.23999786376953,
        470.99249267578125,
        538.5599365234375,
        482.63623046875
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성 발암물질과 DNA 손상이 아닌 다른 메커니즘을 통해 암을 유발하는 비유전독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.23999786376953,
        490.7925109863281,
        544.0796508789062,
        502.4362487792969
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발암물질로 분류된다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.23999786376953,
        510.592529296875,
        212.16033935546875,
        522.2362670898438
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(g) 기타 독성 : 면역독성, 신경독성, 광독성 등을 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        534.3524780273438,
        380.9756164550781,
        545.9962158203125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 면역독성 : 화학물질에 대한 면역 체계 손상, 면역 반응 등을 평가한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        558.2324829101562,
        464.3756103515625,
        569.876220703125
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 신경독성 : 화학물질에 의한 행동장애, 신경 손상, 뇌의 손상 등을 평가한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        581.9924926757812,
        490.17559814453125,
        593.63623046875
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 광독성 : 세포독성을 유발하지 않는 용량 수준에서 자외선/가시광선의 비세포독성 용",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        605.7525024414062,
        538.5599365234375,
        617.396240234375
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "량에 따른 노출/비노출 상태에서 화학물질의 세포독성 여부로 평가한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        105.23999786376953,
        625.552490234375,
        469.05560302734375,
        637.1962280273438
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 11 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 위험성 확인 방법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        74.75249481201172,
        176.1599884033203,
        86.39624786376953
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주요내용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        147.59999084472656,
        107.71974182128906,
        412.9195251464844,
        120.96732330322266
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검토방법",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        147.59999084472656,
        107.71974182128906,
        412.9195251464844,
        120.96732330322266
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 물리화학적 특성 조사",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        134.71974182128906,
        179.52000427246094,
        147.96731567382812
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ Pubchem 등 물리화학적 특성 정보 사이트",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        280.79998779296875,
        156.3197479248047,
        508.4610900878906,
        169.56732177734375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검색",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        295.79998779296875,
        172.2797393798828,
        319.2215576171875,
        185.52731323242188
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 공개된 논문 정보, 국제기구(WHO, FAO, IPCS,",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        280.79998779296875,
        193.2797393798828,
        508.46185302734375,
        206.52731323242188
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IARC) 및 관련기관(EPA, FDA, EU 집행위, 일본",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        295.79998779296875,
        209.23974609375,
        508.58154296875,
        222.48731994628906
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "후생성 등)에서 발간된 보고서 등 독성정보",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        295.79998779296875,
        225.31973266601562,
        508.5805969238281,
        238.5673065185547
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조사",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        295.79998779296875,
        241.2797393798828,
        315.719970703125,
        254.52731323242188
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 국제기구 및 외국 독성평가 기관에서 제시하고",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        280.79998779296875,
        262.2797546386719,
        508.4618835449219,
        275.5273132324219
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있는 지침서를 참고하여 시험 결과에 대한 증",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        295.79998779296875,
        278.23974609375,
        504.9599914550781,
        291.4873046875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거가중치(Weight of Evidence, WoE) 고려",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        295.79998779296875,
        294.31976318359375,
        480.6004333496094,
        307.56732177734375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 피부흡수율 자료, ADME(흡수, 분포, 대사,",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        158.83973693847656,
        274.1014099121094,
        172.08731079101562
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배설, 체내 축적성) 자료 조사",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        79.55999755859375,
        174.79974365234375,
        214.6800079345703,
        188.0473175048828
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 독성자료 조사",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        195.91973876953125,
        144.48001098632812,
        209.1673126220703
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 단회투여독성, 반복투여독성, 피부자극성,",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        211.99974060058594,
        274.1014099121094,
        225.247314453125
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안점막자극성, 피부감작성, 생식발생독성,",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        79.55999755859375,
        227.95973205566406,
        274.1014099121094,
        241.20730590820312
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전독성, 발암성, 광독성 등",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        79.55999755859375,
        243.91973876953125,
        208.9199981689453,
        257.1673278808594
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 발암성이 있는 경우, 임상 및 동물실험",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        259.999755859375,
        273.9810791015625,
        273.247314453125
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과 등을 검토하여 발암성 판단 근거자",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        79.55999755859375,
        275.9597473144531,
        270.4795227050781,
        289.2073059082031
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "료를 확보",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        79.55999755859375,
        291.91973876953125,
        124.43999481201172,
        305.16729736328125
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 인체역학연구 결과, 독성동태자료 등",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        315.91973876953125,
        246.72000122070312,
        329.16729736328125
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 유럽은 화장품 규정 개정에 따라 화장품 성분에 대한 in vivo 동물실험은 더이상 수행할 수 없다.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        341.444580078125,
        462.7637634277344,
        353.415283203125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 국내의 경우, 「화장품법」 제15조의2(동물실험을 실시한 화장품 등의 유통판매 금지)에 따라 동물실험이 금지되어있",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        56.63999938964844,
        359.8045959472656,
        538.4390869140625,
        371.7752990722656
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으나, 제8조제2항의 보존제, 색소, 자외선차단제 등 특별히 사용상의 제한이 필요한 원료의 경우 또는 동물대체시험",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        68.4000015258789,
        374.20458984375,
        538.4390869140625,
        386.17529296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "법이 존재하지 않는 경우, 다른 법령에 따라 동물실험을 실시하여 개발된 원료를 화장품의 제조 등에 사용하는 경우",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        68.4000015258789,
        388.6045837402344,
        541.7237548828125,
        400.5752868652344
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등 동물시험이 허용되는 예외 조항이 있다.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        68.4000015258789,
        403.00457763671875,
        240.4087371826172,
        414.97528076171875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 12 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2-2-2. 위험성 결정",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.22429656982422,
        152.15965270996094,
        86.90835571289062
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 위험성 결정은 평가대상 물질의 인체 또는 동물 독성자료 등을 토대로 위해도 결정에 사",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        111.23249053955078,
        538.5599365234375,
        122.8762435913086
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용되는 독성기준값(Point Of Departure, POD)을 선정하는 단계이다. 독성기준값(POD)는 모",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        131.03250122070312,
        538.5599365234375,
        142.67625427246094
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "든 독성 작용, 용량-반응 관계, 예상 역치를 검토하여, NOAEL, LOAEL, BMDL 등이 사용",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        150.83248901367188,
        538.5599365234375,
        162.4762420654297
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "된다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        170.6324920654297,
        103.65562438964844,
        182.2762451171875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 무독성용량(No Observed Adverse Effect Level, NOAEL) : 투여 시 유해영향이 관찰되지 않는",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        194.39248657226562,
        544.0805053710938,
        206.03623962402344
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최고 용량/노출 수준으로 정의되며, 역치가 존재하는 영향의 경우에 사용한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.63999938964844,
        214.19248962402344,
        455.0155944824219,
        225.83624267578125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 최소독성용량(Lowest Observed Adverse Effect Level, LOAEL) : 실험 동물 또는 사람에서",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        237.95248413085938,
        543.9596557617188,
        249.5962371826172
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정 물질에 의해 독성이 관찰되는 최소한의 농도로 정의되며, NOAEL을 확인할 수 없는",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.87999725341797,
        257.75250244140625,
        543.9596557617188,
        269.396240234375
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우에 사용한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.87999725341797,
        277.5525207519531,
        166.41563415527344,
        289.1962585449219
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 벤치마크용량(Benchmark Dose, BMD) : 용량-반응 모델을 근거로 계산되는 값으로, 어떤",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        301.4324951171875,
        544.0800170898438,
        313.07623291015625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성에 대해 사전에 정한 척도나 생물학적 영향(Benchmark Rresponse level, BMR)의 변화",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.72000122070312,
        321.2325134277344,
        538.5599365234375,
        332.8762512207031
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 대조군에 비해 5% 또는 10%의 유해한 영향이 나타나는 용량으로 정의된다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.72000122070312,
        341.0325012207031,
        543.9595947265625,
        352.6762390136719
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BMDL(Benchmark Dose Lower confidence limit)은 BMD의 95% 신뢰구간의 하한치를 의미",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.72000122070312,
        360.8324890136719,
        538.5599365234375,
        372.4762268066406
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.72000122070312,
        380.63250732421875,
        106.77561950683594,
        392.2762451171875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 일반적으로 경구, 피부 또는 흡입 노출 등 경로별 모든 독성정보를 종합적으로 검토하되",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        404.39251708984375,
        543.9596557617188,
        416.0362548828125
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화장품 사용에 따른 노출 경로 자료를 우선으로 고려할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        424.1925048828125,
        411.3595275878906,
        435.83624267578125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 확실한 경피독성 연구가 없는 경우, 경구 90일(13주) 반복투여독성시험 또는 생식발생독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        447.9525146484375,
        538.5596313476562,
        459.59625244140625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험 결과를 전신 독성기준값(PODsys)으로 결정한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.1199951171875,
        467.75250244140625,
        347.40032958984375,
        479.94281005859375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 흡입 경로에 대한 독성 특이성이 있는 물질의 경우, 흡입 독성기준값을 사용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        491.63250732421875,
        525.8156127929688,
        503.2762451171875
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 시험방법, 독성기준값 등을 고려하여 불확실성 계수로 보정할 수 있다. 예를 들어,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        515.3925170898438,
        501.35955810546875,
        527.0362548828125
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·투여방식이 주당 5일 처치인 경우에는 5/7의 계수로 보정된 독성기준값(POD)를 사용하여",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        539.1525268554688,
        543.9592895507812,
        550.7962646484375
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일일 노출을 보정할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.15999603271484,
        558.9525146484375,
        226.05563354492188,
        570.5962524414062
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "·독성기준값(POD)이 LOAEL에 기초하는 경우에는 3의 불확실성 계수를 추가로 적용하여",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        582.83251953125,
        543.9592895507812,
        594.4762573242188
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보정할 수 있다. 단, 반복투여독성시험에서 용량 간격, 용량-반응 곡선의 형태 및 기울기",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.15999603271484,
        602.6325073242188,
        538.5599365234375,
        614.2762451171875
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 고려하여 사례별(case-by-case)로 불확실성 계수를 1~10까지 조절하여 적용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.15999603271484,
        622.4324951171875,
        539.88037109375,
        634.0762329101562
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·90일(13주) 반복투여독성시험 결과가 유효하지 않은 경우, 28일 반복투여독성시험 결과에",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        646.1925048828125,
        538.5596313476562,
        657.8362426757812
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서 얻은 NOAEL에 사례별(case-by-case)로 1-10의 불확실성 계수를 추가로 적용하여 보정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.15999603271484,
        665.9924926757812,
        538.4396362304688,
        677.63623046875
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.15999603271484,
        685.79248046875,
        143.5203399658203,
        697.4362182617188
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 13 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 위험성 결정 방법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        161.1599884033203,
        86.39624786376953
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주요내용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        152.16000366210938,
        107.71974182128906,
        417.4795227050781,
        120.96732330322266
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검토방법",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        152.16000366210938,
        107.71974182128906,
        417.4795227050781,
        120.96732330322266
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 물질에 대한 POD(NOAEL, LOAEL, BMDL",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        142.87974548339844,
        269.0621337890625,
        156.1273193359375
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등) 조사",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        79.55999755859375,
        158.83973693847656,
        117.47999572753906,
        172.08731079101562
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ WHO, 미국, 일본, 호주, 캐나다 등 선진국",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        289.91998291015625,
        134.83973693847656,
        501.7410888671875,
        148.08731079101562
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료 활용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        304.91998291015625,
        150.79974365234375,
        349.79998779296875,
        164.0473175048828
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 인체 독성시험자료 또는 동물 독성시험",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        289.91998291015625,
        169.87974548339844,
        487.5805969238281,
        183.1273193359375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료를 활용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        304.91998291015625,
        185.83973693847656,
        359.8795166015625,
        199.08731079101562
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 전신 독성기준값(PODsys) 결정",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        219.31973266601562,
        214.91952514648438,
        232.89720153808594
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 시험방법, 독성기준값 등을 고려하여 불확",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        257.3597412109375,
        279.6004333496094,
        270.6072998046875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실성 계수 적용 가능",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        79.55999755859375,
        273.31976318359375,
        172.1999969482422,
        286.56732177734375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 경구 생체이용률(Bioavailability, BA) 적용 가능",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        311.3597412109375,
        278.6399230957031,
        324.6072998046875
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 가장 타당한 독성시험으로부터 가장 민감한",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        289.91998291015625,
        210.79974365234375,
        508.4610900878906,
        224.0473175048828
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "독성기준값 선택",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        305.3999938964844,
        226.75973510742188,
        380.3995056152344,
        240.00730895996094
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 독성기준값 선택은 체중감소, 장기무게 감",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        289.91998291015625,
        245.83973693847656,
        504.9599914550781,
        259.0873107910156
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소, 조직학적 변화, 그 밖의 독성시험 결과",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        305.3999938964844,
        261.79974365234375,
        508.4615478515625,
        275.04730224609375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 인체 역학결과 등을 활용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        305.3999938964844,
        277.759765625,
        435.3599853515625,
        291.00732421875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 불확실성 적용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        289.91998291015625,
        296.8397521972656,
        368.1599426269531,
        310.0873107910156
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- LOAEL 활용하는 경우 : 3 고려, 사례별",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        289.91998291015625,
        315.79974365234375,
        504.9595031738281,
        329.04730224609375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(case-by-case)로 불확실성 계수 1~10 적용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        304.91998291015625,
        331.759765625,
        508.5810852050781,
        345.00732421875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가능",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        304.91998291015625,
        347.8397521972656,
        324.8399963378906,
        361.0873107910156
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 90일(13주) 반복투여독성시험 자료가 유효",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        289.91998291015625,
        366.79974365234375,
        504.96044921875,
        380.04730224609375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하지 않는 경우 : 사례별(case-by-case)로 결",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        304.32000732421875,
        382.759765625,
        504.9599914550781,
        396.00732421875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정되며 불확실성 계수 1~10을 추가로 적용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        304.32000732421875,
        398.8397521972656,
        508.4615478515625,
        412.0873107910156
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가능",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        304.32000732421875,
        414.79974365234375,
        324.239990234375,
        428.04730224609375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 유효한 경구 생체이용률(BA) 자료가 있는 경우,",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        289.91998291015625,
        433.7597351074219,
        508.4618835449219,
        447.0072937011719
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경구 독성결과에 생체이용률(BA) 적용 가능",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        304.91998291015625,
        449.8397521972656,
        503.3995056152344,
        463.0873107910156
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 14 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 20,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2-2-3. 노출평가",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.22429656982422,
        135.7196502685547,
        86.90835571289062
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 노출평가는 최종 제품에서의 사용량, 사용 빈도, 노출경로(경구, 피부, 흡입 등) 등을 기반",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        111.23249053955078,
        538.5599365234375,
        122.8762435913086
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 일반적 또는 합리적으로 예측 가능한 시나리오를 설정하여 이에 따른 화장품 성분의",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        131.03250122070312,
        544.0796508789062,
        142.67625427246094
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인체노출량을 정량적으로 산출하는 단계이다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        150.83248901367188,
        307.05560302734375,
        162.4762420654297
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 효율적인 노출평가를 위해서 단계적 접근방법으로 평가할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        174.59249877929688,
        421.9195251464844,
        186.2362518310547
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 초기에는 보수적인 노출상황을 가정한 시나리오를 적용하여 평가하며, 보수적인 노출상황",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        198.3524932861328,
        538.5596923828125,
        209.99624633789062
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서 안전성이 확인되면 이후 실제 상황을 반영한 노출평가는 생략할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        82.79999542236328,
        218.15249633789062,
        477.4555969238281,
        229.79624938964844
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 보수적 노출상황을 가정한 평가에서 위해 발생이 우려되면 실제 노출상황을 가정한 노출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        242.03248596191406,
        538.5599365234375,
        253.67623901367188
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시나리오를 적용하여 평가할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.5199966430664,
        261.83251953125,
        273.4555969238281,
        273.47625732421875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 화장품은 유형에 따라 사용방법이 다양하므로 화장품 유형별 사용방법을 고려한 노출시나",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        285.5924987792969,
        538.5596313476562,
        297.2362365722656
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리오를 설정하여 노출평가를 수행한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        79.68000030517578,
        305.39251708984375,
        275.1356201171875,
        317.0362548828125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 유형별로 화장품을 평가할 경우, 붙임 5, 표1에 따라 화장품 유형별 사용량을 고려하여",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        329.1524963378906,
        543.9592895507812,
        340.7962341308594
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.27999877929688,
        348.9525146484375,
        163.17562866210938,
        360.59625244140625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 자외선차단제에 대한 통합 일일사용량은 17.0 g/day를 적용할 수 있다(붙임 5, 2항 참고).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        372.8324890136719,
        531.215087890625,
        384.4762268066406
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 화장품 전유형 및 보존제에 대한 통합 일일사용량은 16.9 g/day를 적용할 수 있다(붙임 5,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        396.5924987792969,
        544.07958984375,
        408.2362365722656
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표2 참고).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        416.39251708984375,
        133.53543090820312,
        428.0362548828125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 피부 단위면적당 노출량을 평가할 경우, 체표면적은 붙임 4에서 제시된 값을 적용할 수",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        440.1524963378906,
        543.9596557617188,
        451.7962341308594
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.75999450683594,
        459.9525146484375,
        108.69562530517578,
        471.59625244140625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 전신노출량 산출 시, 잔류지수(retention factor)를 고려할 수 있다(붙임 5 참조).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        483.8324890136719,
        483.0954284667969,
        495.4762268066406
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-‘씻어내는’제품 : 사용법에 따라 씻어내는 제품은 잔류지수(RF)을 측정할 수 있으며, 잔",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        507.592529296875,
        538.5599365234375,
        519.2362670898438
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "류인자를 이용할 수 없는 경우 10%의 잔류지수를 적용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.63999938964844,
        527.3925170898438,
        424.6795349121094,
        539.0362548828125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 영·유아 및 어린이 제품의 노출평가는 다음의 사항을 고려할 수 있다(Renwick, 1998,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        551.1525268554688,
        543.9603881835938,
        562.7962646484375
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SCCS/1628/21, 2021).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.87999725341797,
        570.9525146484375,
        182.73544311523438,
        582.5962524414062
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "① 모든 영·유아 및 어린이 제품 : 체중 대비 피부 표면적의 비율을 고려할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        594.83251953125,
        512.2796020507812,
        606.4762573242188
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 출생 시 신생아의 경우 성인보다 2.3배 높음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        618.5924682617188,
        316.55999755859375,
        630.2362060546875
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 출생 후 6개월 후에는 1.8배 높음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        642.3524780273438,
        261.6000061035156,
        653.9962158203125
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 출생 후 12개월 후에는 1.6배 높음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        666.2324829101562,
        267.1199951171875,
        677.876220703125
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 출생 후 5년 후에는 1.5배 높음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        689.9924926757812,
        250.5599822998047,
        701.63623046875
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 출생 후 10년 후에는 1.3배 높음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        713.7525024414062,
        256.0799865722656,
        725.396240234375
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "② 엉덩이에 사용할 가능성이 높은 제품 : 체계적 노출 용량을 계산할 때, 엉덩이는 민감한",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        737.6325073242188,
        543.9596557617188,
        749.2762451171875
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부분임을 고려하여 100% 피부흡수율을 적용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        89.75999450683594,
        757.4324951171875,
        375.95953369140625,
        769.0762329101562
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 15 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "③ 엉덩이 도포용이 아닌 모든 제품 : 피부흡수에 대한 데이터를 이용할 수 없거나 모델링",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        74.75249481201172,
        538.5599365234375,
        86.39624786376953
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 통한 예측만 존재하는 경우 100% 피부흡수율을 적용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        88.68000030517578,
        94.55249786376953,
        429.81561279296875,
        106.19625091552734
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "④ 일반적으로 10세 이하의 영·유아 및 소아에 대한 불확실성 계수의 추가는 이미 사람",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        118.4324951171875,
        544.0800170898438,
        130.0762481689453
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간 변동성에서 고려되었으므로 필요가 없다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        89.4000015258789,
        138.2324981689453,
        317.7603454589844,
        149.87625122070312
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 16 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 노출평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        117.11965942382812,
        86.39624786376953
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주요내용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        101.15999603271484,
        102.31974029541016,
        366.4795227050781,
        115.56732177734375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수행방법",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        101.15999603271484,
        102.31974029541016,
        366.4795227050781,
        115.56732177734375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 노출시나리오",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        134.59974670410156,
        507.1414794921875,
        150.3673095703125
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 위험에 노출된 대상이 누구이며, 어떻게 노출되었는지를 고려하여",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        134.59974670410156,
        507.1414794921875,
        150.3673095703125
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명확한 노출시나리오 설정",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        204.36000061035156,
        153.07974243164062,
        320.87994384765625,
        166.3273162841797
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 단일 또는 여러 화장품을 함께 사용하는 경우 고려",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        198.1199951171875,
        174.07974243164062,
        437.64044189453125,
        187.3273162841797
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 제품별 특성에 따라 경구, 피부 등 노출 경로 고려",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        198.1199951171875,
        195.07974243164062,
        434.64044189453125,
        208.3273162841797
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 소비자 유형(예, 어린이)에 따른 시나리오 설정",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        198.1199951171875,
        216.07974243164062,
        420.47998046875,
        229.3273162841797
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 적용 방법(예 : 씻어내는 제품, 바르는 제품 등) 고려",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        198.1199951171875,
        237.07974243164062,
        447.719970703125,
        250.3273162841797
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 노출량 산출",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        279.55975341796875,
        423.3604431152344,
        292.80731201171875
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 제품의 종류, 제품 사용방법에 따른 사용량 산출",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        279.55975341796875,
        423.3604431152344,
        292.80731201171875
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 1일 사용횟수",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        198.1199951171875,
        300.55975341796875,
        267.7195129394531,
        313.80731201171875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 1일 사용량 또는 1회 사용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        198.1199951171875,
        321.55975341796875,
        338.2795104980469,
        334.80731201171875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 피부흡수량 또는 피부흡수율",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        190.8000030517578,
        342.55975341796875,
        335.0390319824219,
        355.80731201171875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 제품 사용 시 접촉할 수 있는 피부면적(예 : 입술, 손톱, 목 등)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        189.47999572753906,
        363.55975341796875,
        480.75469970703125,
        376.80731201171875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 흡입에 따른 노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        190.8000030517578,
        384.55975341796875,
        290.8798828125,
        397.80731201171875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 제품 유형, 확산 속도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        189.47999572753906,
        405.55975341796875,
        303.8614807128906,
        418.80731201171875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 17 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2-2-3-1 피부 노출평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        172.3196563720703,
        86.39624786376953
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 피부노출에 의한 전신노출량(systemic exposure dosage, SED)은 일반적으로 대상성분의 농",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.84000015258789,
        110.0324935913086,
        538.5599365234375,
        121.6762466430664
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "도, 특정 성분의 피부흡수, 화장품의 1일 사용량, 사용빈도, 사람의 평균 체중값을 고려하",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.19999694824219,
        129.83248901367188,
        538.5596313476562,
        141.4762420654297
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여 산출한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.19999694824219,
        149.6324920654297,
        139.65562438964844,
        161.2762451171875
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 피부로 노출된 전신노출량(SED)은 제품 중 물질의 단위면적당 피부흡수량(mg/cm2) 또는",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        171.99562072753906,
        544.0800170898438,
        185.03623962402344
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부흡수율(%)로부터 구할 수 있다. 피부흡수율을 이용하는 경우, 결과 값은 피부에 적용",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.95999908447266,
        193.19248962402344,
        538.5599365234375,
        204.83624267578125
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되는 용량 및 면적에 따라 좌우된다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.95999908447266,
        212.99249267578125,
        266.3756103515625,
        224.63624572753906
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 피부흡수율(또는 흡수량)은 사용한도 또는 유사한 용량을 함유하는 제형(formulation)을 사",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        236.7524871826172,
        538.43994140625,
        248.396240234375
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용하여 실제 사용방법을 고려하여(mimicking) in vitro 시험으로부터 선정한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.47999572753906,
        256.5525207519531,
        470.6156005859375,
        268.1962585449219
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 피부흡수율 자료가 없거나 기존에 보고된 자료가 적합하지 않을 경우, 기본값으로 50%를",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        280.4324951171875,
        544.0800170898438,
        292.07623291015625
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용하여 보수적으로 피부흡수율에 적용할 수 있다(SCCS/1628/21, 2021).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.5199966430664,
        300.2325134277344,
        447.215087890625,
        311.8762512207031
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 생체외 피부흡수시험 결과는 가변성이 있기 때문에 일반적으로 인체노출량 계산 시 평균",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        323.99249267578125,
        538.5599365234375,
        335.63623046875
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "값 + 1(또는 2)×표준편차(SD)를 사용한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        84.1199951171875,
        343.7925109863281,
        300.83953857421875,
        355.4362487792969
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부흡수시험 및 결과가 아래와 같은 시험요건의 적정성에 모두 부합하는 경우에 평균 +",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        367.552490234375,
        543.9600219726562,
        379.19622802734375
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1SD를 사용하며, 프로토콜에서 벗어나거나 변동성이 높은 경우에는 평균 + 2SD를 사용한",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        84.1199951171875,
        387.3525085449219,
        538.5596313476562,
        398.9962463378906
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다(SCCS/1628/21, 2021).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        84.1199951171875,
        407.1524963378906,
        200.4954376220703,
        418.7962341308594
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 확산 셀의 설계, 수용액(receptor fluid) 선택, 피부 온도, 피부 온전성 등",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.75999450683594,
        431.0325012207031,
        435.3599853515625,
        442.6762390136719
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 시험물질의 특성 분석을 통해 화장품 제품에 사용되는 성분과 일치",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.75999450683594,
        454.7925109863281,
        438.11968994140625,
        466.4362487792969
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 일반 제형의 시험 물질 최고 농도를 포함한 다양한 농도로 수행",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.75999450683594,
        478.552490234375,
        421.67999267578125,
        490.19622802734375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 사용조건과 동일한 함량 및 제형, 적용량, 피부 접촉시간으로 수행",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.75999450683594,
        502.4324951171875,
        438.5999755859375,
        514.0762329101562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 시험물질의 전체 회수율이 85~115% 범위에 해당",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.75999450683594,
        526.1925048828125,
        342.1199951171875,
        537.8362426757812
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 공여자 4명으로부터 피부 표본 8개 사용",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.75999450683594,
        549.9525146484375,
        300.71966552734375,
        561.5962524414062
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 18 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 피부노출에 의한 전신노출량(SED)은 두가지 방법으로 산출한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        74.75249481201172,
        399.0956115722656,
        86.39624786376953
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "① 단위면적당 피부흡수량(㎍/cm2)을 기초로 한 전신노출량(SED) 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        120.99562072753906,
        420.7200012207031,
        134.03623962402344
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SED =",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        123.95999908447266,
        167.99249267578125,
        160.32000732421875,
        179.63624572753906
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DAa(㎍/cm2) × 10-3mg/㎍ × SSA(cm2) × F(day-1)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        207.47999572753906,
        157.47561645507812,
        459.57000732421875,
        170.63624572753906
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60 (kg)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        316.0799865722656,
        177.83248901367188,
        350.9697265625,
        189.4762420654297
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED (mg/kg bw/day)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.1199951171875,
        216.92062377929688,
        379.6722412109375,
        227.42530822753906
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전신노출량(Systemic Exposure Dosage)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.1199951171875,
        216.92062377929688,
        379.6722412109375,
        227.42530822753906
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DAa (㎍/cm2)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.1199951171875,
        235.25437927246094,
        483.5926513671875,
        247.3162384033203
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가대상 물질의 단위면적당 피부흡수량 (Dermal Absorption)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.1199951171875,
        235.25437927246094,
        483.5926513671875,
        247.3162384033203
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SSA (cm2)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.1199951171875,
        252.2943572998047,
        461.5799865722656,
        264.1452941894531
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가 대상 물질이 함유된 화장품을 도포한 피부 표면적1",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.1199951171875,
        252.2943572998047,
        461.5799865722656,
        264.1452941894531
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Skin Surface Area)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        203.39999389648438,
        267.68060302734375,
        297.3001403808594,
        278.185302734375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "F (day-1)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.1199951171875,
        283.8543701171875,
        413.3995056152344,
        295.5852966308594
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가 대상 물질이 함유된 화장품의 사용 빈도",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.1199951171875,
        283.8543701171875,
        413.3995056152344,
        295.5852966308594
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60 (kg)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.1199951171875,
        304.4006042480469,
        273.3599853515625,
        314.9053039550781
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성인 평균 체중",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.1199951171875,
        304.4006042480469,
        273.3599853515625,
        314.9053039550781
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1 피부 단위면적당 노출량을 평가할 경우 체표면적에 제시된 값을 적용할 수 있다(붙임 4 참조)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.1199951171875,
        327.5699768066406,
        482.6924743652344,
        338.23779296875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 평가대상 물질의 피부흡수율(%)을 기초로 한 전신노출량(SED) 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        358.7925109863281,
        424.32000732421875,
        385.4362487792969
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SED  =",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        122.75999450683594,
        408.9525146484375,
        443.8783264160156,
        428.15625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A(g/day) ×1000mg/g× C(%)/100 × DAp(%)/100",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        122.75999450683594,
        408.9525146484375,
        443.8783264160156,
        428.15625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60 kg",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        310.55999755859375,
        424.9125061035156,
        338.5720520019531,
        436.5562438964844
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED (mg/kg bw/day)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        462.92059326171875,
        386.51177978515625,
        473.42529296875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전신노출량(Systemic Exposure Dosage)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        462.92059326171875,
        386.51177978515625,
        473.42529296875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A (g/day)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        481.4943542480469,
        308.3399963378906,
        493.2253112792969
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품의 1일 사용량1",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        481.4943542480469,
        308.3399963378906,
        493.2253112792969
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "C (%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        502.6405944824219,
        390.1199951171875,
        513.145263671875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 제형 중 평가 대상 성분의 농도",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        502.6405944824219,
        390.1199951171875,
        513.145263671875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DAp (%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        521.8143310546875,
        443.4599914550781,
        533.5452880859375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가 대상 물질의 피부흡수율 (Dermal Absorption)2",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        521.8143310546875,
        443.4599914550781,
        533.5452880859375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60 (kg)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        543.5606079101562,
        280.0799865722656,
        554.0653076171875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성인 평균 체중",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        543.5606079101562,
        280.0799865722656,
        554.0653076171875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1 화장품 유형에 따른 1일 사용량(붙임 5 참조)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        107.63999938964844,
        570.2099609375,
        300.5325012207031,
        580.8778076171875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2 피부흡수율은 문헌에 보고된 값이나 실험값 중 신뢰성 있는 값을 선택하여 적용한다. 다만,",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        107.63999938964844,
        584.6099853515625,
        497.9402770996094,
        595.2777709960938
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료가 없는 경우 보수적으로 50%로 적용할 수 있다.",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        115.07999420166016,
        600.1856079101562,
        329.0657653808594,
        609.6777954101562
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 19 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2-2-3-2 흡입 노출평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        177.71932983398438,
        86.39624786376953
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 화장품은 제형에 따라 분말, 증기, 에어로졸 등의 형태로 직접적으로 흡입되거나 제품 내",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        116.39249420166016,
        543.9596557617188,
        128.0362548828125
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "휘발성분에 의해 피부에 남아 있는 성분이 공기 중으로 증발되어 흡입될 수 있다. 흡입은",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.5199966430664,
        136.19248962402344,
        544.0796508789062,
        147.83624267578125
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화장품 사용에 있어 비의도적인 노출이므로 아래 흐름도에 따라 흡입 노출평가가 필요한지",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.5199966430664,
        155.99249267578125,
        543.9592895507812,
        167.63624572753906
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여부를 결정할 수 있다(SCCS/1628/21, 2021).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.5199966430664,
        175.79249572753906,
        292.2954406738281,
        187.43624877929688
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 20 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "① 흡입 노출 가능성을 판단하기 위해서 평가하고자 하는 제품 내 성분의 자료 수집",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.0,
        74.75249481201172,
        503.760009765625,
        86.39624786376953
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(규정 성분(금지, 배합한도) 확인, 물리화학적 특성 검토)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.0,
        94.55249786376953,
        374.9700012207031,
        106.19625091552734
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "② 흡입을 통해 전신 및 국소 영향을 나타낼 수 있는 성분 확인",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.0,
        118.4324951171875,
        399.23968505859375,
        130.0762481689453
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "③ 전신 및 국소 영향이 있는 것으로 확인된 성분에 대한 노출평가 수행",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.0,
        142.19248962402344,
        443.2799987792969,
        153.83624267578125
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 가장 최악의 시나리오를 고려하여, 단계적(tier) 평가 수행",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.0,
        165.95249938964844,
        387.3599853515625,
        177.59625244140625
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 스프레이 제품 모의시험을 통한 노출량 측정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.0,
        185.7524871826172,
        322.3196716308594,
        197.396240234375
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "④ 스프레이 제품 내 포함된 성분의 농도를 확인하여, 무시할 수 있는 수준의 농도일 경우",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.0,
        209.6324920654297,
        538.4396362304688,
        221.2762451171875
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에는 흡입 노출평가를 수행하지 않으며, 흡입 노출량을 제외한 전신 노출량으로 위해도",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        229.4324951171875,
        544.0796508789062,
        241.0762481689453
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결정 진행",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        249.2324981689453,
        139.4396514892578,
        260.8762512207031
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑤ 위해평가 결과에 따라",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.0,
        272.99249267578125,
        201.47999572753906,
        284.63623046875
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 위해 우려되지 않는 경우, 성분 정보를 포함한 위해평가 보고서 작성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.0,
        296.75250244140625,
        446.2799987792969,
        308.396240234375
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 위해 우려있는 경우, 사용 조건에 따른 스프레이 제품의 최종 입자 크기(또는 분포), 제",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.0,
        316.552490234375,
        538.5599365234375,
        328.19622802734375
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품의 추진제 유형, 개별 성분의 농도 등이 흡입 노출에 영향을 미치므로 이에 대한 조",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.95999908447266,
        336.3525085449219,
        538.43994140625,
        347.9962463378906
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정을 통해 흡입 노출 우려를 낮추도록 함",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.95999908447266,
        356.1524963378906,
        305.8800048828125,
        367.7962341308594
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 흡입노출량은 표준노출조건에서 직접 측정하거나 수학적 모델을 사용하여 추정할 수 있으",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        403.7925109863281,
        538.5599365234375,
        415.4362487792969
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "며, 소비자안전과학위원회(Scientific Committee on Consumer Safety, SCCS), 유럽화학물질",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.47999572753906,
        423.5924987792969,
        538.5592651367188,
        435.2362365722656
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "청(European Chemicals Agency, ECHA) 등 여러 국제기관에서 제시하고 있는 흡입 노출평",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.47999572753906,
        443.39251708984375,
        538.5599365234375,
        455.0362548828125
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 방법을 참고할 수 있다(붙임 7).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.47999572753906,
        463.1925048828125,
        258.72015380859375,
        474.83624267578125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 21 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2-2-4. 위해도 결정",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.22429656982422,
        152.15965270996094,
        86.90835571289062
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 위험성 결정과 노출평가 결과 얻어진 노출량을 비교하여 노출에 따른 인체 위해영향 발생",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        117.9524917602539,
        543.9596557617188,
        129.59625244140625
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가능성을 추정하는 단계이다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        137.7524871826172,
        230.0403289794922,
        149.396240234375
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 화장품 사용으로 인한 평가대상 물질의 노출로 인한 위해 영향을 야기할 가능성은 안전역",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        161.6324920654297,
        538.4396362304688,
        173.2762451171875
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(margin of safety, MOS)으로 나타낸다(SCCS/1628/21, 2021).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.36000061035156,
        181.4324951171875,
        376.0550842285156,
        193.0762481689453
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 화장품 성분의 피부흡수가 매우 낮다는 충분한 증거가 있는 경우에는 전신 노출이 무시될 수",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        205.19248962402344,
        544.0800170898438,
        216.83624267578125
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 수준이므로, MOS 산출에 의한 위해도 결정은 가능하지 않으며 인체 위해영향 발생 가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.47999572753906,
        224.99249267578125,
        538.5599365234375,
        236.63624572753906
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "능성이 낮은 것으로 평가할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.47999572753906,
        244.79249572753906,
        262.8955993652344,
        256.4362487792969
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 위해도 결정을 수행할 때, 불확실성 계수를 적용하여 안전역(MOS)을 산출한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        268.5525207519531,
        464.1356201171875,
        280.1962585449219
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5) 화장품 성분의 경우, 위험성 결정에서 확인된 평가 대상 물질의 전신 독성기준값(PODsys)을",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        292.4324951171875,
        544.0800170898438,
        304.622802734375
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전신노출량으로 나누어 안전역(MOS)을 산출한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.36000061035156,
        312.2325134277344,
        324.57562255859375,
        323.8762512207031
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전역(MOS)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        198.239990234375,
        356.63250732421875,
        279.239990234375,
        368.2762451171875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        198.239990234375,
        356.63250732421875,
        279.239990234375,
        368.2762451171875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PODsys",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        325.79998779296875,
        346.9125061035156,
        356.9042053222656,
        359.1028137207031
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        331.44000244140625,
        367.6725158691406,
        351.30303955078125,
        379.3162536621094
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 일반적으로 안전역(MOS)은 종(실험동물에서 사람), 사람(일반 사람과 취약 집단) 간의 외삽",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        402.3525085449219,
        544.0800170898438,
        413.9962463378906
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과정을 통해 산출된 MOS 값이 100(동물-사람 종간 계수 10 × 사람간 계수 10) 이상이면",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.36000061035156,
        422.1524963378906,
        544.0796508789062,
        433.7962341308594
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해영향 발생 가능성이 낮다고 평가할 수 있다(SCCS/1628/21, 2021; Renwick, 1993).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.36000061035156,
        441.9525146484375,
        505.2950744628906,
        453.59625244140625
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동태학",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        199.0800018310547,
        567.3694458007812,
        223.0802001953125,
        578.063232421875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.0",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        205.79998779296875,
        577.8094482421875,
        216.57994079589844,
        588.5032348632812
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동역학",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        243.59999084472656,
        567.3694458007812,
        267.6002197265625,
        578.063232421875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.5",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        250.3199920654297,
        577.8094482421875,
        261.0999755859375,
        588.5032348632812
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동태학",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        338.5199890136719,
        567.3694458007812,
        362.52020263671875,
        578.063232421875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.2",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        345.239990234375,
        577.8094482421875,
        356.01995849609375,
        588.5032348632812
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동역학",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        383.03997802734375,
        567.3694458007812,
        407.0401916503906,
        578.063232421875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.2",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        389.7599792480469,
        577.8094482421875,
        400.5399475097656,
        588.5032348632812
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 22 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 위해도 결정 방법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        161.1599884033203,
        86.39624786376953
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주요내용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        153.59999084472656,
        104.71974182128906,
        420.239501953125,
        117.96732330322266
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검토방법",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        153.59999084472656,
        104.71974182128906,
        420.239501953125,
        117.96732330322266
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 비발암물질(역치물질)인 경우, 안전역(MOS)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        136.2797393798828,
        285.98175048828125,
        149.52731323242188
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산출",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        82.43999481201172,
        152.3597412109375,
        105.7420425415039,
        165.60731506347656
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 최적의 독성기준값(PODsys)과 전신노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        292.79998779296875,
        133.75973510742188,
        507.8414001464844,
        147.00730895996094
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(SED) 비교",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        307.67999267578125,
        149.83973693847656,
        359.66156005859375,
        163.08731079101562
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "⇒ MOS 값이 100 이상이면 위해 우려 가능",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        292.79998779296875,
        165.79974365234375,
        507.8399658203125,
        179.0473175048828
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성이 낮다고 평가",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        313.44000244140625,
        181.75973510742188,
        392.52044677734375,
        195.00730895996094
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 23 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 위해평가 보고서",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        71.81460571289062,
        177.0,
        89.05242156982422
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전체적인 위해평가 절차를 체계적으로 명확하게 작성한다. 문서에는 아래의 내용을 참고하여",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        124.4324951171875,
        544.0796508789062,
        136.0762481689453
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해평가에 대한 상세 자료가 포함되고, 제한점, 외국 평가 사례 등에 대하여 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        141.95249938964844,
        499.7756042480469,
        153.59625244140625
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 결과보고서 작성 방법",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        62.63999938964844,
        183.47999572753906,
        201.239990234375,
        197.87998962402344
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과보고서",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        138.0,
        215.59974670410156,
        395.3999938964844,
        228.84732055664062
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비고",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        138.0,
        215.59974670410156,
        395.3999938964844,
        228.84732055664062
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 위해평가 보고서 양식에 따라 작성",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        79.55999755859375,
        338.7197570800781,
        246.35992431640625,
        351.9673156738281
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하되 자료 선택의 타당성, 불확실성",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        94.91999816894531,
        354.67974853515625,
        249.98155212402344,
        367.92730712890625
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 제한점 등을 명확히 기술",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        94.91999816894531,
        370.6397399902344,
        218.7599334716797,
        383.8872985839844
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 위해평가 요약, 목적, 범위, 내용, 방법, 결론 및 참고문",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.239990234375,
        245.95973205566406,
        515.5198974609375,
        259.2073059082031
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "헌 등 작성하고 관련 정보 첨부",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        271.0799865722656,
        261.91973876953125,
        409.0799255371094,
        275.16729736328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 위해의 특성과 발생 가능성에 대한 시나리오 및 활용된",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.239990234375,
        306.1997375488281,
        519.1419067382812,
        319.4472961425781
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료 선택의 타당성을 가급적 명확하고 간략하게 기술",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        270.239990234375,
        322.1597595214844,
        505.6803894042969,
        335.4073181152344
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 결과에 영향을 미치는 불확실성, 제한점 및 선택된 가정",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.239990234375,
        369.31976318359375,
        515.5199584960938,
        382.56732177734375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과 이에 따라 예상되는 영향도 기술",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        269.7599792480469,
        385.2797546386719,
        426.71990966796875,
        398.5273132324219
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 과학적 정보와 불확실성 등을 고려하여 정량적 또는 정",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.239990234375,
        427.0397644042969,
        515.52001953125,
        440.2873229980469
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성적으로 위해성을 명시하되, 과학적으로 가능한 범위 내",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        270.1199951171875,
        442.999755859375,
        515.52001953125,
        456.247314453125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에서 정량화",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        270.1199951171875,
        458.9597473144531,
        321.479736328125,
        472.2073059082031
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 24 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제4장 참고문헌",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        71.39431762695312,
        162.36000061035156,
        91.34548950195312
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        122.75248718261719,
        543.9600219726562,
        134.396240234375
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Evaluation 9th Revision",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        142.552490234375,
        189.44024658203125,
        154.1962432861328
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        166.4324951171875,
        543.9600219726562,
        178.0762481689453
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Evaluation 11th Revision",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        186.2324981689453,
        194.96023559570312,
        197.87625122070312
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. Tore Sanner, et al, A Simple Method for Quantitative Risk Assessment of Non- Threshold",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        209.99249267578125,
        543.9583129882812,
        221.63624572753906
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Carcinogens Based on the Dose Descriptor T25, Pharmacology & Toxicology 2001, 88, 331–",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        71.63999938964844,
        229.79249572753906,
        538.5145263671875,
        241.43624877929688
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "341",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        249.5924835205078,
        88.19999694824219,
        261.2362365722656
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. RIVM, Cosmetics Fact Sheet, To assess the risks for the consumer  Updated version for",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        273.3525085449219,
        543.9602661132812,
        284.9962463378906
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ConsExpo 4, 2006",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        293.1524963378906,
        160.1999969482422,
        304.7962341308594
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5. R.J. Safford, The Dermal Sensitisation Threshold—A TTC approach for allergic contact",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        317.0325012207031,
        543.9619140625,
        328.6762390136719
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "dermatitis, Regulatory Toxicology and Pharmacology 2008, 51, 195–200",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        336.83251953125,
        425.8799743652344,
        348.47625732421875
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5. W. Steiling, et al, Principle considerations for the risk assessment of sprayed consumer",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        360.5924987792969,
        544.0797729492188,
        372.2362365722656
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "products, Toxicology Letters 227, 41–49, 2014",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        380.39251708984375,
        300.1199951171875,
        392.0362548828125
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6. IDEA PROJECT, FINAL REPORT ON THE QRA2, Skin Sensitisation Quantitative Risk",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        404.1524963378906,
        543.9590454101562,
        415.7962341308594
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Assessment for Fragrance Ingredients, September 30, 2016",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        423.9525146484375,
        367.3199768066406,
        435.59625244140625
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7. R. Kroes, et al, The Threshold of Toxicological Concern Concept in Risk Assessment,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        447.8324890136719,
        544.0780639648438,
        459.4762268066406
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Toxicological sciences 86(2), 226-230, 2005",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        467.63250732421875,
        285.719970703125,
        479.2762451171875
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8. David W. Roberts, et al, A practical guidance for Cramer class determination, Regulatory",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        491.3924865722656,
        543.9618530273438,
        503.0362243652344
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Toxicology and Pharmacology 73(3), 971-984, 2015",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        511.1925048828125,
        325.1999816894531,
        522.8362426757812
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "9. 식품의약품안전처, 인체적용제품 위해성평가 공통지침서, 2019",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        534.9525146484375,
        384.47998046875,
        546.5962524414062
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10. 식품의약품안전처, 화장품 원료 위해평가 및 국제 협력 연구, 2018",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        558.83251953125,
        411.9599914550781,
        570.4762573242188
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 자료",
      "font_size": 18.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        257.0400085449219,
        117.08917236328125,
        338.03997802734375,
        141.03057861328125
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 1. 화장품 위해평가 관련 용어집",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        184.0994415283203,
        263.8800048828125,
        200.0603790283203
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 2. 화장품 위해평가 보고서 양식",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        212.0594482421875,
        263.8800048828125,
        228.0203857421875
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 3. OECD 독성시험 종류",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        240.0194549560547,
        217.55999755859375,
        255.9803924560547
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 4. 화장품 노출 피부 표면적",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        268.0994567871094,
        244.09873962402344,
        284.0603942871094
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 5. 한국인의 화장품 사용량",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        296.0594482421875,
        233.87998962402344,
        312.0203857421875
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 6. 유럽의 화장품 사용량",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        324.0194396972656,
        221.87998962402344,
        339.9803771972656
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 7. 흡입 노출평가 방법 및 기본 정보",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        352.0994567871094,
        287.8800048828125,
        368.0603942871094
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 8. 피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        380.0594482421875,
        443.1600036621094,
        396.0203857421875
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 9. 화장품 유형별 평가 예시",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        408.0194396972656,
        239.87998962402344,
        423.9803771972656
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 10. 화장품 성분 위해평가를 위한 정보 수집",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        436.0994567871094,
        330.47998046875,
        452.0603942871094
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 26 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 32,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 1. 화장품 위해평가 관련 용어집(Glossary)",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        317.1349182128906,
        87.98039245605469
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 감작 (Sensitization) : 생체 내에 이종항원을 투여하여 항체를 보유시키는 일. 일반적으로 면",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        117.9524917602539,
        538.5599365234375,
        129.59625244140625
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "역 반응 활성화를 지칭함. 민감화",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        137.7524871826172,
        241.19964599609375,
        149.396240234375
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 단회투여독성 (Acute toxicity) : 독성 물질에 대한 짧은 기간의 노출에 의해 발생하는 독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        161.6324920654297,
        538.4396362304688,
        173.2762451171875
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 일반적으로 24시간 이내의 노출에 의해 발생함",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.68000030517578,
        181.4324951171875,
        337.6796875,
        193.0762481689453
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 기준점, 벤치마크 (Benchmark) :",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        205.19248962402344,
        233.73562622070312,
        216.83624267578125
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "a. 효과를 위해 사전에 설정한 변형된 반응을 나타내는 용량이 통계적 하한 신뢰 한계",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        228.95248413085938,
        538.4396362304688,
        240.5962371826172
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(USEPA, 1995 : Benchmark Dose)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        77.04000091552734,
        246.5924835205078,
        245.01036071777344,
        258.2362365722656
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "b. (기준 농도(benchmark concentration, BMC)라고도 함) 배경에 대비하여 부정적 효과에 대한",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        268.1925048828125,
        544.0800170898438,
        279.83624267578125
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반응률에 사전에 설정한 변화(기준 반응(benchma가 response, BMR)를 나타내는 용량의 통",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        77.63999938964844,
        285.83251953125,
        538.5599365234375,
        297.47625732421875
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계적 하한 신뢰 한계(IRIS, 1999, Glossary of IRIS Terms)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        77.63999938964844,
        303.3525085449219,
        362.12994384765625,
        314.9962463378906
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "c. 어떤 독성에 대해 사전에 정한 확률이 작은 증분(통상 1～10%)만 그 발생률을높이는 투여",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.9525146484375,
        538.5599365234375,
        336.59625244140625
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "량에서의 물질에 의한 노출. 혹은 사전에 정한 척도나 생물학적 영향의 변화에 관련 있는",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.55999755859375,
        342.5924987792969,
        544.0800170898438,
        354.2362365722656
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "투여량. (농림수산성 및 후생노동성(일본), 2005; 식품 안전성에 관한 리스크 관리 표준 절",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.55999755859375,
        360.2325134277344,
        538.43994140625,
        371.8762512207031
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "차서(용어정의))",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.55999755859375,
        377.75250244140625,
        152.8498077392578,
        389.396240234375
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "· 기준용량, 벤치마크용량 (Benchmark dose, BMD) : 특정 물질이 생체에 미리 정해진 수준의",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        399.3525085449219,
        543.9598999023438,
        410.9962463378906
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반응(기준 반응, Benchmark response level, BMR)을 야기할 것으로 예측되는 용량",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.43999481201172,
        419.1524963378906,
        475.2000732421875,
        430.7962341308594
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 노출 (Exposure) : 일정기간동안 일정한 빈도로 집단 혹은 개인이 경구 섭취, 호흡하거나 직",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        443.0325012207031,
        538.43994140625,
        454.6762390136719
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "접 접촉(예, 피부나 눈을 통해) 화학물질과 접촉하는 것을 말하며 단기노출(급성)과 장기노",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.19999694824219,
        462.8324890136719,
        538.5599365234375,
        474.4762268066406
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "출(만성)로 구분됨",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.19999694824219,
        482.63250732421875,
        162.59999084472656,
        494.2762451171875
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 노출시나리오 (Exposure scenario) : 특정 물질의 생산부터 실사용까지 생체에 노출되는 방",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        506.39251708984375,
        538.43994140625,
        518.0362548828125
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식을 가상적으로 규정한 것",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.91999816894531,
        526.1925048828125,
        211.3199920654297,
        537.8362426757812
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 노출안전역 (Margin of Exposure, MOE) : 추정 노출량에 대한 NOAEL 등과 같이 독성이 관",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        549.9525146484375,
        538.5599365234375,
        561.5962524414062
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "찰되지 않는 독성값의 비율",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.15999603271484,
        569.7525024414062,
        211.67999267578125,
        581.396240234375
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 대조군 (Control) : 실험 결과의 판정을 위한 표준물질로 연구에 사용되는 물질 또는 샘플군",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        593.6325073242188,
        536.0396118164062,
        605.2762451171875
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 독성기준값 (Point of Departure, POD) : 시험에 사용된 용량 범위 내 자료의 수학적 모델링",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        617.3925170898438,
        538.4396362304688,
        629.0362548828125
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 결정되는 값. NOAEL, LOAEL, BMDL 등을 의미함",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.04000091552734,
        637.1925048828125,
        342.1199951171875,
        648.8362426757812
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 만성독성 (Chronic toxicity) : 물질의 만성적인 투여에 의해 나타나는 독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        660.9525146484375,
        446.6399841308594,
        672.5962524414062
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 반수치사농도 (LC50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 공기",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        684.83251953125,
        543.9596557617188,
        696.4762573242188
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중 농도",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.15999603271484,
        704.6325073242188,
        118.19999694824219,
        716.2762451171875
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 반수치사용량 (LD50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 용량",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        728.3925170898438,
        525.599609375,
        740.0362548828125
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 반복투여독성 (Repeated dose toxicity) : 시험물질을 시험동물에 반복 투여하여 중․장기간 내",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        752.1524658203125,
        538.5599365234375,
        763.7962036132812
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 27 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 33,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 나타나는 독성을 질적, 양적으로 검사하는 시험으로 최대무독성량(NOAEL)등의 산정을",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.04000091552734,
        70.79249572753906,
        544.0796508789062,
        82.43624877929688
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목적으로 수행함.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.04000091552734,
        90.59249114990234,
        159.45562744140625,
        102.23624420166016
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 발생 독성 (Developmental toxicity) : 개체가 발생하는 동안에 노출된 물질에 의해 발생하는",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.35249328613281,
        543.9596557617188,
        125.99624633789062
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자궁 내 사망, 기형, 성장저해 등을 포함하는 위해 반응. 가역적 또는 비가역적 반응이 가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.68000030517578,
        134.15249633789062,
        538.5599365234375,
        145.79624938964844
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "능함",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.68000030517578,
        153.95249938964844,
        95.76000213623047,
        165.59625244140625
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 발암성 (Carcinogenicity) : 어떤 물질의 투여로 인한 영향으로 체내에 악성 종양이 발생되거",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        177.83248901367188,
        538.4396362304688,
        189.4762420654297
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나 발생을 촉진하는 독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.68000030517578,
        197.6324920654297,
        200.1599884033203,
        209.2762451171875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "· 부식성 (Corrosive) : 투여 후 조직의 파괴(necrosis)를 야기하는 성질",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        221.39248657226562,
        416.8800048828125,
        233.03623962402344
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 불확실성계수 (Uncertainty factor, UF) : 동물시험 자료를 활용하여 사람에 대한 효과를 예",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        245.15249633789062,
        538.5599365234375,
        256.7962646484375
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측할 때 발생할 수 있는 여러 불확(실)도의 발생원(예, 종간 차이, 개인 간 차이, 상승 작용,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.68000030517578,
        264.9525146484375,
        544.07958984375,
        276.59625244140625
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서로 다른 노출 경로(경구, 경피, 흡입 등))을 감안하여 조정에 활용되는 계수. 불확실성 계",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.68000030517578,
        284.75250244140625,
        538.5599365234375,
        296.396240234375
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수의 값은 독성의 특성, 보호대상 집단의 규모와 유형, 유용한 독성학적 정보의 질적 수준",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.68000030517578,
        304.552490234375,
        538.5599365234375,
        316.19622802734375
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 따라 달라짐",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.68000030517578,
        324.3525085449219,
        150.71998596191406,
        335.9962463378906
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 생식독성 (Reproductive toxicity) : 자손 생성을 위한 기관의 능력을 감소시키는 몸 또는 조",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        348.2325134277344,
        538.5599365234375,
        359.8762512207031
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "직에 미치는 해로운 영향",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.43999481201172,
        368.0325012207031,
        199.91964721679688,
        379.6762390136719
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 생식․발생독성시험 (Reproductive and developmental toxicity studies) : 시험물질이 포유류의",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        391.7925109863281,
        543.9592895507812,
        403.4362487792969
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생식·발생에 미치는 영향을 규명하는 시험을 말하며, 수태능 및 초기배 발생시험, 출생",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.04000091552734,
        411.5924987792969,
        543.9596557617188,
        423.2362365722656
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전·후 모체기능시험 및 배·태자발생시험 등이 있음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.04000091552734,
        431.39251708984375,
        343.55999755859375,
        443.0362548828125
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "a. 1세대 생식발생독성시험(One Generation Study) : 생식·발생독성시험에서 모세대에만 물질",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        455.1524963378906,
        538.5599365234375,
        466.7962341308594
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 직접 투여하고, 모세대 및 차세대에 미치는 영향을 평가하는 시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        474.9525146484375,
        426.0,
        486.59625244140625
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "b. 2세대 생식발생독성시험(Two Generation Study) : 생식·발생독성시험에서 모체와 차세대(2",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        498.8324890136719,
        538.559814453125,
        510.4762268066406
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세대)에 물질을 직접 투여하고, 모체·차세대 및 그 다음 세대에 미치는 영향(발정․교미․수",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        518.6325073242188,
        538.5599365234375,
        530.2762451171875
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "태․분만․포육 등의 생식기능, 출생 및 이유 후 신생자의 생육)을 평가하는 시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        538.4324951171875,
        471.7200012207031,
        550.0762329101562
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "c. 3세대 생식발생독성시험(Three Generation Study) : 생식․발생독성시험에서 모세대와 차세대",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        562.1925048828125,
        543.9596557617188,
        573.8362426757812
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 그 차세대 (3세대)에 물질을 직접 투여하고, 물질 투여세대 및 그 후세대에 미치는 영향",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        581.9924926757812,
        538.4396362304688,
        593.63623046875
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 평가하는 시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        601.79248046875,
        164.63998413085938,
        613.4362182617188
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 생체 내 시험 (In vivo) : 생체내에서의 시험. 일반적으로 동물 및 인체 실험을 의미함",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        625.552490234375,
        505.31964111328125,
        637.1962280273438
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 생체이용률 (Bioavailability) : 화학물질의 효과를 직접 또는 간접적으로 나타내는 주성분 또",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        649.4324951171875,
        538.43994140625,
        661.0762329101562
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 활성대사체의 노출 후 체내 전신 순환혈까지 도달하는 흡수속도와 양의 비율",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.43999481201172,
        669.2324829101562,
        480.23968505859375,
        680.876220703125
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 시험관 시험 (In vitro) : 생체 바깥의 인공적인 환경에서의 시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        692.9924926757812,
        394.67999267578125,
        704.63623046875
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 신뢰구간 (Confidence interval) : 특정 확률로 참 값을 함유하고 있을 것으로 통계적으로 예",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        716.7525024414062,
        538.5599365234375,
        728.396240234375
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측되는 변수의 구간",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.08000183105469,
        736.552490234375,
        172.07965087890625,
        748.1962280273438
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 28 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 34,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 안전역 (Margin of safety, MOS) : 화장품에 존재하는 위해요소의 최대무독성용량을 일일인",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        538.5599365234375,
        86.39624786376953
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체노출량으로 나눈 값",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.08000183105469,
        94.55249786376953,
        183.1199951171875,
        106.19625091552734
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 역치용량 (Threshold dose) : 효과가 나타나기 직전까지의 용량 또는 노출농도",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        118.4324951171875,
        465.71966552734375,
        130.0762481689453
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 용량 디스크립터 (Dose descriptor) : 생체 또는 환경 독성 시험에서 얻어지는 수치로 특정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        142.19248962402344,
        544.0800170898438,
        153.83624267578125
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부작용을 일으키는 값 (예를 들면 반수 치사량) 또는 독성을 유발하지 않는 최대 농도(예:",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.91999816894531,
        161.99249267578125,
        543.9603881835938,
        173.63624572753906
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "NOAEL) 등의 수치를 일컬음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.91999816894531,
        181.79249572753906,
        217.79965209960938,
        193.43624877929688
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 용량 반응 상관성 (Dose-response relationship) : 물질의 다양한 투여 양에 의한 반응의 차",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        205.552490234375,
        538.5599365234375,
        217.1962432861328
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이. 물질의 효력에 관한 정보를 제공함",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.91999816894531,
        225.3524932861328,
        269.2796936035156,
        236.99624633789062
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "· 위해 평가 (Risk assessment) : 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        249.2324981689453,
        543.9596557617188,
        260.8762512207031
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있는 유해영향과 발생확률을 과학적으로 예측하는 일련의 과정으로 위험성 확인, 위험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        269.0325012207031,
        538.5599365234375,
        280.6762390136719
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성 결정, 노출평가, 위해도 결정 등 일련의 단계",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        288.83251953125,
        316.55999755859375,
        300.47625732421875
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 위험 (Hazard) : 물질의 내재적 독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        312.5924987792969,
        254.1599884033203,
        324.2362365722656
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 유전독성 (Genotoxicity) : 유전정보를 담고 있는 유전자(DNA)나 염색체에 변화를 주어 세포",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        336.3525085449219,
        543.9596557617188,
        347.9962463378906
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 개체에 악영향을 초래하는 성질로 변이원성이라고도 함. 주된 변화로는 유전자 돌연변",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.43999481201172,
        356.1524963378906,
        538.4396362304688,
        367.7962341308594
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이, DNA 손상이나 염색체 이상(중복, 결실)등이 있다. 이와 같은 이상을 일으키는 물질은",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.43999481201172,
        375.9525146484375,
        544.0796508789062,
        387.59625244140625
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "종양 발생에 결부될 가능성이 있으며 생식세포에서 발생하면 다음 세대의 최기형성․유전병",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.43999481201172,
        395.75250244140625,
        543.9596557617188,
        407.396240234375
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유발로 이어질 가능성이 있음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.43999481201172,
        415.552490234375,
        221.87998962402344,
        427.19622802734375
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 전신 노출량 (Systemic exposure dosage, SED) : 화장품 원료의 전신노출량 (Systemic",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        439.4324951171875,
        543.9589233398438,
        451.07623291015625
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Exposure Dosage)은 하루에 체중 당 혈류로 들어가서 전신적으로 작용할 것이 예상되는 외",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.04000091552734,
        459.2325134277344,
        538.43994140625,
        470.8762512207031
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적용량으로서 mg/kg bw/day로 표현함. 화장품 위해 평가 시 피부노출량 또는 피부전신노출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.04000091552734,
        479.0325012207031,
        538.4392700195312,
        490.6762390136719
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "량이라 통칭함",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.04000091552734,
        498.8324890136719,
        145.5596466064453,
        510.4762268066406
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 정량한계 (Limit of Quantitation, LOQ) : 어떤 시료에 규정된 분석방법에서 바람직한 확실성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        522.592529296875,
        538.5596313476562,
        534.2362670898438
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 가지고 정량할 수 있는 화학물질의 최저농도를 말하며, 수치상 유효적인 의미함. 정량하",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        542.3925170898438,
        538.4396362304688,
        554.0362548828125
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한치 미만이란 정량할 수 있는 정도의 양은 아니라는 의미로 0(제로)과는 의미가 다름",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        562.1925048828125,
        510.0,
        573.8362426757812
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 종말점 (Endpoint) : 측정 및 관찰 가능한 물질의 성질을 의미하며 독성학적으로는 일반적으",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        585.9525146484375,
        538.4396362304688,
        597.5962524414062
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 자극감, 발암성, 기관별 독성 등 특정 장기 및 기관에 대한 개별 생물학적 효능을 의미",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.55999755859375,
        605.7525024414062,
        538.5599365234375,
        617.396240234375
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "함",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.55999755859375,
        625.552490234375,
        84.5999984741211,
        637.1962280273438
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 최대무감작성유도용량 (No expected sensitization induced level, NESIL) : 사람 또는 동물에",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        649.4324951171875,
        538.5599365234375,
        661.0762329101562
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게 감작이 나타나지 않는 최대용량",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.08000183105469,
        669.2324829101562,
        249.11964416503906,
        680.876220703125
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 최대무독성용량 (No observed adverse effect level, NOAEL) : 인간과 동물에게 부작용 및",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        692.9924926757812,
        543.9596557617188,
        704.63623046875
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성학적 영향이 관측되지 않는 최대 용량. mg/kg body weight/day로 나타냄",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.15999603271484,
        712.79248046875,
        461.8800048828125,
        724.4362182617188
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 최소독성용량 (Lowest observed adverse effect level, LOAEL) : 실험 동물 또는 사람에서",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        736.552490234375,
        543.9592895507812,
        748.1962280273438
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정 물질에 의해 독성이 관찰되는 최소한의 농도",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.79999542236328,
        756.3524780273438,
        326.760009765625,
        767.9962158203125
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 29 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 35,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 표적기관 (Target organ) : 물질이 나타내는 독성효과를 보이는 기관",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        417.3599853515625,
        86.39624786376953
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 피부 노출 (Dermal exposure) : 화학물질을 함유하는 매체와 피부의 접촉을 통한 노출로서,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        98.63249206542969,
        543.9595947265625,
        110.2762451171875
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부에 있어 흡착이나 흡수될 수 있는 양으로 정량",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.79999542236328,
        118.4324951171875,
        332.15966796875,
        130.0762481689453
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 피부감작성시험 (Skin sensitization Test) : 실험물질(외용으로 사용되는 의약품, 화장품 및",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        142.19248962402344,
        544.0800170898438,
        153.83624267578125
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기타 물질)이 피부에 반복적으로 노출되었을 경우 나타날 수 있는 홍반 및 부종 등의 면역",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        161.99249267578125,
        538.5599365234375,
        173.63624572753906
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "학적 피부과민반응을 평가하는 시험법으로 국소 림프절 검사(Local Lymph Node",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        181.79249572753906,
        543.9616088867188,
        193.43624877929688
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Assay(LLNA)), Magnusson Kligman 기니피그 최대화 시험(Magunusson Kligman Guinea Pig",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        201.59249877929688,
        543.96044921875,
        213.2362518310547
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Maximisation Test, GPMT) 및 Buehler 시험이 있다. 국소 림프절 검사는 동종 번식된 생쥐",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        221.39248657226562,
        538.5599365234375,
        233.03623962402344
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 사용하는 방법으로 대상 성분의 사용부위에서의 국소림프절의 림프구 증식에 기반하고",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        241.19248962402344,
        544.0796508789062,
        252.83624267578125
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있다. 이는 자극성지수(stimulation index, SI)로 결과를 얻을 수 있는 객관적인 방법이며, 실",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        260.99249267578125,
        538.5599365234375,
        272.63623046875
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "험 물질에 의하여 야기된 자극과 기제를 적용한 대조 동물의 자극과의 비율로 나타낸다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        280.7925109863281,
        543.9595947265625,
        292.4362487792969
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Magnusson Kligman 기니피그 최대화 시험은 면역증강제 형태 시험이며 Freunds complete",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        300.5924987792969,
        544.0797729492188,
        312.2362365722656
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역증강제를 사용하거나 사용하지 않는 조건에서 대상 성분의 피내주사에 의한 알레르기",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        320.39251708984375,
        544.0796508789062,
        332.0362548828125
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반응의 증가 여부로 판단한다. GPMT는 LLNA와 감도가 동등하다고 여겨진다. Buehler 시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        340.1925048828125,
        538.5599365234375,
        351.83624267578125
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 국소에만 사용함으로써 면역증강제를 사용하지 않는 방법으로 GPMT와 비교할 때 감도",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        359.99249267578125,
        538.5599365234375,
        371.63623046875
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 낮다. Buehler 실험방법을 사용할 경우에는 과학적으로 정당한 근거를 제시해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        379.7925109863281,
        523.4156494140625,
        391.4362487792969
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "· 화학물질 요약 서비스 등록번호(Chemical abstracts service index number, CAS Number) :",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        403.552490234375,
        543.9595947265625,
        415.19622802734375
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CAS의 화학물질 분류 넘버",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        423.3525085449219,
        205.92041015625,
        434.9962463378906
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 30 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 2. 화장품 위해평가 보고서 양식",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        73.09944915771484,
        263.8800048828125,
        89.06038665771484
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "* 이 보고서 양식은 참고용이며, 제품에 맞게 재구성할 수 있음",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        126.60749816894531,
        407.8800048828125,
        139.2637481689453
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제 목",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        267.0,
        159.24749755859375,
        297.0,
        171.90374755859375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<요약>",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        216.12750244140625,
        92.63999938964844,
        228.78375244140625
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": 위해평가 내용을 요약함",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        242.7675018310547,
        197.87998962402344,
        255.4237518310547
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<목차>",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        295.927490234375,
        92.63999938964844,
        308.583740234375
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 위해평가 배경 및 목적",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        322.5675048828125,
        197.87998962402344,
        335.2237548828125
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": 평가 배경 및 목적 기술",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.75999450683594,
        349.2074890136719,
        222.0,
        361.8637390136719
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 위해평가 방법",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        402.36749267578125,
        149.87998962402344,
        415.02374267578125
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": 위해평가에 사용된 방법을 간략하게 기술",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.75999450683594,
        429.0074768066406,
        318.0,
        441.6637268066406
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 위해평가 방법",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        455.5274963378906,
        156.36000061035156,
        468.1837463378906
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 평가대상 성분의 위해평가 방법",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        482.16748046875,
        252.36000061035156,
        494.82373046875
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 위해평가 결과",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        535.3275146484375,
        149.87998962402344,
        547.9837646484375
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1 위험성 확인",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        561.9674682617188,
        154.9199981689453,
        574.6237182617188
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.1 물리·화학적 성질",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        588.6074829101562,
        211.0800018310547,
        601.2637329101562
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[물질명, IUPAC명, CAS No., 화학식, 분자량, 순도(분석방법), 구조식(추출물의 경",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.75999450683594,
        615.1275024414062,
        538.5599975585938,
        627.7837524414062
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우, 추출방법과 정제법), 물리적 성상, 녹는점, 끓는점, 밀도, 용해도, Log Pow,",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        92.75999450683594,
        636.7274780273438,
        544.4400024414062,
        649.3837280273438
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "헨리상수, 동의어]",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        92.75999450683594,
        658.3275146484375,
        189.84375,
        670.9837646484375
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.2 사용현황",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        684.9674682617188,
        157.0800018310547,
        697.6237182617188
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 표. 각국의 화장품 중 평가대상 성분의 관리 기준",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        92.63999938964844,
        710.8800048828125,
        359.15966796875,
        724.1279907226562
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.3 노출경로",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        735.7274780273438,
        157.0800018310547,
        748.3837280273438
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 31 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.4 독성학적 자료",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        75.84749603271484,
        187.0800018310547,
        88.50374603271484
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 표. 독성학적 자료 확보 유무",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        89.5199966430664,
        100.79999542236328,
        251.63998413085938,
        114.0479965209961
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단회투여",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        93.47999572753906,
        122.5199966430664,
        137.5196533203125,
        135.7679901123047
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        105.95999908447266,
        136.8000030517578,
        127.91966247558594,
        150.04798889160156
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반복투여",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        150.83999633789062,
        122.5199966430664,
        194.87965393066406,
        135.7679901123047
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        163.1999969482422,
        136.8000030517578,
        185.2799835205078,
        150.04798889160156
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        216.36000061035156,
        122.5199966430664,
        238.3196563720703,
        150.04798889160156
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        216.36000061035156,
        122.5199966430664,
        238.3196563720703,
        150.04798889160156
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생식발생",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        261.239990234375,
        122.5199966430664,
        305.2796936035156,
        135.7679901123047
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        273.6000061035156,
        136.8000030517578,
        295.67999267578125,
        150.04798889160156
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        326.7599792480469,
        122.5199966430664,
        491.8800048828125,
        150.04798889160156
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        326.7599792480469,
        122.5199966430664,
        491.8800048828125,
        150.04798889160156
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발암성",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        326.7599792480469,
        122.5199966430664,
        491.8800048828125,
        150.04798889160156
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "광독성",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        326.7599792480469,
        122.5199966430664,
        491.8800048828125,
        150.04798889160156
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기타",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        326.7599792480469,
        122.5199966430664,
        491.8800048828125,
        150.04798889160156
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ü",
      "font_size": 11.039999961853027,
      "font_name": "Wingdings-Regular",
      "bbox": [
        111.23999786376953,
        162.60000610351562,
        483.6787109375,
        175.96875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ü",
      "font_size": 11.039999961853027,
      "font_name": "Wingdings-Regular",
      "bbox": [
        111.23999786376953,
        162.60000610351562,
        483.6787109375,
        175.96875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ü",
      "font_size": 11.039999961853027,
      "font_name": "Wingdings-Regular",
      "bbox": [
        111.23999786376953,
        162.60000610351562,
        483.6787109375,
        175.96875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ü",
      "font_size": 11.039999961853027,
      "font_name": "Wingdings-Regular",
      "bbox": [
        111.23999786376953,
        162.60000610351562,
        483.6787109375,
        175.96875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ü",
      "font_size": 11.039999961853027,
      "font_name": "Wingdings-Regular",
      "bbox": [
        111.23999786376953,
        162.60000610351562,
        483.6787109375,
        175.96875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ü",
      "font_size": 11.039999961853027,
      "font_name": "Wingdings-Regular",
      "bbox": [
        111.23999786376953,
        162.60000610351562,
        483.6787109375,
        175.96875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ü",
      "font_size": 11.039999961853027,
      "font_name": "Wingdings-Regular",
      "bbox": [
        111.23999786376953,
        162.60000610351562,
        483.6787109375,
        175.96875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        111.23999786376953,
        162.60000610351562,
        483.6787109375,
        175.96875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(ü: 독성 자료 있음, -: 독성 자료 없음)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        191.86990356445312,
        285.9598083496094,
        206.2537384033203
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.4.1 독성동태",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        220.8074951171875,
        177.36000061035156,
        233.4637451171875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.1.4.1.1 흡수, 분포, 대사, 배설",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        247.44747924804688,
        273.3599853515625,
        260.1037292480469
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.1.4.1.2 피부흡수율",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        273.9674987792969,
        209.63999938964844,
        286.6237487792969
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.1.4.2 단회투여독성",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        300.60748291015625,
        201.36000061035156,
        313.26373291015625
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.4.3 반복투여독성",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        327.24749755859375,
        201.36000061035156,
        339.90374755859375
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.4.4 피부자극성",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        353.7674865722656,
        189.36000061035156,
        366.4237365722656
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.4.5 안점막자극",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        380.4075012207031,
        189.36000061035156,
        393.0637512207031
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.4.6 피부감작성",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        407.0474853515625,
        189.36000061035156,
        419.7037353515625
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.4.7 생식·발생독성",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        433.5675048828125,
        213.36000061035156,
        446.2237548828125
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.4.8 유전독성",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        460.2074890136719,
        177.36000061035156,
        472.8637390136719
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.4.9 발암성",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        486.8475036621094,
        165.36000061035156,
        499.5037536621094
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.4.10 광독성",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        513.3674926757812,
        171.36000061035156,
        526.0237426757812
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1.4.11 기타(면역독성, 신경독성, 임상자료 포함)",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        540.0075073242188,
        359.30999755859375,
        552.6637573242188
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2 위험성 결정",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        566.6474609375,
        154.9199981689453,
        579.3037109375
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2.1 최적의 전신 독성기준값(PODsys) 선정",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        593.16748046875,
        324.239990234375,
        605.82373046875
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.3 노출평가",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        619.8074951171875,
        136.9199981689453,
        632.4637451171875
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.3.1 노출시나리오",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        646.447509765625,
        181.0800018310547,
        659.103759765625
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.3.2 노출량 산출",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        672.9674682617188,
        175.0800018310547,
        685.6237182617188
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.4 위해도 결정",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        699.6074829101562,
        154.9199981689453,
        712.2637329101562
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. 결론",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        752.7674560546875,
        95.87999725341797,
        765.4237060546875
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 32 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 38,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5. 제한점",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        102.36750030517578,
        107.87999725341797,
        115.02375030517578
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6. 외국의 평가 사례",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        155.64749145507812,
        167.87998962402344,
        168.30374145507812
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7. 참고문헌",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        208.8074951171875,
        119.87999725341797,
        221.4637451171875
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 33 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구분",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        287.1600036621094,
        98.39249420166016,
        309.11968994140625,
        110.03624725341797
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단회투여독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        64.91999816894531,
        194.99249267578125,
        130.91932678222656,
        206.63624572753906
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 시험물질의 LD50 값을 결정하기 위한 목적으로 개발되었으며 단회투여 경구",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        120.71249389648438,
        531.7198486328125,
        132.90281677246094
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성, 단회투여 흡입독성, 단회투여 피부독성으로 구분된다. 단회투여 경구독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        158.27999877929688,
        137.15249633789062,
        537.1201171875,
        181.91624450683594
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 고정용량법(fixed dose method), 단회투여독성 분류법(acute toxic class",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        158.27999877929688,
        137.15249633789062,
        537.1201171875,
        181.91624450683594
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "method), 용량고저법(up-and-down procedure)으로 구분된다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        158.27999877929688,
        137.15249633789062,
        537.1201171875,
        181.91624450683594
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG420) 고정용량법 : 치사율을 종말정으로 사용하지 않고 동물의",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        186.71249389648438,
        537.11962890625,
        198.3562469482422
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사망이나 뚜렷한 고통과 스트레스를 초래하지 않도록 설계",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        157.9199981689453,
        203.27249145507812,
        454.7996826171875,
        214.91624450683594
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG423) 단회투여 분류법 : 치사율이 예상되는 노출량 범위를 확인",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        219.83248901367188,
        516.8397216796875,
        248.4628143310547
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG425) 용량고저법 : LD50 값과 신뢰구간 추정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        219.83248901367188,
        516.8397216796875,
        248.4628143310547
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG403) 단회투여 흡입독성시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        252.83250427246094,
        351.71966552734375,
        281.0362548828125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG402) 단회투여 피부독성시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        252.83250427246094,
        351.71966552734375,
        281.0362548828125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반복투여독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        64.91999816894531,
        341.2724914550781,
        136.4393310546875,
        352.9162292480469
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 특정 기간(28일, 90일) 동안 물질을 매일 반복 투여하거나 물질에 노출됨에",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        291.7124938964844,
        537.2393188476562,
        303.3562316894531
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 나타나는 일반 독성영향(생식, 유전독성 및 발암 효과 제외)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        157.9199981689453,
        308.1524963378906,
        473.7300109863281,
        319.7962341308594
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG407) 반복투여(28일) 경구독성시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        324.7124938964844,
        457.5593566894531,
        402.4762268066406
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG412) 반복투여(28일) 흡입독성시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        324.7124938964844,
        457.5593566894531,
        402.4762268066406
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG408) 설치류 대상 반복투여(90일) 경구독성시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        324.7124938964844,
        457.5593566894531,
        402.4762268066406
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG409) 비설치류 대상 반복투여(90일) 경구독성시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        324.7124938964844,
        457.5593566894531,
        402.4762268066406
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG413) 설치류 대상 반복투여(90일) 흡입독성시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        324.7124938964844,
        457.5593566894531,
        402.4762268066406
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부부식성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.31999969482422,
        446.1524963378906,
        125.399658203125,
        457.7962341308594
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG430) 랫드 경피 전기저항 시험(Rat skin transcutaneous",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        413.0325012207031,
        490.8003845214844,
        424.6762390136719
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Electrical resistance Test, RET)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        157.9199981689453,
        429.5924987792969,
        316.2899475097656,
        441.2362365722656
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG431) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        446.1524963378906,
        536.6400146484375,
        457.7962341308594
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "method",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        158.16000366210938,
        462.5924987792969,
        193.76634216308594,
        474.2362365722656
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG435) in vitro 인공막 장벽시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        479.1524963378906,
        360.9596862792969,
        490.7962341308594
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부자극성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.31999969482422,
        501.4725036621094,
        536.6400146484375,
        521.396240234375
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG439) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.31999969482422,
        501.4725036621094,
        536.6400146484375,
        521.396240234375
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "method)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        159.95999145507812,
        518.032470703125,
        198.9300994873047,
        529.6762084960938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안점막자극성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        64.91999816894531,
        631.1925048828125,
        130.91932678222656,
        642.8362426757812
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG437) 소 각막 혼탁 및 투과성 시험법(Bovine Cornea Opacity",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        540.3524780273438,
        519.6004638671875,
        551.9962158203125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Permeability (BCOP) test method)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        157.9199981689453,
        556.79248046875,
        326.1304016113281,
        568.4362182617188
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG438) 닭의 안구를 이용한 안점막 시험법(Isolated chicken",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        573.3524780273438,
        500.0378112792969,
        584.9962158203125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "eye(ICE) Test method)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        158.51998901367188,
        589.9124755859375,
        270.090087890625,
        601.5562133789062
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG491) 단기노출(Short Time Exposure, STE) 시험법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        606.3524780273438,
        503.8798522949219,
        651.1162109375
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG460) 플로오레세인 누출(Fluorescein leakage, FL) 시험법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        606.3524780273438,
        503.8798522949219,
        651.1162109375
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG492) 인체각막유사상피(Reconstructed Human Cornea-like",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        606.3524780273438,
        503.8798522949219,
        651.1162109375
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Epithelium, RhCE) 시험법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        158.39999389648438,
        655.9124755859375,
        287.3996887207031,
        667.5562133789062
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG492B) 인체각막유사 상피모델을 이용한 안 유해성(심한 안손상 및",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        672.4724731445312,
        537.1199951171875,
        684.1162109375
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안자극)시험법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        158.39999389648438,
        689.032470703125,
        225.59951782226562,
        700.6762084960938
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG494) 인체각막세포주(Vitrigel®)를 이용한 안자극시험법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        704.08251953125,
        469.9188232421875,
        733.6762084960938
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG496) In vitro 고분자시험법: Ocular Irritation®",
      "font_size": 7.079999923706055,
      "font_name": "Haansoft Batang",
      "bbox": [
        141.36000061035156,
        704.08251953125,
        469.9188232421875,
        733.6762084960938
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부감작성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.31999969482422,
        747.3524780273438,
        483.0907897949219,
        758.9962158203125
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG429) 국소림프절시험(Local Lymph Node Assay, LLNA)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.31999969482422,
        747.3524780273438,
        483.0907897949219,
        758.9962158203125
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 3. OECD 독성시험 종류",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        59.52000045776367,
        69.49945068359375,
        220.44000244140625,
        85.46038818359375
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 34 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "* 참고 : OECD Test Guidelines, Section 4 – Health effects (2023년 11월 기준)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        175.9199981689453,
        690.9205932617188,
        538.552490234375,
        701.42529296875
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구분",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        287.1600036621094,
        77.87249755859375,
        309.11968994140625,
        89.51625061035156
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG422A) LLNA Daicel-ATP 시험법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        96.59249114990234,
        370.6796875,
        108.23624420166016
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG422B) LLNA 세포증식효소매개 면역흡수 분석시험(ELISA) BrdU",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        113.15249633789062,
        540.2782592773438,
        141.3562469482422
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG442C) in Chemico 펩타이드 반응성 시험법(DPRA), in Chemico",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        113.15249633789062,
        540.2782592773438,
        141.3562469482422
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아미노산 유도체 결합성 시험법(ADRA), in Chemico 피부감작성 시험법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        159.59999084472656,
        146.15249633789062,
        531.719970703125,
        174.3562469482422
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(kDPRA)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        159.59999084472656,
        146.15249633789062,
        531.719970703125,
        174.3562469482422
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG442D) ARE-Nrf2 루시퍼라아제 시험법(KeratinoSensTM), ARE-Nrf2",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        177.755615234375,
        537.119873046875,
        190.91624450683594
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "루시퍼라아제 LuSens 시험법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        159.59999084472656,
        195.71249389648438,
        298.31951904296875,
        207.3562469482422
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG442E) 인체세포주 활성화 시험법(h-CLAT), IL-8 루시퍼라아제",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        212.27249145507812,
        537.1193237304688,
        223.91624450683594
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        159.59999084472656,
        228.83248901367188,
        192.5996551513672,
        240.4762420654297
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG406) Magnusson Kligman 기니피그 극대화 시험(GPMT)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        245.27249145507812,
        484.7685546875,
        256.916259765625
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG406) Buehler 시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        261.83251953125,
        301.08001708984375,
        273.47625732421875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부흡수",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.83999633789062,
        281.87249755859375,
        346.1993713378906,
        293.5162353515625
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG28) 생체외 피부흡수시험법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.83999633789062,
        281.87249755859375,
        346.1993713378906,
        293.5162353515625
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생식·발생독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        64.68000030517578,
        330.2325134277344,
        131.16143798828125,
        341.8762512207031
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG416) 2세대 생식독성시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        305.39251708984375,
        382.9193420410156,
        366.59625244140625
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG414) 산전 발달 독성시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        305.39251708984375,
        382.9193420410156,
        366.59625244140625
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG421) 생식·발생독성 스크리닝시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        305.39251708984375,
        382.9193420410156,
        366.59625244140625
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG443) 확장형 1세대 생식독성시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        305.39251708984375,
        382.9193420410156,
        366.59625244140625
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.83999633789062,
        468.11248779296875,
        125.399658203125,
        479.7562255859375
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 체외(in vitro) 시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        377.2724914550781,
        418.79998779296875,
        438.4762268066406
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG471, TG472) 박테리아 복귀돌연변이 시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        377.2724914550781,
        418.79998779296875,
        438.4762268066406
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG473) 염색체이상시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        377.2724914550781,
        418.79998779296875,
        438.4762268066406
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG487) 소핵시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        377.2724914550781,
        418.79998779296875,
        438.4762268066406
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG476) 유전자돌연변이시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        443.39251708984375,
        343.56121826171875,
        488.0362243652344
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG470) pig-a gene mutation",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        443.39251708984375,
        343.56121826171875,
        488.0362243652344
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 체내(in vivo) 시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        443.39251708984375,
        343.56121826171875,
        488.0362243652344
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG483) 염색체이상시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        492.9525146484375,
        313.1993713378906,
        570.5962524414062
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG474) 소핵시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        492.9525146484375,
        313.1993713378906,
        570.5962524414062
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG475) 염색체이상시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        492.9525146484375,
        313.1993713378906,
        570.5962524414062
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG478) 우성치사시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        492.9525146484375,
        313.1993713378906,
        570.5962524414062
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (OECD TG488) 유전자변이시험",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        492.9525146484375,
        313.1993713378906,
        570.5962524414062
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발암성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.36000061035156,
        581.2725219726562,
        296.6396789550781,
        609.4762573242188
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG452) 만성 독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.36000061035156,
        581.2725219726562,
        296.6396789550781,
        609.4762573242188
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG453) 만성 발암성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.36000061035156,
        581.2725219726562,
        296.6396789550781,
        609.4762573242188
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "광독성",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        81.36000061035156,
        644.8724975585938,
        114.35966491699219,
        656.5162353515625
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG432) 3T3 뉴트럴 레드 흡수 광독성 시험(3T3 Neutral Red",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        620.1525268554688,
        505.6801452636719,
        631.7962646484375
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Uptake Phototoxicty Test, 3T3 NRU PT)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        159.59999084472656,
        636.5924682617188,
        361.4094543457031,
        648.2362060546875
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG495) 활성산소종(ROS) 분석을 이용한 광독성시험법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        653.1525268554688,
        467.0396728515625,
        681.3562622070312
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- (OECD TG498) 인체피부모델을 이용한 광독성시험법",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.36000061035156,
        653.1525268554688,
        467.0396728515625,
        681.3562622070312
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 35 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 4. 화장품 노출 피부 표면적",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        244.09873962402344,
        87.98039245605469
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 1. 각 제품 유형별 평균 노출 피부 표면적(Bremmer et al. 2006a; Bremmer et al., 2006b)",
      "font_size": 9.719964981079102,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        117.9524917602539,
        480.0851135253906,
        129.59625244140625
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품형태",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        104.39999389648438,
        146.83973693847656,
        316.31951904296875,
        160.08731079101562
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화장품 적용 신체부위",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        104.39999389648438,
        146.83973693847656,
        316.31951904296875,
        160.08731079101562
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부 표면적(㎠)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        390.1199951171875,
        138.3197479248047,
        461.0047912597656,
        151.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RIVM",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        371.5199890136719,
        155.23974609375,
        476.0876159667969,
        168.48731994628906
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "EPA",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        371.5199890136719,
        155.23974609375,
        476.0876159667969,
        168.48731994628906
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모발 관리(Hair care)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        236.63999938964844,
        172.2797393798828,
        330.0350341796875,
        185.52731323242188
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샴푸",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        189.31973266601562,
        477.92523193359375,
        202.5673065185547
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양손 면적 + 1/2 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        189.31973266601562,
        477.92523193359375,
        202.5673065185547
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1440",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        189.31973266601562,
        477.92523193359375,
        202.5673065185547
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1430",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        189.31973266601562,
        477.92523193359375,
        202.5673065185547
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "헤어 컨디셔너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        206.23974609375,
        477.92523193359375,
        219.48731994628906
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양손 면적 + 1/2 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        206.23974609375,
        477.92523193359375,
        219.48731994628906
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1440",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        206.23974609375,
        477.92523193359375,
        219.48731994628906
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1430",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        206.23974609375,
        477.92523193359375,
        219.48731994628906
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "헤어 스프레이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        223.2797393798828,
        475.1654052734375,
        236.52731323242188
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 머리 면적(여성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        223.2797393798828,
        475.1654052734375,
        236.52731323242188
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "565",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        223.2797393798828,
        475.1654052734375,
        236.52731323242188
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "555",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        223.2797393798828,
        475.1654052734375,
        236.52731323242188
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "헤어 스타일링 젤",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        240.31973266601562,
        477.92523193359375,
        253.5673065185547
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 양손 면적, 1/2 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        240.31973266601562,
        477.92523193359375,
        253.5673065185547
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1010",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        240.31973266601562,
        477.92523193359375,
        253.5673065185547
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1010",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        240.31973266601562,
        477.92523193359375,
        253.5673065185547
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "헤어 스타일링 무스",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        257.23974609375,
        477.92523193359375,
        270.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 양손 면적, 1/2 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        257.23974609375,
        477.92523193359375,
        270.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1010",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        257.23974609375,
        477.92523193359375,
        270.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1010",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        257.23974609375,
        477.92523193359375,
        270.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반영구형 염모제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        274.2797546386719,
        475.1654052734375,
        287.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        274.2797546386719,
        475.1654052734375,
        287.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "580",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        274.2797546386719,
        475.1654052734375,
        287.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "590",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        274.2797546386719,
        475.1654052734375,
        287.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산화성/영구적 염모제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        291.31976318359375,
        475.1654052734375,
        304.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        291.31976318359375,
        475.1654052734375,
        304.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "580",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        291.31976318359375,
        475.1654052734375,
        304.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "590",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        291.31976318359375,
        475.1654052734375,
        304.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "두발 탈색제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        308.23974609375,
        475.1654052734375,
        321.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        308.23974609375,
        475.1654052734375,
        321.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "580",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        308.23974609375,
        475.1654052734375,
        321.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "590",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        308.23974609375,
        475.1654052734375,
        321.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "두발 고정용 로션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        325.2797546386719,
        475.1654052734375,
        338.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        325.2797546386719,
        475.1654052734375,
        338.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "580",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        325.2797546386719,
        475.1654052734375,
        338.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "590",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        325.2797546386719,
        475.1654052734375,
        338.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목욕 및 샤워(Bathing, showering)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.0399932861328,
        342.31976318359375,
        360.6342468261719,
        355.56732177734375
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "손세정용 액상 비누",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        359.23974609375,
        475.1654052734375,
        372.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양손 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        359.23974609375,
        475.1654052734375,
        372.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "860",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        359.23974609375,
        475.1654052734375,
        372.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "840",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        359.23974609375,
        475.1654052734375,
        372.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "손세정용 고상 비누",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        376.2797546386719,
        475.1654052734375,
        389.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양손 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        376.2797546386719,
        475.1654052734375,
        389.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "860",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        376.2797546386719,
        475.1654052734375,
        389.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "840",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        376.2797546386719,
        475.1654052734375,
        389.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "샤워용 액상 비누",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        393.31976318359375,
        480.68505859375,
        406.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "총 신체면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        393.31976318359375,
        480.68505859375,
        406.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "17500",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        393.31976318359375,
        480.68505859375,
        406.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "19400",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        393.31976318359375,
        480.68505859375,
        406.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "샤워용 고형 비누",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        410.23974609375,
        480.68505859375,
        423.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "총 신체면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        410.23974609375,
        480.68505859375,
        423.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "17500",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        410.23974609375,
        480.68505859375,
        423.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "19400",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        410.23974609375,
        480.68505859375,
        423.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목욕용 거품제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        427.2797546386719,
        397.4050598144531,
        440.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신체 면적 – 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        427.2797546386719,
        397.4050598144531,
        440.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16340",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        427.2797546386719,
        397.4050598144531,
        440.5273132324219
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목욕용 염제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        444.31976318359375,
        397.4050598144531,
        457.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신체 면적 – 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        444.31976318359375,
        397.4050598144531,
        457.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16340",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        444.31976318359375,
        397.4050598144531,
        457.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목욕용 오일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        461.23974609375,
        397.4050598144531,
        474.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신체 면적 – 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        461.23974609375,
        397.4050598144531,
        474.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16340",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        461.23974609375,
        397.4050598144531,
        474.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부 관리(Skin care)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        236.51998901367188,
        478.2797546386719,
        330.155029296875,
        491.5273132324219
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "얼굴용 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        495.31976318359375,
        475.1654052734375,
        508.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 머리 면적(여성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        495.31976318359375,
        475.1654052734375,
        508.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "565",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        495.31976318359375,
        475.1654052734375,
        508.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "555",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        495.31976318359375,
        475.1654052734375,
        508.56732177734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(+ 목)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        512.23974609375,
        391.8854064941406,
        525.4873657226562
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "320",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        512.23974609375,
        391.8854064941406,
        525.4873657226562
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(+ 뒷목)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        529.2797241210938,
        389.1255798339844,
        542.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "80",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        529.2797241210938,
        389.1255798339844,
        542.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바디 로숀",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        546.3197021484375,
        397.4050598144531,
        559.5673217773438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신체 면적-머리 면적(여성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        546.3197021484375,
        397.4050598144531,
        559.5673217773438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "15670",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        546.3197021484375,
        397.4050598144531,
        559.5673217773438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "핸드 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        563.23974609375,
        391.8854064941406,
        576.4873657226562
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양손 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        563.23974609375,
        391.8854064941406,
        576.4873657226562
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "860",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        563.23974609375,
        391.8854064941406,
        576.4873657226562
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필링/스크럽 젤",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        580.2797241210938,
        475.1654052734375,
        593.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 머리 면적(여성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        580.2797241210938,
        475.1654052734375,
        593.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "565",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        580.2797241210938,
        475.1654052734375,
        593.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "555",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        580.2797241210938,
        475.1654052734375,
        593.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "얼굴 팩",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        597.3197021484375,
        475.1654052734375,
        610.5673217773438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 머리 면적(여성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        597.3197021484375,
        475.1654052734375,
        610.5673217773438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "565",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        597.3197021484375,
        475.1654052734375,
        610.5673217773438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "555",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        597.3197021484375,
        475.1654052734375,
        610.5673217773438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바디 팩",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        614.2396850585938,
        397.4050598144531,
        627.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신체 면적-머리 면적(여성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        614.2396850585938,
        397.4050598144531,
        627.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "15670",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        614.2396850585938,
        397.4050598144531,
        627.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부 미백 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        631.2797241210938,
        475.1654052734375,
        644.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 머리 면적(여성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        631.2797241210938,
        475.1654052734375,
        644.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "565",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        631.2797241210938,
        475.1654052734375,
        644.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "555",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        631.2797241210938,
        475.1654052734375,
        644.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "메이크업 및 손톱 관리(Make-up and nail care)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        174.0,
        648.3197021484375,
        392.55450439453125,
        661.5673217773438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리퀴드 파운데이션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        665.2396850585938,
        475.1654052734375,
        678.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 머리 면적(여성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        665.2396850585938,
        475.1654052734375,
        678.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "565",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        665.2396850585938,
        475.1654052734375,
        678.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "555",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        665.2396850585938,
        475.1654052734375,
        678.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "메이크업 리무버",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        682.2797241210938,
        475.1654052734375,
        695.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 머리 면적(여성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        682.2797241210938,
        475.1654052734375,
        695.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "565",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        682.2797241210938,
        475.1654052734375,
        695.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "555",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        682.2797241210938,
        475.1654052734375,
        695.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아이 섀도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        699.3197021484375,
        389.1255798339844,
        712.5673217773438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "24",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        699.3197021484375,
        389.1255798339844,
        712.5673217773438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마스카라",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        716.2396850585938,
        390.2059020996094,
        729.4873046875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.6",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        716.2396850585938,
        390.2059020996094,
        729.4873046875
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아이라이너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        733.2797241210938,
        390.2059020996094,
        746.52734375
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        733.2797241210938,
        390.2059020996094,
        746.52734375
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아이 메이크업 리무버",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        750.3197021484375,
        389.1255798339844,
        763.5673217773438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "50",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        750.3197021484375,
        389.1255798339844,
        763.5673217773438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 36 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 위해평가를 위한 피부체표면적 조사집(식품의약품안전청, 2010)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        593.3343505859375,
        353.75201416015625,
        605.185302734375
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품형태",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        104.39999389648438,
        82.03974151611328,
        316.31951904296875,
        95.28732299804688
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화장품 적용 신체부위",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        104.39999389648438,
        82.03974151611328,
        316.31951904296875,
        95.28732299804688
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부 표면적(㎠)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        390.1199951171875,
        73.51974487304688,
        461.0047912597656,
        86.76732635498047
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "RIVM",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        371.5199890136719,
        90.43974304199219,
        476.0876159667969,
        103.68732452392578
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EPA",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        371.5199890136719,
        90.43974304199219,
        476.0876159667969,
        103.68732452392578
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "손톱 광택제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        107.47974395751953,
        386.36578369140625,
        120.72732543945312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        107.47974395751953,
        386.36578369140625,
        120.72732543945312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "손톱 광택제 제거제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        124.51974487304688,
        389.1255798339844,
        137.76731872558594
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        124.51974487304688,
        389.1255798339844,
        137.76731872558594
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "립스틱, 입술크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        141.4397430419922,
        390.2059020996094,
        154.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.8",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        141.4397430419922,
        390.2059020996094,
        154.68731689453125
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방취제(deodorant)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        241.55999755859375,
        158.479736328125,
        325.1148376464844,
        171.72731018066406
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "데오도란트 스틱형/롤러형",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        175.51974487304688,
        391.8854064941406,
        188.76731872558594
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양쪽 겨드랑이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        175.51974487304688,
        391.8854064941406,
        188.76731872558594
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "200",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        175.51974487304688,
        391.8854064941406,
        188.76731872558594
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "데오도란트 스프레이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        192.4397430419922,
        391.8854064941406,
        205.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양쪽 겨드랑이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        192.4397430419922,
        391.8854064941406,
        205.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "200",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        192.4397430419922,
        391.8854064941406,
        205.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발관리(Foot care)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        243.1199951171875,
        209.479736328125,
        323.43450927734375,
        222.72731018066406
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제한용 풋크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        226.51974487304688,
        477.92523193359375,
        239.76731872558594
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양발 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        226.51974487304688,
        477.92523193359375,
        239.76731872558594
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1170",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        226.51974487304688,
        477.92523193359375,
        239.76731872558594
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1120",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        226.51974487304688,
        477.92523193359375,
        239.76731872558594
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항균용 풋크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        243.4397430419922,
        477.92523193359375,
        256.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양발 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        243.4397430419922,
        477.92523193359375,
        256.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1170",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        243.4397430419922,
        477.92523193359375,
        256.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1120",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        243.4397430419922,
        477.92523193359375,
        256.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방향제(Fragrances)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        240.95999145507812,
        260.4797668457031,
        325.7139892578125,
        273.7273254394531
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "오드트왈렛 스프레이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        277.5197448730469,
        391.8854064941406,
        290.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "200",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        277.5197448730469,
        391.8854064941406,
        290.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "향수 스프레이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        294.43975830078125,
        391.8854064941406,
        307.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        294.43975830078125,
        391.8854064941406,
        307.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "남성용 화장품(Men’s cosmetics)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        209.75999450683594,
        311.4797668457031,
        356.91436767578125,
        324.7273254394531
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "면도용 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        328.5197448730469,
        475.1654052734375,
        341.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/4 머리 면적(남성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        328.5197448730469,
        475.1654052734375,
        341.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "305",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        328.5197448730469,
        475.1654052734375,
        341.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "325",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        328.5197448730469,
        475.1654052734375,
        341.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에프터쉐이브",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        345.43975830078125,
        475.1654052734375,
        358.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/4 머리 면적(남성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        345.43975830078125,
        475.1654052734375,
        358.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "305",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        345.43975830078125,
        475.1654052734375,
        358.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "325",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        345.43975830078125,
        475.1654052734375,
        358.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자외선 차단 화장품(Sun care cosmetics)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        190.3199920654297,
        362.479736328125,
        376.3543701171875,
        375.727294921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자외선 차단 로숀",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        379.5197448730469,
        480.68505859375,
        392.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "총 신체면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        379.5197448730469,
        480.68505859375,
        392.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "17500",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        379.5197448730469,
        480.68505859375,
        392.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "19400",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        379.5197448730469,
        480.68505859375,
        392.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자외선 차단 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        396.43975830078125,
        480.68505859375,
        409.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "총 신체면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        396.43975830078125,
        480.68505859375,
        409.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "17500",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        396.43975830078125,
        480.68505859375,
        409.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "19400",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        396.43975830078125,
        480.68505859375,
        409.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아기용품(Baby care)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        237.36000061035156,
        413.479736328125,
        329.19451904296875,
        426.727294921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "베이비 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        430.5197448730469,
        391.8854064941406,
        443.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아기 엉덩이(생후 4.5개월)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        430.5197448730469,
        391.8854064941406,
        443.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "190",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        430.5197448730469,
        391.8854064941406,
        443.7673034667969
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "베이비 오일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        447.43975830078125,
        391.8854064941406,
        460.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아기 엉덩이(생후 4.5개월)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        447.43975830078125,
        391.8854064941406,
        460.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "190",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        447.43975830078125,
        391.8854064941406,
        460.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "베이비 파우더",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        464.479736328125,
        391.8854064941406,
        477.727294921875
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아기 엉덩이(생후 4.5개월)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        464.479736328125,
        391.8854064941406,
        477.727294921875
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "190",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        464.479736328125,
        391.8854064941406,
        477.727294921875
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기타(Miscellaneous)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        238.55999755859375,
        481.5197448730469,
        328.11474609375,
        494.7673034667969
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제모용 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        498.43975830078125,
        477.92523193359375,
        511.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다리 면적(여성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        498.43975830078125,
        477.92523193359375,
        511.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5530",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        498.43975830078125,
        477.92523193359375,
        511.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5460",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        498.43975830078125,
        477.92523193359375,
        511.68731689453125
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마사지용 오일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        515.479736328125,
        397.4050598144531,
        528.7273559570312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신체 면적 – 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        515.479736328125,
        397.4050598144531,
        528.7273559570312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16340",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        515.479736328125,
        397.4050598144531,
        528.7273559570312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목욕용 오일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        532.5197143554688,
        397.4050598144531,
        545.767333984375
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신체 면적 – 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        532.5197143554688,
        397.4050598144531,
        545.767333984375
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16340",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        532.5197143554688,
        397.4050598144531,
        545.767333984375
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소아용 얼굴 물감",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        549.439697265625,
        475.1654052734375,
        562.6873168945312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 소아 머리 면적(4.5세)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        549.439697265625,
        475.1654052734375,
        562.6873168945312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "475",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        549.439697265625,
        475.1654052734375,
        562.6873168945312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "496",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        549.439697265625,
        475.1654052734375,
        562.6873168945312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성인용 얼굴 물감",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        566.479736328125,
        475.1654052734375,
        579.7273559570312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1/2 머리 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        566.479736328125,
        475.1654052734375,
        579.7273559570312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "580",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        566.479736328125,
        475.1654052734375,
        579.7273559570312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "650",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        62.318359375,
        566.479736328125,
        475.1654052734375,
        579.7273559570312
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 37 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 5. 한국인의 화장품 사용량",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        233.87998962402344,
        87.98039245605469
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.‘2014년~2016년 화장품 위해평가 선진화 연구’결과에 근거한 화장품 유형별 추정 일일 사",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        121.19248962402344,
        538.5599365234375,
        132.83624267578125
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용량 및 노출량은 다음과 같다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        140.99249267578125,
        223.53562927246094,
        152.63624572753906
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 1. 한국인의 화장품 유형별 추정 일일 사용량 및 노출량",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        188.6324920654297,
        356.5199890136719,
        200.2762451171875
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품 유형",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        112.68000030517578,
        241.63973999023438,
        157.6800079345703,
        254.88731384277344
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "추정 일일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        204.36000061035156,
        227.5997314453125,
        251.06149291992188,
        240.84730529785156
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        211.55999755859375,
        241.63973999023438,
        240.4798583984375,
        254.88731384277344
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(g/day)(90%)",
      "font_size": 9.588688850402832,
      "font_name": "MalgunGothicBold",
      "bbox": [
        199.1999969482422,
        255.6797332763672,
        252.90628051757812,
        268.92730712890625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체중 당 일일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        264.7200012207031,
        220.63973999023438,
        325.58148193359375,
        233.88731384277344
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        276.0,
        234.6797332763672,
        312.7423095703125,
        275.8872985839844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        276.0,
        234.6797332763672,
        312.7423095703125,
        275.8872985839844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "bw/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        276.0,
        234.6797332763672,
        312.7423095703125,
        275.8872985839844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잔류 지수1",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothicBold",
      "bbox": [
        333.47998046875,
        227.19790649414062,
        379.76617431640625,
        240.84730529785156
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Retention",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        334.1999816894531,
        241.63973999023438,
        382.4617614746094,
        254.88731384277344
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "factor)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        342.6000061035156,
        255.6797332763672,
        371.0040283203125,
        268.92730712890625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "계산된",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        399.239990234375,
        220.63973999023438,
        432.6214294433594,
        275.8872985839844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        399.239990234375,
        220.63973999023438,
        432.6214294433594,
        275.8872985839844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        399.239990234375,
        220.63973999023438,
        432.6214294433594,
        275.8872985839844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(g/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        399.239990234375,
        220.63973999023438,
        432.6214294433594,
        275.8872985839844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "계산된 체중",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        455.5199890136719,
        213.6797332763672,
        511.70147705078125,
        226.92730712890625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "당 일일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        464.3999938964844,
        227.5997314453125,
        502.22149658203125,
        282.8473205566406
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        464.3999938964844,
        227.5997314453125,
        502.22149658203125,
        282.8473205566406
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        464.3999938964844,
        227.5997314453125,
        502.22149658203125,
        282.8473205566406
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "bw/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        464.3999938964844,
        227.5997314453125,
        502.22149658203125,
        282.8473205566406
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목욕, 샤워 및 인체세정 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        231.47999572753906,
        287.3597412109375,
        363.5999755859375,
        300.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샤워 젤",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        304.3997497558594,
        491.2462463378906,
        317.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10.40",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        304.3997497558594,
        491.2462463378906,
        317.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "161.55",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        304.3997497558594,
        491.2462463378906,
        317.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.01",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        304.3997497558594,
        491.2462463378906,
        317.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        304.3997497558594,
        491.2462463378906,
        317.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.62",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        304.3997497558594,
        491.2462463378906,
        317.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "손 세정 비누",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        321.31976318359375,
        491.2462463378906,
        334.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24.04",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        321.31976318359375,
        491.2462463378906,
        334.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "382.15",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        321.31976318359375,
        491.2462463378906,
        334.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.01",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        321.31976318359375,
        491.2462463378906,
        334.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.24",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        321.31976318359375,
        491.2462463378906,
        334.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.82",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        321.31976318359375,
        491.2462463378906,
        334.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물휴지",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        338.3597412109375,
        494.0060729980469,
        351.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.57",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        338.3597412109375,
        494.0060729980469,
        351.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "71.15",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        338.3597412109375,
        494.0060729980469,
        351.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        338.3597412109375,
        494.0060729980469,
        351.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.57",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        338.3597412109375,
        494.0060729980469,
        351.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "71.15",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        338.3597412109375,
        494.0060729980469,
        351.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모발 케어(남녀)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        262.0799865722656,
        355.3997497558594,
        333.1546936035156,
        368.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샴푸",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        372.31976318359375,
        491.2462463378906,
        385.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9.25",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        372.31976318359375,
        491.2462463378906,
        385.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "151.84",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        372.31976318359375,
        491.2462463378906,
        385.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.01",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        372.31976318359375,
        491.2462463378906,
        385.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.09",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        372.31976318359375,
        491.2462463378906,
        385.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.52",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        372.31976318359375,
        491.2462463378906,
        385.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "헤어 컨디셔너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        389.3597412109375,
        491.2462463378906,
        402.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6.10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        389.3597412109375,
        491.2462463378906,
        402.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "102.88",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        389.3597412109375,
        491.2462463378906,
        402.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.01",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        389.3597412109375,
        491.2462463378906,
        402.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.06",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        389.3597412109375,
        491.2462463378906,
        402.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.03",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        389.3597412109375,
        491.2462463378906,
        402.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "헤어스타일링제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        406.3997497558594,
        488.4864196777344,
        419.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.76",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        406.3997497558594,
        488.4864196777344,
        419.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        406.3997497558594,
        488.4864196777344,
        419.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.28",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        406.3997497558594,
        488.4864196777344,
        419.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        406.3997497558594,
        488.4864196777344,
        419.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부 관리(남녀)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        262.0799865722656,
        423.31976318359375,
        333.1546936035156,
        436.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바디로션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        440.3597412109375,
        494.0060729980469,
        453.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.48",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        440.3597412109375,
        494.0060729980469,
        453.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "92.23",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        440.3597412109375,
        494.0060729980469,
        453.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        440.3597412109375,
        494.0060729980469,
        453.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.48",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        440.3597412109375,
        494.0060729980469,
        453.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "92.23",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        440.3597412109375,
        494.0060729980469,
        453.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "얼굴크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        457.3997497558594,
        494.0060729980469,
        470.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.76",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        457.3997497558594,
        494.0060729980469,
        470.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "29.14",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        457.3997497558594,
        494.0060729980469,
        470.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        457.3997497558594,
        494.0060729980469,
        470.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.76",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        457.3997497558594,
        494.0060729980469,
        470.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "29.14",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        457.3997497558594,
        494.0060729980469,
        470.6473083496094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핸드크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        474.31976318359375,
        494.0060729980469,
        487.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.38",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        474.31976318359375,
        494.0060729980469,
        487.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "23.59",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        474.31976318359375,
        494.0060729980469,
        487.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        474.31976318359375,
        494.0060729980469,
        487.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.38",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        474.31976318359375,
        494.0060729980469,
        487.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "23.59",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        474.31976318359375,
        494.0060729980469,
        487.56732177734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메이크업(여성)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        264.47998046875,
        491.3597412109375,
        330.63470458984375,
        504.6072998046875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "리퀴드 파운데이션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        508.3997497558594,
        491.2462463378906,
        521.6473388671875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.30",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        508.3997497558594,
        491.2462463378906,
        521.6473388671875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.28",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        508.3997497558594,
        491.2462463378906,
        521.6473388671875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        508.3997497558594,
        491.2462463378906,
        521.6473388671875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.30",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        508.3997497558594,
        491.2462463378906,
        521.6473388671875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.28",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        508.3997497558594,
        491.2462463378906,
        521.6473388671875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메이크업 리무버",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        523.2797241210938,
        156.48001098632812,
        536.52734375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(클렌징 크림/오일)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        531.3197021484375,
        491.2462463378906,
        552.4873657226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.14",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        531.3197021484375,
        491.2462463378906,
        552.4873657226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "36.95",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        531.3197021484375,
        491.2462463378906,
        552.4873657226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        531.3197021484375,
        491.2462463378906,
        552.4873657226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.21",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        531.3197021484375,
        491.2462463378906,
        552.4873657226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.70",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        531.3197021484375,
        491.2462463378906,
        552.4873657226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아이 섀도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        554.23974609375,
        491.2462463378906,
        567.4873657226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.02",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        554.23974609375,
        491.2462463378906,
        567.4873657226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.29",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        554.23974609375,
        491.2462463378906,
        567.4873657226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        554.23974609375,
        491.2462463378906,
        567.4873657226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.02",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        554.23974609375,
        491.2462463378906,
        567.4873657226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.29",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        554.23974609375,
        491.2462463378906,
        567.4873657226562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마스카라",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        571.1597290039062,
        491.2462463378906,
        584.4073486328125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.03",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        571.1597290039062,
        491.2462463378906,
        584.4073486328125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.50",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        571.1597290039062,
        491.2462463378906,
        584.4073486328125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        571.1597290039062,
        491.2462463378906,
        584.4073486328125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.03",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        571.1597290039062,
        491.2462463378906,
        584.4073486328125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.50",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        571.1597290039062,
        491.2462463378906,
        584.4073486328125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아이라이너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        588.19970703125,
        491.2462463378906,
        601.4473266601562
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.01",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        588.19970703125,
        491.2462463378906,
        601.4473266601562
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.23",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        588.19970703125,
        491.2462463378906,
        601.4473266601562
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        588.19970703125,
        491.2462463378906,
        601.4473266601562
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.01",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        588.19970703125,
        491.2462463378906,
        601.4473266601562
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.23",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        588.19970703125,
        491.2462463378906,
        601.4473266601562
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "립스틱, 입술보호제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        605.2396850585938,
        491.2462463378906,
        618.4873046875
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.05",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        605.2396850585938,
        491.2462463378906,
        618.4873046875
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.87",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        605.2396850585938,
        491.2462463378906,
        618.4873046875
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        605.2396850585938,
        491.2462463378906,
        618.4873046875
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.05",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        605.2396850585938,
        491.2462463378906,
        618.4873046875
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.87",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        605.2396850585938,
        491.2462463378906,
        618.4873046875
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "데오도란트(남녀)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        259.55999755859375,
        622.1597290039062,
        335.5546875,
        635.4073486328125
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비분무형 데오도란트",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        639.19970703125,
        494.0060729980469,
        652.4473266601562
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.33",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        639.19970703125,
        494.0060729980469,
        652.4473266601562
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "36.12",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        639.19970703125,
        494.0060729980469,
        652.4473266601562
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        639.19970703125,
        494.0060729980469,
        652.4473266601562
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.33",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        639.19970703125,
        494.0060729980469,
        652.4473266601562
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "36.12",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        639.19970703125,
        494.0060729980469,
        652.4473266601562
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 잔류지수(retention factor)는 젖은 피부나 머리카락에 제품(샤워 젤, 샴푸 등)을 사용함으로써 발생하는 세척 및 희",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        663.5343627929688,
        538.5599975585938,
        675.2653198242188
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "석 효과를 보정하기 위해 SCCNFP 에 의해 사용된 지수임[SCCNFP/0321/00]",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        64.91999816894531,
        680.7056274414062,
        375.6039733886719,
        690.1978149414062
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 38 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 자외선차단제의 경우, 한국인의 평균 체표면적* 16,191 cm2에 0.5 mg/cm2의 양을 적용하여 하",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        73.35562133789062,
        538.5599365234375,
        86.39624786376953
      ],
      "page_num": 44,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "루 2회 사용할 경우를 가정할 때 일일 사용량인 17.0 g/일을 적용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.04000091552734,
        94.55249786376953,
        457.07952880859375,
        106.19625091552734
      ],
      "page_num": 44,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "* 위해평가를 위한 피부체표면적 조사집(식품의약품안전처, 2010)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        117.20999908447266,
        334.73309326171875,
        127.8778076171875
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 보존제 등 평가대상 물질이 여러 제형의 화장품에 포함되는 경우, 소비자가 동시에 여러 제",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        155.15249633789062,
        538.43994140625,
        166.79624938964844
      ],
      "page_num": 44,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형의 화장품을 사용하는 경우를 가정하여 통합 사용량을 고려할 수 있다. SCCS는 보존제의",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        174.95249938964844,
        543.9596557617188,
        186.59625244140625
      ],
      "page_num": 44,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우에 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 통합적인 사용량 및 잔류지수",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        194.7524871826172,
        538.5596313476562,
        206.396240234375
      ],
      "page_num": 44,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 계산하여 이용할 것을 권고한다(SCCNFP/0321/00). 최신의 노출 자료와 최악의 경우까지",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        214.552490234375,
        543.9592895507812,
        226.1962432861328
      ],
      "page_num": 44,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려한 예측상황(worst-case scenario)에서 안전역(MOS) 산출 시, 16.9 g/일 또는 275 mg/kg",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        234.3524932861328,
        543.9602661132812,
        245.99624633789062
      ],
      "page_num": 44,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "bw/day의 수치를 사용할 수 있다(표2).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        254.15248107910156,
        263.37542724609375,
        265.7962341308594
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 기타성분, 색소 등 특정 성분이 여러 유형의 화장품에 함유되어 인체에 노출되는 경우, 노출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        278.0325012207031,
        538.4400634765625,
        289.6762390136719
      ],
      "page_num": 44,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유형에 따라 표 2의 통합 노출량 자료를 사용한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        297.83251953125,
        329.1595458984375,
        309.47625732421875
      ],
      "page_num": 44,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 2. 한국인의 화장품 사용으로 인한 통합 노출량*",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        343.9555969238281,
        316.0199890136719,
        356.9962463378906
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "노출유형",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        99.72000122070312,
        371.8397521972656,
        487.25579833984375,
        385.0873107910156
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        99.72000122070312,
        371.8397521972656,
        487.25579833984375,
        385.0873107910156
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "g/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        99.72000122070312,
        371.8397521972656,
        487.25579833984375,
        385.0873107910156
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        99.72000122070312,
        371.8397521972656,
        487.25579833984375,
        385.0873107910156
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용 후 씻어내는 피부",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        67.19999694824219,
        406.3997497558594,
        175.70106506347656,
        419.6473083496094
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 모발 클렌징 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        422.3597412109375,
        167.16000366210938,
        435.6072998046875
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "샤워 젤",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        238.1999969482422,
        388.8797607421875,
        460.4057312011719,
        402.1273193359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        238.1999969482422,
        388.8797607421875,
        460.4057312011719,
        402.1273193359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.62",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        238.1999969482422,
        388.8797607421875,
        460.4057312011719,
        402.1273193359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "손 세정 비누",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        225.72000122070312,
        405.91973876953125,
        460.4057312011719,
        419.16729736328125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.24",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        225.72000122070312,
        405.91973876953125,
        460.4057312011719,
        419.16729736328125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.82",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        225.72000122070312,
        405.91973876953125,
        460.4057312011719,
        419.16729736328125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샴푸",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        245.75999450683594,
        422.8397521972656,
        460.4057312011719,
        436.0873107910156
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.09",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        245.75999450683594,
        422.8397521972656,
        460.4057312011719,
        436.0873107910156
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.52",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        245.75999450683594,
        422.8397521972656,
        460.4057312011719,
        436.0873107910156
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "헤어 컨디셔너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        223.1999969482422,
        439.8797607421875,
        460.4057312011719,
        453.1273193359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.06",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        223.1999969482422,
        439.8797607421875,
        460.4057312011719,
        453.1273193359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.03",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        223.1999969482422,
        439.8797607421875,
        460.4057312011719,
        453.1273193359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용 후 씻어내지 않는",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        67.19999694824219,
        491.3597412109375,
        175.70106506347656,
        504.6072998046875
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부 및 모발 관리 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.68000030517578,
        507.4397277832031,
        174.60000610351562,
        520.6873168945312
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바디로션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        235.67999267578125,
        456.91973876953125,
        463.1655578613281,
        470.16729736328125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.48",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        235.67999267578125,
        456.91973876953125,
        463.1655578613281,
        470.16729736328125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "92.23",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        235.67999267578125,
        456.91973876953125,
        463.1655578613281,
        470.16729736328125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "얼굴 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.27999877929688,
        473.8397521972656,
        463.1655578613281,
        487.0873107910156
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.76",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.27999877929688,
        473.8397521972656,
        463.1655578613281,
        487.0873107910156
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "29.14",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.27999877929688,
        473.8397521972656,
        463.1655578613281,
        487.0873107910156
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핸드 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.27999877929688,
        490.8797607421875,
        463.1655578613281,
        504.1273193359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.38",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.27999877929688,
        490.8797607421875,
        463.1655578613281,
        504.1273193359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "23.59",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.27999877929688,
        490.8797607421875,
        463.1655578613281,
        504.1273193359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비 분무형 데오도란트",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        205.67999267578125,
        507.9197692871094,
        463.1655578613281,
        521.1673583984375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.33",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        205.67999267578125,
        507.9197692871094,
        463.1655578613281,
        521.1673583984375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "36.12",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        205.67999267578125,
        507.9197692871094,
        463.1655578613281,
        521.1673583984375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "헤어스타일링",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        225.72000122070312,
        524.8397216796875,
        457.6459045410156,
        538.0873413085938
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.28",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        225.72000122070312,
        524.8397216796875,
        457.6459045410156,
        538.0873413085938
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        225.72000122070312,
        524.8397216796875,
        457.6459045410156,
        538.0873413085938
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물휴지",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        240.72000122070312,
        541.8796997070312,
        463.1655578613281,
        555.1273193359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.57",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        240.72000122070312,
        541.8796997070312,
        463.1655578613281,
        555.1273193359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "71.15",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        240.72000122070312,
        541.8796997070312,
        463.1655578613281,
        555.1273193359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메이크업 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        87.23999786376953,
        601.3997192382812,
        152.16000366210938,
        614.6473388671875
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리퀴드 파운데이션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        213.239990234375,
        558.9197387695312,
        460.4057312011719,
        572.1673583984375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.30",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        213.239990234375,
        558.9197387695312,
        460.4057312011719,
        572.1673583984375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.28",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        213.239990234375,
        558.9197387695312,
        460.4057312011719,
        572.1673583984375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메이크업 리무버",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        218.27999877929688,
        575.8397216796875,
        460.4057312011719,
        589.0873413085938
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.21",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        218.27999877929688,
        575.8397216796875,
        460.4057312011719,
        589.0873413085938
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.70",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        218.27999877929688,
        575.8397216796875,
        460.4057312011719,
        589.0873413085938
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아이 섀도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.27999877929688,
        592.8796997070312,
        460.4057312011719,
        606.1273193359375
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.02",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.27999877929688,
        592.8796997070312,
        460.4057312011719,
        606.1273193359375
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.29",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.27999877929688,
        592.8796997070312,
        460.4057312011719,
        606.1273193359375
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마스카라",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        235.67999267578125,
        609.9197387695312,
        460.4057312011719,
        623.1673583984375
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.03",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        235.67999267578125,
        609.9197387695312,
        460.4057312011719,
        623.1673583984375
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.50",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        235.67999267578125,
        609.9197387695312,
        460.4057312011719,
        623.1673583984375
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "립스틱",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        240.72000122070312,
        626.8397216796875,
        460.4057312011719,
        640.0873413085938
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.05",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        240.72000122070312,
        626.8397216796875,
        460.4057312011719,
        640.0873413085938
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.87",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        240.72000122070312,
        626.8397216796875,
        460.4057312011719,
        640.0873413085938
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아이라이너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        230.75999450683594,
        643.8796997070312,
        460.4057312011719,
        657.1273193359375
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.01",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        230.75999450683594,
        643.8796997070312,
        460.4057312011719,
        657.1273193359375
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.23",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        230.75999450683594,
        643.8796997070312,
        460.4057312011719,
        657.1273193359375
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TOTAL",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        179.1599884033203,
        660.9197387695312,
        459.3254089355469,
        674.1673583984375
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "± 16.9",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        179.1599884033203,
        660.9197387695312,
        459.3254089355469,
        674.1673583984375
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "275",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        179.1599884033203,
        660.9197387695312,
        459.3254089355469,
        674.1673583984375
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "* 2014∼2016 화장품 위해평가 선진화 연구",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        686.4656372070312,
        236.75999450683594,
        695.9578247070312
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 39 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 6. 유럽의 화장품 사용량",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        221.87998962402344,
        87.98039245605469
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 유럽 SCCS 가이드라인에서 제시한 유럽의 화장품 유형별 추정 일일 노출량 및 보존제 통합",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        119.63249206542969,
        543.9596557617188,
        131.2762451171875
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일일 사용량 및 노출량은 다음과 같다(Hall et al, 2007, 2011).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        139.4324951171875,
        381.575439453125,
        151.0762481689453
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 1. 유럽의 화장품 유형별 일일 사용량 및 노출량",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        177.95249938964844,
        317.9996643066406,
        189.59625244140625
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품 유형",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        108.47999572753906,
        224.83973693847656,
        153.47952270507812,
        238.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "추정 일일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        194.51998901367188,
        212.83973693847656,
        241.2209930419922,
        226.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        200.63999938964844,
        224.83973693847656,
        232.0449676513672,
        250.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(g/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        200.63999938964844,
        224.83973693847656,
        232.0449676513672,
        250.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체중 당 일일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        252.0,
        206.83973693847656,
        312.8614807128906,
        220.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        263.2799987792969,
        218.83973693847656,
        300.0223083496094,
        256.0873107910156
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        263.2799987792969,
        218.83973693847656,
        300.0223083496094,
        256.0873107910156
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "bw/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        263.2799987792969,
        218.83973693847656,
        300.0223083496094,
        256.0873107910156
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잔류 지수1",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothicBold",
      "bbox": [
        323.5199890136719,
        212.31790161132812,
        369.9261779785156,
        226.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Retention",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        324.239990234375,
        224.83973693847656,
        372.5027770996094,
        238.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "factor)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        332.7599792480469,
        236.83973693847656,
        361.04449462890625,
        250.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "계산된 일일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        385.44000244140625,
        212.83973693847656,
        441.6214904785156,
        226.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        396.3599853515625,
        224.83973693847656,
        427.7649841308594,
        250.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(g/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        396.3599853515625,
        224.83973693847656,
        427.7649841308594,
        250.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "계산된 체중 당",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        451.91998291015625,
        212.83973693847656,
        515.3015747070312,
        238.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일일 노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        451.91998291015625,
        212.83973693847656,
        515.3015747070312,
        238.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg bw/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        450.0,
        236.83973693847656,
        514.1650390625,
        250.08731079101562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목욕 및 샤워",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        267.6000061035156,
        262.1597595214844,
        327.47998046875,
        275.4073181152344
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샤워 젤",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        279.19976806640625,
        491.2462463378906,
        292.44732666015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18.67",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        279.19976806640625,
        491.2462463378906,
        292.44732666015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "279.20",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        279.19976806640625,
        491.2462463378906,
        292.44732666015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.01",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        279.19976806640625,
        491.2462463378906,
        292.44732666015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.19",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        279.19976806640625,
        491.2462463378906,
        292.44732666015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.79",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        279.19976806640625,
        491.2462463378906,
        292.44732666015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모발 관리",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        275.0400085449219,
        296.1197509765625,
        320.03997802734375,
        309.3673095703125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샴푸",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        313.1597595214844,
        491.2462463378906,
        326.4073181152344
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10.46",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        313.1597595214844,
        491.2462463378906,
        326.4073181152344
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "150.49",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        313.1597595214844,
        491.2462463378906,
        326.4073181152344
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.01",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        313.1597595214844,
        491.2462463378906,
        326.4073181152344
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.11",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        313.1597595214844,
        491.2462463378906,
        326.4073181152344
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.51",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        313.1597595214844,
        491.2462463378906,
        326.4073181152344
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "헤어컨디셔너2",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        329.67791748046875,
        282.7251281738281,
        343.4472961425781
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.92",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        329.67791748046875,
        282.7251281738281,
        343.4472961425781
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        329.67791748046875,
        282.7251281738281,
        343.4472961425781
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "헤어스타일링제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        347.1197509765625,
        491.2462463378906,
        360.3673095703125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        347.1197509765625,
        491.2462463378906,
        360.3673095703125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "57.40",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        347.1197509765625,
        491.2462463378906,
        360.3673095703125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        347.1197509765625,
        491.2462463378906,
        360.3673095703125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.40",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        347.1197509765625,
        491.2462463378906,
        360.3673095703125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.74",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        347.1197509765625,
        491.2462463378906,
        360.3673095703125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반영구적 염모제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        364.999755859375,
        423.86212158203125,
        391.2073059082031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "35ml(per",
      "font_size": 9.828072547912598,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        364.999755859375,
        423.86212158203125,
        391.2073059082031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "application)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        364.999755859375,
        423.86212158203125,
        391.2073059082031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        364.999755859375,
        423.86212158203125,
        391.2073059082031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        364.999755859375,
        423.86212158203125,
        391.2073059082031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Not",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        364.999755859375,
        423.86212158203125,
        391.2073059082031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "calculated3",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothic",
      "bbox": [
        387.3599853515625,
        371.479736328125,
        483.8451232910156,
        391.2073059082031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        387.3599853515625,
        371.479736328125,
        483.8451232910156,
        391.2073059082031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "산화성/영구적 염모제2",
      "font_size": 6.231501579284668,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        393.67974853515625,
        423.86212158203125,
        420.0072937011719
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "100ml(per",
      "font_size": 9.828072547912598,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        393.67974853515625,
        423.86212158203125,
        420.0072937011719
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "application)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        393.67974853515625,
        423.86212158203125,
        420.0072937011719
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        393.67974853515625,
        423.86212158203125,
        420.0072937011719
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        393.67974853515625,
        423.86212158203125,
        420.0072937011719
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Not",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        393.67974853515625,
        423.86212158203125,
        420.0072937011719
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "calculated3",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothic",
      "bbox": [
        387.3599853515625,
        400.1597595214844,
        483.8451232910156,
        420.0072937011719
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        387.3599853515625,
        400.1597595214844,
        483.8451232910156,
        420.0072937011719
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부 관리",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        275.0400085449219,
        421.6397399902344,
        320.03997802734375,
        434.8872985839844
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바디로션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        438.55975341796875,
        496.7658996582031,
        451.80731201171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.82",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        438.55975341796875,
        496.7658996582031,
        451.80731201171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "123.20",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        438.55975341796875,
        496.7658996582031,
        451.80731201171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        438.55975341796875,
        496.7658996582031,
        451.80731201171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.82",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        438.55975341796875,
        496.7658996582031,
        451.80731201171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "123.20",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        438.55975341796875,
        496.7658996582031,
        451.80731201171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "얼굴크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        455.5997619628906,
        494.0060729980469,
        468.8473205566406
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.54",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        455.5997619628906,
        494.0060729980469,
        468.8473205566406
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24.14",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        455.5997619628906,
        494.0060729980469,
        468.8473205566406
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        455.5997619628906,
        494.0060729980469,
        468.8473205566406
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.54",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        455.5997619628906,
        494.0060729980469,
        468.8473205566406
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24.14",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        455.5997619628906,
        494.0060729980469,
        468.8473205566406
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핸드크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        472.6397399902344,
        494.0060729980469,
        485.8872985839844
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.16",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        472.6397399902344,
        494.0060729980469,
        485.8872985839844
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "32.70",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        472.6397399902344,
        494.0060729980469,
        485.8872985839844
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        472.6397399902344,
        494.0060729980469,
        485.8872985839844
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.16",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        472.6397399902344,
        494.0060729980469,
        485.8872985839844
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "32.70",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        472.6397399902344,
        494.0060729980469,
        485.8872985839844
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메이크업",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        277.55999755859375,
        489.55975341796875,
        317.5195007324219,
        502.80731201171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "리퀴드 파운데이션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        506.5997619628906,
        491.2462463378906,
        519.8473510742188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.51",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        506.5997619628906,
        491.2462463378906,
        519.8473510742188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.90",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        506.5997619628906,
        491.2462463378906,
        519.8473510742188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        506.5997619628906,
        491.2462463378906,
        519.8473510742188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.51",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        506.5997619628906,
        491.2462463378906,
        519.8473510742188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.90",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        506.5997619628906,
        491.2462463378906,
        519.8473510742188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메이크업 리무버2",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        523.1178588867188,
        491.2462463378906,
        536.8873291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        523.1178588867188,
        491.2462463378906,
        536.8873291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        523.1178588867188,
        491.2462463378906,
        536.8873291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        523.1178588867188,
        491.2462463378906,
        536.8873291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.50",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        523.1178588867188,
        491.2462463378906,
        536.8873291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8.33",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        523.1178588867188,
        491.2462463378906,
        536.8873291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아이 섀도2",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        540.1578979492188,
        491.2462463378906,
        553.8073120117188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.02",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        540.1578979492188,
        491.2462463378906,
        553.8073120117188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        540.1578979492188,
        491.2462463378906,
        553.8073120117188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        540.1578979492188,
        491.2462463378906,
        553.8073120117188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.02",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        540.1578979492188,
        491.2462463378906,
        553.8073120117188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.33",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        540.1578979492188,
        491.2462463378906,
        553.8073120117188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마스카라2",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        557.077880859375,
        491.2462463378906,
        570.8473510742188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.025",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        557.077880859375,
        491.2462463378906,
        570.8473510742188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        557.077880859375,
        491.2462463378906,
        570.8473510742188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        557.077880859375,
        491.2462463378906,
        570.8473510742188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.025",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        557.077880859375,
        491.2462463378906,
        570.8473510742188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.42",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        557.077880859375,
        491.2462463378906,
        570.8473510742188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아이라이너2",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        574.1178588867188,
        491.2462463378906,
        587.8873291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.005",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        574.1178588867188,
        491.2462463378906,
        587.8873291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        574.1178588867188,
        491.2462463378906,
        587.8873291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        574.1178588867188,
        491.2462463378906,
        587.8873291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.005",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        574.1178588867188,
        491.2462463378906,
        587.8873291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.08",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        574.1178588867188,
        491.2462463378906,
        587.8873291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "립스틱, 입술보호제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        591.5596923828125,
        491.2462463378906,
        604.8073120117188
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.057",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        591.5596923828125,
        491.2462463378906,
        604.8073120117188
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.90",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        591.5596923828125,
        491.2462463378906,
        604.8073120117188
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        591.5596923828125,
        491.2462463378906,
        604.8073120117188
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.057",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        591.5596923828125,
        491.2462463378906,
        604.8073120117188
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.90",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        591.5596923828125,
        491.2462463378906,
        604.8073120117188
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "데오도란트",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        272.5199890136719,
        608.5997314453125,
        322.5590515136719,
        621.8473510742188
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비분무형 데오도란트",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        625.6397094726562,
        494.0060729980469,
        638.8873291015625
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.50",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        625.6397094726562,
        494.0060729980469,
        638.8873291015625
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "22.08",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        625.6397094726562,
        494.0060729980469,
        638.8873291015625
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        625.6397094726562,
        494.0060729980469,
        638.8873291015625
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.50",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        625.6397094726562,
        494.0060729980469,
        638.8873291015625
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "22.08",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        625.6397094726562,
        494.0060729980469,
        638.8873291015625
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "데오도란트 에어로졸",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        641.959716796875,
        183.9805908203125,
        681.1273193359375
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스프레이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        641.959716796875,
        183.9805908203125,
        681.1273193359375
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(에탄올 기반제품)4",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        641.959716796875,
        183.9805908203125,
        681.1273193359375
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.43",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.75999450683594,
        654.3978881835938,
        494.0060729980469,
        668.1673583984375
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20.635",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothic",
      "bbox": [
        206.75999450683594,
        654.3978881835938,
        494.0060729980469,
        668.1673583984375
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.75999450683594,
        654.3978881835938,
        494.0060729980469,
        668.1673583984375
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.43",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.75999450683594,
        654.3978881835938,
        494.0060729980469,
        668.1673583984375
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20.63",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.75999450683594,
        654.3978881835938,
        494.0060729980469,
        668.1673583984375
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "데오도란트 에어로졸",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        682.1597290039062,
        183.9805908203125,
        721.4473266601562
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스프레이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        682.1597290039062,
        183.9805908203125,
        721.4473266601562
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(에탄올 비기반제품)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        81.5999984741211,
        682.1597290039062,
        183.9805908203125,
        721.4473266601562
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.69",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.75999450683594,
        695.1196899414062,
        494.0060729980469,
        708.3673095703125
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.75999450683594,
        695.1196899414062,
        494.0060729980469,
        708.3673095703125
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.75999450683594,
        695.1196899414062,
        494.0060729980469,
        708.3673095703125
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.69",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.75999450683594,
        695.1196899414062,
        494.0060729980469,
        708.3673095703125
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10.00",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.75999450683594,
        695.1196899414062,
        494.0060729980469,
        708.3673095703125
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 잔류지수(retention factor)는 젖은 피부나 머리카락에 사용하는 제품(샤워젤, 샴푸 등)의 세척 및 희석",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        734.8143310546875,
        543.4194946289062,
        746.5452880859375
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "효과를 고려하기 위해 SCCNFP에 의해 사용된 지수임(SCCNFP/0321/00)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        752.12060546875,
        396.71246337890625,
        762.6253051757812
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 40 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2 기존 연구(Hall et al, 2007; 2011)에 포함되지 않는 제품 유형",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        73.6143798828125,
        344.6395263671875,
        85.3453140258789
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3 사용빈도가 낮아 일일 노출량을 계산하지 않음",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        93.23999786376953,
        281.3999938964844,
        107.4637451171875
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4‘에탄올 기반’은 에탄올을 주된 성분으로 함유한 제품을 의미함(Steiling et al., 2014)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        116.81437683105469,
        459.5920104980469,
        128.54531860351562
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5 체중 60kg(기본값)이 아닌 연구에 참여한 사람의 체중이 사용되었음",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        136.4399871826172,
        384.1790771484375,
        150.6637420654297
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 2. 유럽의 보존제 평가를 위한 화장품 사용 통합 노출량",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        201.2324981689453,
        356.5199890136719,
        212.87625122070312
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "노출유형",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        98.4000015258789,
        221.479736328125,
        486.2947998046875,
        234.72731018066406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        98.4000015258789,
        221.479736328125,
        486.2947998046875,
        234.72731018066406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "g/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        98.4000015258789,
        221.479736328125,
        486.2947998046875,
        234.72731018066406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        98.4000015258789,
        221.479736328125,
        486.2947998046875,
        234.72731018066406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용 후 씻어내는 피부",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        66.0,
        256.0397644042969,
        174.50106811523438,
        269.2873229980469
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 모발 클렌징 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        70.91999816894531,
        271.999755859375,
        165.9595184326172,
        285.247314453125
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "샤워 젤",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        234.83999633789062,
        238.51974487304688,
        491.7257385253906,
        251.76731872558594
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.19",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        234.83999633789062,
        238.51974487304688,
        491.7257385253906,
        251.76731872558594
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.79",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        234.83999633789062,
        238.51974487304688,
        491.7257385253906,
        251.76731872558594
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "손 세정 비누",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        222.36000061035156,
        255.4397430419922,
        491.7257385253906,
        268.68731689453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.20",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        222.36000061035156,
        255.4397430419922,
        491.7257385253906,
        268.68731689453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.33",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        222.36000061035156,
        255.4397430419922,
        491.7257385253906,
        268.68731689453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샴푸",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        242.39999389648438,
        272.4797668457031,
        491.7257385253906,
        285.7273254394531
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.11",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        242.39999389648438,
        272.4797668457031,
        491.7257385253906,
        285.7273254394531
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.51",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        242.39999389648438,
        272.4797668457031,
        491.7257385253906,
        285.7273254394531
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "헤어 컨디셔너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        289.5197448730469,
        491.7257385253906,
        302.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.04",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        289.5197448730469,
        491.7257385253906,
        302.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.67",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        289.5197448730469,
        491.7257385253906,
        302.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용 후 씻어내지 않는",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        66.0,
        332.4797668457031,
        174.50106811523438,
        345.7273254394531
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부 및 모발 관리 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.47999954223633,
        348.55975341796875,
        173.40000915527344,
        361.80731201171875
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바디로션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        232.3199920654297,
        306.43975830078125,
        491.7253723144531,
        319.68731689453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.82",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        232.3199920654297,
        306.43975830078125,
        491.7253723144531,
        319.68731689453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "123.20",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        232.3199920654297,
        306.43975830078125,
        491.7253723144531,
        319.68731689453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "얼굴 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        229.79998779296875,
        323.4797668457031,
        491.7255554199219,
        336.7273254394531
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.54",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        229.79998779296875,
        323.4797668457031,
        491.7255554199219,
        336.7273254394531
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24.14",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        229.79998779296875,
        323.4797668457031,
        491.7255554199219,
        336.7273254394531
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핸드 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        229.79998779296875,
        340.5197448730469,
        491.7255554199219,
        353.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.16",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        229.79998779296875,
        340.5197448730469,
        491.7255554199219,
        353.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "32.70",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        229.79998779296875,
        340.5197448730469,
        491.7255554199219,
        353.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비 분무형 데오도란트",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        202.3199920654297,
        357.43975830078125,
        491.7255554199219,
        370.68731689453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.50",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        202.3199920654297,
        357.43975830078125,
        491.7255554199219,
        370.68731689453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "22.08",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        202.3199920654297,
        357.43975830078125,
        491.7255554199219,
        370.68731689453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "헤어스타일링",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        222.36000061035156,
        374.479736328125,
        491.7257385253906,
        387.727294921875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.40",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        222.36000061035156,
        374.479736328125,
        491.7257385253906,
        387.727294921875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.74",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        222.36000061035156,
        374.479736328125,
        491.7257385253906,
        387.727294921875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메이크업 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        85.91999816894531,
        433.999755859375,
        150.9595184326172,
        447.247314453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "리퀴드 파운데이션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        209.87998962402344,
        391.5197448730469,
        491.7257385253906,
        404.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.51",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        209.87998962402344,
        391.5197448730469,
        491.7257385253906,
        404.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.90",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        209.87998962402344,
        391.5197448730469,
        491.7257385253906,
        404.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메이크업 리무버",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        214.79998779296875,
        408.55975341796875,
        491.7257385253906,
        421.80731201171875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.50",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        214.79998779296875,
        408.55975341796875,
        491.7257385253906,
        421.80731201171875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8.33",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        214.79998779296875,
        408.55975341796875,
        491.7257385253906,
        421.80731201171875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아이 섀도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        229.79998779296875,
        425.479736328125,
        491.7257385253906,
        438.727294921875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.02",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        229.79998779296875,
        425.479736328125,
        491.7257385253906,
        438.727294921875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.33",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        229.79998779296875,
        425.479736328125,
        491.7257385253906,
        438.727294921875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마스카라",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        232.3199920654297,
        442.5197448730469,
        491.7257385253906,
        455.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.025",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        232.3199920654297,
        442.5197448730469,
        491.7257385253906,
        455.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.42",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        232.3199920654297,
        442.5197448730469,
        491.7257385253906,
        455.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아이라이너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        227.39999389648438,
        459.55975341796875,
        491.7257385253906,
        472.80731201171875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.005",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        227.39999389648438,
        459.55975341796875,
        491.7257385253906,
        472.80731201171875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.08",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        227.39999389648438,
        459.55975341796875,
        491.7257385253906,
        472.80731201171875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "립스틱",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        237.36000061035156,
        476.479736328125,
        491.7257385253906,
        489.727294921875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.06",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        237.36000061035156,
        476.479736328125,
        491.7257385253906,
        489.727294921875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.90",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        237.36000061035156,
        476.479736328125,
        491.7257385253906,
        489.727294921875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구강 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        96.0,
        502.0397644042969,
        140.8800048828125,
        515.287353515625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치약",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        242.39999389648438,
        493.5197448730469,
        491.7257385253906,
        506.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.14",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        242.39999389648438,
        493.5197448730469,
        491.7257385253906,
        506.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.16",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        242.39999389648438,
        493.5197448730469,
        491.7257385253906,
        506.7673034667969
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구강세정액",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        227.39999389648438,
        510.5597229003906,
        491.7255554199219,
        523.8073120117188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.16",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        227.39999389648438,
        510.5597229003906,
        491.7255554199219,
        523.8073120117188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "32.54",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        227.39999389648438,
        510.5597229003906,
        491.7255554199219,
        523.8073120117188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TOTAL",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        177.1199951171875,
        527.5997314453125,
        491.72540283203125,
        540.8473510742188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "± 17.4",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        177.1199951171875,
        527.5997314453125,
        491.72540283203125,
        540.8473510742188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "269",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        177.1199951171875,
        527.5997314453125,
        491.72540283203125,
        540.8473510742188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 41 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 7. 흡입 노출평가 방법 및 기본 정보",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        287.8800048828125,
        87.98039245605469
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 흡입노출에 의한 전신노출량(SED)은 일반적으로 스프레이 유형에 따른 에어로졸의 크기",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        118.19249725341797,
        544.0800170898438,
        129.83624267578125
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분포와 침전 직전 물방울의 크기 분포를 고려하여 화장품의 1일 사용량, 휘발된 물질에",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        79.91999816894531,
        137.99249267578125,
        543.9596557617188,
        149.63624572753906
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 외적 용량으로 추정할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        79.91999816894531,
        157.79249572753906,
        264.3356018066406,
        169.43624877929688
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 수학적 모델을 사용하여 흡입노출량을 추정할 때에는 단계별 접근방식에 따라 1-box 또는",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        181.552490234375,
        543.9596557617188,
        193.1962432861328
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2-box 모델을 사용하거나 상위단계(higher tier) 모델(ConsExpo 모델) 등의 단계별 평가방",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        79.91999816894531,
        201.3524932861328,
        538.5599365234375,
        212.99624633789062
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "법을 사용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        79.91999816894531,
        221.15249633789062,
        192.84033203125,
        232.79624938964844
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2-Box model 모식도",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        250.79998779296875,
        391.3865051269531,
        351.3595275878906,
        403.4912109375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 흡입노출은 화장품 사용에 있어서 의도된 노출경로가 아니므로 다음 내용을 검토하여 평",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        419.51251220703125,
        538.5599365234375,
        431.15625
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가하도록 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        79.91999816894531,
        439.3125,
        154.41563415527344,
        450.95623779296875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스프레이 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.87999725341797,
        486.55975341796875,
        166.8000030517578,
        499.80731201171875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "크기",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        462.55975341796875,
        239.75999450683594,
        475.80731201171875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가압 시스템(분사제 스프레이, 펌프 스프레이)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        478.5197448730469,
        428.0746765136719,
        491.7673034667969
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스프레이 용기(부피)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        494.5997619628906,
        310.9546813964844,
        507.8473205566406
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노즐 등 제품 배출 형태",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        510.5597229003906,
        329.7599792480469,
        523.8073120117188
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스프레이 제형",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.87999725341797,
        544.9996948242188,
        166.8000030517578,
        558.247314453125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정성/정량 구성",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        529.0397338867188,
        288.719970703125,
        542.287353515625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분사제 및 용제 사용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        544.9996948242188,
        314.7599792480469,
        558.247314453125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분사 방식(예: 거품, 무스, 미세 분사 등)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        561.0797119140625,
        402.5146789550781,
        574.3273315429688
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스프레이 사용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.87999725341797,
        603.5596923828125,
        166.8000030517578,
        616.8073120117188
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "빈도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        579.5596923828125,
        239.75999450683594,
        592.8073120117188
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지속시간",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        595.5197143554688,
        259.7995300292969,
        608.767333984375
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분사량/1회 사용, 분사량/시간",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        611.479736328125,
        355.4399719238281,
        624.7273559570312
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분사방향",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        627.5596923828125,
        259.7995300292969,
        640.8073120117188
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "노출형태",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.87999725341797,
        685.9996948242188,
        141.8395233154297,
        699.247314453125
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적용 유형(소비자, 산업/전문)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        646.0397338867188,
        352.11468505859375,
        659.287353515625
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분무 시 Particle/droplet 크기 분포",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        661.9996948242188,
        379.55950927734375,
        675.247314453125
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용공간에서의 노출시간",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        677.959716796875,
        334.7995300292969,
        691.2073364257812
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "노출공간 부피 및 온도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        694.0397338867188,
        324.8395080566406,
        707.287353515625
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환기율",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        709.9996948242188,
        249.8395233154297,
        723.247314453125
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "노출된 개인의 활동 수준(예: 이동, 휴식)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        219.83999633789062,
        725.959716796875,
        405.2746887207031,
        739.2073364257812
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Steiling et al., 2014)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        429.8399963378906,
        747.9055786132812,
        514.9730834960938,
        757.3977661132812
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 42 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 48,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. 흡입노출에 의한 전신노출량(SEDinh)은 다음과 같은 세가지 방법으로 산출할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        500.1356201171875,
        86.94281005859375
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 1-box 모델을 기초로 한 전신노출량 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        98.63249206542969,
        285.9596862792969,
        110.2762451171875
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": 전체 분무량이 즉시 공기 중으로 방출되고 특정 크기의 상자에 분포한다고 가정하여 시뮬",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        122.39248657226562,
        538.4396362304688,
        134.03623962402344
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "레이션을 통한 호흡구역의 공기 농도에 호흡률과 공간에 머무르는 시간을 곱하여 노출량을",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.55999755859375,
        142.19248962402344,
        543.9596557617188,
        153.83624267578125
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산출할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.55999755859375,
        161.99249267578125,
        156.45562744140625,
        173.63624572753906
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SEDinh  =",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        115.31999969482422,
        197.15249633789062,
        521.3399658203125,
        229.46530151367188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A(mg/kg bw/day) × C(%)/100 × fevap",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        115.31999969482422,
        197.15249633789062,
        521.3399658203125,
        229.46530151367188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "× IR × t × fret",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        115.31999969482422,
        197.15249633789062,
        521.3399658203125,
        229.46530151367188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "V",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        115.31999969482422,
        197.15249633789062,
        521.3399658203125,
        229.46530151367188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED (mg/kg bw/day)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        254.12062072753906,
        392.75225830078125,
        264.62530517578125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전신노출량(Systemic Exposure Dosage)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        254.12062072753906,
        392.75225830078125,
        264.62530517578125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A (g/day)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        272.9343566894531,
        309.7799987792969,
        284.6653137207031
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품의 1일 사용량1",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        272.9343566894531,
        309.7799987792969,
        284.6653137207031
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "C (%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        294.32061767578125,
        371.3999938964844,
        304.8253173828125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 중 평가 대상 물질의 농도",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        294.32061767578125,
        371.3999938964844,
        304.8253173828125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "fevap (%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        314.360595703125,
        352.6724853515625,
        325.3621826171875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "증발 비율(보수적으로 1 적용)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        314.360595703125,
        352.6724853515625,
        325.3621826171875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "fret",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        333.1743469238281,
        491.4599914550781,
        345.5221862792969
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        333.1743469238281,
        491.4599914550781,
        345.5221862792969
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "V (m3)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        353.3343505859375,
        408.53997802734375,
        365.0653076171875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용 공간 부피(한국 욕실 부피 9.3 적용)2",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        353.3343505859375,
        408.53997802734375,
        365.0653076171875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IR (m3/min)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        373.3743591308594,
        368.5799865722656,
        385.2253112792969
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "호흡률(한국인 호흡률 0.01 적용)3",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        373.3743591308594,
        368.5799865722656,
        385.2253112792969
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "t (min)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        393.53436279296875,
        370.8599853515625,
        405.2652893066406
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공간 머무름 시간 (10~20분 적용)4",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.95999908447266,
        393.53436279296875,
        370.8599853515625,
        405.2652893066406
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1 화장품 유형에 따른 1일 사용량(붙임 4 참조)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        108.95999908447266,
        415.64996337890625,
        301.8525085449219,
        426.31781005859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        108.95999908447266,
        430.04998779296875,
        351.7730712890625,
        440.7178039550781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3 한국인 호흡률(한국인의 노출계수 핸드북, 환경부, 2019)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        108.95999908447266,
        444.4499816894531,
        347.33306884765625,
        455.1177978515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4 Rothe H, 2011",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        108.95999908447266,
        458.8499755859375,
        175.14028930664062,
        469.5177917480469
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 43 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 49,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 2-box 모델을 기초로 한 전신노출량 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        291.4800109863281,
        86.39624786376953
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": 시간의 경과에 따른 물질의 희석을 고려하여 전체 분무량이 즉시 공기 중으로 방출되면",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        98.63249206542969,
        544.0796508789062,
        110.2762451171875
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "머리 주변(box 1)에 우선적으로 분포한 후, 일정시간 이후에 특정 크기의 상자(box 2)로",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.87999725341797,
        118.4324951171875,
        543.9596557617188,
        130.0762481689453
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확산된다고 가정하여 호흡구역에 존재하는 대상 물질의 양, 흡입/잔류 물질 분율, 사용",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.87999725341797,
        138.2324981689453,
        543.9596557617188,
        149.87625122070312
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "횟수를 곱하여 노출량을 산출할 수 있다. 보수적인 접근하기 위해서는 공기 교환(공기 유",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.87999725341797,
        158.03248596191406,
        538.43994140625,
        169.67623901367188
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입, 배출)을 0으로 가정할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.87999725341797,
        177.83248901367188,
        263.64031982421875,
        189.4762420654297
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SEDinh =",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        138.72000122070312,
        213.95249938964844,
        184.55999755859375,
        226.14280700683594
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Ainh-1 + Ainh-2) × fret × fresp × fappl",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        230.63999938964844,
        204.3524932861328,
        415.5301818847656,
        216.5428009033203
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BW",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        314.6399841308594,
        222.3524932861328,
        331.54656982421875,
        233.99624633789062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "· Aexpo (g) = A × C × fair",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        146.39999389648438,
        241.640625,
        276.8788146972656,
        252.64218139648438
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "· Ainh-1 (mg) = ",
      "font_size": 37.864219665527344,
      "font_name": "HancomEQN",
      "bbox": [
        146.39999389648438,
        280.2806091308594,
        297.21282958984375,
        298.8426513671875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "V",
      "font_size": 6.721034049987793,
      "font_name": "HancomEQN",
      "bbox": [
        146.39999389648438,
        280.2806091308594,
        297.21282958984375,
        298.8426513671875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aexp × IR × t",
      "font_size": 6.721034049987793,
      "font_name": "HancomEQN",
      "bbox": [
        226.67999267578125,
        271.7442321777344,
        296.10205078125,
        284.7042236328125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "· Ainh-2 (mg) = ",
      "font_size": 37.864219665527344,
      "font_name": "HancomEQN",
      "bbox": [
        146.39999389648438,
        316.880615234375,
        297.21282958984375,
        335.4426574707031
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "V",
      "font_size": 6.721034049987793,
      "font_name": "HancomEQN",
      "bbox": [
        146.39999389648438,
        316.880615234375,
        297.21282958984375,
        335.4426574707031
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aexp × IR × t",
      "font_size": 6.721034049987793,
      "font_name": "HancomEQN",
      "bbox": [
        226.67999267578125,
        308.34423828125,
        296.10205078125,
        321.3042297363281
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED (mg/kg bw/day)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        355.7605895996094,
        365.87176513671875,
        366.2652893066406
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전신노출량(Systemic Exposure Dosage)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        355.7605895996094,
        365.87176513671875,
        366.2652893066406
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ainh-1, 2",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        374.2406005859375,
        462.5999755859375,
        385.2421875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "box 1, 2 공간에 존재하는 호흡가능한 평가 대상 물질의 양",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        374.2406005859375,
        462.5999755859375,
        385.2421875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "fret",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        391.3743591308594,
        464.5799865722656,
        403.72216796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        391.3743591308594,
        464.5799865722656,
        403.72216796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "fresp",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        411.2005920410156,
        411.9524841308594,
        422.2021789550781
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "흡입 가능한 물질 분율(분사제/펌프 스프레이 차이)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        411.2005920410156,
        411.9524841308594,
        422.2021789550781
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "fappl (day-1)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        428.3343505859375,
        378.8999938964844,
        440.68218994140625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용 횟수(제품별 매개변수 값으로 2 적용)2",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        428.3343505859375,
        378.8999938964844,
        440.68218994140625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BW",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        448.1606140136719,
        281.39288330078125,
        458.6653137207031
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성인 평균 체중(60kg)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        448.1606140136719,
        281.39288330078125,
        458.6653137207031
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aexpo (g)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        466.6405944824219,
        319.4399719238281,
        477.6421813964844
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분사된 평가 대상 물질의 양",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        466.6405944824219,
        319.4399719238281,
        477.6421813964844
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A (g)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        485.12060546875,
        335.7599792480469,
        495.62530517578125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품(스프레이)에서 분사된 양",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        485.12060546875,
        335.7599792480469,
        495.62530517578125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "C (%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        503.6005859375,
        344.5195007324219,
        514.1052856445312
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 중 평가 대상 물질의 농도",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        503.6005859375,
        344.5195007324219,
        514.1052856445312
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "fair",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        530.0006103515625,
        98.67900085449219,
        541.002197265625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분사된 물질 중 공기 중 부유 비율3",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        189.47999572753906,
        520.734375,
        352.739990234375,
        532.5853271484375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(분사제 스프레이: 1, 펌프 스프레이: 0.2 적용)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        189.47999572753906,
        538.0405883789062,
        401.5124816894531,
        548.5452880859375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IR (m3/min)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        555.1743774414062,
        341.5799865722656,
        567.0253295898438
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "호흡률(한국인 호흡률 0.01 적용)4",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        555.1743774414062,
        341.5799865722656,
        567.0253295898438
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "V1 (L)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        573.6543579101562,
        502.0199890136719,
        586.002197265625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Box 1(호흡영역 근처)의 공간부피(분사제/펌프 스프레이: 1000 적용)6",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        573.6543579101562,
        502.0199890136719,
        586.002197265625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "V2 (L)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        592.1343383789062,
        476.0999755859375,
        604.482177734375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Box 2의 공간부피(분사제/펌프 스프레이: 9300 적용, 예: 욕실)5",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        592.1343383789062,
        476.0999755859375,
        604.482177734375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "t1 (min)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        610.6143188476562,
        415.739990234375,
        622.962158203125
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Box 1의 노출시간(분사제/펌프 스프레이: 2 적용)6",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        610.6143188476562,
        415.739990234375,
        622.962158203125
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "t2 (min)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        629.0943603515625,
        420.77996826171875,
        641.4421997070312
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Box 2의 노출시간(분사제/펌프 스프레이: 10 적용)6",
      "font_size": 6.359999656677246,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        87.23999786376953,
        629.0943603515625,
        420.77996826171875,
        641.4421997070312
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 SCCS NoG 11th에서 제시하는 default 값(Rothe et al., 2011)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.23999786376953,
        648.3299560546875,
        345.1730651855469,
        658.997802734375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2 SCCS NoG 11th에서 제시하는 default 값",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.23999786376953,
        662.72998046875,
        265.32000732421875,
        673.3978271484375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3 SCCS NoG 11th에서 제시하는 default 값(Bremmer et al, 2006)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.23999786376953,
        677.1299438476562,
        355.97308349609375,
        687.7977905273438
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4 한국인의 노출계수 핸드북, 2019",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.23999786376953,
        691.5299682617188,
        233.58029174804688,
        702.1978149414062
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.23999786376953,
        705.9299926757812,
        336.1730651855469,
        716.5977783203125
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6 SCCS NoG 11th에서 제시하는 default 값(SCCS, 옥토크릴렌(Octocrylene))",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        93.23999786376953,
        720.3299560546875,
        396.6533508300781,
        730.997802734375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 44 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 50,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) ConsExpo 모델을 기초로 한 전신노출량 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        305.0400085449219,
        86.39624786376953
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 보다 용이한 흡입 노출평가로 ConsExpo 모델*을 사용할 수 있다. ConsExpo 모델은 소비자",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        97.1156234741211,
        538.5599365234375,
        110.2762451171875
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용 제품 사용으로 인한 인체노출량 산정을 위해 네덜란드 보건당국(RIVM)에서 개발한 위",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.72000122070312,
        118.4324951171875,
        538.5599365234375,
        130.0762481689453
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해평가 시뮬레이션 모델로, 각 제품군에 대한 노출 특성에 맞게 노출경로가 설정되어 있어",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.72000122070312,
        138.2324981689453,
        543.9596557617188,
        149.87625122070312
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상세한 노출량을 예측할 수 있는 소비자 노출평가 모델이다. 또한, 이 모델은 제품군(세부",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.72000122070312,
        158.03248596191406,
        543.9596557617188,
        169.67623901367188
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분류)을 선택하여 내장된 기본값 데이터베이스를 이용하거나 평가하고자 하는 제품의 기",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.72000122070312,
        177.83248901367188,
        538.5599365234375,
        189.4762420654297
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 정보를 알 경우에는 직접 입력할 수 있다. ConsExpo 모델에 내장된 제품군을 선택하면",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.72000122070312,
        197.6324920654297,
        543.9596557617188,
        209.2762451171875
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 제품 사용에 대한 노출시나리오에 따라 노출량을 산출할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.72000122070312,
        217.4324951171875,
        439.05560302734375,
        229.0762481689453
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* ConsExpo 모델 : https://www.consexpoweb.nl/)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        241.265625,
        289.1325378417969,
        250.7578125
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 1. ConsExpo 모델 내 시나리오가 내장된 화장품 제품군",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.95999908447266,
        285.2325134277344,
        367.3196716308594,
        296.8762512207031
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품군",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        123.47999572753906,
        313.8797607421875,
        386.6399841308594,
        327.1273193359375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세부 분류",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        123.47999572753906,
        313.8797607421875,
        386.6399841308594,
        327.1273193359375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모발 관리용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        343.1597595214844,
        131.8800048828125,
        356.4073181152344
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샴푸, 컨디셔너, 헤어스프레이, 헤어스타일링 제품(젤, 무스),",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        210.239990234375,
        335.1197509765625,
        485.7823486328125,
        348.3673095703125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "염모제(탈색), 퍼머넌트 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        210.239990234375,
        351.1997375488281,
        338.3999938964844,
        364.4472961425781
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목욕 샤워용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        372.43975830078125,
        441.1195068359375,
        385.68731689453125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "손세정제품(비누, 젤), 샤워제품(비누, 젤), 목욕제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        372.43975830078125,
        441.1195068359375,
        385.68731689453125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부 관리용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        393.79974365234375,
        503.6402587890625,
        407.04730224609375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "크림, 필링/스크럽제, 마스크팩, 바디팩(머드/클레이), 피부미백제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        393.79974365234375,
        503.6402587890625,
        407.04730224609375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메이크업 및 손톱 관리용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        423.0797424316406,
        191.8800048828125,
        436.3273010253906
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "페이셜 메이크업, 메이크업클린징, 아이쉐도우, 마스카라,",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        210.239990234375,
        415.0397644042969,
        472.46185302734375,
        428.2873229980469
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아이라이너, 아이메이크업리무버, 립스틱, 입술보호제, 네일제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        210.239990234375,
        431.1197509765625,
        498.9595031738281,
        444.3673095703125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "데오도란트",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        452.3597412109375,
        311.2799987792969,
        465.6072998046875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스프레이, 스틱/롤러형",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        452.3597412109375,
        311.2799987792969,
        465.6072998046875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구강 관리용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        473.7197570800781,
        287.3990478515625,
        486.9673156738281
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치약, 구강청결제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        473.7197570800781,
        287.3990478515625,
        486.9673156738281
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발 관리용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        494.9597473144531,
        337.31951904296875,
        508.2073059082031
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발한 억제제 크림, 항진균제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        494.9597473144531,
        337.31951904296875,
        508.2073059082031
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "향수",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        516.3197021484375,
        260.1595153808594,
        529.5673217773438
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "오드트왈렛",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        516.3197021484375,
        260.1595153808594,
        529.5673217773438
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "남성용 화장품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        537.6796875,
        389.5195007324219,
        550.9273071289062
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "면도 비누, 크림 및 거품, 애프터셰이브",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        537.6796875,
        389.5195007324219,
        550.9273071289062
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자외선 차단용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        558.9197387695312,
        284.5199890136719,
        572.1673583984375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "크림, 로션, 오일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        558.9197387695312,
        284.5199890136719,
        572.1673583984375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유아용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        580.2797241210938,
        329.5199890136719,
        593.52734375
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "베이비 연고, 오일, 파우더",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        580.2797241210938,
        329.5199890136719,
        593.52734375
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기타",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        601.5197143554688,
        374.5199890136719,
        614.767333984375
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제모제, 에센셜 오일, 페이스 페인팅",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        76.91999816894531,
        601.5197143554688,
        374.5199890136719,
        614.767333984375
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 45 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 51,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- ConsExpo 모델을 이용한 흡입노출량을 산출방법은 다음과 같다. ConsExpo 프로그램의 자",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        538.5599365234375,
        86.39624786376953
      ],
      "page_num": 51,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세한 사용방법은 ConsExpo Web, Consumer exposure model documentation, 2017을 참고할",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        79.19999694824219,
        94.55249786376953,
        544.0796508789062,
        106.19625091552734
      ],
      "page_num": 51,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        79.19999694824219,
        114.35249328613281,
        120.57562255859375,
        125.99624633789062
      ],
      "page_num": 51,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "①‘Assessments’ 평가화면은 평가 개요를 제공하여, 기존 평가 내용을 가져오거나 새로운",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        138.2324981689453,
        543.9596557617188,
        149.87625122070312
      ],
      "page_num": 51,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가를 수행할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.72000122070312,
        158.03248596191406,
        215.1356201171875,
        169.67623901367188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② ConsExpo에 내장된 노출시나리오를 이용할 경우‘fact sheet’를 이용하여 제품범주,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        309.3525085449219,
        544.07958984375,
        320.9962463378906
      ],
      "page_num": 51,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품 및 시나리오를 선택할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.72000122070312,
        329.1524963378906,
        281.1356201171875,
        340.7962341308594
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 46 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "③ 다음은 Fact sheet를 이용할 경우, 이용 가능한 화장품 제품군 선택 화면이다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        488.735595703125,
        86.39624786376953
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "④‘Assessment settings’에서 평가하고자 하는 성분, 제품 및 대상 인구를 선택하거나 편",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        425.0325012207031,
        538.5599365234375,
        436.6762390136719
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "집할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.72000122070312,
        444.8324890136719,
        165.6956329345703,
        456.4762268066406
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 47 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 53,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "⑤ 선택한 제품에 대한 시나리오는 제품에 맞게 ‘New’를 통해 직접 입력할 수 있고, 내",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        538.5599365234375,
        86.39624786376953
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "장된 시나리오 사용을 위해 ‘Use Fact sheet’를 이용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.72000122070312,
        94.55249786376953,
        433.6556091308594,
        106.19625091552734
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "⑥ 시나리오를 선택하거나, 새 시나리오를 생성하면‘Overview scenario Application’에서",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        231.59249877929688,
        543.9596557617188,
        243.2362518310547
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "선택된 노출 시나리오의 요약을 확인할 수 있다. 시뮬레이션을 위해 어떤 노출 경로가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.72000122070312,
        251.3925018310547,
        543.9596557617188,
        263.0362548828125
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함되었고, 어떤 노출 모델이 선택되었는지 확인할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.72000122070312,
        271.1925048828125,
        404.9756164550781,
        282.83624267578125
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 48 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 54,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5. ConsExpo 모델에서 적용되는 시나리오를 기반으로 노출평가에 필요한 정보는 다음 표 1과",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        543.9600219726562,
        86.39624786376953
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "같다. 해당 정보가 없는 경우, 모델에 내장된 기본값을 이용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.4000015258789,
        94.55249786376953,
        432.0956115722656,
        106.19625091552734
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 화장품 제품에 따라 적용되는 시나리오 및 변수에 대한 설명은 Cosmetics Fact Sheet에서",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        118.4324951171875,
        543.9596557617188,
        130.0762481689453
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확인할 수 있음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.55999755859375,
        138.2324981689453,
        150.59999084472656,
        149.87625122070312
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 2. 화장품 노출평가를 위한 ConsExpo 모델 구동에 적용되는 정보",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.95999908447266,
        174.95249938964844,
        416.8800048828125,
        186.59625244140625
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목록",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        107.63999938964844,
        200.11973571777344,
        419.6399841308594,
        213.3673095703125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구분",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        107.63999938964844,
        200.11973571777344,
        419.6399841308594,
        213.3673095703125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        107.63999938964844,
        200.11973571777344,
        419.6399841308594,
        213.3673095703125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물질정보",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        77.15999603271484,
        242.5997314453125,
        117.11951446533203,
        255.84730529785156
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물질명",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        217.03973388671875,
        198.23951721191406,
        230.2873077392578
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cas No.",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        234.07974243164062,
        204.97882080078125,
        247.3273162841797
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분자량(g/mol, mg/mol)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        251.11973571777344,
        274.83514404296875,
        264.3673095703125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "옥탄올-물 분배계수(Kow)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        268.0397644042969,
        282.7550354003906,
        281.2873229980469
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공통",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        77.15999603271484,
        310.6397399902344,
        97.07999420166016,
        323.8872985839844
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체중(kg)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        285.0797424316406,
        205.3542938232422,
        298.3273010253906
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용빈도(횟수/년)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        302.1197509765625,
        406.3199768066406,
        315.3673095703125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시간 단위당 사용 횟수",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        302.1197509765625,
        406.3199768066406,
        315.3673095703125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품 사용량(g)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        319.0397644042969,
        361.79998779296875,
        332.2873229980469
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1회당 사용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        319.0397644042969,
        361.79998779296875,
        332.2873229980469
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량(%)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        336.0797424316406,
        434.9010925292969,
        349.3273010253906
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체 제품 내 물질의 함유율",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        336.0797424316406,
        434.9010925292969,
        349.3273010253906
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "흡입",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        77.15999603271484,
        421.5197448730469,
        97.07999420166016,
        434.7673034667969
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공통",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        115.68000030517578,
        375.91973876953125,
        135.60000610351562,
        389.16729736328125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노출시간(분)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        352.3997497558594,
        499.8210754394531,
        378.6072998046875
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당 물질 제품을 사용된 공간에서 노출이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        352.3997497558594,
        499.8210754394531,
        378.6072998046875
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "되는 시간",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        352.3997497558594,
        499.8210754394531,
        378.6072998046875
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실내 부피(m3)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        381.27789306640625,
        401.27996826171875,
        394.92730712890625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노출되는 공간의 부피",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        381.27789306640625,
        401.27996826171875,
        394.92730712890625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "환기율(횟수/시간)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        398.7197570800781,
        381.3595275878906,
        411.9673156738281
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시간당 환기 횟수",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        398.7197570800781,
        381.3595275878906,
        411.9673156738281
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "증기",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        115.68000030517578,
        452.8397521972656,
        135.60000610351562,
        466.0873107910156
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품 사용 시간(min)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        415.7597351074219,
        501.3594970703125,
        429.0072937011719
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당 물질 제품을 사용하는 데 걸리는 시간",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        415.7597351074219,
        501.3594970703125,
        429.0072937011719
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품 노출 면적(cm2)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        432.27789306640625,
        461.27996826171875,
        445.92730712890625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당 물질의 제품이 노출되는 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        432.27789306640625,
        461.27996826171875,
        445.92730712890625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "질량 이동률(m/min)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        448.999755859375,
        494.9006042480469,
        475.3273010253906
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당제품의 물질이 공기 중으로 증발되어",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        448.999755859375,
        494.9006042480469,
        475.3273010253906
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기능을 하게 되는 속도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        448.999755859375,
        494.9006042480469,
        475.3273010253906
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분자량 매트릭스(g/mol)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        477.67974853515625,
        519.861083984375,
        504.0072937011719
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품 전체의 분자량에서 해당 물질의 분자량을",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        477.67974853515625,
        519.861083984375,
        504.0072937011719
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "뺀 나머지의 평균",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        477.67974853515625,
        519.861083984375,
        504.0072937011719
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스프레이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        115.68000030517578,
        568.2797241210938,
        155.6395263671875,
        581.52734375
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분사시간(sec)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        507.0797424316406,
        391.3199768066406,
        520.3273315429688
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스프레이 분사 시간",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        507.0797424316406,
        391.3199768066406,
        520.3273315429688
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실내 높이(m)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        523.9996948242188,
        371.27996826171875,
        537.247314453125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용 공간 높이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        523.9996948242188,
        371.27996826171875,
        537.247314453125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "질량 생성률(g/sec)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        541.0397338867188,
        456.3599853515625,
        554.287353515625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당 제품이 시간 당 분사되는 양",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        541.0397338867188,
        456.3599853515625,
        554.287353515625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부유 비율",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        555.9197387695312,
        479.90106201171875,
        582.247314453125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분사 후 비휘발성 물질이 공기 중으로",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        555.9197387695312,
        479.90106201171875,
        582.247314453125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부유되는 비율",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        555.9197387695312,
        479.90106201171875,
        582.247314453125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "밀도(g/cm3)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        583.3578491210938,
        401.27996826171875,
        597.1273193359375
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비휘발성 물질의 밀도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        583.3578491210938,
        401.27996826171875,
        597.1273193359375
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입자분포(㎛)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        600.7997436523438,
        456.3595275878906,
        614.04736328125
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분사된 직후의 입자의 질 량 분포",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        600.7997436523438,
        456.3595275878906,
        614.04736328125
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "흡입 cut-off 직경(㎛)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        617.1196899414062,
        504.861083984375,
        643.4473266601562
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 물질이 폐포까지 도달할 수 있는 입자",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        617.1196899414062,
        504.861083984375,
        643.4473266601562
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "직경",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        168.239990234375,
        617.1196899414062,
        504.861083984375,
        643.4473266601562
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경피",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        77.15999603271484,
        645.9978637695312,
        461.27996826171875,
        659.767333984375
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부 접촉 면적(cm2)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        77.15999603271484,
        645.9978637695312,
        461.27996826171875,
        659.767333984375
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 제품이 피부에 노출되는 면적",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        77.15999603271484,
        645.9978637695312,
        461.27996826171875,
        659.767333984375
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경구",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        77.15999603271484,
        663.5596923828125,
        381.3595275878906,
        676.8073120117188
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "섭취량(g)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        77.15999603271484,
        663.5596923828125,
        381.3595275878906,
        676.8073120117188
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품의 총 섭취량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        77.15999603271484,
        663.5596923828125,
        381.3595275878906,
        676.8073120117188
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Cosmetics Fact Sheet, ConsExpo4,)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        377.7599792480469,
        682.1456298828125,
        527.581787109375,
        691.6378173828125
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 49 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 8. 피부감작성 평가(Quantitative risk assessment, QRA) 및 예시",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        438.47998046875,
        87.98039245605469
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 향료물질 피부감작성 평가의 경우, 허용 노출량(acceptable exposure level, AEL)과 소비자",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        124.19248962402344,
        543.9596557617188,
        135.83624267578125
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "노출량(consumer exposure level, CEL)을 비교하여 정량적 위해평가(quantitative risk",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.68000030517578,
        143.99249267578125,
        544.0794067382812,
        155.63624572753906
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "assessment, QRA)로 수행할 수 있으며, AEL이 CEL보다 크거나 같은 경우에 허용 가능한 위",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.68000030517578,
        163.79249572753906,
        538.5599365234375,
        175.43624877929688
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해로 판단할 수 있다. 피부 감작성 평가 예시는 아래와 같다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.68000030517578,
        183.59249877929688,
        378.93560791015625,
        195.2362518310547
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 데오도란트에 함유된 물질 C에 대한 감작성 평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        221.7524871826172,
        319.55999755859375,
        233.396240234375
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "① 위험성 확인",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        257.75250244140625,
        143.63998413085938,
        269.396240234375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 기니피그에서 감작성 확인됨",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        281.63250732421875,
        225.5996551513672,
        293.2762451171875
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험방법",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        101.87999725341797,
        310.2797546386719,
        487.4399719238281,
        323.5273132324219
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Induction conc.",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        101.87999725341797,
        310.2797546386719,
        487.4399719238281,
        323.5273132324219
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Challenge conc.",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        101.87999725341797,
        310.2797546386719,
        487.4399719238281,
        323.5273132324219
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        101.87999725341797,
        310.2797546386719,
        487.4399719238281,
        323.5273132324219
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Maximization",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        328.759765625,
        504.4795227050781,
        355.0873107910156
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.4% (intradermal; VNR)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        328.759765625,
        504.4795227050781,
        355.0873107910156
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1% (topical; VNR)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        328.759765625,
        504.4795227050781,
        355.0873107910156
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.25% (VNR)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        328.759765625,
        504.4795227050781,
        355.0873107910156
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감작성 있음",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        328.759765625,
        504.4795227050781,
        355.0873107910156
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Maximization",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        361.2797546386719,
        347.19439697265625,
        387.6072998046875
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.2% in 0.9% saline solution (intradermal)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        361.2797546386719,
        347.19439697265625,
        387.6072998046875
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5% in 70:30 acetone/PEG 400 (topical)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        361.2797546386719,
        347.19439697265625,
        387.6072998046875
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5% in 70:30",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        357.8399963378906,
        361.2797546386719,
        504.4795227050781,
        387.6072998046875
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "acetone/PEG 400",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        357.8399963378906,
        361.2797546386719,
        504.4795227050781,
        387.6072998046875
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감작성 있음",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        357.8399963378906,
        361.2797546386719,
        504.4795227050781,
        387.6072998046875
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Buehler",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        392.3597412109375,
        504.4795227050781,
        418.56732177734375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20% in petrolatum",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        392.3597412109375,
        504.4795227050781,
        418.56732177734375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20% in",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        392.3597412109375,
        504.4795227050781,
        418.56732177734375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "petrolatum",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        392.3597412109375,
        504.4795227050781,
        418.56732177734375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감작성 있음",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        89.75999450683594,
        392.3597412109375,
        504.4795227050781,
        418.56732177734375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VNR: vehicle not reported",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        70.79999542236328,
        432.44061279296875,
        191.41868591308594,
        442.9453125
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "② 위험성 결정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        469.552490234375,
        143.63998413085938,
        481.19622802734375
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 최대무감작성유도용량(No expected sensitization induced level, NESIL) 결정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        493.4324951171875,
        461.760009765625,
        505.07623291015625
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "LLNA weighted mean",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        87.36000061035156,
        529.7597045898438,
        191.78134155273438,
        543.00732421875
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "EC3 values",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        112.79999542236328,
        542.7197265625,
        163.240234375,
        555.9673461914062
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(㎍/cm2)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        119.27999877929688,
        555.2778930664062,
        156.92478942871094,
        568.9273071289062
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Human data",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        289.91998291015625,
        520.6397094726562,
        347.8876953125,
        533.8873291015625
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "WoE NESIL",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        452.7599792480469,
        536.23974609375,
        507.74188232421875,
        549.4873657226562
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(µg/cm2)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        459.0,
        548.6778564453125,
        498.5647888183594,
        562.4473266601562
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NOEL – HRIPT",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        201.47999572753906,
        538.9996948242188,
        272.54156494140625,
        552.247314453125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(induction)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        210.95999145507812,
        551.959716796875,
        263.0623779296875,
        578.1673583984375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(µg/cm2)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        210.95999145507812,
        551.959716796875,
        263.0623779296875,
        578.1673583984375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NOEL –  HMT",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        285.239990234375,
        538.9996948242188,
        355.8213195800781,
        552.247314453125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(induction)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        294.47998046875,
        551.959716796875,
        346.58245849609375,
        578.1673583984375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(µg/cm2)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        294.47998046875,
        551.959716796875,
        346.58245849609375,
        578.1673583984375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LOEL",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        391.0799865722656,
        538.9996948242188,
        417.0214538574219,
        552.247314453125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(induction)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        378.0,
        551.959716796875,
        430.1024475097656,
        578.1673583984375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(µg/cm2)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        378.0,
        551.959716796875,
        430.1024475097656,
        578.1673583984375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1414",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        126.83999633789062,
        587.479736328125,
        489.56524658203125,
        600.7273559570312
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1400",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        126.83999633789062,
        587.479736328125,
        489.56524658203125,
        600.7273559570312
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NA",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        126.83999633789062,
        587.479736328125,
        489.56524658203125,
        600.7273559570312
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3876",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        126.83999633789062,
        587.479736328125,
        489.56524658203125,
        600.7273559570312
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1400",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        126.83999633789062,
        587.479736328125,
        489.56524658203125,
        600.7273559570312
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 허용 노출량(acceptable exposure level, AEL) 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        629.9924926757812,
        334.919677734375,
        641.63623046875
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- AEL을 도출하기 위해 개인간 민감도, 제품 구성 성분의 영향, 사용 기간, 신체 부위별 피부",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        653.8724975585938,
        538.4403686523438,
        665.5162353515625
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상태를 고려한 감작평가계수(Sensitisation Assessment Factors, SAF) 선택",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        82.43999481201172,
        673.6724853515625,
        452.1604309082031,
        685.3162231445312
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "AEL  =",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        94.55999755859375,
        719.3925170898438,
        142.1999969482422,
        731.0362548828125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "WoE NESIL",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        164.16000366210938,
        710.1524658203125,
        221.6634063720703,
        721.7962036132812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        252.239990234375,
        719.3925170898438,
        257.7599792480469,
        731.0362548828125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1400 ㎍/cm2",
      "font_size": 7.079999923706055,
      "font_name": "MalgunGothic",
      "bbox": [
        283.67999267578125,
        707.1342163085938,
        345.4195251464844,
        722.3082885742188
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        369.47998046875,
        716.3742065429688,
        457.01953125,
        731.54833984375
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.7 ㎍/cm2",
      "font_size": 7.079999923706055,
      "font_name": "MalgunGothic",
      "bbox": [
        369.47998046875,
        716.3742065429688,
        457.01953125,
        731.54833984375
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SAF",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        183.1199951171875,
        728.6325073242188,
        322.79998779296875,
        740.2762451171875
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "300",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        183.1199951171875,
        728.6325073242188,
        322.79998779296875,
        740.2762451171875
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 50 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 56,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 1. 감작평가계수(Sensitisation Assessment Factors, SAF) 적용",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        376.32000732421875,
        86.39624786376953
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 2. 제품에 따른 SAF",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        254.15248107910156,
        172.14590454101562,
        265.7962341308594
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품 종류",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        108.23999786376953,
        288.31976318359375,
        153.23951721191406,
        301.56732177734375
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SAF",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        317.3999938964844,
        279.91973876953125,
        487.5824279785156,
        293.6473083496094
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Total",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        317.3999938964844,
        279.91973876953125,
        487.5824279785156,
        293.6473083496094
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SAF",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        211.9199981689453,
        296.3597412109375,
        481.62396240234375,
        310.0873107910156
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개인 간",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        211.9199981689453,
        296.3597412109375,
        481.62396240234375,
        310.0873107910156
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        211.9199981689453,
        296.3597412109375,
        481.62396240234375,
        310.0873107910156
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "빈도/사용기간",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        211.9199981689453,
        296.3597412109375,
        481.62396240234375,
        310.0873107910156
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부상태",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        211.9199981689453,
        296.3597412109375,
        481.62396240234375,
        310.0873107910156
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모든 타입의 데오도란트 및",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        311.7197570800781,
        481.1654052734375,
        338.04730224609375
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발한억제제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        311.7197570800781,
        481.1654052734375,
        338.04730224609375
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        311.7197570800781,
        481.1654052734375,
        338.04730224609375
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        311.7197570800781,
        481.1654052734375,
        338.04730224609375
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        311.7197570800781,
        481.1654052734375,
        338.04730224609375
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        311.7197570800781,
        481.1654052734375,
        338.04730224609375
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "300",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        311.7197570800781,
        481.1654052734375,
        338.04730224609375
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하이드로알코올 제품(향수 등)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        339.67974853515625,
        481.1654052734375,
        352.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        339.67974853515625,
        481.1654052734375,
        352.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        339.67974853515625,
        481.1654052734375,
        352.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        339.67974853515625,
        481.1654052734375,
        352.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        339.67974853515625,
        481.1654052734375,
        352.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        339.67974853515625,
        481.1654052734375,
        352.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바디 크림, 로션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        356.7197570800781,
        481.1654052734375,
        369.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        356.7197570800781,
        481.1654052734375,
        369.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        356.7197570800781,
        481.1654052734375,
        369.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        356.7197570800781,
        481.1654052734375,
        369.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        356.7197570800781,
        481.1654052734375,
        369.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "300",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        356.7197570800781,
        481.1654052734375,
        369.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "핸드크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        373.6397399902344,
        481.1654052734375,
        386.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        373.6397399902344,
        481.1654052734375,
        386.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        373.6397399902344,
        481.1654052734375,
        386.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        373.6397399902344,
        481.1654052734375,
        386.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        373.6397399902344,
        481.1654052734375,
        386.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        373.6397399902344,
        481.1654052734375,
        386.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "얼굴크림 및 메이크업제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        390.67974853515625,
        481.1654052734375,
        403.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        390.67974853515625,
        481.1654052734375,
        403.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        390.67974853515625,
        481.1654052734375,
        403.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        390.67974853515625,
        481.1654052734375,
        403.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        390.67974853515625,
        481.1654052734375,
        403.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        390.67974853515625,
        481.1654052734375,
        403.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "메이크업리무버",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        407.7197570800781,
        481.1654052734375,
        420.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        407.7197570800781,
        481.1654052734375,
        420.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        407.7197570800781,
        481.1654052734375,
        420.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        407.7197570800781,
        481.1654052734375,
        420.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        407.7197570800781,
        481.1654052734375,
        420.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        407.7197570800781,
        481.1654052734375,
        420.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입술 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        424.6397399902344,
        481.1654052734375,
        437.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        424.6397399902344,
        481.1654052734375,
        437.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        424.6397399902344,
        481.1654052734375,
        437.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        424.6397399902344,
        481.1654052734375,
        437.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        424.6397399902344,
        481.1654052734375,
        437.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        424.6397399902344,
        481.1654052734375,
        437.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "헤어스타일링제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        441.67974853515625,
        481.1654052734375,
        454.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        441.67974853515625,
        481.1654052734375,
        454.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        441.67974853515625,
        481.1654052734375,
        454.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        441.67974853515625,
        481.1654052734375,
        454.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        441.67974853515625,
        481.1654052734375,
        454.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        441.67974853515625,
        481.1654052734375,
        454.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "헤어스프레이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        458.7197570800781,
        478.40557861328125,
        471.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        458.7197570800781,
        478.40557861328125,
        471.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        458.7197570800781,
        478.40557861328125,
        471.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        458.7197570800781,
        478.40557861328125,
        471.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        458.7197570800781,
        478.40557861328125,
        471.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "30",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        458.7197570800781,
        478.40557861328125,
        471.9673156738281
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "샴푸",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        475.6397399902344,
        481.1654052734375,
        488.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        475.6397399902344,
        481.1654052734375,
        488.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        475.6397399902344,
        481.1654052734375,
        488.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        475.6397399902344,
        481.1654052734375,
        488.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        475.6397399902344,
        481.1654052734375,
        488.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "300",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        475.6397399902344,
        481.1654052734375,
        488.8872985839844
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "헤어컨디셔너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        492.67974853515625,
        481.1654052734375,
        505.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        492.67974853515625,
        481.1654052734375,
        505.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        492.67974853515625,
        481.1654052734375,
        505.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        492.67974853515625,
        481.1654052734375,
        505.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        492.67974853515625,
        481.1654052734375,
        505.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        492.67974853515625,
        481.1654052734375,
        505.92730712890625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고체비누",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        509.7197570800781,
        481.1654052734375,
        522.9673461914062
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        509.7197570800781,
        481.1654052734375,
        522.9673461914062
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        509.7197570800781,
        481.1654052734375,
        522.9673461914062
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        509.7197570800781,
        481.1654052734375,
        522.9673461914062
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        509.7197570800781,
        481.1654052734375,
        522.9673461914062
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "300",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        509.7197570800781,
        481.1654052734375,
        522.9673461914062
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "액체비누",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        526.6397094726562,
        481.1654052734375,
        539.8873291015625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        526.6397094726562,
        481.1654052734375,
        539.8873291015625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        526.6397094726562,
        481.1654052734375,
        539.8873291015625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        526.6397094726562,
        481.1654052734375,
        539.8873291015625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        526.6397094726562,
        481.1654052734375,
        539.8873291015625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        526.6397094726562,
        481.1654052734375,
        539.8873291015625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "샤워젤, 목욕제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        543.6796875,
        481.1654052734375,
        556.9273071289062
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        543.6796875,
        481.1654052734375,
        556.9273071289062
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        543.6796875,
        481.1654052734375,
        556.9273071289062
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        543.6796875,
        481.1654052734375,
        556.9273071289062
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        543.6796875,
        481.1654052734375,
        556.9273071289062
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "300",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.55999755859375,
        543.6796875,
        481.1654052734375,
        556.9273071289062
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고 : 자외선차단제가 포함된 제품은 입술제품에 해당됨",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.0,
        564.4406127929688,
        322.55999755859375,
        574.9453125
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요인",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        99.1199951171875,
        97.87974548339844,
        366.5999755859375,
        111.12732696533203
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SAF",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        99.1199951171875,
        97.87974548339844,
        366.5999755859375,
        111.12732696533203
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내용",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        99.1199951171875,
        97.87974548339844,
        366.5999755859375,
        111.12732696533203
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개인 간",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        91.68000030517578,
        119.11973571777344,
        305.3995056152344,
        132.3673095703125
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        91.68000030517578,
        119.11973571777344,
        305.3995056152344,
        132.3673095703125
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개인 간 차이 고려",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        91.68000030517578,
        119.11973571777344,
        305.3995056152344,
        132.3673095703125
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        99.1199951171875,
        152.71974182128906,
        206.3657684326172,
        165.96731567382812
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.3, 1, 3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        99.1199951171875,
        152.71974182128906,
        206.3657684326172,
        165.96731567382812
      ],
      "page_num": 56,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.3 : 직접 접촉하지 않는 불활성 물질",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        220.44000244140625,
        139.75973510742188,
        485.2799377441406,
        179.0473175048828
      ],
      "page_num": 56,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 : 대부분 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        220.44000244140625,
        139.75973510742188,
        485.2799377441406,
        179.0473175048828
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3 : 실험 조건에서 예상한 것보다 더 큰 침투강화제인 경우",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        220.44000244140625,
        139.75973510742188,
        485.2799377441406,
        179.0473175048828
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "빈도/제품사용기간",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        67.19999694824219,
        186.31973266601562,
        400.3199768066406,
        199.5673065185547
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1, 3",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        67.19999694824219,
        186.31973266601562,
        400.3199768066406,
        199.5673065185547
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품의 장기간 사용 시 생체 축적 고려",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        67.19999694824219,
        186.31973266601562,
        400.3199768066406,
        199.5673065185547
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부 상태",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        86.63999938964844,
        208.99974060058594,
        485.5198669433594,
        222.247314453125
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1, 3, 10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        86.63999938964844,
        208.99974060058594,
        485.5198669433594,
        222.247314453125
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품 사용에 따라 염증 수준이 증가하기 쉬운 신체 부위 고려",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        86.63999938964844,
        208.99974060058594,
        485.5198669433594,
        222.247314453125
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 51 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 57,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "③ 노출평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        74.75249481201172,
        127.19966125488281,
        86.39624786376953
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 해당 유형에 따른 체표면적당 사용량(mg/cm2/day)을 고려하여 노출량(Consumer Exposure",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        97.1156234741211,
        544.0809936523438,
        110.2762451171875
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Leve CEL, mg/cm2/day) 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.5199966430664,
        117.75562286376953,
        230.87998962402344,
        131.10374450683594
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "데오도란트에 함유된 물질 C의 농도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        115.91999816894531,
        156.4397430419922,
        387.6506042480469,
        169.68731689453125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.03%",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        115.91999816894531,
        156.4397430419922,
        387.6506042480469,
        169.68731689453125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체표면적을 고려한 1일 사용량(mg/cm2/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        115.91999816894531,
        177.2779083251953,
        445.7878112792969,
        191.0473175048828
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11.65 mg/cm2/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        115.91999816894531,
        177.2779083251953,
        445.7878112792969,
        191.0473175048828
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CEL = 0.03/100 × 11.65 mg/cm2 × 1000 ㎍/mg = 3.5 ㎍/cm2",
      "font_size": 7.679999828338623,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        211.91998291015625,
        432.5999755859375,
        226.14373779296875
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "④ 위해도 평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        260.63250732421875,
        143.63998413085938,
        272.2762451171875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AEL",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        216.95999145507812,
        291.5924987792969,
        275.15997314453125,
        310.4362487792969
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        216.95999145507812,
        291.5924987792969,
        275.15997314453125,
        310.4362487792969
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.7",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        308.03997802734375,
        289.5525207519531,
        322.07952880859375,
        301.1962585449219
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        354.47998046875,
        298.7925109863281,
        393.2395324707031,
        310.4362487792969
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.3",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        354.47998046875,
        298.7925109863281,
        393.2395324707031,
        310.4362487792969
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CEL",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        217.0800018310547,
        310.072509765625,
        322.07952880859375,
        321.71624755859375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.5",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        217.0800018310547,
        310.072509765625,
        322.07952880859375,
        321.71624755859375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- AEL/CEL이 1 이상이므로 위해 우려 가능성 낮음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        343.1156005859375,
        346.79998779296875,
        356.2762451171875
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 체표면적을 고려한 사용량을 통합적",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        392.1524963378906,
        538.5596313476562,
        403.7962341308594
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 계산한 노출량을 이용할 경우, 51.67438 mg/cm2/day 사용(표3)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.31999969482422,
        408.3955993652344,
        411.45001220703125,
        421.4362487792969
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 52 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 58,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 3. 피부감작성 위해평가를 위한 화장품 통합 노출량",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        334.55999755859375,
        86.39624786376953
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "노출유형",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        108.36000061035156,
        107.31790924072266,
        358.40618896484375,
        127.44732666015625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        108.36000061035156,
        107.31790924072266,
        358.40618896484375,
        127.44732666015625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노출량1",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothicBold",
      "bbox": [
        108.36000061035156,
        107.31790924072266,
        358.40618896484375,
        127.44732666015625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(g/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        325.32000732421875,
        120.79974365234375,
        358.0447082519531,
        134.0473175048828
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용되는",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        376.67999267578125,
        101.23973846435547,
        421.9410705566406,
        127.44732666015625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체표면적2",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothicBold",
      "bbox": [
        376.67999267578125,
        101.23973846435547,
        421.9410705566406,
        127.44732666015625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(cm2)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        386.8800048828125,
        126.75790405273438,
        410.6047668457031,
        140.52731323242188
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체표면적을",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        443.2799987792969,
        101.23973846435547,
        496.7010803222656,
        114.48731994628906
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려한 노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        435.7200012207031,
        114.19974517822266,
        500.6399841308594,
        140.52731323242188
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(mg/cm2/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        435.7200012207031,
        114.19974517822266,
        500.6399841308594,
        140.52731323242188
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용 후 씻어내는 피부 및",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        68.27999877929688,
        168.19973754882812,
        191.78155517578125,
        181.4473114013672
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모발 클렌징 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        88.31999969482422,
        184.1597442626953,
        168.24000549316406,
        197.40731811523438
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샤워 젤",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        238.55999755859375,
        146.3597412109375,
        488.36553955078125,
        159.60731506347656
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        238.55999755859375,
        146.3597412109375,
        488.36553955078125,
        159.60731506347656
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17500",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        238.55999755859375,
        146.3597412109375,
        488.36553955078125,
        159.60731506347656
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.005714",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        238.55999755859375,
        146.3597412109375,
        488.36553955078125,
        159.60731506347656
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "손 세정 비누",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        226.0800018310547,
        166.2797393798828,
        485.605712890625,
        179.52731323242188
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.24",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        226.0800018310547,
        166.2797393798828,
        485.605712890625,
        179.52731323242188
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "860",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        226.0800018310547,
        166.2797393798828,
        485.605712890625,
        179.52731323242188
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.27907",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        226.0800018310547,
        166.2797393798828,
        485.605712890625,
        179.52731323242188
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샴푸",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        246.1199951171875,
        186.07974243164062,
        482.84588623046875,
        199.3273162841797
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.09",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        246.1199951171875,
        186.07974243164062,
        482.84588623046875,
        199.3273162841797
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1440",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        246.1199951171875,
        186.07974243164062,
        482.84588623046875,
        199.3273162841797
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.0625",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        246.1199951171875,
        186.07974243164062,
        482.84588623046875,
        199.3273162841797
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "헤어 컨디셔너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        223.55999755859375,
        205.87974548339844,
        488.36553955078125,
        219.1273193359375
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.06",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        223.55999755859375,
        205.87974548339844,
        488.36553955078125,
        219.1273193359375
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1440",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        223.55999755859375,
        205.87974548339844,
        488.36553955078125,
        219.1273193359375
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.041667",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        223.55999755859375,
        205.87974548339844,
        488.36553955078125,
        219.1273193359375
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용 후 씻어내지 않는",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        75.83999633789062,
        271.0397644042969,
        184.341064453125,
        284.2873229980469
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부 및 모발 케어 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        73.31999969482422,
        286.999755859375,
        183.24000549316406,
        300.247314453125
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바디로션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        236.1599884033203,
        225.6797332763672,
        488.36553955078125,
        238.92730712890625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.48",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        236.1599884033203,
        225.6797332763672,
        488.36553955078125,
        238.92730712890625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15670",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        236.1599884033203,
        225.6797332763672,
        488.36553955078125,
        238.92730712890625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.349713",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        236.1599884033203,
        225.6797332763672,
        488.36553955078125,
        238.92730712890625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "얼굴 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.63999938964844,
        245.59974670410156,
        488.36553955078125,
        258.8473205566406
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.76",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.63999938964844,
        245.59974670410156,
        488.36553955078125,
        258.8473205566406
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "565",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.63999938964844,
        245.59974670410156,
        488.36553955078125,
        258.8473205566406
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.115044",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.63999938964844,
        245.59974670410156,
        488.36553955078125,
        258.8473205566406
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핸드 크림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.63999938964844,
        267.91973876953125,
        488.36553955078125,
        281.16729736328125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.38",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.63999938964844,
        267.91973876953125,
        488.36553955078125,
        281.16729736328125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "860",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.63999938964844,
        267.91973876953125,
        488.36553955078125,
        281.16729736328125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.604651",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.63999938964844,
        267.91973876953125,
        488.36553955078125,
        281.16729736328125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비 분무형 데오도란트",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.1599884033203,
        290.23974609375,
        480.0860595703125,
        303.4873046875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.33",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.1599884033203,
        290.23974609375,
        480.0860595703125,
        303.4873046875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "200",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.1599884033203,
        290.23974609375,
        480.0860595703125,
        303.4873046875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11.65",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        206.1599884033203,
        290.23974609375,
        480.0860595703125,
        303.4873046875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "헤어 스타일링",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        223.55999755859375,
        310.1597595214844,
        488.36553955078125,
        323.4073181152344
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.28",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        223.55999755859375,
        310.1597595214844,
        488.36553955078125,
        323.4073181152344
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1010",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        223.55999755859375,
        310.1597595214844,
        488.36553955078125,
        323.4073181152344
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.277228",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        223.55999755859375,
        310.1597595214844,
        488.36553955078125,
        323.4073181152344
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물휴지",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        241.0800018310547,
        331.0397644042969,
        488.36553955078125,
        344.2873229980469
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.57",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        241.0800018310547,
        331.0397644042969,
        488.36553955078125,
        344.2873229980469
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17500",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        241.0800018310547,
        331.0397644042969,
        488.36553955078125,
        344.2873229980469
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.261143",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        241.0800018310547,
        331.0397644042969,
        488.36553955078125,
        344.2873229980469
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메이크업 제품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.75999450683594,
        401.5997619628906,
        160.7995147705078,
        414.8473205566406
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "리퀴드 파운데이션",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        213.59999084472656,
        352.0397644042969,
        488.36553955078125,
        365.2873229980469
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.30",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        213.59999084472656,
        352.0397644042969,
        488.36553955078125,
        365.2873229980469
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "565",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        213.59999084472656,
        352.0397644042969,
        488.36553955078125,
        365.2873229980469
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.530973",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        213.59999084472656,
        352.0397644042969,
        488.36553955078125,
        365.2873229980469
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메이크업 리무버",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        218.63999938964844,
        371.9597473144531,
        488.36553955078125,
        385.2073059082031
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.21",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        218.63999938964844,
        371.9597473144531,
        488.36553955078125,
        385.2073059082031
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "565",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        218.63999938964844,
        371.9597473144531,
        488.36553955078125,
        385.2073059082031
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.371681",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        218.63999938964844,
        371.9597473144531,
        488.36553955078125,
        385.2073059082031
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아이 섀도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.63999938964844,
        391.759765625,
        488.36553955078125,
        405.00732421875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.02",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.63999938964844,
        391.759765625,
        488.36553955078125,
        405.00732421875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.63999938964844,
        391.759765625,
        488.36553955078125,
        405.00732421875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.833333",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        233.63999938964844,
        391.759765625,
        488.36553955078125,
        405.00732421875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마스카라",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        236.1599884033203,
        411.55975341796875,
        480.0860595703125,
        424.80731201171875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.03",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        236.1599884033203,
        411.55975341796875,
        480.0860595703125,
        424.80731201171875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.6",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        236.1599884033203,
        411.55975341796875,
        480.0860595703125,
        424.80731201171875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18.75",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        236.1599884033203,
        411.55975341796875,
        480.0860595703125,
        424.80731201171875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "립스틱",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        241.0800018310547,
        431.3597412109375,
        488.36553955078125,
        444.6072998046875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.05",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        241.0800018310547,
        431.3597412109375,
        488.36553955078125,
        444.6072998046875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.8",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        241.0800018310547,
        431.3597412109375,
        488.36553955078125,
        444.6072998046875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10.41667",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        241.0800018310547,
        431.3597412109375,
        488.36553955078125,
        444.6072998046875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아이라이너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        231.1199951171875,
        451.2797546386719,
        480.0860595703125,
        464.5273132324219
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.01",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        231.1199951171875,
        451.2797546386719,
        480.0860595703125,
        464.5273132324219
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.2",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        231.1199951171875,
        451.2797546386719,
        480.0860595703125,
        464.5273132324219
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.125",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        231.1199951171875,
        451.2797546386719,
        480.0860595703125,
        464.5273132324219
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1일 총 화장품 사용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        137.0399932861328,
        473.8397521972656,
        488.36553955078125,
        487.0873107910156
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "±16.9",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        137.0399932861328,
        473.8397521972656,
        488.36553955078125,
        487.0873107910156
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "51.67438",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        137.0399932861328,
        473.8397521972656,
        488.36553955078125,
        487.0873107910156
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1 2014∼2016 화장품 위해평가 선진화 연구",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.0,
        496.9578857421875,
        258.4795227050781,
        510.2652893066406
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2 체표면적 : Bremmer et al, 2005(RIVM) 자료 적용",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.0,
        513.9978637695312,
        295.31951904296875,
        527.3052978515625
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 53 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 59,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "붙임 9. 화장품 유형별 위해평가 예시",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        263.8800048828125,
        87.98039245605469
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 자외선차단 성분(에칠헥실메톡시신나메이트)에 대한 위해평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        126.83248901367188,
        379.919677734375,
        138.4762420654297
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 위험성 확인",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        165.59249877929688,
        137.03965759277344,
        177.2362518310547
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        191.6324920654297,
        455.8800048828125,
        203.2762451171875
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성자료",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        96.23999786376953,
        223.87974548339844,
        416.15997314453125,
        237.1273193359375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        96.23999786376953,
        223.87974548339844,
        416.15997314453125,
        237.1273193359375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        96.23999786376953,
        223.87974548339844,
        416.15997314453125,
        237.1273193359375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반복투여",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        96.72000122070312,
        250.2797393798828,
        135.72036743164062,
        263.5273132324219
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(경구)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        103.55999755859375,
        263.23974609375,
        128.91468811035156,
        276.4873046875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 랫드 대상(3주)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        153.0,
        250.2797393798828,
        271.42730712890625,
        276.4873046875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 0, 0.3, 0.9, 2.7 g/kg/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        153.0,
        250.2797393798828,
        271.42730712890625,
        276.4873046875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- NOAEL 0.9 g/kg/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        306.9599914550781,
        243.79974365234375,
        508.9415588378906,
        270.00732421875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 2.7 g/kg/day 농도에서 체중감소, 흉선의",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        306.9599914550781,
        243.79974365234375,
        508.9415588378906,
        270.00732421875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상대적 및 절대적 무게 감소",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        317.3999938964844,
        269.7197570800781,
        443.5204162597656,
        282.9673156738281
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반복투여",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        96.72000122070312,
        298.3997497558594,
        135.72036743164062,
        311.6473083496094
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(경구)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        103.55999755859375,
        311.3597412109375,
        128.91468811035156,
        324.6072998046875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 랫드 대상(13주)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        153.0,
        298.3997497558594,
        296.2665710449219,
        324.6072998046875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 0, 200, 450, 1000 mg/kg/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        153.0,
        298.3997497558594,
        296.2665710449219,
        324.6072998046875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- NOAEL 450 mg/kg/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        306.9599914550781,
        285.43975830078125,
        508.94189453125,
        311.6473083496094
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 1000 mg/kg/day 농도에서 신장무게증가,",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        306.9599914550781,
        285.43975830078125,
        508.94189453125,
        311.6473083496094
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "간의 글라이코겐 감소 및 쿠퍼세포에서",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        316.91998291015625,
        311.3597412109375,
        508.94183349609375,
        337.68731689453125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "철의 양 증가",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        316.91998291015625,
        311.3597412109375,
        508.94183349609375,
        337.68731689453125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반복투여",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        96.72000122070312,
        340.0397644042969,
        135.72036743164062,
        353.2873229980469
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(경피)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        103.55999755859375,
        352.999755859375,
        128.91468811035156,
        366.247314453125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 랫드 대상(13주)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        153.0,
        340.0397644042969,
        428.51995849609375,
        366.247314453125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 0, 55.5, 277, 555 mg/kg/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        153.0,
        340.0397644042969,
        428.51995849609375,
        366.247314453125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 모든 용량에서 영향 없음",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        153.0,
        340.0397644042969,
        428.51995849609375,
        366.247314453125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생식·발생",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.63999938964844,
        375.1997375488281,
        296.2665710449219,
        401.4073181152344
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 랫드 대상",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.63999938964844,
        375.1997375488281,
        296.2665710449219,
        401.4073181152344
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 0, 150, 450, 1000 mg/kg/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.63999938964844,
        375.1997375488281,
        296.2665710449219,
        401.4073181152344
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- NOAEL 450 mg/kg/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        306.9599914550781,
        368.7197570800781,
        505.4398498535156,
        394.92730712890625
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 1000 mg/kg/day 용량에서 모체의 체중감",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        306.9599914550781,
        368.7197570800781,
        505.4398498535156,
        394.92730712890625
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소, 간무게 증가 및 호산구증가증 관찰",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        316.91998291015625,
        394.759765625,
        485.5199279785156,
        408.00732421875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생식·발생",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.63999938964844,
        423.31976318359375,
        296.2665710449219,
        449.6473083496094
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 랫드 대상",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.63999938964844,
        423.31976318359375,
        296.2665710449219,
        449.6473083496094
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 0, 250, 500, 1000 mg/kg/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.63999938964844,
        423.31976318359375,
        296.2665710449219,
        449.6473083496094
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 1000 mg/kg/day 군에서 태자흡수가 증가",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        306.9599914550781,
        410.3597412109375,
        505.4399108886719,
        423.6072998046875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하였으나 실험에 사용한 랫드의 일반적인",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        316.91998291015625,
        423.31976318359375,
        508.94189453125,
        449.6473083496094
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특성",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        316.91998291015625,
        423.31976318359375,
        508.94189453125,
        449.6473083496094
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 그 외 어떠한 영향도 관찰되지 않음",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        306.9599914550781,
        449.3597412109375,
        476.88043212890625,
        462.6072998046875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 피부흡수율",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        491.75250244140625,
        139.07931518554688,
        503.396240234375
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 랫드를 이용한 in vivo 시험결과인 피부흡수율 2.6%를 위해평가에 적용",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        57.599998474121094,
        515.6325073242188,
        449.760009765625,
        527.2762451171875
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        108.83999633789062,
        542.8397216796875,
        128.8795166015625,
        569.04736328125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방법",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        108.83999633789062,
        542.8397216796875,
        128.8795166015625,
        569.04736328125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        150.47999572753906,
        542.8397216796875,
        170.40000915527344,
        569.04736328125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경로",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        150.47999572753906,
        542.8397216796875,
        170.40000915527344,
        569.04736328125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        188.87998962402344,
        542.8397216796875,
        208.91952514648438,
        569.04736328125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대상",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        188.87998962402344,
        542.8397216796875,
        208.91952514648438,
        569.04736328125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노출기간",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        234.1199951171875,
        542.8397216796875,
        274.07952880859375,
        556.0873413085938
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(시간)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        241.0800018310547,
        549.3197021484375,
        481.31903076171875,
        569.04736328125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        241.0800018310547,
        549.3197021484375,
        481.31903076171875,
        569.04736328125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부흡수율",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        241.0800018310547,
        549.3197021484375,
        481.31903076171875,
        569.04736328125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "in vivo",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        102.39836120605469,
        588.9197387695312,
        285.0856018066406,
        602.1673583984375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경피",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        102.39836120605469,
        588.9197387695312,
        285.0856018066406,
        602.1673583984375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "랫드",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        102.39836120605469,
        588.9197387695312,
        285.0856018066406,
        602.1673583984375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1, 2, 4, 8, 12",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        102.39836120605469,
        588.9197387695312,
        285.0856018066406,
        602.1673583984375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.5% 함유",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        321.3599853515625,
        580.8796997070312,
        367.91998291015625,
        594.1273193359375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(에멀젼, 로션 제형)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        300.6000061035156,
        596.959716796875,
        388.8346862792969,
        610.2073364257812
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 에멀젼 : 0.7±0.3%",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        404.2799987792969,
        572.959716796875,
        498.41082763671875,
        586.2073364257812
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 로션 : 1.2±0.7%",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        404.2799987792969,
        588.9197387695312,
        488.330322265625,
        602.1673583984375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 피부흡수율 : 2.6%1)",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothic",
      "bbox": [
        404.2799987792969,
        604.4778442382812,
        505.87640380859375,
        618.1273193359375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "in vitro",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        620.5997314453125,
        367.91998291015625,
        641.767333984375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경피",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        620.5997314453125,
        367.91998291015625,
        641.767333984375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사람",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        620.5997314453125,
        367.91998291015625,
        641.767333984375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        620.5997314453125,
        367.91998291015625,
        641.767333984375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.5% 함유",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        620.5997314453125,
        367.91998291015625,
        641.767333984375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(에멀젼, 바세린 제형)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        295.55999755859375,
        636.5596923828125,
        393.87469482421875,
        649.8073120117188
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 1.6~9.3%",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        404.2799987792969,
        628.5197143554688,
        456.1703186035156,
        641.767333984375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "in vitro",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        660.19970703125,
        256.8857727050781,
        673.4473266601562
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표피",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        660.19970703125,
        256.8857727050781,
        673.4473266601562
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사람",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        660.19970703125,
        256.8857727050781,
        673.4473266601562
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        660.19970703125,
        256.8857727050781,
        673.4473266601562
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.5% 함유",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        321.3599853515625,
        652.1597290039062,
        367.91998291015625,
        665.4073486328125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(로션 제형)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        319.1999816894531,
        668.2396850585938,
        370.23468017578125,
        681.4873046875
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 7~16%",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        404.2799987792969,
        660.19970703125,
        446.2103271484375,
        673.4473266601562
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "in vitro",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        691.8796997070312,
        259.6455993652344,
        705.1273193359375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경피",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        691.8796997070312,
        259.6455993652344,
        705.1273193359375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사람",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        691.8796997070312,
        259.6455993652344,
        705.1273193359375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.318359375,
        691.8796997070312,
        259.6455993652344,
        705.1273193359375
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.5% 함유",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        321.3599853515625,
        683.8397216796875,
        367.91998291015625,
        697.0873413085938
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(에멀젼 제형)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        314.1600036621094,
        691.8796997070312,
        433.7304382324219,
        713.0473022460938
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 10%",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        314.1600036621094,
        691.8796997070312,
        433.7304382324219,
        713.0473022460938
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 피부흡수율 = 평균 + (2 × 표준편차)",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        94.91999816894531,
        718.449462890625,
        243.88967895507812,
        729.1432495117188
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 54 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 60,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 위험성 결정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        137.03965759277344,
        86.39624786376953
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 체중감소 및 간무게 증가를 근거로 NOAEL 450 mg/kg/day를 독성기준값으로 선정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        100.79249572753906,
        494.1600036621094,
        112.43624877929688
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험방법",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        110.75999450683594,
        129.07974243164062,
        382.67950439453125,
        148.80731201171875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여경로",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        110.75999450683594,
        129.07974243164062,
        382.67950439453125,
        148.80731201171875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험대상",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        110.75999450683594,
        129.07974243164062,
        382.67950439453125,
        148.80731201171875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        110.75999450683594,
        129.07974243164062,
        382.67950439453125,
        148.80731201171875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        334.67999267578125,
        142.03973388671875,
        391.2857360839844,
        155.2873077392578
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무독성용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        437.7599792480469,
        129.07974243164062,
        494.36480712890625,
        155.2873077392578
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        437.7599792480469,
        129.07974243164062,
        494.36480712890625,
        155.2873077392578
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생식발생독성시험",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        90.72000122070312,
        164.83973693847656,
        474.0854187011719,
        178.08731079101562
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경구/식이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        90.72000122070312,
        164.83973693847656,
        474.0854187011719,
        178.08731079101562
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "랫드",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        90.72000122070312,
        164.83973693847656,
        474.0854187011719,
        178.08731079101562
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0, 150, 450, 1000",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        90.72000122070312,
        164.83973693847656,
        474.0854187011719,
        178.08731079101562
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "450",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        90.72000122070312,
        164.83973693847656,
        474.0854187011719,
        178.08731079101562
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 노출평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        222.4724884033203,
        125.15966033935547,
        234.11624145507812
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 자외선차단제 중 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 전신노출량",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        246.3524932861328,
        538.5596313476562,
        257.9962463378906
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(SED) 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        266.1524963378906,
        137.2796630859375,
        277.7962341308594
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 에칠헥실메톡시신나메이트 함유 농도 7.5%, 1일 1회 사용, 1일 사용량 17 g/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        289.9125061035156,
        488.64080810546875,
        301.5562438964844
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대상",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        112.43999481201172,
        318.1997375488281,
        135.86155700683594,
        331.4472961425781
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        107.39999389648438,
        331.1597595214844,
        137.39952087402344,
        344.4073181152344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품 내 농도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        158.27999877929688,
        318.1997375488281,
        218.27999877929688,
        331.4472961425781
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(%)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        181.0800018310547,
        331.1597595214844,
        196.0449981689453,
        344.4073181152344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        233.39999389648438,
        318.1997375488281,
        301.8210754394531,
        331.4472961425781
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(g/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        249.72000122070312,
        331.1597595214844,
        282.565185546875,
        344.4073181152344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부흡수율",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        318.47998046875,
        318.1997375488281,
        371.9010925292969,
        331.4472961425781
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(%)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        336.239990234375,
        331.1597595214844,
        351.2049865722656,
        344.4073181152344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체중",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        396.9599914550781,
        318.1997375488281,
        420.5010681152344,
        344.4073181152344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(kg)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        396.9599914550781,
        318.1997375488281,
        420.5010681152344,
        344.4073181152344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전신노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        445.3199768066406,
        318.1997375488281,
        501.92578125,
        344.4073181152344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        445.3199768066406,
        318.1997375488281,
        501.92578125,
        344.4073181152344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자외선",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        107.39999389648438,
        350.7197570800781,
        140.9010772705078,
        363.9673156738281
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "차단제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        107.39999389648438,
        366.67974853515625,
        137.39952087402344,
        379.92730712890625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.5",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        181.67999267578125,
        358.6397399902344,
        488.1253967285156,
        371.8872985839844
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17.0",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        181.67999267578125,
        358.6397399902344,
        488.1253967285156,
        371.8872985839844
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.6",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        181.67999267578125,
        358.6397399902344,
        488.1253967285156,
        371.8872985839844
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        181.67999267578125,
        358.6397399902344,
        488.1253967285156,
        371.8872985839844
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5525",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        181.67999267578125,
        358.6397399902344,
        488.1253967285156,
        371.8872985839844
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.27999877929688,
        417.3525085449219,
        175.55999755859375,
        428.9962463378906
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.27999877929688,
        417.3525085449219,
        175.55999755859375,
        428.9962463378906
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17 (g/day) × 7.5/100 × 2.6/100",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        200.87998962402344,
        407.63250732421875,
        362.1590576171875,
        419.2762451171875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "= 0.5525 mg/kg/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        373.1999816894531,
        417.3525085449219,
        471.8498229980469,
        428.9962463378906
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60 kg",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        267.9599914550781,
        428.39251708984375,
        295.9720458984375,
        440.0362548828125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 위해도 평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        482.87249755859375,
        141.59999084472656,
        494.5162353515625
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 자외선차단제에 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 안전역 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        506.63250732421875,
        507.84039306640625,
        518.2762451171875
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대상 화장품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        114.47999572753906,
        534.9197387695312,
        277.6448059082031,
        561.1273193359375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전신노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        114.47999572753906,
        534.9197387695312,
        277.6448059082031,
        561.1273193359375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        114.47999572753906,
        534.9197387695312,
        277.6448059082031,
        561.1273193359375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "독성기준값",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        328.0799865722656,
        534.9197387695312,
        384.684814453125,
        561.1273193359375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        328.0799865722656,
        534.9197387695312,
        384.684814453125,
        561.1273193359375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전역",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        448.0799865722656,
        534.9197387695312,
        478.0794982910156,
        561.1273193359375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(MOS)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        448.0799865722656,
        534.9197387695312,
        478.0794982910156,
        561.1273193359375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자외선 차단제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        109.55999755859375,
        570.6796875,
        471.3254089355469,
        583.9273071289062
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5525",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        109.55999755859375,
        570.6796875,
        471.3254089355469,
        583.9273071289062
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "450",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        109.55999755859375,
        570.6796875,
        471.3254089355469,
        583.9273071289062
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "814",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        109.55999755859375,
        570.6796875,
        471.3254089355469,
        583.9273071289062
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MOS",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        171.1199951171875,
        622.4324951171875,
        212.39999389648438,
        634.0762329101562
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        171.1199951171875,
        622.4324951171875,
        212.39999389648438,
        634.0762329101562
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NOAEL",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        241.1999969482422,
        612.7125244140625,
        367.5599670410156,
        632.63623046875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        241.1999969482422,
        612.7125244140625,
        367.5599670410156,
        632.63623046875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "450",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        241.1999969482422,
        612.7125244140625,
        367.5599670410156,
        632.63623046875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "= 814",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        395.7599792480469,
        622.4324951171875,
        425.3999938964844,
        634.0762329101562
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        633.3524780273438,
        374.51922607421875,
        644.9962158203125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5525",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        633.3524780273438,
        374.51922607421875,
        644.9962158203125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- MOS 100 이상이므로 위해영향 가능성 낮음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        687.83251953125,
        318.9596862792969,
        699.4762573242188
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 55 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 61,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 보존제(메칠이소치아졸리논)에 대한 위해평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        297.47967529296875,
        86.39624786376953
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 위험성 확인",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        120.23249816894531,
        137.03965759277344,
        131.87625122070312
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        146.15249633789062,
        455.8800048828125,
        157.79624938964844
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독성자료",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        107.63999938964844,
        176.23974609375,
        438.719970703125,
        189.48731994628906
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        107.63999938964844,
        176.23974609375,
        438.719970703125,
        189.48731994628906
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        107.63999938964844,
        176.23974609375,
        438.719970703125,
        189.48731994628906
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반복투여(경구)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.5199966430664,
        204.07974243164062,
        333.1072082519531,
        230.2873077392578
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 랫드 대상(3개월)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.5199966430664,
        204.07974243164062,
        333.1072082519531,
        230.2873077392578
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 6.5~9.8, 19~25, 66~96 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.5199966430664,
        204.07974243164062,
        333.1072082519531,
        230.2873077392578
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- NOAEL 66~94 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        343.67999267578125,
        197.59974670410156,
        513.8399658203125,
        223.80731201171875
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 혈액학적, 임상화학적, 전신, 신경",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        343.67999267578125,
        197.59974670410156,
        513.8399658203125,
        223.80731201171875
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "독성 등이 없음",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        353.7599792480469,
        223.51974487304688,
        423.7195129394531,
        236.76731872558594
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반복투여(경구)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.5199966430664,
        255.07972717285156,
        291.9466552734375,
        281.2873229980469
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 비글견 대상(3개월)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.5199966430664,
        255.07972717285156,
        291.9466552734375,
        281.2873229980469
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 3, 10, 41 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        95.5199966430664,
        255.07972717285156,
        291.9466552734375,
        281.2873229980469
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- NOEL 10 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        343.67999267578125,
        241.99974060058594,
        513.8399658203125,
        281.2873229980469
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- NOAEL 41 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        343.67999267578125,
        241.99974060058594,
        513.8399658203125,
        281.2873229980469
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 41 mg/kg bw/day 용량에서 혈액",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        343.67999267578125,
        241.99974060058594,
        513.8399658203125,
        281.2873229980469
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "학적 변화 없음",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        353.7599792480469,
        280.999755859375,
        423.7195129394531,
        294.247314453125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생식·발생",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        107.04000091552734,
        312.55975341796875,
        309.586669921875,
        338.7673034667969
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 랫드 대상(6~19일)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        107.04000091552734,
        312.55975341796875,
        309.586669921875,
        338.7673034667969
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 5, 20, 40, 60 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        107.04000091552734,
        312.55975341796875,
        309.586669921875,
        338.7673034667969
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 모체독성 NOAEL 20 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        343.67999267578125,
        299.4797668457031,
        517.4606323242188,
        338.7673034667969
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 발달독성 NOAEL 40 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        343.67999267578125,
        299.4797668457031,
        517.4606323242188,
        338.7673034667969
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 40, 60 mg/kg bw/day 용량에서",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        343.67999267578125,
        299.4797668457031,
        517.4606323242188,
        338.7673034667969
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20%의 치사율",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        353.7599792480469,
        338.4797668457031,
        418.07952880859375,
        351.7273254394531
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생식·발생",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        107.04000091552734,
        370.0397644042969,
        291.9466552734375,
        396.247314453125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 토끼 대상(6~28일)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        107.04000091552734,
        370.0397644042969,
        291.9466552734375,
        396.247314453125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 3, 10, 30 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        107.04000091552734,
        370.0397644042969,
        291.9466552734375,
        396.247314453125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 모체독성 NOAEL 10 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        343.67999267578125,
        356.9597473144531,
        517.4611206054688,
        396.247314453125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 발생독성 NOAEL 30 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        343.67999267578125,
        356.9597473144531,
        517.4611206054688,
        396.247314453125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 30 mg/kg bw/day 용량에서 배변",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        343.67999267578125,
        356.9597473144531,
        517.4611206054688,
        396.247314453125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감소, 위장내 검붉은 반점 등 관찰",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        353.7599792480469,
        395.9597473144531,
        510.8399658203125,
        409.2073059082031
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 피부흡수율",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        434.39251708984375,
        139.07931518554688,
        446.0362548828125
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-  피부흡수율 실험자료가 높은 표준편차를 나타냄에 따라 피부흡수율을 계산할 수 없음.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        57.599998474121094,
        458.1524963378906,
        533.3995971679688,
        469.7962341308594
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피부흡수율 50%를 위해평가에 적용",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.5999984741211,
        477.9525146484375,
        269.2796936035156,
        489.59625244140625
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        104.39999389648438,
        505.9997253417969,
        124.31999969482422,
        532.2073364257812
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방법",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        104.39999389648438,
        505.9997253417969,
        124.31999969482422,
        532.2073364257812
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        150.47999572753906,
        505.9997253417969,
        170.40000915527344,
        532.2073364257812
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경로",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        150.47999572753906,
        505.9997253417969,
        170.40000915527344,
        532.2073364257812
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        196.55999755859375,
        505.9997253417969,
        487.19952392578125,
        532.2073364257812
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대상",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        196.55999755859375,
        505.9997253417969,
        487.19952392578125,
        532.2073364257812
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        196.55999755859375,
        505.9997253417969,
        487.19952392578125,
        532.2073364257812
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부흡수율",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        196.55999755859375,
        505.9997253417969,
        487.19952392578125,
        532.2073364257812
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "in vivo",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        97.83836364746094,
        546.6796875,
        500.69110107421875,
        559.9273071289062
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        97.83836364746094,
        546.6796875,
        500.69110107421875,
        559.9273071289062
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "랫드",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        97.83836364746094,
        546.6796875,
        500.69110107421875,
        559.9273071289062
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 25, 75, 100 ppm",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        97.83836364746094,
        546.6796875,
        500.69110107421875,
        559.9273071289062
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 21.4, 33.7, 51.2%",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        97.83836364746094,
        546.6796875,
        500.69110107421875,
        559.9273071289062
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "in vitro",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        96.75836181640625,
        599.1196899414062,
        216.59951782226562,
        612.3673095703125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        96.75836181640625,
        599.1196899414062,
        216.59951782226562,
        612.3673095703125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사람",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        96.75836181640625,
        599.1196899414062,
        216.59951782226562,
        612.3673095703125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 52.2, 104.3 및 313 μg/mL 함유",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        234.72000122070312,
        575.1196899414062,
        393.6215515136719,
        588.3673095703125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "액상제형",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        243.83999633789062,
        591.0797119140625,
        283.7995300292969,
        604.3273315429688
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 100 μg/mL 함유 샴푸, 바디로션,",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        234.72000122070312,
        607.1597290039062,
        397.8218688964844,
        620.4073486328125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "페이셜 크림 제형",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        243.83999633789062,
        623.1196899414062,
        323.8795166015625,
        636.3673095703125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 29.8, 38, 54.7%",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        411.5999755859375,
        591.0797119140625,
        493.0110778808594,
        604.3273315429688
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 29.5, 8.98, 19.6%",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        411.5999755859375,
        607.1597290039062,
        500.69110107421875,
        620.4073486328125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 56 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 62,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 위험성 결정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        137.03965759277344,
        86.39624786376953
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 토끼에 대한 생식발생독성시험에서 얻어진 NOAEL 10 mg/kg bw/day를 독성기준값으로",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        100.79249572753906,
        543.9592895507812,
        112.43624877929688
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "선정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.43999481201172,
        120.59249877929688,
        107.399658203125,
        132.2362518310547
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        122.87999725341797,
        148.87974548339844,
        394.67950439453125,
        168.60731506347656
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여경로",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        122.87999725341797,
        148.87974548339844,
        394.67950439453125,
        168.60731506347656
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험대상",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        122.87999725341797,
        148.87974548339844,
        394.67950439453125,
        168.60731506347656
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        122.87999725341797,
        148.87974548339844,
        394.67950439453125,
        168.60731506347656
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        346.67999267578125,
        161.83973693847656,
        403.2857666015625,
        175.08731079101562
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무독성용량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        449.8800048828125,
        148.87974548339844,
        506.48577880859375,
        175.08731079101562
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        449.8800048828125,
        148.87974548339844,
        506.48577880859375,
        175.08731079101562
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반복독성시험",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        112.79999542236328,
        184.63973999023438,
        483.3255920410156,
        197.88731384277344
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경구",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        112.79999542236328,
        184.63973999023438,
        483.3255920410156,
        197.88731384277344
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "토끼",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        112.79999542236328,
        184.63973999023438,
        483.3255920410156,
        197.88731384277344
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3, 10, 30",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        112.79999542236328,
        184.63973999023438,
        483.3255920410156,
        197.88731384277344
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        112.79999542236328,
        184.63973999023438,
        483.3255920410156,
        197.88731384277344
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 노출평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        242.27249145507812,
        125.15966033935547,
        253.91624450683594
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 대표유형 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 전신노출량(SED)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        266.1524963378906,
        543.9595336914062,
        277.7962341308594
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        285.9525146484375,
        105.11965942382812,
        297.59625244140625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 메칠이소치아졸리논 함유 농도 0.0015%, 1일 1회 사용, 1일 사용량 16.9 g/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        309.7124938964844,
        480.7207946777344,
        321.3562316894531
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대상",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        110.27999877929688,
        337.999755859375,
        140.16000366210938,
        364.2073059082031
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        110.27999877929688,
        337.999755859375,
        140.16000366210938,
        364.2073059082031
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품 내 농도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        161.16000366210938,
        337.999755859375,
        221.15951538085938,
        351.247314453125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(%)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        183.95999145507812,
        350.9597473144531,
        198.9250030517578,
        364.2073059082031
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        233.39999389648438,
        337.999755859375,
        301.8210754394531,
        351.247314453125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(g/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        249.72000122070312,
        350.9597473144531,
        282.565185546875,
        364.2073059082031
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피부흡수율",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        318.47998046875,
        337.999755859375,
        371.9010925292969,
        351.247314453125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(%)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        336.239990234375,
        350.9597473144531,
        351.2049865722656,
        364.2073059082031
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체중",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        396.9599914550781,
        337.999755859375,
        420.5010681152344,
        364.2073059082031
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(kg)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        396.9599914550781,
        337.999755859375,
        420.5010681152344,
        364.2073059082031
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전신노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        445.3199768066406,
        337.999755859375,
        501.92578125,
        364.2073059082031
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        445.3199768066406,
        337.999755859375,
        501.92578125,
        364.2073059082031
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대표 유형",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        102.72000122070312,
        370.5197448730469,
        151.2215576171875,
        383.7673034667969
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        110.27999877929688,
        386.479736328125,
        140.16000366210938,
        399.727294921875
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.0015",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        176.27999877929688,
        378.43975830078125,
        488.1253967285156,
        391.68731689453125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "16.9",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        176.27999877929688,
        378.43975830078125,
        488.1253967285156,
        391.68731689453125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "50",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        176.27999877929688,
        378.43975830078125,
        488.1253967285156,
        391.68731689453125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        176.27999877929688,
        378.43975830078125,
        488.1253967285156,
        391.68731689453125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.0021",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        176.27999877929688,
        378.43975830078125,
        488.1253967285156,
        391.68731689453125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "· SED = 16.9 (g/day) × 0.0015/100 × 50/100 ÷ 60 kg = 0.0021 mg/kg/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        419.2724914550781,
        465.24981689453125,
        430.9162292480469
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4) 위해도 평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        466.9125061035156,
        141.59999084472656,
        478.5562438964844
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 안전역 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        490.6725158691406,
        467.8800048828125,
        502.3162536621094
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대상 화장품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        114.47999572753906,
        518.959716796875,
        277.6448059082031,
        545.1673583984375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전신노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        114.47999572753906,
        518.959716796875,
        277.6448059082031,
        545.1673583984375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        114.47999572753906,
        518.959716796875,
        277.6448059082031,
        545.1673583984375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "독성기준값",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        328.0799865722656,
        518.959716796875,
        384.684814453125,
        545.1673583984375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg/day)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        328.0799865722656,
        518.959716796875,
        384.684814453125,
        545.1673583984375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전역",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        448.0799865722656,
        518.959716796875,
        478.0794982910156,
        545.1673583984375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(MOS)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        448.0799865722656,
        518.959716796875,
        478.0794982910156,
        545.1673583984375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대표 유형 화장품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        102.0,
        556.1597290039062,
        474.0852355957031,
        569.4073486328125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.0021",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        102.0,
        556.1597290039062,
        474.0852355957031,
        569.4073486328125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        102.0,
        556.1597290039062,
        474.0852355957031,
        569.4073486328125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4762",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        102.0,
        556.1597290039062,
        474.0852355957031,
        569.4073486328125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MOS",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        171.1199951171875,
        633.1124877929688,
        212.39999389648438,
        644.7562255859375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        171.1199951171875,
        633.1124877929688,
        212.39999389648438,
        644.7562255859375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NOAEL",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        241.1999969482422,
        623.3925170898438,
        364.79998779296875,
        643.3162231445312
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        241.1999969482422,
        623.3925170898438,
        364.79998779296875,
        643.3162231445312
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        241.1999969482422,
        623.3925170898438,
        364.79998779296875,
        643.3162231445312
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "= 4762",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        395.7599792480469,
        633.1124877929688,
        430.91998291015625,
        644.7562255859375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        644.1525268554688,
        374.51922607421875,
        655.7962646484375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.0021",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        644.1525268554688,
        374.51922607421875,
        655.7962646484375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- MOS 100 이상이므로 위해영향 가능성 낮음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        698.6325073242188,
        318.9596862792969,
        710.2762451171875
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 57 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        405.7200012207031,
        539.9027709960938,
        436.0413513183594,
        552.8507690429688
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "붙임 10. 화장품 성분 위해평가를 위한 정보 수집",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        330.47998046875,
        87.98039245605469
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 성분 및 식별자료 검색",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        117.9524917602539,
        186.1199951171875,
        129.59625244140625
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사이트명",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        107.63999938964844,
        146.59974670410156,
        588.1195678710938,
        159.84732055664062
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        107.63999938964844,
        146.59974670410156,
        588.1195678710938,
        159.84732055664062
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세부정보",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        107.63999938964844,
        146.59974670410156,
        588.1195678710938,
        159.84732055664062
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CAS SciFindern",
      "font_size": 6.359999656677246,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        175.63973999023438,
        402.0041809082031,
        196.92730712890625
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://www.cas.org/solutions/cas-scifinder-",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        175.63973999023438,
        402.0041809082031,
        196.92730712890625
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "discovery-platform/cas-scifinder",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        202.44000244140625,
        191.59974670410156,
        347.5614318847656,
        204.84732055664062
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국화학회(CAS)에서 구축하고 생화학, 의학, 화학공학 등에 특화된",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        175.63973999023438,
        727.4611206054688,
        188.88731384277344
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과학연구 DB로 유료로 운영됨",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        191.59974670410156,
        553.9411010742188,
        204.84732055664062
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STN",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        230.5997314453125,
        360.1027526855469,
        243.84730529785156
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://www.stn-international.com/",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        230.5997314453125,
        360.1027526855469,
        243.84730529785156
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국화학회(CAS)와 독일 연방과학기술센터(FIZ)rk 공동으로 구축한",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        214.63973999023438,
        727.4611206054688,
        227.88731384277344
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "데이터베이스로 구조식, CAS no, 분자식 등의 정보 및 구조식으로",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        230.5997314453125,
        727.4611206054688,
        243.84730529785156
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화합물 검색이 가능하며 유료로 운영됨",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        246.5597381591797,
        592.4395141601562,
        259.80731201171875
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PubChem",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        283.8797607421875,
        353.3858337402344,
        297.1273193359375
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://pubmed.ncbi.nlm.nih.gov/",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        283.8797607421875,
        353.3858337402344,
        297.1273193359375
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국 국립보건원(NIH)의 미국의학도서관(NLM) 내 미국 국립생물공",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        267.91973876953125,
        723.9595336914062,
        281.16729736328125
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "학정보센터(NCIB)가 관리하는 화학분자 및 생물학 관련 논문 데이",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        283.8797607421875,
        723.9595336914062,
        297.1273193359375
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "터베이스임",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        299.9597473144531,
        462.3595275878906,
        313.2073059082031
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "wINCI",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        337.2797546386719,
        394.07208251953125,
        350.5273132324219
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "http://webdictionary.personalcarecouncil.org",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        337.2797546386719,
        394.07208251953125,
        350.5273132324219
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국제적으로 통용되는 화장품 성분의 명칭. 국제명칭위원회(INC)가",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        321.1997375488281,
        727.4615478515625,
        334.4472961425781
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발하고 PCPC(Personal Care Products Council)가 국제화장품성분",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        337.2797546386719,
        723.9590454101562,
        350.5273132324219
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사전(ICID) 및 핸드북에 게재하고 있음. 전자적으로 wINCI로 제공됨",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        353.23974609375,
        721.4395141601562,
        366.4873046875
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한화장품협회 성분사전",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        393.1997375488281,
        381.0992431640625,
        406.4472961425781
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://kcia.or.kr/cid/search/ingd_list.php",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        393.1997375488281,
        381.0992431640625,
        406.4472961425781
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국내 화장품 성분명 표준화 위원회에서 「화장품법」에 따라 화장품",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        377.23974609375,
        727.4611206054688,
        390.4873046875
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성분명을 표준화하여 제시하고 있음. 국문, 영문 성분명, CAS no,",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        393.1997375488281,
        727.461669921875,
        406.4472961425781
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구조식 등 확인 가능함. 일부 내용은 회원사에만 제공되고 있음",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        412.44000244140625,
        409.2797546386719,
        704.6395263671875,
        422.5273132324219
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 58 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        405.7200012207031,
        539.9027709960938,
        436.0413513183594,
        552.8507690429688
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 법률 규제 확인",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        147.59999084472656,
        86.39624786376953
      ],
      "page_num": 64,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사이트명",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        134.27999877929688,
        103.39974212646484,
        637.1995239257812,
        116.64732360839844
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        134.27999877929688,
        103.39974212646484,
        637.1995239257812,
        116.64732360839844
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세부정보",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        134.27999877929688,
        103.39974212646484,
        637.1995239257812,
        116.64732360839844
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한국 의약품안전나라 의약품통합정보시",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        133.63973999023438,
        245.39903259277344,
        146.88731384277344
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스템",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        149.59974670410156,
        83.15951538085938,
        162.84732055664062
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "https://nedrug.mfds.go.kr/index",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        141.5597381591797,
        670.4395141601562,
        154.80731201171875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "국내 화장품원료 정보 및 규제정보",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        141.5597381591797,
        670.4395141601562,
        154.80731201171875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EU CosIng",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        176.59974670410156,
        111.59721374511719,
        189.84732055664062
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(유럽 화장품 성분 정보 데이터베이스",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        192.5597381591797,
        236.15904235839844,
        205.80731201171875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://ec.europa.eu/growth/tools-databases/cosing/",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        184.51974487304688,
        721.0799560546875,
        197.76731872558594
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "EU의 화장품 규정 및 화장품 성분에 대한 정보",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        184.51974487304688,
        721.0799560546875,
        197.76731872558594
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국 FDA(식품의약품청)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        243.5597381591797,
        172.95468139648438,
        256.80731201171875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://www.fda.gov/cosmetics/cosmetics-guidance-reg",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        219.5597381591797,
        499.6766052246094,
        232.80731201171875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ulation",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        235.51974487304688,
        286.0782775878906,
        248.76731872558594
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://www.fda.gov/industry/color-additives-specific-p",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        251.59974670410156,
        497.62213134765625,
        264.8473205566406
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "roducts/color-additives-and-cosmetics-fact-sheet",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        267.55975341796875,
        472.1528625488281,
        280.80731201171875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국 화장품 가이드라인 및 규정",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        235.51974487304688,
        656.0399780273438,
        248.76731872558594
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국 화장품 착색제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        251.59974670410156,
        597.9598999023438,
        264.8473205566406
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중국 NMPA(국가약품감독관리국)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        294.55975341796875,
        615.47998046875,
        307.80731201171875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://www.nmpa.gov.cn/hzhp/index.html",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        294.55975341796875,
        615.47998046875,
        307.80731201171875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중국 화장품 관련 규제",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        294.55975341796875,
        615.47998046875,
        307.80731201171875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일본",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        353.479736328125,
        86.66107940673828,
        366.727294921875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://elaws.e-gov.go.jp/search/elawsSearch/elaws_searc",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        321.55975341796875,
        500.0672912597656,
        334.80731201171875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "h/lsg0500/detail?lawId=335AC0000000145",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        337.5197448730469,
        438.2087707519531,
        350.7673034667969
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://www.mhlw.go.jp/content/000491511.pdf",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        353.479736328125,
        459.3919372558594,
        366.727294921875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://www.mhlw.go.jp/web/t_doc?dataId=81074000&d",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        369.55975341796875,
        497.27825927734375,
        382.80731201171875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ataType=0&pageNo=1",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        385.5197448730469,
        354.68536376953125,
        398.7673034667969
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품, 의료기기 등의 품질, 유효성 및 안전",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        329.4797668457031,
        723.9595336914062,
        342.7273254394531
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성 확보 등에 관한 법률",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        345.55975341796875,
        620.51953125,
        358.80731201171875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 성분 관련 기준",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        361.5197448730469,
        609.7203979492188,
        374.7673034667969
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 색소 관련 기준",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        377.479736328125,
        609.7203979492188,
        390.727294921875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ASEAN Cosmetics Association",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        420.43975830078125,
        201.71798706054688,
        433.68731689453125
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(아세안 화장품협회)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        436.5197448730469,
        154.23468017578125,
        449.7673034667969
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "http://ASEANcosmetics.org/information-center/ASEA",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        412.5197448730469,
        494.4783020019531,
        425.7673034667969
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N-cosmetic-directive/",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        428.479736328125,
        353.6248474121094,
        441.727294921875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "http://ASEANcosmetics.org",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        444.43975830078125,
        377.87799072265625,
        457.68731689453125
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아세안 화장품협회 화장품 지침",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        420.43975830078125,
        655.4400024414062,
        433.68731689453125
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아세안 화장품 성분 정보",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        436.5197448730469,
        625.4400024414062,
        449.7673034667969
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "호주",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        479.479736328125,
        83.15951538085938,
        492.727294921875
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://www.industrialchemicals.gov.au/cosmetics-and",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        471.43975830078125,
        500.1568908691406,
        484.68731689453125
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-soap",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        255.72000122070312,
        487.5197448730469,
        281.26129150390625,
        500.7673034667969
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화장품 관련 규제 및 화학물질 관련 위해성평",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        471.43975830078125,
        723.9595336914062,
        484.68731689453125
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가 보고서 제공",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        487.5197448730469,
        580.4400024414062,
        500.7673034667969
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 59 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        405.7200012207031,
        539.9027709960938,
        436.0413513183594,
        552.8507690429688
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 독성 및 위해 정보",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        156.3524932861328,
        164.03965759277344,
        167.99624633789062
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IFRA",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        94.51974487304688,
        367.4244079589844,
        107.76732635498047
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://ifrafragrance.org/",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        94.51974487304688,
        367.4244079589844,
        107.76732635498047
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IFRA(국제향료협회)에서 제공하는 향료물질의",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        78.43974304199219,
        727.4611206054688,
        91.68732452392578
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제한 금지에 대한 향료안전기준 및 제조법",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        94.51974487304688,
        732.5008544921875,
        107.76732635498047
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 지침 등 제공",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        110.47974395751953,
        585.47998046875,
        123.72732543945312
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이트명",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        148.44000244140625,
        183.5597381591797,
        637.1995239257812,
        196.80731201171875
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        148.44000244140625,
        183.5597381591797,
        637.1995239257812,
        196.80731201171875
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세부정보",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        148.44000244140625,
        183.5597381591797,
        637.1995239257812,
        196.80731201171875
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCCS",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        217.51974487304688,
        86.76871490478516,
        230.76731872558594
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Science Committee on Consumer Safety)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        233.479736328125,
        258.3952941894531,
        246.72731018066406
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://health.ec.europa.eu/scientific-committee",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        284.0400085449219,
        217.51974487304688,
        500.0879211425781,
        230.76731872558594
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "s/scientific-committee-consumer-safety-sccs_en",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        284.0400085449219,
        233.479736328125,
        498.3574523925781,
        246.72731018066406
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비식품 소비자제품(화장품, 완구, 직물, 의류,",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        209.479736328125,
        727.4619140625,
        222.72731018066406
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가정용 제품)의 건강 및 안전에 관한 위해성평",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        225.5597381591797,
        723.9595336914062,
        238.80731201171875
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가 내용 제공",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        241.51974487304688,
        570.47998046875,
        254.76731872558594
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CIR(Cosmetic Ingredient Review)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        278.8397521972656,
        400.6614685058594,
        292.0873107910156
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://www.cir-safety.org/",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        278.8397521972656,
        400.6614685058594,
        292.0873107910156
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관련 전문가로 이루어진 비영리단체로 화장품에",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        262.8797607421875,
        727.3414306640625,
        276.1273193359375
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용되는 성분에 대한 정성적 안전성 평가",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        278.8397521972656,
        703.1015014648438,
        292.0873107910156
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보고서 제공",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        294.79974365234375,
        564.00048828125,
        308.04730224609375
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PubMed",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        332.1197509765625,
        434.98583984375,
        345.3673095703125
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://pubmed.ncbi.nlm.nih.gov/",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        332.1197509765625,
        434.98583984375,
        345.3673095703125
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국 국립보건원(NIH)의 생명과학 및 생물의",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        316.1597595214844,
        723.9595336914062,
        329.4073181152344
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "학에 관한 연구 및 최신동향 관련 논문을 확",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        332.1197509765625,
        723.9600219726562,
        345.3673095703125
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인할 수 있으며 일부 유료로 운영됨",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        348.1997375488281,
        675.4795532226562,
        361.4472961425781
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IARC",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        377.479736328125,
        365.2648010253906,
        390.727294921875
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://www.iarc.fr/",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        377.479736328125,
        365.2648010253906,
        390.727294921875
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세계보건기구 산하의 국제암연구기관으로",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        369.43975830078125,
        693.1434326171875,
        382.68731689453125
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발암물질에 대한 연구내용 및 분류 제공",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        385.5197448730469,
        684.8403930664062,
        398.7673034667969
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OECD SIDS",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        414.79974365234375,
        490.87091064453125,
        428.04730224609375
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://hpvchemicals.oecd.org/ui/Default.aspx",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        414.79974365234375,
        490.87091064453125,
        428.04730224609375
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OECD(경제협력개발기구)의 후원으로 작성된",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        406.7597351074219,
        716.5410766601562,
        420.0072937011719
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화학물질 위험에 관한 연구 보고서 제공",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        422.8397521972656,
        695.51953125,
        436.0873107910156
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OECD library",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        447.1997375488281,
        497.1886291503906,
        468.3673095703125
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://www.oecd-ilibrary.org/environment/oec",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        447.1997375488281,
        497.1886291503906,
        468.3673095703125
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "d-series-on-testing-and-assessment_20777876",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        284.0400085449219,
        463.1597595214844,
        495.32122802734375,
        476.4073181152344
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OECD Guideline 시험 지침 제공",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        455.1197509765625,
        659.6400146484375,
        468.3673095703125
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IPCS INCHEM",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        495.79974365234375,
        381.8233337402344,
        509.04730224609375
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "https://inchem.org/#/",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        495.79974365234375,
        381.8233337402344,
        509.04730224609375
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IPCS(국제화학물질안전프로그램) 및 CCOHS(캐",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        487.7597351074219,
        723.9600219726562,
        501.0072937011719
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나다 산업보건 및 안전센터)에서 운영하는 최",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        503.8397521972656,
        723.9600219726562,
        517.0873413085938
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 60 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        405.7200012207031,
        539.9027709960938,
        436.0413513183594,
        552.8507690429688
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신 화학물질 안전 관련 간행물 및 국제 기구",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        75.67974090576172,
        723.9600219726562,
        88.92732238769531
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 데이터베이스 확인 가능",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        91.63973999023438,
        635.51953125,
        104.88732147216797
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CICADS, EHS, HSGs, ICSCs, JECFA, JMPR,",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        107.59973907470703,
        727.4620971679688,
        120.84732055664062
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "KemI-Riskline, PIMs , UKPID 등이 포함됨",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        123.67974853515625,
        701.280029296875,
        136.9273223876953
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RIFM",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        152.95974731445312,
        356.7430419921875,
        166.2073211669922
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://rifm.org/",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        152.95974731445312,
        356.7430419921875,
        166.2073211669922
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RIFM(향료물질연구소)에서 향료 물질에 대한",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        144.91973876953125,
        727.4611206054688,
        158.1673126220703
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성 평가에 필요한 독성 관련 자료를 제공함",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        510.47998046875,
        160.99974060058594,
        723.7203979492188,
        174.247314453125
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "참고 자료",
      "font_size": 18.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        257.0400085449219,
        136.28916931152344,
        338.03997802734375,
        160.23057556152344
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "참고 1. 발암물질 위해평가 및 예시",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        203.29945373535156,
        251.87998962402344,
        219.26039123535156
      ],
      "page_num": 67,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고 2. TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        231.2594451904297,
        453.3599853515625,
        247.2203826904297
      ],
      "page_num": 67,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 62 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 68,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고 1. 발암물질 위해평가 및 예시",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        251.87998962402344,
        87.98039245605469
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 발암물질의 위험성을 평가하는 경우에는 충분한 정보를 근거로 한 T25 또는 BMDL10 등을",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        124.19248962402344,
        543.9596557617188,
        136.3828125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이용하여 평생발암위해도(lifetime cancer risk, LCR)를 결정하거나 용량 디스크립터와 인체",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.27999877929688,
        143.99249267578125,
        543.9596557617188,
        155.63624572753906
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노출량 추정치 사이의 비율인 노출안전역(margin of exposure, MOE) 산출을 통해 위해도를",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.27999877929688,
        163.79249572753906,
        543.9592895507812,
        175.43624877929688
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결정할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.27999877929688,
        183.59249877929688,
        151.17562866210938,
        195.2362518310547
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- T25 : 시험종의 표준 수명 내에서 자연 발생을 보정한 후, 특정 조직 부위에서 25%의 종양",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        207.3524932861328,
        538.5599365234375,
        218.99624633789062
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 발생시키는 체중 1 kg당 일일 용량을 의미한다. 이것은 단일 관찰된 용량-반응으로부터",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.43999481201172,
        227.15249633789062,
        543.9592895507812,
        238.79624938964844
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "계산된 값이며, 전체 용량 범위에 대한 선형 용량-반응 관계의 가정에 기초한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.43999481201172,
        246.95249938964844,
        480.69561767578125,
        258.59625244140625
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- BMDL10(Benchmark Dose Lower confidence limit) : 용량-반응 모델을 근거로 계산되는 값으",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        270.83251953125,
        538.5599365234375,
        283.0227966308594
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 독성에 대하여 대조군에 비해 10%의 반응이 나타나는 용량의 95% 신뢰구간의 하한값을",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.91999816894531,
        290.63250732421875,
        544.0796508789062,
        302.2762451171875
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의미한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        73.91999816894531,
        310.4324951171875,
        120.93562316894531,
        322.07623291015625
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 평생발암 위험성의 판정을 위해서는 T25 또는 BMDL10 등을 이용하여 평생발암 위험률을 산",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        334.1925048828125,
        538.43994140625,
        346.3828125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "출할 수 있으며, 산출 방법은 다음과 같다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.87999725341797,
        353.99249267578125,
        292.1995544433594,
        365.63623046875
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 평생발암위해도(LCR) 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        377.75250244140625,
        209.99964904785156,
        389.396240234375
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 역학 자료가 있는 경우에는 우선적으로 고려하며, 동물 자료를 이용할 경우에는 사용할 동",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        401.63250732421875,
        538.5599365234375,
        413.2762451171875
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물 데이터 세트와 고려할 종양 유형을 결정한다. 동물 용량 디스크립터(dose-descriptor,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        77.75999450683594,
        421.4324951171875,
        543.9600219726562,
        433.07623291015625
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "T25)는 비교 대사율을 기반으로 인체 용량 디스크립터(HT25)로 변환된다. 또한, 평생발암",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        77.75999450683594,
        441.2325134277344,
        538.5596313476562,
        452.8762512207031
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위해도(LCR)는 EPA, IRIS 등 규제기관에서 산출된 값을 이용할 수 있으며, 10-5 미만이면",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        77.75999450683594,
        459.5155944824219,
        543.9592895507812,
        472.6762390136719
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일반적으로 위해 우려가 되지 않는다고 평가할 수 있다(SCCS/1628/21, 2021).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        77.75999450683594,
        480.8324890136719,
        460.29534912109375,
        492.4762268066406
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평생발암위해도(LCR)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        189.0,
        509.032470703125,
        383.1037902832031,
        529.0762329101562
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        189.0,
        509.032470703125,
        383.1037902832031,
        529.0762329101562
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        189.0,
        509.032470703125,
        383.1037902832031,
        529.0762329101562
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HT25/0.25",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        349.0799865722656,
        527.1525268554688,
        397.4385070800781,
        538.7962646484375
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HT25",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        200.1599884033203,
        562.552490234375,
        254.52000427246094,
        574.1962280273438
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        200.1599884033203,
        562.552490234375,
        254.52000427246094,
        574.1962280273438
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "T25",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        336.0,
        553.072509765625,
        353.88037109375,
        564.7162475585938
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(사람체중/동물체중)0.25",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        289.55999755859375,
        570.8756103515625,
        400.3800964355469,
        583.916259765625
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) BMDL10 또는 T25를 이용한 노출안전역(MOE) 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        610.6724853515625,
        332.7596740722656,
        622.86279296875
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": 동물시험으로부터 BMDL10를 이용한 노출안전역(MOE)이 10,000 이상 또는 T25를 이용한",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.599998474121094,
        634.4324951171875,
        543.9596557617188,
        646.622802734375
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "노출안전역(MOE)이 25,000 이상인 경우, 위해 우려가 되지 않는다고 평가할 수 있다(EFSA,",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.95999908447266,
        654.2324829101562,
        543.9602661132812,
        665.876220703125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005).",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.95999908447266,
        674.032470703125,
        107.37509155273438,
        685.6762084960938
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "노출안전역(MOE)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        187.1999969482422,
        711.83251953125,
        299.8799743652344,
        723.4762573242188
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        187.1999969482422,
        711.83251953125,
        299.8799743652344,
        723.4762573242188
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BMDL10 (또는 T25)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        326.2799987792969,
        702.2324829101562,
        420.2096252441406,
        714.4227905273438
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        363.3599853515625,
        721.552490234375,
        455.6399841308594,
        734.15625
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 63 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 69,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. T25를 활용한 평생발암위해도(LCR) 산출 예시",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        303.0,
        86.39624786376953
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 물질 A에 대한 발암성 연구",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        103.55249786376953,
        212.39999389648438,
        115.19625091552734
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험물질",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        78.72000122070312,
        130.63973999023438,
        142.2757110595703,
        143.88731384277344
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        78.72000122070312,
        130.63973999023438,
        142.2757110595703,
        143.88731384277344
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험종",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        78.72000122070312,
        148.87974548339844,
        155.63999938964844,
        162.1273193359375
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "랫드",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        78.72000122070312,
        148.87974548339844,
        155.63999938964844,
        162.1273193359375
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노출경로",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        78.72000122070312,
        166.99974060058594,
        155.63999938964844,
        180.247314453125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경구",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        78.72000122070312,
        166.99974060058594,
        155.63999938964844,
        180.247314453125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노출농도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        78.72000122070312,
        185.23974609375,
        240.154296875,
        198.48731994628906
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0, 25, 50 ppm(in diet)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        78.72000122070312,
        185.23974609375,
        240.154296875,
        198.48731994628906
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "노출기간",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        78.72000122070312,
        203.3597412109375,
        166.6800079345703,
        216.60731506347656
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24개월",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        78.72000122070312,
        203.3597412109375,
        166.6800079345703,
        216.60731506347656
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험결과",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        78.72000122070312,
        273.31976318359375,
        118.67951202392578,
        286.56732177734375
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사료 중 A 함유량",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        228.92062377929688,
        490.4163818359375,
        239.42530822753906
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0 mg/kg",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        228.92062377929688,
        490.4163818359375,
        239.42530822753906
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "50 mg/kg",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        228.92062377929688,
        490.4163818359375,
        239.42530822753906
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "100 mg/kg",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        228.92062377929688,
        490.4163818359375,
        239.42530822753906
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Tumor type",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        247.40061950683594,
        505.97320556640625,
        257.9053039550781
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "male",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        247.40061950683594,
        505.97320556640625,
        257.9053039550781
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "female",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        247.40061950683594,
        505.97320556640625,
        257.9053039550781
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "male",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        247.40061950683594,
        505.97320556640625,
        257.9053039550781
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "female",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        247.40061950683594,
        505.97320556640625,
        257.9053039550781
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "male",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        247.40061950683594,
        505.97320556640625,
        257.9053039550781
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "female",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        247.40061950683594,
        505.97320556640625,
        257.9053039550781
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Malignant",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        266.7206115722656,
        188.8840789794922,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "lymphomas",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        266.7206115722656,
        188.8840789794922,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2/50",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        242.39999389648438,
        266.7206115722656,
        261.23236083984375,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(4%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        242.39999389648438,
        266.7206115722656,
        261.23236083984375,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0/50",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        290.2799987792969,
        266.7206115722656,
        308.9928283691406,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(0%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        290.2799987792969,
        266.7206115722656,
        308.9928283691406,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "14/50",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        335.6399841308594,
        266.7206115722656,
        359.3935546875,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(28%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        335.6399841308594,
        266.7206115722656,
        359.3935546875,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "16/50",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        383.5199890136719,
        266.7206115722656,
        407.2725830078125,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(32%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        383.5199890136719,
        266.7206115722656,
        407.2725830078125,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25/50",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        431.2799987792969,
        266.7206115722656,
        459.77899169921875,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(50%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        431.2799987792969,
        266.7206115722656,
        459.77899169921875,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "23/50",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        479.1600036621094,
        266.7206115722656,
        507.6600036621094,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(46%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        479.1600036621094,
        266.7206115722656,
        507.6600036621094,
        290.3052978515625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mammary gland,",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        297.68060302734375,
        221.3394317626953,
        334.1053161621094
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "adenomas and",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        297.68060302734375,
        221.3394317626953,
        334.1053161621094
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "adenocarcinomas",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        142.1999969482422,
        297.68060302734375,
        221.3394317626953,
        334.1053161621094
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        304.1606140136719,
        507.6600036621094,
        327.62530517578125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0/50",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        304.1606140136719,
        507.6600036621094,
        327.62530517578125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(0%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        304.1606140136719,
        507.6600036621094,
        327.62530517578125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        304.1606140136719,
        507.6600036621094,
        327.62530517578125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15/50",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        304.1606140136719,
        507.6600036621094,
        327.62530517578125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(30%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        304.1606140136719,
        507.6600036621094,
        327.62530517578125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        304.1606140136719,
        507.6600036621094,
        327.62530517578125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "28/50",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        304.1606140136719,
        507.6600036621094,
        327.62530517578125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(56%)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.36000061035156,
        304.1606140136719,
        507.6600036621094,
        327.62530517578125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "① 종양발생이 유의하게 증가하는 최저 용량",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        378.5924987792969,
        287.5196838378906,
        390.2362365722656
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 대조군 : 0/50 (0%)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        402.3525085449219,
        171.68980407714844,
        413.9962463378906
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 사료 50 mg/kg에 노출된 암컷 마우스에서 악성림프종 발생 비율 : 16/50 (32%)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        426.2325134277344,
        475.8894958496094,
        437.8762512207031
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- net % : 32%",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        449.99249267578125,
        141.1199951171875,
        461.63623046875
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "50 mg/kg을 투여하여 종양이 발생한 비율(32%) - 대조군에서 종양이 발생한 비율(0%)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        98.87999725341797,
        480.9056091308594,
        453.5330810546875,
        490.3977966308594
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        491.1056213378906,
        496.9499816894531,
        500.5978088378906
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "32%",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        491.1056213378906,
        496.9499816894531,
        500.5978088378906
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체 마우스 수의 비율(100%) - 대조군에서 종양이 발생한 마우스 수의 비율(0%)",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        108.5999984741211,
        501.18560791015625,
        443.693359375,
        510.67779541015625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 노출기간 동안 마우스 한 마리당 1일 용량",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        557.9924926757812,
        293.0400085449219,
        569.63623046875
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 마우스 1일 먹이 투여량 : 3.25 g/day(실험값)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        581.8724975585938,
        304.2900085449219,
        593.5162353515625
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "50 mg/kg × 3.25 g/day × kg/1000g = 0.16 mg/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        167.75999450683594,
        605.6325073242188,
        427.3301086425781,
        617.2762451171875
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 노출기간 동안 마우스 체중 1 kg 당 물질 A의 1일 섭취량",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        658.1925048828125,
        372.239990234375,
        669.8362426757812
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 시험자료를 통해 저용량 노출군의 암컷 마우스의 평균 체중은 25 g로 확인됨",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        682.072509765625,
        469.20001220703125,
        693.7162475585938
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.16 mg/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        155.39999389648438,
        705.5924682617188,
        439.44989013671875,
        732.8362426757812
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "×",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        155.39999389648438,
        705.5924682617188,
        439.44989013671875,
        732.8362426757812
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1000 g",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        155.39999389648438,
        705.5924682617188,
        439.44989013671875,
        732.8362426757812
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        155.39999389648438,
        705.5924682617188,
        439.44989013671875,
        732.8362426757812
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6.4 mg/kg bw/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        155.39999389648438,
        705.5924682617188,
        439.44989013671875,
        732.8362426757812
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "25 g bw/mouse",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        155.39999389648438,
        705.5924682617188,
        439.44989013671875,
        732.8362426757812
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "kg",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        155.39999389648438,
        705.5924682617188,
        439.44989013671875,
        732.8362426757812
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 64 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 70,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "④ T25 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        124.08000183105469,
        86.39624786376953
      ],
      "page_num": 70,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 특정 조직에서 25% 종양을 일으킬 수 있는 용량 수준(악성림프종, 체중 1 kg 당 1일 용량)을",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        98.63249206542969,
        543.9600219726562,
        110.2762451171875
      ],
      "page_num": 70,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계산하기 위해, 생물학적으로 유의한 종양이 발생하는 최저용량의 종양 발생 비율(32%)과 최",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        79.19999694824219,
        118.4324951171875,
        538.5599365234375,
        130.0762481689453
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "저용량에서 노출기간 동안 노출된 체중 1 kg 당 1일 용량(6.4 mg/kg bw/day)를 고려하여 계산",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        79.19999694824219,
        138.2324981689453,
        538.4397583007812,
        149.87625122070312
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        79.19999694824219,
        158.03248596191406,
        90.23999786376953,
        169.67623901367188
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "T25",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        125.39999389648438,
        198.2324981689453,
        168.83999633789062,
        209.87625122070312
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        125.39999389648438,
        198.2324981689453,
        168.83999633789062,
        209.87625122070312
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25%",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        198.95999145507812,
        186.95249938964844,
        218.15965270996094,
        198.59625244140625
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "× 6.4 mg/kg bw/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        240.36000061035156,
        196.19248962402344,
        467.7698974609375,
        207.83624267578125
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        240.36000061035156,
        196.19248962402344,
        467.7698974609375,
        207.83624267578125
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.0 mg/kg bw/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        240.36000061035156,
        196.19248962402344,
        467.7698974609375,
        207.83624267578125
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "32%",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        198.95999145507812,
        205.4324951171875,
        218.15965270996094,
        217.0762481689453
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 악성림프종 발생 용량인 50 mg/kg으로부터 T25 = 5.0 mg/kg bw/day을 산출함",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.3524932861328,
        472.7996826171875,
        245.99624633789062
      ],
      "page_num": 70,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "⑤ HT25 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        296.99249267578125,
        131.51998901367188,
        308.63623046875
      ],
      "page_num": 70,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HT25 =",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.75999450683594,
        335.1524963378906,
        122.75999450683594,
        346.7962341308594
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "T25",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        175.44000244140625,
        325.9125061035156,
        193.4396209716797,
        337.5562438964844
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        256.0799865722656,
        335.1524963378906,
        261.5999755859375,
        346.7962341308594
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.0 mg/kg bw/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        272.3999938964844,
        325.9125061035156,
        360.96990966796875,
        337.5562438964844
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "= 0.71 mg/kg bw/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        376.91998291015625,
        335.1524963378906,
        483.1299133300781,
        346.7962341308594
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(사람체중/동물체중)0.25",
      "font_size": 8.279999732971191,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        127.91999816894531,
        341.724365234375,
        347.2195129394531,
        356.7562561035156
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(60/0.025)0.25",
      "font_size": 8.279999732971191,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        127.91999816894531,
        341.724365234375,
        347.2195129394531,
        356.7562561035156
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑥ 노출평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        418.3125,
        122.63966369628906,
        429.95623779296875
      ],
      "page_num": 70,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "손세정 비누에 함유된 물질 A의 농도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        118.31999969482422,
        446.9597473144531,
        427.5944519042969,
        460.2073059082031
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "50 ppb (= 50 ㎍/kg)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        118.31999969482422,
        446.9597473144531,
        427.5944519042969,
        460.2073059082031
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "손세정 1일 노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        118.31999969482422,
        468.31976318359375,
        421.54632568359375,
        481.56732177734375
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.33 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        118.31999969482422,
        468.31976318359375,
        421.54632568359375,
        481.56732177734375
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물질 A의 피부흡수율",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        118.31999969482422,
        489.67974853515625,
        348.77044677734375,
        502.92730712890625
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "65%",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        118.31999969482422,
        489.67974853515625,
        348.77044677734375,
        502.92730712890625
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED = 50 × 1/109 × 3.33 mg/kg bw/day× 65/100",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.72000122070312,
        526.3556518554688,
        523.6799926757812,
        546.5962524414062
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "= 1.1×10-7  mg/kg bw/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.72000122070312,
        526.3556518554688,
        523.6799926757812,
        546.5962524414062
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑦ 위해도 결정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        591.3524780273438,
        139.07965087890625,
        602.9962158203125
      ],
      "page_num": 70,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "LCR =",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        110.5199966430664,
        635.2725219726562,
        147.60000610351562,
        646.916259765625
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        179.51998901367188,
        623.1525268554688,
        199.38412475585938,
        634.7962646484375
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        241.3199920654297,
        635.2725219726562,
        246.83999633789062,
        646.916259765625
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.1×10-7 mg/kg bw/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        270.9599914550781,
        623.6756591796875,
        388.57025146484375,
        636.8362426757812
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "= 3.8 × 10-8",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        412.79998779296875,
        633.755615234375,
        489.6601867675781,
        646.916259765625
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HT25/0.25",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        165.239990234375,
        647.2725219726562,
        393.71954345703125,
        658.916259765625
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.71 mg/kg bw/day / 0.25",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        165.239990234375,
        647.2725219726562,
        393.71954345703125,
        658.916259765625
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- LCR이 10-5 이하이므로 위해 우려 가능성 낮음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        676.8356323242188,
        315.11968994140625,
        689.876220703125
      ],
      "page_num": 70,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 65 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. BMDL10을 활용한 MOE 산출 예시",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        239.99998474121094,
        86.94281005859375
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 물질 B에 대한 MOE 산출",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        98.63249206542969,
        202.07998657226562,
        110.2762451171875
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "① 물질 B의 용량-반응 연구에서 도출된 BMDL10 : 0.018 mg/kg bw/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        146.15249633789062,
        426.250244140625,
        158.34280395507812
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 노출평가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        193.79249572753906,
        127.19966125488281,
        205.43624877929688
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샤워젤에 함유된 물질 B의 농도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.4000015258789,
        222.4397430419922,
        399.9952697753906,
        235.68731689453125
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "50 ppb (= 50 µg/kg)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.4000015258789,
        222.4397430419922,
        399.9952697753906,
        235.68731689453125
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샤워젤 1일 노출량",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.4000015258789,
        243.79974365234375,
        391.9073181152344,
        257.0473327636719
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.62 mg/kg bw/day",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.4000015258789,
        243.79974365234375,
        391.9073181152344,
        257.0473327636719
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물질 B의 피부흡수율",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.4000015258789,
        265.0397644042969,
        319.2504577636719,
        278.2873229980469
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "65%",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        101.4000015258789,
        265.0397644042969,
        319.2504577636719,
        278.2873229980469
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED = 50 × 1/109 × 65/100 × 1.62 mg/kg bw/day = 5.3×10-8 mg/kg bw/day",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        310.7156066894531,
        478.44989013671875,
        323.7562561035156
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 위해도 결정",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        359.75250244140625,
        143.63998413085938,
        371.396240234375
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MOE",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        153.59999084472656,
        397.9125061035156,
        202.67999267578125,
        409.5562438964844
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        153.59999084472656,
        397.9125061035156,
        202.67999267578125,
        409.5562438964844
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BMDL10",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        221.0399932861328,
        388.6725158691406,
        289.79998779296875,
        409.5562438964844
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        221.0399932861328,
        388.6725158691406,
        289.79998779296875,
        409.5562438964844
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.018",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        324.239990234375,
        388.6725158691406,
        387.3599853515625,
        400.7962341308594
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        381.8399963378906,
        396.515625,
        457.260009765625,
        418.3162536621094
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.4 × 105",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        381.8399963378906,
        396.515625,
        457.260009765625,
        418.3162536621094
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SED",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        229.0800018310547,
        405.755615234375,
        361.1401672363281,
        418.7962341308594
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.3× 10-8",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        229.0800018310547,
        405.755615234375,
        361.1401672363281,
        418.7962341308594
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- MOE가 104 이상이므로 위해 우려 가능성 낮음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        458.43560791015625,
        334.9200134277344,
        471.59625244140625
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 66 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5. 프로그램을 활용한 BMDL10 산출 예시",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        74.75249481201172,
        260.6399841308594,
        86.94281005859375
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 가장 잘 알려진 BMD 소프트웨어는 미국 EPA(www.epa.gov/bmds)에서 개발된 BMDS",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        98.63249206542969,
        544.0794067382812,
        110.2762451171875
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Benchmark Dose Software)와 RIVM(https://www.rivm.nl/en/proast)에서 개발된 PROAST가",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.87999725341797,
        118.4324951171875,
        543.9596557617188,
        130.0762481689453
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있다. BMD 접근법은 여러 수학적 모델(probit, gamma, logist, weibull 등)을 활용하여 그",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.87999725341797,
        138.2324981689453,
        543.9596557617188,
        149.87625122070312
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합도를 평가하여 최종 BMDL을 선택하게 된다. 아래 사항은 기본적으로 모델 선택 판단",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.87999725341797,
        158.03248596191406,
        538.5599365234375,
        169.67623901367188
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준이다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.87999725341797,
        177.83248901367188,
        133.319580078125,
        189.4762420654297
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 통계적 모델의 허용(Accept) 여부: p-value > 0.05 (default)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        201.59249877929688,
        377.61114501953125,
        213.2362518310547
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 최적의 모델 적합도 : log-likelihood, AIC(Akaike's Information Criterion) 등",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        225.3524932861328,
        460.0799865722656,
        236.99624633789062
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "· log-likelihood 높은 값을 선택(PROAST)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        249.2324981689453,
        299.9978942871094,
        260.8762512207031
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "· AIC 낮은 값을 선택(BMDS)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        272.99249267578125,
        239.15953063964844,
        284.63623046875
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 보수적 접근으로 p-value > 0.05 인 모델 중 가장 낮은 BMDL 값",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        296.75250244140625,
        410.8800048828125,
        308.396240234375
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 그래프 확인",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        320.63250732421875,
        143.63998413085938,
        332.2762451171875
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- BMD/BMDL 비율 : 낮은 값이 독성값에 대한 불확실성이 낮음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        344.39251708984375,
        394.0796813964844,
        356.0362548828125
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- NOAEL(또는 LOAEL)/BMDL 비율 : 1에 가까울수록 불확실성이 낮음",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        368.1524963378906,
        427.0796813964844,
        379.7962341308594
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ [예시] Benzo(a)pyrene의 BMDS를 활용한 BMD 분석",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        415.7925109863281,
        337.919677734375,
        427.4362487792969
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- BMDL10 산출한 결과 5개의 모델이 통계적으로 수용 가능한 수준(p-value > 0.05)임",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        439.552490234375,
        497.3999938964844,
        451.7427978515625
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- BMDL10의 범위는 0.07∼0.20 mg/kg bw/day임",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        463.4324951171875,
        305.2799987792969,
        475.622802734375
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 통계적 수용 가능 multi-stage 모델의 가장 낮은 BMDL10 0.07mg/kg bw/day 선택",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        487.1925048828125,
        483.23968505859375,
        499.3828125
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Model Name",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        75.23999786376953,
        514.1245727539062,
        380.4601745605469,
        531.0152587890625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "loglik",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        75.23999786376953,
        514.1245727539062,
        380.4601745605469,
        531.0152587890625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "p-value",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        75.23999786376953,
        514.1245727539062,
        380.4601745605469,
        531.0152587890625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "AIC",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        75.23999786376953,
        514.1245727539062,
        380.4601745605469,
        531.0152587890625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Chi-square",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        75.23999786376953,
        514.1245727539062,
        380.4601745605469,
        531.0152587890625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BMD10",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        75.23999786376953,
        514.1245727539062,
        380.4601745605469,
        531.0152587890625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(mg/kg bw/day)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        333.47998046875,
        525.6445922851562,
        400.42156982421875,
        537.6152954101562
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BMDL10",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        435.0,
        514.1245727539062,
        466.25982666015625,
        526.622802734375
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(mg/kg bw/day)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        417.1199951171875,
        525.6445922851562,
        484.0615539550781,
        537.6152954101562
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "gamma",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        539.444580078125,
        459.0379333496094,
        551.415283203125
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-204.6",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        539.444580078125,
        459.0379333496094,
        551.415283203125
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.041",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        539.444580078125,
        459.0379333496094,
        551.415283203125
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "415.2",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        539.444580078125,
        459.0379333496094,
        551.415283203125
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11.0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        539.444580078125,
        459.0379333496094,
        551.415283203125
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.24",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        539.444580078125,
        459.0379333496094,
        551.415283203125
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.09",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        539.444580078125,
        459.0379333496094,
        551.415283203125
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "logistic",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        554.0845947265625,
        459.0379333496094,
        566.0552978515625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-204.1",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        554.0845947265625,
        459.0379333496094,
        566.0552978515625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.105",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        554.0845947265625,
        459.0379333496094,
        566.0552978515625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "412.2",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        554.0845947265625,
        459.0379333496094,
        566.0552978515625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10.1",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        554.0845947265625,
        459.0379333496094,
        566.0552978515625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.14",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        554.0845947265625,
        459.0379333496094,
        566.0552978515625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.12",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        554.0845947265625,
        459.0379333496094,
        566.0552978515625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "log-logistic",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        568.7245483398438,
        459.0379333496094,
        580.6952514648438
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-204.1",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        568.7245483398438,
        459.0379333496094,
        580.6952514648438
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.061",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        568.7245483398438,
        459.0379333496094,
        580.6952514648438
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "414.2",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        568.7245483398438,
        459.0379333496094,
        580.6952514648438
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "9.9",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        568.7245483398438,
        459.0379333496094,
        580.6952514648438
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.28",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        568.7245483398438,
        459.0379333496094,
        580.6952514648438
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.18",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        568.7245483398438,
        459.0379333496094,
        580.6952514648438
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "log-probit",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        583.3645629882812,
        459.0379333496094,
        595.3352661132812
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-204.3",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        583.3645629882812,
        459.0379333496094,
        595.3352661132812
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.052",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        583.3645629882812,
        459.0379333496094,
        595.3352661132812
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "414.6",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        583.3645629882812,
        459.0379333496094,
        595.3352661132812
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10.3",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        583.3645629882812,
        459.0379333496094,
        595.3352661132812
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.29",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        583.3645629882812,
        459.0379333496094,
        595.3352661132812
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.20",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        583.3645629882812,
        459.0379333496094,
        595.3352661132812
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "multi-stage",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        598.0045776367188,
        459.0379333496094,
        609.9752807617188
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-204.3",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        598.0045776367188,
        459.0379333496094,
        609.9752807617188
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.053",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        598.0045776367188,
        459.0379333496094,
        609.9752807617188
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "414.6",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        598.0045776367188,
        459.0379333496094,
        609.9752807617188
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10.5",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        598.0045776367188,
        459.0379333496094,
        609.9752807617188
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.14",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        598.0045776367188,
        459.0379333496094,
        609.9752807617188
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.07",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        598.0045776367188,
        459.0379333496094,
        609.9752807617188
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "probit",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        612.6445922851562,
        459.0379333496094,
        624.6152954101562
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-204.3",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        612.6445922851562,
        459.0379333496094,
        624.6152954101562
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.092",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        612.6445922851562,
        459.0379333496094,
        624.6152954101562
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "412.5",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        612.6445922851562,
        459.0379333496094,
        624.6152954101562
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10.4",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        612.6445922851562,
        459.0379333496094,
        624.6152954101562
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.13",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        612.6445922851562,
        459.0379333496094,
        624.6152954101562
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.12",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        612.6445922851562,
        459.0379333496094,
        624.6152954101562
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "weibull",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        627.2845458984375,
        459.0379333496094,
        639.2552490234375
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-204.6",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        627.2845458984375,
        459.0379333496094,
        639.2552490234375
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.041",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        627.2845458984375,
        459.0379333496094,
        639.2552490234375
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "415.2",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        627.2845458984375,
        459.0379333496094,
        639.2552490234375
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11.0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        627.2845458984375,
        459.0379333496094,
        639.2552490234375
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.18",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        627.2845458984375,
        459.0379333496094,
        639.2552490234375
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.08",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        627.2845458984375,
        459.0379333496094,
        639.2552490234375
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Quantal-linear",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        642.16455078125,
        459.0379333496094,
        654.13525390625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-204.4",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        642.16455078125,
        459.0379333496094,
        654.13525390625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.019",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        642.16455078125,
        459.0379333496094,
        654.13525390625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "416.8",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        642.16455078125,
        459.0379333496094,
        654.13525390625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "14.7",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        642.16455078125,
        459.0379333496094,
        654.13525390625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.07",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        642.16455078125,
        459.0379333496094,
        654.13525390625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.05",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        72.23999786376953,
        642.16455078125,
        459.0379333496094,
        654.13525390625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유해물질의 인체안전기준 설정을 위한 용량-반응 평가 연구, 2016",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        670.3856201171875,
        490.2602844238281,
        679.8778076171875
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 67 -",
      "font_size": 9.960000038146973,
      "font_name": "HCRDotum",
      "bbox": [
        282.3599853515625,
        786.5027465820312,
        312.8013610839844,
        799.4507446289062
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고 2. TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        56.63999938964844,
        72.01945495605469,
        453.3599853515625,
        87.98039245605469
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개별 화학물질의 인체 안전 노출량은 알려진 독성자료로부터 위해평가를 통해 구할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.35249328613281,
        543.9603881835938,
        125.99624633789062
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TTC (Threshold of Toxicological Concern, 독성학적 우려 역치)는 화학물질별 독성자료가 없다",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        134.15249633789062,
        543.9592895507812,
        145.79624938964844
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하더라도 모든 화학물질에 대하여 인체 위해 영향이 없는(무시할만한) 노출량을 설정한다는 개",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        153.95249938964844,
        538.5599365234375,
        165.59625244140625
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "념이다. 이는 독성자료가 없거나 제한적일 때 화학구조에 대한 지식을 기반으로 독성 데이터베",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        173.7524871826172,
        538.5596923828125,
        185.396240234375
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이스에서 유사 구조 화학물질의 독성자료와 비교하는 것으로 Cramer decision tree에 따라 세",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        193.552490234375,
        543.9596557617188,
        205.1962432861328
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가지 등급으로 분류하여 TTC를 활용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        213.3524932861328,
        303.2403259277344,
        224.99624633789062
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발암 가능성이 높은 물질, 무기화학물질, 금속, 유기금속, 단백질, 스테로이드, 생물축적 혹은",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        237.2324981689453,
        543.9596557617188,
        248.87625122070312
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가능성이 있는 물질, 나노물질, 방사성물질 및 화학구조를 확인할 수 없는 물질이 포함된 혼합",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        257.0325012207031,
        538.4396362304688,
        268.6762390136719
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물에는 TTC 방법을 적용할 수 없다. 유전독성 경고가 없는 화학물질에 대해 화학구조를 분석",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        276.83251953125,
        538.5599365234375,
        288.47625732421875
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하고 전신독성 지표로 Cramer 분류를 사용하여 수행된다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        296.63250732421875,
        354.0003356933594,
        308.2762451171875
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원칙적으로 TTC 방법은 매우 낮은 양으로 존재하는 화학물질에 의해 발생하는 전신독성에",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        320.39251708984375,
        544.0796508789062,
        332.0362548828125
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대하여 인체 위해성을 평가하는 것으로, 화학물질별로 전문가의 판단하에 사례별로 수행되어야",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        340.1925048828125,
        543.9592895507812,
        351.83624267578125
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다. 일반적으로 화장품에 사용되는 성분은 Cramer Class Ⅰ 또는 Ⅲ으로 분류하고, Class Ⅱ",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        359.99249267578125,
        538.5599365234375,
        371.63623046875
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 TTC 값에 대해서는 유효한 자료가 부족하기 때문에 이에 해당되는 물질은 Class Ⅲ으로 분",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        379.7925109863281,
        538.5599365234375,
        391.4362487792969
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "류한다. TTC 값은 모든 연령층을 포함한 전체 인구에 적용하기 위해서 일반적으로 1일 체중",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        399.5924987792969,
        544.0800170898438,
        411.2362365722656
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "kg당 양(amount)로 표시한다. 특히, 일부 화학물질의 경우 미숙한 신진대사가 있을 수 있는 6",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        419.39251708984375,
        538.4400024414062,
        431.0362548828125
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개월 미만의 유아에 대하여 특별한 고려가 필요하다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        439.1925048828125,
        329.03955078125,
        450.83624267578125
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TTC는 경구 경로의 전신독성을 나타내는 외부용량 기반의 값이고, 화장품의 주요 노출 경로",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        462.9525146484375,
        538.5599365234375,
        474.59625244140625
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 피부이기 때문에 피부 흡수에 대한 변수를 고려하여 내부 노출량으로 변환하여 TTC 값과",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        482.75250244140625,
        544.0800170898438,
        494.396240234375
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비교하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        502.552490234375,
        147.59957885742188,
        514.1962280273438
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유럽 SCCS에서는 Yang et al. 2017이 제안한 TTC 값 사용을 제안하고 있다.",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        526.4324951171875,
        458.7595520019531,
        538.0762329101562
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 1 . 제안된 TTC 값 요약 (단위: μg/kg bw/day)",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        573.9525146484375,
        315.3606872558594,
        585.5962524414062
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Cramer class",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        65.04000091552734,
        609.5245971679688,
        118.01824951171875,
        621.4953002929688
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCCP/1171/08",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        140.63999938964844,
        597.7645874023438,
        200.80343627929688,
        621.4953002929688
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Munro et al,",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        140.63999938964844,
        597.7645874023438,
        200.80343627929688,
        621.4953002929688
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        158.51998901367188,
        621.2845458984375,
        181.0630645751953,
        633.2552490234375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cosmos-TTC",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        233.75999450683594,
        597.7645874023438,
        284.95263671875,
        609.7352905273438
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(SEURAT-1; EC,",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        228.239990234375,
        609.5245971679688,
        293.5637512207031,
        621.4953002929688
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2009)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        248.0399932861328,
        621.2845458984375,
        270.58306884765625,
        633.2552490234375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cosmos/Munro/",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        322.67999267578125,
        597.7645874023438,
        392.32440185546875,
        609.7352905273438
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Federated DB",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        327.47998046875,
        609.5245971679688,
        384.3317565917969,
        621.4953002929688
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Yang et al,, 2017)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        318.8399963378906,
        621.2845458984375,
        392.98187255859375,
        633.2552490234375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RIFM/Munro/Cosmos/",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        411.47998046875,
        597.7645874023438,
        502.1649475097656,
        609.7352905273438
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Federated DB",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        428.3999938964844,
        609.5245971679688,
        485.25146484375,
        621.4953002929688
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Patel et al., 2020)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        418.0799865722656,
        621.2845458984375,
        495.4630432128906,
        633.2552490234375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Genotoxic",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        67.43999481201172,
        637.3645629882812,
        183.158203125,
        661.0952758789062
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "compounds",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        67.43999481201172,
        637.3645629882812,
        183.158203125,
        661.0952758789062
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.0025",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        67.43999481201172,
        637.3645629882812,
        183.158203125,
        661.0952758789062
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ*",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        665.444580078125,
        465.2779235839844,
        677.415283203125
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "30",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        665.444580078125,
        465.2779235839844,
        677.415283203125
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "42",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        665.444580078125,
        465.2779235839844,
        677.415283203125
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "46",
      "font_size": 9.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        85.31999969482422,
        665.444580078125,
        465.2779235839844,
        677.415283203125
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "49.1",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        665.444580078125,
        465.2779235839844,
        677.415283203125
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ*",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        683.924560546875,
        465.2779235839844,
        695.895263671875
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Not supported**",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        683.924560546875,
        465.2779235839844,
        695.895263671875
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        683.924560546875,
        465.2779235839844,
        695.895263671875
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Not supported**",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        683.924560546875,
        465.2779235839844,
        695.895263671875
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "12.7",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        683.924560546875,
        465.2779235839844,
        695.895263671875
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅲ*",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        702.4046020507812,
        462.7567138671875,
        714.3753051757812
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.5",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        702.4046020507812,
        462.7567138671875,
        714.3753051757812
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7.9",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        702.4046020507812,
        462.7567138671875,
        714.3753051757812
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3",
      "font_size": 9.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        85.31999969482422,
        702.4046020507812,
        462.7567138671875,
        714.3753051757812
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.9",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        85.31999969482422,
        702.4046020507812,
        462.7567138671875,
        714.3753051757812
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "* Non-genotoxic componds",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        724.3645629882812,
        490.99688720703125,
        759.7352905273438
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "** Chemicals of Cramer classⅡ should be treated as ClassⅢ substances.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        63.119998931884766,
        724.3645629882812,
        490.99688720703125,
        759.7352905273438
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Values in bold are those currently recommended by the SCCS for use for cosmetics-related substances",
      "font_size": 9.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        63.119998931884766,
        724.3645629882812,
        490.99688720703125,
        759.7352905273438
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“화장품 위해평가 가이드라인(민원인 안내서)”",
      "font_size": 14.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        139.1999969482422,
        418.0143737792969,
        456.0000915527344,
        432.8221740722656
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발    행    일",
      "font_size": 11.256997108459473,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.79999542236328,
        499.5674743652344,
        229.6793212890625,
        512.2237548828125
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2023. 11.",
      "font_size": 11.256997108459473,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.79999542236328,
        499.5674743652344,
        229.6793212890625,
        512.2237548828125
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발    행    인",
      "font_size": 11.256997108459473,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.79999542236328,
        522.8474731445312,
        224.0399932861328,
        535.5037231445312
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "박 윤 주",
      "font_size": 11.256997108459473,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.79999542236328,
        522.8474731445312,
        224.0399932861328,
        535.5037231445312
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편 집 위 원 장",
      "font_size": 11.256997108459473,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.79999542236328,
        546.1275024414062,
        224.0399932861328,
        558.7837524414062
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "손 수 정",
      "font_size": 11.256997108459473,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.79999542236328,
        546.1275024414062,
        224.0399932861328,
        558.7837524414062
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편  집  위  원",
      "font_size": 11.256997108459473,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.79999542236328,
        569.16748046875,
        492.1199951171875,
        581.82373046875
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "송영미, 김도정, 윤해석, 박은재, 지정은, 심지은, 한지혜, 고미선",
      "font_size": 11.256997108459473,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.79999542236328,
        569.16748046875,
        492.1199951171875,
        581.82373046875
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발    행    처",
      "font_size": 11.256997108459473,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.79999542236328,
        592.3275146484375,
        435.239990234375,
        606.4237060546875
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전평가원 의료제품연구부 화장품연구과",
      "font_size": 11.256997108459473,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        85.79999542236328,
        592.3275146484375,
        435.239990234375,
        606.4237060546875
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[ 전화 : 043-719-4866, 팩스 043-719-4850 ]",
      "font_size": 11.256997108459473,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        181.8000030517578,
        611.5274658203125,
        394.822509765625,
        624.1837158203125
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공익신고자 보호제도란?",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        137.39999389648438,
        544.0397338867188,
        251.82339477539062,
        557.287353515625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공익신고자등(친족 또는 동거인 포함)이 공익신고등으로 인하여 피해를 받지 않도록",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        137.39999389648438,
        559.9996948242188,
        528.3599853515625,
        573.247314453125
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비밀보장, 불이익보호조치, 신변보호조치 등을 통하여 보호하는 제도",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        137.39999389648438,
        576.0797119140625,
        456.719970703125,
        589.3273315429688
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보호조치 요구 방법",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        137.39999389648438,
        597.0797119140625,
        232.32000732421875,
        610.3273315429688
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "우편(30102) 세종특별자치시 도움5로 정부세종청사 7동",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        137.39999389648438,
        613.0397338867188,
        397.0799865722656,
        626.287353515625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국민권익위원회 공익보호지원과 / 전화 044-200-7773 / 팩스 044-200-7949",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        137.39999389648438,
        628.9996948242188,
        492.08343505859375,
        642.247314453125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "“청렴한 식약처",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        63.23999786376953,
        658.2445678710938,
        127.1301498413086,
        682.4552612304688
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "국민 안심의 시작“",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        63.23999786376953,
        658.2445678710938,
        127.1301498413086,
        682.4552612304688
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "【공직자 부조리 및 공익신고안내】     ** 신고자 및 신고내용은 보호됩니다.",
      "font_size": 9.0,
      "font_name": "ÈÞ¸Õ°íµñ",
      "bbox": [
        137.39999389648438,
        649.1597290039062,
        477.82452392578125,
        662.4073486328125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자   부조리 신고” 코너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        137.39999389648438,
        665.1196899414062,
        529.1995239257812,
        691.4473266601562
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        137.39999389648438,
        665.1196899414062,
        529.1995239257812,
        691.4473266601562
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    }
  ],
  "markdown_content": "<!-- PAGE_1 -->\n## 화장품 위해평가\n\n<!-- PAGE_1 -->\n## 가이드라인(민원인 안내서)\n\n- 2023. 11.\n<!-- PAGE_1 -->\n##### 의료제품연구부 화장품연구과\n\n<!-- PAGE_1 -->\n###### 발간등록번호\n\n<!-- PAGE_1 -->\n###### 안내서-0747-02\n\n<!-- PAGE_2 -->\n#### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n<!-- PAGE_2 -->\n###### 명칭\n\n<!-- PAGE_2 -->\n###### 화장품 위해평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_2 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n**[표 시작]**\n\n| 제2조(정의) 1. “화장품”이란 인체를 청결ㆍ미화하여 매력을 더하고 용모를 밝게 변 | 으로 개발되었다. | 데오도란트에 함유된 물질 C의 농도 | 0.03% | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | DAa(㎍/cm2) × 10-3mg/㎍ × SSA(cm2) × F(day-1) | ○ Pubchem 등 물리화학적 특성 정보 사이트 | RIVM | EPA | ■ 예 | □ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 산출할 수 있다. | 함 | 등) 조사 | 대한 외적 용량으로 추정할 수 있다. | 평가를 수행할 수 있다. | 방취제(deodorant) | 제 목 | (mg/kg/day) |\n| 노출경로 | 경구 | 생식발생독성시험 | 경구/식이 | 랫드 | 0, 150, 450, 1000 | 450 | ü | ü | ü | ü | ü | ü | ü | - | 손 세정 비누 | 0.24 | 860 | 0.27907 | ⇒ MOS 값이 100 이상이면 위해 우려 가능 |\n| 조건에 따라 사용하였을 때 인체에 안전하여야 한다. | 된다. | 2. 위해요소의 인체노출 허용량을 산출하는 위험성 결정과정 | SED = | 지침서ㆍ안내서가 있습니까? | 화장품 위해평가 가이드라인 | 모발 관리(Hair care) | - 인체 독성시험자료 또는 동물 독성시험 | 검색 |\n| 물질이 인체 건강에 유해한 영향을 미칠 가능성이 있는지 확인하는 단계이다. | 배설, 체내 축적성) 자료 조사 | 화시키거나 피부ㆍ모발의 건강을 유지 또는 증진하기 위하여 인체에 바르고 문지르 | 독성자료 | 투여용량 | 결과 | 체표면적을 고려한 1일 사용량(mg/cm2/day) | 11.65 mg/cm2/day | - 단일 또는 여러 화장품을 함께 사용하는 경우 고려 |\n| (margin of safety, MOS)으로 나타낸다(SCCS/1628/21, 2021). | 기준이다. | 입, 배출)을 0으로 가정할 수 있다. | 성이 낮다고 평가 | 60 (kg) |\n| 노출농도 | 0, 25, 50 ppm(in diet) | 모발 클렌징 제품 | 반복독성시험 | 경구 | 토끼 | 3, 10, 30 | 10 | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우 | 25% | 샴푸 | 0.09 | 1440 | 0.0625 | 자료를 활용 |\n| 라 사례별(case-by-case)로 평가하는 것이 바람직하다. | 3. 위해요소가 인체에 노출된 양을 산출하는 노출평가과정 | discovery-platform/cas-scifinder |\n| 거나 뿌리는 등 이와 유사한 방법으로 사용되는 물품으로서 인체에 대한 작용이 경 | SEDinh  = | A(mg/kg bw/day) × C(%)/100 × fevap | × IR × t × fret | V | 루시퍼라아제 LuSens 시험법 | - 제품별 특성에 따라 경구, 피부 등 노출 경로 고려 | × 6.4 mg/kg bw/day | = | 5.0 mg/kg bw/day | ○ 공개된 논문 정보, 국제기구(WHO, FAO, IPCS, |\n| 위해도를 결정한다(그림 1). | 목록 | 구분 | 내용 | T25 | = | - NOAEL 66~94 mg/kg bw/day | - 혈액학적, 임상화학적, 전신, 신경 |\n| 노출기간 | 24개월 | 반복투여(경구) | - 랫드 대상(3개월) | - 6.5~9.8, 19~25, 66~96 mg/kg bw/day | 사망이나 뚜렷한 고통과 스트레스를 초래하지 않도록 설계 | 32% | 헤어 컨디셔너 | 0.06 | 1440 | 0.041667 | (Ainh-1 + Ainh-2) × fret × fresp × fappl | 체중 당 일일 |\n| 4. 제1호부터 제3호까지의 결과를 종합하여 인체에 미치는 위해 영향을 판단하는 | 피부 상태 | 1, 3, 10 | 제품 사용에 따라 염증 수준이 증가하기 쉬운 신체 부위 고려 | 발관리(Foot care) | ○ 가장 타당한 독성시험으로부터 가장 민감한 | IARC) 및 관련기관(EPA, FDA, EU 집행위, 일본 | 잔류 지수1 |\n| 미용사 등)에게 안전해야 한다. | 해당 제품 사용에 대한 노출시나리오에 따라 노출량을 산출할 수 있다. | 최고 용량/노출 수준으로 정의되며, 역치가 존재하는 영향의 경우에 사용한다. | 되는 용량 및 면적에 따라 좌우된다. | 미한 것을 말한다. 다만, 「약사법」제2조제4호의 의약품에 해당하는 물품은 제외한다. | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 한다. | 결과보고서 | 비고 | SEDinh = | 물질명 | 추정 일일 | - 소비자 유형(예, 어린이)에 따른 시나리오 설정 | 계산된 일일 | 계산된 체중 당 | 일일 노출량 | 계산된 체중 |\n| 법을 사용할 수 있다. | 에서 안전성이 확인되면 이후 실제 상황을 반영한 노출평가는 생략할 수 있다. | 노출유형 | 제품 | g/day | mg/kg bw/day | 샤워젤에 함유된 물질 B의 농도 | 50 ppb (= 50 µg/kg) | - (OECD TG423) 단회투여 분류법 : 치사율이 예상되는 노출량 범위를 확인 | - (OECD TG425) 용량고저법 : LD50 값과 신뢰구간 추정 | https://www.fda.gov/cosmetics/cosmetics-guidance-reg | 사용량 | (mg/kg | bw/day) | 체중 당 일일 | https://health.ec.europa.eu/scientific-committee | BW | 계산된 | 일일 | 노출량 | (g/day) |\n| 다(붙임 5 참고). | 독성자료 | 투여용량 | 결과 | 제품 유형 | 사용량 | (g/day) | 바디로션 | 5.48 | 15670 | 0.349713 | 후생성 등)에서 발간된 보고서 등 독성정보 | 독성기준값 선택 | (Retention | 잔류 지수1 | 독성 등이 없음 | 노출량 | (g/day) |\n| 안점막자극성, 피부감작성, 생식발생독성, | 고려할 수 있으며, 과학적으로 타당한 방법으로 수행된 자료인 경우에 활용 가능하다. | 제․개정번호 | 승인일자 | 주요 내용 | 위해도 결정과정 | 사료 중 A 함유량 | 0 mg/kg | 50 mg/kg | 100 mg/kg | 시험법 | 추정 일일 | 당 일일 | 노출량 | (mg/kg | bw/day) |\n| DAa (㎍/cm2) | 평가대상 물질의 단위면적당 피부흡수량 (Dermal Absorption) | (사유 :                                                                 ) | Cas No. | - 적용 방법(예 : 씻어내는 제품, 바르는 제품 등) 고려 | ulation | 사용량 | (mg/kg | bw/day) | s/scientific-committee-consumer-safety-sccs_en | factor) | (mg/kg bw/day) |\n| 산출하고 위해평가를 수행한다. | 제8조(화장품 안전기준 등) ① 식품의약품안전처장은 화장품의 제조 등에 사용할 수 | 다. | 제품 유형 | · Aexpo (g) = A × C × fair | 사용량 | 샤워 젤 | 0.19 | 2.79 | 조사 | (Retention | - NOEL 10 mg/kg bw/day | - NOAEL 41 mg/kg bw/day | - 41 mg/kg bw/day 용량에서 혈액 |\n| 3.1.4.1.1 흡수, 분포, 대사, 배설 | (USEPA, 1995 : Benchmark Dose) | 물질정보 | 능성이 낮은 것으로 평가할 수 있다. | 유전독성, 발암성, 광독성 등 | 샤워젤 1일 노출량 | 1.62 mg/kg bw/day | - (OECD TG406) Magnusson Kligman 기니피그 극대화 시험(GPMT) | Tumor type | male | female | male | female | male | female | 얼굴 크림 | 1.76 | 565 | 3.115044 | ○ 위해평가 요약, 목적, 범위, 내용, 방법, 결론 및 참고문 | - 독성기준값 선택은 체중감소, 장기무게 감 | - NOAEL 0.9 g/kg/day | - 2.7 g/kg/day 농도에서 체중감소, 흉선의 |\n| ② 식품의약품안전처장은 제1항에 따른 결과를 근거로 식품의약품안전처장이 정하는 | 결정 진행 | SSA (cm2) | 평가 대상 물질이 함유된 화장품을 도포한 피부 표면적1 | 반복투여 | - 랫드 대상(3주) | - 0, 0.3, 0.9, 2.7 g/kg/day | 분자량(g/mol, mg/mol) | https://www.fda.gov/industry/color-additives-specific-p |\n| 용하여 실제 사용방법을 고려하여(mimicking) in vitro 시험으로부터 선정한다. | 반복투여(경구) | - 비글견 대상(3개월) | - 3, 10, 41 mg/kg bw/day | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | - (OECD TG403) 단회투여 흡입독성시험 | - (OECD TG402) 단회투여 피부독성시험 | (g/day)(90%) | 손 세정 비누 | 0.20 | 3.33 | factor) |\n| 결과 등을 통해 평가한다. | 없는 원료를 지정하여 고시하여야 한다. | 시나리오를 적용하여 평가할 수 있다. | - (OECD TG406) Buehler 시험 | 방향제(Fragrances) | 목욕 및 샤워 | 헌 등 작성하고 관련 정보 첨부 | ○ 국제기구 및 외국 독성평가 기관에서 제시하고 | 소, 조직학적 변화, 그 밖의 독성시험 결과 | □ 예 | ■ 아니오 |\n| (SED) 산출 | 물질 B의 피부흡수율 | 65% | (경구) | Malignant | lymphomas | 2/50 | (4%) | 0/50 | (0%) | 14/50 | (28%) | 16/50 | (32%) | 25/50 | (50%) | 23/50 | (46%) |\n| 는 것이 가장 좋으나 기존의 자료들도 활용할 수 있다. | 기준에 따라 위해여부를 결정한다. 다만, 해당화장품 원료 등에 대하여 국내외의 연 | B2-2011-4-005 | 2011.08. | 화장품 위해평가 가이드라인 제정 | 포함되었고, 어떤 노출 모델이 선택되었는지 확인할 수 있다. | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까? | 옥탄올-물 분배계수(Kow) | (Skin Surface Area) | Aexp × IR × t | 핸드 크림 | 1.38 | 860 | 1.604651 | 샴푸 | 0.11 | 1.51 | roducts/color-additives-and-cosmetics-fact-sheet | 상대적 및 절대적 무게 감소 |\n| 3.1.4.1.2 피부흡수율 | 시험결과 | 결과 등을 검토하여 발암성 판단 근거자 | 실성 계수 적용 가능 | A (g/day) | 화장품의 1일 사용량1 |\n| 경우에 사용한다. | 샤워 젤 | 18.67 | 279.20 | 0.01 | 0.19 | 2.79 | ② 식품의약품안전처장은 보존제, 색소, 자외선차단제 등과 같이 특별히 사용상의 제한 | 성 영향을 말한다. | · Ainh-1 (mg) =  | V | 있는 지침서를 참고하여 시험 결과에 대한 증 | 및 인체 역학결과 등을 활용 | SAF | Total | 학적 변화 없음 |\n| 산출 | F (day-1) | 평가 대상 물질이 함유된 화장품의 사용 빈도 | 체중(kg) | 목욕, 샤워 및 인체세정 제품 | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 농도에서 신장무게증가, |\n| 료를 확보 | 구·검사기관에서 이미 위해평가를 실시하였거나 위해요소에 대한 과학적 시험·분 | 제품 종류 | 비 분무형 데오도란트 | 2.33 | 200 | 11.65 | AEL | = | 헤어 컨디셔너 | 0.04 | 0.67 | 4.7 |\n| 등록대상 | 안전역 산출을 하지 않을 수 있다. | C (%) | 화장품 중 평가 대상 물질의 농도 | SAF | 개인 간 | 제품 | 빈도/사용기간 | 피부상태 | 모발 관리 | ○ 불확실성 적용 | 거가중치(Weight of Evidence, WoE) 고려 |\n| 이 필요한 원료에 대하여는 그 사용기준을 지정하여 고시하여야 하며, 사용기준이 지 | 사용하여 보수적으로 피부흡수율에 적용할 수 있다(SCCS/1628/21, 2021). | 반복투여 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? | □ 예 | ■ 아니오 | Mammary gland, | adenomas and | adenocarcinomas | - 랫드 대상(13주) | - 0, 200, 450, 1000 mg/kg/day | 사용빈도(횟수/년) | 시간 단위당 사용 횟수 | - 1일 사용횟수 | - 모체독성 NOAEL 20 mg/kg bw/day | - 발달독성 NOAEL 40 mg/kg bw/day | - 40, 60 mg/kg bw/day 용량에서 | = | 1.3 | 터베이스임 |\n| 계적 하한 신뢰 한계(IRIS, 1999, Glossary of IRIS Terms) | 리오를 설정하여 노출평가를 수행한다. | 샤워 젤 | 10.40 | 161.55 | 0.01 | 0.10 | 1.62 | 수 있으며, 붙임 10의 사이트를 참고하여 수집할 수 있다. | 60 (kg) | 성인 평균 체중 | - (OECD TG416) 2세대 생식독성시험 | - (OECD TG414) 산전 발달 독성시험 | - (OECD TG421) 생식·발생독성 스크리닝시험 | - (OECD TG443) 확장형 1세대 생식독성시험 | 바디로션 | 7.82 | 123.20 | - | 0/50 | (0%) | - | 15/50 | (30%) | - | 28/50 | (56%) | ○ 위해의 특성과 발생 가능성에 대한 시나리오 및 활용된 |\n| 공통 | 전신노출량으로 나누어 안전역(MOS)을 산출한다. | 석 자료가 있는 경우에는 그 자료를 근거로 위해 여부를 결정할 수 있다. | 취범위, 전처리방법, 분석기기, 정량한계 등을 고려하여 동질성이 인정된 값을 활용한다. | 여부 | 시험방법 | Induction conc. | Challenge conc. | 결과 | (경구) | 따라 나타나는 일반 독성영향(생식, 유전독성 및 발암 효과 제외) | 남성용 화장품(Men’s cosmetics) | CEL | 3.5 | 헤어 스타일링 | 0.28 | 1010 | 0.277228 | Aexp × IR × t | 간의 글라이코겐 감소 및 쿠퍼세포에서 | 철의 양 증가 |\n| 샴푸 | 10.46 | 150.49 | 0.01 | 0.11 | 1.51 | B1-2013-4-002 | 2013.10. | 화장품 위해평가 가이드라인 개정 | fevap (%) | 증발 비율(보수적으로 1 적용) | 생식·발생 | - 랫드 대상(6~19일) | - 5, 20, 40, 60 mg/kg bw/day | 제품군 | 세부 분류 | · Ainh-2 (mg) =  | V | - LOAEL 활용하는 경우 : 3 고려, 사례별 |\n| 손 세정 비누 | 24.04 | 382.15 | 0.01 | 0.24 | 3.82 | 정·고시된 원료 외의 보존제, 색소, 자외선차단제 등은 사용할 수 없다. | 대상 | 제품 내 농도 | 제품 사용량(g) | 1회당 사용량 | - 1일 사용량 또는 1회 사용량 | 화장품 노출량 | https://elaws.e-gov.go.jp/search/elawsSearch/elaws_searc | 자료 선택의 타당성을 가급적 명확하고 간략하게 기술 | 피부흡수율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| - (OECD TG407) 반복투여(28일) 경구독성시험 | - (OECD TG412) 반복투여(28일) 흡입독성시험 | - (OECD TG408) 설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG409) 비설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG413) 설치류 대상 반복투여(90일) 흡입독성시험 | T25 | 얼굴 크림 | 1.54 | 24.14 | 5.0 mg/kg bw/day |\n| 헤어컨디셔너2 | 3.92 | - | ③ 제1항 및 제2항에 따른 위해평가의 기준, 방법 등에 관한 세부 사항은 식품의약 | Maximization | 0.4% (intradermal; VNR) | 1% (topical; VNR) | 0.25% (VNR) | 감작성 있음 | 제품 및 시나리오를 선택할 수 있다. | 1 피부 단위면적당 노출량을 평가할 경우 체표면적에 제시된 값을 적용할 수 있다(붙임 4 참조) | 화장품 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 | (%) | 물휴지 | 4.57 | 17500 | 0.261143 | (g/day) | (case-by-case)로 불확실성 계수 1~10 적용 | (%) | □ 예 | ■ 아니오 |\n| HT25 = | 파악하는 과정 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | 함량(%) | 전체 제품 내 물질의 함유율 | 샴푸, 컨디셔너, 헤어스프레이, 헤어스타일링 제품(젤, 무스), | = | = 0.71 mg/kg bw/day |\n| 1-1. 위해평가 단계 ········································································································· 5 | ○ 위해평가 보고서 양식에 따라 작성 | 율, 감작성 등을 평가할 때, 성분 자체만이 아니라 매질 등의 영향도 고려해야 한다. | 물휴지 | 4.57 | 71.15 | 1.0 | 4.57 | 71.15 | ③ 식품의약품안전처장은 국내외에서 유해물질이 포함되어 있는 것으로 알려지는 등 | 반복투여 | 대상 | 화장품 | (사람체중/동물체중)0.25 | (60/0.025)0.25 | - 랫드 대상(13주) | - 0, 55.5, 277, 555 mg/kg/day | - 모든 용량에서 영향 없음 | 제품 내 농도 | 목욕 및 샤워(Bathing, showering) | 핸드 크림 | 2.16 | 32.70 | 화장품 노출량 | h/lsg0500/detail?lawId=335AC0000000145 | 피부흡수율 | 20%의 치사율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| 모발 관리용 | 헤어스타일링제품 | 4.00 | 57.40 | 0.10 | 0.40 | 5.74 | 값 + 1(또는 2)×표준편차(SD)를 사용한다. | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 입장을 기술하는 | 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 기준에 관한 표준지침을 제공하고 있으므로 이를 참조하여 검토한다. | 및 기능적 영향)을 포함한다. | 해당하는 내용입니까? | ○ 피부흡수량 또는 피부흡수율 | PODsys |\n| : 평가 배경 및 목적 기술 | 품안전처장이 정하여 고시한다. | 평가할 수 있다. | 자외선 | 노출시간(분) | 해당 물질 제품을 사용된 공간에서 노출이 | 되는 시간 | (%) | 염모제(탈색), 퍼머넌트 제품 | 리퀴드 파운데이션 | 0.30 | 565 | 0.530973 | (g/day) | 가능 | (%) |\n| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 에 따라 0 또는 LOQ/2로 처리한다. | 하되 자료 선택의 타당성, 불확실성 | 정을 통해 흡입 노출 우려를 낮추도록 함 | V (m3) | 사용 공간 부피(한국 욕실 부피 9.3 적용)2 | (경피) | 안전역(MOS) | = | 비 분무형 데오도란트 | 1.50 | 22.08 | https://www.mhlw.go.jp/content/000491511.pdf | 모발 케어(남녀) | - 모체독성 NOAEL 10 mg/kg bw/day | - 발생독성 NOAEL 30 mg/kg bw/day | - 30 mg/kg bw/day 용량에서 배변 |\n| 국민보건상 위해 우려가 제기되는 화장품 원료 등의 경우에는 총리령으로 정하는 바 | B1-2016-4-001 | 2016.02. | 화장품 위해평가 가이드라인 개정 | Maximization | 0.2% in 0.9% saline solution (intradermal) | 5% in 70:30 acetone/PEG 400 (topical) | □ 외국 규정을 번역하거나 설명하는 내용입니까? | □ 예 | ■ 아니오 | 7.5 | 17.0 | 2.6 | 60 | 0.5525 | 자외선 차단 화장품(Sun care cosmetics) | 0.5% in 70:30 | acetone/PEG 400 | 감작성 있음 |\n| 1-2. 위해평가 수행에 필요한 일반사항 ····································································· 6 | 반영구적 염모제 | 35ml(per | application) | - | 0.1 | Not | 차단제 | - 제품 사용 시 접촉할 수 있는 피부면적(예 : 입술, 손톱, 목 등) | - 90일(13주) 반복투여독성시험 자료가 유효 |\n| 목욕 샤워용 | 손세정제품(비누, 젤), 샤워제품(비누, 젤), 목욕제품 | 샴푸 | 9.25 | 151.84 | 0.01 | 0.09 | 1.52 | 및 제한점 등을 명확히 기술 | 노출유형 | 제품 | g/day | mg/kg bw/day | 대표 유형 | 생식·발생 | - 토끼 대상(6~28일) | - 3, 10, 30 mg/kg bw/day | 메이크업 리무버 | 0.21 | 565 | 0.371681 | ○ 결과에 영향을 미치는 불확실성, 제한점 및 선택된 가정 | https://www.mhlw.go.jp/web/t_doc?dataId=81074000&d | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 용량에서 모체의 체중감 | SED | calculated3 | - |\n| 위해 우려가 제기되는 경우 위해평가를 통해 안전성을 확보할 수 있다. | 제17조의2(지정·고시된 원료의 사용기준의 안전성 검토) ① 법 제8조제5항에 따른 | Ainh-1, 2 | box 1, 2 공간에 존재하는 호흡가능한 평가 대상 물질의 양 | 생식·발생 | - 랫드 대상 | - 0, 150, 450, 1000 mg/kg/day | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)3 | 공통 | ○ 체외(in vitro) 시험 | - (OECD TG471, TG472) 박테리아 복귀돌연변이 시험 | - (OECD TG473) 염색체이상시험 | - (OECD TG487) 소핵시험 | 헤어스타일링 | 0.40 | 5.74 |\n| 차서(용어정의)) | 로 실험동물을 이용한 독성시험 결과 등으로부터 독성기준값을 결정하는 과정 | 한다. | 에 따라 위해요소를 신속히 평가하여 그 위해 여부를 결정하여야 한다. | 실내 부피(m3) | 노출되는 공간의 부피 | 0.0015 | 16.9 | 50 | 60 | 0.0021 |\n| 화장품 | ○ 흡입에 따른 노출량 | ataType=0&pageNo=1 | 과 이에 따라 예상되는 영향도 기술 | 하지 않는 경우 : 사례별(case-by-case)로 결 |\n| 1-3. 위해평가 대상 ········································································································· 6 | 헤어 컨디셔너 | 6.10 | 102.88 | 0.01 | 0.06 | 1.03 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | Buehler | 20% in petrolatum | 20% in | petrolatum | 감작성 있음 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 리퀴드 파운데이션 | 0.51 | 7.90 | BMDL10 | = | 아이 섀도 | 0.02 | 24 | 0.833333 | 샤워 젤 | 0.10 | 1.62 | 2-Box model 모식도 | 0.018 | □ 예 | ■ 아니오 |\n| 피부 관리용 | 크림, 필링/스크럽제, 마스크팩, 바디팩(머드/클레이), 피부미백제품 | 산화성/영구적 염모제2 | 100ml(per | application) | - | 0.1 | Not | 지정·고시된 원료의 사용기준의 안전성 검토 주기는 5년으로 한다. | t (min) | 공간 머무름 시간 (10~20분 적용)4 | 소, 간무게 증가 및 호산구증가증 관찰 | 감소, 위장내 검붉은 반점 등 관찰 | = | 3.4 × 105 |\n| ④ 식품의약품안전처장은 제3항에 따라 위해평가가 완료된 경우에는 해당 화장품의 | 메이크업 제품 | MOE | = | 환기율(횟수/시간) | 시간당 환기 횟수 | 정되며 불확실성 계수 1~10을 추가로 적용 | calculated3 | - |\n| 헤어스타일링제품 | 2.76 | 0.1 | 0.28 | 4.0 | 으나 과학적으로 가능한 범위 내에서 정량화한다. | 다(SCCS/1628/21, 2021). | B1-2016-4-002 | 2016.11. | 화장품 위해평가 가이드라인 개정 | 정리한 자료입니까? | - 제품 유형, 확산 속도 | 손 세정 비누 | 0.24 | 3.82 | SED | 5.3× 10-8 |\n| 1-4. 위해요소별 위해평가 유형 ··················································································· 7 | ② 식품의약품안전처장은 법 제8조제5항에 따라 지정·고시된 원료의 사용기준의 안 | fresp | 흡입 가능한 물질 분율(분사제/펌프 스프레이 차이) | 는 경우를 포함한다. | SED  = | A(g/day) ×1000mg/g× C(%)/100 × DAp(%)/100 | 17 (g/day) × 7.5/100 × 2.6/100 | 메이크업 리무버 | 0.50 | 8.33 | 마스카라 | 0.03 | 1.6 | 18.75 | - 1000 mg/kg/day 군에서 태자흡수가 증가 |\n| 피부 과민성, 폐 영향)을 검토한다. | 표2 참고). | 1 화장품 유형에 따른 1일 사용량(붙임 4 참조) | SED | = | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니 | - (OECD TG430) 랫드 경피 전기저항 시험(Rat skin transcutaneous | 제품 사용 시간(min) | 해당 물질 제품을 사용하는 데 걸리는 시간 | 페이셜 메이크업, 메이크업클린징, 아이쉐도우, 마스카라, | 아기용품(Baby care) | http://ASEANcosmetics.org/information-center/ASEA | 가능 | = 0.5525 mg/kg/day |\n| 흡입 | 니어야 한다. 또한, 지정·고시된 사용 목적 및 사용한도에 적합하여야 한다. | 노출 수준을 정량적 산출하는 과정 | 원료 등을 화장품의 제조에 사용할 수 없는 원료로 지정하거나 그 사용기준을 지정하 | “화장품 위해평가 가이드라인(민원인 안내서)” | 피부 관리 |\n| 메이크업 및 손톱 관리용 | 화장품 사용에 따른 노출 경로 자료를 우선으로 고려할 수 있다. | 생식·발생 | - 랫드 대상 | - 0, 250, 500, 1000 mg/kg/day | 아이 섀도 | 0.02 | 0.33 | 샴푸 | 0.09 | 1.52 | ○ 과학적 정보와 불확실성 등을 고려하여 정량적 또는 정 | 피부 관리(남녀) | [참고 자료] | 60 kg | 하였으나 실험에 사용한 랫드의 일반적인 | 특성 |\n| ⦁ 확산 셀의 설계, 수용액(receptor fluid) 선택, 피부 온도, 피부 온전성 등 | : 위해평가에 사용된 방법을 간략하게 기술 | 전성을 검토할 때에는 사전에 안전성 검토 대상을 선정하여 실시해야 한다. | fappl (day-1) | 사용 횟수(제품별 매개변수 값으로 2 적용)2 | 2 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007) | Electrical resistance Test, RET) | 제품 노출 면적(cm2) | 해당 물질의 제품이 노출되는 면적 | 아이라이너, 아이메이크업리무버, 립스틱, 입술보호제, 네일제품 | 립스틱 | 0.05 | 4.8 | 10.41667 | N-cosmetic-directive/ | 60 kg |\n| 메이크업 제품 | 다. | ○ 유효한 경구 생체이용률(BA) 자료가 있는 경우, |\n| 위해영향 발생 가능성이 낮다고 평가할 수 있다(SCCS/1628/21, 2021; Renwick, 1993). | 가하도록 한다. | 바디로션 | 5.48 | 92.23 | 1.0 | 5.48 | 92.23 | 바디로션 | 7.82 | 123.20 | 1.00 | 7.82 | 123.20 | 여야 한다. | 헤어 컨디셔너 | 0.06 | 1.03 |\n| 가원 화장품연구과에 문의하시기 바랍니다. | 집할 수 있다. | 3 한국인 호흡률(한국인의 노출계수 핸드북, 환경부, 2019) | 손세정 비누에 함유된 물질 A의 농도 | 50 ppb (= 50 ㎍/kg) | - (OECD TG476) 유전자돌연변이시험 | - (OECD TG470) pig-a gene mutation | ○ 체내(in vivo) 시험 | 마스카라 | 0.025 | 0.42 | http://ASEANcosmetics.org | 성적으로 위해성을 명시하되, 과학적으로 가능한 범위 내 |\n| 데오도란트 | 스프레이, 스틱/롤러형 | 우, 재평가할 수 있다. | 안내서-0747-01 | 2017.03. | 화장품 위해평가 가이드라인 개정 | BW | 성인 평균 체중(60kg) | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. | 질량 이동률(m/min) | 해당제품의 물질이 공기 중으로 증발되어 | 기능을 하게 되는 속도 | 아이라이너 | 0.01 | 3.2 | 3.125 | 경구 독성결과에 생체이용률(BA) 적용 가능 | - 그 외 어떠한 영향도 관찰되지 않음 |\n| 2-1. 위해평가 사전 검토사항 ······················································································· 8 | ⦁ 시험물질의 특성 분석을 통해 화장품 제품에 사용되는 성분과 일치 | 얼굴크림 | 1.76 | 29.14 | 1.0 | 1.76 | 29.14 | 얼굴크림 | 1.54 | 24.14 | 1.00 | 1.54 | 24.14 | 증기 | 바디로션 | 5.48 | 92.23 |\n| ⑤ 식품의약품안전처장은 제2항에 따라 지정ㆍ고시된 원료의 사용기준의 안전성을 정 | 있다. | 4 Rothe H, 2011 | 아이라이너 | 0.005 | 0.08 | 에서 정량화 |\n| 가 방법을 참고할 수 있다(붙임 7). | Aexpo (g) | 분사된 평가 대상 물질의 양 | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 행정사무의 통일을 기하기 위하여 내부적으로 행정사무의 | method | 크기 | d-series-on-testing-and-assessment_20777876 | □ 예(☞지침서) | ■ 아니오 |\n| 시험 결과를 전신 독성기준값(PODsys)으로 결정한다. | 손세정 1일 노출량 | 3.33 mg/kg bw/day | https://www.industrialchemicals.gov.au/cosmetics-and |\n| 을 직접 투여하고, 모세대 및 차세대에 미치는 영향을 평가하는 시험 | 구강 관리용 | 치약, 구강청결제 | 핸드크림 | 1.38 | 23.59 | 1.0 | 1.38 | 23.59 | 핸드크림 | 2.16 | 32.70 | 1.00 | 2.16 | 32.70 | 전화번호: 043-719-4852 | 1일 총 화장품 사용량 | ±16.9 | 51.67438 | 얼굴 크림 | 1.76 | 29.14 | 립스틱 | 0.06 | 0.90 |\n| 2-2. 위해평가 세부 수행절차 ······················································································· 9 | 일반적으로 위해 우려가 되지 않는다고 평가할 수 있다(SCCS/1628/21, 2021). | 전성은 노출량 등을 고려하여 사례별(case-by-case)로 검토되어야 한다. | ⦁ 일반 제형의 시험 물질 최고 농도를 포함한 다양한 농도로 수행 | 기적으로 검토하여야 하고, 그 결과에 따라 지정ㆍ고시된 원료의 사용기준을 변경할 | 피부흡수율 50%를 위해평가에 적용 | 50 mg/kg을 투여하여 종양이 발생한 비율(32%) - 대조군에서 종양이 발생한 비율(0%) | A (g/day) | 화장품의 1일 사용량1 | - (OECD TG435) in vitro 인공막 장벽시험 | 세부기준이나 절차를 제시하는 것입니까? (공무원용) | 분자량 매트릭스(g/mol) | 제품 전체의 분자량에서 해당 물질의 분자량을 | 뺀 나머지의 평균 | 가압 시스템(분사제 스프레이, 펌프 스프레이) | 피부 관리(Skin care) | 기타(Miscellaneous) |\n| 하는 과정 | A (g) | 화장품(스프레이)에서 분사된 양 | 스프레이 제품 |\n| 물질 A의 피부흡수율 | 65% | 핸드 크림 | 1.38 | 23.59 | -soap | 메이크업(여성) | 메이크업 | = | 32% |\n| 발 관리용 | 발한 억제제 크림, 항진균제 | 안내서-0747-02 | 2023.11. | 화장품 위해평가 가이드라인 개정 | □ 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기 | - (OECD TG483) 염색체이상시험 | - (OECD TG474) 소핵시험 | - (OECD TG475) 염색체이상시험 | - (OECD TG478) 우성치사시험 | - (OECD TG488) 유전자변이시험 | 스프레이 용기(부피) | 치약 | 0.14 | 2.16 |\n| ⦁ 사용조건과 동일한 함량 및 제형, 적용량, 피부 접촉시간으로 수행 | 수 있다. 이 경우 안전성 검토의 주기 및 절차 등에 관한 사항은 총리령으로 정한다. | 팩스번호: 043-719-4850 | 발    행    일 | 2023. 11. | 구강 제품 | 전체 마우스 수의 비율(100%) - 대조군에서 종양이 발생한 마우스 수의 비율(0%) | ■ 예(☞안내서) | □ 아니오 |\n| 리퀴드 파운데이션 | 0.51 | 7.90 | 1.00 | 0.51 | 7.90 | 서 구분 | 2-2-1. 위험성 확인 ······································································································ 9 | C (%) | 화장품 중 평가 대상 물질의 농도 | C (%) | 화장품 제형 중 평가 대상 성분의 농도 | 시험 | 방법 | 투여 | 경로 | 분사시간(sec) | 스프레이 분사 시간 | 시험 | 대상 | 투여용량 | 피부흡수율 |\n| 리퀴드 파운데이션 | 0.30 | 5.28 | 1.0 | 0.30 | 5.28 | 발암물질로 분류된다. | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 | 입장을 기술하는 것입니까? (민원인용) | 평생발암위해도(LCR) | = | SED | 비 분무형 데오도란트 | 2.33 | 36.12 | 노즐 등 제품 배출 형태 | 구강세정액 | 2.16 | 32.54 |\n| 향수 | 오드트왈렛 | BMDL10 |\n| 같은 정보가 포함된다. | DAp (%) | 평가 대상 물질의 피부흡수율 (Dermal Absorption)2 | 대상 화장품 | 전신노출량 | (mg/kg/day) | method) | 분사된 물질 중 공기 중 부유 비율3 | Human data | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) |\n| ⦁ 시험물질의 전체 회수율이 85~115% 범위에 해당 | 메이크업 리무버 | 메이크업 리무버2 | 5.00 | - | 0.1 | 0.50 | 8.33 | 류인자를 이용할 수 없는 경우 10%의 잔류지수를 적용할 수 있다. | 발    행    인 | 박 윤 주 | 2-2-2. 위험성 결정 ···································································································· 12 | SED = 50 × 1/109 × 3.33 mg/kg bw/day× 65/100 | = 1.1×10-7  mg/kg bw/day | 실내 높이(m) | 사용 공간 높이 | 헤어스타일링 | 0.28 | 4.0 | (mg/kg bw/day) | HT25/0.25 | (mg/kg bw/day) |\n| (클렌징 크림/오일) | 2.14 | 36.95 | 0.1 | 0.21 | 3.70 | fair | LLNA weighted mean | TOTAL | ± 17.4 | 269 | 정성/정량 구성 |\n| 대상 화장품 | 전신노출량 | (mg/kg/day) | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) | WoE NESIL |\n| 태․분만․포육 등의 생식기능, 출생 및 이유 후 신생자의 생육)을 평가하는 시험 | 남성용 화장품 | 면도 비누, 크림 및 거품, 애프터셰이브 | 아이 섀도2 | 0.02 | - | 1.00 | 0.02 | 0.33 | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | - (OECD TG437) 소 각막 혼탁 및 투과성 시험법(Bovine Cornea Opacity | 질량 생성률(g/sec) | 해당 제품이 시간 당 분사되는 양 | (분사제 스프레이: 1, 펌프 스프레이: 0.2 적용) | NOEL – HRIPT | 물휴지 | 4.57 | 71.15 | NOEL –  HMT | LOEL | - 57 - | - 58 - | - 59 - | - 60 - | □ 예 | ■ 아니오 |\n| 향을 미칠 수 있다. | 편 집 위 원 장 | 손 수 정 | in vivo | 피부 | 랫드 | - 25, 75, 100 ppm | - 21.4, 33.7, 51.2% | 60 (kg) | 성인 평균 체중 | 스프레이 제형 | 시험 | 방법 | EC3 values | 공익신고자 보호제도란? | 투여 | 경로 | 시험 | 대상 | 분사제 및 용제 사용 | 노출기간 |\n| ⦁ 공여자 4명으로부터 피부 표본 8개 사용 | 2-2-3. 노출평가 ·········································································································· 14 | (induction) | (µg/cm2) | (시간) | 투여용량 | 피부흡수율 | (induction) | (µg/cm2) | (induction) | (µg/cm2) | (µg/cm2) |\n| 기타 확인 | 아이 섀도 | 0.02 | 0.29 | 1.0 | 0.02 | 0.29 | 마스카라2 | 0.025 | - | 1.00 | 0.025 | 0.42 | 등을 위해평가 대상으로 한다. | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)4 | 대표 유형 화장품 | 0.0021 | 10 | 4762 | (㎍/cm2) | 민원인을 구속하는 내용이 있습니까? | Permeability (BCOP) test method) | 부유 비율 | 분사 후 비휘발성 물질이 공기 중으로 | 부유되는 비율 | T25 |\n| 자외선 차단용 | 크림, 로션, 오일 | 일일 노출을 보정할 수 있다. | 리퀴드 파운데이션 | 0.30 | 5.28 | 분사 방식(예: 거품, 무스, 미세 분사 등) |\n| 동태학 | HT25 | = | 동역학 | 동태학 | 동역학 |\n| SCCS/1628/21, 2021). | 마스카라 | 0.03 | 0.50 | 1.0 | 0.03 | 0.50 | 편  집  위  원 | 송영미, 김도정, 윤해석, 박은재, 지정은, 심지은, 한지혜, 고미선 | 1 화장품 유형에 따른 1일 사용량(붙임 5 참조) | 자외선 차단제 | 0.5525 | 450 | 814 | 그림 1. 화장품 성분(의도적 사용물질)의 위해성평가 흐름도 | 스프레이 | (사람체중/동물체중)0.25 |\n| 아이라이너2 | 0.005 | - | 1.00 | 0.005 | 0.08 | V1 (L) | Box 1(호흡영역 근처)의 공간부피(분사제/펌프 스프레이: 1000 적용)6 | 사항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서 | - (OECD TG438) 닭의 안구를 이용한 안점막 시험법(Isolated chicken | - 에멀젼 : 0.7±0.3% |\n\n**[표 끝]**\n\n<!-- PAGE_2 -->\n###### 선적으로 고려하시기 바랍니다. 그럼에도 불구하고 동 지침서ㆍ안내서의\n\n<!-- PAGE_2 -->\n###### 제정이 필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n<!-- PAGE_2 -->\n###### 지침서ㆍ안내\n\n<!-- PAGE_2 -->\n###### ㆍ안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n<!-- PAGE_2 -->\n###### 상기 사항에 대하여 확인하였음.\n\n<!-- PAGE_2 -->\n###### 2023년 11월\n\n<!-- PAGE_2 -->\n###### 담당자\n\n<!-- PAGE_2 -->\n###### 확  인(부서장)\n\n<!-- PAGE_2 -->\n###### 박은재\n\n<!-- PAGE_2 -->\n###### 송영미\n\n<!-- PAGE_3 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n###### 이 안내서는 화장품 위해평가에 대하여 알기 쉽게 설명하거나 식품의약\n\n<!-- PAGE_3 -->\n###### 품안전처의 입장을 기술한 것입니다.\n\n<!-- PAGE_3 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_3 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 참고로만 활용하시기 바랍니다. 또한,\n\n<!-- PAGE_3 -->\n###### 본 안내서는 2023년 11월 현재의 과학적ㆍ기술적 사실 및 유효한 법규를\n\n<!-- PAGE_3 -->\n###### 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_3 -->\n###### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n<!-- PAGE_3 -->\n###### ※ “민원인 안내서”란 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기\n\n<!-- PAGE_4 -->\n#### 개정 이력서\n\n목차\n\n<!-- PAGE_5 -->\n###### 제1장 화장품 위해평가 가이드라인의 목적 ························································· 1\n\n<!-- PAGE_5 -->\n###### 1. 목적 ·································································································································· 1\n\n<!-- PAGE_5 -->\n###### 2. 관련 규정 ························································································································ 2\n\n<!-- PAGE_5 -->\n###### 제2장 화장품 안전의 일반사항 ··············································································· 4\n\n<!-- PAGE_5 -->\n###### 1. 일반사항 ·························································································································· 4\n\n<!-- PAGE_5 -->\n###### 2. 화장품 성분 ···················································································································· 4\n\n<!-- PAGE_5 -->\n###### 제3장 화장품 위해평가 ····························································································· 5\n\n<!-- PAGE_5 -->\n###### 1. 위해평가 절차 및 수행에 필요한 일반사항 ···························································· 5\n\n<!-- PAGE_5 -->\n###### 2. 위해평가 방법 ················································································································ 8\n\n<!-- PAGE_5 -->\n###### 2-2-3-1. 피부 노출평가 ························································································ 17\n\n<!-- PAGE_5 -->\n###### 2-2-3-2. 흡입 노출평가 ························································································ 19\n\n<!-- PAGE_5 -->\n###### 2-2-4. 위해도 결정 ···································································································· 21\n\n<!-- PAGE_5 -->\n###### 3. 위해평가 보고서 ········································································································ 23\n\n<!-- PAGE_5 -->\n###### 제4장 참고문헌 ········································································································· 24\n\n<!-- PAGE_6 -->\n###### [붙임 자료]\n\n<!-- PAGE_6 -->\n###### 붙임 1. 화장품 위해평가 관련 용어집(Glossary) ·························································· 26\n\n<!-- PAGE_6 -->\n###### 붙임 2. 화장품 위해평가 보고서 양식 ········································································· 30\n\n<!-- PAGE_6 -->\n###### 붙임 3. OECD 독성시험 종류 ························································································· 33\n\n<!-- PAGE_6 -->\n###### 붙임 4. 화장품 노출 피부 표면적 ················································································· 35\n\n<!-- PAGE_6 -->\n###### 붙임 5. 한국인의 화장품 사용량 ····················································································· 37\n\n<!-- PAGE_6 -->\n###### 붙임 6. 유럽의 화장품 사용량 ························································································· 39\n\n<!-- PAGE_6 -->\n###### 붙임 7. 흡입 노출평가 방법 및 기본 정보 ··································································· 41\n\n<!-- PAGE_6 -->\n###### 붙임 8. 피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시 ················ 49\n\n<!-- PAGE_6 -->\n###### 붙임 9. 화장품 유형별 평가 예시 ··················································································· 53\n\n<!-- PAGE_6 -->\n###### 붙임 10. 화장품 성분 위해평가를 위한 정보 수집 ····················································· 57\n\n<!-- PAGE_6 -->\n###### 참고 1. 발암물질 위해평가 및 예시 ··············································································· 62\n\n<!-- PAGE_6 -->\n###### 참고 2. TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정 ············ 67\n\n- - 1 -\n<!-- PAGE_7 -->\n##### 제1장 화장품 위해평가 가이드라인의 목적\n\n<!-- PAGE_7 -->\n###### 1. 목적\n\n<!-- PAGE_7 -->\n###### 본 가이드라인에는 화장품 위해평가를 수행함에 있어 일반적으로 고려되어야 할 사\n\n<!-- PAGE_7 -->\n###### 항, 절차 및 관련 용어 등을 기술하였다. 본 가이드라인은 화장품의 안전을 확보하기\n\n<!-- PAGE_7 -->\n###### 위하여 「화장품법」, 「화장품법 시행규칙」에 따른 화장품 위해평가 업무에 활용한다.\n\n- - 2 -\n<!-- PAGE_8 -->\n###### 2. 관련 규정\n\n⌜화장품법⌟\n\n- - 3 -\n⌜화장품법 시행규칙⌟\n\n<!-- PAGE_9 -->\n###### 제17조(화장품 원료 등의 위해평가) ① 법 제8조제3항에 따른 위해평가는 다음 각\n\n<!-- PAGE_9 -->\n###### 호의 확인·결정·평가 등의 과정을 거쳐 실시한다.\n\n<!-- PAGE_9 -->\n###### 1. 위해요소의 인체 내 독성을 확인하는 위험성 확인과정\n\n- - 4 -\n<!-- PAGE_10 -->\n##### 제2장 화장품 안전의 일반사항\n\n<!-- PAGE_10 -->\n###### 1. 일반사항\n\n<!-- PAGE_10 -->\n###### 1) 화장품은 제품 설명서, 표시사항 등에 따라 정상적으로 사용하거나 또는 예측가능한 사용\n\n<!-- PAGE_10 -->\n###### 2) 화장품은 일반 소비자뿐만 아니라 화장품을 직업적으로 사용하는 전문가(예, 미용사, 피부\n\n<!-- PAGE_10 -->\n###### 3) 화장품의 안전성은 화장품 성분의 안전성에 기반하며, 화장품 성분의 안전성은 독성시험\n\n<!-- PAGE_10 -->\n###### 2. 화장품 성분\n\n<!-- PAGE_10 -->\n###### 1) 화장품 성분은 화학물질 또는 천연물 등이며, 경우에 따라 단일 또는 혼합물일 수 있다.\n\n<!-- PAGE_10 -->\n###### 최종 제품의 안전성을 확보하기 위해서는 성분의 안전성이 확보되어야 한다. 원료 성분의\n\n<!-- PAGE_10 -->\n###### 2) 화장품 성분은 식약처장이 화장품의 제조에 사용할 수 없는 원료로 지정·고시한 것이 아\n\n<!-- PAGE_10 -->\n###### 3) 미량의 중금속 등 불순물, 제조공정이나 보관 중에 생길 수 있는 비의도적 오염물질을 가\n\n<!-- PAGE_10 -->\n###### 능한 줄이기 위한 충분한 조치를 취하여야 한다. 그럼에도 오염물질이 존재할 경우, 그 안\n\n<!-- PAGE_10 -->\n###### 4) 화장품 성분의 화학구조에 따라 물리․화학적 반응 및 생물학적 반응이 결정되며 화학적 순\n\n<!-- PAGE_10 -->\n###### 도, 조성 내의 다른 성분들과의 상호작용 및 피부투과 등은 효능과 안전성 및 안정성에 영\n\n<!-- PAGE_10 -->\n###### 5) 화장품 성분의 상호작용으로 인해 유해물질 발생(예를 들면, 니트로소아민 형성) 가능성과\n\n<!-- PAGE_10 -->\n###### 식물유래 및 동물에서 추출한 성분에 농약, 살충제, 금속물질 및 생물학적 유해물질이 함\n\n<!-- PAGE_10 -->\n###### 유되어 있을 가능성에 특별한 주의를 기울여야 한다.\n\n<!-- PAGE_10 -->\n###### 6) 피부를 투과한 화장품 성분은 국소 및 전신작용에 영향을 미칠 수 있다.\n\n<!-- PAGE_10 -->\n###### 7) 화장품의 안전성은 각 성분의 독성학적 특징과 유사한 조성의 제품을 사용한 경험, 신물질\n\n<!-- PAGE_10 -->\n###### 의 함유 여부 등을 참고하여 전반적으로 검토한다.\n\n<!-- PAGE_10 -->\n###### 8) 화장품에 대한 안전성은 특정 소비자(영유아, 민감성 피부 등) 대상 여부, 피부 투과 혹은\n\n<!-- PAGE_10 -->\n###### 피부 자극을 증가시킬 수 있는 특정 성분(피부투과 강화제, 유기 용제, 산성 성분 등) 존재\n\n<!-- PAGE_10 -->\n###### 여부, 독성학적 우려가 예측되는 성분 간의 화학반응 유무 등 추가 정보를 고려하여 평가\n\n<!-- PAGE_10 -->\n###### 한다.\n\n- - 5 -\n<!-- PAGE_11 -->\n##### 제3장 화장품 위해평가\n\n<!-- PAGE_11 -->\n###### 1. 위해평가 절차 및 수행에 필요한 일반사항\n\n<!-- PAGE_11 -->\n###### 1-1. 위해평가 절차\n\n<!-- PAGE_11 -->\n###### 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할 수 있는 위해 영향과 발생확\n\n<!-- PAGE_11 -->\n###### 률을 과학적으로 예측하는 위해평가는 위험성 확인, 위험성 결정, 노출평가, 위해도 결정의 4\n\n<!-- PAGE_11 -->\n###### 단계의 과정을 거쳐 실시한다.\n\n<!-- PAGE_11 -->\n###### 1) 위험성 확인(Hazard Identification) : 위해요소에 노출됨에 따라 인체 건강에 위해한 영향\n\n<!-- PAGE_11 -->\n###### 을 미칠 가능성에 대하여 물질의 고유한 물리화학적 특성, 독성의 정도 및 그 영향 등을\n\n<!-- PAGE_11 -->\n###### 2) 위험성 결정(Hazard Characterization) : 노출과 독성반응에 대한 관계를 평가하는 단계로 주\n\n<!-- PAGE_11 -->\n###### 3) 노출평가(Exposure Assessment) : 화장품의 사용으로 인해 위해요소에 노출되는 양 또는\n\n<!-- PAGE_11 -->\n###### 4) 위해도 결정(Risk Characterization) : 위해요소 및 이를 함유한 화장품의 사용에 따라 독성\n\n<!-- PAGE_11 -->\n###### 기준값 및 노출량을 고려하여 사람에게 미칠 수 있는 위해의 정도 등을 정량적으로 예측\n\n- - 6 -\n<!-- PAGE_12 -->\n###### 1-2. 위해평가 수행에 필요한 일반사항\n\n<!-- PAGE_12 -->\n###### 위해평가 수행에 필요한 일반사항은 다음과 같으며, 위해요소 특성에 따라 예외가 있을 수\n\n<!-- PAGE_12 -->\n###### 있다.\n\n<!-- PAGE_12 -->\n###### 1) 위해평가 시 본 가이드라인을 체크리스트로 간주할 수 없으며, 화장품 성분의 특성에 따\n\n<!-- PAGE_12 -->\n###### 2) 독성자료는 OECD 가이드라인 등 국제적으로 인정된 프로토콜에 따른 시험을 우선적으로\n\n<!-- PAGE_12 -->\n###### 3) 반복투여독성시험, 생식독성시험 등 독성시험 자료가 충분하지 않거나 시험결과의 신뢰성\n\n<!-- PAGE_12 -->\n###### 확인 등 독성시험 자료가 제한적인 경우, 위험성 확인 단계에서 자료 부족임을 명시하고\n\n<!-- PAGE_12 -->\n###### 4) 평가성분은 화장품 중 다른 성분에 의해 피부투과에 영향을 받을 수 있으므로 피부흡수\n\n<!-- PAGE_12 -->\n###### 5) 노출평가는 여러 상황을 고려하여 현실적인 노출시나리오를 작성한다.\n\n<!-- PAGE_12 -->\n###### 6) 결과보고서는 관련 자료의 불확실성 등을 고려하여 정량적 또는 정성적으로 표현할 수 있\n\n<!-- PAGE_12 -->\n###### 7) 위해평가 결과는 새로운 독성시험 결과가 보고되는 등 새로운 과학적 사실이 밝혀지는 경\n\n<!-- PAGE_12 -->\n###### 1-3. 위해평가 대상\n\n<!-- PAGE_12 -->\n###### 1) 관련 규정에 따라 국민보건상 위해 우려가 제기되는 화장품 원료, 화장품 사용한도 원료\n\n<!-- PAGE_12 -->\n###### 2) 비의도적 오염물질의 검출허용한도 설정이 필요한 경우에 위해평가를 수행할 수 있다.\n\n- - 7 -\n<!-- PAGE_13 -->\n###### 1-4. 위해요소별 위해평가 유형\n\n<!-- PAGE_13 -->\n###### 1) 위해평가는 위해요소의 용도(화장품 성분 등 의도적 사용물질, 중금속 등 비의도적 오염물\n\n<!-- PAGE_13 -->\n###### 질)에 따라 구분하여 평가한다.\n\n<!-- PAGE_13 -->\n###### 2) 의도적 사용물질로 유전독성 등이 확인되는 경우, 위험성 확인에서 위해평가를 종료하며,\n\n<!-- PAGE_13 -->\n###### 비발암물질, 비유전독성 발암물질과 같이 독성영향이 역치를 가진다고 추정되는 경우에는\n\n<!-- PAGE_13 -->\n###### 3) 비의도적 오염물질과 같이 완전히 제거할 수 없는 경우에는 오염도를 측정하여 노출량을\n\n- - 8 -\n<!-- PAGE_14 -->\n###### 2. 위해평가 방법\n\n<!-- PAGE_14 -->\n###### 2-1. 위해평가 사전 검토사항\n\n<!-- PAGE_14 -->\n###### 1) 위해평가를 수행하기 전, 관련 평가 이력 등 배경을 충분히 검토한다.\n\n<!-- PAGE_14 -->\n###### 2) 위해평가 시 요구되는 관련 자료 등에 대해 검토한다.\n\n<!-- PAGE_14 -->\n###### - 화장품 사용량은 위해요소의 특성과 위해평가의 목적, 평가대상에 적합한 자료를 활용한\n\n<!-- PAGE_14 -->\n###### 3) 유해물질 모니터링 자료를 사용하는 경우, 위해평가를 목적으로 수행된 시험자료를 활용하\n\n<!-- PAGE_14 -->\n###### - 개별적으로 실시한 여러 시험결과를 하나의 위해평가에 활용할 경우에는 시험목적, 시료채\n\n<!-- PAGE_14 -->\n###### - 정량한계(Limit of Quantification, LOQ) 이하 값인 경우 시료 수와 LOQ 이하 값의 분포\n\n<!-- PAGE_14 -->\n###### - 특정 목적으로 수행된 분석 자료는 일반적인 노출평가를 위한 자료에서 제외한다.\n\n- - 9 -\n<!-- PAGE_15 -->\n###### 2-2. 위해평가 단계별 수행절차\n\n<!-- PAGE_15 -->\n###### 2-2-1. 위험성 확인\n\n<!-- PAGE_15 -->\n###### 1) 위험성 확인은 평가대상 물질에 대하여 최근까지 보고된 국내외 자료들을 조사·분석하여\n\n<!-- PAGE_15 -->\n###### ① 물질의 식별정보, 물리화학적 특성 및 고유한 독성학적 특성을 고려하여 in vitro 및  in\n\n<!-- PAGE_15 -->\n###### vivo, 임상자료, 역학자료 등 현재 이용할 수 있는 모든 독성자료를 종합적으로 검토한\n\n<!-- PAGE_15 -->\n###### ② 독성정보는 해외 화장품 위해평가 기관(유럽 소비자안전과학위원회(Scientific Committee\n\n<!-- PAGE_15 -->\n###### on Consumer Safety, SCCS) 등에서 발간한 보고서나 평가원에서 생산된 자료를 활용할\n\n<!-- PAGE_15 -->\n###### ③ 독성자료의 경우, OECD 등 국제적 인정기관에서 독성시험 설계 및 수행에 필요한 최소\n\n<!-- PAGE_15 -->\n###### 2) 독성영향은 인체에서의 생물학적 영향과의 연관성이 있는지를 판단한다.\n\n<!-- PAGE_15 -->\n###### 3) 위험성 확인에서 전신영향(Systemic effect) 또는 국소영향(Local effect)(예: 피부, 눈 자극,\n\n<!-- PAGE_15 -->\n###### 4) 위험성 확인에 필요한 자료는 다음과 같다.\n\n<!-- PAGE_15 -->\n###### ① 물리화학적 성질 : 검토 대상 성분의 물리화학적 특성은 물질의 독성을 예측할 수 있는\n\n<!-- PAGE_15 -->\n###### 중요한 정보이다. 검토 대상 성분의 물질명(INCI명, IUPAC명), CAS 번호, 화학식, 분자량,\n\n<!-- PAGE_15 -->\n###### 구조식, 물리화학적 성질(성상, 녹는점, 끓는점, 밀도, 증기압, pH, 용해도, Log Pow)과\n\n<!-- PAGE_15 -->\n###### ② 흡수·분포·대사·배설(ADME) : 체내에서 검토 대상 성분의 안전성에 대해 설명하기\n\n<!-- PAGE_15 -->\n###### 위해 독성동태학 자료(OECD 417)를 이용할 수 있다. 검토 대상 성분의 체내 흡수, 분포,\n\n<!-- PAGE_15 -->\n###### 대사, 배설에 대한 정보는 독성 가능성을 예측할 수 있으며 독성연구 해석에 도움을 줄\n\n<!-- PAGE_15 -->\n###### 수 있다.\n\n<!-- PAGE_15 -->\n###### ③ 피부흡수 : 화장품 성분의 피부흡수는 통과(penetration), 침투(permeation), 흡수\n\n<!-- PAGE_15 -->\n###### (resorption) 세 단계의 과정으로 이루어진다. 화장품 성분은 혈관과 림프관에 도달하기\n\n<!-- PAGE_15 -->\n###### 위해서 여러 층의 피부조직을 통과하게 되며, 이때 물질의 피부흡수율을 결정하는 층\n\n<!-- PAGE_15 -->\n###### (rate-determining layer)은 각질층이다. 화장품 성분에 대한 피부흡수 연구는 화장품의\n\n<!-- PAGE_15 -->\n###### 사용조건에서 인체의 전신 구획(systemic compartment)으로 들어가는 화합물의 정성적\n\n<!-- PAGE_15 -->\n###### 및 정량적 정보를 얻는 목적으로 수행되며 안전역(margin of safety) 산출에 반영된다.\n\n<!-- PAGE_15 -->\n###### ④ 독성자료 : 검토 대상 성분의 독성연구를 기반으로 화장품 성분의 독성 가능성을 확인할\n\n- - 10 -\n<!-- PAGE_16 -->\n###### 수 있다. 사람과 동일한 노출경로(국소, 경구, 흡입 경로)에 해당하는 독성 데이터를 조\n\n<!-- PAGE_16 -->\n###### 사하여 수집한다. 독성자료에는 다음과 같은 독성연구가 포함된다(SCCS/1628/21, 2021).\n\n<!-- PAGE_16 -->\n###### (a) 단회투여독성 : 경구, 피부, 흡입 경로를 통해 물질에 1회 노출됨에 따라 건강과 관련\n\n<!-- PAGE_16 -->\n###### 하여 발생할 수 있는 이상반응을 설명하는데 사용되며, LD50 값을 결정하기 위한 목적\n\n<!-- PAGE_16 -->\n###### (b) 반복투여독성 : 물질을 장기간(28일/90일/24개월)에 걸쳐 매일 반복하여 투여하거나 노\n\n<!-- PAGE_16 -->\n###### 출됨에 따라 나타나는 일반적인 독성영향(생식독성, 유전독성, 발암성 효과 제외)을 말\n\n<!-- PAGE_16 -->\n###### (c) 피부부식성, 피부자극성, 안점막자극성, 피부감작성 : 검토 대상 성분이 피부 또는 안\n\n<!-- PAGE_16 -->\n###### 점막에 노출되어 표피 또는 진피 내부, 각막에 나타나는 손상으로 피부에 나타나는 독\n\n<!-- PAGE_16 -->\n###### (d) 생식발생독성 : 물질로 인해 포유류 생식의 모든 측면에 발생하는 유해 영향으로 남성\n\n<!-- PAGE_16 -->\n###### /여성의 생식기능 장애, 자손에 유전되지 않는 유해영향 발생(예: 사망, 성장지연, 구조\n\n<!-- PAGE_16 -->\n###### (e) 유전독성 : DNA의 구조나 정보, 분리의 변화를 일으키는 과정으로 물질에 의해 정상\n\n<!-- PAGE_16 -->\n###### 적인 복제과정이 방해되어 DNA 손상을 일으키거나 비생리적 방식으로 복제를 변경하\n\n<!-- PAGE_16 -->\n###### (f) 발암성 : 흡입, 경구, 피부 도포, 주사(injection)를 통해 종양(양성 또는 악성)을 유발하\n\n<!-- PAGE_16 -->\n###### 거나 종양의 발생률과 악성도 증가, 종양 발생 시간을 단축하는 물질을 발암물질로 정\n\n<!-- PAGE_16 -->\n###### 의한다. 발암물질은 DNA와의 상호작용과 돌연변이 유발을 통해 암을 발생시키는 유전\n\n<!-- PAGE_16 -->\n###### 독성 발암물질과 DNA 손상이 아닌 다른 메커니즘을 통해 암을 유발하는 비유전독성\n\n<!-- PAGE_16 -->\n###### (g) 기타 독성 : 면역독성, 신경독성, 광독성 등을 포함한다.\n\n<!-- PAGE_16 -->\n###### - 면역독성 : 화학물질에 대한 면역 체계 손상, 면역 반응 등을 평가한다.\n\n<!-- PAGE_16 -->\n###### - 신경독성 : 화학물질에 의한 행동장애, 신경 손상, 뇌의 손상 등을 평가한다.\n\n<!-- PAGE_16 -->\n###### - 광독성 : 세포독성을 유발하지 않는 용량 수준에서 자외선/가시광선의 비세포독성 용\n\n<!-- PAGE_16 -->\n###### 량에 따른 노출/비노출 상태에서 화학물질의 세포독성 여부로 평가한다.\n\n- - 11 -\n<!-- PAGE_17 -->\n###### □ 위험성 확인 방법\n\n주요내용\n\n검토방법\n\n- ○ 물리화학적 특성 조사\n- ○ 피부흡수율 자료, ADME(흡수, 분포, 대사,\n**[표 시작]**\n\n| ○ 독성자료 조사 | 단회투여독성 | ② 노출평가 |\n| --- | --- | --- |\n| - 통계적 모델의 허용(Accept) 여부: p-value > 0.05 (default) | 나 발생을 촉진하는 독성 |\n**- 단회투여독성, 반복투여독성, 피부자극성,**\n| ○ 전신 독성기준값(PODsys) 결정 | 3) 노출평가 | 3.1.4.1 독성동태 |\n| - 최적의 모델 적합도 : log-likelihood, AIC(Akaike's Information Criterion) 등 | 이. 물질의 효력에 관한 정보를 제공함 |\n**3) 노출평가**\n**계산된 값이며, 전체 용량 범위에 대한 선형 용량-반응 관계의 가정에 기초한다.**\n| 341 | · log-likelihood 높은 값을 선택(PROAST) |\n| - 시험방법, 독성기준값 등을 고려하여 불확 | 사용 후 씻어내는 피부 | bw/day의 수치를 사용할 수 있다(표2). |\n| - 발암성이 있는 경우, 임상 및 동물실험 | ① 위험성 확인 | ④ 위해도 평가 |\n\n**[표 끝]**\n\n- ○ 인체역학연구 결과, 독성동태자료 등\n※ 유럽은 화장품 규정 개정에 따라 화장품 성분에 대한 in vivo 동물실험은 더이상 수행할 수 없다.\n\n※ 국내의 경우, 「화장품법」 제15조의2(동물실험을 실시한 화장품 등의 유통판매 금지)에 따라 동물실험이 금지되어있\n\n으나, 제8조제2항의 보존제, 색소, 자외선차단제 등 특별히 사용상의 제한이 필요한 원료의 경우 또는 동물대체시험\n\n법이 존재하지 않는 경우, 다른 법령에 따라 동물실험을 실시하여 개발된 원료를 화장품의 제조 등에 사용하는 경우\n\n등 동물시험이 허용되는 예외 조항이 있다.\n\n- - 12 -\n<!-- PAGE_18 -->\n###### 2-2-2. 위험성 결정\n\n<!-- PAGE_18 -->\n###### 1) 위험성 결정은 평가대상 물질의 인체 또는 동물 독성자료 등을 토대로 위해도 결정에 사\n\n<!-- PAGE_18 -->\n###### 용되는 독성기준값(Point Of Departure, POD)을 선정하는 단계이다. 독성기준값(POD)는 모\n\n<!-- PAGE_18 -->\n###### 든 독성 작용, 용량-반응 관계, 예상 역치를 검토하여, NOAEL, LOAEL, BMDL 등이 사용\n\n<!-- PAGE_18 -->\n###### - 무독성용량(No Observed Adverse Effect Level, NOAEL) : 투여 시 유해영향이 관찰되지 않는\n\n<!-- PAGE_18 -->\n###### - 최소독성용량(Lowest Observed Adverse Effect Level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_18 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도로 정의되며, NOAEL을 확인할 수 없는\n\n<!-- PAGE_18 -->\n###### - 벤치마크용량(Benchmark Dose, BMD) : 용량-반응 모델을 근거로 계산되는 값으로, 어떤\n\n<!-- PAGE_18 -->\n###### 독성에 대해 사전에 정한 척도나 생물학적 영향(Benchmark Rresponse level, BMR)의 변화\n\n<!-- PAGE_18 -->\n###### 가 대조군에 비해 5% 또는 10%의 유해한 영향이 나타나는 용량으로 정의된다.\n\n<!-- PAGE_18 -->\n###### BMDL(Benchmark Dose Lower confidence limit)은 BMD의 95% 신뢰구간의 하한치를 의미\n\n<!-- PAGE_18 -->\n###### 2) 일반적으로 경구, 피부 또는 흡입 노출 등 경로별 모든 독성정보를 종합적으로 검토하되\n\n<!-- PAGE_18 -->\n###### - 확실한 경피독성 연구가 없는 경우, 경구 90일(13주) 반복투여독성시험 또는 생식발생독성\n\n<!-- PAGE_18 -->\n###### - 흡입 경로에 대한 독성 특이성이 있는 물질의 경우, 흡입 독성기준값을 사용할 수 있다.\n\n<!-- PAGE_18 -->\n###### - 시험방법, 독성기준값 등을 고려하여 불확실성 계수로 보정할 수 있다. 예를 들어,\n\n<!-- PAGE_18 -->\n###### ·투여방식이 주당 5일 처치인 경우에는 5/7의 계수로 보정된 독성기준값(POD)를 사용하여\n\n<!-- PAGE_18 -->\n###### ·독성기준값(POD)이 LOAEL에 기초하는 경우에는 3의 불확실성 계수를 추가로 적용하여\n\n<!-- PAGE_18 -->\n###### 보정할 수 있다. 단, 반복투여독성시험에서 용량 간격, 용량-반응 곡선의 형태 및 기울기\n\n<!-- PAGE_18 -->\n###### 를 고려하여 사례별(case-by-case)로 불확실성 계수를 1~10까지 조절하여 적용할 수 있다.\n\n<!-- PAGE_18 -->\n###### ·90일(13주) 반복투여독성시험 결과가 유효하지 않은 경우, 28일 반복투여독성시험 결과에\n\n<!-- PAGE_18 -->\n###### 서 얻은 NOAEL에 사례별(case-by-case)로 1-10의 불확실성 계수를 추가로 적용하여 보정\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n- - 13 -\n<!-- PAGE_19 -->\n###### □ 위험성 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 물질에 대한 POD(NOAEL, LOAEL, BMDL\n- ○ WHO, 미국, 일본, 호주, 캐나다 등 선진국\n자료 활용\n\n- - 경구 생체이용률(Bioavailability, BA) 적용 가능\n- - 14 -\n<!-- PAGE_20 -->\n###### 2-2-3. 노출평가\n\n<!-- PAGE_20 -->\n###### 1) 노출평가는 최종 제품에서의 사용량, 사용 빈도, 노출경로(경구, 피부, 흡입 등) 등을 기반\n\n<!-- PAGE_20 -->\n###### 으로 일반적 또는 합리적으로 예측 가능한 시나리오를 설정하여 이에 따른 화장품 성분의\n\n<!-- PAGE_20 -->\n###### 인체노출량을 정량적으로 산출하는 단계이다.\n\n<!-- PAGE_20 -->\n###### 2) 효율적인 노출평가를 위해서 단계적 접근방법으로 평가할 수 있다.\n\n<!-- PAGE_20 -->\n###### - 초기에는 보수적인 노출상황을 가정한 시나리오를 적용하여 평가하며, 보수적인 노출상황\n\n<!-- PAGE_20 -->\n###### - 보수적 노출상황을 가정한 평가에서 위해 발생이 우려되면 실제 노출상황을 가정한 노출\n\n<!-- PAGE_20 -->\n###### 3) 화장품은 유형에 따라 사용방법이 다양하므로 화장품 유형별 사용방법을 고려한 노출시나\n\n<!-- PAGE_20 -->\n###### - 유형별로 화장품을 평가할 경우, 붙임 5, 표1에 따라 화장품 유형별 사용량을 고려하여\n\n<!-- PAGE_20 -->\n###### - 자외선차단제에 대한 통합 일일사용량은 17.0 g/day를 적용할 수 있다(붙임 5, 2항 참고).\n\n<!-- PAGE_20 -->\n###### - 화장품 전유형 및 보존제에 대한 통합 일일사용량은 16.9 g/day를 적용할 수 있다(붙임 5,\n\n<!-- PAGE_20 -->\n###### - 피부 단위면적당 노출량을 평가할 경우, 체표면적은 붙임 4에서 제시된 값을 적용할 수\n\n<!-- PAGE_20 -->\n###### - 전신노출량 산출 시, 잔류지수(retention factor)를 고려할 수 있다(붙임 5 참조).\n\n<!-- PAGE_20 -->\n###### -‘씻어내는’제품 : 사용법에 따라 씻어내는 제품은 잔류지수(RF)을 측정할 수 있으며, 잔\n\n<!-- PAGE_20 -->\n###### 4) 영·유아 및 어린이 제품의 노출평가는 다음의 사항을 고려할 수 있다(Renwick, 1998,\n\n<!-- PAGE_20 -->\n###### ① 모든 영·유아 및 어린이 제품 : 체중 대비 피부 표면적의 비율을 고려할 수 있다.\n\n<!-- PAGE_20 -->\n###### - 출생 시 신생아의 경우 성인보다 2.3배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 6개월 후에는 1.8배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 12개월 후에는 1.6배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 5년 후에는 1.5배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 10년 후에는 1.3배 높음\n\n<!-- PAGE_20 -->\n###### ② 엉덩이에 사용할 가능성이 높은 제품 : 체계적 노출 용량을 계산할 때, 엉덩이는 민감한\n\n<!-- PAGE_20 -->\n###### 부분임을 고려하여 100% 피부흡수율을 적용할 수 있다.\n\n- - 15 -\n<!-- PAGE_21 -->\n###### ③ 엉덩이 도포용이 아닌 모든 제품 : 피부흡수에 대한 데이터를 이용할 수 없거나 모델링\n\n<!-- PAGE_21 -->\n###### 을 통한 예측만 존재하는 경우 100% 피부흡수율을 적용할 수 있다.\n\n<!-- PAGE_21 -->\n###### ④ 일반적으로 10세 이하의 영·유아 및 소아에 대한 불확실성 계수의 추가는 이미 사람\n\n<!-- PAGE_21 -->\n###### 간 변동성에서 고려되었으므로 필요가 없다.\n\n- - 16 -\n<!-- PAGE_22 -->\n###### □ 노출평가\n\n주요내용\n\n수행방법\n\n- ○ 노출시나리오\n- ○ 위험에 노출된 대상이 누구이며, 어떻게 노출되었는지를 고려하여\n명확한 노출시나리오 설정\n\n- ○ 노출량 산출\n- ○ 제품의 종류, 제품 사용방법에 따른 사용량 산출\n- - 17 -\n<!-- PAGE_23 -->\n###### 2-2-3-1 피부 노출평가\n\n<!-- PAGE_23 -->\n###### 1) 피부노출에 의한 전신노출량(systemic exposure dosage, SED)은 일반적으로 대상성분의 농\n\n<!-- PAGE_23 -->\n###### 도, 특정 성분의 피부흡수, 화장품의 1일 사용량, 사용빈도, 사람의 평균 체중값을 고려하\n\n<!-- PAGE_23 -->\n###### 여 산출한다.\n\n<!-- PAGE_23 -->\n###### - 피부로 노출된 전신노출량(SED)은 제품 중 물질의 단위면적당 피부흡수량(mg/cm2) 또는\n\n<!-- PAGE_23 -->\n###### 피부흡수율(%)로부터 구할 수 있다. 피부흡수율을 이용하는 경우, 결과 값은 피부에 적용\n\n<!-- PAGE_23 -->\n###### 2) 피부흡수율(또는 흡수량)은 사용한도 또는 유사한 용량을 함유하는 제형(formulation)을 사\n\n<!-- PAGE_23 -->\n###### - 피부흡수율 자료가 없거나 기존에 보고된 자료가 적합하지 않을 경우, 기본값으로 50%를\n\n<!-- PAGE_23 -->\n###### - 생체외 피부흡수시험 결과는 가변성이 있기 때문에 일반적으로 인체노출량 계산 시 평균\n\n<!-- PAGE_23 -->\n###### 피부흡수시험 및 결과가 아래와 같은 시험요건의 적정성에 모두 부합하는 경우에 평균 +\n\n<!-- PAGE_23 -->\n###### 1SD를 사용하며, 프로토콜에서 벗어나거나 변동성이 높은 경우에는 평균 + 2SD를 사용한\n\n- - 18 -\n<!-- PAGE_24 -->\n###### 3) 피부노출에 의한 전신노출량(SED)은 두가지 방법으로 산출한다.\n\n<!-- PAGE_24 -->\n###### ① 단위면적당 피부흡수량(㎍/cm2)을 기초로 한 전신노출량(SED) 산출\n\n<!-- PAGE_24 -->\n###### ② 평가대상 물질의 피부흡수율(%)을 기초로 한 전신노출량(SED) 산출\n\n2 피부흡수율은 문헌에 보고된 값이나 실험값 중 신뢰성 있는 값을 선택하여 적용한다. 다만,\n\n자료가 없는 경우 보수적으로 50%로 적용할 수 있다.\n\n- - 19 -\n<!-- PAGE_25 -->\n###### 2-2-3-2 흡입 노출평가\n\n<!-- PAGE_25 -->\n###### 1) 화장품은 제형에 따라 분말, 증기, 에어로졸 등의 형태로 직접적으로 흡입되거나 제품 내\n\n<!-- PAGE_25 -->\n###### 휘발성분에 의해 피부에 남아 있는 성분이 공기 중으로 증발되어 흡입될 수 있다. 흡입은\n\n<!-- PAGE_25 -->\n###### 화장품 사용에 있어 비의도적인 노출이므로 아래 흐름도에 따라 흡입 노출평가가 필요한지\n\n<!-- PAGE_25 -->\n###### 여부를 결정할 수 있다(SCCS/1628/21, 2021).\n\n- - 20 -\n<!-- PAGE_26 -->\n###### ① 흡입 노출 가능성을 판단하기 위해서 평가하고자 하는 제품 내 성분의 자료 수집\n\n<!-- PAGE_26 -->\n###### (규정 성분(금지, 배합한도) 확인, 물리화학적 특성 검토)\n\n<!-- PAGE_26 -->\n###### ② 흡입을 통해 전신 및 국소 영향을 나타낼 수 있는 성분 확인\n\n<!-- PAGE_26 -->\n###### ③ 전신 및 국소 영향이 있는 것으로 확인된 성분에 대한 노출평가 수행\n\n<!-- PAGE_26 -->\n###### - 가장 최악의 시나리오를 고려하여, 단계적(tier) 평가 수행\n\n<!-- PAGE_26 -->\n###### - 스프레이 제품 모의시험을 통한 노출량 측정\n\n<!-- PAGE_26 -->\n###### ④ 스프레이 제품 내 포함된 성분의 농도를 확인하여, 무시할 수 있는 수준의 농도일 경우\n\n<!-- PAGE_26 -->\n###### 에는 흡입 노출평가를 수행하지 않으며, 흡입 노출량을 제외한 전신 노출량으로 위해도\n\n<!-- PAGE_26 -->\n###### ⑤ 위해평가 결과에 따라\n\n<!-- PAGE_26 -->\n###### - 위해 우려되지 않는 경우, 성분 정보를 포함한 위해평가 보고서 작성\n\n<!-- PAGE_26 -->\n###### - 위해 우려있는 경우, 사용 조건에 따른 스프레이 제품의 최종 입자 크기(또는 분포), 제\n\n<!-- PAGE_26 -->\n###### 품의 추진제 유형, 개별 성분의 농도 등이 흡입 노출에 영향을 미치므로 이에 대한 조\n\n<!-- PAGE_26 -->\n###### 2) 흡입노출량은 표준노출조건에서 직접 측정하거나 수학적 모델을 사용하여 추정할 수 있으\n\n<!-- PAGE_26 -->\n###### 며, 소비자안전과학위원회(Scientific Committee on Consumer Safety, SCCS), 유럽화학물질\n\n<!-- PAGE_26 -->\n###### 청(European Chemicals Agency, ECHA) 등 여러 국제기관에서 제시하고 있는 흡입 노출평\n\n- - 21 -\n<!-- PAGE_27 -->\n###### 2-2-4. 위해도 결정\n\n<!-- PAGE_27 -->\n###### 1) 위험성 결정과 노출평가 결과 얻어진 노출량을 비교하여 노출에 따른 인체 위해영향 발생\n\n<!-- PAGE_27 -->\n###### 가능성을 추정하는 단계이다.\n\n<!-- PAGE_27 -->\n###### 2) 화장품 사용으로 인한 평가대상 물질의 노출로 인한 위해 영향을 야기할 가능성은 안전역\n\n<!-- PAGE_27 -->\n###### 3) 화장품 성분의 피부흡수가 매우 낮다는 충분한 증거가 있는 경우에는 전신 노출이 무시될 수\n\n<!-- PAGE_27 -->\n###### 있는 수준이므로, MOS 산출에 의한 위해도 결정은 가능하지 않으며 인체 위해영향 발생 가\n\n<!-- PAGE_27 -->\n###### 4) 위해도 결정을 수행할 때, 불확실성 계수를 적용하여 안전역(MOS)을 산출한다.\n\n<!-- PAGE_27 -->\n###### 5) 화장품 성분의 경우, 위험성 결정에서 확인된 평가 대상 물질의 전신 독성기준값(PODsys)을\n\n<!-- PAGE_27 -->\n###### 6) 일반적으로 안전역(MOS)은 종(실험동물에서 사람), 사람(일반 사람과 취약 집단) 간의 외삽\n\n<!-- PAGE_27 -->\n###### 과정을 통해 산출된 MOS 값이 100(동물-사람 종간 계수 10 × 사람간 계수 10) 이상이면\n\n- 4.0\n- 2.5\n- 3.2\n- 3.2\n- - 22 -\n<!-- PAGE_28 -->\n###### □ 위해도 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 비발암물질(역치물질)인 경우, 안전역(MOS)\n산출\n\n- ○ 최적의 독성기준값(PODsys)과 전신노출량\n(SED) 비교\n\n- - 23 -\n<!-- PAGE_29 -->\n###### 3. 위해평가 보고서\n\n<!-- PAGE_29 -->\n###### 전체적인 위해평가 절차를 체계적으로 명확하게 작성한다. 문서에는 아래의 내용을 참고하여\n\n<!-- PAGE_29 -->\n###### 위해평가에 대한 상세 자료가 포함되고, 제한점, 외국 평가 사례 등에 대하여 기술한다.\n\n<!-- PAGE_29 -->\n###### □ 결과보고서 작성 방법\n\n- - 24 -\n<!-- PAGE_30 -->\n##### 제4장 참고문헌\n\n<!-- PAGE_30 -->\n###### 1. SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 9th Revision\n\n<!-- PAGE_30 -->\n###### 2. SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 11th Revision\n\n<!-- PAGE_30 -->\n###### 3. Tore Sanner, et al, A Simple Method for Quantitative Risk Assessment of Non- Threshold\n\n<!-- PAGE_30 -->\n###### Carcinogens Based on the Dose Descriptor T25, Pharmacology & Toxicology 2001, 88, 331–\n\n<!-- PAGE_30 -->\n###### 4. RIVM, Cosmetics Fact Sheet, To assess the risks for the consumer  Updated version for\n\n<!-- PAGE_30 -->\n###### ConsExpo 4, 2006\n\n<!-- PAGE_30 -->\n###### 5. R.J. Safford, The Dermal Sensitisation Threshold—A TTC approach for allergic contact\n\n<!-- PAGE_30 -->\n###### dermatitis, Regulatory Toxicology and Pharmacology 2008, 51, 195–200\n\n<!-- PAGE_30 -->\n###### 5. W. Steiling, et al, Principle considerations for the risk assessment of sprayed consumer\n\n<!-- PAGE_30 -->\n###### products, Toxicology Letters 227, 41–49, 2014\n\n<!-- PAGE_30 -->\n###### 6. IDEA PROJECT, FINAL REPORT ON THE QRA2, Skin Sensitisation Quantitative Risk\n\n<!-- PAGE_30 -->\n###### Assessment for Fragrance Ingredients, September 30, 2016\n\n<!-- PAGE_30 -->\n###### 7. R. Kroes, et al, The Threshold of Toxicological Concern Concept in Risk Assessment,\n\n<!-- PAGE_30 -->\n###### Toxicological sciences 86(2), 226-230, 2005\n\n<!-- PAGE_30 -->\n###### 8. David W. Roberts, et al, A practical guidance for Cramer class determination, Regulatory\n\n<!-- PAGE_30 -->\n###### Toxicology and Pharmacology 73(3), 971-984, 2015\n\n<!-- PAGE_30 -->\n###### 9. 식품의약품안전처, 인체적용제품 위해성평가 공통지침서, 2019\n\n<!-- PAGE_30 -->\n###### 10. 식품의약품안전처, 화장품 원료 위해평가 및 국제 협력 연구, 2018\n\n<!-- PAGE_31 -->\n### 붙임 자료\n\n<!-- PAGE_31 -->\n###### 붙임 1. 화장품 위해평가 관련 용어집\n\n<!-- PAGE_31 -->\n###### 붙임 2. 화장품 위해평가 보고서 양식\n\n<!-- PAGE_31 -->\n###### 붙임 3. OECD 독성시험 종류\n\n<!-- PAGE_31 -->\n###### 붙임 4. 화장품 노출 피부 표면적\n\n<!-- PAGE_31 -->\n###### 붙임 5. 한국인의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 6. 유럽의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 7. 흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_31 -->\n###### 붙임 8. 피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시\n\n<!-- PAGE_31 -->\n###### 붙임 9. 화장품 유형별 평가 예시\n\n<!-- PAGE_31 -->\n###### 붙임 10. 화장품 성분 위해평가를 위한 정보 수집\n\n- - 26 -\n<!-- PAGE_32 -->\n###### 붙임 1. 화장품 위해평가 관련 용어집(Glossary)\n\n<!-- PAGE_32 -->\n###### · 감작 (Sensitization) : 생체 내에 이종항원을 투여하여 항체를 보유시키는 일. 일반적으로 면\n\n<!-- PAGE_32 -->\n###### 역 반응 활성화를 지칭함. 민감화\n\n<!-- PAGE_32 -->\n###### · 단회투여독성 (Acute toxicity) : 독성 물질에 대한 짧은 기간의 노출에 의해 발생하는 독성\n\n<!-- PAGE_32 -->\n###### 으로 일반적으로 24시간 이내의 노출에 의해 발생함\n\n<!-- PAGE_32 -->\n###### · 기준점, 벤치마크 (Benchmark) :\n\n<!-- PAGE_32 -->\n###### a. 효과를 위해 사전에 설정한 변형된 반응을 나타내는 용량이 통계적 하한 신뢰 한계\n\n<!-- PAGE_32 -->\n###### b. (기준 농도(benchmark concentration, BMC)라고도 함) 배경에 대비하여 부정적 효과에 대한\n\n<!-- PAGE_32 -->\n###### 반응률에 사전에 설정한 변화(기준 반응(benchma가 response, BMR)를 나타내는 용량의 통\n\n<!-- PAGE_32 -->\n###### c. 어떤 독성에 대해 사전에 정한 확률이 작은 증분(통상 1～10%)만 그 발생률을높이는 투여\n\n<!-- PAGE_32 -->\n###### 량에서의 물질에 의한 노출. 혹은 사전에 정한 척도나 생물학적 영향의 변화에 관련 있는\n\n<!-- PAGE_32 -->\n###### 투여량. (농림수산성 및 후생노동성(일본), 2005; 식품 안전성에 관한 리스크 관리 표준 절\n\n<!-- PAGE_32 -->\n###### · 기준용량, 벤치마크용량 (Benchmark dose, BMD) : 특정 물질이 생체에 미리 정해진 수준의\n\n<!-- PAGE_32 -->\n###### 반응(기준 반응, Benchmark response level, BMR)을 야기할 것으로 예측되는 용량\n\n<!-- PAGE_32 -->\n###### · 노출 (Exposure) : 일정기간동안 일정한 빈도로 집단 혹은 개인이 경구 섭취, 호흡하거나 직\n\n<!-- PAGE_32 -->\n###### 접 접촉(예, 피부나 눈을 통해) 화학물질과 접촉하는 것을 말하며 단기노출(급성)과 장기노\n\n<!-- PAGE_32 -->\n###### 출(만성)로 구분됨\n\n<!-- PAGE_32 -->\n###### · 노출시나리오 (Exposure scenario) : 특정 물질의 생산부터 실사용까지 생체에 노출되는 방\n\n<!-- PAGE_32 -->\n###### 식을 가상적으로 규정한 것\n\n<!-- PAGE_32 -->\n###### · 노출안전역 (Margin of Exposure, MOE) : 추정 노출량에 대한 NOAEL 등과 같이 독성이 관\n\n<!-- PAGE_32 -->\n###### 찰되지 않는 독성값의 비율\n\n<!-- PAGE_32 -->\n###### · 대조군 (Control) : 실험 결과의 판정을 위한 표준물질로 연구에 사용되는 물질 또는 샘플군\n\n<!-- PAGE_32 -->\n###### · 독성기준값 (Point of Departure, POD) : 시험에 사용된 용량 범위 내 자료의 수학적 모델링\n\n<!-- PAGE_32 -->\n###### 에 결정되는 값. NOAEL, LOAEL, BMDL 등을 의미함\n\n<!-- PAGE_32 -->\n###### · 만성독성 (Chronic toxicity) : 물질의 만성적인 투여에 의해 나타나는 독성\n\n<!-- PAGE_32 -->\n###### · 반수치사농도 (LC50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 공기\n\n<!-- PAGE_32 -->\n###### 중 농도\n\n<!-- PAGE_32 -->\n###### · 반수치사용량 (LD50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 용량\n\n<!-- PAGE_32 -->\n###### · 반복투여독성 (Repeated dose toxicity) : 시험물질을 시험동물에 반복 투여하여 중․장기간 내\n\n- - 27 -\n<!-- PAGE_33 -->\n###### 에 나타나는 독성을 질적, 양적으로 검사하는 시험으로 최대무독성량(NOAEL)등의 산정을\n\n<!-- PAGE_33 -->\n###### 목적으로 수행함.\n\n<!-- PAGE_33 -->\n###### · 발생 독성 (Developmental toxicity) : 개체가 발생하는 동안에 노출된 물질에 의해 발생하는\n\n<!-- PAGE_33 -->\n###### 자궁 내 사망, 기형, 성장저해 등을 포함하는 위해 반응. 가역적 또는 비가역적 반응이 가\n\n<!-- PAGE_33 -->\n###### 능함\n\n<!-- PAGE_33 -->\n###### · 발암성 (Carcinogenicity) : 어떤 물질의 투여로 인한 영향으로 체내에 악성 종양이 발생되거\n\n<!-- PAGE_33 -->\n###### · 부식성 (Corrosive) : 투여 후 조직의 파괴(necrosis)를 야기하는 성질\n\n<!-- PAGE_33 -->\n###### · 불확실성계수 (Uncertainty factor, UF) : 동물시험 자료를 활용하여 사람에 대한 효과를 예\n\n<!-- PAGE_33 -->\n###### 측할 때 발생할 수 있는 여러 불확(실)도의 발생원(예, 종간 차이, 개인 간 차이, 상승 작용,\n\n<!-- PAGE_33 -->\n###### 서로 다른 노출 경로(경구, 경피, 흡입 등))을 감안하여 조정에 활용되는 계수. 불확실성 계\n\n<!-- PAGE_33 -->\n###### 수의 값은 독성의 특성, 보호대상 집단의 규모와 유형, 유용한 독성학적 정보의 질적 수준\n\n<!-- PAGE_33 -->\n###### 에 따라 달라짐\n\n<!-- PAGE_33 -->\n###### · 생식독성 (Reproductive toxicity) : 자손 생성을 위한 기관의 능력을 감소시키는 몸 또는 조\n\n<!-- PAGE_33 -->\n###### 직에 미치는 해로운 영향\n\n<!-- PAGE_33 -->\n###### · 생식․발생독성시험 (Reproductive and developmental toxicity studies) : 시험물질이 포유류의\n\n<!-- PAGE_33 -->\n###### 생식·발생에 미치는 영향을 규명하는 시험을 말하며, 수태능 및 초기배 발생시험, 출생\n\n<!-- PAGE_33 -->\n###### 전·후 모체기능시험 및 배·태자발생시험 등이 있음\n\n<!-- PAGE_33 -->\n###### a. 1세대 생식발생독성시험(One Generation Study) : 생식·발생독성시험에서 모세대에만 물질\n\n<!-- PAGE_33 -->\n###### b. 2세대 생식발생독성시험(Two Generation Study) : 생식·발생독성시험에서 모체와 차세대(2\n\n<!-- PAGE_33 -->\n###### 세대)에 물질을 직접 투여하고, 모체·차세대 및 그 다음 세대에 미치는 영향(발정․교미․수\n\n<!-- PAGE_33 -->\n###### c. 3세대 생식발생독성시험(Three Generation Study) : 생식․발생독성시험에서 모세대와 차세대\n\n<!-- PAGE_33 -->\n###### 및 그 차세대 (3세대)에 물질을 직접 투여하고, 물질 투여세대 및 그 후세대에 미치는 영향\n\n<!-- PAGE_33 -->\n###### 을 평가하는 시험\n\n<!-- PAGE_33 -->\n###### · 생체 내 시험 (In vivo) : 생체내에서의 시험. 일반적으로 동물 및 인체 실험을 의미함\n\n<!-- PAGE_33 -->\n###### · 생체이용률 (Bioavailability) : 화학물질의 효과를 직접 또는 간접적으로 나타내는 주성분 또\n\n<!-- PAGE_33 -->\n###### 는 활성대사체의 노출 후 체내 전신 순환혈까지 도달하는 흡수속도와 양의 비율\n\n<!-- PAGE_33 -->\n###### · 시험관 시험 (In vitro) : 생체 바깥의 인공적인 환경에서의 시험\n\n<!-- PAGE_33 -->\n###### · 신뢰구간 (Confidence interval) : 특정 확률로 참 값을 함유하고 있을 것으로 통계적으로 예\n\n<!-- PAGE_33 -->\n###### 측되는 변수의 구간\n\n- - 28 -\n<!-- PAGE_34 -->\n###### · 안전역 (Margin of safety, MOS) : 화장품에 존재하는 위해요소의 최대무독성용량을 일일인\n\n<!-- PAGE_34 -->\n###### 체노출량으로 나눈 값\n\n<!-- PAGE_34 -->\n###### · 역치용량 (Threshold dose) : 효과가 나타나기 직전까지의 용량 또는 노출농도\n\n<!-- PAGE_34 -->\n###### · 용량 디스크립터 (Dose descriptor) : 생체 또는 환경 독성 시험에서 얻어지는 수치로 특정\n\n<!-- PAGE_34 -->\n###### 부작용을 일으키는 값 (예를 들면 반수 치사량) 또는 독성을 유발하지 않는 최대 농도(예:\n\n<!-- PAGE_34 -->\n###### NOAEL) 등의 수치를 일컬음\n\n<!-- PAGE_34 -->\n###### · 용량 반응 상관성 (Dose-response relationship) : 물질의 다양한 투여 양에 의한 반응의 차\n\n<!-- PAGE_34 -->\n###### · 위해 평가 (Risk assessment) : 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할\n\n<!-- PAGE_34 -->\n###### 수 있는 유해영향과 발생확률을 과학적으로 예측하는 일련의 과정으로 위험성 확인, 위험\n\n<!-- PAGE_34 -->\n###### 성 결정, 노출평가, 위해도 결정 등 일련의 단계\n\n<!-- PAGE_34 -->\n###### · 위험 (Hazard) : 물질의 내재적 독성\n\n<!-- PAGE_34 -->\n###### · 유전독성 (Genotoxicity) : 유전정보를 담고 있는 유전자(DNA)나 염색체에 변화를 주어 세포\n\n<!-- PAGE_34 -->\n###### 또는 개체에 악영향을 초래하는 성질로 변이원성이라고도 함. 주된 변화로는 유전자 돌연변\n\n<!-- PAGE_34 -->\n###### 이, DNA 손상이나 염색체 이상(중복, 결실)등이 있다. 이와 같은 이상을 일으키는 물질은\n\n<!-- PAGE_34 -->\n###### 종양 발생에 결부될 가능성이 있으며 생식세포에서 발생하면 다음 세대의 최기형성․유전병\n\n<!-- PAGE_34 -->\n###### 유발로 이어질 가능성이 있음\n\n<!-- PAGE_34 -->\n###### · 전신 노출량 (Systemic exposure dosage, SED) : 화장품 원료의 전신노출량 (Systemic\n\n<!-- PAGE_34 -->\n###### Exposure Dosage)은 하루에 체중 당 혈류로 들어가서 전신적으로 작용할 것이 예상되는 외\n\n<!-- PAGE_34 -->\n###### 적용량으로서 mg/kg bw/day로 표현함. 화장품 위해 평가 시 피부노출량 또는 피부전신노출\n\n<!-- PAGE_34 -->\n###### 량이라 통칭함\n\n<!-- PAGE_34 -->\n###### · 정량한계 (Limit of Quantitation, LOQ) : 어떤 시료에 규정된 분석방법에서 바람직한 확실성\n\n<!-- PAGE_34 -->\n###### 을 가지고 정량할 수 있는 화학물질의 최저농도를 말하며, 수치상 유효적인 의미함. 정량하\n\n<!-- PAGE_34 -->\n###### 한치 미만이란 정량할 수 있는 정도의 양은 아니라는 의미로 0(제로)과는 의미가 다름\n\n<!-- PAGE_34 -->\n###### · 종말점 (Endpoint) : 측정 및 관찰 가능한 물질의 성질을 의미하며 독성학적으로는 일반적으\n\n<!-- PAGE_34 -->\n###### 로 자극감, 발암성, 기관별 독성 등 특정 장기 및 기관에 대한 개별 생물학적 효능을 의미\n\n<!-- PAGE_34 -->\n###### 함\n\n<!-- PAGE_34 -->\n###### · 최대무감작성유도용량 (No expected sensitization induced level, NESIL) : 사람 또는 동물에\n\n<!-- PAGE_34 -->\n###### 게 감작이 나타나지 않는 최대용량\n\n<!-- PAGE_34 -->\n###### · 최대무독성용량 (No observed adverse effect level, NOAEL) : 인간과 동물에게 부작용 및\n\n<!-- PAGE_34 -->\n###### 독성학적 영향이 관측되지 않는 최대 용량. mg/kg body weight/day로 나타냄\n\n<!-- PAGE_34 -->\n###### · 최소독성용량 (Lowest observed adverse effect level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_34 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도\n\n- - 29 -\n<!-- PAGE_35 -->\n###### · 표적기관 (Target organ) : 물질이 나타내는 독성효과를 보이는 기관\n\n<!-- PAGE_35 -->\n###### · 피부 노출 (Dermal exposure) : 화학물질을 함유하는 매체와 피부의 접촉을 통한 노출로서,\n\n<!-- PAGE_35 -->\n###### 피부에 있어 흡착이나 흡수될 수 있는 양으로 정량\n\n<!-- PAGE_35 -->\n###### · 피부감작성시험 (Skin sensitization Test) : 실험물질(외용으로 사용되는 의약품, 화장품 및\n\n<!-- PAGE_35 -->\n###### 기타 물질)이 피부에 반복적으로 노출되었을 경우 나타날 수 있는 홍반 및 부종 등의 면역\n\n<!-- PAGE_35 -->\n###### 학적 피부과민반응을 평가하는 시험법으로 국소 림프절 검사(Local Lymph Node\n\n<!-- PAGE_35 -->\n###### Assay(LLNA)), Magnusson Kligman 기니피그 최대화 시험(Magunusson Kligman Guinea Pig\n\n<!-- PAGE_35 -->\n###### Maximisation Test, GPMT) 및 Buehler 시험이 있다. 국소 림프절 검사는 동종 번식된 생쥐\n\n<!-- PAGE_35 -->\n###### 를 사용하는 방법으로 대상 성분의 사용부위에서의 국소림프절의 림프구 증식에 기반하고\n\n<!-- PAGE_35 -->\n###### 있다. 이는 자극성지수(stimulation index, SI)로 결과를 얻을 수 있는 객관적인 방법이며, 실\n\n<!-- PAGE_35 -->\n###### 험 물질에 의하여 야기된 자극과 기제를 적용한 대조 동물의 자극과의 비율로 나타낸다.\n\n<!-- PAGE_35 -->\n###### Magnusson Kligman 기니피그 최대화 시험은 면역증강제 형태 시험이며 Freunds complete\n\n<!-- PAGE_35 -->\n###### 면역증강제를 사용하거나 사용하지 않는 조건에서 대상 성분의 피내주사에 의한 알레르기\n\n<!-- PAGE_35 -->\n###### 반응의 증가 여부로 판단한다. GPMT는 LLNA와 감도가 동등하다고 여겨진다. Buehler 시험\n\n<!-- PAGE_35 -->\n###### 은 국소에만 사용함으로써 면역증강제를 사용하지 않는 방법으로 GPMT와 비교할 때 감도\n\n<!-- PAGE_35 -->\n###### 가 낮다. Buehler 실험방법을 사용할 경우에는 과학적으로 정당한 근거를 제시해야 한다.\n\n<!-- PAGE_35 -->\n###### · 화학물질 요약 서비스 등록번호(Chemical abstracts service index number, CAS Number) :\n\n<!-- PAGE_35 -->\n###### CAS의 화학물질 분류 넘버\n\n- - 30 -\n<!-- PAGE_36 -->\n###### 붙임 2. 화장품 위해평가 보고서 양식\n\n<!-- PAGE_36 -->\n###### * 이 보고서 양식은 참고용이며, 제품에 맞게 재구성할 수 있음\n\n<!-- PAGE_36 -->\n###### <요약>\n\n<!-- PAGE_36 -->\n###### : 위해평가 내용을 요약함\n\n<!-- PAGE_36 -->\n###### <목차>\n\n<!-- PAGE_36 -->\n###### 1. 위해평가 배경 및 목적\n\n<!-- PAGE_36 -->\n###### 2. 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 1) 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 2) 평가대상 성분의 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 3. 위해평가 결과\n\n<!-- PAGE_36 -->\n###### 3.1 위험성 확인\n\n<!-- PAGE_36 -->\n###### 3.1.1 물리·화학적 성질\n\n<!-- PAGE_36 -->\n###### [물질명, IUPAC명, CAS No., 화학식, 분자량, 순도(분석방법), 구조식(추출물의 경\n\n<!-- PAGE_36 -->\n###### 우, 추출방법과 정제법), 물리적 성상, 녹는점, 끓는점, 밀도, 용해도, Log Pow,\n\n<!-- PAGE_36 -->\n###### 헨리상수, 동의어]\n\n<!-- PAGE_36 -->\n###### 3.1.2 사용현황\n\n<!-- PAGE_36 -->\n###### ※ 표. 각국의 화장품 중 평가대상 성분의 관리 기준\n\n<!-- PAGE_36 -->\n###### 3.1.3 노출경로\n\n- - 31 -\n<!-- PAGE_37 -->\n###### 3.1.4 독성학적 자료\n\n<!-- PAGE_37 -->\n###### ※ 표. 독성학적 자료 확보 유무\n\n<!-- PAGE_37 -->\n###### 단회투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 반복투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 피부\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 생식발생\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 유전\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 발암성\n\n<!-- PAGE_37 -->\n###### 광독성\n\n<!-- PAGE_37 -->\n###### 기타\n\n<!-- PAGE_37 -->\n###### (ü: 독성 자료 있음, -: 독성 자료 없음)\n\n<!-- PAGE_37 -->\n###### 3.1.4.2 단회투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.3 반복투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.4 피부자극성\n\n<!-- PAGE_37 -->\n###### 3.1.4.5 안점막자극\n\n<!-- PAGE_37 -->\n###### 3.1.4.6 피부감작성\n\n<!-- PAGE_37 -->\n###### 3.1.4.7 생식·발생독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.8 유전독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.9 발암성\n\n<!-- PAGE_37 -->\n###### 3.1.4.10 광독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.11 기타(면역독성, 신경독성, 임상자료 포함)\n\n<!-- PAGE_37 -->\n###### 3.2 위험성 결정\n\n<!-- PAGE_37 -->\n###### 3.2.1 최적의 전신 독성기준값(PODsys) 선정\n\n<!-- PAGE_37 -->\n###### 3.3 노출평가\n\n<!-- PAGE_37 -->\n###### 3.3.1 노출시나리오\n\n<!-- PAGE_37 -->\n###### 3.3.2 노출량 산출\n\n<!-- PAGE_37 -->\n###### 3.4 위해도 결정\n\n<!-- PAGE_37 -->\n###### 4. 결론\n\n- - 32 -\n<!-- PAGE_38 -->\n###### 5. 제한점\n\n<!-- PAGE_38 -->\n###### 6. 외국의 평가 사례\n\n<!-- PAGE_38 -->\n###### 7. 참고문헌\n\n- - 33 -\n<!-- PAGE_39 -->\n###### 구분\n\n<!-- PAGE_39 -->\n###### ○ 시험물질의 LD50 값을 결정하기 위한 목적으로 개발되었으며 단회투여 경구\n\n<!-- PAGE_39 -->\n###### 독성, 단회투여 흡입독성, 단회투여 피부독성으로 구분된다. 단회투여 경구독성\n\n<!-- PAGE_39 -->\n###### 은 고정용량법(fixed dose method), 단회투여독성 분류법(acute toxic class\n\n<!-- PAGE_39 -->\n###### method), 용량고저법(up-and-down procedure)으로 구분된다.\n\n<!-- PAGE_39 -->\n###### - (OECD TG420) 고정용량법 : 치사율을 종말정으로 사용하지 않고 동물의\n\n<!-- PAGE_39 -->\n###### 반복투여독성\n\n<!-- PAGE_39 -->\n###### ○ 특정 기간(28일, 90일) 동안 물질을 매일 반복 투여하거나 물질에 노출됨에\n\n<!-- PAGE_39 -->\n###### 피부부식성\n\n<!-- PAGE_39 -->\n###### - (OECD TG431) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 피부자극성\n\n<!-- PAGE_39 -->\n###### - (OECD TG439) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 안점막자극성\n\n<!-- PAGE_39 -->\n###### eye(ICE) Test method)\n\n<!-- PAGE_39 -->\n###### - (OECD TG491) 단기노출(Short Time Exposure, STE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG460) 플로오레세인 누출(Fluorescein leakage, FL) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492) 인체각막유사상피(Reconstructed Human Cornea-like\n\n<!-- PAGE_39 -->\n###### Epithelium, RhCE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492B) 인체각막유사 상피모델을 이용한 안 유해성(심한 안손상 및\n\n<!-- PAGE_39 -->\n###### 안자극)시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG494) 인체각막세포주(Vitrigel®)를 이용한 안자극시험법\n\n- - (OECD TG496) In vitro 고분자시험법: Ocular Irritation®\n<!-- PAGE_39 -->\n###### 피부감작성\n\n<!-- PAGE_39 -->\n###### - (OECD TG429) 국소림프절시험(Local Lymph Node Assay, LLNA)\n\n<!-- PAGE_39 -->\n###### 붙임 3. OECD 독성시험 종류\n\n- - 34 -\n* 참고 : OECD Test Guidelines, Section 4 – Health effects (2023년 11월 기준)\n\n<!-- PAGE_40 -->\n###### 구분\n\n<!-- PAGE_40 -->\n###### - (OECD TG422A) LLNA Daicel-ATP 시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG422B) LLNA 세포증식효소매개 면역흡수 분석시험(ELISA) BrdU\n\n<!-- PAGE_40 -->\n###### - (OECD TG442C) in Chemico 펩타이드 반응성 시험법(DPRA), in Chemico\n\n<!-- PAGE_40 -->\n###### 아미노산 유도체 결합성 시험법(ADRA), in Chemico 피부감작성 시험법\n\n<!-- PAGE_40 -->\n###### (kDPRA)\n\n<!-- PAGE_40 -->\n###### - (OECD TG442D) ARE-Nrf2 루시퍼라아제 시험법(KeratinoSensTM), ARE-Nrf2\n\n<!-- PAGE_40 -->\n###### - (OECD TG442E) 인체세포주 활성화 시험법(h-CLAT), IL-8 루시퍼라아제\n\n<!-- PAGE_40 -->\n###### 피부흡수\n\n<!-- PAGE_40 -->\n###### - (OECD TG28) 생체외 피부흡수시험법\n\n<!-- PAGE_40 -->\n###### 생식·발생독성\n\n<!-- PAGE_40 -->\n###### 유전독성\n\n<!-- PAGE_40 -->\n###### 발암성\n\n<!-- PAGE_40 -->\n###### - (OECD TG452) 만성 독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG453) 만성 발암성\n\n<!-- PAGE_40 -->\n###### 광독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG432) 3T3 뉴트럴 레드 흡수 광독성 시험(3T3 Neutral Red\n\n<!-- PAGE_40 -->\n###### Uptake Phototoxicty Test, 3T3 NRU PT)\n\n<!-- PAGE_40 -->\n###### - (OECD TG495) 활성산소종(ROS) 분석을 이용한 광독성시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG498) 인체피부모델을 이용한 광독성시험법\n\n- - 35 -\n<!-- PAGE_41 -->\n###### 붙임 4. 화장품 노출 피부 표면적\n\n표 1. 각 제품 유형별 평균 노출 피부 표면적(Bremmer et al. 2006a; Bremmer et al., 2006b)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\n샴푸\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 컨디셔너\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 스프레이\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n헤어 스타일링 젤\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n헤어 스타일링 무스\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n반영구형 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n산화성/영구적 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 탈색제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 고정용 로션\n\n1/2 머리 면적\n\n580\n\n590\n\n손세정용 액상 비누\n\n양손 면적\n\n860\n\n840\n\n손세정용 고상 비누\n\n양손 면적\n\n860\n\n840\n\n샤워용 액상 비누\n\n총 신체면적\n\n17500\n\n19400\n\n샤워용 고형 비누\n\n총 신체면적\n\n17500\n\n19400\n\n목욕용 거품제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 염제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n얼굴용 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n(+ 목)\n\n320\n\n(+ 뒷목)\n\n80\n\n바디 로숀\n\n신체 면적-머리 면적(여성)\n\n15670\n\n핸드 크림\n\n양손 면적\n\n860\n\n필링/스크럽 젤\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n얼굴 팩\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n바디 팩\n\n신체 면적-머리 면적(여성)\n\n15670\n\n피부 미백 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 및 손톱 관리(Make-up and nail care)\n\n리퀴드 파운데이션\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 리무버\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n아이 섀도\n\n24\n\n마스카라\n\n- 1.6\n아이라이너\n\n- 3.2\n아이 메이크업 리무버\n\n50\n\n- - 36 -\n1 위해평가를 위한 피부체표면적 조사집(식품의약품안전청, 2010)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\nRIVM\n\nEPA\n\n손톱 광택제\n\n4\n\n손톱 광택제 제거제\n\n11\n\n립스틱, 입술크림\n\n- 4.8\n데오도란트 스틱형/롤러형\n\n양쪽 겨드랑이\n\n200\n\n데오도란트 스프레이\n\n양쪽 겨드랑이\n\n200\n\n제한용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n항균용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n오드트왈렛 스프레이\n\n200\n\n향수 스프레이\n\n100\n\n면도용 크림\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n에프터쉐이브\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n자외선 차단 로숀\n\n총 신체면적\n\n17500\n\n19400\n\n자외선 차단 크림\n\n총 신체면적\n\n17500\n\n19400\n\n베이비 크림\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 오일\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 파우더\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n제모용 크림\n\n다리 면적(여성)\n\n5530\n\n5460\n\n마사지용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n소아용 얼굴 물감\n\n1/2 소아 머리 면적(4.5세)\n\n475\n\n496\n\n성인용 얼굴 물감\n\n1/2 머리 면적\n\n580\n\n650\n\n- - 37 -\n<!-- PAGE_43 -->\n###### 붙임 5. 한국인의 화장품 사용량\n\n<!-- PAGE_43 -->\n###### 1.‘2014년~2016년 화장품 위해평가 선진화 연구’결과에 근거한 화장품 유형별 추정 일일 사\n\n<!-- PAGE_43 -->\n###### 용량 및 노출량은 다음과 같다.\n\n<!-- PAGE_43 -->\n###### 표 1. 한국인의 화장품 유형별 추정 일일 사용량 및 노출량\n\n아이라이너\n\n- 0.01\n- 0.23\n- 1.0\n- 0.01\n- 0.23\n립스틱, 입술보호제\n\n- 0.05\n- 0.87\n- 1.0\n- 0.05\n- 0.87\n데오도란트(남녀)\n\n비분무형 데오도란트\n\n- 2.33\n- 36.12\n- 1.0\n- 2.33\n- 36.12\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 제품(샤워 젤, 샴푸 등)을 사용함으로써 발생하는 세척 및 희\n\n석 효과를 보정하기 위해 SCCNFP 에 의해 사용된 지수임[SCCNFP/0321/00]\n\n- - 38 -\n<!-- PAGE_44 -->\n###### 2. 자외선차단제의 경우, 한국인의 평균 체표면적* 16,191 cm2에 0.5 mg/cm2의 양을 적용하여 하\n\n<!-- PAGE_44 -->\n###### 루 2회 사용할 경우를 가정할 때 일일 사용량인 17.0 g/일을 적용할 수 있다.\n\n* 위해평가를 위한 피부체표면적 조사집(식품의약품안전처, 2010)\n\n<!-- PAGE_44 -->\n###### 3. 보존제 등 평가대상 물질이 여러 제형의 화장품에 포함되는 경우, 소비자가 동시에 여러 제\n\n<!-- PAGE_44 -->\n###### 형의 화장품을 사용하는 경우를 가정하여 통합 사용량을 고려할 수 있다. SCCS는 보존제의\n\n<!-- PAGE_44 -->\n###### 경우에 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 통합적인 사용량 및 잔류지수\n\n<!-- PAGE_44 -->\n###### 를 계산하여 이용할 것을 권고한다(SCCNFP/0321/00). 최신의 노출 자료와 최악의 경우까지\n\n<!-- PAGE_44 -->\n###### 고려한 예측상황(worst-case scenario)에서 안전역(MOS) 산출 시, 16.9 g/일 또는 275 mg/kg\n\n<!-- PAGE_44 -->\n###### - 기타성분, 색소 등 특정 성분이 여러 유형의 화장품에 함유되어 인체에 노출되는 경우, 노출\n\n<!-- PAGE_44 -->\n###### 유형에 따라 표 2의 통합 노출량 자료를 사용한다.\n\n표 2. 한국인의 화장품 사용으로 인한 통합 노출량*\n\n사용 후 씻어내는 피부\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n메이크업 제품\n\n메이크업 리무버\n\n- 0.21\n- 3.70\n아이 섀도\n\n- 0.02\n- 0.29\n마스카라\n\n- 0.03\n- 0.50\n립스틱\n\n- 0.05\n- 0.87\n아이라이너\n\n- 0.01\n- 0.23\nTOTAL\n\n± 16.9\n\n275\n\n* 2014∼2016 화장품 위해평가 선진화 연구\n\n- - 39 -\n<!-- PAGE_45 -->\n###### 붙임 6. 유럽의 화장품 사용량\n\n<!-- PAGE_45 -->\n###### 1. 유럽 SCCS 가이드라인에서 제시한 유럽의 화장품 유형별 추정 일일 노출량 및 보존제 통합\n\n<!-- PAGE_45 -->\n###### 일일 사용량 및 노출량은 다음과 같다(Hall et al, 2007, 2011).\n\n<!-- PAGE_45 -->\n###### 표 1. 유럽의 화장품 유형별 일일 사용량 및 노출량\n\n립스틱, 입술보호제\n\n- 0.057\n- 0.90\n- 1.00\n- 0.057\n- 0.90\n데오도란트\n\n비분무형 데오도란트\n\n- 1.50\n- 22.08\n- 1.00\n- 1.50\n- 22.08\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 기반제품)4\n\n- 1.43\n- 20.635\n- 1.00\n- 1.43\n- 20.63\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 비기반제품)\n\n- 0.69\n- 10.00\n- 1.00\n- 0.69\n- 10.00\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 사용하는 제품(샤워젤, 샴푸 등)의 세척 및 희석\n\n효과를 고려하기 위해 SCCNFP에 의해 사용된 지수임(SCCNFP/0321/00)\n\n- - 40 -\n2 기존 연구(Hall et al, 2007; 2011)에 포함되지 않는 제품 유형\n\n3 사용빈도가 낮아 일일 노출량을 계산하지 않음\n\n4‘에탄올 기반’은 에탄올을 주된 성분으로 함유한 제품을 의미함(Steiling et al., 2014)\n\n5 체중 60kg(기본값)이 아닌 연구에 참여한 사람의 체중이 사용되었음\n\n<!-- PAGE_46 -->\n###### 표 2. 유럽의 보존제 평가를 위한 화장품 사용 통합 노출량\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n- - 41 -\n<!-- PAGE_47 -->\n###### 붙임 7. 흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_47 -->\n###### 1. 흡입노출에 의한 전신노출량(SED)은 일반적으로 스프레이 유형에 따른 에어로졸의 크기\n\n<!-- PAGE_47 -->\n###### 분포와 침전 직전 물방울의 크기 분포를 고려하여 화장품의 1일 사용량, 휘발된 물질에\n\n<!-- PAGE_47 -->\n###### 2. 수학적 모델을 사용하여 흡입노출량을 추정할 때에는 단계별 접근방식에 따라 1-box 또는\n\n<!-- PAGE_47 -->\n###### 2-box 모델을 사용하거나 상위단계(higher tier) 모델(ConsExpo 모델) 등의 단계별 평가방\n\n<!-- PAGE_47 -->\n###### 3. 흡입노출은 화장품 사용에 있어서 의도된 노출경로가 아니므로 다음 내용을 검토하여 평\n\n스프레이 사용\n\n빈도\n\n지속시간\n\n분사량/1회 사용, 분사량/시간\n\n분사방향\n\n노출형태\n\n적용 유형(소비자, 산업/전문)\n\n분무 시 Particle/droplet 크기 분포\n\n사용공간에서의 노출시간\n\n노출공간 부피 및 온도\n\n환기율\n\n노출된 개인의 활동 수준(예: 이동, 휴식)\n\n(Steiling et al., 2014)\n\n- - 42 -\n<!-- PAGE_48 -->\n###### 4. 흡입노출에 의한 전신노출량(SEDinh)은 다음과 같은 세가지 방법으로 산출할 수 있다.\n\n<!-- PAGE_48 -->\n###### 1) 1-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_48 -->\n###### : 전체 분무량이 즉시 공기 중으로 방출되고 특정 크기의 상자에 분포한다고 가정하여 시뮬\n\n<!-- PAGE_48 -->\n###### 레이션을 통한 호흡구역의 공기 농도에 호흡률과 공간에 머무르는 시간을 곱하여 노출량을\n\n- - 43 -\n<!-- PAGE_49 -->\n###### 2) 2-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_49 -->\n###### : 시간의 경과에 따른 물질의 희석을 고려하여 전체 분무량이 즉시 공기 중으로 방출되면\n\n<!-- PAGE_49 -->\n###### 머리 주변(box 1)에 우선적으로 분포한 후, 일정시간 이후에 특정 크기의 상자(box 2)로\n\n<!-- PAGE_49 -->\n###### 확산된다고 가정하여 호흡구역에 존재하는 대상 물질의 양, 흡입/잔류 물질 분율, 사용\n\n<!-- PAGE_49 -->\n###### 횟수를 곱하여 노출량을 산출할 수 있다. 보수적인 접근하기 위해서는 공기 교환(공기 유\n\nV2 (L)\n\nBox 2의 공간부피(분사제/펌프 스프레이: 9300 적용, 예: 욕실)5\n\nt1 (min)\n\nBox 1의 노출시간(분사제/펌프 스프레이: 2 적용)6\n\nt2 (min)\n\nBox 2의 노출시간(분사제/펌프 스프레이: 10 적용)6\n\n1 SCCS NoG 11th에서 제시하는 default 값(Rothe et al., 2011)\n\n2 SCCS NoG 11th에서 제시하는 default 값\n\n3 SCCS NoG 11th에서 제시하는 default 값(Bremmer et al, 2006)\n\n4 한국인의 노출계수 핸드북, 2019\n\n5 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007)\n\n6 SCCS NoG 11th에서 제시하는 default 값(SCCS, 옥토크릴렌(Octocrylene))\n\n- - 44 -\n<!-- PAGE_50 -->\n###### 3) ConsExpo 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_50 -->\n###### - 보다 용이한 흡입 노출평가로 ConsExpo 모델*을 사용할 수 있다. ConsExpo 모델은 소비자\n\n<!-- PAGE_50 -->\n###### 용 제품 사용으로 인한 인체노출량 산정을 위해 네덜란드 보건당국(RIVM)에서 개발한 위\n\n<!-- PAGE_50 -->\n###### 해평가 시뮬레이션 모델로, 각 제품군에 대한 노출 특성에 맞게 노출경로가 설정되어 있어\n\n<!-- PAGE_50 -->\n###### 상세한 노출량을 예측할 수 있는 소비자 노출평가 모델이다. 또한, 이 모델은 제품군(세부\n\n<!-- PAGE_50 -->\n###### 분류)을 선택하여 내장된 기본값 데이터베이스를 이용하거나 평가하고자 하는 제품의 기\n\n<!-- PAGE_50 -->\n###### 본 정보를 알 경우에는 직접 입력할 수 있다. ConsExpo 모델에 내장된 제품군을 선택하면\n\n* ConsExpo 모델 : https://www.consexpoweb.nl/)\n\n<!-- PAGE_50 -->\n###### 표 1. ConsExpo 모델 내 시나리오가 내장된 화장품 제품군\n\n유아용\n\n베이비 연고, 오일, 파우더\n\n기타\n\n제모제, 에센셜 오일, 페이스 페인팅\n\n- - 45 -\n<!-- PAGE_51 -->\n###### - ConsExpo 모델을 이용한 흡입노출량을 산출방법은 다음과 같다. ConsExpo 프로그램의 자\n\n<!-- PAGE_51 -->\n###### 세한 사용방법은 ConsExpo Web, Consumer exposure model documentation, 2017을 참고할\n\n<!-- PAGE_51 -->\n###### 수 있다.\n\n<!-- PAGE_51 -->\n###### ①‘Assessments’ 평가화면은 평가 개요를 제공하여, 기존 평가 내용을 가져오거나 새로운\n\n<!-- PAGE_51 -->\n###### ② ConsExpo에 내장된 노출시나리오를 이용할 경우‘fact sheet’를 이용하여 제품범주,\n\n- - 46 -\n<!-- PAGE_52 -->\n###### ③ 다음은 Fact sheet를 이용할 경우, 이용 가능한 화장품 제품군 선택 화면이다.\n\n<!-- PAGE_52 -->\n###### ④‘Assessment settings’에서 평가하고자 하는 성분, 제품 및 대상 인구를 선택하거나 편\n\n- - 47 -\n<!-- PAGE_53 -->\n###### ⑤ 선택한 제품에 대한 시나리오는 제품에 맞게 ‘New’를 통해 직접 입력할 수 있고, 내\n\n<!-- PAGE_53 -->\n###### 장된 시나리오 사용을 위해 ‘Use Fact sheet’를 이용할 수 있다.\n\n<!-- PAGE_53 -->\n###### ⑥ 시나리오를 선택하거나, 새 시나리오를 생성하면‘Overview scenario Application’에서\n\n<!-- PAGE_53 -->\n###### 선택된 노출 시나리오의 요약을 확인할 수 있다. 시뮬레이션을 위해 어떤 노출 경로가\n\n- - 48 -\n<!-- PAGE_54 -->\n###### 5. ConsExpo 모델에서 적용되는 시나리오를 기반으로 노출평가에 필요한 정보는 다음 표 1과\n\n<!-- PAGE_54 -->\n###### 같다. 해당 정보가 없는 경우, 모델에 내장된 기본값을 이용할 수 있다.\n\n<!-- PAGE_54 -->\n###### - 화장품 제품에 따라 적용되는 시나리오 및 변수에 대한 설명은 Cosmetics Fact Sheet에서\n\n<!-- PAGE_54 -->\n###### 확인할 수 있음\n\n<!-- PAGE_54 -->\n###### 표 2. 화장품 노출평가를 위한 ConsExpo 모델 구동에 적용되는 정보\n\n밀도(g/cm3)\n\n비휘발성 물질의 밀도\n\n입자분포(㎛)\n\n분사된 직후의 입자의 질 량 분포\n\n흡입 cut-off 직경(㎛)\n\n해당 물질이 폐포까지 도달할 수 있는 입자\n\n직경\n\n경피\n\n피부 접촉 면적(cm2)\n\n해당 제품이 피부에 노출되는 면적\n\n경구\n\n섭취량(g)\n\n제품의 총 섭취량\n\n(Cosmetics Fact Sheet, ConsExpo4,)\n\n- - 49 -\n<!-- PAGE_55 -->\n###### 붙임 8. 피부감작성 평가(Quantitative risk assessment, QRA) 및 예시\n\n<!-- PAGE_55 -->\n###### 1. 향료물질 피부감작성 평가의 경우, 허용 노출량(acceptable exposure level, AEL)과 소비자\n\n<!-- PAGE_55 -->\n###### 노출량(consumer exposure level, CEL)을 비교하여 정량적 위해평가(quantitative risk\n\n<!-- PAGE_55 -->\n###### assessment, QRA)로 수행할 수 있으며, AEL이 CEL보다 크거나 같은 경우에 허용 가능한 위\n\n<!-- PAGE_55 -->\n###### 해로 판단할 수 있다. 피부 감작성 평가 예시는 아래와 같다.\n\n<!-- PAGE_55 -->\n###### 2. 데오도란트에 함유된 물질 C에 대한 감작성 평가\n\n<!-- PAGE_55 -->\n###### - 기니피그에서 감작성 확인됨\n\nVNR: vehicle not reported\n\n<!-- PAGE_55 -->\n###### ② 위험성 결정\n\n<!-- PAGE_55 -->\n###### - 최대무감작성유도용량(No expected sensitization induced level, NESIL) 결정\n\n**[표 시작]**\n\n| 비밀보장, 불이익보호조치, 신변보호조치 등을 통하여 보호하는 제도 | - 52.2, 104.3 및 313 μg/mL 함유 |\n| --- | --- |\n**7.5% 함유**\n| 1414 | 1400 | NA | 3876 | 1400 |\n| in vivo | 경피 | 랫드 | 1, 2, 4, 8, 12 | 액상제형 | - 로션 : 1.2±0.7% | - 29.8, 38, 54.7% |\n| 보호조치 요구 방법 | (에멀젼, 로션 제형) |\n| in vitro | 피부 | 사람 | SCCP/1171/08 | (Munro et al, | Cosmos-TTC | Cosmos/Munro/ | RIFM/Munro/Cosmos/ |\n| 50 mg/kg × 3.25 g/day × kg/1000g = 0.16 mg/day | - 100 μg/mL 함유 샴푸, 바디로션, | - 29.5, 8.98, 19.6% |\n| [ 전화 : 043-719-4866, 팩스 043-719-4850 ] | (SEURAT-1; EC, | Federated DB | Federated DB |\n| 우편(30102) 세종특별자치시 도움5로 정부세종청사 7동 | NOAEL | = | 450 |\n| in vitro | 경피 | 사람 | 6 | 7.5% 함유 | 1996) | MOS | = | 2009) | (Yang et al,, 2017) | = 814 | (Patel et al., 2020) |\n| SED | NOAEL | = | 10 | 페이셜 크림 제형 | 1.1×10-7 mg/kg bw/day |\n| 국민권익위원회 공익보호지원과 / 전화 044-200-7773 / 팩스 044-200-7949 | - 1.6~9.3% |\n| LCR = | MOS | = | = | SED | 0.5525 | (에멀젼, 바세린 제형) | = 4762 | = 3.8 × 10-8 |\n| HT25/0.25 | 0.71 mg/kg bw/day / 0.25 | SED | 0.0021 |\n| 【공직자 부조리 및 공익신고안내】     ** 신고자 및 신고내용은 보호됩니다. | 7.5% 함유 |\n| in vitro | 표피 | 사람 | 8 | - 7~16% |\n**(로션 제형)**\n**7.5% 함유**\n| in vitro | 경피 | 사람 | 18 | (에멀젼 제형) | - 10% |\n**BMDL10 (또는 T25)**\n**1400 ㎍/cm2**\n| WoE NESIL | 노출안전역(MOE) | = |\n| AEL  = | 1) 피부흡수율 = 평균 + (2 × 표준편차) | = |\n\n**[표 끝]**\n\n<!-- PAGE_55 -->\n###### - 허용 노출량(acceptable exposure level, AEL) 산출\n\n<!-- PAGE_55 -->\n###### - AEL을 도출하기 위해 개인간 민감도, 제품 구성 성분의 영향, 사용 기간, 신체 부위별 피부\n\n<!-- PAGE_55 -->\n###### 상태를 고려한 감작평가계수(Sensitisation Assessment Factors, SAF) 선택\n\n<!-- PAGE_55 -->\n###### =\n\n- 4.7 ㎍/cm2\n<!-- PAGE_55 -->\n###### SAF\n\n<!-- PAGE_55 -->\n###### 300\n\n- - 50 -\n<!-- PAGE_56 -->\n###### 표 1. 감작평가계수(Sensitisation Assessment Factors, SAF) 적용\n\n<!-- PAGE_56 -->\n###### 표 2. 제품에 따른 SAF\n\n모든 타입의 데오도란트 및\n\n발한억제제\n\n10\n\n1\n\n3\n\n10\n\n300\n\n하이드로알코올 제품(향수 등)\n\n10\n\n1\n\n3\n\n3\n\n100\n\n바디 크림, 로션\n\n10\n\n1\n\n3\n\n10\n\n300\n\n핸드크림\n\n10\n\n1\n\n3\n\n3\n\n100\n\n얼굴크림 및 메이크업제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n메이크업리무버\n\n10\n\n1\n\n3\n\n3\n\n100\n\n입술 제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스타일링제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스프레이\n\n10\n\n1\n\n3\n\n1\n\n30\n\n샴푸\n\n10\n\n1\n\n3\n\n10\n\n300\n\n헤어컨디셔너\n\n10\n\n1\n\n3\n\n3\n\n100\n\n고체비누\n\n10\n\n1\n\n3\n\n10\n\n300\n\n액체비누\n\n10\n\n1\n\n3\n\n3\n\n100\n\n샤워젤, 목욕제품\n\n10\n\n1\n\n3\n\n10\n\n300\n\n참고 : 자외선차단제가 포함된 제품은 입술제품에 해당됨\n\n요인\n\nSAF\n\n내용\n\n개인 간\n\n10\n\n개인 간 차이 고려\n\n제품\n\n- 0.3, 1, 3\n- 0.3 : 직접 접촉하지 않는 불활성 물질\n1 : 대부분 제품\n\n3 : 실험 조건에서 예상한 것보다 더 큰 침투강화제인 경우\n\n빈도/제품사용기간\n\n1, 3\n\n제품의 장기간 사용 시 생체 축적 고려\n\n- - 51 -\n<!-- PAGE_57 -->\n###### ③ 노출평가\n\n<!-- PAGE_57 -->\n###### - 해당 유형에 따른 체표면적당 사용량(mg/cm2/day)을 고려하여 노출량(Consumer Exposure\n\n<!-- PAGE_57 -->\n###### Leve CEL, mg/cm2/day) 산출\n\nCEL = 0.03/100 × 11.65 mg/cm2 × 1000 ㎍/mg = 3.5 ㎍/cm2\n\n<!-- PAGE_57 -->\n###### - AEL/CEL이 1 이상이므로 위해 우려 가능성 낮음\n\n<!-- PAGE_57 -->\n###### ※ 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 체표면적을 고려한 사용량을 통합적\n\n<!-- PAGE_57 -->\n###### 으로 계산한 노출량을 이용할 경우, 51.67438 mg/cm2/day 사용(표3)\n\n- - 52 -\n<!-- PAGE_58 -->\n###### 표 3. 피부감작성 위해평가를 위한 화장품 통합 노출량\n\n**[표 시작]**\n\n| 적용되는 | 체표면적2 | 체표면적을 |\n| --- | --- | --- |\n| 노출유형 | 제품 | 노출량1 |\n| 선정 | (g/day) |\n**(cm2)**\n| 시험물질 | A | 시험방법 | 투여경로 | 시험대상 | 투여용량 | 무독성용량 | (mg/kg/day) |\n**참고 자료**\n**(mg/kg/day)**\n| 샤워 젤 | 0.10 | 17500 | 0.005714 |\n| 시험종 | 랫드 | 시험방법 | 투여경로 | 시험대상 | 투여용량 |\n**사용 후 씻어내지 않는**\n\n**[표 끝]**\n\n고려한 노출량\n\n(mg/cm2/day)\n\n사용 후 씻어내는 피부 및\n\n피부 및 모발 케어 제품\n\n1 2014∼2016 화장품 위해평가 선진화 연구\n\n2 체표면적 : Bremmer et al, 2005(RIVM) 자료 적용\n\n- - 53 -\n<!-- PAGE_59 -->\n###### 붙임 9. 화장품 유형별 위해평가 예시\n\n<!-- PAGE_59 -->\n###### 1. 자외선차단 성분(에칠헥실메톡시신나메이트)에 대한 위해평가\n\n<!-- PAGE_59 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_59 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_59 -->\n###### ② 피부흡수율\n\n<!-- PAGE_59 -->\n###### - 랫드를 이용한 in vivo 시험결과인 피부흡수율 2.6%를 위해평가에 적용\n\n**[표 시작]**\n\n**- 피부흡수율 : 2.6%1)**\n\n**[표 끝]**\n\n- - 54 -\n<!-- PAGE_60 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_60 -->\n###### - 체중감소 및 간무게 증가를 근거로 NOAEL 450 mg/kg/day를 독성기준값으로 선정\n\n<!-- PAGE_60 -->\n###### - 자외선차단제 중 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 전신노출량\n\n<!-- PAGE_60 -->\n###### - 에칠헥실메톡시신나메이트 함유 농도 7.5%, 1일 1회 사용, 1일 사용량 17 g/day\n\n<!-- PAGE_60 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_60 -->\n###### - 자외선차단제에 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_60 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n- - 55 -\n<!-- PAGE_61 -->\n###### 2. 보존제(메칠이소치아졸리논)에 대한 위해평가\n\n<!-- PAGE_61 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_61 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_61 -->\n###### ② 피부흡수율\n\n<!-- PAGE_61 -->\n###### -  피부흡수율 실험자료가 높은 표준편차를 나타냄에 따라 피부흡수율을 계산할 수 없음.\n\n- - 56 -\n<!-- PAGE_62 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_62 -->\n###### - 토끼에 대한 생식발생독성시험에서 얻어진 NOAEL 10 mg/kg bw/day를 독성기준값으로\n\n**[표 시작]**\n\n| 무독성용량 | (mg/kg/day) |\n| --- | --- |\n\n**[표 끝]**\n\n<!-- PAGE_62 -->\n###### - 대표유형 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 전신노출량(SED)\n\n<!-- PAGE_62 -->\n###### - 메칠이소치아졸리논 함유 농도 0.0015%, 1일 1회 사용, 1일 사용량 16.9 g/day\n\n<!-- PAGE_62 -->\n###### · SED = 16.9 (g/day) × 0.0015/100 × 50/100 ÷ 60 kg = 0.0021 mg/kg/day\n\n<!-- PAGE_62 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_62 -->\n###### - 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_62 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n<!-- PAGE_63 -->\n###### 붙임 10. 화장품 성분 위해평가를 위한 정보 수집\n\n<!-- PAGE_63 -->\n###### 1. 성분 및 식별자료 검색\n\n사이트명\n\n홈페이지\n\n세부정보\n\n**[표 시작]**\n\n| CAS SciFindern | https://www.cas.org/solutions/cas-scifinder- | EU CosIng | 미국화학회(CAS)에서 구축하고 생화학, 의학, 화학공학 등에 특화된 |\n| --- | --- | --- | --- |\n| 결정할 수 있다. | 사이트명 | 홈페이지 | 세부정보 | https://ec.europa.eu/growth/tools-databases/cosing/ | EU의 화장품 규정 및 화장품 성분에 대한 정보 |\n**과학연구 DB로 유료로 운영됨**\n**(유럽 화장품 성분 정보 데이터베이스**\n**미국화학회(CAS)와 독일 연방과학기술센터(FIZ)rk 공동으로 구축한**\n**SCCS**\n| 을 발생시키는 체중 1 kg당 일일 용량을 의미한다. 이것은 단일 관찰된 용량-반응으로부터 | 가정용 제품)의 건강 및 안전에 관한 위해성평 |\n| STN | https://www.stn-international.com/ | 데이터베이스로 구조식, CAS no, 분자식 등의 정보 및 구조식으로 |\n| (Science Committee on Consumer Safety) | 미국 화장품 가이드라인 및 규정 |\n**가 내용 제공**\n| 미국 FDA(식품의약품청) | 화합물 검색이 가능하며 유료로 운영됨 |\n**미국 화장품 착색제**\n**관련 전문가로 이루어진 비영리단체로 화장품에**\n**미국 국립보건원(NIH)의 미국의학도서관(NLM) 내 미국 국립생물공**\n**· AIC 낮은 값을 선택(BMDS)**\n| CIR(Cosmetic Ingredient Review) | https://www.cir-safety.org/ | 사용되는 성분에 대한 정성적 안전성 평가 |\n| PubChem | https://pubmed.ncbi.nlm.nih.gov/ | 학정보센터(NCIB)가 관리하는 화학분자 및 생물학 관련 논문 데이 |\n**로 독성에 대하여 대조군에 비해 10%의 반응이 나타나는 용량의 95% 신뢰구간의 하한값을**\n| 중국 NMPA(국가약품감독관리국) | https://www.nmpa.gov.cn/hzhp/index.html | 중국 화장품 관련 규제 | - 보수적 접근으로 p-value > 0.05 인 모델 중 가장 낮은 BMDL 값 | 보고서 제공 |\n| SED = 50 × 1/109 × 65/100 × 1.62 mg/kg bw/day = 5.3×10-8 mg/kg bw/day | 의미한다. |\n**미국 국립보건원(NIH)의 생명과학 및 생물의**\n| - 그래프 확인 | 국제적으로 통용되는 화장품 성분의 명칭. 국제명칭위원회(INC)가 |\n| PubMed | https://pubmed.ncbi.nlm.nih.gov/ | 의약품, 의료기기 등의 품질, 유효성 및 안전 | 학에 관한 연구 및 최신동향 관련 논문을 확 |\n| wINCI | http://webdictionary.personalcarecouncil.org | 개발하고 PCPC(Personal Care Products Council)가 국제화장품성분 |\n| - BMD/BMDL 비율 : 낮은 값이 독성값에 대한 불확실성이 낮음 | 성 확보 등에 관한 법률 |\n**인할 수 있으며 일부 유료로 운영됨**\n| 일본 | 출할 수 있으며, 산출 방법은 다음과 같다. | 사전(ICID) 및 핸드북에 게재하고 있음. 전자적으로 wINCI로 제공됨 |\n| ③ 위해도 결정 | 화장품 성분 관련 기준 |\n| - NOAEL(또는 LOAEL)/BMDL 비율 : 1에 가까울수록 불확실성이 낮음 | 세계보건기구 산하의 국제암연구기관으로 |\n| IARC | https://www.iarc.fr/ | 국내 화장품 성분명 표준화 위원회에서 「화장품법」에 따라 화장품 | 화장품 색소 관련 기준 |\n**1) 평생발암위해도(LCR) 산출**\n**발암물질에 대한 연구내용 및 분류 제공**\n| 대한화장품협회 성분사전 | https://kcia.or.kr/cid/search/ingd_list.php | 성분명을 표준화하여 제시하고 있음. 국문, 영문 성분명, CAS no, |\n\n**[표 끝]**\n\n구조식 등 확인 가능함. 일부 내용은 회원사에만 제공되고 있음\n\n<!-- PAGE_64 -->\n###### 2. 법률 규제 확인\n\n사이트명\n\n홈페이지\n\n세부정보\n\n한국 의약품안전나라 의약품통합정보시\n\n스템\n\nhttps://nedrug.mfds.go.kr/index\n\n국내 화장품원료 정보 및 규제정보\n\n**[표 시작]**\n\n**: 역학 자료가 있는 경우에는 우선적으로 고려하며, 동물 자료를 이용할 경우에는 사용할 동**\n**OECD(경제협력개발기구)의 후원으로 작성된**\n| OECD SIDS | https://hpvchemicals.oecd.org/ui/Default.aspx |\n| ASEAN Cosmetics Association | 물 데이터 세트와 고려할 종양 유형을 결정한다. 동물 용량 디스크립터(dose-descriptor, | 아세안 화장품협회 화장품 지침 |\n**화학물질 위험에 관한 연구 보고서 제공**\n| (아세안 화장품협회) | 아세안 화장품 성분 정보 |\n**T25)는 비교 대사율을 기반으로 인체 용량 디스크립터(HT25)로 변환된다. 또한, 평생발암**\n| OECD library | https://www.oecd-ilibrary.org/environment/oec |\n**OECD Guideline 시험 지침 제공**\n| - MOE가 104 이상이므로 위해 우려 가능성 낮음 | 위해도(LCR)는 EPA, IRIS 등 규제기관에서 산출된 값을 이용할 수 있으며, 10-5 미만이면 |\n**화장품 관련 규제 및 화학물질 관련 위해성평**\n**호주**\n**가 보고서 제공**\n\n**[표 끝]**\n\n<!-- PAGE_65 -->\n###### 3. 독성 및 위해 정보\n\n**[표 시작]**\n\n| IFRA | https://ifrafragrance.org/ | 제한 금지에 대한 향료안전기준 및 제조법 |\n| --- | --- | --- |\n| 및 지침 등 제공 | CICADS, EHS, HSGs, ICSCs, JECFA, JMPR, |\n| 계산하기 위해, 생물학적으로 유의한 종양이 발생하는 최저용량의 종양 발생 비율(32%)과 최 | (Benchmark Dose Software)와 RIVM(https://www.rivm.nl/en/proast)에서 개발된 PROAST가 |\n**KemI-Riskline, PIMs , UKPID 등이 포함됨**\n| 저용량에서 노출기간 동안 노출된 체중 1 kg 당 1일 용량(6.4 mg/kg bw/day)를 고려하여 계산 | 있다. BMD 접근법은 여러 수학적 모델(probit, gamma, logist, weibull 등)을 활용하여 그 |\n| ① 물질 B의 용량-반응 연구에서 도출된 BMDL10 : 0.018 mg/kg bw/day | 이용하여 평생발암위해도(lifetime cancer risk, LCR)를 결정하거나 용량 디스크립터와 인체 | RIFM(향료물질연구소)에서 향료 물질에 대한 |\n| RIFM | https://rifm.org/ |\n| 적합도를 평가하여 최종 BMDL을 선택하게 된다. 아래 사항은 기본적으로 모델 선택 판단 | 안전성 평가에 필요한 독성 관련 자료를 제공함 |\n**노출량 추정치 사이의 비율인 노출안전역(margin of exposure, MOE) 산출을 통해 위해도를**\n**비식품 소비자제품(화장품, 완구, 직물, 의류,**\n\n**[표 끝]**\n\nIFRA(국제향료협회)에서 제공하는 향료물질의\n\nIPCS INCHEM\n\nhttps://inchem.org/#/\n\nIPCS(국제화학물질안전프로그램) 및 CCOHS(캐\n\n나다 산업보건 및 안전센터)에서 운영하는 최\n\n신 화학물질 안전 관련 간행물 및 국제 기구\n\n의 데이터베이스 확인 가능\n\n<!-- PAGE_67 -->\n###### 참고 1. 발암물질 위해평가 및 예시\n\n<!-- PAGE_67 -->\n###### 참고 2. TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n- - 62 -\n<!-- PAGE_68 -->\n###### 참고 1. 발암물질 위해평가 및 예시\n\n<!-- PAGE_68 -->\n###### 1. 발암물질의 위험성을 평가하는 경우에는 충분한 정보를 근거로 한 T25 또는 BMDL10 등을\n\n<!-- PAGE_68 -->\n###### - T25 : 시험종의 표준 수명 내에서 자연 발생을 보정한 후, 특정 조직 부위에서 25%의 종양\n\n<!-- PAGE_68 -->\n###### - BMDL10(Benchmark Dose Lower confidence limit) : 용량-반응 모델을 근거로 계산되는 값으\n\n<!-- PAGE_68 -->\n###### 2. 평생발암 위험성의 판정을 위해서는 T25 또는 BMDL10 등을 이용하여 평생발암 위험률을 산\n\n<!-- PAGE_68 -->\n###### 2) BMDL10 또는 T25를 이용한 노출안전역(MOE) 산출\n\n<!-- PAGE_68 -->\n###### : 동물시험으로부터 BMDL10를 이용한 노출안전역(MOE)이 10,000 이상 또는 T25를 이용한\n\n<!-- PAGE_68 -->\n###### 노출안전역(MOE)이 25,000 이상인 경우, 위해 우려가 되지 않는다고 평가할 수 있다(EFSA,\n\n<!-- PAGE_68 -->\n###### 2005).\n\n<!-- PAGE_68 -->\n###### SED\n\n- - 63 -\n<!-- PAGE_69 -->\n###### 3. T25를 활용한 평생발암위해도(LCR) 산출 예시\n\n<!-- PAGE_69 -->\n###### □ 물질 A에 대한 발암성 연구\n\n<!-- PAGE_69 -->\n###### ① 종양발생이 유의하게 증가하는 최저 용량\n\n<!-- PAGE_69 -->\n###### - 대조군 : 0/50 (0%)\n\n<!-- PAGE_69 -->\n###### - 사료 50 mg/kg에 노출된 암컷 마우스에서 악성림프종 발생 비율 : 16/50 (32%)\n\n<!-- PAGE_69 -->\n###### - net % : 32%\n\n<!-- PAGE_69 -->\n###### ② 노출기간 동안 마우스 한 마리당 1일 용량\n\n<!-- PAGE_69 -->\n###### - 마우스 1일 먹이 투여량 : 3.25 g/day(실험값)\n\n<!-- PAGE_69 -->\n###### ③ 노출기간 동안 마우스 체중 1 kg 당 물질 A의 1일 섭취량\n\n<!-- PAGE_69 -->\n###### - 시험자료를 통해 저용량 노출군의 암컷 마우스의 평균 체중은 25 g로 확인됨\n\n<!-- PAGE_69 -->\n###### 0.16 mg/day\n\n<!-- PAGE_69 -->\n###### ×\n\n<!-- PAGE_69 -->\n###### 1000 g\n\n<!-- PAGE_69 -->\n###### =\n\n<!-- PAGE_69 -->\n###### 6.4 mg/kg bw/day\n\n<!-- PAGE_69 -->\n###### 25 g bw/mouse\n\n<!-- PAGE_69 -->\n###### kg\n\n- - 64 -\n<!-- PAGE_70 -->\n###### ④ T25 산출\n\n<!-- PAGE_70 -->\n###### - 특정 조직에서 25% 종양을 일으킬 수 있는 용량 수준(악성림프종, 체중 1 kg 당 1일 용량)을\n\n<!-- PAGE_70 -->\n###### - 악성림프종 발생 용량인 50 mg/kg으로부터 T25 = 5.0 mg/kg bw/day을 산출함\n\n<!-- PAGE_70 -->\n###### ⑤ HT25 산출\n\n<!-- PAGE_70 -->\n###### ⑥ 노출평가\n\n<!-- PAGE_70 -->\n###### ⑦ 위해도 결정\n\n<!-- PAGE_70 -->\n###### - LCR이 10-5 이하이므로 위해 우려 가능성 낮음\n\n- - 65 -\n<!-- PAGE_71 -->\n###### 4. BMDL10을 활용한 MOE 산출 예시\n\n<!-- PAGE_71 -->\n###### □ 물질 B에 대한 MOE 산출\n\n- - 66 -\n<!-- PAGE_72 -->\n###### 5. 프로그램을 활용한 BMDL10 산출 예시\n\n<!-- PAGE_72 -->\n###### 1) 가장 잘 알려진 BMD 소프트웨어는 미국 EPA(www.epa.gov/bmds)에서 개발된 BMDS\n\n<!-- PAGE_72 -->\n###### ※ [예시] Benzo(a)pyrene의 BMDS를 활용한 BMD 분석\n\n<!-- PAGE_72 -->\n###### - BMDL10 산출한 결과 5개의 모델이 통계적으로 수용 가능한 수준(p-value > 0.05)임\n\n<!-- PAGE_72 -->\n###### - BMDL10의 범위는 0.07∼0.20 mg/kg bw/day임\n\n<!-- PAGE_72 -->\n###### - 통계적 수용 가능 multi-stage 모델의 가장 낮은 BMDL10 0.07mg/kg bw/day 선택\n\nModel Name\n\nloglik\n\np-value\n\nAIC\n\nChi-square\n\nBMD10\n\ngamma\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.24\n- 0.09\nlogistic\n\n- -204.1\n- 0.105\n- 412.2\n- 10.1\n- 0.14\n- 0.12\nlog-logistic\n\n- -204.1\n- 0.061\n- 414.2\n- 9.9\n- 0.28\n- 0.18\nlog-probit\n\n- -204.3\n- 0.052\n- 414.6\n- 10.3\n- 0.29\n- 0.20\nmulti-stage\n\n- -204.3\n- 0.053\n- 414.6\n- 10.5\n- 0.14\n- 0.07\nprobit\n\n- -204.3\n- 0.092\n- 412.5\n- 10.4\n- 0.13\n- 0.12\nweibull\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.18\n- 0.08\nQuantal-linear\n\n- -204.4\n- 0.019\n- 416.8\n- 14.7\n- 0.07\n- 0.05\n유해물질의 인체안전기준 설정을 위한 용량-반응 평가 연구, 2016\n\n- - 67 -\n<!-- PAGE_73 -->\n###### 참고 2. TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n<!-- PAGE_73 -->\n###### 개별 화학물질의 인체 안전 노출량은 알려진 독성자료로부터 위해평가를 통해 구할 수 있다.\n\n<!-- PAGE_73 -->\n###### TTC (Threshold of Toxicological Concern, 독성학적 우려 역치)는 화학물질별 독성자료가 없다\n\n<!-- PAGE_73 -->\n###### 하더라도 모든 화학물질에 대하여 인체 위해 영향이 없는(무시할만한) 노출량을 설정한다는 개\n\n<!-- PAGE_73 -->\n###### 념이다. 이는 독성자료가 없거나 제한적일 때 화학구조에 대한 지식을 기반으로 독성 데이터베\n\n<!-- PAGE_73 -->\n###### 이스에서 유사 구조 화학물질의 독성자료와 비교하는 것으로 Cramer decision tree에 따라 세\n\n<!-- PAGE_73 -->\n###### 가지 등급으로 분류하여 TTC를 활용할 수 있다.\n\n<!-- PAGE_73 -->\n###### 발암 가능성이 높은 물질, 무기화학물질, 금속, 유기금속, 단백질, 스테로이드, 생물축적 혹은\n\n<!-- PAGE_73 -->\n###### 가능성이 있는 물질, 나노물질, 방사성물질 및 화학구조를 확인할 수 없는 물질이 포함된 혼합\n\n<!-- PAGE_73 -->\n###### 물에는 TTC 방법을 적용할 수 없다. 유전독성 경고가 없는 화학물질에 대해 화학구조를 분석\n\n<!-- PAGE_73 -->\n###### 하고 전신독성 지표로 Cramer 분류를 사용하여 수행된다.\n\n<!-- PAGE_73 -->\n###### 원칙적으로 TTC 방법은 매우 낮은 양으로 존재하는 화학물질에 의해 발생하는 전신독성에\n\n<!-- PAGE_73 -->\n###### 대하여 인체 위해성을 평가하는 것으로, 화학물질별로 전문가의 판단하에 사례별로 수행되어야\n\n<!-- PAGE_73 -->\n###### 한다. 일반적으로 화장품에 사용되는 성분은 Cramer Class Ⅰ 또는 Ⅲ으로 분류하고, Class Ⅱ\n\n<!-- PAGE_73 -->\n###### 의 TTC 값에 대해서는 유효한 자료가 부족하기 때문에 이에 해당되는 물질은 Class Ⅲ으로 분\n\n<!-- PAGE_73 -->\n###### 류한다. TTC 값은 모든 연령층을 포함한 전체 인구에 적용하기 위해서 일반적으로 1일 체중\n\n<!-- PAGE_73 -->\n###### kg당 양(amount)로 표시한다. 특히, 일부 화학물질의 경우 미숙한 신진대사가 있을 수 있는 6\n\n<!-- PAGE_73 -->\n###### 개월 미만의 유아에 대하여 특별한 고려가 필요하다.\n\n<!-- PAGE_73 -->\n###### TTC는 경구 경로의 전신독성을 나타내는 외부용량 기반의 값이고, 화장품의 주요 노출 경로\n\n<!-- PAGE_73 -->\n###### 는 피부이기 때문에 피부 흡수에 대한 변수를 고려하여 내부 노출량으로 변환하여 TTC 값과\n\n<!-- PAGE_73 -->\n###### 비교하여야 한다.\n\n<!-- PAGE_73 -->\n###### 유럽 SCCS에서는 Yang et al. 2017이 제안한 TTC 값 사용을 제안하고 있다.\n\n<!-- PAGE_73 -->\n###### 표 1 . 제안된 TTC 값 요약 (단위: μg/kg bw/day)\n\n**[표 시작]**\n\n**Cramer class**\n\n**[표 끝]**\n\nGenotoxic\n\ncompounds\n\n- 0.0025\nⅠ*\n\n30\n\n42\n\n46\n\n- 49.1\nⅡ*\n\nNot supported**\n\n- -\nNot supported**\n\n- 12.7\nⅢ*\n\n- 1.5\n- 7.9\n- 2.3\n- 2.9\n* Non-genotoxic componds\n\n** Chemicals of Cramer classⅡ should be treated as ClassⅢ substances.\n\nValues in bold are those currently recommended by the SCCS for use for cosmetics-related substances\n\n**[표 시작]**\n\n| 발    행    처 | 식품의약품안전평가원 의료제품연구부 화장품연구과 |\n| --- | --- |\n\n**[표 끝]**\n\n공익신고자등(친족 또는 동거인 포함)이 공익신고등으로 인하여 피해를 받지 않도록\n\n“청렴한 식약처\n\n국민 안심의 시작“\n\n▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자   부조리 신고” 코너\n\n▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너\n",
  "chunks": [
    {
      "chunk_id": "chunk_001",
      "text": "<!-- PAGE_1 -->\n## 화장품 위해평가\n\n<!-- PAGE_1 -->\n## 가이드라인(민원인 안내서)\n\n- 2023. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 0,
        "window_size": 3,
        "char_count": 72,
        "word_count": 14,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n## 화장품 위해평가\n\n<!-- PAGE_1 -->\n## 가이드라인(민원인 안내서)\n\n- 2023.  11.\n <!-- PAGE_1 -->\n##### 의료제품연구부 화장품연구과\n\n<!-- PAGE_1 -->\n###### 발간등록번호\n\n<!-- PAGE_1 -->\n###### 안내서-0747-02\n\n<!-- PAGE_2 -->\n#### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n<!-- PAGE_2 -->\n###### 명칭\n\n<!-- PAGE_2 -->\n###### 화장품 위해평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_2 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 제2조(정의) 1. ",
        "original_sentence": "<!-- PAGE_1 -->\n## 화장품 위해평가\n\n<!-- PAGE_1 -->\n## 가이드라인(민원인 안내서)\n\n- 2023. "
      }
    },
    {
      "chunk_id": "chunk_002",
      "text": "11.\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n## 화장품 위해평가\n\n<!-- PAGE_1 -->\n## 가이드라인(민원인 안내서)\n\n- 2023.  11.\n <!-- PAGE_1 -->\n##### 의료제품연구부 화장품연구과\n\n<!-- PAGE_1 -->\n###### 발간등록번호\n\n<!-- PAGE_1 -->\n###### 안내서-0747-02\n\n<!-- PAGE_2 -->\n#### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n<!-- PAGE_2 -->\n###### 명칭\n\n<!-- PAGE_2 -->\n###### 화장품 위해평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_2 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 제2조(정의) 1.  “화장품”이란 인체를 청결ㆍ미화하여 매력을 더하고 용모를 밝게 변 | 으로 개발되었다. ",
        "original_sentence": "11.\n"
      }
    },
    {
      "chunk_id": "chunk_003",
      "text": "<!-- PAGE_1 -->\n##### 의료제품연구부 화장품연구과\n\n<!-- PAGE_1 -->\n###### 발간등록번호\n\n<!-- PAGE_1 -->\n###### 안내서-0747-02\n\n<!-- PAGE_2 -->\n#### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n<!-- PAGE_2 -->\n###### 명칭\n\n<!-- PAGE_2 -->\n###### 화장품 위해평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_2 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 2,
        "window_size": 3,
        "char_count": 271,
        "word_count": 46,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n## 화장품 위해평가\n\n<!-- PAGE_1 -->\n## 가이드라인(민원인 안내서)\n\n- 2023.  11.\n <!-- PAGE_1 -->\n##### 의료제품연구부 화장품연구과\n\n<!-- PAGE_1 -->\n###### 발간등록번호\n\n<!-- PAGE_1 -->\n###### 안내서-0747-02\n\n<!-- PAGE_2 -->\n#### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n<!-- PAGE_2 -->\n###### 명칭\n\n<!-- PAGE_2 -->\n###### 화장품 위해평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_2 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 제2조(정의) 1.  “화장품”이란 인체를 청결ㆍ미화하여 매력을 더하고 용모를 밝게 변 | 으로 개발되었다.  | 데오도란트에 함유된 물질 C의 농도 | 0.03% | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | DAa(㎍/cm2) × 10-3mg/㎍ × SSA(cm2) × F(day-1) | ○ Pubchem 등 물리화학적 특성 정보 사이트 | RIVM | EPA | ■ 예 | □ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 산출할 수 있다. ",
        "original_sentence": "<!-- PAGE_1 -->\n##### 의료제품연구부 화장품연구과\n\n<!-- PAGE_1 -->\n###### 발간등록번호\n\n<!-- PAGE_1 -->\n###### 안내서-0747-02\n\n<!-- PAGE_2 -->\n#### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n<!-- PAGE_2 -->\n###### 명칭\n\n<!-- PAGE_2 -->\n###### 화장품 위해평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_2 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_004",
      "text": "**[표 시작]**\n\n| 제2조(정의) 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 3,
        "window_size": 3,
        "char_count": 25,
        "word_count": 5,
        "page_number": 56,
        "window_text": "<!-- PAGE_1 -->\n## 화장품 위해평가\n\n<!-- PAGE_1 -->\n## 가이드라인(민원인 안내서)\n\n- 2023.  11.\n <!-- PAGE_1 -->\n##### 의료제품연구부 화장품연구과\n\n<!-- PAGE_1 -->\n###### 발간등록번호\n\n<!-- PAGE_1 -->\n###### 안내서-0747-02\n\n<!-- PAGE_2 -->\n#### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n<!-- PAGE_2 -->\n###### 명칭\n\n<!-- PAGE_2 -->\n###### 화장품 위해평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_2 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 제2조(정의) 1.  “화장품”이란 인체를 청결ㆍ미화하여 매력을 더하고 용모를 밝게 변 | 으로 개발되었다.  | 데오도란트에 함유된 물질 C의 농도 | 0.03% | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | DAa(㎍/cm2) × 10-3mg/㎍ × SSA(cm2) × F(day-1) | ○ Pubchem 등 물리화학적 특성 정보 사이트 | RIVM | EPA | ■ 예 | □ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 산출할 수 있다.  | 함 | 등) 조사 | 대한 외적 용량으로 추정할 수 있다. ",
        "original_sentence": "**[표 시작]**\n\n| 제2조(정의) 1. "
      }
    },
    {
      "chunk_id": "chunk_005",
      "text": "“화장품”이란 인체를 청결ㆍ미화하여 매력을 더하고 용모를 밝게 변 | 으로 개발되었다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 4,
        "window_size": 3,
        "char_count": 49,
        "word_count": 11,
        "page_number": 2,
        "window_text": "11.\n <!-- PAGE_1 -->\n##### 의료제품연구부 화장품연구과\n\n<!-- PAGE_1 -->\n###### 발간등록번호\n\n<!-- PAGE_1 -->\n###### 안내서-0747-02\n\n<!-- PAGE_2 -->\n#### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n<!-- PAGE_2 -->\n###### 명칭\n\n<!-- PAGE_2 -->\n###### 화장품 위해평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_2 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 제2조(정의) 1.  “화장품”이란 인체를 청결ㆍ미화하여 매력을 더하고 용모를 밝게 변 | 으로 개발되었다.  | 데오도란트에 함유된 물질 C의 농도 | 0.03% | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | DAa(㎍/cm2) × 10-3mg/㎍ × SSA(cm2) × F(day-1) | ○ Pubchem 등 물리화학적 특성 정보 사이트 | RIVM | EPA | ■ 예 | □ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 산출할 수 있다.  | 함 | 등) 조사 | 대한 외적 용량으로 추정할 수 있다.  | 평가를 수행할 수 있다. ",
        "original_sentence": "“화장품”이란 인체를 청결ㆍ미화하여 매력을 더하고 용모를 밝게 변 | 으로 개발되었다. "
      }
    },
    {
      "chunk_id": "chunk_006",
      "text": "| 데오도란트에 함유된 물질 C의 농도 | 0.03% | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | DAa(㎍/cm2) × 10-3mg/㎍ × SSA(cm2) × F(day-1) | ○ Pubchem 등 물리화학적 특성 정보 사이트 | RIVM | EPA | ■ 예 | □ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 산출할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 5,
        "window_size": 3,
        "char_count": 247,
        "word_count": 70,
        "page_number": 2,
        "window_text": "<!-- PAGE_1 -->\n##### 의료제품연구부 화장품연구과\n\n<!-- PAGE_1 -->\n###### 발간등록번호\n\n<!-- PAGE_1 -->\n###### 안내서-0747-02\n\n<!-- PAGE_2 -->\n#### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n<!-- PAGE_2 -->\n###### 명칭\n\n<!-- PAGE_2 -->\n###### 화장품 위해평가 가이드라인(민원인 안내서)\n\n<!-- PAGE_2 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 제2조(정의) 1.  “화장품”이란 인체를 청결ㆍ미화하여 매력을 더하고 용모를 밝게 변 | 으로 개발되었다.  | 데오도란트에 함유된 물질 C의 농도 | 0.03% | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | DAa(㎍/cm2) × 10-3mg/㎍ × SSA(cm2) × F(day-1) | ○ Pubchem 등 물리화학적 특성 정보 사이트 | RIVM | EPA | ■ 예 | □ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 산출할 수 있다.  | 함 | 등) 조사 | 대한 외적 용량으로 추정할 수 있다.  | 평가를 수행할 수 있다.  | 방취제(deodorant) | 제 목 | (mg/kg/day) |\n| 노출경로 | 경구 | 생식발생독성시험 | 경구/식이 | 랫드 | 0, 150, 450, 1000 | 450 | ü | ü | ü | ü | ü | ü | ü | - | 손 세정 비누 | 0.24 | 860 | 0.27907 | ⇒ MOS 값이 100 이상이면 위해 우려 가능 |\n| 조건에 따라 사용하였을 때 인체에 안전하여야 한다. ",
        "original_sentence": "| 데오도란트에 함유된 물질 C의 농도 | 0.03% | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | DAa(㎍/cm2) × 10-3mg/㎍ × SSA(cm2) × F(day-1) | ○ Pubchem 등 물리화학적 특성 정보 사이트 | RIVM | EPA | ■ 예 | □ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 산출할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_007",
      "text": "| 함 | 등) 조사 | 대한 외적 용량으로 추정할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 6,
        "window_size": 3,
        "char_count": 35,
        "word_count": 12,
        "page_number": 2,
        "window_text": "**[표 시작]**\n\n| 제2조(정의) 1.  “화장품”이란 인체를 청결ㆍ미화하여 매력을 더하고 용모를 밝게 변 | 으로 개발되었다.  | 데오도란트에 함유된 물질 C의 농도 | 0.03% | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | DAa(㎍/cm2) × 10-3mg/㎍ × SSA(cm2) × F(day-1) | ○ Pubchem 등 물리화학적 특성 정보 사이트 | RIVM | EPA | ■ 예 | □ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 산출할 수 있다.  | 함 | 등) 조사 | 대한 외적 용량으로 추정할 수 있다.  | 평가를 수행할 수 있다.  | 방취제(deodorant) | 제 목 | (mg/kg/day) |\n| 노출경로 | 경구 | 생식발생독성시험 | 경구/식이 | 랫드 | 0, 150, 450, 1000 | 450 | ü | ü | ü | ü | ü | ü | ü | - | 손 세정 비누 | 0.24 | 860 | 0.27907 | ⇒ MOS 값이 100 이상이면 위해 우려 가능 |\n| 조건에 따라 사용하였을 때 인체에 안전하여야 한다.  | 된다. ",
        "original_sentence": "| 함 | 등) 조사 | 대한 외적 용량으로 추정할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_008",
      "text": "| 평가를 수행할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 7,
        "window_size": 3,
        "char_count": 16,
        "word_count": 5,
        "page_number": 2,
        "window_text": "“화장품”이란 인체를 청결ㆍ미화하여 매력을 더하고 용모를 밝게 변 | 으로 개발되었다.  | 데오도란트에 함유된 물질 C의 농도 | 0.03% | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | DAa(㎍/cm2) × 10-3mg/㎍ × SSA(cm2) × F(day-1) | ○ Pubchem 등 물리화학적 특성 정보 사이트 | RIVM | EPA | ■ 예 | □ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 산출할 수 있다.  | 함 | 등) 조사 | 대한 외적 용량으로 추정할 수 있다.  | 평가를 수행할 수 있다.  | 방취제(deodorant) | 제 목 | (mg/kg/day) |\n| 노출경로 | 경구 | 생식발생독성시험 | 경구/식이 | 랫드 | 0, 150, 450, 1000 | 450 | ü | ü | ü | ü | ü | ü | ü | - | 손 세정 비누 | 0.24 | 860 | 0.27907 | ⇒ MOS 값이 100 이상이면 위해 우려 가능 |\n| 조건에 따라 사용하였을 때 인체에 안전하여야 한다.  | 된다.  | 2. ",
        "original_sentence": "| 평가를 수행할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_009",
      "text": "| 방취제(deodorant) | 제 목 | (mg/kg/day) |\n| 노출경로 | 경구 | 생식발생독성시험 | 경구/식이 | 랫드 | 0, 150, 450, 1000 | 450 | ü | ü | ü | ü | ü | ü | ü | - | 손 세정 비누 | 0.24 | 860 | 0.27907 | ⇒ MOS 값이 100 이상이면 위해 우려 가능 |\n| 조건에 따라 사용하였을 때 인체에 안전하여야 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 8,
        "window_size": 3,
        "char_count": 228,
        "word_count": 69,
        "page_number": 36,
        "window_text": "| 데오도란트에 함유된 물질 C의 농도 | 0.03% | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | DAa(㎍/cm2) × 10-3mg/㎍ × SSA(cm2) × F(day-1) | ○ Pubchem 등 물리화학적 특성 정보 사이트 | RIVM | EPA | ■ 예 | □ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 산출할 수 있다.  | 함 | 등) 조사 | 대한 외적 용량으로 추정할 수 있다.  | 평가를 수행할 수 있다.  | 방취제(deodorant) | 제 목 | (mg/kg/day) |\n| 노출경로 | 경구 | 생식발생독성시험 | 경구/식이 | 랫드 | 0, 150, 450, 1000 | 450 | ü | ü | ü | ü | ü | ü | ü | - | 손 세정 비누 | 0.24 | 860 | 0.27907 | ⇒ MOS 값이 100 이상이면 위해 우려 가능 |\n| 조건에 따라 사용하였을 때 인체에 안전하여야 한다.  | 된다.  | 2.  위해요소의 인체노출 허용량을 산출하는 위험성 결정과정 | SED = | 지침서ㆍ안내서가 있습니까? ",
        "original_sentence": "| 방취제(deodorant) | 제 목 | (mg/kg/day) |\n| 노출경로 | 경구 | 생식발생독성시험 | 경구/식이 | 랫드 | 0, 150, 450, 1000 | 450 | ü | ü | ü | ü | ü | ü | ü | - | 손 세정 비누 | 0.24 | 860 | 0.27907 | ⇒ MOS 값이 100 이상이면 위해 우려 가능 |\n| 조건에 따라 사용하였을 때 인체에 안전하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_010",
      "text": "| 된다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 9,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 2,
        "window_text": "| 함 | 등) 조사 | 대한 외적 용량으로 추정할 수 있다.  | 평가를 수행할 수 있다.  | 방취제(deodorant) | 제 목 | (mg/kg/day) |\n| 노출경로 | 경구 | 생식발생독성시험 | 경구/식이 | 랫드 | 0, 150, 450, 1000 | 450 | ü | ü | ü | ü | ü | ü | ü | - | 손 세정 비누 | 0.24 | 860 | 0.27907 | ⇒ MOS 값이 100 이상이면 위해 우려 가능 |\n| 조건에 따라 사용하였을 때 인체에 안전하여야 한다.  | 된다.  | 2.  위해요소의 인체노출 허용량을 산출하는 위험성 결정과정 | SED = | 지침서ㆍ안내서가 있습니까?  | 화장품 위해평가 가이드라인 | 모발 관리(Hair care) | - 인체 독성시험자료 또는 동물 독성시험 | 검색 |\n| 물질이 인체 건강에 유해한 영향을 미칠 가능성이 있는지 확인하는 단계이다. ",
        "original_sentence": "| 된다. "
      }
    },
    {
      "chunk_id": "chunk_011",
      "text": "| 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 10,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| 평가를 수행할 수 있다.  | 방취제(deodorant) | 제 목 | (mg/kg/day) |\n| 노출경로 | 경구 | 생식발생독성시험 | 경구/식이 | 랫드 | 0, 150, 450, 1000 | 450 | ü | ü | ü | ü | ü | ü | ü | - | 손 세정 비누 | 0.24 | 860 | 0.27907 | ⇒ MOS 값이 100 이상이면 위해 우려 가능 |\n| 조건에 따라 사용하였을 때 인체에 안전하여야 한다.  | 된다.  | 2.  위해요소의 인체노출 허용량을 산출하는 위험성 결정과정 | SED = | 지침서ㆍ안내서가 있습니까?  | 화장품 위해평가 가이드라인 | 모발 관리(Hair care) | - 인체 독성시험자료 또는 동물 독성시험 | 검색 |\n| 물질이 인체 건강에 유해한 영향을 미칠 가능성이 있는지 확인하는 단계이다.  | 배설, 체내 축적성) 자료 조사 | 화시키거나 피부ㆍ모발의 건강을 유지 또는 증진하기 위하여 인체에 바르고 문지르 | 독성자료 | 투여용량 | 결과 | 체표면적을 고려한 1일 사용량(mg/cm2/day) | 11.65 mg/cm2/day | - 단일 또는 여러 화장품을 함께 사용하는 경우 고려 |\n| (margin of safety, MOS)으로 나타낸다(SCCS/1628/21, 2021). ",
        "original_sentence": "| 2. "
      }
    },
    {
      "chunk_id": "chunk_012",
      "text": "위해요소의 인체노출 허용량을 산출하는 위험성 결정과정 | SED = | 지침서ㆍ안내서가 있습니까? ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 11,
        "window_size": 3,
        "char_count": 55,
        "word_count": 12,
        "page_number": 2,
        "window_text": "| 방취제(deodorant) | 제 목 | (mg/kg/day) |\n| 노출경로 | 경구 | 생식발생독성시험 | 경구/식이 | 랫드 | 0, 150, 450, 1000 | 450 | ü | ü | ü | ü | ü | ü | ü | - | 손 세정 비누 | 0.24 | 860 | 0.27907 | ⇒ MOS 값이 100 이상이면 위해 우려 가능 |\n| 조건에 따라 사용하였을 때 인체에 안전하여야 한다.  | 된다.  | 2.  위해요소의 인체노출 허용량을 산출하는 위험성 결정과정 | SED = | 지침서ㆍ안내서가 있습니까?  | 화장품 위해평가 가이드라인 | 모발 관리(Hair care) | - 인체 독성시험자료 또는 동물 독성시험 | 검색 |\n| 물질이 인체 건강에 유해한 영향을 미칠 가능성이 있는지 확인하는 단계이다.  | 배설, 체내 축적성) 자료 조사 | 화시키거나 피부ㆍ모발의 건강을 유지 또는 증진하기 위하여 인체에 바르고 문지르 | 독성자료 | 투여용량 | 결과 | 체표면적을 고려한 1일 사용량(mg/cm2/day) | 11.65 mg/cm2/day | - 단일 또는 여러 화장품을 함께 사용하는 경우 고려 |\n| (margin of safety, MOS)으로 나타낸다(SCCS/1628/21, 2021).  | 기준이다. ",
        "original_sentence": "위해요소의 인체노출 허용량을 산출하는 위험성 결정과정 | SED = | 지침서ㆍ안내서가 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_013",
      "text": "| 화장품 위해평가 가이드라인 | 모발 관리(Hair care) | - 인체 독성시험자료 또는 동물 독성시험 | 검색 |\n| 물질이 인체 건강에 유해한 영향을 미칠 가능성이 있는지 확인하는 단계이다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 12,
        "window_size": 3,
        "char_count": 112,
        "word_count": 29,
        "page_number": 1,
        "window_text": "| 된다.  | 2.  위해요소의 인체노출 허용량을 산출하는 위험성 결정과정 | SED = | 지침서ㆍ안내서가 있습니까?  | 화장품 위해평가 가이드라인 | 모발 관리(Hair care) | - 인체 독성시험자료 또는 동물 독성시험 | 검색 |\n| 물질이 인체 건강에 유해한 영향을 미칠 가능성이 있는지 확인하는 단계이다.  | 배설, 체내 축적성) 자료 조사 | 화시키거나 피부ㆍ모발의 건강을 유지 또는 증진하기 위하여 인체에 바르고 문지르 | 독성자료 | 투여용량 | 결과 | 체표면적을 고려한 1일 사용량(mg/cm2/day) | 11.65 mg/cm2/day | - 단일 또는 여러 화장품을 함께 사용하는 경우 고려 |\n| (margin of safety, MOS)으로 나타낸다(SCCS/1628/21, 2021).  | 기준이다.  | 입, 배출)을 0으로 가정할 수 있다. ",
        "original_sentence": "| 화장품 위해평가 가이드라인 | 모발 관리(Hair care) | - 인체 독성시험자료 또는 동물 독성시험 | 검색 |\n| 물질이 인체 건강에 유해한 영향을 미칠 가능성이 있는지 확인하는 단계이다. "
      }
    },
    {
      "chunk_id": "chunk_014",
      "text": "| 배설, 체내 축적성) 자료 조사 | 화시키거나 피부ㆍ모발의 건강을 유지 또는 증진하기 위하여 인체에 바르고 문지르 | 독성자료 | 투여용량 | 결과 | 체표면적을 고려한 1일 사용량(mg/cm2/day) | 11.65 mg/cm2/day | - 단일 또는 여러 화장품을 함께 사용하는 경우 고려 |\n| (margin of safety, MOS)으로 나타낸다(SCCS/1628/21, 2021). ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 13,
        "window_size": 3,
        "char_count": 223,
        "word_count": 49,
        "page_number": 17,
        "window_text": "| 2.  위해요소의 인체노출 허용량을 산출하는 위험성 결정과정 | SED = | 지침서ㆍ안내서가 있습니까?  | 화장품 위해평가 가이드라인 | 모발 관리(Hair care) | - 인체 독성시험자료 또는 동물 독성시험 | 검색 |\n| 물질이 인체 건강에 유해한 영향을 미칠 가능성이 있는지 확인하는 단계이다.  | 배설, 체내 축적성) 자료 조사 | 화시키거나 피부ㆍ모발의 건강을 유지 또는 증진하기 위하여 인체에 바르고 문지르 | 독성자료 | 투여용량 | 결과 | 체표면적을 고려한 1일 사용량(mg/cm2/day) | 11.65 mg/cm2/day | - 단일 또는 여러 화장품을 함께 사용하는 경우 고려 |\n| (margin of safety, MOS)으로 나타낸다(SCCS/1628/21, 2021).  | 기준이다.  | 입, 배출)을 0으로 가정할 수 있다.  | 성이 낮다고 평가 | 60 (kg) |\n| 노출농도 | 0, 25, 50 ppm(in diet) | 모발 클렌징 제품 | 반복독성시험 | 경구 | 토끼 | 3, 10, 30 | 10 | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우 | 25% | 샴푸 | 0.09 | 1440 | 0.0625 | 자료를 활용 |\n| 라 사례별(case-by-case)로 평가하는 것이 바람직하다. ",
        "original_sentence": "| 배설, 체내 축적성) 자료 조사 | 화시키거나 피부ㆍ모발의 건강을 유지 또는 증진하기 위하여 인체에 바르고 문지르 | 독성자료 | 투여용량 | 결과 | 체표면적을 고려한 1일 사용량(mg/cm2/day) | 11.65 mg/cm2/day | - 단일 또는 여러 화장품을 함께 사용하는 경우 고려 |\n| (margin of safety, MOS)으로 나타낸다(SCCS/1628/21, 2021). "
      }
    },
    {
      "chunk_id": "chunk_015",
      "text": "| 기준이다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 14,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 2,
        "window_text": "위해요소의 인체노출 허용량을 산출하는 위험성 결정과정 | SED = | 지침서ㆍ안내서가 있습니까?  | 화장품 위해평가 가이드라인 | 모발 관리(Hair care) | - 인체 독성시험자료 또는 동물 독성시험 | 검색 |\n| 물질이 인체 건강에 유해한 영향을 미칠 가능성이 있는지 확인하는 단계이다.  | 배설, 체내 축적성) 자료 조사 | 화시키거나 피부ㆍ모발의 건강을 유지 또는 증진하기 위하여 인체에 바르고 문지르 | 독성자료 | 투여용량 | 결과 | 체표면적을 고려한 1일 사용량(mg/cm2/day) | 11.65 mg/cm2/day | - 단일 또는 여러 화장품을 함께 사용하는 경우 고려 |\n| (margin of safety, MOS)으로 나타낸다(SCCS/1628/21, 2021).  | 기준이다.  | 입, 배출)을 0으로 가정할 수 있다.  | 성이 낮다고 평가 | 60 (kg) |\n| 노출농도 | 0, 25, 50 ppm(in diet) | 모발 클렌징 제품 | 반복독성시험 | 경구 | 토끼 | 3, 10, 30 | 10 | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우 | 25% | 샴푸 | 0.09 | 1440 | 0.0625 | 자료를 활용 |\n| 라 사례별(case-by-case)로 평가하는 것이 바람직하다.  | 3. ",
        "original_sentence": "| 기준이다. "
      }
    },
    {
      "chunk_id": "chunk_016",
      "text": "| 입, 배출)을 0으로 가정할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 15,
        "window_size": 3,
        "char_count": 24,
        "word_count": 7,
        "page_number": 2,
        "window_text": "| 화장품 위해평가 가이드라인 | 모발 관리(Hair care) | - 인체 독성시험자료 또는 동물 독성시험 | 검색 |\n| 물질이 인체 건강에 유해한 영향을 미칠 가능성이 있는지 확인하는 단계이다.  | 배설, 체내 축적성) 자료 조사 | 화시키거나 피부ㆍ모발의 건강을 유지 또는 증진하기 위하여 인체에 바르고 문지르 | 독성자료 | 투여용량 | 결과 | 체표면적을 고려한 1일 사용량(mg/cm2/day) | 11.65 mg/cm2/day | - 단일 또는 여러 화장품을 함께 사용하는 경우 고려 |\n| (margin of safety, MOS)으로 나타낸다(SCCS/1628/21, 2021).  | 기준이다.  | 입, 배출)을 0으로 가정할 수 있다.  | 성이 낮다고 평가 | 60 (kg) |\n| 노출농도 | 0, 25, 50 ppm(in diet) | 모발 클렌징 제품 | 반복독성시험 | 경구 | 토끼 | 3, 10, 30 | 10 | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우 | 25% | 샴푸 | 0.09 | 1440 | 0.0625 | 자료를 활용 |\n| 라 사례별(case-by-case)로 평가하는 것이 바람직하다.  | 3.  위해요소가 인체에 노출된 양을 산출하는 노출평가과정 | discovery-platform/cas-scifinder |\n| 거나 뿌리는 등 이와 유사한 방법으로 사용되는 물품으로서 인체에 대한 작용이 경 | SEDinh  = | A(mg/kg bw/day) × C(%)/100 × fevap | × IR × t × fret | V | 루시퍼라아제 LuSens 시험법 | - 제품별 특성에 따라 경구, 피부 등 노출 경로 고려 | × 6.4 mg/kg bw/day | = | 5.0 mg/kg bw/day | ○ 공개된 논문 정보, 국제기구(WHO, FAO, IPCS, |\n| 위해도를 결정한다(그림 1). ",
        "original_sentence": "| 입, 배출)을 0으로 가정할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_017",
      "text": "| 성이 낮다고 평가 | 60 (kg) |\n| 노출농도 | 0, 25, 50 ppm(in diet) | 모발 클렌징 제품 | 반복독성시험 | 경구 | 토끼 | 3, 10, 30 | 10 | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우 | 25% | 샴푸 | 0.09 | 1440 | 0.0625 | 자료를 활용 |\n| 라 사례별(case-by-case)로 평가하는 것이 바람직하다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 16,
        "window_size": 3,
        "char_count": 230,
        "word_count": 63,
        "page_number": 24,
        "window_text": "| 배설, 체내 축적성) 자료 조사 | 화시키거나 피부ㆍ모발의 건강을 유지 또는 증진하기 위하여 인체에 바르고 문지르 | 독성자료 | 투여용량 | 결과 | 체표면적을 고려한 1일 사용량(mg/cm2/day) | 11.65 mg/cm2/day | - 단일 또는 여러 화장품을 함께 사용하는 경우 고려 |\n| (margin of safety, MOS)으로 나타낸다(SCCS/1628/21, 2021).  | 기준이다.  | 입, 배출)을 0으로 가정할 수 있다.  | 성이 낮다고 평가 | 60 (kg) |\n| 노출농도 | 0, 25, 50 ppm(in diet) | 모발 클렌징 제품 | 반복독성시험 | 경구 | 토끼 | 3, 10, 30 | 10 | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우 | 25% | 샴푸 | 0.09 | 1440 | 0.0625 | 자료를 활용 |\n| 라 사례별(case-by-case)로 평가하는 것이 바람직하다.  | 3.  위해요소가 인체에 노출된 양을 산출하는 노출평가과정 | discovery-platform/cas-scifinder |\n| 거나 뿌리는 등 이와 유사한 방법으로 사용되는 물품으로서 인체에 대한 작용이 경 | SEDinh  = | A(mg/kg bw/day) × C(%)/100 × fevap | × IR × t × fret | V | 루시퍼라아제 LuSens 시험법 | - 제품별 특성에 따라 경구, 피부 등 노출 경로 고려 | × 6.4 mg/kg bw/day | = | 5.0 mg/kg bw/day | ○ 공개된 논문 정보, 국제기구(WHO, FAO, IPCS, |\n| 위해도를 결정한다(그림 1).  | 목록 | 구분 | 내용 | T25 | = | - NOAEL 66~94 mg/kg bw/day | - 혈액학적, 임상화학적, 전신, 신경 |\n| 노출기간 | 24개월 | 반복투여(경구) | - 랫드 대상(3개월) | - 6.5~9.8, 19~25, 66~96 mg/kg bw/day | 사망이나 뚜렷한 고통과 스트레스를 초래하지 않도록 설계 | 32% | 헤어 컨디셔너 | 0.06 | 1440 | 0.041667 | (Ainh-1 + Ainh-2) × fret × fresp × fappl | 체중 당 일일 |\n| 4. ",
        "original_sentence": "| 성이 낮다고 평가 | 60 (kg) |\n| 노출농도 | 0, 25, 50 ppm(in diet) | 모발 클렌징 제품 | 반복독성시험 | 경구 | 토끼 | 3, 10, 30 | 10 | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우 | 25% | 샴푸 | 0.09 | 1440 | 0.0625 | 자료를 활용 |\n| 라 사례별(case-by-case)로 평가하는 것이 바람직하다. "
      }
    },
    {
      "chunk_id": "chunk_018",
      "text": "| 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 17,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 56,
        "window_text": "| 기준이다.  | 입, 배출)을 0으로 가정할 수 있다.  | 성이 낮다고 평가 | 60 (kg) |\n| 노출농도 | 0, 25, 50 ppm(in diet) | 모발 클렌징 제품 | 반복독성시험 | 경구 | 토끼 | 3, 10, 30 | 10 | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우 | 25% | 샴푸 | 0.09 | 1440 | 0.0625 | 자료를 활용 |\n| 라 사례별(case-by-case)로 평가하는 것이 바람직하다.  | 3.  위해요소가 인체에 노출된 양을 산출하는 노출평가과정 | discovery-platform/cas-scifinder |\n| 거나 뿌리는 등 이와 유사한 방법으로 사용되는 물품으로서 인체에 대한 작용이 경 | SEDinh  = | A(mg/kg bw/day) × C(%)/100 × fevap | × IR × t × fret | V | 루시퍼라아제 LuSens 시험법 | - 제품별 특성에 따라 경구, 피부 등 노출 경로 고려 | × 6.4 mg/kg bw/day | = | 5.0 mg/kg bw/day | ○ 공개된 논문 정보, 국제기구(WHO, FAO, IPCS, |\n| 위해도를 결정한다(그림 1).  | 목록 | 구분 | 내용 | T25 | = | - NOAEL 66~94 mg/kg bw/day | - 혈액학적, 임상화학적, 전신, 신경 |\n| 노출기간 | 24개월 | 반복투여(경구) | - 랫드 대상(3개월) | - 6.5~9.8, 19~25, 66~96 mg/kg bw/day | 사망이나 뚜렷한 고통과 스트레스를 초래하지 않도록 설계 | 32% | 헤어 컨디셔너 | 0.06 | 1440 | 0.041667 | (Ainh-1 + Ainh-2) × fret × fresp × fappl | 체중 당 일일 |\n| 4.  제1호부터 제3호까지의 결과를 종합하여 인체에 미치는 위해 영향을 판단하는 | 피부 상태 | 1, 3, 10 | 제품 사용에 따라 염증 수준이 증가하기 쉬운 신체 부위 고려 | 발관리(Foot care) | ○ 가장 타당한 독성시험으로부터 가장 민감한 | IARC) 및 관련기관(EPA, FDA, EU 집행위, 일본 | 잔류 지수1 |\n| 미용사 등)에게 안전해야 한다. ",
        "original_sentence": "| 3. "
      }
    },
    {
      "chunk_id": "chunk_019",
      "text": "위해요소가 인체에 노출된 양을 산출하는 노출평가과정 | discovery-platform/cas-scifinder |\n| 거나 뿌리는 등 이와 유사한 방법으로 사용되는 물품으로서 인체에 대한 작용이 경 | SEDinh  = | A(mg/kg bw/day) × C(%)/100 × fevap | × IR × t × fret | V | 루시퍼라아제 LuSens 시험법 | - 제품별 특성에 따라 경구, 피부 등 노출 경로 고려 | × 6.4 mg/kg bw/day | = | 5.0 mg/kg bw/day | ○ 공개된 논문 정보, 국제기구(WHO, FAO, IPCS, |\n| 위해도를 결정한다(그림 1). ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 18,
        "window_size": 3,
        "char_count": 338,
        "word_count": 80,
        "page_number": 28,
        "window_text": "| 입, 배출)을 0으로 가정할 수 있다.  | 성이 낮다고 평가 | 60 (kg) |\n| 노출농도 | 0, 25, 50 ppm(in diet) | 모발 클렌징 제품 | 반복독성시험 | 경구 | 토끼 | 3, 10, 30 | 10 | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우 | 25% | 샴푸 | 0.09 | 1440 | 0.0625 | 자료를 활용 |\n| 라 사례별(case-by-case)로 평가하는 것이 바람직하다.  | 3.  위해요소가 인체에 노출된 양을 산출하는 노출평가과정 | discovery-platform/cas-scifinder |\n| 거나 뿌리는 등 이와 유사한 방법으로 사용되는 물품으로서 인체에 대한 작용이 경 | SEDinh  = | A(mg/kg bw/day) × C(%)/100 × fevap | × IR × t × fret | V | 루시퍼라아제 LuSens 시험법 | - 제품별 특성에 따라 경구, 피부 등 노출 경로 고려 | × 6.4 mg/kg bw/day | = | 5.0 mg/kg bw/day | ○ 공개된 논문 정보, 국제기구(WHO, FAO, IPCS, |\n| 위해도를 결정한다(그림 1).  | 목록 | 구분 | 내용 | T25 | = | - NOAEL 66~94 mg/kg bw/day | - 혈액학적, 임상화학적, 전신, 신경 |\n| 노출기간 | 24개월 | 반복투여(경구) | - 랫드 대상(3개월) | - 6.5~9.8, 19~25, 66~96 mg/kg bw/day | 사망이나 뚜렷한 고통과 스트레스를 초래하지 않도록 설계 | 32% | 헤어 컨디셔너 | 0.06 | 1440 | 0.041667 | (Ainh-1 + Ainh-2) × fret × fresp × fappl | 체중 당 일일 |\n| 4.  제1호부터 제3호까지의 결과를 종합하여 인체에 미치는 위해 영향을 판단하는 | 피부 상태 | 1, 3, 10 | 제품 사용에 따라 염증 수준이 증가하기 쉬운 신체 부위 고려 | 발관리(Foot care) | ○ 가장 타당한 독성시험으로부터 가장 민감한 | IARC) 및 관련기관(EPA, FDA, EU 집행위, 일본 | 잔류 지수1 |\n| 미용사 등)에게 안전해야 한다.  | 해당 제품 사용에 대한 노출시나리오에 따라 노출량을 산출할 수 있다. ",
        "original_sentence": "위해요소가 인체에 노출된 양을 산출하는 노출평가과정 | discovery-platform/cas-scifinder |\n| 거나 뿌리는 등 이와 유사한 방법으로 사용되는 물품으로서 인체에 대한 작용이 경 | SEDinh  = | A(mg/kg bw/day) × C(%)/100 × fevap | × IR × t × fret | V | 루시퍼라아제 LuSens 시험법 | - 제품별 특성에 따라 경구, 피부 등 노출 경로 고려 | × 6.4 mg/kg bw/day | = | 5.0 mg/kg bw/day | ○ 공개된 논문 정보, 국제기구(WHO, FAO, IPCS, |\n| 위해도를 결정한다(그림 1). "
      }
    },
    {
      "chunk_id": "chunk_020",
      "text": "| 목록 | 구분 | 내용 | T25 | = | - NOAEL 66~94 mg/kg bw/day | - 혈액학적, 임상화학적, 전신, 신경 |\n| 노출기간 | 24개월 | 반복투여(경구) | - 랫드 대상(3개월) | - 6.5~9.8, 19~25, 66~96 mg/kg bw/day | 사망이나 뚜렷한 고통과 스트레스를 초래하지 않도록 설계 | 32% | 헤어 컨디셔너 | 0.06 | 1440 | 0.041667 | (Ainh-1 + Ainh-2) × fret × fresp × fappl | 체중 당 일일 |\n| 4. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 19,
        "window_size": 3,
        "char_count": 293,
        "word_count": 76,
        "page_number": 27,
        "window_text": "| 성이 낮다고 평가 | 60 (kg) |\n| 노출농도 | 0, 25, 50 ppm(in diet) | 모발 클렌징 제품 | 반복독성시험 | 경구 | 토끼 | 3, 10, 30 | 10 | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우 | 25% | 샴푸 | 0.09 | 1440 | 0.0625 | 자료를 활용 |\n| 라 사례별(case-by-case)로 평가하는 것이 바람직하다.  | 3.  위해요소가 인체에 노출된 양을 산출하는 노출평가과정 | discovery-platform/cas-scifinder |\n| 거나 뿌리는 등 이와 유사한 방법으로 사용되는 물품으로서 인체에 대한 작용이 경 | SEDinh  = | A(mg/kg bw/day) × C(%)/100 × fevap | × IR × t × fret | V | 루시퍼라아제 LuSens 시험법 | - 제품별 특성에 따라 경구, 피부 등 노출 경로 고려 | × 6.4 mg/kg bw/day | = | 5.0 mg/kg bw/day | ○ 공개된 논문 정보, 국제기구(WHO, FAO, IPCS, |\n| 위해도를 결정한다(그림 1).  | 목록 | 구분 | 내용 | T25 | = | - NOAEL 66~94 mg/kg bw/day | - 혈액학적, 임상화학적, 전신, 신경 |\n| 노출기간 | 24개월 | 반복투여(경구) | - 랫드 대상(3개월) | - 6.5~9.8, 19~25, 66~96 mg/kg bw/day | 사망이나 뚜렷한 고통과 스트레스를 초래하지 않도록 설계 | 32% | 헤어 컨디셔너 | 0.06 | 1440 | 0.041667 | (Ainh-1 + Ainh-2) × fret × fresp × fappl | 체중 당 일일 |\n| 4.  제1호부터 제3호까지의 결과를 종합하여 인체에 미치는 위해 영향을 판단하는 | 피부 상태 | 1, 3, 10 | 제품 사용에 따라 염증 수준이 증가하기 쉬운 신체 부위 고려 | 발관리(Foot care) | ○ 가장 타당한 독성시험으로부터 가장 민감한 | IARC) 및 관련기관(EPA, FDA, EU 집행위, 일본 | 잔류 지수1 |\n| 미용사 등)에게 안전해야 한다.  | 해당 제품 사용에 대한 노출시나리오에 따라 노출량을 산출할 수 있다.  | 최고 용량/노출 수준으로 정의되며, 역치가 존재하는 영향의 경우에 사용한다. ",
        "original_sentence": "| 목록 | 구분 | 내용 | T25 | = | - NOAEL 66~94 mg/kg bw/day | - 혈액학적, 임상화학적, 전신, 신경 |\n| 노출기간 | 24개월 | 반복투여(경구) | - 랫드 대상(3개월) | - 6.5~9.8, 19~25, 66~96 mg/kg bw/day | 사망이나 뚜렷한 고통과 스트레스를 초래하지 않도록 설계 | 32% | 헤어 컨디셔너 | 0.06 | 1440 | 0.041667 | (Ainh-1 + Ainh-2) × fret × fresp × fappl | 체중 당 일일 |\n| 4. "
      }
    },
    {
      "chunk_id": "chunk_021",
      "text": "제1호부터 제3호까지의 결과를 종합하여 인체에 미치는 위해 영향을 판단하는 | 피부 상태 | 1, 3, 10 | 제품 사용에 따라 염증 수준이 증가하기 쉬운 신체 부위 고려 | 발관리(Foot care) | ○ 가장 타당한 독성시험으로부터 가장 민감한 | IARC) 및 관련기관(EPA, FDA, EU 집행위, 일본 | 잔류 지수1 |\n| 미용사 등)에게 안전해야 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 20,
        "window_size": 3,
        "char_count": 208,
        "word_count": 54,
        "page_number": 37,
        "window_text": "| 3.  위해요소가 인체에 노출된 양을 산출하는 노출평가과정 | discovery-platform/cas-scifinder |\n| 거나 뿌리는 등 이와 유사한 방법으로 사용되는 물품으로서 인체에 대한 작용이 경 | SEDinh  = | A(mg/kg bw/day) × C(%)/100 × fevap | × IR × t × fret | V | 루시퍼라아제 LuSens 시험법 | - 제품별 특성에 따라 경구, 피부 등 노출 경로 고려 | × 6.4 mg/kg bw/day | = | 5.0 mg/kg bw/day | ○ 공개된 논문 정보, 국제기구(WHO, FAO, IPCS, |\n| 위해도를 결정한다(그림 1).  | 목록 | 구분 | 내용 | T25 | = | - NOAEL 66~94 mg/kg bw/day | - 혈액학적, 임상화학적, 전신, 신경 |\n| 노출기간 | 24개월 | 반복투여(경구) | - 랫드 대상(3개월) | - 6.5~9.8, 19~25, 66~96 mg/kg bw/day | 사망이나 뚜렷한 고통과 스트레스를 초래하지 않도록 설계 | 32% | 헤어 컨디셔너 | 0.06 | 1440 | 0.041667 | (Ainh-1 + Ainh-2) × fret × fresp × fappl | 체중 당 일일 |\n| 4.  제1호부터 제3호까지의 결과를 종합하여 인체에 미치는 위해 영향을 판단하는 | 피부 상태 | 1, 3, 10 | 제품 사용에 따라 염증 수준이 증가하기 쉬운 신체 부위 고려 | 발관리(Foot care) | ○ 가장 타당한 독성시험으로부터 가장 민감한 | IARC) 및 관련기관(EPA, FDA, EU 집행위, 일본 | 잔류 지수1 |\n| 미용사 등)에게 안전해야 한다.  | 해당 제품 사용에 대한 노출시나리오에 따라 노출량을 산출할 수 있다.  | 최고 용량/노출 수준으로 정의되며, 역치가 존재하는 영향의 경우에 사용한다.  | 되는 용량 및 면적에 따라 좌우된다. ",
        "original_sentence": "제1호부터 제3호까지의 결과를 종합하여 인체에 미치는 위해 영향을 판단하는 | 피부 상태 | 1, 3, 10 | 제품 사용에 따라 염증 수준이 증가하기 쉬운 신체 부위 고려 | 발관리(Foot care) | ○ 가장 타당한 독성시험으로부터 가장 민감한 | IARC) 및 관련기관(EPA, FDA, EU 집행위, 일본 | 잔류 지수1 |\n| 미용사 등)에게 안전해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_022",
      "text": "| 해당 제품 사용에 대한 노출시나리오에 따라 노출량을 산출할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 21,
        "window_size": 3,
        "char_count": 41,
        "word_count": 11,
        "page_number": 2,
        "window_text": "위해요소가 인체에 노출된 양을 산출하는 노출평가과정 | discovery-platform/cas-scifinder |\n| 거나 뿌리는 등 이와 유사한 방법으로 사용되는 물품으로서 인체에 대한 작용이 경 | SEDinh  = | A(mg/kg bw/day) × C(%)/100 × fevap | × IR × t × fret | V | 루시퍼라아제 LuSens 시험법 | - 제품별 특성에 따라 경구, 피부 등 노출 경로 고려 | × 6.4 mg/kg bw/day | = | 5.0 mg/kg bw/day | ○ 공개된 논문 정보, 국제기구(WHO, FAO, IPCS, |\n| 위해도를 결정한다(그림 1).  | 목록 | 구분 | 내용 | T25 | = | - NOAEL 66~94 mg/kg bw/day | - 혈액학적, 임상화학적, 전신, 신경 |\n| 노출기간 | 24개월 | 반복투여(경구) | - 랫드 대상(3개월) | - 6.5~9.8, 19~25, 66~96 mg/kg bw/day | 사망이나 뚜렷한 고통과 스트레스를 초래하지 않도록 설계 | 32% | 헤어 컨디셔너 | 0.06 | 1440 | 0.041667 | (Ainh-1 + Ainh-2) × fret × fresp × fappl | 체중 당 일일 |\n| 4.  제1호부터 제3호까지의 결과를 종합하여 인체에 미치는 위해 영향을 판단하는 | 피부 상태 | 1, 3, 10 | 제품 사용에 따라 염증 수준이 증가하기 쉬운 신체 부위 고려 | 발관리(Foot care) | ○ 가장 타당한 독성시험으로부터 가장 민감한 | IARC) 및 관련기관(EPA, FDA, EU 집행위, 일본 | 잔류 지수1 |\n| 미용사 등)에게 안전해야 한다.  | 해당 제품 사용에 대한 노출시나리오에 따라 노출량을 산출할 수 있다.  | 최고 용량/노출 수준으로 정의되며, 역치가 존재하는 영향의 경우에 사용한다.  | 되는 용량 및 면적에 따라 좌우된다.  | 미한 것을 말한다. ",
        "original_sentence": "| 해당 제품 사용에 대한 노출시나리오에 따라 노출량을 산출할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_023",
      "text": "| 최고 용량/노출 수준으로 정의되며, 역치가 존재하는 영향의 경우에 사용한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 22,
        "window_size": 3,
        "char_count": 45,
        "word_count": 10,
        "page_number": 2,
        "window_text": "| 목록 | 구분 | 내용 | T25 | = | - NOAEL 66~94 mg/kg bw/day | - 혈액학적, 임상화학적, 전신, 신경 |\n| 노출기간 | 24개월 | 반복투여(경구) | - 랫드 대상(3개월) | - 6.5~9.8, 19~25, 66~96 mg/kg bw/day | 사망이나 뚜렷한 고통과 스트레스를 초래하지 않도록 설계 | 32% | 헤어 컨디셔너 | 0.06 | 1440 | 0.041667 | (Ainh-1 + Ainh-2) × fret × fresp × fappl | 체중 당 일일 |\n| 4.  제1호부터 제3호까지의 결과를 종합하여 인체에 미치는 위해 영향을 판단하는 | 피부 상태 | 1, 3, 10 | 제품 사용에 따라 염증 수준이 증가하기 쉬운 신체 부위 고려 | 발관리(Foot care) | ○ 가장 타당한 독성시험으로부터 가장 민감한 | IARC) 및 관련기관(EPA, FDA, EU 집행위, 일본 | 잔류 지수1 |\n| 미용사 등)에게 안전해야 한다.  | 해당 제품 사용에 대한 노출시나리오에 따라 노출량을 산출할 수 있다.  | 최고 용량/노출 수준으로 정의되며, 역치가 존재하는 영향의 경우에 사용한다.  | 되는 용량 및 면적에 따라 좌우된다.  | 미한 것을 말한다.  다만, 「약사법」제2조제4호의 의약품에 해당하는 물품은 제외한다. ",
        "original_sentence": "| 최고 용량/노출 수준으로 정의되며, 역치가 존재하는 영향의 경우에 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_024",
      "text": "| 되는 용량 및 면적에 따라 좌우된다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 23,
        "window_size": 3,
        "char_count": 23,
        "word_count": 7,
        "page_number": 2,
        "window_text": "제1호부터 제3호까지의 결과를 종합하여 인체에 미치는 위해 영향을 판단하는 | 피부 상태 | 1, 3, 10 | 제품 사용에 따라 염증 수준이 증가하기 쉬운 신체 부위 고려 | 발관리(Foot care) | ○ 가장 타당한 독성시험으로부터 가장 민감한 | IARC) 및 관련기관(EPA, FDA, EU 집행위, 일본 | 잔류 지수1 |\n| 미용사 등)에게 안전해야 한다.  | 해당 제품 사용에 대한 노출시나리오에 따라 노출량을 산출할 수 있다.  | 최고 용량/노출 수준으로 정의되며, 역치가 존재하는 영향의 경우에 사용한다.  | 되는 용량 및 면적에 따라 좌우된다.  | 미한 것을 말한다.  다만, 「약사법」제2조제4호의 의약품에 해당하는 물품은 제외한다.  | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 한다. ",
        "original_sentence": "| 되는 용량 및 면적에 따라 좌우된다. "
      }
    },
    {
      "chunk_id": "chunk_025",
      "text": "| 미한 것을 말한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 24,
        "window_size": 3,
        "char_count": 13,
        "word_count": 4,
        "page_number": 2,
        "window_text": "| 해당 제품 사용에 대한 노출시나리오에 따라 노출량을 산출할 수 있다.  | 최고 용량/노출 수준으로 정의되며, 역치가 존재하는 영향의 경우에 사용한다.  | 되는 용량 및 면적에 따라 좌우된다.  | 미한 것을 말한다.  다만, 「약사법」제2조제4호의 의약품에 해당하는 물품은 제외한다.  | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 한다.  | 결과보고서 | 비고 | SEDinh = | 물질명 | 추정 일일 | - 소비자 유형(예, 어린이)에 따른 시나리오 설정 | 계산된 일일 | 계산된 체중 당 | 일일 노출량 | 계산된 체중 |\n| 법을 사용할 수 있다. ",
        "original_sentence": "| 미한 것을 말한다. "
      }
    },
    {
      "chunk_id": "chunk_026",
      "text": "다만, 「약사법」제2조제4호의 의약품에 해당하는 물품은 제외한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 25,
        "window_size": 3,
        "char_count": 37,
        "word_count": 6,
        "page_number": 2,
        "window_text": "| 최고 용량/노출 수준으로 정의되며, 역치가 존재하는 영향의 경우에 사용한다.  | 되는 용량 및 면적에 따라 좌우된다.  | 미한 것을 말한다.  다만, 「약사법」제2조제4호의 의약품에 해당하는 물품은 제외한다.  | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 한다.  | 결과보고서 | 비고 | SEDinh = | 물질명 | 추정 일일 | - 소비자 유형(예, 어린이)에 따른 시나리오 설정 | 계산된 일일 | 계산된 체중 당 | 일일 노출량 | 계산된 체중 |\n| 법을 사용할 수 있다.  | 에서 안전성이 확인되면 이후 실제 상황을 반영한 노출평가는 생략할 수 있다. ",
        "original_sentence": "다만, 「약사법」제2조제4호의 의약품에 해당하는 물품은 제외한다. "
      }
    },
    {
      "chunk_id": "chunk_027",
      "text": "| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 26,
        "window_size": 3,
        "char_count": 61,
        "word_count": 10,
        "page_number": 24,
        "window_text": "| 되는 용량 및 면적에 따라 좌우된다.  | 미한 것을 말한다.  다만, 「약사법」제2조제4호의 의약품에 해당하는 물품은 제외한다.  | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 한다.  | 결과보고서 | 비고 | SEDinh = | 물질명 | 추정 일일 | - 소비자 유형(예, 어린이)에 따른 시나리오 설정 | 계산된 일일 | 계산된 체중 당 | 일일 노출량 | 계산된 체중 |\n| 법을 사용할 수 있다.  | 에서 안전성이 확인되면 이후 실제 상황을 반영한 노출평가는 생략할 수 있다.  | 노출유형 | 제품 | g/day | mg/kg bw/day | 샤워젤에 함유된 물질 B의 농도 | 50 ppb (= 50 µg/kg) | - (OECD TG423) 단회투여 분류법 : 치사율이 예상되는 노출량 범위를 확인 | - (OECD TG425) 용량고저법 : LD50 값과 신뢰구간 추정 | https://www.fda.gov/cosmetics/cosmetics-guidance-reg | 사용량 | (mg/kg | bw/day) | 체중 당 일일 | https://health.ec.europa.eu/scientific-committee | BW | 계산된 | 일일 | 노출량 | (g/day) |\n| 다(붙임 5 참고). ",
        "original_sentence": "| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 한다. "
      }
    },
    {
      "chunk_id": "chunk_028",
      "text": "| 결과보고서 | 비고 | SEDinh = | 물질명 | 추정 일일 | - 소비자 유형(예, 어린이)에 따른 시나리오 설정 | 계산된 일일 | 계산된 체중 당 | 일일 노출량 | 계산된 체중 |\n| 법을 사용할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 27,
        "window_size": 3,
        "char_count": 124,
        "word_count": 39,
        "page_number": 27,
        "window_text": "| 미한 것을 말한다.  다만, 「약사법」제2조제4호의 의약품에 해당하는 물품은 제외한다.  | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 한다.  | 결과보고서 | 비고 | SEDinh = | 물질명 | 추정 일일 | - 소비자 유형(예, 어린이)에 따른 시나리오 설정 | 계산된 일일 | 계산된 체중 당 | 일일 노출량 | 계산된 체중 |\n| 법을 사용할 수 있다.  | 에서 안전성이 확인되면 이후 실제 상황을 반영한 노출평가는 생략할 수 있다.  | 노출유형 | 제품 | g/day | mg/kg bw/day | 샤워젤에 함유된 물질 B의 농도 | 50 ppb (= 50 µg/kg) | - (OECD TG423) 단회투여 분류법 : 치사율이 예상되는 노출량 범위를 확인 | - (OECD TG425) 용량고저법 : LD50 값과 신뢰구간 추정 | https://www.fda.gov/cosmetics/cosmetics-guidance-reg | 사용량 | (mg/kg | bw/day) | 체중 당 일일 | https://health.ec.europa.eu/scientific-committee | BW | 계산된 | 일일 | 노출량 | (g/day) |\n| 다(붙임 5 참고).  | 독성자료 | 투여용량 | 결과 | 제품 유형 | 사용량 | (g/day) | 바디로션 | 5.48 | 15670 | 0.349713 | 후생성 등)에서 발간된 보고서 등 독성정보 | 독성기준값 선택 | (Retention | 잔류 지수1 | 독성 등이 없음 | 노출량 | (g/day) |\n| 안점막자극성, 피부감작성, 생식발생독성, | 고려할 수 있으며, 과학적으로 타당한 방법으로 수행된 자료인 경우에 활용 가능하다. ",
        "original_sentence": "| 결과보고서 | 비고 | SEDinh = | 물질명 | 추정 일일 | - 소비자 유형(예, 어린이)에 따른 시나리오 설정 | 계산된 일일 | 계산된 체중 당 | 일일 노출량 | 계산된 체중 |\n| 법을 사용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_029",
      "text": "| 에서 안전성이 확인되면 이후 실제 상황을 반영한 노출평가는 생략할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 28,
        "window_size": 3,
        "char_count": 45,
        "word_count": 12,
        "page_number": 2,
        "window_text": "다만, 「약사법」제2조제4호의 의약품에 해당하는 물품은 제외한다.  | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 한다.  | 결과보고서 | 비고 | SEDinh = | 물질명 | 추정 일일 | - 소비자 유형(예, 어린이)에 따른 시나리오 설정 | 계산된 일일 | 계산된 체중 당 | 일일 노출량 | 계산된 체중 |\n| 법을 사용할 수 있다.  | 에서 안전성이 확인되면 이후 실제 상황을 반영한 노출평가는 생략할 수 있다.  | 노출유형 | 제품 | g/day | mg/kg bw/day | 샤워젤에 함유된 물질 B의 농도 | 50 ppb (= 50 µg/kg) | - (OECD TG423) 단회투여 분류법 : 치사율이 예상되는 노출량 범위를 확인 | - (OECD TG425) 용량고저법 : LD50 값과 신뢰구간 추정 | https://www.fda.gov/cosmetics/cosmetics-guidance-reg | 사용량 | (mg/kg | bw/day) | 체중 당 일일 | https://health.ec.europa.eu/scientific-committee | BW | 계산된 | 일일 | 노출량 | (g/day) |\n| 다(붙임 5 참고).  | 독성자료 | 투여용량 | 결과 | 제품 유형 | 사용량 | (g/day) | 바디로션 | 5.48 | 15670 | 0.349713 | 후생성 등)에서 발간된 보고서 등 독성정보 | 독성기준값 선택 | (Retention | 잔류 지수1 | 독성 등이 없음 | 노출량 | (g/day) |\n| 안점막자극성, 피부감작성, 생식발생독성, | 고려할 수 있으며, 과학적으로 타당한 방법으로 수행된 자료인 경우에 활용 가능하다.  | 제․개정번호 | 승인일자 | 주요 내용 | 위해도 결정과정 | 사료 중 A 함유량 | 0 mg/kg | 50 mg/kg | 100 mg/kg | 시험법 | 추정 일일 | 당 일일 | 노출량 | (mg/kg | bw/day) |\n| DAa (㎍/cm2) | 평가대상 물질의 단위면적당 피부흡수량 (Dermal Absorption) | (사유 :                                                                 ) | Cas No. ",
        "original_sentence": "| 에서 안전성이 확인되면 이후 실제 상황을 반영한 노출평가는 생략할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_030",
      "text": "| 노출유형 | 제품 | g/day | mg/kg bw/day | 샤워젤에 함유된 물질 B의 농도 | 50 ppb (= 50 µg/kg) | - (OECD TG423) 단회투여 분류법 : 치사율이 예상되는 노출량 범위를 확인 | - (OECD TG425) 용량고저법 : LD50 값과 신뢰구간 추정 | https://www.fda.gov/cosmetics/cosmetics-guidance-reg | 사용량 | (mg/kg | bw/day) | 체중 당 일일 | https://health.ec.europa.eu/scientific-committee | BW | 계산된 | 일일 | 노출량 | (g/day) |\n| 다(붙임 5 참고). ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 29,
        "window_size": 3,
        "char_count": 356,
        "word_count": 72,
        "page_number": 34,
        "window_text": "| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 한다.  | 결과보고서 | 비고 | SEDinh = | 물질명 | 추정 일일 | - 소비자 유형(예, 어린이)에 따른 시나리오 설정 | 계산된 일일 | 계산된 체중 당 | 일일 노출량 | 계산된 체중 |\n| 법을 사용할 수 있다.  | 에서 안전성이 확인되면 이후 실제 상황을 반영한 노출평가는 생략할 수 있다.  | 노출유형 | 제품 | g/day | mg/kg bw/day | 샤워젤에 함유된 물질 B의 농도 | 50 ppb (= 50 µg/kg) | - (OECD TG423) 단회투여 분류법 : 치사율이 예상되는 노출량 범위를 확인 | - (OECD TG425) 용량고저법 : LD50 값과 신뢰구간 추정 | https://www.fda.gov/cosmetics/cosmetics-guidance-reg | 사용량 | (mg/kg | bw/day) | 체중 당 일일 | https://health.ec.europa.eu/scientific-committee | BW | 계산된 | 일일 | 노출량 | (g/day) |\n| 다(붙임 5 참고).  | 독성자료 | 투여용량 | 결과 | 제품 유형 | 사용량 | (g/day) | 바디로션 | 5.48 | 15670 | 0.349713 | 후생성 등)에서 발간된 보고서 등 독성정보 | 독성기준값 선택 | (Retention | 잔류 지수1 | 독성 등이 없음 | 노출량 | (g/day) |\n| 안점막자극성, 피부감작성, 생식발생독성, | 고려할 수 있으며, 과학적으로 타당한 방법으로 수행된 자료인 경우에 활용 가능하다.  | 제․개정번호 | 승인일자 | 주요 내용 | 위해도 결정과정 | 사료 중 A 함유량 | 0 mg/kg | 50 mg/kg | 100 mg/kg | 시험법 | 추정 일일 | 당 일일 | 노출량 | (mg/kg | bw/day) |\n| DAa (㎍/cm2) | 평가대상 물질의 단위면적당 피부흡수량 (Dermal Absorption) | (사유 :                                                                 ) | Cas No.  | - 적용 방법(예 : 씻어내는 제품, 바르는 제품 등) 고려 | ulation | 사용량 | (mg/kg | bw/day) | s/scientific-committee-consumer-safety-sccs_en | factor) | (mg/kg bw/day) |\n| 산출하고 위해평가를 수행한다. ",
        "original_sentence": "| 노출유형 | 제품 | g/day | mg/kg bw/day | 샤워젤에 함유된 물질 B의 농도 | 50 ppb (= 50 µg/kg) | - (OECD TG423) 단회투여 분류법 : 치사율이 예상되는 노출량 범위를 확인 | - (OECD TG425) 용량고저법 : LD50 값과 신뢰구간 추정 | https://www.fda.gov/cosmetics/cosmetics-guidance-reg | 사용량 | (mg/kg | bw/day) | 체중 당 일일 | https://health.ec.europa.eu/scientific-committee | BW | 계산된 | 일일 | 노출량 | (g/day) |\n| 다(붙임 5 참고). "
      }
    },
    {
      "chunk_id": "chunk_031",
      "text": "| 독성자료 | 투여용량 | 결과 | 제품 유형 | 사용량 | (g/day) | 바디로션 | 5.48 | 15670 | 0.349713 | 후생성 등)에서 발간된 보고서 등 독성정보 | 독성기준값 선택 | (Retention | 잔류 지수1 | 독성 등이 없음 | 노출량 | (g/day) |\n| 안점막자극성, 피부감작성, 생식발생독성, | 고려할 수 있으며, 과학적으로 타당한 방법으로 수행된 자료인 경우에 활용 가능하다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 30,
        "window_size": 3,
        "char_count": 238,
        "word_count": 61,
        "page_number": 37,
        "window_text": "| 결과보고서 | 비고 | SEDinh = | 물질명 | 추정 일일 | - 소비자 유형(예, 어린이)에 따른 시나리오 설정 | 계산된 일일 | 계산된 체중 당 | 일일 노출량 | 계산된 체중 |\n| 법을 사용할 수 있다.  | 에서 안전성이 확인되면 이후 실제 상황을 반영한 노출평가는 생략할 수 있다.  | 노출유형 | 제품 | g/day | mg/kg bw/day | 샤워젤에 함유된 물질 B의 농도 | 50 ppb (= 50 µg/kg) | - (OECD TG423) 단회투여 분류법 : 치사율이 예상되는 노출량 범위를 확인 | - (OECD TG425) 용량고저법 : LD50 값과 신뢰구간 추정 | https://www.fda.gov/cosmetics/cosmetics-guidance-reg | 사용량 | (mg/kg | bw/day) | 체중 당 일일 | https://health.ec.europa.eu/scientific-committee | BW | 계산된 | 일일 | 노출량 | (g/day) |\n| 다(붙임 5 참고).  | 독성자료 | 투여용량 | 결과 | 제품 유형 | 사용량 | (g/day) | 바디로션 | 5.48 | 15670 | 0.349713 | 후생성 등)에서 발간된 보고서 등 독성정보 | 독성기준값 선택 | (Retention | 잔류 지수1 | 독성 등이 없음 | 노출량 | (g/day) |\n| 안점막자극성, 피부감작성, 생식발생독성, | 고려할 수 있으며, 과학적으로 타당한 방법으로 수행된 자료인 경우에 활용 가능하다.  | 제․개정번호 | 승인일자 | 주요 내용 | 위해도 결정과정 | 사료 중 A 함유량 | 0 mg/kg | 50 mg/kg | 100 mg/kg | 시험법 | 추정 일일 | 당 일일 | 노출량 | (mg/kg | bw/day) |\n| DAa (㎍/cm2) | 평가대상 물질의 단위면적당 피부흡수량 (Dermal Absorption) | (사유 :                                                                 ) | Cas No.  | - 적용 방법(예 : 씻어내는 제품, 바르는 제품 등) 고려 | ulation | 사용량 | (mg/kg | bw/day) | s/scientific-committee-consumer-safety-sccs_en | factor) | (mg/kg bw/day) |\n| 산출하고 위해평가를 수행한다.  | 제8조(화장품 안전기준 등) ① 식품의약품안전처장은 화장품의 제조 등에 사용할 수 | 다. ",
        "original_sentence": "| 독성자료 | 투여용량 | 결과 | 제품 유형 | 사용량 | (g/day) | 바디로션 | 5.48 | 15670 | 0.349713 | 후생성 등)에서 발간된 보고서 등 독성정보 | 독성기준값 선택 | (Retention | 잔류 지수1 | 독성 등이 없음 | 노출량 | (g/day) |\n| 안점막자극성, 피부감작성, 생식발생독성, | 고려할 수 있으며, 과학적으로 타당한 방법으로 수행된 자료인 경우에 활용 가능하다. "
      }
    },
    {
      "chunk_id": "chunk_032",
      "text": "| 제․개정번호 | 승인일자 | 주요 내용 | 위해도 결정과정 | 사료 중 A 함유량 | 0 mg/kg | 50 mg/kg | 100 mg/kg | 시험법 | 추정 일일 | 당 일일 | 노출량 | (mg/kg | bw/day) |\n| DAa (㎍/cm2) | 평가대상 물질의 단위면적당 피부흡수량 (Dermal Absorption) | (사유 :                                                                 ) | Cas No. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 31,
        "window_size": 3,
        "char_count": 270,
        "word_count": 56,
        "page_number": 4,
        "window_text": "| 에서 안전성이 확인되면 이후 실제 상황을 반영한 노출평가는 생략할 수 있다.  | 노출유형 | 제품 | g/day | mg/kg bw/day | 샤워젤에 함유된 물질 B의 농도 | 50 ppb (= 50 µg/kg) | - (OECD TG423) 단회투여 분류법 : 치사율이 예상되는 노출량 범위를 확인 | - (OECD TG425) 용량고저법 : LD50 값과 신뢰구간 추정 | https://www.fda.gov/cosmetics/cosmetics-guidance-reg | 사용량 | (mg/kg | bw/day) | 체중 당 일일 | https://health.ec.europa.eu/scientific-committee | BW | 계산된 | 일일 | 노출량 | (g/day) |\n| 다(붙임 5 참고).  | 독성자료 | 투여용량 | 결과 | 제품 유형 | 사용량 | (g/day) | 바디로션 | 5.48 | 15670 | 0.349713 | 후생성 등)에서 발간된 보고서 등 독성정보 | 독성기준값 선택 | (Retention | 잔류 지수1 | 독성 등이 없음 | 노출량 | (g/day) |\n| 안점막자극성, 피부감작성, 생식발생독성, | 고려할 수 있으며, 과학적으로 타당한 방법으로 수행된 자료인 경우에 활용 가능하다.  | 제․개정번호 | 승인일자 | 주요 내용 | 위해도 결정과정 | 사료 중 A 함유량 | 0 mg/kg | 50 mg/kg | 100 mg/kg | 시험법 | 추정 일일 | 당 일일 | 노출량 | (mg/kg | bw/day) |\n| DAa (㎍/cm2) | 평가대상 물질의 단위면적당 피부흡수량 (Dermal Absorption) | (사유 :                                                                 ) | Cas No.  | - 적용 방법(예 : 씻어내는 제품, 바르는 제품 등) 고려 | ulation | 사용량 | (mg/kg | bw/day) | s/scientific-committee-consumer-safety-sccs_en | factor) | (mg/kg bw/day) |\n| 산출하고 위해평가를 수행한다.  | 제8조(화장품 안전기준 등) ① 식품의약품안전처장은 화장품의 제조 등에 사용할 수 | 다.  | 제품 유형 | · Aexpo (g) = A × C × fair | 사용량 | 샤워 젤 | 0.19 | 2.79 | 조사 | (Retention | - NOEL 10 mg/kg bw/day | - NOAEL 41 mg/kg bw/day | - 41 mg/kg bw/day 용량에서 혈액 |\n| 3.1.4.1.1 흡수, 분포, 대사, 배설 | (USEPA, 1995 : Benchmark Dose) | 물질정보 | 능성이 낮은 것으로 평가할 수 있다. ",
        "original_sentence": "| 제․개정번호 | 승인일자 | 주요 내용 | 위해도 결정과정 | 사료 중 A 함유량 | 0 mg/kg | 50 mg/kg | 100 mg/kg | 시험법 | 추정 일일 | 당 일일 | 노출량 | (mg/kg | bw/day) |\n| DAa (㎍/cm2) | 평가대상 물질의 단위면적당 피부흡수량 (Dermal Absorption) | (사유 :                                                                 ) | Cas No. "
      }
    },
    {
      "chunk_id": "chunk_033",
      "text": "| - 적용 방법(예 : 씻어내는 제품, 바르는 제품 등) 고려 | ulation | 사용량 | (mg/kg | bw/day) | s/scientific-committee-consumer-safety-sccs_en | factor) | (mg/kg bw/day) |\n| 산출하고 위해평가를 수행한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 32,
        "window_size": 3,
        "char_count": 168,
        "word_count": 31,
        "page_number": 22,
        "window_text": "| 노출유형 | 제품 | g/day | mg/kg bw/day | 샤워젤에 함유된 물질 B의 농도 | 50 ppb (= 50 µg/kg) | - (OECD TG423) 단회투여 분류법 : 치사율이 예상되는 노출량 범위를 확인 | - (OECD TG425) 용량고저법 : LD50 값과 신뢰구간 추정 | https://www.fda.gov/cosmetics/cosmetics-guidance-reg | 사용량 | (mg/kg | bw/day) | 체중 당 일일 | https://health.ec.europa.eu/scientific-committee | BW | 계산된 | 일일 | 노출량 | (g/day) |\n| 다(붙임 5 참고).  | 독성자료 | 투여용량 | 결과 | 제품 유형 | 사용량 | (g/day) | 바디로션 | 5.48 | 15670 | 0.349713 | 후생성 등)에서 발간된 보고서 등 독성정보 | 독성기준값 선택 | (Retention | 잔류 지수1 | 독성 등이 없음 | 노출량 | (g/day) |\n| 안점막자극성, 피부감작성, 생식발생독성, | 고려할 수 있으며, 과학적으로 타당한 방법으로 수행된 자료인 경우에 활용 가능하다.  | 제․개정번호 | 승인일자 | 주요 내용 | 위해도 결정과정 | 사료 중 A 함유량 | 0 mg/kg | 50 mg/kg | 100 mg/kg | 시험법 | 추정 일일 | 당 일일 | 노출량 | (mg/kg | bw/day) |\n| DAa (㎍/cm2) | 평가대상 물질의 단위면적당 피부흡수량 (Dermal Absorption) | (사유 :                                                                 ) | Cas No.  | - 적용 방법(예 : 씻어내는 제품, 바르는 제품 등) 고려 | ulation | 사용량 | (mg/kg | bw/day) | s/scientific-committee-consumer-safety-sccs_en | factor) | (mg/kg bw/day) |\n| 산출하고 위해평가를 수행한다.  | 제8조(화장품 안전기준 등) ① 식품의약품안전처장은 화장품의 제조 등에 사용할 수 | 다.  | 제품 유형 | · Aexpo (g) = A × C × fair | 사용량 | 샤워 젤 | 0.19 | 2.79 | 조사 | (Retention | - NOEL 10 mg/kg bw/day | - NOAEL 41 mg/kg bw/day | - 41 mg/kg bw/day 용량에서 혈액 |\n| 3.1.4.1.1 흡수, 분포, 대사, 배설 | (USEPA, 1995 : Benchmark Dose) | 물질정보 | 능성이 낮은 것으로 평가할 수 있다.  | 유전독성, 발암성, 광독성 등 | 샤워젤 1일 노출량 | 1.62 mg/kg bw/day | - (OECD TG406) Magnusson Kligman 기니피그 극대화 시험(GPMT) | Tumor type | male | female | male | female | male | female | 얼굴 크림 | 1.76 | 565 | 3.115044 | ○ 위해평가 요약, 목적, 범위, 내용, 방법, 결론 및 참고문 | - 독성기준값 선택은 체중감소, 장기무게 감 | - NOAEL 0.9 g/kg/day | - 2.7 g/kg/day 농도에서 체중감소, 흉선의 |\n| ② 식품의약품안전처장은 제1항에 따른 결과를 근거로 식품의약품안전처장이 정하는 | 결정 진행 | SSA (cm2) | 평가 대상 물질이 함유된 화장품을 도포한 피부 표면적1 | 반복투여 | - 랫드 대상(3주) | - 0, 0.3, 0.9, 2.7 g/kg/day | 분자량(g/mol, mg/mol) | https://www.fda.gov/industry/color-additives-specific-p |\n| 용하여 실제 사용방법을 고려하여(mimicking) in vitro 시험으로부터 선정한다. ",
        "original_sentence": "| - 적용 방법(예 : 씻어내는 제품, 바르는 제품 등) 고려 | ulation | 사용량 | (mg/kg | bw/day) | s/scientific-committee-consumer-safety-sccs_en | factor) | (mg/kg bw/day) |\n| 산출하고 위해평가를 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_034",
      "text": "| 제8조(화장품 안전기준 등) ① 식품의약품안전처장은 화장품의 제조 등에 사용할 수 | 다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 33,
        "window_size": 3,
        "char_count": 53,
        "word_count": 13,
        "page_number": 8,
        "window_text": "| 독성자료 | 투여용량 | 결과 | 제품 유형 | 사용량 | (g/day) | 바디로션 | 5.48 | 15670 | 0.349713 | 후생성 등)에서 발간된 보고서 등 독성정보 | 독성기준값 선택 | (Retention | 잔류 지수1 | 독성 등이 없음 | 노출량 | (g/day) |\n| 안점막자극성, 피부감작성, 생식발생독성, | 고려할 수 있으며, 과학적으로 타당한 방법으로 수행된 자료인 경우에 활용 가능하다.  | 제․개정번호 | 승인일자 | 주요 내용 | 위해도 결정과정 | 사료 중 A 함유량 | 0 mg/kg | 50 mg/kg | 100 mg/kg | 시험법 | 추정 일일 | 당 일일 | 노출량 | (mg/kg | bw/day) |\n| DAa (㎍/cm2) | 평가대상 물질의 단위면적당 피부흡수량 (Dermal Absorption) | (사유 :                                                                 ) | Cas No.  | - 적용 방법(예 : 씻어내는 제품, 바르는 제품 등) 고려 | ulation | 사용량 | (mg/kg | bw/day) | s/scientific-committee-consumer-safety-sccs_en | factor) | (mg/kg bw/day) |\n| 산출하고 위해평가를 수행한다.  | 제8조(화장품 안전기준 등) ① 식품의약품안전처장은 화장품의 제조 등에 사용할 수 | 다.  | 제품 유형 | · Aexpo (g) = A × C × fair | 사용량 | 샤워 젤 | 0.19 | 2.79 | 조사 | (Retention | - NOEL 10 mg/kg bw/day | - NOAEL 41 mg/kg bw/day | - 41 mg/kg bw/day 용량에서 혈액 |\n| 3.1.4.1.1 흡수, 분포, 대사, 배설 | (USEPA, 1995 : Benchmark Dose) | 물질정보 | 능성이 낮은 것으로 평가할 수 있다.  | 유전독성, 발암성, 광독성 등 | 샤워젤 1일 노출량 | 1.62 mg/kg bw/day | - (OECD TG406) Magnusson Kligman 기니피그 극대화 시험(GPMT) | Tumor type | male | female | male | female | male | female | 얼굴 크림 | 1.76 | 565 | 3.115044 | ○ 위해평가 요약, 목적, 범위, 내용, 방법, 결론 및 참고문 | - 독성기준값 선택은 체중감소, 장기무게 감 | - NOAEL 0.9 g/kg/day | - 2.7 g/kg/day 농도에서 체중감소, 흉선의 |\n| ② 식품의약품안전처장은 제1항에 따른 결과를 근거로 식품의약품안전처장이 정하는 | 결정 진행 | SSA (cm2) | 평가 대상 물질이 함유된 화장품을 도포한 피부 표면적1 | 반복투여 | - 랫드 대상(3주) | - 0, 0.3, 0.9, 2.7 g/kg/day | 분자량(g/mol, mg/mol) | https://www.fda.gov/industry/color-additives-specific-p |\n| 용하여 실제 사용방법을 고려하여(mimicking) in vitro 시험으로부터 선정한다.  | 반복투여(경구) | - 비글견 대상(3개월) | - 3, 10, 41 mg/kg bw/day | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | - (OECD TG403) 단회투여 흡입독성시험 | - (OECD TG402) 단회투여 피부독성시험 | (g/day)(90%) | 손 세정 비누 | 0.20 | 3.33 | factor) |\n| 결과 등을 통해 평가한다. ",
        "original_sentence": "| 제8조(화장품 안전기준 등) ① 식품의약품안전처장은 화장품의 제조 등에 사용할 수 | 다. "
      }
    },
    {
      "chunk_id": "chunk_035",
      "text": "| 제품 유형 | · Aexpo (g) = A × C × fair | 사용량 | 샤워 젤 | 0.19 | 2.79 | 조사 | (Retention | - NOEL 10 mg/kg bw/day | - NOAEL 41 mg/kg bw/day | - 41 mg/kg bw/day 용량에서 혈액 |\n| 3.1.4.1.1 흡수, 분포, 대사, 배설 | (USEPA, 1995 : Benchmark Dose) | 물질정보 | 능성이 낮은 것으로 평가할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 34,
        "window_size": 3,
        "char_count": 253,
        "word_count": 67,
        "page_number": 27,
        "window_text": "| 제․개정번호 | 승인일자 | 주요 내용 | 위해도 결정과정 | 사료 중 A 함유량 | 0 mg/kg | 50 mg/kg | 100 mg/kg | 시험법 | 추정 일일 | 당 일일 | 노출량 | (mg/kg | bw/day) |\n| DAa (㎍/cm2) | 평가대상 물질의 단위면적당 피부흡수량 (Dermal Absorption) | (사유 :                                                                 ) | Cas No.  | - 적용 방법(예 : 씻어내는 제품, 바르는 제품 등) 고려 | ulation | 사용량 | (mg/kg | bw/day) | s/scientific-committee-consumer-safety-sccs_en | factor) | (mg/kg bw/day) |\n| 산출하고 위해평가를 수행한다.  | 제8조(화장품 안전기준 등) ① 식품의약품안전처장은 화장품의 제조 등에 사용할 수 | 다.  | 제품 유형 | · Aexpo (g) = A × C × fair | 사용량 | 샤워 젤 | 0.19 | 2.79 | 조사 | (Retention | - NOEL 10 mg/kg bw/day | - NOAEL 41 mg/kg bw/day | - 41 mg/kg bw/day 용량에서 혈액 |\n| 3.1.4.1.1 흡수, 분포, 대사, 배설 | (USEPA, 1995 : Benchmark Dose) | 물질정보 | 능성이 낮은 것으로 평가할 수 있다.  | 유전독성, 발암성, 광독성 등 | 샤워젤 1일 노출량 | 1.62 mg/kg bw/day | - (OECD TG406) Magnusson Kligman 기니피그 극대화 시험(GPMT) | Tumor type | male | female | male | female | male | female | 얼굴 크림 | 1.76 | 565 | 3.115044 | ○ 위해평가 요약, 목적, 범위, 내용, 방법, 결론 및 참고문 | - 독성기준값 선택은 체중감소, 장기무게 감 | - NOAEL 0.9 g/kg/day | - 2.7 g/kg/day 농도에서 체중감소, 흉선의 |\n| ② 식품의약품안전처장은 제1항에 따른 결과를 근거로 식품의약품안전처장이 정하는 | 결정 진행 | SSA (cm2) | 평가 대상 물질이 함유된 화장품을 도포한 피부 표면적1 | 반복투여 | - 랫드 대상(3주) | - 0, 0.3, 0.9, 2.7 g/kg/day | 분자량(g/mol, mg/mol) | https://www.fda.gov/industry/color-additives-specific-p |\n| 용하여 실제 사용방법을 고려하여(mimicking) in vitro 시험으로부터 선정한다.  | 반복투여(경구) | - 비글견 대상(3개월) | - 3, 10, 41 mg/kg bw/day | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | - (OECD TG403) 단회투여 흡입독성시험 | - (OECD TG402) 단회투여 피부독성시험 | (g/day)(90%) | 손 세정 비누 | 0.20 | 3.33 | factor) |\n| 결과 등을 통해 평가한다.  | 없는 원료를 지정하여 고시하여야 한다. ",
        "original_sentence": "| 제품 유형 | · Aexpo (g) = A × C × fair | 사용량 | 샤워 젤 | 0.19 | 2.79 | 조사 | (Retention | - NOEL 10 mg/kg bw/day | - NOAEL 41 mg/kg bw/day | - 41 mg/kg bw/day 용량에서 혈액 |\n| 3.1.4.1.1 흡수, 분포, 대사, 배설 | (USEPA, 1995 : Benchmark Dose) | 물질정보 | 능성이 낮은 것으로 평가할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_036",
      "text": "| 유전독성, 발암성, 광독성 등 | 샤워젤 1일 노출량 | 1.62 mg/kg bw/day | - (OECD TG406) Magnusson Kligman 기니피그 극대화 시험(GPMT) | Tumor type | male | female | male | female | male | female | 얼굴 크림 | 1.76 | 565 | 3.115044 | ○ 위해평가 요약, 목적, 범위, 내용, 방법, 결론 및 참고문 | - 독성기준값 선택은 체중감소, 장기무게 감 | - NOAEL 0.9 g/kg/day | - 2.7 g/kg/day 농도에서 체중감소, 흉선의 |\n| ② 식품의약품안전처장은 제1항에 따른 결과를 근거로 식품의약품안전처장이 정하는 | 결정 진행 | SSA (cm2) | 평가 대상 물질이 함유된 화장품을 도포한 피부 표면적1 | 반복투여 | - 랫드 대상(3주) | - 0, 0.3, 0.9, 2.7 g/kg/day | 분자량(g/mol, mg/mol) | https://www.fda.gov/industry/color-additives-specific-p |\n| 용하여 실제 사용방법을 고려하여(mimicking) in vitro 시험으로부터 선정한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 35,
        "window_size": 3,
        "char_count": 604,
        "word_count": 129,
        "page_number": 17,
        "window_text": "| - 적용 방법(예 : 씻어내는 제품, 바르는 제품 등) 고려 | ulation | 사용량 | (mg/kg | bw/day) | s/scientific-committee-consumer-safety-sccs_en | factor) | (mg/kg bw/day) |\n| 산출하고 위해평가를 수행한다.  | 제8조(화장품 안전기준 등) ① 식품의약품안전처장은 화장품의 제조 등에 사용할 수 | 다.  | 제품 유형 | · Aexpo (g) = A × C × fair | 사용량 | 샤워 젤 | 0.19 | 2.79 | 조사 | (Retention | - NOEL 10 mg/kg bw/day | - NOAEL 41 mg/kg bw/day | - 41 mg/kg bw/day 용량에서 혈액 |\n| 3.1.4.1.1 흡수, 분포, 대사, 배설 | (USEPA, 1995 : Benchmark Dose) | 물질정보 | 능성이 낮은 것으로 평가할 수 있다.  | 유전독성, 발암성, 광독성 등 | 샤워젤 1일 노출량 | 1.62 mg/kg bw/day | - (OECD TG406) Magnusson Kligman 기니피그 극대화 시험(GPMT) | Tumor type | male | female | male | female | male | female | 얼굴 크림 | 1.76 | 565 | 3.115044 | ○ 위해평가 요약, 목적, 범위, 내용, 방법, 결론 및 참고문 | - 독성기준값 선택은 체중감소, 장기무게 감 | - NOAEL 0.9 g/kg/day | - 2.7 g/kg/day 농도에서 체중감소, 흉선의 |\n| ② 식품의약품안전처장은 제1항에 따른 결과를 근거로 식품의약품안전처장이 정하는 | 결정 진행 | SSA (cm2) | 평가 대상 물질이 함유된 화장품을 도포한 피부 표면적1 | 반복투여 | - 랫드 대상(3주) | - 0, 0.3, 0.9, 2.7 g/kg/day | 분자량(g/mol, mg/mol) | https://www.fda.gov/industry/color-additives-specific-p |\n| 용하여 실제 사용방법을 고려하여(mimicking) in vitro 시험으로부터 선정한다.  | 반복투여(경구) | - 비글견 대상(3개월) | - 3, 10, 41 mg/kg bw/day | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | - (OECD TG403) 단회투여 흡입독성시험 | - (OECD TG402) 단회투여 피부독성시험 | (g/day)(90%) | 손 세정 비누 | 0.20 | 3.33 | factor) |\n| 결과 등을 통해 평가한다.  | 없는 원료를 지정하여 고시하여야 한다.  | 시나리오를 적용하여 평가할 수 있다. ",
        "original_sentence": "| 유전독성, 발암성, 광독성 등 | 샤워젤 1일 노출량 | 1.62 mg/kg bw/day | - (OECD TG406) Magnusson Kligman 기니피그 극대화 시험(GPMT) | Tumor type | male | female | male | female | male | female | 얼굴 크림 | 1.76 | 565 | 3.115044 | ○ 위해평가 요약, 목적, 범위, 내용, 방법, 결론 및 참고문 | - 독성기준값 선택은 체중감소, 장기무게 감 | - NOAEL 0.9 g/kg/day | - 2.7 g/kg/day 농도에서 체중감소, 흉선의 |\n| ② 식품의약품안전처장은 제1항에 따른 결과를 근거로 식품의약품안전처장이 정하는 | 결정 진행 | SSA (cm2) | 평가 대상 물질이 함유된 화장품을 도포한 피부 표면적1 | 반복투여 | - 랫드 대상(3주) | - 0, 0.3, 0.9, 2.7 g/kg/day | 분자량(g/mol, mg/mol) | https://www.fda.gov/industry/color-additives-specific-p |\n| 용하여 실제 사용방법을 고려하여(mimicking) in vitro 시험으로부터 선정한다. "
      }
    },
    {
      "chunk_id": "chunk_037",
      "text": "| 반복투여(경구) | - 비글견 대상(3개월) | - 3, 10, 41 mg/kg bw/day | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | - (OECD TG403) 단회투여 흡입독성시험 | - (OECD TG402) 단회투여 피부독성시험 | (g/day)(90%) | 손 세정 비누 | 0.20 | 3.33 | factor) |\n| 결과 등을 통해 평가한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 36,
        "window_size": 3,
        "char_count": 257,
        "word_count": 55,
        "page_number": 37,
        "window_text": "| 제8조(화장품 안전기준 등) ① 식품의약품안전처장은 화장품의 제조 등에 사용할 수 | 다.  | 제품 유형 | · Aexpo (g) = A × C × fair | 사용량 | 샤워 젤 | 0.19 | 2.79 | 조사 | (Retention | - NOEL 10 mg/kg bw/day | - NOAEL 41 mg/kg bw/day | - 41 mg/kg bw/day 용량에서 혈액 |\n| 3.1.4.1.1 흡수, 분포, 대사, 배설 | (USEPA, 1995 : Benchmark Dose) | 물질정보 | 능성이 낮은 것으로 평가할 수 있다.  | 유전독성, 발암성, 광독성 등 | 샤워젤 1일 노출량 | 1.62 mg/kg bw/day | - (OECD TG406) Magnusson Kligman 기니피그 극대화 시험(GPMT) | Tumor type | male | female | male | female | male | female | 얼굴 크림 | 1.76 | 565 | 3.115044 | ○ 위해평가 요약, 목적, 범위, 내용, 방법, 결론 및 참고문 | - 독성기준값 선택은 체중감소, 장기무게 감 | - NOAEL 0.9 g/kg/day | - 2.7 g/kg/day 농도에서 체중감소, 흉선의 |\n| ② 식품의약품안전처장은 제1항에 따른 결과를 근거로 식품의약품안전처장이 정하는 | 결정 진행 | SSA (cm2) | 평가 대상 물질이 함유된 화장품을 도포한 피부 표면적1 | 반복투여 | - 랫드 대상(3주) | - 0, 0.3, 0.9, 2.7 g/kg/day | 분자량(g/mol, mg/mol) | https://www.fda.gov/industry/color-additives-specific-p |\n| 용하여 실제 사용방법을 고려하여(mimicking) in vitro 시험으로부터 선정한다.  | 반복투여(경구) | - 비글견 대상(3개월) | - 3, 10, 41 mg/kg bw/day | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | - (OECD TG403) 단회투여 흡입독성시험 | - (OECD TG402) 단회투여 피부독성시험 | (g/day)(90%) | 손 세정 비누 | 0.20 | 3.33 | factor) |\n| 결과 등을 통해 평가한다.  | 없는 원료를 지정하여 고시하여야 한다.  | 시나리오를 적용하여 평가할 수 있다.  | - (OECD TG406) Buehler 시험 | 방향제(Fragrances) | 목욕 및 샤워 | 헌 등 작성하고 관련 정보 첨부 | ○ 국제기구 및 외국 독성평가 기관에서 제시하고 | 소, 조직학적 변화, 그 밖의 독성시험 결과 | □ 예 | ■ 아니오 |\n| (SED) 산출 | 물질 B의 피부흡수율 | 65% | (경구) | Malignant | lymphomas | 2/50 | (4%) | 0/50 | (0%) | 14/50 | (28%) | 16/50 | (32%) | 25/50 | (50%) | 23/50 | (46%) |\n| 는 것이 가장 좋으나 기존의 자료들도 활용할 수 있다. ",
        "original_sentence": "| 반복투여(경구) | - 비글견 대상(3개월) | - 3, 10, 41 mg/kg bw/day | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | - (OECD TG403) 단회투여 흡입독성시험 | - (OECD TG402) 단회투여 피부독성시험 | (g/day)(90%) | 손 세정 비누 | 0.20 | 3.33 | factor) |\n| 결과 등을 통해 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_038",
      "text": "| 없는 원료를 지정하여 고시하여야 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 37,
        "window_size": 3,
        "char_count": 24,
        "word_count": 6,
        "page_number": 2,
        "window_text": "| 제품 유형 | · Aexpo (g) = A × C × fair | 사용량 | 샤워 젤 | 0.19 | 2.79 | 조사 | (Retention | - NOEL 10 mg/kg bw/day | - NOAEL 41 mg/kg bw/day | - 41 mg/kg bw/day 용량에서 혈액 |\n| 3.1.4.1.1 흡수, 분포, 대사, 배설 | (USEPA, 1995 : Benchmark Dose) | 물질정보 | 능성이 낮은 것으로 평가할 수 있다.  | 유전독성, 발암성, 광독성 등 | 샤워젤 1일 노출량 | 1.62 mg/kg bw/day | - (OECD TG406) Magnusson Kligman 기니피그 극대화 시험(GPMT) | Tumor type | male | female | male | female | male | female | 얼굴 크림 | 1.76 | 565 | 3.115044 | ○ 위해평가 요약, 목적, 범위, 내용, 방법, 결론 및 참고문 | - 독성기준값 선택은 체중감소, 장기무게 감 | - NOAEL 0.9 g/kg/day | - 2.7 g/kg/day 농도에서 체중감소, 흉선의 |\n| ② 식품의약품안전처장은 제1항에 따른 결과를 근거로 식품의약품안전처장이 정하는 | 결정 진행 | SSA (cm2) | 평가 대상 물질이 함유된 화장품을 도포한 피부 표면적1 | 반복투여 | - 랫드 대상(3주) | - 0, 0.3, 0.9, 2.7 g/kg/day | 분자량(g/mol, mg/mol) | https://www.fda.gov/industry/color-additives-specific-p |\n| 용하여 실제 사용방법을 고려하여(mimicking) in vitro 시험으로부터 선정한다.  | 반복투여(경구) | - 비글견 대상(3개월) | - 3, 10, 41 mg/kg bw/day | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | - (OECD TG403) 단회투여 흡입독성시험 | - (OECD TG402) 단회투여 피부독성시험 | (g/day)(90%) | 손 세정 비누 | 0.20 | 3.33 | factor) |\n| 결과 등을 통해 평가한다.  | 없는 원료를 지정하여 고시하여야 한다.  | 시나리오를 적용하여 평가할 수 있다.  | - (OECD TG406) Buehler 시험 | 방향제(Fragrances) | 목욕 및 샤워 | 헌 등 작성하고 관련 정보 첨부 | ○ 국제기구 및 외국 독성평가 기관에서 제시하고 | 소, 조직학적 변화, 그 밖의 독성시험 결과 | □ 예 | ■ 아니오 |\n| (SED) 산출 | 물질 B의 피부흡수율 | 65% | (경구) | Malignant | lymphomas | 2/50 | (4%) | 0/50 | (0%) | 14/50 | (28%) | 16/50 | (32%) | 25/50 | (50%) | 23/50 | (46%) |\n| 는 것이 가장 좋으나 기존의 자료들도 활용할 수 있다.  | 기준에 따라 위해여부를 결정한다. ",
        "original_sentence": "| 없는 원료를 지정하여 고시하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_039",
      "text": "| 시나리오를 적용하여 평가할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 38,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 2,
        "window_text": "| 유전독성, 발암성, 광독성 등 | 샤워젤 1일 노출량 | 1.62 mg/kg bw/day | - (OECD TG406) Magnusson Kligman 기니피그 극대화 시험(GPMT) | Tumor type | male | female | male | female | male | female | 얼굴 크림 | 1.76 | 565 | 3.115044 | ○ 위해평가 요약, 목적, 범위, 내용, 방법, 결론 및 참고문 | - 독성기준값 선택은 체중감소, 장기무게 감 | - NOAEL 0.9 g/kg/day | - 2.7 g/kg/day 농도에서 체중감소, 흉선의 |\n| ② 식품의약품안전처장은 제1항에 따른 결과를 근거로 식품의약품안전처장이 정하는 | 결정 진행 | SSA (cm2) | 평가 대상 물질이 함유된 화장품을 도포한 피부 표면적1 | 반복투여 | - 랫드 대상(3주) | - 0, 0.3, 0.9, 2.7 g/kg/day | 분자량(g/mol, mg/mol) | https://www.fda.gov/industry/color-additives-specific-p |\n| 용하여 실제 사용방법을 고려하여(mimicking) in vitro 시험으로부터 선정한다.  | 반복투여(경구) | - 비글견 대상(3개월) | - 3, 10, 41 mg/kg bw/day | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | - (OECD TG403) 단회투여 흡입독성시험 | - (OECD TG402) 단회투여 피부독성시험 | (g/day)(90%) | 손 세정 비누 | 0.20 | 3.33 | factor) |\n| 결과 등을 통해 평가한다.  | 없는 원료를 지정하여 고시하여야 한다.  | 시나리오를 적용하여 평가할 수 있다.  | - (OECD TG406) Buehler 시험 | 방향제(Fragrances) | 목욕 및 샤워 | 헌 등 작성하고 관련 정보 첨부 | ○ 국제기구 및 외국 독성평가 기관에서 제시하고 | 소, 조직학적 변화, 그 밖의 독성시험 결과 | □ 예 | ■ 아니오 |\n| (SED) 산출 | 물질 B의 피부흡수율 | 65% | (경구) | Malignant | lymphomas | 2/50 | (4%) | 0/50 | (0%) | 14/50 | (28%) | 16/50 | (32%) | 25/50 | (50%) | 23/50 | (46%) |\n| 는 것이 가장 좋으나 기존의 자료들도 활용할 수 있다.  | 기준에 따라 위해여부를 결정한다.  다만, 해당화장품 원료 등에 대하여 국내외의 연 | B2-2011-4-005 | 2011.08. ",
        "original_sentence": "| 시나리오를 적용하여 평가할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_040",
      "text": "| - (OECD TG406) Buehler 시험 | 방향제(Fragrances) | 목욕 및 샤워 | 헌 등 작성하고 관련 정보 첨부 | ○ 국제기구 및 외국 독성평가 기관에서 제시하고 | 소, 조직학적 변화, 그 밖의 독성시험 결과 | □ 예 | ■ 아니오 |\n| (SED) 산출 | 물질 B의 피부흡수율 | 65% | (경구) | Malignant | lymphomas | 2/50 | (4%) | 0/50 | (0%) | 14/50 | (28%) | 16/50 | (32%) | 25/50 | (50%) | 23/50 | (46%) |\n| 는 것이 가장 좋으나 기존의 자료들도 활용할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 39,
        "window_size": 3,
        "char_count": 337,
        "word_count": 92,
        "page_number": 37,
        "window_text": "| 반복투여(경구) | - 비글견 대상(3개월) | - 3, 10, 41 mg/kg bw/day | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | - (OECD TG403) 단회투여 흡입독성시험 | - (OECD TG402) 단회투여 피부독성시험 | (g/day)(90%) | 손 세정 비누 | 0.20 | 3.33 | factor) |\n| 결과 등을 통해 평가한다.  | 없는 원료를 지정하여 고시하여야 한다.  | 시나리오를 적용하여 평가할 수 있다.  | - (OECD TG406) Buehler 시험 | 방향제(Fragrances) | 목욕 및 샤워 | 헌 등 작성하고 관련 정보 첨부 | ○ 국제기구 및 외국 독성평가 기관에서 제시하고 | 소, 조직학적 변화, 그 밖의 독성시험 결과 | □ 예 | ■ 아니오 |\n| (SED) 산출 | 물질 B의 피부흡수율 | 65% | (경구) | Malignant | lymphomas | 2/50 | (4%) | 0/50 | (0%) | 14/50 | (28%) | 16/50 | (32%) | 25/50 | (50%) | 23/50 | (46%) |\n| 는 것이 가장 좋으나 기존의 자료들도 활용할 수 있다.  | 기준에 따라 위해여부를 결정한다.  다만, 해당화장품 원료 등에 대하여 국내외의 연 | B2-2011-4-005 | 2011.08.  | 화장품 위해평가 가이드라인 제정 | 포함되었고, 어떤 노출 모델이 선택되었는지 확인할 수 있다. ",
        "original_sentence": "| - (OECD TG406) Buehler 시험 | 방향제(Fragrances) | 목욕 및 샤워 | 헌 등 작성하고 관련 정보 첨부 | ○ 국제기구 및 외국 독성평가 기관에서 제시하고 | 소, 조직학적 변화, 그 밖의 독성시험 결과 | □ 예 | ■ 아니오 |\n| (SED) 산출 | 물질 B의 피부흡수율 | 65% | (경구) | Malignant | lymphomas | 2/50 | (4%) | 0/50 | (0%) | 14/50 | (28%) | 16/50 | (32%) | 25/50 | (50%) | 23/50 | (46%) |\n| 는 것이 가장 좋으나 기존의 자료들도 활용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_041",
      "text": "| 기준에 따라 위해여부를 결정한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 40,
        "window_size": 3,
        "char_count": 21,
        "word_count": 5,
        "page_number": 2,
        "window_text": "| 없는 원료를 지정하여 고시하여야 한다.  | 시나리오를 적용하여 평가할 수 있다.  | - (OECD TG406) Buehler 시험 | 방향제(Fragrances) | 목욕 및 샤워 | 헌 등 작성하고 관련 정보 첨부 | ○ 국제기구 및 외국 독성평가 기관에서 제시하고 | 소, 조직학적 변화, 그 밖의 독성시험 결과 | □ 예 | ■ 아니오 |\n| (SED) 산출 | 물질 B의 피부흡수율 | 65% | (경구) | Malignant | lymphomas | 2/50 | (4%) | 0/50 | (0%) | 14/50 | (28%) | 16/50 | (32%) | 25/50 | (50%) | 23/50 | (46%) |\n| 는 것이 가장 좋으나 기존의 자료들도 활용할 수 있다.  | 기준에 따라 위해여부를 결정한다.  다만, 해당화장품 원료 등에 대하여 국내외의 연 | B2-2011-4-005 | 2011.08.  | 화장품 위해평가 가이드라인 제정 | 포함되었고, 어떤 노출 모델이 선택되었는지 확인할 수 있다.  | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까? ",
        "original_sentence": "| 기준에 따라 위해여부를 결정한다. "
      }
    },
    {
      "chunk_id": "chunk_042",
      "text": "다만, 해당화장품 원료 등에 대하여 국내외의 연 | B2-2011-4-005 | 2011.08. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 41,
        "window_size": 3,
        "char_count": 54,
        "word_count": 11,
        "page_number": 4,
        "window_text": "| 시나리오를 적용하여 평가할 수 있다.  | - (OECD TG406) Buehler 시험 | 방향제(Fragrances) | 목욕 및 샤워 | 헌 등 작성하고 관련 정보 첨부 | ○ 국제기구 및 외국 독성평가 기관에서 제시하고 | 소, 조직학적 변화, 그 밖의 독성시험 결과 | □ 예 | ■ 아니오 |\n| (SED) 산출 | 물질 B의 피부흡수율 | 65% | (경구) | Malignant | lymphomas | 2/50 | (4%) | 0/50 | (0%) | 14/50 | (28%) | 16/50 | (32%) | 25/50 | (50%) | 23/50 | (46%) |\n| 는 것이 가장 좋으나 기존의 자료들도 활용할 수 있다.  | 기준에 따라 위해여부를 결정한다.  다만, 해당화장품 원료 등에 대하여 국내외의 연 | B2-2011-4-005 | 2011.08.  | 화장품 위해평가 가이드라인 제정 | 포함되었고, 어떤 노출 모델이 선택되었는지 확인할 수 있다.  | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까?  | 옥탄올-물 분배계수(Kow) | (Skin Surface Area) | Aexp × IR × t | 핸드 크림 | 1.38 | 860 | 1.604651 | 샴푸 | 0.11 | 1.51 | roducts/color-additives-and-cosmetics-fact-sheet | 상대적 및 절대적 무게 감소 |\n| 3.1.4.1.2 피부흡수율 | 시험결과 | 결과 등을 검토하여 발암성 판단 근거자 | 실성 계수 적용 가능 | A (g/day) | 화장품의 1일 사용량1 |\n| 경우에 사용한다. ",
        "original_sentence": "다만, 해당화장품 원료 등에 대하여 국내외의 연 | B2-2011-4-005 | 2011.08. "
      }
    },
    {
      "chunk_id": "chunk_043",
      "text": "| 화장품 위해평가 가이드라인 제정 | 포함되었고, 어떤 노출 모델이 선택되었는지 확인할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 42,
        "window_size": 3,
        "char_count": 56,
        "word_count": 14,
        "page_number": 1,
        "window_text": "| - (OECD TG406) Buehler 시험 | 방향제(Fragrances) | 목욕 및 샤워 | 헌 등 작성하고 관련 정보 첨부 | ○ 국제기구 및 외국 독성평가 기관에서 제시하고 | 소, 조직학적 변화, 그 밖의 독성시험 결과 | □ 예 | ■ 아니오 |\n| (SED) 산출 | 물질 B의 피부흡수율 | 65% | (경구) | Malignant | lymphomas | 2/50 | (4%) | 0/50 | (0%) | 14/50 | (28%) | 16/50 | (32%) | 25/50 | (50%) | 23/50 | (46%) |\n| 는 것이 가장 좋으나 기존의 자료들도 활용할 수 있다.  | 기준에 따라 위해여부를 결정한다.  다만, 해당화장품 원료 등에 대하여 국내외의 연 | B2-2011-4-005 | 2011.08.  | 화장품 위해평가 가이드라인 제정 | 포함되었고, 어떤 노출 모델이 선택되었는지 확인할 수 있다.  | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까?  | 옥탄올-물 분배계수(Kow) | (Skin Surface Area) | Aexp × IR × t | 핸드 크림 | 1.38 | 860 | 1.604651 | 샴푸 | 0.11 | 1.51 | roducts/color-additives-and-cosmetics-fact-sheet | 상대적 및 절대적 무게 감소 |\n| 3.1.4.1.2 피부흡수율 | 시험결과 | 결과 등을 검토하여 발암성 판단 근거자 | 실성 계수 적용 가능 | A (g/day) | 화장품의 1일 사용량1 |\n| 경우에 사용한다.  | 샤워 젤 | 18.67 | 279.20 | 0.01 | 0.19 | 2.79 | ② 식품의약품안전처장은 보존제, 색소, 자외선차단제 등과 같이 특별히 사용상의 제한 | 성 영향을 말한다. ",
        "original_sentence": "| 화장품 위해평가 가이드라인 제정 | 포함되었고, 어떤 노출 모델이 선택되었는지 확인할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_044",
      "text": "| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까? ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 43,
        "window_size": 3,
        "char_count": 43,
        "word_count": 9,
        "page_number": 2,
        "window_text": "| 기준에 따라 위해여부를 결정한다.  다만, 해당화장품 원료 등에 대하여 국내외의 연 | B2-2011-4-005 | 2011.08.  | 화장품 위해평가 가이드라인 제정 | 포함되었고, 어떤 노출 모델이 선택되었는지 확인할 수 있다.  | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까?  | 옥탄올-물 분배계수(Kow) | (Skin Surface Area) | Aexp × IR × t | 핸드 크림 | 1.38 | 860 | 1.604651 | 샴푸 | 0.11 | 1.51 | roducts/color-additives-and-cosmetics-fact-sheet | 상대적 및 절대적 무게 감소 |\n| 3.1.4.1.2 피부흡수율 | 시험결과 | 결과 등을 검토하여 발암성 판단 근거자 | 실성 계수 적용 가능 | A (g/day) | 화장품의 1일 사용량1 |\n| 경우에 사용한다.  | 샤워 젤 | 18.67 | 279.20 | 0.01 | 0.19 | 2.79 | ② 식품의약품안전처장은 보존제, 색소, 자외선차단제 등과 같이 특별히 사용상의 제한 | 성 영향을 말한다.  | · Ainh-1 (mg) =  | V | 있는 지침서를 참고하여 시험 결과에 대한 증 | 및 인체 역학결과 등을 활용 | SAF | Total | 학적 변화 없음 |\n| 산출 | F (day-1) | 평가 대상 물질이 함유된 화장품의 사용 빈도 | 체중(kg) | 목욕, 샤워 및 인체세정 제품 | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 농도에서 신장무게증가, |\n| 료를 확보 | 구·검사기관에서 이미 위해평가를 실시하였거나 위해요소에 대한 과학적 시험·분 | 제품 종류 | 비 분무형 데오도란트 | 2.33 | 200 | 11.65 | AEL | = | 헤어 컨디셔너 | 0.04 | 0.67 | 4.7 |\n| 등록대상 | 안전역 산출을 하지 않을 수 있다. ",
        "original_sentence": "| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_045",
      "text": "| 옥탄올-물 분배계수(Kow) | (Skin Surface Area) | Aexp × IR × t | 핸드 크림 | 1.38 | 860 | 1.604651 | 샴푸 | 0.11 | 1.51 | roducts/color-additives-and-cosmetics-fact-sheet | 상대적 및 절대적 무게 감소 |\n| 3.1.4.1.2 피부흡수율 | 시험결과 | 결과 등을 검토하여 발암성 판단 근거자 | 실성 계수 적용 가능 | A (g/day) | 화장품의 1일 사용량1 |\n| 경우에 사용한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 44,
        "window_size": 3,
        "char_count": 284,
        "word_count": 65,
        "page_number": 24,
        "window_text": "다만, 해당화장품 원료 등에 대하여 국내외의 연 | B2-2011-4-005 | 2011.08.  | 화장품 위해평가 가이드라인 제정 | 포함되었고, 어떤 노출 모델이 선택되었는지 확인할 수 있다.  | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까?  | 옥탄올-물 분배계수(Kow) | (Skin Surface Area) | Aexp × IR × t | 핸드 크림 | 1.38 | 860 | 1.604651 | 샴푸 | 0.11 | 1.51 | roducts/color-additives-and-cosmetics-fact-sheet | 상대적 및 절대적 무게 감소 |\n| 3.1.4.1.2 피부흡수율 | 시험결과 | 결과 등을 검토하여 발암성 판단 근거자 | 실성 계수 적용 가능 | A (g/day) | 화장품의 1일 사용량1 |\n| 경우에 사용한다.  | 샤워 젤 | 18.67 | 279.20 | 0.01 | 0.19 | 2.79 | ② 식품의약품안전처장은 보존제, 색소, 자외선차단제 등과 같이 특별히 사용상의 제한 | 성 영향을 말한다.  | · Ainh-1 (mg) =  | V | 있는 지침서를 참고하여 시험 결과에 대한 증 | 및 인체 역학결과 등을 활용 | SAF | Total | 학적 변화 없음 |\n| 산출 | F (day-1) | 평가 대상 물질이 함유된 화장품의 사용 빈도 | 체중(kg) | 목욕, 샤워 및 인체세정 제품 | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 농도에서 신장무게증가, |\n| 료를 확보 | 구·검사기관에서 이미 위해평가를 실시하였거나 위해요소에 대한 과학적 시험·분 | 제품 종류 | 비 분무형 데오도란트 | 2.33 | 200 | 11.65 | AEL | = | 헤어 컨디셔너 | 0.04 | 0.67 | 4.7 |\n| 등록대상 | 안전역 산출을 하지 않을 수 있다.  | C (%) | 화장품 중 평가 대상 물질의 농도 | SAF | 개인 간 | 제품 | 빈도/사용기간 | 피부상태 | 모발 관리 | ○ 불확실성 적용 | 거가중치(Weight of Evidence, WoE) 고려 |\n| 이 필요한 원료에 대하여는 그 사용기준을 지정하여 고시하여야 하며, 사용기준이 지 | 사용하여 보수적으로 피부흡수율에 적용할 수 있다(SCCS/1628/21, 2021). ",
        "original_sentence": "| 옥탄올-물 분배계수(Kow) | (Skin Surface Area) | Aexp × IR × t | 핸드 크림 | 1.38 | 860 | 1.604651 | 샴푸 | 0.11 | 1.51 | roducts/color-additives-and-cosmetics-fact-sheet | 상대적 및 절대적 무게 감소 |\n| 3.1.4.1.2 피부흡수율 | 시험결과 | 결과 등을 검토하여 발암성 판단 근거자 | 실성 계수 적용 가능 | A (g/day) | 화장품의 1일 사용량1 |\n| 경우에 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_046",
      "text": "| 샤워 젤 | 18.67 | 279.20 | 0.01 | 0.19 | 2.79 | ② 식품의약품안전처장은 보존제, 색소, 자외선차단제 등과 같이 특별히 사용상의 제한 | 성 영향을 말한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 45,
        "window_size": 3,
        "char_count": 107,
        "word_count": 28,
        "page_number": 43,
        "window_text": "| 화장품 위해평가 가이드라인 제정 | 포함되었고, 어떤 노출 모델이 선택되었는지 확인할 수 있다.  | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까?  | 옥탄올-물 분배계수(Kow) | (Skin Surface Area) | Aexp × IR × t | 핸드 크림 | 1.38 | 860 | 1.604651 | 샴푸 | 0.11 | 1.51 | roducts/color-additives-and-cosmetics-fact-sheet | 상대적 및 절대적 무게 감소 |\n| 3.1.4.1.2 피부흡수율 | 시험결과 | 결과 등을 검토하여 발암성 판단 근거자 | 실성 계수 적용 가능 | A (g/day) | 화장품의 1일 사용량1 |\n| 경우에 사용한다.  | 샤워 젤 | 18.67 | 279.20 | 0.01 | 0.19 | 2.79 | ② 식품의약품안전처장은 보존제, 색소, 자외선차단제 등과 같이 특별히 사용상의 제한 | 성 영향을 말한다.  | · Ainh-1 (mg) =  | V | 있는 지침서를 참고하여 시험 결과에 대한 증 | 및 인체 역학결과 등을 활용 | SAF | Total | 학적 변화 없음 |\n| 산출 | F (day-1) | 평가 대상 물질이 함유된 화장품의 사용 빈도 | 체중(kg) | 목욕, 샤워 및 인체세정 제품 | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 농도에서 신장무게증가, |\n| 료를 확보 | 구·검사기관에서 이미 위해평가를 실시하였거나 위해요소에 대한 과학적 시험·분 | 제품 종류 | 비 분무형 데오도란트 | 2.33 | 200 | 11.65 | AEL | = | 헤어 컨디셔너 | 0.04 | 0.67 | 4.7 |\n| 등록대상 | 안전역 산출을 하지 않을 수 있다.  | C (%) | 화장품 중 평가 대상 물질의 농도 | SAF | 개인 간 | 제품 | 빈도/사용기간 | 피부상태 | 모발 관리 | ○ 불확실성 적용 | 거가중치(Weight of Evidence, WoE) 고려 |\n| 이 필요한 원료에 대하여는 그 사용기준을 지정하여 고시하여야 하며, 사용기준이 지 | 사용하여 보수적으로 피부흡수율에 적용할 수 있다(SCCS/1628/21, 2021).  | 반복투여 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
        "original_sentence": "| 샤워 젤 | 18.67 | 279.20 | 0.01 | 0.19 | 2.79 | ② 식품의약품안전처장은 보존제, 색소, 자외선차단제 등과 같이 특별히 사용상의 제한 | 성 영향을 말한다. "
      }
    },
    {
      "chunk_id": "chunk_047",
      "text": "| · Ainh-1 (mg) =  | V | 있는 지침서를 참고하여 시험 결과에 대한 증 | 및 인체 역학결과 등을 활용 | SAF | Total | 학적 변화 없음 |\n| 산출 | F (day-1) | 평가 대상 물질이 함유된 화장품의 사용 빈도 | 체중(kg) | 목욕, 샤워 및 인체세정 제품 | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 농도에서 신장무게증가, |\n| 료를 확보 | 구·검사기관에서 이미 위해평가를 실시하였거나 위해요소에 대한 과학적 시험·분 | 제품 종류 | 비 분무형 데오도란트 | 2.33 | 200 | 11.65 | AEL | = | 헤어 컨디셔너 | 0.04 | 0.67 | 4.7 |\n| 등록대상 | 안전역 산출을 하지 않을 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 46,
        "window_size": 3,
        "char_count": 394,
        "word_count": 112,
        "page_number": 27,
        "window_text": "| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까?  | 옥탄올-물 분배계수(Kow) | (Skin Surface Area) | Aexp × IR × t | 핸드 크림 | 1.38 | 860 | 1.604651 | 샴푸 | 0.11 | 1.51 | roducts/color-additives-and-cosmetics-fact-sheet | 상대적 및 절대적 무게 감소 |\n| 3.1.4.1.2 피부흡수율 | 시험결과 | 결과 등을 검토하여 발암성 판단 근거자 | 실성 계수 적용 가능 | A (g/day) | 화장품의 1일 사용량1 |\n| 경우에 사용한다.  | 샤워 젤 | 18.67 | 279.20 | 0.01 | 0.19 | 2.79 | ② 식품의약품안전처장은 보존제, 색소, 자외선차단제 등과 같이 특별히 사용상의 제한 | 성 영향을 말한다.  | · Ainh-1 (mg) =  | V | 있는 지침서를 참고하여 시험 결과에 대한 증 | 및 인체 역학결과 등을 활용 | SAF | Total | 학적 변화 없음 |\n| 산출 | F (day-1) | 평가 대상 물질이 함유된 화장품의 사용 빈도 | 체중(kg) | 목욕, 샤워 및 인체세정 제품 | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 농도에서 신장무게증가, |\n| 료를 확보 | 구·검사기관에서 이미 위해평가를 실시하였거나 위해요소에 대한 과학적 시험·분 | 제품 종류 | 비 분무형 데오도란트 | 2.33 | 200 | 11.65 | AEL | = | 헤어 컨디셔너 | 0.04 | 0.67 | 4.7 |\n| 등록대상 | 안전역 산출을 하지 않을 수 있다.  | C (%) | 화장품 중 평가 대상 물질의 농도 | SAF | 개인 간 | 제품 | 빈도/사용기간 | 피부상태 | 모발 관리 | ○ 불확실성 적용 | 거가중치(Weight of Evidence, WoE) 고려 |\n| 이 필요한 원료에 대하여는 그 사용기준을 지정하여 고시하여야 하며, 사용기준이 지 | 사용하여 보수적으로 피부흡수율에 적용할 수 있다(SCCS/1628/21, 2021).  | 반복투여 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | Mammary gland, | adenomas and | adenocarcinomas | - 랫드 대상(13주) | - 0, 200, 450, 1000 mg/kg/day | 사용빈도(횟수/년) | 시간 단위당 사용 횟수 | - 1일 사용횟수 | - 모체독성 NOAEL 20 mg/kg bw/day | - 발달독성 NOAEL 40 mg/kg bw/day | - 40, 60 mg/kg bw/day 용량에서 | = | 1.3 | 터베이스임 |\n| 계적 하한 신뢰 한계(IRIS, 1999, Glossary of IRIS Terms) | 리오를 설정하여 노출평가를 수행한다. ",
        "original_sentence": "| · Ainh-1 (mg) =  | V | 있는 지침서를 참고하여 시험 결과에 대한 증 | 및 인체 역학결과 등을 활용 | SAF | Total | 학적 변화 없음 |\n| 산출 | F (day-1) | 평가 대상 물질이 함유된 화장품의 사용 빈도 | 체중(kg) | 목욕, 샤워 및 인체세정 제품 | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 농도에서 신장무게증가, |\n| 료를 확보 | 구·검사기관에서 이미 위해평가를 실시하였거나 위해요소에 대한 과학적 시험·분 | 제품 종류 | 비 분무형 데오도란트 | 2.33 | 200 | 11.65 | AEL | = | 헤어 컨디셔너 | 0.04 | 0.67 | 4.7 |\n| 등록대상 | 안전역 산출을 하지 않을 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_048",
      "text": "| C (%) | 화장품 중 평가 대상 물질의 농도 | SAF | 개인 간 | 제품 | 빈도/사용기간 | 피부상태 | 모발 관리 | ○ 불확실성 적용 | 거가중치(Weight of Evidence, WoE) 고려 |\n| 이 필요한 원료에 대하여는 그 사용기준을 지정하여 고시하여야 하며, 사용기준이 지 | 사용하여 보수적으로 피부흡수율에 적용할 수 있다(SCCS/1628/21, 2021). ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 47,
        "window_size": 3,
        "char_count": 219,
        "word_count": 55,
        "page_number": 24,
        "window_text": "| 옥탄올-물 분배계수(Kow) | (Skin Surface Area) | Aexp × IR × t | 핸드 크림 | 1.38 | 860 | 1.604651 | 샴푸 | 0.11 | 1.51 | roducts/color-additives-and-cosmetics-fact-sheet | 상대적 및 절대적 무게 감소 |\n| 3.1.4.1.2 피부흡수율 | 시험결과 | 결과 등을 검토하여 발암성 판단 근거자 | 실성 계수 적용 가능 | A (g/day) | 화장품의 1일 사용량1 |\n| 경우에 사용한다.  | 샤워 젤 | 18.67 | 279.20 | 0.01 | 0.19 | 2.79 | ② 식품의약품안전처장은 보존제, 색소, 자외선차단제 등과 같이 특별히 사용상의 제한 | 성 영향을 말한다.  | · Ainh-1 (mg) =  | V | 있는 지침서를 참고하여 시험 결과에 대한 증 | 및 인체 역학결과 등을 활용 | SAF | Total | 학적 변화 없음 |\n| 산출 | F (day-1) | 평가 대상 물질이 함유된 화장품의 사용 빈도 | 체중(kg) | 목욕, 샤워 및 인체세정 제품 | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 농도에서 신장무게증가, |\n| 료를 확보 | 구·검사기관에서 이미 위해평가를 실시하였거나 위해요소에 대한 과학적 시험·분 | 제품 종류 | 비 분무형 데오도란트 | 2.33 | 200 | 11.65 | AEL | = | 헤어 컨디셔너 | 0.04 | 0.67 | 4.7 |\n| 등록대상 | 안전역 산출을 하지 않을 수 있다.  | C (%) | 화장품 중 평가 대상 물질의 농도 | SAF | 개인 간 | 제품 | 빈도/사용기간 | 피부상태 | 모발 관리 | ○ 불확실성 적용 | 거가중치(Weight of Evidence, WoE) 고려 |\n| 이 필요한 원료에 대하여는 그 사용기준을 지정하여 고시하여야 하며, 사용기준이 지 | 사용하여 보수적으로 피부흡수율에 적용할 수 있다(SCCS/1628/21, 2021).  | 반복투여 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | Mammary gland, | adenomas and | adenocarcinomas | - 랫드 대상(13주) | - 0, 200, 450, 1000 mg/kg/day | 사용빈도(횟수/년) | 시간 단위당 사용 횟수 | - 1일 사용횟수 | - 모체독성 NOAEL 20 mg/kg bw/day | - 발달독성 NOAEL 40 mg/kg bw/day | - 40, 60 mg/kg bw/day 용량에서 | = | 1.3 | 터베이스임 |\n| 계적 하한 신뢰 한계(IRIS, 1999, Glossary of IRIS Terms) | 리오를 설정하여 노출평가를 수행한다.  | 샤워 젤 | 10.40 | 161.55 | 0.01 | 0.10 | 1.62 | 수 있으며, 붙임 10의 사이트를 참고하여 수집할 수 있다. ",
        "original_sentence": "| C (%) | 화장품 중 평가 대상 물질의 농도 | SAF | 개인 간 | 제품 | 빈도/사용기간 | 피부상태 | 모발 관리 | ○ 불확실성 적용 | 거가중치(Weight of Evidence, WoE) 고려 |\n| 이 필요한 원료에 대하여는 그 사용기준을 지정하여 고시하여야 하며, 사용기준이 지 | 사용하여 보수적으로 피부흡수율에 적용할 수 있다(SCCS/1628/21, 2021). "
      }
    },
    {
      "chunk_id": "chunk_049",
      "text": "| 반복투여 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 48,
        "window_size": 3,
        "char_count": 40,
        "word_count": 10,
        "page_number": 2,
        "window_text": "| 샤워 젤 | 18.67 | 279.20 | 0.01 | 0.19 | 2.79 | ② 식품의약품안전처장은 보존제, 색소, 자외선차단제 등과 같이 특별히 사용상의 제한 | 성 영향을 말한다.  | · Ainh-1 (mg) =  | V | 있는 지침서를 참고하여 시험 결과에 대한 증 | 및 인체 역학결과 등을 활용 | SAF | Total | 학적 변화 없음 |\n| 산출 | F (day-1) | 평가 대상 물질이 함유된 화장품의 사용 빈도 | 체중(kg) | 목욕, 샤워 및 인체세정 제품 | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 농도에서 신장무게증가, |\n| 료를 확보 | 구·검사기관에서 이미 위해평가를 실시하였거나 위해요소에 대한 과학적 시험·분 | 제품 종류 | 비 분무형 데오도란트 | 2.33 | 200 | 11.65 | AEL | = | 헤어 컨디셔너 | 0.04 | 0.67 | 4.7 |\n| 등록대상 | 안전역 산출을 하지 않을 수 있다.  | C (%) | 화장품 중 평가 대상 물질의 농도 | SAF | 개인 간 | 제품 | 빈도/사용기간 | 피부상태 | 모발 관리 | ○ 불확실성 적용 | 거가중치(Weight of Evidence, WoE) 고려 |\n| 이 필요한 원료에 대하여는 그 사용기준을 지정하여 고시하여야 하며, 사용기준이 지 | 사용하여 보수적으로 피부흡수율에 적용할 수 있다(SCCS/1628/21, 2021).  | 반복투여 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | Mammary gland, | adenomas and | adenocarcinomas | - 랫드 대상(13주) | - 0, 200, 450, 1000 mg/kg/day | 사용빈도(횟수/년) | 시간 단위당 사용 횟수 | - 1일 사용횟수 | - 모체독성 NOAEL 20 mg/kg bw/day | - 발달독성 NOAEL 40 mg/kg bw/day | - 40, 60 mg/kg bw/day 용량에서 | = | 1.3 | 터베이스임 |\n| 계적 하한 신뢰 한계(IRIS, 1999, Glossary of IRIS Terms) | 리오를 설정하여 노출평가를 수행한다.  | 샤워 젤 | 10.40 | 161.55 | 0.01 | 0.10 | 1.62 | 수 있으며, 붙임 10의 사이트를 참고하여 수집할 수 있다.  | 60 (kg) | 성인 평균 체중 | - (OECD TG416) 2세대 생식독성시험 | - (OECD TG414) 산전 발달 독성시험 | - (OECD TG421) 생식·발생독성 스크리닝시험 | - (OECD TG443) 확장형 1세대 생식독성시험 | 바디로션 | 7.82 | 123.20 | - | 0/50 | (0%) | - | 15/50 | (30%) | - | 28/50 | (56%) | ○ 위해의 특성과 발생 가능성에 대한 시나리오 및 활용된 |\n| 공통 | 전신노출량으로 나누어 안전역(MOS)을 산출한다. ",
        "original_sentence": "| 반복투여 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_050",
      "text": "| □ 예 | ■ 아니오 | Mammary gland, | adenomas and | adenocarcinomas | - 랫드 대상(13주) | - 0, 200, 450, 1000 mg/kg/day | 사용빈도(횟수/년) | 시간 단위당 사용 횟수 | - 1일 사용횟수 | - 모체독성 NOAEL 20 mg/kg bw/day | - 발달독성 NOAEL 40 mg/kg bw/day | - 40, 60 mg/kg bw/day 용량에서 | = | 1.3 | 터베이스임 |\n| 계적 하한 신뢰 한계(IRIS, 1999, Glossary of IRIS Terms) | 리오를 설정하여 노출평가를 수행한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 49,
        "window_size": 3,
        "char_count": 335,
        "word_count": 79,
        "page_number": 2,
        "window_text": "| · Ainh-1 (mg) =  | V | 있는 지침서를 참고하여 시험 결과에 대한 증 | 및 인체 역학결과 등을 활용 | SAF | Total | 학적 변화 없음 |\n| 산출 | F (day-1) | 평가 대상 물질이 함유된 화장품의 사용 빈도 | 체중(kg) | 목욕, 샤워 및 인체세정 제품 | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 농도에서 신장무게증가, |\n| 료를 확보 | 구·검사기관에서 이미 위해평가를 실시하였거나 위해요소에 대한 과학적 시험·분 | 제품 종류 | 비 분무형 데오도란트 | 2.33 | 200 | 11.65 | AEL | = | 헤어 컨디셔너 | 0.04 | 0.67 | 4.7 |\n| 등록대상 | 안전역 산출을 하지 않을 수 있다.  | C (%) | 화장품 중 평가 대상 물질의 농도 | SAF | 개인 간 | 제품 | 빈도/사용기간 | 피부상태 | 모발 관리 | ○ 불확실성 적용 | 거가중치(Weight of Evidence, WoE) 고려 |\n| 이 필요한 원료에 대하여는 그 사용기준을 지정하여 고시하여야 하며, 사용기준이 지 | 사용하여 보수적으로 피부흡수율에 적용할 수 있다(SCCS/1628/21, 2021).  | 반복투여 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | Mammary gland, | adenomas and | adenocarcinomas | - 랫드 대상(13주) | - 0, 200, 450, 1000 mg/kg/day | 사용빈도(횟수/년) | 시간 단위당 사용 횟수 | - 1일 사용횟수 | - 모체독성 NOAEL 20 mg/kg bw/day | - 발달독성 NOAEL 40 mg/kg bw/day | - 40, 60 mg/kg bw/day 용량에서 | = | 1.3 | 터베이스임 |\n| 계적 하한 신뢰 한계(IRIS, 1999, Glossary of IRIS Terms) | 리오를 설정하여 노출평가를 수행한다.  | 샤워 젤 | 10.40 | 161.55 | 0.01 | 0.10 | 1.62 | 수 있으며, 붙임 10의 사이트를 참고하여 수집할 수 있다.  | 60 (kg) | 성인 평균 체중 | - (OECD TG416) 2세대 생식독성시험 | - (OECD TG414) 산전 발달 독성시험 | - (OECD TG421) 생식·발생독성 스크리닝시험 | - (OECD TG443) 확장형 1세대 생식독성시험 | 바디로션 | 7.82 | 123.20 | - | 0/50 | (0%) | - | 15/50 | (30%) | - | 28/50 | (56%) | ○ 위해의 특성과 발생 가능성에 대한 시나리오 및 활용된 |\n| 공통 | 전신노출량으로 나누어 안전역(MOS)을 산출한다.  | 석 자료가 있는 경우에는 그 자료를 근거로 위해 여부를 결정할 수 있다. ",
        "original_sentence": "| □ 예 | ■ 아니오 | Mammary gland, | adenomas and | adenocarcinomas | - 랫드 대상(13주) | - 0, 200, 450, 1000 mg/kg/day | 사용빈도(횟수/년) | 시간 단위당 사용 횟수 | - 1일 사용횟수 | - 모체독성 NOAEL 20 mg/kg bw/day | - 발달독성 NOAEL 40 mg/kg bw/day | - 40, 60 mg/kg bw/day 용량에서 | = | 1.3 | 터베이스임 |\n| 계적 하한 신뢰 한계(IRIS, 1999, Glossary of IRIS Terms) | 리오를 설정하여 노출평가를 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_051",
      "text": "| 샤워 젤 | 10.40 | 161.55 | 0.01 | 0.10 | 1.62 | 수 있으며, 붙임 10의 사이트를 참고하여 수집할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 50,
        "window_size": 3,
        "char_count": 81,
        "word_count": 23,
        "page_number": 41,
        "window_text": "| C (%) | 화장품 중 평가 대상 물질의 농도 | SAF | 개인 간 | 제품 | 빈도/사용기간 | 피부상태 | 모발 관리 | ○ 불확실성 적용 | 거가중치(Weight of Evidence, WoE) 고려 |\n| 이 필요한 원료에 대하여는 그 사용기준을 지정하여 고시하여야 하며, 사용기준이 지 | 사용하여 보수적으로 피부흡수율에 적용할 수 있다(SCCS/1628/21, 2021).  | 반복투여 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | Mammary gland, | adenomas and | adenocarcinomas | - 랫드 대상(13주) | - 0, 200, 450, 1000 mg/kg/day | 사용빈도(횟수/년) | 시간 단위당 사용 횟수 | - 1일 사용횟수 | - 모체독성 NOAEL 20 mg/kg bw/day | - 발달독성 NOAEL 40 mg/kg bw/day | - 40, 60 mg/kg bw/day 용량에서 | = | 1.3 | 터베이스임 |\n| 계적 하한 신뢰 한계(IRIS, 1999, Glossary of IRIS Terms) | 리오를 설정하여 노출평가를 수행한다.  | 샤워 젤 | 10.40 | 161.55 | 0.01 | 0.10 | 1.62 | 수 있으며, 붙임 10의 사이트를 참고하여 수집할 수 있다.  | 60 (kg) | 성인 평균 체중 | - (OECD TG416) 2세대 생식독성시험 | - (OECD TG414) 산전 발달 독성시험 | - (OECD TG421) 생식·발생독성 스크리닝시험 | - (OECD TG443) 확장형 1세대 생식독성시험 | 바디로션 | 7.82 | 123.20 | - | 0/50 | (0%) | - | 15/50 | (30%) | - | 28/50 | (56%) | ○ 위해의 특성과 발생 가능성에 대한 시나리오 및 활용된 |\n| 공통 | 전신노출량으로 나누어 안전역(MOS)을 산출한다.  | 석 자료가 있는 경우에는 그 자료를 근거로 위해 여부를 결정할 수 있다.  | 취범위, 전처리방법, 분석기기, 정량한계 등을 고려하여 동질성이 인정된 값을 활용한다. ",
        "original_sentence": "| 샤워 젤 | 10.40 | 161.55 | 0.01 | 0.10 | 1.62 | 수 있으며, 붙임 10의 사이트를 참고하여 수집할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_052",
      "text": "| 60 (kg) | 성인 평균 체중 | - (OECD TG416) 2세대 생식독성시험 | - (OECD TG414) 산전 발달 독성시험 | - (OECD TG421) 생식·발생독성 스크리닝시험 | - (OECD TG443) 확장형 1세대 생식독성시험 | 바디로션 | 7.82 | 123.20 | - | 0/50 | (0%) | - | 15/50 | (30%) | - | 28/50 | (56%) | ○ 위해의 특성과 발생 가능성에 대한 시나리오 및 활용된 |\n| 공통 | 전신노출량으로 나누어 안전역(MOS)을 산출한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 51,
        "window_size": 3,
        "char_count": 293,
        "word_count": 75,
        "page_number": 24,
        "window_text": "| 반복투여 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | Mammary gland, | adenomas and | adenocarcinomas | - 랫드 대상(13주) | - 0, 200, 450, 1000 mg/kg/day | 사용빈도(횟수/년) | 시간 단위당 사용 횟수 | - 1일 사용횟수 | - 모체독성 NOAEL 20 mg/kg bw/day | - 발달독성 NOAEL 40 mg/kg bw/day | - 40, 60 mg/kg bw/day 용량에서 | = | 1.3 | 터베이스임 |\n| 계적 하한 신뢰 한계(IRIS, 1999, Glossary of IRIS Terms) | 리오를 설정하여 노출평가를 수행한다.  | 샤워 젤 | 10.40 | 161.55 | 0.01 | 0.10 | 1.62 | 수 있으며, 붙임 10의 사이트를 참고하여 수집할 수 있다.  | 60 (kg) | 성인 평균 체중 | - (OECD TG416) 2세대 생식독성시험 | - (OECD TG414) 산전 발달 독성시험 | - (OECD TG421) 생식·발생독성 스크리닝시험 | - (OECD TG443) 확장형 1세대 생식독성시험 | 바디로션 | 7.82 | 123.20 | - | 0/50 | (0%) | - | 15/50 | (30%) | - | 28/50 | (56%) | ○ 위해의 특성과 발생 가능성에 대한 시나리오 및 활용된 |\n| 공통 | 전신노출량으로 나누어 안전역(MOS)을 산출한다.  | 석 자료가 있는 경우에는 그 자료를 근거로 위해 여부를 결정할 수 있다.  | 취범위, 전처리방법, 분석기기, 정량한계 등을 고려하여 동질성이 인정된 값을 활용한다.  | 여부 | 시험방법 | Induction conc. ",
        "original_sentence": "| 60 (kg) | 성인 평균 체중 | - (OECD TG416) 2세대 생식독성시험 | - (OECD TG414) 산전 발달 독성시험 | - (OECD TG421) 생식·발생독성 스크리닝시험 | - (OECD TG443) 확장형 1세대 생식독성시험 | 바디로션 | 7.82 | 123.20 | - | 0/50 | (0%) | - | 15/50 | (30%) | - | 28/50 | (56%) | ○ 위해의 특성과 발생 가능성에 대한 시나리오 및 활용된 |\n| 공통 | 전신노출량으로 나누어 안전역(MOS)을 산출한다. "
      }
    },
    {
      "chunk_id": "chunk_053",
      "text": "| 석 자료가 있는 경우에는 그 자료를 근거로 위해 여부를 결정할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 52,
        "window_size": 3,
        "char_count": 43,
        "word_count": 13,
        "page_number": 2,
        "window_text": "| □ 예 | ■ 아니오 | Mammary gland, | adenomas and | adenocarcinomas | - 랫드 대상(13주) | - 0, 200, 450, 1000 mg/kg/day | 사용빈도(횟수/년) | 시간 단위당 사용 횟수 | - 1일 사용횟수 | - 모체독성 NOAEL 20 mg/kg bw/day | - 발달독성 NOAEL 40 mg/kg bw/day | - 40, 60 mg/kg bw/day 용량에서 | = | 1.3 | 터베이스임 |\n| 계적 하한 신뢰 한계(IRIS, 1999, Glossary of IRIS Terms) | 리오를 설정하여 노출평가를 수행한다.  | 샤워 젤 | 10.40 | 161.55 | 0.01 | 0.10 | 1.62 | 수 있으며, 붙임 10의 사이트를 참고하여 수집할 수 있다.  | 60 (kg) | 성인 평균 체중 | - (OECD TG416) 2세대 생식독성시험 | - (OECD TG414) 산전 발달 독성시험 | - (OECD TG421) 생식·발생독성 스크리닝시험 | - (OECD TG443) 확장형 1세대 생식독성시험 | 바디로션 | 7.82 | 123.20 | - | 0/50 | (0%) | - | 15/50 | (30%) | - | 28/50 | (56%) | ○ 위해의 특성과 발생 가능성에 대한 시나리오 및 활용된 |\n| 공통 | 전신노출량으로 나누어 안전역(MOS)을 산출한다.  | 석 자료가 있는 경우에는 그 자료를 근거로 위해 여부를 결정할 수 있다.  | 취범위, 전처리방법, 분석기기, 정량한계 등을 고려하여 동질성이 인정된 값을 활용한다.  | 여부 | 시험방법 | Induction conc.  | Challenge conc. ",
        "original_sentence": "| 석 자료가 있는 경우에는 그 자료를 근거로 위해 여부를 결정할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_054",
      "text": "| 취범위, 전처리방법, 분석기기, 정량한계 등을 고려하여 동질성이 인정된 값을 활용한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 53,
        "window_size": 3,
        "char_count": 51,
        "word_count": 11,
        "page_number": 2,
        "window_text": "| 샤워 젤 | 10.40 | 161.55 | 0.01 | 0.10 | 1.62 | 수 있으며, 붙임 10의 사이트를 참고하여 수집할 수 있다.  | 60 (kg) | 성인 평균 체중 | - (OECD TG416) 2세대 생식독성시험 | - (OECD TG414) 산전 발달 독성시험 | - (OECD TG421) 생식·발생독성 스크리닝시험 | - (OECD TG443) 확장형 1세대 생식독성시험 | 바디로션 | 7.82 | 123.20 | - | 0/50 | (0%) | - | 15/50 | (30%) | - | 28/50 | (56%) | ○ 위해의 특성과 발생 가능성에 대한 시나리오 및 활용된 |\n| 공통 | 전신노출량으로 나누어 안전역(MOS)을 산출한다.  | 석 자료가 있는 경우에는 그 자료를 근거로 위해 여부를 결정할 수 있다.  | 취범위, 전처리방법, 분석기기, 정량한계 등을 고려하여 동질성이 인정된 값을 활용한다.  | 여부 | 시험방법 | Induction conc.  | Challenge conc.  | 결과 | (경구) | 따라 나타나는 일반 독성영향(생식, 유전독성 및 발암 효과 제외) | 남성용 화장품(Men’s cosmetics) | CEL | 3.5 | 헤어 스타일링 | 0.28 | 1010 | 0.277228 | Aexp × IR × t | 간의 글라이코겐 감소 및 쿠퍼세포에서 | 철의 양 증가 |\n| 샴푸 | 10.46 | 150.49 | 0.01 | 0.11 | 1.51 | B1-2013-4-002 | 2013.10. ",
        "original_sentence": "| 취범위, 전처리방법, 분석기기, 정량한계 등을 고려하여 동질성이 인정된 값을 활용한다. "
      }
    },
    {
      "chunk_id": "chunk_055",
      "text": "| 여부 | 시험방법 | Induction conc. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 54,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 2,
        "window_text": "| 60 (kg) | 성인 평균 체중 | - (OECD TG416) 2세대 생식독성시험 | - (OECD TG414) 산전 발달 독성시험 | - (OECD TG421) 생식·발생독성 스크리닝시험 | - (OECD TG443) 확장형 1세대 생식독성시험 | 바디로션 | 7.82 | 123.20 | - | 0/50 | (0%) | - | 15/50 | (30%) | - | 28/50 | (56%) | ○ 위해의 특성과 발생 가능성에 대한 시나리오 및 활용된 |\n| 공통 | 전신노출량으로 나누어 안전역(MOS)을 산출한다.  | 석 자료가 있는 경우에는 그 자료를 근거로 위해 여부를 결정할 수 있다.  | 취범위, 전처리방법, 분석기기, 정량한계 등을 고려하여 동질성이 인정된 값을 활용한다.  | 여부 | 시험방법 | Induction conc.  | Challenge conc.  | 결과 | (경구) | 따라 나타나는 일반 독성영향(생식, 유전독성 및 발암 효과 제외) | 남성용 화장품(Men’s cosmetics) | CEL | 3.5 | 헤어 스타일링 | 0.28 | 1010 | 0.277228 | Aexp × IR × t | 간의 글라이코겐 감소 및 쿠퍼세포에서 | 철의 양 증가 |\n| 샴푸 | 10.46 | 150.49 | 0.01 | 0.11 | 1.51 | B1-2013-4-002 | 2013.10.  | 화장품 위해평가 가이드라인 개정 | fevap (%) | 증발 비율(보수적으로 1 적용) | 생식·발생 | - 랫드 대상(6~19일) | - 5, 20, 40, 60 mg/kg bw/day | 제품군 | 세부 분류 | · Ainh-2 (mg) =  | V | - LOAEL 활용하는 경우 : 3 고려, 사례별 |\n| 손 세정 비누 | 24.04 | 382.15 | 0.01 | 0.24 | 3.82 | 정·고시된 원료 외의 보존제, 색소, 자외선차단제 등은 사용할 수 없다. ",
        "original_sentence": "| 여부 | 시험방법 | Induction conc. "
      }
    },
    {
      "chunk_id": "chunk_056",
      "text": "| Challenge conc. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 55,
        "window_size": 3,
        "char_count": 18,
        "word_count": 3,
        "page_number": 55,
        "window_text": "| 석 자료가 있는 경우에는 그 자료를 근거로 위해 여부를 결정할 수 있다.  | 취범위, 전처리방법, 분석기기, 정량한계 등을 고려하여 동질성이 인정된 값을 활용한다.  | 여부 | 시험방법 | Induction conc.  | Challenge conc.  | 결과 | (경구) | 따라 나타나는 일반 독성영향(생식, 유전독성 및 발암 효과 제외) | 남성용 화장품(Men’s cosmetics) | CEL | 3.5 | 헤어 스타일링 | 0.28 | 1010 | 0.277228 | Aexp × IR × t | 간의 글라이코겐 감소 및 쿠퍼세포에서 | 철의 양 증가 |\n| 샴푸 | 10.46 | 150.49 | 0.01 | 0.11 | 1.51 | B1-2013-4-002 | 2013.10.  | 화장품 위해평가 가이드라인 개정 | fevap (%) | 증발 비율(보수적으로 1 적용) | 생식·발생 | - 랫드 대상(6~19일) | - 5, 20, 40, 60 mg/kg bw/day | 제품군 | 세부 분류 | · Ainh-2 (mg) =  | V | - LOAEL 활용하는 경우 : 3 고려, 사례별 |\n| 손 세정 비누 | 24.04 | 382.15 | 0.01 | 0.24 | 3.82 | 정·고시된 원료 외의 보존제, 색소, 자외선차단제 등은 사용할 수 없다.  | 대상 | 제품 내 농도 | 제품 사용량(g) | 1회당 사용량 | - 1일 사용량 또는 1회 사용량 | 화장품 노출량 | https://elaws.e-gov.go.jp/search/elawsSearch/elaws_searc | 자료 선택의 타당성을 가급적 명확하고 간략하게 기술 | 피부흡수율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| - (OECD TG407) 반복투여(28일) 경구독성시험 | - (OECD TG412) 반복투여(28일) 흡입독성시험 | - (OECD TG408) 설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG409) 비설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG413) 설치류 대상 반복투여(90일) 흡입독성시험 | T25 | 얼굴 크림 | 1.54 | 24.14 | 5.0 mg/kg bw/day |\n| 헤어컨디셔너2 | 3.92 | - | ③ 제1항 및 제2항에 따른 위해평가의 기준, 방법 등에 관한 세부 사항은 식품의약 | Maximization | 0.4% (intradermal; VNR) | 1% (topical; VNR) | 0.25% (VNR) | 감작성 있음 | 제품 및 시나리오를 선택할 수 있다. ",
        "original_sentence": "| Challenge conc. "
      }
    },
    {
      "chunk_id": "chunk_057",
      "text": "| 결과 | (경구) | 따라 나타나는 일반 독성영향(생식, 유전독성 및 발암 효과 제외) | 남성용 화장품(Men’s cosmetics) | CEL | 3.5 | 헤어 스타일링 | 0.28 | 1010 | 0.277228 | Aexp × IR × t | 간의 글라이코겐 감소 및 쿠퍼세포에서 | 철의 양 증가 |\n| 샴푸 | 10.46 | 150.49 | 0.01 | 0.11 | 1.51 | B1-2013-4-002 | 2013.10. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 56,
        "window_size": 3,
        "char_count": 248,
        "word_count": 64,
        "page_number": 37,
        "window_text": "| 취범위, 전처리방법, 분석기기, 정량한계 등을 고려하여 동질성이 인정된 값을 활용한다.  | 여부 | 시험방법 | Induction conc.  | Challenge conc.  | 결과 | (경구) | 따라 나타나는 일반 독성영향(생식, 유전독성 및 발암 효과 제외) | 남성용 화장품(Men’s cosmetics) | CEL | 3.5 | 헤어 스타일링 | 0.28 | 1010 | 0.277228 | Aexp × IR × t | 간의 글라이코겐 감소 및 쿠퍼세포에서 | 철의 양 증가 |\n| 샴푸 | 10.46 | 150.49 | 0.01 | 0.11 | 1.51 | B1-2013-4-002 | 2013.10.  | 화장품 위해평가 가이드라인 개정 | fevap (%) | 증발 비율(보수적으로 1 적용) | 생식·발생 | - 랫드 대상(6~19일) | - 5, 20, 40, 60 mg/kg bw/day | 제품군 | 세부 분류 | · Ainh-2 (mg) =  | V | - LOAEL 활용하는 경우 : 3 고려, 사례별 |\n| 손 세정 비누 | 24.04 | 382.15 | 0.01 | 0.24 | 3.82 | 정·고시된 원료 외의 보존제, 색소, 자외선차단제 등은 사용할 수 없다.  | 대상 | 제품 내 농도 | 제품 사용량(g) | 1회당 사용량 | - 1일 사용량 또는 1회 사용량 | 화장품 노출량 | https://elaws.e-gov.go.jp/search/elawsSearch/elaws_searc | 자료 선택의 타당성을 가급적 명확하고 간략하게 기술 | 피부흡수율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| - (OECD TG407) 반복투여(28일) 경구독성시험 | - (OECD TG412) 반복투여(28일) 흡입독성시험 | - (OECD TG408) 설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG409) 비설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG413) 설치류 대상 반복투여(90일) 흡입독성시험 | T25 | 얼굴 크림 | 1.54 | 24.14 | 5.0 mg/kg bw/day |\n| 헤어컨디셔너2 | 3.92 | - | ③ 제1항 및 제2항에 따른 위해평가의 기준, 방법 등에 관한 세부 사항은 식품의약 | Maximization | 0.4% (intradermal; VNR) | 1% (topical; VNR) | 0.25% (VNR) | 감작성 있음 | 제품 및 시나리오를 선택할 수 있다.  | 1 피부 단위면적당 노출량을 평가할 경우 체표면적에 제시된 값을 적용할 수 있다(붙임 4 참조) | 화장품 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 | (%) | 물휴지 | 4.57 | 17500 | 0.261143 | (g/day) | (case-by-case)로 불확실성 계수 1~10 적용 | (%) | □ 예 | ■ 아니오 |\n| HT25 = | 파악하는 과정 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | 함량(%) | 전체 제품 내 물질의 함유율 | 샴푸, 컨디셔너, 헤어스프레이, 헤어스타일링 제품(젤, 무스), | = | = 0.71 mg/kg bw/day |\n| 1-1. ",
        "original_sentence": "| 결과 | (경구) | 따라 나타나는 일반 독성영향(생식, 유전독성 및 발암 효과 제외) | 남성용 화장품(Men’s cosmetics) | CEL | 3.5 | 헤어 스타일링 | 0.28 | 1010 | 0.277228 | Aexp × IR × t | 간의 글라이코겐 감소 및 쿠퍼세포에서 | 철의 양 증가 |\n| 샴푸 | 10.46 | 150.49 | 0.01 | 0.11 | 1.51 | B1-2013-4-002 | 2013.10. "
      }
    },
    {
      "chunk_id": "chunk_058",
      "text": "| 화장품 위해평가 가이드라인 개정 | fevap (%) | 증발 비율(보수적으로 1 적용) | 생식·발생 | - 랫드 대상(6~19일) | - 5, 20, 40, 60 mg/kg bw/day | 제품군 | 세부 분류 | · Ainh-2 (mg) =  | V | - LOAEL 활용하는 경우 : 3 고려, 사례별 |\n| 손 세정 비누 | 24.04 | 382.15 | 0.01 | 0.24 | 3.82 | 정·고시된 원료 외의 보존제, 색소, 자외선차단제 등은 사용할 수 없다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 57,
        "window_size": 3,
        "char_count": 270,
        "word_count": 75,
        "page_number": 1,
        "window_text": "| 여부 | 시험방법 | Induction conc.  | Challenge conc.  | 결과 | (경구) | 따라 나타나는 일반 독성영향(생식, 유전독성 및 발암 효과 제외) | 남성용 화장품(Men’s cosmetics) | CEL | 3.5 | 헤어 스타일링 | 0.28 | 1010 | 0.277228 | Aexp × IR × t | 간의 글라이코겐 감소 및 쿠퍼세포에서 | 철의 양 증가 |\n| 샴푸 | 10.46 | 150.49 | 0.01 | 0.11 | 1.51 | B1-2013-4-002 | 2013.10.  | 화장품 위해평가 가이드라인 개정 | fevap (%) | 증발 비율(보수적으로 1 적용) | 생식·발생 | - 랫드 대상(6~19일) | - 5, 20, 40, 60 mg/kg bw/day | 제품군 | 세부 분류 | · Ainh-2 (mg) =  | V | - LOAEL 활용하는 경우 : 3 고려, 사례별 |\n| 손 세정 비누 | 24.04 | 382.15 | 0.01 | 0.24 | 3.82 | 정·고시된 원료 외의 보존제, 색소, 자외선차단제 등은 사용할 수 없다.  | 대상 | 제품 내 농도 | 제품 사용량(g) | 1회당 사용량 | - 1일 사용량 또는 1회 사용량 | 화장품 노출량 | https://elaws.e-gov.go.jp/search/elawsSearch/elaws_searc | 자료 선택의 타당성을 가급적 명확하고 간략하게 기술 | 피부흡수율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| - (OECD TG407) 반복투여(28일) 경구독성시험 | - (OECD TG412) 반복투여(28일) 흡입독성시험 | - (OECD TG408) 설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG409) 비설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG413) 설치류 대상 반복투여(90일) 흡입독성시험 | T25 | 얼굴 크림 | 1.54 | 24.14 | 5.0 mg/kg bw/day |\n| 헤어컨디셔너2 | 3.92 | - | ③ 제1항 및 제2항에 따른 위해평가의 기준, 방법 등에 관한 세부 사항은 식품의약 | Maximization | 0.4% (intradermal; VNR) | 1% (topical; VNR) | 0.25% (VNR) | 감작성 있음 | 제품 및 시나리오를 선택할 수 있다.  | 1 피부 단위면적당 노출량을 평가할 경우 체표면적에 제시된 값을 적용할 수 있다(붙임 4 참조) | 화장품 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 | (%) | 물휴지 | 4.57 | 17500 | 0.261143 | (g/day) | (case-by-case)로 불확실성 계수 1~10 적용 | (%) | □ 예 | ■ 아니오 |\n| HT25 = | 파악하는 과정 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | 함량(%) | 전체 제품 내 물질의 함유율 | 샴푸, 컨디셔너, 헤어스프레이, 헤어스타일링 제품(젤, 무스), | = | = 0.71 mg/kg bw/day |\n| 1-1.  위해평가 단계 ········································································································· 5 | ○ 위해평가 보고서 양식에 따라 작성 | 율, 감작성 등을 평가할 때, 성분 자체만이 아니라 매질 등의 영향도 고려해야 한다. ",
        "original_sentence": "| 화장품 위해평가 가이드라인 개정 | fevap (%) | 증발 비율(보수적으로 1 적용) | 생식·발생 | - 랫드 대상(6~19일) | - 5, 20, 40, 60 mg/kg bw/day | 제품군 | 세부 분류 | · Ainh-2 (mg) =  | V | - LOAEL 활용하는 경우 : 3 고려, 사례별 |\n| 손 세정 비누 | 24.04 | 382.15 | 0.01 | 0.24 | 3.82 | 정·고시된 원료 외의 보존제, 색소, 자외선차단제 등은 사용할 수 없다. "
      }
    },
    {
      "chunk_id": "chunk_059",
      "text": "| 대상 | 제품 내 농도 | 제품 사용량(g) | 1회당 사용량 | - 1일 사용량 또는 1회 사용량 | 화장품 노출량 | https://elaws.e-gov.go.jp/search/elawsSearch/elaws_searc | 자료 선택의 타당성을 가급적 명확하고 간략하게 기술 | 피부흡수율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| - (OECD TG407) 반복투여(28일) 경구독성시험 | - (OECD TG412) 반복투여(28일) 흡입독성시험 | - (OECD TG408) 설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG409) 비설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG413) 설치류 대상 반복투여(90일) 흡입독성시험 | T25 | 얼굴 크림 | 1.54 | 24.14 | 5.0 mg/kg bw/day |\n| 헤어컨디셔너2 | 3.92 | - | ③ 제1항 및 제2항에 따른 위해평가의 기준, 방법 등에 관한 세부 사항은 식품의약 | Maximization | 0.4% (intradermal; VNR) | 1% (topical; VNR) | 0.25% (VNR) | 감작성 있음 | 제품 및 시나리오를 선택할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 58,
        "window_size": 3,
        "char_count": 621,
        "word_count": 136,
        "page_number": 37,
        "window_text": "| Challenge conc.  | 결과 | (경구) | 따라 나타나는 일반 독성영향(생식, 유전독성 및 발암 효과 제외) | 남성용 화장품(Men’s cosmetics) | CEL | 3.5 | 헤어 스타일링 | 0.28 | 1010 | 0.277228 | Aexp × IR × t | 간의 글라이코겐 감소 및 쿠퍼세포에서 | 철의 양 증가 |\n| 샴푸 | 10.46 | 150.49 | 0.01 | 0.11 | 1.51 | B1-2013-4-002 | 2013.10.  | 화장품 위해평가 가이드라인 개정 | fevap (%) | 증발 비율(보수적으로 1 적용) | 생식·발생 | - 랫드 대상(6~19일) | - 5, 20, 40, 60 mg/kg bw/day | 제품군 | 세부 분류 | · Ainh-2 (mg) =  | V | - LOAEL 활용하는 경우 : 3 고려, 사례별 |\n| 손 세정 비누 | 24.04 | 382.15 | 0.01 | 0.24 | 3.82 | 정·고시된 원료 외의 보존제, 색소, 자외선차단제 등은 사용할 수 없다.  | 대상 | 제품 내 농도 | 제품 사용량(g) | 1회당 사용량 | - 1일 사용량 또는 1회 사용량 | 화장품 노출량 | https://elaws.e-gov.go.jp/search/elawsSearch/elaws_searc | 자료 선택의 타당성을 가급적 명확하고 간략하게 기술 | 피부흡수율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| - (OECD TG407) 반복투여(28일) 경구독성시험 | - (OECD TG412) 반복투여(28일) 흡입독성시험 | - (OECD TG408) 설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG409) 비설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG413) 설치류 대상 반복투여(90일) 흡입독성시험 | T25 | 얼굴 크림 | 1.54 | 24.14 | 5.0 mg/kg bw/day |\n| 헤어컨디셔너2 | 3.92 | - | ③ 제1항 및 제2항에 따른 위해평가의 기준, 방법 등에 관한 세부 사항은 식품의약 | Maximization | 0.4% (intradermal; VNR) | 1% (topical; VNR) | 0.25% (VNR) | 감작성 있음 | 제품 및 시나리오를 선택할 수 있다.  | 1 피부 단위면적당 노출량을 평가할 경우 체표면적에 제시된 값을 적용할 수 있다(붙임 4 참조) | 화장품 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 | (%) | 물휴지 | 4.57 | 17500 | 0.261143 | (g/day) | (case-by-case)로 불확실성 계수 1~10 적용 | (%) | □ 예 | ■ 아니오 |\n| HT25 = | 파악하는 과정 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | 함량(%) | 전체 제품 내 물질의 함유율 | 샴푸, 컨디셔너, 헤어스프레이, 헤어스타일링 제품(젤, 무스), | = | = 0.71 mg/kg bw/day |\n| 1-1.  위해평가 단계 ········································································································· 5 | ○ 위해평가 보고서 양식에 따라 작성 | 율, 감작성 등을 평가할 때, 성분 자체만이 아니라 매질 등의 영향도 고려해야 한다.  | 물휴지 | 4.57 | 71.15 | 1.0 | 4.57 | 71.15 | ③ 식품의약품안전처장은 국내외에서 유해물질이 포함되어 있는 것으로 알려지는 등 | 반복투여 | 대상 | 화장품 | (사람체중/동물체중)0.25 | (60/0.025)0.25 | - 랫드 대상(13주) | - 0, 55.5, 277, 555 mg/kg/day | - 모든 용량에서 영향 없음 | 제품 내 농도 | 목욕 및 샤워(Bathing, showering) | 핸드 크림 | 2.16 | 32.70 | 화장품 노출량 | h/lsg0500/detail?lawId=335AC0000000145 | 피부흡수율 | 20%의 치사율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| 모발 관리용 | 헤어스타일링제품 | 4.00 | 57.40 | 0.10 | 0.40 | 5.74 | 값 + 1(또는 2)×표준편차(SD)를 사용한다. ",
        "original_sentence": "| 대상 | 제품 내 농도 | 제품 사용량(g) | 1회당 사용량 | - 1일 사용량 또는 1회 사용량 | 화장품 노출량 | https://elaws.e-gov.go.jp/search/elawsSearch/elaws_searc | 자료 선택의 타당성을 가급적 명확하고 간략하게 기술 | 피부흡수율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| - (OECD TG407) 반복투여(28일) 경구독성시험 | - (OECD TG412) 반복투여(28일) 흡입독성시험 | - (OECD TG408) 설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG409) 비설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG413) 설치류 대상 반복투여(90일) 흡입독성시험 | T25 | 얼굴 크림 | 1.54 | 24.14 | 5.0 mg/kg bw/day |\n| 헤어컨디셔너2 | 3.92 | - | ③ 제1항 및 제2항에 따른 위해평가의 기준, 방법 등에 관한 세부 사항은 식품의약 | Maximization | 0.4% (intradermal; VNR) | 1% (topical; VNR) | 0.25% (VNR) | 감작성 있음 | 제품 및 시나리오를 선택할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_060",
      "text": "| 1 피부 단위면적당 노출량을 평가할 경우 체표면적에 제시된 값을 적용할 수 있다(붙임 4 참조) | 화장품 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 | (%) | 물휴지 | 4.57 | 17500 | 0.261143 | (g/day) | (case-by-case)로 불확실성 계수 1~10 적용 | (%) | □ 예 | ■ 아니오 |\n| HT25 = | 파악하는 과정 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | 함량(%) | 전체 제품 내 물질의 함유율 | 샴푸, 컨디셔너, 헤어스프레이, 헤어스타일링 제품(젤, 무스), | = | = 0.71 mg/kg bw/day |\n| 1-1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 59,
        "window_size": 3,
        "char_count": 363,
        "word_count": 95,
        "page_number": 37,
        "window_text": "| 결과 | (경구) | 따라 나타나는 일반 독성영향(생식, 유전독성 및 발암 효과 제외) | 남성용 화장품(Men’s cosmetics) | CEL | 3.5 | 헤어 스타일링 | 0.28 | 1010 | 0.277228 | Aexp × IR × t | 간의 글라이코겐 감소 및 쿠퍼세포에서 | 철의 양 증가 |\n| 샴푸 | 10.46 | 150.49 | 0.01 | 0.11 | 1.51 | B1-2013-4-002 | 2013.10.  | 화장품 위해평가 가이드라인 개정 | fevap (%) | 증발 비율(보수적으로 1 적용) | 생식·발생 | - 랫드 대상(6~19일) | - 5, 20, 40, 60 mg/kg bw/day | 제품군 | 세부 분류 | · Ainh-2 (mg) =  | V | - LOAEL 활용하는 경우 : 3 고려, 사례별 |\n| 손 세정 비누 | 24.04 | 382.15 | 0.01 | 0.24 | 3.82 | 정·고시된 원료 외의 보존제, 색소, 자외선차단제 등은 사용할 수 없다.  | 대상 | 제품 내 농도 | 제품 사용량(g) | 1회당 사용량 | - 1일 사용량 또는 1회 사용량 | 화장품 노출량 | https://elaws.e-gov.go.jp/search/elawsSearch/elaws_searc | 자료 선택의 타당성을 가급적 명확하고 간략하게 기술 | 피부흡수율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| - (OECD TG407) 반복투여(28일) 경구독성시험 | - (OECD TG412) 반복투여(28일) 흡입독성시험 | - (OECD TG408) 설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG409) 비설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG413) 설치류 대상 반복투여(90일) 흡입독성시험 | T25 | 얼굴 크림 | 1.54 | 24.14 | 5.0 mg/kg bw/day |\n| 헤어컨디셔너2 | 3.92 | - | ③ 제1항 및 제2항에 따른 위해평가의 기준, 방법 등에 관한 세부 사항은 식품의약 | Maximization | 0.4% (intradermal; VNR) | 1% (topical; VNR) | 0.25% (VNR) | 감작성 있음 | 제품 및 시나리오를 선택할 수 있다.  | 1 피부 단위면적당 노출량을 평가할 경우 체표면적에 제시된 값을 적용할 수 있다(붙임 4 참조) | 화장품 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 | (%) | 물휴지 | 4.57 | 17500 | 0.261143 | (g/day) | (case-by-case)로 불확실성 계수 1~10 적용 | (%) | □ 예 | ■ 아니오 |\n| HT25 = | 파악하는 과정 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | 함량(%) | 전체 제품 내 물질의 함유율 | 샴푸, 컨디셔너, 헤어스프레이, 헤어스타일링 제품(젤, 무스), | = | = 0.71 mg/kg bw/day |\n| 1-1.  위해평가 단계 ········································································································· 5 | ○ 위해평가 보고서 양식에 따라 작성 | 율, 감작성 등을 평가할 때, 성분 자체만이 아니라 매질 등의 영향도 고려해야 한다.  | 물휴지 | 4.57 | 71.15 | 1.0 | 4.57 | 71.15 | ③ 식품의약품안전처장은 국내외에서 유해물질이 포함되어 있는 것으로 알려지는 등 | 반복투여 | 대상 | 화장품 | (사람체중/동물체중)0.25 | (60/0.025)0.25 | - 랫드 대상(13주) | - 0, 55.5, 277, 555 mg/kg/day | - 모든 용량에서 영향 없음 | 제품 내 농도 | 목욕 및 샤워(Bathing, showering) | 핸드 크림 | 2.16 | 32.70 | 화장품 노출량 | h/lsg0500/detail?lawId=335AC0000000145 | 피부흡수율 | 20%의 치사율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| 모발 관리용 | 헤어스타일링제품 | 4.00 | 57.40 | 0.10 | 0.40 | 5.74 | 값 + 1(또는 2)×표준편차(SD)를 사용한다.  | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 입장을 기술하는 | 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 기준에 관한 표준지침을 제공하고 있으므로 이를 참조하여 검토한다. ",
        "original_sentence": "| 1 피부 단위면적당 노출량을 평가할 경우 체표면적에 제시된 값을 적용할 수 있다(붙임 4 참조) | 화장품 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 | (%) | 물휴지 | 4.57 | 17500 | 0.261143 | (g/day) | (case-by-case)로 불확실성 계수 1~10 적용 | (%) | □ 예 | ■ 아니오 |\n| HT25 = | 파악하는 과정 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | 함량(%) | 전체 제품 내 물질의 함유율 | 샴푸, 컨디셔너, 헤어스프레이, 헤어스타일링 제품(젤, 무스), | = | = 0.71 mg/kg bw/day |\n| 1-1. "
      }
    },
    {
      "chunk_id": "chunk_061",
      "text": "위해평가 단계 ········································································································· 5 | ○ 위해평가 보고서 양식에 따라 작성 | 율, 감작성 등을 평가할 때, 성분 자체만이 아니라 매질 등의 영향도 고려해야 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 60,
        "window_size": 3,
        "char_count": 189,
        "word_count": 25,
        "page_number": 5,
        "window_text": "| 화장품 위해평가 가이드라인 개정 | fevap (%) | 증발 비율(보수적으로 1 적용) | 생식·발생 | - 랫드 대상(6~19일) | - 5, 20, 40, 60 mg/kg bw/day | 제품군 | 세부 분류 | · Ainh-2 (mg) =  | V | - LOAEL 활용하는 경우 : 3 고려, 사례별 |\n| 손 세정 비누 | 24.04 | 382.15 | 0.01 | 0.24 | 3.82 | 정·고시된 원료 외의 보존제, 색소, 자외선차단제 등은 사용할 수 없다.  | 대상 | 제품 내 농도 | 제품 사용량(g) | 1회당 사용량 | - 1일 사용량 또는 1회 사용량 | 화장품 노출량 | https://elaws.e-gov.go.jp/search/elawsSearch/elaws_searc | 자료 선택의 타당성을 가급적 명확하고 간략하게 기술 | 피부흡수율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| - (OECD TG407) 반복투여(28일) 경구독성시험 | - (OECD TG412) 반복투여(28일) 흡입독성시험 | - (OECD TG408) 설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG409) 비설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG413) 설치류 대상 반복투여(90일) 흡입독성시험 | T25 | 얼굴 크림 | 1.54 | 24.14 | 5.0 mg/kg bw/day |\n| 헤어컨디셔너2 | 3.92 | - | ③ 제1항 및 제2항에 따른 위해평가의 기준, 방법 등에 관한 세부 사항은 식품의약 | Maximization | 0.4% (intradermal; VNR) | 1% (topical; VNR) | 0.25% (VNR) | 감작성 있음 | 제품 및 시나리오를 선택할 수 있다.  | 1 피부 단위면적당 노출량을 평가할 경우 체표면적에 제시된 값을 적용할 수 있다(붙임 4 참조) | 화장품 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 | (%) | 물휴지 | 4.57 | 17500 | 0.261143 | (g/day) | (case-by-case)로 불확실성 계수 1~10 적용 | (%) | □ 예 | ■ 아니오 |\n| HT25 = | 파악하는 과정 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | 함량(%) | 전체 제품 내 물질의 함유율 | 샴푸, 컨디셔너, 헤어스프레이, 헤어스타일링 제품(젤, 무스), | = | = 0.71 mg/kg bw/day |\n| 1-1.  위해평가 단계 ········································································································· 5 | ○ 위해평가 보고서 양식에 따라 작성 | 율, 감작성 등을 평가할 때, 성분 자체만이 아니라 매질 등의 영향도 고려해야 한다.  | 물휴지 | 4.57 | 71.15 | 1.0 | 4.57 | 71.15 | ③ 식품의약품안전처장은 국내외에서 유해물질이 포함되어 있는 것으로 알려지는 등 | 반복투여 | 대상 | 화장품 | (사람체중/동물체중)0.25 | (60/0.025)0.25 | - 랫드 대상(13주) | - 0, 55.5, 277, 555 mg/kg/day | - 모든 용량에서 영향 없음 | 제품 내 농도 | 목욕 및 샤워(Bathing, showering) | 핸드 크림 | 2.16 | 32.70 | 화장품 노출량 | h/lsg0500/detail?lawId=335AC0000000145 | 피부흡수율 | 20%의 치사율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| 모발 관리용 | 헤어스타일링제품 | 4.00 | 57.40 | 0.10 | 0.40 | 5.74 | 값 + 1(또는 2)×표준편차(SD)를 사용한다.  | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 입장을 기술하는 | 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 기준에 관한 표준지침을 제공하고 있으므로 이를 참조하여 검토한다.  | 및 기능적 영향)을 포함한다. ",
        "original_sentence": "위해평가 단계 ········································································································· 5 | ○ 위해평가 보고서 양식에 따라 작성 | 율, 감작성 등을 평가할 때, 성분 자체만이 아니라 매질 등의 영향도 고려해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_062",
      "text": "| 물휴지 | 4.57 | 71.15 | 1.0 | 4.57 | 71.15 | ③ 식품의약품안전처장은 국내외에서 유해물질이 포함되어 있는 것으로 알려지는 등 | 반복투여 | 대상 | 화장품 | (사람체중/동물체중)0.25 | (60/0.025)0.25 | - 랫드 대상(13주) | - 0, 55.5, 277, 555 mg/kg/day | - 모든 용량에서 영향 없음 | 제품 내 농도 | 목욕 및 샤워(Bathing, showering) | 핸드 크림 | 2.16 | 32.70 | 화장품 노출량 | h/lsg0500/detail?lawId=335AC0000000145 | 피부흡수율 | 20%의 치사율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| 모발 관리용 | 헤어스타일링제품 | 4.00 | 57.40 | 0.10 | 0.40 | 5.74 | 값 + 1(또는 2)×표준편차(SD)를 사용한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 61,
        "window_size": 3,
        "char_count": 461,
        "word_count": 105,
        "page_number": 42,
        "window_text": "| 대상 | 제품 내 농도 | 제품 사용량(g) | 1회당 사용량 | - 1일 사용량 또는 1회 사용량 | 화장품 노출량 | https://elaws.e-gov.go.jp/search/elawsSearch/elaws_searc | 자료 선택의 타당성을 가급적 명확하고 간략하게 기술 | 피부흡수율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| - (OECD TG407) 반복투여(28일) 경구독성시험 | - (OECD TG412) 반복투여(28일) 흡입독성시험 | - (OECD TG408) 설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG409) 비설치류 대상 반복투여(90일) 경구독성시험 | - (OECD TG413) 설치류 대상 반복투여(90일) 흡입독성시험 | T25 | 얼굴 크림 | 1.54 | 24.14 | 5.0 mg/kg bw/day |\n| 헤어컨디셔너2 | 3.92 | - | ③ 제1항 및 제2항에 따른 위해평가의 기준, 방법 등에 관한 세부 사항은 식품의약 | Maximization | 0.4% (intradermal; VNR) | 1% (topical; VNR) | 0.25% (VNR) | 감작성 있음 | 제품 및 시나리오를 선택할 수 있다.  | 1 피부 단위면적당 노출량을 평가할 경우 체표면적에 제시된 값을 적용할 수 있다(붙임 4 참조) | 화장품 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 | (%) | 물휴지 | 4.57 | 17500 | 0.261143 | (g/day) | (case-by-case)로 불확실성 계수 1~10 적용 | (%) | □ 예 | ■ 아니오 |\n| HT25 = | 파악하는 과정 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | 함량(%) | 전체 제품 내 물질의 함유율 | 샴푸, 컨디셔너, 헤어스프레이, 헤어스타일링 제품(젤, 무스), | = | = 0.71 mg/kg bw/day |\n| 1-1.  위해평가 단계 ········································································································· 5 | ○ 위해평가 보고서 양식에 따라 작성 | 율, 감작성 등을 평가할 때, 성분 자체만이 아니라 매질 등의 영향도 고려해야 한다.  | 물휴지 | 4.57 | 71.15 | 1.0 | 4.57 | 71.15 | ③ 식품의약품안전처장은 국내외에서 유해물질이 포함되어 있는 것으로 알려지는 등 | 반복투여 | 대상 | 화장품 | (사람체중/동물체중)0.25 | (60/0.025)0.25 | - 랫드 대상(13주) | - 0, 55.5, 277, 555 mg/kg/day | - 모든 용량에서 영향 없음 | 제품 내 농도 | 목욕 및 샤워(Bathing, showering) | 핸드 크림 | 2.16 | 32.70 | 화장품 노출량 | h/lsg0500/detail?lawId=335AC0000000145 | 피부흡수율 | 20%의 치사율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| 모발 관리용 | 헤어스타일링제품 | 4.00 | 57.40 | 0.10 | 0.40 | 5.74 | 값 + 1(또는 2)×표준편차(SD)를 사용한다.  | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 입장을 기술하는 | 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 기준에 관한 표준지침을 제공하고 있으므로 이를 참조하여 검토한다.  | 및 기능적 영향)을 포함한다.  | 해당하는 내용입니까? ",
        "original_sentence": "| 물휴지 | 4.57 | 71.15 | 1.0 | 4.57 | 71.15 | ③ 식품의약품안전처장은 국내외에서 유해물질이 포함되어 있는 것으로 알려지는 등 | 반복투여 | 대상 | 화장품 | (사람체중/동물체중)0.25 | (60/0.025)0.25 | - 랫드 대상(13주) | - 0, 55.5, 277, 555 mg/kg/day | - 모든 용량에서 영향 없음 | 제품 내 농도 | 목욕 및 샤워(Bathing, showering) | 핸드 크림 | 2.16 | 32.70 | 화장품 노출량 | h/lsg0500/detail?lawId=335AC0000000145 | 피부흡수율 | 20%의 치사율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| 모발 관리용 | 헤어스타일링제품 | 4.00 | 57.40 | 0.10 | 0.40 | 5.74 | 값 + 1(또는 2)×표준편차(SD)를 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_063",
      "text": "| 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 입장을 기술하는 | 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 기준에 관한 표준지침을 제공하고 있으므로 이를 참조하여 검토한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 62,
        "window_size": 3,
        "char_count": 116,
        "word_count": 26,
        "page_number": 2,
        "window_text": "| 1 피부 단위면적당 노출량을 평가할 경우 체표면적에 제시된 값을 적용할 수 있다(붙임 4 참조) | 화장품 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 | (%) | 물휴지 | 4.57 | 17500 | 0.261143 | (g/day) | (case-by-case)로 불확실성 계수 1~10 적용 | (%) | □ 예 | ■ 아니오 |\n| HT25 = | 파악하는 과정 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | 함량(%) | 전체 제품 내 물질의 함유율 | 샴푸, 컨디셔너, 헤어스프레이, 헤어스타일링 제품(젤, 무스), | = | = 0.71 mg/kg bw/day |\n| 1-1.  위해평가 단계 ········································································································· 5 | ○ 위해평가 보고서 양식에 따라 작성 | 율, 감작성 등을 평가할 때, 성분 자체만이 아니라 매질 등의 영향도 고려해야 한다.  | 물휴지 | 4.57 | 71.15 | 1.0 | 4.57 | 71.15 | ③ 식품의약품안전처장은 국내외에서 유해물질이 포함되어 있는 것으로 알려지는 등 | 반복투여 | 대상 | 화장품 | (사람체중/동물체중)0.25 | (60/0.025)0.25 | - 랫드 대상(13주) | - 0, 55.5, 277, 555 mg/kg/day | - 모든 용량에서 영향 없음 | 제품 내 농도 | 목욕 및 샤워(Bathing, showering) | 핸드 크림 | 2.16 | 32.70 | 화장품 노출량 | h/lsg0500/detail?lawId=335AC0000000145 | 피부흡수율 | 20%의 치사율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| 모발 관리용 | 헤어스타일링제품 | 4.00 | 57.40 | 0.10 | 0.40 | 5.74 | 값 + 1(또는 2)×표준편차(SD)를 사용한다.  | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 입장을 기술하는 | 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 기준에 관한 표준지침을 제공하고 있으므로 이를 참조하여 검토한다.  | 및 기능적 영향)을 포함한다.  | 해당하는 내용입니까?  | ○ 피부흡수량 또는 피부흡수율 | PODsys |\n| : 평가 배경 및 목적 기술 | 품안전처장이 정하여 고시한다. ",
        "original_sentence": "| 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 입장을 기술하는 | 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 기준에 관한 표준지침을 제공하고 있으므로 이를 참조하여 검토한다. "
      }
    },
    {
      "chunk_id": "chunk_064",
      "text": "| 및 기능적 영향)을 포함한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 63,
        "window_size": 3,
        "char_count": 19,
        "word_count": 5,
        "page_number": 2,
        "window_text": "위해평가 단계 ········································································································· 5 | ○ 위해평가 보고서 양식에 따라 작성 | 율, 감작성 등을 평가할 때, 성분 자체만이 아니라 매질 등의 영향도 고려해야 한다.  | 물휴지 | 4.57 | 71.15 | 1.0 | 4.57 | 71.15 | ③ 식품의약품안전처장은 국내외에서 유해물질이 포함되어 있는 것으로 알려지는 등 | 반복투여 | 대상 | 화장품 | (사람체중/동물체중)0.25 | (60/0.025)0.25 | - 랫드 대상(13주) | - 0, 55.5, 277, 555 mg/kg/day | - 모든 용량에서 영향 없음 | 제품 내 농도 | 목욕 및 샤워(Bathing, showering) | 핸드 크림 | 2.16 | 32.70 | 화장품 노출량 | h/lsg0500/detail?lawId=335AC0000000145 | 피부흡수율 | 20%의 치사율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| 모발 관리용 | 헤어스타일링제품 | 4.00 | 57.40 | 0.10 | 0.40 | 5.74 | 값 + 1(또는 2)×표준편차(SD)를 사용한다.  | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 입장을 기술하는 | 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 기준에 관한 표준지침을 제공하고 있으므로 이를 참조하여 검토한다.  | 및 기능적 영향)을 포함한다.  | 해당하는 내용입니까?  | ○ 피부흡수량 또는 피부흡수율 | PODsys |\n| : 평가 배경 및 목적 기술 | 품안전처장이 정하여 고시한다.  | 평가할 수 있다. ",
        "original_sentence": "| 및 기능적 영향)을 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_065",
      "text": "| 해당하는 내용입니까? ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 64,
        "window_size": 3,
        "char_count": 14,
        "word_count": 3,
        "page_number": 2,
        "window_text": "| 물휴지 | 4.57 | 71.15 | 1.0 | 4.57 | 71.15 | ③ 식품의약품안전처장은 국내외에서 유해물질이 포함되어 있는 것으로 알려지는 등 | 반복투여 | 대상 | 화장품 | (사람체중/동물체중)0.25 | (60/0.025)0.25 | - 랫드 대상(13주) | - 0, 55.5, 277, 555 mg/kg/day | - 모든 용량에서 영향 없음 | 제품 내 농도 | 목욕 및 샤워(Bathing, showering) | 핸드 크림 | 2.16 | 32.70 | 화장품 노출량 | h/lsg0500/detail?lawId=335AC0000000145 | 피부흡수율 | 20%의 치사율 | 체중 | (kg) | 전신노출량 | (mg/kg/day) |\n| 모발 관리용 | 헤어스타일링제품 | 4.00 | 57.40 | 0.10 | 0.40 | 5.74 | 값 + 1(또는 2)×표준편차(SD)를 사용한다.  | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 입장을 기술하는 | 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 기준에 관한 표준지침을 제공하고 있으므로 이를 참조하여 검토한다.  | 및 기능적 영향)을 포함한다.  | 해당하는 내용입니까?  | ○ 피부흡수량 또는 피부흡수율 | PODsys |\n| : 평가 배경 및 목적 기술 | 품안전처장이 정하여 고시한다.  | 평가할 수 있다.  | 자외선 | 노출시간(분) | 해당 물질 제품을 사용된 공간에서 노출이 | 되는 시간 | (%) | 염모제(탈색), 퍼머넌트 제품 | 리퀴드 파운데이션 | 0.30 | 565 | 0.530973 | (g/day) | 가능 | (%) |\n| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 에 따라 0 또는 LOQ/2로 처리한다. ",
        "original_sentence": "| 해당하는 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_066",
      "text": "| ○ 피부흡수량 또는 피부흡수율 | PODsys |\n| : 평가 배경 및 목적 기술 | 품안전처장이 정하여 고시한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 65,
        "window_size": 3,
        "char_count": 67,
        "word_count": 19,
        "page_number": 22,
        "window_text": "| 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 입장을 기술하는 | 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 기준에 관한 표준지침을 제공하고 있으므로 이를 참조하여 검토한다.  | 및 기능적 영향)을 포함한다.  | 해당하는 내용입니까?  | ○ 피부흡수량 또는 피부흡수율 | PODsys |\n| : 평가 배경 및 목적 기술 | 품안전처장이 정하여 고시한다.  | 평가할 수 있다.  | 자외선 | 노출시간(분) | 해당 물질 제품을 사용된 공간에서 노출이 | 되는 시간 | (%) | 염모제(탈색), 퍼머넌트 제품 | 리퀴드 파운데이션 | 0.30 | 565 | 0.530973 | (g/day) | 가능 | (%) |\n| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 에 따라 0 또는 LOQ/2로 처리한다.  | 하되 자료 선택의 타당성, 불확실성 | 정을 통해 흡입 노출 우려를 낮추도록 함 | V (m3) | 사용 공간 부피(한국 욕실 부피 9.3 적용)2 | (경피) | 안전역(MOS) | = | 비 분무형 데오도란트 | 1.50 | 22.08 | https://www.mhlw.go.jp/content/000491511.pdf | 모발 케어(남녀) | - 모체독성 NOAEL 10 mg/kg bw/day | - 발생독성 NOAEL 30 mg/kg bw/day | - 30 mg/kg bw/day 용량에서 배변 |\n| 국민보건상 위해 우려가 제기되는 화장품 원료 등의 경우에는 총리령으로 정하는 바 | B1-2016-4-001 | 2016.02. ",
        "original_sentence": "| ○ 피부흡수량 또는 피부흡수율 | PODsys |\n| : 평가 배경 및 목적 기술 | 품안전처장이 정하여 고시한다. "
      }
    },
    {
      "chunk_id": "chunk_067",
      "text": "| 평가할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 66,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 2,
        "window_text": "| 및 기능적 영향)을 포함한다.  | 해당하는 내용입니까?  | ○ 피부흡수량 또는 피부흡수율 | PODsys |\n| : 평가 배경 및 목적 기술 | 품안전처장이 정하여 고시한다.  | 평가할 수 있다.  | 자외선 | 노출시간(분) | 해당 물질 제품을 사용된 공간에서 노출이 | 되는 시간 | (%) | 염모제(탈색), 퍼머넌트 제품 | 리퀴드 파운데이션 | 0.30 | 565 | 0.530973 | (g/day) | 가능 | (%) |\n| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 에 따라 0 또는 LOQ/2로 처리한다.  | 하되 자료 선택의 타당성, 불확실성 | 정을 통해 흡입 노출 우려를 낮추도록 함 | V (m3) | 사용 공간 부피(한국 욕실 부피 9.3 적용)2 | (경피) | 안전역(MOS) | = | 비 분무형 데오도란트 | 1.50 | 22.08 | https://www.mhlw.go.jp/content/000491511.pdf | 모발 케어(남녀) | - 모체독성 NOAEL 10 mg/kg bw/day | - 발생독성 NOAEL 30 mg/kg bw/day | - 30 mg/kg bw/day 용량에서 배변 |\n| 국민보건상 위해 우려가 제기되는 화장품 원료 등의 경우에는 총리령으로 정하는 바 | B1-2016-4-001 | 2016.02.  | 화장품 위해평가 가이드라인 개정 | Maximization | 0.2% in 0.9% saline solution (intradermal) | 5% in 70:30 acetone/PEG 400 (topical) | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
        "original_sentence": "| 평가할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_068",
      "text": "| 자외선 | 노출시간(분) | 해당 물질 제품을 사용된 공간에서 노출이 | 되는 시간 | (%) | 염모제(탈색), 퍼머넌트 제품 | 리퀴드 파운데이션 | 0.30 | 565 | 0.530973 | (g/day) | 가능 | (%) |\n| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 에 따라 0 또는 LOQ/2로 처리한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 67,
        "window_size": 3,
        "char_count": 213,
        "word_count": 51,
        "page_number": 44,
        "window_text": "| 해당하는 내용입니까?  | ○ 피부흡수량 또는 피부흡수율 | PODsys |\n| : 평가 배경 및 목적 기술 | 품안전처장이 정하여 고시한다.  | 평가할 수 있다.  | 자외선 | 노출시간(분) | 해당 물질 제품을 사용된 공간에서 노출이 | 되는 시간 | (%) | 염모제(탈색), 퍼머넌트 제품 | 리퀴드 파운데이션 | 0.30 | 565 | 0.530973 | (g/day) | 가능 | (%) |\n| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 에 따라 0 또는 LOQ/2로 처리한다.  | 하되 자료 선택의 타당성, 불확실성 | 정을 통해 흡입 노출 우려를 낮추도록 함 | V (m3) | 사용 공간 부피(한국 욕실 부피 9.3 적용)2 | (경피) | 안전역(MOS) | = | 비 분무형 데오도란트 | 1.50 | 22.08 | https://www.mhlw.go.jp/content/000491511.pdf | 모발 케어(남녀) | - 모체독성 NOAEL 10 mg/kg bw/day | - 발생독성 NOAEL 30 mg/kg bw/day | - 30 mg/kg bw/day 용량에서 배변 |\n| 국민보건상 위해 우려가 제기되는 화장품 원료 등의 경우에는 총리령으로 정하는 바 | B1-2016-4-001 | 2016.02.  | 화장품 위해평가 가이드라인 개정 | Maximization | 0.2% in 0.9% saline solution (intradermal) | 5% in 70:30 acetone/PEG 400 (topical) | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | 7.5 | 17.0 | 2.6 | 60 | 0.5525 | 자외선 차단 화장품(Sun care cosmetics) | 0.5% in 70:30 | acetone/PEG 400 | 감작성 있음 |\n| 1-2. ",
        "original_sentence": "| 자외선 | 노출시간(분) | 해당 물질 제품을 사용된 공간에서 노출이 | 되는 시간 | (%) | 염모제(탈색), 퍼머넌트 제품 | 리퀴드 파운데이션 | 0.30 | 565 | 0.530973 | (g/day) | 가능 | (%) |\n| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 에 따라 0 또는 LOQ/2로 처리한다. "
      }
    },
    {
      "chunk_id": "chunk_069",
      "text": "| 하되 자료 선택의 타당성, 불확실성 | 정을 통해 흡입 노출 우려를 낮추도록 함 | V (m3) | 사용 공간 부피(한국 욕실 부피 9.3 적용)2 | (경피) | 안전역(MOS) | = | 비 분무형 데오도란트 | 1.50 | 22.08 | https://www.mhlw.go.jp/content/000491511.pdf | 모발 케어(남녀) | - 모체독성 NOAEL 10 mg/kg bw/day | - 발생독성 NOAEL 30 mg/kg bw/day | - 30 mg/kg bw/day 용량에서 배변 |\n| 국민보건상 위해 우려가 제기되는 화장품 원료 등의 경우에는 총리령으로 정하는 바 | B1-2016-4-001 | 2016.02. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 68,
        "window_size": 3,
        "char_count": 361,
        "word_count": 82,
        "page_number": 26,
        "window_text": "| ○ 피부흡수량 또는 피부흡수율 | PODsys |\n| : 평가 배경 및 목적 기술 | 품안전처장이 정하여 고시한다.  | 평가할 수 있다.  | 자외선 | 노출시간(분) | 해당 물질 제품을 사용된 공간에서 노출이 | 되는 시간 | (%) | 염모제(탈색), 퍼머넌트 제품 | 리퀴드 파운데이션 | 0.30 | 565 | 0.530973 | (g/day) | 가능 | (%) |\n| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 에 따라 0 또는 LOQ/2로 처리한다.  | 하되 자료 선택의 타당성, 불확실성 | 정을 통해 흡입 노출 우려를 낮추도록 함 | V (m3) | 사용 공간 부피(한국 욕실 부피 9.3 적용)2 | (경피) | 안전역(MOS) | = | 비 분무형 데오도란트 | 1.50 | 22.08 | https://www.mhlw.go.jp/content/000491511.pdf | 모발 케어(남녀) | - 모체독성 NOAEL 10 mg/kg bw/day | - 발생독성 NOAEL 30 mg/kg bw/day | - 30 mg/kg bw/day 용량에서 배변 |\n| 국민보건상 위해 우려가 제기되는 화장품 원료 등의 경우에는 총리령으로 정하는 바 | B1-2016-4-001 | 2016.02.  | 화장품 위해평가 가이드라인 개정 | Maximization | 0.2% in 0.9% saline solution (intradermal) | 5% in 70:30 acetone/PEG 400 (topical) | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | 7.5 | 17.0 | 2.6 | 60 | 0.5525 | 자외선 차단 화장품(Sun care cosmetics) | 0.5% in 70:30 | acetone/PEG 400 | 감작성 있음 |\n| 1-2.  위해평가 수행에 필요한 일반사항 ····································································· 6 | 반영구적 염모제 | 35ml(per | application) | - | 0.1 | Not | 차단제 | - 제품 사용 시 접촉할 수 있는 피부면적(예 : 입술, 손톱, 목 등) | - 90일(13주) 반복투여독성시험 자료가 유효 |\n| 목욕 샤워용 | 손세정제품(비누, 젤), 샤워제품(비누, 젤), 목욕제품 | 샴푸 | 9.25 | 151.84 | 0.01 | 0.09 | 1.52 | 및 제한점 등을 명확히 기술 | 노출유형 | 제품 | g/day | mg/kg bw/day | 대표 유형 | 생식·발생 | - 토끼 대상(6~28일) | - 3, 10, 30 mg/kg bw/day | 메이크업 리무버 | 0.21 | 565 | 0.371681 | ○ 결과에 영향을 미치는 불확실성, 제한점 및 선택된 가정 | https://www.mhlw.go.jp/web/t_doc?dataId=81074000&d | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 용량에서 모체의 체중감 | SED | calculated3 | - |\n| 위해 우려가 제기되는 경우 위해평가를 통해 안전성을 확보할 수 있다. ",
        "original_sentence": "| 하되 자료 선택의 타당성, 불확실성 | 정을 통해 흡입 노출 우려를 낮추도록 함 | V (m3) | 사용 공간 부피(한국 욕실 부피 9.3 적용)2 | (경피) | 안전역(MOS) | = | 비 분무형 데오도란트 | 1.50 | 22.08 | https://www.mhlw.go.jp/content/000491511.pdf | 모발 케어(남녀) | - 모체독성 NOAEL 10 mg/kg bw/day | - 발생독성 NOAEL 30 mg/kg bw/day | - 30 mg/kg bw/day 용량에서 배변 |\n| 국민보건상 위해 우려가 제기되는 화장품 원료 등의 경우에는 총리령으로 정하는 바 | B1-2016-4-001 | 2016.02. "
      }
    },
    {
      "chunk_id": "chunk_070",
      "text": "| 화장품 위해평가 가이드라인 개정 | Maximization | 0.2% in 0.9% saline solution (intradermal) | 5% in 70:30 acetone/PEG 400 (topical) | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 69,
        "window_size": 3,
        "char_count": 149,
        "word_count": 28,
        "page_number": 1,
        "window_text": "| 평가할 수 있다.  | 자외선 | 노출시간(분) | 해당 물질 제품을 사용된 공간에서 노출이 | 되는 시간 | (%) | 염모제(탈색), 퍼머넌트 제품 | 리퀴드 파운데이션 | 0.30 | 565 | 0.530973 | (g/day) | 가능 | (%) |\n| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 에 따라 0 또는 LOQ/2로 처리한다.  | 하되 자료 선택의 타당성, 불확실성 | 정을 통해 흡입 노출 우려를 낮추도록 함 | V (m3) | 사용 공간 부피(한국 욕실 부피 9.3 적용)2 | (경피) | 안전역(MOS) | = | 비 분무형 데오도란트 | 1.50 | 22.08 | https://www.mhlw.go.jp/content/000491511.pdf | 모발 케어(남녀) | - 모체독성 NOAEL 10 mg/kg bw/day | - 발생독성 NOAEL 30 mg/kg bw/day | - 30 mg/kg bw/day 용량에서 배변 |\n| 국민보건상 위해 우려가 제기되는 화장품 원료 등의 경우에는 총리령으로 정하는 바 | B1-2016-4-001 | 2016.02.  | 화장품 위해평가 가이드라인 개정 | Maximization | 0.2% in 0.9% saline solution (intradermal) | 5% in 70:30 acetone/PEG 400 (topical) | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | 7.5 | 17.0 | 2.6 | 60 | 0.5525 | 자외선 차단 화장품(Sun care cosmetics) | 0.5% in 70:30 | acetone/PEG 400 | 감작성 있음 |\n| 1-2.  위해평가 수행에 필요한 일반사항 ····································································· 6 | 반영구적 염모제 | 35ml(per | application) | - | 0.1 | Not | 차단제 | - 제품 사용 시 접촉할 수 있는 피부면적(예 : 입술, 손톱, 목 등) | - 90일(13주) 반복투여독성시험 자료가 유효 |\n| 목욕 샤워용 | 손세정제품(비누, 젤), 샤워제품(비누, 젤), 목욕제품 | 샴푸 | 9.25 | 151.84 | 0.01 | 0.09 | 1.52 | 및 제한점 등을 명확히 기술 | 노출유형 | 제품 | g/day | mg/kg bw/day | 대표 유형 | 생식·발생 | - 토끼 대상(6~28일) | - 3, 10, 30 mg/kg bw/day | 메이크업 리무버 | 0.21 | 565 | 0.371681 | ○ 결과에 영향을 미치는 불확실성, 제한점 및 선택된 가정 | https://www.mhlw.go.jp/web/t_doc?dataId=81074000&d | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 용량에서 모체의 체중감 | SED | calculated3 | - |\n| 위해 우려가 제기되는 경우 위해평가를 통해 안전성을 확보할 수 있다.  | 제17조의2(지정·고시된 원료의 사용기준의 안전성 검토) ① 법 제8조제5항에 따른 | Ainh-1, 2 | box 1, 2 공간에 존재하는 호흡가능한 평가 대상 물질의 양 | 생식·발생 | - 랫드 대상 | - 0, 150, 450, 1000 mg/kg/day | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)3 | 공통 | ○ 체외(in vitro) 시험 | - (OECD TG471, TG472) 박테리아 복귀돌연변이 시험 | - (OECD TG473) 염색체이상시험 | - (OECD TG487) 소핵시험 | 헤어스타일링 | 0.40 | 5.74 |\n| 차서(용어정의)) | 로 실험동물을 이용한 독성시험 결과 등으로부터 독성기준값을 결정하는 과정 | 한다. ",
        "original_sentence": "| 화장품 위해평가 가이드라인 개정 | Maximization | 0.2% in 0.9% saline solution (intradermal) | 5% in 70:30 acetone/PEG 400 (topical) | □ 외국 규정을 번역하거나 설명하는 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_071",
      "text": "| □ 예 | ■ 아니오 | 7.5 | 17.0 | 2.6 | 60 | 0.5525 | 자외선 차단 화장품(Sun care cosmetics) | 0.5% in 70:30 | acetone/PEG 400 | 감작성 있음 |\n| 1-2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 70,
        "window_size": 3,
        "char_count": 132,
        "word_count": 35,
        "page_number": 2,
        "window_text": "| 자외선 | 노출시간(분) | 해당 물질 제품을 사용된 공간에서 노출이 | 되는 시간 | (%) | 염모제(탈색), 퍼머넌트 제품 | 리퀴드 파운데이션 | 0.30 | 565 | 0.530973 | (g/day) | 가능 | (%) |\n| SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | 에 따라 0 또는 LOQ/2로 처리한다.  | 하되 자료 선택의 타당성, 불확실성 | 정을 통해 흡입 노출 우려를 낮추도록 함 | V (m3) | 사용 공간 부피(한국 욕실 부피 9.3 적용)2 | (경피) | 안전역(MOS) | = | 비 분무형 데오도란트 | 1.50 | 22.08 | https://www.mhlw.go.jp/content/000491511.pdf | 모발 케어(남녀) | - 모체독성 NOAEL 10 mg/kg bw/day | - 발생독성 NOAEL 30 mg/kg bw/day | - 30 mg/kg bw/day 용량에서 배변 |\n| 국민보건상 위해 우려가 제기되는 화장품 원료 등의 경우에는 총리령으로 정하는 바 | B1-2016-4-001 | 2016.02.  | 화장품 위해평가 가이드라인 개정 | Maximization | 0.2% in 0.9% saline solution (intradermal) | 5% in 70:30 acetone/PEG 400 (topical) | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | 7.5 | 17.0 | 2.6 | 60 | 0.5525 | 자외선 차단 화장품(Sun care cosmetics) | 0.5% in 70:30 | acetone/PEG 400 | 감작성 있음 |\n| 1-2.  위해평가 수행에 필요한 일반사항 ····································································· 6 | 반영구적 염모제 | 35ml(per | application) | - | 0.1 | Not | 차단제 | - 제품 사용 시 접촉할 수 있는 피부면적(예 : 입술, 손톱, 목 등) | - 90일(13주) 반복투여독성시험 자료가 유효 |\n| 목욕 샤워용 | 손세정제품(비누, 젤), 샤워제품(비누, 젤), 목욕제품 | 샴푸 | 9.25 | 151.84 | 0.01 | 0.09 | 1.52 | 및 제한점 등을 명확히 기술 | 노출유형 | 제품 | g/day | mg/kg bw/day | 대표 유형 | 생식·발생 | - 토끼 대상(6~28일) | - 3, 10, 30 mg/kg bw/day | 메이크업 리무버 | 0.21 | 565 | 0.371681 | ○ 결과에 영향을 미치는 불확실성, 제한점 및 선택된 가정 | https://www.mhlw.go.jp/web/t_doc?dataId=81074000&d | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 용량에서 모체의 체중감 | SED | calculated3 | - |\n| 위해 우려가 제기되는 경우 위해평가를 통해 안전성을 확보할 수 있다.  | 제17조의2(지정·고시된 원료의 사용기준의 안전성 검토) ① 법 제8조제5항에 따른 | Ainh-1, 2 | box 1, 2 공간에 존재하는 호흡가능한 평가 대상 물질의 양 | 생식·발생 | - 랫드 대상 | - 0, 150, 450, 1000 mg/kg/day | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)3 | 공통 | ○ 체외(in vitro) 시험 | - (OECD TG471, TG472) 박테리아 복귀돌연변이 시험 | - (OECD TG473) 염색체이상시험 | - (OECD TG487) 소핵시험 | 헤어스타일링 | 0.40 | 5.74 |\n| 차서(용어정의)) | 로 실험동물을 이용한 독성시험 결과 등으로부터 독성기준값을 결정하는 과정 | 한다.  | 에 따라 위해요소를 신속히 평가하여 그 위해 여부를 결정하여야 한다. ",
        "original_sentence": "| □ 예 | ■ 아니오 | 7.5 | 17.0 | 2.6 | 60 | 0.5525 | 자외선 차단 화장품(Sun care cosmetics) | 0.5% in 70:30 | acetone/PEG 400 | 감작성 있음 |\n| 1-2. "
      }
    },
    {
      "chunk_id": "chunk_072",
      "text": "위해평가 수행에 필요한 일반사항 ····································································· 6 | 반영구적 염모제 | 35ml(per | application) | - | 0.1 | Not | 차단제 | - 제품 사용 시 접촉할 수 있는 피부면적(예 : 입술, 손톱, 목 등) | - 90일(13주) 반복투여독성시험 자료가 유효 |\n| 목욕 샤워용 | 손세정제품(비누, 젤), 샤워제품(비누, 젤), 목욕제품 | 샴푸 | 9.25 | 151.84 | 0.01 | 0.09 | 1.52 | 및 제한점 등을 명확히 기술 | 노출유형 | 제품 | g/day | mg/kg bw/day | 대표 유형 | 생식·발생 | - 토끼 대상(6~28일) | - 3, 10, 30 mg/kg bw/day | 메이크업 리무버 | 0.21 | 565 | 0.371681 | ○ 결과에 영향을 미치는 불확실성, 제한점 및 선택된 가정 | https://www.mhlw.go.jp/web/t_doc?dataId=81074000&d | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 용량에서 모체의 체중감 | SED | calculated3 | - |\n| 위해 우려가 제기되는 경우 위해평가를 통해 안전성을 확보할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 71,
        "window_size": 3,
        "char_count": 667,
        "word_count": 145,
        "page_number": 2,
        "window_text": "| 하되 자료 선택의 타당성, 불확실성 | 정을 통해 흡입 노출 우려를 낮추도록 함 | V (m3) | 사용 공간 부피(한국 욕실 부피 9.3 적용)2 | (경피) | 안전역(MOS) | = | 비 분무형 데오도란트 | 1.50 | 22.08 | https://www.mhlw.go.jp/content/000491511.pdf | 모발 케어(남녀) | - 모체독성 NOAEL 10 mg/kg bw/day | - 발생독성 NOAEL 30 mg/kg bw/day | - 30 mg/kg bw/day 용량에서 배변 |\n| 국민보건상 위해 우려가 제기되는 화장품 원료 등의 경우에는 총리령으로 정하는 바 | B1-2016-4-001 | 2016.02.  | 화장품 위해평가 가이드라인 개정 | Maximization | 0.2% in 0.9% saline solution (intradermal) | 5% in 70:30 acetone/PEG 400 (topical) | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | 7.5 | 17.0 | 2.6 | 60 | 0.5525 | 자외선 차단 화장품(Sun care cosmetics) | 0.5% in 70:30 | acetone/PEG 400 | 감작성 있음 |\n| 1-2.  위해평가 수행에 필요한 일반사항 ····································································· 6 | 반영구적 염모제 | 35ml(per | application) | - | 0.1 | Not | 차단제 | - 제품 사용 시 접촉할 수 있는 피부면적(예 : 입술, 손톱, 목 등) | - 90일(13주) 반복투여독성시험 자료가 유효 |\n| 목욕 샤워용 | 손세정제품(비누, 젤), 샤워제품(비누, 젤), 목욕제품 | 샴푸 | 9.25 | 151.84 | 0.01 | 0.09 | 1.52 | 및 제한점 등을 명확히 기술 | 노출유형 | 제품 | g/day | mg/kg bw/day | 대표 유형 | 생식·발생 | - 토끼 대상(6~28일) | - 3, 10, 30 mg/kg bw/day | 메이크업 리무버 | 0.21 | 565 | 0.371681 | ○ 결과에 영향을 미치는 불확실성, 제한점 및 선택된 가정 | https://www.mhlw.go.jp/web/t_doc?dataId=81074000&d | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 용량에서 모체의 체중감 | SED | calculated3 | - |\n| 위해 우려가 제기되는 경우 위해평가를 통해 안전성을 확보할 수 있다.  | 제17조의2(지정·고시된 원료의 사용기준의 안전성 검토) ① 법 제8조제5항에 따른 | Ainh-1, 2 | box 1, 2 공간에 존재하는 호흡가능한 평가 대상 물질의 양 | 생식·발생 | - 랫드 대상 | - 0, 150, 450, 1000 mg/kg/day | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)3 | 공통 | ○ 체외(in vitro) 시험 | - (OECD TG471, TG472) 박테리아 복귀돌연변이 시험 | - (OECD TG473) 염색체이상시험 | - (OECD TG487) 소핵시험 | 헤어스타일링 | 0.40 | 5.74 |\n| 차서(용어정의)) | 로 실험동물을 이용한 독성시험 결과 등으로부터 독성기준값을 결정하는 과정 | 한다.  | 에 따라 위해요소를 신속히 평가하여 그 위해 여부를 결정하여야 한다.  | 실내 부피(m3) | 노출되는 공간의 부피 | 0.0015 | 16.9 | 50 | 60 | 0.0021 |\n| 화장품 | ○ 흡입에 따른 노출량 | ataType=0&pageNo=1 | 과 이에 따라 예상되는 영향도 기술 | 하지 않는 경우 : 사례별(case-by-case)로 결 |\n| 1-3. ",
        "original_sentence": "위해평가 수행에 필요한 일반사항 ····································································· 6 | 반영구적 염모제 | 35ml(per | application) | - | 0.1 | Not | 차단제 | - 제품 사용 시 접촉할 수 있는 피부면적(예 : 입술, 손톱, 목 등) | - 90일(13주) 반복투여독성시험 자료가 유효 |\n| 목욕 샤워용 | 손세정제품(비누, 젤), 샤워제품(비누, 젤), 목욕제품 | 샴푸 | 9.25 | 151.84 | 0.01 | 0.09 | 1.52 | 및 제한점 등을 명확히 기술 | 노출유형 | 제품 | g/day | mg/kg bw/day | 대표 유형 | 생식·발생 | - 토끼 대상(6~28일) | - 3, 10, 30 mg/kg bw/day | 메이크업 리무버 | 0.21 | 565 | 0.371681 | ○ 결과에 영향을 미치는 불확실성, 제한점 및 선택된 가정 | https://www.mhlw.go.jp/web/t_doc?dataId=81074000&d | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 용량에서 모체의 체중감 | SED | calculated3 | - |\n| 위해 우려가 제기되는 경우 위해평가를 통해 안전성을 확보할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_073",
      "text": "| 제17조의2(지정·고시된 원료의 사용기준의 안전성 검토) ① 법 제8조제5항에 따른 | Ainh-1, 2 | box 1, 2 공간에 존재하는 호흡가능한 평가 대상 물질의 양 | 생식·발생 | - 랫드 대상 | - 0, 150, 450, 1000 mg/kg/day | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)3 | 공통 | ○ 체외(in vitro) 시험 | - (OECD TG471, TG472) 박테리아 복귀돌연변이 시험 | - (OECD TG473) 염색체이상시험 | - (OECD TG487) 소핵시험 | 헤어스타일링 | 0.40 | 5.74 |\n| 차서(용어정의)) | 로 실험동물을 이용한 독성시험 결과 등으로부터 독성기준값을 결정하는 과정 | 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 72,
        "window_size": 3,
        "char_count": 384,
        "word_count": 91,
        "page_number": 9,
        "window_text": "| 화장품 위해평가 가이드라인 개정 | Maximization | 0.2% in 0.9% saline solution (intradermal) | 5% in 70:30 acetone/PEG 400 (topical) | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | 7.5 | 17.0 | 2.6 | 60 | 0.5525 | 자외선 차단 화장품(Sun care cosmetics) | 0.5% in 70:30 | acetone/PEG 400 | 감작성 있음 |\n| 1-2.  위해평가 수행에 필요한 일반사항 ····································································· 6 | 반영구적 염모제 | 35ml(per | application) | - | 0.1 | Not | 차단제 | - 제품 사용 시 접촉할 수 있는 피부면적(예 : 입술, 손톱, 목 등) | - 90일(13주) 반복투여독성시험 자료가 유효 |\n| 목욕 샤워용 | 손세정제품(비누, 젤), 샤워제품(비누, 젤), 목욕제품 | 샴푸 | 9.25 | 151.84 | 0.01 | 0.09 | 1.52 | 및 제한점 등을 명확히 기술 | 노출유형 | 제품 | g/day | mg/kg bw/day | 대표 유형 | 생식·발생 | - 토끼 대상(6~28일) | - 3, 10, 30 mg/kg bw/day | 메이크업 리무버 | 0.21 | 565 | 0.371681 | ○ 결과에 영향을 미치는 불확실성, 제한점 및 선택된 가정 | https://www.mhlw.go.jp/web/t_doc?dataId=81074000&d | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 용량에서 모체의 체중감 | SED | calculated3 | - |\n| 위해 우려가 제기되는 경우 위해평가를 통해 안전성을 확보할 수 있다.  | 제17조의2(지정·고시된 원료의 사용기준의 안전성 검토) ① 법 제8조제5항에 따른 | Ainh-1, 2 | box 1, 2 공간에 존재하는 호흡가능한 평가 대상 물질의 양 | 생식·발생 | - 랫드 대상 | - 0, 150, 450, 1000 mg/kg/day | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)3 | 공통 | ○ 체외(in vitro) 시험 | - (OECD TG471, TG472) 박테리아 복귀돌연변이 시험 | - (OECD TG473) 염색체이상시험 | - (OECD TG487) 소핵시험 | 헤어스타일링 | 0.40 | 5.74 |\n| 차서(용어정의)) | 로 실험동물을 이용한 독성시험 결과 등으로부터 독성기준값을 결정하는 과정 | 한다.  | 에 따라 위해요소를 신속히 평가하여 그 위해 여부를 결정하여야 한다.  | 실내 부피(m3) | 노출되는 공간의 부피 | 0.0015 | 16.9 | 50 | 60 | 0.0021 |\n| 화장품 | ○ 흡입에 따른 노출량 | ataType=0&pageNo=1 | 과 이에 따라 예상되는 영향도 기술 | 하지 않는 경우 : 사례별(case-by-case)로 결 |\n| 1-3.  위해평가 대상 ········································································································· 6 | 헤어 컨디셔너 | 6.10 | 102.88 | 0.01 | 0.06 | 1.03 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | Buehler | 20% in petrolatum | 20% in | petrolatum | 감작성 있음 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 리퀴드 파운데이션 | 0.51 | 7.90 | BMDL10 | = | 아이 섀도 | 0.02 | 24 | 0.833333 | 샤워 젤 | 0.10 | 1.62 | 2-Box model 모식도 | 0.018 | □ 예 | ■ 아니오 |\n| 피부 관리용 | 크림, 필링/스크럽제, 마스크팩, 바디팩(머드/클레이), 피부미백제품 | 산화성/영구적 염모제2 | 100ml(per | application) | - | 0.1 | Not | 지정·고시된 원료의 사용기준의 안전성 검토 주기는 5년으로 한다. ",
        "original_sentence": "| 제17조의2(지정·고시된 원료의 사용기준의 안전성 검토) ① 법 제8조제5항에 따른 | Ainh-1, 2 | box 1, 2 공간에 존재하는 호흡가능한 평가 대상 물질의 양 | 생식·발생 | - 랫드 대상 | - 0, 150, 450, 1000 mg/kg/day | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)3 | 공통 | ○ 체외(in vitro) 시험 | - (OECD TG471, TG472) 박테리아 복귀돌연변이 시험 | - (OECD TG473) 염색체이상시험 | - (OECD TG487) 소핵시험 | 헤어스타일링 | 0.40 | 5.74 |\n| 차서(용어정의)) | 로 실험동물을 이용한 독성시험 결과 등으로부터 독성기준값을 결정하는 과정 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_074",
      "text": "| 에 따라 위해요소를 신속히 평가하여 그 위해 여부를 결정하여야 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 73,
        "window_size": 3,
        "char_count": 41,
        "word_count": 11,
        "page_number": 2,
        "window_text": "| □ 예 | ■ 아니오 | 7.5 | 17.0 | 2.6 | 60 | 0.5525 | 자외선 차단 화장품(Sun care cosmetics) | 0.5% in 70:30 | acetone/PEG 400 | 감작성 있음 |\n| 1-2.  위해평가 수행에 필요한 일반사항 ····································································· 6 | 반영구적 염모제 | 35ml(per | application) | - | 0.1 | Not | 차단제 | - 제품 사용 시 접촉할 수 있는 피부면적(예 : 입술, 손톱, 목 등) | - 90일(13주) 반복투여독성시험 자료가 유효 |\n| 목욕 샤워용 | 손세정제품(비누, 젤), 샤워제품(비누, 젤), 목욕제품 | 샴푸 | 9.25 | 151.84 | 0.01 | 0.09 | 1.52 | 및 제한점 등을 명확히 기술 | 노출유형 | 제품 | g/day | mg/kg bw/day | 대표 유형 | 생식·발생 | - 토끼 대상(6~28일) | - 3, 10, 30 mg/kg bw/day | 메이크업 리무버 | 0.21 | 565 | 0.371681 | ○ 결과에 영향을 미치는 불확실성, 제한점 및 선택된 가정 | https://www.mhlw.go.jp/web/t_doc?dataId=81074000&d | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 용량에서 모체의 체중감 | SED | calculated3 | - |\n| 위해 우려가 제기되는 경우 위해평가를 통해 안전성을 확보할 수 있다.  | 제17조의2(지정·고시된 원료의 사용기준의 안전성 검토) ① 법 제8조제5항에 따른 | Ainh-1, 2 | box 1, 2 공간에 존재하는 호흡가능한 평가 대상 물질의 양 | 생식·발생 | - 랫드 대상 | - 0, 150, 450, 1000 mg/kg/day | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)3 | 공통 | ○ 체외(in vitro) 시험 | - (OECD TG471, TG472) 박테리아 복귀돌연변이 시험 | - (OECD TG473) 염색체이상시험 | - (OECD TG487) 소핵시험 | 헤어스타일링 | 0.40 | 5.74 |\n| 차서(용어정의)) | 로 실험동물을 이용한 독성시험 결과 등으로부터 독성기준값을 결정하는 과정 | 한다.  | 에 따라 위해요소를 신속히 평가하여 그 위해 여부를 결정하여야 한다.  | 실내 부피(m3) | 노출되는 공간의 부피 | 0.0015 | 16.9 | 50 | 60 | 0.0021 |\n| 화장품 | ○ 흡입에 따른 노출량 | ataType=0&pageNo=1 | 과 이에 따라 예상되는 영향도 기술 | 하지 않는 경우 : 사례별(case-by-case)로 결 |\n| 1-3.  위해평가 대상 ········································································································· 6 | 헤어 컨디셔너 | 6.10 | 102.88 | 0.01 | 0.06 | 1.03 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | Buehler | 20% in petrolatum | 20% in | petrolatum | 감작성 있음 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 리퀴드 파운데이션 | 0.51 | 7.90 | BMDL10 | = | 아이 섀도 | 0.02 | 24 | 0.833333 | 샤워 젤 | 0.10 | 1.62 | 2-Box model 모식도 | 0.018 | □ 예 | ■ 아니오 |\n| 피부 관리용 | 크림, 필링/스크럽제, 마스크팩, 바디팩(머드/클레이), 피부미백제품 | 산화성/영구적 염모제2 | 100ml(per | application) | - | 0.1 | Not | 지정·고시된 원료의 사용기준의 안전성 검토 주기는 5년으로 한다.  | t (min) | 공간 머무름 시간 (10~20분 적용)4 | 소, 간무게 증가 및 호산구증가증 관찰 | 감소, 위장내 검붉은 반점 등 관찰 | = | 3.4 × 105 |\n| ④ 식품의약품안전처장은 제3항에 따라 위해평가가 완료된 경우에는 해당 화장품의 | 메이크업 제품 | MOE | = | 환기율(횟수/시간) | 시간당 환기 횟수 | 정되며 불확실성 계수 1~10을 추가로 적용 | calculated3 | - |\n| 헤어스타일링제품 | 2.76 | 0.1 | 0.28 | 4.0 | 으나 과학적으로 가능한 범위 내에서 정량화한다. ",
        "original_sentence": "| 에 따라 위해요소를 신속히 평가하여 그 위해 여부를 결정하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_075",
      "text": "| 실내 부피(m3) | 노출되는 공간의 부피 | 0.0015 | 16.9 | 50 | 60 | 0.0021 |\n| 화장품 | ○ 흡입에 따른 노출량 | ataType=0&pageNo=1 | 과 이에 따라 예상되는 영향도 기술 | 하지 않는 경우 : 사례별(case-by-case)로 결 |\n| 1-3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 74,
        "window_size": 3,
        "char_count": 170,
        "word_count": 44,
        "page_number": 41,
        "window_text": "위해평가 수행에 필요한 일반사항 ····································································· 6 | 반영구적 염모제 | 35ml(per | application) | - | 0.1 | Not | 차단제 | - 제품 사용 시 접촉할 수 있는 피부면적(예 : 입술, 손톱, 목 등) | - 90일(13주) 반복투여독성시험 자료가 유효 |\n| 목욕 샤워용 | 손세정제품(비누, 젤), 샤워제품(비누, 젤), 목욕제품 | 샴푸 | 9.25 | 151.84 | 0.01 | 0.09 | 1.52 | 및 제한점 등을 명확히 기술 | 노출유형 | 제품 | g/day | mg/kg bw/day | 대표 유형 | 생식·발생 | - 토끼 대상(6~28일) | - 3, 10, 30 mg/kg bw/day | 메이크업 리무버 | 0.21 | 565 | 0.371681 | ○ 결과에 영향을 미치는 불확실성, 제한점 및 선택된 가정 | https://www.mhlw.go.jp/web/t_doc?dataId=81074000&d | - NOAEL 450 mg/kg/day | - 1000 mg/kg/day 용량에서 모체의 체중감 | SED | calculated3 | - |\n| 위해 우려가 제기되는 경우 위해평가를 통해 안전성을 확보할 수 있다.  | 제17조의2(지정·고시된 원료의 사용기준의 안전성 검토) ① 법 제8조제5항에 따른 | Ainh-1, 2 | box 1, 2 공간에 존재하는 호흡가능한 평가 대상 물질의 양 | 생식·발생 | - 랫드 대상 | - 0, 150, 450, 1000 mg/kg/day | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)3 | 공통 | ○ 체외(in vitro) 시험 | - (OECD TG471, TG472) 박테리아 복귀돌연변이 시험 | - (OECD TG473) 염색체이상시험 | - (OECD TG487) 소핵시험 | 헤어스타일링 | 0.40 | 5.74 |\n| 차서(용어정의)) | 로 실험동물을 이용한 독성시험 결과 등으로부터 독성기준값을 결정하는 과정 | 한다.  | 에 따라 위해요소를 신속히 평가하여 그 위해 여부를 결정하여야 한다.  | 실내 부피(m3) | 노출되는 공간의 부피 | 0.0015 | 16.9 | 50 | 60 | 0.0021 |\n| 화장품 | ○ 흡입에 따른 노출량 | ataType=0&pageNo=1 | 과 이에 따라 예상되는 영향도 기술 | 하지 않는 경우 : 사례별(case-by-case)로 결 |\n| 1-3.  위해평가 대상 ········································································································· 6 | 헤어 컨디셔너 | 6.10 | 102.88 | 0.01 | 0.06 | 1.03 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | Buehler | 20% in petrolatum | 20% in | petrolatum | 감작성 있음 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 리퀴드 파운데이션 | 0.51 | 7.90 | BMDL10 | = | 아이 섀도 | 0.02 | 24 | 0.833333 | 샤워 젤 | 0.10 | 1.62 | 2-Box model 모식도 | 0.018 | □ 예 | ■ 아니오 |\n| 피부 관리용 | 크림, 필링/스크럽제, 마스크팩, 바디팩(머드/클레이), 피부미백제품 | 산화성/영구적 염모제2 | 100ml(per | application) | - | 0.1 | Not | 지정·고시된 원료의 사용기준의 안전성 검토 주기는 5년으로 한다.  | t (min) | 공간 머무름 시간 (10~20분 적용)4 | 소, 간무게 증가 및 호산구증가증 관찰 | 감소, 위장내 검붉은 반점 등 관찰 | = | 3.4 × 105 |\n| ④ 식품의약품안전처장은 제3항에 따라 위해평가가 완료된 경우에는 해당 화장품의 | 메이크업 제품 | MOE | = | 환기율(횟수/시간) | 시간당 환기 횟수 | 정되며 불확실성 계수 1~10을 추가로 적용 | calculated3 | - |\n| 헤어스타일링제품 | 2.76 | 0.1 | 0.28 | 4.0 | 으나 과학적으로 가능한 범위 내에서 정량화한다.  | 다(SCCS/1628/21, 2021). ",
        "original_sentence": "| 실내 부피(m3) | 노출되는 공간의 부피 | 0.0015 | 16.9 | 50 | 60 | 0.0021 |\n| 화장품 | ○ 흡입에 따른 노출량 | ataType=0&pageNo=1 | 과 이에 따라 예상되는 영향도 기술 | 하지 않는 경우 : 사례별(case-by-case)로 결 |\n| 1-3. "
      }
    },
    {
      "chunk_id": "chunk_076",
      "text": "위해평가 대상 ········································································································· 6 | 헤어 컨디셔너 | 6.10 | 102.88 | 0.01 | 0.06 | 1.03 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | Buehler | 20% in petrolatum | 20% in | petrolatum | 감작성 있음 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 리퀴드 파운데이션 | 0.51 | 7.90 | BMDL10 | = | 아이 섀도 | 0.02 | 24 | 0.833333 | 샤워 젤 | 0.10 | 1.62 | 2-Box model 모식도 | 0.018 | □ 예 | ■ 아니오 |\n| 피부 관리용 | 크림, 필링/스크럽제, 마스크팩, 바디팩(머드/클레이), 피부미백제품 | 산화성/영구적 염모제2 | 100ml(per | application) | - | 0.1 | Not | 지정·고시된 원료의 사용기준의 안전성 검토 주기는 5년으로 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 75,
        "window_size": 3,
        "char_count": 587,
        "word_count": 124,
        "page_number": 5,
        "window_text": "| 제17조의2(지정·고시된 원료의 사용기준의 안전성 검토) ① 법 제8조제5항에 따른 | Ainh-1, 2 | box 1, 2 공간에 존재하는 호흡가능한 평가 대상 물질의 양 | 생식·발생 | - 랫드 대상 | - 0, 150, 450, 1000 mg/kg/day | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)3 | 공통 | ○ 체외(in vitro) 시험 | - (OECD TG471, TG472) 박테리아 복귀돌연변이 시험 | - (OECD TG473) 염색체이상시험 | - (OECD TG487) 소핵시험 | 헤어스타일링 | 0.40 | 5.74 |\n| 차서(용어정의)) | 로 실험동물을 이용한 독성시험 결과 등으로부터 독성기준값을 결정하는 과정 | 한다.  | 에 따라 위해요소를 신속히 평가하여 그 위해 여부를 결정하여야 한다.  | 실내 부피(m3) | 노출되는 공간의 부피 | 0.0015 | 16.9 | 50 | 60 | 0.0021 |\n| 화장품 | ○ 흡입에 따른 노출량 | ataType=0&pageNo=1 | 과 이에 따라 예상되는 영향도 기술 | 하지 않는 경우 : 사례별(case-by-case)로 결 |\n| 1-3.  위해평가 대상 ········································································································· 6 | 헤어 컨디셔너 | 6.10 | 102.88 | 0.01 | 0.06 | 1.03 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | Buehler | 20% in petrolatum | 20% in | petrolatum | 감작성 있음 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 리퀴드 파운데이션 | 0.51 | 7.90 | BMDL10 | = | 아이 섀도 | 0.02 | 24 | 0.833333 | 샤워 젤 | 0.10 | 1.62 | 2-Box model 모식도 | 0.018 | □ 예 | ■ 아니오 |\n| 피부 관리용 | 크림, 필링/스크럽제, 마스크팩, 바디팩(머드/클레이), 피부미백제품 | 산화성/영구적 염모제2 | 100ml(per | application) | - | 0.1 | Not | 지정·고시된 원료의 사용기준의 안전성 검토 주기는 5년으로 한다.  | t (min) | 공간 머무름 시간 (10~20분 적용)4 | 소, 간무게 증가 및 호산구증가증 관찰 | 감소, 위장내 검붉은 반점 등 관찰 | = | 3.4 × 105 |\n| ④ 식품의약품안전처장은 제3항에 따라 위해평가가 완료된 경우에는 해당 화장품의 | 메이크업 제품 | MOE | = | 환기율(횟수/시간) | 시간당 환기 횟수 | 정되며 불확실성 계수 1~10을 추가로 적용 | calculated3 | - |\n| 헤어스타일링제품 | 2.76 | 0.1 | 0.28 | 4.0 | 으나 과학적으로 가능한 범위 내에서 정량화한다.  | 다(SCCS/1628/21, 2021).  | B1-2016-4-002 | 2016.11. ",
        "original_sentence": "위해평가 대상 ········································································································· 6 | 헤어 컨디셔너 | 6.10 | 102.88 | 0.01 | 0.06 | 1.03 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | Buehler | 20% in petrolatum | 20% in | petrolatum | 감작성 있음 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 리퀴드 파운데이션 | 0.51 | 7.90 | BMDL10 | = | 아이 섀도 | 0.02 | 24 | 0.833333 | 샤워 젤 | 0.10 | 1.62 | 2-Box model 모식도 | 0.018 | □ 예 | ■ 아니오 |\n| 피부 관리용 | 크림, 필링/스크럽제, 마스크팩, 바디팩(머드/클레이), 피부미백제품 | 산화성/영구적 염모제2 | 100ml(per | application) | - | 0.1 | Not | 지정·고시된 원료의 사용기준의 안전성 검토 주기는 5년으로 한다. "
      }
    },
    {
      "chunk_id": "chunk_077",
      "text": "| t (min) | 공간 머무름 시간 (10~20분 적용)4 | 소, 간무게 증가 및 호산구증가증 관찰 | 감소, 위장내 검붉은 반점 등 관찰 | = | 3.4 × 105 |\n| ④ 식품의약품안전처장은 제3항에 따라 위해평가가 완료된 경우에는 해당 화장품의 | 메이크업 제품 | MOE | = | 환기율(횟수/시간) | 시간당 환기 횟수 | 정되며 불확실성 계수 1~10을 추가로 적용 | calculated3 | - |\n| 헤어스타일링제품 | 2.76 | 0.1 | 0.28 | 4.0 | 으나 과학적으로 가능한 범위 내에서 정량화한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 76,
        "window_size": 3,
        "char_count": 303,
        "word_count": 82,
        "page_number": 42,
        "window_text": "| 에 따라 위해요소를 신속히 평가하여 그 위해 여부를 결정하여야 한다.  | 실내 부피(m3) | 노출되는 공간의 부피 | 0.0015 | 16.9 | 50 | 60 | 0.0021 |\n| 화장품 | ○ 흡입에 따른 노출량 | ataType=0&pageNo=1 | 과 이에 따라 예상되는 영향도 기술 | 하지 않는 경우 : 사례별(case-by-case)로 결 |\n| 1-3.  위해평가 대상 ········································································································· 6 | 헤어 컨디셔너 | 6.10 | 102.88 | 0.01 | 0.06 | 1.03 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | Buehler | 20% in petrolatum | 20% in | petrolatum | 감작성 있음 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 리퀴드 파운데이션 | 0.51 | 7.90 | BMDL10 | = | 아이 섀도 | 0.02 | 24 | 0.833333 | 샤워 젤 | 0.10 | 1.62 | 2-Box model 모식도 | 0.018 | □ 예 | ■ 아니오 |\n| 피부 관리용 | 크림, 필링/스크럽제, 마스크팩, 바디팩(머드/클레이), 피부미백제품 | 산화성/영구적 염모제2 | 100ml(per | application) | - | 0.1 | Not | 지정·고시된 원료의 사용기준의 안전성 검토 주기는 5년으로 한다.  | t (min) | 공간 머무름 시간 (10~20분 적용)4 | 소, 간무게 증가 및 호산구증가증 관찰 | 감소, 위장내 검붉은 반점 등 관찰 | = | 3.4 × 105 |\n| ④ 식품의약품안전처장은 제3항에 따라 위해평가가 완료된 경우에는 해당 화장품의 | 메이크업 제품 | MOE | = | 환기율(횟수/시간) | 시간당 환기 횟수 | 정되며 불확실성 계수 1~10을 추가로 적용 | calculated3 | - |\n| 헤어스타일링제품 | 2.76 | 0.1 | 0.28 | 4.0 | 으나 과학적으로 가능한 범위 내에서 정량화한다.  | 다(SCCS/1628/21, 2021).  | B1-2016-4-002 | 2016.11.  | 화장품 위해평가 가이드라인 개정 | 정리한 자료입니까? ",
        "original_sentence": "| t (min) | 공간 머무름 시간 (10~20분 적용)4 | 소, 간무게 증가 및 호산구증가증 관찰 | 감소, 위장내 검붉은 반점 등 관찰 | = | 3.4 × 105 |\n| ④ 식품의약품안전처장은 제3항에 따라 위해평가가 완료된 경우에는 해당 화장품의 | 메이크업 제품 | MOE | = | 환기율(횟수/시간) | 시간당 환기 횟수 | 정되며 불확실성 계수 1~10을 추가로 적용 | calculated3 | - |\n| 헤어스타일링제품 | 2.76 | 0.1 | 0.28 | 4.0 | 으나 과학적으로 가능한 범위 내에서 정량화한다. "
      }
    },
    {
      "chunk_id": "chunk_078",
      "text": "| 다(SCCS/1628/21, 2021). ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 77,
        "window_size": 3,
        "char_count": 25,
        "word_count": 3,
        "page_number": 20,
        "window_text": "| 실내 부피(m3) | 노출되는 공간의 부피 | 0.0015 | 16.9 | 50 | 60 | 0.0021 |\n| 화장품 | ○ 흡입에 따른 노출량 | ataType=0&pageNo=1 | 과 이에 따라 예상되는 영향도 기술 | 하지 않는 경우 : 사례별(case-by-case)로 결 |\n| 1-3.  위해평가 대상 ········································································································· 6 | 헤어 컨디셔너 | 6.10 | 102.88 | 0.01 | 0.06 | 1.03 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | Buehler | 20% in petrolatum | 20% in | petrolatum | 감작성 있음 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 리퀴드 파운데이션 | 0.51 | 7.90 | BMDL10 | = | 아이 섀도 | 0.02 | 24 | 0.833333 | 샤워 젤 | 0.10 | 1.62 | 2-Box model 모식도 | 0.018 | □ 예 | ■ 아니오 |\n| 피부 관리용 | 크림, 필링/스크럽제, 마스크팩, 바디팩(머드/클레이), 피부미백제품 | 산화성/영구적 염모제2 | 100ml(per | application) | - | 0.1 | Not | 지정·고시된 원료의 사용기준의 안전성 검토 주기는 5년으로 한다.  | t (min) | 공간 머무름 시간 (10~20분 적용)4 | 소, 간무게 증가 및 호산구증가증 관찰 | 감소, 위장내 검붉은 반점 등 관찰 | = | 3.4 × 105 |\n| ④ 식품의약품안전처장은 제3항에 따라 위해평가가 완료된 경우에는 해당 화장품의 | 메이크업 제품 | MOE | = | 환기율(횟수/시간) | 시간당 환기 횟수 | 정되며 불확실성 계수 1~10을 추가로 적용 | calculated3 | - |\n| 헤어스타일링제품 | 2.76 | 0.1 | 0.28 | 4.0 | 으나 과학적으로 가능한 범위 내에서 정량화한다.  | 다(SCCS/1628/21, 2021).  | B1-2016-4-002 | 2016.11.  | 화장품 위해평가 가이드라인 개정 | 정리한 자료입니까?  | - 제품 유형, 확산 속도 | 손 세정 비누 | 0.24 | 3.82 | SED | 5.3× 10-8 |\n| 1-4. ",
        "original_sentence": "| 다(SCCS/1628/21, 2021). "
      }
    },
    {
      "chunk_id": "chunk_079",
      "text": "| B1-2016-4-002 | 2016.11. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 78,
        "window_size": 3,
        "char_count": 27,
        "word_count": 4,
        "page_number": 4,
        "window_text": "위해평가 대상 ········································································································· 6 | 헤어 컨디셔너 | 6.10 | 102.88 | 0.01 | 0.06 | 1.03 | fret | 폐에 잔류하는 물질 분율(날숨으로 25% 배출되므로 0.75 적용)1 | Buehler | 20% in petrolatum | 20% in | petrolatum | 감작성 있음 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 리퀴드 파운데이션 | 0.51 | 7.90 | BMDL10 | = | 아이 섀도 | 0.02 | 24 | 0.833333 | 샤워 젤 | 0.10 | 1.62 | 2-Box model 모식도 | 0.018 | □ 예 | ■ 아니오 |\n| 피부 관리용 | 크림, 필링/스크럽제, 마스크팩, 바디팩(머드/클레이), 피부미백제품 | 산화성/영구적 염모제2 | 100ml(per | application) | - | 0.1 | Not | 지정·고시된 원료의 사용기준의 안전성 검토 주기는 5년으로 한다.  | t (min) | 공간 머무름 시간 (10~20분 적용)4 | 소, 간무게 증가 및 호산구증가증 관찰 | 감소, 위장내 검붉은 반점 등 관찰 | = | 3.4 × 105 |\n| ④ 식품의약품안전처장은 제3항에 따라 위해평가가 완료된 경우에는 해당 화장품의 | 메이크업 제품 | MOE | = | 환기율(횟수/시간) | 시간당 환기 횟수 | 정되며 불확실성 계수 1~10을 추가로 적용 | calculated3 | - |\n| 헤어스타일링제품 | 2.76 | 0.1 | 0.28 | 4.0 | 으나 과학적으로 가능한 범위 내에서 정량화한다.  | 다(SCCS/1628/21, 2021).  | B1-2016-4-002 | 2016.11.  | 화장품 위해평가 가이드라인 개정 | 정리한 자료입니까?  | - 제품 유형, 확산 속도 | 손 세정 비누 | 0.24 | 3.82 | SED | 5.3× 10-8 |\n| 1-4.  위해요소별 위해평가 유형 ··················································································· 7 | ② 식품의약품안전처장은 법 제8조제5항에 따라 지정·고시된 원료의 사용기준의 안 | fresp | 흡입 가능한 물질 분율(분사제/펌프 스프레이 차이) | 는 경우를 포함한다. ",
        "original_sentence": "| B1-2016-4-002 | 2016.11. "
      }
    },
    {
      "chunk_id": "chunk_080",
      "text": "| 화장품 위해평가 가이드라인 개정 | 정리한 자료입니까? ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 79,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 1,
        "window_text": "| t (min) | 공간 머무름 시간 (10~20분 적용)4 | 소, 간무게 증가 및 호산구증가증 관찰 | 감소, 위장내 검붉은 반점 등 관찰 | = | 3.4 × 105 |\n| ④ 식품의약품안전처장은 제3항에 따라 위해평가가 완료된 경우에는 해당 화장품의 | 메이크업 제품 | MOE | = | 환기율(횟수/시간) | 시간당 환기 횟수 | 정되며 불확실성 계수 1~10을 추가로 적용 | calculated3 | - |\n| 헤어스타일링제품 | 2.76 | 0.1 | 0.28 | 4.0 | 으나 과학적으로 가능한 범위 내에서 정량화한다.  | 다(SCCS/1628/21, 2021).  | B1-2016-4-002 | 2016.11.  | 화장품 위해평가 가이드라인 개정 | 정리한 자료입니까?  | - 제품 유형, 확산 속도 | 손 세정 비누 | 0.24 | 3.82 | SED | 5.3× 10-8 |\n| 1-4.  위해요소별 위해평가 유형 ··················································································· 7 | ② 식품의약품안전처장은 법 제8조제5항에 따라 지정·고시된 원료의 사용기준의 안 | fresp | 흡입 가능한 물질 분율(분사제/펌프 스프레이 차이) | 는 경우를 포함한다.  | SED  = | A(g/day) ×1000mg/g× C(%)/100 × DAp(%)/100 | 17 (g/day) × 7.5/100 × 2.6/100 | 메이크업 리무버 | 0.50 | 8.33 | 마스카라 | 0.03 | 1.6 | 18.75 | - 1000 mg/kg/day 군에서 태자흡수가 증가 |\n| 피부 과민성, 폐 영향)을 검토한다. ",
        "original_sentence": "| 화장품 위해평가 가이드라인 개정 | 정리한 자료입니까? "
      }
    },
    {
      "chunk_id": "chunk_081",
      "text": "| - 제품 유형, 확산 속도 | 손 세정 비누 | 0.24 | 3.82 | SED | 5.3× 10-8 |\n| 1-4. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 80,
        "window_size": 3,
        "char_count": 68,
        "word_count": 22,
        "page_number": 22,
        "window_text": "| 다(SCCS/1628/21, 2021).  | B1-2016-4-002 | 2016.11.  | 화장품 위해평가 가이드라인 개정 | 정리한 자료입니까?  | - 제품 유형, 확산 속도 | 손 세정 비누 | 0.24 | 3.82 | SED | 5.3× 10-8 |\n| 1-4.  위해요소별 위해평가 유형 ··················································································· 7 | ② 식품의약품안전처장은 법 제8조제5항에 따라 지정·고시된 원료의 사용기준의 안 | fresp | 흡입 가능한 물질 분율(분사제/펌프 스프레이 차이) | 는 경우를 포함한다.  | SED  = | A(g/day) ×1000mg/g× C(%)/100 × DAp(%)/100 | 17 (g/day) × 7.5/100 × 2.6/100 | 메이크업 리무버 | 0.50 | 8.33 | 마스카라 | 0.03 | 1.6 | 18.75 | - 1000 mg/kg/day 군에서 태자흡수가 증가 |\n| 피부 과민성, 폐 영향)을 검토한다.  | 표2 참고). ",
        "original_sentence": "| - 제품 유형, 확산 속도 | 손 세정 비누 | 0.24 | 3.82 | SED | 5.3× 10-8 |\n| 1-4. "
      }
    },
    {
      "chunk_id": "chunk_082",
      "text": "위해요소별 위해평가 유형 ··················································································· 7 | ② 식품의약품안전처장은 법 제8조제5항에 따라 지정·고시된 원료의 사용기준의 안 | fresp | 흡입 가능한 물질 분율(분사제/펌프 스프레이 차이) | 는 경우를 포함한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 81,
        "window_size": 3,
        "char_count": 200,
        "word_count": 28,
        "page_number": 5,
        "window_text": "| B1-2016-4-002 | 2016.11.  | 화장품 위해평가 가이드라인 개정 | 정리한 자료입니까?  | - 제품 유형, 확산 속도 | 손 세정 비누 | 0.24 | 3.82 | SED | 5.3× 10-8 |\n| 1-4.  위해요소별 위해평가 유형 ··················································································· 7 | ② 식품의약품안전처장은 법 제8조제5항에 따라 지정·고시된 원료의 사용기준의 안 | fresp | 흡입 가능한 물질 분율(분사제/펌프 스프레이 차이) | 는 경우를 포함한다.  | SED  = | A(g/day) ×1000mg/g× C(%)/100 × DAp(%)/100 | 17 (g/day) × 7.5/100 × 2.6/100 | 메이크업 리무버 | 0.50 | 8.33 | 마스카라 | 0.03 | 1.6 | 18.75 | - 1000 mg/kg/day 군에서 태자흡수가 증가 |\n| 피부 과민성, 폐 영향)을 검토한다.  | 표2 참고).  | 1 화장품 유형에 따른 1일 사용량(붙임 4 참조) | SED | = | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니 | - (OECD TG430) 랫드 경피 전기저항 시험(Rat skin transcutaneous | 제품 사용 시간(min) | 해당 물질 제품을 사용하는 데 걸리는 시간 | 페이셜 메이크업, 메이크업클린징, 아이쉐도우, 마스카라, | 아기용품(Baby care) | http://ASEANcosmetics.org/information-center/ASEA | 가능 | = 0.5525 mg/kg/day |\n| 흡입 | 니어야 한다. ",
        "original_sentence": "위해요소별 위해평가 유형 ··················································································· 7 | ② 식품의약품안전처장은 법 제8조제5항에 따라 지정·고시된 원료의 사용기준의 안 | fresp | 흡입 가능한 물질 분율(분사제/펌프 스프레이 차이) | 는 경우를 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_083",
      "text": "| SED  = | A(g/day) ×1000mg/g× C(%)/100 × DAp(%)/100 | 17 (g/day) × 7.5/100 × 2.6/100 | 메이크업 리무버 | 0.50 | 8.33 | 마스카라 | 0.03 | 1.6 | 18.75 | - 1000 mg/kg/day 군에서 태자흡수가 증가 |\n| 피부 과민성, 폐 영향)을 검토한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 82,
        "window_size": 3,
        "char_count": 196,
        "word_count": 45,
        "page_number": 24,
        "window_text": "| 화장품 위해평가 가이드라인 개정 | 정리한 자료입니까?  | - 제품 유형, 확산 속도 | 손 세정 비누 | 0.24 | 3.82 | SED | 5.3× 10-8 |\n| 1-4.  위해요소별 위해평가 유형 ··················································································· 7 | ② 식품의약품안전처장은 법 제8조제5항에 따라 지정·고시된 원료의 사용기준의 안 | fresp | 흡입 가능한 물질 분율(분사제/펌프 스프레이 차이) | 는 경우를 포함한다.  | SED  = | A(g/day) ×1000mg/g× C(%)/100 × DAp(%)/100 | 17 (g/day) × 7.5/100 × 2.6/100 | 메이크업 리무버 | 0.50 | 8.33 | 마스카라 | 0.03 | 1.6 | 18.75 | - 1000 mg/kg/day 군에서 태자흡수가 증가 |\n| 피부 과민성, 폐 영향)을 검토한다.  | 표2 참고).  | 1 화장품 유형에 따른 1일 사용량(붙임 4 참조) | SED | = | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니 | - (OECD TG430) 랫드 경피 전기저항 시험(Rat skin transcutaneous | 제품 사용 시간(min) | 해당 물질 제품을 사용하는 데 걸리는 시간 | 페이셜 메이크업, 메이크업클린징, 아이쉐도우, 마스카라, | 아기용품(Baby care) | http://ASEANcosmetics.org/information-center/ASEA | 가능 | = 0.5525 mg/kg/day |\n| 흡입 | 니어야 한다.  또한, 지정·고시된 사용 목적 및 사용한도에 적합하여야 한다. ",
        "original_sentence": "| SED  = | A(g/day) ×1000mg/g× C(%)/100 × DAp(%)/100 | 17 (g/day) × 7.5/100 × 2.6/100 | 메이크업 리무버 | 0.50 | 8.33 | 마스카라 | 0.03 | 1.6 | 18.75 | - 1000 mg/kg/day 군에서 태자흡수가 증가 |\n| 피부 과민성, 폐 영향)을 검토한다. "
      }
    },
    {
      "chunk_id": "chunk_084",
      "text": "| 표2 참고). ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 83,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 20,
        "window_text": "| - 제품 유형, 확산 속도 | 손 세정 비누 | 0.24 | 3.82 | SED | 5.3× 10-8 |\n| 1-4.  위해요소별 위해평가 유형 ··················································································· 7 | ② 식품의약품안전처장은 법 제8조제5항에 따라 지정·고시된 원료의 사용기준의 안 | fresp | 흡입 가능한 물질 분율(분사제/펌프 스프레이 차이) | 는 경우를 포함한다.  | SED  = | A(g/day) ×1000mg/g× C(%)/100 × DAp(%)/100 | 17 (g/day) × 7.5/100 × 2.6/100 | 메이크업 리무버 | 0.50 | 8.33 | 마스카라 | 0.03 | 1.6 | 18.75 | - 1000 mg/kg/day 군에서 태자흡수가 증가 |\n| 피부 과민성, 폐 영향)을 검토한다.  | 표2 참고).  | 1 화장품 유형에 따른 1일 사용량(붙임 4 참조) | SED | = | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니 | - (OECD TG430) 랫드 경피 전기저항 시험(Rat skin transcutaneous | 제품 사용 시간(min) | 해당 물질 제품을 사용하는 데 걸리는 시간 | 페이셜 메이크업, 메이크업클린징, 아이쉐도우, 마스카라, | 아기용품(Baby care) | http://ASEANcosmetics.org/information-center/ASEA | 가능 | = 0.5525 mg/kg/day |\n| 흡입 | 니어야 한다.  또한, 지정·고시된 사용 목적 및 사용한도에 적합하여야 한다.  | 노출 수준을 정량적 산출하는 과정 | 원료 등을 화장품의 제조에 사용할 수 없는 원료로 지정하거나 그 사용기준을 지정하 | “화장품 위해평가 가이드라인(민원인 안내서)” | 피부 관리 |\n| 메이크업 및 손톱 관리용 | 화장품 사용에 따른 노출 경로 자료를 우선으로 고려할 수 있다. ",
        "original_sentence": "| 표2 참고). "
      }
    },
    {
      "chunk_id": "chunk_085",
      "text": "| 1 화장품 유형에 따른 1일 사용량(붙임 4 참조) | SED | = | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니 | - (OECD TG430) 랫드 경피 전기저항 시험(Rat skin transcutaneous | 제품 사용 시간(min) | 해당 물질 제품을 사용하는 데 걸리는 시간 | 페이셜 메이크업, 메이크업클린징, 아이쉐도우, 마스카라, | 아기용품(Baby care) | http://ASEANcosmetics.org/information-center/ASEA | 가능 | = 0.5525 mg/kg/day |\n| 흡입 | 니어야 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 84,
        "window_size": 3,
        "char_count": 338,
        "word_count": 72,
        "page_number": 2,
        "window_text": "위해요소별 위해평가 유형 ··················································································· 7 | ② 식품의약품안전처장은 법 제8조제5항에 따라 지정·고시된 원료의 사용기준의 안 | fresp | 흡입 가능한 물질 분율(분사제/펌프 스프레이 차이) | 는 경우를 포함한다.  | SED  = | A(g/day) ×1000mg/g× C(%)/100 × DAp(%)/100 | 17 (g/day) × 7.5/100 × 2.6/100 | 메이크업 리무버 | 0.50 | 8.33 | 마스카라 | 0.03 | 1.6 | 18.75 | - 1000 mg/kg/day 군에서 태자흡수가 증가 |\n| 피부 과민성, 폐 영향)을 검토한다.  | 표2 참고).  | 1 화장품 유형에 따른 1일 사용량(붙임 4 참조) | SED | = | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니 | - (OECD TG430) 랫드 경피 전기저항 시험(Rat skin transcutaneous | 제품 사용 시간(min) | 해당 물질 제품을 사용하는 데 걸리는 시간 | 페이셜 메이크업, 메이크업클린징, 아이쉐도우, 마스카라, | 아기용품(Baby care) | http://ASEANcosmetics.org/information-center/ASEA | 가능 | = 0.5525 mg/kg/day |\n| 흡입 | 니어야 한다.  또한, 지정·고시된 사용 목적 및 사용한도에 적합하여야 한다.  | 노출 수준을 정량적 산출하는 과정 | 원료 등을 화장품의 제조에 사용할 수 없는 원료로 지정하거나 그 사용기준을 지정하 | “화장품 위해평가 가이드라인(민원인 안내서)” | 피부 관리 |\n| 메이크업 및 손톱 관리용 | 화장품 사용에 따른 노출 경로 자료를 우선으로 고려할 수 있다.  | 생식·발생 | - 랫드 대상 | - 0, 250, 500, 1000 mg/kg/day | 아이 섀도 | 0.02 | 0.33 | 샴푸 | 0.09 | 1.52 | ○ 과학적 정보와 불확실성 등을 고려하여 정량적 또는 정 | 피부 관리(남녀) | [참고 자료] | 60 kg | 하였으나 실험에 사용한 랫드의 일반적인 | 특성 |\n| ⦁ 확산 셀의 설계, 수용액(receptor fluid) 선택, 피부 온도, 피부 온전성 등 | : 위해평가에 사용된 방법을 간략하게 기술 | 전성을 검토할 때에는 사전에 안전성 검토 대상을 선정하여 실시해야 한다. ",
        "original_sentence": "| 1 화장품 유형에 따른 1일 사용량(붙임 4 참조) | SED | = | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니 | - (OECD TG430) 랫드 경피 전기저항 시험(Rat skin transcutaneous | 제품 사용 시간(min) | 해당 물질 제품을 사용하는 데 걸리는 시간 | 페이셜 메이크업, 메이크업클린징, 아이쉐도우, 마스카라, | 아기용품(Baby care) | http://ASEANcosmetics.org/information-center/ASEA | 가능 | = 0.5525 mg/kg/day |\n| 흡입 | 니어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_086",
      "text": "또한, 지정·고시된 사용 목적 및 사용한도에 적합하여야 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 85,
        "window_size": 3,
        "char_count": 35,
        "word_count": 8,
        "page_number": 2,
        "window_text": "| SED  = | A(g/day) ×1000mg/g× C(%)/100 × DAp(%)/100 | 17 (g/day) × 7.5/100 × 2.6/100 | 메이크업 리무버 | 0.50 | 8.33 | 마스카라 | 0.03 | 1.6 | 18.75 | - 1000 mg/kg/day 군에서 태자흡수가 증가 |\n| 피부 과민성, 폐 영향)을 검토한다.  | 표2 참고).  | 1 화장품 유형에 따른 1일 사용량(붙임 4 참조) | SED | = | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니 | - (OECD TG430) 랫드 경피 전기저항 시험(Rat skin transcutaneous | 제품 사용 시간(min) | 해당 물질 제품을 사용하는 데 걸리는 시간 | 페이셜 메이크업, 메이크업클린징, 아이쉐도우, 마스카라, | 아기용품(Baby care) | http://ASEANcosmetics.org/information-center/ASEA | 가능 | = 0.5525 mg/kg/day |\n| 흡입 | 니어야 한다.  또한, 지정·고시된 사용 목적 및 사용한도에 적합하여야 한다.  | 노출 수준을 정량적 산출하는 과정 | 원료 등을 화장품의 제조에 사용할 수 없는 원료로 지정하거나 그 사용기준을 지정하 | “화장품 위해평가 가이드라인(민원인 안내서)” | 피부 관리 |\n| 메이크업 및 손톱 관리용 | 화장품 사용에 따른 노출 경로 자료를 우선으로 고려할 수 있다.  | 생식·발생 | - 랫드 대상 | - 0, 250, 500, 1000 mg/kg/day | 아이 섀도 | 0.02 | 0.33 | 샴푸 | 0.09 | 1.52 | ○ 과학적 정보와 불확실성 등을 고려하여 정량적 또는 정 | 피부 관리(남녀) | [참고 자료] | 60 kg | 하였으나 실험에 사용한 랫드의 일반적인 | 특성 |\n| ⦁ 확산 셀의 설계, 수용액(receptor fluid) 선택, 피부 온도, 피부 온전성 등 | : 위해평가에 사용된 방법을 간략하게 기술 | 전성을 검토할 때에는 사전에 안전성 검토 대상을 선정하여 실시해야 한다.  | fappl (day-1) | 사용 횟수(제품별 매개변수 값으로 2 적용)2 | 2 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007) | Electrical resistance Test, RET) | 제품 노출 면적(cm2) | 해당 물질의 제품이 노출되는 면적 | 아이라이너, 아이메이크업리무버, 립스틱, 입술보호제, 네일제품 | 립스틱 | 0.05 | 4.8 | 10.41667 | N-cosmetic-directive/ | 60 kg |\n| 메이크업 제품 | 다. ",
        "original_sentence": "또한, 지정·고시된 사용 목적 및 사용한도에 적합하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_087",
      "text": "| 노출 수준을 정량적 산출하는 과정 | 원료 등을 화장품의 제조에 사용할 수 없는 원료로 지정하거나 그 사용기준을 지정하 | “화장품 위해평가 가이드라인(민원인 안내서)” | 피부 관리 |\n| 메이크업 및 손톱 관리용 | 화장품 사용에 따른 노출 경로 자료를 우선으로 고려할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 86,
        "window_size": 3,
        "char_count": 161,
        "word_count": 44,
        "page_number": 11,
        "window_text": "| 표2 참고).  | 1 화장품 유형에 따른 1일 사용량(붙임 4 참조) | SED | = | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니 | - (OECD TG430) 랫드 경피 전기저항 시험(Rat skin transcutaneous | 제품 사용 시간(min) | 해당 물질 제품을 사용하는 데 걸리는 시간 | 페이셜 메이크업, 메이크업클린징, 아이쉐도우, 마스카라, | 아기용품(Baby care) | http://ASEANcosmetics.org/information-center/ASEA | 가능 | = 0.5525 mg/kg/day |\n| 흡입 | 니어야 한다.  또한, 지정·고시된 사용 목적 및 사용한도에 적합하여야 한다.  | 노출 수준을 정량적 산출하는 과정 | 원료 등을 화장품의 제조에 사용할 수 없는 원료로 지정하거나 그 사용기준을 지정하 | “화장품 위해평가 가이드라인(민원인 안내서)” | 피부 관리 |\n| 메이크업 및 손톱 관리용 | 화장품 사용에 따른 노출 경로 자료를 우선으로 고려할 수 있다.  | 생식·발생 | - 랫드 대상 | - 0, 250, 500, 1000 mg/kg/day | 아이 섀도 | 0.02 | 0.33 | 샴푸 | 0.09 | 1.52 | ○ 과학적 정보와 불확실성 등을 고려하여 정량적 또는 정 | 피부 관리(남녀) | [참고 자료] | 60 kg | 하였으나 실험에 사용한 랫드의 일반적인 | 특성 |\n| ⦁ 확산 셀의 설계, 수용액(receptor fluid) 선택, 피부 온도, 피부 온전성 등 | : 위해평가에 사용된 방법을 간략하게 기술 | 전성을 검토할 때에는 사전에 안전성 검토 대상을 선정하여 실시해야 한다.  | fappl (day-1) | 사용 횟수(제품별 매개변수 값으로 2 적용)2 | 2 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007) | Electrical resistance Test, RET) | 제품 노출 면적(cm2) | 해당 물질의 제품이 노출되는 면적 | 아이라이너, 아이메이크업리무버, 립스틱, 입술보호제, 네일제품 | 립스틱 | 0.05 | 4.8 | 10.41667 | N-cosmetic-directive/ | 60 kg |\n| 메이크업 제품 | 다.  | ○ 유효한 경구 생체이용률(BA) 자료가 있는 경우, |\n| 위해영향 발생 가능성이 낮다고 평가할 수 있다(SCCS/1628/21, 2021; Renwick, 1993). ",
        "original_sentence": "| 노출 수준을 정량적 산출하는 과정 | 원료 등을 화장품의 제조에 사용할 수 없는 원료로 지정하거나 그 사용기준을 지정하 | “화장품 위해평가 가이드라인(민원인 안내서)” | 피부 관리 |\n| 메이크업 및 손톱 관리용 | 화장품 사용에 따른 노출 경로 자료를 우선으로 고려할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_088",
      "text": "| 생식·발생 | - 랫드 대상 | - 0, 250, 500, 1000 mg/kg/day | 아이 섀도 | 0.02 | 0.33 | 샴푸 | 0.09 | 1.52 | ○ 과학적 정보와 불확실성 등을 고려하여 정량적 또는 정 | 피부 관리(남녀) | [참고 자료] | 60 kg | 하였으나 실험에 사용한 랫드의 일반적인 | 특성 |\n| ⦁ 확산 셀의 설계, 수용액(receptor fluid) 선택, 피부 온도, 피부 온전성 등 | : 위해평가에 사용된 방법을 간략하게 기술 | 전성을 검토할 때에는 사전에 안전성 검토 대상을 선정하여 실시해야 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 87,
        "window_size": 3,
        "char_count": 309,
        "word_count": 85,
        "page_number": 37,
        "window_text": "| 1 화장품 유형에 따른 1일 사용량(붙임 4 참조) | SED | = | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니 | - (OECD TG430) 랫드 경피 전기저항 시험(Rat skin transcutaneous | 제품 사용 시간(min) | 해당 물질 제품을 사용하는 데 걸리는 시간 | 페이셜 메이크업, 메이크업클린징, 아이쉐도우, 마스카라, | 아기용품(Baby care) | http://ASEANcosmetics.org/information-center/ASEA | 가능 | = 0.5525 mg/kg/day |\n| 흡입 | 니어야 한다.  또한, 지정·고시된 사용 목적 및 사용한도에 적합하여야 한다.  | 노출 수준을 정량적 산출하는 과정 | 원료 등을 화장품의 제조에 사용할 수 없는 원료로 지정하거나 그 사용기준을 지정하 | “화장품 위해평가 가이드라인(민원인 안내서)” | 피부 관리 |\n| 메이크업 및 손톱 관리용 | 화장품 사용에 따른 노출 경로 자료를 우선으로 고려할 수 있다.  | 생식·발생 | - 랫드 대상 | - 0, 250, 500, 1000 mg/kg/day | 아이 섀도 | 0.02 | 0.33 | 샴푸 | 0.09 | 1.52 | ○ 과학적 정보와 불확실성 등을 고려하여 정량적 또는 정 | 피부 관리(남녀) | [참고 자료] | 60 kg | 하였으나 실험에 사용한 랫드의 일반적인 | 특성 |\n| ⦁ 확산 셀의 설계, 수용액(receptor fluid) 선택, 피부 온도, 피부 온전성 등 | : 위해평가에 사용된 방법을 간략하게 기술 | 전성을 검토할 때에는 사전에 안전성 검토 대상을 선정하여 실시해야 한다.  | fappl (day-1) | 사용 횟수(제품별 매개변수 값으로 2 적용)2 | 2 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007) | Electrical resistance Test, RET) | 제품 노출 면적(cm2) | 해당 물질의 제품이 노출되는 면적 | 아이라이너, 아이메이크업리무버, 립스틱, 입술보호제, 네일제품 | 립스틱 | 0.05 | 4.8 | 10.41667 | N-cosmetic-directive/ | 60 kg |\n| 메이크업 제품 | 다.  | ○ 유효한 경구 생체이용률(BA) 자료가 있는 경우, |\n| 위해영향 발생 가능성이 낮다고 평가할 수 있다(SCCS/1628/21, 2021; Renwick, 1993).  | 가하도록 한다. ",
        "original_sentence": "| 생식·발생 | - 랫드 대상 | - 0, 250, 500, 1000 mg/kg/day | 아이 섀도 | 0.02 | 0.33 | 샴푸 | 0.09 | 1.52 | ○ 과학적 정보와 불확실성 등을 고려하여 정량적 또는 정 | 피부 관리(남녀) | [참고 자료] | 60 kg | 하였으나 실험에 사용한 랫드의 일반적인 | 특성 |\n| ⦁ 확산 셀의 설계, 수용액(receptor fluid) 선택, 피부 온도, 피부 온전성 등 | : 위해평가에 사용된 방법을 간략하게 기술 | 전성을 검토할 때에는 사전에 안전성 검토 대상을 선정하여 실시해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_089",
      "text": "| fappl (day-1) | 사용 횟수(제품별 매개변수 값으로 2 적용)2 | 2 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007) | Electrical resistance Test, RET) | 제품 노출 면적(cm2) | 해당 물질의 제품이 노출되는 면적 | 아이라이너, 아이메이크업리무버, 립스틱, 입술보호제, 네일제품 | 립스틱 | 0.05 | 4.8 | 10.41667 | N-cosmetic-directive/ | 60 kg |\n| 메이크업 제품 | 다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 88,
        "window_size": 3,
        "char_count": 271,
        "word_count": 59,
        "page_number": 37,
        "window_text": "또한, 지정·고시된 사용 목적 및 사용한도에 적합하여야 한다.  | 노출 수준을 정량적 산출하는 과정 | 원료 등을 화장품의 제조에 사용할 수 없는 원료로 지정하거나 그 사용기준을 지정하 | “화장품 위해평가 가이드라인(민원인 안내서)” | 피부 관리 |\n| 메이크업 및 손톱 관리용 | 화장품 사용에 따른 노출 경로 자료를 우선으로 고려할 수 있다.  | 생식·발생 | - 랫드 대상 | - 0, 250, 500, 1000 mg/kg/day | 아이 섀도 | 0.02 | 0.33 | 샴푸 | 0.09 | 1.52 | ○ 과학적 정보와 불확실성 등을 고려하여 정량적 또는 정 | 피부 관리(남녀) | [참고 자료] | 60 kg | 하였으나 실험에 사용한 랫드의 일반적인 | 특성 |\n| ⦁ 확산 셀의 설계, 수용액(receptor fluid) 선택, 피부 온도, 피부 온전성 등 | : 위해평가에 사용된 방법을 간략하게 기술 | 전성을 검토할 때에는 사전에 안전성 검토 대상을 선정하여 실시해야 한다.  | fappl (day-1) | 사용 횟수(제품별 매개변수 값으로 2 적용)2 | 2 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007) | Electrical resistance Test, RET) | 제품 노출 면적(cm2) | 해당 물질의 제품이 노출되는 면적 | 아이라이너, 아이메이크업리무버, 립스틱, 입술보호제, 네일제품 | 립스틱 | 0.05 | 4.8 | 10.41667 | N-cosmetic-directive/ | 60 kg |\n| 메이크업 제품 | 다.  | ○ 유효한 경구 생체이용률(BA) 자료가 있는 경우, |\n| 위해영향 발생 가능성이 낮다고 평가할 수 있다(SCCS/1628/21, 2021; Renwick, 1993).  | 가하도록 한다.  | 바디로션 | 5.48 | 92.23 | 1.0 | 5.48 | 92.23 | 바디로션 | 7.82 | 123.20 | 1.00 | 7.82 | 123.20 | 여야 한다. ",
        "original_sentence": "| fappl (day-1) | 사용 횟수(제품별 매개변수 값으로 2 적용)2 | 2 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007) | Electrical resistance Test, RET) | 제품 노출 면적(cm2) | 해당 물질의 제품이 노출되는 면적 | 아이라이너, 아이메이크업리무버, 립스틱, 입술보호제, 네일제품 | 립스틱 | 0.05 | 4.8 | 10.41667 | N-cosmetic-directive/ | 60 kg |\n| 메이크업 제품 | 다. "
      }
    },
    {
      "chunk_id": "chunk_090",
      "text": "| ○ 유효한 경구 생체이용률(BA) 자료가 있는 경우, |\n| 위해영향 발생 가능성이 낮다고 평가할 수 있다(SCCS/1628/21, 2021; Renwick, 1993). ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 89,
        "window_size": 3,
        "char_count": 98,
        "word_count": 20,
        "page_number": 19,
        "window_text": "| 노출 수준을 정량적 산출하는 과정 | 원료 등을 화장품의 제조에 사용할 수 없는 원료로 지정하거나 그 사용기준을 지정하 | “화장품 위해평가 가이드라인(민원인 안내서)” | 피부 관리 |\n| 메이크업 및 손톱 관리용 | 화장품 사용에 따른 노출 경로 자료를 우선으로 고려할 수 있다.  | 생식·발생 | - 랫드 대상 | - 0, 250, 500, 1000 mg/kg/day | 아이 섀도 | 0.02 | 0.33 | 샴푸 | 0.09 | 1.52 | ○ 과학적 정보와 불확실성 등을 고려하여 정량적 또는 정 | 피부 관리(남녀) | [참고 자료] | 60 kg | 하였으나 실험에 사용한 랫드의 일반적인 | 특성 |\n| ⦁ 확산 셀의 설계, 수용액(receptor fluid) 선택, 피부 온도, 피부 온전성 등 | : 위해평가에 사용된 방법을 간략하게 기술 | 전성을 검토할 때에는 사전에 안전성 검토 대상을 선정하여 실시해야 한다.  | fappl (day-1) | 사용 횟수(제품별 매개변수 값으로 2 적용)2 | 2 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007) | Electrical resistance Test, RET) | 제품 노출 면적(cm2) | 해당 물질의 제품이 노출되는 면적 | 아이라이너, 아이메이크업리무버, 립스틱, 입술보호제, 네일제품 | 립스틱 | 0.05 | 4.8 | 10.41667 | N-cosmetic-directive/ | 60 kg |\n| 메이크업 제품 | 다.  | ○ 유효한 경구 생체이용률(BA) 자료가 있는 경우, |\n| 위해영향 발생 가능성이 낮다고 평가할 수 있다(SCCS/1628/21, 2021; Renwick, 1993).  | 가하도록 한다.  | 바디로션 | 5.48 | 92.23 | 1.0 | 5.48 | 92.23 | 바디로션 | 7.82 | 123.20 | 1.00 | 7.82 | 123.20 | 여야 한다.  | 헤어 컨디셔너 | 0.06 | 1.03 |\n| 가원 화장품연구과에 문의하시기 바랍니다. ",
        "original_sentence": "| ○ 유효한 경구 생체이용률(BA) 자료가 있는 경우, |\n| 위해영향 발생 가능성이 낮다고 평가할 수 있다(SCCS/1628/21, 2021; Renwick, 1993). "
      }
    },
    {
      "chunk_id": "chunk_091",
      "text": "| 가하도록 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 90,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 2,
        "window_text": "| 생식·발생 | - 랫드 대상 | - 0, 250, 500, 1000 mg/kg/day | 아이 섀도 | 0.02 | 0.33 | 샴푸 | 0.09 | 1.52 | ○ 과학적 정보와 불확실성 등을 고려하여 정량적 또는 정 | 피부 관리(남녀) | [참고 자료] | 60 kg | 하였으나 실험에 사용한 랫드의 일반적인 | 특성 |\n| ⦁ 확산 셀의 설계, 수용액(receptor fluid) 선택, 피부 온도, 피부 온전성 등 | : 위해평가에 사용된 방법을 간략하게 기술 | 전성을 검토할 때에는 사전에 안전성 검토 대상을 선정하여 실시해야 한다.  | fappl (day-1) | 사용 횟수(제품별 매개변수 값으로 2 적용)2 | 2 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007) | Electrical resistance Test, RET) | 제품 노출 면적(cm2) | 해당 물질의 제품이 노출되는 면적 | 아이라이너, 아이메이크업리무버, 립스틱, 입술보호제, 네일제품 | 립스틱 | 0.05 | 4.8 | 10.41667 | N-cosmetic-directive/ | 60 kg |\n| 메이크업 제품 | 다.  | ○ 유효한 경구 생체이용률(BA) 자료가 있는 경우, |\n| 위해영향 발생 가능성이 낮다고 평가할 수 있다(SCCS/1628/21, 2021; Renwick, 1993).  | 가하도록 한다.  | 바디로션 | 5.48 | 92.23 | 1.0 | 5.48 | 92.23 | 바디로션 | 7.82 | 123.20 | 1.00 | 7.82 | 123.20 | 여야 한다.  | 헤어 컨디셔너 | 0.06 | 1.03 |\n| 가원 화장품연구과에 문의하시기 바랍니다.  | 집할 수 있다. ",
        "original_sentence": "| 가하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_092",
      "text": "| 바디로션 | 5.48 | 92.23 | 1.0 | 5.48 | 92.23 | 바디로션 | 7.82 | 123.20 | 1.00 | 7.82 | 123.20 | 여야 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 91,
        "window_size": 3,
        "char_count": 98,
        "word_count": 27,
        "page_number": 42,
        "window_text": "| fappl (day-1) | 사용 횟수(제품별 매개변수 값으로 2 적용)2 | 2 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007) | Electrical resistance Test, RET) | 제품 노출 면적(cm2) | 해당 물질의 제품이 노출되는 면적 | 아이라이너, 아이메이크업리무버, 립스틱, 입술보호제, 네일제품 | 립스틱 | 0.05 | 4.8 | 10.41667 | N-cosmetic-directive/ | 60 kg |\n| 메이크업 제품 | 다.  | ○ 유효한 경구 생체이용률(BA) 자료가 있는 경우, |\n| 위해영향 발생 가능성이 낮다고 평가할 수 있다(SCCS/1628/21, 2021; Renwick, 1993).  | 가하도록 한다.  | 바디로션 | 5.48 | 92.23 | 1.0 | 5.48 | 92.23 | 바디로션 | 7.82 | 123.20 | 1.00 | 7.82 | 123.20 | 여야 한다.  | 헤어 컨디셔너 | 0.06 | 1.03 |\n| 가원 화장품연구과에 문의하시기 바랍니다.  | 집할 수 있다.  | 3 한국인 호흡률(한국인의 노출계수 핸드북, 환경부, 2019) | 손세정 비누에 함유된 물질 A의 농도 | 50 ppb (= 50 ㎍/kg) | - (OECD TG476) 유전자돌연변이시험 | - (OECD TG470) pig-a gene mutation | ○ 체내(in vivo) 시험 | 마스카라 | 0.025 | 0.42 | http://ASEANcosmetics.org | 성적으로 위해성을 명시하되, 과학적으로 가능한 범위 내 |\n| 데오도란트 | 스프레이, 스틱/롤러형 | 우, 재평가할 수 있다. ",
        "original_sentence": "| 바디로션 | 5.48 | 92.23 | 1.0 | 5.48 | 92.23 | 바디로션 | 7.82 | 123.20 | 1.00 | 7.82 | 123.20 | 여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_093",
      "text": "| 헤어 컨디셔너 | 0.06 | 1.03 |\n| 가원 화장품연구과에 문의하시기 바랍니다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 92,
        "window_size": 3,
        "char_count": 51,
        "word_count": 13,
        "page_number": 2,
        "window_text": "| ○ 유효한 경구 생체이용률(BA) 자료가 있는 경우, |\n| 위해영향 발생 가능성이 낮다고 평가할 수 있다(SCCS/1628/21, 2021; Renwick, 1993).  | 가하도록 한다.  | 바디로션 | 5.48 | 92.23 | 1.0 | 5.48 | 92.23 | 바디로션 | 7.82 | 123.20 | 1.00 | 7.82 | 123.20 | 여야 한다.  | 헤어 컨디셔너 | 0.06 | 1.03 |\n| 가원 화장품연구과에 문의하시기 바랍니다.  | 집할 수 있다.  | 3 한국인 호흡률(한국인의 노출계수 핸드북, 환경부, 2019) | 손세정 비누에 함유된 물질 A의 농도 | 50 ppb (= 50 ㎍/kg) | - (OECD TG476) 유전자돌연변이시험 | - (OECD TG470) pig-a gene mutation | ○ 체내(in vivo) 시험 | 마스카라 | 0.025 | 0.42 | http://ASEANcosmetics.org | 성적으로 위해성을 명시하되, 과학적으로 가능한 범위 내 |\n| 데오도란트 | 스프레이, 스틱/롤러형 | 우, 재평가할 수 있다.  | 안내서-0747-01 | 2017.03. ",
        "original_sentence": "| 헤어 컨디셔너 | 0.06 | 1.03 |\n| 가원 화장품연구과에 문의하시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_094",
      "text": "| 집할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 93,
        "window_size": 3,
        "char_count": 11,
        "word_count": 4,
        "page_number": 2,
        "window_text": "| 가하도록 한다.  | 바디로션 | 5.48 | 92.23 | 1.0 | 5.48 | 92.23 | 바디로션 | 7.82 | 123.20 | 1.00 | 7.82 | 123.20 | 여야 한다.  | 헤어 컨디셔너 | 0.06 | 1.03 |\n| 가원 화장품연구과에 문의하시기 바랍니다.  | 집할 수 있다.  | 3 한국인 호흡률(한국인의 노출계수 핸드북, 환경부, 2019) | 손세정 비누에 함유된 물질 A의 농도 | 50 ppb (= 50 ㎍/kg) | - (OECD TG476) 유전자돌연변이시험 | - (OECD TG470) pig-a gene mutation | ○ 체내(in vivo) 시험 | 마스카라 | 0.025 | 0.42 | http://ASEANcosmetics.org | 성적으로 위해성을 명시하되, 과학적으로 가능한 범위 내 |\n| 데오도란트 | 스프레이, 스틱/롤러형 | 우, 재평가할 수 있다.  | 안내서-0747-01 | 2017.03.  | 화장품 위해평가 가이드라인 개정 | BW | 성인 평균 체중(60kg) | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. ",
        "original_sentence": "| 집할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_095",
      "text": "| 3 한국인 호흡률(한국인의 노출계수 핸드북, 환경부, 2019) | 손세정 비누에 함유된 물질 A의 농도 | 50 ppb (= 50 ㎍/kg) | - (OECD TG476) 유전자돌연변이시험 | - (OECD TG470) pig-a gene mutation | ○ 체내(in vivo) 시험 | 마스카라 | 0.025 | 0.42 | http://ASEANcosmetics.org | 성적으로 위해성을 명시하되, 과학적으로 가능한 범위 내 |\n| 데오도란트 | 스프레이, 스틱/롤러형 | 우, 재평가할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 94,
        "window_size": 3,
        "char_count": 289,
        "word_count": 65,
        "page_number": 34,
        "window_text": "| 바디로션 | 5.48 | 92.23 | 1.0 | 5.48 | 92.23 | 바디로션 | 7.82 | 123.20 | 1.00 | 7.82 | 123.20 | 여야 한다.  | 헤어 컨디셔너 | 0.06 | 1.03 |\n| 가원 화장품연구과에 문의하시기 바랍니다.  | 집할 수 있다.  | 3 한국인 호흡률(한국인의 노출계수 핸드북, 환경부, 2019) | 손세정 비누에 함유된 물질 A의 농도 | 50 ppb (= 50 ㎍/kg) | - (OECD TG476) 유전자돌연변이시험 | - (OECD TG470) pig-a gene mutation | ○ 체내(in vivo) 시험 | 마스카라 | 0.025 | 0.42 | http://ASEANcosmetics.org | 성적으로 위해성을 명시하되, 과학적으로 가능한 범위 내 |\n| 데오도란트 | 스프레이, 스틱/롤러형 | 우, 재평가할 수 있다.  | 안내서-0747-01 | 2017.03.  | 화장품 위해평가 가이드라인 개정 | BW | 성인 평균 체중(60kg) | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 질량 이동률(m/min) | 해당제품의 물질이 공기 중으로 증발되어 | 기능을 하게 되는 속도 | 아이라이너 | 0.01 | 3.2 | 3.125 | 경구 독성결과에 생체이용률(BA) 적용 가능 | - 그 외 어떠한 영향도 관찰되지 않음 |\n| 2-1. ",
        "original_sentence": "| 3 한국인 호흡률(한국인의 노출계수 핸드북, 환경부, 2019) | 손세정 비누에 함유된 물질 A의 농도 | 50 ppb (= 50 ㎍/kg) | - (OECD TG476) 유전자돌연변이시험 | - (OECD TG470) pig-a gene mutation | ○ 체내(in vivo) 시험 | 마스카라 | 0.025 | 0.42 | http://ASEANcosmetics.org | 성적으로 위해성을 명시하되, 과학적으로 가능한 범위 내 |\n| 데오도란트 | 스프레이, 스틱/롤러형 | 우, 재평가할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_096",
      "text": "| 안내서-0747-01 | 2017.03. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 95,
        "window_size": 3,
        "char_count": 25,
        "word_count": 4,
        "page_number": 4,
        "window_text": "| 헤어 컨디셔너 | 0.06 | 1.03 |\n| 가원 화장품연구과에 문의하시기 바랍니다.  | 집할 수 있다.  | 3 한국인 호흡률(한국인의 노출계수 핸드북, 환경부, 2019) | 손세정 비누에 함유된 물질 A의 농도 | 50 ppb (= 50 ㎍/kg) | - (OECD TG476) 유전자돌연변이시험 | - (OECD TG470) pig-a gene mutation | ○ 체내(in vivo) 시험 | 마스카라 | 0.025 | 0.42 | http://ASEANcosmetics.org | 성적으로 위해성을 명시하되, 과학적으로 가능한 범위 내 |\n| 데오도란트 | 스프레이, 스틱/롤러형 | 우, 재평가할 수 있다.  | 안내서-0747-01 | 2017.03.  | 화장품 위해평가 가이드라인 개정 | BW | 성인 평균 체중(60kg) | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 질량 이동률(m/min) | 해당제품의 물질이 공기 중으로 증발되어 | 기능을 하게 되는 속도 | 아이라이너 | 0.01 | 3.2 | 3.125 | 경구 독성결과에 생체이용률(BA) 적용 가능 | - 그 외 어떠한 영향도 관찰되지 않음 |\n| 2-1.  위해평가 사전 검토사항 ······················································································· 8 | ⦁ 시험물질의 특성 분석을 통해 화장품 제품에 사용되는 성분과 일치 | 얼굴크림 | 1.76 | 29.14 | 1.0 | 1.76 | 29.14 | 얼굴크림 | 1.54 | 24.14 | 1.00 | 1.54 | 24.14 | 증기 | 바디로션 | 5.48 | 92.23 |\n| ⑤ 식품의약품안전처장은 제2항에 따라 지정ㆍ고시된 원료의 사용기준의 안전성을 정 | 있다. ",
        "original_sentence": "| 안내서-0747-01 | 2017.03. "
      }
    },
    {
      "chunk_id": "chunk_097",
      "text": "| 화장품 위해평가 가이드라인 개정 | BW | 성인 평균 체중(60kg) | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 96,
        "window_size": 3,
        "char_count": 76,
        "word_count": 18,
        "page_number": 1,
        "window_text": "| 집할 수 있다.  | 3 한국인 호흡률(한국인의 노출계수 핸드북, 환경부, 2019) | 손세정 비누에 함유된 물질 A의 농도 | 50 ppb (= 50 ㎍/kg) | - (OECD TG476) 유전자돌연변이시험 | - (OECD TG470) pig-a gene mutation | ○ 체내(in vivo) 시험 | 마스카라 | 0.025 | 0.42 | http://ASEANcosmetics.org | 성적으로 위해성을 명시하되, 과학적으로 가능한 범위 내 |\n| 데오도란트 | 스프레이, 스틱/롤러형 | 우, 재평가할 수 있다.  | 안내서-0747-01 | 2017.03.  | 화장품 위해평가 가이드라인 개정 | BW | 성인 평균 체중(60kg) | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 질량 이동률(m/min) | 해당제품의 물질이 공기 중으로 증발되어 | 기능을 하게 되는 속도 | 아이라이너 | 0.01 | 3.2 | 3.125 | 경구 독성결과에 생체이용률(BA) 적용 가능 | - 그 외 어떠한 영향도 관찰되지 않음 |\n| 2-1.  위해평가 사전 검토사항 ······················································································· 8 | ⦁ 시험물질의 특성 분석을 통해 화장품 제품에 사용되는 성분과 일치 | 얼굴크림 | 1.76 | 29.14 | 1.0 | 1.76 | 29.14 | 얼굴크림 | 1.54 | 24.14 | 1.00 | 1.54 | 24.14 | 증기 | 바디로션 | 5.48 | 92.23 |\n| ⑤ 식품의약품안전처장은 제2항에 따라 지정ㆍ고시된 원료의 사용기준의 안전성을 정 | 있다.  | 4 Rothe H, 2011 | 아이라이너 | 0.005 | 0.08 | 에서 정량화 |\n| 가 방법을 참고할 수 있다(붙임 7). ",
        "original_sentence": "| 화장품 위해평가 가이드라인 개정 | BW | 성인 평균 체중(60kg) | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. "
      }
    },
    {
      "chunk_id": "chunk_098",
      "text": "| 질량 이동률(m/min) | 해당제품의 물질이 공기 중으로 증발되어 | 기능을 하게 되는 속도 | 아이라이너 | 0.01 | 3.2 | 3.125 | 경구 독성결과에 생체이용률(BA) 적용 가능 | - 그 외 어떠한 영향도 관찰되지 않음 |\n| 2-1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 97,
        "window_size": 3,
        "char_count": 144,
        "word_count": 39,
        "page_number": 44,
        "window_text": "| 3 한국인 호흡률(한국인의 노출계수 핸드북, 환경부, 2019) | 손세정 비누에 함유된 물질 A의 농도 | 50 ppb (= 50 ㎍/kg) | - (OECD TG476) 유전자돌연변이시험 | - (OECD TG470) pig-a gene mutation | ○ 체내(in vivo) 시험 | 마스카라 | 0.025 | 0.42 | http://ASEANcosmetics.org | 성적으로 위해성을 명시하되, 과학적으로 가능한 범위 내 |\n| 데오도란트 | 스프레이, 스틱/롤러형 | 우, 재평가할 수 있다.  | 안내서-0747-01 | 2017.03.  | 화장품 위해평가 가이드라인 개정 | BW | 성인 평균 체중(60kg) | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 질량 이동률(m/min) | 해당제품의 물질이 공기 중으로 증발되어 | 기능을 하게 되는 속도 | 아이라이너 | 0.01 | 3.2 | 3.125 | 경구 독성결과에 생체이용률(BA) 적용 가능 | - 그 외 어떠한 영향도 관찰되지 않음 |\n| 2-1.  위해평가 사전 검토사항 ······················································································· 8 | ⦁ 시험물질의 특성 분석을 통해 화장품 제품에 사용되는 성분과 일치 | 얼굴크림 | 1.76 | 29.14 | 1.0 | 1.76 | 29.14 | 얼굴크림 | 1.54 | 24.14 | 1.00 | 1.54 | 24.14 | 증기 | 바디로션 | 5.48 | 92.23 |\n| ⑤ 식품의약품안전처장은 제2항에 따라 지정ㆍ고시된 원료의 사용기준의 안전성을 정 | 있다.  | 4 Rothe H, 2011 | 아이라이너 | 0.005 | 0.08 | 에서 정량화 |\n| 가 방법을 참고할 수 있다(붙임 7).  | Aexpo (g) | 분사된 평가 대상 물질의 양 | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 행정사무의 통일을 기하기 위하여 내부적으로 행정사무의 | method | 크기 | d-series-on-testing-and-assessment_20777876 | □ 예(☞지침서) | ■ 아니오 |\n| 시험 결과를 전신 독성기준값(PODsys)으로 결정한다. ",
        "original_sentence": "| 질량 이동률(m/min) | 해당제품의 물질이 공기 중으로 증발되어 | 기능을 하게 되는 속도 | 아이라이너 | 0.01 | 3.2 | 3.125 | 경구 독성결과에 생체이용률(BA) 적용 가능 | - 그 외 어떠한 영향도 관찰되지 않음 |\n| 2-1. "
      }
    },
    {
      "chunk_id": "chunk_099",
      "text": "위해평가 사전 검토사항 ······················································································· 8 | ⦁ 시험물질의 특성 분석을 통해 화장품 제품에 사용되는 성분과 일치 | 얼굴크림 | 1.76 | 29.14 | 1.0 | 1.76 | 29.14 | 얼굴크림 | 1.54 | 24.14 | 1.00 | 1.54 | 24.14 | 증기 | 바디로션 | 5.48 | 92.23 |\n| ⑤ 식품의약품안전처장은 제2항에 따라 지정ㆍ고시된 원료의 사용기준의 안전성을 정 | 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 98,
        "window_size": 3,
        "char_count": 312,
        "word_count": 61,
        "page_number": 2,
        "window_text": "| 안내서-0747-01 | 2017.03.  | 화장품 위해평가 가이드라인 개정 | BW | 성인 평균 체중(60kg) | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 질량 이동률(m/min) | 해당제품의 물질이 공기 중으로 증발되어 | 기능을 하게 되는 속도 | 아이라이너 | 0.01 | 3.2 | 3.125 | 경구 독성결과에 생체이용률(BA) 적용 가능 | - 그 외 어떠한 영향도 관찰되지 않음 |\n| 2-1.  위해평가 사전 검토사항 ······················································································· 8 | ⦁ 시험물질의 특성 분석을 통해 화장품 제품에 사용되는 성분과 일치 | 얼굴크림 | 1.76 | 29.14 | 1.0 | 1.76 | 29.14 | 얼굴크림 | 1.54 | 24.14 | 1.00 | 1.54 | 24.14 | 증기 | 바디로션 | 5.48 | 92.23 |\n| ⑤ 식품의약품안전처장은 제2항에 따라 지정ㆍ고시된 원료의 사용기준의 안전성을 정 | 있다.  | 4 Rothe H, 2011 | 아이라이너 | 0.005 | 0.08 | 에서 정량화 |\n| 가 방법을 참고할 수 있다(붙임 7).  | Aexpo (g) | 분사된 평가 대상 물질의 양 | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 행정사무의 통일을 기하기 위하여 내부적으로 행정사무의 | method | 크기 | d-series-on-testing-and-assessment_20777876 | □ 예(☞지침서) | ■ 아니오 |\n| 시험 결과를 전신 독성기준값(PODsys)으로 결정한다.  | 손세정 1일 노출량 | 3.33 mg/kg bw/day | https://www.industrialchemicals.gov.au/cosmetics-and |\n| 을 직접 투여하고, 모세대 및 차세대에 미치는 영향을 평가하는 시험 | 구강 관리용 | 치약, 구강청결제 | 핸드크림 | 1.38 | 23.59 | 1.0 | 1.38 | 23.59 | 핸드크림 | 2.16 | 32.70 | 1.00 | 2.16 | 32.70 | 전화번호: 043-719-4852 | 1일 총 화장품 사용량 | ±16.9 | 51.67438 | 얼굴 크림 | 1.76 | 29.14 | 립스틱 | 0.06 | 0.90 |\n| 2-2. ",
        "original_sentence": "위해평가 사전 검토사항 ······················································································· 8 | ⦁ 시험물질의 특성 분석을 통해 화장품 제품에 사용되는 성분과 일치 | 얼굴크림 | 1.76 | 29.14 | 1.0 | 1.76 | 29.14 | 얼굴크림 | 1.54 | 24.14 | 1.00 | 1.54 | 24.14 | 증기 | 바디로션 | 5.48 | 92.23 |\n| ⑤ 식품의약품안전처장은 제2항에 따라 지정ㆍ고시된 원료의 사용기준의 안전성을 정 | 있다. "
      }
    },
    {
      "chunk_id": "chunk_100",
      "text": "| 4 Rothe H, 2011 | 아이라이너 | 0.005 | 0.08 | 에서 정량화 |\n| 가 방법을 참고할 수 있다(붙임 7). ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 99,
        "window_size": 3,
        "char_count": 76,
        "word_count": 22,
        "page_number": 29,
        "window_text": "| 화장품 위해평가 가이드라인 개정 | BW | 성인 평균 체중(60kg) | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 질량 이동률(m/min) | 해당제품의 물질이 공기 중으로 증발되어 | 기능을 하게 되는 속도 | 아이라이너 | 0.01 | 3.2 | 3.125 | 경구 독성결과에 생체이용률(BA) 적용 가능 | - 그 외 어떠한 영향도 관찰되지 않음 |\n| 2-1.  위해평가 사전 검토사항 ······················································································· 8 | ⦁ 시험물질의 특성 분석을 통해 화장품 제품에 사용되는 성분과 일치 | 얼굴크림 | 1.76 | 29.14 | 1.0 | 1.76 | 29.14 | 얼굴크림 | 1.54 | 24.14 | 1.00 | 1.54 | 24.14 | 증기 | 바디로션 | 5.48 | 92.23 |\n| ⑤ 식품의약품안전처장은 제2항에 따라 지정ㆍ고시된 원료의 사용기준의 안전성을 정 | 있다.  | 4 Rothe H, 2011 | 아이라이너 | 0.005 | 0.08 | 에서 정량화 |\n| 가 방법을 참고할 수 있다(붙임 7).  | Aexpo (g) | 분사된 평가 대상 물질의 양 | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 행정사무의 통일을 기하기 위하여 내부적으로 행정사무의 | method | 크기 | d-series-on-testing-and-assessment_20777876 | □ 예(☞지침서) | ■ 아니오 |\n| 시험 결과를 전신 독성기준값(PODsys)으로 결정한다.  | 손세정 1일 노출량 | 3.33 mg/kg bw/day | https://www.industrialchemicals.gov.au/cosmetics-and |\n| 을 직접 투여하고, 모세대 및 차세대에 미치는 영향을 평가하는 시험 | 구강 관리용 | 치약, 구강청결제 | 핸드크림 | 1.38 | 23.59 | 1.0 | 1.38 | 23.59 | 핸드크림 | 2.16 | 32.70 | 1.00 | 2.16 | 32.70 | 전화번호: 043-719-4852 | 1일 총 화장품 사용량 | ±16.9 | 51.67438 | 얼굴 크림 | 1.76 | 29.14 | 립스틱 | 0.06 | 0.90 |\n| 2-2.  위해평가 세부 수행절차 ······················································································· 9 | 일반적으로 위해 우려가 되지 않는다고 평가할 수 있다(SCCS/1628/21, 2021). ",
        "original_sentence": "| 4 Rothe H, 2011 | 아이라이너 | 0.005 | 0.08 | 에서 정량화 |\n| 가 방법을 참고할 수 있다(붙임 7). "
      }
    },
    {
      "chunk_id": "chunk_101",
      "text": "| Aexpo (g) | 분사된 평가 대상 물질의 양 | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 행정사무의 통일을 기하기 위하여 내부적으로 행정사무의 | method | 크기 | d-series-on-testing-and-assessment_20777876 | □ 예(☞지침서) | ■ 아니오 |\n| 시험 결과를 전신 독성기준값(PODsys)으로 결정한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 100,
        "window_size": 3,
        "char_count": 235,
        "word_count": 44,
        "page_number": 24,
        "window_text": "| 질량 이동률(m/min) | 해당제품의 물질이 공기 중으로 증발되어 | 기능을 하게 되는 속도 | 아이라이너 | 0.01 | 3.2 | 3.125 | 경구 독성결과에 생체이용률(BA) 적용 가능 | - 그 외 어떠한 영향도 관찰되지 않음 |\n| 2-1.  위해평가 사전 검토사항 ······················································································· 8 | ⦁ 시험물질의 특성 분석을 통해 화장품 제품에 사용되는 성분과 일치 | 얼굴크림 | 1.76 | 29.14 | 1.0 | 1.76 | 29.14 | 얼굴크림 | 1.54 | 24.14 | 1.00 | 1.54 | 24.14 | 증기 | 바디로션 | 5.48 | 92.23 |\n| ⑤ 식품의약품안전처장은 제2항에 따라 지정ㆍ고시된 원료의 사용기준의 안전성을 정 | 있다.  | 4 Rothe H, 2011 | 아이라이너 | 0.005 | 0.08 | 에서 정량화 |\n| 가 방법을 참고할 수 있다(붙임 7).  | Aexpo (g) | 분사된 평가 대상 물질의 양 | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 행정사무의 통일을 기하기 위하여 내부적으로 행정사무의 | method | 크기 | d-series-on-testing-and-assessment_20777876 | □ 예(☞지침서) | ■ 아니오 |\n| 시험 결과를 전신 독성기준값(PODsys)으로 결정한다.  | 손세정 1일 노출량 | 3.33 mg/kg bw/day | https://www.industrialchemicals.gov.au/cosmetics-and |\n| 을 직접 투여하고, 모세대 및 차세대에 미치는 영향을 평가하는 시험 | 구강 관리용 | 치약, 구강청결제 | 핸드크림 | 1.38 | 23.59 | 1.0 | 1.38 | 23.59 | 핸드크림 | 2.16 | 32.70 | 1.00 | 2.16 | 32.70 | 전화번호: 043-719-4852 | 1일 총 화장품 사용량 | ±16.9 | 51.67438 | 얼굴 크림 | 1.76 | 29.14 | 립스틱 | 0.06 | 0.90 |\n| 2-2.  위해평가 세부 수행절차 ······················································································· 9 | 일반적으로 위해 우려가 되지 않는다고 평가할 수 있다(SCCS/1628/21, 2021).  | 전성은 노출량 등을 고려하여 사례별(case-by-case)로 검토되어야 한다. ",
        "original_sentence": "| Aexpo (g) | 분사된 평가 대상 물질의 양 | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 행정사무의 통일을 기하기 위하여 내부적으로 행정사무의 | method | 크기 | d-series-on-testing-and-assessment_20777876 | □ 예(☞지침서) | ■ 아니오 |\n| 시험 결과를 전신 독성기준값(PODsys)으로 결정한다. "
      }
    },
    {
      "chunk_id": "chunk_102",
      "text": "| 손세정 1일 노출량 | 3.33 mg/kg bw/day | https://www.industrialchemicals.gov.au/cosmetics-and |\n| 을 직접 투여하고, 모세대 및 차세대에 미치는 영향을 평가하는 시험 | 구강 관리용 | 치약, 구강청결제 | 핸드크림 | 1.38 | 23.59 | 1.0 | 1.38 | 23.59 | 핸드크림 | 2.16 | 32.70 | 1.00 | 2.16 | 32.70 | 전화번호: 043-719-4852 | 1일 총 화장품 사용량 | ±16.9 | 51.67438 | 얼굴 크림 | 1.76 | 29.14 | 립스틱 | 0.06 | 0.90 |\n| 2-2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 101,
        "window_size": 3,
        "char_count": 345,
        "word_count": 80,
        "page_number": 43,
        "window_text": "위해평가 사전 검토사항 ······················································································· 8 | ⦁ 시험물질의 특성 분석을 통해 화장품 제품에 사용되는 성분과 일치 | 얼굴크림 | 1.76 | 29.14 | 1.0 | 1.76 | 29.14 | 얼굴크림 | 1.54 | 24.14 | 1.00 | 1.54 | 24.14 | 증기 | 바디로션 | 5.48 | 92.23 |\n| ⑤ 식품의약품안전처장은 제2항에 따라 지정ㆍ고시된 원료의 사용기준의 안전성을 정 | 있다.  | 4 Rothe H, 2011 | 아이라이너 | 0.005 | 0.08 | 에서 정량화 |\n| 가 방법을 참고할 수 있다(붙임 7).  | Aexpo (g) | 분사된 평가 대상 물질의 양 | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 행정사무의 통일을 기하기 위하여 내부적으로 행정사무의 | method | 크기 | d-series-on-testing-and-assessment_20777876 | □ 예(☞지침서) | ■ 아니오 |\n| 시험 결과를 전신 독성기준값(PODsys)으로 결정한다.  | 손세정 1일 노출량 | 3.33 mg/kg bw/day | https://www.industrialchemicals.gov.au/cosmetics-and |\n| 을 직접 투여하고, 모세대 및 차세대에 미치는 영향을 평가하는 시험 | 구강 관리용 | 치약, 구강청결제 | 핸드크림 | 1.38 | 23.59 | 1.0 | 1.38 | 23.59 | 핸드크림 | 2.16 | 32.70 | 1.00 | 2.16 | 32.70 | 전화번호: 043-719-4852 | 1일 총 화장품 사용량 | ±16.9 | 51.67438 | 얼굴 크림 | 1.76 | 29.14 | 립스틱 | 0.06 | 0.90 |\n| 2-2.  위해평가 세부 수행절차 ······················································································· 9 | 일반적으로 위해 우려가 되지 않는다고 평가할 수 있다(SCCS/1628/21, 2021).  | 전성은 노출량 등을 고려하여 사례별(case-by-case)로 검토되어야 한다.  | ⦁ 일반 제형의 시험 물질 최고 농도를 포함한 다양한 농도로 수행 | 기적으로 검토하여야 하고, 그 결과에 따라 지정ㆍ고시된 원료의 사용기준을 변경할 | 피부흡수율 50%를 위해평가에 적용 | 50 mg/kg을 투여하여 종양이 발생한 비율(32%) - 대조군에서 종양이 발생한 비율(0%) | A (g/day) | 화장품의 1일 사용량1 | - (OECD TG435) in vitro 인공막 장벽시험 | 세부기준이나 절차를 제시하는 것입니까? ",
        "original_sentence": "| 손세정 1일 노출량 | 3.33 mg/kg bw/day | https://www.industrialchemicals.gov.au/cosmetics-and |\n| 을 직접 투여하고, 모세대 및 차세대에 미치는 영향을 평가하는 시험 | 구강 관리용 | 치약, 구강청결제 | 핸드크림 | 1.38 | 23.59 | 1.0 | 1.38 | 23.59 | 핸드크림 | 2.16 | 32.70 | 1.00 | 2.16 | 32.70 | 전화번호: 043-719-4852 | 1일 총 화장품 사용량 | ±16.9 | 51.67438 | 얼굴 크림 | 1.76 | 29.14 | 립스틱 | 0.06 | 0.90 |\n| 2-2. "
      }
    },
    {
      "chunk_id": "chunk_103",
      "text": "위해평가 세부 수행절차 ······················································································· 9 | 일반적으로 위해 우려가 되지 않는다고 평가할 수 있다(SCCS/1628/21, 2021). ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 102,
        "window_size": 3,
        "char_count": 156,
        "word_count": 15,
        "page_number": 5,
        "window_text": "| 4 Rothe H, 2011 | 아이라이너 | 0.005 | 0.08 | 에서 정량화 |\n| 가 방법을 참고할 수 있다(붙임 7).  | Aexpo (g) | 분사된 평가 대상 물질의 양 | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 행정사무의 통일을 기하기 위하여 내부적으로 행정사무의 | method | 크기 | d-series-on-testing-and-assessment_20777876 | □ 예(☞지침서) | ■ 아니오 |\n| 시험 결과를 전신 독성기준값(PODsys)으로 결정한다.  | 손세정 1일 노출량 | 3.33 mg/kg bw/day | https://www.industrialchemicals.gov.au/cosmetics-and |\n| 을 직접 투여하고, 모세대 및 차세대에 미치는 영향을 평가하는 시험 | 구강 관리용 | 치약, 구강청결제 | 핸드크림 | 1.38 | 23.59 | 1.0 | 1.38 | 23.59 | 핸드크림 | 2.16 | 32.70 | 1.00 | 2.16 | 32.70 | 전화번호: 043-719-4852 | 1일 총 화장품 사용량 | ±16.9 | 51.67438 | 얼굴 크림 | 1.76 | 29.14 | 립스틱 | 0.06 | 0.90 |\n| 2-2.  위해평가 세부 수행절차 ······················································································· 9 | 일반적으로 위해 우려가 되지 않는다고 평가할 수 있다(SCCS/1628/21, 2021).  | 전성은 노출량 등을 고려하여 사례별(case-by-case)로 검토되어야 한다.  | ⦁ 일반 제형의 시험 물질 최고 농도를 포함한 다양한 농도로 수행 | 기적으로 검토하여야 하고, 그 결과에 따라 지정ㆍ고시된 원료의 사용기준을 변경할 | 피부흡수율 50%를 위해평가에 적용 | 50 mg/kg을 투여하여 종양이 발생한 비율(32%) - 대조군에서 종양이 발생한 비율(0%) | A (g/day) | 화장품의 1일 사용량1 | - (OECD TG435) in vitro 인공막 장벽시험 | 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 분자량 매트릭스(g/mol) | 제품 전체의 분자량에서 해당 물질의 분자량을 | 뺀 나머지의 평균 | 가압 시스템(분사제 스프레이, 펌프 스프레이) | 피부 관리(Skin care) | 기타(Miscellaneous) |\n| 하는 과정 | A (g) | 화장품(스프레이)에서 분사된 양 | 스프레이 제품 |\n| 물질 A의 피부흡수율 | 65% | 핸드 크림 | 1.38 | 23.59 | -soap | 메이크업(여성) | 메이크업 | = | 32% |\n| 발 관리용 | 발한 억제제 크림, 항진균제 | 안내서-0747-02 | 2023.11. ",
        "original_sentence": "위해평가 세부 수행절차 ······················································································· 9 | 일반적으로 위해 우려가 되지 않는다고 평가할 수 있다(SCCS/1628/21, 2021). "
      }
    },
    {
      "chunk_id": "chunk_104",
      "text": "| 전성은 노출량 등을 고려하여 사례별(case-by-case)로 검토되어야 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 103,
        "window_size": 3,
        "char_count": 47,
        "word_count": 8,
        "page_number": 2,
        "window_text": "| Aexpo (g) | 분사된 평가 대상 물질의 양 | SED (mg/kg bw/day) | 전신노출량(Systemic Exposure Dosage) | □ 행정사무의 통일을 기하기 위하여 내부적으로 행정사무의 | method | 크기 | d-series-on-testing-and-assessment_20777876 | □ 예(☞지침서) | ■ 아니오 |\n| 시험 결과를 전신 독성기준값(PODsys)으로 결정한다.  | 손세정 1일 노출량 | 3.33 mg/kg bw/day | https://www.industrialchemicals.gov.au/cosmetics-and |\n| 을 직접 투여하고, 모세대 및 차세대에 미치는 영향을 평가하는 시험 | 구강 관리용 | 치약, 구강청결제 | 핸드크림 | 1.38 | 23.59 | 1.0 | 1.38 | 23.59 | 핸드크림 | 2.16 | 32.70 | 1.00 | 2.16 | 32.70 | 전화번호: 043-719-4852 | 1일 총 화장품 사용량 | ±16.9 | 51.67438 | 얼굴 크림 | 1.76 | 29.14 | 립스틱 | 0.06 | 0.90 |\n| 2-2.  위해평가 세부 수행절차 ······················································································· 9 | 일반적으로 위해 우려가 되지 않는다고 평가할 수 있다(SCCS/1628/21, 2021).  | 전성은 노출량 등을 고려하여 사례별(case-by-case)로 검토되어야 한다.  | ⦁ 일반 제형의 시험 물질 최고 농도를 포함한 다양한 농도로 수행 | 기적으로 검토하여야 하고, 그 결과에 따라 지정ㆍ고시된 원료의 사용기준을 변경할 | 피부흡수율 50%를 위해평가에 적용 | 50 mg/kg을 투여하여 종양이 발생한 비율(32%) - 대조군에서 종양이 발생한 비율(0%) | A (g/day) | 화장품의 1일 사용량1 | - (OECD TG435) in vitro 인공막 장벽시험 | 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 분자량 매트릭스(g/mol) | 제품 전체의 분자량에서 해당 물질의 분자량을 | 뺀 나머지의 평균 | 가압 시스템(분사제 스프레이, 펌프 스프레이) | 피부 관리(Skin care) | 기타(Miscellaneous) |\n| 하는 과정 | A (g) | 화장품(스프레이)에서 분사된 양 | 스프레이 제품 |\n| 물질 A의 피부흡수율 | 65% | 핸드 크림 | 1.38 | 23.59 | -soap | 메이크업(여성) | 메이크업 | = | 32% |\n| 발 관리용 | 발한 억제제 크림, 항진균제 | 안내서-0747-02 | 2023.11.  | 화장품 위해평가 가이드라인 개정 | □ 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기 | - (OECD TG483) 염색체이상시험 | - (OECD TG474) 소핵시험 | - (OECD TG475) 염색체이상시험 | - (OECD TG478) 우성치사시험 | - (OECD TG488) 유전자변이시험 | 스프레이 용기(부피) | 치약 | 0.14 | 2.16 |\n| ⦁ 사용조건과 동일한 함량 및 제형, 적용량, 피부 접촉시간으로 수행 | 수 있다. ",
        "original_sentence": "| 전성은 노출량 등을 고려하여 사례별(case-by-case)로 검토되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_105",
      "text": "| ⦁ 일반 제형의 시험 물질 최고 농도를 포함한 다양한 농도로 수행 | 기적으로 검토하여야 하고, 그 결과에 따라 지정ㆍ고시된 원료의 사용기준을 변경할 | 피부흡수율 50%를 위해평가에 적용 | 50 mg/kg을 투여하여 종양이 발생한 비율(32%) - 대조군에서 종양이 발생한 비율(0%) | A (g/day) | 화장품의 1일 사용량1 | - (OECD TG435) in vitro 인공막 장벽시험 | 세부기준이나 절차를 제시하는 것입니까? ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 104,
        "window_size": 3,
        "char_count": 250,
        "word_count": 60,
        "page_number": 23,
        "window_text": "| 손세정 1일 노출량 | 3.33 mg/kg bw/day | https://www.industrialchemicals.gov.au/cosmetics-and |\n| 을 직접 투여하고, 모세대 및 차세대에 미치는 영향을 평가하는 시험 | 구강 관리용 | 치약, 구강청결제 | 핸드크림 | 1.38 | 23.59 | 1.0 | 1.38 | 23.59 | 핸드크림 | 2.16 | 32.70 | 1.00 | 2.16 | 32.70 | 전화번호: 043-719-4852 | 1일 총 화장품 사용량 | ±16.9 | 51.67438 | 얼굴 크림 | 1.76 | 29.14 | 립스틱 | 0.06 | 0.90 |\n| 2-2.  위해평가 세부 수행절차 ······················································································· 9 | 일반적으로 위해 우려가 되지 않는다고 평가할 수 있다(SCCS/1628/21, 2021).  | 전성은 노출량 등을 고려하여 사례별(case-by-case)로 검토되어야 한다.  | ⦁ 일반 제형의 시험 물질 최고 농도를 포함한 다양한 농도로 수행 | 기적으로 검토하여야 하고, 그 결과에 따라 지정ㆍ고시된 원료의 사용기준을 변경할 | 피부흡수율 50%를 위해평가에 적용 | 50 mg/kg을 투여하여 종양이 발생한 비율(32%) - 대조군에서 종양이 발생한 비율(0%) | A (g/day) | 화장품의 1일 사용량1 | - (OECD TG435) in vitro 인공막 장벽시험 | 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 분자량 매트릭스(g/mol) | 제품 전체의 분자량에서 해당 물질의 분자량을 | 뺀 나머지의 평균 | 가압 시스템(분사제 스프레이, 펌프 스프레이) | 피부 관리(Skin care) | 기타(Miscellaneous) |\n| 하는 과정 | A (g) | 화장품(스프레이)에서 분사된 양 | 스프레이 제품 |\n| 물질 A의 피부흡수율 | 65% | 핸드 크림 | 1.38 | 23.59 | -soap | 메이크업(여성) | 메이크업 | = | 32% |\n| 발 관리용 | 발한 억제제 크림, 항진균제 | 안내서-0747-02 | 2023.11.  | 화장품 위해평가 가이드라인 개정 | □ 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기 | - (OECD TG483) 염색체이상시험 | - (OECD TG474) 소핵시험 | - (OECD TG475) 염색체이상시험 | - (OECD TG478) 우성치사시험 | - (OECD TG488) 유전자변이시험 | 스프레이 용기(부피) | 치약 | 0.14 | 2.16 |\n| ⦁ 사용조건과 동일한 함량 및 제형, 적용량, 피부 접촉시간으로 수행 | 수 있다.  이 경우 안전성 검토의 주기 및 절차 등에 관한 사항은 총리령으로 정한다. ",
        "original_sentence": "| ⦁ 일반 제형의 시험 물질 최고 농도를 포함한 다양한 농도로 수행 | 기적으로 검토하여야 하고, 그 결과에 따라 지정ㆍ고시된 원료의 사용기준을 변경할 | 피부흡수율 50%를 위해평가에 적용 | 50 mg/kg을 투여하여 종양이 발생한 비율(32%) - 대조군에서 종양이 발생한 비율(0%) | A (g/day) | 화장품의 1일 사용량1 | - (OECD TG435) in vitro 인공막 장벽시험 | 세부기준이나 절차를 제시하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_106",
      "text": "(공무원용) | 분자량 매트릭스(g/mol) | 제품 전체의 분자량에서 해당 물질의 분자량을 | 뺀 나머지의 평균 | 가압 시스템(분사제 스프레이, 펌프 스프레이) | 피부 관리(Skin care) | 기타(Miscellaneous) |\n| 하는 과정 | A (g) | 화장품(스프레이)에서 분사된 양 | 스프레이 제품 |\n| 물질 A의 피부흡수율 | 65% | 핸드 크림 | 1.38 | 23.59 | -soap | 메이크업(여성) | 메이크업 | = | 32% |\n| 발 관리용 | 발한 억제제 크림, 항진균제 | 안내서-0747-02 | 2023.11. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 105,
        "window_size": 3,
        "char_count": 313,
        "word_count": 78,
        "page_number": 44,
        "window_text": "위해평가 세부 수행절차 ······················································································· 9 | 일반적으로 위해 우려가 되지 않는다고 평가할 수 있다(SCCS/1628/21, 2021).  | 전성은 노출량 등을 고려하여 사례별(case-by-case)로 검토되어야 한다.  | ⦁ 일반 제형의 시험 물질 최고 농도를 포함한 다양한 농도로 수행 | 기적으로 검토하여야 하고, 그 결과에 따라 지정ㆍ고시된 원료의 사용기준을 변경할 | 피부흡수율 50%를 위해평가에 적용 | 50 mg/kg을 투여하여 종양이 발생한 비율(32%) - 대조군에서 종양이 발생한 비율(0%) | A (g/day) | 화장품의 1일 사용량1 | - (OECD TG435) in vitro 인공막 장벽시험 | 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 분자량 매트릭스(g/mol) | 제품 전체의 분자량에서 해당 물질의 분자량을 | 뺀 나머지의 평균 | 가압 시스템(분사제 스프레이, 펌프 스프레이) | 피부 관리(Skin care) | 기타(Miscellaneous) |\n| 하는 과정 | A (g) | 화장품(스프레이)에서 분사된 양 | 스프레이 제품 |\n| 물질 A의 피부흡수율 | 65% | 핸드 크림 | 1.38 | 23.59 | -soap | 메이크업(여성) | 메이크업 | = | 32% |\n| 발 관리용 | 발한 억제제 크림, 항진균제 | 안내서-0747-02 | 2023.11.  | 화장품 위해평가 가이드라인 개정 | □ 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기 | - (OECD TG483) 염색체이상시험 | - (OECD TG474) 소핵시험 | - (OECD TG475) 염색체이상시험 | - (OECD TG478) 우성치사시험 | - (OECD TG488) 유전자변이시험 | 스프레이 용기(부피) | 치약 | 0.14 | 2.16 |\n| ⦁ 사용조건과 동일한 함량 및 제형, 적용량, 피부 접촉시간으로 수행 | 수 있다.  이 경우 안전성 검토의 주기 및 절차 등에 관한 사항은 총리령으로 정한다.  | 팩스번호: 043-719-4850 | 발    행    일 | 2023. ",
        "original_sentence": "(공무원용) | 분자량 매트릭스(g/mol) | 제품 전체의 분자량에서 해당 물질의 분자량을 | 뺀 나머지의 평균 | 가압 시스템(분사제 스프레이, 펌프 스프레이) | 피부 관리(Skin care) | 기타(Miscellaneous) |\n| 하는 과정 | A (g) | 화장품(스프레이)에서 분사된 양 | 스프레이 제품 |\n| 물질 A의 피부흡수율 | 65% | 핸드 크림 | 1.38 | 23.59 | -soap | 메이크업(여성) | 메이크업 | = | 32% |\n| 발 관리용 | 발한 억제제 크림, 항진균제 | 안내서-0747-02 | 2023.11. "
      }
    },
    {
      "chunk_id": "chunk_107",
      "text": "| 화장품 위해평가 가이드라인 개정 | □ 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기 | - (OECD TG483) 염색체이상시험 | - (OECD TG474) 소핵시험 | - (OECD TG475) 염색체이상시험 | - (OECD TG478) 우성치사시험 | - (OECD TG488) 유전자변이시험 | 스프레이 용기(부피) | 치약 | 0.14 | 2.16 |\n| ⦁ 사용조건과 동일한 함량 및 제형, 적용량, 피부 접촉시간으로 수행 | 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 106,
        "window_size": 3,
        "char_count": 261,
        "word_count": 64,
        "page_number": 1,
        "window_text": "| 전성은 노출량 등을 고려하여 사례별(case-by-case)로 검토되어야 한다.  | ⦁ 일반 제형의 시험 물질 최고 농도를 포함한 다양한 농도로 수행 | 기적으로 검토하여야 하고, 그 결과에 따라 지정ㆍ고시된 원료의 사용기준을 변경할 | 피부흡수율 50%를 위해평가에 적용 | 50 mg/kg을 투여하여 종양이 발생한 비율(32%) - 대조군에서 종양이 발생한 비율(0%) | A (g/day) | 화장품의 1일 사용량1 | - (OECD TG435) in vitro 인공막 장벽시험 | 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 분자량 매트릭스(g/mol) | 제품 전체의 분자량에서 해당 물질의 분자량을 | 뺀 나머지의 평균 | 가압 시스템(분사제 스프레이, 펌프 스프레이) | 피부 관리(Skin care) | 기타(Miscellaneous) |\n| 하는 과정 | A (g) | 화장품(스프레이)에서 분사된 양 | 스프레이 제품 |\n| 물질 A의 피부흡수율 | 65% | 핸드 크림 | 1.38 | 23.59 | -soap | 메이크업(여성) | 메이크업 | = | 32% |\n| 발 관리용 | 발한 억제제 크림, 항진균제 | 안내서-0747-02 | 2023.11.  | 화장품 위해평가 가이드라인 개정 | □ 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기 | - (OECD TG483) 염색체이상시험 | - (OECD TG474) 소핵시험 | - (OECD TG475) 염색체이상시험 | - (OECD TG478) 우성치사시험 | - (OECD TG488) 유전자변이시험 | 스프레이 용기(부피) | 치약 | 0.14 | 2.16 |\n| ⦁ 사용조건과 동일한 함량 및 제형, 적용량, 피부 접촉시간으로 수행 | 수 있다.  이 경우 안전성 검토의 주기 및 절차 등에 관한 사항은 총리령으로 정한다.  | 팩스번호: 043-719-4850 | 발    행    일 | 2023.  11. ",
        "original_sentence": "| 화장품 위해평가 가이드라인 개정 | □ 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기 | - (OECD TG483) 염색체이상시험 | - (OECD TG474) 소핵시험 | - (OECD TG475) 염색체이상시험 | - (OECD TG478) 우성치사시험 | - (OECD TG488) 유전자변이시험 | 스프레이 용기(부피) | 치약 | 0.14 | 2.16 |\n| ⦁ 사용조건과 동일한 함량 및 제형, 적용량, 피부 접촉시간으로 수행 | 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_108",
      "text": "이 경우 안전성 검토의 주기 및 절차 등에 관한 사항은 총리령으로 정한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 107,
        "window_size": 3,
        "char_count": 42,
        "word_count": 12,
        "page_number": 2,
        "window_text": "| ⦁ 일반 제형의 시험 물질 최고 농도를 포함한 다양한 농도로 수행 | 기적으로 검토하여야 하고, 그 결과에 따라 지정ㆍ고시된 원료의 사용기준을 변경할 | 피부흡수율 50%를 위해평가에 적용 | 50 mg/kg을 투여하여 종양이 발생한 비율(32%) - 대조군에서 종양이 발생한 비율(0%) | A (g/day) | 화장품의 1일 사용량1 | - (OECD TG435) in vitro 인공막 장벽시험 | 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 분자량 매트릭스(g/mol) | 제품 전체의 분자량에서 해당 물질의 분자량을 | 뺀 나머지의 평균 | 가압 시스템(분사제 스프레이, 펌프 스프레이) | 피부 관리(Skin care) | 기타(Miscellaneous) |\n| 하는 과정 | A (g) | 화장품(스프레이)에서 분사된 양 | 스프레이 제품 |\n| 물질 A의 피부흡수율 | 65% | 핸드 크림 | 1.38 | 23.59 | -soap | 메이크업(여성) | 메이크업 | = | 32% |\n| 발 관리용 | 발한 억제제 크림, 항진균제 | 안내서-0747-02 | 2023.11.  | 화장품 위해평가 가이드라인 개정 | □ 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기 | - (OECD TG483) 염색체이상시험 | - (OECD TG474) 소핵시험 | - (OECD TG475) 염색체이상시험 | - (OECD TG478) 우성치사시험 | - (OECD TG488) 유전자변이시험 | 스프레이 용기(부피) | 치약 | 0.14 | 2.16 |\n| ⦁ 사용조건과 동일한 함량 및 제형, 적용량, 피부 접촉시간으로 수행 | 수 있다.  이 경우 안전성 검토의 주기 및 절차 등에 관한 사항은 총리령으로 정한다.  | 팩스번호: 043-719-4850 | 발    행    일 | 2023.  11.  | 구강 제품 | 전체 마우스 수의 비율(100%) - 대조군에서 종양이 발생한 마우스 수의 비율(0%) | ■ 예(☞안내서) | □ 아니오 |\n| 리퀴드 파운데이션 | 0.51 | 7.90 | 1.00 | 0.51 | 7.90 | 서 구분 | 2-2-1. ",
        "original_sentence": "이 경우 안전성 검토의 주기 및 절차 등에 관한 사항은 총리령으로 정한다. "
      }
    },
    {
      "chunk_id": "chunk_109",
      "text": "| 팩스번호: 043-719-4850 | 발    행    일 | 2023. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 108,
        "window_size": 3,
        "char_count": 43,
        "word_count": 9,
        "page_number": 3,
        "window_text": "(공무원용) | 분자량 매트릭스(g/mol) | 제품 전체의 분자량에서 해당 물질의 분자량을 | 뺀 나머지의 평균 | 가압 시스템(분사제 스프레이, 펌프 스프레이) | 피부 관리(Skin care) | 기타(Miscellaneous) |\n| 하는 과정 | A (g) | 화장품(스프레이)에서 분사된 양 | 스프레이 제품 |\n| 물질 A의 피부흡수율 | 65% | 핸드 크림 | 1.38 | 23.59 | -soap | 메이크업(여성) | 메이크업 | = | 32% |\n| 발 관리용 | 발한 억제제 크림, 항진균제 | 안내서-0747-02 | 2023.11.  | 화장품 위해평가 가이드라인 개정 | □ 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기 | - (OECD TG483) 염색체이상시험 | - (OECD TG474) 소핵시험 | - (OECD TG475) 염색체이상시험 | - (OECD TG478) 우성치사시험 | - (OECD TG488) 유전자변이시험 | 스프레이 용기(부피) | 치약 | 0.14 | 2.16 |\n| ⦁ 사용조건과 동일한 함량 및 제형, 적용량, 피부 접촉시간으로 수행 | 수 있다.  이 경우 안전성 검토의 주기 및 절차 등에 관한 사항은 총리령으로 정한다.  | 팩스번호: 043-719-4850 | 발    행    일 | 2023.  11.  | 구강 제품 | 전체 마우스 수의 비율(100%) - 대조군에서 종양이 발생한 마우스 수의 비율(0%) | ■ 예(☞안내서) | □ 아니오 |\n| 리퀴드 파운데이션 | 0.51 | 7.90 | 1.00 | 0.51 | 7.90 | 서 구분 | 2-2-1.  위험성 확인 ······································································································ 9 | C (%) | 화장품 중 평가 대상 물질의 농도 | C (%) | 화장품 제형 중 평가 대상 성분의 농도 | 시험 | 방법 | 투여 | 경로 | 분사시간(sec) | 스프레이 분사 시간 | 시험 | 대상 | 투여용량 | 피부흡수율 |\n| 리퀴드 파운데이션 | 0.30 | 5.28 | 1.0 | 0.30 | 5.28 | 발암물질로 분류된다. ",
        "original_sentence": "| 팩스번호: 043-719-4850 | 발    행    일 | 2023. "
      }
    },
    {
      "chunk_id": "chunk_110",
      "text": "11. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 109,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 1,
        "window_text": "| 화장품 위해평가 가이드라인 개정 | □ 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기 | - (OECD TG483) 염색체이상시험 | - (OECD TG474) 소핵시험 | - (OECD TG475) 염색체이상시험 | - (OECD TG478) 우성치사시험 | - (OECD TG488) 유전자변이시험 | 스프레이 용기(부피) | 치약 | 0.14 | 2.16 |\n| ⦁ 사용조건과 동일한 함량 및 제형, 적용량, 피부 접촉시간으로 수행 | 수 있다.  이 경우 안전성 검토의 주기 및 절차 등에 관한 사항은 총리령으로 정한다.  | 팩스번호: 043-719-4850 | 발    행    일 | 2023.  11.  | 구강 제품 | 전체 마우스 수의 비율(100%) - 대조군에서 종양이 발생한 마우스 수의 비율(0%) | ■ 예(☞안내서) | □ 아니오 |\n| 리퀴드 파운데이션 | 0.51 | 7.90 | 1.00 | 0.51 | 7.90 | 서 구분 | 2-2-1.  위험성 확인 ······································································································ 9 | C (%) | 화장품 중 평가 대상 물질의 농도 | C (%) | 화장품 제형 중 평가 대상 성분의 농도 | 시험 | 방법 | 투여 | 경로 | 분사시간(sec) | 스프레이 분사 시간 | 시험 | 대상 | 투여용량 | 피부흡수율 |\n| 리퀴드 파운데이션 | 0.30 | 5.28 | 1.0 | 0.30 | 5.28 | 발암물질로 분류된다.  | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 | 입장을 기술하는 것입니까? ",
        "original_sentence": "11. "
      }
    },
    {
      "chunk_id": "chunk_111",
      "text": "| 구강 제품 | 전체 마우스 수의 비율(100%) - 대조군에서 종양이 발생한 마우스 수의 비율(0%) | ■ 예(☞안내서) | □ 아니오 |\n| 리퀴드 파운데이션 | 0.51 | 7.90 | 1.00 | 0.51 | 7.90 | 서 구분 | 2-2-1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 110,
        "window_size": 3,
        "char_count": 144,
        "word_count": 40,
        "page_number": 37,
        "window_text": "이 경우 안전성 검토의 주기 및 절차 등에 관한 사항은 총리령으로 정한다.  | 팩스번호: 043-719-4850 | 발    행    일 | 2023.  11.  | 구강 제품 | 전체 마우스 수의 비율(100%) - 대조군에서 종양이 발생한 마우스 수의 비율(0%) | ■ 예(☞안내서) | □ 아니오 |\n| 리퀴드 파운데이션 | 0.51 | 7.90 | 1.00 | 0.51 | 7.90 | 서 구분 | 2-2-1.  위험성 확인 ······································································································ 9 | C (%) | 화장품 중 평가 대상 물질의 농도 | C (%) | 화장품 제형 중 평가 대상 성분의 농도 | 시험 | 방법 | 투여 | 경로 | 분사시간(sec) | 스프레이 분사 시간 | 시험 | 대상 | 투여용량 | 피부흡수율 |\n| 리퀴드 파운데이션 | 0.30 | 5.28 | 1.0 | 0.30 | 5.28 | 발암물질로 분류된다.  | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 | 입장을 기술하는 것입니까?  (민원인용) | 평생발암위해도(LCR) | = | SED | 비 분무형 데오도란트 | 2.33 | 36.12 | 노즐 등 제품 배출 형태 | 구강세정액 | 2.16 | 32.54 |\n| 향수 | 오드트왈렛 | BMDL10 |\n| 같은 정보가 포함된다. ",
        "original_sentence": "| 구강 제품 | 전체 마우스 수의 비율(100%) - 대조군에서 종양이 발생한 마우스 수의 비율(0%) | ■ 예(☞안내서) | □ 아니오 |\n| 리퀴드 파운데이션 | 0.51 | 7.90 | 1.00 | 0.51 | 7.90 | 서 구분 | 2-2-1. "
      }
    },
    {
      "chunk_id": "chunk_112",
      "text": "위험성 확인 ······································································································ 9 | C (%) | 화장품 중 평가 대상 물질의 농도 | C (%) | 화장품 제형 중 평가 대상 성분의 농도 | 시험 | 방법 | 투여 | 경로 | 분사시간(sec) | 스프레이 분사 시간 | 시험 | 대상 | 투여용량 | 피부흡수율 |\n| 리퀴드 파운데이션 | 0.30 | 5.28 | 1.0 | 0.30 | 5.28 | 발암물질로 분류된다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 111,
        "window_size": 3,
        "char_count": 305,
        "word_count": 64,
        "page_number": 5,
        "window_text": "| 팩스번호: 043-719-4850 | 발    행    일 | 2023.  11.  | 구강 제품 | 전체 마우스 수의 비율(100%) - 대조군에서 종양이 발생한 마우스 수의 비율(0%) | ■ 예(☞안내서) | □ 아니오 |\n| 리퀴드 파운데이션 | 0.51 | 7.90 | 1.00 | 0.51 | 7.90 | 서 구분 | 2-2-1.  위험성 확인 ······································································································ 9 | C (%) | 화장품 중 평가 대상 물질의 농도 | C (%) | 화장품 제형 중 평가 대상 성분의 농도 | 시험 | 방법 | 투여 | 경로 | 분사시간(sec) | 스프레이 분사 시간 | 시험 | 대상 | 투여용량 | 피부흡수율 |\n| 리퀴드 파운데이션 | 0.30 | 5.28 | 1.0 | 0.30 | 5.28 | 발암물질로 분류된다.  | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 | 입장을 기술하는 것입니까?  (민원인용) | 평생발암위해도(LCR) | = | SED | 비 분무형 데오도란트 | 2.33 | 36.12 | 노즐 등 제품 배출 형태 | 구강세정액 | 2.16 | 32.54 |\n| 향수 | 오드트왈렛 | BMDL10 |\n| 같은 정보가 포함된다.  | DAp (%) | 평가 대상 물질의 피부흡수율 (Dermal Absorption)2 | 대상 화장품 | 전신노출량 | (mg/kg/day) | method) | 분사된 물질 중 공기 중 부유 비율3 | Human data | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) |\n| ⦁ 시험물질의 전체 회수율이 85~115% 범위에 해당 | 메이크업 리무버 | 메이크업 리무버2 | 5.00 | - | 0.1 | 0.50 | 8.33 | 류인자를 이용할 수 없는 경우 10%의 잔류지수를 적용할 수 있다. ",
        "original_sentence": "위험성 확인 ······································································································ 9 | C (%) | 화장품 중 평가 대상 물질의 농도 | C (%) | 화장품 제형 중 평가 대상 성분의 농도 | 시험 | 방법 | 투여 | 경로 | 분사시간(sec) | 스프레이 분사 시간 | 시험 | 대상 | 투여용량 | 피부흡수율 |\n| 리퀴드 파운데이션 | 0.30 | 5.28 | 1.0 | 0.30 | 5.28 | 발암물질로 분류된다. "
      }
    },
    {
      "chunk_id": "chunk_113",
      "text": "| 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 | 입장을 기술하는 것입니까? ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 112,
        "window_size": 3,
        "char_count": 51,
        "word_count": 12,
        "page_number": 2,
        "window_text": "11.  | 구강 제품 | 전체 마우스 수의 비율(100%) - 대조군에서 종양이 발생한 마우스 수의 비율(0%) | ■ 예(☞안내서) | □ 아니오 |\n| 리퀴드 파운데이션 | 0.51 | 7.90 | 1.00 | 0.51 | 7.90 | 서 구분 | 2-2-1.  위험성 확인 ······································································································ 9 | C (%) | 화장품 중 평가 대상 물질의 농도 | C (%) | 화장품 제형 중 평가 대상 성분의 농도 | 시험 | 방법 | 투여 | 경로 | 분사시간(sec) | 스프레이 분사 시간 | 시험 | 대상 | 투여용량 | 피부흡수율 |\n| 리퀴드 파운데이션 | 0.30 | 5.28 | 1.0 | 0.30 | 5.28 | 발암물질로 분류된다.  | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 | 입장을 기술하는 것입니까?  (민원인용) | 평생발암위해도(LCR) | = | SED | 비 분무형 데오도란트 | 2.33 | 36.12 | 노즐 등 제품 배출 형태 | 구강세정액 | 2.16 | 32.54 |\n| 향수 | 오드트왈렛 | BMDL10 |\n| 같은 정보가 포함된다.  | DAp (%) | 평가 대상 물질의 피부흡수율 (Dermal Absorption)2 | 대상 화장품 | 전신노출량 | (mg/kg/day) | method) | 분사된 물질 중 공기 중 부유 비율3 | Human data | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) |\n| ⦁ 시험물질의 전체 회수율이 85~115% 범위에 해당 | 메이크업 리무버 | 메이크업 리무버2 | 5.00 | - | 0.1 | 0.50 | 8.33 | 류인자를 이용할 수 없는 경우 10%의 잔류지수를 적용할 수 있다.  | 발    행    인 | 박 윤 주 | 2-2-2. ",
        "original_sentence": "| 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 | 입장을 기술하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_114",
      "text": "(민원인용) | 평생발암위해도(LCR) | = | SED | 비 분무형 데오도란트 | 2.33 | 36.12 | 노즐 등 제품 배출 형태 | 구강세정액 | 2.16 | 32.54 |\n| 향수 | 오드트왈렛 | BMDL10 |\n| 같은 정보가 포함된다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 113,
        "window_size": 3,
        "char_count": 141,
        "word_count": 39,
        "page_number": 27,
        "window_text": "| 구강 제품 | 전체 마우스 수의 비율(100%) - 대조군에서 종양이 발생한 마우스 수의 비율(0%) | ■ 예(☞안내서) | □ 아니오 |\n| 리퀴드 파운데이션 | 0.51 | 7.90 | 1.00 | 0.51 | 7.90 | 서 구분 | 2-2-1.  위험성 확인 ······································································································ 9 | C (%) | 화장품 중 평가 대상 물질의 농도 | C (%) | 화장품 제형 중 평가 대상 성분의 농도 | 시험 | 방법 | 투여 | 경로 | 분사시간(sec) | 스프레이 분사 시간 | 시험 | 대상 | 투여용량 | 피부흡수율 |\n| 리퀴드 파운데이션 | 0.30 | 5.28 | 1.0 | 0.30 | 5.28 | 발암물질로 분류된다.  | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 | 입장을 기술하는 것입니까?  (민원인용) | 평생발암위해도(LCR) | = | SED | 비 분무형 데오도란트 | 2.33 | 36.12 | 노즐 등 제품 배출 형태 | 구강세정액 | 2.16 | 32.54 |\n| 향수 | 오드트왈렛 | BMDL10 |\n| 같은 정보가 포함된다.  | DAp (%) | 평가 대상 물질의 피부흡수율 (Dermal Absorption)2 | 대상 화장품 | 전신노출량 | (mg/kg/day) | method) | 분사된 물질 중 공기 중 부유 비율3 | Human data | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) |\n| ⦁ 시험물질의 전체 회수율이 85~115% 범위에 해당 | 메이크업 리무버 | 메이크업 리무버2 | 5.00 | - | 0.1 | 0.50 | 8.33 | 류인자를 이용할 수 없는 경우 10%의 잔류지수를 적용할 수 있다.  | 발    행    인 | 박 윤 주 | 2-2-2.  위험성 결정 ···································································································· 12 | SED = 50 × 1/109 × 3.33 mg/kg bw/day× 65/100 | = 1.1×10-7  mg/kg bw/day | 실내 높이(m) | 사용 공간 높이 | 헤어스타일링 | 0.28 | 4.0 | (mg/kg bw/day) | HT25/0.25 | (mg/kg bw/day) |\n| (클렌징 크림/오일) | 2.14 | 36.95 | 0.1 | 0.21 | 3.70 | fair | LLNA weighted mean | TOTAL | ± 17.4 | 269 | 정성/정량 구성 |\n| 대상 화장품 | 전신노출량 | (mg/kg/day) | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) | WoE NESIL |\n| 태․분만․포육 등의 생식기능, 출생 및 이유 후 신생자의 생육)을 평가하는 시험 | 남성용 화장품 | 면도 비누, 크림 및 거품, 애프터셰이브 | 아이 섀도2 | 0.02 | - | 1.00 | 0.02 | 0.33 | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | - (OECD TG437) 소 각막 혼탁 및 투과성 시험법(Bovine Cornea Opacity | 질량 생성률(g/sec) | 해당 제품이 시간 당 분사되는 양 | (분사제 스프레이: 1, 펌프 스프레이: 0.2 적용) | NOEL – HRIPT | 물휴지 | 4.57 | 71.15 | NOEL –  HMT | LOEL | - 57 - | - 58 - | - 59 - | - 60 - | □ 예 | ■ 아니오 |\n| 향을 미칠 수 있다. ",
        "original_sentence": "(민원인용) | 평생발암위해도(LCR) | = | SED | 비 분무형 데오도란트 | 2.33 | 36.12 | 노즐 등 제품 배출 형태 | 구강세정액 | 2.16 | 32.54 |\n| 향수 | 오드트왈렛 | BMDL10 |\n| 같은 정보가 포함된다. "
      }
    },
    {
      "chunk_id": "chunk_115",
      "text": "| DAp (%) | 평가 대상 물질의 피부흡수율 (Dermal Absorption)2 | 대상 화장품 | 전신노출량 | (mg/kg/day) | method) | 분사된 물질 중 공기 중 부유 비율3 | Human data | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) |\n| ⦁ 시험물질의 전체 회수율이 85~115% 범위에 해당 | 메이크업 리무버 | 메이크업 리무버2 | 5.00 | - | 0.1 | 0.50 | 8.33 | 류인자를 이용할 수 없는 경우 10%의 잔류지수를 적용할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 114,
        "window_size": 3,
        "char_count": 291,
        "word_count": 74,
        "page_number": 24,
        "window_text": "위험성 확인 ······································································································ 9 | C (%) | 화장품 중 평가 대상 물질의 농도 | C (%) | 화장품 제형 중 평가 대상 성분의 농도 | 시험 | 방법 | 투여 | 경로 | 분사시간(sec) | 스프레이 분사 시간 | 시험 | 대상 | 투여용량 | 피부흡수율 |\n| 리퀴드 파운데이션 | 0.30 | 5.28 | 1.0 | 0.30 | 5.28 | 발암물질로 분류된다.  | 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 | 입장을 기술하는 것입니까?  (민원인용) | 평생발암위해도(LCR) | = | SED | 비 분무형 데오도란트 | 2.33 | 36.12 | 노즐 등 제품 배출 형태 | 구강세정액 | 2.16 | 32.54 |\n| 향수 | 오드트왈렛 | BMDL10 |\n| 같은 정보가 포함된다.  | DAp (%) | 평가 대상 물질의 피부흡수율 (Dermal Absorption)2 | 대상 화장품 | 전신노출량 | (mg/kg/day) | method) | 분사된 물질 중 공기 중 부유 비율3 | Human data | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) |\n| ⦁ 시험물질의 전체 회수율이 85~115% 범위에 해당 | 메이크업 리무버 | 메이크업 리무버2 | 5.00 | - | 0.1 | 0.50 | 8.33 | 류인자를 이용할 수 없는 경우 10%의 잔류지수를 적용할 수 있다.  | 발    행    인 | 박 윤 주 | 2-2-2.  위험성 결정 ···································································································· 12 | SED = 50 × 1/109 × 3.33 mg/kg bw/day× 65/100 | = 1.1×10-7  mg/kg bw/day | 실내 높이(m) | 사용 공간 높이 | 헤어스타일링 | 0.28 | 4.0 | (mg/kg bw/day) | HT25/0.25 | (mg/kg bw/day) |\n| (클렌징 크림/오일) | 2.14 | 36.95 | 0.1 | 0.21 | 3.70 | fair | LLNA weighted mean | TOTAL | ± 17.4 | 269 | 정성/정량 구성 |\n| 대상 화장품 | 전신노출량 | (mg/kg/day) | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) | WoE NESIL |\n| 태․분만․포육 등의 생식기능, 출생 및 이유 후 신생자의 생육)을 평가하는 시험 | 남성용 화장품 | 면도 비누, 크림 및 거품, 애프터셰이브 | 아이 섀도2 | 0.02 | - | 1.00 | 0.02 | 0.33 | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | - (OECD TG437) 소 각막 혼탁 및 투과성 시험법(Bovine Cornea Opacity | 질량 생성률(g/sec) | 해당 제품이 시간 당 분사되는 양 | (분사제 스프레이: 1, 펌프 스프레이: 0.2 적용) | NOEL – HRIPT | 물휴지 | 4.57 | 71.15 | NOEL –  HMT | LOEL | - 57 - | - 58 - | - 59 - | - 60 - | □ 예 | ■ 아니오 |\n| 향을 미칠 수 있다.  | 편 집 위 원 장 | 손 수 정 | in vivo | 피부 | 랫드 | - 25, 75, 100 ppm | - 21.4, 33.7, 51.2% | 60 (kg) | 성인 평균 체중 | 스프레이 제형 | 시험 | 방법 | EC3 values | 공익신고자 보호제도란? ",
        "original_sentence": "| DAp (%) | 평가 대상 물질의 피부흡수율 (Dermal Absorption)2 | 대상 화장품 | 전신노출량 | (mg/kg/day) | method) | 분사된 물질 중 공기 중 부유 비율3 | Human data | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) |\n| ⦁ 시험물질의 전체 회수율이 85~115% 범위에 해당 | 메이크업 리무버 | 메이크업 리무버2 | 5.00 | - | 0.1 | 0.50 | 8.33 | 류인자를 이용할 수 없는 경우 10%의 잔류지수를 적용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_116",
      "text": "| 발    행    인 | 박 윤 주 | 2-2-2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 115,
        "window_size": 3,
        "char_count": 31,
        "word_count": 10,
        "page_number": 37,
        "window_text": "| 쉽게 설명하거나 특정 민원업무에 대한 행정기관의 대외적인 | 입장을 기술하는 것입니까?  (민원인용) | 평생발암위해도(LCR) | = | SED | 비 분무형 데오도란트 | 2.33 | 36.12 | 노즐 등 제품 배출 형태 | 구강세정액 | 2.16 | 32.54 |\n| 향수 | 오드트왈렛 | BMDL10 |\n| 같은 정보가 포함된다.  | DAp (%) | 평가 대상 물질의 피부흡수율 (Dermal Absorption)2 | 대상 화장품 | 전신노출량 | (mg/kg/day) | method) | 분사된 물질 중 공기 중 부유 비율3 | Human data | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) |\n| ⦁ 시험물질의 전체 회수율이 85~115% 범위에 해당 | 메이크업 리무버 | 메이크업 리무버2 | 5.00 | - | 0.1 | 0.50 | 8.33 | 류인자를 이용할 수 없는 경우 10%의 잔류지수를 적용할 수 있다.  | 발    행    인 | 박 윤 주 | 2-2-2.  위험성 결정 ···································································································· 12 | SED = 50 × 1/109 × 3.33 mg/kg bw/day× 65/100 | = 1.1×10-7  mg/kg bw/day | 실내 높이(m) | 사용 공간 높이 | 헤어스타일링 | 0.28 | 4.0 | (mg/kg bw/day) | HT25/0.25 | (mg/kg bw/day) |\n| (클렌징 크림/오일) | 2.14 | 36.95 | 0.1 | 0.21 | 3.70 | fair | LLNA weighted mean | TOTAL | ± 17.4 | 269 | 정성/정량 구성 |\n| 대상 화장품 | 전신노출량 | (mg/kg/day) | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) | WoE NESIL |\n| 태․분만․포육 등의 생식기능, 출생 및 이유 후 신생자의 생육)을 평가하는 시험 | 남성용 화장품 | 면도 비누, 크림 및 거품, 애프터셰이브 | 아이 섀도2 | 0.02 | - | 1.00 | 0.02 | 0.33 | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | - (OECD TG437) 소 각막 혼탁 및 투과성 시험법(Bovine Cornea Opacity | 질량 생성률(g/sec) | 해당 제품이 시간 당 분사되는 양 | (분사제 스프레이: 1, 펌프 스프레이: 0.2 적용) | NOEL – HRIPT | 물휴지 | 4.57 | 71.15 | NOEL –  HMT | LOEL | - 57 - | - 58 - | - 59 - | - 60 - | □ 예 | ■ 아니오 |\n| 향을 미칠 수 있다.  | 편 집 위 원 장 | 손 수 정 | in vivo | 피부 | 랫드 | - 25, 75, 100 ppm | - 21.4, 33.7, 51.2% | 60 (kg) | 성인 평균 체중 | 스프레이 제형 | 시험 | 방법 | EC3 values | 공익신고자 보호제도란?  | 투여 | 경로 | 시험 | 대상 | 분사제 및 용제 사용 | 노출기간 |\n| ⦁ 공여자 4명으로부터 피부 표본 8개 사용 | 2-2-3. ",
        "original_sentence": "| 발    행    인 | 박 윤 주 | 2-2-2. "
      }
    },
    {
      "chunk_id": "chunk_117",
      "text": "위험성 결정 ···································································································· 12 | SED = 50 × 1/109 × 3.33 mg/kg bw/day× 65/100 | = 1.1×10-7  mg/kg bw/day | 실내 높이(m) | 사용 공간 높이 | 헤어스타일링 | 0.28 | 4.0 | (mg/kg bw/day) | HT25/0.25 | (mg/kg bw/day) |\n| (클렌징 크림/오일) | 2.14 | 36.95 | 0.1 | 0.21 | 3.70 | fair | LLNA weighted mean | TOTAL | ± 17.4 | 269 | 정성/정량 구성 |\n| 대상 화장품 | 전신노출량 | (mg/kg/day) | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) | WoE NESIL |\n| 태․분만․포육 등의 생식기능, 출생 및 이유 후 신생자의 생육)을 평가하는 시험 | 남성용 화장품 | 면도 비누, 크림 및 거품, 애프터셰이브 | 아이 섀도2 | 0.02 | - | 1.00 | 0.02 | 0.33 | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | - (OECD TG437) 소 각막 혼탁 및 투과성 시험법(Bovine Cornea Opacity | 질량 생성률(g/sec) | 해당 제품이 시간 당 분사되는 양 | (분사제 스프레이: 1, 펌프 스프레이: 0.2 적용) | NOEL – HRIPT | 물휴지 | 4.57 | 71.15 | NOEL –  HMT | LOEL | - 57 - | - 58 - | - 59 - | - 60 - | □ 예 | ■ 아니오 |\n| 향을 미칠 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 116,
        "window_size": 3,
        "char_count": 877,
        "word_count": 208,
        "page_number": 5,
        "window_text": "(민원인용) | 평생발암위해도(LCR) | = | SED | 비 분무형 데오도란트 | 2.33 | 36.12 | 노즐 등 제품 배출 형태 | 구강세정액 | 2.16 | 32.54 |\n| 향수 | 오드트왈렛 | BMDL10 |\n| 같은 정보가 포함된다.  | DAp (%) | 평가 대상 물질의 피부흡수율 (Dermal Absorption)2 | 대상 화장품 | 전신노출량 | (mg/kg/day) | method) | 분사된 물질 중 공기 중 부유 비율3 | Human data | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) |\n| ⦁ 시험물질의 전체 회수율이 85~115% 범위에 해당 | 메이크업 리무버 | 메이크업 리무버2 | 5.00 | - | 0.1 | 0.50 | 8.33 | 류인자를 이용할 수 없는 경우 10%의 잔류지수를 적용할 수 있다.  | 발    행    인 | 박 윤 주 | 2-2-2.  위험성 결정 ···································································································· 12 | SED = 50 × 1/109 × 3.33 mg/kg bw/day× 65/100 | = 1.1×10-7  mg/kg bw/day | 실내 높이(m) | 사용 공간 높이 | 헤어스타일링 | 0.28 | 4.0 | (mg/kg bw/day) | HT25/0.25 | (mg/kg bw/day) |\n| (클렌징 크림/오일) | 2.14 | 36.95 | 0.1 | 0.21 | 3.70 | fair | LLNA weighted mean | TOTAL | ± 17.4 | 269 | 정성/정량 구성 |\n| 대상 화장품 | 전신노출량 | (mg/kg/day) | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) | WoE NESIL |\n| 태․분만․포육 등의 생식기능, 출생 및 이유 후 신생자의 생육)을 평가하는 시험 | 남성용 화장품 | 면도 비누, 크림 및 거품, 애프터셰이브 | 아이 섀도2 | 0.02 | - | 1.00 | 0.02 | 0.33 | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | - (OECD TG437) 소 각막 혼탁 및 투과성 시험법(Bovine Cornea Opacity | 질량 생성률(g/sec) | 해당 제품이 시간 당 분사되는 양 | (분사제 스프레이: 1, 펌프 스프레이: 0.2 적용) | NOEL – HRIPT | 물휴지 | 4.57 | 71.15 | NOEL –  HMT | LOEL | - 57 - | - 58 - | - 59 - | - 60 - | □ 예 | ■ 아니오 |\n| 향을 미칠 수 있다.  | 편 집 위 원 장 | 손 수 정 | in vivo | 피부 | 랫드 | - 25, 75, 100 ppm | - 21.4, 33.7, 51.2% | 60 (kg) | 성인 평균 체중 | 스프레이 제형 | 시험 | 방법 | EC3 values | 공익신고자 보호제도란?  | 투여 | 경로 | 시험 | 대상 | 분사제 및 용제 사용 | 노출기간 |\n| ⦁ 공여자 4명으로부터 피부 표본 8개 사용 | 2-2-3.  노출평가 ·········································································································· 14 | (induction) | (µg/cm2) | (시간) | 투여용량 | 피부흡수율 | (induction) | (µg/cm2) | (induction) | (µg/cm2) | (µg/cm2) |\n| 기타 확인 | 아이 섀도 | 0.02 | 0.29 | 1.0 | 0.02 | 0.29 | 마스카라2 | 0.025 | - | 1.00 | 0.025 | 0.42 | 등을 위해평가 대상으로 한다. ",
        "original_sentence": "위험성 결정 ···································································································· 12 | SED = 50 × 1/109 × 3.33 mg/kg bw/day× 65/100 | = 1.1×10-7  mg/kg bw/day | 실내 높이(m) | 사용 공간 높이 | 헤어스타일링 | 0.28 | 4.0 | (mg/kg bw/day) | HT25/0.25 | (mg/kg bw/day) |\n| (클렌징 크림/오일) | 2.14 | 36.95 | 0.1 | 0.21 | 3.70 | fair | LLNA weighted mean | TOTAL | ± 17.4 | 269 | 정성/정량 구성 |\n| 대상 화장품 | 전신노출량 | (mg/kg/day) | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) | WoE NESIL |\n| 태․분만․포육 등의 생식기능, 출생 및 이유 후 신생자의 생육)을 평가하는 시험 | 남성용 화장품 | 면도 비누, 크림 및 거품, 애프터셰이브 | 아이 섀도2 | 0.02 | - | 1.00 | 0.02 | 0.33 | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | - (OECD TG437) 소 각막 혼탁 및 투과성 시험법(Bovine Cornea Opacity | 질량 생성률(g/sec) | 해당 제품이 시간 당 분사되는 양 | (분사제 스프레이: 1, 펌프 스프레이: 0.2 적용) | NOEL – HRIPT | 물휴지 | 4.57 | 71.15 | NOEL –  HMT | LOEL | - 57 - | - 58 - | - 59 - | - 60 - | □ 예 | ■ 아니오 |\n| 향을 미칠 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_118",
      "text": "| 편 집 위 원 장 | 손 수 정 | in vivo | 피부 | 랫드 | - 25, 75, 100 ppm | - 21.4, 33.7, 51.2% | 60 (kg) | 성인 평균 체중 | 스프레이 제형 | 시험 | 방법 | EC3 values | 공익신고자 보호제도란? ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 117,
        "window_size": 3,
        "char_count": 151,
        "word_count": 48,
        "page_number": 37,
        "window_text": "| DAp (%) | 평가 대상 물질의 피부흡수율 (Dermal Absorption)2 | 대상 화장품 | 전신노출량 | (mg/kg/day) | method) | 분사된 물질 중 공기 중 부유 비율3 | Human data | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) |\n| ⦁ 시험물질의 전체 회수율이 85~115% 범위에 해당 | 메이크업 리무버 | 메이크업 리무버2 | 5.00 | - | 0.1 | 0.50 | 8.33 | 류인자를 이용할 수 없는 경우 10%의 잔류지수를 적용할 수 있다.  | 발    행    인 | 박 윤 주 | 2-2-2.  위험성 결정 ···································································································· 12 | SED = 50 × 1/109 × 3.33 mg/kg bw/day× 65/100 | = 1.1×10-7  mg/kg bw/day | 실내 높이(m) | 사용 공간 높이 | 헤어스타일링 | 0.28 | 4.0 | (mg/kg bw/day) | HT25/0.25 | (mg/kg bw/day) |\n| (클렌징 크림/오일) | 2.14 | 36.95 | 0.1 | 0.21 | 3.70 | fair | LLNA weighted mean | TOTAL | ± 17.4 | 269 | 정성/정량 구성 |\n| 대상 화장품 | 전신노출량 | (mg/kg/day) | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) | WoE NESIL |\n| 태․분만․포육 등의 생식기능, 출생 및 이유 후 신생자의 생육)을 평가하는 시험 | 남성용 화장품 | 면도 비누, 크림 및 거품, 애프터셰이브 | 아이 섀도2 | 0.02 | - | 1.00 | 0.02 | 0.33 | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | - (OECD TG437) 소 각막 혼탁 및 투과성 시험법(Bovine Cornea Opacity | 질량 생성률(g/sec) | 해당 제품이 시간 당 분사되는 양 | (분사제 스프레이: 1, 펌프 스프레이: 0.2 적용) | NOEL – HRIPT | 물휴지 | 4.57 | 71.15 | NOEL –  HMT | LOEL | - 57 - | - 58 - | - 59 - | - 60 - | □ 예 | ■ 아니오 |\n| 향을 미칠 수 있다.  | 편 집 위 원 장 | 손 수 정 | in vivo | 피부 | 랫드 | - 25, 75, 100 ppm | - 21.4, 33.7, 51.2% | 60 (kg) | 성인 평균 체중 | 스프레이 제형 | 시험 | 방법 | EC3 values | 공익신고자 보호제도란?  | 투여 | 경로 | 시험 | 대상 | 분사제 및 용제 사용 | 노출기간 |\n| ⦁ 공여자 4명으로부터 피부 표본 8개 사용 | 2-2-3.  노출평가 ·········································································································· 14 | (induction) | (µg/cm2) | (시간) | 투여용량 | 피부흡수율 | (induction) | (µg/cm2) | (induction) | (µg/cm2) | (µg/cm2) |\n| 기타 확인 | 아이 섀도 | 0.02 | 0.29 | 1.0 | 0.02 | 0.29 | 마스카라2 | 0.025 | - | 1.00 | 0.025 | 0.42 | 등을 위해평가 대상으로 한다.  | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)4 | 대표 유형 화장품 | 0.0021 | 10 | 4762 | (㎍/cm2) | 민원인을 구속하는 내용이 있습니까? ",
        "original_sentence": "| 편 집 위 원 장 | 손 수 정 | in vivo | 피부 | 랫드 | - 25, 75, 100 ppm | - 21.4, 33.7, 51.2% | 60 (kg) | 성인 평균 체중 | 스프레이 제형 | 시험 | 방법 | EC3 values | 공익신고자 보호제도란? "
      }
    },
    {
      "chunk_id": "chunk_119",
      "text": "| 투여 | 경로 | 시험 | 대상 | 분사제 및 용제 사용 | 노출기간 |\n| ⦁ 공여자 4명으로부터 피부 표본 8개 사용 | 2-2-3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 118,
        "window_size": 3,
        "char_count": 79,
        "word_count": 26,
        "page_number": 47,
        "window_text": "| 발    행    인 | 박 윤 주 | 2-2-2.  위험성 결정 ···································································································· 12 | SED = 50 × 1/109 × 3.33 mg/kg bw/day× 65/100 | = 1.1×10-7  mg/kg bw/day | 실내 높이(m) | 사용 공간 높이 | 헤어스타일링 | 0.28 | 4.0 | (mg/kg bw/day) | HT25/0.25 | (mg/kg bw/day) |\n| (클렌징 크림/오일) | 2.14 | 36.95 | 0.1 | 0.21 | 3.70 | fair | LLNA weighted mean | TOTAL | ± 17.4 | 269 | 정성/정량 구성 |\n| 대상 화장품 | 전신노출량 | (mg/kg/day) | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) | WoE NESIL |\n| 태․분만․포육 등의 생식기능, 출생 및 이유 후 신생자의 생육)을 평가하는 시험 | 남성용 화장품 | 면도 비누, 크림 및 거품, 애프터셰이브 | 아이 섀도2 | 0.02 | - | 1.00 | 0.02 | 0.33 | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | - (OECD TG437) 소 각막 혼탁 및 투과성 시험법(Bovine Cornea Opacity | 질량 생성률(g/sec) | 해당 제품이 시간 당 분사되는 양 | (분사제 스프레이: 1, 펌프 스프레이: 0.2 적용) | NOEL – HRIPT | 물휴지 | 4.57 | 71.15 | NOEL –  HMT | LOEL | - 57 - | - 58 - | - 59 - | - 60 - | □ 예 | ■ 아니오 |\n| 향을 미칠 수 있다.  | 편 집 위 원 장 | 손 수 정 | in vivo | 피부 | 랫드 | - 25, 75, 100 ppm | - 21.4, 33.7, 51.2% | 60 (kg) | 성인 평균 체중 | 스프레이 제형 | 시험 | 방법 | EC3 values | 공익신고자 보호제도란?  | 투여 | 경로 | 시험 | 대상 | 분사제 및 용제 사용 | 노출기간 |\n| ⦁ 공여자 4명으로부터 피부 표본 8개 사용 | 2-2-3.  노출평가 ·········································································································· 14 | (induction) | (µg/cm2) | (시간) | 투여용량 | 피부흡수율 | (induction) | (µg/cm2) | (induction) | (µg/cm2) | (µg/cm2) |\n| 기타 확인 | 아이 섀도 | 0.02 | 0.29 | 1.0 | 0.02 | 0.29 | 마스카라2 | 0.025 | - | 1.00 | 0.025 | 0.42 | 등을 위해평가 대상으로 한다.  | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)4 | 대표 유형 화장품 | 0.0021 | 10 | 4762 | (㎍/cm2) | 민원인을 구속하는 내용이 있습니까?  | Permeability (BCOP) test method) | 부유 비율 | 분사 후 비휘발성 물질이 공기 중으로 | 부유되는 비율 | T25 |\n| 자외선 차단용 | 크림, 로션, 오일 | 일일 노출을 보정할 수 있다. ",
        "original_sentence": "| 투여 | 경로 | 시험 | 대상 | 분사제 및 용제 사용 | 노출기간 |\n| ⦁ 공여자 4명으로부터 피부 표본 8개 사용 | 2-2-3. "
      }
    },
    {
      "chunk_id": "chunk_120",
      "text": "노출평가 ·········································································································· 14 | (induction) | (µg/cm2) | (시간) | 투여용량 | 피부흡수율 | (induction) | (µg/cm2) | (induction) | (µg/cm2) | (µg/cm2) |\n| 기타 확인 | 아이 섀도 | 0.02 | 0.29 | 1.0 | 0.02 | 0.29 | 마스카라2 | 0.025 | - | 1.00 | 0.025 | 0.42 | 등을 위해평가 대상으로 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 119,
        "window_size": 3,
        "char_count": 336,
        "word_count": 57,
        "page_number": 5,
        "window_text": "위험성 결정 ···································································································· 12 | SED = 50 × 1/109 × 3.33 mg/kg bw/day× 65/100 | = 1.1×10-7  mg/kg bw/day | 실내 높이(m) | 사용 공간 높이 | 헤어스타일링 | 0.28 | 4.0 | (mg/kg bw/day) | HT25/0.25 | (mg/kg bw/day) |\n| (클렌징 크림/오일) | 2.14 | 36.95 | 0.1 | 0.21 | 3.70 | fair | LLNA weighted mean | TOTAL | ± 17.4 | 269 | 정성/정량 구성 |\n| 대상 화장품 | 전신노출량 | (mg/kg/day) | 독성기준값 | (mg/kg/day) | 안전역 | (MOS) | WoE NESIL |\n| 태․분만․포육 등의 생식기능, 출생 및 이유 후 신생자의 생육)을 평가하는 시험 | 남성용 화장품 | 면도 비누, 크림 및 거품, 애프터셰이브 | 아이 섀도2 | 0.02 | - | 1.00 | 0.02 | 0.33 | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | - (OECD TG437) 소 각막 혼탁 및 투과성 시험법(Bovine Cornea Opacity | 질량 생성률(g/sec) | 해당 제품이 시간 당 분사되는 양 | (분사제 스프레이: 1, 펌프 스프레이: 0.2 적용) | NOEL – HRIPT | 물휴지 | 4.57 | 71.15 | NOEL –  HMT | LOEL | - 57 - | - 58 - | - 59 - | - 60 - | □ 예 | ■ 아니오 |\n| 향을 미칠 수 있다.  | 편 집 위 원 장 | 손 수 정 | in vivo | 피부 | 랫드 | - 25, 75, 100 ppm | - 21.4, 33.7, 51.2% | 60 (kg) | 성인 평균 체중 | 스프레이 제형 | 시험 | 방법 | EC3 values | 공익신고자 보호제도란?  | 투여 | 경로 | 시험 | 대상 | 분사제 및 용제 사용 | 노출기간 |\n| ⦁ 공여자 4명으로부터 피부 표본 8개 사용 | 2-2-3.  노출평가 ·········································································································· 14 | (induction) | (µg/cm2) | (시간) | 투여용량 | 피부흡수율 | (induction) | (µg/cm2) | (induction) | (µg/cm2) | (µg/cm2) |\n| 기타 확인 | 아이 섀도 | 0.02 | 0.29 | 1.0 | 0.02 | 0.29 | 마스카라2 | 0.025 | - | 1.00 | 0.025 | 0.42 | 등을 위해평가 대상으로 한다.  | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)4 | 대표 유형 화장품 | 0.0021 | 10 | 4762 | (㎍/cm2) | 민원인을 구속하는 내용이 있습니까?  | Permeability (BCOP) test method) | 부유 비율 | 분사 후 비휘발성 물질이 공기 중으로 | 부유되는 비율 | T25 |\n| 자외선 차단용 | 크림, 로션, 오일 | 일일 노출을 보정할 수 있다.  | 리퀴드 파운데이션 | 0.30 | 5.28 | 분사 방식(예: 거품, 무스, 미세 분사 등) |\n| 동태학 | HT25 | = | 동역학 | 동태학 | 동역학 |\n| SCCS/1628/21, 2021). ",
        "original_sentence": "노출평가 ·········································································································· 14 | (induction) | (µg/cm2) | (시간) | 투여용량 | 피부흡수율 | (induction) | (µg/cm2) | (induction) | (µg/cm2) | (µg/cm2) |\n| 기타 확인 | 아이 섀도 | 0.02 | 0.29 | 1.0 | 0.02 | 0.29 | 마스카라2 | 0.025 | - | 1.00 | 0.025 | 0.42 | 등을 위해평가 대상으로 한다. "
      }
    },
    {
      "chunk_id": "chunk_121",
      "text": "| IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)4 | 대표 유형 화장품 | 0.0021 | 10 | 4762 | (㎍/cm2) | 민원인을 구속하는 내용이 있습니까? ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 120,
        "window_size": 3,
        "char_count": 103,
        "word_count": 25,
        "page_number": 42,
        "window_text": "| 편 집 위 원 장 | 손 수 정 | in vivo | 피부 | 랫드 | - 25, 75, 100 ppm | - 21.4, 33.7, 51.2% | 60 (kg) | 성인 평균 체중 | 스프레이 제형 | 시험 | 방법 | EC3 values | 공익신고자 보호제도란?  | 투여 | 경로 | 시험 | 대상 | 분사제 및 용제 사용 | 노출기간 |\n| ⦁ 공여자 4명으로부터 피부 표본 8개 사용 | 2-2-3.  노출평가 ·········································································································· 14 | (induction) | (µg/cm2) | (시간) | 투여용량 | 피부흡수율 | (induction) | (µg/cm2) | (induction) | (µg/cm2) | (µg/cm2) |\n| 기타 확인 | 아이 섀도 | 0.02 | 0.29 | 1.0 | 0.02 | 0.29 | 마스카라2 | 0.025 | - | 1.00 | 0.025 | 0.42 | 등을 위해평가 대상으로 한다.  | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)4 | 대표 유형 화장품 | 0.0021 | 10 | 4762 | (㎍/cm2) | 민원인을 구속하는 내용이 있습니까?  | Permeability (BCOP) test method) | 부유 비율 | 분사 후 비휘발성 물질이 공기 중으로 | 부유되는 비율 | T25 |\n| 자외선 차단용 | 크림, 로션, 오일 | 일일 노출을 보정할 수 있다.  | 리퀴드 파운데이션 | 0.30 | 5.28 | 분사 방식(예: 거품, 무스, 미세 분사 등) |\n| 동태학 | HT25 | = | 동역학 | 동태학 | 동역학 |\n| SCCS/1628/21, 2021).  | 마스카라 | 0.03 | 0.50 | 1.0 | 0.03 | 0.50 | 편  집  위  원 | 송영미, 김도정, 윤해석, 박은재, 지정은, 심지은, 한지혜, 고미선 | 1 화장품 유형에 따른 1일 사용량(붙임 5 참조) | 자외선 차단제 | 0.5525 | 450 | 814 | 그림 1. ",
        "original_sentence": "| IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)4 | 대표 유형 화장품 | 0.0021 | 10 | 4762 | (㎍/cm2) | 민원인을 구속하는 내용이 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_122",
      "text": "| Permeability (BCOP) test method) | 부유 비율 | 분사 후 비휘발성 물질이 공기 중으로 | 부유되는 비율 | T25 |\n| 자외선 차단용 | 크림, 로션, 오일 | 일일 노출을 보정할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 121,
        "window_size": 3,
        "char_count": 126,
        "word_count": 34,
        "page_number": 39,
        "window_text": "| 투여 | 경로 | 시험 | 대상 | 분사제 및 용제 사용 | 노출기간 |\n| ⦁ 공여자 4명으로부터 피부 표본 8개 사용 | 2-2-3.  노출평가 ·········································································································· 14 | (induction) | (µg/cm2) | (시간) | 투여용량 | 피부흡수율 | (induction) | (µg/cm2) | (induction) | (µg/cm2) | (µg/cm2) |\n| 기타 확인 | 아이 섀도 | 0.02 | 0.29 | 1.0 | 0.02 | 0.29 | 마스카라2 | 0.025 | - | 1.00 | 0.025 | 0.42 | 등을 위해평가 대상으로 한다.  | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)4 | 대표 유형 화장품 | 0.0021 | 10 | 4762 | (㎍/cm2) | 민원인을 구속하는 내용이 있습니까?  | Permeability (BCOP) test method) | 부유 비율 | 분사 후 비휘발성 물질이 공기 중으로 | 부유되는 비율 | T25 |\n| 자외선 차단용 | 크림, 로션, 오일 | 일일 노출을 보정할 수 있다.  | 리퀴드 파운데이션 | 0.30 | 5.28 | 분사 방식(예: 거품, 무스, 미세 분사 등) |\n| 동태학 | HT25 | = | 동역학 | 동태학 | 동역학 |\n| SCCS/1628/21, 2021).  | 마스카라 | 0.03 | 0.50 | 1.0 | 0.03 | 0.50 | 편  집  위  원 | 송영미, 김도정, 윤해석, 박은재, 지정은, 심지은, 한지혜, 고미선 | 1 화장품 유형에 따른 1일 사용량(붙임 5 참조) | 자외선 차단제 | 0.5525 | 450 | 814 | 그림 1.  화장품 성분(의도적 사용물질)의 위해성평가 흐름도 | 스프레이 | (사람체중/동물체중)0.25 |\n| 아이라이너2 | 0.005 | - | 1.00 | 0.005 | 0.08 | V1 (L) | Box 1(호흡영역 근처)의 공간부피(분사제/펌프 스프레이: 1000 적용)6 | 사항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서 | - (OECD TG438) 닭의 안구를 이용한 안점막 시험법(Isolated chicken | - 에멀젼 : 0.7±0.3% |\n\n**[표 끝]**\n\n<!-- PAGE_2 -->\n###### 선적으로 고려하시기 바랍니다. ",
        "original_sentence": "| Permeability (BCOP) test method) | 부유 비율 | 분사 후 비휘발성 물질이 공기 중으로 | 부유되는 비율 | T25 |\n| 자외선 차단용 | 크림, 로션, 오일 | 일일 노출을 보정할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_123",
      "text": "| 리퀴드 파운데이션 | 0.30 | 5.28 | 분사 방식(예: 거품, 무스, 미세 분사 등) |\n| 동태학 | HT25 | = | 동역학 | 동태학 | 동역학 |\n| SCCS/1628/21, 2021). ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 122,
        "window_size": 3,
        "char_count": 116,
        "word_count": 32,
        "page_number": 41,
        "window_text": "노출평가 ·········································································································· 14 | (induction) | (µg/cm2) | (시간) | 투여용량 | 피부흡수율 | (induction) | (µg/cm2) | (induction) | (µg/cm2) | (µg/cm2) |\n| 기타 확인 | 아이 섀도 | 0.02 | 0.29 | 1.0 | 0.02 | 0.29 | 마스카라2 | 0.025 | - | 1.00 | 0.025 | 0.42 | 등을 위해평가 대상으로 한다.  | IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)4 | 대표 유형 화장품 | 0.0021 | 10 | 4762 | (㎍/cm2) | 민원인을 구속하는 내용이 있습니까?  | Permeability (BCOP) test method) | 부유 비율 | 분사 후 비휘발성 물질이 공기 중으로 | 부유되는 비율 | T25 |\n| 자외선 차단용 | 크림, 로션, 오일 | 일일 노출을 보정할 수 있다.  | 리퀴드 파운데이션 | 0.30 | 5.28 | 분사 방식(예: 거품, 무스, 미세 분사 등) |\n| 동태학 | HT25 | = | 동역학 | 동태학 | 동역학 |\n| SCCS/1628/21, 2021).  | 마스카라 | 0.03 | 0.50 | 1.0 | 0.03 | 0.50 | 편  집  위  원 | 송영미, 김도정, 윤해석, 박은재, 지정은, 심지은, 한지혜, 고미선 | 1 화장품 유형에 따른 1일 사용량(붙임 5 참조) | 자외선 차단제 | 0.5525 | 450 | 814 | 그림 1.  화장품 성분(의도적 사용물질)의 위해성평가 흐름도 | 스프레이 | (사람체중/동물체중)0.25 |\n| 아이라이너2 | 0.005 | - | 1.00 | 0.005 | 0.08 | V1 (L) | Box 1(호흡영역 근처)의 공간부피(분사제/펌프 스프레이: 1000 적용)6 | 사항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서 | - (OECD TG438) 닭의 안구를 이용한 안점막 시험법(Isolated chicken | - 에멀젼 : 0.7±0.3% |\n\n**[표 끝]**\n\n<!-- PAGE_2 -->\n###### 선적으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의\n\n<!-- PAGE_2 -->\n###### 제정이 필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n",
        "original_sentence": "| 리퀴드 파운데이션 | 0.30 | 5.28 | 분사 방식(예: 거품, 무스, 미세 분사 등) |\n| 동태학 | HT25 | = | 동역학 | 동태학 | 동역학 |\n| SCCS/1628/21, 2021). "
      }
    },
    {
      "chunk_id": "chunk_124",
      "text": "| 마스카라 | 0.03 | 0.50 | 1.0 | 0.03 | 0.50 | 편  집  위  원 | 송영미, 김도정, 윤해석, 박은재, 지정은, 심지은, 한지혜, 고미선 | 1 화장품 유형에 따른 1일 사용량(붙임 5 참조) | 자외선 차단제 | 0.5525 | 450 | 814 | 그림 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 123,
        "window_size": 3,
        "char_count": 165,
        "word_count": 47,
        "page_number": 41,
        "window_text": "| IR (m3/min) | 호흡률(한국인 호흡률 0.01 적용)4 | 대표 유형 화장품 | 0.0021 | 10 | 4762 | (㎍/cm2) | 민원인을 구속하는 내용이 있습니까?  | Permeability (BCOP) test method) | 부유 비율 | 분사 후 비휘발성 물질이 공기 중으로 | 부유되는 비율 | T25 |\n| 자외선 차단용 | 크림, 로션, 오일 | 일일 노출을 보정할 수 있다.  | 리퀴드 파운데이션 | 0.30 | 5.28 | 분사 방식(예: 거품, 무스, 미세 분사 등) |\n| 동태학 | HT25 | = | 동역학 | 동태학 | 동역학 |\n| SCCS/1628/21, 2021).  | 마스카라 | 0.03 | 0.50 | 1.0 | 0.03 | 0.50 | 편  집  위  원 | 송영미, 김도정, 윤해석, 박은재, 지정은, 심지은, 한지혜, 고미선 | 1 화장품 유형에 따른 1일 사용량(붙임 5 참조) | 자외선 차단제 | 0.5525 | 450 | 814 | 그림 1.  화장품 성분(의도적 사용물질)의 위해성평가 흐름도 | 스프레이 | (사람체중/동물체중)0.25 |\n| 아이라이너2 | 0.005 | - | 1.00 | 0.005 | 0.08 | V1 (L) | Box 1(호흡영역 근처)의 공간부피(분사제/펌프 스프레이: 1000 적용)6 | 사항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서 | - (OECD TG438) 닭의 안구를 이용한 안점막 시험법(Isolated chicken | - 에멀젼 : 0.7±0.3% |\n\n**[표 끝]**\n\n<!-- PAGE_2 -->\n###### 선적으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의\n\n<!-- PAGE_2 -->\n###### 제정이 필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 지침서ㆍ안내\n\n<!-- PAGE_2 -->\n###### ㆍ안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n",
        "original_sentence": "| 마스카라 | 0.03 | 0.50 | 1.0 | 0.03 | 0.50 | 편  집  위  원 | 송영미, 김도정, 윤해석, 박은재, 지정은, 심지은, 한지혜, 고미선 | 1 화장품 유형에 따른 1일 사용량(붙임 5 참조) | 자외선 차단제 | 0.5525 | 450 | 814 | 그림 1. "
      }
    },
    {
      "chunk_id": "chunk_125",
      "text": "화장품 성분(의도적 사용물질)의 위해성평가 흐름도 | 스프레이 | (사람체중/동물체중)0.25 |\n| 아이라이너2 | 0.005 | - | 1.00 | 0.005 | 0.08 | V1 (L) | Box 1(호흡영역 근처)의 공간부피(분사제/펌프 스프레이: 1000 적용)6 | 사항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서 | - (OECD TG438) 닭의 안구를 이용한 안점막 시험법(Isolated chicken | - 에멀젼 : 0.7±0.3% |\n\n**[표 끝]**\n\n<!-- PAGE_2 -->\n###### 선적으로 고려하시기 바랍니다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 124,
        "window_size": 3,
        "char_count": 330,
        "word_count": 72,
        "page_number": 2,
        "window_text": "| Permeability (BCOP) test method) | 부유 비율 | 분사 후 비휘발성 물질이 공기 중으로 | 부유되는 비율 | T25 |\n| 자외선 차단용 | 크림, 로션, 오일 | 일일 노출을 보정할 수 있다.  | 리퀴드 파운데이션 | 0.30 | 5.28 | 분사 방식(예: 거품, 무스, 미세 분사 등) |\n| 동태학 | HT25 | = | 동역학 | 동태학 | 동역학 |\n| SCCS/1628/21, 2021).  | 마스카라 | 0.03 | 0.50 | 1.0 | 0.03 | 0.50 | 편  집  위  원 | 송영미, 김도정, 윤해석, 박은재, 지정은, 심지은, 한지혜, 고미선 | 1 화장품 유형에 따른 1일 사용량(붙임 5 참조) | 자외선 차단제 | 0.5525 | 450 | 814 | 그림 1.  화장품 성분(의도적 사용물질)의 위해성평가 흐름도 | 스프레이 | (사람체중/동물체중)0.25 |\n| 아이라이너2 | 0.005 | - | 1.00 | 0.005 | 0.08 | V1 (L) | Box 1(호흡영역 근처)의 공간부피(분사제/펌프 스프레이: 1000 적용)6 | 사항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서 | - (OECD TG438) 닭의 안구를 이용한 안점막 시험법(Isolated chicken | - 에멀젼 : 0.7±0.3% |\n\n**[표 끝]**\n\n<!-- PAGE_2 -->\n###### 선적으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의\n\n<!-- PAGE_2 -->\n###### 제정이 필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 지침서ㆍ안내\n\n<!-- PAGE_2 -->\n###### ㆍ안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 상기 사항에 대하여 확인하였음.\n\n",
        "original_sentence": "화장품 성분(의도적 사용물질)의 위해성평가 흐름도 | 스프레이 | (사람체중/동물체중)0.25 |\n| 아이라이너2 | 0.005 | - | 1.00 | 0.005 | 0.08 | V1 (L) | Box 1(호흡영역 근처)의 공간부피(분사제/펌프 스프레이: 1000 적용)6 | 사항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서 | - (OECD TG438) 닭의 안구를 이용한 안점막 시험법(Isolated chicken | - 에멀젼 : 0.7±0.3% |\n\n**[표 끝]**\n\n<!-- PAGE_2 -->\n###### 선적으로 고려하시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_126",
      "text": "그럼에도 불구하고 동 지침서ㆍ안내서의\n\n<!-- PAGE_2 -->\n###### 제정이 필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 125,
        "window_size": 3,
        "char_count": 81,
        "word_count": 17,
        "page_number": 2,
        "window_text": "| 리퀴드 파운데이션 | 0.30 | 5.28 | 분사 방식(예: 거품, 무스, 미세 분사 등) |\n| 동태학 | HT25 | = | 동역학 | 동태학 | 동역학 |\n| SCCS/1628/21, 2021).  | 마스카라 | 0.03 | 0.50 | 1.0 | 0.03 | 0.50 | 편  집  위  원 | 송영미, 김도정, 윤해석, 박은재, 지정은, 심지은, 한지혜, 고미선 | 1 화장품 유형에 따른 1일 사용량(붙임 5 참조) | 자외선 차단제 | 0.5525 | 450 | 814 | 그림 1.  화장품 성분(의도적 사용물질)의 위해성평가 흐름도 | 스프레이 | (사람체중/동물체중)0.25 |\n| 아이라이너2 | 0.005 | - | 1.00 | 0.005 | 0.08 | V1 (L) | Box 1(호흡영역 근처)의 공간부피(분사제/펌프 스프레이: 1000 적용)6 | 사항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서 | - (OECD TG438) 닭의 안구를 이용한 안점막 시험법(Isolated chicken | - 에멀젼 : 0.7±0.3% |\n\n**[표 끝]**\n\n<!-- PAGE_2 -->\n###### 선적으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의\n\n<!-- PAGE_2 -->\n###### 제정이 필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 지침서ㆍ안내\n\n<!-- PAGE_2 -->\n###### ㆍ안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_2 -->\n###### 2023년 11월\n\n<!-- PAGE_2 -->\n###### 담당자\n\n<!-- PAGE_2 -->\n###### 확  인(부서장)\n\n<!-- PAGE_2 -->\n###### 박은재\n\n<!-- PAGE_2 -->\n###### 송영미\n\n<!-- PAGE_3 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n###### 이 안내서는 화장품 위해평가에 대하여 알기 쉽게 설명하거나 식품의약\n\n<!-- PAGE_3 -->\n###### 품안전처의 입장을 기술한 것입니다.\n\n",
        "original_sentence": "그럼에도 불구하고 동 지침서ㆍ안내서의\n\n<!-- PAGE_2 -->\n###### 제정이 필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_127",
      "text": "<!-- PAGE_2 -->\n###### 지침서ㆍ안내\n\n<!-- PAGE_2 -->\n###### ㆍ안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 126,
        "window_size": 3,
        "char_count": 81,
        "word_count": 14,
        "page_number": 2,
        "window_text": "| 마스카라 | 0.03 | 0.50 | 1.0 | 0.03 | 0.50 | 편  집  위  원 | 송영미, 김도정, 윤해석, 박은재, 지정은, 심지은, 한지혜, 고미선 | 1 화장품 유형에 따른 1일 사용량(붙임 5 참조) | 자외선 차단제 | 0.5525 | 450 | 814 | 그림 1.  화장품 성분(의도적 사용물질)의 위해성평가 흐름도 | 스프레이 | (사람체중/동물체중)0.25 |\n| 아이라이너2 | 0.005 | - | 1.00 | 0.005 | 0.08 | V1 (L) | Box 1(호흡영역 근처)의 공간부피(분사제/펌프 스프레이: 1000 적용)6 | 사항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서 | - (OECD TG438) 닭의 안구를 이용한 안점막 시험법(Isolated chicken | - 에멀젼 : 0.7±0.3% |\n\n**[표 끝]**\n\n<!-- PAGE_2 -->\n###### 선적으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의\n\n<!-- PAGE_2 -->\n###### 제정이 필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 지침서ㆍ안내\n\n<!-- PAGE_2 -->\n###### ㆍ안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_2 -->\n###### 2023년 11월\n\n<!-- PAGE_2 -->\n###### 담당자\n\n<!-- PAGE_2 -->\n###### 확  인(부서장)\n\n<!-- PAGE_2 -->\n###### 박은재\n\n<!-- PAGE_2 -->\n###### 송영미\n\n<!-- PAGE_3 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n###### 이 안내서는 화장품 위해평가에 대하여 알기 쉽게 설명하거나 식품의약\n\n<!-- PAGE_3 -->\n###### 품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_3 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_3 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 참고로만 활용하시기 바랍니다. ",
        "original_sentence": "<!-- PAGE_2 -->\n###### 지침서ㆍ안내\n\n<!-- PAGE_2 -->\n###### ㆍ안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_128",
      "text": "<!-- PAGE_2 -->\n###### 상기 사항에 대하여 확인하였음.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 127,
        "window_size": 3,
        "char_count": 42,
        "word_count": 8,
        "page_number": 2,
        "window_text": "화장품 성분(의도적 사용물질)의 위해성평가 흐름도 | 스프레이 | (사람체중/동물체중)0.25 |\n| 아이라이너2 | 0.005 | - | 1.00 | 0.005 | 0.08 | V1 (L) | Box 1(호흡영역 근처)의 공간부피(분사제/펌프 스프레이: 1000 적용)6 | 사항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서 | - (OECD TG438) 닭의 안구를 이용한 안점막 시험법(Isolated chicken | - 에멀젼 : 0.7±0.3% |\n\n**[표 끝]**\n\n<!-- PAGE_2 -->\n###### 선적으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의\n\n<!-- PAGE_2 -->\n###### 제정이 필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 지침서ㆍ안내\n\n<!-- PAGE_2 -->\n###### ㆍ안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_2 -->\n###### 2023년 11월\n\n<!-- PAGE_2 -->\n###### 담당자\n\n<!-- PAGE_2 -->\n###### 확  인(부서장)\n\n<!-- PAGE_2 -->\n###### 박은재\n\n<!-- PAGE_2 -->\n###### 송영미\n\n<!-- PAGE_3 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n###### 이 안내서는 화장품 위해평가에 대하여 알기 쉽게 설명하거나 식품의약\n\n<!-- PAGE_3 -->\n###### 품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_3 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_3 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 참고로만 활용하시기 바랍니다.  또한,\n\n<!-- PAGE_3 -->\n###### 본 안내서는 2023년 11월 현재의 과학적ㆍ기술적 사실 및 유효한 법규를\n\n<!-- PAGE_3 -->\n###### 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_3 -->\n###### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n",
        "original_sentence": "<!-- PAGE_2 -->\n###### 상기 사항에 대하여 확인하였음.\n\n"
      }
    },
    {
      "chunk_id": "chunk_129",
      "text": "<!-- PAGE_2 -->\n###### 2023년 11월\n\n<!-- PAGE_2 -->\n###### 담당자\n\n<!-- PAGE_2 -->\n###### 확  인(부서장)\n\n<!-- PAGE_2 -->\n###### 박은재\n\n<!-- PAGE_2 -->\n###### 송영미\n\n<!-- PAGE_3 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n###### 이 안내서는 화장품 위해평가에 대하여 알기 쉽게 설명하거나 식품의약\n\n<!-- PAGE_3 -->\n###### 품안전처의 입장을 기술한 것입니다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 128,
        "window_size": 3,
        "char_count": 329,
        "word_count": 62,
        "page_number": 2,
        "window_text": "그럼에도 불구하고 동 지침서ㆍ안내서의\n\n<!-- PAGE_2 -->\n###### 제정이 필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 지침서ㆍ안내\n\n<!-- PAGE_2 -->\n###### ㆍ안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_2 -->\n###### 2023년 11월\n\n<!-- PAGE_2 -->\n###### 담당자\n\n<!-- PAGE_2 -->\n###### 확  인(부서장)\n\n<!-- PAGE_2 -->\n###### 박은재\n\n<!-- PAGE_2 -->\n###### 송영미\n\n<!-- PAGE_3 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n###### 이 안내서는 화장품 위해평가에 대하여 알기 쉽게 설명하거나 식품의약\n\n<!-- PAGE_3 -->\n###### 품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_3 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_3 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 참고로만 활용하시기 바랍니다.  또한,\n\n<!-- PAGE_3 -->\n###### 본 안내서는 2023년 11월 현재의 과학적ㆍ기술적 사실 및 유효한 법규를\n\n<!-- PAGE_3 -->\n###### 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_3 -->\n###### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_3 -->\n###### ※ “민원인 안내서”란 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기\n\n<!-- PAGE_4 -->\n#### 개정 이력서\n\n목차\n\n<!-- PAGE_5 -->\n###### 제1장 화장품 위해평가 가이드라인의 목적 ························································· 1\n\n<!-- PAGE_5 -->\n###### 1. ",
        "original_sentence": "<!-- PAGE_2 -->\n###### 2023년 11월\n\n<!-- PAGE_2 -->\n###### 담당자\n\n<!-- PAGE_2 -->\n###### 확  인(부서장)\n\n<!-- PAGE_2 -->\n###### 박은재\n\n<!-- PAGE_2 -->\n###### 송영미\n\n<!-- PAGE_3 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n###### 이 안내서는 화장품 위해평가에 대하여 알기 쉽게 설명하거나 식품의약\n\n<!-- PAGE_3 -->\n###### 품안전처의 입장을 기술한 것입니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_130",
      "text": "<!-- PAGE_3 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_3 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 참고로만 활용하시기 바랍니다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 129,
        "window_size": 3,
        "char_count": 126,
        "word_count": 25,
        "page_number": 3,
        "window_text": "<!-- PAGE_2 -->\n###### 지침서ㆍ안내\n\n<!-- PAGE_2 -->\n###### ㆍ안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_2 -->\n###### 2023년 11월\n\n<!-- PAGE_2 -->\n###### 담당자\n\n<!-- PAGE_2 -->\n###### 확  인(부서장)\n\n<!-- PAGE_2 -->\n###### 박은재\n\n<!-- PAGE_2 -->\n###### 송영미\n\n<!-- PAGE_3 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n###### 이 안내서는 화장품 위해평가에 대하여 알기 쉽게 설명하거나 식품의약\n\n<!-- PAGE_3 -->\n###### 품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_3 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_3 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 참고로만 활용하시기 바랍니다.  또한,\n\n<!-- PAGE_3 -->\n###### 본 안내서는 2023년 11월 현재의 과학적ㆍ기술적 사실 및 유효한 법규를\n\n<!-- PAGE_3 -->\n###### 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_3 -->\n###### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_3 -->\n###### ※ “민원인 안내서”란 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기\n\n<!-- PAGE_4 -->\n#### 개정 이력서\n\n목차\n\n<!-- PAGE_5 -->\n###### 제1장 화장품 위해평가 가이드라인의 목적 ························································· 1\n\n<!-- PAGE_5 -->\n###### 1.  목적 ·································································································································· 1\n\n<!-- PAGE_5 -->\n###### 2. ",
        "original_sentence": "<!-- PAGE_3 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_3 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 참고로만 활용하시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_131",
      "text": "또한,\n\n<!-- PAGE_3 -->\n###### 본 안내서는 2023년 11월 현재의 과학적ㆍ기술적 사실 및 유효한 법규를\n\n<!-- PAGE_3 -->\n###### 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_3 -->\n###### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 130,
        "window_size": 3,
        "char_count": 185,
        "word_count": 40,
        "page_number": 3,
        "window_text": "<!-- PAGE_2 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_2 -->\n###### 2023년 11월\n\n<!-- PAGE_2 -->\n###### 담당자\n\n<!-- PAGE_2 -->\n###### 확  인(부서장)\n\n<!-- PAGE_2 -->\n###### 박은재\n\n<!-- PAGE_2 -->\n###### 송영미\n\n<!-- PAGE_3 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n###### 이 안내서는 화장품 위해평가에 대하여 알기 쉽게 설명하거나 식품의약\n\n<!-- PAGE_3 -->\n###### 품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_3 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_3 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 참고로만 활용하시기 바랍니다.  또한,\n\n<!-- PAGE_3 -->\n###### 본 안내서는 2023년 11월 현재의 과학적ㆍ기술적 사실 및 유효한 법규를\n\n<!-- PAGE_3 -->\n###### 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_3 -->\n###### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_3 -->\n###### ※ “민원인 안내서”란 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기\n\n<!-- PAGE_4 -->\n#### 개정 이력서\n\n목차\n\n<!-- PAGE_5 -->\n###### 제1장 화장품 위해평가 가이드라인의 목적 ························································· 1\n\n<!-- PAGE_5 -->\n###### 1.  목적 ·································································································································· 1\n\n<!-- PAGE_5 -->\n###### 2.  관련 규정 ························································································································ 2\n\n<!-- PAGE_5 -->\n###### 제2장 화장품 안전의 일반사항 ··············································································· 4\n\n<!-- PAGE_5 -->\n###### 1. ",
        "original_sentence": "또한,\n\n<!-- PAGE_3 -->\n###### 본 안내서는 2023년 11월 현재의 과학적ㆍ기술적 사실 및 유효한 법규를\n\n<!-- PAGE_3 -->\n###### 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_3 -->\n###### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_132",
      "text": "<!-- PAGE_3 -->\n###### ※ “민원인 안내서”란 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기\n\n<!-- PAGE_4 -->\n#### 개정 이력서\n\n목차\n\n<!-- PAGE_5 -->\n###### 제1장 화장품 위해평가 가이드라인의 목적 ························································· 1\n\n<!-- PAGE_5 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 131,
        "window_size": 3,
        "char_count": 235,
        "word_count": 38,
        "page_number": 3,
        "window_text": "<!-- PAGE_2 -->\n###### 2023년 11월\n\n<!-- PAGE_2 -->\n###### 담당자\n\n<!-- PAGE_2 -->\n###### 확  인(부서장)\n\n<!-- PAGE_2 -->\n###### 박은재\n\n<!-- PAGE_2 -->\n###### 송영미\n\n<!-- PAGE_3 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처 식품의약품안전평\n\n<!-- PAGE_3 -->\n###### 이 안내서는 화장품 위해평가에 대하여 알기 쉽게 설명하거나 식품의약\n\n<!-- PAGE_3 -->\n###### 품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_3 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_3 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 참고로만 활용하시기 바랍니다.  또한,\n\n<!-- PAGE_3 -->\n###### 본 안내서는 2023년 11월 현재의 과학적ㆍ기술적 사실 및 유효한 법규를\n\n<!-- PAGE_3 -->\n###### 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_3 -->\n###### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_3 -->\n###### ※ “민원인 안내서”란 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기\n\n<!-- PAGE_4 -->\n#### 개정 이력서\n\n목차\n\n<!-- PAGE_5 -->\n###### 제1장 화장품 위해평가 가이드라인의 목적 ························································· 1\n\n<!-- PAGE_5 -->\n###### 1.  목적 ·································································································································· 1\n\n<!-- PAGE_5 -->\n###### 2.  관련 규정 ························································································································ 2\n\n<!-- PAGE_5 -->\n###### 제2장 화장품 안전의 일반사항 ··············································································· 4\n\n<!-- PAGE_5 -->\n###### 1.  일반사항 ·························································································································· 4\n\n<!-- PAGE_5 -->\n###### 2. ",
        "original_sentence": "<!-- PAGE_3 -->\n###### ※ “민원인 안내서”란 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기\n\n<!-- PAGE_4 -->\n#### 개정 이력서\n\n목차\n\n<!-- PAGE_5 -->\n###### 제1장 화장품 위해평가 가이드라인의 목적 ························································· 1\n\n<!-- PAGE_5 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_133",
      "text": "목적 ·································································································································· 1\n\n<!-- PAGE_5 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 132,
        "window_size": 3,
        "char_count": 163,
        "word_count": 8,
        "page_number": 5,
        "window_text": "<!-- PAGE_3 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n<!-- PAGE_3 -->\n###### 방식(‘∼하여야 한다’ 등)에도 불구하고 참고로만 활용하시기 바랍니다.  또한,\n\n<!-- PAGE_3 -->\n###### 본 안내서는 2023년 11월 현재의 과학적ㆍ기술적 사실 및 유효한 법규를\n\n<!-- PAGE_3 -->\n###### 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_3 -->\n###### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_3 -->\n###### ※ “민원인 안내서”란 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기\n\n<!-- PAGE_4 -->\n#### 개정 이력서\n\n목차\n\n<!-- PAGE_5 -->\n###### 제1장 화장품 위해평가 가이드라인의 목적 ························································· 1\n\n<!-- PAGE_5 -->\n###### 1.  목적 ·································································································································· 1\n\n<!-- PAGE_5 -->\n###### 2.  관련 규정 ························································································································ 2\n\n<!-- PAGE_5 -->\n###### 제2장 화장품 안전의 일반사항 ··············································································· 4\n\n<!-- PAGE_5 -->\n###### 1.  일반사항 ·························································································································· 4\n\n<!-- PAGE_5 -->\n###### 2.  화장품 성분 ···················································································································· 4\n\n<!-- PAGE_5 -->\n###### 제3장 화장품 위해평가 ····························································································· 5\n\n<!-- PAGE_5 -->\n###### 1. ",
        "original_sentence": "목적 ·································································································································· 1\n\n<!-- PAGE_5 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_134",
      "text": "관련 규정 ························································································································ 2\n\n<!-- PAGE_5 -->\n###### 제2장 화장품 안전의 일반사항 ··············································································· 4\n\n<!-- PAGE_5 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 133,
        "window_size": 3,
        "char_count": 279,
        "word_count": 19,
        "page_number": 5,
        "window_text": "또한,\n\n<!-- PAGE_3 -->\n###### 본 안내서는 2023년 11월 현재의 과학적ㆍ기술적 사실 및 유효한 법규를\n\n<!-- PAGE_3 -->\n###### 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_3 -->\n###### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_3 -->\n###### ※ “민원인 안내서”란 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기\n\n<!-- PAGE_4 -->\n#### 개정 이력서\n\n목차\n\n<!-- PAGE_5 -->\n###### 제1장 화장품 위해평가 가이드라인의 목적 ························································· 1\n\n<!-- PAGE_5 -->\n###### 1.  목적 ·································································································································· 1\n\n<!-- PAGE_5 -->\n###### 2.  관련 규정 ························································································································ 2\n\n<!-- PAGE_5 -->\n###### 제2장 화장품 안전의 일반사항 ··············································································· 4\n\n<!-- PAGE_5 -->\n###### 1.  일반사항 ·························································································································· 4\n\n<!-- PAGE_5 -->\n###### 2.  화장품 성분 ···················································································································· 4\n\n<!-- PAGE_5 -->\n###### 제3장 화장품 위해평가 ····························································································· 5\n\n<!-- PAGE_5 -->\n###### 1.  위해평가 절차 및 수행에 필요한 일반사항 ···························································· 5\n\n<!-- PAGE_5 -->\n###### 2. ",
        "original_sentence": "관련 규정 ························································································································ 2\n\n<!-- PAGE_5 -->\n###### 제2장 화장품 안전의 일반사항 ··············································································· 4\n\n<!-- PAGE_5 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_135",
      "text": "일반사항 ·························································································································· 4\n\n<!-- PAGE_5 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 134,
        "window_size": 3,
        "char_count": 157,
        "word_count": 8,
        "page_number": 5,
        "window_text": "<!-- PAGE_3 -->\n###### ※ “민원인 안내서”란 민원인들의 이해를 돕기 위하여 법령 또는 행정규칙을 알기\n\n<!-- PAGE_4 -->\n#### 개정 이력서\n\n목차\n\n<!-- PAGE_5 -->\n###### 제1장 화장품 위해평가 가이드라인의 목적 ························································· 1\n\n<!-- PAGE_5 -->\n###### 1.  목적 ·································································································································· 1\n\n<!-- PAGE_5 -->\n###### 2.  관련 규정 ························································································································ 2\n\n<!-- PAGE_5 -->\n###### 제2장 화장품 안전의 일반사항 ··············································································· 4\n\n<!-- PAGE_5 -->\n###### 1.  일반사항 ·························································································································· 4\n\n<!-- PAGE_5 -->\n###### 2.  화장품 성분 ···················································································································· 4\n\n<!-- PAGE_5 -->\n###### 제3장 화장품 위해평가 ····························································································· 5\n\n<!-- PAGE_5 -->\n###### 1.  위해평가 절차 및 수행에 필요한 일반사항 ···························································· 5\n\n<!-- PAGE_5 -->\n###### 2.  위해평가 방법 ················································································································ 8\n\n<!-- PAGE_5 -->\n###### 2-2-3-1. ",
        "original_sentence": "일반사항 ·························································································································· 4\n\n<!-- PAGE_5 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_136",
      "text": "화장품 성분 ···················································································································· 4\n\n<!-- PAGE_5 -->\n###### 제3장 화장품 위해평가 ····························································································· 5\n\n<!-- PAGE_5 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 135,
        "window_size": 3,
        "char_count": 286,
        "word_count": 18,
        "page_number": 5,
        "window_text": "목적 ·································································································································· 1\n\n<!-- PAGE_5 -->\n###### 2.  관련 규정 ························································································································ 2\n\n<!-- PAGE_5 -->\n###### 제2장 화장품 안전의 일반사항 ··············································································· 4\n\n<!-- PAGE_5 -->\n###### 1.  일반사항 ·························································································································· 4\n\n<!-- PAGE_5 -->\n###### 2.  화장품 성분 ···················································································································· 4\n\n<!-- PAGE_5 -->\n###### 제3장 화장품 위해평가 ····························································································· 5\n\n<!-- PAGE_5 -->\n###### 1.  위해평가 절차 및 수행에 필요한 일반사항 ···························································· 5\n\n<!-- PAGE_5 -->\n###### 2.  위해평가 방법 ················································································································ 8\n\n<!-- PAGE_5 -->\n###### 2-2-3-1.  피부 노출평가 ························································································ 17\n\n<!-- PAGE_5 -->\n###### 2-2-3-2. ",
        "original_sentence": "화장품 성분 ···················································································································· 4\n\n<!-- PAGE_5 -->\n###### 제3장 화장품 위해평가 ····························································································· 5\n\n<!-- PAGE_5 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_137",
      "text": "위해평가 절차 및 수행에 필요한 일반사항 ···························································· 5\n\n<!-- PAGE_5 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 136,
        "window_size": 3,
        "char_count": 113,
        "word_count": 13,
        "page_number": 5,
        "window_text": "관련 규정 ························································································································ 2\n\n<!-- PAGE_5 -->\n###### 제2장 화장품 안전의 일반사항 ··············································································· 4\n\n<!-- PAGE_5 -->\n###### 1.  일반사항 ·························································································································· 4\n\n<!-- PAGE_5 -->\n###### 2.  화장품 성분 ···················································································································· 4\n\n<!-- PAGE_5 -->\n###### 제3장 화장품 위해평가 ····························································································· 5\n\n<!-- PAGE_5 -->\n###### 1.  위해평가 절차 및 수행에 필요한 일반사항 ···························································· 5\n\n<!-- PAGE_5 -->\n###### 2.  위해평가 방법 ················································································································ 8\n\n<!-- PAGE_5 -->\n###### 2-2-3-1.  피부 노출평가 ························································································ 17\n\n<!-- PAGE_5 -->\n###### 2-2-3-2.  흡입 노출평가 ························································································ 19\n\n<!-- PAGE_5 -->\n###### 2-2-4. ",
        "original_sentence": "위해평가 절차 및 수행에 필요한 일반사항 ···························································· 5\n\n<!-- PAGE_5 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_138",
      "text": "위해평가 방법 ················································································································ 8\n\n<!-- PAGE_5 -->\n###### 2-2-3-1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 137,
        "window_size": 3,
        "char_count": 156,
        "word_count": 9,
        "page_number": 5,
        "window_text": "일반사항 ·························································································································· 4\n\n<!-- PAGE_5 -->\n###### 2.  화장품 성분 ···················································································································· 4\n\n<!-- PAGE_5 -->\n###### 제3장 화장품 위해평가 ····························································································· 5\n\n<!-- PAGE_5 -->\n###### 1.  위해평가 절차 및 수행에 필요한 일반사항 ···························································· 5\n\n<!-- PAGE_5 -->\n###### 2.  위해평가 방법 ················································································································ 8\n\n<!-- PAGE_5 -->\n###### 2-2-3-1.  피부 노출평가 ························································································ 17\n\n<!-- PAGE_5 -->\n###### 2-2-3-2.  흡입 노출평가 ························································································ 19\n\n<!-- PAGE_5 -->\n###### 2-2-4.  위해도 결정 ···································································································· 21\n\n<!-- PAGE_5 -->\n###### 3. ",
        "original_sentence": "위해평가 방법 ················································································································ 8\n\n<!-- PAGE_5 -->\n###### 2-2-3-1. "
      }
    },
    {
      "chunk_id": "chunk_139",
      "text": "피부 노출평가 ························································································ 17\n\n<!-- PAGE_5 -->\n###### 2-2-3-2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 138,
        "window_size": 3,
        "char_count": 133,
        "word_count": 9,
        "page_number": 5,
        "window_text": "화장품 성분 ···················································································································· 4\n\n<!-- PAGE_5 -->\n###### 제3장 화장품 위해평가 ····························································································· 5\n\n<!-- PAGE_5 -->\n###### 1.  위해평가 절차 및 수행에 필요한 일반사항 ···························································· 5\n\n<!-- PAGE_5 -->\n###### 2.  위해평가 방법 ················································································································ 8\n\n<!-- PAGE_5 -->\n###### 2-2-3-1.  피부 노출평가 ························································································ 17\n\n<!-- PAGE_5 -->\n###### 2-2-3-2.  흡입 노출평가 ························································································ 19\n\n<!-- PAGE_5 -->\n###### 2-2-4.  위해도 결정 ···································································································· 21\n\n<!-- PAGE_5 -->\n###### 3.  위해평가 보고서 ········································································································ 23\n\n<!-- PAGE_5 -->\n###### 제4장 참고문헌 ········································································································· 24\n\n<!-- PAGE_6 -->\n###### [붙임 자료]\n\n<!-- PAGE_6 -->\n###### 붙임 1. ",
        "original_sentence": "피부 노출평가 ························································································ 17\n\n<!-- PAGE_5 -->\n###### 2-2-3-2. "
      }
    },
    {
      "chunk_id": "chunk_140",
      "text": "흡입 노출평가 ························································································ 19\n\n<!-- PAGE_5 -->\n###### 2-2-4. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 139,
        "window_size": 3,
        "char_count": 131,
        "word_count": 9,
        "page_number": 5,
        "window_text": "위해평가 절차 및 수행에 필요한 일반사항 ···························································· 5\n\n<!-- PAGE_5 -->\n###### 2.  위해평가 방법 ················································································································ 8\n\n<!-- PAGE_5 -->\n###### 2-2-3-1.  피부 노출평가 ························································································ 17\n\n<!-- PAGE_5 -->\n###### 2-2-3-2.  흡입 노출평가 ························································································ 19\n\n<!-- PAGE_5 -->\n###### 2-2-4.  위해도 결정 ···································································································· 21\n\n<!-- PAGE_5 -->\n###### 3.  위해평가 보고서 ········································································································ 23\n\n<!-- PAGE_5 -->\n###### 제4장 참고문헌 ········································································································· 24\n\n<!-- PAGE_6 -->\n###### [붙임 자료]\n\n<!-- PAGE_6 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집(Glossary) ·························································· 26\n\n<!-- PAGE_6 -->\n###### 붙임 2. ",
        "original_sentence": "흡입 노출평가 ························································································ 19\n\n<!-- PAGE_5 -->\n###### 2-2-4. "
      }
    },
    {
      "chunk_id": "chunk_141",
      "text": "위해도 결정 ···································································································· 21\n\n<!-- PAGE_5 -->\n###### 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 140,
        "window_size": 3,
        "char_count": 138,
        "word_count": 9,
        "page_number": 5,
        "window_text": "위해평가 방법 ················································································································ 8\n\n<!-- PAGE_5 -->\n###### 2-2-3-1.  피부 노출평가 ························································································ 17\n\n<!-- PAGE_5 -->\n###### 2-2-3-2.  흡입 노출평가 ························································································ 19\n\n<!-- PAGE_5 -->\n###### 2-2-4.  위해도 결정 ···································································································· 21\n\n<!-- PAGE_5 -->\n###### 3.  위해평가 보고서 ········································································································ 23\n\n<!-- PAGE_5 -->\n###### 제4장 참고문헌 ········································································································· 24\n\n<!-- PAGE_6 -->\n###### [붙임 자료]\n\n<!-- PAGE_6 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집(Glossary) ·························································· 26\n\n<!-- PAGE_6 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식 ········································································· 30\n\n<!-- PAGE_6 -->\n###### 붙임 3. ",
        "original_sentence": "위해도 결정 ···································································································· 21\n\n<!-- PAGE_5 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_142",
      "text": "위해평가 보고서 ········································································································ 23\n\n<!-- PAGE_5 -->\n###### 제4장 참고문헌 ········································································································· 24\n\n<!-- PAGE_6 -->\n###### [붙임 자료]\n\n<!-- PAGE_6 -->\n###### 붙임 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 141,
        "window_size": 3,
        "char_count": 321,
        "word_count": 24,
        "page_number": 5,
        "window_text": "피부 노출평가 ························································································ 17\n\n<!-- PAGE_5 -->\n###### 2-2-3-2.  흡입 노출평가 ························································································ 19\n\n<!-- PAGE_5 -->\n###### 2-2-4.  위해도 결정 ···································································································· 21\n\n<!-- PAGE_5 -->\n###### 3.  위해평가 보고서 ········································································································ 23\n\n<!-- PAGE_5 -->\n###### 제4장 참고문헌 ········································································································· 24\n\n<!-- PAGE_6 -->\n###### [붙임 자료]\n\n<!-- PAGE_6 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집(Glossary) ·························································· 26\n\n<!-- PAGE_6 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식 ········································································· 30\n\n<!-- PAGE_6 -->\n###### 붙임 3.  OECD 독성시험 종류 ························································································· 33\n\n<!-- PAGE_6 -->\n###### 붙임 4. ",
        "original_sentence": "위해평가 보고서 ········································································································ 23\n\n<!-- PAGE_5 -->\n###### 제4장 참고문헌 ········································································································· 24\n\n<!-- PAGE_6 -->\n###### [붙임 자료]\n\n<!-- PAGE_6 -->\n###### 붙임 1. "
      }
    },
    {
      "chunk_id": "chunk_143",
      "text": "화장품 위해평가 관련 용어집(Glossary) ·························································· 26\n\n<!-- PAGE_6 -->\n###### 붙임 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 142,
        "window_size": 3,
        "char_count": 118,
        "word_count": 12,
        "page_number": 6,
        "window_text": "흡입 노출평가 ························································································ 19\n\n<!-- PAGE_5 -->\n###### 2-2-4.  위해도 결정 ···································································································· 21\n\n<!-- PAGE_5 -->\n###### 3.  위해평가 보고서 ········································································································ 23\n\n<!-- PAGE_5 -->\n###### 제4장 참고문헌 ········································································································· 24\n\n<!-- PAGE_6 -->\n###### [붙임 자료]\n\n<!-- PAGE_6 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집(Glossary) ·························································· 26\n\n<!-- PAGE_6 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식 ········································································· 30\n\n<!-- PAGE_6 -->\n###### 붙임 3.  OECD 독성시험 종류 ························································································· 33\n\n<!-- PAGE_6 -->\n###### 붙임 4.  화장품 노출 피부 표면적 ················································································· 35\n\n<!-- PAGE_6 -->\n###### 붙임 5. ",
        "original_sentence": "화장품 위해평가 관련 용어집(Glossary) ·························································· 26\n\n<!-- PAGE_6 -->\n###### 붙임 2. "
      }
    },
    {
      "chunk_id": "chunk_144",
      "text": "화장품 위해평가 보고서 양식 ········································································· 30\n\n<!-- PAGE_6 -->\n###### 붙임 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 143,
        "window_size": 3,
        "char_count": 123,
        "word_count": 12,
        "page_number": 6,
        "window_text": "위해도 결정 ···································································································· 21\n\n<!-- PAGE_5 -->\n###### 3.  위해평가 보고서 ········································································································ 23\n\n<!-- PAGE_5 -->\n###### 제4장 참고문헌 ········································································································· 24\n\n<!-- PAGE_6 -->\n###### [붙임 자료]\n\n<!-- PAGE_6 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집(Glossary) ·························································· 26\n\n<!-- PAGE_6 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식 ········································································· 30\n\n<!-- PAGE_6 -->\n###### 붙임 3.  OECD 독성시험 종류 ························································································· 33\n\n<!-- PAGE_6 -->\n###### 붙임 4.  화장품 노출 피부 표면적 ················································································· 35\n\n<!-- PAGE_6 -->\n###### 붙임 5.  한국인의 화장품 사용량 ····················································································· 37\n\n<!-- PAGE_6 -->\n###### 붙임 6. ",
        "original_sentence": "화장품 위해평가 보고서 양식 ········································································· 30\n\n<!-- PAGE_6 -->\n###### 붙임 3. "
      }
    },
    {
      "chunk_id": "chunk_145",
      "text": "OECD 독성시험 종류 ························································································· 33\n\n<!-- PAGE_6 -->\n###### 붙임 4. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 144,
        "window_size": 3,
        "char_count": 136,
        "word_count": 11,
        "page_number": 6,
        "window_text": "위해평가 보고서 ········································································································ 23\n\n<!-- PAGE_5 -->\n###### 제4장 참고문헌 ········································································································· 24\n\n<!-- PAGE_6 -->\n###### [붙임 자료]\n\n<!-- PAGE_6 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집(Glossary) ·························································· 26\n\n<!-- PAGE_6 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식 ········································································· 30\n\n<!-- PAGE_6 -->\n###### 붙임 3.  OECD 독성시험 종류 ························································································· 33\n\n<!-- PAGE_6 -->\n###### 붙임 4.  화장품 노출 피부 표면적 ················································································· 35\n\n<!-- PAGE_6 -->\n###### 붙임 5.  한국인의 화장품 사용량 ····················································································· 37\n\n<!-- PAGE_6 -->\n###### 붙임 6.  유럽의 화장품 사용량 ························································································· 39\n\n<!-- PAGE_6 -->\n###### 붙임 7. ",
        "original_sentence": "OECD 독성시험 종류 ························································································· 33\n\n<!-- PAGE_6 -->\n###### 붙임 4. "
      }
    },
    {
      "chunk_id": "chunk_146",
      "text": "화장품 노출 피부 표면적 ················································································· 35\n\n<!-- PAGE_6 -->\n###### 붙임 5. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 145,
        "window_size": 3,
        "char_count": 129,
        "word_count": 12,
        "page_number": 6,
        "window_text": "화장품 위해평가 관련 용어집(Glossary) ·························································· 26\n\n<!-- PAGE_6 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식 ········································································· 30\n\n<!-- PAGE_6 -->\n###### 붙임 3.  OECD 독성시험 종류 ························································································· 33\n\n<!-- PAGE_6 -->\n###### 붙임 4.  화장품 노출 피부 표면적 ················································································· 35\n\n<!-- PAGE_6 -->\n###### 붙임 5.  한국인의 화장품 사용량 ····················································································· 37\n\n<!-- PAGE_6 -->\n###### 붙임 6.  유럽의 화장품 사용량 ························································································· 39\n\n<!-- PAGE_6 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보 ··································································· 41\n\n<!-- PAGE_6 -->\n###### 붙임 8. ",
        "original_sentence": "화장품 노출 피부 표면적 ················································································· 35\n\n<!-- PAGE_6 -->\n###### 붙임 5. "
      }
    },
    {
      "chunk_id": "chunk_147",
      "text": "한국인의 화장품 사용량 ····················································································· 37\n\n<!-- PAGE_6 -->\n###### 붙임 6. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 146,
        "window_size": 3,
        "char_count": 132,
        "word_count": 11,
        "page_number": 6,
        "window_text": "화장품 위해평가 보고서 양식 ········································································· 30\n\n<!-- PAGE_6 -->\n###### 붙임 3.  OECD 독성시험 종류 ························································································· 33\n\n<!-- PAGE_6 -->\n###### 붙임 4.  화장품 노출 피부 표면적 ················································································· 35\n\n<!-- PAGE_6 -->\n###### 붙임 5.  한국인의 화장품 사용량 ····················································································· 37\n\n<!-- PAGE_6 -->\n###### 붙임 6.  유럽의 화장품 사용량 ························································································· 39\n\n<!-- PAGE_6 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보 ··································································· 41\n\n<!-- PAGE_6 -->\n###### 붙임 8.  피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시 ················ 49\n\n<!-- PAGE_6 -->\n###### 붙임 9. ",
        "original_sentence": "한국인의 화장품 사용량 ····················································································· 37\n\n<!-- PAGE_6 -->\n###### 붙임 6. "
      }
    },
    {
      "chunk_id": "chunk_148",
      "text": "유럽의 화장품 사용량 ························································································· 39\n\n<!-- PAGE_6 -->\n###### 붙임 7. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 147,
        "window_size": 3,
        "char_count": 135,
        "word_count": 11,
        "page_number": 6,
        "window_text": "OECD 독성시험 종류 ························································································· 33\n\n<!-- PAGE_6 -->\n###### 붙임 4.  화장품 노출 피부 표면적 ················································································· 35\n\n<!-- PAGE_6 -->\n###### 붙임 5.  한국인의 화장품 사용량 ····················································································· 37\n\n<!-- PAGE_6 -->\n###### 붙임 6.  유럽의 화장품 사용량 ························································································· 39\n\n<!-- PAGE_6 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보 ··································································· 41\n\n<!-- PAGE_6 -->\n###### 붙임 8.  피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시 ················ 49\n\n<!-- PAGE_6 -->\n###### 붙임 9.  화장품 유형별 평가 예시 ··················································································· 53\n\n<!-- PAGE_6 -->\n###### 붙임 10. ",
        "original_sentence": "유럽의 화장품 사용량 ························································································· 39\n\n<!-- PAGE_6 -->\n###### 붙임 7. "
      }
    },
    {
      "chunk_id": "chunk_149",
      "text": "흡입 노출평가 방법 및 기본 정보 ··································································· 41\n\n<!-- PAGE_6 -->\n###### 붙임 8. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 148,
        "window_size": 3,
        "char_count": 120,
        "word_count": 14,
        "page_number": 6,
        "window_text": "화장품 노출 피부 표면적 ················································································· 35\n\n<!-- PAGE_6 -->\n###### 붙임 5.  한국인의 화장품 사용량 ····················································································· 37\n\n<!-- PAGE_6 -->\n###### 붙임 6.  유럽의 화장품 사용량 ························································································· 39\n\n<!-- PAGE_6 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보 ··································································· 41\n\n<!-- PAGE_6 -->\n###### 붙임 8.  피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시 ················ 49\n\n<!-- PAGE_6 -->\n###### 붙임 9.  화장품 유형별 평가 예시 ··················································································· 53\n\n<!-- PAGE_6 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집 ····················································· 57\n\n<!-- PAGE_6 -->\n###### 참고 1. ",
        "original_sentence": "흡입 노출평가 방법 및 기본 정보 ··································································· 41\n\n<!-- PAGE_6 -->\n###### 붙임 8. "
      }
    },
    {
      "chunk_id": "chunk_150",
      "text": "피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시 ················ 49\n\n<!-- PAGE_6 -->\n###### 붙임 9. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 149,
        "window_size": 3,
        "char_count": 99,
        "word_count": 15,
        "page_number": 6,
        "window_text": "한국인의 화장품 사용량 ····················································································· 37\n\n<!-- PAGE_6 -->\n###### 붙임 6.  유럽의 화장품 사용량 ························································································· 39\n\n<!-- PAGE_6 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보 ··································································· 41\n\n<!-- PAGE_6 -->\n###### 붙임 8.  피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시 ················ 49\n\n<!-- PAGE_6 -->\n###### 붙임 9.  화장품 유형별 평가 예시 ··················································································· 53\n\n<!-- PAGE_6 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집 ····················································· 57\n\n<!-- PAGE_6 -->\n###### 참고 1.  발암물질 위해평가 및 예시 ··············································································· 62\n\n<!-- PAGE_6 -->\n###### 참고 2. ",
        "original_sentence": "피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시 ················ 49\n\n<!-- PAGE_6 -->\n###### 붙임 9. "
      }
    },
    {
      "chunk_id": "chunk_151",
      "text": "화장품 유형별 평가 예시 ··················································································· 53\n\n<!-- PAGE_6 -->\n###### 붙임 10. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 150,
        "window_size": 3,
        "char_count": 132,
        "word_count": 12,
        "page_number": 6,
        "window_text": "유럽의 화장품 사용량 ························································································· 39\n\n<!-- PAGE_6 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보 ··································································· 41\n\n<!-- PAGE_6 -->\n###### 붙임 8.  피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시 ················ 49\n\n<!-- PAGE_6 -->\n###### 붙임 9.  화장품 유형별 평가 예시 ··················································································· 53\n\n<!-- PAGE_6 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집 ····················································· 57\n\n<!-- PAGE_6 -->\n###### 참고 1.  발암물질 위해평가 및 예시 ··············································································· 62\n\n<!-- PAGE_6 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정 ············ 67\n\n- - 1 -\n<!-- PAGE_7 -->\n##### 제1장 화장품 위해평가 가이드라인의 목적\n\n<!-- PAGE_7 -->\n###### 1. ",
        "original_sentence": "화장품 유형별 평가 예시 ··················································································· 53\n\n<!-- PAGE_6 -->\n###### 붙임 10. "
      }
    },
    {
      "chunk_id": "chunk_152",
      "text": "화장품 성분 위해평가를 위한 정보 수집 ····················································· 57\n\n<!-- PAGE_6 -->\n###### 참고 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 151,
        "window_size": 3,
        "char_count": 109,
        "word_count": 14,
        "page_number": 6,
        "window_text": "흡입 노출평가 방법 및 기본 정보 ··································································· 41\n\n<!-- PAGE_6 -->\n###### 붙임 8.  피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시 ················ 49\n\n<!-- PAGE_6 -->\n###### 붙임 9.  화장품 유형별 평가 예시 ··················································································· 53\n\n<!-- PAGE_6 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집 ····················································· 57\n\n<!-- PAGE_6 -->\n###### 참고 1.  발암물질 위해평가 및 예시 ··············································································· 62\n\n<!-- PAGE_6 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정 ············ 67\n\n- - 1 -\n<!-- PAGE_7 -->\n##### 제1장 화장품 위해평가 가이드라인의 목적\n\n<!-- PAGE_7 -->\n###### 1.  목적\n\n<!-- PAGE_7 -->\n###### 본 가이드라인에는 화장품 위해평가를 수행함에 있어 일반적으로 고려되어야 할 사\n\n<!-- PAGE_7 -->\n###### 항, 절차 및 관련 용어 등을 기술하였다. ",
        "original_sentence": "화장품 성분 위해평가를 위한 정보 수집 ····················································· 57\n\n<!-- PAGE_6 -->\n###### 참고 1. "
      }
    },
    {
      "chunk_id": "chunk_153",
      "text": "발암물질 위해평가 및 예시 ··············································································· 62\n\n<!-- PAGE_6 -->\n###### 참고 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 152,
        "window_size": 3,
        "char_count": 128,
        "word_count": 12,
        "page_number": 6,
        "window_text": "피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시 ················ 49\n\n<!-- PAGE_6 -->\n###### 붙임 9.  화장품 유형별 평가 예시 ··················································································· 53\n\n<!-- PAGE_6 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집 ····················································· 57\n\n<!-- PAGE_6 -->\n###### 참고 1.  발암물질 위해평가 및 예시 ··············································································· 62\n\n<!-- PAGE_6 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정 ············ 67\n\n- - 1 -\n<!-- PAGE_7 -->\n##### 제1장 화장품 위해평가 가이드라인의 목적\n\n<!-- PAGE_7 -->\n###### 1.  목적\n\n<!-- PAGE_7 -->\n###### 본 가이드라인에는 화장품 위해평가를 수행함에 있어 일반적으로 고려되어야 할 사\n\n<!-- PAGE_7 -->\n###### 항, 절차 및 관련 용어 등을 기술하였다.  본 가이드라인은 화장품의 안전을 확보하기\n\n<!-- PAGE_7 -->\n###### 위하여 「화장품법」, 「화장품법 시행규칙」에 따른 화장품 위해평가 업무에 활용한다.\n\n",
        "original_sentence": "발암물질 위해평가 및 예시 ··············································································· 62\n\n<!-- PAGE_6 -->\n###### 참고 2. "
      }
    },
    {
      "chunk_id": "chunk_154",
      "text": "TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정 ············ 67\n\n- - 1 -\n<!-- PAGE_7 -->\n##### 제1장 화장품 위해평가 가이드라인의 목적\n\n<!-- PAGE_7 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 153,
        "window_size": 3,
        "char_count": 149,
        "word_count": 27,
        "page_number": 7,
        "window_text": "화장품 유형별 평가 예시 ··················································································· 53\n\n<!-- PAGE_6 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집 ····················································· 57\n\n<!-- PAGE_6 -->\n###### 참고 1.  발암물질 위해평가 및 예시 ··············································································· 62\n\n<!-- PAGE_6 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정 ············ 67\n\n- - 1 -\n<!-- PAGE_7 -->\n##### 제1장 화장품 위해평가 가이드라인의 목적\n\n<!-- PAGE_7 -->\n###### 1.  목적\n\n<!-- PAGE_7 -->\n###### 본 가이드라인에는 화장품 위해평가를 수행함에 있어 일반적으로 고려되어야 할 사\n\n<!-- PAGE_7 -->\n###### 항, 절차 및 관련 용어 등을 기술하였다.  본 가이드라인은 화장품의 안전을 확보하기\n\n<!-- PAGE_7 -->\n###### 위하여 「화장품법」, 「화장품법 시행규칙」에 따른 화장품 위해평가 업무에 활용한다.\n\n - - 2 -\n<!-- PAGE_8 -->\n###### 2. ",
        "original_sentence": "TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정 ············ 67\n\n- - 1 -\n<!-- PAGE_7 -->\n##### 제1장 화장품 위해평가 가이드라인의 목적\n\n<!-- PAGE_7 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_155",
      "text": "목적\n\n<!-- PAGE_7 -->\n###### 본 가이드라인에는 화장품 위해평가를 수행함에 있어 일반적으로 고려되어야 할 사\n\n<!-- PAGE_7 -->\n###### 항, 절차 및 관련 용어 등을 기술하였다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 154,
        "window_size": 3,
        "char_count": 119,
        "word_count": 26,
        "page_number": 7,
        "window_text": "화장품 성분 위해평가를 위한 정보 수집 ····················································· 57\n\n<!-- PAGE_6 -->\n###### 참고 1.  발암물질 위해평가 및 예시 ··············································································· 62\n\n<!-- PAGE_6 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정 ············ 67\n\n- - 1 -\n<!-- PAGE_7 -->\n##### 제1장 화장품 위해평가 가이드라인의 목적\n\n<!-- PAGE_7 -->\n###### 1.  목적\n\n<!-- PAGE_7 -->\n###### 본 가이드라인에는 화장품 위해평가를 수행함에 있어 일반적으로 고려되어야 할 사\n\n<!-- PAGE_7 -->\n###### 항, 절차 및 관련 용어 등을 기술하였다.  본 가이드라인은 화장품의 안전을 확보하기\n\n<!-- PAGE_7 -->\n###### 위하여 「화장품법」, 「화장품법 시행규칙」에 따른 화장품 위해평가 업무에 활용한다.\n\n - - 2 -\n<!-- PAGE_8 -->\n###### 2.  관련 규정\n\n⌜화장품법⌟\n\n- - 3 -\n⌜화장품법 시행규칙⌟\n\n<!-- PAGE_9 -->\n###### 제17조(화장품 원료 등의 위해평가) ① 법 제8조제3항에 따른 위해평가는 다음 각\n\n<!-- PAGE_9 -->\n###### 호의 확인·결정·평가 등의 과정을 거쳐 실시한다.\n\n",
        "original_sentence": "목적\n\n<!-- PAGE_7 -->\n###### 본 가이드라인에는 화장품 위해평가를 수행함에 있어 일반적으로 고려되어야 할 사\n\n<!-- PAGE_7 -->\n###### 항, 절차 및 관련 용어 등을 기술하였다. "
      }
    },
    {
      "chunk_id": "chunk_156",
      "text": "본 가이드라인은 화장품의 안전을 확보하기\n\n<!-- PAGE_7 -->\n###### 위하여 「화장품법」, 「화장품법 시행규칙」에 따른 화장품 위해평가 업무에 활용한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 155,
        "window_size": 3,
        "char_count": 95,
        "word_count": 18,
        "page_number": 7,
        "window_text": "발암물질 위해평가 및 예시 ··············································································· 62\n\n<!-- PAGE_6 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정 ············ 67\n\n- - 1 -\n<!-- PAGE_7 -->\n##### 제1장 화장품 위해평가 가이드라인의 목적\n\n<!-- PAGE_7 -->\n###### 1.  목적\n\n<!-- PAGE_7 -->\n###### 본 가이드라인에는 화장품 위해평가를 수행함에 있어 일반적으로 고려되어야 할 사\n\n<!-- PAGE_7 -->\n###### 항, 절차 및 관련 용어 등을 기술하였다.  본 가이드라인은 화장품의 안전을 확보하기\n\n<!-- PAGE_7 -->\n###### 위하여 「화장품법」, 「화장품법 시행규칙」에 따른 화장품 위해평가 업무에 활용한다.\n\n - - 2 -\n<!-- PAGE_8 -->\n###### 2.  관련 규정\n\n⌜화장품법⌟\n\n- - 3 -\n⌜화장품법 시행규칙⌟\n\n<!-- PAGE_9 -->\n###### 제17조(화장품 원료 등의 위해평가) ① 법 제8조제3항에 따른 위해평가는 다음 각\n\n<!-- PAGE_9 -->\n###### 호의 확인·결정·평가 등의 과정을 거쳐 실시한다.\n\n <!-- PAGE_9 -->\n###### 1. ",
        "original_sentence": "본 가이드라인은 화장품의 안전을 확보하기\n\n<!-- PAGE_7 -->\n###### 위하여 「화장품법」, 「화장품법 시행규칙」에 따른 화장품 위해평가 업무에 활용한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_157",
      "text": "- - 2 -\n<!-- PAGE_8 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 156,
        "window_size": 3,
        "char_count": 34,
        "word_count": 9,
        "page_number": 8,
        "window_text": "TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정 ············ 67\n\n- - 1 -\n<!-- PAGE_7 -->\n##### 제1장 화장품 위해평가 가이드라인의 목적\n\n<!-- PAGE_7 -->\n###### 1.  목적\n\n<!-- PAGE_7 -->\n###### 본 가이드라인에는 화장품 위해평가를 수행함에 있어 일반적으로 고려되어야 할 사\n\n<!-- PAGE_7 -->\n###### 항, 절차 및 관련 용어 등을 기술하였다.  본 가이드라인은 화장품의 안전을 확보하기\n\n<!-- PAGE_7 -->\n###### 위하여 「화장품법」, 「화장품법 시행규칙」에 따른 화장품 위해평가 업무에 활용한다.\n\n - - 2 -\n<!-- PAGE_8 -->\n###### 2.  관련 규정\n\n⌜화장품법⌟\n\n- - 3 -\n⌜화장품법 시행규칙⌟\n\n<!-- PAGE_9 -->\n###### 제17조(화장품 원료 등의 위해평가) ① 법 제8조제3항에 따른 위해평가는 다음 각\n\n<!-- PAGE_9 -->\n###### 호의 확인·결정·평가 등의 과정을 거쳐 실시한다.\n\n <!-- PAGE_9 -->\n###### 1.  위해요소의 인체 내 독성을 확인하는 위험성 확인과정\n\n- - 4 -\n<!-- PAGE_10 -->\n##### 제2장 화장품 안전의 일반사항\n\n<!-- PAGE_10 -->\n###### 1. ",
        "original_sentence": "- - 2 -\n<!-- PAGE_8 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_158",
      "text": "관련 규정\n\n⌜화장품법⌟\n\n- - 3 -\n⌜화장품법 시행규칙⌟\n\n<!-- PAGE_9 -->\n###### 제17조(화장품 원료 등의 위해평가) ① 법 제8조제3항에 따른 위해평가는 다음 각\n\n<!-- PAGE_9 -->\n###### 호의 확인·결정·평가 등의 과정을 거쳐 실시한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 157,
        "window_size": 3,
        "char_count": 159,
        "word_count": 34,
        "page_number": 9,
        "window_text": "목적\n\n<!-- PAGE_7 -->\n###### 본 가이드라인에는 화장품 위해평가를 수행함에 있어 일반적으로 고려되어야 할 사\n\n<!-- PAGE_7 -->\n###### 항, 절차 및 관련 용어 등을 기술하였다.  본 가이드라인은 화장품의 안전을 확보하기\n\n<!-- PAGE_7 -->\n###### 위하여 「화장품법」, 「화장품법 시행규칙」에 따른 화장품 위해평가 업무에 활용한다.\n\n - - 2 -\n<!-- PAGE_8 -->\n###### 2.  관련 규정\n\n⌜화장품법⌟\n\n- - 3 -\n⌜화장품법 시행규칙⌟\n\n<!-- PAGE_9 -->\n###### 제17조(화장품 원료 등의 위해평가) ① 법 제8조제3항에 따른 위해평가는 다음 각\n\n<!-- PAGE_9 -->\n###### 호의 확인·결정·평가 등의 과정을 거쳐 실시한다.\n\n <!-- PAGE_9 -->\n###### 1.  위해요소의 인체 내 독성을 확인하는 위험성 확인과정\n\n- - 4 -\n<!-- PAGE_10 -->\n##### 제2장 화장품 안전의 일반사항\n\n<!-- PAGE_10 -->\n###### 1.  일반사항\n\n<!-- PAGE_10 -->\n###### 1) 화장품은 제품 설명서, 표시사항 등에 따라 정상적으로 사용하거나 또는 예측가능한 사용\n\n<!-- PAGE_10 -->\n###### 2) 화장품은 일반 소비자뿐만 아니라 화장품을 직업적으로 사용하는 전문가(예, 미용사, 피부\n\n<!-- PAGE_10 -->\n###### 3) 화장품의 안전성은 화장품 성분의 안전성에 기반하며, 화장품 성분의 안전성은 독성시험\n\n<!-- PAGE_10 -->\n###### 2. ",
        "original_sentence": "관련 규정\n\n⌜화장품법⌟\n\n- - 3 -\n⌜화장품법 시행규칙⌟\n\n<!-- PAGE_9 -->\n###### 제17조(화장품 원료 등의 위해평가) ① 법 제8조제3항에 따른 위해평가는 다음 각\n\n<!-- PAGE_9 -->\n###### 호의 확인·결정·평가 등의 과정을 거쳐 실시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_159",
      "text": "<!-- PAGE_9 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 158,
        "window_size": 3,
        "char_count": 26,
        "word_count": 5,
        "page_number": 9,
        "window_text": "본 가이드라인은 화장품의 안전을 확보하기\n\n<!-- PAGE_7 -->\n###### 위하여 「화장품법」, 「화장품법 시행규칙」에 따른 화장품 위해평가 업무에 활용한다.\n\n - - 2 -\n<!-- PAGE_8 -->\n###### 2.  관련 규정\n\n⌜화장품법⌟\n\n- - 3 -\n⌜화장품법 시행규칙⌟\n\n<!-- PAGE_9 -->\n###### 제17조(화장품 원료 등의 위해평가) ① 법 제8조제3항에 따른 위해평가는 다음 각\n\n<!-- PAGE_9 -->\n###### 호의 확인·결정·평가 등의 과정을 거쳐 실시한다.\n\n <!-- PAGE_9 -->\n###### 1.  위해요소의 인체 내 독성을 확인하는 위험성 확인과정\n\n- - 4 -\n<!-- PAGE_10 -->\n##### 제2장 화장품 안전의 일반사항\n\n<!-- PAGE_10 -->\n###### 1.  일반사항\n\n<!-- PAGE_10 -->\n###### 1) 화장품은 제품 설명서, 표시사항 등에 따라 정상적으로 사용하거나 또는 예측가능한 사용\n\n<!-- PAGE_10 -->\n###### 2) 화장품은 일반 소비자뿐만 아니라 화장품을 직업적으로 사용하는 전문가(예, 미용사, 피부\n\n<!-- PAGE_10 -->\n###### 3) 화장품의 안전성은 화장품 성분의 안전성에 기반하며, 화장품 성분의 안전성은 독성시험\n\n<!-- PAGE_10 -->\n###### 2.  화장품 성분\n\n<!-- PAGE_10 -->\n###### 1) 화장품 성분은 화학물질 또는 천연물 등이며, 경우에 따라 단일 또는 혼합물일 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_9 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_160",
      "text": "위해요소의 인체 내 독성을 확인하는 위험성 확인과정\n\n- - 4 -\n<!-- PAGE_10 -->\n##### 제2장 화장품 안전의 일반사항\n\n<!-- PAGE_10 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 159,
        "window_size": 3,
        "char_count": 106,
        "word_count": 24,
        "page_number": 10,
        "window_text": "- - 2 -\n<!-- PAGE_8 -->\n###### 2.  관련 규정\n\n⌜화장품법⌟\n\n- - 3 -\n⌜화장품법 시행규칙⌟\n\n<!-- PAGE_9 -->\n###### 제17조(화장품 원료 등의 위해평가) ① 법 제8조제3항에 따른 위해평가는 다음 각\n\n<!-- PAGE_9 -->\n###### 호의 확인·결정·평가 등의 과정을 거쳐 실시한다.\n\n <!-- PAGE_9 -->\n###### 1.  위해요소의 인체 내 독성을 확인하는 위험성 확인과정\n\n- - 4 -\n<!-- PAGE_10 -->\n##### 제2장 화장품 안전의 일반사항\n\n<!-- PAGE_10 -->\n###### 1.  일반사항\n\n<!-- PAGE_10 -->\n###### 1) 화장품은 제품 설명서, 표시사항 등에 따라 정상적으로 사용하거나 또는 예측가능한 사용\n\n<!-- PAGE_10 -->\n###### 2) 화장품은 일반 소비자뿐만 아니라 화장품을 직업적으로 사용하는 전문가(예, 미용사, 피부\n\n<!-- PAGE_10 -->\n###### 3) 화장품의 안전성은 화장품 성분의 안전성에 기반하며, 화장품 성분의 안전성은 독성시험\n\n<!-- PAGE_10 -->\n###### 2.  화장품 성분\n\n<!-- PAGE_10 -->\n###### 1) 화장품 성분은 화학물질 또는 천연물 등이며, 경우에 따라 단일 또는 혼합물일 수 있다.\n\n <!-- PAGE_10 -->\n###### 최종 제품의 안전성을 확보하기 위해서는 성분의 안전성이 확보되어야 한다. ",
        "original_sentence": "위해요소의 인체 내 독성을 확인하는 위험성 확인과정\n\n- - 4 -\n<!-- PAGE_10 -->\n##### 제2장 화장품 안전의 일반사항\n\n<!-- PAGE_10 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_161",
      "text": "일반사항\n\n<!-- PAGE_10 -->\n###### 1) 화장품은 제품 설명서, 표시사항 등에 따라 정상적으로 사용하거나 또는 예측가능한 사용\n\n<!-- PAGE_10 -->\n###### 2) 화장품은 일반 소비자뿐만 아니라 화장품을 직업적으로 사용하는 전문가(예, 미용사, 피부\n\n<!-- PAGE_10 -->\n###### 3) 화장품의 안전성은 화장품 성분의 안전성에 기반하며, 화장품 성분의 안전성은 독성시험\n\n<!-- PAGE_10 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 160,
        "window_size": 3,
        "char_count": 261,
        "word_count": 52,
        "page_number": 10,
        "window_text": "관련 규정\n\n⌜화장품법⌟\n\n- - 3 -\n⌜화장품법 시행규칙⌟\n\n<!-- PAGE_9 -->\n###### 제17조(화장품 원료 등의 위해평가) ① 법 제8조제3항에 따른 위해평가는 다음 각\n\n<!-- PAGE_9 -->\n###### 호의 확인·결정·평가 등의 과정을 거쳐 실시한다.\n\n <!-- PAGE_9 -->\n###### 1.  위해요소의 인체 내 독성을 확인하는 위험성 확인과정\n\n- - 4 -\n<!-- PAGE_10 -->\n##### 제2장 화장품 안전의 일반사항\n\n<!-- PAGE_10 -->\n###### 1.  일반사항\n\n<!-- PAGE_10 -->\n###### 1) 화장품은 제품 설명서, 표시사항 등에 따라 정상적으로 사용하거나 또는 예측가능한 사용\n\n<!-- PAGE_10 -->\n###### 2) 화장품은 일반 소비자뿐만 아니라 화장품을 직업적으로 사용하는 전문가(예, 미용사, 피부\n\n<!-- PAGE_10 -->\n###### 3) 화장품의 안전성은 화장품 성분의 안전성에 기반하며, 화장품 성분의 안전성은 독성시험\n\n<!-- PAGE_10 -->\n###### 2.  화장품 성분\n\n<!-- PAGE_10 -->\n###### 1) 화장품 성분은 화학물질 또는 천연물 등이며, 경우에 따라 단일 또는 혼합물일 수 있다.\n\n <!-- PAGE_10 -->\n###### 최종 제품의 안전성을 확보하기 위해서는 성분의 안전성이 확보되어야 한다.  원료 성분의\n\n<!-- PAGE_10 -->\n###### 2) 화장품 성분은 식약처장이 화장품의 제조에 사용할 수 없는 원료로 지정·고시한 것이 아\n\n<!-- PAGE_10 -->\n###### 3) 미량의 중금속 등 불순물, 제조공정이나 보관 중에 생길 수 있는 비의도적 오염물질을 가\n\n<!-- PAGE_10 -->\n###### 능한 줄이기 위한 충분한 조치를 취하여야 한다. ",
        "original_sentence": "일반사항\n\n<!-- PAGE_10 -->\n###### 1) 화장품은 제품 설명서, 표시사항 등에 따라 정상적으로 사용하거나 또는 예측가능한 사용\n\n<!-- PAGE_10 -->\n###### 2) 화장품은 일반 소비자뿐만 아니라 화장품을 직업적으로 사용하는 전문가(예, 미용사, 피부\n\n<!-- PAGE_10 -->\n###### 3) 화장품의 안전성은 화장품 성분의 안전성에 기반하며, 화장품 성분의 안전성은 독성시험\n\n<!-- PAGE_10 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_162",
      "text": "화장품 성분\n\n<!-- PAGE_10 -->\n###### 1) 화장품 성분은 화학물질 또는 천연물 등이며, 경우에 따라 단일 또는 혼합물일 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 161,
        "window_size": 3,
        "char_count": 85,
        "word_count": 20,
        "page_number": 10,
        "window_text": "<!-- PAGE_9 -->\n###### 1.  위해요소의 인체 내 독성을 확인하는 위험성 확인과정\n\n- - 4 -\n<!-- PAGE_10 -->\n##### 제2장 화장품 안전의 일반사항\n\n<!-- PAGE_10 -->\n###### 1.  일반사항\n\n<!-- PAGE_10 -->\n###### 1) 화장품은 제품 설명서, 표시사항 등에 따라 정상적으로 사용하거나 또는 예측가능한 사용\n\n<!-- PAGE_10 -->\n###### 2) 화장품은 일반 소비자뿐만 아니라 화장품을 직업적으로 사용하는 전문가(예, 미용사, 피부\n\n<!-- PAGE_10 -->\n###### 3) 화장품의 안전성은 화장품 성분의 안전성에 기반하며, 화장품 성분의 안전성은 독성시험\n\n<!-- PAGE_10 -->\n###### 2.  화장품 성분\n\n<!-- PAGE_10 -->\n###### 1) 화장품 성분은 화학물질 또는 천연물 등이며, 경우에 따라 단일 또는 혼합물일 수 있다.\n\n <!-- PAGE_10 -->\n###### 최종 제품의 안전성을 확보하기 위해서는 성분의 안전성이 확보되어야 한다.  원료 성분의\n\n<!-- PAGE_10 -->\n###### 2) 화장품 성분은 식약처장이 화장품의 제조에 사용할 수 없는 원료로 지정·고시한 것이 아\n\n<!-- PAGE_10 -->\n###### 3) 미량의 중금속 등 불순물, 제조공정이나 보관 중에 생길 수 있는 비의도적 오염물질을 가\n\n<!-- PAGE_10 -->\n###### 능한 줄이기 위한 충분한 조치를 취하여야 한다.  그럼에도 오염물질이 존재할 경우, 그 안\n\n<!-- PAGE_10 -->\n###### 4) 화장품 성분의 화학구조에 따라 물리․화학적 반응 및 생물학적 반응이 결정되며 화학적 순\n\n<!-- PAGE_10 -->\n###### 도, 조성 내의 다른 성분들과의 상호작용 및 피부투과 등은 효능과 안전성 및 안정성에 영\n\n<!-- PAGE_10 -->\n###### 5) 화장품 성분의 상호작용으로 인해 유해물질 발생(예를 들면, 니트로소아민 형성) 가능성과\n\n<!-- PAGE_10 -->\n###### 식물유래 및 동물에서 추출한 성분에 농약, 살충제, 금속물질 및 생물학적 유해물질이 함\n\n<!-- PAGE_10 -->\n###### 유되어 있을 가능성에 특별한 주의를 기울여야 한다.\n\n",
        "original_sentence": "화장품 성분\n\n<!-- PAGE_10 -->\n###### 1) 화장품 성분은 화학물질 또는 천연물 등이며, 경우에 따라 단일 또는 혼합물일 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_163",
      "text": "<!-- PAGE_10 -->\n###### 최종 제품의 안전성을 확보하기 위해서는 성분의 안전성이 확보되어야 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 162,
        "window_size": 3,
        "char_count": 65,
        "word_count": 13,
        "page_number": 10,
        "window_text": "위해요소의 인체 내 독성을 확인하는 위험성 확인과정\n\n- - 4 -\n<!-- PAGE_10 -->\n##### 제2장 화장품 안전의 일반사항\n\n<!-- PAGE_10 -->\n###### 1.  일반사항\n\n<!-- PAGE_10 -->\n###### 1) 화장품은 제품 설명서, 표시사항 등에 따라 정상적으로 사용하거나 또는 예측가능한 사용\n\n<!-- PAGE_10 -->\n###### 2) 화장품은 일반 소비자뿐만 아니라 화장품을 직업적으로 사용하는 전문가(예, 미용사, 피부\n\n<!-- PAGE_10 -->\n###### 3) 화장품의 안전성은 화장품 성분의 안전성에 기반하며, 화장품 성분의 안전성은 독성시험\n\n<!-- PAGE_10 -->\n###### 2.  화장품 성분\n\n<!-- PAGE_10 -->\n###### 1) 화장품 성분은 화학물질 또는 천연물 등이며, 경우에 따라 단일 또는 혼합물일 수 있다.\n\n <!-- PAGE_10 -->\n###### 최종 제품의 안전성을 확보하기 위해서는 성분의 안전성이 확보되어야 한다.  원료 성분의\n\n<!-- PAGE_10 -->\n###### 2) 화장품 성분은 식약처장이 화장품의 제조에 사용할 수 없는 원료로 지정·고시한 것이 아\n\n<!-- PAGE_10 -->\n###### 3) 미량의 중금속 등 불순물, 제조공정이나 보관 중에 생길 수 있는 비의도적 오염물질을 가\n\n<!-- PAGE_10 -->\n###### 능한 줄이기 위한 충분한 조치를 취하여야 한다.  그럼에도 오염물질이 존재할 경우, 그 안\n\n<!-- PAGE_10 -->\n###### 4) 화장품 성분의 화학구조에 따라 물리․화학적 반응 및 생물학적 반응이 결정되며 화학적 순\n\n<!-- PAGE_10 -->\n###### 도, 조성 내의 다른 성분들과의 상호작용 및 피부투과 등은 효능과 안전성 및 안정성에 영\n\n<!-- PAGE_10 -->\n###### 5) 화장품 성분의 상호작용으로 인해 유해물질 발생(예를 들면, 니트로소아민 형성) 가능성과\n\n<!-- PAGE_10 -->\n###### 식물유래 및 동물에서 추출한 성분에 농약, 살충제, 금속물질 및 생물학적 유해물질이 함\n\n<!-- PAGE_10 -->\n###### 유되어 있을 가능성에 특별한 주의를 기울여야 한다.\n\n <!-- PAGE_10 -->\n###### 6) 피부를 투과한 화장품 성분은 국소 및 전신작용에 영향을 미칠 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 최종 제품의 안전성을 확보하기 위해서는 성분의 안전성이 확보되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_164",
      "text": "원료 성분의\n\n<!-- PAGE_10 -->\n###### 2) 화장품 성분은 식약처장이 화장품의 제조에 사용할 수 없는 원료로 지정·고시한 것이 아\n\n<!-- PAGE_10 -->\n###### 3) 미량의 중금속 등 불순물, 제조공정이나 보관 중에 생길 수 있는 비의도적 오염물질을 가\n\n<!-- PAGE_10 -->\n###### 능한 줄이기 위한 충분한 조치를 취하여야 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 163,
        "window_size": 3,
        "char_count": 212,
        "word_count": 48,
        "page_number": 10,
        "window_text": "일반사항\n\n<!-- PAGE_10 -->\n###### 1) 화장품은 제품 설명서, 표시사항 등에 따라 정상적으로 사용하거나 또는 예측가능한 사용\n\n<!-- PAGE_10 -->\n###### 2) 화장품은 일반 소비자뿐만 아니라 화장품을 직업적으로 사용하는 전문가(예, 미용사, 피부\n\n<!-- PAGE_10 -->\n###### 3) 화장품의 안전성은 화장품 성분의 안전성에 기반하며, 화장품 성분의 안전성은 독성시험\n\n<!-- PAGE_10 -->\n###### 2.  화장품 성분\n\n<!-- PAGE_10 -->\n###### 1) 화장품 성분은 화학물질 또는 천연물 등이며, 경우에 따라 단일 또는 혼합물일 수 있다.\n\n <!-- PAGE_10 -->\n###### 최종 제품의 안전성을 확보하기 위해서는 성분의 안전성이 확보되어야 한다.  원료 성분의\n\n<!-- PAGE_10 -->\n###### 2) 화장품 성분은 식약처장이 화장품의 제조에 사용할 수 없는 원료로 지정·고시한 것이 아\n\n<!-- PAGE_10 -->\n###### 3) 미량의 중금속 등 불순물, 제조공정이나 보관 중에 생길 수 있는 비의도적 오염물질을 가\n\n<!-- PAGE_10 -->\n###### 능한 줄이기 위한 충분한 조치를 취하여야 한다.  그럼에도 오염물질이 존재할 경우, 그 안\n\n<!-- PAGE_10 -->\n###### 4) 화장품 성분의 화학구조에 따라 물리․화학적 반응 및 생물학적 반응이 결정되며 화학적 순\n\n<!-- PAGE_10 -->\n###### 도, 조성 내의 다른 성분들과의 상호작용 및 피부투과 등은 효능과 안전성 및 안정성에 영\n\n<!-- PAGE_10 -->\n###### 5) 화장품 성분의 상호작용으로 인해 유해물질 발생(예를 들면, 니트로소아민 형성) 가능성과\n\n<!-- PAGE_10 -->\n###### 식물유래 및 동물에서 추출한 성분에 농약, 살충제, 금속물질 및 생물학적 유해물질이 함\n\n<!-- PAGE_10 -->\n###### 유되어 있을 가능성에 특별한 주의를 기울여야 한다.\n\n <!-- PAGE_10 -->\n###### 6) 피부를 투과한 화장품 성분은 국소 및 전신작용에 영향을 미칠 수 있다.\n\n <!-- PAGE_10 -->\n###### 7) 화장품의 안전성은 각 성분의 독성학적 특징과 유사한 조성의 제품을 사용한 경험, 신물질\n\n<!-- PAGE_10 -->\n###### 의 함유 여부 등을 참고하여 전반적으로 검토한다.\n\n",
        "original_sentence": "원료 성분의\n\n<!-- PAGE_10 -->\n###### 2) 화장품 성분은 식약처장이 화장품의 제조에 사용할 수 없는 원료로 지정·고시한 것이 아\n\n<!-- PAGE_10 -->\n###### 3) 미량의 중금속 등 불순물, 제조공정이나 보관 중에 생길 수 있는 비의도적 오염물질을 가\n\n<!-- PAGE_10 -->\n###### 능한 줄이기 위한 충분한 조치를 취하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_165",
      "text": "그럼에도 오염물질이 존재할 경우, 그 안\n\n<!-- PAGE_10 -->\n###### 4) 화장품 성분의 화학구조에 따라 물리․화학적 반응 및 생물학적 반응이 결정되며 화학적 순\n\n<!-- PAGE_10 -->\n###### 도, 조성 내의 다른 성분들과의 상호작용 및 피부투과 등은 효능과 안전성 및 안정성에 영\n\n<!-- PAGE_10 -->\n###### 5) 화장품 성분의 상호작용으로 인해 유해물질 발생(예를 들면, 니트로소아민 형성) 가능성과\n\n<!-- PAGE_10 -->\n###### 식물유래 및 동물에서 추출한 성분에 농약, 살충제, 금속물질 및 생물학적 유해물질이 함\n\n<!-- PAGE_10 -->\n###### 유되어 있을 가능성에 특별한 주의를 기울여야 한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 164,
        "window_size": 3,
        "char_count": 381,
        "word_count": 83,
        "page_number": 10,
        "window_text": "화장품 성분\n\n<!-- PAGE_10 -->\n###### 1) 화장품 성분은 화학물질 또는 천연물 등이며, 경우에 따라 단일 또는 혼합물일 수 있다.\n\n <!-- PAGE_10 -->\n###### 최종 제품의 안전성을 확보하기 위해서는 성분의 안전성이 확보되어야 한다.  원료 성분의\n\n<!-- PAGE_10 -->\n###### 2) 화장품 성분은 식약처장이 화장품의 제조에 사용할 수 없는 원료로 지정·고시한 것이 아\n\n<!-- PAGE_10 -->\n###### 3) 미량의 중금속 등 불순물, 제조공정이나 보관 중에 생길 수 있는 비의도적 오염물질을 가\n\n<!-- PAGE_10 -->\n###### 능한 줄이기 위한 충분한 조치를 취하여야 한다.  그럼에도 오염물질이 존재할 경우, 그 안\n\n<!-- PAGE_10 -->\n###### 4) 화장품 성분의 화학구조에 따라 물리․화학적 반응 및 생물학적 반응이 결정되며 화학적 순\n\n<!-- PAGE_10 -->\n###### 도, 조성 내의 다른 성분들과의 상호작용 및 피부투과 등은 효능과 안전성 및 안정성에 영\n\n<!-- PAGE_10 -->\n###### 5) 화장품 성분의 상호작용으로 인해 유해물질 발생(예를 들면, 니트로소아민 형성) 가능성과\n\n<!-- PAGE_10 -->\n###### 식물유래 및 동물에서 추출한 성분에 농약, 살충제, 금속물질 및 생물학적 유해물질이 함\n\n<!-- PAGE_10 -->\n###### 유되어 있을 가능성에 특별한 주의를 기울여야 한다.\n\n <!-- PAGE_10 -->\n###### 6) 피부를 투과한 화장품 성분은 국소 및 전신작용에 영향을 미칠 수 있다.\n\n <!-- PAGE_10 -->\n###### 7) 화장품의 안전성은 각 성분의 독성학적 특징과 유사한 조성의 제품을 사용한 경험, 신물질\n\n<!-- PAGE_10 -->\n###### 의 함유 여부 등을 참고하여 전반적으로 검토한다.\n\n <!-- PAGE_10 -->\n###### 8) 화장품에 대한 안전성은 특정 소비자(영유아, 민감성 피부 등) 대상 여부, 피부 투과 혹은\n\n<!-- PAGE_10 -->\n###### 피부 자극을 증가시킬 수 있는 특정 성분(피부투과 강화제, 유기 용제, 산성 성분 등) 존재\n\n<!-- PAGE_10 -->\n###### 여부, 독성학적 우려가 예측되는 성분 간의 화학반응 유무 등 추가 정보를 고려하여 평가\n\n<!-- PAGE_10 -->\n###### 한다.\n\n",
        "original_sentence": "그럼에도 오염물질이 존재할 경우, 그 안\n\n<!-- PAGE_10 -->\n###### 4) 화장품 성분의 화학구조에 따라 물리․화학적 반응 및 생물학적 반응이 결정되며 화학적 순\n\n<!-- PAGE_10 -->\n###### 도, 조성 내의 다른 성분들과의 상호작용 및 피부투과 등은 효능과 안전성 및 안정성에 영\n\n<!-- PAGE_10 -->\n###### 5) 화장품 성분의 상호작용으로 인해 유해물질 발생(예를 들면, 니트로소아민 형성) 가능성과\n\n<!-- PAGE_10 -->\n###### 식물유래 및 동물에서 추출한 성분에 농약, 살충제, 금속물질 및 생물학적 유해물질이 함\n\n<!-- PAGE_10 -->\n###### 유되어 있을 가능성에 특별한 주의를 기울여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_166",
      "text": "<!-- PAGE_10 -->\n###### 6) 피부를 투과한 화장품 성분은 국소 및 전신작용에 영향을 미칠 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 165,
        "window_size": 3,
        "char_count": 68,
        "word_count": 16,
        "page_number": 10,
        "window_text": "<!-- PAGE_10 -->\n###### 최종 제품의 안전성을 확보하기 위해서는 성분의 안전성이 확보되어야 한다.  원료 성분의\n\n<!-- PAGE_10 -->\n###### 2) 화장품 성분은 식약처장이 화장품의 제조에 사용할 수 없는 원료로 지정·고시한 것이 아\n\n<!-- PAGE_10 -->\n###### 3) 미량의 중금속 등 불순물, 제조공정이나 보관 중에 생길 수 있는 비의도적 오염물질을 가\n\n<!-- PAGE_10 -->\n###### 능한 줄이기 위한 충분한 조치를 취하여야 한다.  그럼에도 오염물질이 존재할 경우, 그 안\n\n<!-- PAGE_10 -->\n###### 4) 화장품 성분의 화학구조에 따라 물리․화학적 반응 및 생물학적 반응이 결정되며 화학적 순\n\n<!-- PAGE_10 -->\n###### 도, 조성 내의 다른 성분들과의 상호작용 및 피부투과 등은 효능과 안전성 및 안정성에 영\n\n<!-- PAGE_10 -->\n###### 5) 화장품 성분의 상호작용으로 인해 유해물질 발생(예를 들면, 니트로소아민 형성) 가능성과\n\n<!-- PAGE_10 -->\n###### 식물유래 및 동물에서 추출한 성분에 농약, 살충제, 금속물질 및 생물학적 유해물질이 함\n\n<!-- PAGE_10 -->\n###### 유되어 있을 가능성에 특별한 주의를 기울여야 한다.\n\n <!-- PAGE_10 -->\n###### 6) 피부를 투과한 화장품 성분은 국소 및 전신작용에 영향을 미칠 수 있다.\n\n <!-- PAGE_10 -->\n###### 7) 화장품의 안전성은 각 성분의 독성학적 특징과 유사한 조성의 제품을 사용한 경험, 신물질\n\n<!-- PAGE_10 -->\n###### 의 함유 여부 등을 참고하여 전반적으로 검토한다.\n\n <!-- PAGE_10 -->\n###### 8) 화장품에 대한 안전성은 특정 소비자(영유아, 민감성 피부 등) 대상 여부, 피부 투과 혹은\n\n<!-- PAGE_10 -->\n###### 피부 자극을 증가시킬 수 있는 특정 성분(피부투과 강화제, 유기 용제, 산성 성분 등) 존재\n\n<!-- PAGE_10 -->\n###### 여부, 독성학적 우려가 예측되는 성분 간의 화학반응 유무 등 추가 정보를 고려하여 평가\n\n<!-- PAGE_10 -->\n###### 한다.\n\n - - 5 -\n<!-- PAGE_11 -->\n##### 제3장 화장품 위해평가\n\n<!-- PAGE_11 -->\n###### 1. ",
        "original_sentence": "<!-- PAGE_10 -->\n###### 6) 피부를 투과한 화장품 성분은 국소 및 전신작용에 영향을 미칠 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_167",
      "text": "<!-- PAGE_10 -->\n###### 7) 화장품의 안전성은 각 성분의 독성학적 특징과 유사한 조성의 제품을 사용한 경험, 신물질\n\n<!-- PAGE_10 -->\n###### 의 함유 여부 등을 참고하여 전반적으로 검토한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 166,
        "window_size": 3,
        "char_count": 130,
        "word_count": 28,
        "page_number": 10,
        "window_text": "원료 성분의\n\n<!-- PAGE_10 -->\n###### 2) 화장품 성분은 식약처장이 화장품의 제조에 사용할 수 없는 원료로 지정·고시한 것이 아\n\n<!-- PAGE_10 -->\n###### 3) 미량의 중금속 등 불순물, 제조공정이나 보관 중에 생길 수 있는 비의도적 오염물질을 가\n\n<!-- PAGE_10 -->\n###### 능한 줄이기 위한 충분한 조치를 취하여야 한다.  그럼에도 오염물질이 존재할 경우, 그 안\n\n<!-- PAGE_10 -->\n###### 4) 화장품 성분의 화학구조에 따라 물리․화학적 반응 및 생물학적 반응이 결정되며 화학적 순\n\n<!-- PAGE_10 -->\n###### 도, 조성 내의 다른 성분들과의 상호작용 및 피부투과 등은 효능과 안전성 및 안정성에 영\n\n<!-- PAGE_10 -->\n###### 5) 화장품 성분의 상호작용으로 인해 유해물질 발생(예를 들면, 니트로소아민 형성) 가능성과\n\n<!-- PAGE_10 -->\n###### 식물유래 및 동물에서 추출한 성분에 농약, 살충제, 금속물질 및 생물학적 유해물질이 함\n\n<!-- PAGE_10 -->\n###### 유되어 있을 가능성에 특별한 주의를 기울여야 한다.\n\n <!-- PAGE_10 -->\n###### 6) 피부를 투과한 화장품 성분은 국소 및 전신작용에 영향을 미칠 수 있다.\n\n <!-- PAGE_10 -->\n###### 7) 화장품의 안전성은 각 성분의 독성학적 특징과 유사한 조성의 제품을 사용한 경험, 신물질\n\n<!-- PAGE_10 -->\n###### 의 함유 여부 등을 참고하여 전반적으로 검토한다.\n\n <!-- PAGE_10 -->\n###### 8) 화장품에 대한 안전성은 특정 소비자(영유아, 민감성 피부 등) 대상 여부, 피부 투과 혹은\n\n<!-- PAGE_10 -->\n###### 피부 자극을 증가시킬 수 있는 특정 성분(피부투과 강화제, 유기 용제, 산성 성분 등) 존재\n\n<!-- PAGE_10 -->\n###### 여부, 독성학적 우려가 예측되는 성분 간의 화학반응 유무 등 추가 정보를 고려하여 평가\n\n<!-- PAGE_10 -->\n###### 한다.\n\n - - 5 -\n<!-- PAGE_11 -->\n##### 제3장 화장품 위해평가\n\n<!-- PAGE_11 -->\n###### 1.  위해평가 절차 및 수행에 필요한 일반사항\n\n<!-- PAGE_11 -->\n###### 1-1. ",
        "original_sentence": "<!-- PAGE_10 -->\n###### 7) 화장품의 안전성은 각 성분의 독성학적 특징과 유사한 조성의 제품을 사용한 경험, 신물질\n\n<!-- PAGE_10 -->\n###### 의 함유 여부 등을 참고하여 전반적으로 검토한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_168",
      "text": "<!-- PAGE_10 -->\n###### 8) 화장품에 대한 안전성은 특정 소비자(영유아, 민감성 피부 등) 대상 여부, 피부 투과 혹은\n\n<!-- PAGE_10 -->\n###### 피부 자극을 증가시킬 수 있는 특정 성분(피부투과 강화제, 유기 용제, 산성 성분 등) 존재\n\n<!-- PAGE_10 -->\n###### 여부, 독성학적 우려가 예측되는 성분 간의 화학반응 유무 등 추가 정보를 고려하여 평가\n\n<!-- PAGE_10 -->\n###### 한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 167,
        "window_size": 3,
        "char_count": 259,
        "word_count": 58,
        "page_number": 10,
        "window_text": "그럼에도 오염물질이 존재할 경우, 그 안\n\n<!-- PAGE_10 -->\n###### 4) 화장품 성분의 화학구조에 따라 물리․화학적 반응 및 생물학적 반응이 결정되며 화학적 순\n\n<!-- PAGE_10 -->\n###### 도, 조성 내의 다른 성분들과의 상호작용 및 피부투과 등은 효능과 안전성 및 안정성에 영\n\n<!-- PAGE_10 -->\n###### 5) 화장품 성분의 상호작용으로 인해 유해물질 발생(예를 들면, 니트로소아민 형성) 가능성과\n\n<!-- PAGE_10 -->\n###### 식물유래 및 동물에서 추출한 성분에 농약, 살충제, 금속물질 및 생물학적 유해물질이 함\n\n<!-- PAGE_10 -->\n###### 유되어 있을 가능성에 특별한 주의를 기울여야 한다.\n\n <!-- PAGE_10 -->\n###### 6) 피부를 투과한 화장품 성분은 국소 및 전신작용에 영향을 미칠 수 있다.\n\n <!-- PAGE_10 -->\n###### 7) 화장품의 안전성은 각 성분의 독성학적 특징과 유사한 조성의 제품을 사용한 경험, 신물질\n\n<!-- PAGE_10 -->\n###### 의 함유 여부 등을 참고하여 전반적으로 검토한다.\n\n <!-- PAGE_10 -->\n###### 8) 화장품에 대한 안전성은 특정 소비자(영유아, 민감성 피부 등) 대상 여부, 피부 투과 혹은\n\n<!-- PAGE_10 -->\n###### 피부 자극을 증가시킬 수 있는 특정 성분(피부투과 강화제, 유기 용제, 산성 성분 등) 존재\n\n<!-- PAGE_10 -->\n###### 여부, 독성학적 우려가 예측되는 성분 간의 화학반응 유무 등 추가 정보를 고려하여 평가\n\n<!-- PAGE_10 -->\n###### 한다.\n\n - - 5 -\n<!-- PAGE_11 -->\n##### 제3장 화장품 위해평가\n\n<!-- PAGE_11 -->\n###### 1.  위해평가 절차 및 수행에 필요한 일반사항\n\n<!-- PAGE_11 -->\n###### 1-1.  위해평가 절차\n\n<!-- PAGE_11 -->\n###### 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할 수 있는 위해 영향과 발생확\n\n<!-- PAGE_11 -->\n###### 률을 과학적으로 예측하는 위해평가는 위험성 확인, 위험성 결정, 노출평가, 위해도 결정의 4\n\n<!-- PAGE_11 -->\n###### 단계의 과정을 거쳐 실시한다.\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 8) 화장품에 대한 안전성은 특정 소비자(영유아, 민감성 피부 등) 대상 여부, 피부 투과 혹은\n\n<!-- PAGE_10 -->\n###### 피부 자극을 증가시킬 수 있는 특정 성분(피부투과 강화제, 유기 용제, 산성 성분 등) 존재\n\n<!-- PAGE_10 -->\n###### 여부, 독성학적 우려가 예측되는 성분 간의 화학반응 유무 등 추가 정보를 고려하여 평가\n\n<!-- PAGE_10 -->\n###### 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_169",
      "text": "- - 5 -\n<!-- PAGE_11 -->\n##### 제3장 화장품 위해평가\n\n<!-- PAGE_11 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 168,
        "window_size": 3,
        "char_count": 72,
        "word_count": 16,
        "page_number": 11,
        "window_text": "<!-- PAGE_10 -->\n###### 6) 피부를 투과한 화장품 성분은 국소 및 전신작용에 영향을 미칠 수 있다.\n\n <!-- PAGE_10 -->\n###### 7) 화장품의 안전성은 각 성분의 독성학적 특징과 유사한 조성의 제품을 사용한 경험, 신물질\n\n<!-- PAGE_10 -->\n###### 의 함유 여부 등을 참고하여 전반적으로 검토한다.\n\n <!-- PAGE_10 -->\n###### 8) 화장품에 대한 안전성은 특정 소비자(영유아, 민감성 피부 등) 대상 여부, 피부 투과 혹은\n\n<!-- PAGE_10 -->\n###### 피부 자극을 증가시킬 수 있는 특정 성분(피부투과 강화제, 유기 용제, 산성 성분 등) 존재\n\n<!-- PAGE_10 -->\n###### 여부, 독성학적 우려가 예측되는 성분 간의 화학반응 유무 등 추가 정보를 고려하여 평가\n\n<!-- PAGE_10 -->\n###### 한다.\n\n - - 5 -\n<!-- PAGE_11 -->\n##### 제3장 화장품 위해평가\n\n<!-- PAGE_11 -->\n###### 1.  위해평가 절차 및 수행에 필요한 일반사항\n\n<!-- PAGE_11 -->\n###### 1-1.  위해평가 절차\n\n<!-- PAGE_11 -->\n###### 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할 수 있는 위해 영향과 발생확\n\n<!-- PAGE_11 -->\n###### 률을 과학적으로 예측하는 위해평가는 위험성 확인, 위험성 결정, 노출평가, 위해도 결정의 4\n\n<!-- PAGE_11 -->\n###### 단계의 과정을 거쳐 실시한다.\n\n <!-- PAGE_11 -->\n###### 1) 위험성 확인(Hazard Identification) : 위해요소에 노출됨에 따라 인체 건강에 위해한 영향\n\n<!-- PAGE_11 -->\n###### 을 미칠 가능성에 대하여 물질의 고유한 물리화학적 특성, 독성의 정도 및 그 영향 등을\n\n<!-- PAGE_11 -->\n###### 2) 위험성 결정(Hazard Characterization) : 노출과 독성반응에 대한 관계를 평가하는 단계로 주\n\n<!-- PAGE_11 -->\n###### 3) 노출평가(Exposure Assessment) : 화장품의 사용으로 인해 위해요소에 노출되는 양 또는\n\n<!-- PAGE_11 -->\n###### 4) 위해도 결정(Risk Characterization) : 위해요소 및 이를 함유한 화장품의 사용에 따라 독성\n\n<!-- PAGE_11 -->\n###### 기준값 및 노출량을 고려하여 사람에게 미칠 수 있는 위해의 정도 등을 정량적으로 예측\n\n- - 6 -\n<!-- PAGE_12 -->\n###### 1-2. ",
        "original_sentence": "- - 5 -\n<!-- PAGE_11 -->\n##### 제3장 화장품 위해평가\n\n<!-- PAGE_11 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_170",
      "text": "위해평가 절차 및 수행에 필요한 일반사항\n\n<!-- PAGE_11 -->\n###### 1-1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 169,
        "window_size": 3,
        "char_count": 53,
        "word_count": 11,
        "page_number": 11,
        "window_text": "<!-- PAGE_10 -->\n###### 7) 화장품의 안전성은 각 성분의 독성학적 특징과 유사한 조성의 제품을 사용한 경험, 신물질\n\n<!-- PAGE_10 -->\n###### 의 함유 여부 등을 참고하여 전반적으로 검토한다.\n\n <!-- PAGE_10 -->\n###### 8) 화장품에 대한 안전성은 특정 소비자(영유아, 민감성 피부 등) 대상 여부, 피부 투과 혹은\n\n<!-- PAGE_10 -->\n###### 피부 자극을 증가시킬 수 있는 특정 성분(피부투과 강화제, 유기 용제, 산성 성분 등) 존재\n\n<!-- PAGE_10 -->\n###### 여부, 독성학적 우려가 예측되는 성분 간의 화학반응 유무 등 추가 정보를 고려하여 평가\n\n<!-- PAGE_10 -->\n###### 한다.\n\n - - 5 -\n<!-- PAGE_11 -->\n##### 제3장 화장품 위해평가\n\n<!-- PAGE_11 -->\n###### 1.  위해평가 절차 및 수행에 필요한 일반사항\n\n<!-- PAGE_11 -->\n###### 1-1.  위해평가 절차\n\n<!-- PAGE_11 -->\n###### 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할 수 있는 위해 영향과 발생확\n\n<!-- PAGE_11 -->\n###### 률을 과학적으로 예측하는 위해평가는 위험성 확인, 위험성 결정, 노출평가, 위해도 결정의 4\n\n<!-- PAGE_11 -->\n###### 단계의 과정을 거쳐 실시한다.\n\n <!-- PAGE_11 -->\n###### 1) 위험성 확인(Hazard Identification) : 위해요소에 노출됨에 따라 인체 건강에 위해한 영향\n\n<!-- PAGE_11 -->\n###### 을 미칠 가능성에 대하여 물질의 고유한 물리화학적 특성, 독성의 정도 및 그 영향 등을\n\n<!-- PAGE_11 -->\n###### 2) 위험성 결정(Hazard Characterization) : 노출과 독성반응에 대한 관계를 평가하는 단계로 주\n\n<!-- PAGE_11 -->\n###### 3) 노출평가(Exposure Assessment) : 화장품의 사용으로 인해 위해요소에 노출되는 양 또는\n\n<!-- PAGE_11 -->\n###### 4) 위해도 결정(Risk Characterization) : 위해요소 및 이를 함유한 화장품의 사용에 따라 독성\n\n<!-- PAGE_11 -->\n###### 기준값 및 노출량을 고려하여 사람에게 미칠 수 있는 위해의 정도 등을 정량적으로 예측\n\n- - 6 -\n<!-- PAGE_12 -->\n###### 1-2.  위해평가 수행에 필요한 일반사항\n\n<!-- PAGE_12 -->\n###### 위해평가 수행에 필요한 일반사항은 다음과 같으며, 위해요소 특성에 따라 예외가 있을 수\n\n<!-- PAGE_12 -->\n###### 있다.\n\n",
        "original_sentence": "위해평가 절차 및 수행에 필요한 일반사항\n\n<!-- PAGE_11 -->\n###### 1-1. "
      }
    },
    {
      "chunk_id": "chunk_171",
      "text": "위해평가 절차\n\n<!-- PAGE_11 -->\n###### 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할 수 있는 위해 영향과 발생확\n\n<!-- PAGE_11 -->\n###### 률을 과학적으로 예측하는 위해평가는 위험성 확인, 위험성 결정, 노출평가, 위해도 결정의 4\n\n<!-- PAGE_11 -->\n###### 단계의 과정을 거쳐 실시한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 170,
        "window_size": 3,
        "char_count": 201,
        "word_count": 42,
        "page_number": 11,
        "window_text": "<!-- PAGE_10 -->\n###### 8) 화장품에 대한 안전성은 특정 소비자(영유아, 민감성 피부 등) 대상 여부, 피부 투과 혹은\n\n<!-- PAGE_10 -->\n###### 피부 자극을 증가시킬 수 있는 특정 성분(피부투과 강화제, 유기 용제, 산성 성분 등) 존재\n\n<!-- PAGE_10 -->\n###### 여부, 독성학적 우려가 예측되는 성분 간의 화학반응 유무 등 추가 정보를 고려하여 평가\n\n<!-- PAGE_10 -->\n###### 한다.\n\n - - 5 -\n<!-- PAGE_11 -->\n##### 제3장 화장품 위해평가\n\n<!-- PAGE_11 -->\n###### 1.  위해평가 절차 및 수행에 필요한 일반사항\n\n<!-- PAGE_11 -->\n###### 1-1.  위해평가 절차\n\n<!-- PAGE_11 -->\n###### 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할 수 있는 위해 영향과 발생확\n\n<!-- PAGE_11 -->\n###### 률을 과학적으로 예측하는 위해평가는 위험성 확인, 위험성 결정, 노출평가, 위해도 결정의 4\n\n<!-- PAGE_11 -->\n###### 단계의 과정을 거쳐 실시한다.\n\n <!-- PAGE_11 -->\n###### 1) 위험성 확인(Hazard Identification) : 위해요소에 노출됨에 따라 인체 건강에 위해한 영향\n\n<!-- PAGE_11 -->\n###### 을 미칠 가능성에 대하여 물질의 고유한 물리화학적 특성, 독성의 정도 및 그 영향 등을\n\n<!-- PAGE_11 -->\n###### 2) 위험성 결정(Hazard Characterization) : 노출과 독성반응에 대한 관계를 평가하는 단계로 주\n\n<!-- PAGE_11 -->\n###### 3) 노출평가(Exposure Assessment) : 화장품의 사용으로 인해 위해요소에 노출되는 양 또는\n\n<!-- PAGE_11 -->\n###### 4) 위해도 결정(Risk Characterization) : 위해요소 및 이를 함유한 화장품의 사용에 따라 독성\n\n<!-- PAGE_11 -->\n###### 기준값 및 노출량을 고려하여 사람에게 미칠 수 있는 위해의 정도 등을 정량적으로 예측\n\n- - 6 -\n<!-- PAGE_12 -->\n###### 1-2.  위해평가 수행에 필요한 일반사항\n\n<!-- PAGE_12 -->\n###### 위해평가 수행에 필요한 일반사항은 다음과 같으며, 위해요소 특성에 따라 예외가 있을 수\n\n<!-- PAGE_12 -->\n###### 있다.\n\n <!-- PAGE_12 -->\n###### 1) 위해평가 시 본 가이드라인을 체크리스트로 간주할 수 없으며, 화장품 성분의 특성에 따\n\n<!-- PAGE_12 -->\n###### 2) 독성자료는 OECD 가이드라인 등 국제적으로 인정된 프로토콜에 따른 시험을 우선적으로\n\n<!-- PAGE_12 -->\n###### 3) 반복투여독성시험, 생식독성시험 등 독성시험 자료가 충분하지 않거나 시험결과의 신뢰성\n\n<!-- PAGE_12 -->\n###### 확인 등 독성시험 자료가 제한적인 경우, 위험성 확인 단계에서 자료 부족임을 명시하고\n\n<!-- PAGE_12 -->\n###### 4) 평가성분은 화장품 중 다른 성분에 의해 피부투과에 영향을 받을 수 있으므로 피부흡수\n\n<!-- PAGE_12 -->\n###### 5) 노출평가는 여러 상황을 고려하여 현실적인 노출시나리오를 작성한다.\n\n",
        "original_sentence": "위해평가 절차\n\n<!-- PAGE_11 -->\n###### 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할 수 있는 위해 영향과 발생확\n\n<!-- PAGE_11 -->\n###### 률을 과학적으로 예측하는 위해평가는 위험성 확인, 위험성 결정, 노출평가, 위해도 결정의 4\n\n<!-- PAGE_11 -->\n###### 단계의 과정을 거쳐 실시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_172",
      "text": "<!-- PAGE_11 -->\n###### 1) 위험성 확인(Hazard Identification) : 위해요소에 노출됨에 따라 인체 건강에 위해한 영향\n\n<!-- PAGE_11 -->\n###### 을 미칠 가능성에 대하여 물질의 고유한 물리화학적 특성, 독성의 정도 및 그 영향 등을\n\n<!-- PAGE_11 -->\n###### 2) 위험성 결정(Hazard Characterization) : 노출과 독성반응에 대한 관계를 평가하는 단계로 주\n\n<!-- PAGE_11 -->\n###### 3) 노출평가(Exposure Assessment) : 화장품의 사용으로 인해 위해요소에 노출되는 양 또는\n\n<!-- PAGE_11 -->\n###### 4) 위해도 결정(Risk Characterization) : 위해요소 및 이를 함유한 화장품의 사용에 따라 독성\n\n<!-- PAGE_11 -->\n###### 기준값 및 노출량을 고려하여 사람에게 미칠 수 있는 위해의 정도 등을 정량적으로 예측\n\n- - 6 -\n<!-- PAGE_12 -->\n###### 1-2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 171,
        "window_size": 3,
        "char_count": 536,
        "word_count": 108,
        "page_number": 11,
        "window_text": "- - 5 -\n<!-- PAGE_11 -->\n##### 제3장 화장품 위해평가\n\n<!-- PAGE_11 -->\n###### 1.  위해평가 절차 및 수행에 필요한 일반사항\n\n<!-- PAGE_11 -->\n###### 1-1.  위해평가 절차\n\n<!-- PAGE_11 -->\n###### 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할 수 있는 위해 영향과 발생확\n\n<!-- PAGE_11 -->\n###### 률을 과학적으로 예측하는 위해평가는 위험성 확인, 위험성 결정, 노출평가, 위해도 결정의 4\n\n<!-- PAGE_11 -->\n###### 단계의 과정을 거쳐 실시한다.\n\n <!-- PAGE_11 -->\n###### 1) 위험성 확인(Hazard Identification) : 위해요소에 노출됨에 따라 인체 건강에 위해한 영향\n\n<!-- PAGE_11 -->\n###### 을 미칠 가능성에 대하여 물질의 고유한 물리화학적 특성, 독성의 정도 및 그 영향 등을\n\n<!-- PAGE_11 -->\n###### 2) 위험성 결정(Hazard Characterization) : 노출과 독성반응에 대한 관계를 평가하는 단계로 주\n\n<!-- PAGE_11 -->\n###### 3) 노출평가(Exposure Assessment) : 화장품의 사용으로 인해 위해요소에 노출되는 양 또는\n\n<!-- PAGE_11 -->\n###### 4) 위해도 결정(Risk Characterization) : 위해요소 및 이를 함유한 화장품의 사용에 따라 독성\n\n<!-- PAGE_11 -->\n###### 기준값 및 노출량을 고려하여 사람에게 미칠 수 있는 위해의 정도 등을 정량적으로 예측\n\n- - 6 -\n<!-- PAGE_12 -->\n###### 1-2.  위해평가 수행에 필요한 일반사항\n\n<!-- PAGE_12 -->\n###### 위해평가 수행에 필요한 일반사항은 다음과 같으며, 위해요소 특성에 따라 예외가 있을 수\n\n<!-- PAGE_12 -->\n###### 있다.\n\n <!-- PAGE_12 -->\n###### 1) 위해평가 시 본 가이드라인을 체크리스트로 간주할 수 없으며, 화장품 성분의 특성에 따\n\n<!-- PAGE_12 -->\n###### 2) 독성자료는 OECD 가이드라인 등 국제적으로 인정된 프로토콜에 따른 시험을 우선적으로\n\n<!-- PAGE_12 -->\n###### 3) 반복투여독성시험, 생식독성시험 등 독성시험 자료가 충분하지 않거나 시험결과의 신뢰성\n\n<!-- PAGE_12 -->\n###### 확인 등 독성시험 자료가 제한적인 경우, 위험성 확인 단계에서 자료 부족임을 명시하고\n\n<!-- PAGE_12 -->\n###### 4) 평가성분은 화장품 중 다른 성분에 의해 피부투과에 영향을 받을 수 있으므로 피부흡수\n\n<!-- PAGE_12 -->\n###### 5) 노출평가는 여러 상황을 고려하여 현실적인 노출시나리오를 작성한다.\n\n <!-- PAGE_12 -->\n###### 6) 결과보고서는 관련 자료의 불확실성 등을 고려하여 정량적 또는 정성적으로 표현할 수 있\n\n<!-- PAGE_12 -->\n###### 7) 위해평가 결과는 새로운 독성시험 결과가 보고되는 등 새로운 과학적 사실이 밝혀지는 경\n\n<!-- PAGE_12 -->\n###### 1-3. ",
        "original_sentence": "<!-- PAGE_11 -->\n###### 1) 위험성 확인(Hazard Identification) : 위해요소에 노출됨에 따라 인체 건강에 위해한 영향\n\n<!-- PAGE_11 -->\n###### 을 미칠 가능성에 대하여 물질의 고유한 물리화학적 특성, 독성의 정도 및 그 영향 등을\n\n<!-- PAGE_11 -->\n###### 2) 위험성 결정(Hazard Characterization) : 노출과 독성반응에 대한 관계를 평가하는 단계로 주\n\n<!-- PAGE_11 -->\n###### 3) 노출평가(Exposure Assessment) : 화장품의 사용으로 인해 위해요소에 노출되는 양 또는\n\n<!-- PAGE_11 -->\n###### 4) 위해도 결정(Risk Characterization) : 위해요소 및 이를 함유한 화장품의 사용에 따라 독성\n\n<!-- PAGE_11 -->\n###### 기준값 및 노출량을 고려하여 사람에게 미칠 수 있는 위해의 정도 등을 정량적으로 예측\n\n- - 6 -\n<!-- PAGE_12 -->\n###### 1-2. "
      }
    },
    {
      "chunk_id": "chunk_173",
      "text": "위해평가 수행에 필요한 일반사항\n\n<!-- PAGE_12 -->\n###### 위해평가 수행에 필요한 일반사항은 다음과 같으며, 위해요소 특성에 따라 예외가 있을 수\n\n<!-- PAGE_12 -->\n###### 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 172,
        "window_size": 3,
        "char_count": 122,
        "word_count": 25,
        "page_number": 12,
        "window_text": "위해평가 절차 및 수행에 필요한 일반사항\n\n<!-- PAGE_11 -->\n###### 1-1.  위해평가 절차\n\n<!-- PAGE_11 -->\n###### 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할 수 있는 위해 영향과 발생확\n\n<!-- PAGE_11 -->\n###### 률을 과학적으로 예측하는 위해평가는 위험성 확인, 위험성 결정, 노출평가, 위해도 결정의 4\n\n<!-- PAGE_11 -->\n###### 단계의 과정을 거쳐 실시한다.\n\n <!-- PAGE_11 -->\n###### 1) 위험성 확인(Hazard Identification) : 위해요소에 노출됨에 따라 인체 건강에 위해한 영향\n\n<!-- PAGE_11 -->\n###### 을 미칠 가능성에 대하여 물질의 고유한 물리화학적 특성, 독성의 정도 및 그 영향 등을\n\n<!-- PAGE_11 -->\n###### 2) 위험성 결정(Hazard Characterization) : 노출과 독성반응에 대한 관계를 평가하는 단계로 주\n\n<!-- PAGE_11 -->\n###### 3) 노출평가(Exposure Assessment) : 화장품의 사용으로 인해 위해요소에 노출되는 양 또는\n\n<!-- PAGE_11 -->\n###### 4) 위해도 결정(Risk Characterization) : 위해요소 및 이를 함유한 화장품의 사용에 따라 독성\n\n<!-- PAGE_11 -->\n###### 기준값 및 노출량을 고려하여 사람에게 미칠 수 있는 위해의 정도 등을 정량적으로 예측\n\n- - 6 -\n<!-- PAGE_12 -->\n###### 1-2.  위해평가 수행에 필요한 일반사항\n\n<!-- PAGE_12 -->\n###### 위해평가 수행에 필요한 일반사항은 다음과 같으며, 위해요소 특성에 따라 예외가 있을 수\n\n<!-- PAGE_12 -->\n###### 있다.\n\n <!-- PAGE_12 -->\n###### 1) 위해평가 시 본 가이드라인을 체크리스트로 간주할 수 없으며, 화장품 성분의 특성에 따\n\n<!-- PAGE_12 -->\n###### 2) 독성자료는 OECD 가이드라인 등 국제적으로 인정된 프로토콜에 따른 시험을 우선적으로\n\n<!-- PAGE_12 -->\n###### 3) 반복투여독성시험, 생식독성시험 등 독성시험 자료가 충분하지 않거나 시험결과의 신뢰성\n\n<!-- PAGE_12 -->\n###### 확인 등 독성시험 자료가 제한적인 경우, 위험성 확인 단계에서 자료 부족임을 명시하고\n\n<!-- PAGE_12 -->\n###### 4) 평가성분은 화장품 중 다른 성분에 의해 피부투과에 영향을 받을 수 있으므로 피부흡수\n\n<!-- PAGE_12 -->\n###### 5) 노출평가는 여러 상황을 고려하여 현실적인 노출시나리오를 작성한다.\n\n <!-- PAGE_12 -->\n###### 6) 결과보고서는 관련 자료의 불확실성 등을 고려하여 정량적 또는 정성적으로 표현할 수 있\n\n<!-- PAGE_12 -->\n###### 7) 위해평가 결과는 새로운 독성시험 결과가 보고되는 등 새로운 과학적 사실이 밝혀지는 경\n\n<!-- PAGE_12 -->\n###### 1-3.  위해평가 대상\n\n<!-- PAGE_12 -->\n###### 1) 관련 규정에 따라 국민보건상 위해 우려가 제기되는 화장품 원료, 화장품 사용한도 원료\n\n<!-- PAGE_12 -->\n###### 2) 비의도적 오염물질의 검출허용한도 설정이 필요한 경우에 위해평가를 수행할 수 있다.\n\n",
        "original_sentence": "위해평가 수행에 필요한 일반사항\n\n<!-- PAGE_12 -->\n###### 위해평가 수행에 필요한 일반사항은 다음과 같으며, 위해요소 특성에 따라 예외가 있을 수\n\n<!-- PAGE_12 -->\n###### 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_174",
      "text": "<!-- PAGE_12 -->\n###### 1) 위해평가 시 본 가이드라인을 체크리스트로 간주할 수 없으며, 화장품 성분의 특성에 따\n\n<!-- PAGE_12 -->\n###### 2) 독성자료는 OECD 가이드라인 등 국제적으로 인정된 프로토콜에 따른 시험을 우선적으로\n\n<!-- PAGE_12 -->\n###### 3) 반복투여독성시험, 생식독성시험 등 독성시험 자료가 충분하지 않거나 시험결과의 신뢰성\n\n<!-- PAGE_12 -->\n###### 확인 등 독성시험 자료가 제한적인 경우, 위험성 확인 단계에서 자료 부족임을 명시하고\n\n<!-- PAGE_12 -->\n###### 4) 평가성분은 화장품 중 다른 성분에 의해 피부투과에 영향을 받을 수 있으므로 피부흡수\n\n<!-- PAGE_12 -->\n###### 5) 노출평가는 여러 상황을 고려하여 현실적인 노출시나리오를 작성한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 173,
        "window_size": 3,
        "char_count": 440,
        "word_count": 91,
        "page_number": 12,
        "window_text": "위해평가 절차\n\n<!-- PAGE_11 -->\n###### 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할 수 있는 위해 영향과 발생확\n\n<!-- PAGE_11 -->\n###### 률을 과학적으로 예측하는 위해평가는 위험성 확인, 위험성 결정, 노출평가, 위해도 결정의 4\n\n<!-- PAGE_11 -->\n###### 단계의 과정을 거쳐 실시한다.\n\n <!-- PAGE_11 -->\n###### 1) 위험성 확인(Hazard Identification) : 위해요소에 노출됨에 따라 인체 건강에 위해한 영향\n\n<!-- PAGE_11 -->\n###### 을 미칠 가능성에 대하여 물질의 고유한 물리화학적 특성, 독성의 정도 및 그 영향 등을\n\n<!-- PAGE_11 -->\n###### 2) 위험성 결정(Hazard Characterization) : 노출과 독성반응에 대한 관계를 평가하는 단계로 주\n\n<!-- PAGE_11 -->\n###### 3) 노출평가(Exposure Assessment) : 화장품의 사용으로 인해 위해요소에 노출되는 양 또는\n\n<!-- PAGE_11 -->\n###### 4) 위해도 결정(Risk Characterization) : 위해요소 및 이를 함유한 화장품의 사용에 따라 독성\n\n<!-- PAGE_11 -->\n###### 기준값 및 노출량을 고려하여 사람에게 미칠 수 있는 위해의 정도 등을 정량적으로 예측\n\n- - 6 -\n<!-- PAGE_12 -->\n###### 1-2.  위해평가 수행에 필요한 일반사항\n\n<!-- PAGE_12 -->\n###### 위해평가 수행에 필요한 일반사항은 다음과 같으며, 위해요소 특성에 따라 예외가 있을 수\n\n<!-- PAGE_12 -->\n###### 있다.\n\n <!-- PAGE_12 -->\n###### 1) 위해평가 시 본 가이드라인을 체크리스트로 간주할 수 없으며, 화장품 성분의 특성에 따\n\n<!-- PAGE_12 -->\n###### 2) 독성자료는 OECD 가이드라인 등 국제적으로 인정된 프로토콜에 따른 시험을 우선적으로\n\n<!-- PAGE_12 -->\n###### 3) 반복투여독성시험, 생식독성시험 등 독성시험 자료가 충분하지 않거나 시험결과의 신뢰성\n\n<!-- PAGE_12 -->\n###### 확인 등 독성시험 자료가 제한적인 경우, 위험성 확인 단계에서 자료 부족임을 명시하고\n\n<!-- PAGE_12 -->\n###### 4) 평가성분은 화장품 중 다른 성분에 의해 피부투과에 영향을 받을 수 있으므로 피부흡수\n\n<!-- PAGE_12 -->\n###### 5) 노출평가는 여러 상황을 고려하여 현실적인 노출시나리오를 작성한다.\n\n <!-- PAGE_12 -->\n###### 6) 결과보고서는 관련 자료의 불확실성 등을 고려하여 정량적 또는 정성적으로 표현할 수 있\n\n<!-- PAGE_12 -->\n###### 7) 위해평가 결과는 새로운 독성시험 결과가 보고되는 등 새로운 과학적 사실이 밝혀지는 경\n\n<!-- PAGE_12 -->\n###### 1-3.  위해평가 대상\n\n<!-- PAGE_12 -->\n###### 1) 관련 규정에 따라 국민보건상 위해 우려가 제기되는 화장품 원료, 화장품 사용한도 원료\n\n<!-- PAGE_12 -->\n###### 2) 비의도적 오염물질의 검출허용한도 설정이 필요한 경우에 위해평가를 수행할 수 있다.\n\n - - 7 -\n<!-- PAGE_13 -->\n###### 1-4. ",
        "original_sentence": "<!-- PAGE_12 -->\n###### 1) 위해평가 시 본 가이드라인을 체크리스트로 간주할 수 없으며, 화장품 성분의 특성에 따\n\n<!-- PAGE_12 -->\n###### 2) 독성자료는 OECD 가이드라인 등 국제적으로 인정된 프로토콜에 따른 시험을 우선적으로\n\n<!-- PAGE_12 -->\n###### 3) 반복투여독성시험, 생식독성시험 등 독성시험 자료가 충분하지 않거나 시험결과의 신뢰성\n\n<!-- PAGE_12 -->\n###### 확인 등 독성시험 자료가 제한적인 경우, 위험성 확인 단계에서 자료 부족임을 명시하고\n\n<!-- PAGE_12 -->\n###### 4) 평가성분은 화장품 중 다른 성분에 의해 피부투과에 영향을 받을 수 있으므로 피부흡수\n\n<!-- PAGE_12 -->\n###### 5) 노출평가는 여러 상황을 고려하여 현실적인 노출시나리오를 작성한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_175",
      "text": "<!-- PAGE_12 -->\n###### 6) 결과보고서는 관련 자료의 불확실성 등을 고려하여 정량적 또는 정성적으로 표현할 수 있\n\n<!-- PAGE_12 -->\n###### 7) 위해평가 결과는 새로운 독성시험 결과가 보고되는 등 새로운 과학적 사실이 밝혀지는 경\n\n<!-- PAGE_12 -->\n###### 1-3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 174,
        "window_size": 3,
        "char_count": 181,
        "word_count": 39,
        "page_number": 12,
        "window_text": "<!-- PAGE_11 -->\n###### 1) 위험성 확인(Hazard Identification) : 위해요소에 노출됨에 따라 인체 건강에 위해한 영향\n\n<!-- PAGE_11 -->\n###### 을 미칠 가능성에 대하여 물질의 고유한 물리화학적 특성, 독성의 정도 및 그 영향 등을\n\n<!-- PAGE_11 -->\n###### 2) 위험성 결정(Hazard Characterization) : 노출과 독성반응에 대한 관계를 평가하는 단계로 주\n\n<!-- PAGE_11 -->\n###### 3) 노출평가(Exposure Assessment) : 화장품의 사용으로 인해 위해요소에 노출되는 양 또는\n\n<!-- PAGE_11 -->\n###### 4) 위해도 결정(Risk Characterization) : 위해요소 및 이를 함유한 화장품의 사용에 따라 독성\n\n<!-- PAGE_11 -->\n###### 기준값 및 노출량을 고려하여 사람에게 미칠 수 있는 위해의 정도 등을 정량적으로 예측\n\n- - 6 -\n<!-- PAGE_12 -->\n###### 1-2.  위해평가 수행에 필요한 일반사항\n\n<!-- PAGE_12 -->\n###### 위해평가 수행에 필요한 일반사항은 다음과 같으며, 위해요소 특성에 따라 예외가 있을 수\n\n<!-- PAGE_12 -->\n###### 있다.\n\n <!-- PAGE_12 -->\n###### 1) 위해평가 시 본 가이드라인을 체크리스트로 간주할 수 없으며, 화장품 성분의 특성에 따\n\n<!-- PAGE_12 -->\n###### 2) 독성자료는 OECD 가이드라인 등 국제적으로 인정된 프로토콜에 따른 시험을 우선적으로\n\n<!-- PAGE_12 -->\n###### 3) 반복투여독성시험, 생식독성시험 등 독성시험 자료가 충분하지 않거나 시험결과의 신뢰성\n\n<!-- PAGE_12 -->\n###### 확인 등 독성시험 자료가 제한적인 경우, 위험성 확인 단계에서 자료 부족임을 명시하고\n\n<!-- PAGE_12 -->\n###### 4) 평가성분은 화장품 중 다른 성분에 의해 피부투과에 영향을 받을 수 있으므로 피부흡수\n\n<!-- PAGE_12 -->\n###### 5) 노출평가는 여러 상황을 고려하여 현실적인 노출시나리오를 작성한다.\n\n <!-- PAGE_12 -->\n###### 6) 결과보고서는 관련 자료의 불확실성 등을 고려하여 정량적 또는 정성적으로 표현할 수 있\n\n<!-- PAGE_12 -->\n###### 7) 위해평가 결과는 새로운 독성시험 결과가 보고되는 등 새로운 과학적 사실이 밝혀지는 경\n\n<!-- PAGE_12 -->\n###### 1-3.  위해평가 대상\n\n<!-- PAGE_12 -->\n###### 1) 관련 규정에 따라 국민보건상 위해 우려가 제기되는 화장품 원료, 화장품 사용한도 원료\n\n<!-- PAGE_12 -->\n###### 2) 비의도적 오염물질의 검출허용한도 설정이 필요한 경우에 위해평가를 수행할 수 있다.\n\n - - 7 -\n<!-- PAGE_13 -->\n###### 1-4.  위해요소별 위해평가 유형\n\n<!-- PAGE_13 -->\n###### 1) 위해평가는 위해요소의 용도(화장품 성분 등 의도적 사용물질, 중금속 등 비의도적 오염물\n\n<!-- PAGE_13 -->\n###### 질)에 따라 구분하여 평가한다.\n\n",
        "original_sentence": "<!-- PAGE_12 -->\n###### 6) 결과보고서는 관련 자료의 불확실성 등을 고려하여 정량적 또는 정성적으로 표현할 수 있\n\n<!-- PAGE_12 -->\n###### 7) 위해평가 결과는 새로운 독성시험 결과가 보고되는 등 새로운 과학적 사실이 밝혀지는 경\n\n<!-- PAGE_12 -->\n###### 1-3. "
      }
    },
    {
      "chunk_id": "chunk_176",
      "text": "위해평가 대상\n\n<!-- PAGE_12 -->\n###### 1) 관련 규정에 따라 국민보건상 위해 우려가 제기되는 화장품 원료, 화장품 사용한도 원료\n\n<!-- PAGE_12 -->\n###### 2) 비의도적 오염물질의 검출허용한도 설정이 필요한 경우에 위해평가를 수행할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 175,
        "window_size": 3,
        "char_count": 159,
        "word_count": 34,
        "page_number": 12,
        "window_text": "위해평가 수행에 필요한 일반사항\n\n<!-- PAGE_12 -->\n###### 위해평가 수행에 필요한 일반사항은 다음과 같으며, 위해요소 특성에 따라 예외가 있을 수\n\n<!-- PAGE_12 -->\n###### 있다.\n\n <!-- PAGE_12 -->\n###### 1) 위해평가 시 본 가이드라인을 체크리스트로 간주할 수 없으며, 화장품 성분의 특성에 따\n\n<!-- PAGE_12 -->\n###### 2) 독성자료는 OECD 가이드라인 등 국제적으로 인정된 프로토콜에 따른 시험을 우선적으로\n\n<!-- PAGE_12 -->\n###### 3) 반복투여독성시험, 생식독성시험 등 독성시험 자료가 충분하지 않거나 시험결과의 신뢰성\n\n<!-- PAGE_12 -->\n###### 확인 등 독성시험 자료가 제한적인 경우, 위험성 확인 단계에서 자료 부족임을 명시하고\n\n<!-- PAGE_12 -->\n###### 4) 평가성분은 화장품 중 다른 성분에 의해 피부투과에 영향을 받을 수 있으므로 피부흡수\n\n<!-- PAGE_12 -->\n###### 5) 노출평가는 여러 상황을 고려하여 현실적인 노출시나리오를 작성한다.\n\n <!-- PAGE_12 -->\n###### 6) 결과보고서는 관련 자료의 불확실성 등을 고려하여 정량적 또는 정성적으로 표현할 수 있\n\n<!-- PAGE_12 -->\n###### 7) 위해평가 결과는 새로운 독성시험 결과가 보고되는 등 새로운 과학적 사실이 밝혀지는 경\n\n<!-- PAGE_12 -->\n###### 1-3.  위해평가 대상\n\n<!-- PAGE_12 -->\n###### 1) 관련 규정에 따라 국민보건상 위해 우려가 제기되는 화장품 원료, 화장품 사용한도 원료\n\n<!-- PAGE_12 -->\n###### 2) 비의도적 오염물질의 검출허용한도 설정이 필요한 경우에 위해평가를 수행할 수 있다.\n\n - - 7 -\n<!-- PAGE_13 -->\n###### 1-4.  위해요소별 위해평가 유형\n\n<!-- PAGE_13 -->\n###### 1) 위해평가는 위해요소의 용도(화장품 성분 등 의도적 사용물질, 중금속 등 비의도적 오염물\n\n<!-- PAGE_13 -->\n###### 질)에 따라 구분하여 평가한다.\n\n <!-- PAGE_13 -->\n###### 2) 의도적 사용물질로 유전독성 등이 확인되는 경우, 위험성 확인에서 위해평가를 종료하며,\n\n<!-- PAGE_13 -->\n###### 비발암물질, 비유전독성 발암물질과 같이 독성영향이 역치를 가진다고 추정되는 경우에는\n\n<!-- PAGE_13 -->\n###### 3) 비의도적 오염물질과 같이 완전히 제거할 수 없는 경우에는 오염도를 측정하여 노출량을\n\n- - 8 -\n<!-- PAGE_14 -->\n###### 2. ",
        "original_sentence": "위해평가 대상\n\n<!-- PAGE_12 -->\n###### 1) 관련 규정에 따라 국민보건상 위해 우려가 제기되는 화장품 원료, 화장품 사용한도 원료\n\n<!-- PAGE_12 -->\n###### 2) 비의도적 오염물질의 검출허용한도 설정이 필요한 경우에 위해평가를 수행할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_177",
      "text": "- - 7 -\n<!-- PAGE_13 -->\n###### 1-4. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 176,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 13,
        "window_text": "<!-- PAGE_12 -->\n###### 1) 위해평가 시 본 가이드라인을 체크리스트로 간주할 수 없으며, 화장품 성분의 특성에 따\n\n<!-- PAGE_12 -->\n###### 2) 독성자료는 OECD 가이드라인 등 국제적으로 인정된 프로토콜에 따른 시험을 우선적으로\n\n<!-- PAGE_12 -->\n###### 3) 반복투여독성시험, 생식독성시험 등 독성시험 자료가 충분하지 않거나 시험결과의 신뢰성\n\n<!-- PAGE_12 -->\n###### 확인 등 독성시험 자료가 제한적인 경우, 위험성 확인 단계에서 자료 부족임을 명시하고\n\n<!-- PAGE_12 -->\n###### 4) 평가성분은 화장품 중 다른 성분에 의해 피부투과에 영향을 받을 수 있으므로 피부흡수\n\n<!-- PAGE_12 -->\n###### 5) 노출평가는 여러 상황을 고려하여 현실적인 노출시나리오를 작성한다.\n\n <!-- PAGE_12 -->\n###### 6) 결과보고서는 관련 자료의 불확실성 등을 고려하여 정량적 또는 정성적으로 표현할 수 있\n\n<!-- PAGE_12 -->\n###### 7) 위해평가 결과는 새로운 독성시험 결과가 보고되는 등 새로운 과학적 사실이 밝혀지는 경\n\n<!-- PAGE_12 -->\n###### 1-3.  위해평가 대상\n\n<!-- PAGE_12 -->\n###### 1) 관련 규정에 따라 국민보건상 위해 우려가 제기되는 화장품 원료, 화장품 사용한도 원료\n\n<!-- PAGE_12 -->\n###### 2) 비의도적 오염물질의 검출허용한도 설정이 필요한 경우에 위해평가를 수행할 수 있다.\n\n - - 7 -\n<!-- PAGE_13 -->\n###### 1-4.  위해요소별 위해평가 유형\n\n<!-- PAGE_13 -->\n###### 1) 위해평가는 위해요소의 용도(화장품 성분 등 의도적 사용물질, 중금속 등 비의도적 오염물\n\n<!-- PAGE_13 -->\n###### 질)에 따라 구분하여 평가한다.\n\n <!-- PAGE_13 -->\n###### 2) 의도적 사용물질로 유전독성 등이 확인되는 경우, 위험성 확인에서 위해평가를 종료하며,\n\n<!-- PAGE_13 -->\n###### 비발암물질, 비유전독성 발암물질과 같이 독성영향이 역치를 가진다고 추정되는 경우에는\n\n<!-- PAGE_13 -->\n###### 3) 비의도적 오염물질과 같이 완전히 제거할 수 없는 경우에는 오염도를 측정하여 노출량을\n\n- - 8 -\n<!-- PAGE_14 -->\n###### 2.  위해평가 방법\n\n<!-- PAGE_14 -->\n###### 2-1. ",
        "original_sentence": "- - 7 -\n<!-- PAGE_13 -->\n###### 1-4. "
      }
    },
    {
      "chunk_id": "chunk_178",
      "text": "위해요소별 위해평가 유형\n\n<!-- PAGE_13 -->\n###### 1) 위해평가는 위해요소의 용도(화장품 성분 등 의도적 사용물질, 중금속 등 비의도적 오염물\n\n<!-- PAGE_13 -->\n###### 질)에 따라 구분하여 평가한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 177,
        "window_size": 3,
        "char_count": 135,
        "word_count": 27,
        "page_number": 13,
        "window_text": "<!-- PAGE_12 -->\n###### 6) 결과보고서는 관련 자료의 불확실성 등을 고려하여 정량적 또는 정성적으로 표현할 수 있\n\n<!-- PAGE_12 -->\n###### 7) 위해평가 결과는 새로운 독성시험 결과가 보고되는 등 새로운 과학적 사실이 밝혀지는 경\n\n<!-- PAGE_12 -->\n###### 1-3.  위해평가 대상\n\n<!-- PAGE_12 -->\n###### 1) 관련 규정에 따라 국민보건상 위해 우려가 제기되는 화장품 원료, 화장품 사용한도 원료\n\n<!-- PAGE_12 -->\n###### 2) 비의도적 오염물질의 검출허용한도 설정이 필요한 경우에 위해평가를 수행할 수 있다.\n\n - - 7 -\n<!-- PAGE_13 -->\n###### 1-4.  위해요소별 위해평가 유형\n\n<!-- PAGE_13 -->\n###### 1) 위해평가는 위해요소의 용도(화장품 성분 등 의도적 사용물질, 중금속 등 비의도적 오염물\n\n<!-- PAGE_13 -->\n###### 질)에 따라 구분하여 평가한다.\n\n <!-- PAGE_13 -->\n###### 2) 의도적 사용물질로 유전독성 등이 확인되는 경우, 위험성 확인에서 위해평가를 종료하며,\n\n<!-- PAGE_13 -->\n###### 비발암물질, 비유전독성 발암물질과 같이 독성영향이 역치를 가진다고 추정되는 경우에는\n\n<!-- PAGE_13 -->\n###### 3) 비의도적 오염물질과 같이 완전히 제거할 수 없는 경우에는 오염도를 측정하여 노출량을\n\n- - 8 -\n<!-- PAGE_14 -->\n###### 2.  위해평가 방법\n\n<!-- PAGE_14 -->\n###### 2-1.  위해평가 사전 검토사항\n\n<!-- PAGE_14 -->\n###### 1) 위해평가를 수행하기 전, 관련 평가 이력 등 배경을 충분히 검토한다.\n\n",
        "original_sentence": "위해요소별 위해평가 유형\n\n<!-- PAGE_13 -->\n###### 1) 위해평가는 위해요소의 용도(화장품 성분 등 의도적 사용물질, 중금속 등 비의도적 오염물\n\n<!-- PAGE_13 -->\n###### 질)에 따라 구분하여 평가한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_179",
      "text": "<!-- PAGE_13 -->\n###### 2) 의도적 사용물질로 유전독성 등이 확인되는 경우, 위험성 확인에서 위해평가를 종료하며,\n\n<!-- PAGE_13 -->\n###### 비발암물질, 비유전독성 발암물질과 같이 독성영향이 역치를 가진다고 추정되는 경우에는\n\n<!-- PAGE_13 -->\n###### 3) 비의도적 오염물질과 같이 완전히 제거할 수 없는 경우에는 오염도를 측정하여 노출량을\n\n- - 8 -\n<!-- PAGE_14 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 178,
        "window_size": 3,
        "char_count": 258,
        "word_count": 53,
        "page_number": 13,
        "window_text": "위해평가 대상\n\n<!-- PAGE_12 -->\n###### 1) 관련 규정에 따라 국민보건상 위해 우려가 제기되는 화장품 원료, 화장품 사용한도 원료\n\n<!-- PAGE_12 -->\n###### 2) 비의도적 오염물질의 검출허용한도 설정이 필요한 경우에 위해평가를 수행할 수 있다.\n\n - - 7 -\n<!-- PAGE_13 -->\n###### 1-4.  위해요소별 위해평가 유형\n\n<!-- PAGE_13 -->\n###### 1) 위해평가는 위해요소의 용도(화장품 성분 등 의도적 사용물질, 중금속 등 비의도적 오염물\n\n<!-- PAGE_13 -->\n###### 질)에 따라 구분하여 평가한다.\n\n <!-- PAGE_13 -->\n###### 2) 의도적 사용물질로 유전독성 등이 확인되는 경우, 위험성 확인에서 위해평가를 종료하며,\n\n<!-- PAGE_13 -->\n###### 비발암물질, 비유전독성 발암물질과 같이 독성영향이 역치를 가진다고 추정되는 경우에는\n\n<!-- PAGE_13 -->\n###### 3) 비의도적 오염물질과 같이 완전히 제거할 수 없는 경우에는 오염도를 측정하여 노출량을\n\n- - 8 -\n<!-- PAGE_14 -->\n###### 2.  위해평가 방법\n\n<!-- PAGE_14 -->\n###### 2-1.  위해평가 사전 검토사항\n\n<!-- PAGE_14 -->\n###### 1) 위해평가를 수행하기 전, 관련 평가 이력 등 배경을 충분히 검토한다.\n\n <!-- PAGE_14 -->\n###### 2) 위해평가 시 요구되는 관련 자료 등에 대해 검토한다.\n\n",
        "original_sentence": "<!-- PAGE_13 -->\n###### 2) 의도적 사용물질로 유전독성 등이 확인되는 경우, 위험성 확인에서 위해평가를 종료하며,\n\n<!-- PAGE_13 -->\n###### 비발암물질, 비유전독성 발암물질과 같이 독성영향이 역치를 가진다고 추정되는 경우에는\n\n<!-- PAGE_13 -->\n###### 3) 비의도적 오염물질과 같이 완전히 제거할 수 없는 경우에는 오염도를 측정하여 노출량을\n\n- - 8 -\n<!-- PAGE_14 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_180",
      "text": "위해평가 방법\n\n<!-- PAGE_14 -->\n###### 2-1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 179,
        "window_size": 3,
        "char_count": 38,
        "word_count": 7,
        "page_number": 14,
        "window_text": "- - 7 -\n<!-- PAGE_13 -->\n###### 1-4.  위해요소별 위해평가 유형\n\n<!-- PAGE_13 -->\n###### 1) 위해평가는 위해요소의 용도(화장품 성분 등 의도적 사용물질, 중금속 등 비의도적 오염물\n\n<!-- PAGE_13 -->\n###### 질)에 따라 구분하여 평가한다.\n\n <!-- PAGE_13 -->\n###### 2) 의도적 사용물질로 유전독성 등이 확인되는 경우, 위험성 확인에서 위해평가를 종료하며,\n\n<!-- PAGE_13 -->\n###### 비발암물질, 비유전독성 발암물질과 같이 독성영향이 역치를 가진다고 추정되는 경우에는\n\n<!-- PAGE_13 -->\n###### 3) 비의도적 오염물질과 같이 완전히 제거할 수 없는 경우에는 오염도를 측정하여 노출량을\n\n- - 8 -\n<!-- PAGE_14 -->\n###### 2.  위해평가 방법\n\n<!-- PAGE_14 -->\n###### 2-1.  위해평가 사전 검토사항\n\n<!-- PAGE_14 -->\n###### 1) 위해평가를 수행하기 전, 관련 평가 이력 등 배경을 충분히 검토한다.\n\n <!-- PAGE_14 -->\n###### 2) 위해평가 시 요구되는 관련 자료 등에 대해 검토한다.\n\n <!-- PAGE_14 -->\n###### - 화장품 사용량은 위해요소의 특성과 위해평가의 목적, 평가대상에 적합한 자료를 활용한\n\n<!-- PAGE_14 -->\n###### 3) 유해물질 모니터링 자료를 사용하는 경우, 위해평가를 목적으로 수행된 시험자료를 활용하\n\n<!-- PAGE_14 -->\n###### - 개별적으로 실시한 여러 시험결과를 하나의 위해평가에 활용할 경우에는 시험목적, 시료채\n\n<!-- PAGE_14 -->\n###### - 정량한계(Limit of Quantification, LOQ) 이하 값인 경우 시료 수와 LOQ 이하 값의 분포\n\n<!-- PAGE_14 -->\n###### - 특정 목적으로 수행된 분석 자료는 일반적인 노출평가를 위한 자료에서 제외한다.\n\n",
        "original_sentence": "위해평가 방법\n\n<!-- PAGE_14 -->\n###### 2-1. "
      }
    },
    {
      "chunk_id": "chunk_181",
      "text": "위해평가 사전 검토사항\n\n<!-- PAGE_14 -->\n###### 1) 위해평가를 수행하기 전, 관련 평가 이력 등 배경을 충분히 검토한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 180,
        "window_size": 3,
        "char_count": 81,
        "word_count": 18,
        "page_number": 14,
        "window_text": "위해요소별 위해평가 유형\n\n<!-- PAGE_13 -->\n###### 1) 위해평가는 위해요소의 용도(화장품 성분 등 의도적 사용물질, 중금속 등 비의도적 오염물\n\n<!-- PAGE_13 -->\n###### 질)에 따라 구분하여 평가한다.\n\n <!-- PAGE_13 -->\n###### 2) 의도적 사용물질로 유전독성 등이 확인되는 경우, 위험성 확인에서 위해평가를 종료하며,\n\n<!-- PAGE_13 -->\n###### 비발암물질, 비유전독성 발암물질과 같이 독성영향이 역치를 가진다고 추정되는 경우에는\n\n<!-- PAGE_13 -->\n###### 3) 비의도적 오염물질과 같이 완전히 제거할 수 없는 경우에는 오염도를 측정하여 노출량을\n\n- - 8 -\n<!-- PAGE_14 -->\n###### 2.  위해평가 방법\n\n<!-- PAGE_14 -->\n###### 2-1.  위해평가 사전 검토사항\n\n<!-- PAGE_14 -->\n###### 1) 위해평가를 수행하기 전, 관련 평가 이력 등 배경을 충분히 검토한다.\n\n <!-- PAGE_14 -->\n###### 2) 위해평가 시 요구되는 관련 자료 등에 대해 검토한다.\n\n <!-- PAGE_14 -->\n###### - 화장품 사용량은 위해요소의 특성과 위해평가의 목적, 평가대상에 적합한 자료를 활용한\n\n<!-- PAGE_14 -->\n###### 3) 유해물질 모니터링 자료를 사용하는 경우, 위해평가를 목적으로 수행된 시험자료를 활용하\n\n<!-- PAGE_14 -->\n###### - 개별적으로 실시한 여러 시험결과를 하나의 위해평가에 활용할 경우에는 시험목적, 시료채\n\n<!-- PAGE_14 -->\n###### - 정량한계(Limit of Quantification, LOQ) 이하 값인 경우 시료 수와 LOQ 이하 값의 분포\n\n<!-- PAGE_14 -->\n###### - 특정 목적으로 수행된 분석 자료는 일반적인 노출평가를 위한 자료에서 제외한다.\n\n - - 9 -\n<!-- PAGE_15 -->\n###### 2-2. ",
        "original_sentence": "위해평가 사전 검토사항\n\n<!-- PAGE_14 -->\n###### 1) 위해평가를 수행하기 전, 관련 평가 이력 등 배경을 충분히 검토한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_182",
      "text": "<!-- PAGE_14 -->\n###### 2) 위해평가 시 요구되는 관련 자료 등에 대해 검토한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 181,
        "window_size": 3,
        "char_count": 58,
        "word_count": 13,
        "page_number": 14,
        "window_text": "<!-- PAGE_13 -->\n###### 2) 의도적 사용물질로 유전독성 등이 확인되는 경우, 위험성 확인에서 위해평가를 종료하며,\n\n<!-- PAGE_13 -->\n###### 비발암물질, 비유전독성 발암물질과 같이 독성영향이 역치를 가진다고 추정되는 경우에는\n\n<!-- PAGE_13 -->\n###### 3) 비의도적 오염물질과 같이 완전히 제거할 수 없는 경우에는 오염도를 측정하여 노출량을\n\n- - 8 -\n<!-- PAGE_14 -->\n###### 2.  위해평가 방법\n\n<!-- PAGE_14 -->\n###### 2-1.  위해평가 사전 검토사항\n\n<!-- PAGE_14 -->\n###### 1) 위해평가를 수행하기 전, 관련 평가 이력 등 배경을 충분히 검토한다.\n\n <!-- PAGE_14 -->\n###### 2) 위해평가 시 요구되는 관련 자료 등에 대해 검토한다.\n\n <!-- PAGE_14 -->\n###### - 화장품 사용량은 위해요소의 특성과 위해평가의 목적, 평가대상에 적합한 자료를 활용한\n\n<!-- PAGE_14 -->\n###### 3) 유해물질 모니터링 자료를 사용하는 경우, 위해평가를 목적으로 수행된 시험자료를 활용하\n\n<!-- PAGE_14 -->\n###### - 개별적으로 실시한 여러 시험결과를 하나의 위해평가에 활용할 경우에는 시험목적, 시료채\n\n<!-- PAGE_14 -->\n###### - 정량한계(Limit of Quantification, LOQ) 이하 값인 경우 시료 수와 LOQ 이하 값의 분포\n\n<!-- PAGE_14 -->\n###### - 특정 목적으로 수행된 분석 자료는 일반적인 노출평가를 위한 자료에서 제외한다.\n\n - - 9 -\n<!-- PAGE_15 -->\n###### 2-2.  위해평가 단계별 수행절차\n\n<!-- PAGE_15 -->\n###### 2-2-1. ",
        "original_sentence": "<!-- PAGE_14 -->\n###### 2) 위해평가 시 요구되는 관련 자료 등에 대해 검토한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_183",
      "text": "<!-- PAGE_14 -->\n###### - 화장품 사용량은 위해요소의 특성과 위해평가의 목적, 평가대상에 적합한 자료를 활용한\n\n<!-- PAGE_14 -->\n###### 3) 유해물질 모니터링 자료를 사용하는 경우, 위해평가를 목적으로 수행된 시험자료를 활용하\n\n<!-- PAGE_14 -->\n###### - 개별적으로 실시한 여러 시험결과를 하나의 위해평가에 활용할 경우에는 시험목적, 시료채\n\n<!-- PAGE_14 -->\n###### - 정량한계(Limit of Quantification, LOQ) 이하 값인 경우 시료 수와 LOQ 이하 값의 분포\n\n<!-- PAGE_14 -->\n###### - 특정 목적으로 수행된 분석 자료는 일반적인 노출평가를 위한 자료에서 제외한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 182,
        "window_size": 3,
        "char_count": 386,
        "word_count": 78,
        "page_number": 14,
        "window_text": "위해평가 방법\n\n<!-- PAGE_14 -->\n###### 2-1.  위해평가 사전 검토사항\n\n<!-- PAGE_14 -->\n###### 1) 위해평가를 수행하기 전, 관련 평가 이력 등 배경을 충분히 검토한다.\n\n <!-- PAGE_14 -->\n###### 2) 위해평가 시 요구되는 관련 자료 등에 대해 검토한다.\n\n <!-- PAGE_14 -->\n###### - 화장품 사용량은 위해요소의 특성과 위해평가의 목적, 평가대상에 적합한 자료를 활용한\n\n<!-- PAGE_14 -->\n###### 3) 유해물질 모니터링 자료를 사용하는 경우, 위해평가를 목적으로 수행된 시험자료를 활용하\n\n<!-- PAGE_14 -->\n###### - 개별적으로 실시한 여러 시험결과를 하나의 위해평가에 활용할 경우에는 시험목적, 시료채\n\n<!-- PAGE_14 -->\n###### - 정량한계(Limit of Quantification, LOQ) 이하 값인 경우 시료 수와 LOQ 이하 값의 분포\n\n<!-- PAGE_14 -->\n###### - 특정 목적으로 수행된 분석 자료는 일반적인 노출평가를 위한 자료에서 제외한다.\n\n - - 9 -\n<!-- PAGE_15 -->\n###### 2-2.  위해평가 단계별 수행절차\n\n<!-- PAGE_15 -->\n###### 2-2-1.  위험성 확인\n\n<!-- PAGE_15 -->\n###### 1) 위험성 확인은 평가대상 물질에 대하여 최근까지 보고된 국내외 자료들을 조사·분석하여\n\n<!-- PAGE_15 -->\n###### ① 물질의 식별정보, 물리화학적 특성 및 고유한 독성학적 특성을 고려하여 in vitro 및  in\n\n<!-- PAGE_15 -->\n###### vivo, 임상자료, 역학자료 등 현재 이용할 수 있는 모든 독성자료를 종합적으로 검토한\n\n<!-- PAGE_15 -->\n###### ② 독성정보는 해외 화장품 위해평가 기관(유럽 소비자안전과학위원회(Scientific Committee\n\n<!-- PAGE_15 -->\n###### on Consumer Safety, SCCS) 등에서 발간한 보고서나 평가원에서 생산된 자료를 활용할\n\n<!-- PAGE_15 -->\n###### ③ 독성자료의 경우, OECD 등 국제적 인정기관에서 독성시험 설계 및 수행에 필요한 최소\n\n<!-- PAGE_15 -->\n###### 2) 독성영향은 인체에서의 생물학적 영향과의 연관성이 있는지를 판단한다.\n\n",
        "original_sentence": "<!-- PAGE_14 -->\n###### - 화장품 사용량은 위해요소의 특성과 위해평가의 목적, 평가대상에 적합한 자료를 활용한\n\n<!-- PAGE_14 -->\n###### 3) 유해물질 모니터링 자료를 사용하는 경우, 위해평가를 목적으로 수행된 시험자료를 활용하\n\n<!-- PAGE_14 -->\n###### - 개별적으로 실시한 여러 시험결과를 하나의 위해평가에 활용할 경우에는 시험목적, 시료채\n\n<!-- PAGE_14 -->\n###### - 정량한계(Limit of Quantification, LOQ) 이하 값인 경우 시료 수와 LOQ 이하 값의 분포\n\n<!-- PAGE_14 -->\n###### - 특정 목적으로 수행된 분석 자료는 일반적인 노출평가를 위한 자료에서 제외한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_184",
      "text": "- - 9 -\n<!-- PAGE_15 -->\n###### 2-2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 183,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 15,
        "window_text": "위해평가 사전 검토사항\n\n<!-- PAGE_14 -->\n###### 1) 위해평가를 수행하기 전, 관련 평가 이력 등 배경을 충분히 검토한다.\n\n <!-- PAGE_14 -->\n###### 2) 위해평가 시 요구되는 관련 자료 등에 대해 검토한다.\n\n <!-- PAGE_14 -->\n###### - 화장품 사용량은 위해요소의 특성과 위해평가의 목적, 평가대상에 적합한 자료를 활용한\n\n<!-- PAGE_14 -->\n###### 3) 유해물질 모니터링 자료를 사용하는 경우, 위해평가를 목적으로 수행된 시험자료를 활용하\n\n<!-- PAGE_14 -->\n###### - 개별적으로 실시한 여러 시험결과를 하나의 위해평가에 활용할 경우에는 시험목적, 시료채\n\n<!-- PAGE_14 -->\n###### - 정량한계(Limit of Quantification, LOQ) 이하 값인 경우 시료 수와 LOQ 이하 값의 분포\n\n<!-- PAGE_14 -->\n###### - 특정 목적으로 수행된 분석 자료는 일반적인 노출평가를 위한 자료에서 제외한다.\n\n - - 9 -\n<!-- PAGE_15 -->\n###### 2-2.  위해평가 단계별 수행절차\n\n<!-- PAGE_15 -->\n###### 2-2-1.  위험성 확인\n\n<!-- PAGE_15 -->\n###### 1) 위험성 확인은 평가대상 물질에 대하여 최근까지 보고된 국내외 자료들을 조사·분석하여\n\n<!-- PAGE_15 -->\n###### ① 물질의 식별정보, 물리화학적 특성 및 고유한 독성학적 특성을 고려하여 in vitro 및  in\n\n<!-- PAGE_15 -->\n###### vivo, 임상자료, 역학자료 등 현재 이용할 수 있는 모든 독성자료를 종합적으로 검토한\n\n<!-- PAGE_15 -->\n###### ② 독성정보는 해외 화장품 위해평가 기관(유럽 소비자안전과학위원회(Scientific Committee\n\n<!-- PAGE_15 -->\n###### on Consumer Safety, SCCS) 등에서 발간한 보고서나 평가원에서 생산된 자료를 활용할\n\n<!-- PAGE_15 -->\n###### ③ 독성자료의 경우, OECD 등 국제적 인정기관에서 독성시험 설계 및 수행에 필요한 최소\n\n<!-- PAGE_15 -->\n###### 2) 독성영향은 인체에서의 생물학적 영향과의 연관성이 있는지를 판단한다.\n\n <!-- PAGE_15 -->\n###### 3) 위험성 확인에서 전신영향(Systemic effect) 또는 국소영향(Local effect)(예: 피부, 눈 자극,\n\n<!-- PAGE_15 -->\n###### 4) 위험성 확인에 필요한 자료는 다음과 같다.\n\n",
        "original_sentence": "- - 9 -\n<!-- PAGE_15 -->\n###### 2-2. "
      }
    },
    {
      "chunk_id": "chunk_185",
      "text": "위해평가 단계별 수행절차\n\n<!-- PAGE_15 -->\n###### 2-2-1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 184,
        "window_size": 3,
        "char_count": 46,
        "word_count": 8,
        "page_number": 15,
        "window_text": "<!-- PAGE_14 -->\n###### 2) 위해평가 시 요구되는 관련 자료 등에 대해 검토한다.\n\n <!-- PAGE_14 -->\n###### - 화장품 사용량은 위해요소의 특성과 위해평가의 목적, 평가대상에 적합한 자료를 활용한\n\n<!-- PAGE_14 -->\n###### 3) 유해물질 모니터링 자료를 사용하는 경우, 위해평가를 목적으로 수행된 시험자료를 활용하\n\n<!-- PAGE_14 -->\n###### - 개별적으로 실시한 여러 시험결과를 하나의 위해평가에 활용할 경우에는 시험목적, 시료채\n\n<!-- PAGE_14 -->\n###### - 정량한계(Limit of Quantification, LOQ) 이하 값인 경우 시료 수와 LOQ 이하 값의 분포\n\n<!-- PAGE_14 -->\n###### - 특정 목적으로 수행된 분석 자료는 일반적인 노출평가를 위한 자료에서 제외한다.\n\n - - 9 -\n<!-- PAGE_15 -->\n###### 2-2.  위해평가 단계별 수행절차\n\n<!-- PAGE_15 -->\n###### 2-2-1.  위험성 확인\n\n<!-- PAGE_15 -->\n###### 1) 위험성 확인은 평가대상 물질에 대하여 최근까지 보고된 국내외 자료들을 조사·분석하여\n\n<!-- PAGE_15 -->\n###### ① 물질의 식별정보, 물리화학적 특성 및 고유한 독성학적 특성을 고려하여 in vitro 및  in\n\n<!-- PAGE_15 -->\n###### vivo, 임상자료, 역학자료 등 현재 이용할 수 있는 모든 독성자료를 종합적으로 검토한\n\n<!-- PAGE_15 -->\n###### ② 독성정보는 해외 화장품 위해평가 기관(유럽 소비자안전과학위원회(Scientific Committee\n\n<!-- PAGE_15 -->\n###### on Consumer Safety, SCCS) 등에서 발간한 보고서나 평가원에서 생산된 자료를 활용할\n\n<!-- PAGE_15 -->\n###### ③ 독성자료의 경우, OECD 등 국제적 인정기관에서 독성시험 설계 및 수행에 필요한 최소\n\n<!-- PAGE_15 -->\n###### 2) 독성영향은 인체에서의 생물학적 영향과의 연관성이 있는지를 판단한다.\n\n <!-- PAGE_15 -->\n###### 3) 위험성 확인에서 전신영향(Systemic effect) 또는 국소영향(Local effect)(예: 피부, 눈 자극,\n\n<!-- PAGE_15 -->\n###### 4) 위험성 확인에 필요한 자료는 다음과 같다.\n\n <!-- PAGE_15 -->\n###### ① 물리화학적 성질 : 검토 대상 성분의 물리화학적 특성은 물질의 독성을 예측할 수 있는\n\n<!-- PAGE_15 -->\n###### 중요한 정보이다. ",
        "original_sentence": "위해평가 단계별 수행절차\n\n<!-- PAGE_15 -->\n###### 2-2-1. "
      }
    },
    {
      "chunk_id": "chunk_186",
      "text": "위험성 확인\n\n<!-- PAGE_15 -->\n###### 1) 위험성 확인은 평가대상 물질에 대하여 최근까지 보고된 국내외 자료들을 조사·분석하여\n\n<!-- PAGE_15 -->\n###### ① 물질의 식별정보, 물리화학적 특성 및 고유한 독성학적 특성을 고려하여 in vitro 및  in\n\n<!-- PAGE_15 -->\n###### vivo, 임상자료, 역학자료 등 현재 이용할 수 있는 모든 독성자료를 종합적으로 검토한\n\n<!-- PAGE_15 -->\n###### ② 독성정보는 해외 화장품 위해평가 기관(유럽 소비자안전과학위원회(Scientific Committee\n\n<!-- PAGE_15 -->\n###### on Consumer Safety, SCCS) 등에서 발간한 보고서나 평가원에서 생산된 자료를 활용할\n\n<!-- PAGE_15 -->\n###### ③ 독성자료의 경우, OECD 등 국제적 인정기관에서 독성시험 설계 및 수행에 필요한 최소\n\n<!-- PAGE_15 -->\n###### 2) 독성영향은 인체에서의 생물학적 영향과의 연관성이 있는지를 판단한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 185,
        "window_size": 3,
        "char_count": 546,
        "word_count": 107,
        "page_number": 15,
        "window_text": "<!-- PAGE_14 -->\n###### - 화장품 사용량은 위해요소의 특성과 위해평가의 목적, 평가대상에 적합한 자료를 활용한\n\n<!-- PAGE_14 -->\n###### 3) 유해물질 모니터링 자료를 사용하는 경우, 위해평가를 목적으로 수행된 시험자료를 활용하\n\n<!-- PAGE_14 -->\n###### - 개별적으로 실시한 여러 시험결과를 하나의 위해평가에 활용할 경우에는 시험목적, 시료채\n\n<!-- PAGE_14 -->\n###### - 정량한계(Limit of Quantification, LOQ) 이하 값인 경우 시료 수와 LOQ 이하 값의 분포\n\n<!-- PAGE_14 -->\n###### - 특정 목적으로 수행된 분석 자료는 일반적인 노출평가를 위한 자료에서 제외한다.\n\n - - 9 -\n<!-- PAGE_15 -->\n###### 2-2.  위해평가 단계별 수행절차\n\n<!-- PAGE_15 -->\n###### 2-2-1.  위험성 확인\n\n<!-- PAGE_15 -->\n###### 1) 위험성 확인은 평가대상 물질에 대하여 최근까지 보고된 국내외 자료들을 조사·분석하여\n\n<!-- PAGE_15 -->\n###### ① 물질의 식별정보, 물리화학적 특성 및 고유한 독성학적 특성을 고려하여 in vitro 및  in\n\n<!-- PAGE_15 -->\n###### vivo, 임상자료, 역학자료 등 현재 이용할 수 있는 모든 독성자료를 종합적으로 검토한\n\n<!-- PAGE_15 -->\n###### ② 독성정보는 해외 화장품 위해평가 기관(유럽 소비자안전과학위원회(Scientific Committee\n\n<!-- PAGE_15 -->\n###### on Consumer Safety, SCCS) 등에서 발간한 보고서나 평가원에서 생산된 자료를 활용할\n\n<!-- PAGE_15 -->\n###### ③ 독성자료의 경우, OECD 등 국제적 인정기관에서 독성시험 설계 및 수행에 필요한 최소\n\n<!-- PAGE_15 -->\n###### 2) 독성영향은 인체에서의 생물학적 영향과의 연관성이 있는지를 판단한다.\n\n <!-- PAGE_15 -->\n###### 3) 위험성 확인에서 전신영향(Systemic effect) 또는 국소영향(Local effect)(예: 피부, 눈 자극,\n\n<!-- PAGE_15 -->\n###### 4) 위험성 확인에 필요한 자료는 다음과 같다.\n\n <!-- PAGE_15 -->\n###### ① 물리화학적 성질 : 검토 대상 성분의 물리화학적 특성은 물질의 독성을 예측할 수 있는\n\n<!-- PAGE_15 -->\n###### 중요한 정보이다.  검토 대상 성분의 물질명(INCI명, IUPAC명), CAS 번호, 화학식, 분자량,\n\n<!-- PAGE_15 -->\n###### 구조식, 물리화학적 성질(성상, 녹는점, 끓는점, 밀도, 증기압, pH, 용해도, Log Pow)과\n\n<!-- PAGE_15 -->\n###### ② 흡수·분포·대사·배설(ADME) : 체내에서 검토 대상 성분의 안전성에 대해 설명하기\n\n<!-- PAGE_15 -->\n###### 위해 독성동태학 자료(OECD 417)를 이용할 수 있다. ",
        "original_sentence": "위험성 확인\n\n<!-- PAGE_15 -->\n###### 1) 위험성 확인은 평가대상 물질에 대하여 최근까지 보고된 국내외 자료들을 조사·분석하여\n\n<!-- PAGE_15 -->\n###### ① 물질의 식별정보, 물리화학적 특성 및 고유한 독성학적 특성을 고려하여 in vitro 및  in\n\n<!-- PAGE_15 -->\n###### vivo, 임상자료, 역학자료 등 현재 이용할 수 있는 모든 독성자료를 종합적으로 검토한\n\n<!-- PAGE_15 -->\n###### ② 독성정보는 해외 화장품 위해평가 기관(유럽 소비자안전과학위원회(Scientific Committee\n\n<!-- PAGE_15 -->\n###### on Consumer Safety, SCCS) 등에서 발간한 보고서나 평가원에서 생산된 자료를 활용할\n\n<!-- PAGE_15 -->\n###### ③ 독성자료의 경우, OECD 등 국제적 인정기관에서 독성시험 설계 및 수행에 필요한 최소\n\n<!-- PAGE_15 -->\n###### 2) 독성영향은 인체에서의 생물학적 영향과의 연관성이 있는지를 판단한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_187",
      "text": "<!-- PAGE_15 -->\n###### 3) 위험성 확인에서 전신영향(Systemic effect) 또는 국소영향(Local effect)(예: 피부, 눈 자극,\n\n<!-- PAGE_15 -->\n###### 4) 위험성 확인에 필요한 자료는 다음과 같다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 186,
        "window_size": 3,
        "char_count": 146,
        "word_count": 26,
        "page_number": 15,
        "window_text": "- - 9 -\n<!-- PAGE_15 -->\n###### 2-2.  위해평가 단계별 수행절차\n\n<!-- PAGE_15 -->\n###### 2-2-1.  위험성 확인\n\n<!-- PAGE_15 -->\n###### 1) 위험성 확인은 평가대상 물질에 대하여 최근까지 보고된 국내외 자료들을 조사·분석하여\n\n<!-- PAGE_15 -->\n###### ① 물질의 식별정보, 물리화학적 특성 및 고유한 독성학적 특성을 고려하여 in vitro 및  in\n\n<!-- PAGE_15 -->\n###### vivo, 임상자료, 역학자료 등 현재 이용할 수 있는 모든 독성자료를 종합적으로 검토한\n\n<!-- PAGE_15 -->\n###### ② 독성정보는 해외 화장품 위해평가 기관(유럽 소비자안전과학위원회(Scientific Committee\n\n<!-- PAGE_15 -->\n###### on Consumer Safety, SCCS) 등에서 발간한 보고서나 평가원에서 생산된 자료를 활용할\n\n<!-- PAGE_15 -->\n###### ③ 독성자료의 경우, OECD 등 국제적 인정기관에서 독성시험 설계 및 수행에 필요한 최소\n\n<!-- PAGE_15 -->\n###### 2) 독성영향은 인체에서의 생물학적 영향과의 연관성이 있는지를 판단한다.\n\n <!-- PAGE_15 -->\n###### 3) 위험성 확인에서 전신영향(Systemic effect) 또는 국소영향(Local effect)(예: 피부, 눈 자극,\n\n<!-- PAGE_15 -->\n###### 4) 위험성 확인에 필요한 자료는 다음과 같다.\n\n <!-- PAGE_15 -->\n###### ① 물리화학적 성질 : 검토 대상 성분의 물리화학적 특성은 물질의 독성을 예측할 수 있는\n\n<!-- PAGE_15 -->\n###### 중요한 정보이다.  검토 대상 성분의 물질명(INCI명, IUPAC명), CAS 번호, 화학식, 분자량,\n\n<!-- PAGE_15 -->\n###### 구조식, 물리화학적 성질(성상, 녹는점, 끓는점, 밀도, 증기압, pH, 용해도, Log Pow)과\n\n<!-- PAGE_15 -->\n###### ② 흡수·분포·대사·배설(ADME) : 체내에서 검토 대상 성분의 안전성에 대해 설명하기\n\n<!-- PAGE_15 -->\n###### 위해 독성동태학 자료(OECD 417)를 이용할 수 있다.  검토 대상 성분의 체내 흡수, 분포,\n\n<!-- PAGE_15 -->\n###### 대사, 배설에 대한 정보는 독성 가능성을 예측할 수 있으며 독성연구 해석에 도움을 줄\n\n<!-- PAGE_15 -->\n###### 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_15 -->\n###### 3) 위험성 확인에서 전신영향(Systemic effect) 또는 국소영향(Local effect)(예: 피부, 눈 자극,\n\n<!-- PAGE_15 -->\n###### 4) 위험성 확인에 필요한 자료는 다음과 같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_188",
      "text": "<!-- PAGE_15 -->\n###### ① 물리화학적 성질 : 검토 대상 성분의 물리화학적 특성은 물질의 독성을 예측할 수 있는\n\n<!-- PAGE_15 -->\n###### 중요한 정보이다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 187,
        "window_size": 3,
        "char_count": 109,
        "word_count": 24,
        "page_number": 15,
        "window_text": "위해평가 단계별 수행절차\n\n<!-- PAGE_15 -->\n###### 2-2-1.  위험성 확인\n\n<!-- PAGE_15 -->\n###### 1) 위험성 확인은 평가대상 물질에 대하여 최근까지 보고된 국내외 자료들을 조사·분석하여\n\n<!-- PAGE_15 -->\n###### ① 물질의 식별정보, 물리화학적 특성 및 고유한 독성학적 특성을 고려하여 in vitro 및  in\n\n<!-- PAGE_15 -->\n###### vivo, 임상자료, 역학자료 등 현재 이용할 수 있는 모든 독성자료를 종합적으로 검토한\n\n<!-- PAGE_15 -->\n###### ② 독성정보는 해외 화장품 위해평가 기관(유럽 소비자안전과학위원회(Scientific Committee\n\n<!-- PAGE_15 -->\n###### on Consumer Safety, SCCS) 등에서 발간한 보고서나 평가원에서 생산된 자료를 활용할\n\n<!-- PAGE_15 -->\n###### ③ 독성자료의 경우, OECD 등 국제적 인정기관에서 독성시험 설계 및 수행에 필요한 최소\n\n<!-- PAGE_15 -->\n###### 2) 독성영향은 인체에서의 생물학적 영향과의 연관성이 있는지를 판단한다.\n\n <!-- PAGE_15 -->\n###### 3) 위험성 확인에서 전신영향(Systemic effect) 또는 국소영향(Local effect)(예: 피부, 눈 자극,\n\n<!-- PAGE_15 -->\n###### 4) 위험성 확인에 필요한 자료는 다음과 같다.\n\n <!-- PAGE_15 -->\n###### ① 물리화학적 성질 : 검토 대상 성분의 물리화학적 특성은 물질의 독성을 예측할 수 있는\n\n<!-- PAGE_15 -->\n###### 중요한 정보이다.  검토 대상 성분의 물질명(INCI명, IUPAC명), CAS 번호, 화학식, 분자량,\n\n<!-- PAGE_15 -->\n###### 구조식, 물리화학적 성질(성상, 녹는점, 끓는점, 밀도, 증기압, pH, 용해도, Log Pow)과\n\n<!-- PAGE_15 -->\n###### ② 흡수·분포·대사·배설(ADME) : 체내에서 검토 대상 성분의 안전성에 대해 설명하기\n\n<!-- PAGE_15 -->\n###### 위해 독성동태학 자료(OECD 417)를 이용할 수 있다.  검토 대상 성분의 체내 흡수, 분포,\n\n<!-- PAGE_15 -->\n###### 대사, 배설에 대한 정보는 독성 가능성을 예측할 수 있으며 독성연구 해석에 도움을 줄\n\n<!-- PAGE_15 -->\n###### 수 있다.\n\n <!-- PAGE_15 -->\n###### ③ 피부흡수 : 화장품 성분의 피부흡수는 통과(penetration), 침투(permeation), 흡수\n\n<!-- PAGE_15 -->\n###### (resorption) 세 단계의 과정으로 이루어진다. ",
        "original_sentence": "<!-- PAGE_15 -->\n###### ① 물리화학적 성질 : 검토 대상 성분의 물리화학적 특성은 물질의 독성을 예측할 수 있는\n\n<!-- PAGE_15 -->\n###### 중요한 정보이다. "
      }
    },
    {
      "chunk_id": "chunk_189",
      "text": "검토 대상 성분의 물질명(INCI명, IUPAC명), CAS 번호, 화학식, 분자량,\n\n<!-- PAGE_15 -->\n###### 구조식, 물리화학적 성질(성상, 녹는점, 끓는점, 밀도, 증기압, pH, 용해도, Log Pow)과\n\n<!-- PAGE_15 -->\n###### ② 흡수·분포·대사·배설(ADME) : 체내에서 검토 대상 성분의 안전성에 대해 설명하기\n\n<!-- PAGE_15 -->\n###### 위해 독성동태학 자료(OECD 417)를 이용할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 188,
        "window_size": 3,
        "char_count": 262,
        "word_count": 49,
        "page_number": 15,
        "window_text": "위험성 확인\n\n<!-- PAGE_15 -->\n###### 1) 위험성 확인은 평가대상 물질에 대하여 최근까지 보고된 국내외 자료들을 조사·분석하여\n\n<!-- PAGE_15 -->\n###### ① 물질의 식별정보, 물리화학적 특성 및 고유한 독성학적 특성을 고려하여 in vitro 및  in\n\n<!-- PAGE_15 -->\n###### vivo, 임상자료, 역학자료 등 현재 이용할 수 있는 모든 독성자료를 종합적으로 검토한\n\n<!-- PAGE_15 -->\n###### ② 독성정보는 해외 화장품 위해평가 기관(유럽 소비자안전과학위원회(Scientific Committee\n\n<!-- PAGE_15 -->\n###### on Consumer Safety, SCCS) 등에서 발간한 보고서나 평가원에서 생산된 자료를 활용할\n\n<!-- PAGE_15 -->\n###### ③ 독성자료의 경우, OECD 등 국제적 인정기관에서 독성시험 설계 및 수행에 필요한 최소\n\n<!-- PAGE_15 -->\n###### 2) 독성영향은 인체에서의 생물학적 영향과의 연관성이 있는지를 판단한다.\n\n <!-- PAGE_15 -->\n###### 3) 위험성 확인에서 전신영향(Systemic effect) 또는 국소영향(Local effect)(예: 피부, 눈 자극,\n\n<!-- PAGE_15 -->\n###### 4) 위험성 확인에 필요한 자료는 다음과 같다.\n\n <!-- PAGE_15 -->\n###### ① 물리화학적 성질 : 검토 대상 성분의 물리화학적 특성은 물질의 독성을 예측할 수 있는\n\n<!-- PAGE_15 -->\n###### 중요한 정보이다.  검토 대상 성분의 물질명(INCI명, IUPAC명), CAS 번호, 화학식, 분자량,\n\n<!-- PAGE_15 -->\n###### 구조식, 물리화학적 성질(성상, 녹는점, 끓는점, 밀도, 증기압, pH, 용해도, Log Pow)과\n\n<!-- PAGE_15 -->\n###### ② 흡수·분포·대사·배설(ADME) : 체내에서 검토 대상 성분의 안전성에 대해 설명하기\n\n<!-- PAGE_15 -->\n###### 위해 독성동태학 자료(OECD 417)를 이용할 수 있다.  검토 대상 성분의 체내 흡수, 분포,\n\n<!-- PAGE_15 -->\n###### 대사, 배설에 대한 정보는 독성 가능성을 예측할 수 있으며 독성연구 해석에 도움을 줄\n\n<!-- PAGE_15 -->\n###### 수 있다.\n\n <!-- PAGE_15 -->\n###### ③ 피부흡수 : 화장품 성분의 피부흡수는 통과(penetration), 침투(permeation), 흡수\n\n<!-- PAGE_15 -->\n###### (resorption) 세 단계의 과정으로 이루어진다.  화장품 성분은 혈관과 림프관에 도달하기\n\n<!-- PAGE_15 -->\n###### 위해서 여러 층의 피부조직을 통과하게 되며, 이때 물질의 피부흡수율을 결정하는 층\n\n<!-- PAGE_15 -->\n###### (rate-determining layer)은 각질층이다. ",
        "original_sentence": "검토 대상 성분의 물질명(INCI명, IUPAC명), CAS 번호, 화학식, 분자량,\n\n<!-- PAGE_15 -->\n###### 구조식, 물리화학적 성질(성상, 녹는점, 끓는점, 밀도, 증기압, pH, 용해도, Log Pow)과\n\n<!-- PAGE_15 -->\n###### ② 흡수·분포·대사·배설(ADME) : 체내에서 검토 대상 성분의 안전성에 대해 설명하기\n\n<!-- PAGE_15 -->\n###### 위해 독성동태학 자료(OECD 417)를 이용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_190",
      "text": "검토 대상 성분의 체내 흡수, 분포,\n\n<!-- PAGE_15 -->\n###### 대사, 배설에 대한 정보는 독성 가능성을 예측할 수 있으며 독성연구 해석에 도움을 줄\n\n<!-- PAGE_15 -->\n###### 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 189,
        "window_size": 3,
        "char_count": 126,
        "word_count": 29,
        "page_number": 15,
        "window_text": "<!-- PAGE_15 -->\n###### 3) 위험성 확인에서 전신영향(Systemic effect) 또는 국소영향(Local effect)(예: 피부, 눈 자극,\n\n<!-- PAGE_15 -->\n###### 4) 위험성 확인에 필요한 자료는 다음과 같다.\n\n <!-- PAGE_15 -->\n###### ① 물리화학적 성질 : 검토 대상 성분의 물리화학적 특성은 물질의 독성을 예측할 수 있는\n\n<!-- PAGE_15 -->\n###### 중요한 정보이다.  검토 대상 성분의 물질명(INCI명, IUPAC명), CAS 번호, 화학식, 분자량,\n\n<!-- PAGE_15 -->\n###### 구조식, 물리화학적 성질(성상, 녹는점, 끓는점, 밀도, 증기압, pH, 용해도, Log Pow)과\n\n<!-- PAGE_15 -->\n###### ② 흡수·분포·대사·배설(ADME) : 체내에서 검토 대상 성분의 안전성에 대해 설명하기\n\n<!-- PAGE_15 -->\n###### 위해 독성동태학 자료(OECD 417)를 이용할 수 있다.  검토 대상 성분의 체내 흡수, 분포,\n\n<!-- PAGE_15 -->\n###### 대사, 배설에 대한 정보는 독성 가능성을 예측할 수 있으며 독성연구 해석에 도움을 줄\n\n<!-- PAGE_15 -->\n###### 수 있다.\n\n <!-- PAGE_15 -->\n###### ③ 피부흡수 : 화장품 성분의 피부흡수는 통과(penetration), 침투(permeation), 흡수\n\n<!-- PAGE_15 -->\n###### (resorption) 세 단계의 과정으로 이루어진다.  화장품 성분은 혈관과 림프관에 도달하기\n\n<!-- PAGE_15 -->\n###### 위해서 여러 층의 피부조직을 통과하게 되며, 이때 물질의 피부흡수율을 결정하는 층\n\n<!-- PAGE_15 -->\n###### (rate-determining layer)은 각질층이다.  화장품 성분에 대한 피부흡수 연구는 화장품의\n\n<!-- PAGE_15 -->\n###### 사용조건에서 인체의 전신 구획(systemic compartment)으로 들어가는 화합물의 정성적\n\n<!-- PAGE_15 -->\n###### 및 정량적 정보를 얻는 목적으로 수행되며 안전역(margin of safety) 산출에 반영된다.\n\n",
        "original_sentence": "검토 대상 성분의 체내 흡수, 분포,\n\n<!-- PAGE_15 -->\n###### 대사, 배설에 대한 정보는 독성 가능성을 예측할 수 있으며 독성연구 해석에 도움을 줄\n\n<!-- PAGE_15 -->\n###### 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_191",
      "text": "<!-- PAGE_15 -->\n###### ③ 피부흡수 : 화장품 성분의 피부흡수는 통과(penetration), 침투(permeation), 흡수\n\n<!-- PAGE_15 -->\n###### (resorption) 세 단계의 과정으로 이루어진다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 190,
        "window_size": 3,
        "char_count": 139,
        "word_count": 22,
        "page_number": 15,
        "window_text": "<!-- PAGE_15 -->\n###### ① 물리화학적 성질 : 검토 대상 성분의 물리화학적 특성은 물질의 독성을 예측할 수 있는\n\n<!-- PAGE_15 -->\n###### 중요한 정보이다.  검토 대상 성분의 물질명(INCI명, IUPAC명), CAS 번호, 화학식, 분자량,\n\n<!-- PAGE_15 -->\n###### 구조식, 물리화학적 성질(성상, 녹는점, 끓는점, 밀도, 증기압, pH, 용해도, Log Pow)과\n\n<!-- PAGE_15 -->\n###### ② 흡수·분포·대사·배설(ADME) : 체내에서 검토 대상 성분의 안전성에 대해 설명하기\n\n<!-- PAGE_15 -->\n###### 위해 독성동태학 자료(OECD 417)를 이용할 수 있다.  검토 대상 성분의 체내 흡수, 분포,\n\n<!-- PAGE_15 -->\n###### 대사, 배설에 대한 정보는 독성 가능성을 예측할 수 있으며 독성연구 해석에 도움을 줄\n\n<!-- PAGE_15 -->\n###### 수 있다.\n\n <!-- PAGE_15 -->\n###### ③ 피부흡수 : 화장품 성분의 피부흡수는 통과(penetration), 침투(permeation), 흡수\n\n<!-- PAGE_15 -->\n###### (resorption) 세 단계의 과정으로 이루어진다.  화장품 성분은 혈관과 림프관에 도달하기\n\n<!-- PAGE_15 -->\n###### 위해서 여러 층의 피부조직을 통과하게 되며, 이때 물질의 피부흡수율을 결정하는 층\n\n<!-- PAGE_15 -->\n###### (rate-determining layer)은 각질층이다.  화장품 성분에 대한 피부흡수 연구는 화장품의\n\n<!-- PAGE_15 -->\n###### 사용조건에서 인체의 전신 구획(systemic compartment)으로 들어가는 화합물의 정성적\n\n<!-- PAGE_15 -->\n###### 및 정량적 정보를 얻는 목적으로 수행되며 안전역(margin of safety) 산출에 반영된다.\n\n <!-- PAGE_15 -->\n###### ④ 독성자료 : 검토 대상 성분의 독성연구를 기반으로 화장품 성분의 독성 가능성을 확인할\n\n- - 10 -\n<!-- PAGE_16 -->\n###### 수 있다. ",
        "original_sentence": "<!-- PAGE_15 -->\n###### ③ 피부흡수 : 화장품 성분의 피부흡수는 통과(penetration), 침투(permeation), 흡수\n\n<!-- PAGE_15 -->\n###### (resorption) 세 단계의 과정으로 이루어진다. "
      }
    },
    {
      "chunk_id": "chunk_192",
      "text": "화장품 성분은 혈관과 림프관에 도달하기\n\n<!-- PAGE_15 -->\n###### 위해서 여러 층의 피부조직을 통과하게 되며, 이때 물질의 피부흡수율을 결정하는 층\n\n<!-- PAGE_15 -->\n###### (rate-determining layer)은 각질층이다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 191,
        "window_size": 3,
        "char_count": 151,
        "word_count": 27,
        "page_number": 15,
        "window_text": "검토 대상 성분의 물질명(INCI명, IUPAC명), CAS 번호, 화학식, 분자량,\n\n<!-- PAGE_15 -->\n###### 구조식, 물리화학적 성질(성상, 녹는점, 끓는점, 밀도, 증기압, pH, 용해도, Log Pow)과\n\n<!-- PAGE_15 -->\n###### ② 흡수·분포·대사·배설(ADME) : 체내에서 검토 대상 성분의 안전성에 대해 설명하기\n\n<!-- PAGE_15 -->\n###### 위해 독성동태학 자료(OECD 417)를 이용할 수 있다.  검토 대상 성분의 체내 흡수, 분포,\n\n<!-- PAGE_15 -->\n###### 대사, 배설에 대한 정보는 독성 가능성을 예측할 수 있으며 독성연구 해석에 도움을 줄\n\n<!-- PAGE_15 -->\n###### 수 있다.\n\n <!-- PAGE_15 -->\n###### ③ 피부흡수 : 화장품 성분의 피부흡수는 통과(penetration), 침투(permeation), 흡수\n\n<!-- PAGE_15 -->\n###### (resorption) 세 단계의 과정으로 이루어진다.  화장품 성분은 혈관과 림프관에 도달하기\n\n<!-- PAGE_15 -->\n###### 위해서 여러 층의 피부조직을 통과하게 되며, 이때 물질의 피부흡수율을 결정하는 층\n\n<!-- PAGE_15 -->\n###### (rate-determining layer)은 각질층이다.  화장품 성분에 대한 피부흡수 연구는 화장품의\n\n<!-- PAGE_15 -->\n###### 사용조건에서 인체의 전신 구획(systemic compartment)으로 들어가는 화합물의 정성적\n\n<!-- PAGE_15 -->\n###### 및 정량적 정보를 얻는 목적으로 수행되며 안전역(margin of safety) 산출에 반영된다.\n\n <!-- PAGE_15 -->\n###### ④ 독성자료 : 검토 대상 성분의 독성연구를 기반으로 화장품 성분의 독성 가능성을 확인할\n\n- - 10 -\n<!-- PAGE_16 -->\n###### 수 있다.  사람과 동일한 노출경로(국소, 경구, 흡입 경로)에 해당하는 독성 데이터를 조\n\n<!-- PAGE_16 -->\n###### 사하여 수집한다. ",
        "original_sentence": "화장품 성분은 혈관과 림프관에 도달하기\n\n<!-- PAGE_15 -->\n###### 위해서 여러 층의 피부조직을 통과하게 되며, 이때 물질의 피부흡수율을 결정하는 층\n\n<!-- PAGE_15 -->\n###### (rate-determining layer)은 각질층이다. "
      }
    },
    {
      "chunk_id": "chunk_193",
      "text": "화장품 성분에 대한 피부흡수 연구는 화장품의\n\n<!-- PAGE_15 -->\n###### 사용조건에서 인체의 전신 구획(systemic compartment)으로 들어가는 화합물의 정성적\n\n<!-- PAGE_15 -->\n###### 및 정량적 정보를 얻는 목적으로 수행되며 안전역(margin of safety) 산출에 반영된다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 192,
        "window_size": 3,
        "char_count": 186,
        "word_count": 33,
        "page_number": 15,
        "window_text": "검토 대상 성분의 체내 흡수, 분포,\n\n<!-- PAGE_15 -->\n###### 대사, 배설에 대한 정보는 독성 가능성을 예측할 수 있으며 독성연구 해석에 도움을 줄\n\n<!-- PAGE_15 -->\n###### 수 있다.\n\n <!-- PAGE_15 -->\n###### ③ 피부흡수 : 화장품 성분의 피부흡수는 통과(penetration), 침투(permeation), 흡수\n\n<!-- PAGE_15 -->\n###### (resorption) 세 단계의 과정으로 이루어진다.  화장품 성분은 혈관과 림프관에 도달하기\n\n<!-- PAGE_15 -->\n###### 위해서 여러 층의 피부조직을 통과하게 되며, 이때 물질의 피부흡수율을 결정하는 층\n\n<!-- PAGE_15 -->\n###### (rate-determining layer)은 각질층이다.  화장품 성분에 대한 피부흡수 연구는 화장품의\n\n<!-- PAGE_15 -->\n###### 사용조건에서 인체의 전신 구획(systemic compartment)으로 들어가는 화합물의 정성적\n\n<!-- PAGE_15 -->\n###### 및 정량적 정보를 얻는 목적으로 수행되며 안전역(margin of safety) 산출에 반영된다.\n\n <!-- PAGE_15 -->\n###### ④ 독성자료 : 검토 대상 성분의 독성연구를 기반으로 화장품 성분의 독성 가능성을 확인할\n\n- - 10 -\n<!-- PAGE_16 -->\n###### 수 있다.  사람과 동일한 노출경로(국소, 경구, 흡입 경로)에 해당하는 독성 데이터를 조\n\n<!-- PAGE_16 -->\n###### 사하여 수집한다.  독성자료에는 다음과 같은 독성연구가 포함된다(SCCS/1628/21, 2021).\n\n",
        "original_sentence": "화장품 성분에 대한 피부흡수 연구는 화장품의\n\n<!-- PAGE_15 -->\n###### 사용조건에서 인체의 전신 구획(systemic compartment)으로 들어가는 화합물의 정성적\n\n<!-- PAGE_15 -->\n###### 및 정량적 정보를 얻는 목적으로 수행되며 안전역(margin of safety) 산출에 반영된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_194",
      "text": "<!-- PAGE_15 -->\n###### ④ 독성자료 : 검토 대상 성분의 독성연구를 기반으로 화장품 성분의 독성 가능성을 확인할\n\n- - 10 -\n<!-- PAGE_16 -->\n###### 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 193,
        "window_size": 3,
        "char_count": 114,
        "word_count": 27,
        "page_number": 15,
        "window_text": "<!-- PAGE_15 -->\n###### ③ 피부흡수 : 화장품 성분의 피부흡수는 통과(penetration), 침투(permeation), 흡수\n\n<!-- PAGE_15 -->\n###### (resorption) 세 단계의 과정으로 이루어진다.  화장품 성분은 혈관과 림프관에 도달하기\n\n<!-- PAGE_15 -->\n###### 위해서 여러 층의 피부조직을 통과하게 되며, 이때 물질의 피부흡수율을 결정하는 층\n\n<!-- PAGE_15 -->\n###### (rate-determining layer)은 각질층이다.  화장품 성분에 대한 피부흡수 연구는 화장품의\n\n<!-- PAGE_15 -->\n###### 사용조건에서 인체의 전신 구획(systemic compartment)으로 들어가는 화합물의 정성적\n\n<!-- PAGE_15 -->\n###### 및 정량적 정보를 얻는 목적으로 수행되며 안전역(margin of safety) 산출에 반영된다.\n\n <!-- PAGE_15 -->\n###### ④ 독성자료 : 검토 대상 성분의 독성연구를 기반으로 화장품 성분의 독성 가능성을 확인할\n\n- - 10 -\n<!-- PAGE_16 -->\n###### 수 있다.  사람과 동일한 노출경로(국소, 경구, 흡입 경로)에 해당하는 독성 데이터를 조\n\n<!-- PAGE_16 -->\n###### 사하여 수집한다.  독성자료에는 다음과 같은 독성연구가 포함된다(SCCS/1628/21, 2021).\n\n <!-- PAGE_16 -->\n###### (a) 단회투여독성 : 경구, 피부, 흡입 경로를 통해 물질에 1회 노출됨에 따라 건강과 관련\n\n<!-- PAGE_16 -->\n###### 하여 발생할 수 있는 이상반응을 설명하는데 사용되며, LD50 값을 결정하기 위한 목적\n\n<!-- PAGE_16 -->\n###### (b) 반복투여독성 : 물질을 장기간(28일/90일/24개월)에 걸쳐 매일 반복하여 투여하거나 노\n\n<!-- PAGE_16 -->\n###### 출됨에 따라 나타나는 일반적인 독성영향(생식독성, 유전독성, 발암성 효과 제외)을 말\n\n<!-- PAGE_16 -->\n###### (c) 피부부식성, 피부자극성, 안점막자극성, 피부감작성 : 검토 대상 성분이 피부 또는 안\n\n<!-- PAGE_16 -->\n###### 점막에 노출되어 표피 또는 진피 내부, 각막에 나타나는 손상으로 피부에 나타나는 독\n\n<!-- PAGE_16 -->\n###### (d) 생식발생독성 : 물질로 인해 포유류 생식의 모든 측면에 발생하는 유해 영향으로 남성\n\n<!-- PAGE_16 -->\n###### /여성의 생식기능 장애, 자손에 유전되지 않는 유해영향 발생(예: 사망, 성장지연, 구조\n\n<!-- PAGE_16 -->\n###### (e) 유전독성 : DNA의 구조나 정보, 분리의 변화를 일으키는 과정으로 물질에 의해 정상\n\n<!-- PAGE_16 -->\n###### 적인 복제과정이 방해되어 DNA 손상을 일으키거나 비생리적 방식으로 복제를 변경하\n\n<!-- PAGE_16 -->\n###### (f) 발암성 : 흡입, 경구, 피부 도포, 주사(injection)를 통해 종양(양성 또는 악성)을 유발하\n\n<!-- PAGE_16 -->\n###### 거나 종양의 발생률과 악성도 증가, 종양 발생 시간을 단축하는 물질을 발암물질로 정\n\n<!-- PAGE_16 -->\n###### 의한다. ",
        "original_sentence": "<!-- PAGE_15 -->\n###### ④ 독성자료 : 검토 대상 성분의 독성연구를 기반으로 화장품 성분의 독성 가능성을 확인할\n\n- - 10 -\n<!-- PAGE_16 -->\n###### 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_195",
      "text": "사람과 동일한 노출경로(국소, 경구, 흡입 경로)에 해당하는 독성 데이터를 조\n\n<!-- PAGE_16 -->\n###### 사하여 수집한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 194,
        "window_size": 3,
        "char_count": 79,
        "word_count": 16,
        "page_number": 16,
        "window_text": "화장품 성분은 혈관과 림프관에 도달하기\n\n<!-- PAGE_15 -->\n###### 위해서 여러 층의 피부조직을 통과하게 되며, 이때 물질의 피부흡수율을 결정하는 층\n\n<!-- PAGE_15 -->\n###### (rate-determining layer)은 각질층이다.  화장품 성분에 대한 피부흡수 연구는 화장품의\n\n<!-- PAGE_15 -->\n###### 사용조건에서 인체의 전신 구획(systemic compartment)으로 들어가는 화합물의 정성적\n\n<!-- PAGE_15 -->\n###### 및 정량적 정보를 얻는 목적으로 수행되며 안전역(margin of safety) 산출에 반영된다.\n\n <!-- PAGE_15 -->\n###### ④ 독성자료 : 검토 대상 성분의 독성연구를 기반으로 화장품 성분의 독성 가능성을 확인할\n\n- - 10 -\n<!-- PAGE_16 -->\n###### 수 있다.  사람과 동일한 노출경로(국소, 경구, 흡입 경로)에 해당하는 독성 데이터를 조\n\n<!-- PAGE_16 -->\n###### 사하여 수집한다.  독성자료에는 다음과 같은 독성연구가 포함된다(SCCS/1628/21, 2021).\n\n <!-- PAGE_16 -->\n###### (a) 단회투여독성 : 경구, 피부, 흡입 경로를 통해 물질에 1회 노출됨에 따라 건강과 관련\n\n<!-- PAGE_16 -->\n###### 하여 발생할 수 있는 이상반응을 설명하는데 사용되며, LD50 값을 결정하기 위한 목적\n\n<!-- PAGE_16 -->\n###### (b) 반복투여독성 : 물질을 장기간(28일/90일/24개월)에 걸쳐 매일 반복하여 투여하거나 노\n\n<!-- PAGE_16 -->\n###### 출됨에 따라 나타나는 일반적인 독성영향(생식독성, 유전독성, 발암성 효과 제외)을 말\n\n<!-- PAGE_16 -->\n###### (c) 피부부식성, 피부자극성, 안점막자극성, 피부감작성 : 검토 대상 성분이 피부 또는 안\n\n<!-- PAGE_16 -->\n###### 점막에 노출되어 표피 또는 진피 내부, 각막에 나타나는 손상으로 피부에 나타나는 독\n\n<!-- PAGE_16 -->\n###### (d) 생식발생독성 : 물질로 인해 포유류 생식의 모든 측면에 발생하는 유해 영향으로 남성\n\n<!-- PAGE_16 -->\n###### /여성의 생식기능 장애, 자손에 유전되지 않는 유해영향 발생(예: 사망, 성장지연, 구조\n\n<!-- PAGE_16 -->\n###### (e) 유전독성 : DNA의 구조나 정보, 분리의 변화를 일으키는 과정으로 물질에 의해 정상\n\n<!-- PAGE_16 -->\n###### 적인 복제과정이 방해되어 DNA 손상을 일으키거나 비생리적 방식으로 복제를 변경하\n\n<!-- PAGE_16 -->\n###### (f) 발암성 : 흡입, 경구, 피부 도포, 주사(injection)를 통해 종양(양성 또는 악성)을 유발하\n\n<!-- PAGE_16 -->\n###### 거나 종양의 발생률과 악성도 증가, 종양 발생 시간을 단축하는 물질을 발암물질로 정\n\n<!-- PAGE_16 -->\n###### 의한다.  발암물질은 DNA와의 상호작용과 돌연변이 유발을 통해 암을 발생시키는 유전\n\n<!-- PAGE_16 -->\n###### 독성 발암물질과 DNA 손상이 아닌 다른 메커니즘을 통해 암을 유발하는 비유전독성\n\n<!-- PAGE_16 -->\n###### (g) 기타 독성 : 면역독성, 신경독성, 광독성 등을 포함한다.\n\n",
        "original_sentence": "사람과 동일한 노출경로(국소, 경구, 흡입 경로)에 해당하는 독성 데이터를 조\n\n<!-- PAGE_16 -->\n###### 사하여 수집한다. "
      }
    },
    {
      "chunk_id": "chunk_196",
      "text": "독성자료에는 다음과 같은 독성연구가 포함된다(SCCS/1628/21, 2021).\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 195,
        "window_size": 3,
        "char_count": 47,
        "word_count": 6,
        "page_number": 16,
        "window_text": "화장품 성분에 대한 피부흡수 연구는 화장품의\n\n<!-- PAGE_15 -->\n###### 사용조건에서 인체의 전신 구획(systemic compartment)으로 들어가는 화합물의 정성적\n\n<!-- PAGE_15 -->\n###### 및 정량적 정보를 얻는 목적으로 수행되며 안전역(margin of safety) 산출에 반영된다.\n\n <!-- PAGE_15 -->\n###### ④ 독성자료 : 검토 대상 성분의 독성연구를 기반으로 화장품 성분의 독성 가능성을 확인할\n\n- - 10 -\n<!-- PAGE_16 -->\n###### 수 있다.  사람과 동일한 노출경로(국소, 경구, 흡입 경로)에 해당하는 독성 데이터를 조\n\n<!-- PAGE_16 -->\n###### 사하여 수집한다.  독성자료에는 다음과 같은 독성연구가 포함된다(SCCS/1628/21, 2021).\n\n <!-- PAGE_16 -->\n###### (a) 단회투여독성 : 경구, 피부, 흡입 경로를 통해 물질에 1회 노출됨에 따라 건강과 관련\n\n<!-- PAGE_16 -->\n###### 하여 발생할 수 있는 이상반응을 설명하는데 사용되며, LD50 값을 결정하기 위한 목적\n\n<!-- PAGE_16 -->\n###### (b) 반복투여독성 : 물질을 장기간(28일/90일/24개월)에 걸쳐 매일 반복하여 투여하거나 노\n\n<!-- PAGE_16 -->\n###### 출됨에 따라 나타나는 일반적인 독성영향(생식독성, 유전독성, 발암성 효과 제외)을 말\n\n<!-- PAGE_16 -->\n###### (c) 피부부식성, 피부자극성, 안점막자극성, 피부감작성 : 검토 대상 성분이 피부 또는 안\n\n<!-- PAGE_16 -->\n###### 점막에 노출되어 표피 또는 진피 내부, 각막에 나타나는 손상으로 피부에 나타나는 독\n\n<!-- PAGE_16 -->\n###### (d) 생식발생독성 : 물질로 인해 포유류 생식의 모든 측면에 발생하는 유해 영향으로 남성\n\n<!-- PAGE_16 -->\n###### /여성의 생식기능 장애, 자손에 유전되지 않는 유해영향 발생(예: 사망, 성장지연, 구조\n\n<!-- PAGE_16 -->\n###### (e) 유전독성 : DNA의 구조나 정보, 분리의 변화를 일으키는 과정으로 물질에 의해 정상\n\n<!-- PAGE_16 -->\n###### 적인 복제과정이 방해되어 DNA 손상을 일으키거나 비생리적 방식으로 복제를 변경하\n\n<!-- PAGE_16 -->\n###### (f) 발암성 : 흡입, 경구, 피부 도포, 주사(injection)를 통해 종양(양성 또는 악성)을 유발하\n\n<!-- PAGE_16 -->\n###### 거나 종양의 발생률과 악성도 증가, 종양 발생 시간을 단축하는 물질을 발암물질로 정\n\n<!-- PAGE_16 -->\n###### 의한다.  발암물질은 DNA와의 상호작용과 돌연변이 유발을 통해 암을 발생시키는 유전\n\n<!-- PAGE_16 -->\n###### 독성 발암물질과 DNA 손상이 아닌 다른 메커니즘을 통해 암을 유발하는 비유전독성\n\n<!-- PAGE_16 -->\n###### (g) 기타 독성 : 면역독성, 신경독성, 광독성 등을 포함한다.\n\n <!-- PAGE_16 -->\n###### - 면역독성 : 화학물질에 대한 면역 체계 손상, 면역 반응 등을 평가한다.\n\n",
        "original_sentence": "독성자료에는 다음과 같은 독성연구가 포함된다(SCCS/1628/21, 2021).\n\n"
      }
    },
    {
      "chunk_id": "chunk_197",
      "text": "<!-- PAGE_16 -->\n###### (a) 단회투여독성 : 경구, 피부, 흡입 경로를 통해 물질에 1회 노출됨에 따라 건강과 관련\n\n<!-- PAGE_16 -->\n###### 하여 발생할 수 있는 이상반응을 설명하는데 사용되며, LD50 값을 결정하기 위한 목적\n\n<!-- PAGE_16 -->\n###### (b) 반복투여독성 : 물질을 장기간(28일/90일/24개월)에 걸쳐 매일 반복하여 투여하거나 노\n\n<!-- PAGE_16 -->\n###### 출됨에 따라 나타나는 일반적인 독성영향(생식독성, 유전독성, 발암성 효과 제외)을 말\n\n<!-- PAGE_16 -->\n###### (c) 피부부식성, 피부자극성, 안점막자극성, 피부감작성 : 검토 대상 성분이 피부 또는 안\n\n<!-- PAGE_16 -->\n###### 점막에 노출되어 표피 또는 진피 내부, 각막에 나타나는 손상으로 피부에 나타나는 독\n\n<!-- PAGE_16 -->\n###### (d) 생식발생독성 : 물질로 인해 포유류 생식의 모든 측면에 발생하는 유해 영향으로 남성\n\n<!-- PAGE_16 -->\n###### /여성의 생식기능 장애, 자손에 유전되지 않는 유해영향 발생(예: 사망, 성장지연, 구조\n\n<!-- PAGE_16 -->\n###### (e) 유전독성 : DNA의 구조나 정보, 분리의 변화를 일으키는 과정으로 물질에 의해 정상\n\n<!-- PAGE_16 -->\n###### 적인 복제과정이 방해되어 DNA 손상을 일으키거나 비생리적 방식으로 복제를 변경하\n\n<!-- PAGE_16 -->\n###### (f) 발암성 : 흡입, 경구, 피부 도포, 주사(injection)를 통해 종양(양성 또는 악성)을 유발하\n\n<!-- PAGE_16 -->\n###### 거나 종양의 발생률과 악성도 증가, 종양 발생 시간을 단축하는 물질을 발암물질로 정\n\n<!-- PAGE_16 -->\n###### 의한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 196,
        "window_size": 3,
        "char_count": 940,
        "word_count": 195,
        "page_number": 16,
        "window_text": "<!-- PAGE_15 -->\n###### ④ 독성자료 : 검토 대상 성분의 독성연구를 기반으로 화장품 성분의 독성 가능성을 확인할\n\n- - 10 -\n<!-- PAGE_16 -->\n###### 수 있다.  사람과 동일한 노출경로(국소, 경구, 흡입 경로)에 해당하는 독성 데이터를 조\n\n<!-- PAGE_16 -->\n###### 사하여 수집한다.  독성자료에는 다음과 같은 독성연구가 포함된다(SCCS/1628/21, 2021).\n\n <!-- PAGE_16 -->\n###### (a) 단회투여독성 : 경구, 피부, 흡입 경로를 통해 물질에 1회 노출됨에 따라 건강과 관련\n\n<!-- PAGE_16 -->\n###### 하여 발생할 수 있는 이상반응을 설명하는데 사용되며, LD50 값을 결정하기 위한 목적\n\n<!-- PAGE_16 -->\n###### (b) 반복투여독성 : 물질을 장기간(28일/90일/24개월)에 걸쳐 매일 반복하여 투여하거나 노\n\n<!-- PAGE_16 -->\n###### 출됨에 따라 나타나는 일반적인 독성영향(생식독성, 유전독성, 발암성 효과 제외)을 말\n\n<!-- PAGE_16 -->\n###### (c) 피부부식성, 피부자극성, 안점막자극성, 피부감작성 : 검토 대상 성분이 피부 또는 안\n\n<!-- PAGE_16 -->\n###### 점막에 노출되어 표피 또는 진피 내부, 각막에 나타나는 손상으로 피부에 나타나는 독\n\n<!-- PAGE_16 -->\n###### (d) 생식발생독성 : 물질로 인해 포유류 생식의 모든 측면에 발생하는 유해 영향으로 남성\n\n<!-- PAGE_16 -->\n###### /여성의 생식기능 장애, 자손에 유전되지 않는 유해영향 발생(예: 사망, 성장지연, 구조\n\n<!-- PAGE_16 -->\n###### (e) 유전독성 : DNA의 구조나 정보, 분리의 변화를 일으키는 과정으로 물질에 의해 정상\n\n<!-- PAGE_16 -->\n###### 적인 복제과정이 방해되어 DNA 손상을 일으키거나 비생리적 방식으로 복제를 변경하\n\n<!-- PAGE_16 -->\n###### (f) 발암성 : 흡입, 경구, 피부 도포, 주사(injection)를 통해 종양(양성 또는 악성)을 유발하\n\n<!-- PAGE_16 -->\n###### 거나 종양의 발생률과 악성도 증가, 종양 발생 시간을 단축하는 물질을 발암물질로 정\n\n<!-- PAGE_16 -->\n###### 의한다.  발암물질은 DNA와의 상호작용과 돌연변이 유발을 통해 암을 발생시키는 유전\n\n<!-- PAGE_16 -->\n###### 독성 발암물질과 DNA 손상이 아닌 다른 메커니즘을 통해 암을 유발하는 비유전독성\n\n<!-- PAGE_16 -->\n###### (g) 기타 독성 : 면역독성, 신경독성, 광독성 등을 포함한다.\n\n <!-- PAGE_16 -->\n###### - 면역독성 : 화학물질에 대한 면역 체계 손상, 면역 반응 등을 평가한다.\n\n <!-- PAGE_16 -->\n###### - 신경독성 : 화학물질에 의한 행동장애, 신경 손상, 뇌의 손상 등을 평가한다.\n\n",
        "original_sentence": "<!-- PAGE_16 -->\n###### (a) 단회투여독성 : 경구, 피부, 흡입 경로를 통해 물질에 1회 노출됨에 따라 건강과 관련\n\n<!-- PAGE_16 -->\n###### 하여 발생할 수 있는 이상반응을 설명하는데 사용되며, LD50 값을 결정하기 위한 목적\n\n<!-- PAGE_16 -->\n###### (b) 반복투여독성 : 물질을 장기간(28일/90일/24개월)에 걸쳐 매일 반복하여 투여하거나 노\n\n<!-- PAGE_16 -->\n###### 출됨에 따라 나타나는 일반적인 독성영향(생식독성, 유전독성, 발암성 효과 제외)을 말\n\n<!-- PAGE_16 -->\n###### (c) 피부부식성, 피부자극성, 안점막자극성, 피부감작성 : 검토 대상 성분이 피부 또는 안\n\n<!-- PAGE_16 -->\n###### 점막에 노출되어 표피 또는 진피 내부, 각막에 나타나는 손상으로 피부에 나타나는 독\n\n<!-- PAGE_16 -->\n###### (d) 생식발생독성 : 물질로 인해 포유류 생식의 모든 측면에 발생하는 유해 영향으로 남성\n\n<!-- PAGE_16 -->\n###### /여성의 생식기능 장애, 자손에 유전되지 않는 유해영향 발생(예: 사망, 성장지연, 구조\n\n<!-- PAGE_16 -->\n###### (e) 유전독성 : DNA의 구조나 정보, 분리의 변화를 일으키는 과정으로 물질에 의해 정상\n\n<!-- PAGE_16 -->\n###### 적인 복제과정이 방해되어 DNA 손상을 일으키거나 비생리적 방식으로 복제를 변경하\n\n<!-- PAGE_16 -->\n###### (f) 발암성 : 흡입, 경구, 피부 도포, 주사(injection)를 통해 종양(양성 또는 악성)을 유발하\n\n<!-- PAGE_16 -->\n###### 거나 종양의 발생률과 악성도 증가, 종양 발생 시간을 단축하는 물질을 발암물질로 정\n\n<!-- PAGE_16 -->\n###### 의한다. "
      }
    },
    {
      "chunk_id": "chunk_198",
      "text": "발암물질은 DNA와의 상호작용과 돌연변이 유발을 통해 암을 발생시키는 유전\n\n<!-- PAGE_16 -->\n###### 독성 발암물질과 DNA 손상이 아닌 다른 메커니즘을 통해 암을 유발하는 비유전독성\n\n<!-- PAGE_16 -->\n###### (g) 기타 독성 : 면역독성, 신경독성, 광독성 등을 포함한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 197,
        "window_size": 3,
        "char_count": 176,
        "word_count": 37,
        "page_number": 16,
        "window_text": "사람과 동일한 노출경로(국소, 경구, 흡입 경로)에 해당하는 독성 데이터를 조\n\n<!-- PAGE_16 -->\n###### 사하여 수집한다.  독성자료에는 다음과 같은 독성연구가 포함된다(SCCS/1628/21, 2021).\n\n <!-- PAGE_16 -->\n###### (a) 단회투여독성 : 경구, 피부, 흡입 경로를 통해 물질에 1회 노출됨에 따라 건강과 관련\n\n<!-- PAGE_16 -->\n###### 하여 발생할 수 있는 이상반응을 설명하는데 사용되며, LD50 값을 결정하기 위한 목적\n\n<!-- PAGE_16 -->\n###### (b) 반복투여독성 : 물질을 장기간(28일/90일/24개월)에 걸쳐 매일 반복하여 투여하거나 노\n\n<!-- PAGE_16 -->\n###### 출됨에 따라 나타나는 일반적인 독성영향(생식독성, 유전독성, 발암성 효과 제외)을 말\n\n<!-- PAGE_16 -->\n###### (c) 피부부식성, 피부자극성, 안점막자극성, 피부감작성 : 검토 대상 성분이 피부 또는 안\n\n<!-- PAGE_16 -->\n###### 점막에 노출되어 표피 또는 진피 내부, 각막에 나타나는 손상으로 피부에 나타나는 독\n\n<!-- PAGE_16 -->\n###### (d) 생식발생독성 : 물질로 인해 포유류 생식의 모든 측면에 발생하는 유해 영향으로 남성\n\n<!-- PAGE_16 -->\n###### /여성의 생식기능 장애, 자손에 유전되지 않는 유해영향 발생(예: 사망, 성장지연, 구조\n\n<!-- PAGE_16 -->\n###### (e) 유전독성 : DNA의 구조나 정보, 분리의 변화를 일으키는 과정으로 물질에 의해 정상\n\n<!-- PAGE_16 -->\n###### 적인 복제과정이 방해되어 DNA 손상을 일으키거나 비생리적 방식으로 복제를 변경하\n\n<!-- PAGE_16 -->\n###### (f) 발암성 : 흡입, 경구, 피부 도포, 주사(injection)를 통해 종양(양성 또는 악성)을 유발하\n\n<!-- PAGE_16 -->\n###### 거나 종양의 발생률과 악성도 증가, 종양 발생 시간을 단축하는 물질을 발암물질로 정\n\n<!-- PAGE_16 -->\n###### 의한다.  발암물질은 DNA와의 상호작용과 돌연변이 유발을 통해 암을 발생시키는 유전\n\n<!-- PAGE_16 -->\n###### 독성 발암물질과 DNA 손상이 아닌 다른 메커니즘을 통해 암을 유발하는 비유전독성\n\n<!-- PAGE_16 -->\n###### (g) 기타 독성 : 면역독성, 신경독성, 광독성 등을 포함한다.\n\n <!-- PAGE_16 -->\n###### - 면역독성 : 화학물질에 대한 면역 체계 손상, 면역 반응 등을 평가한다.\n\n <!-- PAGE_16 -->\n###### - 신경독성 : 화학물질에 의한 행동장애, 신경 손상, 뇌의 손상 등을 평가한다.\n\n <!-- PAGE_16 -->\n###### - 광독성 : 세포독성을 유발하지 않는 용량 수준에서 자외선/가시광선의 비세포독성 용\n\n<!-- PAGE_16 -->\n###### 량에 따른 노출/비노출 상태에서 화학물질의 세포독성 여부로 평가한다.\n\n",
        "original_sentence": "발암물질은 DNA와의 상호작용과 돌연변이 유발을 통해 암을 발생시키는 유전\n\n<!-- PAGE_16 -->\n###### 독성 발암물질과 DNA 손상이 아닌 다른 메커니즘을 통해 암을 유발하는 비유전독성\n\n<!-- PAGE_16 -->\n###### (g) 기타 독성 : 면역독성, 신경독성, 광독성 등을 포함한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_199",
      "text": "<!-- PAGE_16 -->\n###### - 면역독성 : 화학물질에 대한 면역 체계 손상, 면역 반응 등을 평가한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 198,
        "window_size": 3,
        "char_count": 68,
        "word_count": 16,
        "page_number": 16,
        "window_text": "독성자료에는 다음과 같은 독성연구가 포함된다(SCCS/1628/21, 2021).\n\n <!-- PAGE_16 -->\n###### (a) 단회투여독성 : 경구, 피부, 흡입 경로를 통해 물질에 1회 노출됨에 따라 건강과 관련\n\n<!-- PAGE_16 -->\n###### 하여 발생할 수 있는 이상반응을 설명하는데 사용되며, LD50 값을 결정하기 위한 목적\n\n<!-- PAGE_16 -->\n###### (b) 반복투여독성 : 물질을 장기간(28일/90일/24개월)에 걸쳐 매일 반복하여 투여하거나 노\n\n<!-- PAGE_16 -->\n###### 출됨에 따라 나타나는 일반적인 독성영향(생식독성, 유전독성, 발암성 효과 제외)을 말\n\n<!-- PAGE_16 -->\n###### (c) 피부부식성, 피부자극성, 안점막자극성, 피부감작성 : 검토 대상 성분이 피부 또는 안\n\n<!-- PAGE_16 -->\n###### 점막에 노출되어 표피 또는 진피 내부, 각막에 나타나는 손상으로 피부에 나타나는 독\n\n<!-- PAGE_16 -->\n###### (d) 생식발생독성 : 물질로 인해 포유류 생식의 모든 측면에 발생하는 유해 영향으로 남성\n\n<!-- PAGE_16 -->\n###### /여성의 생식기능 장애, 자손에 유전되지 않는 유해영향 발생(예: 사망, 성장지연, 구조\n\n<!-- PAGE_16 -->\n###### (e) 유전독성 : DNA의 구조나 정보, 분리의 변화를 일으키는 과정으로 물질에 의해 정상\n\n<!-- PAGE_16 -->\n###### 적인 복제과정이 방해되어 DNA 손상을 일으키거나 비생리적 방식으로 복제를 변경하\n\n<!-- PAGE_16 -->\n###### (f) 발암성 : 흡입, 경구, 피부 도포, 주사(injection)를 통해 종양(양성 또는 악성)을 유발하\n\n<!-- PAGE_16 -->\n###### 거나 종양의 발생률과 악성도 증가, 종양 발생 시간을 단축하는 물질을 발암물질로 정\n\n<!-- PAGE_16 -->\n###### 의한다.  발암물질은 DNA와의 상호작용과 돌연변이 유발을 통해 암을 발생시키는 유전\n\n<!-- PAGE_16 -->\n###### 독성 발암물질과 DNA 손상이 아닌 다른 메커니즘을 통해 암을 유발하는 비유전독성\n\n<!-- PAGE_16 -->\n###### (g) 기타 독성 : 면역독성, 신경독성, 광독성 등을 포함한다.\n\n <!-- PAGE_16 -->\n###### - 면역독성 : 화학물질에 대한 면역 체계 손상, 면역 반응 등을 평가한다.\n\n <!-- PAGE_16 -->\n###### - 신경독성 : 화학물질에 의한 행동장애, 신경 손상, 뇌의 손상 등을 평가한다.\n\n <!-- PAGE_16 -->\n###### - 광독성 : 세포독성을 유발하지 않는 용량 수준에서 자외선/가시광선의 비세포독성 용\n\n<!-- PAGE_16 -->\n###### 량에 따른 노출/비노출 상태에서 화학물질의 세포독성 여부로 평가한다.\n\n - - 11 -\n<!-- PAGE_17 -->\n###### □ 위험성 확인 방법\n\n주요내용\n\n검토방법\n\n- ○ 물리화학적 특성 조사\n- ○ 피부흡수율 자료, ADME(흡수, 분포, 대사,\n**[표 시작]**\n\n| ○ 독성자료 조사 | 단회투여독성 | ② 노출평가 |\n| --- | --- | --- |\n| - 통계적 모델의 허용(Accept) 여부: p-value > 0.05 (default) | 나 발생을 촉진하는 독성 |\n**- 단회투여독성, 반복투여독성, 피부자극성,**\n| ○ 전신 독성기준값(PODsys) 결정 | 3) 노출평가 | 3.1.4.1 독성동태 |\n| - 최적의 모델 적합도 : log-likelihood, AIC(Akaike's Information Criterion) 등 | 이. ",
        "original_sentence": "<!-- PAGE_16 -->\n###### - 면역독성 : 화학물질에 대한 면역 체계 손상, 면역 반응 등을 평가한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_200",
      "text": "<!-- PAGE_16 -->\n###### - 신경독성 : 화학물질에 의한 행동장애, 신경 손상, 뇌의 손상 등을 평가한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 199,
        "window_size": 3,
        "char_count": 71,
        "word_count": 16,
        "page_number": 16,
        "window_text": "<!-- PAGE_16 -->\n###### (a) 단회투여독성 : 경구, 피부, 흡입 경로를 통해 물질에 1회 노출됨에 따라 건강과 관련\n\n<!-- PAGE_16 -->\n###### 하여 발생할 수 있는 이상반응을 설명하는데 사용되며, LD50 값을 결정하기 위한 목적\n\n<!-- PAGE_16 -->\n###### (b) 반복투여독성 : 물질을 장기간(28일/90일/24개월)에 걸쳐 매일 반복하여 투여하거나 노\n\n<!-- PAGE_16 -->\n###### 출됨에 따라 나타나는 일반적인 독성영향(생식독성, 유전독성, 발암성 효과 제외)을 말\n\n<!-- PAGE_16 -->\n###### (c) 피부부식성, 피부자극성, 안점막자극성, 피부감작성 : 검토 대상 성분이 피부 또는 안\n\n<!-- PAGE_16 -->\n###### 점막에 노출되어 표피 또는 진피 내부, 각막에 나타나는 손상으로 피부에 나타나는 독\n\n<!-- PAGE_16 -->\n###### (d) 생식발생독성 : 물질로 인해 포유류 생식의 모든 측면에 발생하는 유해 영향으로 남성\n\n<!-- PAGE_16 -->\n###### /여성의 생식기능 장애, 자손에 유전되지 않는 유해영향 발생(예: 사망, 성장지연, 구조\n\n<!-- PAGE_16 -->\n###### (e) 유전독성 : DNA의 구조나 정보, 분리의 변화를 일으키는 과정으로 물질에 의해 정상\n\n<!-- PAGE_16 -->\n###### 적인 복제과정이 방해되어 DNA 손상을 일으키거나 비생리적 방식으로 복제를 변경하\n\n<!-- PAGE_16 -->\n###### (f) 발암성 : 흡입, 경구, 피부 도포, 주사(injection)를 통해 종양(양성 또는 악성)을 유발하\n\n<!-- PAGE_16 -->\n###### 거나 종양의 발생률과 악성도 증가, 종양 발생 시간을 단축하는 물질을 발암물질로 정\n\n<!-- PAGE_16 -->\n###### 의한다.  발암물질은 DNA와의 상호작용과 돌연변이 유발을 통해 암을 발생시키는 유전\n\n<!-- PAGE_16 -->\n###### 독성 발암물질과 DNA 손상이 아닌 다른 메커니즘을 통해 암을 유발하는 비유전독성\n\n<!-- PAGE_16 -->\n###### (g) 기타 독성 : 면역독성, 신경독성, 광독성 등을 포함한다.\n\n <!-- PAGE_16 -->\n###### - 면역독성 : 화학물질에 대한 면역 체계 손상, 면역 반응 등을 평가한다.\n\n <!-- PAGE_16 -->\n###### - 신경독성 : 화학물질에 의한 행동장애, 신경 손상, 뇌의 손상 등을 평가한다.\n\n <!-- PAGE_16 -->\n###### - 광독성 : 세포독성을 유발하지 않는 용량 수준에서 자외선/가시광선의 비세포독성 용\n\n<!-- PAGE_16 -->\n###### 량에 따른 노출/비노출 상태에서 화학물질의 세포독성 여부로 평가한다.\n\n - - 11 -\n<!-- PAGE_17 -->\n###### □ 위험성 확인 방법\n\n주요내용\n\n검토방법\n\n- ○ 물리화학적 특성 조사\n- ○ 피부흡수율 자료, ADME(흡수, 분포, 대사,\n**[표 시작]**\n\n| ○ 독성자료 조사 | 단회투여독성 | ② 노출평가 |\n| --- | --- | --- |\n| - 통계적 모델의 허용(Accept) 여부: p-value > 0.05 (default) | 나 발생을 촉진하는 독성 |\n**- 단회투여독성, 반복투여독성, 피부자극성,**\n| ○ 전신 독성기준값(PODsys) 결정 | 3) 노출평가 | 3.1.4.1 독성동태 |\n| - 최적의 모델 적합도 : log-likelihood, AIC(Akaike's Information Criterion) 등 | 이.  물질의 효력에 관한 정보를 제공함 |\n**3) 노출평가**\n**계산된 값이며, 전체 용량 범위에 대한 선형 용량-반응 관계의 가정에 기초한다.",
        "original_sentence": "<!-- PAGE_16 -->\n###### - 신경독성 : 화학물질에 의한 행동장애, 신경 손상, 뇌의 손상 등을 평가한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_201",
      "text": "<!-- PAGE_16 -->\n###### - 광독성 : 세포독성을 유발하지 않는 용량 수준에서 자외선/가시광선의 비세포독성 용\n\n<!-- PAGE_16 -->\n###### 량에 따른 노출/비노출 상태에서 화학물질의 세포독성 여부로 평가한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 200,
        "window_size": 3,
        "char_count": 137,
        "word_count": 27,
        "page_number": 16,
        "window_text": "발암물질은 DNA와의 상호작용과 돌연변이 유발을 통해 암을 발생시키는 유전\n\n<!-- PAGE_16 -->\n###### 독성 발암물질과 DNA 손상이 아닌 다른 메커니즘을 통해 암을 유발하는 비유전독성\n\n<!-- PAGE_16 -->\n###### (g) 기타 독성 : 면역독성, 신경독성, 광독성 등을 포함한다.\n\n <!-- PAGE_16 -->\n###### - 면역독성 : 화학물질에 대한 면역 체계 손상, 면역 반응 등을 평가한다.\n\n <!-- PAGE_16 -->\n###### - 신경독성 : 화학물질에 의한 행동장애, 신경 손상, 뇌의 손상 등을 평가한다.\n\n <!-- PAGE_16 -->\n###### - 광독성 : 세포독성을 유발하지 않는 용량 수준에서 자외선/가시광선의 비세포독성 용\n\n<!-- PAGE_16 -->\n###### 량에 따른 노출/비노출 상태에서 화학물질의 세포독성 여부로 평가한다.\n\n - - 11 -\n<!-- PAGE_17 -->\n###### □ 위험성 확인 방법\n\n주요내용\n\n검토방법\n\n- ○ 물리화학적 특성 조사\n- ○ 피부흡수율 자료, ADME(흡수, 분포, 대사,\n**[표 시작]**\n\n| ○ 독성자료 조사 | 단회투여독성 | ② 노출평가 |\n| --- | --- | --- |\n| - 통계적 모델의 허용(Accept) 여부: p-value > 0.05 (default) | 나 발생을 촉진하는 독성 |\n**- 단회투여독성, 반복투여독성, 피부자극성,**\n| ○ 전신 독성기준값(PODsys) 결정 | 3) 노출평가 | 3.1.4.1 독성동태 |\n| - 최적의 모델 적합도 : log-likelihood, AIC(Akaike's Information Criterion) 등 | 이.  물질의 효력에 관한 정보를 제공함 |\n**3) 노출평가**\n**계산된 값이며, 전체 용량 범위에 대한 선형 용량-반응 관계의 가정에 기초한다. **\n| 341 | · log-likelihood 높은 값을 선택(PROAST) |\n| - 시험방법, 독성기준값 등을 고려하여 불확 | 사용 후 씻어내는 피부 | bw/day의 수치를 사용할 수 있다(표2). ",
        "original_sentence": "<!-- PAGE_16 -->\n###### - 광독성 : 세포독성을 유발하지 않는 용량 수준에서 자외선/가시광선의 비세포독성 용\n\n<!-- PAGE_16 -->\n###### 량에 따른 노출/비노출 상태에서 화학물질의 세포독성 여부로 평가한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_202",
      "text": "- - 11 -\n<!-- PAGE_17 -->\n###### □ 위험성 확인 방법\n\n주요내용\n\n검토방법\n\n- ○ 물리화학적 특성 조사\n- ○ 피부흡수율 자료, ADME(흡수, 분포, 대사,\n**[표 시작]**\n\n| ○ 독성자료 조사 | 단회투여독성 | ② 노출평가 |\n| --- | --- | --- |\n| - 통계적 모델의 허용(Accept) 여부: p-value > 0.05 (default) | 나 발생을 촉진하는 독성 |\n**- 단회투여독성, 반복투여독성, 피부자극성,**\n| ○ 전신 독성기준값(PODsys) 결정 | 3) 노출평가 | 3.1.4.1 독성동태 |\n| - 최적의 모델 적합도 : log-likelihood, AIC(Akaike's Information Criterion) 등 | 이. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 201,
        "window_size": 3,
        "char_count": 395,
        "word_count": 90,
        "page_number": 17,
        "window_text": "<!-- PAGE_16 -->\n###### - 면역독성 : 화학물질에 대한 면역 체계 손상, 면역 반응 등을 평가한다.\n\n <!-- PAGE_16 -->\n###### - 신경독성 : 화학물질에 의한 행동장애, 신경 손상, 뇌의 손상 등을 평가한다.\n\n <!-- PAGE_16 -->\n###### - 광독성 : 세포독성을 유발하지 않는 용량 수준에서 자외선/가시광선의 비세포독성 용\n\n<!-- PAGE_16 -->\n###### 량에 따른 노출/비노출 상태에서 화학물질의 세포독성 여부로 평가한다.\n\n - - 11 -\n<!-- PAGE_17 -->\n###### □ 위험성 확인 방법\n\n주요내용\n\n검토방법\n\n- ○ 물리화학적 특성 조사\n- ○ 피부흡수율 자료, ADME(흡수, 분포, 대사,\n**[표 시작]**\n\n| ○ 독성자료 조사 | 단회투여독성 | ② 노출평가 |\n| --- | --- | --- |\n| - 통계적 모델의 허용(Accept) 여부: p-value > 0.05 (default) | 나 발생을 촉진하는 독성 |\n**- 단회투여독성, 반복투여독성, 피부자극성,**\n| ○ 전신 독성기준값(PODsys) 결정 | 3) 노출평가 | 3.1.4.1 독성동태 |\n| - 최적의 모델 적합도 : log-likelihood, AIC(Akaike's Information Criterion) 등 | 이.  물질의 효력에 관한 정보를 제공함 |\n**3) 노출평가**\n**계산된 값이며, 전체 용량 범위에 대한 선형 용량-반응 관계의 가정에 기초한다. **\n| 341 | · log-likelihood 높은 값을 선택(PROAST) |\n| - 시험방법, 독성기준값 등을 고려하여 불확 | 사용 후 씻어내는 피부 | bw/day의 수치를 사용할 수 있다(표2).  |\n| - 발암성이 있는 경우, 임상 및 동물실험 | ① 위험성 확인 | ④ 위해도 평가 |\n\n**[표 끝]**\n\n- ○ 인체역학연구 결과, 독성동태자료 등\n※ 유럽은 화장품 규정 개정에 따라 화장품 성분에 대한 in vivo 동물실험은 더이상 수행할 수 없다.\n\n",
        "original_sentence": "- - 11 -\n<!-- PAGE_17 -->\n###### □ 위험성 확인 방법\n\n주요내용\n\n검토방법\n\n- ○ 물리화학적 특성 조사\n- ○ 피부흡수율 자료, ADME(흡수, 분포, 대사,\n**[표 시작]**\n\n| ○ 독성자료 조사 | 단회투여독성 | ② 노출평가 |\n| --- | --- | --- |\n| - 통계적 모델의 허용(Accept) 여부: p-value > 0.05 (default) | 나 발생을 촉진하는 독성 |\n**- 단회투여독성, 반복투여독성, 피부자극성,**\n| ○ 전신 독성기준값(PODsys) 결정 | 3) 노출평가 | 3.1.4.1 독성동태 |\n| - 최적의 모델 적합도 : log-likelihood, AIC(Akaike's Information Criterion) 등 | 이. "
      }
    },
    {
      "chunk_id": "chunk_203",
      "text": "물질의 효력에 관한 정보를 제공함 |\n**3) 노출평가**\n**계산된 값이며, 전체 용량 범위에 대한 선형 용량-반응 관계의 가정에 기초한다.",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 202,
        "window_size": 3,
        "char_count": 79,
        "word_count": 19,
        "page_number": 34,
        "window_text": "<!-- PAGE_16 -->\n###### - 신경독성 : 화학물질에 의한 행동장애, 신경 손상, 뇌의 손상 등을 평가한다.\n\n <!-- PAGE_16 -->\n###### - 광독성 : 세포독성을 유발하지 않는 용량 수준에서 자외선/가시광선의 비세포독성 용\n\n<!-- PAGE_16 -->\n###### 량에 따른 노출/비노출 상태에서 화학물질의 세포독성 여부로 평가한다.\n\n - - 11 -\n<!-- PAGE_17 -->\n###### □ 위험성 확인 방법\n\n주요내용\n\n검토방법\n\n- ○ 물리화학적 특성 조사\n- ○ 피부흡수율 자료, ADME(흡수, 분포, 대사,\n**[표 시작]**\n\n| ○ 독성자료 조사 | 단회투여독성 | ② 노출평가 |\n| --- | --- | --- |\n| - 통계적 모델의 허용(Accept) 여부: p-value > 0.05 (default) | 나 발생을 촉진하는 독성 |\n**- 단회투여독성, 반복투여독성, 피부자극성,**\n| ○ 전신 독성기준값(PODsys) 결정 | 3) 노출평가 | 3.1.4.1 독성동태 |\n| - 최적의 모델 적합도 : log-likelihood, AIC(Akaike's Information Criterion) 등 | 이.  물질의 효력에 관한 정보를 제공함 |\n**3) 노출평가**\n**계산된 값이며, 전체 용량 범위에 대한 선형 용량-반응 관계의 가정에 기초한다. **\n| 341 | · log-likelihood 높은 값을 선택(PROAST) |\n| - 시험방법, 독성기준값 등을 고려하여 불확 | 사용 후 씻어내는 피부 | bw/day의 수치를 사용할 수 있다(표2).  |\n| - 발암성이 있는 경우, 임상 및 동물실험 | ① 위험성 확인 | ④ 위해도 평가 |\n\n**[표 끝]**\n\n- ○ 인체역학연구 결과, 독성동태자료 등\n※ 유럽은 화장품 규정 개정에 따라 화장품 성분에 대한 in vivo 동물실험은 더이상 수행할 수 없다.\n\n ※ 국내의 경우, 「화장품법」 제15조의2(동물실험을 실시한 화장품 등의 유통판매 금지)에 따라 동물실험이 금지되어있\n\n으나, 제8조제2항의 보존제, 색소, 자외선차단제 등 특별히 사용상의 제한이 필요한 원료의 경우 또는 동물대체시험\n\n법이 존재하지 않는 경우, 다른 법령에 따라 동물실험을 실시하여 개발된 원료를 화장품의 제조 등에 사용하는 경우\n\n등 동물시험이 허용되는 예외 조항이 있다.\n\n",
        "original_sentence": "물질의 효력에 관한 정보를 제공함 |\n**3) 노출평가**\n**계산된 값이며, 전체 용량 범위에 대한 선형 용량-반응 관계의 가정에 기초한다."
      }
    },
    {
      "chunk_id": "chunk_204",
      "text": "**\n| 341 | · log-likelihood 높은 값을 선택(PROAST) |\n| - 시험방법, 독성기준값 등을 고려하여 불확 | 사용 후 씻어내는 피부 | bw/day의 수치를 사용할 수 있다(표2). ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 203,
        "window_size": 3,
        "char_count": 117,
        "word_count": 28,
        "page_number": 30,
        "window_text": "<!-- PAGE_16 -->\n###### - 광독성 : 세포독성을 유발하지 않는 용량 수준에서 자외선/가시광선의 비세포독성 용\n\n<!-- PAGE_16 -->\n###### 량에 따른 노출/비노출 상태에서 화학물질의 세포독성 여부로 평가한다.\n\n - - 11 -\n<!-- PAGE_17 -->\n###### □ 위험성 확인 방법\n\n주요내용\n\n검토방법\n\n- ○ 물리화학적 특성 조사\n- ○ 피부흡수율 자료, ADME(흡수, 분포, 대사,\n**[표 시작]**\n\n| ○ 독성자료 조사 | 단회투여독성 | ② 노출평가 |\n| --- | --- | --- |\n| - 통계적 모델의 허용(Accept) 여부: p-value > 0.05 (default) | 나 발생을 촉진하는 독성 |\n**- 단회투여독성, 반복투여독성, 피부자극성,**\n| ○ 전신 독성기준값(PODsys) 결정 | 3) 노출평가 | 3.1.4.1 독성동태 |\n| - 최적의 모델 적합도 : log-likelihood, AIC(Akaike's Information Criterion) 등 | 이.  물질의 효력에 관한 정보를 제공함 |\n**3) 노출평가**\n**계산된 값이며, 전체 용량 범위에 대한 선형 용량-반응 관계의 가정에 기초한다. **\n| 341 | · log-likelihood 높은 값을 선택(PROAST) |\n| - 시험방법, 독성기준값 등을 고려하여 불확 | 사용 후 씻어내는 피부 | bw/day의 수치를 사용할 수 있다(표2).  |\n| - 발암성이 있는 경우, 임상 및 동물실험 | ① 위험성 확인 | ④ 위해도 평가 |\n\n**[표 끝]**\n\n- ○ 인체역학연구 결과, 독성동태자료 등\n※ 유럽은 화장품 규정 개정에 따라 화장품 성분에 대한 in vivo 동물실험은 더이상 수행할 수 없다.\n\n ※ 국내의 경우, 「화장품법」 제15조의2(동물실험을 실시한 화장품 등의 유통판매 금지)에 따라 동물실험이 금지되어있\n\n으나, 제8조제2항의 보존제, 색소, 자외선차단제 등 특별히 사용상의 제한이 필요한 원료의 경우 또는 동물대체시험\n\n법이 존재하지 않는 경우, 다른 법령에 따라 동물실험을 실시하여 개발된 원료를 화장품의 제조 등에 사용하는 경우\n\n등 동물시험이 허용되는 예외 조항이 있다.\n\n - - 12 -\n<!-- PAGE_18 -->\n###### 2-2-2. ",
        "original_sentence": "**\n| 341 | · log-likelihood 높은 값을 선택(PROAST) |\n| - 시험방법, 독성기준값 등을 고려하여 불확 | 사용 후 씻어내는 피부 | bw/day의 수치를 사용할 수 있다(표2). "
      }
    },
    {
      "chunk_id": "chunk_205",
      "text": "|\n| - 발암성이 있는 경우, 임상 및 동물실험 | ① 위험성 확인 | ④ 위해도 평가 |\n\n**[표 끝]**\n\n- ○ 인체역학연구 결과, 독성동태자료 등\n※ 유럽은 화장품 규정 개정에 따라 화장품 성분에 대한 in vivo 동물실험은 더이상 수행할 수 없다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 204,
        "window_size": 3,
        "char_count": 148,
        "word_count": 42,
        "page_number": 17,
        "window_text": "- - 11 -\n<!-- PAGE_17 -->\n###### □ 위험성 확인 방법\n\n주요내용\n\n검토방법\n\n- ○ 물리화학적 특성 조사\n- ○ 피부흡수율 자료, ADME(흡수, 분포, 대사,\n**[표 시작]**\n\n| ○ 독성자료 조사 | 단회투여독성 | ② 노출평가 |\n| --- | --- | --- |\n| - 통계적 모델의 허용(Accept) 여부: p-value > 0.05 (default) | 나 발생을 촉진하는 독성 |\n**- 단회투여독성, 반복투여독성, 피부자극성,**\n| ○ 전신 독성기준값(PODsys) 결정 | 3) 노출평가 | 3.1.4.1 독성동태 |\n| - 최적의 모델 적합도 : log-likelihood, AIC(Akaike's Information Criterion) 등 | 이.  물질의 효력에 관한 정보를 제공함 |\n**3) 노출평가**\n**계산된 값이며, 전체 용량 범위에 대한 선형 용량-반응 관계의 가정에 기초한다. **\n| 341 | · log-likelihood 높은 값을 선택(PROAST) |\n| - 시험방법, 독성기준값 등을 고려하여 불확 | 사용 후 씻어내는 피부 | bw/day의 수치를 사용할 수 있다(표2).  |\n| - 발암성이 있는 경우, 임상 및 동물실험 | ① 위험성 확인 | ④ 위해도 평가 |\n\n**[표 끝]**\n\n- ○ 인체역학연구 결과, 독성동태자료 등\n※ 유럽은 화장품 규정 개정에 따라 화장품 성분에 대한 in vivo 동물실험은 더이상 수행할 수 없다.\n\n ※ 국내의 경우, 「화장품법」 제15조의2(동물실험을 실시한 화장품 등의 유통판매 금지)에 따라 동물실험이 금지되어있\n\n으나, 제8조제2항의 보존제, 색소, 자외선차단제 등 특별히 사용상의 제한이 필요한 원료의 경우 또는 동물대체시험\n\n법이 존재하지 않는 경우, 다른 법령에 따라 동물실험을 실시하여 개발된 원료를 화장품의 제조 등에 사용하는 경우\n\n등 동물시험이 허용되는 예외 조항이 있다.\n\n - - 12 -\n<!-- PAGE_18 -->\n###### 2-2-2.  위험성 결정\n\n<!-- PAGE_18 -->\n###### 1) 위험성 결정은 평가대상 물질의 인체 또는 동물 독성자료 등을 토대로 위해도 결정에 사\n\n<!-- PAGE_18 -->\n###### 용되는 독성기준값(Point Of Departure, POD)을 선정하는 단계이다. ",
        "original_sentence": "|\n| - 발암성이 있는 경우, 임상 및 동물실험 | ① 위험성 확인 | ④ 위해도 평가 |\n\n**[표 끝]**\n\n- ○ 인체역학연구 결과, 독성동태자료 등\n※ 유럽은 화장품 규정 개정에 따라 화장품 성분에 대한 in vivo 동물실험은 더이상 수행할 수 없다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_206",
      "text": "※ 국내의 경우, 「화장품법」 제15조의2(동물실험을 실시한 화장품 등의 유통판매 금지)에 따라 동물실험이 금지되어있\n\n으나, 제8조제2항의 보존제, 색소, 자외선차단제 등 특별히 사용상의 제한이 필요한 원료의 경우 또는 동물대체시험\n\n법이 존재하지 않는 경우, 다른 법령에 따라 동물실험을 실시하여 개발된 원료를 화장품의 제조 등에 사용하는 경우\n\n등 동물시험이 허용되는 예외 조항이 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 205,
        "window_size": 3,
        "char_count": 221,
        "word_count": 49,
        "page_number": 17,
        "window_text": "물질의 효력에 관한 정보를 제공함 |\n**3) 노출평가**\n**계산된 값이며, 전체 용량 범위에 대한 선형 용량-반응 관계의 가정에 기초한다. **\n| 341 | · log-likelihood 높은 값을 선택(PROAST) |\n| - 시험방법, 독성기준값 등을 고려하여 불확 | 사용 후 씻어내는 피부 | bw/day의 수치를 사용할 수 있다(표2).  |\n| - 발암성이 있는 경우, 임상 및 동물실험 | ① 위험성 확인 | ④ 위해도 평가 |\n\n**[표 끝]**\n\n- ○ 인체역학연구 결과, 독성동태자료 등\n※ 유럽은 화장품 규정 개정에 따라 화장품 성분에 대한 in vivo 동물실험은 더이상 수행할 수 없다.\n\n ※ 국내의 경우, 「화장품법」 제15조의2(동물실험을 실시한 화장품 등의 유통판매 금지)에 따라 동물실험이 금지되어있\n\n으나, 제8조제2항의 보존제, 색소, 자외선차단제 등 특별히 사용상의 제한이 필요한 원료의 경우 또는 동물대체시험\n\n법이 존재하지 않는 경우, 다른 법령에 따라 동물실험을 실시하여 개발된 원료를 화장품의 제조 등에 사용하는 경우\n\n등 동물시험이 허용되는 예외 조항이 있다.\n\n - - 12 -\n<!-- PAGE_18 -->\n###### 2-2-2.  위험성 결정\n\n<!-- PAGE_18 -->\n###### 1) 위험성 결정은 평가대상 물질의 인체 또는 동물 독성자료 등을 토대로 위해도 결정에 사\n\n<!-- PAGE_18 -->\n###### 용되는 독성기준값(Point Of Departure, POD)을 선정하는 단계이다.  독성기준값(POD)는 모\n\n<!-- PAGE_18 -->\n###### 든 독성 작용, 용량-반응 관계, 예상 역치를 검토하여, NOAEL, LOAEL, BMDL 등이 사용\n\n<!-- PAGE_18 -->\n###### - 무독성용량(No Observed Adverse Effect Level, NOAEL) : 투여 시 유해영향이 관찰되지 않는\n\n<!-- PAGE_18 -->\n###### - 최소독성용량(Lowest Observed Adverse Effect Level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_18 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도로 정의되며, NOAEL을 확인할 수 없는\n\n<!-- PAGE_18 -->\n###### - 벤치마크용량(Benchmark Dose, BMD) : 용량-반응 모델을 근거로 계산되는 값으로, 어떤\n\n<!-- PAGE_18 -->\n###### 독성에 대해 사전에 정한 척도나 생물학적 영향(Benchmark Rresponse level, BMR)의 변화\n\n<!-- PAGE_18 -->\n###### 가 대조군에 비해 5% 또는 10%의 유해한 영향이 나타나는 용량으로 정의된다.\n\n",
        "original_sentence": "※ 국내의 경우, 「화장품법」 제15조의2(동물실험을 실시한 화장품 등의 유통판매 금지)에 따라 동물실험이 금지되어있\n\n으나, 제8조제2항의 보존제, 색소, 자외선차단제 등 특별히 사용상의 제한이 필요한 원료의 경우 또는 동물대체시험\n\n법이 존재하지 않는 경우, 다른 법령에 따라 동물실험을 실시하여 개발된 원료를 화장품의 제조 등에 사용하는 경우\n\n등 동물시험이 허용되는 예외 조항이 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_207",
      "text": "- - 12 -\n<!-- PAGE_18 -->\n###### 2-2-2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 206,
        "window_size": 3,
        "char_count": 40,
        "word_count": 9,
        "page_number": 18,
        "window_text": "**\n| 341 | · log-likelihood 높은 값을 선택(PROAST) |\n| - 시험방법, 독성기준값 등을 고려하여 불확 | 사용 후 씻어내는 피부 | bw/day의 수치를 사용할 수 있다(표2).  |\n| - 발암성이 있는 경우, 임상 및 동물실험 | ① 위험성 확인 | ④ 위해도 평가 |\n\n**[표 끝]**\n\n- ○ 인체역학연구 결과, 독성동태자료 등\n※ 유럽은 화장품 규정 개정에 따라 화장품 성분에 대한 in vivo 동물실험은 더이상 수행할 수 없다.\n\n ※ 국내의 경우, 「화장품법」 제15조의2(동물실험을 실시한 화장품 등의 유통판매 금지)에 따라 동물실험이 금지되어있\n\n으나, 제8조제2항의 보존제, 색소, 자외선차단제 등 특별히 사용상의 제한이 필요한 원료의 경우 또는 동물대체시험\n\n법이 존재하지 않는 경우, 다른 법령에 따라 동물실험을 실시하여 개발된 원료를 화장품의 제조 등에 사용하는 경우\n\n등 동물시험이 허용되는 예외 조항이 있다.\n\n - - 12 -\n<!-- PAGE_18 -->\n###### 2-2-2.  위험성 결정\n\n<!-- PAGE_18 -->\n###### 1) 위험성 결정은 평가대상 물질의 인체 또는 동물 독성자료 등을 토대로 위해도 결정에 사\n\n<!-- PAGE_18 -->\n###### 용되는 독성기준값(Point Of Departure, POD)을 선정하는 단계이다.  독성기준값(POD)는 모\n\n<!-- PAGE_18 -->\n###### 든 독성 작용, 용량-반응 관계, 예상 역치를 검토하여, NOAEL, LOAEL, BMDL 등이 사용\n\n<!-- PAGE_18 -->\n###### - 무독성용량(No Observed Adverse Effect Level, NOAEL) : 투여 시 유해영향이 관찰되지 않는\n\n<!-- PAGE_18 -->\n###### - 최소독성용량(Lowest Observed Adverse Effect Level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_18 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도로 정의되며, NOAEL을 확인할 수 없는\n\n<!-- PAGE_18 -->\n###### - 벤치마크용량(Benchmark Dose, BMD) : 용량-반응 모델을 근거로 계산되는 값으로, 어떤\n\n<!-- PAGE_18 -->\n###### 독성에 대해 사전에 정한 척도나 생물학적 영향(Benchmark Rresponse level, BMR)의 변화\n\n<!-- PAGE_18 -->\n###### 가 대조군에 비해 5% 또는 10%의 유해한 영향이 나타나는 용량으로 정의된다.\n\n <!-- PAGE_18 -->\n###### BMDL(Benchmark Dose Lower confidence limit)은 BMD의 95% 신뢰구간의 하한치를 의미\n\n<!-- PAGE_18 -->\n###### 2) 일반적으로 경구, 피부 또는 흡입 노출 등 경로별 모든 독성정보를 종합적으로 검토하되\n\n<!-- PAGE_18 -->\n###### - 확실한 경피독성 연구가 없는 경우, 경구 90일(13주) 반복투여독성시험 또는 생식발생독성\n\n<!-- PAGE_18 -->\n###### - 흡입 경로에 대한 독성 특이성이 있는 물질의 경우, 흡입 독성기준값을 사용할 수 있다.\n\n",
        "original_sentence": "- - 12 -\n<!-- PAGE_18 -->\n###### 2-2-2. "
      }
    },
    {
      "chunk_id": "chunk_208",
      "text": "위험성 결정\n\n<!-- PAGE_18 -->\n###### 1) 위험성 결정은 평가대상 물질의 인체 또는 동물 독성자료 등을 토대로 위해도 결정에 사\n\n<!-- PAGE_18 -->\n###### 용되는 독성기준값(Point Of Departure, POD)을 선정하는 단계이다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 207,
        "window_size": 3,
        "char_count": 155,
        "word_count": 31,
        "page_number": 18,
        "window_text": "|\n| - 발암성이 있는 경우, 임상 및 동물실험 | ① 위험성 확인 | ④ 위해도 평가 |\n\n**[표 끝]**\n\n- ○ 인체역학연구 결과, 독성동태자료 등\n※ 유럽은 화장품 규정 개정에 따라 화장품 성분에 대한 in vivo 동물실험은 더이상 수행할 수 없다.\n\n ※ 국내의 경우, 「화장품법」 제15조의2(동물실험을 실시한 화장품 등의 유통판매 금지)에 따라 동물실험이 금지되어있\n\n으나, 제8조제2항의 보존제, 색소, 자외선차단제 등 특별히 사용상의 제한이 필요한 원료의 경우 또는 동물대체시험\n\n법이 존재하지 않는 경우, 다른 법령에 따라 동물실험을 실시하여 개발된 원료를 화장품의 제조 등에 사용하는 경우\n\n등 동물시험이 허용되는 예외 조항이 있다.\n\n - - 12 -\n<!-- PAGE_18 -->\n###### 2-2-2.  위험성 결정\n\n<!-- PAGE_18 -->\n###### 1) 위험성 결정은 평가대상 물질의 인체 또는 동물 독성자료 등을 토대로 위해도 결정에 사\n\n<!-- PAGE_18 -->\n###### 용되는 독성기준값(Point Of Departure, POD)을 선정하는 단계이다.  독성기준값(POD)는 모\n\n<!-- PAGE_18 -->\n###### 든 독성 작용, 용량-반응 관계, 예상 역치를 검토하여, NOAEL, LOAEL, BMDL 등이 사용\n\n<!-- PAGE_18 -->\n###### - 무독성용량(No Observed Adverse Effect Level, NOAEL) : 투여 시 유해영향이 관찰되지 않는\n\n<!-- PAGE_18 -->\n###### - 최소독성용량(Lowest Observed Adverse Effect Level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_18 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도로 정의되며, NOAEL을 확인할 수 없는\n\n<!-- PAGE_18 -->\n###### - 벤치마크용량(Benchmark Dose, BMD) : 용량-반응 모델을 근거로 계산되는 값으로, 어떤\n\n<!-- PAGE_18 -->\n###### 독성에 대해 사전에 정한 척도나 생물학적 영향(Benchmark Rresponse level, BMR)의 변화\n\n<!-- PAGE_18 -->\n###### 가 대조군에 비해 5% 또는 10%의 유해한 영향이 나타나는 용량으로 정의된다.\n\n <!-- PAGE_18 -->\n###### BMDL(Benchmark Dose Lower confidence limit)은 BMD의 95% 신뢰구간의 하한치를 의미\n\n<!-- PAGE_18 -->\n###### 2) 일반적으로 경구, 피부 또는 흡입 노출 등 경로별 모든 독성정보를 종합적으로 검토하되\n\n<!-- PAGE_18 -->\n###### - 확실한 경피독성 연구가 없는 경우, 경구 90일(13주) 반복투여독성시험 또는 생식발생독성\n\n<!-- PAGE_18 -->\n###### - 흡입 경로에 대한 독성 특이성이 있는 물질의 경우, 흡입 독성기준값을 사용할 수 있다.\n\n <!-- PAGE_18 -->\n###### - 시험방법, 독성기준값 등을 고려하여 불확실성 계수로 보정할 수 있다. ",
        "original_sentence": "위험성 결정\n\n<!-- PAGE_18 -->\n###### 1) 위험성 결정은 평가대상 물질의 인체 또는 동물 독성자료 등을 토대로 위해도 결정에 사\n\n<!-- PAGE_18 -->\n###### 용되는 독성기준값(Point Of Departure, POD)을 선정하는 단계이다. "
      }
    },
    {
      "chunk_id": "chunk_209",
      "text": "독성기준값(POD)는 모\n\n<!-- PAGE_18 -->\n###### 든 독성 작용, 용량-반응 관계, 예상 역치를 검토하여, NOAEL, LOAEL, BMDL 등이 사용\n\n<!-- PAGE_18 -->\n###### - 무독성용량(No Observed Adverse Effect Level, NOAEL) : 투여 시 유해영향이 관찰되지 않는\n\n<!-- PAGE_18 -->\n###### - 최소독성용량(Lowest Observed Adverse Effect Level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_18 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도로 정의되며, NOAEL을 확인할 수 없는\n\n<!-- PAGE_18 -->\n###### - 벤치마크용량(Benchmark Dose, BMD) : 용량-반응 모델을 근거로 계산되는 값으로, 어떤\n\n<!-- PAGE_18 -->\n###### 독성에 대해 사전에 정한 척도나 생물학적 영향(Benchmark Rresponse level, BMR)의 변화\n\n<!-- PAGE_18 -->\n###### 가 대조군에 비해 5% 또는 10%의 유해한 영향이 나타나는 용량으로 정의된다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 208,
        "window_size": 3,
        "char_count": 603,
        "word_count": 113,
        "page_number": 18,
        "window_text": "※ 국내의 경우, 「화장품법」 제15조의2(동물실험을 실시한 화장품 등의 유통판매 금지)에 따라 동물실험이 금지되어있\n\n으나, 제8조제2항의 보존제, 색소, 자외선차단제 등 특별히 사용상의 제한이 필요한 원료의 경우 또는 동물대체시험\n\n법이 존재하지 않는 경우, 다른 법령에 따라 동물실험을 실시하여 개발된 원료를 화장품의 제조 등에 사용하는 경우\n\n등 동물시험이 허용되는 예외 조항이 있다.\n\n - - 12 -\n<!-- PAGE_18 -->\n###### 2-2-2.  위험성 결정\n\n<!-- PAGE_18 -->\n###### 1) 위험성 결정은 평가대상 물질의 인체 또는 동물 독성자료 등을 토대로 위해도 결정에 사\n\n<!-- PAGE_18 -->\n###### 용되는 독성기준값(Point Of Departure, POD)을 선정하는 단계이다.  독성기준값(POD)는 모\n\n<!-- PAGE_18 -->\n###### 든 독성 작용, 용량-반응 관계, 예상 역치를 검토하여, NOAEL, LOAEL, BMDL 등이 사용\n\n<!-- PAGE_18 -->\n###### - 무독성용량(No Observed Adverse Effect Level, NOAEL) : 투여 시 유해영향이 관찰되지 않는\n\n<!-- PAGE_18 -->\n###### - 최소독성용량(Lowest Observed Adverse Effect Level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_18 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도로 정의되며, NOAEL을 확인할 수 없는\n\n<!-- PAGE_18 -->\n###### - 벤치마크용량(Benchmark Dose, BMD) : 용량-반응 모델을 근거로 계산되는 값으로, 어떤\n\n<!-- PAGE_18 -->\n###### 독성에 대해 사전에 정한 척도나 생물학적 영향(Benchmark Rresponse level, BMR)의 변화\n\n<!-- PAGE_18 -->\n###### 가 대조군에 비해 5% 또는 10%의 유해한 영향이 나타나는 용량으로 정의된다.\n\n <!-- PAGE_18 -->\n###### BMDL(Benchmark Dose Lower confidence limit)은 BMD의 95% 신뢰구간의 하한치를 의미\n\n<!-- PAGE_18 -->\n###### 2) 일반적으로 경구, 피부 또는 흡입 노출 등 경로별 모든 독성정보를 종합적으로 검토하되\n\n<!-- PAGE_18 -->\n###### - 확실한 경피독성 연구가 없는 경우, 경구 90일(13주) 반복투여독성시험 또는 생식발생독성\n\n<!-- PAGE_18 -->\n###### - 흡입 경로에 대한 독성 특이성이 있는 물질의 경우, 흡입 독성기준값을 사용할 수 있다.\n\n <!-- PAGE_18 -->\n###### - 시험방법, 독성기준값 등을 고려하여 불확실성 계수로 보정할 수 있다.  예를 들어,\n\n<!-- PAGE_18 -->\n###### ·투여방식이 주당 5일 처치인 경우에는 5/7의 계수로 보정된 독성기준값(POD)를 사용하여\n\n<!-- PAGE_18 -->\n###### ·독성기준값(POD)이 LOAEL에 기초하는 경우에는 3의 불확실성 계수를 추가로 적용하여\n\n<!-- PAGE_18 -->\n###### 보정할 수 있다. ",
        "original_sentence": "독성기준값(POD)는 모\n\n<!-- PAGE_18 -->\n###### 든 독성 작용, 용량-반응 관계, 예상 역치를 검토하여, NOAEL, LOAEL, BMDL 등이 사용\n\n<!-- PAGE_18 -->\n###### - 무독성용량(No Observed Adverse Effect Level, NOAEL) : 투여 시 유해영향이 관찰되지 않는\n\n<!-- PAGE_18 -->\n###### - 최소독성용량(Lowest Observed Adverse Effect Level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_18 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도로 정의되며, NOAEL을 확인할 수 없는\n\n<!-- PAGE_18 -->\n###### - 벤치마크용량(Benchmark Dose, BMD) : 용량-반응 모델을 근거로 계산되는 값으로, 어떤\n\n<!-- PAGE_18 -->\n###### 독성에 대해 사전에 정한 척도나 생물학적 영향(Benchmark Rresponse level, BMR)의 변화\n\n<!-- PAGE_18 -->\n###### 가 대조군에 비해 5% 또는 10%의 유해한 영향이 나타나는 용량으로 정의된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_210",
      "text": "<!-- PAGE_18 -->\n###### BMDL(Benchmark Dose Lower confidence limit)은 BMD의 95% 신뢰구간의 하한치를 의미\n\n<!-- PAGE_18 -->\n###### 2) 일반적으로 경구, 피부 또는 흡입 노출 등 경로별 모든 독성정보를 종합적으로 검토하되\n\n<!-- PAGE_18 -->\n###### - 확실한 경피독성 연구가 없는 경우, 경구 90일(13주) 반복투여독성시험 또는 생식발생독성\n\n<!-- PAGE_18 -->\n###### - 흡입 경로에 대한 독성 특이성이 있는 물질의 경우, 흡입 독성기준값을 사용할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 209,
        "window_size": 3,
        "char_count": 323,
        "word_count": 64,
        "page_number": 18,
        "window_text": "- - 12 -\n<!-- PAGE_18 -->\n###### 2-2-2.  위험성 결정\n\n<!-- PAGE_18 -->\n###### 1) 위험성 결정은 평가대상 물질의 인체 또는 동물 독성자료 등을 토대로 위해도 결정에 사\n\n<!-- PAGE_18 -->\n###### 용되는 독성기준값(Point Of Departure, POD)을 선정하는 단계이다.  독성기준값(POD)는 모\n\n<!-- PAGE_18 -->\n###### 든 독성 작용, 용량-반응 관계, 예상 역치를 검토하여, NOAEL, LOAEL, BMDL 등이 사용\n\n<!-- PAGE_18 -->\n###### - 무독성용량(No Observed Adverse Effect Level, NOAEL) : 투여 시 유해영향이 관찰되지 않는\n\n<!-- PAGE_18 -->\n###### - 최소독성용량(Lowest Observed Adverse Effect Level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_18 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도로 정의되며, NOAEL을 확인할 수 없는\n\n<!-- PAGE_18 -->\n###### - 벤치마크용량(Benchmark Dose, BMD) : 용량-반응 모델을 근거로 계산되는 값으로, 어떤\n\n<!-- PAGE_18 -->\n###### 독성에 대해 사전에 정한 척도나 생물학적 영향(Benchmark Rresponse level, BMR)의 변화\n\n<!-- PAGE_18 -->\n###### 가 대조군에 비해 5% 또는 10%의 유해한 영향이 나타나는 용량으로 정의된다.\n\n <!-- PAGE_18 -->\n###### BMDL(Benchmark Dose Lower confidence limit)은 BMD의 95% 신뢰구간의 하한치를 의미\n\n<!-- PAGE_18 -->\n###### 2) 일반적으로 경구, 피부 또는 흡입 노출 등 경로별 모든 독성정보를 종합적으로 검토하되\n\n<!-- PAGE_18 -->\n###### - 확실한 경피독성 연구가 없는 경우, 경구 90일(13주) 반복투여독성시험 또는 생식발생독성\n\n<!-- PAGE_18 -->\n###### - 흡입 경로에 대한 독성 특이성이 있는 물질의 경우, 흡입 독성기준값을 사용할 수 있다.\n\n <!-- PAGE_18 -->\n###### - 시험방법, 독성기준값 등을 고려하여 불확실성 계수로 보정할 수 있다.  예를 들어,\n\n<!-- PAGE_18 -->\n###### ·투여방식이 주당 5일 처치인 경우에는 5/7의 계수로 보정된 독성기준값(POD)를 사용하여\n\n<!-- PAGE_18 -->\n###### ·독성기준값(POD)이 LOAEL에 기초하는 경우에는 3의 불확실성 계수를 추가로 적용하여\n\n<!-- PAGE_18 -->\n###### 보정할 수 있다.  단, 반복투여독성시험에서 용량 간격, 용량-반응 곡선의 형태 및 기울기\n\n<!-- PAGE_18 -->\n###### 를 고려하여 사례별(case-by-case)로 불확실성 계수를 1~10까지 조절하여 적용할 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_18 -->\n###### BMDL(Benchmark Dose Lower confidence limit)은 BMD의 95% 신뢰구간의 하한치를 의미\n\n<!-- PAGE_18 -->\n###### 2) 일반적으로 경구, 피부 또는 흡입 노출 등 경로별 모든 독성정보를 종합적으로 검토하되\n\n<!-- PAGE_18 -->\n###### - 확실한 경피독성 연구가 없는 경우, 경구 90일(13주) 반복투여독성시험 또는 생식발생독성\n\n<!-- PAGE_18 -->\n###### - 흡입 경로에 대한 독성 특이성이 있는 물질의 경우, 흡입 독성기준값을 사용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_211",
      "text": "<!-- PAGE_18 -->\n###### - 시험방법, 독성기준값 등을 고려하여 불확실성 계수로 보정할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 210,
        "window_size": 3,
        "char_count": 65,
        "word_count": 14,
        "page_number": 18,
        "window_text": "위험성 결정\n\n<!-- PAGE_18 -->\n###### 1) 위험성 결정은 평가대상 물질의 인체 또는 동물 독성자료 등을 토대로 위해도 결정에 사\n\n<!-- PAGE_18 -->\n###### 용되는 독성기준값(Point Of Departure, POD)을 선정하는 단계이다.  독성기준값(POD)는 모\n\n<!-- PAGE_18 -->\n###### 든 독성 작용, 용량-반응 관계, 예상 역치를 검토하여, NOAEL, LOAEL, BMDL 등이 사용\n\n<!-- PAGE_18 -->\n###### - 무독성용량(No Observed Adverse Effect Level, NOAEL) : 투여 시 유해영향이 관찰되지 않는\n\n<!-- PAGE_18 -->\n###### - 최소독성용량(Lowest Observed Adverse Effect Level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_18 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도로 정의되며, NOAEL을 확인할 수 없는\n\n<!-- PAGE_18 -->\n###### - 벤치마크용량(Benchmark Dose, BMD) : 용량-반응 모델을 근거로 계산되는 값으로, 어떤\n\n<!-- PAGE_18 -->\n###### 독성에 대해 사전에 정한 척도나 생물학적 영향(Benchmark Rresponse level, BMR)의 변화\n\n<!-- PAGE_18 -->\n###### 가 대조군에 비해 5% 또는 10%의 유해한 영향이 나타나는 용량으로 정의된다.\n\n <!-- PAGE_18 -->\n###### BMDL(Benchmark Dose Lower confidence limit)은 BMD의 95% 신뢰구간의 하한치를 의미\n\n<!-- PAGE_18 -->\n###### 2) 일반적으로 경구, 피부 또는 흡입 노출 등 경로별 모든 독성정보를 종합적으로 검토하되\n\n<!-- PAGE_18 -->\n###### - 확실한 경피독성 연구가 없는 경우, 경구 90일(13주) 반복투여독성시험 또는 생식발생독성\n\n<!-- PAGE_18 -->\n###### - 흡입 경로에 대한 독성 특이성이 있는 물질의 경우, 흡입 독성기준값을 사용할 수 있다.\n\n <!-- PAGE_18 -->\n###### - 시험방법, 독성기준값 등을 고려하여 불확실성 계수로 보정할 수 있다.  예를 들어,\n\n<!-- PAGE_18 -->\n###### ·투여방식이 주당 5일 처치인 경우에는 5/7의 계수로 보정된 독성기준값(POD)를 사용하여\n\n<!-- PAGE_18 -->\n###### ·독성기준값(POD)이 LOAEL에 기초하는 경우에는 3의 불확실성 계수를 추가로 적용하여\n\n<!-- PAGE_18 -->\n###### 보정할 수 있다.  단, 반복투여독성시험에서 용량 간격, 용량-반응 곡선의 형태 및 기울기\n\n<!-- PAGE_18 -->\n###### 를 고려하여 사례별(case-by-case)로 불확실성 계수를 1~10까지 조절하여 적용할 수 있다.\n\n <!-- PAGE_18 -->\n###### ·90일(13주) 반복투여독성시험 결과가 유효하지 않은 경우, 28일 반복투여독성시험 결과에\n\n<!-- PAGE_18 -->\n###### 서 얻은 NOAEL에 사례별(case-by-case)로 1-10의 불확실성 계수를 추가로 적용하여 보정\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_18 -->\n###### - 시험방법, 독성기준값 등을 고려하여 불확실성 계수로 보정할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_212",
      "text": "예를 들어,\n\n<!-- PAGE_18 -->\n###### ·투여방식이 주당 5일 처치인 경우에는 5/7의 계수로 보정된 독성기준값(POD)를 사용하여\n\n<!-- PAGE_18 -->\n###### ·독성기준값(POD)이 LOAEL에 기초하는 경우에는 3의 불확실성 계수를 추가로 적용하여\n\n<!-- PAGE_18 -->\n###### 보정할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 211,
        "window_size": 3,
        "char_count": 195,
        "word_count": 36,
        "page_number": 18,
        "window_text": "독성기준값(POD)는 모\n\n<!-- PAGE_18 -->\n###### 든 독성 작용, 용량-반응 관계, 예상 역치를 검토하여, NOAEL, LOAEL, BMDL 등이 사용\n\n<!-- PAGE_18 -->\n###### - 무독성용량(No Observed Adverse Effect Level, NOAEL) : 투여 시 유해영향이 관찰되지 않는\n\n<!-- PAGE_18 -->\n###### - 최소독성용량(Lowest Observed Adverse Effect Level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_18 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도로 정의되며, NOAEL을 확인할 수 없는\n\n<!-- PAGE_18 -->\n###### - 벤치마크용량(Benchmark Dose, BMD) : 용량-반응 모델을 근거로 계산되는 값으로, 어떤\n\n<!-- PAGE_18 -->\n###### 독성에 대해 사전에 정한 척도나 생물학적 영향(Benchmark Rresponse level, BMR)의 변화\n\n<!-- PAGE_18 -->\n###### 가 대조군에 비해 5% 또는 10%의 유해한 영향이 나타나는 용량으로 정의된다.\n\n <!-- PAGE_18 -->\n###### BMDL(Benchmark Dose Lower confidence limit)은 BMD의 95% 신뢰구간의 하한치를 의미\n\n<!-- PAGE_18 -->\n###### 2) 일반적으로 경구, 피부 또는 흡입 노출 등 경로별 모든 독성정보를 종합적으로 검토하되\n\n<!-- PAGE_18 -->\n###### - 확실한 경피독성 연구가 없는 경우, 경구 90일(13주) 반복투여독성시험 또는 생식발생독성\n\n<!-- PAGE_18 -->\n###### - 흡입 경로에 대한 독성 특이성이 있는 물질의 경우, 흡입 독성기준값을 사용할 수 있다.\n\n <!-- PAGE_18 -->\n###### - 시험방법, 독성기준값 등을 고려하여 불확실성 계수로 보정할 수 있다.  예를 들어,\n\n<!-- PAGE_18 -->\n###### ·투여방식이 주당 5일 처치인 경우에는 5/7의 계수로 보정된 독성기준값(POD)를 사용하여\n\n<!-- PAGE_18 -->\n###### ·독성기준값(POD)이 LOAEL에 기초하는 경우에는 3의 불확실성 계수를 추가로 적용하여\n\n<!-- PAGE_18 -->\n###### 보정할 수 있다.  단, 반복투여독성시험에서 용량 간격, 용량-반응 곡선의 형태 및 기울기\n\n<!-- PAGE_18 -->\n###### 를 고려하여 사례별(case-by-case)로 불확실성 계수를 1~10까지 조절하여 적용할 수 있다.\n\n <!-- PAGE_18 -->\n###### ·90일(13주) 반복투여독성시험 결과가 유효하지 않은 경우, 28일 반복투여독성시험 결과에\n\n<!-- PAGE_18 -->\n###### 서 얻은 NOAEL에 사례별(case-by-case)로 1-10의 불확실성 계수를 추가로 적용하여 보정\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n - - 13 -\n<!-- PAGE_19 -->\n###### □ 위험성 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 물질에 대한 POD(NOAEL, LOAEL, BMDL\n- ○ WHO, 미국, 일본, 호주, 캐나다 등 선진국\n자료 활용\n\n- - 경구 생체이용률(Bioavailability, BA) 적용 가능\n- - 14 -\n<!-- PAGE_20 -->\n###### 2-2-3. ",
        "original_sentence": "예를 들어,\n\n<!-- PAGE_18 -->\n###### ·투여방식이 주당 5일 처치인 경우에는 5/7의 계수로 보정된 독성기준값(POD)를 사용하여\n\n<!-- PAGE_18 -->\n###### ·독성기준값(POD)이 LOAEL에 기초하는 경우에는 3의 불확실성 계수를 추가로 적용하여\n\n<!-- PAGE_18 -->\n###### 보정할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_213",
      "text": "단, 반복투여독성시험에서 용량 간격, 용량-반응 곡선의 형태 및 기울기\n\n<!-- PAGE_18 -->\n###### 를 고려하여 사례별(case-by-case)로 불확실성 계수를 1~10까지 조절하여 적용할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 212,
        "window_size": 3,
        "char_count": 123,
        "word_count": 23,
        "page_number": 18,
        "window_text": "<!-- PAGE_18 -->\n###### BMDL(Benchmark Dose Lower confidence limit)은 BMD의 95% 신뢰구간의 하한치를 의미\n\n<!-- PAGE_18 -->\n###### 2) 일반적으로 경구, 피부 또는 흡입 노출 등 경로별 모든 독성정보를 종합적으로 검토하되\n\n<!-- PAGE_18 -->\n###### - 확실한 경피독성 연구가 없는 경우, 경구 90일(13주) 반복투여독성시험 또는 생식발생독성\n\n<!-- PAGE_18 -->\n###### - 흡입 경로에 대한 독성 특이성이 있는 물질의 경우, 흡입 독성기준값을 사용할 수 있다.\n\n <!-- PAGE_18 -->\n###### - 시험방법, 독성기준값 등을 고려하여 불확실성 계수로 보정할 수 있다.  예를 들어,\n\n<!-- PAGE_18 -->\n###### ·투여방식이 주당 5일 처치인 경우에는 5/7의 계수로 보정된 독성기준값(POD)를 사용하여\n\n<!-- PAGE_18 -->\n###### ·독성기준값(POD)이 LOAEL에 기초하는 경우에는 3의 불확실성 계수를 추가로 적용하여\n\n<!-- PAGE_18 -->\n###### 보정할 수 있다.  단, 반복투여독성시험에서 용량 간격, 용량-반응 곡선의 형태 및 기울기\n\n<!-- PAGE_18 -->\n###### 를 고려하여 사례별(case-by-case)로 불확실성 계수를 1~10까지 조절하여 적용할 수 있다.\n\n <!-- PAGE_18 -->\n###### ·90일(13주) 반복투여독성시험 결과가 유효하지 않은 경우, 28일 반복투여독성시험 결과에\n\n<!-- PAGE_18 -->\n###### 서 얻은 NOAEL에 사례별(case-by-case)로 1-10의 불확실성 계수를 추가로 적용하여 보정\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n - - 13 -\n<!-- PAGE_19 -->\n###### □ 위험성 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 물질에 대한 POD(NOAEL, LOAEL, BMDL\n- ○ WHO, 미국, 일본, 호주, 캐나다 등 선진국\n자료 활용\n\n- - 경구 생체이용률(Bioavailability, BA) 적용 가능\n- - 14 -\n<!-- PAGE_20 -->\n###### 2-2-3.  노출평가\n\n<!-- PAGE_20 -->\n###### 1) 노출평가는 최종 제품에서의 사용량, 사용 빈도, 노출경로(경구, 피부, 흡입 등) 등을 기반\n\n<!-- PAGE_20 -->\n###### 으로 일반적 또는 합리적으로 예측 가능한 시나리오를 설정하여 이에 따른 화장품 성분의\n\n<!-- PAGE_20 -->\n###### 인체노출량을 정량적으로 산출하는 단계이다.\n\n",
        "original_sentence": "단, 반복투여독성시험에서 용량 간격, 용량-반응 곡선의 형태 및 기울기\n\n<!-- PAGE_18 -->\n###### 를 고려하여 사례별(case-by-case)로 불확실성 계수를 1~10까지 조절하여 적용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_214",
      "text": "<!-- PAGE_18 -->\n###### ·90일(13주) 반복투여독성시험 결과가 유효하지 않은 경우, 28일 반복투여독성시험 결과에\n\n<!-- PAGE_18 -->\n###### 서 얻은 NOAEL에 사례별(case-by-case)로 1-10의 불확실성 계수를 추가로 적용하여 보정\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 213,
        "window_size": 3,
        "char_count": 193,
        "word_count": 34,
        "page_number": 18,
        "window_text": "<!-- PAGE_18 -->\n###### - 시험방법, 독성기준값 등을 고려하여 불확실성 계수로 보정할 수 있다.  예를 들어,\n\n<!-- PAGE_18 -->\n###### ·투여방식이 주당 5일 처치인 경우에는 5/7의 계수로 보정된 독성기준값(POD)를 사용하여\n\n<!-- PAGE_18 -->\n###### ·독성기준값(POD)이 LOAEL에 기초하는 경우에는 3의 불확실성 계수를 추가로 적용하여\n\n<!-- PAGE_18 -->\n###### 보정할 수 있다.  단, 반복투여독성시험에서 용량 간격, 용량-반응 곡선의 형태 및 기울기\n\n<!-- PAGE_18 -->\n###### 를 고려하여 사례별(case-by-case)로 불확실성 계수를 1~10까지 조절하여 적용할 수 있다.\n\n <!-- PAGE_18 -->\n###### ·90일(13주) 반복투여독성시험 결과가 유효하지 않은 경우, 28일 반복투여독성시험 결과에\n\n<!-- PAGE_18 -->\n###### 서 얻은 NOAEL에 사례별(case-by-case)로 1-10의 불확실성 계수를 추가로 적용하여 보정\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n - - 13 -\n<!-- PAGE_19 -->\n###### □ 위험성 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 물질에 대한 POD(NOAEL, LOAEL, BMDL\n- ○ WHO, 미국, 일본, 호주, 캐나다 등 선진국\n자료 활용\n\n- - 경구 생체이용률(Bioavailability, BA) 적용 가능\n- - 14 -\n<!-- PAGE_20 -->\n###### 2-2-3.  노출평가\n\n<!-- PAGE_20 -->\n###### 1) 노출평가는 최종 제품에서의 사용량, 사용 빈도, 노출경로(경구, 피부, 흡입 등) 등을 기반\n\n<!-- PAGE_20 -->\n###### 으로 일반적 또는 합리적으로 예측 가능한 시나리오를 설정하여 이에 따른 화장품 성분의\n\n<!-- PAGE_20 -->\n###### 인체노출량을 정량적으로 산출하는 단계이다.\n\n <!-- PAGE_20 -->\n###### 2) 효율적인 노출평가를 위해서 단계적 접근방법으로 평가할 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_18 -->\n###### ·90일(13주) 반복투여독성시험 결과가 유효하지 않은 경우, 28일 반복투여독성시험 결과에\n\n<!-- PAGE_18 -->\n###### 서 얻은 NOAEL에 사례별(case-by-case)로 1-10의 불확실성 계수를 추가로 적용하여 보정\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_215",
      "text": "- - 13 -\n<!-- PAGE_19 -->\n###### □ 위험성 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 물질에 대한 POD(NOAEL, LOAEL, BMDL\n- ○ WHO, 미국, 일본, 호주, 캐나다 등 선진국\n자료 활용\n\n- - 경구 생체이용률(Bioavailability, BA) 적용 가능\n- - 14 -\n<!-- PAGE_20 -->\n###### 2-2-3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 214,
        "window_size": 3,
        "char_count": 210,
        "word_count": 48,
        "page_number": 19,
        "window_text": "예를 들어,\n\n<!-- PAGE_18 -->\n###### ·투여방식이 주당 5일 처치인 경우에는 5/7의 계수로 보정된 독성기준값(POD)를 사용하여\n\n<!-- PAGE_18 -->\n###### ·독성기준값(POD)이 LOAEL에 기초하는 경우에는 3의 불확실성 계수를 추가로 적용하여\n\n<!-- PAGE_18 -->\n###### 보정할 수 있다.  단, 반복투여독성시험에서 용량 간격, 용량-반응 곡선의 형태 및 기울기\n\n<!-- PAGE_18 -->\n###### 를 고려하여 사례별(case-by-case)로 불확실성 계수를 1~10까지 조절하여 적용할 수 있다.\n\n <!-- PAGE_18 -->\n###### ·90일(13주) 반복투여독성시험 결과가 유효하지 않은 경우, 28일 반복투여독성시험 결과에\n\n<!-- PAGE_18 -->\n###### 서 얻은 NOAEL에 사례별(case-by-case)로 1-10의 불확실성 계수를 추가로 적용하여 보정\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n - - 13 -\n<!-- PAGE_19 -->\n###### □ 위험성 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 물질에 대한 POD(NOAEL, LOAEL, BMDL\n- ○ WHO, 미국, 일본, 호주, 캐나다 등 선진국\n자료 활용\n\n- - 경구 생체이용률(Bioavailability, BA) 적용 가능\n- - 14 -\n<!-- PAGE_20 -->\n###### 2-2-3.  노출평가\n\n<!-- PAGE_20 -->\n###### 1) 노출평가는 최종 제품에서의 사용량, 사용 빈도, 노출경로(경구, 피부, 흡입 등) 등을 기반\n\n<!-- PAGE_20 -->\n###### 으로 일반적 또는 합리적으로 예측 가능한 시나리오를 설정하여 이에 따른 화장품 성분의\n\n<!-- PAGE_20 -->\n###### 인체노출량을 정량적으로 산출하는 단계이다.\n\n <!-- PAGE_20 -->\n###### 2) 효율적인 노출평가를 위해서 단계적 접근방법으로 평가할 수 있다.\n\n <!-- PAGE_20 -->\n###### - 초기에는 보수적인 노출상황을 가정한 시나리오를 적용하여 평가하며, 보수적인 노출상황\n\n<!-- PAGE_20 -->\n###### - 보수적 노출상황을 가정한 평가에서 위해 발생이 우려되면 실제 노출상황을 가정한 노출\n\n<!-- PAGE_20 -->\n###### 3) 화장품은 유형에 따라 사용방법이 다양하므로 화장품 유형별 사용방법을 고려한 노출시나\n\n<!-- PAGE_20 -->\n###### - 유형별로 화장품을 평가할 경우, 붙임 5, 표1에 따라 화장품 유형별 사용량을 고려하여\n\n<!-- PAGE_20 -->\n###### - 자외선차단제에 대한 통합 일일사용량은 17.0 g/day를 적용할 수 있다(붙임 5, 2항 참고).\n\n",
        "original_sentence": "- - 13 -\n<!-- PAGE_19 -->\n###### □ 위험성 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 물질에 대한 POD(NOAEL, LOAEL, BMDL\n- ○ WHO, 미국, 일본, 호주, 캐나다 등 선진국\n자료 활용\n\n- - 경구 생체이용률(Bioavailability, BA) 적용 가능\n- - 14 -\n<!-- PAGE_20 -->\n###### 2-2-3. "
      }
    },
    {
      "chunk_id": "chunk_216",
      "text": "노출평가\n\n<!-- PAGE_20 -->\n###### 1) 노출평가는 최종 제품에서의 사용량, 사용 빈도, 노출경로(경구, 피부, 흡입 등) 등을 기반\n\n<!-- PAGE_20 -->\n###### 으로 일반적 또는 합리적으로 예측 가능한 시나리오를 설정하여 이에 따른 화장품 성분의\n\n<!-- PAGE_20 -->\n###### 인체노출량을 정량적으로 산출하는 단계이다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 215,
        "window_size": 3,
        "char_count": 208,
        "word_count": 42,
        "page_number": 20,
        "window_text": "단, 반복투여독성시험에서 용량 간격, 용량-반응 곡선의 형태 및 기울기\n\n<!-- PAGE_18 -->\n###### 를 고려하여 사례별(case-by-case)로 불확실성 계수를 1~10까지 조절하여 적용할 수 있다.\n\n <!-- PAGE_18 -->\n###### ·90일(13주) 반복투여독성시험 결과가 유효하지 않은 경우, 28일 반복투여독성시험 결과에\n\n<!-- PAGE_18 -->\n###### 서 얻은 NOAEL에 사례별(case-by-case)로 1-10의 불확실성 계수를 추가로 적용하여 보정\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n - - 13 -\n<!-- PAGE_19 -->\n###### □ 위험성 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 물질에 대한 POD(NOAEL, LOAEL, BMDL\n- ○ WHO, 미국, 일본, 호주, 캐나다 등 선진국\n자료 활용\n\n- - 경구 생체이용률(Bioavailability, BA) 적용 가능\n- - 14 -\n<!-- PAGE_20 -->\n###### 2-2-3.  노출평가\n\n<!-- PAGE_20 -->\n###### 1) 노출평가는 최종 제품에서의 사용량, 사용 빈도, 노출경로(경구, 피부, 흡입 등) 등을 기반\n\n<!-- PAGE_20 -->\n###### 으로 일반적 또는 합리적으로 예측 가능한 시나리오를 설정하여 이에 따른 화장품 성분의\n\n<!-- PAGE_20 -->\n###### 인체노출량을 정량적으로 산출하는 단계이다.\n\n <!-- PAGE_20 -->\n###### 2) 효율적인 노출평가를 위해서 단계적 접근방법으로 평가할 수 있다.\n\n <!-- PAGE_20 -->\n###### - 초기에는 보수적인 노출상황을 가정한 시나리오를 적용하여 평가하며, 보수적인 노출상황\n\n<!-- PAGE_20 -->\n###### - 보수적 노출상황을 가정한 평가에서 위해 발생이 우려되면 실제 노출상황을 가정한 노출\n\n<!-- PAGE_20 -->\n###### 3) 화장품은 유형에 따라 사용방법이 다양하므로 화장품 유형별 사용방법을 고려한 노출시나\n\n<!-- PAGE_20 -->\n###### - 유형별로 화장품을 평가할 경우, 붙임 5, 표1에 따라 화장품 유형별 사용량을 고려하여\n\n<!-- PAGE_20 -->\n###### - 자외선차단제에 대한 통합 일일사용량은 17.0 g/day를 적용할 수 있다(붙임 5, 2항 참고).\n\n <!-- PAGE_20 -->\n###### - 화장품 전유형 및 보존제에 대한 통합 일일사용량은 16.9 g/day를 적용할 수 있다(붙임 5,\n\n<!-- PAGE_20 -->\n###### - 피부 단위면적당 노출량을 평가할 경우, 체표면적은 붙임 4에서 제시된 값을 적용할 수\n\n<!-- PAGE_20 -->\n###### - 전신노출량 산출 시, 잔류지수(retention factor)를 고려할 수 있다(붙임 5 참조).\n\n",
        "original_sentence": "노출평가\n\n<!-- PAGE_20 -->\n###### 1) 노출평가는 최종 제품에서의 사용량, 사용 빈도, 노출경로(경구, 피부, 흡입 등) 등을 기반\n\n<!-- PAGE_20 -->\n###### 으로 일반적 또는 합리적으로 예측 가능한 시나리오를 설정하여 이에 따른 화장품 성분의\n\n<!-- PAGE_20 -->\n###### 인체노출량을 정량적으로 산출하는 단계이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_217",
      "text": "<!-- PAGE_20 -->\n###### 2) 효율적인 노출평가를 위해서 단계적 접근방법으로 평가할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 216,
        "window_size": 3,
        "char_count": 64,
        "word_count": 13,
        "page_number": 20,
        "window_text": "<!-- PAGE_18 -->\n###### ·90일(13주) 반복투여독성시험 결과가 유효하지 않은 경우, 28일 반복투여독성시험 결과에\n\n<!-- PAGE_18 -->\n###### 서 얻은 NOAEL에 사례별(case-by-case)로 1-10의 불확실성 계수를 추가로 적용하여 보정\n\n<!-- PAGE_18 -->\n###### 할 수 있다.\n\n - - 13 -\n<!-- PAGE_19 -->\n###### □ 위험성 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 물질에 대한 POD(NOAEL, LOAEL, BMDL\n- ○ WHO, 미국, 일본, 호주, 캐나다 등 선진국\n자료 활용\n\n- - 경구 생체이용률(Bioavailability, BA) 적용 가능\n- - 14 -\n<!-- PAGE_20 -->\n###### 2-2-3.  노출평가\n\n<!-- PAGE_20 -->\n###### 1) 노출평가는 최종 제품에서의 사용량, 사용 빈도, 노출경로(경구, 피부, 흡입 등) 등을 기반\n\n<!-- PAGE_20 -->\n###### 으로 일반적 또는 합리적으로 예측 가능한 시나리오를 설정하여 이에 따른 화장품 성분의\n\n<!-- PAGE_20 -->\n###### 인체노출량을 정량적으로 산출하는 단계이다.\n\n <!-- PAGE_20 -->\n###### 2) 효율적인 노출평가를 위해서 단계적 접근방법으로 평가할 수 있다.\n\n <!-- PAGE_20 -->\n###### - 초기에는 보수적인 노출상황을 가정한 시나리오를 적용하여 평가하며, 보수적인 노출상황\n\n<!-- PAGE_20 -->\n###### - 보수적 노출상황을 가정한 평가에서 위해 발생이 우려되면 실제 노출상황을 가정한 노출\n\n<!-- PAGE_20 -->\n###### 3) 화장품은 유형에 따라 사용방법이 다양하므로 화장품 유형별 사용방법을 고려한 노출시나\n\n<!-- PAGE_20 -->\n###### - 유형별로 화장품을 평가할 경우, 붙임 5, 표1에 따라 화장품 유형별 사용량을 고려하여\n\n<!-- PAGE_20 -->\n###### - 자외선차단제에 대한 통합 일일사용량은 17.0 g/day를 적용할 수 있다(붙임 5, 2항 참고).\n\n <!-- PAGE_20 -->\n###### - 화장품 전유형 및 보존제에 대한 통합 일일사용량은 16.9 g/day를 적용할 수 있다(붙임 5,\n\n<!-- PAGE_20 -->\n###### - 피부 단위면적당 노출량을 평가할 경우, 체표면적은 붙임 4에서 제시된 값을 적용할 수\n\n<!-- PAGE_20 -->\n###### - 전신노출량 산출 시, 잔류지수(retention factor)를 고려할 수 있다(붙임 5 참조).\n\n <!-- PAGE_20 -->\n###### -‘씻어내는’제품 : 사용법에 따라 씻어내는 제품은 잔류지수(RF)을 측정할 수 있으며, 잔\n\n<!-- PAGE_20 -->\n###### 4) 영·유아 및 어린이 제품의 노출평가는 다음의 사항을 고려할 수 있다(Renwick, 1998,\n\n<!-- PAGE_20 -->\n###### ① 모든 영·유아 및 어린이 제품 : 체중 대비 피부 표면적의 비율을 고려할 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_20 -->\n###### 2) 효율적인 노출평가를 위해서 단계적 접근방법으로 평가할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_218",
      "text": "<!-- PAGE_20 -->\n###### - 초기에는 보수적인 노출상황을 가정한 시나리오를 적용하여 평가하며, 보수적인 노출상황\n\n<!-- PAGE_20 -->\n###### - 보수적 노출상황을 가정한 평가에서 위해 발생이 우려되면 실제 노출상황을 가정한 노출\n\n<!-- PAGE_20 -->\n###### 3) 화장품은 유형에 따라 사용방법이 다양하므로 화장품 유형별 사용방법을 고려한 노출시나\n\n<!-- PAGE_20 -->\n###### - 유형별로 화장품을 평가할 경우, 붙임 5, 표1에 따라 화장품 유형별 사용량을 고려하여\n\n<!-- PAGE_20 -->\n###### - 자외선차단제에 대한 통합 일일사용량은 17.0 g/day를 적용할 수 있다(붙임 5, 2항 참고).\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 217,
        "window_size": 3,
        "char_count": 382,
        "word_count": 79,
        "page_number": 20,
        "window_text": "- - 13 -\n<!-- PAGE_19 -->\n###### □ 위험성 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 물질에 대한 POD(NOAEL, LOAEL, BMDL\n- ○ WHO, 미국, 일본, 호주, 캐나다 등 선진국\n자료 활용\n\n- - 경구 생체이용률(Bioavailability, BA) 적용 가능\n- - 14 -\n<!-- PAGE_20 -->\n###### 2-2-3.  노출평가\n\n<!-- PAGE_20 -->\n###### 1) 노출평가는 최종 제품에서의 사용량, 사용 빈도, 노출경로(경구, 피부, 흡입 등) 등을 기반\n\n<!-- PAGE_20 -->\n###### 으로 일반적 또는 합리적으로 예측 가능한 시나리오를 설정하여 이에 따른 화장품 성분의\n\n<!-- PAGE_20 -->\n###### 인체노출량을 정량적으로 산출하는 단계이다.\n\n <!-- PAGE_20 -->\n###### 2) 효율적인 노출평가를 위해서 단계적 접근방법으로 평가할 수 있다.\n\n <!-- PAGE_20 -->\n###### - 초기에는 보수적인 노출상황을 가정한 시나리오를 적용하여 평가하며, 보수적인 노출상황\n\n<!-- PAGE_20 -->\n###### - 보수적 노출상황을 가정한 평가에서 위해 발생이 우려되면 실제 노출상황을 가정한 노출\n\n<!-- PAGE_20 -->\n###### 3) 화장품은 유형에 따라 사용방법이 다양하므로 화장품 유형별 사용방법을 고려한 노출시나\n\n<!-- PAGE_20 -->\n###### - 유형별로 화장품을 평가할 경우, 붙임 5, 표1에 따라 화장품 유형별 사용량을 고려하여\n\n<!-- PAGE_20 -->\n###### - 자외선차단제에 대한 통합 일일사용량은 17.0 g/day를 적용할 수 있다(붙임 5, 2항 참고).\n\n <!-- PAGE_20 -->\n###### - 화장품 전유형 및 보존제에 대한 통합 일일사용량은 16.9 g/day를 적용할 수 있다(붙임 5,\n\n<!-- PAGE_20 -->\n###### - 피부 단위면적당 노출량을 평가할 경우, 체표면적은 붙임 4에서 제시된 값을 적용할 수\n\n<!-- PAGE_20 -->\n###### - 전신노출량 산출 시, 잔류지수(retention factor)를 고려할 수 있다(붙임 5 참조).\n\n <!-- PAGE_20 -->\n###### -‘씻어내는’제품 : 사용법에 따라 씻어내는 제품은 잔류지수(RF)을 측정할 수 있으며, 잔\n\n<!-- PAGE_20 -->\n###### 4) 영·유아 및 어린이 제품의 노출평가는 다음의 사항을 고려할 수 있다(Renwick, 1998,\n\n<!-- PAGE_20 -->\n###### ① 모든 영·유아 및 어린이 제품 : 체중 대비 피부 표면적의 비율을 고려할 수 있다.\n\n <!-- PAGE_20 -->\n###### - 출생 시 신생아의 경우 성인보다 2.3배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 6개월 후에는 1.8배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 12개월 후에는 1.6배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 5년 후에는 1.5배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 10년 후에는 1.3배 높음\n\n<!-- PAGE_20 -->\n###### ② 엉덩이에 사용할 가능성이 높은 제품 : 체계적 노출 용량을 계산할 때, 엉덩이는 민감한\n\n<!-- PAGE_20 -->\n###### 부분임을 고려하여 100% 피부흡수율을 적용할 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_20 -->\n###### - 초기에는 보수적인 노출상황을 가정한 시나리오를 적용하여 평가하며, 보수적인 노출상황\n\n<!-- PAGE_20 -->\n###### - 보수적 노출상황을 가정한 평가에서 위해 발생이 우려되면 실제 노출상황을 가정한 노출\n\n<!-- PAGE_20 -->\n###### 3) 화장품은 유형에 따라 사용방법이 다양하므로 화장품 유형별 사용방법을 고려한 노출시나\n\n<!-- PAGE_20 -->\n###### - 유형별로 화장품을 평가할 경우, 붙임 5, 표1에 따라 화장품 유형별 사용량을 고려하여\n\n<!-- PAGE_20 -->\n###### - 자외선차단제에 대한 통합 일일사용량은 17.0 g/day를 적용할 수 있다(붙임 5, 2항 참고).\n\n"
      }
    },
    {
      "chunk_id": "chunk_219",
      "text": "<!-- PAGE_20 -->\n###### - 화장품 전유형 및 보존제에 대한 통합 일일사용량은 16.9 g/day를 적용할 수 있다(붙임 5,\n\n<!-- PAGE_20 -->\n###### - 피부 단위면적당 노출량을 평가할 경우, 체표면적은 붙임 4에서 제시된 값을 적용할 수\n\n<!-- PAGE_20 -->\n###### - 전신노출량 산출 시, 잔류지수(retention factor)를 고려할 수 있다(붙임 5 참조).\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 218,
        "window_size": 3,
        "char_count": 239,
        "word_count": 50,
        "page_number": 20,
        "window_text": "노출평가\n\n<!-- PAGE_20 -->\n###### 1) 노출평가는 최종 제품에서의 사용량, 사용 빈도, 노출경로(경구, 피부, 흡입 등) 등을 기반\n\n<!-- PAGE_20 -->\n###### 으로 일반적 또는 합리적으로 예측 가능한 시나리오를 설정하여 이에 따른 화장품 성분의\n\n<!-- PAGE_20 -->\n###### 인체노출량을 정량적으로 산출하는 단계이다.\n\n <!-- PAGE_20 -->\n###### 2) 효율적인 노출평가를 위해서 단계적 접근방법으로 평가할 수 있다.\n\n <!-- PAGE_20 -->\n###### - 초기에는 보수적인 노출상황을 가정한 시나리오를 적용하여 평가하며, 보수적인 노출상황\n\n<!-- PAGE_20 -->\n###### - 보수적 노출상황을 가정한 평가에서 위해 발생이 우려되면 실제 노출상황을 가정한 노출\n\n<!-- PAGE_20 -->\n###### 3) 화장품은 유형에 따라 사용방법이 다양하므로 화장품 유형별 사용방법을 고려한 노출시나\n\n<!-- PAGE_20 -->\n###### - 유형별로 화장품을 평가할 경우, 붙임 5, 표1에 따라 화장품 유형별 사용량을 고려하여\n\n<!-- PAGE_20 -->\n###### - 자외선차단제에 대한 통합 일일사용량은 17.0 g/day를 적용할 수 있다(붙임 5, 2항 참고).\n\n <!-- PAGE_20 -->\n###### - 화장품 전유형 및 보존제에 대한 통합 일일사용량은 16.9 g/day를 적용할 수 있다(붙임 5,\n\n<!-- PAGE_20 -->\n###### - 피부 단위면적당 노출량을 평가할 경우, 체표면적은 붙임 4에서 제시된 값을 적용할 수\n\n<!-- PAGE_20 -->\n###### - 전신노출량 산출 시, 잔류지수(retention factor)를 고려할 수 있다(붙임 5 참조).\n\n <!-- PAGE_20 -->\n###### -‘씻어내는’제품 : 사용법에 따라 씻어내는 제품은 잔류지수(RF)을 측정할 수 있으며, 잔\n\n<!-- PAGE_20 -->\n###### 4) 영·유아 및 어린이 제품의 노출평가는 다음의 사항을 고려할 수 있다(Renwick, 1998,\n\n<!-- PAGE_20 -->\n###### ① 모든 영·유아 및 어린이 제품 : 체중 대비 피부 표면적의 비율을 고려할 수 있다.\n\n <!-- PAGE_20 -->\n###### - 출생 시 신생아의 경우 성인보다 2.3배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 6개월 후에는 1.8배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 12개월 후에는 1.6배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 5년 후에는 1.5배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 10년 후에는 1.3배 높음\n\n<!-- PAGE_20 -->\n###### ② 엉덩이에 사용할 가능성이 높은 제품 : 체계적 노출 용량을 계산할 때, 엉덩이는 민감한\n\n<!-- PAGE_20 -->\n###### 부분임을 고려하여 100% 피부흡수율을 적용할 수 있다.\n\n - - 15 -\n<!-- PAGE_21 -->\n###### ③ 엉덩이 도포용이 아닌 모든 제품 : 피부흡수에 대한 데이터를 이용할 수 없거나 모델링\n\n<!-- PAGE_21 -->\n###### 을 통한 예측만 존재하는 경우 100% 피부흡수율을 적용할 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_20 -->\n###### - 화장품 전유형 및 보존제에 대한 통합 일일사용량은 16.9 g/day를 적용할 수 있다(붙임 5,\n\n<!-- PAGE_20 -->\n###### - 피부 단위면적당 노출량을 평가할 경우, 체표면적은 붙임 4에서 제시된 값을 적용할 수\n\n<!-- PAGE_20 -->\n###### - 전신노출량 산출 시, 잔류지수(retention factor)를 고려할 수 있다(붙임 5 참조).\n\n"
      }
    },
    {
      "chunk_id": "chunk_220",
      "text": "<!-- PAGE_20 -->\n###### -‘씻어내는’제품 : 사용법에 따라 씻어내는 제품은 잔류지수(RF)을 측정할 수 있으며, 잔\n\n<!-- PAGE_20 -->\n###### 4) 영·유아 및 어린이 제품의 노출평가는 다음의 사항을 고려할 수 있다(Renwick, 1998,\n\n<!-- PAGE_20 -->\n###### ① 모든 영·유아 및 어린이 제품 : 체중 대비 피부 표면적의 비율을 고려할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 219,
        "window_size": 3,
        "char_count": 232,
        "word_count": 50,
        "page_number": 20,
        "window_text": "<!-- PAGE_20 -->\n###### 2) 효율적인 노출평가를 위해서 단계적 접근방법으로 평가할 수 있다.\n\n <!-- PAGE_20 -->\n###### - 초기에는 보수적인 노출상황을 가정한 시나리오를 적용하여 평가하며, 보수적인 노출상황\n\n<!-- PAGE_20 -->\n###### - 보수적 노출상황을 가정한 평가에서 위해 발생이 우려되면 실제 노출상황을 가정한 노출\n\n<!-- PAGE_20 -->\n###### 3) 화장품은 유형에 따라 사용방법이 다양하므로 화장품 유형별 사용방법을 고려한 노출시나\n\n<!-- PAGE_20 -->\n###### - 유형별로 화장품을 평가할 경우, 붙임 5, 표1에 따라 화장품 유형별 사용량을 고려하여\n\n<!-- PAGE_20 -->\n###### - 자외선차단제에 대한 통합 일일사용량은 17.0 g/day를 적용할 수 있다(붙임 5, 2항 참고).\n\n <!-- PAGE_20 -->\n###### - 화장품 전유형 및 보존제에 대한 통합 일일사용량은 16.9 g/day를 적용할 수 있다(붙임 5,\n\n<!-- PAGE_20 -->\n###### - 피부 단위면적당 노출량을 평가할 경우, 체표면적은 붙임 4에서 제시된 값을 적용할 수\n\n<!-- PAGE_20 -->\n###### - 전신노출량 산출 시, 잔류지수(retention factor)를 고려할 수 있다(붙임 5 참조).\n\n <!-- PAGE_20 -->\n###### -‘씻어내는’제품 : 사용법에 따라 씻어내는 제품은 잔류지수(RF)을 측정할 수 있으며, 잔\n\n<!-- PAGE_20 -->\n###### 4) 영·유아 및 어린이 제품의 노출평가는 다음의 사항을 고려할 수 있다(Renwick, 1998,\n\n<!-- PAGE_20 -->\n###### ① 모든 영·유아 및 어린이 제품 : 체중 대비 피부 표면적의 비율을 고려할 수 있다.\n\n <!-- PAGE_20 -->\n###### - 출생 시 신생아의 경우 성인보다 2.3배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 6개월 후에는 1.8배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 12개월 후에는 1.6배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 5년 후에는 1.5배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 10년 후에는 1.3배 높음\n\n<!-- PAGE_20 -->\n###### ② 엉덩이에 사용할 가능성이 높은 제품 : 체계적 노출 용량을 계산할 때, 엉덩이는 민감한\n\n<!-- PAGE_20 -->\n###### 부분임을 고려하여 100% 피부흡수율을 적용할 수 있다.\n\n - - 15 -\n<!-- PAGE_21 -->\n###### ③ 엉덩이 도포용이 아닌 모든 제품 : 피부흡수에 대한 데이터를 이용할 수 없거나 모델링\n\n<!-- PAGE_21 -->\n###### 을 통한 예측만 존재하는 경우 100% 피부흡수율을 적용할 수 있다.\n\n <!-- PAGE_21 -->\n###### ④ 일반적으로 10세 이하의 영·유아 및 소아에 대한 불확실성 계수의 추가는 이미 사람\n\n<!-- PAGE_21 -->\n###### 간 변동성에서 고려되었으므로 필요가 없다.\n\n",
        "original_sentence": "<!-- PAGE_20 -->\n###### -‘씻어내는’제품 : 사용법에 따라 씻어내는 제품은 잔류지수(RF)을 측정할 수 있으며, 잔\n\n<!-- PAGE_20 -->\n###### 4) 영·유아 및 어린이 제품의 노출평가는 다음의 사항을 고려할 수 있다(Renwick, 1998,\n\n<!-- PAGE_20 -->\n###### ① 모든 영·유아 및 어린이 제품 : 체중 대비 피부 표면적의 비율을 고려할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_221",
      "text": "<!-- PAGE_20 -->\n###### - 출생 시 신생아의 경우 성인보다 2.3배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 6개월 후에는 1.8배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 12개월 후에는 1.6배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 5년 후에는 1.5배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 10년 후에는 1.3배 높음\n\n<!-- PAGE_20 -->\n###### ② 엉덩이에 사용할 가능성이 높은 제품 : 체계적 노출 용량을 계산할 때, 엉덩이는 민감한\n\n<!-- PAGE_20 -->\n###### 부분임을 고려하여 100% 피부흡수율을 적용할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 220,
        "window_size": 3,
        "char_count": 378,
        "word_count": 85,
        "page_number": 20,
        "window_text": "<!-- PAGE_20 -->\n###### - 초기에는 보수적인 노출상황을 가정한 시나리오를 적용하여 평가하며, 보수적인 노출상황\n\n<!-- PAGE_20 -->\n###### - 보수적 노출상황을 가정한 평가에서 위해 발생이 우려되면 실제 노출상황을 가정한 노출\n\n<!-- PAGE_20 -->\n###### 3) 화장품은 유형에 따라 사용방법이 다양하므로 화장품 유형별 사용방법을 고려한 노출시나\n\n<!-- PAGE_20 -->\n###### - 유형별로 화장품을 평가할 경우, 붙임 5, 표1에 따라 화장품 유형별 사용량을 고려하여\n\n<!-- PAGE_20 -->\n###### - 자외선차단제에 대한 통합 일일사용량은 17.0 g/day를 적용할 수 있다(붙임 5, 2항 참고).\n\n <!-- PAGE_20 -->\n###### - 화장품 전유형 및 보존제에 대한 통합 일일사용량은 16.9 g/day를 적용할 수 있다(붙임 5,\n\n<!-- PAGE_20 -->\n###### - 피부 단위면적당 노출량을 평가할 경우, 체표면적은 붙임 4에서 제시된 값을 적용할 수\n\n<!-- PAGE_20 -->\n###### - 전신노출량 산출 시, 잔류지수(retention factor)를 고려할 수 있다(붙임 5 참조).\n\n <!-- PAGE_20 -->\n###### -‘씻어내는’제품 : 사용법에 따라 씻어내는 제품은 잔류지수(RF)을 측정할 수 있으며, 잔\n\n<!-- PAGE_20 -->\n###### 4) 영·유아 및 어린이 제품의 노출평가는 다음의 사항을 고려할 수 있다(Renwick, 1998,\n\n<!-- PAGE_20 -->\n###### ① 모든 영·유아 및 어린이 제품 : 체중 대비 피부 표면적의 비율을 고려할 수 있다.\n\n <!-- PAGE_20 -->\n###### - 출생 시 신생아의 경우 성인보다 2.3배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 6개월 후에는 1.8배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 12개월 후에는 1.6배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 5년 후에는 1.5배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 10년 후에는 1.3배 높음\n\n<!-- PAGE_20 -->\n###### ② 엉덩이에 사용할 가능성이 높은 제품 : 체계적 노출 용량을 계산할 때, 엉덩이는 민감한\n\n<!-- PAGE_20 -->\n###### 부분임을 고려하여 100% 피부흡수율을 적용할 수 있다.\n\n - - 15 -\n<!-- PAGE_21 -->\n###### ③ 엉덩이 도포용이 아닌 모든 제품 : 피부흡수에 대한 데이터를 이용할 수 없거나 모델링\n\n<!-- PAGE_21 -->\n###### 을 통한 예측만 존재하는 경우 100% 피부흡수율을 적용할 수 있다.\n\n <!-- PAGE_21 -->\n###### ④ 일반적으로 10세 이하의 영·유아 및 소아에 대한 불확실성 계수의 추가는 이미 사람\n\n<!-- PAGE_21 -->\n###### 간 변동성에서 고려되었으므로 필요가 없다.\n\n - - 16 -\n<!-- PAGE_22 -->\n###### □ 노출평가\n\n주요내용\n\n수행방법\n\n- ○ 노출시나리오\n- ○ 위험에 노출된 대상이 누구이며, 어떻게 노출되었는지를 고려하여\n명확한 노출시나리오 설정\n\n- ○ 노출량 산출\n- ○ 제품의 종류, 제품 사용방법에 따른 사용량 산출\n- - 17 -\n<!-- PAGE_23 -->\n###### 2-2-3-1 피부 노출평가\n\n<!-- PAGE_23 -->\n###### 1) 피부노출에 의한 전신노출량(systemic exposure dosage, SED)은 일반적으로 대상성분의 농\n\n<!-- PAGE_23 -->\n###### 도, 특정 성분의 피부흡수, 화장품의 1일 사용량, 사용빈도, 사람의 평균 체중값을 고려하\n\n<!-- PAGE_23 -->\n###### 여 산출한다.\n\n",
        "original_sentence": "<!-- PAGE_20 -->\n###### - 출생 시 신생아의 경우 성인보다 2.3배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 6개월 후에는 1.8배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 12개월 후에는 1.6배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 5년 후에는 1.5배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 10년 후에는 1.3배 높음\n\n<!-- PAGE_20 -->\n###### ② 엉덩이에 사용할 가능성이 높은 제품 : 체계적 노출 용량을 계산할 때, 엉덩이는 민감한\n\n<!-- PAGE_20 -->\n###### 부분임을 고려하여 100% 피부흡수율을 적용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_222",
      "text": "- - 15 -\n<!-- PAGE_21 -->\n###### ③ 엉덩이 도포용이 아닌 모든 제품 : 피부흡수에 대한 데이터를 이용할 수 없거나 모델링\n\n<!-- PAGE_21 -->\n###### 을 통한 예측만 존재하는 경우 100% 피부흡수율을 적용할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 221,
        "window_size": 3,
        "char_count": 148,
        "word_count": 36,
        "page_number": 21,
        "window_text": "<!-- PAGE_20 -->\n###### - 화장품 전유형 및 보존제에 대한 통합 일일사용량은 16.9 g/day를 적용할 수 있다(붙임 5,\n\n<!-- PAGE_20 -->\n###### - 피부 단위면적당 노출량을 평가할 경우, 체표면적은 붙임 4에서 제시된 값을 적용할 수\n\n<!-- PAGE_20 -->\n###### - 전신노출량 산출 시, 잔류지수(retention factor)를 고려할 수 있다(붙임 5 참조).\n\n <!-- PAGE_20 -->\n###### -‘씻어내는’제품 : 사용법에 따라 씻어내는 제품은 잔류지수(RF)을 측정할 수 있으며, 잔\n\n<!-- PAGE_20 -->\n###### 4) 영·유아 및 어린이 제품의 노출평가는 다음의 사항을 고려할 수 있다(Renwick, 1998,\n\n<!-- PAGE_20 -->\n###### ① 모든 영·유아 및 어린이 제품 : 체중 대비 피부 표면적의 비율을 고려할 수 있다.\n\n <!-- PAGE_20 -->\n###### - 출생 시 신생아의 경우 성인보다 2.3배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 6개월 후에는 1.8배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 12개월 후에는 1.6배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 5년 후에는 1.5배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 10년 후에는 1.3배 높음\n\n<!-- PAGE_20 -->\n###### ② 엉덩이에 사용할 가능성이 높은 제품 : 체계적 노출 용량을 계산할 때, 엉덩이는 민감한\n\n<!-- PAGE_20 -->\n###### 부분임을 고려하여 100% 피부흡수율을 적용할 수 있다.\n\n - - 15 -\n<!-- PAGE_21 -->\n###### ③ 엉덩이 도포용이 아닌 모든 제품 : 피부흡수에 대한 데이터를 이용할 수 없거나 모델링\n\n<!-- PAGE_21 -->\n###### 을 통한 예측만 존재하는 경우 100% 피부흡수율을 적용할 수 있다.\n\n <!-- PAGE_21 -->\n###### ④ 일반적으로 10세 이하의 영·유아 및 소아에 대한 불확실성 계수의 추가는 이미 사람\n\n<!-- PAGE_21 -->\n###### 간 변동성에서 고려되었으므로 필요가 없다.\n\n - - 16 -\n<!-- PAGE_22 -->\n###### □ 노출평가\n\n주요내용\n\n수행방법\n\n- ○ 노출시나리오\n- ○ 위험에 노출된 대상이 누구이며, 어떻게 노출되었는지를 고려하여\n명확한 노출시나리오 설정\n\n- ○ 노출량 산출\n- ○ 제품의 종류, 제품 사용방법에 따른 사용량 산출\n- - 17 -\n<!-- PAGE_23 -->\n###### 2-2-3-1 피부 노출평가\n\n<!-- PAGE_23 -->\n###### 1) 피부노출에 의한 전신노출량(systemic exposure dosage, SED)은 일반적으로 대상성분의 농\n\n<!-- PAGE_23 -->\n###### 도, 특정 성분의 피부흡수, 화장품의 1일 사용량, 사용빈도, 사람의 평균 체중값을 고려하\n\n<!-- PAGE_23 -->\n###### 여 산출한다.\n\n <!-- PAGE_23 -->\n###### - 피부로 노출된 전신노출량(SED)은 제품 중 물질의 단위면적당 피부흡수량(mg/cm2) 또는\n\n<!-- PAGE_23 -->\n###### 피부흡수율(%)로부터 구할 수 있다. ",
        "original_sentence": "- - 15 -\n<!-- PAGE_21 -->\n###### ③ 엉덩이 도포용이 아닌 모든 제품 : 피부흡수에 대한 데이터를 이용할 수 없거나 모델링\n\n<!-- PAGE_21 -->\n###### 을 통한 예측만 존재하는 경우 100% 피부흡수율을 적용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_223",
      "text": "<!-- PAGE_21 -->\n###### ④ 일반적으로 10세 이하의 영·유아 및 소아에 대한 불확실성 계수의 추가는 이미 사람\n\n<!-- PAGE_21 -->\n###### 간 변동성에서 고려되었으므로 필요가 없다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 222,
        "window_size": 3,
        "char_count": 123,
        "word_count": 26,
        "page_number": 21,
        "window_text": "<!-- PAGE_20 -->\n###### -‘씻어내는’제품 : 사용법에 따라 씻어내는 제품은 잔류지수(RF)을 측정할 수 있으며, 잔\n\n<!-- PAGE_20 -->\n###### 4) 영·유아 및 어린이 제품의 노출평가는 다음의 사항을 고려할 수 있다(Renwick, 1998,\n\n<!-- PAGE_20 -->\n###### ① 모든 영·유아 및 어린이 제품 : 체중 대비 피부 표면적의 비율을 고려할 수 있다.\n\n <!-- PAGE_20 -->\n###### - 출생 시 신생아의 경우 성인보다 2.3배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 6개월 후에는 1.8배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 12개월 후에는 1.6배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 5년 후에는 1.5배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 10년 후에는 1.3배 높음\n\n<!-- PAGE_20 -->\n###### ② 엉덩이에 사용할 가능성이 높은 제품 : 체계적 노출 용량을 계산할 때, 엉덩이는 민감한\n\n<!-- PAGE_20 -->\n###### 부분임을 고려하여 100% 피부흡수율을 적용할 수 있다.\n\n - - 15 -\n<!-- PAGE_21 -->\n###### ③ 엉덩이 도포용이 아닌 모든 제품 : 피부흡수에 대한 데이터를 이용할 수 없거나 모델링\n\n<!-- PAGE_21 -->\n###### 을 통한 예측만 존재하는 경우 100% 피부흡수율을 적용할 수 있다.\n\n <!-- PAGE_21 -->\n###### ④ 일반적으로 10세 이하의 영·유아 및 소아에 대한 불확실성 계수의 추가는 이미 사람\n\n<!-- PAGE_21 -->\n###### 간 변동성에서 고려되었으므로 필요가 없다.\n\n - - 16 -\n<!-- PAGE_22 -->\n###### □ 노출평가\n\n주요내용\n\n수행방법\n\n- ○ 노출시나리오\n- ○ 위험에 노출된 대상이 누구이며, 어떻게 노출되었는지를 고려하여\n명확한 노출시나리오 설정\n\n- ○ 노출량 산출\n- ○ 제품의 종류, 제품 사용방법에 따른 사용량 산출\n- - 17 -\n<!-- PAGE_23 -->\n###### 2-2-3-1 피부 노출평가\n\n<!-- PAGE_23 -->\n###### 1) 피부노출에 의한 전신노출량(systemic exposure dosage, SED)은 일반적으로 대상성분의 농\n\n<!-- PAGE_23 -->\n###### 도, 특정 성분의 피부흡수, 화장품의 1일 사용량, 사용빈도, 사람의 평균 체중값을 고려하\n\n<!-- PAGE_23 -->\n###### 여 산출한다.\n\n <!-- PAGE_23 -->\n###### - 피부로 노출된 전신노출량(SED)은 제품 중 물질의 단위면적당 피부흡수량(mg/cm2) 또는\n\n<!-- PAGE_23 -->\n###### 피부흡수율(%)로부터 구할 수 있다.  피부흡수율을 이용하는 경우, 결과 값은 피부에 적용\n\n<!-- PAGE_23 -->\n###### 2) 피부흡수율(또는 흡수량)은 사용한도 또는 유사한 용량을 함유하는 제형(formulation)을 사\n\n<!-- PAGE_23 -->\n###### - 피부흡수율 자료가 없거나 기존에 보고된 자료가 적합하지 않을 경우, 기본값으로 50%를\n\n<!-- PAGE_23 -->\n###### - 생체외 피부흡수시험 결과는 가변성이 있기 때문에 일반적으로 인체노출량 계산 시 평균\n\n<!-- PAGE_23 -->\n###### 피부흡수시험 및 결과가 아래와 같은 시험요건의 적정성에 모두 부합하는 경우에 평균 +\n\n<!-- PAGE_23 -->\n###### 1SD를 사용하며, 프로토콜에서 벗어나거나 변동성이 높은 경우에는 평균 + 2SD를 사용한\n\n- - 18 -\n<!-- PAGE_24 -->\n###### 3) 피부노출에 의한 전신노출량(SED)은 두가지 방법으로 산출한다.\n\n",
        "original_sentence": "<!-- PAGE_21 -->\n###### ④ 일반적으로 10세 이하의 영·유아 및 소아에 대한 불확실성 계수의 추가는 이미 사람\n\n<!-- PAGE_21 -->\n###### 간 변동성에서 고려되었으므로 필요가 없다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_224",
      "text": "- - 16 -\n<!-- PAGE_22 -->\n###### □ 노출평가\n\n주요내용\n\n수행방법\n\n- ○ 노출시나리오\n- ○ 위험에 노출된 대상이 누구이며, 어떻게 노출되었는지를 고려하여\n명확한 노출시나리오 설정\n\n- ○ 노출량 산출\n- ○ 제품의 종류, 제품 사용방법에 따른 사용량 산출\n- - 17 -\n<!-- PAGE_23 -->\n###### 2-2-3-1 피부 노출평가\n\n<!-- PAGE_23 -->\n###### 1) 피부노출에 의한 전신노출량(systemic exposure dosage, SED)은 일반적으로 대상성분의 농\n\n<!-- PAGE_23 -->\n###### 도, 특정 성분의 피부흡수, 화장품의 1일 사용량, 사용빈도, 사람의 평균 체중값을 고려하\n\n<!-- PAGE_23 -->\n###### 여 산출한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 223,
        "window_size": 3,
        "char_count": 408,
        "word_count": 87,
        "page_number": 22,
        "window_text": "<!-- PAGE_20 -->\n###### - 출생 시 신생아의 경우 성인보다 2.3배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 6개월 후에는 1.8배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 12개월 후에는 1.6배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 5년 후에는 1.5배 높음\n\n<!-- PAGE_20 -->\n###### - 출생 후 10년 후에는 1.3배 높음\n\n<!-- PAGE_20 -->\n###### ② 엉덩이에 사용할 가능성이 높은 제품 : 체계적 노출 용량을 계산할 때, 엉덩이는 민감한\n\n<!-- PAGE_20 -->\n###### 부분임을 고려하여 100% 피부흡수율을 적용할 수 있다.\n\n - - 15 -\n<!-- PAGE_21 -->\n###### ③ 엉덩이 도포용이 아닌 모든 제품 : 피부흡수에 대한 데이터를 이용할 수 없거나 모델링\n\n<!-- PAGE_21 -->\n###### 을 통한 예측만 존재하는 경우 100% 피부흡수율을 적용할 수 있다.\n\n <!-- PAGE_21 -->\n###### ④ 일반적으로 10세 이하의 영·유아 및 소아에 대한 불확실성 계수의 추가는 이미 사람\n\n<!-- PAGE_21 -->\n###### 간 변동성에서 고려되었으므로 필요가 없다.\n\n - - 16 -\n<!-- PAGE_22 -->\n###### □ 노출평가\n\n주요내용\n\n수행방법\n\n- ○ 노출시나리오\n- ○ 위험에 노출된 대상이 누구이며, 어떻게 노출되었는지를 고려하여\n명확한 노출시나리오 설정\n\n- ○ 노출량 산출\n- ○ 제품의 종류, 제품 사용방법에 따른 사용량 산출\n- - 17 -\n<!-- PAGE_23 -->\n###### 2-2-3-1 피부 노출평가\n\n<!-- PAGE_23 -->\n###### 1) 피부노출에 의한 전신노출량(systemic exposure dosage, SED)은 일반적으로 대상성분의 농\n\n<!-- PAGE_23 -->\n###### 도, 특정 성분의 피부흡수, 화장품의 1일 사용량, 사용빈도, 사람의 평균 체중값을 고려하\n\n<!-- PAGE_23 -->\n###### 여 산출한다.\n\n <!-- PAGE_23 -->\n###### - 피부로 노출된 전신노출량(SED)은 제품 중 물질의 단위면적당 피부흡수량(mg/cm2) 또는\n\n<!-- PAGE_23 -->\n###### 피부흡수율(%)로부터 구할 수 있다.  피부흡수율을 이용하는 경우, 결과 값은 피부에 적용\n\n<!-- PAGE_23 -->\n###### 2) 피부흡수율(또는 흡수량)은 사용한도 또는 유사한 용량을 함유하는 제형(formulation)을 사\n\n<!-- PAGE_23 -->\n###### - 피부흡수율 자료가 없거나 기존에 보고된 자료가 적합하지 않을 경우, 기본값으로 50%를\n\n<!-- PAGE_23 -->\n###### - 생체외 피부흡수시험 결과는 가변성이 있기 때문에 일반적으로 인체노출량 계산 시 평균\n\n<!-- PAGE_23 -->\n###### 피부흡수시험 및 결과가 아래와 같은 시험요건의 적정성에 모두 부합하는 경우에 평균 +\n\n<!-- PAGE_23 -->\n###### 1SD를 사용하며, 프로토콜에서 벗어나거나 변동성이 높은 경우에는 평균 + 2SD를 사용한\n\n- - 18 -\n<!-- PAGE_24 -->\n###### 3) 피부노출에 의한 전신노출량(SED)은 두가지 방법으로 산출한다.\n\n <!-- PAGE_24 -->\n###### ① 단위면적당 피부흡수량(㎍/cm2)을 기초로 한 전신노출량(SED) 산출\n\n<!-- PAGE_24 -->\n###### ② 평가대상 물질의 피부흡수율(%)을 기초로 한 전신노출량(SED) 산출\n\n2 피부흡수율은 문헌에 보고된 값이나 실험값 중 신뢰성 있는 값을 선택하여 적용한다. ",
        "original_sentence": "- - 16 -\n<!-- PAGE_22 -->\n###### □ 노출평가\n\n주요내용\n\n수행방법\n\n- ○ 노출시나리오\n- ○ 위험에 노출된 대상이 누구이며, 어떻게 노출되었는지를 고려하여\n명확한 노출시나리오 설정\n\n- ○ 노출량 산출\n- ○ 제품의 종류, 제품 사용방법에 따른 사용량 산출\n- - 17 -\n<!-- PAGE_23 -->\n###### 2-2-3-1 피부 노출평가\n\n<!-- PAGE_23 -->\n###### 1) 피부노출에 의한 전신노출량(systemic exposure dosage, SED)은 일반적으로 대상성분의 농\n\n<!-- PAGE_23 -->\n###### 도, 특정 성분의 피부흡수, 화장품의 1일 사용량, 사용빈도, 사람의 평균 체중값을 고려하\n\n<!-- PAGE_23 -->\n###### 여 산출한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_225",
      "text": "<!-- PAGE_23 -->\n###### - 피부로 노출된 전신노출량(SED)은 제품 중 물질의 단위면적당 피부흡수량(mg/cm2) 또는\n\n<!-- PAGE_23 -->\n###### 피부흡수율(%)로부터 구할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 224,
        "window_size": 3,
        "char_count": 124,
        "word_count": 22,
        "page_number": 23,
        "window_text": "- - 15 -\n<!-- PAGE_21 -->\n###### ③ 엉덩이 도포용이 아닌 모든 제품 : 피부흡수에 대한 데이터를 이용할 수 없거나 모델링\n\n<!-- PAGE_21 -->\n###### 을 통한 예측만 존재하는 경우 100% 피부흡수율을 적용할 수 있다.\n\n <!-- PAGE_21 -->\n###### ④ 일반적으로 10세 이하의 영·유아 및 소아에 대한 불확실성 계수의 추가는 이미 사람\n\n<!-- PAGE_21 -->\n###### 간 변동성에서 고려되었으므로 필요가 없다.\n\n - - 16 -\n<!-- PAGE_22 -->\n###### □ 노출평가\n\n주요내용\n\n수행방법\n\n- ○ 노출시나리오\n- ○ 위험에 노출된 대상이 누구이며, 어떻게 노출되었는지를 고려하여\n명확한 노출시나리오 설정\n\n- ○ 노출량 산출\n- ○ 제품의 종류, 제품 사용방법에 따른 사용량 산출\n- - 17 -\n<!-- PAGE_23 -->\n###### 2-2-3-1 피부 노출평가\n\n<!-- PAGE_23 -->\n###### 1) 피부노출에 의한 전신노출량(systemic exposure dosage, SED)은 일반적으로 대상성분의 농\n\n<!-- PAGE_23 -->\n###### 도, 특정 성분의 피부흡수, 화장품의 1일 사용량, 사용빈도, 사람의 평균 체중값을 고려하\n\n<!-- PAGE_23 -->\n###### 여 산출한다.\n\n <!-- PAGE_23 -->\n###### - 피부로 노출된 전신노출량(SED)은 제품 중 물질의 단위면적당 피부흡수량(mg/cm2) 또는\n\n<!-- PAGE_23 -->\n###### 피부흡수율(%)로부터 구할 수 있다.  피부흡수율을 이용하는 경우, 결과 값은 피부에 적용\n\n<!-- PAGE_23 -->\n###### 2) 피부흡수율(또는 흡수량)은 사용한도 또는 유사한 용량을 함유하는 제형(formulation)을 사\n\n<!-- PAGE_23 -->\n###### - 피부흡수율 자료가 없거나 기존에 보고된 자료가 적합하지 않을 경우, 기본값으로 50%를\n\n<!-- PAGE_23 -->\n###### - 생체외 피부흡수시험 결과는 가변성이 있기 때문에 일반적으로 인체노출량 계산 시 평균\n\n<!-- PAGE_23 -->\n###### 피부흡수시험 및 결과가 아래와 같은 시험요건의 적정성에 모두 부합하는 경우에 평균 +\n\n<!-- PAGE_23 -->\n###### 1SD를 사용하며, 프로토콜에서 벗어나거나 변동성이 높은 경우에는 평균 + 2SD를 사용한\n\n- - 18 -\n<!-- PAGE_24 -->\n###### 3) 피부노출에 의한 전신노출량(SED)은 두가지 방법으로 산출한다.\n\n <!-- PAGE_24 -->\n###### ① 단위면적당 피부흡수량(㎍/cm2)을 기초로 한 전신노출량(SED) 산출\n\n<!-- PAGE_24 -->\n###### ② 평가대상 물질의 피부흡수율(%)을 기초로 한 전신노출량(SED) 산출\n\n2 피부흡수율은 문헌에 보고된 값이나 실험값 중 신뢰성 있는 값을 선택하여 적용한다.  다만,\n\n자료가 없는 경우 보수적으로 50%로 적용할 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_23 -->\n###### - 피부로 노출된 전신노출량(SED)은 제품 중 물질의 단위면적당 피부흡수량(mg/cm2) 또는\n\n<!-- PAGE_23 -->\n###### 피부흡수율(%)로부터 구할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_226",
      "text": "피부흡수율을 이용하는 경우, 결과 값은 피부에 적용\n\n<!-- PAGE_23 -->\n###### 2) 피부흡수율(또는 흡수량)은 사용한도 또는 유사한 용량을 함유하는 제형(formulation)을 사\n\n<!-- PAGE_23 -->\n###### - 피부흡수율 자료가 없거나 기존에 보고된 자료가 적합하지 않을 경우, 기본값으로 50%를\n\n<!-- PAGE_23 -->\n###### - 생체외 피부흡수시험 결과는 가변성이 있기 때문에 일반적으로 인체노출량 계산 시 평균\n\n<!-- PAGE_23 -->\n###### 피부흡수시험 및 결과가 아래와 같은 시험요건의 적정성에 모두 부합하는 경우에 평균 +\n\n<!-- PAGE_23 -->\n###### 1SD를 사용하며, 프로토콜에서 벗어나거나 변동성이 높은 경우에는 평균 + 2SD를 사용한\n\n- - 18 -\n<!-- PAGE_24 -->\n###### 3) 피부노출에 의한 전신노출량(SED)은 두가지 방법으로 산출한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 225,
        "window_size": 3,
        "char_count": 485,
        "word_count": 99,
        "page_number": 23,
        "window_text": "<!-- PAGE_21 -->\n###### ④ 일반적으로 10세 이하의 영·유아 및 소아에 대한 불확실성 계수의 추가는 이미 사람\n\n<!-- PAGE_21 -->\n###### 간 변동성에서 고려되었으므로 필요가 없다.\n\n - - 16 -\n<!-- PAGE_22 -->\n###### □ 노출평가\n\n주요내용\n\n수행방법\n\n- ○ 노출시나리오\n- ○ 위험에 노출된 대상이 누구이며, 어떻게 노출되었는지를 고려하여\n명확한 노출시나리오 설정\n\n- ○ 노출량 산출\n- ○ 제품의 종류, 제품 사용방법에 따른 사용량 산출\n- - 17 -\n<!-- PAGE_23 -->\n###### 2-2-3-1 피부 노출평가\n\n<!-- PAGE_23 -->\n###### 1) 피부노출에 의한 전신노출량(systemic exposure dosage, SED)은 일반적으로 대상성분의 농\n\n<!-- PAGE_23 -->\n###### 도, 특정 성분의 피부흡수, 화장품의 1일 사용량, 사용빈도, 사람의 평균 체중값을 고려하\n\n<!-- PAGE_23 -->\n###### 여 산출한다.\n\n <!-- PAGE_23 -->\n###### - 피부로 노출된 전신노출량(SED)은 제품 중 물질의 단위면적당 피부흡수량(mg/cm2) 또는\n\n<!-- PAGE_23 -->\n###### 피부흡수율(%)로부터 구할 수 있다.  피부흡수율을 이용하는 경우, 결과 값은 피부에 적용\n\n<!-- PAGE_23 -->\n###### 2) 피부흡수율(또는 흡수량)은 사용한도 또는 유사한 용량을 함유하는 제형(formulation)을 사\n\n<!-- PAGE_23 -->\n###### - 피부흡수율 자료가 없거나 기존에 보고된 자료가 적합하지 않을 경우, 기본값으로 50%를\n\n<!-- PAGE_23 -->\n###### - 생체외 피부흡수시험 결과는 가변성이 있기 때문에 일반적으로 인체노출량 계산 시 평균\n\n<!-- PAGE_23 -->\n###### 피부흡수시험 및 결과가 아래와 같은 시험요건의 적정성에 모두 부합하는 경우에 평균 +\n\n<!-- PAGE_23 -->\n###### 1SD를 사용하며, 프로토콜에서 벗어나거나 변동성이 높은 경우에는 평균 + 2SD를 사용한\n\n- - 18 -\n<!-- PAGE_24 -->\n###### 3) 피부노출에 의한 전신노출량(SED)은 두가지 방법으로 산출한다.\n\n <!-- PAGE_24 -->\n###### ① 단위면적당 피부흡수량(㎍/cm2)을 기초로 한 전신노출량(SED) 산출\n\n<!-- PAGE_24 -->\n###### ② 평가대상 물질의 피부흡수율(%)을 기초로 한 전신노출량(SED) 산출\n\n2 피부흡수율은 문헌에 보고된 값이나 실험값 중 신뢰성 있는 값을 선택하여 적용한다.  다만,\n\n자료가 없는 경우 보수적으로 50%로 적용할 수 있다.\n\n - - 19 -\n<!-- PAGE_25 -->\n###### 2-2-3-2 흡입 노출평가\n\n<!-- PAGE_25 -->\n###### 1) 화장품은 제형에 따라 분말, 증기, 에어로졸 등의 형태로 직접적으로 흡입되거나 제품 내\n\n<!-- PAGE_25 -->\n###### 휘발성분에 의해 피부에 남아 있는 성분이 공기 중으로 증발되어 흡입될 수 있다. ",
        "original_sentence": "피부흡수율을 이용하는 경우, 결과 값은 피부에 적용\n\n<!-- PAGE_23 -->\n###### 2) 피부흡수율(또는 흡수량)은 사용한도 또는 유사한 용량을 함유하는 제형(formulation)을 사\n\n<!-- PAGE_23 -->\n###### - 피부흡수율 자료가 없거나 기존에 보고된 자료가 적합하지 않을 경우, 기본값으로 50%를\n\n<!-- PAGE_23 -->\n###### - 생체외 피부흡수시험 결과는 가변성이 있기 때문에 일반적으로 인체노출량 계산 시 평균\n\n<!-- PAGE_23 -->\n###### 피부흡수시험 및 결과가 아래와 같은 시험요건의 적정성에 모두 부합하는 경우에 평균 +\n\n<!-- PAGE_23 -->\n###### 1SD를 사용하며, 프로토콜에서 벗어나거나 변동성이 높은 경우에는 평균 + 2SD를 사용한\n\n- - 18 -\n<!-- PAGE_24 -->\n###### 3) 피부노출에 의한 전신노출량(SED)은 두가지 방법으로 산출한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_227",
      "text": "<!-- PAGE_24 -->\n###### ① 단위면적당 피부흡수량(㎍/cm2)을 기초로 한 전신노출량(SED) 산출\n\n<!-- PAGE_24 -->\n###### ② 평가대상 물질의 피부흡수율(%)을 기초로 한 전신노출량(SED) 산출\n\n2 피부흡수율은 문헌에 보고된 값이나 실험값 중 신뢰성 있는 값을 선택하여 적용한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 226,
        "window_size": 3,
        "char_count": 181,
        "word_count": 35,
        "page_number": 24,
        "window_text": "- - 16 -\n<!-- PAGE_22 -->\n###### □ 노출평가\n\n주요내용\n\n수행방법\n\n- ○ 노출시나리오\n- ○ 위험에 노출된 대상이 누구이며, 어떻게 노출되었는지를 고려하여\n명확한 노출시나리오 설정\n\n- ○ 노출량 산출\n- ○ 제품의 종류, 제품 사용방법에 따른 사용량 산출\n- - 17 -\n<!-- PAGE_23 -->\n###### 2-2-3-1 피부 노출평가\n\n<!-- PAGE_23 -->\n###### 1) 피부노출에 의한 전신노출량(systemic exposure dosage, SED)은 일반적으로 대상성분의 농\n\n<!-- PAGE_23 -->\n###### 도, 특정 성분의 피부흡수, 화장품의 1일 사용량, 사용빈도, 사람의 평균 체중값을 고려하\n\n<!-- PAGE_23 -->\n###### 여 산출한다.\n\n <!-- PAGE_23 -->\n###### - 피부로 노출된 전신노출량(SED)은 제품 중 물질의 단위면적당 피부흡수량(mg/cm2) 또는\n\n<!-- PAGE_23 -->\n###### 피부흡수율(%)로부터 구할 수 있다.  피부흡수율을 이용하는 경우, 결과 값은 피부에 적용\n\n<!-- PAGE_23 -->\n###### 2) 피부흡수율(또는 흡수량)은 사용한도 또는 유사한 용량을 함유하는 제형(formulation)을 사\n\n<!-- PAGE_23 -->\n###### - 피부흡수율 자료가 없거나 기존에 보고된 자료가 적합하지 않을 경우, 기본값으로 50%를\n\n<!-- PAGE_23 -->\n###### - 생체외 피부흡수시험 결과는 가변성이 있기 때문에 일반적으로 인체노출량 계산 시 평균\n\n<!-- PAGE_23 -->\n###### 피부흡수시험 및 결과가 아래와 같은 시험요건의 적정성에 모두 부합하는 경우에 평균 +\n\n<!-- PAGE_23 -->\n###### 1SD를 사용하며, 프로토콜에서 벗어나거나 변동성이 높은 경우에는 평균 + 2SD를 사용한\n\n- - 18 -\n<!-- PAGE_24 -->\n###### 3) 피부노출에 의한 전신노출량(SED)은 두가지 방법으로 산출한다.\n\n <!-- PAGE_24 -->\n###### ① 단위면적당 피부흡수량(㎍/cm2)을 기초로 한 전신노출량(SED) 산출\n\n<!-- PAGE_24 -->\n###### ② 평가대상 물질의 피부흡수율(%)을 기초로 한 전신노출량(SED) 산출\n\n2 피부흡수율은 문헌에 보고된 값이나 실험값 중 신뢰성 있는 값을 선택하여 적용한다.  다만,\n\n자료가 없는 경우 보수적으로 50%로 적용할 수 있다.\n\n - - 19 -\n<!-- PAGE_25 -->\n###### 2-2-3-2 흡입 노출평가\n\n<!-- PAGE_25 -->\n###### 1) 화장품은 제형에 따라 분말, 증기, 에어로졸 등의 형태로 직접적으로 흡입되거나 제품 내\n\n<!-- PAGE_25 -->\n###### 휘발성분에 의해 피부에 남아 있는 성분이 공기 중으로 증발되어 흡입될 수 있다.  흡입은\n\n<!-- PAGE_25 -->\n###### 화장품 사용에 있어 비의도적인 노출이므로 아래 흐름도에 따라 흡입 노출평가가 필요한지\n\n<!-- PAGE_25 -->\n###### 여부를 결정할 수 있다(SCCS/1628/21, 2021).\n\n",
        "original_sentence": "<!-- PAGE_24 -->\n###### ① 단위면적당 피부흡수량(㎍/cm2)을 기초로 한 전신노출량(SED) 산출\n\n<!-- PAGE_24 -->\n###### ② 평가대상 물질의 피부흡수율(%)을 기초로 한 전신노출량(SED) 산출\n\n2 피부흡수율은 문헌에 보고된 값이나 실험값 중 신뢰성 있는 값을 선택하여 적용한다. "
      }
    },
    {
      "chunk_id": "chunk_228",
      "text": "다만,\n\n자료가 없는 경우 보수적으로 50%로 적용할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 227,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 2,
        "window_text": "<!-- PAGE_23 -->\n###### - 피부로 노출된 전신노출량(SED)은 제품 중 물질의 단위면적당 피부흡수량(mg/cm2) 또는\n\n<!-- PAGE_23 -->\n###### 피부흡수율(%)로부터 구할 수 있다.  피부흡수율을 이용하는 경우, 결과 값은 피부에 적용\n\n<!-- PAGE_23 -->\n###### 2) 피부흡수율(또는 흡수량)은 사용한도 또는 유사한 용량을 함유하는 제형(formulation)을 사\n\n<!-- PAGE_23 -->\n###### - 피부흡수율 자료가 없거나 기존에 보고된 자료가 적합하지 않을 경우, 기본값으로 50%를\n\n<!-- PAGE_23 -->\n###### - 생체외 피부흡수시험 결과는 가변성이 있기 때문에 일반적으로 인체노출량 계산 시 평균\n\n<!-- PAGE_23 -->\n###### 피부흡수시험 및 결과가 아래와 같은 시험요건의 적정성에 모두 부합하는 경우에 평균 +\n\n<!-- PAGE_23 -->\n###### 1SD를 사용하며, 프로토콜에서 벗어나거나 변동성이 높은 경우에는 평균 + 2SD를 사용한\n\n- - 18 -\n<!-- PAGE_24 -->\n###### 3) 피부노출에 의한 전신노출량(SED)은 두가지 방법으로 산출한다.\n\n <!-- PAGE_24 -->\n###### ① 단위면적당 피부흡수량(㎍/cm2)을 기초로 한 전신노출량(SED) 산출\n\n<!-- PAGE_24 -->\n###### ② 평가대상 물질의 피부흡수율(%)을 기초로 한 전신노출량(SED) 산출\n\n2 피부흡수율은 문헌에 보고된 값이나 실험값 중 신뢰성 있는 값을 선택하여 적용한다.  다만,\n\n자료가 없는 경우 보수적으로 50%로 적용할 수 있다.\n\n - - 19 -\n<!-- PAGE_25 -->\n###### 2-2-3-2 흡입 노출평가\n\n<!-- PAGE_25 -->\n###### 1) 화장품은 제형에 따라 분말, 증기, 에어로졸 등의 형태로 직접적으로 흡입되거나 제품 내\n\n<!-- PAGE_25 -->\n###### 휘발성분에 의해 피부에 남아 있는 성분이 공기 중으로 증발되어 흡입될 수 있다.  흡입은\n\n<!-- PAGE_25 -->\n###### 화장품 사용에 있어 비의도적인 노출이므로 아래 흐름도에 따라 흡입 노출평가가 필요한지\n\n<!-- PAGE_25 -->\n###### 여부를 결정할 수 있다(SCCS/1628/21, 2021).\n\n - - 20 -\n<!-- PAGE_26 -->\n###### ① 흡입 노출 가능성을 판단하기 위해서 평가하고자 하는 제품 내 성분의 자료 수집\n\n<!-- PAGE_26 -->\n###### (규정 성분(금지, 배합한도) 확인, 물리화학적 특성 검토)\n\n<!-- PAGE_26 -->\n###### ② 흡입을 통해 전신 및 국소 영향을 나타낼 수 있는 성분 확인\n\n<!-- PAGE_26 -->\n###### ③ 전신 및 국소 영향이 있는 것으로 확인된 성분에 대한 노출평가 수행\n\n<!-- PAGE_26 -->\n###### - 가장 최악의 시나리오를 고려하여, 단계적(tier) 평가 수행\n\n<!-- PAGE_26 -->\n###### - 스프레이 제품 모의시험을 통한 노출량 측정\n\n<!-- PAGE_26 -->\n###### ④ 스프레이 제품 내 포함된 성분의 농도를 확인하여, 무시할 수 있는 수준의 농도일 경우\n\n<!-- PAGE_26 -->\n###### 에는 흡입 노출평가를 수행하지 않으며, 흡입 노출량을 제외한 전신 노출량으로 위해도\n\n<!-- PAGE_26 -->\n###### ⑤ 위해평가 결과에 따라\n\n<!-- PAGE_26 -->\n###### - 위해 우려되지 않는 경우, 성분 정보를 포함한 위해평가 보고서 작성\n\n<!-- PAGE_26 -->\n###### - 위해 우려있는 경우, 사용 조건에 따른 스프레이 제품의 최종 입자 크기(또는 분포), 제\n\n<!-- PAGE_26 -->\n###### 품의 추진제 유형, 개별 성분의 농도 등이 흡입 노출에 영향을 미치므로 이에 대한 조\n\n<!-- PAGE_26 -->\n###### 2) 흡입노출량은 표준노출조건에서 직접 측정하거나 수학적 모델을 사용하여 추정할 수 있으\n\n<!-- PAGE_26 -->\n###### 며, 소비자안전과학위원회(Scientific Committee on Consumer Safety, SCCS), 유럽화학물질\n\n<!-- PAGE_26 -->\n###### 청(European Chemicals Agency, ECHA) 등 여러 국제기관에서 제시하고 있는 흡입 노출평\n\n- - 21 -\n<!-- PAGE_27 -->\n###### 2-2-4. ",
        "original_sentence": "다만,\n\n자료가 없는 경우 보수적으로 50%로 적용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_229",
      "text": "- - 19 -\n<!-- PAGE_25 -->\n###### 2-2-3-2 흡입 노출평가\n\n<!-- PAGE_25 -->\n###### 1) 화장품은 제형에 따라 분말, 증기, 에어로졸 등의 형태로 직접적으로 흡입되거나 제품 내\n\n<!-- PAGE_25 -->\n###### 휘발성분에 의해 피부에 남아 있는 성분이 공기 중으로 증발되어 흡입될 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 228,
        "window_size": 3,
        "char_count": 196,
        "word_count": 44,
        "page_number": 25,
        "window_text": "피부흡수율을 이용하는 경우, 결과 값은 피부에 적용\n\n<!-- PAGE_23 -->\n###### 2) 피부흡수율(또는 흡수량)은 사용한도 또는 유사한 용량을 함유하는 제형(formulation)을 사\n\n<!-- PAGE_23 -->\n###### - 피부흡수율 자료가 없거나 기존에 보고된 자료가 적합하지 않을 경우, 기본값으로 50%를\n\n<!-- PAGE_23 -->\n###### - 생체외 피부흡수시험 결과는 가변성이 있기 때문에 일반적으로 인체노출량 계산 시 평균\n\n<!-- PAGE_23 -->\n###### 피부흡수시험 및 결과가 아래와 같은 시험요건의 적정성에 모두 부합하는 경우에 평균 +\n\n<!-- PAGE_23 -->\n###### 1SD를 사용하며, 프로토콜에서 벗어나거나 변동성이 높은 경우에는 평균 + 2SD를 사용한\n\n- - 18 -\n<!-- PAGE_24 -->\n###### 3) 피부노출에 의한 전신노출량(SED)은 두가지 방법으로 산출한다.\n\n <!-- PAGE_24 -->\n###### ① 단위면적당 피부흡수량(㎍/cm2)을 기초로 한 전신노출량(SED) 산출\n\n<!-- PAGE_24 -->\n###### ② 평가대상 물질의 피부흡수율(%)을 기초로 한 전신노출량(SED) 산출\n\n2 피부흡수율은 문헌에 보고된 값이나 실험값 중 신뢰성 있는 값을 선택하여 적용한다.  다만,\n\n자료가 없는 경우 보수적으로 50%로 적용할 수 있다.\n\n - - 19 -\n<!-- PAGE_25 -->\n###### 2-2-3-2 흡입 노출평가\n\n<!-- PAGE_25 -->\n###### 1) 화장품은 제형에 따라 분말, 증기, 에어로졸 등의 형태로 직접적으로 흡입되거나 제품 내\n\n<!-- PAGE_25 -->\n###### 휘발성분에 의해 피부에 남아 있는 성분이 공기 중으로 증발되어 흡입될 수 있다.  흡입은\n\n<!-- PAGE_25 -->\n###### 화장품 사용에 있어 비의도적인 노출이므로 아래 흐름도에 따라 흡입 노출평가가 필요한지\n\n<!-- PAGE_25 -->\n###### 여부를 결정할 수 있다(SCCS/1628/21, 2021).\n\n - - 20 -\n<!-- PAGE_26 -->\n###### ① 흡입 노출 가능성을 판단하기 위해서 평가하고자 하는 제품 내 성분의 자료 수집\n\n<!-- PAGE_26 -->\n###### (규정 성분(금지, 배합한도) 확인, 물리화학적 특성 검토)\n\n<!-- PAGE_26 -->\n###### ② 흡입을 통해 전신 및 국소 영향을 나타낼 수 있는 성분 확인\n\n<!-- PAGE_26 -->\n###### ③ 전신 및 국소 영향이 있는 것으로 확인된 성분에 대한 노출평가 수행\n\n<!-- PAGE_26 -->\n###### - 가장 최악의 시나리오를 고려하여, 단계적(tier) 평가 수행\n\n<!-- PAGE_26 -->\n###### - 스프레이 제품 모의시험을 통한 노출량 측정\n\n<!-- PAGE_26 -->\n###### ④ 스프레이 제품 내 포함된 성분의 농도를 확인하여, 무시할 수 있는 수준의 농도일 경우\n\n<!-- PAGE_26 -->\n###### 에는 흡입 노출평가를 수행하지 않으며, 흡입 노출량을 제외한 전신 노출량으로 위해도\n\n<!-- PAGE_26 -->\n###### ⑤ 위해평가 결과에 따라\n\n<!-- PAGE_26 -->\n###### - 위해 우려되지 않는 경우, 성분 정보를 포함한 위해평가 보고서 작성\n\n<!-- PAGE_26 -->\n###### - 위해 우려있는 경우, 사용 조건에 따른 스프레이 제품의 최종 입자 크기(또는 분포), 제\n\n<!-- PAGE_26 -->\n###### 품의 추진제 유형, 개별 성분의 농도 등이 흡입 노출에 영향을 미치므로 이에 대한 조\n\n<!-- PAGE_26 -->\n###### 2) 흡입노출량은 표준노출조건에서 직접 측정하거나 수학적 모델을 사용하여 추정할 수 있으\n\n<!-- PAGE_26 -->\n###### 며, 소비자안전과학위원회(Scientific Committee on Consumer Safety, SCCS), 유럽화학물질\n\n<!-- PAGE_26 -->\n###### 청(European Chemicals Agency, ECHA) 등 여러 국제기관에서 제시하고 있는 흡입 노출평\n\n- - 21 -\n<!-- PAGE_27 -->\n###### 2-2-4.  위해도 결정\n\n<!-- PAGE_27 -->\n###### 1) 위험성 결정과 노출평가 결과 얻어진 노출량을 비교하여 노출에 따른 인체 위해영향 발생\n\n<!-- PAGE_27 -->\n###### 가능성을 추정하는 단계이다.\n\n",
        "original_sentence": "- - 19 -\n<!-- PAGE_25 -->\n###### 2-2-3-2 흡입 노출평가\n\n<!-- PAGE_25 -->\n###### 1) 화장품은 제형에 따라 분말, 증기, 에어로졸 등의 형태로 직접적으로 흡입되거나 제품 내\n\n<!-- PAGE_25 -->\n###### 휘발성분에 의해 피부에 남아 있는 성분이 공기 중으로 증발되어 흡입될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_230",
      "text": "흡입은\n\n<!-- PAGE_25 -->\n###### 화장품 사용에 있어 비의도적인 노출이므로 아래 흐름도에 따라 흡입 노출평가가 필요한지\n\n<!-- PAGE_25 -->\n###### 여부를 결정할 수 있다(SCCS/1628/21, 2021).\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 229,
        "window_size": 3,
        "char_count": 137,
        "word_count": 25,
        "page_number": 25,
        "window_text": "<!-- PAGE_24 -->\n###### ① 단위면적당 피부흡수량(㎍/cm2)을 기초로 한 전신노출량(SED) 산출\n\n<!-- PAGE_24 -->\n###### ② 평가대상 물질의 피부흡수율(%)을 기초로 한 전신노출량(SED) 산출\n\n2 피부흡수율은 문헌에 보고된 값이나 실험값 중 신뢰성 있는 값을 선택하여 적용한다.  다만,\n\n자료가 없는 경우 보수적으로 50%로 적용할 수 있다.\n\n - - 19 -\n<!-- PAGE_25 -->\n###### 2-2-3-2 흡입 노출평가\n\n<!-- PAGE_25 -->\n###### 1) 화장품은 제형에 따라 분말, 증기, 에어로졸 등의 형태로 직접적으로 흡입되거나 제품 내\n\n<!-- PAGE_25 -->\n###### 휘발성분에 의해 피부에 남아 있는 성분이 공기 중으로 증발되어 흡입될 수 있다.  흡입은\n\n<!-- PAGE_25 -->\n###### 화장품 사용에 있어 비의도적인 노출이므로 아래 흐름도에 따라 흡입 노출평가가 필요한지\n\n<!-- PAGE_25 -->\n###### 여부를 결정할 수 있다(SCCS/1628/21, 2021).\n\n - - 20 -\n<!-- PAGE_26 -->\n###### ① 흡입 노출 가능성을 판단하기 위해서 평가하고자 하는 제품 내 성분의 자료 수집\n\n<!-- PAGE_26 -->\n###### (규정 성분(금지, 배합한도) 확인, 물리화학적 특성 검토)\n\n<!-- PAGE_26 -->\n###### ② 흡입을 통해 전신 및 국소 영향을 나타낼 수 있는 성분 확인\n\n<!-- PAGE_26 -->\n###### ③ 전신 및 국소 영향이 있는 것으로 확인된 성분에 대한 노출평가 수행\n\n<!-- PAGE_26 -->\n###### - 가장 최악의 시나리오를 고려하여, 단계적(tier) 평가 수행\n\n<!-- PAGE_26 -->\n###### - 스프레이 제품 모의시험을 통한 노출량 측정\n\n<!-- PAGE_26 -->\n###### ④ 스프레이 제품 내 포함된 성분의 농도를 확인하여, 무시할 수 있는 수준의 농도일 경우\n\n<!-- PAGE_26 -->\n###### 에는 흡입 노출평가를 수행하지 않으며, 흡입 노출량을 제외한 전신 노출량으로 위해도\n\n<!-- PAGE_26 -->\n###### ⑤ 위해평가 결과에 따라\n\n<!-- PAGE_26 -->\n###### - 위해 우려되지 않는 경우, 성분 정보를 포함한 위해평가 보고서 작성\n\n<!-- PAGE_26 -->\n###### - 위해 우려있는 경우, 사용 조건에 따른 스프레이 제품의 최종 입자 크기(또는 분포), 제\n\n<!-- PAGE_26 -->\n###### 품의 추진제 유형, 개별 성분의 농도 등이 흡입 노출에 영향을 미치므로 이에 대한 조\n\n<!-- PAGE_26 -->\n###### 2) 흡입노출량은 표준노출조건에서 직접 측정하거나 수학적 모델을 사용하여 추정할 수 있으\n\n<!-- PAGE_26 -->\n###### 며, 소비자안전과학위원회(Scientific Committee on Consumer Safety, SCCS), 유럽화학물질\n\n<!-- PAGE_26 -->\n###### 청(European Chemicals Agency, ECHA) 등 여러 국제기관에서 제시하고 있는 흡입 노출평\n\n- - 21 -\n<!-- PAGE_27 -->\n###### 2-2-4.  위해도 결정\n\n<!-- PAGE_27 -->\n###### 1) 위험성 결정과 노출평가 결과 얻어진 노출량을 비교하여 노출에 따른 인체 위해영향 발생\n\n<!-- PAGE_27 -->\n###### 가능성을 추정하는 단계이다.\n\n <!-- PAGE_27 -->\n###### 2) 화장품 사용으로 인한 평가대상 물질의 노출로 인한 위해 영향을 야기할 가능성은 안전역\n\n<!-- PAGE_27 -->\n###### 3) 화장품 성분의 피부흡수가 매우 낮다는 충분한 증거가 있는 경우에는 전신 노출이 무시될 수\n\n<!-- PAGE_27 -->\n###### 있는 수준이므로, MOS 산출에 의한 위해도 결정은 가능하지 않으며 인체 위해영향 발생 가\n\n<!-- PAGE_27 -->\n###### 4) 위해도 결정을 수행할 때, 불확실성 계수를 적용하여 안전역(MOS)을 산출한다.\n\n",
        "original_sentence": "흡입은\n\n<!-- PAGE_25 -->\n###### 화장품 사용에 있어 비의도적인 노출이므로 아래 흐름도에 따라 흡입 노출평가가 필요한지\n\n<!-- PAGE_25 -->\n###### 여부를 결정할 수 있다(SCCS/1628/21, 2021).\n\n"
      }
    },
    {
      "chunk_id": "chunk_231",
      "text": "- - 20 -\n<!-- PAGE_26 -->\n###### ① 흡입 노출 가능성을 판단하기 위해서 평가하고자 하는 제품 내 성분의 자료 수집\n\n<!-- PAGE_26 -->\n###### (규정 성분(금지, 배합한도) 확인, 물리화학적 특성 검토)\n\n<!-- PAGE_26 -->\n###### ② 흡입을 통해 전신 및 국소 영향을 나타낼 수 있는 성분 확인\n\n<!-- PAGE_26 -->\n###### ③ 전신 및 국소 영향이 있는 것으로 확인된 성분에 대한 노출평가 수행\n\n<!-- PAGE_26 -->\n###### - 가장 최악의 시나리오를 고려하여, 단계적(tier) 평가 수행\n\n<!-- PAGE_26 -->\n###### - 스프레이 제품 모의시험을 통한 노출량 측정\n\n<!-- PAGE_26 -->\n###### ④ 스프레이 제품 내 포함된 성분의 농도를 확인하여, 무시할 수 있는 수준의 농도일 경우\n\n<!-- PAGE_26 -->\n###### 에는 흡입 노출평가를 수행하지 않으며, 흡입 노출량을 제외한 전신 노출량으로 위해도\n\n<!-- PAGE_26 -->\n###### ⑤ 위해평가 결과에 따라\n\n<!-- PAGE_26 -->\n###### - 위해 우려되지 않는 경우, 성분 정보를 포함한 위해평가 보고서 작성\n\n<!-- PAGE_26 -->\n###### - 위해 우려있는 경우, 사용 조건에 따른 스프레이 제품의 최종 입자 크기(또는 분포), 제\n\n<!-- PAGE_26 -->\n###### 품의 추진제 유형, 개별 성분의 농도 등이 흡입 노출에 영향을 미치므로 이에 대한 조\n\n<!-- PAGE_26 -->\n###### 2) 흡입노출량은 표준노출조건에서 직접 측정하거나 수학적 모델을 사용하여 추정할 수 있으\n\n<!-- PAGE_26 -->\n###### 며, 소비자안전과학위원회(Scientific Committee on Consumer Safety, SCCS), 유럽화학물질\n\n<!-- PAGE_26 -->\n###### 청(European Chemicals Agency, ECHA) 등 여러 국제기관에서 제시하고 있는 흡입 노출평\n\n- - 21 -\n<!-- PAGE_27 -->\n###### 2-2-4. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 230,
        "window_size": 3,
        "char_count": 1075,
        "word_count": 230,
        "page_number": 26,
        "window_text": "다만,\n\n자료가 없는 경우 보수적으로 50%로 적용할 수 있다.\n\n - - 19 -\n<!-- PAGE_25 -->\n###### 2-2-3-2 흡입 노출평가\n\n<!-- PAGE_25 -->\n###### 1) 화장품은 제형에 따라 분말, 증기, 에어로졸 등의 형태로 직접적으로 흡입되거나 제품 내\n\n<!-- PAGE_25 -->\n###### 휘발성분에 의해 피부에 남아 있는 성분이 공기 중으로 증발되어 흡입될 수 있다.  흡입은\n\n<!-- PAGE_25 -->\n###### 화장품 사용에 있어 비의도적인 노출이므로 아래 흐름도에 따라 흡입 노출평가가 필요한지\n\n<!-- PAGE_25 -->\n###### 여부를 결정할 수 있다(SCCS/1628/21, 2021).\n\n - - 20 -\n<!-- PAGE_26 -->\n###### ① 흡입 노출 가능성을 판단하기 위해서 평가하고자 하는 제품 내 성분의 자료 수집\n\n<!-- PAGE_26 -->\n###### (규정 성분(금지, 배합한도) 확인, 물리화학적 특성 검토)\n\n<!-- PAGE_26 -->\n###### ② 흡입을 통해 전신 및 국소 영향을 나타낼 수 있는 성분 확인\n\n<!-- PAGE_26 -->\n###### ③ 전신 및 국소 영향이 있는 것으로 확인된 성분에 대한 노출평가 수행\n\n<!-- PAGE_26 -->\n###### - 가장 최악의 시나리오를 고려하여, 단계적(tier) 평가 수행\n\n<!-- PAGE_26 -->\n###### - 스프레이 제품 모의시험을 통한 노출량 측정\n\n<!-- PAGE_26 -->\n###### ④ 스프레이 제품 내 포함된 성분의 농도를 확인하여, 무시할 수 있는 수준의 농도일 경우\n\n<!-- PAGE_26 -->\n###### 에는 흡입 노출평가를 수행하지 않으며, 흡입 노출량을 제외한 전신 노출량으로 위해도\n\n<!-- PAGE_26 -->\n###### ⑤ 위해평가 결과에 따라\n\n<!-- PAGE_26 -->\n###### - 위해 우려되지 않는 경우, 성분 정보를 포함한 위해평가 보고서 작성\n\n<!-- PAGE_26 -->\n###### - 위해 우려있는 경우, 사용 조건에 따른 스프레이 제품의 최종 입자 크기(또는 분포), 제\n\n<!-- PAGE_26 -->\n###### 품의 추진제 유형, 개별 성분의 농도 등이 흡입 노출에 영향을 미치므로 이에 대한 조\n\n<!-- PAGE_26 -->\n###### 2) 흡입노출량은 표준노출조건에서 직접 측정하거나 수학적 모델을 사용하여 추정할 수 있으\n\n<!-- PAGE_26 -->\n###### 며, 소비자안전과학위원회(Scientific Committee on Consumer Safety, SCCS), 유럽화학물질\n\n<!-- PAGE_26 -->\n###### 청(European Chemicals Agency, ECHA) 등 여러 국제기관에서 제시하고 있는 흡입 노출평\n\n- - 21 -\n<!-- PAGE_27 -->\n###### 2-2-4.  위해도 결정\n\n<!-- PAGE_27 -->\n###### 1) 위험성 결정과 노출평가 결과 얻어진 노출량을 비교하여 노출에 따른 인체 위해영향 발생\n\n<!-- PAGE_27 -->\n###### 가능성을 추정하는 단계이다.\n\n <!-- PAGE_27 -->\n###### 2) 화장품 사용으로 인한 평가대상 물질의 노출로 인한 위해 영향을 야기할 가능성은 안전역\n\n<!-- PAGE_27 -->\n###### 3) 화장품 성분의 피부흡수가 매우 낮다는 충분한 증거가 있는 경우에는 전신 노출이 무시될 수\n\n<!-- PAGE_27 -->\n###### 있는 수준이므로, MOS 산출에 의한 위해도 결정은 가능하지 않으며 인체 위해영향 발생 가\n\n<!-- PAGE_27 -->\n###### 4) 위해도 결정을 수행할 때, 불확실성 계수를 적용하여 안전역(MOS)을 산출한다.\n\n <!-- PAGE_27 -->\n###### 5) 화장품 성분의 경우, 위험성 결정에서 확인된 평가 대상 물질의 전신 독성기준값(PODsys)을\n\n<!-- PAGE_27 -->\n###### 6) 일반적으로 안전역(MOS)은 종(실험동물에서 사람), 사람(일반 사람과 취약 집단) 간의 외삽\n\n<!-- PAGE_27 -->\n###### 과정을 통해 산출된 MOS 값이 100(동물-사람 종간 계수 10 × 사람간 계수 10) 이상이면\n\n- 4.0\n- 2.5\n- 3.2\n- 3.2\n- - 22 -\n<!-- PAGE_28 -->\n###### □ 위해도 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 비발암물질(역치물질)인 경우, 안전역(MOS)\n산출\n\n- ○ 최적의 독성기준값(PODsys)과 전신노출량\n(SED) 비교\n\n- - 23 -\n<!-- PAGE_29 -->\n###### 3. ",
        "original_sentence": "- - 20 -\n<!-- PAGE_26 -->\n###### ① 흡입 노출 가능성을 판단하기 위해서 평가하고자 하는 제품 내 성분의 자료 수집\n\n<!-- PAGE_26 -->\n###### (규정 성분(금지, 배합한도) 확인, 물리화학적 특성 검토)\n\n<!-- PAGE_26 -->\n###### ② 흡입을 통해 전신 및 국소 영향을 나타낼 수 있는 성분 확인\n\n<!-- PAGE_26 -->\n###### ③ 전신 및 국소 영향이 있는 것으로 확인된 성분에 대한 노출평가 수행\n\n<!-- PAGE_26 -->\n###### - 가장 최악의 시나리오를 고려하여, 단계적(tier) 평가 수행\n\n<!-- PAGE_26 -->\n###### - 스프레이 제품 모의시험을 통한 노출량 측정\n\n<!-- PAGE_26 -->\n###### ④ 스프레이 제품 내 포함된 성분의 농도를 확인하여, 무시할 수 있는 수준의 농도일 경우\n\n<!-- PAGE_26 -->\n###### 에는 흡입 노출평가를 수행하지 않으며, 흡입 노출량을 제외한 전신 노출량으로 위해도\n\n<!-- PAGE_26 -->\n###### ⑤ 위해평가 결과에 따라\n\n<!-- PAGE_26 -->\n###### - 위해 우려되지 않는 경우, 성분 정보를 포함한 위해평가 보고서 작성\n\n<!-- PAGE_26 -->\n###### - 위해 우려있는 경우, 사용 조건에 따른 스프레이 제품의 최종 입자 크기(또는 분포), 제\n\n<!-- PAGE_26 -->\n###### 품의 추진제 유형, 개별 성분의 농도 등이 흡입 노출에 영향을 미치므로 이에 대한 조\n\n<!-- PAGE_26 -->\n###### 2) 흡입노출량은 표준노출조건에서 직접 측정하거나 수학적 모델을 사용하여 추정할 수 있으\n\n<!-- PAGE_26 -->\n###### 며, 소비자안전과학위원회(Scientific Committee on Consumer Safety, SCCS), 유럽화학물질\n\n<!-- PAGE_26 -->\n###### 청(European Chemicals Agency, ECHA) 등 여러 국제기관에서 제시하고 있는 흡입 노출평\n\n- - 21 -\n<!-- PAGE_27 -->\n###### 2-2-4. "
      }
    },
    {
      "chunk_id": "chunk_232",
      "text": "위해도 결정\n\n<!-- PAGE_27 -->\n###### 1) 위험성 결정과 노출평가 결과 얻어진 노출량을 비교하여 노출에 따른 인체 위해영향 발생\n\n<!-- PAGE_27 -->\n###### 가능성을 추정하는 단계이다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 231,
        "window_size": 3,
        "char_count": 125,
        "word_count": 26,
        "page_number": 27,
        "window_text": "- - 19 -\n<!-- PAGE_25 -->\n###### 2-2-3-2 흡입 노출평가\n\n<!-- PAGE_25 -->\n###### 1) 화장품은 제형에 따라 분말, 증기, 에어로졸 등의 형태로 직접적으로 흡입되거나 제품 내\n\n<!-- PAGE_25 -->\n###### 휘발성분에 의해 피부에 남아 있는 성분이 공기 중으로 증발되어 흡입될 수 있다.  흡입은\n\n<!-- PAGE_25 -->\n###### 화장품 사용에 있어 비의도적인 노출이므로 아래 흐름도에 따라 흡입 노출평가가 필요한지\n\n<!-- PAGE_25 -->\n###### 여부를 결정할 수 있다(SCCS/1628/21, 2021).\n\n - - 20 -\n<!-- PAGE_26 -->\n###### ① 흡입 노출 가능성을 판단하기 위해서 평가하고자 하는 제품 내 성분의 자료 수집\n\n<!-- PAGE_26 -->\n###### (규정 성분(금지, 배합한도) 확인, 물리화학적 특성 검토)\n\n<!-- PAGE_26 -->\n###### ② 흡입을 통해 전신 및 국소 영향을 나타낼 수 있는 성분 확인\n\n<!-- PAGE_26 -->\n###### ③ 전신 및 국소 영향이 있는 것으로 확인된 성분에 대한 노출평가 수행\n\n<!-- PAGE_26 -->\n###### - 가장 최악의 시나리오를 고려하여, 단계적(tier) 평가 수행\n\n<!-- PAGE_26 -->\n###### - 스프레이 제품 모의시험을 통한 노출량 측정\n\n<!-- PAGE_26 -->\n###### ④ 스프레이 제품 내 포함된 성분의 농도를 확인하여, 무시할 수 있는 수준의 농도일 경우\n\n<!-- PAGE_26 -->\n###### 에는 흡입 노출평가를 수행하지 않으며, 흡입 노출량을 제외한 전신 노출량으로 위해도\n\n<!-- PAGE_26 -->\n###### ⑤ 위해평가 결과에 따라\n\n<!-- PAGE_26 -->\n###### - 위해 우려되지 않는 경우, 성분 정보를 포함한 위해평가 보고서 작성\n\n<!-- PAGE_26 -->\n###### - 위해 우려있는 경우, 사용 조건에 따른 스프레이 제품의 최종 입자 크기(또는 분포), 제\n\n<!-- PAGE_26 -->\n###### 품의 추진제 유형, 개별 성분의 농도 등이 흡입 노출에 영향을 미치므로 이에 대한 조\n\n<!-- PAGE_26 -->\n###### 2) 흡입노출량은 표준노출조건에서 직접 측정하거나 수학적 모델을 사용하여 추정할 수 있으\n\n<!-- PAGE_26 -->\n###### 며, 소비자안전과학위원회(Scientific Committee on Consumer Safety, SCCS), 유럽화학물질\n\n<!-- PAGE_26 -->\n###### 청(European Chemicals Agency, ECHA) 등 여러 국제기관에서 제시하고 있는 흡입 노출평\n\n- - 21 -\n<!-- PAGE_27 -->\n###### 2-2-4.  위해도 결정\n\n<!-- PAGE_27 -->\n###### 1) 위험성 결정과 노출평가 결과 얻어진 노출량을 비교하여 노출에 따른 인체 위해영향 발생\n\n<!-- PAGE_27 -->\n###### 가능성을 추정하는 단계이다.\n\n <!-- PAGE_27 -->\n###### 2) 화장품 사용으로 인한 평가대상 물질의 노출로 인한 위해 영향을 야기할 가능성은 안전역\n\n<!-- PAGE_27 -->\n###### 3) 화장품 성분의 피부흡수가 매우 낮다는 충분한 증거가 있는 경우에는 전신 노출이 무시될 수\n\n<!-- PAGE_27 -->\n###### 있는 수준이므로, MOS 산출에 의한 위해도 결정은 가능하지 않으며 인체 위해영향 발생 가\n\n<!-- PAGE_27 -->\n###### 4) 위해도 결정을 수행할 때, 불확실성 계수를 적용하여 안전역(MOS)을 산출한다.\n\n <!-- PAGE_27 -->\n###### 5) 화장품 성분의 경우, 위험성 결정에서 확인된 평가 대상 물질의 전신 독성기준값(PODsys)을\n\n<!-- PAGE_27 -->\n###### 6) 일반적으로 안전역(MOS)은 종(실험동물에서 사람), 사람(일반 사람과 취약 집단) 간의 외삽\n\n<!-- PAGE_27 -->\n###### 과정을 통해 산출된 MOS 값이 100(동물-사람 종간 계수 10 × 사람간 계수 10) 이상이면\n\n- 4.0\n- 2.5\n- 3.2\n- 3.2\n- - 22 -\n<!-- PAGE_28 -->\n###### □ 위해도 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 비발암물질(역치물질)인 경우, 안전역(MOS)\n산출\n\n- ○ 최적의 독성기준값(PODsys)과 전신노출량\n(SED) 비교\n\n- - 23 -\n<!-- PAGE_29 -->\n###### 3.  위해평가 보고서\n\n<!-- PAGE_29 -->\n###### 전체적인 위해평가 절차를 체계적으로 명확하게 작성한다. ",
        "original_sentence": "위해도 결정\n\n<!-- PAGE_27 -->\n###### 1) 위험성 결정과 노출평가 결과 얻어진 노출량을 비교하여 노출에 따른 인체 위해영향 발생\n\n<!-- PAGE_27 -->\n###### 가능성을 추정하는 단계이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_233",
      "text": "<!-- PAGE_27 -->\n###### 2) 화장품 사용으로 인한 평가대상 물질의 노출로 인한 위해 영향을 야기할 가능성은 안전역\n\n<!-- PAGE_27 -->\n###### 3) 화장품 성분의 피부흡수가 매우 낮다는 충분한 증거가 있는 경우에는 전신 노출이 무시될 수\n\n<!-- PAGE_27 -->\n###### 있는 수준이므로, MOS 산출에 의한 위해도 결정은 가능하지 않으며 인체 위해영향 발생 가\n\n<!-- PAGE_27 -->\n###### 4) 위해도 결정을 수행할 때, 불확실성 계수를 적용하여 안전역(MOS)을 산출한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 232,
        "window_size": 3,
        "char_count": 303,
        "word_count": 66,
        "page_number": 27,
        "window_text": "흡입은\n\n<!-- PAGE_25 -->\n###### 화장품 사용에 있어 비의도적인 노출이므로 아래 흐름도에 따라 흡입 노출평가가 필요한지\n\n<!-- PAGE_25 -->\n###### 여부를 결정할 수 있다(SCCS/1628/21, 2021).\n\n - - 20 -\n<!-- PAGE_26 -->\n###### ① 흡입 노출 가능성을 판단하기 위해서 평가하고자 하는 제품 내 성분의 자료 수집\n\n<!-- PAGE_26 -->\n###### (규정 성분(금지, 배합한도) 확인, 물리화학적 특성 검토)\n\n<!-- PAGE_26 -->\n###### ② 흡입을 통해 전신 및 국소 영향을 나타낼 수 있는 성분 확인\n\n<!-- PAGE_26 -->\n###### ③ 전신 및 국소 영향이 있는 것으로 확인된 성분에 대한 노출평가 수행\n\n<!-- PAGE_26 -->\n###### - 가장 최악의 시나리오를 고려하여, 단계적(tier) 평가 수행\n\n<!-- PAGE_26 -->\n###### - 스프레이 제품 모의시험을 통한 노출량 측정\n\n<!-- PAGE_26 -->\n###### ④ 스프레이 제품 내 포함된 성분의 농도를 확인하여, 무시할 수 있는 수준의 농도일 경우\n\n<!-- PAGE_26 -->\n###### 에는 흡입 노출평가를 수행하지 않으며, 흡입 노출량을 제외한 전신 노출량으로 위해도\n\n<!-- PAGE_26 -->\n###### ⑤ 위해평가 결과에 따라\n\n<!-- PAGE_26 -->\n###### - 위해 우려되지 않는 경우, 성분 정보를 포함한 위해평가 보고서 작성\n\n<!-- PAGE_26 -->\n###### - 위해 우려있는 경우, 사용 조건에 따른 스프레이 제품의 최종 입자 크기(또는 분포), 제\n\n<!-- PAGE_26 -->\n###### 품의 추진제 유형, 개별 성분의 농도 등이 흡입 노출에 영향을 미치므로 이에 대한 조\n\n<!-- PAGE_26 -->\n###### 2) 흡입노출량은 표준노출조건에서 직접 측정하거나 수학적 모델을 사용하여 추정할 수 있으\n\n<!-- PAGE_26 -->\n###### 며, 소비자안전과학위원회(Scientific Committee on Consumer Safety, SCCS), 유럽화학물질\n\n<!-- PAGE_26 -->\n###### 청(European Chemicals Agency, ECHA) 등 여러 국제기관에서 제시하고 있는 흡입 노출평\n\n- - 21 -\n<!-- PAGE_27 -->\n###### 2-2-4.  위해도 결정\n\n<!-- PAGE_27 -->\n###### 1) 위험성 결정과 노출평가 결과 얻어진 노출량을 비교하여 노출에 따른 인체 위해영향 발생\n\n<!-- PAGE_27 -->\n###### 가능성을 추정하는 단계이다.\n\n <!-- PAGE_27 -->\n###### 2) 화장품 사용으로 인한 평가대상 물질의 노출로 인한 위해 영향을 야기할 가능성은 안전역\n\n<!-- PAGE_27 -->\n###### 3) 화장품 성분의 피부흡수가 매우 낮다는 충분한 증거가 있는 경우에는 전신 노출이 무시될 수\n\n<!-- PAGE_27 -->\n###### 있는 수준이므로, MOS 산출에 의한 위해도 결정은 가능하지 않으며 인체 위해영향 발생 가\n\n<!-- PAGE_27 -->\n###### 4) 위해도 결정을 수행할 때, 불확실성 계수를 적용하여 안전역(MOS)을 산출한다.\n\n <!-- PAGE_27 -->\n###### 5) 화장품 성분의 경우, 위험성 결정에서 확인된 평가 대상 물질의 전신 독성기준값(PODsys)을\n\n<!-- PAGE_27 -->\n###### 6) 일반적으로 안전역(MOS)은 종(실험동물에서 사람), 사람(일반 사람과 취약 집단) 간의 외삽\n\n<!-- PAGE_27 -->\n###### 과정을 통해 산출된 MOS 값이 100(동물-사람 종간 계수 10 × 사람간 계수 10) 이상이면\n\n- 4.0\n- 2.5\n- 3.2\n- 3.2\n- - 22 -\n<!-- PAGE_28 -->\n###### □ 위해도 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 비발암물질(역치물질)인 경우, 안전역(MOS)\n산출\n\n- ○ 최적의 독성기준값(PODsys)과 전신노출량\n(SED) 비교\n\n- - 23 -\n<!-- PAGE_29 -->\n###### 3.  위해평가 보고서\n\n<!-- PAGE_29 -->\n###### 전체적인 위해평가 절차를 체계적으로 명확하게 작성한다.  문서에는 아래의 내용을 참고하여\n\n<!-- PAGE_29 -->\n###### 위해평가에 대한 상세 자료가 포함되고, 제한점, 외국 평가 사례 등에 대하여 기술한다.\n\n",
        "original_sentence": "<!-- PAGE_27 -->\n###### 2) 화장품 사용으로 인한 평가대상 물질의 노출로 인한 위해 영향을 야기할 가능성은 안전역\n\n<!-- PAGE_27 -->\n###### 3) 화장품 성분의 피부흡수가 매우 낮다는 충분한 증거가 있는 경우에는 전신 노출이 무시될 수\n\n<!-- PAGE_27 -->\n###### 있는 수준이므로, MOS 산출에 의한 위해도 결정은 가능하지 않으며 인체 위해영향 발생 가\n\n<!-- PAGE_27 -->\n###### 4) 위해도 결정을 수행할 때, 불확실성 계수를 적용하여 안전역(MOS)을 산출한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_234",
      "text": "<!-- PAGE_27 -->\n###### 5) 화장품 성분의 경우, 위험성 결정에서 확인된 평가 대상 물질의 전신 독성기준값(PODsys)을\n\n<!-- PAGE_27 -->\n###### 6) 일반적으로 안전역(MOS)은 종(실험동물에서 사람), 사람(일반 사람과 취약 집단) 간의 외삽\n\n<!-- PAGE_27 -->\n###### 과정을 통해 산출된 MOS 값이 100(동물-사람 종간 계수 10 × 사람간 계수 10) 이상이면\n\n- 4.0\n- 2.5\n- 3.2\n- 3.2\n- - 22 -\n<!-- PAGE_28 -->\n###### □ 위해도 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 비발암물질(역치물질)인 경우, 안전역(MOS)\n산출\n\n- ○ 최적의 독성기준값(PODsys)과 전신노출량\n(SED) 비교\n\n- - 23 -\n<!-- PAGE_29 -->\n###### 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 233,
        "window_size": 3,
        "char_count": 433,
        "word_count": 93,
        "page_number": 27,
        "window_text": "- - 20 -\n<!-- PAGE_26 -->\n###### ① 흡입 노출 가능성을 판단하기 위해서 평가하고자 하는 제품 내 성분의 자료 수집\n\n<!-- PAGE_26 -->\n###### (규정 성분(금지, 배합한도) 확인, 물리화학적 특성 검토)\n\n<!-- PAGE_26 -->\n###### ② 흡입을 통해 전신 및 국소 영향을 나타낼 수 있는 성분 확인\n\n<!-- PAGE_26 -->\n###### ③ 전신 및 국소 영향이 있는 것으로 확인된 성분에 대한 노출평가 수행\n\n<!-- PAGE_26 -->\n###### - 가장 최악의 시나리오를 고려하여, 단계적(tier) 평가 수행\n\n<!-- PAGE_26 -->\n###### - 스프레이 제품 모의시험을 통한 노출량 측정\n\n<!-- PAGE_26 -->\n###### ④ 스프레이 제품 내 포함된 성분의 농도를 확인하여, 무시할 수 있는 수준의 농도일 경우\n\n<!-- PAGE_26 -->\n###### 에는 흡입 노출평가를 수행하지 않으며, 흡입 노출량을 제외한 전신 노출량으로 위해도\n\n<!-- PAGE_26 -->\n###### ⑤ 위해평가 결과에 따라\n\n<!-- PAGE_26 -->\n###### - 위해 우려되지 않는 경우, 성분 정보를 포함한 위해평가 보고서 작성\n\n<!-- PAGE_26 -->\n###### - 위해 우려있는 경우, 사용 조건에 따른 스프레이 제품의 최종 입자 크기(또는 분포), 제\n\n<!-- PAGE_26 -->\n###### 품의 추진제 유형, 개별 성분의 농도 등이 흡입 노출에 영향을 미치므로 이에 대한 조\n\n<!-- PAGE_26 -->\n###### 2) 흡입노출량은 표준노출조건에서 직접 측정하거나 수학적 모델을 사용하여 추정할 수 있으\n\n<!-- PAGE_26 -->\n###### 며, 소비자안전과학위원회(Scientific Committee on Consumer Safety, SCCS), 유럽화학물질\n\n<!-- PAGE_26 -->\n###### 청(European Chemicals Agency, ECHA) 등 여러 국제기관에서 제시하고 있는 흡입 노출평\n\n- - 21 -\n<!-- PAGE_27 -->\n###### 2-2-4.  위해도 결정\n\n<!-- PAGE_27 -->\n###### 1) 위험성 결정과 노출평가 결과 얻어진 노출량을 비교하여 노출에 따른 인체 위해영향 발생\n\n<!-- PAGE_27 -->\n###### 가능성을 추정하는 단계이다.\n\n <!-- PAGE_27 -->\n###### 2) 화장품 사용으로 인한 평가대상 물질의 노출로 인한 위해 영향을 야기할 가능성은 안전역\n\n<!-- PAGE_27 -->\n###### 3) 화장품 성분의 피부흡수가 매우 낮다는 충분한 증거가 있는 경우에는 전신 노출이 무시될 수\n\n<!-- PAGE_27 -->\n###### 있는 수준이므로, MOS 산출에 의한 위해도 결정은 가능하지 않으며 인체 위해영향 발생 가\n\n<!-- PAGE_27 -->\n###### 4) 위해도 결정을 수행할 때, 불확실성 계수를 적용하여 안전역(MOS)을 산출한다.\n\n <!-- PAGE_27 -->\n###### 5) 화장품 성분의 경우, 위험성 결정에서 확인된 평가 대상 물질의 전신 독성기준값(PODsys)을\n\n<!-- PAGE_27 -->\n###### 6) 일반적으로 안전역(MOS)은 종(실험동물에서 사람), 사람(일반 사람과 취약 집단) 간의 외삽\n\n<!-- PAGE_27 -->\n###### 과정을 통해 산출된 MOS 값이 100(동물-사람 종간 계수 10 × 사람간 계수 10) 이상이면\n\n- 4.0\n- 2.5\n- 3.2\n- 3.2\n- - 22 -\n<!-- PAGE_28 -->\n###### □ 위해도 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 비발암물질(역치물질)인 경우, 안전역(MOS)\n산출\n\n- ○ 최적의 독성기준값(PODsys)과 전신노출량\n(SED) 비교\n\n- - 23 -\n<!-- PAGE_29 -->\n###### 3.  위해평가 보고서\n\n<!-- PAGE_29 -->\n###### 전체적인 위해평가 절차를 체계적으로 명확하게 작성한다.  문서에는 아래의 내용을 참고하여\n\n<!-- PAGE_29 -->\n###### 위해평가에 대한 상세 자료가 포함되고, 제한점, 외국 평가 사례 등에 대하여 기술한다.\n\n <!-- PAGE_29 -->\n###### □ 결과보고서 작성 방법\n\n- - 24 -\n<!-- PAGE_30 -->\n##### 제4장 참고문헌\n\n<!-- PAGE_30 -->\n###### 1. ",
        "original_sentence": "<!-- PAGE_27 -->\n###### 5) 화장품 성분의 경우, 위험성 결정에서 확인된 평가 대상 물질의 전신 독성기준값(PODsys)을\n\n<!-- PAGE_27 -->\n###### 6) 일반적으로 안전역(MOS)은 종(실험동물에서 사람), 사람(일반 사람과 취약 집단) 간의 외삽\n\n<!-- PAGE_27 -->\n###### 과정을 통해 산출된 MOS 값이 100(동물-사람 종간 계수 10 × 사람간 계수 10) 이상이면\n\n- 4.0\n- 2.5\n- 3.2\n- 3.2\n- - 22 -\n<!-- PAGE_28 -->\n###### □ 위해도 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 비발암물질(역치물질)인 경우, 안전역(MOS)\n산출\n\n- ○ 최적의 독성기준값(PODsys)과 전신노출량\n(SED) 비교\n\n- - 23 -\n<!-- PAGE_29 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_235",
      "text": "위해평가 보고서\n\n<!-- PAGE_29 -->\n###### 전체적인 위해평가 절차를 체계적으로 명확하게 작성한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 234,
        "window_size": 3,
        "char_count": 65,
        "word_count": 12,
        "page_number": 29,
        "window_text": "위해도 결정\n\n<!-- PAGE_27 -->\n###### 1) 위험성 결정과 노출평가 결과 얻어진 노출량을 비교하여 노출에 따른 인체 위해영향 발생\n\n<!-- PAGE_27 -->\n###### 가능성을 추정하는 단계이다.\n\n <!-- PAGE_27 -->\n###### 2) 화장품 사용으로 인한 평가대상 물질의 노출로 인한 위해 영향을 야기할 가능성은 안전역\n\n<!-- PAGE_27 -->\n###### 3) 화장품 성분의 피부흡수가 매우 낮다는 충분한 증거가 있는 경우에는 전신 노출이 무시될 수\n\n<!-- PAGE_27 -->\n###### 있는 수준이므로, MOS 산출에 의한 위해도 결정은 가능하지 않으며 인체 위해영향 발생 가\n\n<!-- PAGE_27 -->\n###### 4) 위해도 결정을 수행할 때, 불확실성 계수를 적용하여 안전역(MOS)을 산출한다.\n\n <!-- PAGE_27 -->\n###### 5) 화장품 성분의 경우, 위험성 결정에서 확인된 평가 대상 물질의 전신 독성기준값(PODsys)을\n\n<!-- PAGE_27 -->\n###### 6) 일반적으로 안전역(MOS)은 종(실험동물에서 사람), 사람(일반 사람과 취약 집단) 간의 외삽\n\n<!-- PAGE_27 -->\n###### 과정을 통해 산출된 MOS 값이 100(동물-사람 종간 계수 10 × 사람간 계수 10) 이상이면\n\n- 4.0\n- 2.5\n- 3.2\n- 3.2\n- - 22 -\n<!-- PAGE_28 -->\n###### □ 위해도 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 비발암물질(역치물질)인 경우, 안전역(MOS)\n산출\n\n- ○ 최적의 독성기준값(PODsys)과 전신노출량\n(SED) 비교\n\n- - 23 -\n<!-- PAGE_29 -->\n###### 3.  위해평가 보고서\n\n<!-- PAGE_29 -->\n###### 전체적인 위해평가 절차를 체계적으로 명확하게 작성한다.  문서에는 아래의 내용을 참고하여\n\n<!-- PAGE_29 -->\n###### 위해평가에 대한 상세 자료가 포함되고, 제한점, 외국 평가 사례 등에 대하여 기술한다.\n\n <!-- PAGE_29 -->\n###### □ 결과보고서 작성 방법\n\n- - 24 -\n<!-- PAGE_30 -->\n##### 제4장 참고문헌\n\n<!-- PAGE_30 -->\n###### 1.  SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 9th Revision\n\n<!-- PAGE_30 -->\n###### 2. ",
        "original_sentence": "위해평가 보고서\n\n<!-- PAGE_29 -->\n###### 전체적인 위해평가 절차를 체계적으로 명확하게 작성한다. "
      }
    },
    {
      "chunk_id": "chunk_236",
      "text": "문서에는 아래의 내용을 참고하여\n\n<!-- PAGE_29 -->\n###### 위해평가에 대한 상세 자료가 포함되고, 제한점, 외국 평가 사례 등에 대하여 기술한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 235,
        "window_size": 3,
        "char_count": 93,
        "word_count": 20,
        "page_number": 29,
        "window_text": "<!-- PAGE_27 -->\n###### 2) 화장품 사용으로 인한 평가대상 물질의 노출로 인한 위해 영향을 야기할 가능성은 안전역\n\n<!-- PAGE_27 -->\n###### 3) 화장품 성분의 피부흡수가 매우 낮다는 충분한 증거가 있는 경우에는 전신 노출이 무시될 수\n\n<!-- PAGE_27 -->\n###### 있는 수준이므로, MOS 산출에 의한 위해도 결정은 가능하지 않으며 인체 위해영향 발생 가\n\n<!-- PAGE_27 -->\n###### 4) 위해도 결정을 수행할 때, 불확실성 계수를 적용하여 안전역(MOS)을 산출한다.\n\n <!-- PAGE_27 -->\n###### 5) 화장품 성분의 경우, 위험성 결정에서 확인된 평가 대상 물질의 전신 독성기준값(PODsys)을\n\n<!-- PAGE_27 -->\n###### 6) 일반적으로 안전역(MOS)은 종(실험동물에서 사람), 사람(일반 사람과 취약 집단) 간의 외삽\n\n<!-- PAGE_27 -->\n###### 과정을 통해 산출된 MOS 값이 100(동물-사람 종간 계수 10 × 사람간 계수 10) 이상이면\n\n- 4.0\n- 2.5\n- 3.2\n- 3.2\n- - 22 -\n<!-- PAGE_28 -->\n###### □ 위해도 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 비발암물질(역치물질)인 경우, 안전역(MOS)\n산출\n\n- ○ 최적의 독성기준값(PODsys)과 전신노출량\n(SED) 비교\n\n- - 23 -\n<!-- PAGE_29 -->\n###### 3.  위해평가 보고서\n\n<!-- PAGE_29 -->\n###### 전체적인 위해평가 절차를 체계적으로 명확하게 작성한다.  문서에는 아래의 내용을 참고하여\n\n<!-- PAGE_29 -->\n###### 위해평가에 대한 상세 자료가 포함되고, 제한점, 외국 평가 사례 등에 대하여 기술한다.\n\n <!-- PAGE_29 -->\n###### □ 결과보고서 작성 방법\n\n- - 24 -\n<!-- PAGE_30 -->\n##### 제4장 참고문헌\n\n<!-- PAGE_30 -->\n###### 1.  SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 9th Revision\n\n<!-- PAGE_30 -->\n###### 2.  SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 11th Revision\n\n<!-- PAGE_30 -->\n###### 3. ",
        "original_sentence": "문서에는 아래의 내용을 참고하여\n\n<!-- PAGE_29 -->\n###### 위해평가에 대한 상세 자료가 포함되고, 제한점, 외국 평가 사례 등에 대하여 기술한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_237",
      "text": "<!-- PAGE_29 -->\n###### □ 결과보고서 작성 방법\n\n- - 24 -\n<!-- PAGE_30 -->\n##### 제4장 참고문헌\n\n<!-- PAGE_30 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 236,
        "window_size": 3,
        "char_count": 108,
        "word_count": 23,
        "page_number": 29,
        "window_text": "<!-- PAGE_27 -->\n###### 5) 화장품 성분의 경우, 위험성 결정에서 확인된 평가 대상 물질의 전신 독성기준값(PODsys)을\n\n<!-- PAGE_27 -->\n###### 6) 일반적으로 안전역(MOS)은 종(실험동물에서 사람), 사람(일반 사람과 취약 집단) 간의 외삽\n\n<!-- PAGE_27 -->\n###### 과정을 통해 산출된 MOS 값이 100(동물-사람 종간 계수 10 × 사람간 계수 10) 이상이면\n\n- 4.0\n- 2.5\n- 3.2\n- 3.2\n- - 22 -\n<!-- PAGE_28 -->\n###### □ 위해도 결정 방법\n\n주요내용\n\n검토방법\n\n- ○ 비발암물질(역치물질)인 경우, 안전역(MOS)\n산출\n\n- ○ 최적의 독성기준값(PODsys)과 전신노출량\n(SED) 비교\n\n- - 23 -\n<!-- PAGE_29 -->\n###### 3.  위해평가 보고서\n\n<!-- PAGE_29 -->\n###### 전체적인 위해평가 절차를 체계적으로 명확하게 작성한다.  문서에는 아래의 내용을 참고하여\n\n<!-- PAGE_29 -->\n###### 위해평가에 대한 상세 자료가 포함되고, 제한점, 외국 평가 사례 등에 대하여 기술한다.\n\n <!-- PAGE_29 -->\n###### □ 결과보고서 작성 방법\n\n- - 24 -\n<!-- PAGE_30 -->\n##### 제4장 참고문헌\n\n<!-- PAGE_30 -->\n###### 1.  SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 9th Revision\n\n<!-- PAGE_30 -->\n###### 2.  SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 11th Revision\n\n<!-- PAGE_30 -->\n###### 3.  Tore Sanner, et al, A Simple Method for Quantitative Risk Assessment of Non- Threshold\n\n<!-- PAGE_30 -->\n###### Carcinogens Based on the Dose Descriptor T25, Pharmacology & Toxicology 2001, 88, 331–\n\n<!-- PAGE_30 -->\n###### 4. ",
        "original_sentence": "<!-- PAGE_29 -->\n###### □ 결과보고서 작성 방법\n\n- - 24 -\n<!-- PAGE_30 -->\n##### 제4장 참고문헌\n\n<!-- PAGE_30 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_238",
      "text": "SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 9th Revision\n\n<!-- PAGE_30 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 237,
        "window_size": 3,
        "char_count": 158,
        "word_count": 25,
        "page_number": 30,
        "window_text": "위해평가 보고서\n\n<!-- PAGE_29 -->\n###### 전체적인 위해평가 절차를 체계적으로 명확하게 작성한다.  문서에는 아래의 내용을 참고하여\n\n<!-- PAGE_29 -->\n###### 위해평가에 대한 상세 자료가 포함되고, 제한점, 외국 평가 사례 등에 대하여 기술한다.\n\n <!-- PAGE_29 -->\n###### □ 결과보고서 작성 방법\n\n- - 24 -\n<!-- PAGE_30 -->\n##### 제4장 참고문헌\n\n<!-- PAGE_30 -->\n###### 1.  SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 9th Revision\n\n<!-- PAGE_30 -->\n###### 2.  SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 11th Revision\n\n<!-- PAGE_30 -->\n###### 3.  Tore Sanner, et al, A Simple Method for Quantitative Risk Assessment of Non- Threshold\n\n<!-- PAGE_30 -->\n###### Carcinogens Based on the Dose Descriptor T25, Pharmacology & Toxicology 2001, 88, 331–\n\n<!-- PAGE_30 -->\n###### 4.  RIVM, Cosmetics Fact Sheet, To assess the risks for the consumer  Updated version for\n\n<!-- PAGE_30 -->\n###### ConsExpo 4, 2006\n\n<!-- PAGE_30 -->\n###### 5. ",
        "original_sentence": "SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 9th Revision\n\n<!-- PAGE_30 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_239",
      "text": "SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 11th Revision\n\n<!-- PAGE_30 -->\n###### 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 238,
        "window_size": 3,
        "char_count": 159,
        "word_count": 25,
        "page_number": 30,
        "window_text": "문서에는 아래의 내용을 참고하여\n\n<!-- PAGE_29 -->\n###### 위해평가에 대한 상세 자료가 포함되고, 제한점, 외국 평가 사례 등에 대하여 기술한다.\n\n <!-- PAGE_29 -->\n###### □ 결과보고서 작성 방법\n\n- - 24 -\n<!-- PAGE_30 -->\n##### 제4장 참고문헌\n\n<!-- PAGE_30 -->\n###### 1.  SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 9th Revision\n\n<!-- PAGE_30 -->\n###### 2.  SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 11th Revision\n\n<!-- PAGE_30 -->\n###### 3.  Tore Sanner, et al, A Simple Method for Quantitative Risk Assessment of Non- Threshold\n\n<!-- PAGE_30 -->\n###### Carcinogens Based on the Dose Descriptor T25, Pharmacology & Toxicology 2001, 88, 331–\n\n<!-- PAGE_30 -->\n###### 4.  RIVM, Cosmetics Fact Sheet, To assess the risks for the consumer  Updated version for\n\n<!-- PAGE_30 -->\n###### ConsExpo 4, 2006\n\n<!-- PAGE_30 -->\n###### 5.  R.J. ",
        "original_sentence": "SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 11th Revision\n\n<!-- PAGE_30 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_240",
      "text": "Tore Sanner, et al, A Simple Method for Quantitative Risk Assessment of Non- Threshold\n\n<!-- PAGE_30 -->\n###### Carcinogens Based on the Dose Descriptor T25, Pharmacology & Toxicology 2001, 88, 331–\n\n<!-- PAGE_30 -->\n###### 4. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 239,
        "window_size": 3,
        "char_count": 227,
        "word_count": 36,
        "page_number": 30,
        "window_text": "<!-- PAGE_29 -->\n###### □ 결과보고서 작성 방법\n\n- - 24 -\n<!-- PAGE_30 -->\n##### 제4장 참고문헌\n\n<!-- PAGE_30 -->\n###### 1.  SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 9th Revision\n\n<!-- PAGE_30 -->\n###### 2.  SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 11th Revision\n\n<!-- PAGE_30 -->\n###### 3.  Tore Sanner, et al, A Simple Method for Quantitative Risk Assessment of Non- Threshold\n\n<!-- PAGE_30 -->\n###### Carcinogens Based on the Dose Descriptor T25, Pharmacology & Toxicology 2001, 88, 331–\n\n<!-- PAGE_30 -->\n###### 4.  RIVM, Cosmetics Fact Sheet, To assess the risks for the consumer  Updated version for\n\n<!-- PAGE_30 -->\n###### ConsExpo 4, 2006\n\n<!-- PAGE_30 -->\n###### 5.  R.J.  Safford, The Dermal Sensitisation Threshold—A TTC approach for allergic contact\n\n<!-- PAGE_30 -->\n###### dermatitis, Regulatory Toxicology and Pharmacology 2008, 51, 195–200\n\n<!-- PAGE_30 -->\n###### 5. ",
        "original_sentence": "Tore Sanner, et al, A Simple Method for Quantitative Risk Assessment of Non- Threshold\n\n<!-- PAGE_30 -->\n###### Carcinogens Based on the Dose Descriptor T25, Pharmacology & Toxicology 2001, 88, 331–\n\n<!-- PAGE_30 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_241",
      "text": "RIVM, Cosmetics Fact Sheet, To assess the risks for the consumer  Updated version for\n\n<!-- PAGE_30 -->\n###### ConsExpo 4, 2006\n\n<!-- PAGE_30 -->\n###### 5. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 240,
        "window_size": 3,
        "char_count": 156,
        "word_count": 26,
        "page_number": 30,
        "window_text": "SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 9th Revision\n\n<!-- PAGE_30 -->\n###### 2.  SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 11th Revision\n\n<!-- PAGE_30 -->\n###### 3.  Tore Sanner, et al, A Simple Method for Quantitative Risk Assessment of Non- Threshold\n\n<!-- PAGE_30 -->\n###### Carcinogens Based on the Dose Descriptor T25, Pharmacology & Toxicology 2001, 88, 331–\n\n<!-- PAGE_30 -->\n###### 4.  RIVM, Cosmetics Fact Sheet, To assess the risks for the consumer  Updated version for\n\n<!-- PAGE_30 -->\n###### ConsExpo 4, 2006\n\n<!-- PAGE_30 -->\n###### 5.  R.J.  Safford, The Dermal Sensitisation Threshold—A TTC approach for allergic contact\n\n<!-- PAGE_30 -->\n###### dermatitis, Regulatory Toxicology and Pharmacology 2008, 51, 195–200\n\n<!-- PAGE_30 -->\n###### 5.  W. Steiling, et al, Principle considerations for the risk assessment of sprayed consumer\n\n<!-- PAGE_30 -->\n###### products, Toxicology Letters 227, 41–49, 2014\n\n<!-- PAGE_30 -->\n###### 6. ",
        "original_sentence": "RIVM, Cosmetics Fact Sheet, To assess the risks for the consumer  Updated version for\n\n<!-- PAGE_30 -->\n###### ConsExpo 4, 2006\n\n<!-- PAGE_30 -->\n###### 5. "
      }
    },
    {
      "chunk_id": "chunk_242",
      "text": "R.J. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 241,
        "window_size": 3,
        "char_count": 5,
        "word_count": 1,
        "page_number": 30,
        "window_text": "SCCS's Notes of Guidance for the Testing of Cosmetic Substances and Their Safety\n\n<!-- PAGE_30 -->\n###### Evaluation 11th Revision\n\n<!-- PAGE_30 -->\n###### 3.  Tore Sanner, et al, A Simple Method for Quantitative Risk Assessment of Non- Threshold\n\n<!-- PAGE_30 -->\n###### Carcinogens Based on the Dose Descriptor T25, Pharmacology & Toxicology 2001, 88, 331–\n\n<!-- PAGE_30 -->\n###### 4.  RIVM, Cosmetics Fact Sheet, To assess the risks for the consumer  Updated version for\n\n<!-- PAGE_30 -->\n###### ConsExpo 4, 2006\n\n<!-- PAGE_30 -->\n###### 5.  R.J.  Safford, The Dermal Sensitisation Threshold—A TTC approach for allergic contact\n\n<!-- PAGE_30 -->\n###### dermatitis, Regulatory Toxicology and Pharmacology 2008, 51, 195–200\n\n<!-- PAGE_30 -->\n###### 5.  W. Steiling, et al, Principle considerations for the risk assessment of sprayed consumer\n\n<!-- PAGE_30 -->\n###### products, Toxicology Letters 227, 41–49, 2014\n\n<!-- PAGE_30 -->\n###### 6.  IDEA PROJECT, FINAL REPORT ON THE QRA2, Skin Sensitisation Quantitative Risk\n\n<!-- PAGE_30 -->\n###### Assessment for Fragrance Ingredients, September 30, 2016\n\n<!-- PAGE_30 -->\n###### 7. ",
        "original_sentence": "R.J. "
      }
    },
    {
      "chunk_id": "chunk_243",
      "text": "Safford, The Dermal Sensitisation Threshold—A TTC approach for allergic contact\n\n<!-- PAGE_30 -->\n###### dermatitis, Regulatory Toxicology and Pharmacology 2008, 51, 195–200\n\n<!-- PAGE_30 -->\n###### 5. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 242,
        "window_size": 3,
        "char_count": 202,
        "word_count": 27,
        "page_number": 30,
        "window_text": "Tore Sanner, et al, A Simple Method for Quantitative Risk Assessment of Non- Threshold\n\n<!-- PAGE_30 -->\n###### Carcinogens Based on the Dose Descriptor T25, Pharmacology & Toxicology 2001, 88, 331–\n\n<!-- PAGE_30 -->\n###### 4.  RIVM, Cosmetics Fact Sheet, To assess the risks for the consumer  Updated version for\n\n<!-- PAGE_30 -->\n###### ConsExpo 4, 2006\n\n<!-- PAGE_30 -->\n###### 5.  R.J.  Safford, The Dermal Sensitisation Threshold—A TTC approach for allergic contact\n\n<!-- PAGE_30 -->\n###### dermatitis, Regulatory Toxicology and Pharmacology 2008, 51, 195–200\n\n<!-- PAGE_30 -->\n###### 5.  W. Steiling, et al, Principle considerations for the risk assessment of sprayed consumer\n\n<!-- PAGE_30 -->\n###### products, Toxicology Letters 227, 41–49, 2014\n\n<!-- PAGE_30 -->\n###### 6.  IDEA PROJECT, FINAL REPORT ON THE QRA2, Skin Sensitisation Quantitative Risk\n\n<!-- PAGE_30 -->\n###### Assessment for Fragrance Ingredients, September 30, 2016\n\n<!-- PAGE_30 -->\n###### 7.  R. Kroes, et al, The Threshold of Toxicological Concern Concept in Risk Assessment,\n\n<!-- PAGE_30 -->\n###### Toxicological sciences 86(2), 226-230, 2005\n\n<!-- PAGE_30 -->\n###### 8. ",
        "original_sentence": "Safford, The Dermal Sensitisation Threshold—A TTC approach for allergic contact\n\n<!-- PAGE_30 -->\n###### dermatitis, Regulatory Toxicology and Pharmacology 2008, 51, 195–200\n\n<!-- PAGE_30 -->\n###### 5. "
      }
    },
    {
      "chunk_id": "chunk_244",
      "text": "W. Steiling, et al, Principle considerations for the risk assessment of sprayed consumer\n\n<!-- PAGE_30 -->\n###### products, Toxicology Letters 227, 41–49, 2014\n\n<!-- PAGE_30 -->\n###### 6. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 243,
        "window_size": 3,
        "char_count": 188,
        "word_count": 28,
        "page_number": 30,
        "window_text": "RIVM, Cosmetics Fact Sheet, To assess the risks for the consumer  Updated version for\n\n<!-- PAGE_30 -->\n###### ConsExpo 4, 2006\n\n<!-- PAGE_30 -->\n###### 5.  R.J.  Safford, The Dermal Sensitisation Threshold—A TTC approach for allergic contact\n\n<!-- PAGE_30 -->\n###### dermatitis, Regulatory Toxicology and Pharmacology 2008, 51, 195–200\n\n<!-- PAGE_30 -->\n###### 5.  W. Steiling, et al, Principle considerations for the risk assessment of sprayed consumer\n\n<!-- PAGE_30 -->\n###### products, Toxicology Letters 227, 41–49, 2014\n\n<!-- PAGE_30 -->\n###### 6.  IDEA PROJECT, FINAL REPORT ON THE QRA2, Skin Sensitisation Quantitative Risk\n\n<!-- PAGE_30 -->\n###### Assessment for Fragrance Ingredients, September 30, 2016\n\n<!-- PAGE_30 -->\n###### 7.  R. Kroes, et al, The Threshold of Toxicological Concern Concept in Risk Assessment,\n\n<!-- PAGE_30 -->\n###### Toxicological sciences 86(2), 226-230, 2005\n\n<!-- PAGE_30 -->\n###### 8.  David W. Roberts, et al, A practical guidance for Cramer class determination, Regulatory\n\n<!-- PAGE_30 -->\n###### Toxicology and Pharmacology 73(3), 971-984, 2015\n\n<!-- PAGE_30 -->\n###### 9. ",
        "original_sentence": "W. Steiling, et al, Principle considerations for the risk assessment of sprayed consumer\n\n<!-- PAGE_30 -->\n###### products, Toxicology Letters 227, 41–49, 2014\n\n<!-- PAGE_30 -->\n###### 6. "
      }
    },
    {
      "chunk_id": "chunk_245",
      "text": "IDEA PROJECT, FINAL REPORT ON THE QRA2, Skin Sensitisation Quantitative Risk\n\n<!-- PAGE_30 -->\n###### Assessment for Fragrance Ingredients, September 30, 2016\n\n<!-- PAGE_30 -->\n###### 7. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 244,
        "window_size": 3,
        "char_count": 187,
        "word_count": 27,
        "page_number": 30,
        "window_text": "R.J.  Safford, The Dermal Sensitisation Threshold—A TTC approach for allergic contact\n\n<!-- PAGE_30 -->\n###### dermatitis, Regulatory Toxicology and Pharmacology 2008, 51, 195–200\n\n<!-- PAGE_30 -->\n###### 5.  W. Steiling, et al, Principle considerations for the risk assessment of sprayed consumer\n\n<!-- PAGE_30 -->\n###### products, Toxicology Letters 227, 41–49, 2014\n\n<!-- PAGE_30 -->\n###### 6.  IDEA PROJECT, FINAL REPORT ON THE QRA2, Skin Sensitisation Quantitative Risk\n\n<!-- PAGE_30 -->\n###### Assessment for Fragrance Ingredients, September 30, 2016\n\n<!-- PAGE_30 -->\n###### 7.  R. Kroes, et al, The Threshold of Toxicological Concern Concept in Risk Assessment,\n\n<!-- PAGE_30 -->\n###### Toxicological sciences 86(2), 226-230, 2005\n\n<!-- PAGE_30 -->\n###### 8.  David W. Roberts, et al, A practical guidance for Cramer class determination, Regulatory\n\n<!-- PAGE_30 -->\n###### Toxicology and Pharmacology 73(3), 971-984, 2015\n\n<!-- PAGE_30 -->\n###### 9.  식품의약품안전처, 인체적용제품 위해성평가 공통지침서, 2019\n\n<!-- PAGE_30 -->\n###### 10. ",
        "original_sentence": "IDEA PROJECT, FINAL REPORT ON THE QRA2, Skin Sensitisation Quantitative Risk\n\n<!-- PAGE_30 -->\n###### Assessment for Fragrance Ingredients, September 30, 2016\n\n<!-- PAGE_30 -->\n###### 7. "
      }
    },
    {
      "chunk_id": "chunk_246",
      "text": "R. Kroes, et al, The Threshold of Toxicological Concern Concept in Risk Assessment,\n\n<!-- PAGE_30 -->\n###### Toxicological sciences 86(2), 226-230, 2005\n\n<!-- PAGE_30 -->\n###### 8. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 245,
        "window_size": 3,
        "char_count": 181,
        "word_count": 27,
        "page_number": 30,
        "window_text": "Safford, The Dermal Sensitisation Threshold—A TTC approach for allergic contact\n\n<!-- PAGE_30 -->\n###### dermatitis, Regulatory Toxicology and Pharmacology 2008, 51, 195–200\n\n<!-- PAGE_30 -->\n###### 5.  W. Steiling, et al, Principle considerations for the risk assessment of sprayed consumer\n\n<!-- PAGE_30 -->\n###### products, Toxicology Letters 227, 41–49, 2014\n\n<!-- PAGE_30 -->\n###### 6.  IDEA PROJECT, FINAL REPORT ON THE QRA2, Skin Sensitisation Quantitative Risk\n\n<!-- PAGE_30 -->\n###### Assessment for Fragrance Ingredients, September 30, 2016\n\n<!-- PAGE_30 -->\n###### 7.  R. Kroes, et al, The Threshold of Toxicological Concern Concept in Risk Assessment,\n\n<!-- PAGE_30 -->\n###### Toxicological sciences 86(2), 226-230, 2005\n\n<!-- PAGE_30 -->\n###### 8.  David W. Roberts, et al, A practical guidance for Cramer class determination, Regulatory\n\n<!-- PAGE_30 -->\n###### Toxicology and Pharmacology 73(3), 971-984, 2015\n\n<!-- PAGE_30 -->\n###### 9.  식품의약품안전처, 인체적용제품 위해성평가 공통지침서, 2019\n\n<!-- PAGE_30 -->\n###### 10.  식품의약품안전처, 화장품 원료 위해평가 및 국제 협력 연구, 2018\n\n<!-- PAGE_31 -->\n### 붙임 자료\n\n<!-- PAGE_31 -->\n###### 붙임 1. ",
        "original_sentence": "R. Kroes, et al, The Threshold of Toxicological Concern Concept in Risk Assessment,\n\n<!-- PAGE_30 -->\n###### Toxicological sciences 86(2), 226-230, 2005\n\n<!-- PAGE_30 -->\n###### 8. "
      }
    },
    {
      "chunk_id": "chunk_247",
      "text": "David W. Roberts, et al, A practical guidance for Cramer class determination, Regulatory\n\n<!-- PAGE_30 -->\n###### Toxicology and Pharmacology 73(3), 971-984, 2015\n\n<!-- PAGE_30 -->\n###### 9. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 246,
        "window_size": 3,
        "char_count": 191,
        "word_count": 28,
        "page_number": 30,
        "window_text": "W. Steiling, et al, Principle considerations for the risk assessment of sprayed consumer\n\n<!-- PAGE_30 -->\n###### products, Toxicology Letters 227, 41–49, 2014\n\n<!-- PAGE_30 -->\n###### 6.  IDEA PROJECT, FINAL REPORT ON THE QRA2, Skin Sensitisation Quantitative Risk\n\n<!-- PAGE_30 -->\n###### Assessment for Fragrance Ingredients, September 30, 2016\n\n<!-- PAGE_30 -->\n###### 7.  R. Kroes, et al, The Threshold of Toxicological Concern Concept in Risk Assessment,\n\n<!-- PAGE_30 -->\n###### Toxicological sciences 86(2), 226-230, 2005\n\n<!-- PAGE_30 -->\n###### 8.  David W. Roberts, et al, A practical guidance for Cramer class determination, Regulatory\n\n<!-- PAGE_30 -->\n###### Toxicology and Pharmacology 73(3), 971-984, 2015\n\n<!-- PAGE_30 -->\n###### 9.  식품의약품안전처, 인체적용제품 위해성평가 공통지침서, 2019\n\n<!-- PAGE_30 -->\n###### 10.  식품의약품안전처, 화장품 원료 위해평가 및 국제 협력 연구, 2018\n\n<!-- PAGE_31 -->\n### 붙임 자료\n\n<!-- PAGE_31 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집\n\n<!-- PAGE_31 -->\n###### 붙임 2. ",
        "original_sentence": "David W. Roberts, et al, A practical guidance for Cramer class determination, Regulatory\n\n<!-- PAGE_30 -->\n###### Toxicology and Pharmacology 73(3), 971-984, 2015\n\n<!-- PAGE_30 -->\n###### 9. "
      }
    },
    {
      "chunk_id": "chunk_248",
      "text": "식품의약품안전처, 인체적용제품 위해성평가 공통지침서, 2019\n\n<!-- PAGE_30 -->\n###### 10. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 247,
        "window_size": 3,
        "char_count": 64,
        "word_count": 10,
        "page_number": 30,
        "window_text": "IDEA PROJECT, FINAL REPORT ON THE QRA2, Skin Sensitisation Quantitative Risk\n\n<!-- PAGE_30 -->\n###### Assessment for Fragrance Ingredients, September 30, 2016\n\n<!-- PAGE_30 -->\n###### 7.  R. Kroes, et al, The Threshold of Toxicological Concern Concept in Risk Assessment,\n\n<!-- PAGE_30 -->\n###### Toxicological sciences 86(2), 226-230, 2005\n\n<!-- PAGE_30 -->\n###### 8.  David W. Roberts, et al, A practical guidance for Cramer class determination, Regulatory\n\n<!-- PAGE_30 -->\n###### Toxicology and Pharmacology 73(3), 971-984, 2015\n\n<!-- PAGE_30 -->\n###### 9.  식품의약품안전처, 인체적용제품 위해성평가 공통지침서, 2019\n\n<!-- PAGE_30 -->\n###### 10.  식품의약품안전처, 화장품 원료 위해평가 및 국제 협력 연구, 2018\n\n<!-- PAGE_31 -->\n### 붙임 자료\n\n<!-- PAGE_31 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집\n\n<!-- PAGE_31 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식\n\n<!-- PAGE_31 -->\n###### 붙임 3. ",
        "original_sentence": "식품의약품안전처, 인체적용제품 위해성평가 공통지침서, 2019\n\n<!-- PAGE_30 -->\n###### 10. "
      }
    },
    {
      "chunk_id": "chunk_249",
      "text": "식품의약품안전처, 화장품 원료 위해평가 및 국제 협력 연구, 2018\n\n<!-- PAGE_31 -->\n### 붙임 자료\n\n<!-- PAGE_31 -->\n###### 붙임 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 248,
        "window_size": 3,
        "char_count": 98,
        "word_count": 21,
        "page_number": 31,
        "window_text": "R. Kroes, et al, The Threshold of Toxicological Concern Concept in Risk Assessment,\n\n<!-- PAGE_30 -->\n###### Toxicological sciences 86(2), 226-230, 2005\n\n<!-- PAGE_30 -->\n###### 8.  David W. Roberts, et al, A practical guidance for Cramer class determination, Regulatory\n\n<!-- PAGE_30 -->\n###### Toxicology and Pharmacology 73(3), 971-984, 2015\n\n<!-- PAGE_30 -->\n###### 9.  식품의약품안전처, 인체적용제품 위해성평가 공통지침서, 2019\n\n<!-- PAGE_30 -->\n###### 10.  식품의약품안전처, 화장품 원료 위해평가 및 국제 협력 연구, 2018\n\n<!-- PAGE_31 -->\n### 붙임 자료\n\n<!-- PAGE_31 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집\n\n<!-- PAGE_31 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식\n\n<!-- PAGE_31 -->\n###### 붙임 3.  OECD 독성시험 종류\n\n<!-- PAGE_31 -->\n###### 붙임 4. ",
        "original_sentence": "식품의약품안전처, 화장품 원료 위해평가 및 국제 협력 연구, 2018\n\n<!-- PAGE_31 -->\n### 붙임 자료\n\n<!-- PAGE_31 -->\n###### 붙임 1. "
      }
    },
    {
      "chunk_id": "chunk_250",
      "text": "화장품 위해평가 관련 용어집\n\n<!-- PAGE_31 -->\n###### 붙임 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 249,
        "window_size": 3,
        "char_count": 47,
        "word_count": 10,
        "page_number": 31,
        "window_text": "David W. Roberts, et al, A practical guidance for Cramer class determination, Regulatory\n\n<!-- PAGE_30 -->\n###### Toxicology and Pharmacology 73(3), 971-984, 2015\n\n<!-- PAGE_30 -->\n###### 9.  식품의약품안전처, 인체적용제품 위해성평가 공통지침서, 2019\n\n<!-- PAGE_30 -->\n###### 10.  식품의약품안전처, 화장품 원료 위해평가 및 국제 협력 연구, 2018\n\n<!-- PAGE_31 -->\n### 붙임 자료\n\n<!-- PAGE_31 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집\n\n<!-- PAGE_31 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식\n\n<!-- PAGE_31 -->\n###### 붙임 3.  OECD 독성시험 종류\n\n<!-- PAGE_31 -->\n###### 붙임 4.  화장품 노출 피부 표면적\n\n<!-- PAGE_31 -->\n###### 붙임 5. ",
        "original_sentence": "화장품 위해평가 관련 용어집\n\n<!-- PAGE_31 -->\n###### 붙임 2. "
      }
    },
    {
      "chunk_id": "chunk_251",
      "text": "화장품 위해평가 보고서 양식\n\n<!-- PAGE_31 -->\n###### 붙임 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 250,
        "window_size": 3,
        "char_count": 47,
        "word_count": 10,
        "page_number": 31,
        "window_text": "식품의약품안전처, 인체적용제품 위해성평가 공통지침서, 2019\n\n<!-- PAGE_30 -->\n###### 10.  식품의약품안전처, 화장품 원료 위해평가 및 국제 협력 연구, 2018\n\n<!-- PAGE_31 -->\n### 붙임 자료\n\n<!-- PAGE_31 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집\n\n<!-- PAGE_31 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식\n\n<!-- PAGE_31 -->\n###### 붙임 3.  OECD 독성시험 종류\n\n<!-- PAGE_31 -->\n###### 붙임 4.  화장품 노출 피부 표면적\n\n<!-- PAGE_31 -->\n###### 붙임 5.  한국인의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 6. ",
        "original_sentence": "화장품 위해평가 보고서 양식\n\n<!-- PAGE_31 -->\n###### 붙임 3. "
      }
    },
    {
      "chunk_id": "chunk_252",
      "text": "OECD 독성시험 종류\n\n<!-- PAGE_31 -->\n###### 붙임 4. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 251,
        "window_size": 3,
        "char_count": 44,
        "word_count": 9,
        "page_number": 31,
        "window_text": "식품의약품안전처, 화장품 원료 위해평가 및 국제 협력 연구, 2018\n\n<!-- PAGE_31 -->\n### 붙임 자료\n\n<!-- PAGE_31 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집\n\n<!-- PAGE_31 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식\n\n<!-- PAGE_31 -->\n###### 붙임 3.  OECD 독성시험 종류\n\n<!-- PAGE_31 -->\n###### 붙임 4.  화장품 노출 피부 표면적\n\n<!-- PAGE_31 -->\n###### 붙임 5.  한국인의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 6.  유럽의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 7. ",
        "original_sentence": "OECD 독성시험 종류\n\n<!-- PAGE_31 -->\n###### 붙임 4. "
      }
    },
    {
      "chunk_id": "chunk_253",
      "text": "화장품 노출 피부 표면적\n\n<!-- PAGE_31 -->\n###### 붙임 5. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 252,
        "window_size": 3,
        "char_count": 45,
        "word_count": 10,
        "page_number": 31,
        "window_text": "화장품 위해평가 관련 용어집\n\n<!-- PAGE_31 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식\n\n<!-- PAGE_31 -->\n###### 붙임 3.  OECD 독성시험 종류\n\n<!-- PAGE_31 -->\n###### 붙임 4.  화장품 노출 피부 표면적\n\n<!-- PAGE_31 -->\n###### 붙임 5.  한국인의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 6.  유럽의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_31 -->\n###### 붙임 8. ",
        "original_sentence": "화장품 노출 피부 표면적\n\n<!-- PAGE_31 -->\n###### 붙임 5. "
      }
    },
    {
      "chunk_id": "chunk_254",
      "text": "한국인의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 6. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 253,
        "window_size": 3,
        "char_count": 44,
        "word_count": 9,
        "page_number": 31,
        "window_text": "화장품 위해평가 보고서 양식\n\n<!-- PAGE_31 -->\n###### 붙임 3.  OECD 독성시험 종류\n\n<!-- PAGE_31 -->\n###### 붙임 4.  화장품 노출 피부 표면적\n\n<!-- PAGE_31 -->\n###### 붙임 5.  한국인의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 6.  유럽의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_31 -->\n###### 붙임 8.  피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시\n\n<!-- PAGE_31 -->\n###### 붙임 9. ",
        "original_sentence": "한국인의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 6. "
      }
    },
    {
      "chunk_id": "chunk_255",
      "text": "유럽의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 7. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 254,
        "window_size": 3,
        "char_count": 43,
        "word_count": 9,
        "page_number": 31,
        "window_text": "OECD 독성시험 종류\n\n<!-- PAGE_31 -->\n###### 붙임 4.  화장품 노출 피부 표면적\n\n<!-- PAGE_31 -->\n###### 붙임 5.  한국인의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 6.  유럽의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_31 -->\n###### 붙임 8.  피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시\n\n<!-- PAGE_31 -->\n###### 붙임 9.  화장품 유형별 평가 예시\n\n<!-- PAGE_31 -->\n###### 붙임 10. ",
        "original_sentence": "유럽의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 7. "
      }
    },
    {
      "chunk_id": "chunk_256",
      "text": "흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_31 -->\n###### 붙임 8. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 255,
        "window_size": 3,
        "char_count": 50,
        "word_count": 12,
        "page_number": 31,
        "window_text": "화장품 노출 피부 표면적\n\n<!-- PAGE_31 -->\n###### 붙임 5.  한국인의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 6.  유럽의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_31 -->\n###### 붙임 8.  피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시\n\n<!-- PAGE_31 -->\n###### 붙임 9.  화장품 유형별 평가 예시\n\n<!-- PAGE_31 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집\n\n- - 26 -\n<!-- PAGE_32 -->\n###### 붙임 1. ",
        "original_sentence": "흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_31 -->\n###### 붙임 8. "
      }
    },
    {
      "chunk_id": "chunk_257",
      "text": "피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시\n\n<!-- PAGE_31 -->\n###### 붙임 9. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 256,
        "window_size": 3,
        "char_count": 80,
        "word_count": 13,
        "page_number": 31,
        "window_text": "한국인의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 6.  유럽의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_31 -->\n###### 붙임 8.  피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시\n\n<!-- PAGE_31 -->\n###### 붙임 9.  화장품 유형별 평가 예시\n\n<!-- PAGE_31 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집\n\n- - 26 -\n<!-- PAGE_32 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집(Glossary)\n\n<!-- PAGE_32 -->\n###### · 감작 (Sensitization) : 생체 내에 이종항원을 투여하여 항체를 보유시키는 일. ",
        "original_sentence": "피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시\n\n<!-- PAGE_31 -->\n###### 붙임 9. "
      }
    },
    {
      "chunk_id": "chunk_258",
      "text": "화장품 유형별 평가 예시\n\n<!-- PAGE_31 -->\n###### 붙임 10. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 257,
        "window_size": 3,
        "char_count": 46,
        "word_count": 10,
        "page_number": 31,
        "window_text": "유럽의 화장품 사용량\n\n<!-- PAGE_31 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_31 -->\n###### 붙임 8.  피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시\n\n<!-- PAGE_31 -->\n###### 붙임 9.  화장품 유형별 평가 예시\n\n<!-- PAGE_31 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집\n\n- - 26 -\n<!-- PAGE_32 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집(Glossary)\n\n<!-- PAGE_32 -->\n###### · 감작 (Sensitization) : 생체 내에 이종항원을 투여하여 항체를 보유시키는 일.  일반적으로 면\n\n<!-- PAGE_32 -->\n###### 역 반응 활성화를 지칭함. ",
        "original_sentence": "화장품 유형별 평가 예시\n\n<!-- PAGE_31 -->\n###### 붙임 10. "
      }
    },
    {
      "chunk_id": "chunk_259",
      "text": "화장품 성분 위해평가를 위한 정보 수집\n\n- - 26 -\n<!-- PAGE_32 -->\n###### 붙임 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 258,
        "window_size": 3,
        "char_count": 62,
        "word_count": 16,
        "page_number": 32,
        "window_text": "흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_31 -->\n###### 붙임 8.  피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시\n\n<!-- PAGE_31 -->\n###### 붙임 9.  화장품 유형별 평가 예시\n\n<!-- PAGE_31 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집\n\n- - 26 -\n<!-- PAGE_32 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집(Glossary)\n\n<!-- PAGE_32 -->\n###### · 감작 (Sensitization) : 생체 내에 이종항원을 투여하여 항체를 보유시키는 일.  일반적으로 면\n\n<!-- PAGE_32 -->\n###### 역 반응 활성화를 지칭함.  민감화\n\n<!-- PAGE_32 -->\n###### · 단회투여독성 (Acute toxicity) : 독성 물질에 대한 짧은 기간의 노출에 의해 발생하는 독성\n\n<!-- PAGE_32 -->\n###### 으로 일반적으로 24시간 이내의 노출에 의해 발생함\n\n<!-- PAGE_32 -->\n###### · 기준점, 벤치마크 (Benchmark) :\n\n<!-- PAGE_32 -->\n###### a. ",
        "original_sentence": "화장품 성분 위해평가를 위한 정보 수집\n\n- - 26 -\n<!-- PAGE_32 -->\n###### 붙임 1. "
      }
    },
    {
      "chunk_id": "chunk_260",
      "text": "화장품 위해평가 관련 용어집(Glossary)\n\n<!-- PAGE_32 -->\n###### · 감작 (Sensitization) : 생체 내에 이종항원을 투여하여 항체를 보유시키는 일. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 259,
        "window_size": 3,
        "char_count": 104,
        "word_count": 19,
        "page_number": 32,
        "window_text": "피부감작성 평가(Quantitative Risk Assessment, QRA) 및 예시\n\n<!-- PAGE_31 -->\n###### 붙임 9.  화장품 유형별 평가 예시\n\n<!-- PAGE_31 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집\n\n- - 26 -\n<!-- PAGE_32 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집(Glossary)\n\n<!-- PAGE_32 -->\n###### · 감작 (Sensitization) : 생체 내에 이종항원을 투여하여 항체를 보유시키는 일.  일반적으로 면\n\n<!-- PAGE_32 -->\n###### 역 반응 활성화를 지칭함.  민감화\n\n<!-- PAGE_32 -->\n###### · 단회투여독성 (Acute toxicity) : 독성 물질에 대한 짧은 기간의 노출에 의해 발생하는 독성\n\n<!-- PAGE_32 -->\n###### 으로 일반적으로 24시간 이내의 노출에 의해 발생함\n\n<!-- PAGE_32 -->\n###### · 기준점, 벤치마크 (Benchmark) :\n\n<!-- PAGE_32 -->\n###### a.  효과를 위해 사전에 설정한 변형된 반응을 나타내는 용량이 통계적 하한 신뢰 한계\n\n<!-- PAGE_32 -->\n###### b. ",
        "original_sentence": "화장품 위해평가 관련 용어집(Glossary)\n\n<!-- PAGE_32 -->\n###### · 감작 (Sensitization) : 생체 내에 이종항원을 투여하여 항체를 보유시키는 일. "
      }
    },
    {
      "chunk_id": "chunk_261",
      "text": "일반적으로 면\n\n<!-- PAGE_32 -->\n###### 역 반응 활성화를 지칭함. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 260,
        "window_size": 3,
        "char_count": 48,
        "word_count": 10,
        "page_number": 32,
        "window_text": "화장품 유형별 평가 예시\n\n<!-- PAGE_31 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집\n\n- - 26 -\n<!-- PAGE_32 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집(Glossary)\n\n<!-- PAGE_32 -->\n###### · 감작 (Sensitization) : 생체 내에 이종항원을 투여하여 항체를 보유시키는 일.  일반적으로 면\n\n<!-- PAGE_32 -->\n###### 역 반응 활성화를 지칭함.  민감화\n\n<!-- PAGE_32 -->\n###### · 단회투여독성 (Acute toxicity) : 독성 물질에 대한 짧은 기간의 노출에 의해 발생하는 독성\n\n<!-- PAGE_32 -->\n###### 으로 일반적으로 24시간 이내의 노출에 의해 발생함\n\n<!-- PAGE_32 -->\n###### · 기준점, 벤치마크 (Benchmark) :\n\n<!-- PAGE_32 -->\n###### a.  효과를 위해 사전에 설정한 변형된 반응을 나타내는 용량이 통계적 하한 신뢰 한계\n\n<!-- PAGE_32 -->\n###### b.  (기준 농도(benchmark concentration, BMC)라고도 함) 배경에 대비하여 부정적 효과에 대한\n\n<!-- PAGE_32 -->\n###### 반응률에 사전에 설정한 변화(기준 반응(benchma가 response, BMR)를 나타내는 용량의 통\n\n<!-- PAGE_32 -->\n###### c. ",
        "original_sentence": "일반적으로 면\n\n<!-- PAGE_32 -->\n###### 역 반응 활성화를 지칭함. "
      }
    },
    {
      "chunk_id": "chunk_262",
      "text": "민감화\n\n<!-- PAGE_32 -->\n###### · 단회투여독성 (Acute toxicity) : 독성 물질에 대한 짧은 기간의 노출에 의해 발생하는 독성\n\n<!-- PAGE_32 -->\n###### 으로 일반적으로 24시간 이내의 노출에 의해 발생함\n\n<!-- PAGE_32 -->\n###### · 기준점, 벤치마크 (Benchmark) :\n\n<!-- PAGE_32 -->\n###### a. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 261,
        "window_size": 3,
        "char_count": 222,
        "word_count": 44,
        "page_number": 32,
        "window_text": "화장품 성분 위해평가를 위한 정보 수집\n\n- - 26 -\n<!-- PAGE_32 -->\n###### 붙임 1.  화장품 위해평가 관련 용어집(Glossary)\n\n<!-- PAGE_32 -->\n###### · 감작 (Sensitization) : 생체 내에 이종항원을 투여하여 항체를 보유시키는 일.  일반적으로 면\n\n<!-- PAGE_32 -->\n###### 역 반응 활성화를 지칭함.  민감화\n\n<!-- PAGE_32 -->\n###### · 단회투여독성 (Acute toxicity) : 독성 물질에 대한 짧은 기간의 노출에 의해 발생하는 독성\n\n<!-- PAGE_32 -->\n###### 으로 일반적으로 24시간 이내의 노출에 의해 발생함\n\n<!-- PAGE_32 -->\n###### · 기준점, 벤치마크 (Benchmark) :\n\n<!-- PAGE_32 -->\n###### a.  효과를 위해 사전에 설정한 변형된 반응을 나타내는 용량이 통계적 하한 신뢰 한계\n\n<!-- PAGE_32 -->\n###### b.  (기준 농도(benchmark concentration, BMC)라고도 함) 배경에 대비하여 부정적 효과에 대한\n\n<!-- PAGE_32 -->\n###### 반응률에 사전에 설정한 변화(기준 반응(benchma가 response, BMR)를 나타내는 용량의 통\n\n<!-- PAGE_32 -->\n###### c.  어떤 독성에 대해 사전에 정한 확률이 작은 증분(통상 1～10%)만 그 발생률을높이는 투여\n\n<!-- PAGE_32 -->\n###### 량에서의 물질에 의한 노출. ",
        "original_sentence": "민감화\n\n<!-- PAGE_32 -->\n###### · 단회투여독성 (Acute toxicity) : 독성 물질에 대한 짧은 기간의 노출에 의해 발생하는 독성\n\n<!-- PAGE_32 -->\n###### 으로 일반적으로 24시간 이내의 노출에 의해 발생함\n\n<!-- PAGE_32 -->\n###### · 기준점, 벤치마크 (Benchmark) :\n\n<!-- PAGE_32 -->\n###### a. "
      }
    },
    {
      "chunk_id": "chunk_263",
      "text": "효과를 위해 사전에 설정한 변형된 반응을 나타내는 용량이 통계적 하한 신뢰 한계\n\n<!-- PAGE_32 -->\n###### b. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 262,
        "window_size": 3,
        "char_count": 73,
        "word_count": 17,
        "page_number": 32,
        "window_text": "화장품 위해평가 관련 용어집(Glossary)\n\n<!-- PAGE_32 -->\n###### · 감작 (Sensitization) : 생체 내에 이종항원을 투여하여 항체를 보유시키는 일.  일반적으로 면\n\n<!-- PAGE_32 -->\n###### 역 반응 활성화를 지칭함.  민감화\n\n<!-- PAGE_32 -->\n###### · 단회투여독성 (Acute toxicity) : 독성 물질에 대한 짧은 기간의 노출에 의해 발생하는 독성\n\n<!-- PAGE_32 -->\n###### 으로 일반적으로 24시간 이내의 노출에 의해 발생함\n\n<!-- PAGE_32 -->\n###### · 기준점, 벤치마크 (Benchmark) :\n\n<!-- PAGE_32 -->\n###### a.  효과를 위해 사전에 설정한 변형된 반응을 나타내는 용량이 통계적 하한 신뢰 한계\n\n<!-- PAGE_32 -->\n###### b.  (기준 농도(benchmark concentration, BMC)라고도 함) 배경에 대비하여 부정적 효과에 대한\n\n<!-- PAGE_32 -->\n###### 반응률에 사전에 설정한 변화(기준 반응(benchma가 response, BMR)를 나타내는 용량의 통\n\n<!-- PAGE_32 -->\n###### c.  어떤 독성에 대해 사전에 정한 확률이 작은 증분(통상 1～10%)만 그 발생률을높이는 투여\n\n<!-- PAGE_32 -->\n###### 량에서의 물질에 의한 노출.  혹은 사전에 정한 척도나 생물학적 영향의 변화에 관련 있는\n\n<!-- PAGE_32 -->\n###### 투여량. ",
        "original_sentence": "효과를 위해 사전에 설정한 변형된 반응을 나타내는 용량이 통계적 하한 신뢰 한계\n\n<!-- PAGE_32 -->\n###### b. "
      }
    },
    {
      "chunk_id": "chunk_264",
      "text": "(기준 농도(benchmark concentration, BMC)라고도 함) 배경에 대비하여 부정적 효과에 대한\n\n<!-- PAGE_32 -->\n###### 반응률에 사전에 설정한 변화(기준 반응(benchma가 response, BMR)를 나타내는 용량의 통\n\n<!-- PAGE_32 -->\n###### c. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 263,
        "window_size": 3,
        "char_count": 174,
        "word_count": 29,
        "page_number": 32,
        "window_text": "일반적으로 면\n\n<!-- PAGE_32 -->\n###### 역 반응 활성화를 지칭함.  민감화\n\n<!-- PAGE_32 -->\n###### · 단회투여독성 (Acute toxicity) : 독성 물질에 대한 짧은 기간의 노출에 의해 발생하는 독성\n\n<!-- PAGE_32 -->\n###### 으로 일반적으로 24시간 이내의 노출에 의해 발생함\n\n<!-- PAGE_32 -->\n###### · 기준점, 벤치마크 (Benchmark) :\n\n<!-- PAGE_32 -->\n###### a.  효과를 위해 사전에 설정한 변형된 반응을 나타내는 용량이 통계적 하한 신뢰 한계\n\n<!-- PAGE_32 -->\n###### b.  (기준 농도(benchmark concentration, BMC)라고도 함) 배경에 대비하여 부정적 효과에 대한\n\n<!-- PAGE_32 -->\n###### 반응률에 사전에 설정한 변화(기준 반응(benchma가 response, BMR)를 나타내는 용량의 통\n\n<!-- PAGE_32 -->\n###### c.  어떤 독성에 대해 사전에 정한 확률이 작은 증분(통상 1～10%)만 그 발생률을높이는 투여\n\n<!-- PAGE_32 -->\n###### 량에서의 물질에 의한 노출.  혹은 사전에 정한 척도나 생물학적 영향의 변화에 관련 있는\n\n<!-- PAGE_32 -->\n###### 투여량.  (농림수산성 및 후생노동성(일본), 2005; 식품 안전성에 관한 리스크 관리 표준 절\n\n<!-- PAGE_32 -->\n###### · 기준용량, 벤치마크용량 (Benchmark dose, BMD) : 특정 물질이 생체에 미리 정해진 수준의\n\n<!-- PAGE_32 -->\n###### 반응(기준 반응, Benchmark response level, BMR)을 야기할 것으로 예측되는 용량\n\n<!-- PAGE_32 -->\n###### · 노출 (Exposure) : 일정기간동안 일정한 빈도로 집단 혹은 개인이 경구 섭취, 호흡하거나 직\n\n<!-- PAGE_32 -->\n###### 접 접촉(예, 피부나 눈을 통해) 화학물질과 접촉하는 것을 말하며 단기노출(급성)과 장기노\n\n<!-- PAGE_32 -->\n###### 출(만성)로 구분됨\n\n<!-- PAGE_32 -->\n###### · 노출시나리오 (Exposure scenario) : 특정 물질의 생산부터 실사용까지 생체에 노출되는 방\n\n<!-- PAGE_32 -->\n###### 식을 가상적으로 규정한 것\n\n<!-- PAGE_32 -->\n###### · 노출안전역 (Margin of Exposure, MOE) : 추정 노출량에 대한 NOAEL 등과 같이 독성이 관\n\n<!-- PAGE_32 -->\n###### 찰되지 않는 독성값의 비율\n\n<!-- PAGE_32 -->\n###### · 대조군 (Control) : 실험 결과의 판정을 위한 표준물질로 연구에 사용되는 물질 또는 샘플군\n\n<!-- PAGE_32 -->\n###### · 독성기준값 (Point of Departure, POD) : 시험에 사용된 용량 범위 내 자료의 수학적 모델링\n\n<!-- PAGE_32 -->\n###### 에 결정되는 값. NOAEL, LOAEL, BMDL 등을 의미함\n\n<!-- PAGE_32 -->\n###### · 만성독성 (Chronic toxicity) : 물질의 만성적인 투여에 의해 나타나는 독성\n\n<!-- PAGE_32 -->\n###### · 반수치사농도 (LC50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 공기\n\n<!-- PAGE_32 -->\n###### 중 농도\n\n<!-- PAGE_32 -->\n###### · 반수치사용량 (LD50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 용량\n\n<!-- PAGE_32 -->\n###### · 반복투여독성 (Repeated dose toxicity) : 시험물질을 시험동물에 반복 투여하여 중․장기간 내\n\n- - 27 -\n<!-- PAGE_33 -->\n###### 에 나타나는 독성을 질적, 양적으로 검사하는 시험으로 최대무독성량(NOAEL)등의 산정을\n\n<!-- PAGE_33 -->\n###### 목적으로 수행함.\n\n",
        "original_sentence": "(기준 농도(benchmark concentration, BMC)라고도 함) 배경에 대비하여 부정적 효과에 대한\n\n<!-- PAGE_32 -->\n###### 반응률에 사전에 설정한 변화(기준 반응(benchma가 response, BMR)를 나타내는 용량의 통\n\n<!-- PAGE_32 -->\n###### c. "
      }
    },
    {
      "chunk_id": "chunk_265",
      "text": "어떤 독성에 대해 사전에 정한 확률이 작은 증분(통상 1～10%)만 그 발생률을높이는 투여\n\n<!-- PAGE_32 -->\n###### 량에서의 물질에 의한 노출. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 264,
        "window_size": 3,
        "char_count": 92,
        "word_count": 20,
        "page_number": 32,
        "window_text": "민감화\n\n<!-- PAGE_32 -->\n###### · 단회투여독성 (Acute toxicity) : 독성 물질에 대한 짧은 기간의 노출에 의해 발생하는 독성\n\n<!-- PAGE_32 -->\n###### 으로 일반적으로 24시간 이내의 노출에 의해 발생함\n\n<!-- PAGE_32 -->\n###### · 기준점, 벤치마크 (Benchmark) :\n\n<!-- PAGE_32 -->\n###### a.  효과를 위해 사전에 설정한 변형된 반응을 나타내는 용량이 통계적 하한 신뢰 한계\n\n<!-- PAGE_32 -->\n###### b.  (기준 농도(benchmark concentration, BMC)라고도 함) 배경에 대비하여 부정적 효과에 대한\n\n<!-- PAGE_32 -->\n###### 반응률에 사전에 설정한 변화(기준 반응(benchma가 response, BMR)를 나타내는 용량의 통\n\n<!-- PAGE_32 -->\n###### c.  어떤 독성에 대해 사전에 정한 확률이 작은 증분(통상 1～10%)만 그 발생률을높이는 투여\n\n<!-- PAGE_32 -->\n###### 량에서의 물질에 의한 노출.  혹은 사전에 정한 척도나 생물학적 영향의 변화에 관련 있는\n\n<!-- PAGE_32 -->\n###### 투여량.  (농림수산성 및 후생노동성(일본), 2005; 식품 안전성에 관한 리스크 관리 표준 절\n\n<!-- PAGE_32 -->\n###### · 기준용량, 벤치마크용량 (Benchmark dose, BMD) : 특정 물질이 생체에 미리 정해진 수준의\n\n<!-- PAGE_32 -->\n###### 반응(기준 반응, Benchmark response level, BMR)을 야기할 것으로 예측되는 용량\n\n<!-- PAGE_32 -->\n###### · 노출 (Exposure) : 일정기간동안 일정한 빈도로 집단 혹은 개인이 경구 섭취, 호흡하거나 직\n\n<!-- PAGE_32 -->\n###### 접 접촉(예, 피부나 눈을 통해) 화학물질과 접촉하는 것을 말하며 단기노출(급성)과 장기노\n\n<!-- PAGE_32 -->\n###### 출(만성)로 구분됨\n\n<!-- PAGE_32 -->\n###### · 노출시나리오 (Exposure scenario) : 특정 물질의 생산부터 실사용까지 생체에 노출되는 방\n\n<!-- PAGE_32 -->\n###### 식을 가상적으로 규정한 것\n\n<!-- PAGE_32 -->\n###### · 노출안전역 (Margin of Exposure, MOE) : 추정 노출량에 대한 NOAEL 등과 같이 독성이 관\n\n<!-- PAGE_32 -->\n###### 찰되지 않는 독성값의 비율\n\n<!-- PAGE_32 -->\n###### · 대조군 (Control) : 실험 결과의 판정을 위한 표준물질로 연구에 사용되는 물질 또는 샘플군\n\n<!-- PAGE_32 -->\n###### · 독성기준값 (Point of Departure, POD) : 시험에 사용된 용량 범위 내 자료의 수학적 모델링\n\n<!-- PAGE_32 -->\n###### 에 결정되는 값. NOAEL, LOAEL, BMDL 등을 의미함\n\n<!-- PAGE_32 -->\n###### · 만성독성 (Chronic toxicity) : 물질의 만성적인 투여에 의해 나타나는 독성\n\n<!-- PAGE_32 -->\n###### · 반수치사농도 (LC50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 공기\n\n<!-- PAGE_32 -->\n###### 중 농도\n\n<!-- PAGE_32 -->\n###### · 반수치사용량 (LD50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 용량\n\n<!-- PAGE_32 -->\n###### · 반복투여독성 (Repeated dose toxicity) : 시험물질을 시험동물에 반복 투여하여 중․장기간 내\n\n- - 27 -\n<!-- PAGE_33 -->\n###### 에 나타나는 독성을 질적, 양적으로 검사하는 시험으로 최대무독성량(NOAEL)등의 산정을\n\n<!-- PAGE_33 -->\n###### 목적으로 수행함.\n\n <!-- PAGE_33 -->\n###### · 발생 독성 (Developmental toxicity) : 개체가 발생하는 동안에 노출된 물질에 의해 발생하는\n\n<!-- PAGE_33 -->\n###### 자궁 내 사망, 기형, 성장저해 등을 포함하는 위해 반응. ",
        "original_sentence": "어떤 독성에 대해 사전에 정한 확률이 작은 증분(통상 1～10%)만 그 발생률을높이는 투여\n\n<!-- PAGE_32 -->\n###### 량에서의 물질에 의한 노출. "
      }
    },
    {
      "chunk_id": "chunk_266",
      "text": "혹은 사전에 정한 척도나 생물학적 영향의 변화에 관련 있는\n\n<!-- PAGE_32 -->\n###### 투여량. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 265,
        "window_size": 3,
        "char_count": 63,
        "word_count": 14,
        "page_number": 32,
        "window_text": "효과를 위해 사전에 설정한 변형된 반응을 나타내는 용량이 통계적 하한 신뢰 한계\n\n<!-- PAGE_32 -->\n###### b.  (기준 농도(benchmark concentration, BMC)라고도 함) 배경에 대비하여 부정적 효과에 대한\n\n<!-- PAGE_32 -->\n###### 반응률에 사전에 설정한 변화(기준 반응(benchma가 response, BMR)를 나타내는 용량의 통\n\n<!-- PAGE_32 -->\n###### c.  어떤 독성에 대해 사전에 정한 확률이 작은 증분(통상 1～10%)만 그 발생률을높이는 투여\n\n<!-- PAGE_32 -->\n###### 량에서의 물질에 의한 노출.  혹은 사전에 정한 척도나 생물학적 영향의 변화에 관련 있는\n\n<!-- PAGE_32 -->\n###### 투여량.  (농림수산성 및 후생노동성(일본), 2005; 식품 안전성에 관한 리스크 관리 표준 절\n\n<!-- PAGE_32 -->\n###### · 기준용량, 벤치마크용량 (Benchmark dose, BMD) : 특정 물질이 생체에 미리 정해진 수준의\n\n<!-- PAGE_32 -->\n###### 반응(기준 반응, Benchmark response level, BMR)을 야기할 것으로 예측되는 용량\n\n<!-- PAGE_32 -->\n###### · 노출 (Exposure) : 일정기간동안 일정한 빈도로 집단 혹은 개인이 경구 섭취, 호흡하거나 직\n\n<!-- PAGE_32 -->\n###### 접 접촉(예, 피부나 눈을 통해) 화학물질과 접촉하는 것을 말하며 단기노출(급성)과 장기노\n\n<!-- PAGE_32 -->\n###### 출(만성)로 구분됨\n\n<!-- PAGE_32 -->\n###### · 노출시나리오 (Exposure scenario) : 특정 물질의 생산부터 실사용까지 생체에 노출되는 방\n\n<!-- PAGE_32 -->\n###### 식을 가상적으로 규정한 것\n\n<!-- PAGE_32 -->\n###### · 노출안전역 (Margin of Exposure, MOE) : 추정 노출량에 대한 NOAEL 등과 같이 독성이 관\n\n<!-- PAGE_32 -->\n###### 찰되지 않는 독성값의 비율\n\n<!-- PAGE_32 -->\n###### · 대조군 (Control) : 실험 결과의 판정을 위한 표준물질로 연구에 사용되는 물질 또는 샘플군\n\n<!-- PAGE_32 -->\n###### · 독성기준값 (Point of Departure, POD) : 시험에 사용된 용량 범위 내 자료의 수학적 모델링\n\n<!-- PAGE_32 -->\n###### 에 결정되는 값. NOAEL, LOAEL, BMDL 등을 의미함\n\n<!-- PAGE_32 -->\n###### · 만성독성 (Chronic toxicity) : 물질의 만성적인 투여에 의해 나타나는 독성\n\n<!-- PAGE_32 -->\n###### · 반수치사농도 (LC50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 공기\n\n<!-- PAGE_32 -->\n###### 중 농도\n\n<!-- PAGE_32 -->\n###### · 반수치사용량 (LD50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 용량\n\n<!-- PAGE_32 -->\n###### · 반복투여독성 (Repeated dose toxicity) : 시험물질을 시험동물에 반복 투여하여 중․장기간 내\n\n- - 27 -\n<!-- PAGE_33 -->\n###### 에 나타나는 독성을 질적, 양적으로 검사하는 시험으로 최대무독성량(NOAEL)등의 산정을\n\n<!-- PAGE_33 -->\n###### 목적으로 수행함.\n\n <!-- PAGE_33 -->\n###### · 발생 독성 (Developmental toxicity) : 개체가 발생하는 동안에 노출된 물질에 의해 발생하는\n\n<!-- PAGE_33 -->\n###### 자궁 내 사망, 기형, 성장저해 등을 포함하는 위해 반응.  가역적 또는 비가역적 반응이 가\n\n<!-- PAGE_33 -->\n###### 능함\n\n<!-- PAGE_33 -->\n###### · 발암성 (Carcinogenicity) : 어떤 물질의 투여로 인한 영향으로 체내에 악성 종양이 발생되거\n\n<!-- PAGE_33 -->\n###### · 부식성 (Corrosive) : 투여 후 조직의 파괴(necrosis)를 야기하는 성질\n\n<!-- PAGE_33 -->\n###### · 불확실성계수 (Uncertainty factor, UF) : 동물시험 자료를 활용하여 사람에 대한 효과를 예\n\n<!-- PAGE_33 -->\n###### 측할 때 발생할 수 있는 여러 불확(실)도의 발생원(예, 종간 차이, 개인 간 차이, 상승 작용,\n\n<!-- PAGE_33 -->\n###### 서로 다른 노출 경로(경구, 경피, 흡입 등))을 감안하여 조정에 활용되는 계수. ",
        "original_sentence": "혹은 사전에 정한 척도나 생물학적 영향의 변화에 관련 있는\n\n<!-- PAGE_32 -->\n###### 투여량. "
      }
    },
    {
      "chunk_id": "chunk_267",
      "text": "(농림수산성 및 후생노동성(일본), 2005; 식품 안전성에 관한 리스크 관리 표준 절\n\n<!-- PAGE_32 -->\n###### · 기준용량, 벤치마크용량 (Benchmark dose, BMD) : 특정 물질이 생체에 미리 정해진 수준의\n\n<!-- PAGE_32 -->\n###### 반응(기준 반응, Benchmark response level, BMR)을 야기할 것으로 예측되는 용량\n\n<!-- PAGE_32 -->\n###### · 노출 (Exposure) : 일정기간동안 일정한 빈도로 집단 혹은 개인이 경구 섭취, 호흡하거나 직\n\n<!-- PAGE_32 -->\n###### 접 접촉(예, 피부나 눈을 통해) 화학물질과 접촉하는 것을 말하며 단기노출(급성)과 장기노\n\n<!-- PAGE_32 -->\n###### 출(만성)로 구분됨\n\n<!-- PAGE_32 -->\n###### · 노출시나리오 (Exposure scenario) : 특정 물질의 생산부터 실사용까지 생체에 노출되는 방\n\n<!-- PAGE_32 -->\n###### 식을 가상적으로 규정한 것\n\n<!-- PAGE_32 -->\n###### · 노출안전역 (Margin of Exposure, MOE) : 추정 노출량에 대한 NOAEL 등과 같이 독성이 관\n\n<!-- PAGE_32 -->\n###### 찰되지 않는 독성값의 비율\n\n<!-- PAGE_32 -->\n###### · 대조군 (Control) : 실험 결과의 판정을 위한 표준물질로 연구에 사용되는 물질 또는 샘플군\n\n<!-- PAGE_32 -->\n###### · 독성기준값 (Point of Departure, POD) : 시험에 사용된 용량 범위 내 자료의 수학적 모델링\n\n<!-- PAGE_32 -->\n###### 에 결정되는 값. NOAEL, LOAEL, BMDL 등을 의미함\n\n<!-- PAGE_32 -->\n###### · 만성독성 (Chronic toxicity) : 물질의 만성적인 투여에 의해 나타나는 독성\n\n<!-- PAGE_32 -->\n###### · 반수치사농도 (LC50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 공기\n\n<!-- PAGE_32 -->\n###### 중 농도\n\n<!-- PAGE_32 -->\n###### · 반수치사용량 (LD50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 용량\n\n<!-- PAGE_32 -->\n###### · 반복투여독성 (Repeated dose toxicity) : 시험물질을 시험동물에 반복 투여하여 중․장기간 내\n\n- - 27 -\n<!-- PAGE_33 -->\n###### 에 나타나는 독성을 질적, 양적으로 검사하는 시험으로 최대무독성량(NOAEL)등의 산정을\n\n<!-- PAGE_33 -->\n###### 목적으로 수행함.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 266,
        "window_size": 3,
        "char_count": 1374,
        "word_count": 277,
        "page_number": 32,
        "window_text": "(기준 농도(benchmark concentration, BMC)라고도 함) 배경에 대비하여 부정적 효과에 대한\n\n<!-- PAGE_32 -->\n###### 반응률에 사전에 설정한 변화(기준 반응(benchma가 response, BMR)를 나타내는 용량의 통\n\n<!-- PAGE_32 -->\n###### c.  어떤 독성에 대해 사전에 정한 확률이 작은 증분(통상 1～10%)만 그 발생률을높이는 투여\n\n<!-- PAGE_32 -->\n###### 량에서의 물질에 의한 노출.  혹은 사전에 정한 척도나 생물학적 영향의 변화에 관련 있는\n\n<!-- PAGE_32 -->\n###### 투여량.  (농림수산성 및 후생노동성(일본), 2005; 식품 안전성에 관한 리스크 관리 표준 절\n\n<!-- PAGE_32 -->\n###### · 기준용량, 벤치마크용량 (Benchmark dose, BMD) : 특정 물질이 생체에 미리 정해진 수준의\n\n<!-- PAGE_32 -->\n###### 반응(기준 반응, Benchmark response level, BMR)을 야기할 것으로 예측되는 용량\n\n<!-- PAGE_32 -->\n###### · 노출 (Exposure) : 일정기간동안 일정한 빈도로 집단 혹은 개인이 경구 섭취, 호흡하거나 직\n\n<!-- PAGE_32 -->\n###### 접 접촉(예, 피부나 눈을 통해) 화학물질과 접촉하는 것을 말하며 단기노출(급성)과 장기노\n\n<!-- PAGE_32 -->\n###### 출(만성)로 구분됨\n\n<!-- PAGE_32 -->\n###### · 노출시나리오 (Exposure scenario) : 특정 물질의 생산부터 실사용까지 생체에 노출되는 방\n\n<!-- PAGE_32 -->\n###### 식을 가상적으로 규정한 것\n\n<!-- PAGE_32 -->\n###### · 노출안전역 (Margin of Exposure, MOE) : 추정 노출량에 대한 NOAEL 등과 같이 독성이 관\n\n<!-- PAGE_32 -->\n###### 찰되지 않는 독성값의 비율\n\n<!-- PAGE_32 -->\n###### · 대조군 (Control) : 실험 결과의 판정을 위한 표준물질로 연구에 사용되는 물질 또는 샘플군\n\n<!-- PAGE_32 -->\n###### · 독성기준값 (Point of Departure, POD) : 시험에 사용된 용량 범위 내 자료의 수학적 모델링\n\n<!-- PAGE_32 -->\n###### 에 결정되는 값. NOAEL, LOAEL, BMDL 등을 의미함\n\n<!-- PAGE_32 -->\n###### · 만성독성 (Chronic toxicity) : 물질의 만성적인 투여에 의해 나타나는 독성\n\n<!-- PAGE_32 -->\n###### · 반수치사농도 (LC50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 공기\n\n<!-- PAGE_32 -->\n###### 중 농도\n\n<!-- PAGE_32 -->\n###### · 반수치사용량 (LD50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 용량\n\n<!-- PAGE_32 -->\n###### · 반복투여독성 (Repeated dose toxicity) : 시험물질을 시험동물에 반복 투여하여 중․장기간 내\n\n- - 27 -\n<!-- PAGE_33 -->\n###### 에 나타나는 독성을 질적, 양적으로 검사하는 시험으로 최대무독성량(NOAEL)등의 산정을\n\n<!-- PAGE_33 -->\n###### 목적으로 수행함.\n\n <!-- PAGE_33 -->\n###### · 발생 독성 (Developmental toxicity) : 개체가 발생하는 동안에 노출된 물질에 의해 발생하는\n\n<!-- PAGE_33 -->\n###### 자궁 내 사망, 기형, 성장저해 등을 포함하는 위해 반응.  가역적 또는 비가역적 반응이 가\n\n<!-- PAGE_33 -->\n###### 능함\n\n<!-- PAGE_33 -->\n###### · 발암성 (Carcinogenicity) : 어떤 물질의 투여로 인한 영향으로 체내에 악성 종양이 발생되거\n\n<!-- PAGE_33 -->\n###### · 부식성 (Corrosive) : 투여 후 조직의 파괴(necrosis)를 야기하는 성질\n\n<!-- PAGE_33 -->\n###### · 불확실성계수 (Uncertainty factor, UF) : 동물시험 자료를 활용하여 사람에 대한 효과를 예\n\n<!-- PAGE_33 -->\n###### 측할 때 발생할 수 있는 여러 불확(실)도의 발생원(예, 종간 차이, 개인 간 차이, 상승 작용,\n\n<!-- PAGE_33 -->\n###### 서로 다른 노출 경로(경구, 경피, 흡입 등))을 감안하여 조정에 활용되는 계수.  불확실성 계\n\n<!-- PAGE_33 -->\n###### 수의 값은 독성의 특성, 보호대상 집단의 규모와 유형, 유용한 독성학적 정보의 질적 수준\n\n<!-- PAGE_33 -->\n###### 에 따라 달라짐\n\n<!-- PAGE_33 -->\n###### · 생식독성 (Reproductive toxicity) : 자손 생성을 위한 기관의 능력을 감소시키는 몸 또는 조\n\n<!-- PAGE_33 -->\n###### 직에 미치는 해로운 영향\n\n<!-- PAGE_33 -->\n###### · 생식․발생독성시험 (Reproductive and developmental toxicity studies) : 시험물질이 포유류의\n\n<!-- PAGE_33 -->\n###### 생식·발생에 미치는 영향을 규명하는 시험을 말하며, 수태능 및 초기배 발생시험, 출생\n\n<!-- PAGE_33 -->\n###### 전·후 모체기능시험 및 배·태자발생시험 등이 있음\n\n<!-- PAGE_33 -->\n###### a. ",
        "original_sentence": "(농림수산성 및 후생노동성(일본), 2005; 식품 안전성에 관한 리스크 관리 표준 절\n\n<!-- PAGE_32 -->\n###### · 기준용량, 벤치마크용량 (Benchmark dose, BMD) : 특정 물질이 생체에 미리 정해진 수준의\n\n<!-- PAGE_32 -->\n###### 반응(기준 반응, Benchmark response level, BMR)을 야기할 것으로 예측되는 용량\n\n<!-- PAGE_32 -->\n###### · 노출 (Exposure) : 일정기간동안 일정한 빈도로 집단 혹은 개인이 경구 섭취, 호흡하거나 직\n\n<!-- PAGE_32 -->\n###### 접 접촉(예, 피부나 눈을 통해) 화학물질과 접촉하는 것을 말하며 단기노출(급성)과 장기노\n\n<!-- PAGE_32 -->\n###### 출(만성)로 구분됨\n\n<!-- PAGE_32 -->\n###### · 노출시나리오 (Exposure scenario) : 특정 물질의 생산부터 실사용까지 생체에 노출되는 방\n\n<!-- PAGE_32 -->\n###### 식을 가상적으로 규정한 것\n\n<!-- PAGE_32 -->\n###### · 노출안전역 (Margin of Exposure, MOE) : 추정 노출량에 대한 NOAEL 등과 같이 독성이 관\n\n<!-- PAGE_32 -->\n###### 찰되지 않는 독성값의 비율\n\n<!-- PAGE_32 -->\n###### · 대조군 (Control) : 실험 결과의 판정을 위한 표준물질로 연구에 사용되는 물질 또는 샘플군\n\n<!-- PAGE_32 -->\n###### · 독성기준값 (Point of Departure, POD) : 시험에 사용된 용량 범위 내 자료의 수학적 모델링\n\n<!-- PAGE_32 -->\n###### 에 결정되는 값. NOAEL, LOAEL, BMDL 등을 의미함\n\n<!-- PAGE_32 -->\n###### · 만성독성 (Chronic toxicity) : 물질의 만성적인 투여에 의해 나타나는 독성\n\n<!-- PAGE_32 -->\n###### · 반수치사농도 (LC50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 공기\n\n<!-- PAGE_32 -->\n###### 중 농도\n\n<!-- PAGE_32 -->\n###### · 반수치사용량 (LD50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 용량\n\n<!-- PAGE_32 -->\n###### · 반복투여독성 (Repeated dose toxicity) : 시험물질을 시험동물에 반복 투여하여 중․장기간 내\n\n- - 27 -\n<!-- PAGE_33 -->\n###### 에 나타나는 독성을 질적, 양적으로 검사하는 시험으로 최대무독성량(NOAEL)등의 산정을\n\n<!-- PAGE_33 -->\n###### 목적으로 수행함.\n\n"
      }
    },
    {
      "chunk_id": "chunk_268",
      "text": "<!-- PAGE_33 -->\n###### · 발생 독성 (Developmental toxicity) : 개체가 발생하는 동안에 노출된 물질에 의해 발생하는\n\n<!-- PAGE_33 -->\n###### 자궁 내 사망, 기형, 성장저해 등을 포함하는 위해 반응. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 267,
        "window_size": 3,
        "char_count": 146,
        "word_count": 30,
        "page_number": 33,
        "window_text": "어떤 독성에 대해 사전에 정한 확률이 작은 증분(통상 1～10%)만 그 발생률을높이는 투여\n\n<!-- PAGE_32 -->\n###### 량에서의 물질에 의한 노출.  혹은 사전에 정한 척도나 생물학적 영향의 변화에 관련 있는\n\n<!-- PAGE_32 -->\n###### 투여량.  (농림수산성 및 후생노동성(일본), 2005; 식품 안전성에 관한 리스크 관리 표준 절\n\n<!-- PAGE_32 -->\n###### · 기준용량, 벤치마크용량 (Benchmark dose, BMD) : 특정 물질이 생체에 미리 정해진 수준의\n\n<!-- PAGE_32 -->\n###### 반응(기준 반응, Benchmark response level, BMR)을 야기할 것으로 예측되는 용량\n\n<!-- PAGE_32 -->\n###### · 노출 (Exposure) : 일정기간동안 일정한 빈도로 집단 혹은 개인이 경구 섭취, 호흡하거나 직\n\n<!-- PAGE_32 -->\n###### 접 접촉(예, 피부나 눈을 통해) 화학물질과 접촉하는 것을 말하며 단기노출(급성)과 장기노\n\n<!-- PAGE_32 -->\n###### 출(만성)로 구분됨\n\n<!-- PAGE_32 -->\n###### · 노출시나리오 (Exposure scenario) : 특정 물질의 생산부터 실사용까지 생체에 노출되는 방\n\n<!-- PAGE_32 -->\n###### 식을 가상적으로 규정한 것\n\n<!-- PAGE_32 -->\n###### · 노출안전역 (Margin of Exposure, MOE) : 추정 노출량에 대한 NOAEL 등과 같이 독성이 관\n\n<!-- PAGE_32 -->\n###### 찰되지 않는 독성값의 비율\n\n<!-- PAGE_32 -->\n###### · 대조군 (Control) : 실험 결과의 판정을 위한 표준물질로 연구에 사용되는 물질 또는 샘플군\n\n<!-- PAGE_32 -->\n###### · 독성기준값 (Point of Departure, POD) : 시험에 사용된 용량 범위 내 자료의 수학적 모델링\n\n<!-- PAGE_32 -->\n###### 에 결정되는 값. NOAEL, LOAEL, BMDL 등을 의미함\n\n<!-- PAGE_32 -->\n###### · 만성독성 (Chronic toxicity) : 물질의 만성적인 투여에 의해 나타나는 독성\n\n<!-- PAGE_32 -->\n###### · 반수치사농도 (LC50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 공기\n\n<!-- PAGE_32 -->\n###### 중 농도\n\n<!-- PAGE_32 -->\n###### · 반수치사용량 (LD50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 용량\n\n<!-- PAGE_32 -->\n###### · 반복투여독성 (Repeated dose toxicity) : 시험물질을 시험동물에 반복 투여하여 중․장기간 내\n\n- - 27 -\n<!-- PAGE_33 -->\n###### 에 나타나는 독성을 질적, 양적으로 검사하는 시험으로 최대무독성량(NOAEL)등의 산정을\n\n<!-- PAGE_33 -->\n###### 목적으로 수행함.\n\n <!-- PAGE_33 -->\n###### · 발생 독성 (Developmental toxicity) : 개체가 발생하는 동안에 노출된 물질에 의해 발생하는\n\n<!-- PAGE_33 -->\n###### 자궁 내 사망, 기형, 성장저해 등을 포함하는 위해 반응.  가역적 또는 비가역적 반응이 가\n\n<!-- PAGE_33 -->\n###### 능함\n\n<!-- PAGE_33 -->\n###### · 발암성 (Carcinogenicity) : 어떤 물질의 투여로 인한 영향으로 체내에 악성 종양이 발생되거\n\n<!-- PAGE_33 -->\n###### · 부식성 (Corrosive) : 투여 후 조직의 파괴(necrosis)를 야기하는 성질\n\n<!-- PAGE_33 -->\n###### · 불확실성계수 (Uncertainty factor, UF) : 동물시험 자료를 활용하여 사람에 대한 효과를 예\n\n<!-- PAGE_33 -->\n###### 측할 때 발생할 수 있는 여러 불확(실)도의 발생원(예, 종간 차이, 개인 간 차이, 상승 작용,\n\n<!-- PAGE_33 -->\n###### 서로 다른 노출 경로(경구, 경피, 흡입 등))을 감안하여 조정에 활용되는 계수.  불확실성 계\n\n<!-- PAGE_33 -->\n###### 수의 값은 독성의 특성, 보호대상 집단의 규모와 유형, 유용한 독성학적 정보의 질적 수준\n\n<!-- PAGE_33 -->\n###### 에 따라 달라짐\n\n<!-- PAGE_33 -->\n###### · 생식독성 (Reproductive toxicity) : 자손 생성을 위한 기관의 능력을 감소시키는 몸 또는 조\n\n<!-- PAGE_33 -->\n###### 직에 미치는 해로운 영향\n\n<!-- PAGE_33 -->\n###### · 생식․발생독성시험 (Reproductive and developmental toxicity studies) : 시험물질이 포유류의\n\n<!-- PAGE_33 -->\n###### 생식·발생에 미치는 영향을 규명하는 시험을 말하며, 수태능 및 초기배 발생시험, 출생\n\n<!-- PAGE_33 -->\n###### 전·후 모체기능시험 및 배·태자발생시험 등이 있음\n\n<!-- PAGE_33 -->\n###### a.  1세대 생식발생독성시험(One Generation Study) : 생식·발생독성시험에서 모세대에만 물질\n\n<!-- PAGE_33 -->\n###### b. ",
        "original_sentence": "<!-- PAGE_33 -->\n###### · 발생 독성 (Developmental toxicity) : 개체가 발생하는 동안에 노출된 물질에 의해 발생하는\n\n<!-- PAGE_33 -->\n###### 자궁 내 사망, 기형, 성장저해 등을 포함하는 위해 반응. "
      }
    },
    {
      "chunk_id": "chunk_269",
      "text": "가역적 또는 비가역적 반응이 가\n\n<!-- PAGE_33 -->\n###### 능함\n\n<!-- PAGE_33 -->\n###### · 발암성 (Carcinogenicity) : 어떤 물질의 투여로 인한 영향으로 체내에 악성 종양이 발생되거\n\n<!-- PAGE_33 -->\n###### · 부식성 (Corrosive) : 투여 후 조직의 파괴(necrosis)를 야기하는 성질\n\n<!-- PAGE_33 -->\n###### · 불확실성계수 (Uncertainty factor, UF) : 동물시험 자료를 활용하여 사람에 대한 효과를 예\n\n<!-- PAGE_33 -->\n###### 측할 때 발생할 수 있는 여러 불확(실)도의 발생원(예, 종간 차이, 개인 간 차이, 상승 작용,\n\n<!-- PAGE_33 -->\n###### 서로 다른 노출 경로(경구, 경피, 흡입 등))을 감안하여 조정에 활용되는 계수. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 268,
        "window_size": 3,
        "char_count": 447,
        "word_count": 92,
        "page_number": 33,
        "window_text": "혹은 사전에 정한 척도나 생물학적 영향의 변화에 관련 있는\n\n<!-- PAGE_32 -->\n###### 투여량.  (농림수산성 및 후생노동성(일본), 2005; 식품 안전성에 관한 리스크 관리 표준 절\n\n<!-- PAGE_32 -->\n###### · 기준용량, 벤치마크용량 (Benchmark dose, BMD) : 특정 물질이 생체에 미리 정해진 수준의\n\n<!-- PAGE_32 -->\n###### 반응(기준 반응, Benchmark response level, BMR)을 야기할 것으로 예측되는 용량\n\n<!-- PAGE_32 -->\n###### · 노출 (Exposure) : 일정기간동안 일정한 빈도로 집단 혹은 개인이 경구 섭취, 호흡하거나 직\n\n<!-- PAGE_32 -->\n###### 접 접촉(예, 피부나 눈을 통해) 화학물질과 접촉하는 것을 말하며 단기노출(급성)과 장기노\n\n<!-- PAGE_32 -->\n###### 출(만성)로 구분됨\n\n<!-- PAGE_32 -->\n###### · 노출시나리오 (Exposure scenario) : 특정 물질의 생산부터 실사용까지 생체에 노출되는 방\n\n<!-- PAGE_32 -->\n###### 식을 가상적으로 규정한 것\n\n<!-- PAGE_32 -->\n###### · 노출안전역 (Margin of Exposure, MOE) : 추정 노출량에 대한 NOAEL 등과 같이 독성이 관\n\n<!-- PAGE_32 -->\n###### 찰되지 않는 독성값의 비율\n\n<!-- PAGE_32 -->\n###### · 대조군 (Control) : 실험 결과의 판정을 위한 표준물질로 연구에 사용되는 물질 또는 샘플군\n\n<!-- PAGE_32 -->\n###### · 독성기준값 (Point of Departure, POD) : 시험에 사용된 용량 범위 내 자료의 수학적 모델링\n\n<!-- PAGE_32 -->\n###### 에 결정되는 값. NOAEL, LOAEL, BMDL 등을 의미함\n\n<!-- PAGE_32 -->\n###### · 만성독성 (Chronic toxicity) : 물질의 만성적인 투여에 의해 나타나는 독성\n\n<!-- PAGE_32 -->\n###### · 반수치사농도 (LC50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 공기\n\n<!-- PAGE_32 -->\n###### 중 농도\n\n<!-- PAGE_32 -->\n###### · 반수치사용량 (LD50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 용량\n\n<!-- PAGE_32 -->\n###### · 반복투여독성 (Repeated dose toxicity) : 시험물질을 시험동물에 반복 투여하여 중․장기간 내\n\n- - 27 -\n<!-- PAGE_33 -->\n###### 에 나타나는 독성을 질적, 양적으로 검사하는 시험으로 최대무독성량(NOAEL)등의 산정을\n\n<!-- PAGE_33 -->\n###### 목적으로 수행함.\n\n <!-- PAGE_33 -->\n###### · 발생 독성 (Developmental toxicity) : 개체가 발생하는 동안에 노출된 물질에 의해 발생하는\n\n<!-- PAGE_33 -->\n###### 자궁 내 사망, 기형, 성장저해 등을 포함하는 위해 반응.  가역적 또는 비가역적 반응이 가\n\n<!-- PAGE_33 -->\n###### 능함\n\n<!-- PAGE_33 -->\n###### · 발암성 (Carcinogenicity) : 어떤 물질의 투여로 인한 영향으로 체내에 악성 종양이 발생되거\n\n<!-- PAGE_33 -->\n###### · 부식성 (Corrosive) : 투여 후 조직의 파괴(necrosis)를 야기하는 성질\n\n<!-- PAGE_33 -->\n###### · 불확실성계수 (Uncertainty factor, UF) : 동물시험 자료를 활용하여 사람에 대한 효과를 예\n\n<!-- PAGE_33 -->\n###### 측할 때 발생할 수 있는 여러 불확(실)도의 발생원(예, 종간 차이, 개인 간 차이, 상승 작용,\n\n<!-- PAGE_33 -->\n###### 서로 다른 노출 경로(경구, 경피, 흡입 등))을 감안하여 조정에 활용되는 계수.  불확실성 계\n\n<!-- PAGE_33 -->\n###### 수의 값은 독성의 특성, 보호대상 집단의 규모와 유형, 유용한 독성학적 정보의 질적 수준\n\n<!-- PAGE_33 -->\n###### 에 따라 달라짐\n\n<!-- PAGE_33 -->\n###### · 생식독성 (Reproductive toxicity) : 자손 생성을 위한 기관의 능력을 감소시키는 몸 또는 조\n\n<!-- PAGE_33 -->\n###### 직에 미치는 해로운 영향\n\n<!-- PAGE_33 -->\n###### · 생식․발생독성시험 (Reproductive and developmental toxicity studies) : 시험물질이 포유류의\n\n<!-- PAGE_33 -->\n###### 생식·발생에 미치는 영향을 규명하는 시험을 말하며, 수태능 및 초기배 발생시험, 출생\n\n<!-- PAGE_33 -->\n###### 전·후 모체기능시험 및 배·태자발생시험 등이 있음\n\n<!-- PAGE_33 -->\n###### a.  1세대 생식발생독성시험(One Generation Study) : 생식·발생독성시험에서 모세대에만 물질\n\n<!-- PAGE_33 -->\n###### b.  2세대 생식발생독성시험(Two Generation Study) : 생식·발생독성시험에서 모체와 차세대(2\n\n<!-- PAGE_33 -->\n###### 세대)에 물질을 직접 투여하고, 모체·차세대 및 그 다음 세대에 미치는 영향(발정․교미․수\n\n<!-- PAGE_33 -->\n###### c. ",
        "original_sentence": "가역적 또는 비가역적 반응이 가\n\n<!-- PAGE_33 -->\n###### 능함\n\n<!-- PAGE_33 -->\n###### · 발암성 (Carcinogenicity) : 어떤 물질의 투여로 인한 영향으로 체내에 악성 종양이 발생되거\n\n<!-- PAGE_33 -->\n###### · 부식성 (Corrosive) : 투여 후 조직의 파괴(necrosis)를 야기하는 성질\n\n<!-- PAGE_33 -->\n###### · 불확실성계수 (Uncertainty factor, UF) : 동물시험 자료를 활용하여 사람에 대한 효과를 예\n\n<!-- PAGE_33 -->\n###### 측할 때 발생할 수 있는 여러 불확(실)도의 발생원(예, 종간 차이, 개인 간 차이, 상승 작용,\n\n<!-- PAGE_33 -->\n###### 서로 다른 노출 경로(경구, 경피, 흡입 등))을 감안하여 조정에 활용되는 계수. "
      }
    },
    {
      "chunk_id": "chunk_270",
      "text": "불확실성 계\n\n<!-- PAGE_33 -->\n###### 수의 값은 독성의 특성, 보호대상 집단의 규모와 유형, 유용한 독성학적 정보의 질적 수준\n\n<!-- PAGE_33 -->\n###### 에 따라 달라짐\n\n<!-- PAGE_33 -->\n###### · 생식독성 (Reproductive toxicity) : 자손 생성을 위한 기관의 능력을 감소시키는 몸 또는 조\n\n<!-- PAGE_33 -->\n###### 직에 미치는 해로운 영향\n\n<!-- PAGE_33 -->\n###### · 생식․발생독성시험 (Reproductive and developmental toxicity studies) : 시험물질이 포유류의\n\n<!-- PAGE_33 -->\n###### 생식·발생에 미치는 영향을 규명하는 시험을 말하며, 수태능 및 초기배 발생시험, 출생\n\n<!-- PAGE_33 -->\n###### 전·후 모체기능시험 및 배·태자발생시험 등이 있음\n\n<!-- PAGE_33 -->\n###### a. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 269,
        "window_size": 3,
        "char_count": 498,
        "word_count": 96,
        "page_number": 33,
        "window_text": "(농림수산성 및 후생노동성(일본), 2005; 식품 안전성에 관한 리스크 관리 표준 절\n\n<!-- PAGE_32 -->\n###### · 기준용량, 벤치마크용량 (Benchmark dose, BMD) : 특정 물질이 생체에 미리 정해진 수준의\n\n<!-- PAGE_32 -->\n###### 반응(기준 반응, Benchmark response level, BMR)을 야기할 것으로 예측되는 용량\n\n<!-- PAGE_32 -->\n###### · 노출 (Exposure) : 일정기간동안 일정한 빈도로 집단 혹은 개인이 경구 섭취, 호흡하거나 직\n\n<!-- PAGE_32 -->\n###### 접 접촉(예, 피부나 눈을 통해) 화학물질과 접촉하는 것을 말하며 단기노출(급성)과 장기노\n\n<!-- PAGE_32 -->\n###### 출(만성)로 구분됨\n\n<!-- PAGE_32 -->\n###### · 노출시나리오 (Exposure scenario) : 특정 물질의 생산부터 실사용까지 생체에 노출되는 방\n\n<!-- PAGE_32 -->\n###### 식을 가상적으로 규정한 것\n\n<!-- PAGE_32 -->\n###### · 노출안전역 (Margin of Exposure, MOE) : 추정 노출량에 대한 NOAEL 등과 같이 독성이 관\n\n<!-- PAGE_32 -->\n###### 찰되지 않는 독성값의 비율\n\n<!-- PAGE_32 -->\n###### · 대조군 (Control) : 실험 결과의 판정을 위한 표준물질로 연구에 사용되는 물질 또는 샘플군\n\n<!-- PAGE_32 -->\n###### · 독성기준값 (Point of Departure, POD) : 시험에 사용된 용량 범위 내 자료의 수학적 모델링\n\n<!-- PAGE_32 -->\n###### 에 결정되는 값. NOAEL, LOAEL, BMDL 등을 의미함\n\n<!-- PAGE_32 -->\n###### · 만성독성 (Chronic toxicity) : 물질의 만성적인 투여에 의해 나타나는 독성\n\n<!-- PAGE_32 -->\n###### · 반수치사농도 (LC50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 공기\n\n<!-- PAGE_32 -->\n###### 중 농도\n\n<!-- PAGE_32 -->\n###### · 반수치사용량 (LD50) : 급성 노출 시에 반수의 실험동물에서 치사를 유발할 수 있는 용량\n\n<!-- PAGE_32 -->\n###### · 반복투여독성 (Repeated dose toxicity) : 시험물질을 시험동물에 반복 투여하여 중․장기간 내\n\n- - 27 -\n<!-- PAGE_33 -->\n###### 에 나타나는 독성을 질적, 양적으로 검사하는 시험으로 최대무독성량(NOAEL)등의 산정을\n\n<!-- PAGE_33 -->\n###### 목적으로 수행함.\n\n <!-- PAGE_33 -->\n###### · 발생 독성 (Developmental toxicity) : 개체가 발생하는 동안에 노출된 물질에 의해 발생하는\n\n<!-- PAGE_33 -->\n###### 자궁 내 사망, 기형, 성장저해 등을 포함하는 위해 반응.  가역적 또는 비가역적 반응이 가\n\n<!-- PAGE_33 -->\n###### 능함\n\n<!-- PAGE_33 -->\n###### · 발암성 (Carcinogenicity) : 어떤 물질의 투여로 인한 영향으로 체내에 악성 종양이 발생되거\n\n<!-- PAGE_33 -->\n###### · 부식성 (Corrosive) : 투여 후 조직의 파괴(necrosis)를 야기하는 성질\n\n<!-- PAGE_33 -->\n###### · 불확실성계수 (Uncertainty factor, UF) : 동물시험 자료를 활용하여 사람에 대한 효과를 예\n\n<!-- PAGE_33 -->\n###### 측할 때 발생할 수 있는 여러 불확(실)도의 발생원(예, 종간 차이, 개인 간 차이, 상승 작용,\n\n<!-- PAGE_33 -->\n###### 서로 다른 노출 경로(경구, 경피, 흡입 등))을 감안하여 조정에 활용되는 계수.  불확실성 계\n\n<!-- PAGE_33 -->\n###### 수의 값은 독성의 특성, 보호대상 집단의 규모와 유형, 유용한 독성학적 정보의 질적 수준\n\n<!-- PAGE_33 -->\n###### 에 따라 달라짐\n\n<!-- PAGE_33 -->\n###### · 생식독성 (Reproductive toxicity) : 자손 생성을 위한 기관의 능력을 감소시키는 몸 또는 조\n\n<!-- PAGE_33 -->\n###### 직에 미치는 해로운 영향\n\n<!-- PAGE_33 -->\n###### · 생식․발생독성시험 (Reproductive and developmental toxicity studies) : 시험물질이 포유류의\n\n<!-- PAGE_33 -->\n###### 생식·발생에 미치는 영향을 규명하는 시험을 말하며, 수태능 및 초기배 발생시험, 출생\n\n<!-- PAGE_33 -->\n###### 전·후 모체기능시험 및 배·태자발생시험 등이 있음\n\n<!-- PAGE_33 -->\n###### a.  1세대 생식발생독성시험(One Generation Study) : 생식·발생독성시험에서 모세대에만 물질\n\n<!-- PAGE_33 -->\n###### b.  2세대 생식발생독성시험(Two Generation Study) : 생식·발생독성시험에서 모체와 차세대(2\n\n<!-- PAGE_33 -->\n###### 세대)에 물질을 직접 투여하고, 모체·차세대 및 그 다음 세대에 미치는 영향(발정․교미․수\n\n<!-- PAGE_33 -->\n###### c.  3세대 생식발생독성시험(Three Generation Study) : 생식․발생독성시험에서 모세대와 차세대\n\n<!-- PAGE_33 -->\n###### 및 그 차세대 (3세대)에 물질을 직접 투여하고, 물질 투여세대 및 그 후세대에 미치는 영향\n\n<!-- PAGE_33 -->\n###### 을 평가하는 시험\n\n<!-- PAGE_33 -->\n###### · 생체 내 시험 (In vivo) : 생체내에서의 시험. ",
        "original_sentence": "불확실성 계\n\n<!-- PAGE_33 -->\n###### 수의 값은 독성의 특성, 보호대상 집단의 규모와 유형, 유용한 독성학적 정보의 질적 수준\n\n<!-- PAGE_33 -->\n###### 에 따라 달라짐\n\n<!-- PAGE_33 -->\n###### · 생식독성 (Reproductive toxicity) : 자손 생성을 위한 기관의 능력을 감소시키는 몸 또는 조\n\n<!-- PAGE_33 -->\n###### 직에 미치는 해로운 영향\n\n<!-- PAGE_33 -->\n###### · 생식․발생독성시험 (Reproductive and developmental toxicity studies) : 시험물질이 포유류의\n\n<!-- PAGE_33 -->\n###### 생식·발생에 미치는 영향을 규명하는 시험을 말하며, 수태능 및 초기배 발생시험, 출생\n\n<!-- PAGE_33 -->\n###### 전·후 모체기능시험 및 배·태자발생시험 등이 있음\n\n<!-- PAGE_33 -->\n###### a. "
      }
    },
    {
      "chunk_id": "chunk_271",
      "text": "1세대 생식발생독성시험(One Generation Study) : 생식·발생독성시험에서 모세대에만 물질\n\n<!-- PAGE_33 -->\n###### b. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 270,
        "window_size": 3,
        "char_count": 86,
        "word_count": 13,
        "page_number": 33,
        "window_text": "<!-- PAGE_33 -->\n###### · 발생 독성 (Developmental toxicity) : 개체가 발생하는 동안에 노출된 물질에 의해 발생하는\n\n<!-- PAGE_33 -->\n###### 자궁 내 사망, 기형, 성장저해 등을 포함하는 위해 반응.  가역적 또는 비가역적 반응이 가\n\n<!-- PAGE_33 -->\n###### 능함\n\n<!-- PAGE_33 -->\n###### · 발암성 (Carcinogenicity) : 어떤 물질의 투여로 인한 영향으로 체내에 악성 종양이 발생되거\n\n<!-- PAGE_33 -->\n###### · 부식성 (Corrosive) : 투여 후 조직의 파괴(necrosis)를 야기하는 성질\n\n<!-- PAGE_33 -->\n###### · 불확실성계수 (Uncertainty factor, UF) : 동물시험 자료를 활용하여 사람에 대한 효과를 예\n\n<!-- PAGE_33 -->\n###### 측할 때 발생할 수 있는 여러 불확(실)도의 발생원(예, 종간 차이, 개인 간 차이, 상승 작용,\n\n<!-- PAGE_33 -->\n###### 서로 다른 노출 경로(경구, 경피, 흡입 등))을 감안하여 조정에 활용되는 계수.  불확실성 계\n\n<!-- PAGE_33 -->\n###### 수의 값은 독성의 특성, 보호대상 집단의 규모와 유형, 유용한 독성학적 정보의 질적 수준\n\n<!-- PAGE_33 -->\n###### 에 따라 달라짐\n\n<!-- PAGE_33 -->\n###### · 생식독성 (Reproductive toxicity) : 자손 생성을 위한 기관의 능력을 감소시키는 몸 또는 조\n\n<!-- PAGE_33 -->\n###### 직에 미치는 해로운 영향\n\n<!-- PAGE_33 -->\n###### · 생식․발생독성시험 (Reproductive and developmental toxicity studies) : 시험물질이 포유류의\n\n<!-- PAGE_33 -->\n###### 생식·발생에 미치는 영향을 규명하는 시험을 말하며, 수태능 및 초기배 발생시험, 출생\n\n<!-- PAGE_33 -->\n###### 전·후 모체기능시험 및 배·태자발생시험 등이 있음\n\n<!-- PAGE_33 -->\n###### a.  1세대 생식발생독성시험(One Generation Study) : 생식·발생독성시험에서 모세대에만 물질\n\n<!-- PAGE_33 -->\n###### b.  2세대 생식발생독성시험(Two Generation Study) : 생식·발생독성시험에서 모체와 차세대(2\n\n<!-- PAGE_33 -->\n###### 세대)에 물질을 직접 투여하고, 모체·차세대 및 그 다음 세대에 미치는 영향(발정․교미․수\n\n<!-- PAGE_33 -->\n###### c.  3세대 생식발생독성시험(Three Generation Study) : 생식․발생독성시험에서 모세대와 차세대\n\n<!-- PAGE_33 -->\n###### 및 그 차세대 (3세대)에 물질을 직접 투여하고, 물질 투여세대 및 그 후세대에 미치는 영향\n\n<!-- PAGE_33 -->\n###### 을 평가하는 시험\n\n<!-- PAGE_33 -->\n###### · 생체 내 시험 (In vivo) : 생체내에서의 시험.  일반적으로 동물 및 인체 실험을 의미함\n\n<!-- PAGE_33 -->\n###### · 생체이용률 (Bioavailability) : 화학물질의 효과를 직접 또는 간접적으로 나타내는 주성분 또\n\n<!-- PAGE_33 -->\n###### 는 활성대사체의 노출 후 체내 전신 순환혈까지 도달하는 흡수속도와 양의 비율\n\n<!-- PAGE_33 -->\n###### · 시험관 시험 (In vitro) : 생체 바깥의 인공적인 환경에서의 시험\n\n<!-- PAGE_33 -->\n###### · 신뢰구간 (Confidence interval) : 특정 확률로 참 값을 함유하고 있을 것으로 통계적으로 예\n\n<!-- PAGE_33 -->\n###### 측되는 변수의 구간\n\n- - 28 -\n<!-- PAGE_34 -->\n###### · 안전역 (Margin of safety, MOS) : 화장품에 존재하는 위해요소의 최대무독성용량을 일일인\n\n<!-- PAGE_34 -->\n###### 체노출량으로 나눈 값\n\n<!-- PAGE_34 -->\n###### · 역치용량 (Threshold dose) : 효과가 나타나기 직전까지의 용량 또는 노출농도\n\n<!-- PAGE_34 -->\n###### · 용량 디스크립터 (Dose descriptor) : 생체 또는 환경 독성 시험에서 얻어지는 수치로 특정\n\n<!-- PAGE_34 -->\n###### 부작용을 일으키는 값 (예를 들면 반수 치사량) 또는 독성을 유발하지 않는 최대 농도(예:\n\n<!-- PAGE_34 -->\n###### NOAEL) 등의 수치를 일컬음\n\n<!-- PAGE_34 -->\n###### · 용량 반응 상관성 (Dose-response relationship) : 물질의 다양한 투여 양에 의한 반응의 차\n\n<!-- PAGE_34 -->\n###### · 위해 평가 (Risk assessment) : 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할\n\n<!-- PAGE_34 -->\n###### 수 있는 유해영향과 발생확률을 과학적으로 예측하는 일련의 과정으로 위험성 확인, 위험\n\n<!-- PAGE_34 -->\n###### 성 결정, 노출평가, 위해도 결정 등 일련의 단계\n\n<!-- PAGE_34 -->\n###### · 위험 (Hazard) : 물질의 내재적 독성\n\n<!-- PAGE_34 -->\n###### · 유전독성 (Genotoxicity) : 유전정보를 담고 있는 유전자(DNA)나 염색체에 변화를 주어 세포\n\n<!-- PAGE_34 -->\n###### 또는 개체에 악영향을 초래하는 성질로 변이원성이라고도 함. ",
        "original_sentence": "1세대 생식발생독성시험(One Generation Study) : 생식·발생독성시험에서 모세대에만 물질\n\n<!-- PAGE_33 -->\n###### b. "
      }
    },
    {
      "chunk_id": "chunk_272",
      "text": "2세대 생식발생독성시험(Two Generation Study) : 생식·발생독성시험에서 모체와 차세대(2\n\n<!-- PAGE_33 -->\n###### 세대)에 물질을 직접 투여하고, 모체·차세대 및 그 다음 세대에 미치는 영향(발정․교미․수\n\n<!-- PAGE_33 -->\n###### c. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 271,
        "window_size": 3,
        "char_count": 163,
        "word_count": 28,
        "page_number": 33,
        "window_text": "가역적 또는 비가역적 반응이 가\n\n<!-- PAGE_33 -->\n###### 능함\n\n<!-- PAGE_33 -->\n###### · 발암성 (Carcinogenicity) : 어떤 물질의 투여로 인한 영향으로 체내에 악성 종양이 발생되거\n\n<!-- PAGE_33 -->\n###### · 부식성 (Corrosive) : 투여 후 조직의 파괴(necrosis)를 야기하는 성질\n\n<!-- PAGE_33 -->\n###### · 불확실성계수 (Uncertainty factor, UF) : 동물시험 자료를 활용하여 사람에 대한 효과를 예\n\n<!-- PAGE_33 -->\n###### 측할 때 발생할 수 있는 여러 불확(실)도의 발생원(예, 종간 차이, 개인 간 차이, 상승 작용,\n\n<!-- PAGE_33 -->\n###### 서로 다른 노출 경로(경구, 경피, 흡입 등))을 감안하여 조정에 활용되는 계수.  불확실성 계\n\n<!-- PAGE_33 -->\n###### 수의 값은 독성의 특성, 보호대상 집단의 규모와 유형, 유용한 독성학적 정보의 질적 수준\n\n<!-- PAGE_33 -->\n###### 에 따라 달라짐\n\n<!-- PAGE_33 -->\n###### · 생식독성 (Reproductive toxicity) : 자손 생성을 위한 기관의 능력을 감소시키는 몸 또는 조\n\n<!-- PAGE_33 -->\n###### 직에 미치는 해로운 영향\n\n<!-- PAGE_33 -->\n###### · 생식․발생독성시험 (Reproductive and developmental toxicity studies) : 시험물질이 포유류의\n\n<!-- PAGE_33 -->\n###### 생식·발생에 미치는 영향을 규명하는 시험을 말하며, 수태능 및 초기배 발생시험, 출생\n\n<!-- PAGE_33 -->\n###### 전·후 모체기능시험 및 배·태자발생시험 등이 있음\n\n<!-- PAGE_33 -->\n###### a.  1세대 생식발생독성시험(One Generation Study) : 생식·발생독성시험에서 모세대에만 물질\n\n<!-- PAGE_33 -->\n###### b.  2세대 생식발생독성시험(Two Generation Study) : 생식·발생독성시험에서 모체와 차세대(2\n\n<!-- PAGE_33 -->\n###### 세대)에 물질을 직접 투여하고, 모체·차세대 및 그 다음 세대에 미치는 영향(발정․교미․수\n\n<!-- PAGE_33 -->\n###### c.  3세대 생식발생독성시험(Three Generation Study) : 생식․발생독성시험에서 모세대와 차세대\n\n<!-- PAGE_33 -->\n###### 및 그 차세대 (3세대)에 물질을 직접 투여하고, 물질 투여세대 및 그 후세대에 미치는 영향\n\n<!-- PAGE_33 -->\n###### 을 평가하는 시험\n\n<!-- PAGE_33 -->\n###### · 생체 내 시험 (In vivo) : 생체내에서의 시험.  일반적으로 동물 및 인체 실험을 의미함\n\n<!-- PAGE_33 -->\n###### · 생체이용률 (Bioavailability) : 화학물질의 효과를 직접 또는 간접적으로 나타내는 주성분 또\n\n<!-- PAGE_33 -->\n###### 는 활성대사체의 노출 후 체내 전신 순환혈까지 도달하는 흡수속도와 양의 비율\n\n<!-- PAGE_33 -->\n###### · 시험관 시험 (In vitro) : 생체 바깥의 인공적인 환경에서의 시험\n\n<!-- PAGE_33 -->\n###### · 신뢰구간 (Confidence interval) : 특정 확률로 참 값을 함유하고 있을 것으로 통계적으로 예\n\n<!-- PAGE_33 -->\n###### 측되는 변수의 구간\n\n- - 28 -\n<!-- PAGE_34 -->\n###### · 안전역 (Margin of safety, MOS) : 화장품에 존재하는 위해요소의 최대무독성용량을 일일인\n\n<!-- PAGE_34 -->\n###### 체노출량으로 나눈 값\n\n<!-- PAGE_34 -->\n###### · 역치용량 (Threshold dose) : 효과가 나타나기 직전까지의 용량 또는 노출농도\n\n<!-- PAGE_34 -->\n###### · 용량 디스크립터 (Dose descriptor) : 생체 또는 환경 독성 시험에서 얻어지는 수치로 특정\n\n<!-- PAGE_34 -->\n###### 부작용을 일으키는 값 (예를 들면 반수 치사량) 또는 독성을 유발하지 않는 최대 농도(예:\n\n<!-- PAGE_34 -->\n###### NOAEL) 등의 수치를 일컬음\n\n<!-- PAGE_34 -->\n###### · 용량 반응 상관성 (Dose-response relationship) : 물질의 다양한 투여 양에 의한 반응의 차\n\n<!-- PAGE_34 -->\n###### · 위해 평가 (Risk assessment) : 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할\n\n<!-- PAGE_34 -->\n###### 수 있는 유해영향과 발생확률을 과학적으로 예측하는 일련의 과정으로 위험성 확인, 위험\n\n<!-- PAGE_34 -->\n###### 성 결정, 노출평가, 위해도 결정 등 일련의 단계\n\n<!-- PAGE_34 -->\n###### · 위험 (Hazard) : 물질의 내재적 독성\n\n<!-- PAGE_34 -->\n###### · 유전독성 (Genotoxicity) : 유전정보를 담고 있는 유전자(DNA)나 염색체에 변화를 주어 세포\n\n<!-- PAGE_34 -->\n###### 또는 개체에 악영향을 초래하는 성질로 변이원성이라고도 함.  주된 변화로는 유전자 돌연변\n\n<!-- PAGE_34 -->\n###### 이, DNA 손상이나 염색체 이상(중복, 결실)등이 있다. ",
        "original_sentence": "2세대 생식발생독성시험(Two Generation Study) : 생식·발생독성시험에서 모체와 차세대(2\n\n<!-- PAGE_33 -->\n###### 세대)에 물질을 직접 투여하고, 모체·차세대 및 그 다음 세대에 미치는 영향(발정․교미․수\n\n<!-- PAGE_33 -->\n###### c. "
      }
    },
    {
      "chunk_id": "chunk_273",
      "text": "3세대 생식발생독성시험(Three Generation Study) : 생식․발생독성시험에서 모세대와 차세대\n\n<!-- PAGE_33 -->\n###### 및 그 차세대 (3세대)에 물질을 직접 투여하고, 물질 투여세대 및 그 후세대에 미치는 영향\n\n<!-- PAGE_33 -->\n###### 을 평가하는 시험\n\n<!-- PAGE_33 -->\n###### · 생체 내 시험 (In vivo) : 생체내에서의 시험. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 272,
        "window_size": 3,
        "char_count": 230,
        "word_count": 46,
        "page_number": 33,
        "window_text": "불확실성 계\n\n<!-- PAGE_33 -->\n###### 수의 값은 독성의 특성, 보호대상 집단의 규모와 유형, 유용한 독성학적 정보의 질적 수준\n\n<!-- PAGE_33 -->\n###### 에 따라 달라짐\n\n<!-- PAGE_33 -->\n###### · 생식독성 (Reproductive toxicity) : 자손 생성을 위한 기관의 능력을 감소시키는 몸 또는 조\n\n<!-- PAGE_33 -->\n###### 직에 미치는 해로운 영향\n\n<!-- PAGE_33 -->\n###### · 생식․발생독성시험 (Reproductive and developmental toxicity studies) : 시험물질이 포유류의\n\n<!-- PAGE_33 -->\n###### 생식·발생에 미치는 영향을 규명하는 시험을 말하며, 수태능 및 초기배 발생시험, 출생\n\n<!-- PAGE_33 -->\n###### 전·후 모체기능시험 및 배·태자발생시험 등이 있음\n\n<!-- PAGE_33 -->\n###### a.  1세대 생식발생독성시험(One Generation Study) : 생식·발생독성시험에서 모세대에만 물질\n\n<!-- PAGE_33 -->\n###### b.  2세대 생식발생독성시험(Two Generation Study) : 생식·발생독성시험에서 모체와 차세대(2\n\n<!-- PAGE_33 -->\n###### 세대)에 물질을 직접 투여하고, 모체·차세대 및 그 다음 세대에 미치는 영향(발정․교미․수\n\n<!-- PAGE_33 -->\n###### c.  3세대 생식발생독성시험(Three Generation Study) : 생식․발생독성시험에서 모세대와 차세대\n\n<!-- PAGE_33 -->\n###### 및 그 차세대 (3세대)에 물질을 직접 투여하고, 물질 투여세대 및 그 후세대에 미치는 영향\n\n<!-- PAGE_33 -->\n###### 을 평가하는 시험\n\n<!-- PAGE_33 -->\n###### · 생체 내 시험 (In vivo) : 생체내에서의 시험.  일반적으로 동물 및 인체 실험을 의미함\n\n<!-- PAGE_33 -->\n###### · 생체이용률 (Bioavailability) : 화학물질의 효과를 직접 또는 간접적으로 나타내는 주성분 또\n\n<!-- PAGE_33 -->\n###### 는 활성대사체의 노출 후 체내 전신 순환혈까지 도달하는 흡수속도와 양의 비율\n\n<!-- PAGE_33 -->\n###### · 시험관 시험 (In vitro) : 생체 바깥의 인공적인 환경에서의 시험\n\n<!-- PAGE_33 -->\n###### · 신뢰구간 (Confidence interval) : 특정 확률로 참 값을 함유하고 있을 것으로 통계적으로 예\n\n<!-- PAGE_33 -->\n###### 측되는 변수의 구간\n\n- - 28 -\n<!-- PAGE_34 -->\n###### · 안전역 (Margin of safety, MOS) : 화장품에 존재하는 위해요소의 최대무독성용량을 일일인\n\n<!-- PAGE_34 -->\n###### 체노출량으로 나눈 값\n\n<!-- PAGE_34 -->\n###### · 역치용량 (Threshold dose) : 효과가 나타나기 직전까지의 용량 또는 노출농도\n\n<!-- PAGE_34 -->\n###### · 용량 디스크립터 (Dose descriptor) : 생체 또는 환경 독성 시험에서 얻어지는 수치로 특정\n\n<!-- PAGE_34 -->\n###### 부작용을 일으키는 값 (예를 들면 반수 치사량) 또는 독성을 유발하지 않는 최대 농도(예:\n\n<!-- PAGE_34 -->\n###### NOAEL) 등의 수치를 일컬음\n\n<!-- PAGE_34 -->\n###### · 용량 반응 상관성 (Dose-response relationship) : 물질의 다양한 투여 양에 의한 반응의 차\n\n<!-- PAGE_34 -->\n###### · 위해 평가 (Risk assessment) : 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할\n\n<!-- PAGE_34 -->\n###### 수 있는 유해영향과 발생확률을 과학적으로 예측하는 일련의 과정으로 위험성 확인, 위험\n\n<!-- PAGE_34 -->\n###### 성 결정, 노출평가, 위해도 결정 등 일련의 단계\n\n<!-- PAGE_34 -->\n###### · 위험 (Hazard) : 물질의 내재적 독성\n\n<!-- PAGE_34 -->\n###### · 유전독성 (Genotoxicity) : 유전정보를 담고 있는 유전자(DNA)나 염색체에 변화를 주어 세포\n\n<!-- PAGE_34 -->\n###### 또는 개체에 악영향을 초래하는 성질로 변이원성이라고도 함.  주된 변화로는 유전자 돌연변\n\n<!-- PAGE_34 -->\n###### 이, DNA 손상이나 염색체 이상(중복, 결실)등이 있다.  이와 같은 이상을 일으키는 물질은\n\n<!-- PAGE_34 -->\n###### 종양 발생에 결부될 가능성이 있으며 생식세포에서 발생하면 다음 세대의 최기형성․유전병\n\n<!-- PAGE_34 -->\n###### 유발로 이어질 가능성이 있음\n\n<!-- PAGE_34 -->\n###### · 전신 노출량 (Systemic exposure dosage, SED) : 화장품 원료의 전신노출량 (Systemic\n\n<!-- PAGE_34 -->\n###### Exposure Dosage)은 하루에 체중 당 혈류로 들어가서 전신적으로 작용할 것이 예상되는 외\n\n<!-- PAGE_34 -->\n###### 적용량으로서 mg/kg bw/day로 표현함. ",
        "original_sentence": "3세대 생식발생독성시험(Three Generation Study) : 생식․발생독성시험에서 모세대와 차세대\n\n<!-- PAGE_33 -->\n###### 및 그 차세대 (3세대)에 물질을 직접 투여하고, 물질 투여세대 및 그 후세대에 미치는 영향\n\n<!-- PAGE_33 -->\n###### 을 평가하는 시험\n\n<!-- PAGE_33 -->\n###### · 생체 내 시험 (In vivo) : 생체내에서의 시험. "
      }
    },
    {
      "chunk_id": "chunk_274",
      "text": "일반적으로 동물 및 인체 실험을 의미함\n\n<!-- PAGE_33 -->\n###### · 생체이용률 (Bioavailability) : 화학물질의 효과를 직접 또는 간접적으로 나타내는 주성분 또\n\n<!-- PAGE_33 -->\n###### 는 활성대사체의 노출 후 체내 전신 순환혈까지 도달하는 흡수속도와 양의 비율\n\n<!-- PAGE_33 -->\n###### · 시험관 시험 (In vitro) : 생체 바깥의 인공적인 환경에서의 시험\n\n<!-- PAGE_33 -->\n###### · 신뢰구간 (Confidence interval) : 특정 확률로 참 값을 함유하고 있을 것으로 통계적으로 예\n\n<!-- PAGE_33 -->\n###### 측되는 변수의 구간\n\n- - 28 -\n<!-- PAGE_34 -->\n###### · 안전역 (Margin of safety, MOS) : 화장품에 존재하는 위해요소의 최대무독성용량을 일일인\n\n<!-- PAGE_34 -->\n###### 체노출량으로 나눈 값\n\n<!-- PAGE_34 -->\n###### · 역치용량 (Threshold dose) : 효과가 나타나기 직전까지의 용량 또는 노출농도\n\n<!-- PAGE_34 -->\n###### · 용량 디스크립터 (Dose descriptor) : 생체 또는 환경 독성 시험에서 얻어지는 수치로 특정\n\n<!-- PAGE_34 -->\n###### 부작용을 일으키는 값 (예를 들면 반수 치사량) 또는 독성을 유발하지 않는 최대 농도(예:\n\n<!-- PAGE_34 -->\n###### NOAEL) 등의 수치를 일컬음\n\n<!-- PAGE_34 -->\n###### · 용량 반응 상관성 (Dose-response relationship) : 물질의 다양한 투여 양에 의한 반응의 차\n\n<!-- PAGE_34 -->\n###### · 위해 평가 (Risk assessment) : 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할\n\n<!-- PAGE_34 -->\n###### 수 있는 유해영향과 발생확률을 과학적으로 예측하는 일련의 과정으로 위험성 확인, 위험\n\n<!-- PAGE_34 -->\n###### 성 결정, 노출평가, 위해도 결정 등 일련의 단계\n\n<!-- PAGE_34 -->\n###### · 위험 (Hazard) : 물질의 내재적 독성\n\n<!-- PAGE_34 -->\n###### · 유전독성 (Genotoxicity) : 유전정보를 담고 있는 유전자(DNA)나 염색체에 변화를 주어 세포\n\n<!-- PAGE_34 -->\n###### 또는 개체에 악영향을 초래하는 성질로 변이원성이라고도 함. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 273,
        "window_size": 3,
        "char_count": 1279,
        "word_count": 262,
        "page_number": 33,
        "window_text": "1세대 생식발생독성시험(One Generation Study) : 생식·발생독성시험에서 모세대에만 물질\n\n<!-- PAGE_33 -->\n###### b.  2세대 생식발생독성시험(Two Generation Study) : 생식·발생독성시험에서 모체와 차세대(2\n\n<!-- PAGE_33 -->\n###### 세대)에 물질을 직접 투여하고, 모체·차세대 및 그 다음 세대에 미치는 영향(발정․교미․수\n\n<!-- PAGE_33 -->\n###### c.  3세대 생식발생독성시험(Three Generation Study) : 생식․발생독성시험에서 모세대와 차세대\n\n<!-- PAGE_33 -->\n###### 및 그 차세대 (3세대)에 물질을 직접 투여하고, 물질 투여세대 및 그 후세대에 미치는 영향\n\n<!-- PAGE_33 -->\n###### 을 평가하는 시험\n\n<!-- PAGE_33 -->\n###### · 생체 내 시험 (In vivo) : 생체내에서의 시험.  일반적으로 동물 및 인체 실험을 의미함\n\n<!-- PAGE_33 -->\n###### · 생체이용률 (Bioavailability) : 화학물질의 효과를 직접 또는 간접적으로 나타내는 주성분 또\n\n<!-- PAGE_33 -->\n###### 는 활성대사체의 노출 후 체내 전신 순환혈까지 도달하는 흡수속도와 양의 비율\n\n<!-- PAGE_33 -->\n###### · 시험관 시험 (In vitro) : 생체 바깥의 인공적인 환경에서의 시험\n\n<!-- PAGE_33 -->\n###### · 신뢰구간 (Confidence interval) : 특정 확률로 참 값을 함유하고 있을 것으로 통계적으로 예\n\n<!-- PAGE_33 -->\n###### 측되는 변수의 구간\n\n- - 28 -\n<!-- PAGE_34 -->\n###### · 안전역 (Margin of safety, MOS) : 화장품에 존재하는 위해요소의 최대무독성용량을 일일인\n\n<!-- PAGE_34 -->\n###### 체노출량으로 나눈 값\n\n<!-- PAGE_34 -->\n###### · 역치용량 (Threshold dose) : 효과가 나타나기 직전까지의 용량 또는 노출농도\n\n<!-- PAGE_34 -->\n###### · 용량 디스크립터 (Dose descriptor) : 생체 또는 환경 독성 시험에서 얻어지는 수치로 특정\n\n<!-- PAGE_34 -->\n###### 부작용을 일으키는 값 (예를 들면 반수 치사량) 또는 독성을 유발하지 않는 최대 농도(예:\n\n<!-- PAGE_34 -->\n###### NOAEL) 등의 수치를 일컬음\n\n<!-- PAGE_34 -->\n###### · 용량 반응 상관성 (Dose-response relationship) : 물질의 다양한 투여 양에 의한 반응의 차\n\n<!-- PAGE_34 -->\n###### · 위해 평가 (Risk assessment) : 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할\n\n<!-- PAGE_34 -->\n###### 수 있는 유해영향과 발생확률을 과학적으로 예측하는 일련의 과정으로 위험성 확인, 위험\n\n<!-- PAGE_34 -->\n###### 성 결정, 노출평가, 위해도 결정 등 일련의 단계\n\n<!-- PAGE_34 -->\n###### · 위험 (Hazard) : 물질의 내재적 독성\n\n<!-- PAGE_34 -->\n###### · 유전독성 (Genotoxicity) : 유전정보를 담고 있는 유전자(DNA)나 염색체에 변화를 주어 세포\n\n<!-- PAGE_34 -->\n###### 또는 개체에 악영향을 초래하는 성질로 변이원성이라고도 함.  주된 변화로는 유전자 돌연변\n\n<!-- PAGE_34 -->\n###### 이, DNA 손상이나 염색체 이상(중복, 결실)등이 있다.  이와 같은 이상을 일으키는 물질은\n\n<!-- PAGE_34 -->\n###### 종양 발생에 결부될 가능성이 있으며 생식세포에서 발생하면 다음 세대의 최기형성․유전병\n\n<!-- PAGE_34 -->\n###### 유발로 이어질 가능성이 있음\n\n<!-- PAGE_34 -->\n###### · 전신 노출량 (Systemic exposure dosage, SED) : 화장품 원료의 전신노출량 (Systemic\n\n<!-- PAGE_34 -->\n###### Exposure Dosage)은 하루에 체중 당 혈류로 들어가서 전신적으로 작용할 것이 예상되는 외\n\n<!-- PAGE_34 -->\n###### 적용량으로서 mg/kg bw/day로 표현함.  화장품 위해 평가 시 피부노출량 또는 피부전신노출\n\n<!-- PAGE_34 -->\n###### 량이라 통칭함\n\n<!-- PAGE_34 -->\n###### · 정량한계 (Limit of Quantitation, LOQ) : 어떤 시료에 규정된 분석방법에서 바람직한 확실성\n\n<!-- PAGE_34 -->\n###### 을 가지고 정량할 수 있는 화학물질의 최저농도를 말하며, 수치상 유효적인 의미함. ",
        "original_sentence": "일반적으로 동물 및 인체 실험을 의미함\n\n<!-- PAGE_33 -->\n###### · 생체이용률 (Bioavailability) : 화학물질의 효과를 직접 또는 간접적으로 나타내는 주성분 또\n\n<!-- PAGE_33 -->\n###### 는 활성대사체의 노출 후 체내 전신 순환혈까지 도달하는 흡수속도와 양의 비율\n\n<!-- PAGE_33 -->\n###### · 시험관 시험 (In vitro) : 생체 바깥의 인공적인 환경에서의 시험\n\n<!-- PAGE_33 -->\n###### · 신뢰구간 (Confidence interval) : 특정 확률로 참 값을 함유하고 있을 것으로 통계적으로 예\n\n<!-- PAGE_33 -->\n###### 측되는 변수의 구간\n\n- - 28 -\n<!-- PAGE_34 -->\n###### · 안전역 (Margin of safety, MOS) : 화장품에 존재하는 위해요소의 최대무독성용량을 일일인\n\n<!-- PAGE_34 -->\n###### 체노출량으로 나눈 값\n\n<!-- PAGE_34 -->\n###### · 역치용량 (Threshold dose) : 효과가 나타나기 직전까지의 용량 또는 노출농도\n\n<!-- PAGE_34 -->\n###### · 용량 디스크립터 (Dose descriptor) : 생체 또는 환경 독성 시험에서 얻어지는 수치로 특정\n\n<!-- PAGE_34 -->\n###### 부작용을 일으키는 값 (예를 들면 반수 치사량) 또는 독성을 유발하지 않는 최대 농도(예:\n\n<!-- PAGE_34 -->\n###### NOAEL) 등의 수치를 일컬음\n\n<!-- PAGE_34 -->\n###### · 용량 반응 상관성 (Dose-response relationship) : 물질의 다양한 투여 양에 의한 반응의 차\n\n<!-- PAGE_34 -->\n###### · 위해 평가 (Risk assessment) : 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할\n\n<!-- PAGE_34 -->\n###### 수 있는 유해영향과 발생확률을 과학적으로 예측하는 일련의 과정으로 위험성 확인, 위험\n\n<!-- PAGE_34 -->\n###### 성 결정, 노출평가, 위해도 결정 등 일련의 단계\n\n<!-- PAGE_34 -->\n###### · 위험 (Hazard) : 물질의 내재적 독성\n\n<!-- PAGE_34 -->\n###### · 유전독성 (Genotoxicity) : 유전정보를 담고 있는 유전자(DNA)나 염색체에 변화를 주어 세포\n\n<!-- PAGE_34 -->\n###### 또는 개체에 악영향을 초래하는 성질로 변이원성이라고도 함. "
      }
    },
    {
      "chunk_id": "chunk_275",
      "text": "주된 변화로는 유전자 돌연변\n\n<!-- PAGE_34 -->\n###### 이, DNA 손상이나 염색체 이상(중복, 결실)등이 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 274,
        "window_size": 3,
        "char_count": 74,
        "word_count": 15,
        "page_number": 34,
        "window_text": "2세대 생식발생독성시험(Two Generation Study) : 생식·발생독성시험에서 모체와 차세대(2\n\n<!-- PAGE_33 -->\n###### 세대)에 물질을 직접 투여하고, 모체·차세대 및 그 다음 세대에 미치는 영향(발정․교미․수\n\n<!-- PAGE_33 -->\n###### c.  3세대 생식발생독성시험(Three Generation Study) : 생식․발생독성시험에서 모세대와 차세대\n\n<!-- PAGE_33 -->\n###### 및 그 차세대 (3세대)에 물질을 직접 투여하고, 물질 투여세대 및 그 후세대에 미치는 영향\n\n<!-- PAGE_33 -->\n###### 을 평가하는 시험\n\n<!-- PAGE_33 -->\n###### · 생체 내 시험 (In vivo) : 생체내에서의 시험.  일반적으로 동물 및 인체 실험을 의미함\n\n<!-- PAGE_33 -->\n###### · 생체이용률 (Bioavailability) : 화학물질의 효과를 직접 또는 간접적으로 나타내는 주성분 또\n\n<!-- PAGE_33 -->\n###### 는 활성대사체의 노출 후 체내 전신 순환혈까지 도달하는 흡수속도와 양의 비율\n\n<!-- PAGE_33 -->\n###### · 시험관 시험 (In vitro) : 생체 바깥의 인공적인 환경에서의 시험\n\n<!-- PAGE_33 -->\n###### · 신뢰구간 (Confidence interval) : 특정 확률로 참 값을 함유하고 있을 것으로 통계적으로 예\n\n<!-- PAGE_33 -->\n###### 측되는 변수의 구간\n\n- - 28 -\n<!-- PAGE_34 -->\n###### · 안전역 (Margin of safety, MOS) : 화장품에 존재하는 위해요소의 최대무독성용량을 일일인\n\n<!-- PAGE_34 -->\n###### 체노출량으로 나눈 값\n\n<!-- PAGE_34 -->\n###### · 역치용량 (Threshold dose) : 효과가 나타나기 직전까지의 용량 또는 노출농도\n\n<!-- PAGE_34 -->\n###### · 용량 디스크립터 (Dose descriptor) : 생체 또는 환경 독성 시험에서 얻어지는 수치로 특정\n\n<!-- PAGE_34 -->\n###### 부작용을 일으키는 값 (예를 들면 반수 치사량) 또는 독성을 유발하지 않는 최대 농도(예:\n\n<!-- PAGE_34 -->\n###### NOAEL) 등의 수치를 일컬음\n\n<!-- PAGE_34 -->\n###### · 용량 반응 상관성 (Dose-response relationship) : 물질의 다양한 투여 양에 의한 반응의 차\n\n<!-- PAGE_34 -->\n###### · 위해 평가 (Risk assessment) : 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할\n\n<!-- PAGE_34 -->\n###### 수 있는 유해영향과 발생확률을 과학적으로 예측하는 일련의 과정으로 위험성 확인, 위험\n\n<!-- PAGE_34 -->\n###### 성 결정, 노출평가, 위해도 결정 등 일련의 단계\n\n<!-- PAGE_34 -->\n###### · 위험 (Hazard) : 물질의 내재적 독성\n\n<!-- PAGE_34 -->\n###### · 유전독성 (Genotoxicity) : 유전정보를 담고 있는 유전자(DNA)나 염색체에 변화를 주어 세포\n\n<!-- PAGE_34 -->\n###### 또는 개체에 악영향을 초래하는 성질로 변이원성이라고도 함.  주된 변화로는 유전자 돌연변\n\n<!-- PAGE_34 -->\n###### 이, DNA 손상이나 염색체 이상(중복, 결실)등이 있다.  이와 같은 이상을 일으키는 물질은\n\n<!-- PAGE_34 -->\n###### 종양 발생에 결부될 가능성이 있으며 생식세포에서 발생하면 다음 세대의 최기형성․유전병\n\n<!-- PAGE_34 -->\n###### 유발로 이어질 가능성이 있음\n\n<!-- PAGE_34 -->\n###### · 전신 노출량 (Systemic exposure dosage, SED) : 화장품 원료의 전신노출량 (Systemic\n\n<!-- PAGE_34 -->\n###### Exposure Dosage)은 하루에 체중 당 혈류로 들어가서 전신적으로 작용할 것이 예상되는 외\n\n<!-- PAGE_34 -->\n###### 적용량으로서 mg/kg bw/day로 표현함.  화장품 위해 평가 시 피부노출량 또는 피부전신노출\n\n<!-- PAGE_34 -->\n###### 량이라 통칭함\n\n<!-- PAGE_34 -->\n###### · 정량한계 (Limit of Quantitation, LOQ) : 어떤 시료에 규정된 분석방법에서 바람직한 확실성\n\n<!-- PAGE_34 -->\n###### 을 가지고 정량할 수 있는 화학물질의 최저농도를 말하며, 수치상 유효적인 의미함.  정량하\n\n<!-- PAGE_34 -->\n###### 한치 미만이란 정량할 수 있는 정도의 양은 아니라는 의미로 0(제로)과는 의미가 다름\n\n<!-- PAGE_34 -->\n###### · 종말점 (Endpoint) : 측정 및 관찰 가능한 물질의 성질을 의미하며 독성학적으로는 일반적으\n\n<!-- PAGE_34 -->\n###### 로 자극감, 발암성, 기관별 독성 등 특정 장기 및 기관에 대한 개별 생물학적 효능을 의미\n\n<!-- PAGE_34 -->\n###### 함\n\n<!-- PAGE_34 -->\n###### · 최대무감작성유도용량 (No expected sensitization induced level, NESIL) : 사람 또는 동물에\n\n<!-- PAGE_34 -->\n###### 게 감작이 나타나지 않는 최대용량\n\n<!-- PAGE_34 -->\n###### · 최대무독성용량 (No observed adverse effect level, NOAEL) : 인간과 동물에게 부작용 및\n\n<!-- PAGE_34 -->\n###### 독성학적 영향이 관측되지 않는 최대 용량. ",
        "original_sentence": "주된 변화로는 유전자 돌연변\n\n<!-- PAGE_34 -->\n###### 이, DNA 손상이나 염색체 이상(중복, 결실)등이 있다. "
      }
    },
    {
      "chunk_id": "chunk_276",
      "text": "이와 같은 이상을 일으키는 물질은\n\n<!-- PAGE_34 -->\n###### 종양 발생에 결부될 가능성이 있으며 생식세포에서 발생하면 다음 세대의 최기형성․유전병\n\n<!-- PAGE_34 -->\n###### 유발로 이어질 가능성이 있음\n\n<!-- PAGE_34 -->\n###### · 전신 노출량 (Systemic exposure dosage, SED) : 화장품 원료의 전신노출량 (Systemic\n\n<!-- PAGE_34 -->\n###### Exposure Dosage)은 하루에 체중 당 혈류로 들어가서 전신적으로 작용할 것이 예상되는 외\n\n<!-- PAGE_34 -->\n###### 적용량으로서 mg/kg bw/day로 표현함. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 275,
        "window_size": 3,
        "char_count": 357,
        "word_count": 67,
        "page_number": 34,
        "window_text": "3세대 생식발생독성시험(Three Generation Study) : 생식․발생독성시험에서 모세대와 차세대\n\n<!-- PAGE_33 -->\n###### 및 그 차세대 (3세대)에 물질을 직접 투여하고, 물질 투여세대 및 그 후세대에 미치는 영향\n\n<!-- PAGE_33 -->\n###### 을 평가하는 시험\n\n<!-- PAGE_33 -->\n###### · 생체 내 시험 (In vivo) : 생체내에서의 시험.  일반적으로 동물 및 인체 실험을 의미함\n\n<!-- PAGE_33 -->\n###### · 생체이용률 (Bioavailability) : 화학물질의 효과를 직접 또는 간접적으로 나타내는 주성분 또\n\n<!-- PAGE_33 -->\n###### 는 활성대사체의 노출 후 체내 전신 순환혈까지 도달하는 흡수속도와 양의 비율\n\n<!-- PAGE_33 -->\n###### · 시험관 시험 (In vitro) : 생체 바깥의 인공적인 환경에서의 시험\n\n<!-- PAGE_33 -->\n###### · 신뢰구간 (Confidence interval) : 특정 확률로 참 값을 함유하고 있을 것으로 통계적으로 예\n\n<!-- PAGE_33 -->\n###### 측되는 변수의 구간\n\n- - 28 -\n<!-- PAGE_34 -->\n###### · 안전역 (Margin of safety, MOS) : 화장품에 존재하는 위해요소의 최대무독성용량을 일일인\n\n<!-- PAGE_34 -->\n###### 체노출량으로 나눈 값\n\n<!-- PAGE_34 -->\n###### · 역치용량 (Threshold dose) : 효과가 나타나기 직전까지의 용량 또는 노출농도\n\n<!-- PAGE_34 -->\n###### · 용량 디스크립터 (Dose descriptor) : 생체 또는 환경 독성 시험에서 얻어지는 수치로 특정\n\n<!-- PAGE_34 -->\n###### 부작용을 일으키는 값 (예를 들면 반수 치사량) 또는 독성을 유발하지 않는 최대 농도(예:\n\n<!-- PAGE_34 -->\n###### NOAEL) 등의 수치를 일컬음\n\n<!-- PAGE_34 -->\n###### · 용량 반응 상관성 (Dose-response relationship) : 물질의 다양한 투여 양에 의한 반응의 차\n\n<!-- PAGE_34 -->\n###### · 위해 평가 (Risk assessment) : 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할\n\n<!-- PAGE_34 -->\n###### 수 있는 유해영향과 발생확률을 과학적으로 예측하는 일련의 과정으로 위험성 확인, 위험\n\n<!-- PAGE_34 -->\n###### 성 결정, 노출평가, 위해도 결정 등 일련의 단계\n\n<!-- PAGE_34 -->\n###### · 위험 (Hazard) : 물질의 내재적 독성\n\n<!-- PAGE_34 -->\n###### · 유전독성 (Genotoxicity) : 유전정보를 담고 있는 유전자(DNA)나 염색체에 변화를 주어 세포\n\n<!-- PAGE_34 -->\n###### 또는 개체에 악영향을 초래하는 성질로 변이원성이라고도 함.  주된 변화로는 유전자 돌연변\n\n<!-- PAGE_34 -->\n###### 이, DNA 손상이나 염색체 이상(중복, 결실)등이 있다.  이와 같은 이상을 일으키는 물질은\n\n<!-- PAGE_34 -->\n###### 종양 발생에 결부될 가능성이 있으며 생식세포에서 발생하면 다음 세대의 최기형성․유전병\n\n<!-- PAGE_34 -->\n###### 유발로 이어질 가능성이 있음\n\n<!-- PAGE_34 -->\n###### · 전신 노출량 (Systemic exposure dosage, SED) : 화장품 원료의 전신노출량 (Systemic\n\n<!-- PAGE_34 -->\n###### Exposure Dosage)은 하루에 체중 당 혈류로 들어가서 전신적으로 작용할 것이 예상되는 외\n\n<!-- PAGE_34 -->\n###### 적용량으로서 mg/kg bw/day로 표현함.  화장품 위해 평가 시 피부노출량 또는 피부전신노출\n\n<!-- PAGE_34 -->\n###### 량이라 통칭함\n\n<!-- PAGE_34 -->\n###### · 정량한계 (Limit of Quantitation, LOQ) : 어떤 시료에 규정된 분석방법에서 바람직한 확실성\n\n<!-- PAGE_34 -->\n###### 을 가지고 정량할 수 있는 화학물질의 최저농도를 말하며, 수치상 유효적인 의미함.  정량하\n\n<!-- PAGE_34 -->\n###### 한치 미만이란 정량할 수 있는 정도의 양은 아니라는 의미로 0(제로)과는 의미가 다름\n\n<!-- PAGE_34 -->\n###### · 종말점 (Endpoint) : 측정 및 관찰 가능한 물질의 성질을 의미하며 독성학적으로는 일반적으\n\n<!-- PAGE_34 -->\n###### 로 자극감, 발암성, 기관별 독성 등 특정 장기 및 기관에 대한 개별 생물학적 효능을 의미\n\n<!-- PAGE_34 -->\n###### 함\n\n<!-- PAGE_34 -->\n###### · 최대무감작성유도용량 (No expected sensitization induced level, NESIL) : 사람 또는 동물에\n\n<!-- PAGE_34 -->\n###### 게 감작이 나타나지 않는 최대용량\n\n<!-- PAGE_34 -->\n###### · 최대무독성용량 (No observed adverse effect level, NOAEL) : 인간과 동물에게 부작용 및\n\n<!-- PAGE_34 -->\n###### 독성학적 영향이 관측되지 않는 최대 용량.  mg/kg body weight/day로 나타냄\n\n<!-- PAGE_34 -->\n###### · 최소독성용량 (Lowest observed adverse effect level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_34 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도\n\n- - 29 -\n<!-- PAGE_35 -->\n###### · 표적기관 (Target organ) : 물질이 나타내는 독성효과를 보이는 기관\n\n<!-- PAGE_35 -->\n###### · 피부 노출 (Dermal exposure) : 화학물질을 함유하는 매체와 피부의 접촉을 통한 노출로서,\n\n<!-- PAGE_35 -->\n###### 피부에 있어 흡착이나 흡수될 수 있는 양으로 정량\n\n<!-- PAGE_35 -->\n###### · 피부감작성시험 (Skin sensitization Test) : 실험물질(외용으로 사용되는 의약품, 화장품 및\n\n<!-- PAGE_35 -->\n###### 기타 물질)이 피부에 반복적으로 노출되었을 경우 나타날 수 있는 홍반 및 부종 등의 면역\n\n<!-- PAGE_35 -->\n###### 학적 피부과민반응을 평가하는 시험법으로 국소 림프절 검사(Local Lymph Node\n\n<!-- PAGE_35 -->\n###### Assay(LLNA)), Magnusson Kligman 기니피그 최대화 시험(Magunusson Kligman Guinea Pig\n\n<!-- PAGE_35 -->\n###### Maximisation Test, GPMT) 및 Buehler 시험이 있다. ",
        "original_sentence": "이와 같은 이상을 일으키는 물질은\n\n<!-- PAGE_34 -->\n###### 종양 발생에 결부될 가능성이 있으며 생식세포에서 발생하면 다음 세대의 최기형성․유전병\n\n<!-- PAGE_34 -->\n###### 유발로 이어질 가능성이 있음\n\n<!-- PAGE_34 -->\n###### · 전신 노출량 (Systemic exposure dosage, SED) : 화장품 원료의 전신노출량 (Systemic\n\n<!-- PAGE_34 -->\n###### Exposure Dosage)은 하루에 체중 당 혈류로 들어가서 전신적으로 작용할 것이 예상되는 외\n\n<!-- PAGE_34 -->\n###### 적용량으로서 mg/kg bw/day로 표현함. "
      }
    },
    {
      "chunk_id": "chunk_277",
      "text": "화장품 위해 평가 시 피부노출량 또는 피부전신노출\n\n<!-- PAGE_34 -->\n###### 량이라 통칭함\n\n<!-- PAGE_34 -->\n###### · 정량한계 (Limit of Quantitation, LOQ) : 어떤 시료에 규정된 분석방법에서 바람직한 확실성\n\n<!-- PAGE_34 -->\n###### 을 가지고 정량할 수 있는 화학물질의 최저농도를 말하며, 수치상 유효적인 의미함. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 276,
        "window_size": 3,
        "char_count": 222,
        "word_count": 45,
        "page_number": 34,
        "window_text": "일반적으로 동물 및 인체 실험을 의미함\n\n<!-- PAGE_33 -->\n###### · 생체이용률 (Bioavailability) : 화학물질의 효과를 직접 또는 간접적으로 나타내는 주성분 또\n\n<!-- PAGE_33 -->\n###### 는 활성대사체의 노출 후 체내 전신 순환혈까지 도달하는 흡수속도와 양의 비율\n\n<!-- PAGE_33 -->\n###### · 시험관 시험 (In vitro) : 생체 바깥의 인공적인 환경에서의 시험\n\n<!-- PAGE_33 -->\n###### · 신뢰구간 (Confidence interval) : 특정 확률로 참 값을 함유하고 있을 것으로 통계적으로 예\n\n<!-- PAGE_33 -->\n###### 측되는 변수의 구간\n\n- - 28 -\n<!-- PAGE_34 -->\n###### · 안전역 (Margin of safety, MOS) : 화장품에 존재하는 위해요소의 최대무독성용량을 일일인\n\n<!-- PAGE_34 -->\n###### 체노출량으로 나눈 값\n\n<!-- PAGE_34 -->\n###### · 역치용량 (Threshold dose) : 효과가 나타나기 직전까지의 용량 또는 노출농도\n\n<!-- PAGE_34 -->\n###### · 용량 디스크립터 (Dose descriptor) : 생체 또는 환경 독성 시험에서 얻어지는 수치로 특정\n\n<!-- PAGE_34 -->\n###### 부작용을 일으키는 값 (예를 들면 반수 치사량) 또는 독성을 유발하지 않는 최대 농도(예:\n\n<!-- PAGE_34 -->\n###### NOAEL) 등의 수치를 일컬음\n\n<!-- PAGE_34 -->\n###### · 용량 반응 상관성 (Dose-response relationship) : 물질의 다양한 투여 양에 의한 반응의 차\n\n<!-- PAGE_34 -->\n###### · 위해 평가 (Risk assessment) : 인체가 화장품에 존재하는 위해요소에 노출되었을 때 발생할\n\n<!-- PAGE_34 -->\n###### 수 있는 유해영향과 발생확률을 과학적으로 예측하는 일련의 과정으로 위험성 확인, 위험\n\n<!-- PAGE_34 -->\n###### 성 결정, 노출평가, 위해도 결정 등 일련의 단계\n\n<!-- PAGE_34 -->\n###### · 위험 (Hazard) : 물질의 내재적 독성\n\n<!-- PAGE_34 -->\n###### · 유전독성 (Genotoxicity) : 유전정보를 담고 있는 유전자(DNA)나 염색체에 변화를 주어 세포\n\n<!-- PAGE_34 -->\n###### 또는 개체에 악영향을 초래하는 성질로 변이원성이라고도 함.  주된 변화로는 유전자 돌연변\n\n<!-- PAGE_34 -->\n###### 이, DNA 손상이나 염색체 이상(중복, 결실)등이 있다.  이와 같은 이상을 일으키는 물질은\n\n<!-- PAGE_34 -->\n###### 종양 발생에 결부될 가능성이 있으며 생식세포에서 발생하면 다음 세대의 최기형성․유전병\n\n<!-- PAGE_34 -->\n###### 유발로 이어질 가능성이 있음\n\n<!-- PAGE_34 -->\n###### · 전신 노출량 (Systemic exposure dosage, SED) : 화장품 원료의 전신노출량 (Systemic\n\n<!-- PAGE_34 -->\n###### Exposure Dosage)은 하루에 체중 당 혈류로 들어가서 전신적으로 작용할 것이 예상되는 외\n\n<!-- PAGE_34 -->\n###### 적용량으로서 mg/kg bw/day로 표현함.  화장품 위해 평가 시 피부노출량 또는 피부전신노출\n\n<!-- PAGE_34 -->\n###### 량이라 통칭함\n\n<!-- PAGE_34 -->\n###### · 정량한계 (Limit of Quantitation, LOQ) : 어떤 시료에 규정된 분석방법에서 바람직한 확실성\n\n<!-- PAGE_34 -->\n###### 을 가지고 정량할 수 있는 화학물질의 최저농도를 말하며, 수치상 유효적인 의미함.  정량하\n\n<!-- PAGE_34 -->\n###### 한치 미만이란 정량할 수 있는 정도의 양은 아니라는 의미로 0(제로)과는 의미가 다름\n\n<!-- PAGE_34 -->\n###### · 종말점 (Endpoint) : 측정 및 관찰 가능한 물질의 성질을 의미하며 독성학적으로는 일반적으\n\n<!-- PAGE_34 -->\n###### 로 자극감, 발암성, 기관별 독성 등 특정 장기 및 기관에 대한 개별 생물학적 효능을 의미\n\n<!-- PAGE_34 -->\n###### 함\n\n<!-- PAGE_34 -->\n###### · 최대무감작성유도용량 (No expected sensitization induced level, NESIL) : 사람 또는 동물에\n\n<!-- PAGE_34 -->\n###### 게 감작이 나타나지 않는 최대용량\n\n<!-- PAGE_34 -->\n###### · 최대무독성용량 (No observed adverse effect level, NOAEL) : 인간과 동물에게 부작용 및\n\n<!-- PAGE_34 -->\n###### 독성학적 영향이 관측되지 않는 최대 용량.  mg/kg body weight/day로 나타냄\n\n<!-- PAGE_34 -->\n###### · 최소독성용량 (Lowest observed adverse effect level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_34 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도\n\n- - 29 -\n<!-- PAGE_35 -->\n###### · 표적기관 (Target organ) : 물질이 나타내는 독성효과를 보이는 기관\n\n<!-- PAGE_35 -->\n###### · 피부 노출 (Dermal exposure) : 화학물질을 함유하는 매체와 피부의 접촉을 통한 노출로서,\n\n<!-- PAGE_35 -->\n###### 피부에 있어 흡착이나 흡수될 수 있는 양으로 정량\n\n<!-- PAGE_35 -->\n###### · 피부감작성시험 (Skin sensitization Test) : 실험물질(외용으로 사용되는 의약품, 화장품 및\n\n<!-- PAGE_35 -->\n###### 기타 물질)이 피부에 반복적으로 노출되었을 경우 나타날 수 있는 홍반 및 부종 등의 면역\n\n<!-- PAGE_35 -->\n###### 학적 피부과민반응을 평가하는 시험법으로 국소 림프절 검사(Local Lymph Node\n\n<!-- PAGE_35 -->\n###### Assay(LLNA)), Magnusson Kligman 기니피그 최대화 시험(Magunusson Kligman Guinea Pig\n\n<!-- PAGE_35 -->\n###### Maximisation Test, GPMT) 및 Buehler 시험이 있다.  국소 림프절 검사는 동종 번식된 생쥐\n\n<!-- PAGE_35 -->\n###### 를 사용하는 방법으로 대상 성분의 사용부위에서의 국소림프절의 림프구 증식에 기반하고\n\n<!-- PAGE_35 -->\n###### 있다. ",
        "original_sentence": "화장품 위해 평가 시 피부노출량 또는 피부전신노출\n\n<!-- PAGE_34 -->\n###### 량이라 통칭함\n\n<!-- PAGE_34 -->\n###### · 정량한계 (Limit of Quantitation, LOQ) : 어떤 시료에 규정된 분석방법에서 바람직한 확실성\n\n<!-- PAGE_34 -->\n###### 을 가지고 정량할 수 있는 화학물질의 최저농도를 말하며, 수치상 유효적인 의미함. "
      }
    },
    {
      "chunk_id": "chunk_278",
      "text": "정량하\n\n<!-- PAGE_34 -->\n###### 한치 미만이란 정량할 수 있는 정도의 양은 아니라는 의미로 0(제로)과는 의미가 다름\n\n<!-- PAGE_34 -->\n###### · 종말점 (Endpoint) : 측정 및 관찰 가능한 물질의 성질을 의미하며 독성학적으로는 일반적으\n\n<!-- PAGE_34 -->\n###### 로 자극감, 발암성, 기관별 독성 등 특정 장기 및 기관에 대한 개별 생물학적 효능을 의미\n\n<!-- PAGE_34 -->\n###### 함\n\n<!-- PAGE_34 -->\n###### · 최대무감작성유도용량 (No expected sensitization induced level, NESIL) : 사람 또는 동물에\n\n<!-- PAGE_34 -->\n###### 게 감작이 나타나지 않는 최대용량\n\n<!-- PAGE_34 -->\n###### · 최대무독성용량 (No observed adverse effect level, NOAEL) : 인간과 동물에게 부작용 및\n\n<!-- PAGE_34 -->\n###### 독성학적 영향이 관측되지 않는 최대 용량. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 277,
        "window_size": 3,
        "char_count": 548,
        "word_count": 110,
        "page_number": 34,
        "window_text": "주된 변화로는 유전자 돌연변\n\n<!-- PAGE_34 -->\n###### 이, DNA 손상이나 염색체 이상(중복, 결실)등이 있다.  이와 같은 이상을 일으키는 물질은\n\n<!-- PAGE_34 -->\n###### 종양 발생에 결부될 가능성이 있으며 생식세포에서 발생하면 다음 세대의 최기형성․유전병\n\n<!-- PAGE_34 -->\n###### 유발로 이어질 가능성이 있음\n\n<!-- PAGE_34 -->\n###### · 전신 노출량 (Systemic exposure dosage, SED) : 화장품 원료의 전신노출량 (Systemic\n\n<!-- PAGE_34 -->\n###### Exposure Dosage)은 하루에 체중 당 혈류로 들어가서 전신적으로 작용할 것이 예상되는 외\n\n<!-- PAGE_34 -->\n###### 적용량으로서 mg/kg bw/day로 표현함.  화장품 위해 평가 시 피부노출량 또는 피부전신노출\n\n<!-- PAGE_34 -->\n###### 량이라 통칭함\n\n<!-- PAGE_34 -->\n###### · 정량한계 (Limit of Quantitation, LOQ) : 어떤 시료에 규정된 분석방법에서 바람직한 확실성\n\n<!-- PAGE_34 -->\n###### 을 가지고 정량할 수 있는 화학물질의 최저농도를 말하며, 수치상 유효적인 의미함.  정량하\n\n<!-- PAGE_34 -->\n###### 한치 미만이란 정량할 수 있는 정도의 양은 아니라는 의미로 0(제로)과는 의미가 다름\n\n<!-- PAGE_34 -->\n###### · 종말점 (Endpoint) : 측정 및 관찰 가능한 물질의 성질을 의미하며 독성학적으로는 일반적으\n\n<!-- PAGE_34 -->\n###### 로 자극감, 발암성, 기관별 독성 등 특정 장기 및 기관에 대한 개별 생물학적 효능을 의미\n\n<!-- PAGE_34 -->\n###### 함\n\n<!-- PAGE_34 -->\n###### · 최대무감작성유도용량 (No expected sensitization induced level, NESIL) : 사람 또는 동물에\n\n<!-- PAGE_34 -->\n###### 게 감작이 나타나지 않는 최대용량\n\n<!-- PAGE_34 -->\n###### · 최대무독성용량 (No observed adverse effect level, NOAEL) : 인간과 동물에게 부작용 및\n\n<!-- PAGE_34 -->\n###### 독성학적 영향이 관측되지 않는 최대 용량.  mg/kg body weight/day로 나타냄\n\n<!-- PAGE_34 -->\n###### · 최소독성용량 (Lowest observed adverse effect level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_34 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도\n\n- - 29 -\n<!-- PAGE_35 -->\n###### · 표적기관 (Target organ) : 물질이 나타내는 독성효과를 보이는 기관\n\n<!-- PAGE_35 -->\n###### · 피부 노출 (Dermal exposure) : 화학물질을 함유하는 매체와 피부의 접촉을 통한 노출로서,\n\n<!-- PAGE_35 -->\n###### 피부에 있어 흡착이나 흡수될 수 있는 양으로 정량\n\n<!-- PAGE_35 -->\n###### · 피부감작성시험 (Skin sensitization Test) : 실험물질(외용으로 사용되는 의약품, 화장품 및\n\n<!-- PAGE_35 -->\n###### 기타 물질)이 피부에 반복적으로 노출되었을 경우 나타날 수 있는 홍반 및 부종 등의 면역\n\n<!-- PAGE_35 -->\n###### 학적 피부과민반응을 평가하는 시험법으로 국소 림프절 검사(Local Lymph Node\n\n<!-- PAGE_35 -->\n###### Assay(LLNA)), Magnusson Kligman 기니피그 최대화 시험(Magunusson Kligman Guinea Pig\n\n<!-- PAGE_35 -->\n###### Maximisation Test, GPMT) 및 Buehler 시험이 있다.  국소 림프절 검사는 동종 번식된 생쥐\n\n<!-- PAGE_35 -->\n###### 를 사용하는 방법으로 대상 성분의 사용부위에서의 국소림프절의 림프구 증식에 기반하고\n\n<!-- PAGE_35 -->\n###### 있다.  이는 자극성지수(stimulation index, SI)로 결과를 얻을 수 있는 객관적인 방법이며, 실\n\n<!-- PAGE_35 -->\n###### 험 물질에 의하여 야기된 자극과 기제를 적용한 대조 동물의 자극과의 비율로 나타낸다.\n\n",
        "original_sentence": "정량하\n\n<!-- PAGE_34 -->\n###### 한치 미만이란 정량할 수 있는 정도의 양은 아니라는 의미로 0(제로)과는 의미가 다름\n\n<!-- PAGE_34 -->\n###### · 종말점 (Endpoint) : 측정 및 관찰 가능한 물질의 성질을 의미하며 독성학적으로는 일반적으\n\n<!-- PAGE_34 -->\n###### 로 자극감, 발암성, 기관별 독성 등 특정 장기 및 기관에 대한 개별 생물학적 효능을 의미\n\n<!-- PAGE_34 -->\n###### 함\n\n<!-- PAGE_34 -->\n###### · 최대무감작성유도용량 (No expected sensitization induced level, NESIL) : 사람 또는 동물에\n\n<!-- PAGE_34 -->\n###### 게 감작이 나타나지 않는 최대용량\n\n<!-- PAGE_34 -->\n###### · 최대무독성용량 (No observed adverse effect level, NOAEL) : 인간과 동물에게 부작용 및\n\n<!-- PAGE_34 -->\n###### 독성학적 영향이 관측되지 않는 최대 용량. "
      }
    },
    {
      "chunk_id": "chunk_279",
      "text": "mg/kg body weight/day로 나타냄\n\n<!-- PAGE_34 -->\n###### · 최소독성용량 (Lowest observed adverse effect level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_34 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도\n\n- - 29 -\n<!-- PAGE_35 -->\n###### · 표적기관 (Target organ) : 물질이 나타내는 독성효과를 보이는 기관\n\n<!-- PAGE_35 -->\n###### · 피부 노출 (Dermal exposure) : 화학물질을 함유하는 매체와 피부의 접촉을 통한 노출로서,\n\n<!-- PAGE_35 -->\n###### 피부에 있어 흡착이나 흡수될 수 있는 양으로 정량\n\n<!-- PAGE_35 -->\n###### · 피부감작성시험 (Skin sensitization Test) : 실험물질(외용으로 사용되는 의약품, 화장품 및\n\n<!-- PAGE_35 -->\n###### 기타 물질)이 피부에 반복적으로 노출되었을 경우 나타날 수 있는 홍반 및 부종 등의 면역\n\n<!-- PAGE_35 -->\n###### 학적 피부과민반응을 평가하는 시험법으로 국소 림프절 검사(Local Lymph Node\n\n<!-- PAGE_35 -->\n###### Assay(LLNA)), Magnusson Kligman 기니피그 최대화 시험(Magunusson Kligman Guinea Pig\n\n<!-- PAGE_35 -->\n###### Maximisation Test, GPMT) 및 Buehler 시험이 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 278,
        "window_size": 3,
        "char_count": 798,
        "word_count": 149,
        "page_number": 34,
        "window_text": "이와 같은 이상을 일으키는 물질은\n\n<!-- PAGE_34 -->\n###### 종양 발생에 결부될 가능성이 있으며 생식세포에서 발생하면 다음 세대의 최기형성․유전병\n\n<!-- PAGE_34 -->\n###### 유발로 이어질 가능성이 있음\n\n<!-- PAGE_34 -->\n###### · 전신 노출량 (Systemic exposure dosage, SED) : 화장품 원료의 전신노출량 (Systemic\n\n<!-- PAGE_34 -->\n###### Exposure Dosage)은 하루에 체중 당 혈류로 들어가서 전신적으로 작용할 것이 예상되는 외\n\n<!-- PAGE_34 -->\n###### 적용량으로서 mg/kg bw/day로 표현함.  화장품 위해 평가 시 피부노출량 또는 피부전신노출\n\n<!-- PAGE_34 -->\n###### 량이라 통칭함\n\n<!-- PAGE_34 -->\n###### · 정량한계 (Limit of Quantitation, LOQ) : 어떤 시료에 규정된 분석방법에서 바람직한 확실성\n\n<!-- PAGE_34 -->\n###### 을 가지고 정량할 수 있는 화학물질의 최저농도를 말하며, 수치상 유효적인 의미함.  정량하\n\n<!-- PAGE_34 -->\n###### 한치 미만이란 정량할 수 있는 정도의 양은 아니라는 의미로 0(제로)과는 의미가 다름\n\n<!-- PAGE_34 -->\n###### · 종말점 (Endpoint) : 측정 및 관찰 가능한 물질의 성질을 의미하며 독성학적으로는 일반적으\n\n<!-- PAGE_34 -->\n###### 로 자극감, 발암성, 기관별 독성 등 특정 장기 및 기관에 대한 개별 생물학적 효능을 의미\n\n<!-- PAGE_34 -->\n###### 함\n\n<!-- PAGE_34 -->\n###### · 최대무감작성유도용량 (No expected sensitization induced level, NESIL) : 사람 또는 동물에\n\n<!-- PAGE_34 -->\n###### 게 감작이 나타나지 않는 최대용량\n\n<!-- PAGE_34 -->\n###### · 최대무독성용량 (No observed adverse effect level, NOAEL) : 인간과 동물에게 부작용 및\n\n<!-- PAGE_34 -->\n###### 독성학적 영향이 관측되지 않는 최대 용량.  mg/kg body weight/day로 나타냄\n\n<!-- PAGE_34 -->\n###### · 최소독성용량 (Lowest observed adverse effect level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_34 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도\n\n- - 29 -\n<!-- PAGE_35 -->\n###### · 표적기관 (Target organ) : 물질이 나타내는 독성효과를 보이는 기관\n\n<!-- PAGE_35 -->\n###### · 피부 노출 (Dermal exposure) : 화학물질을 함유하는 매체와 피부의 접촉을 통한 노출로서,\n\n<!-- PAGE_35 -->\n###### 피부에 있어 흡착이나 흡수될 수 있는 양으로 정량\n\n<!-- PAGE_35 -->\n###### · 피부감작성시험 (Skin sensitization Test) : 실험물질(외용으로 사용되는 의약품, 화장품 및\n\n<!-- PAGE_35 -->\n###### 기타 물질)이 피부에 반복적으로 노출되었을 경우 나타날 수 있는 홍반 및 부종 등의 면역\n\n<!-- PAGE_35 -->\n###### 학적 피부과민반응을 평가하는 시험법으로 국소 림프절 검사(Local Lymph Node\n\n<!-- PAGE_35 -->\n###### Assay(LLNA)), Magnusson Kligman 기니피그 최대화 시험(Magunusson Kligman Guinea Pig\n\n<!-- PAGE_35 -->\n###### Maximisation Test, GPMT) 및 Buehler 시험이 있다.  국소 림프절 검사는 동종 번식된 생쥐\n\n<!-- PAGE_35 -->\n###### 를 사용하는 방법으로 대상 성분의 사용부위에서의 국소림프절의 림프구 증식에 기반하고\n\n<!-- PAGE_35 -->\n###### 있다.  이는 자극성지수(stimulation index, SI)로 결과를 얻을 수 있는 객관적인 방법이며, 실\n\n<!-- PAGE_35 -->\n###### 험 물질에 의하여 야기된 자극과 기제를 적용한 대조 동물의 자극과의 비율로 나타낸다.\n\n <!-- PAGE_35 -->\n###### Magnusson Kligman 기니피그 최대화 시험은 면역증강제 형태 시험이며 Freunds complete\n\n<!-- PAGE_35 -->\n###### 면역증강제를 사용하거나 사용하지 않는 조건에서 대상 성분의 피내주사에 의한 알레르기\n\n<!-- PAGE_35 -->\n###### 반응의 증가 여부로 판단한다. ",
        "original_sentence": "mg/kg body weight/day로 나타냄\n\n<!-- PAGE_34 -->\n###### · 최소독성용량 (Lowest observed adverse effect level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_34 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도\n\n- - 29 -\n<!-- PAGE_35 -->\n###### · 표적기관 (Target organ) : 물질이 나타내는 독성효과를 보이는 기관\n\n<!-- PAGE_35 -->\n###### · 피부 노출 (Dermal exposure) : 화학물질을 함유하는 매체와 피부의 접촉을 통한 노출로서,\n\n<!-- PAGE_35 -->\n###### 피부에 있어 흡착이나 흡수될 수 있는 양으로 정량\n\n<!-- PAGE_35 -->\n###### · 피부감작성시험 (Skin sensitization Test) : 실험물질(외용으로 사용되는 의약품, 화장품 및\n\n<!-- PAGE_35 -->\n###### 기타 물질)이 피부에 반복적으로 노출되었을 경우 나타날 수 있는 홍반 및 부종 등의 면역\n\n<!-- PAGE_35 -->\n###### 학적 피부과민반응을 평가하는 시험법으로 국소 림프절 검사(Local Lymph Node\n\n<!-- PAGE_35 -->\n###### Assay(LLNA)), Magnusson Kligman 기니피그 최대화 시험(Magunusson Kligman Guinea Pig\n\n<!-- PAGE_35 -->\n###### Maximisation Test, GPMT) 및 Buehler 시험이 있다. "
      }
    },
    {
      "chunk_id": "chunk_280",
      "text": "국소 림프절 검사는 동종 번식된 생쥐\n\n<!-- PAGE_35 -->\n###### 를 사용하는 방법으로 대상 성분의 사용부위에서의 국소림프절의 림프구 증식에 기반하고\n\n<!-- PAGE_35 -->\n###### 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 279,
        "window_size": 3,
        "char_count": 122,
        "word_count": 25,
        "page_number": 35,
        "window_text": "화장품 위해 평가 시 피부노출량 또는 피부전신노출\n\n<!-- PAGE_34 -->\n###### 량이라 통칭함\n\n<!-- PAGE_34 -->\n###### · 정량한계 (Limit of Quantitation, LOQ) : 어떤 시료에 규정된 분석방법에서 바람직한 확실성\n\n<!-- PAGE_34 -->\n###### 을 가지고 정량할 수 있는 화학물질의 최저농도를 말하며, 수치상 유효적인 의미함.  정량하\n\n<!-- PAGE_34 -->\n###### 한치 미만이란 정량할 수 있는 정도의 양은 아니라는 의미로 0(제로)과는 의미가 다름\n\n<!-- PAGE_34 -->\n###### · 종말점 (Endpoint) : 측정 및 관찰 가능한 물질의 성질을 의미하며 독성학적으로는 일반적으\n\n<!-- PAGE_34 -->\n###### 로 자극감, 발암성, 기관별 독성 등 특정 장기 및 기관에 대한 개별 생물학적 효능을 의미\n\n<!-- PAGE_34 -->\n###### 함\n\n<!-- PAGE_34 -->\n###### · 최대무감작성유도용량 (No expected sensitization induced level, NESIL) : 사람 또는 동물에\n\n<!-- PAGE_34 -->\n###### 게 감작이 나타나지 않는 최대용량\n\n<!-- PAGE_34 -->\n###### · 최대무독성용량 (No observed adverse effect level, NOAEL) : 인간과 동물에게 부작용 및\n\n<!-- PAGE_34 -->\n###### 독성학적 영향이 관측되지 않는 최대 용량.  mg/kg body weight/day로 나타냄\n\n<!-- PAGE_34 -->\n###### · 최소독성용량 (Lowest observed adverse effect level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_34 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도\n\n- - 29 -\n<!-- PAGE_35 -->\n###### · 표적기관 (Target organ) : 물질이 나타내는 독성효과를 보이는 기관\n\n<!-- PAGE_35 -->\n###### · 피부 노출 (Dermal exposure) : 화학물질을 함유하는 매체와 피부의 접촉을 통한 노출로서,\n\n<!-- PAGE_35 -->\n###### 피부에 있어 흡착이나 흡수될 수 있는 양으로 정량\n\n<!-- PAGE_35 -->\n###### · 피부감작성시험 (Skin sensitization Test) : 실험물질(외용으로 사용되는 의약품, 화장품 및\n\n<!-- PAGE_35 -->\n###### 기타 물질)이 피부에 반복적으로 노출되었을 경우 나타날 수 있는 홍반 및 부종 등의 면역\n\n<!-- PAGE_35 -->\n###### 학적 피부과민반응을 평가하는 시험법으로 국소 림프절 검사(Local Lymph Node\n\n<!-- PAGE_35 -->\n###### Assay(LLNA)), Magnusson Kligman 기니피그 최대화 시험(Magunusson Kligman Guinea Pig\n\n<!-- PAGE_35 -->\n###### Maximisation Test, GPMT) 및 Buehler 시험이 있다.  국소 림프절 검사는 동종 번식된 생쥐\n\n<!-- PAGE_35 -->\n###### 를 사용하는 방법으로 대상 성분의 사용부위에서의 국소림프절의 림프구 증식에 기반하고\n\n<!-- PAGE_35 -->\n###### 있다.  이는 자극성지수(stimulation index, SI)로 결과를 얻을 수 있는 객관적인 방법이며, 실\n\n<!-- PAGE_35 -->\n###### 험 물질에 의하여 야기된 자극과 기제를 적용한 대조 동물의 자극과의 비율로 나타낸다.\n\n <!-- PAGE_35 -->\n###### Magnusson Kligman 기니피그 최대화 시험은 면역증강제 형태 시험이며 Freunds complete\n\n<!-- PAGE_35 -->\n###### 면역증강제를 사용하거나 사용하지 않는 조건에서 대상 성분의 피내주사에 의한 알레르기\n\n<!-- PAGE_35 -->\n###### 반응의 증가 여부로 판단한다.  GPMT는 LLNA와 감도가 동등하다고 여겨진다. ",
        "original_sentence": "국소 림프절 검사는 동종 번식된 생쥐\n\n<!-- PAGE_35 -->\n###### 를 사용하는 방법으로 대상 성분의 사용부위에서의 국소림프절의 림프구 증식에 기반하고\n\n<!-- PAGE_35 -->\n###### 있다. "
      }
    },
    {
      "chunk_id": "chunk_281",
      "text": "이는 자극성지수(stimulation index, SI)로 결과를 얻을 수 있는 객관적인 방법이며, 실\n\n<!-- PAGE_35 -->\n###### 험 물질에 의하여 야기된 자극과 기제를 적용한 대조 동물의 자극과의 비율로 나타낸다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 280,
        "window_size": 3,
        "char_count": 132,
        "word_count": 27,
        "page_number": 35,
        "window_text": "정량하\n\n<!-- PAGE_34 -->\n###### 한치 미만이란 정량할 수 있는 정도의 양은 아니라는 의미로 0(제로)과는 의미가 다름\n\n<!-- PAGE_34 -->\n###### · 종말점 (Endpoint) : 측정 및 관찰 가능한 물질의 성질을 의미하며 독성학적으로는 일반적으\n\n<!-- PAGE_34 -->\n###### 로 자극감, 발암성, 기관별 독성 등 특정 장기 및 기관에 대한 개별 생물학적 효능을 의미\n\n<!-- PAGE_34 -->\n###### 함\n\n<!-- PAGE_34 -->\n###### · 최대무감작성유도용량 (No expected sensitization induced level, NESIL) : 사람 또는 동물에\n\n<!-- PAGE_34 -->\n###### 게 감작이 나타나지 않는 최대용량\n\n<!-- PAGE_34 -->\n###### · 최대무독성용량 (No observed adverse effect level, NOAEL) : 인간과 동물에게 부작용 및\n\n<!-- PAGE_34 -->\n###### 독성학적 영향이 관측되지 않는 최대 용량.  mg/kg body weight/day로 나타냄\n\n<!-- PAGE_34 -->\n###### · 최소독성용량 (Lowest observed adverse effect level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_34 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도\n\n- - 29 -\n<!-- PAGE_35 -->\n###### · 표적기관 (Target organ) : 물질이 나타내는 독성효과를 보이는 기관\n\n<!-- PAGE_35 -->\n###### · 피부 노출 (Dermal exposure) : 화학물질을 함유하는 매체와 피부의 접촉을 통한 노출로서,\n\n<!-- PAGE_35 -->\n###### 피부에 있어 흡착이나 흡수될 수 있는 양으로 정량\n\n<!-- PAGE_35 -->\n###### · 피부감작성시험 (Skin sensitization Test) : 실험물질(외용으로 사용되는 의약품, 화장품 및\n\n<!-- PAGE_35 -->\n###### 기타 물질)이 피부에 반복적으로 노출되었을 경우 나타날 수 있는 홍반 및 부종 등의 면역\n\n<!-- PAGE_35 -->\n###### 학적 피부과민반응을 평가하는 시험법으로 국소 림프절 검사(Local Lymph Node\n\n<!-- PAGE_35 -->\n###### Assay(LLNA)), Magnusson Kligman 기니피그 최대화 시험(Magunusson Kligman Guinea Pig\n\n<!-- PAGE_35 -->\n###### Maximisation Test, GPMT) 및 Buehler 시험이 있다.  국소 림프절 검사는 동종 번식된 생쥐\n\n<!-- PAGE_35 -->\n###### 를 사용하는 방법으로 대상 성분의 사용부위에서의 국소림프절의 림프구 증식에 기반하고\n\n<!-- PAGE_35 -->\n###### 있다.  이는 자극성지수(stimulation index, SI)로 결과를 얻을 수 있는 객관적인 방법이며, 실\n\n<!-- PAGE_35 -->\n###### 험 물질에 의하여 야기된 자극과 기제를 적용한 대조 동물의 자극과의 비율로 나타낸다.\n\n <!-- PAGE_35 -->\n###### Magnusson Kligman 기니피그 최대화 시험은 면역증강제 형태 시험이며 Freunds complete\n\n<!-- PAGE_35 -->\n###### 면역증강제를 사용하거나 사용하지 않는 조건에서 대상 성분의 피내주사에 의한 알레르기\n\n<!-- PAGE_35 -->\n###### 반응의 증가 여부로 판단한다.  GPMT는 LLNA와 감도가 동등하다고 여겨진다.  Buehler 시험\n\n<!-- PAGE_35 -->\n###### 은 국소에만 사용함으로써 면역증강제를 사용하지 않는 방법으로 GPMT와 비교할 때 감도\n\n<!-- PAGE_35 -->\n###### 가 낮다. ",
        "original_sentence": "이는 자극성지수(stimulation index, SI)로 결과를 얻을 수 있는 객관적인 방법이며, 실\n\n<!-- PAGE_35 -->\n###### 험 물질에 의하여 야기된 자극과 기제를 적용한 대조 동물의 자극과의 비율로 나타낸다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_282",
      "text": "<!-- PAGE_35 -->\n###### Magnusson Kligman 기니피그 최대화 시험은 면역증강제 형태 시험이며 Freunds complete\n\n<!-- PAGE_35 -->\n###### 면역증강제를 사용하거나 사용하지 않는 조건에서 대상 성분의 피내주사에 의한 알레르기\n\n<!-- PAGE_35 -->\n###### 반응의 증가 여부로 판단한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 281,
        "window_size": 3,
        "char_count": 200,
        "word_count": 36,
        "page_number": 35,
        "window_text": "mg/kg body weight/day로 나타냄\n\n<!-- PAGE_34 -->\n###### · 최소독성용량 (Lowest observed adverse effect level, LOAEL) : 실험 동물 또는 사람에서\n\n<!-- PAGE_34 -->\n###### 특정 물질에 의해 독성이 관찰되는 최소한의 농도\n\n- - 29 -\n<!-- PAGE_35 -->\n###### · 표적기관 (Target organ) : 물질이 나타내는 독성효과를 보이는 기관\n\n<!-- PAGE_35 -->\n###### · 피부 노출 (Dermal exposure) : 화학물질을 함유하는 매체와 피부의 접촉을 통한 노출로서,\n\n<!-- PAGE_35 -->\n###### 피부에 있어 흡착이나 흡수될 수 있는 양으로 정량\n\n<!-- PAGE_35 -->\n###### · 피부감작성시험 (Skin sensitization Test) : 실험물질(외용으로 사용되는 의약품, 화장품 및\n\n<!-- PAGE_35 -->\n###### 기타 물질)이 피부에 반복적으로 노출되었을 경우 나타날 수 있는 홍반 및 부종 등의 면역\n\n<!-- PAGE_35 -->\n###### 학적 피부과민반응을 평가하는 시험법으로 국소 림프절 검사(Local Lymph Node\n\n<!-- PAGE_35 -->\n###### Assay(LLNA)), Magnusson Kligman 기니피그 최대화 시험(Magunusson Kligman Guinea Pig\n\n<!-- PAGE_35 -->\n###### Maximisation Test, GPMT) 및 Buehler 시험이 있다.  국소 림프절 검사는 동종 번식된 생쥐\n\n<!-- PAGE_35 -->\n###### 를 사용하는 방법으로 대상 성분의 사용부위에서의 국소림프절의 림프구 증식에 기반하고\n\n<!-- PAGE_35 -->\n###### 있다.  이는 자극성지수(stimulation index, SI)로 결과를 얻을 수 있는 객관적인 방법이며, 실\n\n<!-- PAGE_35 -->\n###### 험 물질에 의하여 야기된 자극과 기제를 적용한 대조 동물의 자극과의 비율로 나타낸다.\n\n <!-- PAGE_35 -->\n###### Magnusson Kligman 기니피그 최대화 시험은 면역증강제 형태 시험이며 Freunds complete\n\n<!-- PAGE_35 -->\n###### 면역증강제를 사용하거나 사용하지 않는 조건에서 대상 성분의 피내주사에 의한 알레르기\n\n<!-- PAGE_35 -->\n###### 반응의 증가 여부로 판단한다.  GPMT는 LLNA와 감도가 동등하다고 여겨진다.  Buehler 시험\n\n<!-- PAGE_35 -->\n###### 은 국소에만 사용함으로써 면역증강제를 사용하지 않는 방법으로 GPMT와 비교할 때 감도\n\n<!-- PAGE_35 -->\n###### 가 낮다.  Buehler 실험방법을 사용할 경우에는 과학적으로 정당한 근거를 제시해야 한다.\n\n",
        "original_sentence": "<!-- PAGE_35 -->\n###### Magnusson Kligman 기니피그 최대화 시험은 면역증강제 형태 시험이며 Freunds complete\n\n<!-- PAGE_35 -->\n###### 면역증강제를 사용하거나 사용하지 않는 조건에서 대상 성분의 피내주사에 의한 알레르기\n\n<!-- PAGE_35 -->\n###### 반응의 증가 여부로 판단한다. "
      }
    },
    {
      "chunk_id": "chunk_283",
      "text": "GPMT는 LLNA와 감도가 동등하다고 여겨진다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 282,
        "window_size": 3,
        "char_count": 28,
        "word_count": 5,
        "page_number": 2,
        "window_text": "국소 림프절 검사는 동종 번식된 생쥐\n\n<!-- PAGE_35 -->\n###### 를 사용하는 방법으로 대상 성분의 사용부위에서의 국소림프절의 림프구 증식에 기반하고\n\n<!-- PAGE_35 -->\n###### 있다.  이는 자극성지수(stimulation index, SI)로 결과를 얻을 수 있는 객관적인 방법이며, 실\n\n<!-- PAGE_35 -->\n###### 험 물질에 의하여 야기된 자극과 기제를 적용한 대조 동물의 자극과의 비율로 나타낸다.\n\n <!-- PAGE_35 -->\n###### Magnusson Kligman 기니피그 최대화 시험은 면역증강제 형태 시험이며 Freunds complete\n\n<!-- PAGE_35 -->\n###### 면역증강제를 사용하거나 사용하지 않는 조건에서 대상 성분의 피내주사에 의한 알레르기\n\n<!-- PAGE_35 -->\n###### 반응의 증가 여부로 판단한다.  GPMT는 LLNA와 감도가 동등하다고 여겨진다.  Buehler 시험\n\n<!-- PAGE_35 -->\n###### 은 국소에만 사용함으로써 면역증강제를 사용하지 않는 방법으로 GPMT와 비교할 때 감도\n\n<!-- PAGE_35 -->\n###### 가 낮다.  Buehler 실험방법을 사용할 경우에는 과학적으로 정당한 근거를 제시해야 한다.\n\n <!-- PAGE_35 -->\n###### · 화학물질 요약 서비스 등록번호(Chemical abstracts service index number, CAS Number) :\n\n<!-- PAGE_35 -->\n###### CAS의 화학물질 분류 넘버\n\n- - 30 -\n<!-- PAGE_36 -->\n###### 붙임 2. ",
        "original_sentence": "GPMT는 LLNA와 감도가 동등하다고 여겨진다. "
      }
    },
    {
      "chunk_id": "chunk_284",
      "text": "Buehler 시험\n\n<!-- PAGE_35 -->\n###### 은 국소에만 사용함으로써 면역증강제를 사용하지 않는 방법으로 GPMT와 비교할 때 감도\n\n<!-- PAGE_35 -->\n###### 가 낮다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 283,
        "window_size": 3,
        "char_count": 116,
        "word_count": 23,
        "page_number": 35,
        "window_text": "이는 자극성지수(stimulation index, SI)로 결과를 얻을 수 있는 객관적인 방법이며, 실\n\n<!-- PAGE_35 -->\n###### 험 물질에 의하여 야기된 자극과 기제를 적용한 대조 동물의 자극과의 비율로 나타낸다.\n\n <!-- PAGE_35 -->\n###### Magnusson Kligman 기니피그 최대화 시험은 면역증강제 형태 시험이며 Freunds complete\n\n<!-- PAGE_35 -->\n###### 면역증강제를 사용하거나 사용하지 않는 조건에서 대상 성분의 피내주사에 의한 알레르기\n\n<!-- PAGE_35 -->\n###### 반응의 증가 여부로 판단한다.  GPMT는 LLNA와 감도가 동등하다고 여겨진다.  Buehler 시험\n\n<!-- PAGE_35 -->\n###### 은 국소에만 사용함으로써 면역증강제를 사용하지 않는 방법으로 GPMT와 비교할 때 감도\n\n<!-- PAGE_35 -->\n###### 가 낮다.  Buehler 실험방법을 사용할 경우에는 과학적으로 정당한 근거를 제시해야 한다.\n\n <!-- PAGE_35 -->\n###### · 화학물질 요약 서비스 등록번호(Chemical abstracts service index number, CAS Number) :\n\n<!-- PAGE_35 -->\n###### CAS의 화학물질 분류 넘버\n\n- - 30 -\n<!-- PAGE_36 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식\n\n<!-- PAGE_36 -->\n###### * 이 보고서 양식은 참고용이며, 제품에 맞게 재구성할 수 있음\n\n<!-- PAGE_36 -->\n###### <요약>\n\n<!-- PAGE_36 -->\n###### : 위해평가 내용을 요약함\n\n<!-- PAGE_36 -->\n###### <목차>\n\n<!-- PAGE_36 -->\n###### 1. ",
        "original_sentence": "Buehler 시험\n\n<!-- PAGE_35 -->\n###### 은 국소에만 사용함으로써 면역증강제를 사용하지 않는 방법으로 GPMT와 비교할 때 감도\n\n<!-- PAGE_35 -->\n###### 가 낮다. "
      }
    },
    {
      "chunk_id": "chunk_285",
      "text": "Buehler 실험방법을 사용할 경우에는 과학적으로 정당한 근거를 제시해야 한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 284,
        "window_size": 3,
        "char_count": 47,
        "word_count": 9,
        "page_number": 2,
        "window_text": "<!-- PAGE_35 -->\n###### Magnusson Kligman 기니피그 최대화 시험은 면역증강제 형태 시험이며 Freunds complete\n\n<!-- PAGE_35 -->\n###### 면역증강제를 사용하거나 사용하지 않는 조건에서 대상 성분의 피내주사에 의한 알레르기\n\n<!-- PAGE_35 -->\n###### 반응의 증가 여부로 판단한다.  GPMT는 LLNA와 감도가 동등하다고 여겨진다.  Buehler 시험\n\n<!-- PAGE_35 -->\n###### 은 국소에만 사용함으로써 면역증강제를 사용하지 않는 방법으로 GPMT와 비교할 때 감도\n\n<!-- PAGE_35 -->\n###### 가 낮다.  Buehler 실험방법을 사용할 경우에는 과학적으로 정당한 근거를 제시해야 한다.\n\n <!-- PAGE_35 -->\n###### · 화학물질 요약 서비스 등록번호(Chemical abstracts service index number, CAS Number) :\n\n<!-- PAGE_35 -->\n###### CAS의 화학물질 분류 넘버\n\n- - 30 -\n<!-- PAGE_36 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식\n\n<!-- PAGE_36 -->\n###### * 이 보고서 양식은 참고용이며, 제품에 맞게 재구성할 수 있음\n\n<!-- PAGE_36 -->\n###### <요약>\n\n<!-- PAGE_36 -->\n###### : 위해평가 내용을 요약함\n\n<!-- PAGE_36 -->\n###### <목차>\n\n<!-- PAGE_36 -->\n###### 1.  위해평가 배경 및 목적\n\n<!-- PAGE_36 -->\n###### 2. ",
        "original_sentence": "Buehler 실험방법을 사용할 경우에는 과학적으로 정당한 근거를 제시해야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_286",
      "text": "<!-- PAGE_35 -->\n###### · 화학물질 요약 서비스 등록번호(Chemical abstracts service index number, CAS Number) :\n\n<!-- PAGE_35 -->\n###### CAS의 화학물질 분류 넘버\n\n- - 30 -\n<!-- PAGE_36 -->\n###### 붙임 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 285,
        "window_size": 3,
        "char_count": 179,
        "word_count": 34,
        "page_number": 35,
        "window_text": "GPMT는 LLNA와 감도가 동등하다고 여겨진다.  Buehler 시험\n\n<!-- PAGE_35 -->\n###### 은 국소에만 사용함으로써 면역증강제를 사용하지 않는 방법으로 GPMT와 비교할 때 감도\n\n<!-- PAGE_35 -->\n###### 가 낮다.  Buehler 실험방법을 사용할 경우에는 과학적으로 정당한 근거를 제시해야 한다.\n\n <!-- PAGE_35 -->\n###### · 화학물질 요약 서비스 등록번호(Chemical abstracts service index number, CAS Number) :\n\n<!-- PAGE_35 -->\n###### CAS의 화학물질 분류 넘버\n\n- - 30 -\n<!-- PAGE_36 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식\n\n<!-- PAGE_36 -->\n###### * 이 보고서 양식은 참고용이며, 제품에 맞게 재구성할 수 있음\n\n<!-- PAGE_36 -->\n###### <요약>\n\n<!-- PAGE_36 -->\n###### : 위해평가 내용을 요약함\n\n<!-- PAGE_36 -->\n###### <목차>\n\n<!-- PAGE_36 -->\n###### 1.  위해평가 배경 및 목적\n\n<!-- PAGE_36 -->\n###### 2.  위해평가 방법\n\n<!-- PAGE_36 -->\n###### 1) 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 2) 평가대상 성분의 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 3. ",
        "original_sentence": "<!-- PAGE_35 -->\n###### · 화학물질 요약 서비스 등록번호(Chemical abstracts service index number, CAS Number) :\n\n<!-- PAGE_35 -->\n###### CAS의 화학물질 분류 넘버\n\n- - 30 -\n<!-- PAGE_36 -->\n###### 붙임 2. "
      }
    },
    {
      "chunk_id": "chunk_287",
      "text": "화장품 위해평가 보고서 양식\n\n<!-- PAGE_36 -->\n###### * 이 보고서 양식은 참고용이며, 제품에 맞게 재구성할 수 있음\n\n<!-- PAGE_36 -->\n###### <요약>\n\n<!-- PAGE_36 -->\n###### : 위해평가 내용을 요약함\n\n<!-- PAGE_36 -->\n###### <목차>\n\n<!-- PAGE_36 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 286,
        "window_size": 3,
        "char_count": 205,
        "word_count": 41,
        "page_number": 36,
        "window_text": "Buehler 시험\n\n<!-- PAGE_35 -->\n###### 은 국소에만 사용함으로써 면역증강제를 사용하지 않는 방법으로 GPMT와 비교할 때 감도\n\n<!-- PAGE_35 -->\n###### 가 낮다.  Buehler 실험방법을 사용할 경우에는 과학적으로 정당한 근거를 제시해야 한다.\n\n <!-- PAGE_35 -->\n###### · 화학물질 요약 서비스 등록번호(Chemical abstracts service index number, CAS Number) :\n\n<!-- PAGE_35 -->\n###### CAS의 화학물질 분류 넘버\n\n- - 30 -\n<!-- PAGE_36 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식\n\n<!-- PAGE_36 -->\n###### * 이 보고서 양식은 참고용이며, 제품에 맞게 재구성할 수 있음\n\n<!-- PAGE_36 -->\n###### <요약>\n\n<!-- PAGE_36 -->\n###### : 위해평가 내용을 요약함\n\n<!-- PAGE_36 -->\n###### <목차>\n\n<!-- PAGE_36 -->\n###### 1.  위해평가 배경 및 목적\n\n<!-- PAGE_36 -->\n###### 2.  위해평가 방법\n\n<!-- PAGE_36 -->\n###### 1) 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 2) 평가대상 성분의 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 3.  위해평가 결과\n\n<!-- PAGE_36 -->\n###### 3.1 위험성 확인\n\n<!-- PAGE_36 -->\n###### 3.1.1 물리·화학적 성질\n\n<!-- PAGE_36 -->\n###### [물질명, IUPAC명, CAS No., 화학식, 분자량, 순도(분석방법), 구조식(추출물의 경\n\n<!-- PAGE_36 -->\n###### 우, 추출방법과 정제법), 물리적 성상, 녹는점, 끓는점, 밀도, 용해도, Log Pow,\n\n<!-- PAGE_36 -->\n###### 헨리상수, 동의어]\n\n<!-- PAGE_36 -->\n###### 3.1.2 사용현황\n\n<!-- PAGE_36 -->\n###### ※ 표. ",
        "original_sentence": "화장품 위해평가 보고서 양식\n\n<!-- PAGE_36 -->\n###### * 이 보고서 양식은 참고용이며, 제품에 맞게 재구성할 수 있음\n\n<!-- PAGE_36 -->\n###### <요약>\n\n<!-- PAGE_36 -->\n###### : 위해평가 내용을 요약함\n\n<!-- PAGE_36 -->\n###### <목차>\n\n<!-- PAGE_36 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_288",
      "text": "위해평가 배경 및 목적\n\n<!-- PAGE_36 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 287,
        "window_size": 3,
        "char_count": 41,
        "word_count": 9,
        "page_number": 36,
        "window_text": "Buehler 실험방법을 사용할 경우에는 과학적으로 정당한 근거를 제시해야 한다.\n\n <!-- PAGE_35 -->\n###### · 화학물질 요약 서비스 등록번호(Chemical abstracts service index number, CAS Number) :\n\n<!-- PAGE_35 -->\n###### CAS의 화학물질 분류 넘버\n\n- - 30 -\n<!-- PAGE_36 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식\n\n<!-- PAGE_36 -->\n###### * 이 보고서 양식은 참고용이며, 제품에 맞게 재구성할 수 있음\n\n<!-- PAGE_36 -->\n###### <요약>\n\n<!-- PAGE_36 -->\n###### : 위해평가 내용을 요약함\n\n<!-- PAGE_36 -->\n###### <목차>\n\n<!-- PAGE_36 -->\n###### 1.  위해평가 배경 및 목적\n\n<!-- PAGE_36 -->\n###### 2.  위해평가 방법\n\n<!-- PAGE_36 -->\n###### 1) 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 2) 평가대상 성분의 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 3.  위해평가 결과\n\n<!-- PAGE_36 -->\n###### 3.1 위험성 확인\n\n<!-- PAGE_36 -->\n###### 3.1.1 물리·화학적 성질\n\n<!-- PAGE_36 -->\n###### [물질명, IUPAC명, CAS No., 화학식, 분자량, 순도(분석방법), 구조식(추출물의 경\n\n<!-- PAGE_36 -->\n###### 우, 추출방법과 정제법), 물리적 성상, 녹는점, 끓는점, 밀도, 용해도, Log Pow,\n\n<!-- PAGE_36 -->\n###### 헨리상수, 동의어]\n\n<!-- PAGE_36 -->\n###### 3.1.2 사용현황\n\n<!-- PAGE_36 -->\n###### ※ 표.  각국의 화장품 중 평가대상 성분의 관리 기준\n\n<!-- PAGE_36 -->\n###### 3.1.3 노출경로\n\n- - 31 -\n<!-- PAGE_37 -->\n###### 3.1.4 독성학적 자료\n\n<!-- PAGE_37 -->\n###### ※ 표. ",
        "original_sentence": "위해평가 배경 및 목적\n\n<!-- PAGE_36 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_289",
      "text": "위해평가 방법\n\n<!-- PAGE_36 -->\n###### 1) 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 2) 평가대상 성분의 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 288,
        "window_size": 3,
        "char_count": 117,
        "word_count": 23,
        "page_number": 36,
        "window_text": "<!-- PAGE_35 -->\n###### · 화학물질 요약 서비스 등록번호(Chemical abstracts service index number, CAS Number) :\n\n<!-- PAGE_35 -->\n###### CAS의 화학물질 분류 넘버\n\n- - 30 -\n<!-- PAGE_36 -->\n###### 붙임 2.  화장품 위해평가 보고서 양식\n\n<!-- PAGE_36 -->\n###### * 이 보고서 양식은 참고용이며, 제품에 맞게 재구성할 수 있음\n\n<!-- PAGE_36 -->\n###### <요약>\n\n<!-- PAGE_36 -->\n###### : 위해평가 내용을 요약함\n\n<!-- PAGE_36 -->\n###### <목차>\n\n<!-- PAGE_36 -->\n###### 1.  위해평가 배경 및 목적\n\n<!-- PAGE_36 -->\n###### 2.  위해평가 방법\n\n<!-- PAGE_36 -->\n###### 1) 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 2) 평가대상 성분의 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 3.  위해평가 결과\n\n<!-- PAGE_36 -->\n###### 3.1 위험성 확인\n\n<!-- PAGE_36 -->\n###### 3.1.1 물리·화학적 성질\n\n<!-- PAGE_36 -->\n###### [물질명, IUPAC명, CAS No., 화학식, 분자량, 순도(분석방법), 구조식(추출물의 경\n\n<!-- PAGE_36 -->\n###### 우, 추출방법과 정제법), 물리적 성상, 녹는점, 끓는점, 밀도, 용해도, Log Pow,\n\n<!-- PAGE_36 -->\n###### 헨리상수, 동의어]\n\n<!-- PAGE_36 -->\n###### 3.1.2 사용현황\n\n<!-- PAGE_36 -->\n###### ※ 표.  각국의 화장품 중 평가대상 성분의 관리 기준\n\n<!-- PAGE_36 -->\n###### 3.1.3 노출경로\n\n- - 31 -\n<!-- PAGE_37 -->\n###### 3.1.4 독성학적 자료\n\n<!-- PAGE_37 -->\n###### ※ 표.  독성학적 자료 확보 유무\n\n<!-- PAGE_37 -->\n###### 단회투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 반복투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 피부\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 생식발생\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 유전\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 발암성\n\n<!-- PAGE_37 -->\n###### 광독성\n\n<!-- PAGE_37 -->\n###### 기타\n\n<!-- PAGE_37 -->\n###### (ü: 독성 자료 있음, -: 독성 자료 없음)\n\n<!-- PAGE_37 -->\n###### 3.1.4.2 단회투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.3 반복투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.4 피부자극성\n\n<!-- PAGE_37 -->\n###### 3.1.4.5 안점막자극\n\n<!-- PAGE_37 -->\n###### 3.1.4.6 피부감작성\n\n<!-- PAGE_37 -->\n###### 3.1.4.7 생식·발생독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.8 유전독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.9 발암성\n\n<!-- PAGE_37 -->\n###### 3.1.4.10 광독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.11 기타(면역독성, 신경독성, 임상자료 포함)\n\n<!-- PAGE_37 -->\n###### 3.2 위험성 결정\n\n<!-- PAGE_37 -->\n###### 3.2.1 최적의 전신 독성기준값(PODsys) 선정\n\n<!-- PAGE_37 -->\n###### 3.3 노출평가\n\n<!-- PAGE_37 -->\n###### 3.3.1 노출시나리오\n\n<!-- PAGE_37 -->\n###### 3.3.2 노출량 산출\n\n<!-- PAGE_37 -->\n###### 3.4 위해도 결정\n\n<!-- PAGE_37 -->\n###### 4. ",
        "original_sentence": "위해평가 방법\n\n<!-- PAGE_36 -->\n###### 1) 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 2) 평가대상 성분의 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_290",
      "text": "위해평가 결과\n\n<!-- PAGE_36 -->\n###### 3.1 위험성 확인\n\n<!-- PAGE_36 -->\n###### 3.1.1 물리·화학적 성질\n\n<!-- PAGE_36 -->\n###### [물질명, IUPAC명, CAS No., 화학식, 분자량, 순도(분석방법), 구조식(추출물의 경\n\n<!-- PAGE_36 -->\n###### 우, 추출방법과 정제법), 물리적 성상, 녹는점, 끓는점, 밀도, 용해도, Log Pow,\n\n<!-- PAGE_36 -->\n###### 헨리상수, 동의어]\n\n<!-- PAGE_36 -->\n###### 3.1.2 사용현황\n\n<!-- PAGE_36 -->\n###### ※ 표. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 289,
        "window_size": 3,
        "char_count": 342,
        "word_count": 62,
        "page_number": 36,
        "window_text": "화장품 위해평가 보고서 양식\n\n<!-- PAGE_36 -->\n###### * 이 보고서 양식은 참고용이며, 제품에 맞게 재구성할 수 있음\n\n<!-- PAGE_36 -->\n###### <요약>\n\n<!-- PAGE_36 -->\n###### : 위해평가 내용을 요약함\n\n<!-- PAGE_36 -->\n###### <목차>\n\n<!-- PAGE_36 -->\n###### 1.  위해평가 배경 및 목적\n\n<!-- PAGE_36 -->\n###### 2.  위해평가 방법\n\n<!-- PAGE_36 -->\n###### 1) 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 2) 평가대상 성분의 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 3.  위해평가 결과\n\n<!-- PAGE_36 -->\n###### 3.1 위험성 확인\n\n<!-- PAGE_36 -->\n###### 3.1.1 물리·화학적 성질\n\n<!-- PAGE_36 -->\n###### [물질명, IUPAC명, CAS No., 화학식, 분자량, 순도(분석방법), 구조식(추출물의 경\n\n<!-- PAGE_36 -->\n###### 우, 추출방법과 정제법), 물리적 성상, 녹는점, 끓는점, 밀도, 용해도, Log Pow,\n\n<!-- PAGE_36 -->\n###### 헨리상수, 동의어]\n\n<!-- PAGE_36 -->\n###### 3.1.2 사용현황\n\n<!-- PAGE_36 -->\n###### ※ 표.  각국의 화장품 중 평가대상 성분의 관리 기준\n\n<!-- PAGE_36 -->\n###### 3.1.3 노출경로\n\n- - 31 -\n<!-- PAGE_37 -->\n###### 3.1.4 독성학적 자료\n\n<!-- PAGE_37 -->\n###### ※ 표.  독성학적 자료 확보 유무\n\n<!-- PAGE_37 -->\n###### 단회투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 반복투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 피부\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 생식발생\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 유전\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 발암성\n\n<!-- PAGE_37 -->\n###### 광독성\n\n<!-- PAGE_37 -->\n###### 기타\n\n<!-- PAGE_37 -->\n###### (ü: 독성 자료 있음, -: 독성 자료 없음)\n\n<!-- PAGE_37 -->\n###### 3.1.4.2 단회투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.3 반복투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.4 피부자극성\n\n<!-- PAGE_37 -->\n###### 3.1.4.5 안점막자극\n\n<!-- PAGE_37 -->\n###### 3.1.4.6 피부감작성\n\n<!-- PAGE_37 -->\n###### 3.1.4.7 생식·발생독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.8 유전독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.9 발암성\n\n<!-- PAGE_37 -->\n###### 3.1.4.10 광독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.11 기타(면역독성, 신경독성, 임상자료 포함)\n\n<!-- PAGE_37 -->\n###### 3.2 위험성 결정\n\n<!-- PAGE_37 -->\n###### 3.2.1 최적의 전신 독성기준값(PODsys) 선정\n\n<!-- PAGE_37 -->\n###### 3.3 노출평가\n\n<!-- PAGE_37 -->\n###### 3.3.1 노출시나리오\n\n<!-- PAGE_37 -->\n###### 3.3.2 노출량 산출\n\n<!-- PAGE_37 -->\n###### 3.4 위해도 결정\n\n<!-- PAGE_37 -->\n###### 4.  결론\n\n- - 32 -\n<!-- PAGE_38 -->\n###### 5. ",
        "original_sentence": "위해평가 결과\n\n<!-- PAGE_36 -->\n###### 3.1 위험성 확인\n\n<!-- PAGE_36 -->\n###### 3.1.1 물리·화학적 성질\n\n<!-- PAGE_36 -->\n###### [물질명, IUPAC명, CAS No., 화학식, 분자량, 순도(분석방법), 구조식(추출물의 경\n\n<!-- PAGE_36 -->\n###### 우, 추출방법과 정제법), 물리적 성상, 녹는점, 끓는점, 밀도, 용해도, Log Pow,\n\n<!-- PAGE_36 -->\n###### 헨리상수, 동의어]\n\n<!-- PAGE_36 -->\n###### 3.1.2 사용현황\n\n<!-- PAGE_36 -->\n###### ※ 표. "
      }
    },
    {
      "chunk_id": "chunk_291",
      "text": "각국의 화장품 중 평가대상 성분의 관리 기준\n\n<!-- PAGE_36 -->\n###### 3.1.3 노출경로\n\n- - 31 -\n<!-- PAGE_37 -->\n###### 3.1.4 독성학적 자료\n\n<!-- PAGE_37 -->\n###### ※ 표. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 290,
        "window_size": 3,
        "char_count": 139,
        "word_count": 30,
        "page_number": 36,
        "window_text": "위해평가 배경 및 목적\n\n<!-- PAGE_36 -->\n###### 2.  위해평가 방법\n\n<!-- PAGE_36 -->\n###### 1) 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 2) 평가대상 성분의 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 3.  위해평가 결과\n\n<!-- PAGE_36 -->\n###### 3.1 위험성 확인\n\n<!-- PAGE_36 -->\n###### 3.1.1 물리·화학적 성질\n\n<!-- PAGE_36 -->\n###### [물질명, IUPAC명, CAS No., 화학식, 분자량, 순도(분석방법), 구조식(추출물의 경\n\n<!-- PAGE_36 -->\n###### 우, 추출방법과 정제법), 물리적 성상, 녹는점, 끓는점, 밀도, 용해도, Log Pow,\n\n<!-- PAGE_36 -->\n###### 헨리상수, 동의어]\n\n<!-- PAGE_36 -->\n###### 3.1.2 사용현황\n\n<!-- PAGE_36 -->\n###### ※ 표.  각국의 화장품 중 평가대상 성분의 관리 기준\n\n<!-- PAGE_36 -->\n###### 3.1.3 노출경로\n\n- - 31 -\n<!-- PAGE_37 -->\n###### 3.1.4 독성학적 자료\n\n<!-- PAGE_37 -->\n###### ※ 표.  독성학적 자료 확보 유무\n\n<!-- PAGE_37 -->\n###### 단회투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 반복투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 피부\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 생식발생\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 유전\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 발암성\n\n<!-- PAGE_37 -->\n###### 광독성\n\n<!-- PAGE_37 -->\n###### 기타\n\n<!-- PAGE_37 -->\n###### (ü: 독성 자료 있음, -: 독성 자료 없음)\n\n<!-- PAGE_37 -->\n###### 3.1.4.2 단회투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.3 반복투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.4 피부자극성\n\n<!-- PAGE_37 -->\n###### 3.1.4.5 안점막자극\n\n<!-- PAGE_37 -->\n###### 3.1.4.6 피부감작성\n\n<!-- PAGE_37 -->\n###### 3.1.4.7 생식·발생독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.8 유전독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.9 발암성\n\n<!-- PAGE_37 -->\n###### 3.1.4.10 광독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.11 기타(면역독성, 신경독성, 임상자료 포함)\n\n<!-- PAGE_37 -->\n###### 3.2 위험성 결정\n\n<!-- PAGE_37 -->\n###### 3.2.1 최적의 전신 독성기준값(PODsys) 선정\n\n<!-- PAGE_37 -->\n###### 3.3 노출평가\n\n<!-- PAGE_37 -->\n###### 3.3.1 노출시나리오\n\n<!-- PAGE_37 -->\n###### 3.3.2 노출량 산출\n\n<!-- PAGE_37 -->\n###### 3.4 위해도 결정\n\n<!-- PAGE_37 -->\n###### 4.  결론\n\n- - 32 -\n<!-- PAGE_38 -->\n###### 5.  제한점\n\n<!-- PAGE_38 -->\n###### 6. ",
        "original_sentence": "각국의 화장품 중 평가대상 성분의 관리 기준\n\n<!-- PAGE_36 -->\n###### 3.1.3 노출경로\n\n- - 31 -\n<!-- PAGE_37 -->\n###### 3.1.4 독성학적 자료\n\n<!-- PAGE_37 -->\n###### ※ 표. "
      }
    },
    {
      "chunk_id": "chunk_292",
      "text": "독성학적 자료 확보 유무\n\n<!-- PAGE_37 -->\n###### 단회투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 반복투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 피부\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 생식발생\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 유전\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 발암성\n\n<!-- PAGE_37 -->\n###### 광독성\n\n<!-- PAGE_37 -->\n###### 기타\n\n<!-- PAGE_37 -->\n###### (ü: 독성 자료 있음, -: 독성 자료 없음)\n\n<!-- PAGE_37 -->\n###### 3.1.4.2 단회투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.3 반복투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.4 피부자극성\n\n<!-- PAGE_37 -->\n###### 3.1.4.5 안점막자극\n\n<!-- PAGE_37 -->\n###### 3.1.4.6 피부감작성\n\n<!-- PAGE_37 -->\n###### 3.1.4.7 생식·발생독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.8 유전독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.9 발암성\n\n<!-- PAGE_37 -->\n###### 3.1.4.10 광독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.11 기타(면역독성, 신경독성, 임상자료 포함)\n\n<!-- PAGE_37 -->\n###### 3.2 위험성 결정\n\n<!-- PAGE_37 -->\n###### 3.2.1 최적의 전신 독성기준값(PODsys) 선정\n\n<!-- PAGE_37 -->\n###### 3.3 노출평가\n\n<!-- PAGE_37 -->\n###### 3.3.1 노출시나리오\n\n<!-- PAGE_37 -->\n###### 3.3.2 노출량 산출\n\n<!-- PAGE_37 -->\n###### 3.4 위해도 결정\n\n<!-- PAGE_37 -->\n###### 4. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 291,
        "window_size": 3,
        "char_count": 1112,
        "word_count": 191,
        "page_number": 37,
        "window_text": "위해평가 방법\n\n<!-- PAGE_36 -->\n###### 1) 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 2) 평가대상 성분의 위해평가 방법\n\n<!-- PAGE_36 -->\n###### 3.  위해평가 결과\n\n<!-- PAGE_36 -->\n###### 3.1 위험성 확인\n\n<!-- PAGE_36 -->\n###### 3.1.1 물리·화학적 성질\n\n<!-- PAGE_36 -->\n###### [물질명, IUPAC명, CAS No., 화학식, 분자량, 순도(분석방법), 구조식(추출물의 경\n\n<!-- PAGE_36 -->\n###### 우, 추출방법과 정제법), 물리적 성상, 녹는점, 끓는점, 밀도, 용해도, Log Pow,\n\n<!-- PAGE_36 -->\n###### 헨리상수, 동의어]\n\n<!-- PAGE_36 -->\n###### 3.1.2 사용현황\n\n<!-- PAGE_36 -->\n###### ※ 표.  각국의 화장품 중 평가대상 성분의 관리 기준\n\n<!-- PAGE_36 -->\n###### 3.1.3 노출경로\n\n- - 31 -\n<!-- PAGE_37 -->\n###### 3.1.4 독성학적 자료\n\n<!-- PAGE_37 -->\n###### ※ 표.  독성학적 자료 확보 유무\n\n<!-- PAGE_37 -->\n###### 단회투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 반복투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 피부\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 생식발생\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 유전\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 발암성\n\n<!-- PAGE_37 -->\n###### 광독성\n\n<!-- PAGE_37 -->\n###### 기타\n\n<!-- PAGE_37 -->\n###### (ü: 독성 자료 있음, -: 독성 자료 없음)\n\n<!-- PAGE_37 -->\n###### 3.1.4.2 단회투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.3 반복투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.4 피부자극성\n\n<!-- PAGE_37 -->\n###### 3.1.4.5 안점막자극\n\n<!-- PAGE_37 -->\n###### 3.1.4.6 피부감작성\n\n<!-- PAGE_37 -->\n###### 3.1.4.7 생식·발생독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.8 유전독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.9 발암성\n\n<!-- PAGE_37 -->\n###### 3.1.4.10 광독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.11 기타(면역독성, 신경독성, 임상자료 포함)\n\n<!-- PAGE_37 -->\n###### 3.2 위험성 결정\n\n<!-- PAGE_37 -->\n###### 3.2.1 최적의 전신 독성기준값(PODsys) 선정\n\n<!-- PAGE_37 -->\n###### 3.3 노출평가\n\n<!-- PAGE_37 -->\n###### 3.3.1 노출시나리오\n\n<!-- PAGE_37 -->\n###### 3.3.2 노출량 산출\n\n<!-- PAGE_37 -->\n###### 3.4 위해도 결정\n\n<!-- PAGE_37 -->\n###### 4.  결론\n\n- - 32 -\n<!-- PAGE_38 -->\n###### 5.  제한점\n\n<!-- PAGE_38 -->\n###### 6.  외국의 평가 사례\n\n<!-- PAGE_38 -->\n###### 7. ",
        "original_sentence": "독성학적 자료 확보 유무\n\n<!-- PAGE_37 -->\n###### 단회투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 반복투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 피부\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 생식발생\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 유전\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 발암성\n\n<!-- PAGE_37 -->\n###### 광독성\n\n<!-- PAGE_37 -->\n###### 기타\n\n<!-- PAGE_37 -->\n###### (ü: 독성 자료 있음, -: 독성 자료 없음)\n\n<!-- PAGE_37 -->\n###### 3.1.4.2 단회투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.3 반복투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.4 피부자극성\n\n<!-- PAGE_37 -->\n###### 3.1.4.5 안점막자극\n\n<!-- PAGE_37 -->\n###### 3.1.4.6 피부감작성\n\n<!-- PAGE_37 -->\n###### 3.1.4.7 생식·발생독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.8 유전독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.9 발암성\n\n<!-- PAGE_37 -->\n###### 3.1.4.10 광독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.11 기타(면역독성, 신경독성, 임상자료 포함)\n\n<!-- PAGE_37 -->\n###### 3.2 위험성 결정\n\n<!-- PAGE_37 -->\n###### 3.2.1 최적의 전신 독성기준값(PODsys) 선정\n\n<!-- PAGE_37 -->\n###### 3.3 노출평가\n\n<!-- PAGE_37 -->\n###### 3.3.1 노출시나리오\n\n<!-- PAGE_37 -->\n###### 3.3.2 노출량 산출\n\n<!-- PAGE_37 -->\n###### 3.4 위해도 결정\n\n<!-- PAGE_37 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_293",
      "text": "결론\n\n- - 32 -\n<!-- PAGE_38 -->\n###### 5. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 292,
        "window_size": 3,
        "char_count": 40,
        "word_count": 10,
        "page_number": 38,
        "window_text": "위해평가 결과\n\n<!-- PAGE_36 -->\n###### 3.1 위험성 확인\n\n<!-- PAGE_36 -->\n###### 3.1.1 물리·화학적 성질\n\n<!-- PAGE_36 -->\n###### [물질명, IUPAC명, CAS No., 화학식, 분자량, 순도(분석방법), 구조식(추출물의 경\n\n<!-- PAGE_36 -->\n###### 우, 추출방법과 정제법), 물리적 성상, 녹는점, 끓는점, 밀도, 용해도, Log Pow,\n\n<!-- PAGE_36 -->\n###### 헨리상수, 동의어]\n\n<!-- PAGE_36 -->\n###### 3.1.2 사용현황\n\n<!-- PAGE_36 -->\n###### ※ 표.  각국의 화장품 중 평가대상 성분의 관리 기준\n\n<!-- PAGE_36 -->\n###### 3.1.3 노출경로\n\n- - 31 -\n<!-- PAGE_37 -->\n###### 3.1.4 독성학적 자료\n\n<!-- PAGE_37 -->\n###### ※ 표.  독성학적 자료 확보 유무\n\n<!-- PAGE_37 -->\n###### 단회투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 반복투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 피부\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 생식발생\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 유전\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 발암성\n\n<!-- PAGE_37 -->\n###### 광독성\n\n<!-- PAGE_37 -->\n###### 기타\n\n<!-- PAGE_37 -->\n###### (ü: 독성 자료 있음, -: 독성 자료 없음)\n\n<!-- PAGE_37 -->\n###### 3.1.4.2 단회투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.3 반복투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.4 피부자극성\n\n<!-- PAGE_37 -->\n###### 3.1.4.5 안점막자극\n\n<!-- PAGE_37 -->\n###### 3.1.4.6 피부감작성\n\n<!-- PAGE_37 -->\n###### 3.1.4.7 생식·발생독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.8 유전독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.9 발암성\n\n<!-- PAGE_37 -->\n###### 3.1.4.10 광독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.11 기타(면역독성, 신경독성, 임상자료 포함)\n\n<!-- PAGE_37 -->\n###### 3.2 위험성 결정\n\n<!-- PAGE_37 -->\n###### 3.2.1 최적의 전신 독성기준값(PODsys) 선정\n\n<!-- PAGE_37 -->\n###### 3.3 노출평가\n\n<!-- PAGE_37 -->\n###### 3.3.1 노출시나리오\n\n<!-- PAGE_37 -->\n###### 3.3.2 노출량 산출\n\n<!-- PAGE_37 -->\n###### 3.4 위해도 결정\n\n<!-- PAGE_37 -->\n###### 4.  결론\n\n- - 32 -\n<!-- PAGE_38 -->\n###### 5.  제한점\n\n<!-- PAGE_38 -->\n###### 6.  외국의 평가 사례\n\n<!-- PAGE_38 -->\n###### 7.  참고문헌\n\n- - 33 -\n<!-- PAGE_39 -->\n###### 구분\n\n<!-- PAGE_39 -->\n###### ○ 시험물질의 LD50 값을 결정하기 위한 목적으로 개발되었으며 단회투여 경구\n\n<!-- PAGE_39 -->\n###### 독성, 단회투여 흡입독성, 단회투여 피부독성으로 구분된다. ",
        "original_sentence": "결론\n\n- - 32 -\n<!-- PAGE_38 -->\n###### 5. "
      }
    },
    {
      "chunk_id": "chunk_294",
      "text": "제한점\n\n<!-- PAGE_38 -->\n###### 6. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 293,
        "window_size": 3,
        "char_count": 32,
        "word_count": 6,
        "page_number": 38,
        "window_text": "각국의 화장품 중 평가대상 성분의 관리 기준\n\n<!-- PAGE_36 -->\n###### 3.1.3 노출경로\n\n- - 31 -\n<!-- PAGE_37 -->\n###### 3.1.4 독성학적 자료\n\n<!-- PAGE_37 -->\n###### ※ 표.  독성학적 자료 확보 유무\n\n<!-- PAGE_37 -->\n###### 단회투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 반복투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 피부\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 생식발생\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 유전\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 발암성\n\n<!-- PAGE_37 -->\n###### 광독성\n\n<!-- PAGE_37 -->\n###### 기타\n\n<!-- PAGE_37 -->\n###### (ü: 독성 자료 있음, -: 독성 자료 없음)\n\n<!-- PAGE_37 -->\n###### 3.1.4.2 단회투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.3 반복투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.4 피부자극성\n\n<!-- PAGE_37 -->\n###### 3.1.4.5 안점막자극\n\n<!-- PAGE_37 -->\n###### 3.1.4.6 피부감작성\n\n<!-- PAGE_37 -->\n###### 3.1.4.7 생식·발생독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.8 유전독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.9 발암성\n\n<!-- PAGE_37 -->\n###### 3.1.4.10 광독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.11 기타(면역독성, 신경독성, 임상자료 포함)\n\n<!-- PAGE_37 -->\n###### 3.2 위험성 결정\n\n<!-- PAGE_37 -->\n###### 3.2.1 최적의 전신 독성기준값(PODsys) 선정\n\n<!-- PAGE_37 -->\n###### 3.3 노출평가\n\n<!-- PAGE_37 -->\n###### 3.3.1 노출시나리오\n\n<!-- PAGE_37 -->\n###### 3.3.2 노출량 산출\n\n<!-- PAGE_37 -->\n###### 3.4 위해도 결정\n\n<!-- PAGE_37 -->\n###### 4.  결론\n\n- - 32 -\n<!-- PAGE_38 -->\n###### 5.  제한점\n\n<!-- PAGE_38 -->\n###### 6.  외국의 평가 사례\n\n<!-- PAGE_38 -->\n###### 7.  참고문헌\n\n- - 33 -\n<!-- PAGE_39 -->\n###### 구분\n\n<!-- PAGE_39 -->\n###### ○ 시험물질의 LD50 값을 결정하기 위한 목적으로 개발되었으며 단회투여 경구\n\n<!-- PAGE_39 -->\n###### 독성, 단회투여 흡입독성, 단회투여 피부독성으로 구분된다.  단회투여 경구독성\n\n<!-- PAGE_39 -->\n###### 은 고정용량법(fixed dose method), 단회투여독성 분류법(acute toxic class\n\n<!-- PAGE_39 -->\n###### method), 용량고저법(up-and-down procedure)으로 구분된다.\n\n",
        "original_sentence": "제한점\n\n<!-- PAGE_38 -->\n###### 6. "
      }
    },
    {
      "chunk_id": "chunk_295",
      "text": "외국의 평가 사례\n\n<!-- PAGE_38 -->\n###### 7. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 294,
        "window_size": 3,
        "char_count": 38,
        "word_count": 8,
        "page_number": 38,
        "window_text": "독성학적 자료 확보 유무\n\n<!-- PAGE_37 -->\n###### 단회투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 반복투여\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 피부\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 생식발생\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 유전\n\n<!-- PAGE_37 -->\n###### 독성\n\n<!-- PAGE_37 -->\n###### 발암성\n\n<!-- PAGE_37 -->\n###### 광독성\n\n<!-- PAGE_37 -->\n###### 기타\n\n<!-- PAGE_37 -->\n###### (ü: 독성 자료 있음, -: 독성 자료 없음)\n\n<!-- PAGE_37 -->\n###### 3.1.4.2 단회투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.3 반복투여독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.4 피부자극성\n\n<!-- PAGE_37 -->\n###### 3.1.4.5 안점막자극\n\n<!-- PAGE_37 -->\n###### 3.1.4.6 피부감작성\n\n<!-- PAGE_37 -->\n###### 3.1.4.7 생식·발생독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.8 유전독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.9 발암성\n\n<!-- PAGE_37 -->\n###### 3.1.4.10 광독성\n\n<!-- PAGE_37 -->\n###### 3.1.4.11 기타(면역독성, 신경독성, 임상자료 포함)\n\n<!-- PAGE_37 -->\n###### 3.2 위험성 결정\n\n<!-- PAGE_37 -->\n###### 3.2.1 최적의 전신 독성기준값(PODsys) 선정\n\n<!-- PAGE_37 -->\n###### 3.3 노출평가\n\n<!-- PAGE_37 -->\n###### 3.3.1 노출시나리오\n\n<!-- PAGE_37 -->\n###### 3.3.2 노출량 산출\n\n<!-- PAGE_37 -->\n###### 3.4 위해도 결정\n\n<!-- PAGE_37 -->\n###### 4.  결론\n\n- - 32 -\n<!-- PAGE_38 -->\n###### 5.  제한점\n\n<!-- PAGE_38 -->\n###### 6.  외국의 평가 사례\n\n<!-- PAGE_38 -->\n###### 7.  참고문헌\n\n- - 33 -\n<!-- PAGE_39 -->\n###### 구분\n\n<!-- PAGE_39 -->\n###### ○ 시험물질의 LD50 값을 결정하기 위한 목적으로 개발되었으며 단회투여 경구\n\n<!-- PAGE_39 -->\n###### 독성, 단회투여 흡입독성, 단회투여 피부독성으로 구분된다.  단회투여 경구독성\n\n<!-- PAGE_39 -->\n###### 은 고정용량법(fixed dose method), 단회투여독성 분류법(acute toxic class\n\n<!-- PAGE_39 -->\n###### method), 용량고저법(up-and-down procedure)으로 구분된다.\n\n <!-- PAGE_39 -->\n###### - (OECD TG420) 고정용량법 : 치사율을 종말정으로 사용하지 않고 동물의\n\n<!-- PAGE_39 -->\n###### 반복투여독성\n\n<!-- PAGE_39 -->\n###### ○ 특정 기간(28일, 90일) 동안 물질을 매일 반복 투여하거나 물질에 노출됨에\n\n<!-- PAGE_39 -->\n###### 피부부식성\n\n<!-- PAGE_39 -->\n###### - (OECD TG431) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 피부자극성\n\n<!-- PAGE_39 -->\n###### - (OECD TG439) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 안점막자극성\n\n<!-- PAGE_39 -->\n###### eye(ICE) Test method)\n\n<!-- PAGE_39 -->\n###### - (OECD TG491) 단기노출(Short Time Exposure, STE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG460) 플로오레세인 누출(Fluorescein leakage, FL) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492) 인체각막유사상피(Reconstructed Human Cornea-like\n\n<!-- PAGE_39 -->\n###### Epithelium, RhCE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492B) 인체각막유사 상피모델을 이용한 안 유해성(심한 안손상 및\n\n<!-- PAGE_39 -->\n###### 안자극)시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG494) 인체각막세포주(Vitrigel®)를 이용한 안자극시험법\n\n- - (OECD TG496) In vitro 고분자시험법: Ocular Irritation®\n<!-- PAGE_39 -->\n###### 피부감작성\n\n<!-- PAGE_39 -->\n###### - (OECD TG429) 국소림프절시험(Local Lymph Node Assay, LLNA)\n\n<!-- PAGE_39 -->\n###### 붙임 3. ",
        "original_sentence": "외국의 평가 사례\n\n<!-- PAGE_38 -->\n###### 7. "
      }
    },
    {
      "chunk_id": "chunk_296",
      "text": "참고문헌\n\n- - 33 -\n<!-- PAGE_39 -->\n###### 구분\n\n<!-- PAGE_39 -->\n###### ○ 시험물질의 LD50 값을 결정하기 위한 목적으로 개발되었으며 단회투여 경구\n\n<!-- PAGE_39 -->\n###### 독성, 단회투여 흡입독성, 단회투여 피부독성으로 구분된다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 295,
        "window_size": 3,
        "char_count": 169,
        "word_count": 34,
        "page_number": 39,
        "window_text": "결론\n\n- - 32 -\n<!-- PAGE_38 -->\n###### 5.  제한점\n\n<!-- PAGE_38 -->\n###### 6.  외국의 평가 사례\n\n<!-- PAGE_38 -->\n###### 7.  참고문헌\n\n- - 33 -\n<!-- PAGE_39 -->\n###### 구분\n\n<!-- PAGE_39 -->\n###### ○ 시험물질의 LD50 값을 결정하기 위한 목적으로 개발되었으며 단회투여 경구\n\n<!-- PAGE_39 -->\n###### 독성, 단회투여 흡입독성, 단회투여 피부독성으로 구분된다.  단회투여 경구독성\n\n<!-- PAGE_39 -->\n###### 은 고정용량법(fixed dose method), 단회투여독성 분류법(acute toxic class\n\n<!-- PAGE_39 -->\n###### method), 용량고저법(up-and-down procedure)으로 구분된다.\n\n <!-- PAGE_39 -->\n###### - (OECD TG420) 고정용량법 : 치사율을 종말정으로 사용하지 않고 동물의\n\n<!-- PAGE_39 -->\n###### 반복투여독성\n\n<!-- PAGE_39 -->\n###### ○ 특정 기간(28일, 90일) 동안 물질을 매일 반복 투여하거나 물질에 노출됨에\n\n<!-- PAGE_39 -->\n###### 피부부식성\n\n<!-- PAGE_39 -->\n###### - (OECD TG431) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 피부자극성\n\n<!-- PAGE_39 -->\n###### - (OECD TG439) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 안점막자극성\n\n<!-- PAGE_39 -->\n###### eye(ICE) Test method)\n\n<!-- PAGE_39 -->\n###### - (OECD TG491) 단기노출(Short Time Exposure, STE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG460) 플로오레세인 누출(Fluorescein leakage, FL) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492) 인체각막유사상피(Reconstructed Human Cornea-like\n\n<!-- PAGE_39 -->\n###### Epithelium, RhCE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492B) 인체각막유사 상피모델을 이용한 안 유해성(심한 안손상 및\n\n<!-- PAGE_39 -->\n###### 안자극)시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG494) 인체각막세포주(Vitrigel®)를 이용한 안자극시험법\n\n- - (OECD TG496) In vitro 고분자시험법: Ocular Irritation®\n<!-- PAGE_39 -->\n###### 피부감작성\n\n<!-- PAGE_39 -->\n###### - (OECD TG429) 국소림프절시험(Local Lymph Node Assay, LLNA)\n\n<!-- PAGE_39 -->\n###### 붙임 3.  OECD 독성시험 종류\n\n- - 34 -\n* 참고 : OECD Test Guidelines, Section 4 – Health effects (2023년 11월 기준)\n\n<!-- PAGE_40 -->\n###### 구분\n\n<!-- PAGE_40 -->\n###### - (OECD TG422A) LLNA Daicel-ATP 시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG422B) LLNA 세포증식효소매개 면역흡수 분석시험(ELISA) BrdU\n\n<!-- PAGE_40 -->\n###### - (OECD TG442C) in Chemico 펩타이드 반응성 시험법(DPRA), in Chemico\n\n<!-- PAGE_40 -->\n###### 아미노산 유도체 결합성 시험법(ADRA), in Chemico 피부감작성 시험법\n\n<!-- PAGE_40 -->\n###### (kDPRA)\n\n<!-- PAGE_40 -->\n###### - (OECD TG442D) ARE-Nrf2 루시퍼라아제 시험법(KeratinoSensTM), ARE-Nrf2\n\n<!-- PAGE_40 -->\n###### - (OECD TG442E) 인체세포주 활성화 시험법(h-CLAT), IL-8 루시퍼라아제\n\n<!-- PAGE_40 -->\n###### 피부흡수\n\n<!-- PAGE_40 -->\n###### - (OECD TG28) 생체외 피부흡수시험법\n\n<!-- PAGE_40 -->\n###### 생식·발생독성\n\n<!-- PAGE_40 -->\n###### 유전독성\n\n<!-- PAGE_40 -->\n###### 발암성\n\n<!-- PAGE_40 -->\n###### - (OECD TG452) 만성 독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG453) 만성 발암성\n\n<!-- PAGE_40 -->\n###### 광독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG432) 3T3 뉴트럴 레드 흡수 광독성 시험(3T3 Neutral Red\n\n<!-- PAGE_40 -->\n###### Uptake Phototoxicty Test, 3T3 NRU PT)\n\n<!-- PAGE_40 -->\n###### - (OECD TG495) 활성산소종(ROS) 분석을 이용한 광독성시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG498) 인체피부모델을 이용한 광독성시험법\n\n- - 35 -\n<!-- PAGE_41 -->\n###### 붙임 4. ",
        "original_sentence": "참고문헌\n\n- - 33 -\n<!-- PAGE_39 -->\n###### 구분\n\n<!-- PAGE_39 -->\n###### ○ 시험물질의 LD50 값을 결정하기 위한 목적으로 개발되었으며 단회투여 경구\n\n<!-- PAGE_39 -->\n###### 독성, 단회투여 흡입독성, 단회투여 피부독성으로 구분된다. "
      }
    },
    {
      "chunk_id": "chunk_297",
      "text": "단회투여 경구독성\n\n<!-- PAGE_39 -->\n###### 은 고정용량법(fixed dose method), 단회투여독성 분류법(acute toxic class\n\n<!-- PAGE_39 -->\n###### method), 용량고저법(up-and-down procedure)으로 구분된다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 296,
        "window_size": 3,
        "char_count": 164,
        "word_count": 22,
        "page_number": 39,
        "window_text": "제한점\n\n<!-- PAGE_38 -->\n###### 6.  외국의 평가 사례\n\n<!-- PAGE_38 -->\n###### 7.  참고문헌\n\n- - 33 -\n<!-- PAGE_39 -->\n###### 구분\n\n<!-- PAGE_39 -->\n###### ○ 시험물질의 LD50 값을 결정하기 위한 목적으로 개발되었으며 단회투여 경구\n\n<!-- PAGE_39 -->\n###### 독성, 단회투여 흡입독성, 단회투여 피부독성으로 구분된다.  단회투여 경구독성\n\n<!-- PAGE_39 -->\n###### 은 고정용량법(fixed dose method), 단회투여독성 분류법(acute toxic class\n\n<!-- PAGE_39 -->\n###### method), 용량고저법(up-and-down procedure)으로 구분된다.\n\n <!-- PAGE_39 -->\n###### - (OECD TG420) 고정용량법 : 치사율을 종말정으로 사용하지 않고 동물의\n\n<!-- PAGE_39 -->\n###### 반복투여독성\n\n<!-- PAGE_39 -->\n###### ○ 특정 기간(28일, 90일) 동안 물질을 매일 반복 투여하거나 물질에 노출됨에\n\n<!-- PAGE_39 -->\n###### 피부부식성\n\n<!-- PAGE_39 -->\n###### - (OECD TG431) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 피부자극성\n\n<!-- PAGE_39 -->\n###### - (OECD TG439) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 안점막자극성\n\n<!-- PAGE_39 -->\n###### eye(ICE) Test method)\n\n<!-- PAGE_39 -->\n###### - (OECD TG491) 단기노출(Short Time Exposure, STE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG460) 플로오레세인 누출(Fluorescein leakage, FL) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492) 인체각막유사상피(Reconstructed Human Cornea-like\n\n<!-- PAGE_39 -->\n###### Epithelium, RhCE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492B) 인체각막유사 상피모델을 이용한 안 유해성(심한 안손상 및\n\n<!-- PAGE_39 -->\n###### 안자극)시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG494) 인체각막세포주(Vitrigel®)를 이용한 안자극시험법\n\n- - (OECD TG496) In vitro 고분자시험법: Ocular Irritation®\n<!-- PAGE_39 -->\n###### 피부감작성\n\n<!-- PAGE_39 -->\n###### - (OECD TG429) 국소림프절시험(Local Lymph Node Assay, LLNA)\n\n<!-- PAGE_39 -->\n###### 붙임 3.  OECD 독성시험 종류\n\n- - 34 -\n* 참고 : OECD Test Guidelines, Section 4 – Health effects (2023년 11월 기준)\n\n<!-- PAGE_40 -->\n###### 구분\n\n<!-- PAGE_40 -->\n###### - (OECD TG422A) LLNA Daicel-ATP 시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG422B) LLNA 세포증식효소매개 면역흡수 분석시험(ELISA) BrdU\n\n<!-- PAGE_40 -->\n###### - (OECD TG442C) in Chemico 펩타이드 반응성 시험법(DPRA), in Chemico\n\n<!-- PAGE_40 -->\n###### 아미노산 유도체 결합성 시험법(ADRA), in Chemico 피부감작성 시험법\n\n<!-- PAGE_40 -->\n###### (kDPRA)\n\n<!-- PAGE_40 -->\n###### - (OECD TG442D) ARE-Nrf2 루시퍼라아제 시험법(KeratinoSensTM), ARE-Nrf2\n\n<!-- PAGE_40 -->\n###### - (OECD TG442E) 인체세포주 활성화 시험법(h-CLAT), IL-8 루시퍼라아제\n\n<!-- PAGE_40 -->\n###### 피부흡수\n\n<!-- PAGE_40 -->\n###### - (OECD TG28) 생체외 피부흡수시험법\n\n<!-- PAGE_40 -->\n###### 생식·발생독성\n\n<!-- PAGE_40 -->\n###### 유전독성\n\n<!-- PAGE_40 -->\n###### 발암성\n\n<!-- PAGE_40 -->\n###### - (OECD TG452) 만성 독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG453) 만성 발암성\n\n<!-- PAGE_40 -->\n###### 광독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG432) 3T3 뉴트럴 레드 흡수 광독성 시험(3T3 Neutral Red\n\n<!-- PAGE_40 -->\n###### Uptake Phototoxicty Test, 3T3 NRU PT)\n\n<!-- PAGE_40 -->\n###### - (OECD TG495) 활성산소종(ROS) 분석을 이용한 광독성시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG498) 인체피부모델을 이용한 광독성시험법\n\n- - 35 -\n<!-- PAGE_41 -->\n###### 붙임 4.  화장품 노출 피부 표면적\n\n표 1. ",
        "original_sentence": "단회투여 경구독성\n\n<!-- PAGE_39 -->\n###### 은 고정용량법(fixed dose method), 단회투여독성 분류법(acute toxic class\n\n<!-- PAGE_39 -->\n###### method), 용량고저법(up-and-down procedure)으로 구분된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_298",
      "text": "<!-- PAGE_39 -->\n###### - (OECD TG420) 고정용량법 : 치사율을 종말정으로 사용하지 않고 동물의\n\n<!-- PAGE_39 -->\n###### 반복투여독성\n\n<!-- PAGE_39 -->\n###### ○ 특정 기간(28일, 90일) 동안 물질을 매일 반복 투여하거나 물질에 노출됨에\n\n<!-- PAGE_39 -->\n###### 피부부식성\n\n<!-- PAGE_39 -->\n###### - (OECD TG431) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 피부자극성\n\n<!-- PAGE_39 -->\n###### - (OECD TG439) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 안점막자극성\n\n<!-- PAGE_39 -->\n###### eye(ICE) Test method)\n\n<!-- PAGE_39 -->\n###### - (OECD TG491) 단기노출(Short Time Exposure, STE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG460) 플로오레세인 누출(Fluorescein leakage, FL) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492) 인체각막유사상피(Reconstructed Human Cornea-like\n\n<!-- PAGE_39 -->\n###### Epithelium, RhCE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492B) 인체각막유사 상피모델을 이용한 안 유해성(심한 안손상 및\n\n<!-- PAGE_39 -->\n###### 안자극)시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG494) 인체각막세포주(Vitrigel®)를 이용한 안자극시험법\n\n- - (OECD TG496) In vitro 고분자시험법: Ocular Irritation®\n<!-- PAGE_39 -->\n###### 피부감작성\n\n<!-- PAGE_39 -->\n###### - (OECD TG429) 국소림프절시험(Local Lymph Node Assay, LLNA)\n\n<!-- PAGE_39 -->\n###### 붙임 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 297,
        "window_size": 3,
        "char_count": 1142,
        "word_count": 180,
        "page_number": 39,
        "window_text": "외국의 평가 사례\n\n<!-- PAGE_38 -->\n###### 7.  참고문헌\n\n- - 33 -\n<!-- PAGE_39 -->\n###### 구분\n\n<!-- PAGE_39 -->\n###### ○ 시험물질의 LD50 값을 결정하기 위한 목적으로 개발되었으며 단회투여 경구\n\n<!-- PAGE_39 -->\n###### 독성, 단회투여 흡입독성, 단회투여 피부독성으로 구분된다.  단회투여 경구독성\n\n<!-- PAGE_39 -->\n###### 은 고정용량법(fixed dose method), 단회투여독성 분류법(acute toxic class\n\n<!-- PAGE_39 -->\n###### method), 용량고저법(up-and-down procedure)으로 구분된다.\n\n <!-- PAGE_39 -->\n###### - (OECD TG420) 고정용량법 : 치사율을 종말정으로 사용하지 않고 동물의\n\n<!-- PAGE_39 -->\n###### 반복투여독성\n\n<!-- PAGE_39 -->\n###### ○ 특정 기간(28일, 90일) 동안 물질을 매일 반복 투여하거나 물질에 노출됨에\n\n<!-- PAGE_39 -->\n###### 피부부식성\n\n<!-- PAGE_39 -->\n###### - (OECD TG431) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 피부자극성\n\n<!-- PAGE_39 -->\n###### - (OECD TG439) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 안점막자극성\n\n<!-- PAGE_39 -->\n###### eye(ICE) Test method)\n\n<!-- PAGE_39 -->\n###### - (OECD TG491) 단기노출(Short Time Exposure, STE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG460) 플로오레세인 누출(Fluorescein leakage, FL) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492) 인체각막유사상피(Reconstructed Human Cornea-like\n\n<!-- PAGE_39 -->\n###### Epithelium, RhCE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492B) 인체각막유사 상피모델을 이용한 안 유해성(심한 안손상 및\n\n<!-- PAGE_39 -->\n###### 안자극)시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG494) 인체각막세포주(Vitrigel®)를 이용한 안자극시험법\n\n- - (OECD TG496) In vitro 고분자시험법: Ocular Irritation®\n<!-- PAGE_39 -->\n###### 피부감작성\n\n<!-- PAGE_39 -->\n###### - (OECD TG429) 국소림프절시험(Local Lymph Node Assay, LLNA)\n\n<!-- PAGE_39 -->\n###### 붙임 3.  OECD 독성시험 종류\n\n- - 34 -\n* 참고 : OECD Test Guidelines, Section 4 – Health effects (2023년 11월 기준)\n\n<!-- PAGE_40 -->\n###### 구분\n\n<!-- PAGE_40 -->\n###### - (OECD TG422A) LLNA Daicel-ATP 시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG422B) LLNA 세포증식효소매개 면역흡수 분석시험(ELISA) BrdU\n\n<!-- PAGE_40 -->\n###### - (OECD TG442C) in Chemico 펩타이드 반응성 시험법(DPRA), in Chemico\n\n<!-- PAGE_40 -->\n###### 아미노산 유도체 결합성 시험법(ADRA), in Chemico 피부감작성 시험법\n\n<!-- PAGE_40 -->\n###### (kDPRA)\n\n<!-- PAGE_40 -->\n###### - (OECD TG442D) ARE-Nrf2 루시퍼라아제 시험법(KeratinoSensTM), ARE-Nrf2\n\n<!-- PAGE_40 -->\n###### - (OECD TG442E) 인체세포주 활성화 시험법(h-CLAT), IL-8 루시퍼라아제\n\n<!-- PAGE_40 -->\n###### 피부흡수\n\n<!-- PAGE_40 -->\n###### - (OECD TG28) 생체외 피부흡수시험법\n\n<!-- PAGE_40 -->\n###### 생식·발생독성\n\n<!-- PAGE_40 -->\n###### 유전독성\n\n<!-- PAGE_40 -->\n###### 발암성\n\n<!-- PAGE_40 -->\n###### - (OECD TG452) 만성 독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG453) 만성 발암성\n\n<!-- PAGE_40 -->\n###### 광독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG432) 3T3 뉴트럴 레드 흡수 광독성 시험(3T3 Neutral Red\n\n<!-- PAGE_40 -->\n###### Uptake Phototoxicty Test, 3T3 NRU PT)\n\n<!-- PAGE_40 -->\n###### - (OECD TG495) 활성산소종(ROS) 분석을 이용한 광독성시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG498) 인체피부모델을 이용한 광독성시험법\n\n- - 35 -\n<!-- PAGE_41 -->\n###### 붙임 4.  화장품 노출 피부 표면적\n\n표 1.  각 제품 유형별 평균 노출 피부 표면적(Bremmer et al. ",
        "original_sentence": "<!-- PAGE_39 -->\n###### - (OECD TG420) 고정용량법 : 치사율을 종말정으로 사용하지 않고 동물의\n\n<!-- PAGE_39 -->\n###### 반복투여독성\n\n<!-- PAGE_39 -->\n###### ○ 특정 기간(28일, 90일) 동안 물질을 매일 반복 투여하거나 물질에 노출됨에\n\n<!-- PAGE_39 -->\n###### 피부부식성\n\n<!-- PAGE_39 -->\n###### - (OECD TG431) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 피부자극성\n\n<!-- PAGE_39 -->\n###### - (OECD TG439) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 안점막자극성\n\n<!-- PAGE_39 -->\n###### eye(ICE) Test method)\n\n<!-- PAGE_39 -->\n###### - (OECD TG491) 단기노출(Short Time Exposure, STE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG460) 플로오레세인 누출(Fluorescein leakage, FL) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492) 인체각막유사상피(Reconstructed Human Cornea-like\n\n<!-- PAGE_39 -->\n###### Epithelium, RhCE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492B) 인체각막유사 상피모델을 이용한 안 유해성(심한 안손상 및\n\n<!-- PAGE_39 -->\n###### 안자극)시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG494) 인체각막세포주(Vitrigel®)를 이용한 안자극시험법\n\n- - (OECD TG496) In vitro 고분자시험법: Ocular Irritation®\n<!-- PAGE_39 -->\n###### 피부감작성\n\n<!-- PAGE_39 -->\n###### - (OECD TG429) 국소림프절시험(Local Lymph Node Assay, LLNA)\n\n<!-- PAGE_39 -->\n###### 붙임 3. "
      }
    },
    {
      "chunk_id": "chunk_299",
      "text": "OECD 독성시험 종류\n\n- - 34 -\n* 참고 : OECD Test Guidelines, Section 4 – Health effects (2023년 11월 기준)\n\n<!-- PAGE_40 -->\n###### 구분\n\n<!-- PAGE_40 -->\n###### - (OECD TG422A) LLNA Daicel-ATP 시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG422B) LLNA 세포증식효소매개 면역흡수 분석시험(ELISA) BrdU\n\n<!-- PAGE_40 -->\n###### - (OECD TG442C) in Chemico 펩타이드 반응성 시험법(DPRA), in Chemico\n\n<!-- PAGE_40 -->\n###### 아미노산 유도체 결합성 시험법(ADRA), in Chemico 피부감작성 시험법\n\n<!-- PAGE_40 -->\n###### (kDPRA)\n\n<!-- PAGE_40 -->\n###### - (OECD TG442D) ARE-Nrf2 루시퍼라아제 시험법(KeratinoSensTM), ARE-Nrf2\n\n<!-- PAGE_40 -->\n###### - (OECD TG442E) 인체세포주 활성화 시험법(h-CLAT), IL-8 루시퍼라아제\n\n<!-- PAGE_40 -->\n###### 피부흡수\n\n<!-- PAGE_40 -->\n###### - (OECD TG28) 생체외 피부흡수시험법\n\n<!-- PAGE_40 -->\n###### 생식·발생독성\n\n<!-- PAGE_40 -->\n###### 유전독성\n\n<!-- PAGE_40 -->\n###### 발암성\n\n<!-- PAGE_40 -->\n###### - (OECD TG452) 만성 독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG453) 만성 발암성\n\n<!-- PAGE_40 -->\n###### 광독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG432) 3T3 뉴트럴 레드 흡수 광독성 시험(3T3 Neutral Red\n\n<!-- PAGE_40 -->\n###### Uptake Phototoxicty Test, 3T3 NRU PT)\n\n<!-- PAGE_40 -->\n###### - (OECD TG495) 활성산소종(ROS) 분석을 이용한 광독성시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG498) 인체피부모델을 이용한 광독성시험법\n\n- - 35 -\n<!-- PAGE_41 -->\n###### 붙임 4. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 298,
        "window_size": 3,
        "char_count": 1209,
        "word_count": 210,
        "page_number": 40,
        "window_text": "참고문헌\n\n- - 33 -\n<!-- PAGE_39 -->\n###### 구분\n\n<!-- PAGE_39 -->\n###### ○ 시험물질의 LD50 값을 결정하기 위한 목적으로 개발되었으며 단회투여 경구\n\n<!-- PAGE_39 -->\n###### 독성, 단회투여 흡입독성, 단회투여 피부독성으로 구분된다.  단회투여 경구독성\n\n<!-- PAGE_39 -->\n###### 은 고정용량법(fixed dose method), 단회투여독성 분류법(acute toxic class\n\n<!-- PAGE_39 -->\n###### method), 용량고저법(up-and-down procedure)으로 구분된다.\n\n <!-- PAGE_39 -->\n###### - (OECD TG420) 고정용량법 : 치사율을 종말정으로 사용하지 않고 동물의\n\n<!-- PAGE_39 -->\n###### 반복투여독성\n\n<!-- PAGE_39 -->\n###### ○ 특정 기간(28일, 90일) 동안 물질을 매일 반복 투여하거나 물질에 노출됨에\n\n<!-- PAGE_39 -->\n###### 피부부식성\n\n<!-- PAGE_39 -->\n###### - (OECD TG431) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 피부자극성\n\n<!-- PAGE_39 -->\n###### - (OECD TG439) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 안점막자극성\n\n<!-- PAGE_39 -->\n###### eye(ICE) Test method)\n\n<!-- PAGE_39 -->\n###### - (OECD TG491) 단기노출(Short Time Exposure, STE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG460) 플로오레세인 누출(Fluorescein leakage, FL) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492) 인체각막유사상피(Reconstructed Human Cornea-like\n\n<!-- PAGE_39 -->\n###### Epithelium, RhCE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492B) 인체각막유사 상피모델을 이용한 안 유해성(심한 안손상 및\n\n<!-- PAGE_39 -->\n###### 안자극)시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG494) 인체각막세포주(Vitrigel®)를 이용한 안자극시험법\n\n- - (OECD TG496) In vitro 고분자시험법: Ocular Irritation®\n<!-- PAGE_39 -->\n###### 피부감작성\n\n<!-- PAGE_39 -->\n###### - (OECD TG429) 국소림프절시험(Local Lymph Node Assay, LLNA)\n\n<!-- PAGE_39 -->\n###### 붙임 3.  OECD 독성시험 종류\n\n- - 34 -\n* 참고 : OECD Test Guidelines, Section 4 – Health effects (2023년 11월 기준)\n\n<!-- PAGE_40 -->\n###### 구분\n\n<!-- PAGE_40 -->\n###### - (OECD TG422A) LLNA Daicel-ATP 시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG422B) LLNA 세포증식효소매개 면역흡수 분석시험(ELISA) BrdU\n\n<!-- PAGE_40 -->\n###### - (OECD TG442C) in Chemico 펩타이드 반응성 시험법(DPRA), in Chemico\n\n<!-- PAGE_40 -->\n###### 아미노산 유도체 결합성 시험법(ADRA), in Chemico 피부감작성 시험법\n\n<!-- PAGE_40 -->\n###### (kDPRA)\n\n<!-- PAGE_40 -->\n###### - (OECD TG442D) ARE-Nrf2 루시퍼라아제 시험법(KeratinoSensTM), ARE-Nrf2\n\n<!-- PAGE_40 -->\n###### - (OECD TG442E) 인체세포주 활성화 시험법(h-CLAT), IL-8 루시퍼라아제\n\n<!-- PAGE_40 -->\n###### 피부흡수\n\n<!-- PAGE_40 -->\n###### - (OECD TG28) 생체외 피부흡수시험법\n\n<!-- PAGE_40 -->\n###### 생식·발생독성\n\n<!-- PAGE_40 -->\n###### 유전독성\n\n<!-- PAGE_40 -->\n###### 발암성\n\n<!-- PAGE_40 -->\n###### - (OECD TG452) 만성 독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG453) 만성 발암성\n\n<!-- PAGE_40 -->\n###### 광독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG432) 3T3 뉴트럴 레드 흡수 광독성 시험(3T3 Neutral Red\n\n<!-- PAGE_40 -->\n###### Uptake Phototoxicty Test, 3T3 NRU PT)\n\n<!-- PAGE_40 -->\n###### - (OECD TG495) 활성산소종(ROS) 분석을 이용한 광독성시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG498) 인체피부모델을 이용한 광독성시험법\n\n- - 35 -\n<!-- PAGE_41 -->\n###### 붙임 4.  화장품 노출 피부 표면적\n\n표 1.  각 제품 유형별 평균 노출 피부 표면적(Bremmer et al.  2006a; Bremmer et al., 2006b)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\n샴푸\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 컨디셔너\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 스프레이\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n헤어 스타일링 젤\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n헤어 스타일링 무스\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n반영구형 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n산화성/영구적 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 탈색제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 고정용 로션\n\n1/2 머리 면적\n\n580\n\n590\n\n손세정용 액상 비누\n\n양손 면적\n\n860\n\n840\n\n손세정용 고상 비누\n\n양손 면적\n\n860\n\n840\n\n샤워용 액상 비누\n\n총 신체면적\n\n17500\n\n19400\n\n샤워용 고형 비누\n\n총 신체면적\n\n17500\n\n19400\n\n목욕용 거품제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 염제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n얼굴용 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n(+ 목)\n\n320\n\n(+ 뒷목)\n\n80\n\n바디 로숀\n\n신체 면적-머리 면적(여성)\n\n15670\n\n핸드 크림\n\n양손 면적\n\n860\n\n필링/스크럽 젤\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n얼굴 팩\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n바디 팩\n\n신체 면적-머리 면적(여성)\n\n15670\n\n피부 미백 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 및 손톱 관리(Make-up and nail care)\n\n리퀴드 파운데이션\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 리무버\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n아이 섀도\n\n24\n\n마스카라\n\n- 1.6\n아이라이너\n\n- 3.2\n아이 메이크업 리무버\n\n50\n\n- - 36 -\n1 위해평가를 위한 피부체표면적 조사집(식품의약품안전청, 2010)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\nRIVM\n\nEPA\n\n손톱 광택제\n\n4\n\n손톱 광택제 제거제\n\n11\n\n립스틱, 입술크림\n\n- 4.8\n데오도란트 스틱형/롤러형\n\n양쪽 겨드랑이\n\n200\n\n데오도란트 스프레이\n\n양쪽 겨드랑이\n\n200\n\n제한용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n항균용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n오드트왈렛 스프레이\n\n200\n\n향수 스프레이\n\n100\n\n면도용 크림\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n에프터쉐이브\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n자외선 차단 로숀\n\n총 신체면적\n\n17500\n\n19400\n\n자외선 차단 크림\n\n총 신체면적\n\n17500\n\n19400\n\n베이비 크림\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 오일\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 파우더\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n제모용 크림\n\n다리 면적(여성)\n\n5530\n\n5460\n\n마사지용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n소아용 얼굴 물감\n\n1/2 소아 머리 면적(4.5세)\n\n475\n\n496\n\n성인용 얼굴 물감\n\n1/2 머리 면적\n\n580\n\n650\n\n- - 37 -\n<!-- PAGE_43 -->\n###### 붙임 5. ",
        "original_sentence": "OECD 독성시험 종류\n\n- - 34 -\n* 참고 : OECD Test Guidelines, Section 4 – Health effects (2023년 11월 기준)\n\n<!-- PAGE_40 -->\n###### 구분\n\n<!-- PAGE_40 -->\n###### - (OECD TG422A) LLNA Daicel-ATP 시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG422B) LLNA 세포증식효소매개 면역흡수 분석시험(ELISA) BrdU\n\n<!-- PAGE_40 -->\n###### - (OECD TG442C) in Chemico 펩타이드 반응성 시험법(DPRA), in Chemico\n\n<!-- PAGE_40 -->\n###### 아미노산 유도체 결합성 시험법(ADRA), in Chemico 피부감작성 시험법\n\n<!-- PAGE_40 -->\n###### (kDPRA)\n\n<!-- PAGE_40 -->\n###### - (OECD TG442D) ARE-Nrf2 루시퍼라아제 시험법(KeratinoSensTM), ARE-Nrf2\n\n<!-- PAGE_40 -->\n###### - (OECD TG442E) 인체세포주 활성화 시험법(h-CLAT), IL-8 루시퍼라아제\n\n<!-- PAGE_40 -->\n###### 피부흡수\n\n<!-- PAGE_40 -->\n###### - (OECD TG28) 생체외 피부흡수시험법\n\n<!-- PAGE_40 -->\n###### 생식·발생독성\n\n<!-- PAGE_40 -->\n###### 유전독성\n\n<!-- PAGE_40 -->\n###### 발암성\n\n<!-- PAGE_40 -->\n###### - (OECD TG452) 만성 독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG453) 만성 발암성\n\n<!-- PAGE_40 -->\n###### 광독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG432) 3T3 뉴트럴 레드 흡수 광독성 시험(3T3 Neutral Red\n\n<!-- PAGE_40 -->\n###### Uptake Phototoxicty Test, 3T3 NRU PT)\n\n<!-- PAGE_40 -->\n###### - (OECD TG495) 활성산소종(ROS) 분석을 이용한 광독성시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG498) 인체피부모델을 이용한 광독성시험법\n\n- - 35 -\n<!-- PAGE_41 -->\n###### 붙임 4. "
      }
    },
    {
      "chunk_id": "chunk_300",
      "text": "화장품 노출 피부 표면적\n\n표 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 299,
        "window_size": 3,
        "char_count": 20,
        "word_count": 6,
        "page_number": 37,
        "window_text": "단회투여 경구독성\n\n<!-- PAGE_39 -->\n###### 은 고정용량법(fixed dose method), 단회투여독성 분류법(acute toxic class\n\n<!-- PAGE_39 -->\n###### method), 용량고저법(up-and-down procedure)으로 구분된다.\n\n <!-- PAGE_39 -->\n###### - (OECD TG420) 고정용량법 : 치사율을 종말정으로 사용하지 않고 동물의\n\n<!-- PAGE_39 -->\n###### 반복투여독성\n\n<!-- PAGE_39 -->\n###### ○ 특정 기간(28일, 90일) 동안 물질을 매일 반복 투여하거나 물질에 노출됨에\n\n<!-- PAGE_39 -->\n###### 피부부식성\n\n<!-- PAGE_39 -->\n###### - (OECD TG431) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 피부자극성\n\n<!-- PAGE_39 -->\n###### - (OECD TG439) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 안점막자극성\n\n<!-- PAGE_39 -->\n###### eye(ICE) Test method)\n\n<!-- PAGE_39 -->\n###### - (OECD TG491) 단기노출(Short Time Exposure, STE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG460) 플로오레세인 누출(Fluorescein leakage, FL) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492) 인체각막유사상피(Reconstructed Human Cornea-like\n\n<!-- PAGE_39 -->\n###### Epithelium, RhCE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492B) 인체각막유사 상피모델을 이용한 안 유해성(심한 안손상 및\n\n<!-- PAGE_39 -->\n###### 안자극)시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG494) 인체각막세포주(Vitrigel®)를 이용한 안자극시험법\n\n- - (OECD TG496) In vitro 고분자시험법: Ocular Irritation®\n<!-- PAGE_39 -->\n###### 피부감작성\n\n<!-- PAGE_39 -->\n###### - (OECD TG429) 국소림프절시험(Local Lymph Node Assay, LLNA)\n\n<!-- PAGE_39 -->\n###### 붙임 3.  OECD 독성시험 종류\n\n- - 34 -\n* 참고 : OECD Test Guidelines, Section 4 – Health effects (2023년 11월 기준)\n\n<!-- PAGE_40 -->\n###### 구분\n\n<!-- PAGE_40 -->\n###### - (OECD TG422A) LLNA Daicel-ATP 시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG422B) LLNA 세포증식효소매개 면역흡수 분석시험(ELISA) BrdU\n\n<!-- PAGE_40 -->\n###### - (OECD TG442C) in Chemico 펩타이드 반응성 시험법(DPRA), in Chemico\n\n<!-- PAGE_40 -->\n###### 아미노산 유도체 결합성 시험법(ADRA), in Chemico 피부감작성 시험법\n\n<!-- PAGE_40 -->\n###### (kDPRA)\n\n<!-- PAGE_40 -->\n###### - (OECD TG442D) ARE-Nrf2 루시퍼라아제 시험법(KeratinoSensTM), ARE-Nrf2\n\n<!-- PAGE_40 -->\n###### - (OECD TG442E) 인체세포주 활성화 시험법(h-CLAT), IL-8 루시퍼라아제\n\n<!-- PAGE_40 -->\n###### 피부흡수\n\n<!-- PAGE_40 -->\n###### - (OECD TG28) 생체외 피부흡수시험법\n\n<!-- PAGE_40 -->\n###### 생식·발생독성\n\n<!-- PAGE_40 -->\n###### 유전독성\n\n<!-- PAGE_40 -->\n###### 발암성\n\n<!-- PAGE_40 -->\n###### - (OECD TG452) 만성 독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG453) 만성 발암성\n\n<!-- PAGE_40 -->\n###### 광독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG432) 3T3 뉴트럴 레드 흡수 광독성 시험(3T3 Neutral Red\n\n<!-- PAGE_40 -->\n###### Uptake Phototoxicty Test, 3T3 NRU PT)\n\n<!-- PAGE_40 -->\n###### - (OECD TG495) 활성산소종(ROS) 분석을 이용한 광독성시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG498) 인체피부모델을 이용한 광독성시험법\n\n- - 35 -\n<!-- PAGE_41 -->\n###### 붙임 4.  화장품 노출 피부 표면적\n\n표 1.  각 제품 유형별 평균 노출 피부 표면적(Bremmer et al.  2006a; Bremmer et al., 2006b)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\n샴푸\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 컨디셔너\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 스프레이\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n헤어 스타일링 젤\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n헤어 스타일링 무스\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n반영구형 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n산화성/영구적 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 탈색제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 고정용 로션\n\n1/2 머리 면적\n\n580\n\n590\n\n손세정용 액상 비누\n\n양손 면적\n\n860\n\n840\n\n손세정용 고상 비누\n\n양손 면적\n\n860\n\n840\n\n샤워용 액상 비누\n\n총 신체면적\n\n17500\n\n19400\n\n샤워용 고형 비누\n\n총 신체면적\n\n17500\n\n19400\n\n목욕용 거품제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 염제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n얼굴용 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n(+ 목)\n\n320\n\n(+ 뒷목)\n\n80\n\n바디 로숀\n\n신체 면적-머리 면적(여성)\n\n15670\n\n핸드 크림\n\n양손 면적\n\n860\n\n필링/스크럽 젤\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n얼굴 팩\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n바디 팩\n\n신체 면적-머리 면적(여성)\n\n15670\n\n피부 미백 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 및 손톱 관리(Make-up and nail care)\n\n리퀴드 파운데이션\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 리무버\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n아이 섀도\n\n24\n\n마스카라\n\n- 1.6\n아이라이너\n\n- 3.2\n아이 메이크업 리무버\n\n50\n\n- - 36 -\n1 위해평가를 위한 피부체표면적 조사집(식품의약품안전청, 2010)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\nRIVM\n\nEPA\n\n손톱 광택제\n\n4\n\n손톱 광택제 제거제\n\n11\n\n립스틱, 입술크림\n\n- 4.8\n데오도란트 스틱형/롤러형\n\n양쪽 겨드랑이\n\n200\n\n데오도란트 스프레이\n\n양쪽 겨드랑이\n\n200\n\n제한용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n항균용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n오드트왈렛 스프레이\n\n200\n\n향수 스프레이\n\n100\n\n면도용 크림\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n에프터쉐이브\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n자외선 차단 로숀\n\n총 신체면적\n\n17500\n\n19400\n\n자외선 차단 크림\n\n총 신체면적\n\n17500\n\n19400\n\n베이비 크림\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 오일\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 파우더\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n제모용 크림\n\n다리 면적(여성)\n\n5530\n\n5460\n\n마사지용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n소아용 얼굴 물감\n\n1/2 소아 머리 면적(4.5세)\n\n475\n\n496\n\n성인용 얼굴 물감\n\n1/2 머리 면적\n\n580\n\n650\n\n- - 37 -\n<!-- PAGE_43 -->\n###### 붙임 5.  한국인의 화장품 사용량\n\n<!-- PAGE_43 -->\n###### 1.‘2014년~2016년 화장품 위해평가 선진화 연구’결과에 근거한 화장품 유형별 추정 일일 사\n\n<!-- PAGE_43 -->\n###### 용량 및 노출량은 다음과 같다.\n\n",
        "original_sentence": "화장품 노출 피부 표면적\n\n표 1. "
      }
    },
    {
      "chunk_id": "chunk_301",
      "text": "각 제품 유형별 평균 노출 피부 표면적(Bremmer et al. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 300,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 37,
        "window_text": "<!-- PAGE_39 -->\n###### - (OECD TG420) 고정용량법 : 치사율을 종말정으로 사용하지 않고 동물의\n\n<!-- PAGE_39 -->\n###### 반복투여독성\n\n<!-- PAGE_39 -->\n###### ○ 특정 기간(28일, 90일) 동안 물질을 매일 반복 투여하거나 물질에 노출됨에\n\n<!-- PAGE_39 -->\n###### 피부부식성\n\n<!-- PAGE_39 -->\n###### - (OECD TG431) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 피부자극성\n\n<!-- PAGE_39 -->\n###### - (OECD TG439) 인체표피시험법(Reconstructed Human Epidermis(RhE) Test\n\n<!-- PAGE_39 -->\n###### 안점막자극성\n\n<!-- PAGE_39 -->\n###### eye(ICE) Test method)\n\n<!-- PAGE_39 -->\n###### - (OECD TG491) 단기노출(Short Time Exposure, STE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG460) 플로오레세인 누출(Fluorescein leakage, FL) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492) 인체각막유사상피(Reconstructed Human Cornea-like\n\n<!-- PAGE_39 -->\n###### Epithelium, RhCE) 시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG492B) 인체각막유사 상피모델을 이용한 안 유해성(심한 안손상 및\n\n<!-- PAGE_39 -->\n###### 안자극)시험법\n\n<!-- PAGE_39 -->\n###### - (OECD TG494) 인체각막세포주(Vitrigel®)를 이용한 안자극시험법\n\n- - (OECD TG496) In vitro 고분자시험법: Ocular Irritation®\n<!-- PAGE_39 -->\n###### 피부감작성\n\n<!-- PAGE_39 -->\n###### - (OECD TG429) 국소림프절시험(Local Lymph Node Assay, LLNA)\n\n<!-- PAGE_39 -->\n###### 붙임 3.  OECD 독성시험 종류\n\n- - 34 -\n* 참고 : OECD Test Guidelines, Section 4 – Health effects (2023년 11월 기준)\n\n<!-- PAGE_40 -->\n###### 구분\n\n<!-- PAGE_40 -->\n###### - (OECD TG422A) LLNA Daicel-ATP 시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG422B) LLNA 세포증식효소매개 면역흡수 분석시험(ELISA) BrdU\n\n<!-- PAGE_40 -->\n###### - (OECD TG442C) in Chemico 펩타이드 반응성 시험법(DPRA), in Chemico\n\n<!-- PAGE_40 -->\n###### 아미노산 유도체 결합성 시험법(ADRA), in Chemico 피부감작성 시험법\n\n<!-- PAGE_40 -->\n###### (kDPRA)\n\n<!-- PAGE_40 -->\n###### - (OECD TG442D) ARE-Nrf2 루시퍼라아제 시험법(KeratinoSensTM), ARE-Nrf2\n\n<!-- PAGE_40 -->\n###### - (OECD TG442E) 인체세포주 활성화 시험법(h-CLAT), IL-8 루시퍼라아제\n\n<!-- PAGE_40 -->\n###### 피부흡수\n\n<!-- PAGE_40 -->\n###### - (OECD TG28) 생체외 피부흡수시험법\n\n<!-- PAGE_40 -->\n###### 생식·발생독성\n\n<!-- PAGE_40 -->\n###### 유전독성\n\n<!-- PAGE_40 -->\n###### 발암성\n\n<!-- PAGE_40 -->\n###### - (OECD TG452) 만성 독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG453) 만성 발암성\n\n<!-- PAGE_40 -->\n###### 광독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG432) 3T3 뉴트럴 레드 흡수 광독성 시험(3T3 Neutral Red\n\n<!-- PAGE_40 -->\n###### Uptake Phototoxicty Test, 3T3 NRU PT)\n\n<!-- PAGE_40 -->\n###### - (OECD TG495) 활성산소종(ROS) 분석을 이용한 광독성시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG498) 인체피부모델을 이용한 광독성시험법\n\n- - 35 -\n<!-- PAGE_41 -->\n###### 붙임 4.  화장품 노출 피부 표면적\n\n표 1.  각 제품 유형별 평균 노출 피부 표면적(Bremmer et al.  2006a; Bremmer et al., 2006b)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\n샴푸\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 컨디셔너\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 스프레이\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n헤어 스타일링 젤\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n헤어 스타일링 무스\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n반영구형 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n산화성/영구적 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 탈색제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 고정용 로션\n\n1/2 머리 면적\n\n580\n\n590\n\n손세정용 액상 비누\n\n양손 면적\n\n860\n\n840\n\n손세정용 고상 비누\n\n양손 면적\n\n860\n\n840\n\n샤워용 액상 비누\n\n총 신체면적\n\n17500\n\n19400\n\n샤워용 고형 비누\n\n총 신체면적\n\n17500\n\n19400\n\n목욕용 거품제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 염제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n얼굴용 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n(+ 목)\n\n320\n\n(+ 뒷목)\n\n80\n\n바디 로숀\n\n신체 면적-머리 면적(여성)\n\n15670\n\n핸드 크림\n\n양손 면적\n\n860\n\n필링/스크럽 젤\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n얼굴 팩\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n바디 팩\n\n신체 면적-머리 면적(여성)\n\n15670\n\n피부 미백 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 및 손톱 관리(Make-up and nail care)\n\n리퀴드 파운데이션\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 리무버\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n아이 섀도\n\n24\n\n마스카라\n\n- 1.6\n아이라이너\n\n- 3.2\n아이 메이크업 리무버\n\n50\n\n- - 36 -\n1 위해평가를 위한 피부체표면적 조사집(식품의약품안전청, 2010)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\nRIVM\n\nEPA\n\n손톱 광택제\n\n4\n\n손톱 광택제 제거제\n\n11\n\n립스틱, 입술크림\n\n- 4.8\n데오도란트 스틱형/롤러형\n\n양쪽 겨드랑이\n\n200\n\n데오도란트 스프레이\n\n양쪽 겨드랑이\n\n200\n\n제한용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n항균용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n오드트왈렛 스프레이\n\n200\n\n향수 스프레이\n\n100\n\n면도용 크림\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n에프터쉐이브\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n자외선 차단 로숀\n\n총 신체면적\n\n17500\n\n19400\n\n자외선 차단 크림\n\n총 신체면적\n\n17500\n\n19400\n\n베이비 크림\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 오일\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 파우더\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n제모용 크림\n\n다리 면적(여성)\n\n5530\n\n5460\n\n마사지용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n소아용 얼굴 물감\n\n1/2 소아 머리 면적(4.5세)\n\n475\n\n496\n\n성인용 얼굴 물감\n\n1/2 머리 면적\n\n580\n\n650\n\n- - 37 -\n<!-- PAGE_43 -->\n###### 붙임 5.  한국인의 화장품 사용량\n\n<!-- PAGE_43 -->\n###### 1.‘2014년~2016년 화장품 위해평가 선진화 연구’결과에 근거한 화장품 유형별 추정 일일 사\n\n<!-- PAGE_43 -->\n###### 용량 및 노출량은 다음과 같다.\n\n <!-- PAGE_43 -->\n###### 표 1. ",
        "original_sentence": "각 제품 유형별 평균 노출 피부 표면적(Bremmer et al. "
      }
    },
    {
      "chunk_id": "chunk_302",
      "text": "2006a; Bremmer et al., 2006b)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\n샴푸\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 컨디셔너\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 스프레이\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n헤어 스타일링 젤\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n헤어 스타일링 무스\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n반영구형 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n산화성/영구적 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 탈색제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 고정용 로션\n\n1/2 머리 면적\n\n580\n\n590\n\n손세정용 액상 비누\n\n양손 면적\n\n860\n\n840\n\n손세정용 고상 비누\n\n양손 면적\n\n860\n\n840\n\n샤워용 액상 비누\n\n총 신체면적\n\n17500\n\n19400\n\n샤워용 고형 비누\n\n총 신체면적\n\n17500\n\n19400\n\n목욕용 거품제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 염제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n얼굴용 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n(+ 목)\n\n320\n\n(+ 뒷목)\n\n80\n\n바디 로숀\n\n신체 면적-머리 면적(여성)\n\n15670\n\n핸드 크림\n\n양손 면적\n\n860\n\n필링/스크럽 젤\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n얼굴 팩\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n바디 팩\n\n신체 면적-머리 면적(여성)\n\n15670\n\n피부 미백 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 및 손톱 관리(Make-up and nail care)\n\n리퀴드 파운데이션\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 리무버\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n아이 섀도\n\n24\n\n마스카라\n\n- 1.6\n아이라이너\n\n- 3.2\n아이 메이크업 리무버\n\n50\n\n- - 36 -\n1 위해평가를 위한 피부체표면적 조사집(식품의약품안전청, 2010)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\nRIVM\n\nEPA\n\n손톱 광택제\n\n4\n\n손톱 광택제 제거제\n\n11\n\n립스틱, 입술크림\n\n- 4.8\n데오도란트 스틱형/롤러형\n\n양쪽 겨드랑이\n\n200\n\n데오도란트 스프레이\n\n양쪽 겨드랑이\n\n200\n\n제한용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n항균용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n오드트왈렛 스프레이\n\n200\n\n향수 스프레이\n\n100\n\n면도용 크림\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n에프터쉐이브\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n자외선 차단 로숀\n\n총 신체면적\n\n17500\n\n19400\n\n자외선 차단 크림\n\n총 신체면적\n\n17500\n\n19400\n\n베이비 크림\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 오일\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 파우더\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n제모용 크림\n\n다리 면적(여성)\n\n5530\n\n5460\n\n마사지용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n소아용 얼굴 물감\n\n1/2 소아 머리 면적(4.5세)\n\n475\n\n496\n\n성인용 얼굴 물감\n\n1/2 머리 면적\n\n580\n\n650\n\n- - 37 -\n<!-- PAGE_43 -->\n###### 붙임 5. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 301,
        "window_size": 3,
        "char_count": 1706,
        "word_count": 377,
        "page_number": 43,
        "window_text": "OECD 독성시험 종류\n\n- - 34 -\n* 참고 : OECD Test Guidelines, Section 4 – Health effects (2023년 11월 기준)\n\n<!-- PAGE_40 -->\n###### 구분\n\n<!-- PAGE_40 -->\n###### - (OECD TG422A) LLNA Daicel-ATP 시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG422B) LLNA 세포증식효소매개 면역흡수 분석시험(ELISA) BrdU\n\n<!-- PAGE_40 -->\n###### - (OECD TG442C) in Chemico 펩타이드 반응성 시험법(DPRA), in Chemico\n\n<!-- PAGE_40 -->\n###### 아미노산 유도체 결합성 시험법(ADRA), in Chemico 피부감작성 시험법\n\n<!-- PAGE_40 -->\n###### (kDPRA)\n\n<!-- PAGE_40 -->\n###### - (OECD TG442D) ARE-Nrf2 루시퍼라아제 시험법(KeratinoSensTM), ARE-Nrf2\n\n<!-- PAGE_40 -->\n###### - (OECD TG442E) 인체세포주 활성화 시험법(h-CLAT), IL-8 루시퍼라아제\n\n<!-- PAGE_40 -->\n###### 피부흡수\n\n<!-- PAGE_40 -->\n###### - (OECD TG28) 생체외 피부흡수시험법\n\n<!-- PAGE_40 -->\n###### 생식·발생독성\n\n<!-- PAGE_40 -->\n###### 유전독성\n\n<!-- PAGE_40 -->\n###### 발암성\n\n<!-- PAGE_40 -->\n###### - (OECD TG452) 만성 독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG453) 만성 발암성\n\n<!-- PAGE_40 -->\n###### 광독성\n\n<!-- PAGE_40 -->\n###### - (OECD TG432) 3T3 뉴트럴 레드 흡수 광독성 시험(3T3 Neutral Red\n\n<!-- PAGE_40 -->\n###### Uptake Phototoxicty Test, 3T3 NRU PT)\n\n<!-- PAGE_40 -->\n###### - (OECD TG495) 활성산소종(ROS) 분석을 이용한 광독성시험법\n\n<!-- PAGE_40 -->\n###### - (OECD TG498) 인체피부모델을 이용한 광독성시험법\n\n- - 35 -\n<!-- PAGE_41 -->\n###### 붙임 4.  화장품 노출 피부 표면적\n\n표 1.  각 제품 유형별 평균 노출 피부 표면적(Bremmer et al.  2006a; Bremmer et al., 2006b)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\n샴푸\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 컨디셔너\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 스프레이\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n헤어 스타일링 젤\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n헤어 스타일링 무스\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n반영구형 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n산화성/영구적 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 탈색제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 고정용 로션\n\n1/2 머리 면적\n\n580\n\n590\n\n손세정용 액상 비누\n\n양손 면적\n\n860\n\n840\n\n손세정용 고상 비누\n\n양손 면적\n\n860\n\n840\n\n샤워용 액상 비누\n\n총 신체면적\n\n17500\n\n19400\n\n샤워용 고형 비누\n\n총 신체면적\n\n17500\n\n19400\n\n목욕용 거품제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 염제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n얼굴용 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n(+ 목)\n\n320\n\n(+ 뒷목)\n\n80\n\n바디 로숀\n\n신체 면적-머리 면적(여성)\n\n15670\n\n핸드 크림\n\n양손 면적\n\n860\n\n필링/스크럽 젤\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n얼굴 팩\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n바디 팩\n\n신체 면적-머리 면적(여성)\n\n15670\n\n피부 미백 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 및 손톱 관리(Make-up and nail care)\n\n리퀴드 파운데이션\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 리무버\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n아이 섀도\n\n24\n\n마스카라\n\n- 1.6\n아이라이너\n\n- 3.2\n아이 메이크업 리무버\n\n50\n\n- - 36 -\n1 위해평가를 위한 피부체표면적 조사집(식품의약품안전청, 2010)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\nRIVM\n\nEPA\n\n손톱 광택제\n\n4\n\n손톱 광택제 제거제\n\n11\n\n립스틱, 입술크림\n\n- 4.8\n데오도란트 스틱형/롤러형\n\n양쪽 겨드랑이\n\n200\n\n데오도란트 스프레이\n\n양쪽 겨드랑이\n\n200\n\n제한용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n항균용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n오드트왈렛 스프레이\n\n200\n\n향수 스프레이\n\n100\n\n면도용 크림\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n에프터쉐이브\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n자외선 차단 로숀\n\n총 신체면적\n\n17500\n\n19400\n\n자외선 차단 크림\n\n총 신체면적\n\n17500\n\n19400\n\n베이비 크림\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 오일\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 파우더\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n제모용 크림\n\n다리 면적(여성)\n\n5530\n\n5460\n\n마사지용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n소아용 얼굴 물감\n\n1/2 소아 머리 면적(4.5세)\n\n475\n\n496\n\n성인용 얼굴 물감\n\n1/2 머리 면적\n\n580\n\n650\n\n- - 37 -\n<!-- PAGE_43 -->\n###### 붙임 5.  한국인의 화장품 사용량\n\n<!-- PAGE_43 -->\n###### 1.‘2014년~2016년 화장품 위해평가 선진화 연구’결과에 근거한 화장품 유형별 추정 일일 사\n\n<!-- PAGE_43 -->\n###### 용량 및 노출량은 다음과 같다.\n\n <!-- PAGE_43 -->\n###### 표 1.  한국인의 화장품 유형별 추정 일일 사용량 및 노출량\n\n아이라이너\n\n- 0.01\n- 0.23\n- 1.0\n- 0.01\n- 0.23\n립스틱, 입술보호제\n\n- 0.05\n- 0.87\n- 1.0\n- 0.05\n- 0.87\n데오도란트(남녀)\n\n비분무형 데오도란트\n\n- 2.33\n- 36.12\n- 1.0\n- 2.33\n- 36.12\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 제품(샤워 젤, 샴푸 등)을 사용함으로써 발생하는 세척 및 희\n\n석 효과를 보정하기 위해 SCCNFP 에 의해 사용된 지수임[SCCNFP/0321/00]\n\n- - 38 -\n<!-- PAGE_44 -->\n###### 2. ",
        "original_sentence": "2006a; Bremmer et al., 2006b)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\n샴푸\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 컨디셔너\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 스프레이\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n헤어 스타일링 젤\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n헤어 스타일링 무스\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n반영구형 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n산화성/영구적 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 탈색제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 고정용 로션\n\n1/2 머리 면적\n\n580\n\n590\n\n손세정용 액상 비누\n\n양손 면적\n\n860\n\n840\n\n손세정용 고상 비누\n\n양손 면적\n\n860\n\n840\n\n샤워용 액상 비누\n\n총 신체면적\n\n17500\n\n19400\n\n샤워용 고형 비누\n\n총 신체면적\n\n17500\n\n19400\n\n목욕용 거품제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 염제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n얼굴용 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n(+ 목)\n\n320\n\n(+ 뒷목)\n\n80\n\n바디 로숀\n\n신체 면적-머리 면적(여성)\n\n15670\n\n핸드 크림\n\n양손 면적\n\n860\n\n필링/스크럽 젤\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n얼굴 팩\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n바디 팩\n\n신체 면적-머리 면적(여성)\n\n15670\n\n피부 미백 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 및 손톱 관리(Make-up and nail care)\n\n리퀴드 파운데이션\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 리무버\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n아이 섀도\n\n24\n\n마스카라\n\n- 1.6\n아이라이너\n\n- 3.2\n아이 메이크업 리무버\n\n50\n\n- - 36 -\n1 위해평가를 위한 피부체표면적 조사집(식품의약품안전청, 2010)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\nRIVM\n\nEPA\n\n손톱 광택제\n\n4\n\n손톱 광택제 제거제\n\n11\n\n립스틱, 입술크림\n\n- 4.8\n데오도란트 스틱형/롤러형\n\n양쪽 겨드랑이\n\n200\n\n데오도란트 스프레이\n\n양쪽 겨드랑이\n\n200\n\n제한용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n항균용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n오드트왈렛 스프레이\n\n200\n\n향수 스프레이\n\n100\n\n면도용 크림\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n에프터쉐이브\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n자외선 차단 로숀\n\n총 신체면적\n\n17500\n\n19400\n\n자외선 차단 크림\n\n총 신체면적\n\n17500\n\n19400\n\n베이비 크림\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 오일\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 파우더\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n제모용 크림\n\n다리 면적(여성)\n\n5530\n\n5460\n\n마사지용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n소아용 얼굴 물감\n\n1/2 소아 머리 면적(4.5세)\n\n475\n\n496\n\n성인용 얼굴 물감\n\n1/2 머리 면적\n\n580\n\n650\n\n- - 37 -\n<!-- PAGE_43 -->\n###### 붙임 5. "
      }
    },
    {
      "chunk_id": "chunk_303",
      "text": "한국인의 화장품 사용량\n\n<!-- PAGE_43 -->\n###### 1.‘2014년~2016년 화장품 위해평가 선진화 연구’결과에 근거한 화장품 유형별 추정 일일 사\n\n<!-- PAGE_43 -->\n###### 용량 및 노출량은 다음과 같다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 302,
        "window_size": 3,
        "char_count": 137,
        "word_count": 27,
        "page_number": 43,
        "window_text": "화장품 노출 피부 표면적\n\n표 1.  각 제품 유형별 평균 노출 피부 표면적(Bremmer et al.  2006a; Bremmer et al., 2006b)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\n샴푸\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 컨디셔너\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 스프레이\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n헤어 스타일링 젤\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n헤어 스타일링 무스\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n반영구형 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n산화성/영구적 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 탈색제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 고정용 로션\n\n1/2 머리 면적\n\n580\n\n590\n\n손세정용 액상 비누\n\n양손 면적\n\n860\n\n840\n\n손세정용 고상 비누\n\n양손 면적\n\n860\n\n840\n\n샤워용 액상 비누\n\n총 신체면적\n\n17500\n\n19400\n\n샤워용 고형 비누\n\n총 신체면적\n\n17500\n\n19400\n\n목욕용 거품제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 염제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n얼굴용 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n(+ 목)\n\n320\n\n(+ 뒷목)\n\n80\n\n바디 로숀\n\n신체 면적-머리 면적(여성)\n\n15670\n\n핸드 크림\n\n양손 면적\n\n860\n\n필링/스크럽 젤\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n얼굴 팩\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n바디 팩\n\n신체 면적-머리 면적(여성)\n\n15670\n\n피부 미백 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 및 손톱 관리(Make-up and nail care)\n\n리퀴드 파운데이션\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 리무버\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n아이 섀도\n\n24\n\n마스카라\n\n- 1.6\n아이라이너\n\n- 3.2\n아이 메이크업 리무버\n\n50\n\n- - 36 -\n1 위해평가를 위한 피부체표면적 조사집(식품의약품안전청, 2010)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\nRIVM\n\nEPA\n\n손톱 광택제\n\n4\n\n손톱 광택제 제거제\n\n11\n\n립스틱, 입술크림\n\n- 4.8\n데오도란트 스틱형/롤러형\n\n양쪽 겨드랑이\n\n200\n\n데오도란트 스프레이\n\n양쪽 겨드랑이\n\n200\n\n제한용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n항균용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n오드트왈렛 스프레이\n\n200\n\n향수 스프레이\n\n100\n\n면도용 크림\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n에프터쉐이브\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n자외선 차단 로숀\n\n총 신체면적\n\n17500\n\n19400\n\n자외선 차단 크림\n\n총 신체면적\n\n17500\n\n19400\n\n베이비 크림\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 오일\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 파우더\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n제모용 크림\n\n다리 면적(여성)\n\n5530\n\n5460\n\n마사지용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n소아용 얼굴 물감\n\n1/2 소아 머리 면적(4.5세)\n\n475\n\n496\n\n성인용 얼굴 물감\n\n1/2 머리 면적\n\n580\n\n650\n\n- - 37 -\n<!-- PAGE_43 -->\n###### 붙임 5.  한국인의 화장품 사용량\n\n<!-- PAGE_43 -->\n###### 1.‘2014년~2016년 화장품 위해평가 선진화 연구’결과에 근거한 화장품 유형별 추정 일일 사\n\n<!-- PAGE_43 -->\n###### 용량 및 노출량은 다음과 같다.\n\n <!-- PAGE_43 -->\n###### 표 1.  한국인의 화장품 유형별 추정 일일 사용량 및 노출량\n\n아이라이너\n\n- 0.01\n- 0.23\n- 1.0\n- 0.01\n- 0.23\n립스틱, 입술보호제\n\n- 0.05\n- 0.87\n- 1.0\n- 0.05\n- 0.87\n데오도란트(남녀)\n\n비분무형 데오도란트\n\n- 2.33\n- 36.12\n- 1.0\n- 2.33\n- 36.12\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 제품(샤워 젤, 샴푸 등)을 사용함으로써 발생하는 세척 및 희\n\n석 효과를 보정하기 위해 SCCNFP 에 의해 사용된 지수임[SCCNFP/0321/00]\n\n- - 38 -\n<!-- PAGE_44 -->\n###### 2.  자외선차단제의 경우, 한국인의 평균 체표면적* 16,191 cm2에 0.5 mg/cm2의 양을 적용하여 하\n\n<!-- PAGE_44 -->\n###### 루 2회 사용할 경우를 가정할 때 일일 사용량인 17.0 g/일을 적용할 수 있다.\n\n",
        "original_sentence": "한국인의 화장품 사용량\n\n<!-- PAGE_43 -->\n###### 1.‘2014년~2016년 화장품 위해평가 선진화 연구’결과에 근거한 화장품 유형별 추정 일일 사\n\n<!-- PAGE_43 -->\n###### 용량 및 노출량은 다음과 같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_304",
      "text": "<!-- PAGE_43 -->\n###### 표 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 303,
        "window_size": 3,
        "char_count": 29,
        "word_count": 6,
        "page_number": 43,
        "window_text": "각 제품 유형별 평균 노출 피부 표면적(Bremmer et al.  2006a; Bremmer et al., 2006b)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\n샴푸\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 컨디셔너\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 스프레이\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n헤어 스타일링 젤\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n헤어 스타일링 무스\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n반영구형 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n산화성/영구적 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 탈색제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 고정용 로션\n\n1/2 머리 면적\n\n580\n\n590\n\n손세정용 액상 비누\n\n양손 면적\n\n860\n\n840\n\n손세정용 고상 비누\n\n양손 면적\n\n860\n\n840\n\n샤워용 액상 비누\n\n총 신체면적\n\n17500\n\n19400\n\n샤워용 고형 비누\n\n총 신체면적\n\n17500\n\n19400\n\n목욕용 거품제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 염제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n얼굴용 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n(+ 목)\n\n320\n\n(+ 뒷목)\n\n80\n\n바디 로숀\n\n신체 면적-머리 면적(여성)\n\n15670\n\n핸드 크림\n\n양손 면적\n\n860\n\n필링/스크럽 젤\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n얼굴 팩\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n바디 팩\n\n신체 면적-머리 면적(여성)\n\n15670\n\n피부 미백 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 및 손톱 관리(Make-up and nail care)\n\n리퀴드 파운데이션\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 리무버\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n아이 섀도\n\n24\n\n마스카라\n\n- 1.6\n아이라이너\n\n- 3.2\n아이 메이크업 리무버\n\n50\n\n- - 36 -\n1 위해평가를 위한 피부체표면적 조사집(식품의약품안전청, 2010)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\nRIVM\n\nEPA\n\n손톱 광택제\n\n4\n\n손톱 광택제 제거제\n\n11\n\n립스틱, 입술크림\n\n- 4.8\n데오도란트 스틱형/롤러형\n\n양쪽 겨드랑이\n\n200\n\n데오도란트 스프레이\n\n양쪽 겨드랑이\n\n200\n\n제한용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n항균용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n오드트왈렛 스프레이\n\n200\n\n향수 스프레이\n\n100\n\n면도용 크림\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n에프터쉐이브\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n자외선 차단 로숀\n\n총 신체면적\n\n17500\n\n19400\n\n자외선 차단 크림\n\n총 신체면적\n\n17500\n\n19400\n\n베이비 크림\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 오일\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 파우더\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n제모용 크림\n\n다리 면적(여성)\n\n5530\n\n5460\n\n마사지용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n소아용 얼굴 물감\n\n1/2 소아 머리 면적(4.5세)\n\n475\n\n496\n\n성인용 얼굴 물감\n\n1/2 머리 면적\n\n580\n\n650\n\n- - 37 -\n<!-- PAGE_43 -->\n###### 붙임 5.  한국인의 화장품 사용량\n\n<!-- PAGE_43 -->\n###### 1.‘2014년~2016년 화장품 위해평가 선진화 연구’결과에 근거한 화장품 유형별 추정 일일 사\n\n<!-- PAGE_43 -->\n###### 용량 및 노출량은 다음과 같다.\n\n <!-- PAGE_43 -->\n###### 표 1.  한국인의 화장품 유형별 추정 일일 사용량 및 노출량\n\n아이라이너\n\n- 0.01\n- 0.23\n- 1.0\n- 0.01\n- 0.23\n립스틱, 입술보호제\n\n- 0.05\n- 0.87\n- 1.0\n- 0.05\n- 0.87\n데오도란트(남녀)\n\n비분무형 데오도란트\n\n- 2.33\n- 36.12\n- 1.0\n- 2.33\n- 36.12\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 제품(샤워 젤, 샴푸 등)을 사용함으로써 발생하는 세척 및 희\n\n석 효과를 보정하기 위해 SCCNFP 에 의해 사용된 지수임[SCCNFP/0321/00]\n\n- - 38 -\n<!-- PAGE_44 -->\n###### 2.  자외선차단제의 경우, 한국인의 평균 체표면적* 16,191 cm2에 0.5 mg/cm2의 양을 적용하여 하\n\n<!-- PAGE_44 -->\n###### 루 2회 사용할 경우를 가정할 때 일일 사용량인 17.0 g/일을 적용할 수 있다.\n\n * 위해평가를 위한 피부체표면적 조사집(식품의약품안전처, 2010)\n\n<!-- PAGE_44 -->\n###### 3. ",
        "original_sentence": "<!-- PAGE_43 -->\n###### 표 1. "
      }
    },
    {
      "chunk_id": "chunk_305",
      "text": "한국인의 화장품 유형별 추정 일일 사용량 및 노출량\n\n아이라이너\n\n- 0.01\n- 0.23\n- 1.0\n- 0.01\n- 0.23\n립스틱, 입술보호제\n\n- 0.05\n- 0.87\n- 1.0\n- 0.05\n- 0.87\n데오도란트(남녀)\n\n비분무형 데오도란트\n\n- 2.33\n- 36.12\n- 1.0\n- 2.33\n- 36.12\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 제품(샤워 젤, 샴푸 등)을 사용함으로써 발생하는 세척 및 희\n\n석 효과를 보정하기 위해 SCCNFP 에 의해 사용된 지수임[SCCNFP/0321/00]\n\n- - 38 -\n<!-- PAGE_44 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 304,
        "window_size": 3,
        "char_count": 338,
        "word_count": 77,
        "page_number": 44,
        "window_text": "2006a; Bremmer et al., 2006b)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\n샴푸\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 컨디셔너\n\n양손 면적 + 1/2 머리 면적\n\n1440\n\n1430\n\n헤어 스프레이\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n헤어 스타일링 젤\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n헤어 스타일링 무스\n\n1/2 양손 면적, 1/2 머리 면적\n\n1010\n\n1010\n\n반영구형 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n산화성/영구적 염모제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 탈색제\n\n1/2 머리 면적\n\n580\n\n590\n\n두발 고정용 로션\n\n1/2 머리 면적\n\n580\n\n590\n\n손세정용 액상 비누\n\n양손 면적\n\n860\n\n840\n\n손세정용 고상 비누\n\n양손 면적\n\n860\n\n840\n\n샤워용 액상 비누\n\n총 신체면적\n\n17500\n\n19400\n\n샤워용 고형 비누\n\n총 신체면적\n\n17500\n\n19400\n\n목욕용 거품제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 염제\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n얼굴용 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n(+ 목)\n\n320\n\n(+ 뒷목)\n\n80\n\n바디 로숀\n\n신체 면적-머리 면적(여성)\n\n15670\n\n핸드 크림\n\n양손 면적\n\n860\n\n필링/스크럽 젤\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n얼굴 팩\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n바디 팩\n\n신체 면적-머리 면적(여성)\n\n15670\n\n피부 미백 크림\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 및 손톱 관리(Make-up and nail care)\n\n리퀴드 파운데이션\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n메이크업 리무버\n\n1/2 머리 면적(여성)\n\n565\n\n555\n\n아이 섀도\n\n24\n\n마스카라\n\n- 1.6\n아이라이너\n\n- 3.2\n아이 메이크업 리무버\n\n50\n\n- - 36 -\n1 위해평가를 위한 피부체표면적 조사집(식품의약품안전청, 2010)\n\n제품형태\n\n화장품 적용 신체부위\n\n피부 표면적(㎠)\n\nRIVM\n\nEPA\n\n손톱 광택제\n\n4\n\n손톱 광택제 제거제\n\n11\n\n립스틱, 입술크림\n\n- 4.8\n데오도란트 스틱형/롤러형\n\n양쪽 겨드랑이\n\n200\n\n데오도란트 스프레이\n\n양쪽 겨드랑이\n\n200\n\n제한용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n항균용 풋크림\n\n양발 면적\n\n1170\n\n1120\n\n오드트왈렛 스프레이\n\n200\n\n향수 스프레이\n\n100\n\n면도용 크림\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n에프터쉐이브\n\n1/4 머리 면적(남성)\n\n305\n\n325\n\n자외선 차단 로숀\n\n총 신체면적\n\n17500\n\n19400\n\n자외선 차단 크림\n\n총 신체면적\n\n17500\n\n19400\n\n베이비 크림\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 오일\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n베이비 파우더\n\n아기 엉덩이(생후 4.5개월)\n\n190\n\n제모용 크림\n\n다리 면적(여성)\n\n5530\n\n5460\n\n마사지용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n목욕용 오일\n\n신체 면적 – 머리 면적\n\n16340\n\n소아용 얼굴 물감\n\n1/2 소아 머리 면적(4.5세)\n\n475\n\n496\n\n성인용 얼굴 물감\n\n1/2 머리 면적\n\n580\n\n650\n\n- - 37 -\n<!-- PAGE_43 -->\n###### 붙임 5.  한국인의 화장품 사용량\n\n<!-- PAGE_43 -->\n###### 1.‘2014년~2016년 화장품 위해평가 선진화 연구’결과에 근거한 화장품 유형별 추정 일일 사\n\n<!-- PAGE_43 -->\n###### 용량 및 노출량은 다음과 같다.\n\n <!-- PAGE_43 -->\n###### 표 1.  한국인의 화장품 유형별 추정 일일 사용량 및 노출량\n\n아이라이너\n\n- 0.01\n- 0.23\n- 1.0\n- 0.01\n- 0.23\n립스틱, 입술보호제\n\n- 0.05\n- 0.87\n- 1.0\n- 0.05\n- 0.87\n데오도란트(남녀)\n\n비분무형 데오도란트\n\n- 2.33\n- 36.12\n- 1.0\n- 2.33\n- 36.12\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 제품(샤워 젤, 샴푸 등)을 사용함으로써 발생하는 세척 및 희\n\n석 효과를 보정하기 위해 SCCNFP 에 의해 사용된 지수임[SCCNFP/0321/00]\n\n- - 38 -\n<!-- PAGE_44 -->\n###### 2.  자외선차단제의 경우, 한국인의 평균 체표면적* 16,191 cm2에 0.5 mg/cm2의 양을 적용하여 하\n\n<!-- PAGE_44 -->\n###### 루 2회 사용할 경우를 가정할 때 일일 사용량인 17.0 g/일을 적용할 수 있다.\n\n * 위해평가를 위한 피부체표면적 조사집(식품의약품안전처, 2010)\n\n<!-- PAGE_44 -->\n###### 3.  보존제 등 평가대상 물질이 여러 제형의 화장품에 포함되는 경우, 소비자가 동시에 여러 제\n\n<!-- PAGE_44 -->\n###### 형의 화장품을 사용하는 경우를 가정하여 통합 사용량을 고려할 수 있다. ",
        "original_sentence": "한국인의 화장품 유형별 추정 일일 사용량 및 노출량\n\n아이라이너\n\n- 0.01\n- 0.23\n- 1.0\n- 0.01\n- 0.23\n립스틱, 입술보호제\n\n- 0.05\n- 0.87\n- 1.0\n- 0.05\n- 0.87\n데오도란트(남녀)\n\n비분무형 데오도란트\n\n- 2.33\n- 36.12\n- 1.0\n- 2.33\n- 36.12\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 제품(샤워 젤, 샴푸 등)을 사용함으로써 발생하는 세척 및 희\n\n석 효과를 보정하기 위해 SCCNFP 에 의해 사용된 지수임[SCCNFP/0321/00]\n\n- - 38 -\n<!-- PAGE_44 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_306",
      "text": "자외선차단제의 경우, 한국인의 평균 체표면적* 16,191 cm2에 0.5 mg/cm2의 양을 적용하여 하\n\n<!-- PAGE_44 -->\n###### 루 2회 사용할 경우를 가정할 때 일일 사용량인 17.0 g/일을 적용할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 305,
        "window_size": 3,
        "char_count": 133,
        "word_count": 29,
        "page_number": 44,
        "window_text": "한국인의 화장품 사용량\n\n<!-- PAGE_43 -->\n###### 1.‘2014년~2016년 화장품 위해평가 선진화 연구’결과에 근거한 화장품 유형별 추정 일일 사\n\n<!-- PAGE_43 -->\n###### 용량 및 노출량은 다음과 같다.\n\n <!-- PAGE_43 -->\n###### 표 1.  한국인의 화장품 유형별 추정 일일 사용량 및 노출량\n\n아이라이너\n\n- 0.01\n- 0.23\n- 1.0\n- 0.01\n- 0.23\n립스틱, 입술보호제\n\n- 0.05\n- 0.87\n- 1.0\n- 0.05\n- 0.87\n데오도란트(남녀)\n\n비분무형 데오도란트\n\n- 2.33\n- 36.12\n- 1.0\n- 2.33\n- 36.12\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 제품(샤워 젤, 샴푸 등)을 사용함으로써 발생하는 세척 및 희\n\n석 효과를 보정하기 위해 SCCNFP 에 의해 사용된 지수임[SCCNFP/0321/00]\n\n- - 38 -\n<!-- PAGE_44 -->\n###### 2.  자외선차단제의 경우, 한국인의 평균 체표면적* 16,191 cm2에 0.5 mg/cm2의 양을 적용하여 하\n\n<!-- PAGE_44 -->\n###### 루 2회 사용할 경우를 가정할 때 일일 사용량인 17.0 g/일을 적용할 수 있다.\n\n * 위해평가를 위한 피부체표면적 조사집(식품의약품안전처, 2010)\n\n<!-- PAGE_44 -->\n###### 3.  보존제 등 평가대상 물질이 여러 제형의 화장품에 포함되는 경우, 소비자가 동시에 여러 제\n\n<!-- PAGE_44 -->\n###### 형의 화장품을 사용하는 경우를 가정하여 통합 사용량을 고려할 수 있다.  SCCS는 보존제의\n\n<!-- PAGE_44 -->\n###### 경우에 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 통합적인 사용량 및 잔류지수\n\n<!-- PAGE_44 -->\n###### 를 계산하여 이용할 것을 권고한다(SCCNFP/0321/00). ",
        "original_sentence": "자외선차단제의 경우, 한국인의 평균 체표면적* 16,191 cm2에 0.5 mg/cm2의 양을 적용하여 하\n\n<!-- PAGE_44 -->\n###### 루 2회 사용할 경우를 가정할 때 일일 사용량인 17.0 g/일을 적용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_307",
      "text": "* 위해평가를 위한 피부체표면적 조사집(식품의약품안전처, 2010)\n\n<!-- PAGE_44 -->\n###### 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 306,
        "window_size": 3,
        "char_count": 66,
        "word_count": 11,
        "page_number": 44,
        "window_text": "<!-- PAGE_43 -->\n###### 표 1.  한국인의 화장품 유형별 추정 일일 사용량 및 노출량\n\n아이라이너\n\n- 0.01\n- 0.23\n- 1.0\n- 0.01\n- 0.23\n립스틱, 입술보호제\n\n- 0.05\n- 0.87\n- 1.0\n- 0.05\n- 0.87\n데오도란트(남녀)\n\n비분무형 데오도란트\n\n- 2.33\n- 36.12\n- 1.0\n- 2.33\n- 36.12\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 제품(샤워 젤, 샴푸 등)을 사용함으로써 발생하는 세척 및 희\n\n석 효과를 보정하기 위해 SCCNFP 에 의해 사용된 지수임[SCCNFP/0321/00]\n\n- - 38 -\n<!-- PAGE_44 -->\n###### 2.  자외선차단제의 경우, 한국인의 평균 체표면적* 16,191 cm2에 0.5 mg/cm2의 양을 적용하여 하\n\n<!-- PAGE_44 -->\n###### 루 2회 사용할 경우를 가정할 때 일일 사용량인 17.0 g/일을 적용할 수 있다.\n\n * 위해평가를 위한 피부체표면적 조사집(식품의약품안전처, 2010)\n\n<!-- PAGE_44 -->\n###### 3.  보존제 등 평가대상 물질이 여러 제형의 화장품에 포함되는 경우, 소비자가 동시에 여러 제\n\n<!-- PAGE_44 -->\n###### 형의 화장품을 사용하는 경우를 가정하여 통합 사용량을 고려할 수 있다.  SCCS는 보존제의\n\n<!-- PAGE_44 -->\n###### 경우에 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 통합적인 사용량 및 잔류지수\n\n<!-- PAGE_44 -->\n###### 를 계산하여 이용할 것을 권고한다(SCCNFP/0321/00).  최신의 노출 자료와 최악의 경우까지\n\n<!-- PAGE_44 -->\n###### 고려한 예측상황(worst-case scenario)에서 안전역(MOS) 산출 시, 16.9 g/일 또는 275 mg/kg\n\n<!-- PAGE_44 -->\n###### - 기타성분, 색소 등 특정 성분이 여러 유형의 화장품에 함유되어 인체에 노출되는 경우, 노출\n\n<!-- PAGE_44 -->\n###### 유형에 따라 표 2의 통합 노출량 자료를 사용한다.\n\n",
        "original_sentence": "* 위해평가를 위한 피부체표면적 조사집(식품의약품안전처, 2010)\n\n<!-- PAGE_44 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_308",
      "text": "보존제 등 평가대상 물질이 여러 제형의 화장품에 포함되는 경우, 소비자가 동시에 여러 제\n\n<!-- PAGE_44 -->\n###### 형의 화장품을 사용하는 경우를 가정하여 통합 사용량을 고려할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 307,
        "window_size": 3,
        "char_count": 115,
        "word_count": 27,
        "page_number": 44,
        "window_text": "한국인의 화장품 유형별 추정 일일 사용량 및 노출량\n\n아이라이너\n\n- 0.01\n- 0.23\n- 1.0\n- 0.01\n- 0.23\n립스틱, 입술보호제\n\n- 0.05\n- 0.87\n- 1.0\n- 0.05\n- 0.87\n데오도란트(남녀)\n\n비분무형 데오도란트\n\n- 2.33\n- 36.12\n- 1.0\n- 2.33\n- 36.12\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 제품(샤워 젤, 샴푸 등)을 사용함으로써 발생하는 세척 및 희\n\n석 효과를 보정하기 위해 SCCNFP 에 의해 사용된 지수임[SCCNFP/0321/00]\n\n- - 38 -\n<!-- PAGE_44 -->\n###### 2.  자외선차단제의 경우, 한국인의 평균 체표면적* 16,191 cm2에 0.5 mg/cm2의 양을 적용하여 하\n\n<!-- PAGE_44 -->\n###### 루 2회 사용할 경우를 가정할 때 일일 사용량인 17.0 g/일을 적용할 수 있다.\n\n * 위해평가를 위한 피부체표면적 조사집(식품의약품안전처, 2010)\n\n<!-- PAGE_44 -->\n###### 3.  보존제 등 평가대상 물질이 여러 제형의 화장품에 포함되는 경우, 소비자가 동시에 여러 제\n\n<!-- PAGE_44 -->\n###### 형의 화장품을 사용하는 경우를 가정하여 통합 사용량을 고려할 수 있다.  SCCS는 보존제의\n\n<!-- PAGE_44 -->\n###### 경우에 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 통합적인 사용량 및 잔류지수\n\n<!-- PAGE_44 -->\n###### 를 계산하여 이용할 것을 권고한다(SCCNFP/0321/00).  최신의 노출 자료와 최악의 경우까지\n\n<!-- PAGE_44 -->\n###### 고려한 예측상황(worst-case scenario)에서 안전역(MOS) 산출 시, 16.9 g/일 또는 275 mg/kg\n\n<!-- PAGE_44 -->\n###### - 기타성분, 색소 등 특정 성분이 여러 유형의 화장품에 함유되어 인체에 노출되는 경우, 노출\n\n<!-- PAGE_44 -->\n###### 유형에 따라 표 2의 통합 노출량 자료를 사용한다.\n\n 표 2. ",
        "original_sentence": "보존제 등 평가대상 물질이 여러 제형의 화장품에 포함되는 경우, 소비자가 동시에 여러 제\n\n<!-- PAGE_44 -->\n###### 형의 화장품을 사용하는 경우를 가정하여 통합 사용량을 고려할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_309",
      "text": "SCCS는 보존제의\n\n<!-- PAGE_44 -->\n###### 경우에 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 통합적인 사용량 및 잔류지수\n\n<!-- PAGE_44 -->\n###### 를 계산하여 이용할 것을 권고한다(SCCNFP/0321/00). ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 308,
        "window_size": 3,
        "char_count": 146,
        "word_count": 28,
        "page_number": 44,
        "window_text": "자외선차단제의 경우, 한국인의 평균 체표면적* 16,191 cm2에 0.5 mg/cm2의 양을 적용하여 하\n\n<!-- PAGE_44 -->\n###### 루 2회 사용할 경우를 가정할 때 일일 사용량인 17.0 g/일을 적용할 수 있다.\n\n * 위해평가를 위한 피부체표면적 조사집(식품의약품안전처, 2010)\n\n<!-- PAGE_44 -->\n###### 3.  보존제 등 평가대상 물질이 여러 제형의 화장품에 포함되는 경우, 소비자가 동시에 여러 제\n\n<!-- PAGE_44 -->\n###### 형의 화장품을 사용하는 경우를 가정하여 통합 사용량을 고려할 수 있다.  SCCS는 보존제의\n\n<!-- PAGE_44 -->\n###### 경우에 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 통합적인 사용량 및 잔류지수\n\n<!-- PAGE_44 -->\n###### 를 계산하여 이용할 것을 권고한다(SCCNFP/0321/00).  최신의 노출 자료와 최악의 경우까지\n\n<!-- PAGE_44 -->\n###### 고려한 예측상황(worst-case scenario)에서 안전역(MOS) 산출 시, 16.9 g/일 또는 275 mg/kg\n\n<!-- PAGE_44 -->\n###### - 기타성분, 색소 등 특정 성분이 여러 유형의 화장품에 함유되어 인체에 노출되는 경우, 노출\n\n<!-- PAGE_44 -->\n###### 유형에 따라 표 2의 통합 노출량 자료를 사용한다.\n\n 표 2.  한국인의 화장품 사용으로 인한 통합 노출량*\n\n사용 후 씻어내는 피부\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n메이크업 제품\n\n메이크업 리무버\n\n- 0.21\n- 3.70\n아이 섀도\n\n- 0.02\n- 0.29\n마스카라\n\n- 0.03\n- 0.50\n립스틱\n\n- 0.05\n- 0.87\n아이라이너\n\n- 0.01\n- 0.23\nTOTAL\n\n± 16.9\n\n275\n\n* 2014∼2016 화장품 위해평가 선진화 연구\n\n- - 39 -\n<!-- PAGE_45 -->\n###### 붙임 6. ",
        "original_sentence": "SCCS는 보존제의\n\n<!-- PAGE_44 -->\n###### 경우에 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 통합적인 사용량 및 잔류지수\n\n<!-- PAGE_44 -->\n###### 를 계산하여 이용할 것을 권고한다(SCCNFP/0321/00). "
      }
    },
    {
      "chunk_id": "chunk_310",
      "text": "최신의 노출 자료와 최악의 경우까지\n\n<!-- PAGE_44 -->\n###### 고려한 예측상황(worst-case scenario)에서 안전역(MOS) 산출 시, 16.9 g/일 또는 275 mg/kg\n\n<!-- PAGE_44 -->\n###### - 기타성분, 색소 등 특정 성분이 여러 유형의 화장품에 함유되어 인체에 노출되는 경우, 노출\n\n<!-- PAGE_44 -->\n###### 유형에 따라 표 2의 통합 노출량 자료를 사용한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 309,
        "window_size": 3,
        "char_count": 247,
        "word_count": 50,
        "page_number": 44,
        "window_text": "* 위해평가를 위한 피부체표면적 조사집(식품의약품안전처, 2010)\n\n<!-- PAGE_44 -->\n###### 3.  보존제 등 평가대상 물질이 여러 제형의 화장품에 포함되는 경우, 소비자가 동시에 여러 제\n\n<!-- PAGE_44 -->\n###### 형의 화장품을 사용하는 경우를 가정하여 통합 사용량을 고려할 수 있다.  SCCS는 보존제의\n\n<!-- PAGE_44 -->\n###### 경우에 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 통합적인 사용량 및 잔류지수\n\n<!-- PAGE_44 -->\n###### 를 계산하여 이용할 것을 권고한다(SCCNFP/0321/00).  최신의 노출 자료와 최악의 경우까지\n\n<!-- PAGE_44 -->\n###### 고려한 예측상황(worst-case scenario)에서 안전역(MOS) 산출 시, 16.9 g/일 또는 275 mg/kg\n\n<!-- PAGE_44 -->\n###### - 기타성분, 색소 등 특정 성분이 여러 유형의 화장품에 함유되어 인체에 노출되는 경우, 노출\n\n<!-- PAGE_44 -->\n###### 유형에 따라 표 2의 통합 노출량 자료를 사용한다.\n\n 표 2.  한국인의 화장품 사용으로 인한 통합 노출량*\n\n사용 후 씻어내는 피부\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n메이크업 제품\n\n메이크업 리무버\n\n- 0.21\n- 3.70\n아이 섀도\n\n- 0.02\n- 0.29\n마스카라\n\n- 0.03\n- 0.50\n립스틱\n\n- 0.05\n- 0.87\n아이라이너\n\n- 0.01\n- 0.23\nTOTAL\n\n± 16.9\n\n275\n\n* 2014∼2016 화장품 위해평가 선진화 연구\n\n- - 39 -\n<!-- PAGE_45 -->\n###### 붙임 6.  유럽의 화장품 사용량\n\n<!-- PAGE_45 -->\n###### 1. ",
        "original_sentence": "최신의 노출 자료와 최악의 경우까지\n\n<!-- PAGE_44 -->\n###### 고려한 예측상황(worst-case scenario)에서 안전역(MOS) 산출 시, 16.9 g/일 또는 275 mg/kg\n\n<!-- PAGE_44 -->\n###### - 기타성분, 색소 등 특정 성분이 여러 유형의 화장품에 함유되어 인체에 노출되는 경우, 노출\n\n<!-- PAGE_44 -->\n###### 유형에 따라 표 2의 통합 노출량 자료를 사용한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_311",
      "text": "표 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 310,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 44,
        "window_text": "보존제 등 평가대상 물질이 여러 제형의 화장품에 포함되는 경우, 소비자가 동시에 여러 제\n\n<!-- PAGE_44 -->\n###### 형의 화장품을 사용하는 경우를 가정하여 통합 사용량을 고려할 수 있다.  SCCS는 보존제의\n\n<!-- PAGE_44 -->\n###### 경우에 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 통합적인 사용량 및 잔류지수\n\n<!-- PAGE_44 -->\n###### 를 계산하여 이용할 것을 권고한다(SCCNFP/0321/00).  최신의 노출 자료와 최악의 경우까지\n\n<!-- PAGE_44 -->\n###### 고려한 예측상황(worst-case scenario)에서 안전역(MOS) 산출 시, 16.9 g/일 또는 275 mg/kg\n\n<!-- PAGE_44 -->\n###### - 기타성분, 색소 등 특정 성분이 여러 유형의 화장품에 함유되어 인체에 노출되는 경우, 노출\n\n<!-- PAGE_44 -->\n###### 유형에 따라 표 2의 통합 노출량 자료를 사용한다.\n\n 표 2.  한국인의 화장품 사용으로 인한 통합 노출량*\n\n사용 후 씻어내는 피부\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n메이크업 제품\n\n메이크업 리무버\n\n- 0.21\n- 3.70\n아이 섀도\n\n- 0.02\n- 0.29\n마스카라\n\n- 0.03\n- 0.50\n립스틱\n\n- 0.05\n- 0.87\n아이라이너\n\n- 0.01\n- 0.23\nTOTAL\n\n± 16.9\n\n275\n\n* 2014∼2016 화장품 위해평가 선진화 연구\n\n- - 39 -\n<!-- PAGE_45 -->\n###### 붙임 6.  유럽의 화장품 사용량\n\n<!-- PAGE_45 -->\n###### 1.  유럽 SCCS 가이드라인에서 제시한 유럽의 화장품 유형별 추정 일일 노출량 및 보존제 통합\n\n<!-- PAGE_45 -->\n###### 일일 사용량 및 노출량은 다음과 같다(Hall et al, 2007, 2011).\n\n",
        "original_sentence": "표 2. "
      }
    },
    {
      "chunk_id": "chunk_312",
      "text": "한국인의 화장품 사용으로 인한 통합 노출량*\n\n사용 후 씻어내는 피부\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n메이크업 제품\n\n메이크업 리무버\n\n- 0.21\n- 3.70\n아이 섀도\n\n- 0.02\n- 0.29\n마스카라\n\n- 0.03\n- 0.50\n립스틱\n\n- 0.05\n- 0.87\n아이라이너\n\n- 0.01\n- 0.23\nTOTAL\n\n± 16.9\n\n275\n\n* 2014∼2016 화장품 위해평가 선진화 연구\n\n- - 39 -\n<!-- PAGE_45 -->\n###### 붙임 6. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 311,
        "window_size": 3,
        "char_count": 284,
        "word_count": 72,
        "page_number": 45,
        "window_text": "SCCS는 보존제의\n\n<!-- PAGE_44 -->\n###### 경우에 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 통합적인 사용량 및 잔류지수\n\n<!-- PAGE_44 -->\n###### 를 계산하여 이용할 것을 권고한다(SCCNFP/0321/00).  최신의 노출 자료와 최악의 경우까지\n\n<!-- PAGE_44 -->\n###### 고려한 예측상황(worst-case scenario)에서 안전역(MOS) 산출 시, 16.9 g/일 또는 275 mg/kg\n\n<!-- PAGE_44 -->\n###### - 기타성분, 색소 등 특정 성분이 여러 유형의 화장품에 함유되어 인체에 노출되는 경우, 노출\n\n<!-- PAGE_44 -->\n###### 유형에 따라 표 2의 통합 노출량 자료를 사용한다.\n\n 표 2.  한국인의 화장품 사용으로 인한 통합 노출량*\n\n사용 후 씻어내는 피부\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n메이크업 제품\n\n메이크업 리무버\n\n- 0.21\n- 3.70\n아이 섀도\n\n- 0.02\n- 0.29\n마스카라\n\n- 0.03\n- 0.50\n립스틱\n\n- 0.05\n- 0.87\n아이라이너\n\n- 0.01\n- 0.23\nTOTAL\n\n± 16.9\n\n275\n\n* 2014∼2016 화장품 위해평가 선진화 연구\n\n- - 39 -\n<!-- PAGE_45 -->\n###### 붙임 6.  유럽의 화장품 사용량\n\n<!-- PAGE_45 -->\n###### 1.  유럽 SCCS 가이드라인에서 제시한 유럽의 화장품 유형별 추정 일일 노출량 및 보존제 통합\n\n<!-- PAGE_45 -->\n###### 일일 사용량 및 노출량은 다음과 같다(Hall et al, 2007, 2011).\n\n <!-- PAGE_45 -->\n###### 표 1. ",
        "original_sentence": "한국인의 화장품 사용으로 인한 통합 노출량*\n\n사용 후 씻어내는 피부\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n메이크업 제품\n\n메이크업 리무버\n\n- 0.21\n- 3.70\n아이 섀도\n\n- 0.02\n- 0.29\n마스카라\n\n- 0.03\n- 0.50\n립스틱\n\n- 0.05\n- 0.87\n아이라이너\n\n- 0.01\n- 0.23\nTOTAL\n\n± 16.9\n\n275\n\n* 2014∼2016 화장품 위해평가 선진화 연구\n\n- - 39 -\n<!-- PAGE_45 -->\n###### 붙임 6. "
      }
    },
    {
      "chunk_id": "chunk_313",
      "text": "유럽의 화장품 사용량\n\n<!-- PAGE_45 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 312,
        "window_size": 3,
        "char_count": 40,
        "word_count": 8,
        "page_number": 45,
        "window_text": "최신의 노출 자료와 최악의 경우까지\n\n<!-- PAGE_44 -->\n###### 고려한 예측상황(worst-case scenario)에서 안전역(MOS) 산출 시, 16.9 g/일 또는 275 mg/kg\n\n<!-- PAGE_44 -->\n###### - 기타성분, 색소 등 특정 성분이 여러 유형의 화장품에 함유되어 인체에 노출되는 경우, 노출\n\n<!-- PAGE_44 -->\n###### 유형에 따라 표 2의 통합 노출량 자료를 사용한다.\n\n 표 2.  한국인의 화장품 사용으로 인한 통합 노출량*\n\n사용 후 씻어내는 피부\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n메이크업 제품\n\n메이크업 리무버\n\n- 0.21\n- 3.70\n아이 섀도\n\n- 0.02\n- 0.29\n마스카라\n\n- 0.03\n- 0.50\n립스틱\n\n- 0.05\n- 0.87\n아이라이너\n\n- 0.01\n- 0.23\nTOTAL\n\n± 16.9\n\n275\n\n* 2014∼2016 화장품 위해평가 선진화 연구\n\n- - 39 -\n<!-- PAGE_45 -->\n###### 붙임 6.  유럽의 화장품 사용량\n\n<!-- PAGE_45 -->\n###### 1.  유럽 SCCS 가이드라인에서 제시한 유럽의 화장품 유형별 추정 일일 노출량 및 보존제 통합\n\n<!-- PAGE_45 -->\n###### 일일 사용량 및 노출량은 다음과 같다(Hall et al, 2007, 2011).\n\n <!-- PAGE_45 -->\n###### 표 1.  유럽의 화장품 유형별 일일 사용량 및 노출량\n\n립스틱, 입술보호제\n\n- 0.057\n- 0.90\n- 1.00\n- 0.057\n- 0.90\n데오도란트\n\n비분무형 데오도란트\n\n- 1.50\n- 22.08\n- 1.00\n- 1.50\n- 22.08\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 기반제품)4\n\n- 1.43\n- 20.635\n- 1.00\n- 1.43\n- 20.63\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 비기반제품)\n\n- 0.69\n- 10.00\n- 1.00\n- 0.69\n- 10.00\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 사용하는 제품(샤워젤, 샴푸 등)의 세척 및 희석\n\n효과를 고려하기 위해 SCCNFP에 의해 사용된 지수임(SCCNFP/0321/00)\n\n- - 40 -\n2 기존 연구(Hall et al, 2007; 2011)에 포함되지 않는 제품 유형\n\n3 사용빈도가 낮아 일일 노출량을 계산하지 않음\n\n4‘에탄올 기반’은 에탄올을 주된 성분으로 함유한 제품을 의미함(Steiling et al., 2014)\n\n5 체중 60kg(기본값)이 아닌 연구에 참여한 사람의 체중이 사용되었음\n\n<!-- PAGE_46 -->\n###### 표 2. ",
        "original_sentence": "유럽의 화장품 사용량\n\n<!-- PAGE_45 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_314",
      "text": "유럽 SCCS 가이드라인에서 제시한 유럽의 화장품 유형별 추정 일일 노출량 및 보존제 통합\n\n<!-- PAGE_45 -->\n###### 일일 사용량 및 노출량은 다음과 같다(Hall et al, 2007, 2011).\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 313,
        "window_size": 3,
        "char_count": 123,
        "word_count": 27,
        "page_number": 45,
        "window_text": "표 2.  한국인의 화장품 사용으로 인한 통합 노출량*\n\n사용 후 씻어내는 피부\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n메이크업 제품\n\n메이크업 리무버\n\n- 0.21\n- 3.70\n아이 섀도\n\n- 0.02\n- 0.29\n마스카라\n\n- 0.03\n- 0.50\n립스틱\n\n- 0.05\n- 0.87\n아이라이너\n\n- 0.01\n- 0.23\nTOTAL\n\n± 16.9\n\n275\n\n* 2014∼2016 화장품 위해평가 선진화 연구\n\n- - 39 -\n<!-- PAGE_45 -->\n###### 붙임 6.  유럽의 화장품 사용량\n\n<!-- PAGE_45 -->\n###### 1.  유럽 SCCS 가이드라인에서 제시한 유럽의 화장품 유형별 추정 일일 노출량 및 보존제 통합\n\n<!-- PAGE_45 -->\n###### 일일 사용량 및 노출량은 다음과 같다(Hall et al, 2007, 2011).\n\n <!-- PAGE_45 -->\n###### 표 1.  유럽의 화장품 유형별 일일 사용량 및 노출량\n\n립스틱, 입술보호제\n\n- 0.057\n- 0.90\n- 1.00\n- 0.057\n- 0.90\n데오도란트\n\n비분무형 데오도란트\n\n- 1.50\n- 22.08\n- 1.00\n- 1.50\n- 22.08\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 기반제품)4\n\n- 1.43\n- 20.635\n- 1.00\n- 1.43\n- 20.63\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 비기반제품)\n\n- 0.69\n- 10.00\n- 1.00\n- 0.69\n- 10.00\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 사용하는 제품(샤워젤, 샴푸 등)의 세척 및 희석\n\n효과를 고려하기 위해 SCCNFP에 의해 사용된 지수임(SCCNFP/0321/00)\n\n- - 40 -\n2 기존 연구(Hall et al, 2007; 2011)에 포함되지 않는 제품 유형\n\n3 사용빈도가 낮아 일일 노출량을 계산하지 않음\n\n4‘에탄올 기반’은 에탄올을 주된 성분으로 함유한 제품을 의미함(Steiling et al., 2014)\n\n5 체중 60kg(기본값)이 아닌 연구에 참여한 사람의 체중이 사용되었음\n\n<!-- PAGE_46 -->\n###### 표 2.  유럽의 보존제 평가를 위한 화장품 사용 통합 노출량\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n- - 41 -\n<!-- PAGE_47 -->\n###### 붙임 7. ",
        "original_sentence": "유럽 SCCS 가이드라인에서 제시한 유럽의 화장품 유형별 추정 일일 노출량 및 보존제 통합\n\n<!-- PAGE_45 -->\n###### 일일 사용량 및 노출량은 다음과 같다(Hall et al, 2007, 2011).\n\n"
      }
    },
    {
      "chunk_id": "chunk_315",
      "text": "<!-- PAGE_45 -->\n###### 표 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 314,
        "window_size": 3,
        "char_count": 29,
        "word_count": 6,
        "page_number": 45,
        "window_text": "한국인의 화장품 사용으로 인한 통합 노출량*\n\n사용 후 씻어내는 피부\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n메이크업 제품\n\n메이크업 리무버\n\n- 0.21\n- 3.70\n아이 섀도\n\n- 0.02\n- 0.29\n마스카라\n\n- 0.03\n- 0.50\n립스틱\n\n- 0.05\n- 0.87\n아이라이너\n\n- 0.01\n- 0.23\nTOTAL\n\n± 16.9\n\n275\n\n* 2014∼2016 화장품 위해평가 선진화 연구\n\n- - 39 -\n<!-- PAGE_45 -->\n###### 붙임 6.  유럽의 화장품 사용량\n\n<!-- PAGE_45 -->\n###### 1.  유럽 SCCS 가이드라인에서 제시한 유럽의 화장품 유형별 추정 일일 노출량 및 보존제 통합\n\n<!-- PAGE_45 -->\n###### 일일 사용량 및 노출량은 다음과 같다(Hall et al, 2007, 2011).\n\n <!-- PAGE_45 -->\n###### 표 1.  유럽의 화장품 유형별 일일 사용량 및 노출량\n\n립스틱, 입술보호제\n\n- 0.057\n- 0.90\n- 1.00\n- 0.057\n- 0.90\n데오도란트\n\n비분무형 데오도란트\n\n- 1.50\n- 22.08\n- 1.00\n- 1.50\n- 22.08\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 기반제품)4\n\n- 1.43\n- 20.635\n- 1.00\n- 1.43\n- 20.63\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 비기반제품)\n\n- 0.69\n- 10.00\n- 1.00\n- 0.69\n- 10.00\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 사용하는 제품(샤워젤, 샴푸 등)의 세척 및 희석\n\n효과를 고려하기 위해 SCCNFP에 의해 사용된 지수임(SCCNFP/0321/00)\n\n- - 40 -\n2 기존 연구(Hall et al, 2007; 2011)에 포함되지 않는 제품 유형\n\n3 사용빈도가 낮아 일일 노출량을 계산하지 않음\n\n4‘에탄올 기반’은 에탄올을 주된 성분으로 함유한 제품을 의미함(Steiling et al., 2014)\n\n5 체중 60kg(기본값)이 아닌 연구에 참여한 사람의 체중이 사용되었음\n\n<!-- PAGE_46 -->\n###### 표 2.  유럽의 보존제 평가를 위한 화장품 사용 통합 노출량\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n- - 41 -\n<!-- PAGE_47 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_47 -->\n###### 1. ",
        "original_sentence": "<!-- PAGE_45 -->\n###### 표 1. "
      }
    },
    {
      "chunk_id": "chunk_316",
      "text": "유럽의 화장품 유형별 일일 사용량 및 노출량\n\n립스틱, 입술보호제\n\n- 0.057\n- 0.90\n- 1.00\n- 0.057\n- 0.90\n데오도란트\n\n비분무형 데오도란트\n\n- 1.50\n- 22.08\n- 1.00\n- 1.50\n- 22.08\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 기반제품)4\n\n- 1.43\n- 20.635\n- 1.00\n- 1.43\n- 20.63\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 비기반제품)\n\n- 0.69\n- 10.00\n- 1.00\n- 0.69\n- 10.00\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 사용하는 제품(샤워젤, 샴푸 등)의 세척 및 희석\n\n효과를 고려하기 위해 SCCNFP에 의해 사용된 지수임(SCCNFP/0321/00)\n\n- - 40 -\n2 기존 연구(Hall et al, 2007; 2011)에 포함되지 않는 제품 유형\n\n3 사용빈도가 낮아 일일 노출량을 계산하지 않음\n\n4‘에탄올 기반’은 에탄올을 주된 성분으로 함유한 제품을 의미함(Steiling et al., 2014)\n\n5 체중 60kg(기본값)이 아닌 연구에 참여한 사람의 체중이 사용되었음\n\n<!-- PAGE_46 -->\n###### 표 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 315,
        "window_size": 3,
        "char_count": 600,
        "word_count": 130,
        "page_number": 46,
        "window_text": "유럽의 화장품 사용량\n\n<!-- PAGE_45 -->\n###### 1.  유럽 SCCS 가이드라인에서 제시한 유럽의 화장품 유형별 추정 일일 노출량 및 보존제 통합\n\n<!-- PAGE_45 -->\n###### 일일 사용량 및 노출량은 다음과 같다(Hall et al, 2007, 2011).\n\n <!-- PAGE_45 -->\n###### 표 1.  유럽의 화장품 유형별 일일 사용량 및 노출량\n\n립스틱, 입술보호제\n\n- 0.057\n- 0.90\n- 1.00\n- 0.057\n- 0.90\n데오도란트\n\n비분무형 데오도란트\n\n- 1.50\n- 22.08\n- 1.00\n- 1.50\n- 22.08\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 기반제품)4\n\n- 1.43\n- 20.635\n- 1.00\n- 1.43\n- 20.63\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 비기반제품)\n\n- 0.69\n- 10.00\n- 1.00\n- 0.69\n- 10.00\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 사용하는 제품(샤워젤, 샴푸 등)의 세척 및 희석\n\n효과를 고려하기 위해 SCCNFP에 의해 사용된 지수임(SCCNFP/0321/00)\n\n- - 40 -\n2 기존 연구(Hall et al, 2007; 2011)에 포함되지 않는 제품 유형\n\n3 사용빈도가 낮아 일일 노출량을 계산하지 않음\n\n4‘에탄올 기반’은 에탄올을 주된 성분으로 함유한 제품을 의미함(Steiling et al., 2014)\n\n5 체중 60kg(기본값)이 아닌 연구에 참여한 사람의 체중이 사용되었음\n\n<!-- PAGE_46 -->\n###### 표 2.  유럽의 보존제 평가를 위한 화장품 사용 통합 노출량\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n- - 41 -\n<!-- PAGE_47 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_47 -->\n###### 1.  흡입노출에 의한 전신노출량(SED)은 일반적으로 스프레이 유형에 따른 에어로졸의 크기\n\n<!-- PAGE_47 -->\n###### 분포와 침전 직전 물방울의 크기 분포를 고려하여 화장품의 1일 사용량, 휘발된 물질에\n\n<!-- PAGE_47 -->\n###### 2. ",
        "original_sentence": "유럽의 화장품 유형별 일일 사용량 및 노출량\n\n립스틱, 입술보호제\n\n- 0.057\n- 0.90\n- 1.00\n- 0.057\n- 0.90\n데오도란트\n\n비분무형 데오도란트\n\n- 1.50\n- 22.08\n- 1.00\n- 1.50\n- 22.08\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 기반제품)4\n\n- 1.43\n- 20.635\n- 1.00\n- 1.43\n- 20.63\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 비기반제품)\n\n- 0.69\n- 10.00\n- 1.00\n- 0.69\n- 10.00\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 사용하는 제품(샤워젤, 샴푸 등)의 세척 및 희석\n\n효과를 고려하기 위해 SCCNFP에 의해 사용된 지수임(SCCNFP/0321/00)\n\n- - 40 -\n2 기존 연구(Hall et al, 2007; 2011)에 포함되지 않는 제품 유형\n\n3 사용빈도가 낮아 일일 노출량을 계산하지 않음\n\n4‘에탄올 기반’은 에탄올을 주된 성분으로 함유한 제품을 의미함(Steiling et al., 2014)\n\n5 체중 60kg(기본값)이 아닌 연구에 참여한 사람의 체중이 사용되었음\n\n<!-- PAGE_46 -->\n###### 표 2. "
      }
    },
    {
      "chunk_id": "chunk_317",
      "text": "유럽의 보존제 평가를 위한 화장품 사용 통합 노출량\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n- - 41 -\n<!-- PAGE_47 -->\n###### 붙임 7. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 316,
        "window_size": 3,
        "char_count": 111,
        "word_count": 31,
        "page_number": 47,
        "window_text": "유럽 SCCS 가이드라인에서 제시한 유럽의 화장품 유형별 추정 일일 노출량 및 보존제 통합\n\n<!-- PAGE_45 -->\n###### 일일 사용량 및 노출량은 다음과 같다(Hall et al, 2007, 2011).\n\n <!-- PAGE_45 -->\n###### 표 1.  유럽의 화장품 유형별 일일 사용량 및 노출량\n\n립스틱, 입술보호제\n\n- 0.057\n- 0.90\n- 1.00\n- 0.057\n- 0.90\n데오도란트\n\n비분무형 데오도란트\n\n- 1.50\n- 22.08\n- 1.00\n- 1.50\n- 22.08\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 기반제품)4\n\n- 1.43\n- 20.635\n- 1.00\n- 1.43\n- 20.63\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 비기반제품)\n\n- 0.69\n- 10.00\n- 1.00\n- 0.69\n- 10.00\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 사용하는 제품(샤워젤, 샴푸 등)의 세척 및 희석\n\n효과를 고려하기 위해 SCCNFP에 의해 사용된 지수임(SCCNFP/0321/00)\n\n- - 40 -\n2 기존 연구(Hall et al, 2007; 2011)에 포함되지 않는 제품 유형\n\n3 사용빈도가 낮아 일일 노출량을 계산하지 않음\n\n4‘에탄올 기반’은 에탄올을 주된 성분으로 함유한 제품을 의미함(Steiling et al., 2014)\n\n5 체중 60kg(기본값)이 아닌 연구에 참여한 사람의 체중이 사용되었음\n\n<!-- PAGE_46 -->\n###### 표 2.  유럽의 보존제 평가를 위한 화장품 사용 통합 노출량\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n- - 41 -\n<!-- PAGE_47 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_47 -->\n###### 1.  흡입노출에 의한 전신노출량(SED)은 일반적으로 스프레이 유형에 따른 에어로졸의 크기\n\n<!-- PAGE_47 -->\n###### 분포와 침전 직전 물방울의 크기 분포를 고려하여 화장품의 1일 사용량, 휘발된 물질에\n\n<!-- PAGE_47 -->\n###### 2.  수학적 모델을 사용하여 흡입노출량을 추정할 때에는 단계별 접근방식에 따라 1-box 또는\n\n<!-- PAGE_47 -->\n###### 2-box 모델을 사용하거나 상위단계(higher tier) 모델(ConsExpo 모델) 등의 단계별 평가방\n\n<!-- PAGE_47 -->\n###### 3. ",
        "original_sentence": "유럽의 보존제 평가를 위한 화장품 사용 통합 노출량\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n- - 41 -\n<!-- PAGE_47 -->\n###### 붙임 7. "
      }
    },
    {
      "chunk_id": "chunk_318",
      "text": "흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_47 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 317,
        "window_size": 3,
        "char_count": 47,
        "word_count": 11,
        "page_number": 47,
        "window_text": "<!-- PAGE_45 -->\n###### 표 1.  유럽의 화장품 유형별 일일 사용량 및 노출량\n\n립스틱, 입술보호제\n\n- 0.057\n- 0.90\n- 1.00\n- 0.057\n- 0.90\n데오도란트\n\n비분무형 데오도란트\n\n- 1.50\n- 22.08\n- 1.00\n- 1.50\n- 22.08\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 기반제품)4\n\n- 1.43\n- 20.635\n- 1.00\n- 1.43\n- 20.63\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 비기반제품)\n\n- 0.69\n- 10.00\n- 1.00\n- 0.69\n- 10.00\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 사용하는 제품(샤워젤, 샴푸 등)의 세척 및 희석\n\n효과를 고려하기 위해 SCCNFP에 의해 사용된 지수임(SCCNFP/0321/00)\n\n- - 40 -\n2 기존 연구(Hall et al, 2007; 2011)에 포함되지 않는 제품 유형\n\n3 사용빈도가 낮아 일일 노출량을 계산하지 않음\n\n4‘에탄올 기반’은 에탄올을 주된 성분으로 함유한 제품을 의미함(Steiling et al., 2014)\n\n5 체중 60kg(기본값)이 아닌 연구에 참여한 사람의 체중이 사용되었음\n\n<!-- PAGE_46 -->\n###### 표 2.  유럽의 보존제 평가를 위한 화장품 사용 통합 노출량\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n- - 41 -\n<!-- PAGE_47 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_47 -->\n###### 1.  흡입노출에 의한 전신노출량(SED)은 일반적으로 스프레이 유형에 따른 에어로졸의 크기\n\n<!-- PAGE_47 -->\n###### 분포와 침전 직전 물방울의 크기 분포를 고려하여 화장품의 1일 사용량, 휘발된 물질에\n\n<!-- PAGE_47 -->\n###### 2.  수학적 모델을 사용하여 흡입노출량을 추정할 때에는 단계별 접근방식에 따라 1-box 또는\n\n<!-- PAGE_47 -->\n###### 2-box 모델을 사용하거나 상위단계(higher tier) 모델(ConsExpo 모델) 등의 단계별 평가방\n\n<!-- PAGE_47 -->\n###### 3.  흡입노출은 화장품 사용에 있어서 의도된 노출경로가 아니므로 다음 내용을 검토하여 평\n\n스프레이 사용\n\n빈도\n\n지속시간\n\n분사량/1회 사용, 분사량/시간\n\n분사방향\n\n노출형태\n\n적용 유형(소비자, 산업/전문)\n\n분무 시 Particle/droplet 크기 분포\n\n사용공간에서의 노출시간\n\n노출공간 부피 및 온도\n\n환기율\n\n노출된 개인의 활동 수준(예: 이동, 휴식)\n\n(Steiling et al., 2014)\n\n- - 42 -\n<!-- PAGE_48 -->\n###### 4. ",
        "original_sentence": "흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_47 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_319",
      "text": "흡입노출에 의한 전신노출량(SED)은 일반적으로 스프레이 유형에 따른 에어로졸의 크기\n\n<!-- PAGE_47 -->\n###### 분포와 침전 직전 물방울의 크기 분포를 고려하여 화장품의 1일 사용량, 휘발된 물질에\n\n<!-- PAGE_47 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 318,
        "window_size": 3,
        "char_count": 149,
        "word_count": 30,
        "page_number": 47,
        "window_text": "유럽의 화장품 유형별 일일 사용량 및 노출량\n\n립스틱, 입술보호제\n\n- 0.057\n- 0.90\n- 1.00\n- 0.057\n- 0.90\n데오도란트\n\n비분무형 데오도란트\n\n- 1.50\n- 22.08\n- 1.00\n- 1.50\n- 22.08\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 기반제품)4\n\n- 1.43\n- 20.635\n- 1.00\n- 1.43\n- 20.63\n데오도란트 에어로졸\n\n스프레이\n\n(에탄올 비기반제품)\n\n- 0.69\n- 10.00\n- 1.00\n- 0.69\n- 10.00\n1 잔류지수(retention factor)는 젖은 피부나 머리카락에 사용하는 제품(샤워젤, 샴푸 등)의 세척 및 희석\n\n효과를 고려하기 위해 SCCNFP에 의해 사용된 지수임(SCCNFP/0321/00)\n\n- - 40 -\n2 기존 연구(Hall et al, 2007; 2011)에 포함되지 않는 제품 유형\n\n3 사용빈도가 낮아 일일 노출량을 계산하지 않음\n\n4‘에탄올 기반’은 에탄올을 주된 성분으로 함유한 제품을 의미함(Steiling et al., 2014)\n\n5 체중 60kg(기본값)이 아닌 연구에 참여한 사람의 체중이 사용되었음\n\n<!-- PAGE_46 -->\n###### 표 2.  유럽의 보존제 평가를 위한 화장품 사용 통합 노출량\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n- - 41 -\n<!-- PAGE_47 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_47 -->\n###### 1.  흡입노출에 의한 전신노출량(SED)은 일반적으로 스프레이 유형에 따른 에어로졸의 크기\n\n<!-- PAGE_47 -->\n###### 분포와 침전 직전 물방울의 크기 분포를 고려하여 화장품의 1일 사용량, 휘발된 물질에\n\n<!-- PAGE_47 -->\n###### 2.  수학적 모델을 사용하여 흡입노출량을 추정할 때에는 단계별 접근방식에 따라 1-box 또는\n\n<!-- PAGE_47 -->\n###### 2-box 모델을 사용하거나 상위단계(higher tier) 모델(ConsExpo 모델) 등의 단계별 평가방\n\n<!-- PAGE_47 -->\n###### 3.  흡입노출은 화장품 사용에 있어서 의도된 노출경로가 아니므로 다음 내용을 검토하여 평\n\n스프레이 사용\n\n빈도\n\n지속시간\n\n분사량/1회 사용, 분사량/시간\n\n분사방향\n\n노출형태\n\n적용 유형(소비자, 산업/전문)\n\n분무 시 Particle/droplet 크기 분포\n\n사용공간에서의 노출시간\n\n노출공간 부피 및 온도\n\n환기율\n\n노출된 개인의 활동 수준(예: 이동, 휴식)\n\n(Steiling et al., 2014)\n\n- - 42 -\n<!-- PAGE_48 -->\n###### 4.  흡입노출에 의한 전신노출량(SEDinh)은 다음과 같은 세가지 방법으로 산출할 수 있다.\n\n",
        "original_sentence": "흡입노출에 의한 전신노출량(SED)은 일반적으로 스프레이 유형에 따른 에어로졸의 크기\n\n<!-- PAGE_47 -->\n###### 분포와 침전 직전 물방울의 크기 분포를 고려하여 화장품의 1일 사용량, 휘발된 물질에\n\n<!-- PAGE_47 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_320",
      "text": "수학적 모델을 사용하여 흡입노출량을 추정할 때에는 단계별 접근방식에 따라 1-box 또는\n\n<!-- PAGE_47 -->\n###### 2-box 모델을 사용하거나 상위단계(higher tier) 모델(ConsExpo 모델) 등의 단계별 평가방\n\n<!-- PAGE_47 -->\n###### 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 319,
        "window_size": 3,
        "char_count": 164,
        "word_count": 30,
        "page_number": 47,
        "window_text": "유럽의 보존제 평가를 위한 화장품 사용 통합 노출량\n\n및 모발 클렌징 제품\n\n사용 후 씻어내지 않는\n\n피부 및 모발 관리 제품\n\n- - 41 -\n<!-- PAGE_47 -->\n###### 붙임 7.  흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_47 -->\n###### 1.  흡입노출에 의한 전신노출량(SED)은 일반적으로 스프레이 유형에 따른 에어로졸의 크기\n\n<!-- PAGE_47 -->\n###### 분포와 침전 직전 물방울의 크기 분포를 고려하여 화장품의 1일 사용량, 휘발된 물질에\n\n<!-- PAGE_47 -->\n###### 2.  수학적 모델을 사용하여 흡입노출량을 추정할 때에는 단계별 접근방식에 따라 1-box 또는\n\n<!-- PAGE_47 -->\n###### 2-box 모델을 사용하거나 상위단계(higher tier) 모델(ConsExpo 모델) 등의 단계별 평가방\n\n<!-- PAGE_47 -->\n###### 3.  흡입노출은 화장품 사용에 있어서 의도된 노출경로가 아니므로 다음 내용을 검토하여 평\n\n스프레이 사용\n\n빈도\n\n지속시간\n\n분사량/1회 사용, 분사량/시간\n\n분사방향\n\n노출형태\n\n적용 유형(소비자, 산업/전문)\n\n분무 시 Particle/droplet 크기 분포\n\n사용공간에서의 노출시간\n\n노출공간 부피 및 온도\n\n환기율\n\n노출된 개인의 활동 수준(예: 이동, 휴식)\n\n(Steiling et al., 2014)\n\n- - 42 -\n<!-- PAGE_48 -->\n###### 4.  흡입노출에 의한 전신노출량(SEDinh)은 다음과 같은 세가지 방법으로 산출할 수 있다.\n\n <!-- PAGE_48 -->\n###### 1) 1-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_48 -->\n###### : 전체 분무량이 즉시 공기 중으로 방출되고 특정 크기의 상자에 분포한다고 가정하여 시뮬\n\n<!-- PAGE_48 -->\n###### 레이션을 통한 호흡구역의 공기 농도에 호흡률과 공간에 머무르는 시간을 곱하여 노출량을\n\n- - 43 -\n<!-- PAGE_49 -->\n###### 2) 2-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_49 -->\n###### : 시간의 경과에 따른 물질의 희석을 고려하여 전체 분무량이 즉시 공기 중으로 방출되면\n\n<!-- PAGE_49 -->\n###### 머리 주변(box 1)에 우선적으로 분포한 후, 일정시간 이후에 특정 크기의 상자(box 2)로\n\n<!-- PAGE_49 -->\n###### 확산된다고 가정하여 호흡구역에 존재하는 대상 물질의 양, 흡입/잔류 물질 분율, 사용\n\n<!-- PAGE_49 -->\n###### 횟수를 곱하여 노출량을 산출할 수 있다. ",
        "original_sentence": "수학적 모델을 사용하여 흡입노출량을 추정할 때에는 단계별 접근방식에 따라 1-box 또는\n\n<!-- PAGE_47 -->\n###### 2-box 모델을 사용하거나 상위단계(higher tier) 모델(ConsExpo 모델) 등의 단계별 평가방\n\n<!-- PAGE_47 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_321",
      "text": "흡입노출은 화장품 사용에 있어서 의도된 노출경로가 아니므로 다음 내용을 검토하여 평\n\n스프레이 사용\n\n빈도\n\n지속시간\n\n분사량/1회 사용, 분사량/시간\n\n분사방향\n\n노출형태\n\n적용 유형(소비자, 산업/전문)\n\n분무 시 Particle/droplet 크기 분포\n\n사용공간에서의 노출시간\n\n노출공간 부피 및 온도\n\n환기율\n\n노출된 개인의 활동 수준(예: 이동, 휴식)\n\n(Steiling et al., 2014)\n\n- - 42 -\n<!-- PAGE_48 -->\n###### 4. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 320,
        "window_size": 3,
        "char_count": 266,
        "word_count": 54,
        "page_number": 48,
        "window_text": "흡입 노출평가 방법 및 기본 정보\n\n<!-- PAGE_47 -->\n###### 1.  흡입노출에 의한 전신노출량(SED)은 일반적으로 스프레이 유형에 따른 에어로졸의 크기\n\n<!-- PAGE_47 -->\n###### 분포와 침전 직전 물방울의 크기 분포를 고려하여 화장품의 1일 사용량, 휘발된 물질에\n\n<!-- PAGE_47 -->\n###### 2.  수학적 모델을 사용하여 흡입노출량을 추정할 때에는 단계별 접근방식에 따라 1-box 또는\n\n<!-- PAGE_47 -->\n###### 2-box 모델을 사용하거나 상위단계(higher tier) 모델(ConsExpo 모델) 등의 단계별 평가방\n\n<!-- PAGE_47 -->\n###### 3.  흡입노출은 화장품 사용에 있어서 의도된 노출경로가 아니므로 다음 내용을 검토하여 평\n\n스프레이 사용\n\n빈도\n\n지속시간\n\n분사량/1회 사용, 분사량/시간\n\n분사방향\n\n노출형태\n\n적용 유형(소비자, 산업/전문)\n\n분무 시 Particle/droplet 크기 분포\n\n사용공간에서의 노출시간\n\n노출공간 부피 및 온도\n\n환기율\n\n노출된 개인의 활동 수준(예: 이동, 휴식)\n\n(Steiling et al., 2014)\n\n- - 42 -\n<!-- PAGE_48 -->\n###### 4.  흡입노출에 의한 전신노출량(SEDinh)은 다음과 같은 세가지 방법으로 산출할 수 있다.\n\n <!-- PAGE_48 -->\n###### 1) 1-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_48 -->\n###### : 전체 분무량이 즉시 공기 중으로 방출되고 특정 크기의 상자에 분포한다고 가정하여 시뮬\n\n<!-- PAGE_48 -->\n###### 레이션을 통한 호흡구역의 공기 농도에 호흡률과 공간에 머무르는 시간을 곱하여 노출량을\n\n- - 43 -\n<!-- PAGE_49 -->\n###### 2) 2-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_49 -->\n###### : 시간의 경과에 따른 물질의 희석을 고려하여 전체 분무량이 즉시 공기 중으로 방출되면\n\n<!-- PAGE_49 -->\n###### 머리 주변(box 1)에 우선적으로 분포한 후, 일정시간 이후에 특정 크기의 상자(box 2)로\n\n<!-- PAGE_49 -->\n###### 확산된다고 가정하여 호흡구역에 존재하는 대상 물질의 양, 흡입/잔류 물질 분율, 사용\n\n<!-- PAGE_49 -->\n###### 횟수를 곱하여 노출량을 산출할 수 있다.  보수적인 접근하기 위해서는 공기 교환(공기 유\n\nV2 (L)\n\nBox 2의 공간부피(분사제/펌프 스프레이: 9300 적용, 예: 욕실)5\n\nt1 (min)\n\nBox 1의 노출시간(분사제/펌프 스프레이: 2 적용)6\n\nt2 (min)\n\nBox 2의 노출시간(분사제/펌프 스프레이: 10 적용)6\n\n1 SCCS NoG 11th에서 제시하는 default 값(Rothe et al., 2011)\n\n2 SCCS NoG 11th에서 제시하는 default 값\n\n3 SCCS NoG 11th에서 제시하는 default 값(Bremmer et al, 2006)\n\n4 한국인의 노출계수 핸드북, 2019\n\n5 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007)\n\n6 SCCS NoG 11th에서 제시하는 default 값(SCCS, 옥토크릴렌(Octocrylene))\n\n- - 44 -\n<!-- PAGE_50 -->\n###### 3) ConsExpo 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_50 -->\n###### - 보다 용이한 흡입 노출평가로 ConsExpo 모델*을 사용할 수 있다. ",
        "original_sentence": "흡입노출은 화장품 사용에 있어서 의도된 노출경로가 아니므로 다음 내용을 검토하여 평\n\n스프레이 사용\n\n빈도\n\n지속시간\n\n분사량/1회 사용, 분사량/시간\n\n분사방향\n\n노출형태\n\n적용 유형(소비자, 산업/전문)\n\n분무 시 Particle/droplet 크기 분포\n\n사용공간에서의 노출시간\n\n노출공간 부피 및 온도\n\n환기율\n\n노출된 개인의 활동 수준(예: 이동, 휴식)\n\n(Steiling et al., 2014)\n\n- - 42 -\n<!-- PAGE_48 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_322",
      "text": "흡입노출에 의한 전신노출량(SEDinh)은 다음과 같은 세가지 방법으로 산출할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 321,
        "window_size": 3,
        "char_count": 51,
        "word_count": 10,
        "page_number": 2,
        "window_text": "흡입노출에 의한 전신노출량(SED)은 일반적으로 스프레이 유형에 따른 에어로졸의 크기\n\n<!-- PAGE_47 -->\n###### 분포와 침전 직전 물방울의 크기 분포를 고려하여 화장품의 1일 사용량, 휘발된 물질에\n\n<!-- PAGE_47 -->\n###### 2.  수학적 모델을 사용하여 흡입노출량을 추정할 때에는 단계별 접근방식에 따라 1-box 또는\n\n<!-- PAGE_47 -->\n###### 2-box 모델을 사용하거나 상위단계(higher tier) 모델(ConsExpo 모델) 등의 단계별 평가방\n\n<!-- PAGE_47 -->\n###### 3.  흡입노출은 화장품 사용에 있어서 의도된 노출경로가 아니므로 다음 내용을 검토하여 평\n\n스프레이 사용\n\n빈도\n\n지속시간\n\n분사량/1회 사용, 분사량/시간\n\n분사방향\n\n노출형태\n\n적용 유형(소비자, 산업/전문)\n\n분무 시 Particle/droplet 크기 분포\n\n사용공간에서의 노출시간\n\n노출공간 부피 및 온도\n\n환기율\n\n노출된 개인의 활동 수준(예: 이동, 휴식)\n\n(Steiling et al., 2014)\n\n- - 42 -\n<!-- PAGE_48 -->\n###### 4.  흡입노출에 의한 전신노출량(SEDinh)은 다음과 같은 세가지 방법으로 산출할 수 있다.\n\n <!-- PAGE_48 -->\n###### 1) 1-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_48 -->\n###### : 전체 분무량이 즉시 공기 중으로 방출되고 특정 크기의 상자에 분포한다고 가정하여 시뮬\n\n<!-- PAGE_48 -->\n###### 레이션을 통한 호흡구역의 공기 농도에 호흡률과 공간에 머무르는 시간을 곱하여 노출량을\n\n- - 43 -\n<!-- PAGE_49 -->\n###### 2) 2-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_49 -->\n###### : 시간의 경과에 따른 물질의 희석을 고려하여 전체 분무량이 즉시 공기 중으로 방출되면\n\n<!-- PAGE_49 -->\n###### 머리 주변(box 1)에 우선적으로 분포한 후, 일정시간 이후에 특정 크기의 상자(box 2)로\n\n<!-- PAGE_49 -->\n###### 확산된다고 가정하여 호흡구역에 존재하는 대상 물질의 양, 흡입/잔류 물질 분율, 사용\n\n<!-- PAGE_49 -->\n###### 횟수를 곱하여 노출량을 산출할 수 있다.  보수적인 접근하기 위해서는 공기 교환(공기 유\n\nV2 (L)\n\nBox 2의 공간부피(분사제/펌프 스프레이: 9300 적용, 예: 욕실)5\n\nt1 (min)\n\nBox 1의 노출시간(분사제/펌프 스프레이: 2 적용)6\n\nt2 (min)\n\nBox 2의 노출시간(분사제/펌프 스프레이: 10 적용)6\n\n1 SCCS NoG 11th에서 제시하는 default 값(Rothe et al., 2011)\n\n2 SCCS NoG 11th에서 제시하는 default 값\n\n3 SCCS NoG 11th에서 제시하는 default 값(Bremmer et al, 2006)\n\n4 한국인의 노출계수 핸드북, 2019\n\n5 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007)\n\n6 SCCS NoG 11th에서 제시하는 default 값(SCCS, 옥토크릴렌(Octocrylene))\n\n- - 44 -\n<!-- PAGE_50 -->\n###### 3) ConsExpo 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_50 -->\n###### - 보다 용이한 흡입 노출평가로 ConsExpo 모델*을 사용할 수 있다.  ConsExpo 모델은 소비자\n\n<!-- PAGE_50 -->\n###### 용 제품 사용으로 인한 인체노출량 산정을 위해 네덜란드 보건당국(RIVM)에서 개발한 위\n\n<!-- PAGE_50 -->\n###### 해평가 시뮬레이션 모델로, 각 제품군에 대한 노출 특성에 맞게 노출경로가 설정되어 있어\n\n<!-- PAGE_50 -->\n###### 상세한 노출량을 예측할 수 있는 소비자 노출평가 모델이다. ",
        "original_sentence": "흡입노출에 의한 전신노출량(SEDinh)은 다음과 같은 세가지 방법으로 산출할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_323",
      "text": "<!-- PAGE_48 -->\n###### 1) 1-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_48 -->\n###### : 전체 분무량이 즉시 공기 중으로 방출되고 특정 크기의 상자에 분포한다고 가정하여 시뮬\n\n<!-- PAGE_48 -->\n###### 레이션을 통한 호흡구역의 공기 농도에 호흡률과 공간에 머무르는 시간을 곱하여 노출량을\n\n- - 43 -\n<!-- PAGE_49 -->\n###### 2) 2-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_49 -->\n###### : 시간의 경과에 따른 물질의 희석을 고려하여 전체 분무량이 즉시 공기 중으로 방출되면\n\n<!-- PAGE_49 -->\n###### 머리 주변(box 1)에 우선적으로 분포한 후, 일정시간 이후에 특정 크기의 상자(box 2)로\n\n<!-- PAGE_49 -->\n###### 확산된다고 가정하여 호흡구역에 존재하는 대상 물질의 양, 흡입/잔류 물질 분율, 사용\n\n<!-- PAGE_49 -->\n###### 횟수를 곱하여 노출량을 산출할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 322,
        "window_size": 3,
        "char_count": 536,
        "word_count": 116,
        "page_number": 48,
        "window_text": "수학적 모델을 사용하여 흡입노출량을 추정할 때에는 단계별 접근방식에 따라 1-box 또는\n\n<!-- PAGE_47 -->\n###### 2-box 모델을 사용하거나 상위단계(higher tier) 모델(ConsExpo 모델) 등의 단계별 평가방\n\n<!-- PAGE_47 -->\n###### 3.  흡입노출은 화장품 사용에 있어서 의도된 노출경로가 아니므로 다음 내용을 검토하여 평\n\n스프레이 사용\n\n빈도\n\n지속시간\n\n분사량/1회 사용, 분사량/시간\n\n분사방향\n\n노출형태\n\n적용 유형(소비자, 산업/전문)\n\n분무 시 Particle/droplet 크기 분포\n\n사용공간에서의 노출시간\n\n노출공간 부피 및 온도\n\n환기율\n\n노출된 개인의 활동 수준(예: 이동, 휴식)\n\n(Steiling et al., 2014)\n\n- - 42 -\n<!-- PAGE_48 -->\n###### 4.  흡입노출에 의한 전신노출량(SEDinh)은 다음과 같은 세가지 방법으로 산출할 수 있다.\n\n <!-- PAGE_48 -->\n###### 1) 1-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_48 -->\n###### : 전체 분무량이 즉시 공기 중으로 방출되고 특정 크기의 상자에 분포한다고 가정하여 시뮬\n\n<!-- PAGE_48 -->\n###### 레이션을 통한 호흡구역의 공기 농도에 호흡률과 공간에 머무르는 시간을 곱하여 노출량을\n\n- - 43 -\n<!-- PAGE_49 -->\n###### 2) 2-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_49 -->\n###### : 시간의 경과에 따른 물질의 희석을 고려하여 전체 분무량이 즉시 공기 중으로 방출되면\n\n<!-- PAGE_49 -->\n###### 머리 주변(box 1)에 우선적으로 분포한 후, 일정시간 이후에 특정 크기의 상자(box 2)로\n\n<!-- PAGE_49 -->\n###### 확산된다고 가정하여 호흡구역에 존재하는 대상 물질의 양, 흡입/잔류 물질 분율, 사용\n\n<!-- PAGE_49 -->\n###### 횟수를 곱하여 노출량을 산출할 수 있다.  보수적인 접근하기 위해서는 공기 교환(공기 유\n\nV2 (L)\n\nBox 2의 공간부피(분사제/펌프 스프레이: 9300 적용, 예: 욕실)5\n\nt1 (min)\n\nBox 1의 노출시간(분사제/펌프 스프레이: 2 적용)6\n\nt2 (min)\n\nBox 2의 노출시간(분사제/펌프 스프레이: 10 적용)6\n\n1 SCCS NoG 11th에서 제시하는 default 값(Rothe et al., 2011)\n\n2 SCCS NoG 11th에서 제시하는 default 값\n\n3 SCCS NoG 11th에서 제시하는 default 값(Bremmer et al, 2006)\n\n4 한국인의 노출계수 핸드북, 2019\n\n5 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007)\n\n6 SCCS NoG 11th에서 제시하는 default 값(SCCS, 옥토크릴렌(Octocrylene))\n\n- - 44 -\n<!-- PAGE_50 -->\n###### 3) ConsExpo 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_50 -->\n###### - 보다 용이한 흡입 노출평가로 ConsExpo 모델*을 사용할 수 있다.  ConsExpo 모델은 소비자\n\n<!-- PAGE_50 -->\n###### 용 제품 사용으로 인한 인체노출량 산정을 위해 네덜란드 보건당국(RIVM)에서 개발한 위\n\n<!-- PAGE_50 -->\n###### 해평가 시뮬레이션 모델로, 각 제품군에 대한 노출 특성에 맞게 노출경로가 설정되어 있어\n\n<!-- PAGE_50 -->\n###### 상세한 노출량을 예측할 수 있는 소비자 노출평가 모델이다.  또한, 이 모델은 제품군(세부\n\n<!-- PAGE_50 -->\n###### 분류)을 선택하여 내장된 기본값 데이터베이스를 이용하거나 평가하고자 하는 제품의 기\n\n<!-- PAGE_50 -->\n###### 본 정보를 알 경우에는 직접 입력할 수 있다. ",
        "original_sentence": "<!-- PAGE_48 -->\n###### 1) 1-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_48 -->\n###### : 전체 분무량이 즉시 공기 중으로 방출되고 특정 크기의 상자에 분포한다고 가정하여 시뮬\n\n<!-- PAGE_48 -->\n###### 레이션을 통한 호흡구역의 공기 농도에 호흡률과 공간에 머무르는 시간을 곱하여 노출량을\n\n- - 43 -\n<!-- PAGE_49 -->\n###### 2) 2-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_49 -->\n###### : 시간의 경과에 따른 물질의 희석을 고려하여 전체 분무량이 즉시 공기 중으로 방출되면\n\n<!-- PAGE_49 -->\n###### 머리 주변(box 1)에 우선적으로 분포한 후, 일정시간 이후에 특정 크기의 상자(box 2)로\n\n<!-- PAGE_49 -->\n###### 확산된다고 가정하여 호흡구역에 존재하는 대상 물질의 양, 흡입/잔류 물질 분율, 사용\n\n<!-- PAGE_49 -->\n###### 횟수를 곱하여 노출량을 산출할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_324",
      "text": "보수적인 접근하기 위해서는 공기 교환(공기 유\n\nV2 (L)\n\nBox 2의 공간부피(분사제/펌프 스프레이: 9300 적용, 예: 욕실)5\n\nt1 (min)\n\nBox 1의 노출시간(분사제/펌프 스프레이: 2 적용)6\n\nt2 (min)\n\nBox 2의 노출시간(분사제/펌프 스프레이: 10 적용)6\n\n1 SCCS NoG 11th에서 제시하는 default 값(Rothe et al., 2011)\n\n2 SCCS NoG 11th에서 제시하는 default 값\n\n3 SCCS NoG 11th에서 제시하는 default 값(Bremmer et al, 2006)\n\n4 한국인의 노출계수 핸드북, 2019\n\n5 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007)\n\n6 SCCS NoG 11th에서 제시하는 default 값(SCCS, 옥토크릴렌(Octocrylene))\n\n- - 44 -\n<!-- PAGE_50 -->\n###### 3) ConsExpo 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_50 -->\n###### - 보다 용이한 흡입 노출평가로 ConsExpo 모델*을 사용할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 323,
        "window_size": 3,
        "char_count": 560,
        "word_count": 109,
        "page_number": 50,
        "window_text": "흡입노출은 화장품 사용에 있어서 의도된 노출경로가 아니므로 다음 내용을 검토하여 평\n\n스프레이 사용\n\n빈도\n\n지속시간\n\n분사량/1회 사용, 분사량/시간\n\n분사방향\n\n노출형태\n\n적용 유형(소비자, 산업/전문)\n\n분무 시 Particle/droplet 크기 분포\n\n사용공간에서의 노출시간\n\n노출공간 부피 및 온도\n\n환기율\n\n노출된 개인의 활동 수준(예: 이동, 휴식)\n\n(Steiling et al., 2014)\n\n- - 42 -\n<!-- PAGE_48 -->\n###### 4.  흡입노출에 의한 전신노출량(SEDinh)은 다음과 같은 세가지 방법으로 산출할 수 있다.\n\n <!-- PAGE_48 -->\n###### 1) 1-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_48 -->\n###### : 전체 분무량이 즉시 공기 중으로 방출되고 특정 크기의 상자에 분포한다고 가정하여 시뮬\n\n<!-- PAGE_48 -->\n###### 레이션을 통한 호흡구역의 공기 농도에 호흡률과 공간에 머무르는 시간을 곱하여 노출량을\n\n- - 43 -\n<!-- PAGE_49 -->\n###### 2) 2-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_49 -->\n###### : 시간의 경과에 따른 물질의 희석을 고려하여 전체 분무량이 즉시 공기 중으로 방출되면\n\n<!-- PAGE_49 -->\n###### 머리 주변(box 1)에 우선적으로 분포한 후, 일정시간 이후에 특정 크기의 상자(box 2)로\n\n<!-- PAGE_49 -->\n###### 확산된다고 가정하여 호흡구역에 존재하는 대상 물질의 양, 흡입/잔류 물질 분율, 사용\n\n<!-- PAGE_49 -->\n###### 횟수를 곱하여 노출량을 산출할 수 있다.  보수적인 접근하기 위해서는 공기 교환(공기 유\n\nV2 (L)\n\nBox 2의 공간부피(분사제/펌프 스프레이: 9300 적용, 예: 욕실)5\n\nt1 (min)\n\nBox 1의 노출시간(분사제/펌프 스프레이: 2 적용)6\n\nt2 (min)\n\nBox 2의 노출시간(분사제/펌프 스프레이: 10 적용)6\n\n1 SCCS NoG 11th에서 제시하는 default 값(Rothe et al., 2011)\n\n2 SCCS NoG 11th에서 제시하는 default 값\n\n3 SCCS NoG 11th에서 제시하는 default 값(Bremmer et al, 2006)\n\n4 한국인의 노출계수 핸드북, 2019\n\n5 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007)\n\n6 SCCS NoG 11th에서 제시하는 default 값(SCCS, 옥토크릴렌(Octocrylene))\n\n- - 44 -\n<!-- PAGE_50 -->\n###### 3) ConsExpo 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_50 -->\n###### - 보다 용이한 흡입 노출평가로 ConsExpo 모델*을 사용할 수 있다.  ConsExpo 모델은 소비자\n\n<!-- PAGE_50 -->\n###### 용 제품 사용으로 인한 인체노출량 산정을 위해 네덜란드 보건당국(RIVM)에서 개발한 위\n\n<!-- PAGE_50 -->\n###### 해평가 시뮬레이션 모델로, 각 제품군에 대한 노출 특성에 맞게 노출경로가 설정되어 있어\n\n<!-- PAGE_50 -->\n###### 상세한 노출량을 예측할 수 있는 소비자 노출평가 모델이다.  또한, 이 모델은 제품군(세부\n\n<!-- PAGE_50 -->\n###### 분류)을 선택하여 내장된 기본값 데이터베이스를 이용하거나 평가하고자 하는 제품의 기\n\n<!-- PAGE_50 -->\n###### 본 정보를 알 경우에는 직접 입력할 수 있다.  ConsExpo 모델에 내장된 제품군을 선택하면\n\n* ConsExpo 모델 : https://www.consexpoweb.nl/)\n\n<!-- PAGE_50 -->\n###### 표 1. ",
        "original_sentence": "보수적인 접근하기 위해서는 공기 교환(공기 유\n\nV2 (L)\n\nBox 2의 공간부피(분사제/펌프 스프레이: 9300 적용, 예: 욕실)5\n\nt1 (min)\n\nBox 1의 노출시간(분사제/펌프 스프레이: 2 적용)6\n\nt2 (min)\n\nBox 2의 노출시간(분사제/펌프 스프레이: 10 적용)6\n\n1 SCCS NoG 11th에서 제시하는 default 값(Rothe et al., 2011)\n\n2 SCCS NoG 11th에서 제시하는 default 값\n\n3 SCCS NoG 11th에서 제시하는 default 값(Bremmer et al, 2006)\n\n4 한국인의 노출계수 핸드북, 2019\n\n5 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007)\n\n6 SCCS NoG 11th에서 제시하는 default 값(SCCS, 옥토크릴렌(Octocrylene))\n\n- - 44 -\n<!-- PAGE_50 -->\n###### 3) ConsExpo 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_50 -->\n###### - 보다 용이한 흡입 노출평가로 ConsExpo 모델*을 사용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_325",
      "text": "ConsExpo 모델은 소비자\n\n<!-- PAGE_50 -->\n###### 용 제품 사용으로 인한 인체노출량 산정을 위해 네덜란드 보건당국(RIVM)에서 개발한 위\n\n<!-- PAGE_50 -->\n###### 해평가 시뮬레이션 모델로, 각 제품군에 대한 노출 특성에 맞게 노출경로가 설정되어 있어\n\n<!-- PAGE_50 -->\n###### 상세한 노출량을 예측할 수 있는 소비자 노출평가 모델이다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 324,
        "window_size": 3,
        "char_count": 224,
        "word_count": 46,
        "page_number": 50,
        "window_text": "흡입노출에 의한 전신노출량(SEDinh)은 다음과 같은 세가지 방법으로 산출할 수 있다.\n\n <!-- PAGE_48 -->\n###### 1) 1-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_48 -->\n###### : 전체 분무량이 즉시 공기 중으로 방출되고 특정 크기의 상자에 분포한다고 가정하여 시뮬\n\n<!-- PAGE_48 -->\n###### 레이션을 통한 호흡구역의 공기 농도에 호흡률과 공간에 머무르는 시간을 곱하여 노출량을\n\n- - 43 -\n<!-- PAGE_49 -->\n###### 2) 2-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_49 -->\n###### : 시간의 경과에 따른 물질의 희석을 고려하여 전체 분무량이 즉시 공기 중으로 방출되면\n\n<!-- PAGE_49 -->\n###### 머리 주변(box 1)에 우선적으로 분포한 후, 일정시간 이후에 특정 크기의 상자(box 2)로\n\n<!-- PAGE_49 -->\n###### 확산된다고 가정하여 호흡구역에 존재하는 대상 물질의 양, 흡입/잔류 물질 분율, 사용\n\n<!-- PAGE_49 -->\n###### 횟수를 곱하여 노출량을 산출할 수 있다.  보수적인 접근하기 위해서는 공기 교환(공기 유\n\nV2 (L)\n\nBox 2의 공간부피(분사제/펌프 스프레이: 9300 적용, 예: 욕실)5\n\nt1 (min)\n\nBox 1의 노출시간(분사제/펌프 스프레이: 2 적용)6\n\nt2 (min)\n\nBox 2의 노출시간(분사제/펌프 스프레이: 10 적용)6\n\n1 SCCS NoG 11th에서 제시하는 default 값(Rothe et al., 2011)\n\n2 SCCS NoG 11th에서 제시하는 default 값\n\n3 SCCS NoG 11th에서 제시하는 default 값(Bremmer et al, 2006)\n\n4 한국인의 노출계수 핸드북, 2019\n\n5 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007)\n\n6 SCCS NoG 11th에서 제시하는 default 값(SCCS, 옥토크릴렌(Octocrylene))\n\n- - 44 -\n<!-- PAGE_50 -->\n###### 3) ConsExpo 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_50 -->\n###### - 보다 용이한 흡입 노출평가로 ConsExpo 모델*을 사용할 수 있다.  ConsExpo 모델은 소비자\n\n<!-- PAGE_50 -->\n###### 용 제품 사용으로 인한 인체노출량 산정을 위해 네덜란드 보건당국(RIVM)에서 개발한 위\n\n<!-- PAGE_50 -->\n###### 해평가 시뮬레이션 모델로, 각 제품군에 대한 노출 특성에 맞게 노출경로가 설정되어 있어\n\n<!-- PAGE_50 -->\n###### 상세한 노출량을 예측할 수 있는 소비자 노출평가 모델이다.  또한, 이 모델은 제품군(세부\n\n<!-- PAGE_50 -->\n###### 분류)을 선택하여 내장된 기본값 데이터베이스를 이용하거나 평가하고자 하는 제품의 기\n\n<!-- PAGE_50 -->\n###### 본 정보를 알 경우에는 직접 입력할 수 있다.  ConsExpo 모델에 내장된 제품군을 선택하면\n\n* ConsExpo 모델 : https://www.consexpoweb.nl/)\n\n<!-- PAGE_50 -->\n###### 표 1.  ConsExpo 모델 내 시나리오가 내장된 화장품 제품군\n\n유아용\n\n베이비 연고, 오일, 파우더\n\n기타\n\n제모제, 에센셜 오일, 페이스 페인팅\n\n- - 45 -\n<!-- PAGE_51 -->\n###### - ConsExpo 모델을 이용한 흡입노출량을 산출방법은 다음과 같다. ",
        "original_sentence": "ConsExpo 모델은 소비자\n\n<!-- PAGE_50 -->\n###### 용 제품 사용으로 인한 인체노출량 산정을 위해 네덜란드 보건당국(RIVM)에서 개발한 위\n\n<!-- PAGE_50 -->\n###### 해평가 시뮬레이션 모델로, 각 제품군에 대한 노출 특성에 맞게 노출경로가 설정되어 있어\n\n<!-- PAGE_50 -->\n###### 상세한 노출량을 예측할 수 있는 소비자 노출평가 모델이다. "
      }
    },
    {
      "chunk_id": "chunk_326",
      "text": "또한, 이 모델은 제품군(세부\n\n<!-- PAGE_50 -->\n###### 분류)을 선택하여 내장된 기본값 데이터베이스를 이용하거나 평가하고자 하는 제품의 기\n\n<!-- PAGE_50 -->\n###### 본 정보를 알 경우에는 직접 입력할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 325,
        "window_size": 3,
        "char_count": 140,
        "word_count": 30,
        "page_number": 50,
        "window_text": "<!-- PAGE_48 -->\n###### 1) 1-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_48 -->\n###### : 전체 분무량이 즉시 공기 중으로 방출되고 특정 크기의 상자에 분포한다고 가정하여 시뮬\n\n<!-- PAGE_48 -->\n###### 레이션을 통한 호흡구역의 공기 농도에 호흡률과 공간에 머무르는 시간을 곱하여 노출량을\n\n- - 43 -\n<!-- PAGE_49 -->\n###### 2) 2-box 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_49 -->\n###### : 시간의 경과에 따른 물질의 희석을 고려하여 전체 분무량이 즉시 공기 중으로 방출되면\n\n<!-- PAGE_49 -->\n###### 머리 주변(box 1)에 우선적으로 분포한 후, 일정시간 이후에 특정 크기의 상자(box 2)로\n\n<!-- PAGE_49 -->\n###### 확산된다고 가정하여 호흡구역에 존재하는 대상 물질의 양, 흡입/잔류 물질 분율, 사용\n\n<!-- PAGE_49 -->\n###### 횟수를 곱하여 노출량을 산출할 수 있다.  보수적인 접근하기 위해서는 공기 교환(공기 유\n\nV2 (L)\n\nBox 2의 공간부피(분사제/펌프 스프레이: 9300 적용, 예: 욕실)5\n\nt1 (min)\n\nBox 1의 노출시간(분사제/펌프 스프레이: 2 적용)6\n\nt2 (min)\n\nBox 2의 노출시간(분사제/펌프 스프레이: 10 적용)6\n\n1 SCCS NoG 11th에서 제시하는 default 값(Rothe et al., 2011)\n\n2 SCCS NoG 11th에서 제시하는 default 값\n\n3 SCCS NoG 11th에서 제시하는 default 값(Bremmer et al, 2006)\n\n4 한국인의 노출계수 핸드북, 2019\n\n5 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007)\n\n6 SCCS NoG 11th에서 제시하는 default 값(SCCS, 옥토크릴렌(Octocrylene))\n\n- - 44 -\n<!-- PAGE_50 -->\n###### 3) ConsExpo 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_50 -->\n###### - 보다 용이한 흡입 노출평가로 ConsExpo 모델*을 사용할 수 있다.  ConsExpo 모델은 소비자\n\n<!-- PAGE_50 -->\n###### 용 제품 사용으로 인한 인체노출량 산정을 위해 네덜란드 보건당국(RIVM)에서 개발한 위\n\n<!-- PAGE_50 -->\n###### 해평가 시뮬레이션 모델로, 각 제품군에 대한 노출 특성에 맞게 노출경로가 설정되어 있어\n\n<!-- PAGE_50 -->\n###### 상세한 노출량을 예측할 수 있는 소비자 노출평가 모델이다.  또한, 이 모델은 제품군(세부\n\n<!-- PAGE_50 -->\n###### 분류)을 선택하여 내장된 기본값 데이터베이스를 이용하거나 평가하고자 하는 제품의 기\n\n<!-- PAGE_50 -->\n###### 본 정보를 알 경우에는 직접 입력할 수 있다.  ConsExpo 모델에 내장된 제품군을 선택하면\n\n* ConsExpo 모델 : https://www.consexpoweb.nl/)\n\n<!-- PAGE_50 -->\n###### 표 1.  ConsExpo 모델 내 시나리오가 내장된 화장품 제품군\n\n유아용\n\n베이비 연고, 오일, 파우더\n\n기타\n\n제모제, 에센셜 오일, 페이스 페인팅\n\n- - 45 -\n<!-- PAGE_51 -->\n###### - ConsExpo 모델을 이용한 흡입노출량을 산출방법은 다음과 같다.  ConsExpo 프로그램의 자\n\n<!-- PAGE_51 -->\n###### 세한 사용방법은 ConsExpo Web, Consumer exposure model documentation, 2017을 참고할\n\n<!-- PAGE_51 -->\n###### 수 있다.\n\n",
        "original_sentence": "또한, 이 모델은 제품군(세부\n\n<!-- PAGE_50 -->\n###### 분류)을 선택하여 내장된 기본값 데이터베이스를 이용하거나 평가하고자 하는 제품의 기\n\n<!-- PAGE_50 -->\n###### 본 정보를 알 경우에는 직접 입력할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_327",
      "text": "ConsExpo 모델에 내장된 제품군을 선택하면\n\n* ConsExpo 모델 : https://www.consexpoweb.nl/)\n\n<!-- PAGE_50 -->\n###### 표 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 326,
        "window_size": 3,
        "char_count": 103,
        "word_count": 16,
        "page_number": 50,
        "window_text": "보수적인 접근하기 위해서는 공기 교환(공기 유\n\nV2 (L)\n\nBox 2의 공간부피(분사제/펌프 스프레이: 9300 적용, 예: 욕실)5\n\nt1 (min)\n\nBox 1의 노출시간(분사제/펌프 스프레이: 2 적용)6\n\nt2 (min)\n\nBox 2의 노출시간(분사제/펌프 스프레이: 10 적용)6\n\n1 SCCS NoG 11th에서 제시하는 default 값(Rothe et al., 2011)\n\n2 SCCS NoG 11th에서 제시하는 default 값\n\n3 SCCS NoG 11th에서 제시하는 default 값(Bremmer et al, 2006)\n\n4 한국인의 노출계수 핸드북, 2019\n\n5 한국 욕실 부피(한국인의 노출계수 핸드북, 환경부, 2007)\n\n6 SCCS NoG 11th에서 제시하는 default 값(SCCS, 옥토크릴렌(Octocrylene))\n\n- - 44 -\n<!-- PAGE_50 -->\n###### 3) ConsExpo 모델을 기초로 한 전신노출량 산출\n\n<!-- PAGE_50 -->\n###### - 보다 용이한 흡입 노출평가로 ConsExpo 모델*을 사용할 수 있다.  ConsExpo 모델은 소비자\n\n<!-- PAGE_50 -->\n###### 용 제품 사용으로 인한 인체노출량 산정을 위해 네덜란드 보건당국(RIVM)에서 개발한 위\n\n<!-- PAGE_50 -->\n###### 해평가 시뮬레이션 모델로, 각 제품군에 대한 노출 특성에 맞게 노출경로가 설정되어 있어\n\n<!-- PAGE_50 -->\n###### 상세한 노출량을 예측할 수 있는 소비자 노출평가 모델이다.  또한, 이 모델은 제품군(세부\n\n<!-- PAGE_50 -->\n###### 분류)을 선택하여 내장된 기본값 데이터베이스를 이용하거나 평가하고자 하는 제품의 기\n\n<!-- PAGE_50 -->\n###### 본 정보를 알 경우에는 직접 입력할 수 있다.  ConsExpo 모델에 내장된 제품군을 선택하면\n\n* ConsExpo 모델 : https://www.consexpoweb.nl/)\n\n<!-- PAGE_50 -->\n###### 표 1.  ConsExpo 모델 내 시나리오가 내장된 화장품 제품군\n\n유아용\n\n베이비 연고, 오일, 파우더\n\n기타\n\n제모제, 에센셜 오일, 페이스 페인팅\n\n- - 45 -\n<!-- PAGE_51 -->\n###### - ConsExpo 모델을 이용한 흡입노출량을 산출방법은 다음과 같다.  ConsExpo 프로그램의 자\n\n<!-- PAGE_51 -->\n###### 세한 사용방법은 ConsExpo Web, Consumer exposure model documentation, 2017을 참고할\n\n<!-- PAGE_51 -->\n###### 수 있다.\n\n <!-- PAGE_51 -->\n###### ①‘Assessments’ 평가화면은 평가 개요를 제공하여, 기존 평가 내용을 가져오거나 새로운\n\n<!-- PAGE_51 -->\n###### ② ConsExpo에 내장된 노출시나리오를 이용할 경우‘fact sheet’를 이용하여 제품범주,\n\n- - 46 -\n<!-- PAGE_52 -->\n###### ③ 다음은 Fact sheet를 이용할 경우, 이용 가능한 화장품 제품군 선택 화면이다.\n\n",
        "original_sentence": "ConsExpo 모델에 내장된 제품군을 선택하면\n\n* ConsExpo 모델 : https://www.consexpoweb.nl/)\n\n<!-- PAGE_50 -->\n###### 표 1. "
      }
    },
    {
      "chunk_id": "chunk_328",
      "text": "ConsExpo 모델 내 시나리오가 내장된 화장품 제품군\n\n유아용\n\n베이비 연고, 오일, 파우더\n\n기타\n\n제모제, 에센셜 오일, 페이스 페인팅\n\n- - 45 -\n<!-- PAGE_51 -->\n###### - ConsExpo 모델을 이용한 흡입노출량을 산출방법은 다음과 같다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 327,
        "window_size": 3,
        "char_count": 154,
        "word_count": 34,
        "page_number": 51,
        "window_text": "ConsExpo 모델은 소비자\n\n<!-- PAGE_50 -->\n###### 용 제품 사용으로 인한 인체노출량 산정을 위해 네덜란드 보건당국(RIVM)에서 개발한 위\n\n<!-- PAGE_50 -->\n###### 해평가 시뮬레이션 모델로, 각 제품군에 대한 노출 특성에 맞게 노출경로가 설정되어 있어\n\n<!-- PAGE_50 -->\n###### 상세한 노출량을 예측할 수 있는 소비자 노출평가 모델이다.  또한, 이 모델은 제품군(세부\n\n<!-- PAGE_50 -->\n###### 분류)을 선택하여 내장된 기본값 데이터베이스를 이용하거나 평가하고자 하는 제품의 기\n\n<!-- PAGE_50 -->\n###### 본 정보를 알 경우에는 직접 입력할 수 있다.  ConsExpo 모델에 내장된 제품군을 선택하면\n\n* ConsExpo 모델 : https://www.consexpoweb.nl/)\n\n<!-- PAGE_50 -->\n###### 표 1.  ConsExpo 모델 내 시나리오가 내장된 화장품 제품군\n\n유아용\n\n베이비 연고, 오일, 파우더\n\n기타\n\n제모제, 에센셜 오일, 페이스 페인팅\n\n- - 45 -\n<!-- PAGE_51 -->\n###### - ConsExpo 모델을 이용한 흡입노출량을 산출방법은 다음과 같다.  ConsExpo 프로그램의 자\n\n<!-- PAGE_51 -->\n###### 세한 사용방법은 ConsExpo Web, Consumer exposure model documentation, 2017을 참고할\n\n<!-- PAGE_51 -->\n###### 수 있다.\n\n <!-- PAGE_51 -->\n###### ①‘Assessments’ 평가화면은 평가 개요를 제공하여, 기존 평가 내용을 가져오거나 새로운\n\n<!-- PAGE_51 -->\n###### ② ConsExpo에 내장된 노출시나리오를 이용할 경우‘fact sheet’를 이용하여 제품범주,\n\n- - 46 -\n<!-- PAGE_52 -->\n###### ③ 다음은 Fact sheet를 이용할 경우, 이용 가능한 화장품 제품군 선택 화면이다.\n\n <!-- PAGE_52 -->\n###### ④‘Assessment settings’에서 평가하고자 하는 성분, 제품 및 대상 인구를 선택하거나 편\n\n- - 47 -\n<!-- PAGE_53 -->\n###### ⑤ 선택한 제품에 대한 시나리오는 제품에 맞게 ‘New’를 통해 직접 입력할 수 있고, 내\n\n<!-- PAGE_53 -->\n###### 장된 시나리오 사용을 위해 ‘Use Fact sheet’를 이용할 수 있다.\n\n",
        "original_sentence": "ConsExpo 모델 내 시나리오가 내장된 화장품 제품군\n\n유아용\n\n베이비 연고, 오일, 파우더\n\n기타\n\n제모제, 에센셜 오일, 페이스 페인팅\n\n- - 45 -\n<!-- PAGE_51 -->\n###### - ConsExpo 모델을 이용한 흡입노출량을 산출방법은 다음과 같다. "
      }
    },
    {
      "chunk_id": "chunk_329",
      "text": "ConsExpo 프로그램의 자\n\n<!-- PAGE_51 -->\n###### 세한 사용방법은 ConsExpo Web, Consumer exposure model documentation, 2017을 참고할\n\n<!-- PAGE_51 -->\n###### 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 328,
        "window_size": 3,
        "char_count": 146,
        "word_count": 23,
        "page_number": 51,
        "window_text": "또한, 이 모델은 제품군(세부\n\n<!-- PAGE_50 -->\n###### 분류)을 선택하여 내장된 기본값 데이터베이스를 이용하거나 평가하고자 하는 제품의 기\n\n<!-- PAGE_50 -->\n###### 본 정보를 알 경우에는 직접 입력할 수 있다.  ConsExpo 모델에 내장된 제품군을 선택하면\n\n* ConsExpo 모델 : https://www.consexpoweb.nl/)\n\n<!-- PAGE_50 -->\n###### 표 1.  ConsExpo 모델 내 시나리오가 내장된 화장품 제품군\n\n유아용\n\n베이비 연고, 오일, 파우더\n\n기타\n\n제모제, 에센셜 오일, 페이스 페인팅\n\n- - 45 -\n<!-- PAGE_51 -->\n###### - ConsExpo 모델을 이용한 흡입노출량을 산출방법은 다음과 같다.  ConsExpo 프로그램의 자\n\n<!-- PAGE_51 -->\n###### 세한 사용방법은 ConsExpo Web, Consumer exposure model documentation, 2017을 참고할\n\n<!-- PAGE_51 -->\n###### 수 있다.\n\n <!-- PAGE_51 -->\n###### ①‘Assessments’ 평가화면은 평가 개요를 제공하여, 기존 평가 내용을 가져오거나 새로운\n\n<!-- PAGE_51 -->\n###### ② ConsExpo에 내장된 노출시나리오를 이용할 경우‘fact sheet’를 이용하여 제품범주,\n\n- - 46 -\n<!-- PAGE_52 -->\n###### ③ 다음은 Fact sheet를 이용할 경우, 이용 가능한 화장품 제품군 선택 화면이다.\n\n <!-- PAGE_52 -->\n###### ④‘Assessment settings’에서 평가하고자 하는 성분, 제품 및 대상 인구를 선택하거나 편\n\n- - 47 -\n<!-- PAGE_53 -->\n###### ⑤ 선택한 제품에 대한 시나리오는 제품에 맞게 ‘New’를 통해 직접 입력할 수 있고, 내\n\n<!-- PAGE_53 -->\n###### 장된 시나리오 사용을 위해 ‘Use Fact sheet’를 이용할 수 있다.\n\n <!-- PAGE_53 -->\n###### ⑥ 시나리오를 선택하거나, 새 시나리오를 생성하면‘Overview scenario Application’에서\n\n<!-- PAGE_53 -->\n###### 선택된 노출 시나리오의 요약을 확인할 수 있다. ",
        "original_sentence": "ConsExpo 프로그램의 자\n\n<!-- PAGE_51 -->\n###### 세한 사용방법은 ConsExpo Web, Consumer exposure model documentation, 2017을 참고할\n\n<!-- PAGE_51 -->\n###### 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_330",
      "text": "<!-- PAGE_51 -->\n###### ①‘Assessments’ 평가화면은 평가 개요를 제공하여, 기존 평가 내용을 가져오거나 새로운\n\n<!-- PAGE_51 -->\n###### ② ConsExpo에 내장된 노출시나리오를 이용할 경우‘fact sheet’를 이용하여 제품범주,\n\n- - 46 -\n<!-- PAGE_52 -->\n###### ③ 다음은 Fact sheet를 이용할 경우, 이용 가능한 화장품 제품군 선택 화면이다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 329,
        "window_size": 3,
        "char_count": 243,
        "word_count": 47,
        "page_number": 51,
        "window_text": "ConsExpo 모델에 내장된 제품군을 선택하면\n\n* ConsExpo 모델 : https://www.consexpoweb.nl/)\n\n<!-- PAGE_50 -->\n###### 표 1.  ConsExpo 모델 내 시나리오가 내장된 화장품 제품군\n\n유아용\n\n베이비 연고, 오일, 파우더\n\n기타\n\n제모제, 에센셜 오일, 페이스 페인팅\n\n- - 45 -\n<!-- PAGE_51 -->\n###### - ConsExpo 모델을 이용한 흡입노출량을 산출방법은 다음과 같다.  ConsExpo 프로그램의 자\n\n<!-- PAGE_51 -->\n###### 세한 사용방법은 ConsExpo Web, Consumer exposure model documentation, 2017을 참고할\n\n<!-- PAGE_51 -->\n###### 수 있다.\n\n <!-- PAGE_51 -->\n###### ①‘Assessments’ 평가화면은 평가 개요를 제공하여, 기존 평가 내용을 가져오거나 새로운\n\n<!-- PAGE_51 -->\n###### ② ConsExpo에 내장된 노출시나리오를 이용할 경우‘fact sheet’를 이용하여 제품범주,\n\n- - 46 -\n<!-- PAGE_52 -->\n###### ③ 다음은 Fact sheet를 이용할 경우, 이용 가능한 화장품 제품군 선택 화면이다.\n\n <!-- PAGE_52 -->\n###### ④‘Assessment settings’에서 평가하고자 하는 성분, 제품 및 대상 인구를 선택하거나 편\n\n- - 47 -\n<!-- PAGE_53 -->\n###### ⑤ 선택한 제품에 대한 시나리오는 제품에 맞게 ‘New’를 통해 직접 입력할 수 있고, 내\n\n<!-- PAGE_53 -->\n###### 장된 시나리오 사용을 위해 ‘Use Fact sheet’를 이용할 수 있다.\n\n <!-- PAGE_53 -->\n###### ⑥ 시나리오를 선택하거나, 새 시나리오를 생성하면‘Overview scenario Application’에서\n\n<!-- PAGE_53 -->\n###### 선택된 노출 시나리오의 요약을 확인할 수 있다.  시뮬레이션을 위해 어떤 노출 경로가\n\n- - 48 -\n<!-- PAGE_54 -->\n###### 5. ",
        "original_sentence": "<!-- PAGE_51 -->\n###### ①‘Assessments’ 평가화면은 평가 개요를 제공하여, 기존 평가 내용을 가져오거나 새로운\n\n<!-- PAGE_51 -->\n###### ② ConsExpo에 내장된 노출시나리오를 이용할 경우‘fact sheet’를 이용하여 제품범주,\n\n- - 46 -\n<!-- PAGE_52 -->\n###### ③ 다음은 Fact sheet를 이용할 경우, 이용 가능한 화장품 제품군 선택 화면이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_331",
      "text": "<!-- PAGE_52 -->\n###### ④‘Assessment settings’에서 평가하고자 하는 성분, 제품 및 대상 인구를 선택하거나 편\n\n- - 47 -\n<!-- PAGE_53 -->\n###### ⑤ 선택한 제품에 대한 시나리오는 제품에 맞게 ‘New’를 통해 직접 입력할 수 있고, 내\n\n<!-- PAGE_53 -->\n###### 장된 시나리오 사용을 위해 ‘Use Fact sheet’를 이용할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 330,
        "window_size": 3,
        "char_count": 236,
        "word_count": 51,
        "page_number": 52,
        "window_text": "ConsExpo 모델 내 시나리오가 내장된 화장품 제품군\n\n유아용\n\n베이비 연고, 오일, 파우더\n\n기타\n\n제모제, 에센셜 오일, 페이스 페인팅\n\n- - 45 -\n<!-- PAGE_51 -->\n###### - ConsExpo 모델을 이용한 흡입노출량을 산출방법은 다음과 같다.  ConsExpo 프로그램의 자\n\n<!-- PAGE_51 -->\n###### 세한 사용방법은 ConsExpo Web, Consumer exposure model documentation, 2017을 참고할\n\n<!-- PAGE_51 -->\n###### 수 있다.\n\n <!-- PAGE_51 -->\n###### ①‘Assessments’ 평가화면은 평가 개요를 제공하여, 기존 평가 내용을 가져오거나 새로운\n\n<!-- PAGE_51 -->\n###### ② ConsExpo에 내장된 노출시나리오를 이용할 경우‘fact sheet’를 이용하여 제품범주,\n\n- - 46 -\n<!-- PAGE_52 -->\n###### ③ 다음은 Fact sheet를 이용할 경우, 이용 가능한 화장품 제품군 선택 화면이다.\n\n <!-- PAGE_52 -->\n###### ④‘Assessment settings’에서 평가하고자 하는 성분, 제품 및 대상 인구를 선택하거나 편\n\n- - 47 -\n<!-- PAGE_53 -->\n###### ⑤ 선택한 제품에 대한 시나리오는 제품에 맞게 ‘New’를 통해 직접 입력할 수 있고, 내\n\n<!-- PAGE_53 -->\n###### 장된 시나리오 사용을 위해 ‘Use Fact sheet’를 이용할 수 있다.\n\n <!-- PAGE_53 -->\n###### ⑥ 시나리오를 선택하거나, 새 시나리오를 생성하면‘Overview scenario Application’에서\n\n<!-- PAGE_53 -->\n###### 선택된 노출 시나리오의 요약을 확인할 수 있다.  시뮬레이션을 위해 어떤 노출 경로가\n\n- - 48 -\n<!-- PAGE_54 -->\n###### 5.  ConsExpo 모델에서 적용되는 시나리오를 기반으로 노출평가에 필요한 정보는 다음 표 1과\n\n<!-- PAGE_54 -->\n###### 같다. ",
        "original_sentence": "<!-- PAGE_52 -->\n###### ④‘Assessment settings’에서 평가하고자 하는 성분, 제품 및 대상 인구를 선택하거나 편\n\n- - 47 -\n<!-- PAGE_53 -->\n###### ⑤ 선택한 제품에 대한 시나리오는 제품에 맞게 ‘New’를 통해 직접 입력할 수 있고, 내\n\n<!-- PAGE_53 -->\n###### 장된 시나리오 사용을 위해 ‘Use Fact sheet’를 이용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_332",
      "text": "<!-- PAGE_53 -->\n###### ⑥ 시나리오를 선택하거나, 새 시나리오를 생성하면‘Overview scenario Application’에서\n\n<!-- PAGE_53 -->\n###### 선택된 노출 시나리오의 요약을 확인할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 331,
        "window_size": 3,
        "char_count": 137,
        "word_count": 23,
        "page_number": 53,
        "window_text": "ConsExpo 프로그램의 자\n\n<!-- PAGE_51 -->\n###### 세한 사용방법은 ConsExpo Web, Consumer exposure model documentation, 2017을 참고할\n\n<!-- PAGE_51 -->\n###### 수 있다.\n\n <!-- PAGE_51 -->\n###### ①‘Assessments’ 평가화면은 평가 개요를 제공하여, 기존 평가 내용을 가져오거나 새로운\n\n<!-- PAGE_51 -->\n###### ② ConsExpo에 내장된 노출시나리오를 이용할 경우‘fact sheet’를 이용하여 제품범주,\n\n- - 46 -\n<!-- PAGE_52 -->\n###### ③ 다음은 Fact sheet를 이용할 경우, 이용 가능한 화장품 제품군 선택 화면이다.\n\n <!-- PAGE_52 -->\n###### ④‘Assessment settings’에서 평가하고자 하는 성분, 제품 및 대상 인구를 선택하거나 편\n\n- - 47 -\n<!-- PAGE_53 -->\n###### ⑤ 선택한 제품에 대한 시나리오는 제품에 맞게 ‘New’를 통해 직접 입력할 수 있고, 내\n\n<!-- PAGE_53 -->\n###### 장된 시나리오 사용을 위해 ‘Use Fact sheet’를 이용할 수 있다.\n\n <!-- PAGE_53 -->\n###### ⑥ 시나리오를 선택하거나, 새 시나리오를 생성하면‘Overview scenario Application’에서\n\n<!-- PAGE_53 -->\n###### 선택된 노출 시나리오의 요약을 확인할 수 있다.  시뮬레이션을 위해 어떤 노출 경로가\n\n- - 48 -\n<!-- PAGE_54 -->\n###### 5.  ConsExpo 모델에서 적용되는 시나리오를 기반으로 노출평가에 필요한 정보는 다음 표 1과\n\n<!-- PAGE_54 -->\n###### 같다.  해당 정보가 없는 경우, 모델에 내장된 기본값을 이용할 수 있다.\n\n",
        "original_sentence": "<!-- PAGE_53 -->\n###### ⑥ 시나리오를 선택하거나, 새 시나리오를 생성하면‘Overview scenario Application’에서\n\n<!-- PAGE_53 -->\n###### 선택된 노출 시나리오의 요약을 확인할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_333",
      "text": "시뮬레이션을 위해 어떤 노출 경로가\n\n- - 48 -\n<!-- PAGE_54 -->\n###### 5. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 332,
        "window_size": 3,
        "char_count": 57,
        "word_count": 14,
        "page_number": 54,
        "window_text": "<!-- PAGE_51 -->\n###### ①‘Assessments’ 평가화면은 평가 개요를 제공하여, 기존 평가 내용을 가져오거나 새로운\n\n<!-- PAGE_51 -->\n###### ② ConsExpo에 내장된 노출시나리오를 이용할 경우‘fact sheet’를 이용하여 제품범주,\n\n- - 46 -\n<!-- PAGE_52 -->\n###### ③ 다음은 Fact sheet를 이용할 경우, 이용 가능한 화장품 제품군 선택 화면이다.\n\n <!-- PAGE_52 -->\n###### ④‘Assessment settings’에서 평가하고자 하는 성분, 제품 및 대상 인구를 선택하거나 편\n\n- - 47 -\n<!-- PAGE_53 -->\n###### ⑤ 선택한 제품에 대한 시나리오는 제품에 맞게 ‘New’를 통해 직접 입력할 수 있고, 내\n\n<!-- PAGE_53 -->\n###### 장된 시나리오 사용을 위해 ‘Use Fact sheet’를 이용할 수 있다.\n\n <!-- PAGE_53 -->\n###### ⑥ 시나리오를 선택하거나, 새 시나리오를 생성하면‘Overview scenario Application’에서\n\n<!-- PAGE_53 -->\n###### 선택된 노출 시나리오의 요약을 확인할 수 있다.  시뮬레이션을 위해 어떤 노출 경로가\n\n- - 48 -\n<!-- PAGE_54 -->\n###### 5.  ConsExpo 모델에서 적용되는 시나리오를 기반으로 노출평가에 필요한 정보는 다음 표 1과\n\n<!-- PAGE_54 -->\n###### 같다.  해당 정보가 없는 경우, 모델에 내장된 기본값을 이용할 수 있다.\n\n <!-- PAGE_54 -->\n###### - 화장품 제품에 따라 적용되는 시나리오 및 변수에 대한 설명은 Cosmetics Fact Sheet에서\n\n<!-- PAGE_54 -->\n###### 확인할 수 있음\n\n<!-- PAGE_54 -->\n###### 표 2. ",
        "original_sentence": "시뮬레이션을 위해 어떤 노출 경로가\n\n- - 48 -\n<!-- PAGE_54 -->\n###### 5. "
      }
    },
    {
      "chunk_id": "chunk_334",
      "text": "ConsExpo 모델에서 적용되는 시나리오를 기반으로 노출평가에 필요한 정보는 다음 표 1과\n\n<!-- PAGE_54 -->\n###### 같다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 333,
        "window_size": 3,
        "char_count": 81,
        "word_count": 16,
        "page_number": 54,
        "window_text": "<!-- PAGE_52 -->\n###### ④‘Assessment settings’에서 평가하고자 하는 성분, 제품 및 대상 인구를 선택하거나 편\n\n- - 47 -\n<!-- PAGE_53 -->\n###### ⑤ 선택한 제품에 대한 시나리오는 제품에 맞게 ‘New’를 통해 직접 입력할 수 있고, 내\n\n<!-- PAGE_53 -->\n###### 장된 시나리오 사용을 위해 ‘Use Fact sheet’를 이용할 수 있다.\n\n <!-- PAGE_53 -->\n###### ⑥ 시나리오를 선택하거나, 새 시나리오를 생성하면‘Overview scenario Application’에서\n\n<!-- PAGE_53 -->\n###### 선택된 노출 시나리오의 요약을 확인할 수 있다.  시뮬레이션을 위해 어떤 노출 경로가\n\n- - 48 -\n<!-- PAGE_54 -->\n###### 5.  ConsExpo 모델에서 적용되는 시나리오를 기반으로 노출평가에 필요한 정보는 다음 표 1과\n\n<!-- PAGE_54 -->\n###### 같다.  해당 정보가 없는 경우, 모델에 내장된 기본값을 이용할 수 있다.\n\n <!-- PAGE_54 -->\n###### - 화장품 제품에 따라 적용되는 시나리오 및 변수에 대한 설명은 Cosmetics Fact Sheet에서\n\n<!-- PAGE_54 -->\n###### 확인할 수 있음\n\n<!-- PAGE_54 -->\n###### 표 2.  화장품 노출평가를 위한 ConsExpo 모델 구동에 적용되는 정보\n\n밀도(g/cm3)\n\n비휘발성 물질의 밀도\n\n입자분포(㎛)\n\n분사된 직후의 입자의 질 량 분포\n\n흡입 cut-off 직경(㎛)\n\n해당 물질이 폐포까지 도달할 수 있는 입자\n\n직경\n\n경피\n\n피부 접촉 면적(cm2)\n\n해당 제품이 피부에 노출되는 면적\n\n경구\n\n섭취량(g)\n\n제품의 총 섭취량\n\n(Cosmetics Fact Sheet, ConsExpo4,)\n\n- - 49 -\n<!-- PAGE_55 -->\n###### 붙임 8. ",
        "original_sentence": "ConsExpo 모델에서 적용되는 시나리오를 기반으로 노출평가에 필요한 정보는 다음 표 1과\n\n<!-- PAGE_54 -->\n###### 같다. "
      }
    },
    {
      "chunk_id": "chunk_335",
      "text": "해당 정보가 없는 경우, 모델에 내장된 기본값을 이용할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 334,
        "window_size": 3,
        "char_count": 38,
        "word_count": 10,
        "page_number": 2,
        "window_text": "<!-- PAGE_53 -->\n###### ⑥ 시나리오를 선택하거나, 새 시나리오를 생성하면‘Overview scenario Application’에서\n\n<!-- PAGE_53 -->\n###### 선택된 노출 시나리오의 요약을 확인할 수 있다.  시뮬레이션을 위해 어떤 노출 경로가\n\n- - 48 -\n<!-- PAGE_54 -->\n###### 5.  ConsExpo 모델에서 적용되는 시나리오를 기반으로 노출평가에 필요한 정보는 다음 표 1과\n\n<!-- PAGE_54 -->\n###### 같다.  해당 정보가 없는 경우, 모델에 내장된 기본값을 이용할 수 있다.\n\n <!-- PAGE_54 -->\n###### - 화장품 제품에 따라 적용되는 시나리오 및 변수에 대한 설명은 Cosmetics Fact Sheet에서\n\n<!-- PAGE_54 -->\n###### 확인할 수 있음\n\n<!-- PAGE_54 -->\n###### 표 2.  화장품 노출평가를 위한 ConsExpo 모델 구동에 적용되는 정보\n\n밀도(g/cm3)\n\n비휘발성 물질의 밀도\n\n입자분포(㎛)\n\n분사된 직후의 입자의 질 량 분포\n\n흡입 cut-off 직경(㎛)\n\n해당 물질이 폐포까지 도달할 수 있는 입자\n\n직경\n\n경피\n\n피부 접촉 면적(cm2)\n\n해당 제품이 피부에 노출되는 면적\n\n경구\n\n섭취량(g)\n\n제품의 총 섭취량\n\n(Cosmetics Fact Sheet, ConsExpo4,)\n\n- - 49 -\n<!-- PAGE_55 -->\n###### 붙임 8.  피부감작성 평가(Quantitative risk assessment, QRA) 및 예시\n\n<!-- PAGE_55 -->\n###### 1. ",
        "original_sentence": "해당 정보가 없는 경우, 모델에 내장된 기본값을 이용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_336",
      "text": "<!-- PAGE_54 -->\n###### - 화장품 제품에 따라 적용되는 시나리오 및 변수에 대한 설명은 Cosmetics Fact Sheet에서\n\n<!-- PAGE_54 -->\n###### 확인할 수 있음\n\n<!-- PAGE_54 -->\n###### 표 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 335,
        "window_size": 3,
        "char_count": 147,
        "word_count": 30,
        "page_number": 54,
        "window_text": "시뮬레이션을 위해 어떤 노출 경로가\n\n- - 48 -\n<!-- PAGE_54 -->\n###### 5.  ConsExpo 모델에서 적용되는 시나리오를 기반으로 노출평가에 필요한 정보는 다음 표 1과\n\n<!-- PAGE_54 -->\n###### 같다.  해당 정보가 없는 경우, 모델에 내장된 기본값을 이용할 수 있다.\n\n <!-- PAGE_54 -->\n###### - 화장품 제품에 따라 적용되는 시나리오 및 변수에 대한 설명은 Cosmetics Fact Sheet에서\n\n<!-- PAGE_54 -->\n###### 확인할 수 있음\n\n<!-- PAGE_54 -->\n###### 표 2.  화장품 노출평가를 위한 ConsExpo 모델 구동에 적용되는 정보\n\n밀도(g/cm3)\n\n비휘발성 물질의 밀도\n\n입자분포(㎛)\n\n분사된 직후의 입자의 질 량 분포\n\n흡입 cut-off 직경(㎛)\n\n해당 물질이 폐포까지 도달할 수 있는 입자\n\n직경\n\n경피\n\n피부 접촉 면적(cm2)\n\n해당 제품이 피부에 노출되는 면적\n\n경구\n\n섭취량(g)\n\n제품의 총 섭취량\n\n(Cosmetics Fact Sheet, ConsExpo4,)\n\n- - 49 -\n<!-- PAGE_55 -->\n###### 붙임 8.  피부감작성 평가(Quantitative risk assessment, QRA) 및 예시\n\n<!-- PAGE_55 -->\n###### 1.  향료물질 피부감작성 평가의 경우, 허용 노출량(acceptable exposure level, AEL)과 소비자\n\n<!-- PAGE_55 -->\n###### 노출량(consumer exposure level, CEL)을 비교하여 정량적 위해평가(quantitative risk\n\n<!-- PAGE_55 -->\n###### assessment, QRA)로 수행할 수 있으며, AEL이 CEL보다 크거나 같은 경우에 허용 가능한 위\n\n<!-- PAGE_55 -->\n###### 해로 판단할 수 있다. ",
        "original_sentence": "<!-- PAGE_54 -->\n###### - 화장품 제품에 따라 적용되는 시나리오 및 변수에 대한 설명은 Cosmetics Fact Sheet에서\n\n<!-- PAGE_54 -->\n###### 확인할 수 있음\n\n<!-- PAGE_54 -->\n###### 표 2. "
      }
    },
    {
      "chunk_id": "chunk_337",
      "text": "화장품 노출평가를 위한 ConsExpo 모델 구동에 적용되는 정보\n\n밀도(g/cm3)\n\n비휘발성 물질의 밀도\n\n입자분포(㎛)\n\n분사된 직후의 입자의 질 량 분포\n\n흡입 cut-off 직경(㎛)\n\n해당 물질이 폐포까지 도달할 수 있는 입자\n\n직경\n\n경피\n\n피부 접촉 면적(cm2)\n\n해당 제품이 피부에 노출되는 면적\n\n경구\n\n섭취량(g)\n\n제품의 총 섭취량\n\n(Cosmetics Fact Sheet, ConsExpo4,)\n\n- - 49 -\n<!-- PAGE_55 -->\n###### 붙임 8. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 336,
        "window_size": 3,
        "char_count": 275,
        "word_count": 58,
        "page_number": 55,
        "window_text": "ConsExpo 모델에서 적용되는 시나리오를 기반으로 노출평가에 필요한 정보는 다음 표 1과\n\n<!-- PAGE_54 -->\n###### 같다.  해당 정보가 없는 경우, 모델에 내장된 기본값을 이용할 수 있다.\n\n <!-- PAGE_54 -->\n###### - 화장품 제품에 따라 적용되는 시나리오 및 변수에 대한 설명은 Cosmetics Fact Sheet에서\n\n<!-- PAGE_54 -->\n###### 확인할 수 있음\n\n<!-- PAGE_54 -->\n###### 표 2.  화장품 노출평가를 위한 ConsExpo 모델 구동에 적용되는 정보\n\n밀도(g/cm3)\n\n비휘발성 물질의 밀도\n\n입자분포(㎛)\n\n분사된 직후의 입자의 질 량 분포\n\n흡입 cut-off 직경(㎛)\n\n해당 물질이 폐포까지 도달할 수 있는 입자\n\n직경\n\n경피\n\n피부 접촉 면적(cm2)\n\n해당 제품이 피부에 노출되는 면적\n\n경구\n\n섭취량(g)\n\n제품의 총 섭취량\n\n(Cosmetics Fact Sheet, ConsExpo4,)\n\n- - 49 -\n<!-- PAGE_55 -->\n###### 붙임 8.  피부감작성 평가(Quantitative risk assessment, QRA) 및 예시\n\n<!-- PAGE_55 -->\n###### 1.  향료물질 피부감작성 평가의 경우, 허용 노출량(acceptable exposure level, AEL)과 소비자\n\n<!-- PAGE_55 -->\n###### 노출량(consumer exposure level, CEL)을 비교하여 정량적 위해평가(quantitative risk\n\n<!-- PAGE_55 -->\n###### assessment, QRA)로 수행할 수 있으며, AEL이 CEL보다 크거나 같은 경우에 허용 가능한 위\n\n<!-- PAGE_55 -->\n###### 해로 판단할 수 있다.  피부 감작성 평가 예시는 아래와 같다.\n\n",
        "original_sentence": "화장품 노출평가를 위한 ConsExpo 모델 구동에 적용되는 정보\n\n밀도(g/cm3)\n\n비휘발성 물질의 밀도\n\n입자분포(㎛)\n\n분사된 직후의 입자의 질 량 분포\n\n흡입 cut-off 직경(㎛)\n\n해당 물질이 폐포까지 도달할 수 있는 입자\n\n직경\n\n경피\n\n피부 접촉 면적(cm2)\n\n해당 제품이 피부에 노출되는 면적\n\n경구\n\n섭취량(g)\n\n제품의 총 섭취량\n\n(Cosmetics Fact Sheet, ConsExpo4,)\n\n- - 49 -\n<!-- PAGE_55 -->\n###### 붙임 8. "
      }
    },
    {
      "chunk_id": "chunk_338",
      "text": "피부감작성 평가(Quantitative risk assessment, QRA) 및 예시\n\n<!-- PAGE_55 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 337,
        "window_size": 3,
        "char_count": 77,
        "word_count": 12,
        "page_number": 55,
        "window_text": "해당 정보가 없는 경우, 모델에 내장된 기본값을 이용할 수 있다.\n\n <!-- PAGE_54 -->\n###### - 화장품 제품에 따라 적용되는 시나리오 및 변수에 대한 설명은 Cosmetics Fact Sheet에서\n\n<!-- PAGE_54 -->\n###### 확인할 수 있음\n\n<!-- PAGE_54 -->\n###### 표 2.  화장품 노출평가를 위한 ConsExpo 모델 구동에 적용되는 정보\n\n밀도(g/cm3)\n\n비휘발성 물질의 밀도\n\n입자분포(㎛)\n\n분사된 직후의 입자의 질 량 분포\n\n흡입 cut-off 직경(㎛)\n\n해당 물질이 폐포까지 도달할 수 있는 입자\n\n직경\n\n경피\n\n피부 접촉 면적(cm2)\n\n해당 제품이 피부에 노출되는 면적\n\n경구\n\n섭취량(g)\n\n제품의 총 섭취량\n\n(Cosmetics Fact Sheet, ConsExpo4,)\n\n- - 49 -\n<!-- PAGE_55 -->\n###### 붙임 8.  피부감작성 평가(Quantitative risk assessment, QRA) 및 예시\n\n<!-- PAGE_55 -->\n###### 1.  향료물질 피부감작성 평가의 경우, 허용 노출량(acceptable exposure level, AEL)과 소비자\n\n<!-- PAGE_55 -->\n###### 노출량(consumer exposure level, CEL)을 비교하여 정량적 위해평가(quantitative risk\n\n<!-- PAGE_55 -->\n###### assessment, QRA)로 수행할 수 있으며, AEL이 CEL보다 크거나 같은 경우에 허용 가능한 위\n\n<!-- PAGE_55 -->\n###### 해로 판단할 수 있다.  피부 감작성 평가 예시는 아래와 같다.\n\n <!-- PAGE_55 -->\n###### 2. ",
        "original_sentence": "피부감작성 평가(Quantitative risk assessment, QRA) 및 예시\n\n<!-- PAGE_55 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_339",
      "text": "향료물질 피부감작성 평가의 경우, 허용 노출량(acceptable exposure level, AEL)과 소비자\n\n<!-- PAGE_55 -->\n###### 노출량(consumer exposure level, CEL)을 비교하여 정량적 위해평가(quantitative risk\n\n<!-- PAGE_55 -->\n###### assessment, QRA)로 수행할 수 있으며, AEL이 CEL보다 크거나 같은 경우에 허용 가능한 위\n\n<!-- PAGE_55 -->\n###### 해로 판단할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 338,
        "window_size": 3,
        "char_count": 278,
        "word_count": 47,
        "page_number": 55,
        "window_text": "<!-- PAGE_54 -->\n###### - 화장품 제품에 따라 적용되는 시나리오 및 변수에 대한 설명은 Cosmetics Fact Sheet에서\n\n<!-- PAGE_54 -->\n###### 확인할 수 있음\n\n<!-- PAGE_54 -->\n###### 표 2.  화장품 노출평가를 위한 ConsExpo 모델 구동에 적용되는 정보\n\n밀도(g/cm3)\n\n비휘발성 물질의 밀도\n\n입자분포(㎛)\n\n분사된 직후의 입자의 질 량 분포\n\n흡입 cut-off 직경(㎛)\n\n해당 물질이 폐포까지 도달할 수 있는 입자\n\n직경\n\n경피\n\n피부 접촉 면적(cm2)\n\n해당 제품이 피부에 노출되는 면적\n\n경구\n\n섭취량(g)\n\n제품의 총 섭취량\n\n(Cosmetics Fact Sheet, ConsExpo4,)\n\n- - 49 -\n<!-- PAGE_55 -->\n###### 붙임 8.  피부감작성 평가(Quantitative risk assessment, QRA) 및 예시\n\n<!-- PAGE_55 -->\n###### 1.  향료물질 피부감작성 평가의 경우, 허용 노출량(acceptable exposure level, AEL)과 소비자\n\n<!-- PAGE_55 -->\n###### 노출량(consumer exposure level, CEL)을 비교하여 정량적 위해평가(quantitative risk\n\n<!-- PAGE_55 -->\n###### assessment, QRA)로 수행할 수 있으며, AEL이 CEL보다 크거나 같은 경우에 허용 가능한 위\n\n<!-- PAGE_55 -->\n###### 해로 판단할 수 있다.  피부 감작성 평가 예시는 아래와 같다.\n\n <!-- PAGE_55 -->\n###### 2.  데오도란트에 함유된 물질 C에 대한 감작성 평가\n\n<!-- PAGE_55 -->\n###### - 기니피그에서 감작성 확인됨\n\nVNR: vehicle not reported\n\n<!-- PAGE_55 -->\n###### ② 위험성 결정\n\n<!-- PAGE_55 -->\n###### - 최대무감작성유도용량(No expected sensitization induced level, NESIL) 결정\n\n**[표 시작]**\n\n| 비밀보장, 불이익보호조치, 신변보호조치 등을 통하여 보호하는 제도 | - 52.2, 104.3 및 313 μg/mL 함유 |\n| --- | --- |\n**7.5% 함유**\n| 1414 | 1400 | NA | 3876 | 1400 |\n| in vivo | 경피 | 랫드 | 1, 2, 4, 8, 12 | 액상제형 | - 로션 : 1.2±0.7% | - 29.8, 38, 54.7% |\n| 보호조치 요구 방법 | (에멀젼, 로션 제형) |\n| in vitro | 피부 | 사람 | SCCP/1171/08 | (Munro et al, | Cosmos-TTC | Cosmos/Munro/ | RIFM/Munro/Cosmos/ |\n| 50 mg/kg × 3.25 g/day × kg/1000g = 0.16 mg/day | - 100 μg/mL 함유 샴푸, 바디로션, | - 29.5, 8.98, 19.6% |\n| [ 전화 : 043-719-4866, 팩스 043-719-4850 ] | (SEURAT-1; EC, | Federated DB | Federated DB |\n| 우편(30102) 세종특별자치시 도움5로 정부세종청사 7동 | NOAEL | = | 450 |\n| in vitro | 경피 | 사람 | 6 | 7.5% 함유 | 1996) | MOS | = | 2009) | (Yang et al,, 2017) | = 814 | (Patel et al., 2020) |\n| SED | NOAEL | = | 10 | 페이셜 크림 제형 | 1.1×10-7 mg/kg bw/day |\n| 국민권익위원회 공익보호지원과 / 전화 044-200-7773 / 팩스 044-200-7949 | - 1.6~9.3% |\n| LCR = | MOS | = | = | SED | 0.5525 | (에멀젼, 바세린 제형) | = 4762 | = 3.8 × 10-8 |\n| HT25/0.25 | 0.71 mg/kg bw/day / 0.25 | SED | 0.0021 |\n| 【공직자 부조리 및 공익신고안내】     ** 신고자 및 신고내용은 보호됩니다. ",
        "original_sentence": "향료물질 피부감작성 평가의 경우, 허용 노출량(acceptable exposure level, AEL)과 소비자\n\n<!-- PAGE_55 -->\n###### 노출량(consumer exposure level, CEL)을 비교하여 정량적 위해평가(quantitative risk\n\n<!-- PAGE_55 -->\n###### assessment, QRA)로 수행할 수 있으며, AEL이 CEL보다 크거나 같은 경우에 허용 가능한 위\n\n<!-- PAGE_55 -->\n###### 해로 판단할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_340",
      "text": "피부 감작성 평가 예시는 아래와 같다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 339,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 2,
        "window_text": "화장품 노출평가를 위한 ConsExpo 모델 구동에 적용되는 정보\n\n밀도(g/cm3)\n\n비휘발성 물질의 밀도\n\n입자분포(㎛)\n\n분사된 직후의 입자의 질 량 분포\n\n흡입 cut-off 직경(㎛)\n\n해당 물질이 폐포까지 도달할 수 있는 입자\n\n직경\n\n경피\n\n피부 접촉 면적(cm2)\n\n해당 제품이 피부에 노출되는 면적\n\n경구\n\n섭취량(g)\n\n제품의 총 섭취량\n\n(Cosmetics Fact Sheet, ConsExpo4,)\n\n- - 49 -\n<!-- PAGE_55 -->\n###### 붙임 8.  피부감작성 평가(Quantitative risk assessment, QRA) 및 예시\n\n<!-- PAGE_55 -->\n###### 1.  향료물질 피부감작성 평가의 경우, 허용 노출량(acceptable exposure level, AEL)과 소비자\n\n<!-- PAGE_55 -->\n###### 노출량(consumer exposure level, CEL)을 비교하여 정량적 위해평가(quantitative risk\n\n<!-- PAGE_55 -->\n###### assessment, QRA)로 수행할 수 있으며, AEL이 CEL보다 크거나 같은 경우에 허용 가능한 위\n\n<!-- PAGE_55 -->\n###### 해로 판단할 수 있다.  피부 감작성 평가 예시는 아래와 같다.\n\n <!-- PAGE_55 -->\n###### 2.  데오도란트에 함유된 물질 C에 대한 감작성 평가\n\n<!-- PAGE_55 -->\n###### - 기니피그에서 감작성 확인됨\n\nVNR: vehicle not reported\n\n<!-- PAGE_55 -->\n###### ② 위험성 결정\n\n<!-- PAGE_55 -->\n###### - 최대무감작성유도용량(No expected sensitization induced level, NESIL) 결정\n\n**[표 시작]**\n\n| 비밀보장, 불이익보호조치, 신변보호조치 등을 통하여 보호하는 제도 | - 52.2, 104.3 및 313 μg/mL 함유 |\n| --- | --- |\n**7.5% 함유**\n| 1414 | 1400 | NA | 3876 | 1400 |\n| in vivo | 경피 | 랫드 | 1, 2, 4, 8, 12 | 액상제형 | - 로션 : 1.2±0.7% | - 29.8, 38, 54.7% |\n| 보호조치 요구 방법 | (에멀젼, 로션 제형) |\n| in vitro | 피부 | 사람 | SCCP/1171/08 | (Munro et al, | Cosmos-TTC | Cosmos/Munro/ | RIFM/Munro/Cosmos/ |\n| 50 mg/kg × 3.25 g/day × kg/1000g = 0.16 mg/day | - 100 μg/mL 함유 샴푸, 바디로션, | - 29.5, 8.98, 19.6% |\n| [ 전화 : 043-719-4866, 팩스 043-719-4850 ] | (SEURAT-1; EC, | Federated DB | Federated DB |\n| 우편(30102) 세종특별자치시 도움5로 정부세종청사 7동 | NOAEL | = | 450 |\n| in vitro | 경피 | 사람 | 6 | 7.5% 함유 | 1996) | MOS | = | 2009) | (Yang et al,, 2017) | = 814 | (Patel et al., 2020) |\n| SED | NOAEL | = | 10 | 페이셜 크림 제형 | 1.1×10-7 mg/kg bw/day |\n| 국민권익위원회 공익보호지원과 / 전화 044-200-7773 / 팩스 044-200-7949 | - 1.6~9.3% |\n| LCR = | MOS | = | = | SED | 0.5525 | (에멀젼, 바세린 제형) | = 4762 | = 3.8 × 10-8 |\n| HT25/0.25 | 0.71 mg/kg bw/day / 0.25 | SED | 0.0021 |\n| 【공직자 부조리 및 공익신고안내】     ** 신고자 및 신고내용은 보호됩니다.  | 7.5% 함유 |\n| in vitro | 표피 | 사람 | 8 | - 7~16% |\n**(로션 제형)**\n**7.5% 함유**\n| in vitro | 경피 | 사람 | 18 | (에멀젼 제형) | - 10% |\n**BMDL10 (또는 T25)**\n**1400 ㎍/cm2**\n| WoE NESIL | 노출안전역(MOE) | = |\n| AEL  = | 1) 피부흡수율 = 평균 + (2 × 표준편차) | = |\n\n**[표 끝]**\n\n<!-- PAGE_55 -->\n###### - 허용 노출량(acceptable exposure level, AEL) 산출\n\n<!-- PAGE_55 -->\n###### - AEL을 도출하기 위해 개인간 민감도, 제품 구성 성분의 영향, 사용 기간, 신체 부위별 피부\n\n<!-- PAGE_55 -->\n###### 상태를 고려한 감작평가계수(Sensitisation Assessment Factors, SAF) 선택\n\n<!-- PAGE_55 -->\n###### =\n\n- 4.7 ㎍/cm2\n<!-- PAGE_55 -->\n###### SAF\n\n<!-- PAGE_55 -->\n###### 300\n\n- - 50 -\n<!-- PAGE_56 -->\n###### 표 1. ",
        "original_sentence": "피부 감작성 평가 예시는 아래와 같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_341",
      "text": "<!-- PAGE_55 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 340,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 55,
        "window_text": "피부감작성 평가(Quantitative risk assessment, QRA) 및 예시\n\n<!-- PAGE_55 -->\n###### 1.  향료물질 피부감작성 평가의 경우, 허용 노출량(acceptable exposure level, AEL)과 소비자\n\n<!-- PAGE_55 -->\n###### 노출량(consumer exposure level, CEL)을 비교하여 정량적 위해평가(quantitative risk\n\n<!-- PAGE_55 -->\n###### assessment, QRA)로 수행할 수 있으며, AEL이 CEL보다 크거나 같은 경우에 허용 가능한 위\n\n<!-- PAGE_55 -->\n###### 해로 판단할 수 있다.  피부 감작성 평가 예시는 아래와 같다.\n\n <!-- PAGE_55 -->\n###### 2.  데오도란트에 함유된 물질 C에 대한 감작성 평가\n\n<!-- PAGE_55 -->\n###### - 기니피그에서 감작성 확인됨\n\nVNR: vehicle not reported\n\n<!-- PAGE_55 -->\n###### ② 위험성 결정\n\n<!-- PAGE_55 -->\n###### - 최대무감작성유도용량(No expected sensitization induced level, NESIL) 결정\n\n**[표 시작]**\n\n| 비밀보장, 불이익보호조치, 신변보호조치 등을 통하여 보호하는 제도 | - 52.2, 104.3 및 313 μg/mL 함유 |\n| --- | --- |\n**7.5% 함유**\n| 1414 | 1400 | NA | 3876 | 1400 |\n| in vivo | 경피 | 랫드 | 1, 2, 4, 8, 12 | 액상제형 | - 로션 : 1.2±0.7% | - 29.8, 38, 54.7% |\n| 보호조치 요구 방법 | (에멀젼, 로션 제형) |\n| in vitro | 피부 | 사람 | SCCP/1171/08 | (Munro et al, | Cosmos-TTC | Cosmos/Munro/ | RIFM/Munro/Cosmos/ |\n| 50 mg/kg × 3.25 g/day × kg/1000g = 0.16 mg/day | - 100 μg/mL 함유 샴푸, 바디로션, | - 29.5, 8.98, 19.6% |\n| [ 전화 : 043-719-4866, 팩스 043-719-4850 ] | (SEURAT-1; EC, | Federated DB | Federated DB |\n| 우편(30102) 세종특별자치시 도움5로 정부세종청사 7동 | NOAEL | = | 450 |\n| in vitro | 경피 | 사람 | 6 | 7.5% 함유 | 1996) | MOS | = | 2009) | (Yang et al,, 2017) | = 814 | (Patel et al., 2020) |\n| SED | NOAEL | = | 10 | 페이셜 크림 제형 | 1.1×10-7 mg/kg bw/day |\n| 국민권익위원회 공익보호지원과 / 전화 044-200-7773 / 팩스 044-200-7949 | - 1.6~9.3% |\n| LCR = | MOS | = | = | SED | 0.5525 | (에멀젼, 바세린 제형) | = 4762 | = 3.8 × 10-8 |\n| HT25/0.25 | 0.71 mg/kg bw/day / 0.25 | SED | 0.0021 |\n| 【공직자 부조리 및 공익신고안내】     ** 신고자 및 신고내용은 보호됩니다.  | 7.5% 함유 |\n| in vitro | 표피 | 사람 | 8 | - 7~16% |\n**(로션 제형)**\n**7.5% 함유**\n| in vitro | 경피 | 사람 | 18 | (에멀젼 제형) | - 10% |\n**BMDL10 (또는 T25)**\n**1400 ㎍/cm2**\n| WoE NESIL | 노출안전역(MOE) | = |\n| AEL  = | 1) 피부흡수율 = 평균 + (2 × 표준편차) | = |\n\n**[표 끝]**\n\n<!-- PAGE_55 -->\n###### - 허용 노출량(acceptable exposure level, AEL) 산출\n\n<!-- PAGE_55 -->\n###### - AEL을 도출하기 위해 개인간 민감도, 제품 구성 성분의 영향, 사용 기간, 신체 부위별 피부\n\n<!-- PAGE_55 -->\n###### 상태를 고려한 감작평가계수(Sensitisation Assessment Factors, SAF) 선택\n\n<!-- PAGE_55 -->\n###### =\n\n- 4.7 ㎍/cm2\n<!-- PAGE_55 -->\n###### SAF\n\n<!-- PAGE_55 -->\n###### 300\n\n- - 50 -\n<!-- PAGE_56 -->\n###### 표 1.  감작평가계수(Sensitisation Assessment Factors, SAF) 적용\n\n<!-- PAGE_56 -->\n###### 표 2. ",
        "original_sentence": "<!-- PAGE_55 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_342",
      "text": "데오도란트에 함유된 물질 C에 대한 감작성 평가\n\n<!-- PAGE_55 -->\n###### - 기니피그에서 감작성 확인됨\n\nVNR: vehicle not reported\n\n<!-- PAGE_55 -->\n###### ② 위험성 결정\n\n<!-- PAGE_55 -->\n###### - 최대무감작성유도용량(No expected sensitization induced level, NESIL) 결정\n\n**[표 시작]**\n\n| 비밀보장, 불이익보호조치, 신변보호조치 등을 통하여 보호하는 제도 | - 52.2, 104.3 및 313 μg/mL 함유 |\n| --- | --- |\n**7.5% 함유**\n| 1414 | 1400 | NA | 3876 | 1400 |\n| in vivo | 경피 | 랫드 | 1, 2, 4, 8, 12 | 액상제형 | - 로션 : 1.2±0.7% | - 29.8, 38, 54.7% |\n| 보호조치 요구 방법 | (에멀젼, 로션 제형) |\n| in vitro | 피부 | 사람 | SCCP/1171/08 | (Munro et al, | Cosmos-TTC | Cosmos/Munro/ | RIFM/Munro/Cosmos/ |\n| 50 mg/kg × 3.25 g/day × kg/1000g = 0.16 mg/day | - 100 μg/mL 함유 샴푸, 바디로션, | - 29.5, 8.98, 19.6% |\n| [ 전화 : 043-719-4866, 팩스 043-719-4850 ] | (SEURAT-1; EC, | Federated DB | Federated DB |\n| 우편(30102) 세종특별자치시 도움5로 정부세종청사 7동 | NOAEL | = | 450 |\n| in vitro | 경피 | 사람 | 6 | 7.5% 함유 | 1996) | MOS | = | 2009) | (Yang et al,, 2017) | = 814 | (Patel et al., 2020) |\n| SED | NOAEL | = | 10 | 페이셜 크림 제형 | 1.1×10-7 mg/kg bw/day |\n| 국민권익위원회 공익보호지원과 / 전화 044-200-7773 / 팩스 044-200-7949 | - 1.6~9.3% |\n| LCR = | MOS | = | = | SED | 0.5525 | (에멀젼, 바세린 제형) | = 4762 | = 3.8 × 10-8 |\n| HT25/0.25 | 0.71 mg/kg bw/day / 0.25 | SED | 0.0021 |\n| 【공직자 부조리 및 공익신고안내】     ** 신고자 및 신고내용은 보호됩니다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 341,
        "window_size": 3,
        "char_count": 1256,
        "word_count": 298,
        "page_number": 55,
        "window_text": "향료물질 피부감작성 평가의 경우, 허용 노출량(acceptable exposure level, AEL)과 소비자\n\n<!-- PAGE_55 -->\n###### 노출량(consumer exposure level, CEL)을 비교하여 정량적 위해평가(quantitative risk\n\n<!-- PAGE_55 -->\n###### assessment, QRA)로 수행할 수 있으며, AEL이 CEL보다 크거나 같은 경우에 허용 가능한 위\n\n<!-- PAGE_55 -->\n###### 해로 판단할 수 있다.  피부 감작성 평가 예시는 아래와 같다.\n\n <!-- PAGE_55 -->\n###### 2.  데오도란트에 함유된 물질 C에 대한 감작성 평가\n\n<!-- PAGE_55 -->\n###### - 기니피그에서 감작성 확인됨\n\nVNR: vehicle not reported\n\n<!-- PAGE_55 -->\n###### ② 위험성 결정\n\n<!-- PAGE_55 -->\n###### - 최대무감작성유도용량(No expected sensitization induced level, NESIL) 결정\n\n**[표 시작]**\n\n| 비밀보장, 불이익보호조치, 신변보호조치 등을 통하여 보호하는 제도 | - 52.2, 104.3 및 313 μg/mL 함유 |\n| --- | --- |\n**7.5% 함유**\n| 1414 | 1400 | NA | 3876 | 1400 |\n| in vivo | 경피 | 랫드 | 1, 2, 4, 8, 12 | 액상제형 | - 로션 : 1.2±0.7% | - 29.8, 38, 54.7% |\n| 보호조치 요구 방법 | (에멀젼, 로션 제형) |\n| in vitro | 피부 | 사람 | SCCP/1171/08 | (Munro et al, | Cosmos-TTC | Cosmos/Munro/ | RIFM/Munro/Cosmos/ |\n| 50 mg/kg × 3.25 g/day × kg/1000g = 0.16 mg/day | - 100 μg/mL 함유 샴푸, 바디로션, | - 29.5, 8.98, 19.6% |\n| [ 전화 : 043-719-4866, 팩스 043-719-4850 ] | (SEURAT-1; EC, | Federated DB | Federated DB |\n| 우편(30102) 세종특별자치시 도움5로 정부세종청사 7동 | NOAEL | = | 450 |\n| in vitro | 경피 | 사람 | 6 | 7.5% 함유 | 1996) | MOS | = | 2009) | (Yang et al,, 2017) | = 814 | (Patel et al., 2020) |\n| SED | NOAEL | = | 10 | 페이셜 크림 제형 | 1.1×10-7 mg/kg bw/day |\n| 국민권익위원회 공익보호지원과 / 전화 044-200-7773 / 팩스 044-200-7949 | - 1.6~9.3% |\n| LCR = | MOS | = | = | SED | 0.5525 | (에멀젼, 바세린 제형) | = 4762 | = 3.8 × 10-8 |\n| HT25/0.25 | 0.71 mg/kg bw/day / 0.25 | SED | 0.0021 |\n| 【공직자 부조리 및 공익신고안내】     ** 신고자 및 신고내용은 보호됩니다.  | 7.5% 함유 |\n| in vitro | 표피 | 사람 | 8 | - 7~16% |\n**(로션 제형)**\n**7.5% 함유**\n| in vitro | 경피 | 사람 | 18 | (에멀젼 제형) | - 10% |\n**BMDL10 (또는 T25)**\n**1400 ㎍/cm2**\n| WoE NESIL | 노출안전역(MOE) | = |\n| AEL  = | 1) 피부흡수율 = 평균 + (2 × 표준편차) | = |\n\n**[표 끝]**\n\n<!-- PAGE_55 -->\n###### - 허용 노출량(acceptable exposure level, AEL) 산출\n\n<!-- PAGE_55 -->\n###### - AEL을 도출하기 위해 개인간 민감도, 제품 구성 성분의 영향, 사용 기간, 신체 부위별 피부\n\n<!-- PAGE_55 -->\n###### 상태를 고려한 감작평가계수(Sensitisation Assessment Factors, SAF) 선택\n\n<!-- PAGE_55 -->\n###### =\n\n- 4.7 ㎍/cm2\n<!-- PAGE_55 -->\n###### SAF\n\n<!-- PAGE_55 -->\n###### 300\n\n- - 50 -\n<!-- PAGE_56 -->\n###### 표 1.  감작평가계수(Sensitisation Assessment Factors, SAF) 적용\n\n<!-- PAGE_56 -->\n###### 표 2.  제품에 따른 SAF\n\n모든 타입의 데오도란트 및\n\n발한억제제\n\n10\n\n1\n\n3\n\n10\n\n300\n\n하이드로알코올 제품(향수 등)\n\n10\n\n1\n\n3\n\n3\n\n100\n\n바디 크림, 로션\n\n10\n\n1\n\n3\n\n10\n\n300\n\n핸드크림\n\n10\n\n1\n\n3\n\n3\n\n100\n\n얼굴크림 및 메이크업제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n메이크업리무버\n\n10\n\n1\n\n3\n\n3\n\n100\n\n입술 제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스타일링제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스프레이\n\n10\n\n1\n\n3\n\n1\n\n30\n\n샴푸\n\n10\n\n1\n\n3\n\n10\n\n300\n\n헤어컨디셔너\n\n10\n\n1\n\n3\n\n3\n\n100\n\n고체비누\n\n10\n\n1\n\n3\n\n10\n\n300\n\n액체비누\n\n10\n\n1\n\n3\n\n3\n\n100\n\n샤워젤, 목욕제품\n\n10\n\n1\n\n3\n\n10\n\n300\n\n참고 : 자외선차단제가 포함된 제품은 입술제품에 해당됨\n\n요인\n\nSAF\n\n내용\n\n개인 간\n\n10\n\n개인 간 차이 고려\n\n제품\n\n- 0.3, 1, 3\n- 0.3 : 직접 접촉하지 않는 불활성 물질\n1 : 대부분 제품\n\n3 : 실험 조건에서 예상한 것보다 더 큰 침투강화제인 경우\n\n빈도/제품사용기간\n\n1, 3\n\n제품의 장기간 사용 시 생체 축적 고려\n\n- - 51 -\n<!-- PAGE_57 -->\n###### ③ 노출평가\n\n<!-- PAGE_57 -->\n###### - 해당 유형에 따른 체표면적당 사용량(mg/cm2/day)을 고려하여 노출량(Consumer Exposure\n\n<!-- PAGE_57 -->\n###### Leve CEL, mg/cm2/day) 산출\n\nCEL = 0.03/100 × 11.65 mg/cm2 × 1000 ㎍/mg = 3.5 ㎍/cm2\n\n<!-- PAGE_57 -->\n###### - AEL/CEL이 1 이상이므로 위해 우려 가능성 낮음\n\n<!-- PAGE_57 -->\n###### ※ 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 체표면적을 고려한 사용량을 통합적\n\n<!-- PAGE_57 -->\n###### 으로 계산한 노출량을 이용할 경우, 51.67438 mg/cm2/day 사용(표3)\n\n- - 52 -\n<!-- PAGE_58 -->\n###### 표 3. ",
        "original_sentence": "데오도란트에 함유된 물질 C에 대한 감작성 평가\n\n<!-- PAGE_55 -->\n###### - 기니피그에서 감작성 확인됨\n\nVNR: vehicle not reported\n\n<!-- PAGE_55 -->\n###### ② 위험성 결정\n\n<!-- PAGE_55 -->\n###### - 최대무감작성유도용량(No expected sensitization induced level, NESIL) 결정\n\n**[표 시작]**\n\n| 비밀보장, 불이익보호조치, 신변보호조치 등을 통하여 보호하는 제도 | - 52.2, 104.3 및 313 μg/mL 함유 |\n| --- | --- |\n**7.5% 함유**\n| 1414 | 1400 | NA | 3876 | 1400 |\n| in vivo | 경피 | 랫드 | 1, 2, 4, 8, 12 | 액상제형 | - 로션 : 1.2±0.7% | - 29.8, 38, 54.7% |\n| 보호조치 요구 방법 | (에멀젼, 로션 제형) |\n| in vitro | 피부 | 사람 | SCCP/1171/08 | (Munro et al, | Cosmos-TTC | Cosmos/Munro/ | RIFM/Munro/Cosmos/ |\n| 50 mg/kg × 3.25 g/day × kg/1000g = 0.16 mg/day | - 100 μg/mL 함유 샴푸, 바디로션, | - 29.5, 8.98, 19.6% |\n| [ 전화 : 043-719-4866, 팩스 043-719-4850 ] | (SEURAT-1; EC, | Federated DB | Federated DB |\n| 우편(30102) 세종특별자치시 도움5로 정부세종청사 7동 | NOAEL | = | 450 |\n| in vitro | 경피 | 사람 | 6 | 7.5% 함유 | 1996) | MOS | = | 2009) | (Yang et al,, 2017) | = 814 | (Patel et al., 2020) |\n| SED | NOAEL | = | 10 | 페이셜 크림 제형 | 1.1×10-7 mg/kg bw/day |\n| 국민권익위원회 공익보호지원과 / 전화 044-200-7773 / 팩스 044-200-7949 | - 1.6~9.3% |\n| LCR = | MOS | = | = | SED | 0.5525 | (에멀젼, 바세린 제형) | = 4762 | = 3.8 × 10-8 |\n| HT25/0.25 | 0.71 mg/kg bw/day / 0.25 | SED | 0.0021 |\n| 【공직자 부조리 및 공익신고안내】     ** 신고자 및 신고내용은 보호됩니다. "
      }
    },
    {
      "chunk_id": "chunk_343",
      "text": "| 7.5% 함유 |\n| in vitro | 표피 | 사람 | 8 | - 7~16% |\n**(로션 제형)**\n**7.5% 함유**\n| in vitro | 경피 | 사람 | 18 | (에멀젼 제형) | - 10% |\n**BMDL10 (또는 T25)**\n**1400 ㎍/cm2**\n| WoE NESIL | 노출안전역(MOE) | = |\n| AEL  = | 1) 피부흡수율 = 평균 + (2 × 표준편차) | = |\n\n**[표 끝]**\n\n<!-- PAGE_55 -->\n###### - 허용 노출량(acceptable exposure level, AEL) 산출\n\n<!-- PAGE_55 -->\n###### - AEL을 도출하기 위해 개인간 민감도, 제품 구성 성분의 영향, 사용 기간, 신체 부위별 피부\n\n<!-- PAGE_55 -->\n###### 상태를 고려한 감작평가계수(Sensitisation Assessment Factors, SAF) 선택\n\n<!-- PAGE_55 -->\n###### =\n\n- 4.7 ㎍/cm2\n<!-- PAGE_55 -->\n###### SAF\n\n<!-- PAGE_55 -->\n###### 300\n\n- - 50 -\n<!-- PAGE_56 -->\n###### 표 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 342,
        "window_size": 3,
        "char_count": 608,
        "word_count": 136,
        "page_number": 55,
        "window_text": "피부 감작성 평가 예시는 아래와 같다.\n\n <!-- PAGE_55 -->\n###### 2.  데오도란트에 함유된 물질 C에 대한 감작성 평가\n\n<!-- PAGE_55 -->\n###### - 기니피그에서 감작성 확인됨\n\nVNR: vehicle not reported\n\n<!-- PAGE_55 -->\n###### ② 위험성 결정\n\n<!-- PAGE_55 -->\n###### - 최대무감작성유도용량(No expected sensitization induced level, NESIL) 결정\n\n**[표 시작]**\n\n| 비밀보장, 불이익보호조치, 신변보호조치 등을 통하여 보호하는 제도 | - 52.2, 104.3 및 313 μg/mL 함유 |\n| --- | --- |\n**7.5% 함유**\n| 1414 | 1400 | NA | 3876 | 1400 |\n| in vivo | 경피 | 랫드 | 1, 2, 4, 8, 12 | 액상제형 | - 로션 : 1.2±0.7% | - 29.8, 38, 54.7% |\n| 보호조치 요구 방법 | (에멀젼, 로션 제형) |\n| in vitro | 피부 | 사람 | SCCP/1171/08 | (Munro et al, | Cosmos-TTC | Cosmos/Munro/ | RIFM/Munro/Cosmos/ |\n| 50 mg/kg × 3.25 g/day × kg/1000g = 0.16 mg/day | - 100 μg/mL 함유 샴푸, 바디로션, | - 29.5, 8.98, 19.6% |\n| [ 전화 : 043-719-4866, 팩스 043-719-4850 ] | (SEURAT-1; EC, | Federated DB | Federated DB |\n| 우편(30102) 세종특별자치시 도움5로 정부세종청사 7동 | NOAEL | = | 450 |\n| in vitro | 경피 | 사람 | 6 | 7.5% 함유 | 1996) | MOS | = | 2009) | (Yang et al,, 2017) | = 814 | (Patel et al., 2020) |\n| SED | NOAEL | = | 10 | 페이셜 크림 제형 | 1.1×10-7 mg/kg bw/day |\n| 국민권익위원회 공익보호지원과 / 전화 044-200-7773 / 팩스 044-200-7949 | - 1.6~9.3% |\n| LCR = | MOS | = | = | SED | 0.5525 | (에멀젼, 바세린 제형) | = 4762 | = 3.8 × 10-8 |\n| HT25/0.25 | 0.71 mg/kg bw/day / 0.25 | SED | 0.0021 |\n| 【공직자 부조리 및 공익신고안내】     ** 신고자 및 신고내용은 보호됩니다.  | 7.5% 함유 |\n| in vitro | 표피 | 사람 | 8 | - 7~16% |\n**(로션 제형)**\n**7.5% 함유**\n| in vitro | 경피 | 사람 | 18 | (에멀젼 제형) | - 10% |\n**BMDL10 (또는 T25)**\n**1400 ㎍/cm2**\n| WoE NESIL | 노출안전역(MOE) | = |\n| AEL  = | 1) 피부흡수율 = 평균 + (2 × 표준편차) | = |\n\n**[표 끝]**\n\n<!-- PAGE_55 -->\n###### - 허용 노출량(acceptable exposure level, AEL) 산출\n\n<!-- PAGE_55 -->\n###### - AEL을 도출하기 위해 개인간 민감도, 제품 구성 성분의 영향, 사용 기간, 신체 부위별 피부\n\n<!-- PAGE_55 -->\n###### 상태를 고려한 감작평가계수(Sensitisation Assessment Factors, SAF) 선택\n\n<!-- PAGE_55 -->\n###### =\n\n- 4.7 ㎍/cm2\n<!-- PAGE_55 -->\n###### SAF\n\n<!-- PAGE_55 -->\n###### 300\n\n- - 50 -\n<!-- PAGE_56 -->\n###### 표 1.  감작평가계수(Sensitisation Assessment Factors, SAF) 적용\n\n<!-- PAGE_56 -->\n###### 표 2.  제품에 따른 SAF\n\n모든 타입의 데오도란트 및\n\n발한억제제\n\n10\n\n1\n\n3\n\n10\n\n300\n\n하이드로알코올 제품(향수 등)\n\n10\n\n1\n\n3\n\n3\n\n100\n\n바디 크림, 로션\n\n10\n\n1\n\n3\n\n10\n\n300\n\n핸드크림\n\n10\n\n1\n\n3\n\n3\n\n100\n\n얼굴크림 및 메이크업제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n메이크업리무버\n\n10\n\n1\n\n3\n\n3\n\n100\n\n입술 제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스타일링제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스프레이\n\n10\n\n1\n\n3\n\n1\n\n30\n\n샴푸\n\n10\n\n1\n\n3\n\n10\n\n300\n\n헤어컨디셔너\n\n10\n\n1\n\n3\n\n3\n\n100\n\n고체비누\n\n10\n\n1\n\n3\n\n10\n\n300\n\n액체비누\n\n10\n\n1\n\n3\n\n3\n\n100\n\n샤워젤, 목욕제품\n\n10\n\n1\n\n3\n\n10\n\n300\n\n참고 : 자외선차단제가 포함된 제품은 입술제품에 해당됨\n\n요인\n\nSAF\n\n내용\n\n개인 간\n\n10\n\n개인 간 차이 고려\n\n제품\n\n- 0.3, 1, 3\n- 0.3 : 직접 접촉하지 않는 불활성 물질\n1 : 대부분 제품\n\n3 : 실험 조건에서 예상한 것보다 더 큰 침투강화제인 경우\n\n빈도/제품사용기간\n\n1, 3\n\n제품의 장기간 사용 시 생체 축적 고려\n\n- - 51 -\n<!-- PAGE_57 -->\n###### ③ 노출평가\n\n<!-- PAGE_57 -->\n###### - 해당 유형에 따른 체표면적당 사용량(mg/cm2/day)을 고려하여 노출량(Consumer Exposure\n\n<!-- PAGE_57 -->\n###### Leve CEL, mg/cm2/day) 산출\n\nCEL = 0.03/100 × 11.65 mg/cm2 × 1000 ㎍/mg = 3.5 ㎍/cm2\n\n<!-- PAGE_57 -->\n###### - AEL/CEL이 1 이상이므로 위해 우려 가능성 낮음\n\n<!-- PAGE_57 -->\n###### ※ 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 체표면적을 고려한 사용량을 통합적\n\n<!-- PAGE_57 -->\n###### 으로 계산한 노출량을 이용할 경우, 51.67438 mg/cm2/day 사용(표3)\n\n- - 52 -\n<!-- PAGE_58 -->\n###### 표 3.  피부감작성 위해평가를 위한 화장품 통합 노출량\n\n**[표 시작]**\n\n| 적용되는 | 체표면적2 | 체표면적을 |\n| --- | --- | --- |\n| 노출유형 | 제품 | 노출량1 |\n| 선정 | (g/day) |\n**(cm2)**\n| 시험물질 | A | 시험방법 | 투여경로 | 시험대상 | 투여용량 | 무독성용량 | (mg/kg/day) |\n**참고 자료**\n**(mg/kg/day)**\n| 샤워 젤 | 0.10 | 17500 | 0.005714 |\n| 시험종 | 랫드 | 시험방법 | 투여경로 | 시험대상 | 투여용량 |\n**사용 후 씻어내지 않는**\n\n**[표 끝]**\n\n고려한 노출량\n\n(mg/cm2/day)\n\n사용 후 씻어내는 피부 및\n\n피부 및 모발 케어 제품\n\n1 2014∼2016 화장품 위해평가 선진화 연구\n\n2 체표면적 : Bremmer et al, 2005(RIVM) 자료 적용\n\n- - 53 -\n<!-- PAGE_59 -->\n###### 붙임 9. ",
        "original_sentence": "| 7.5% 함유 |\n| in vitro | 표피 | 사람 | 8 | - 7~16% |\n**(로션 제형)**\n**7.5% 함유**\n| in vitro | 경피 | 사람 | 18 | (에멀젼 제형) | - 10% |\n**BMDL10 (또는 T25)**\n**1400 ㎍/cm2**\n| WoE NESIL | 노출안전역(MOE) | = |\n| AEL  = | 1) 피부흡수율 = 평균 + (2 × 표준편차) | = |\n\n**[표 끝]**\n\n<!-- PAGE_55 -->\n###### - 허용 노출량(acceptable exposure level, AEL) 산출\n\n<!-- PAGE_55 -->\n###### - AEL을 도출하기 위해 개인간 민감도, 제품 구성 성분의 영향, 사용 기간, 신체 부위별 피부\n\n<!-- PAGE_55 -->\n###### 상태를 고려한 감작평가계수(Sensitisation Assessment Factors, SAF) 선택\n\n<!-- PAGE_55 -->\n###### =\n\n- 4.7 ㎍/cm2\n<!-- PAGE_55 -->\n###### SAF\n\n<!-- PAGE_55 -->\n###### 300\n\n- - 50 -\n<!-- PAGE_56 -->\n###### 표 1. "
      }
    },
    {
      "chunk_id": "chunk_344",
      "text": "감작평가계수(Sensitisation Assessment Factors, SAF) 적용\n\n<!-- PAGE_56 -->\n###### 표 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 343,
        "window_size": 3,
        "char_count": 79,
        "word_count": 11,
        "page_number": 56,
        "window_text": "<!-- PAGE_55 -->\n###### 2.  데오도란트에 함유된 물질 C에 대한 감작성 평가\n\n<!-- PAGE_55 -->\n###### - 기니피그에서 감작성 확인됨\n\nVNR: vehicle not reported\n\n<!-- PAGE_55 -->\n###### ② 위험성 결정\n\n<!-- PAGE_55 -->\n###### - 최대무감작성유도용량(No expected sensitization induced level, NESIL) 결정\n\n**[표 시작]**\n\n| 비밀보장, 불이익보호조치, 신변보호조치 등을 통하여 보호하는 제도 | - 52.2, 104.3 및 313 μg/mL 함유 |\n| --- | --- |\n**7.5% 함유**\n| 1414 | 1400 | NA | 3876 | 1400 |\n| in vivo | 경피 | 랫드 | 1, 2, 4, 8, 12 | 액상제형 | - 로션 : 1.2±0.7% | - 29.8, 38, 54.7% |\n| 보호조치 요구 방법 | (에멀젼, 로션 제형) |\n| in vitro | 피부 | 사람 | SCCP/1171/08 | (Munro et al, | Cosmos-TTC | Cosmos/Munro/ | RIFM/Munro/Cosmos/ |\n| 50 mg/kg × 3.25 g/day × kg/1000g = 0.16 mg/day | - 100 μg/mL 함유 샴푸, 바디로션, | - 29.5, 8.98, 19.6% |\n| [ 전화 : 043-719-4866, 팩스 043-719-4850 ] | (SEURAT-1; EC, | Federated DB | Federated DB |\n| 우편(30102) 세종특별자치시 도움5로 정부세종청사 7동 | NOAEL | = | 450 |\n| in vitro | 경피 | 사람 | 6 | 7.5% 함유 | 1996) | MOS | = | 2009) | (Yang et al,, 2017) | = 814 | (Patel et al., 2020) |\n| SED | NOAEL | = | 10 | 페이셜 크림 제형 | 1.1×10-7 mg/kg bw/day |\n| 국민권익위원회 공익보호지원과 / 전화 044-200-7773 / 팩스 044-200-7949 | - 1.6~9.3% |\n| LCR = | MOS | = | = | SED | 0.5525 | (에멀젼, 바세린 제형) | = 4762 | = 3.8 × 10-8 |\n| HT25/0.25 | 0.71 mg/kg bw/day / 0.25 | SED | 0.0021 |\n| 【공직자 부조리 및 공익신고안내】     ** 신고자 및 신고내용은 보호됩니다.  | 7.5% 함유 |\n| in vitro | 표피 | 사람 | 8 | - 7~16% |\n**(로션 제형)**\n**7.5% 함유**\n| in vitro | 경피 | 사람 | 18 | (에멀젼 제형) | - 10% |\n**BMDL10 (또는 T25)**\n**1400 ㎍/cm2**\n| WoE NESIL | 노출안전역(MOE) | = |\n| AEL  = | 1) 피부흡수율 = 평균 + (2 × 표준편차) | = |\n\n**[표 끝]**\n\n<!-- PAGE_55 -->\n###### - 허용 노출량(acceptable exposure level, AEL) 산출\n\n<!-- PAGE_55 -->\n###### - AEL을 도출하기 위해 개인간 민감도, 제품 구성 성분의 영향, 사용 기간, 신체 부위별 피부\n\n<!-- PAGE_55 -->\n###### 상태를 고려한 감작평가계수(Sensitisation Assessment Factors, SAF) 선택\n\n<!-- PAGE_55 -->\n###### =\n\n- 4.7 ㎍/cm2\n<!-- PAGE_55 -->\n###### SAF\n\n<!-- PAGE_55 -->\n###### 300\n\n- - 50 -\n<!-- PAGE_56 -->\n###### 표 1.  감작평가계수(Sensitisation Assessment Factors, SAF) 적용\n\n<!-- PAGE_56 -->\n###### 표 2.  제품에 따른 SAF\n\n모든 타입의 데오도란트 및\n\n발한억제제\n\n10\n\n1\n\n3\n\n10\n\n300\n\n하이드로알코올 제품(향수 등)\n\n10\n\n1\n\n3\n\n3\n\n100\n\n바디 크림, 로션\n\n10\n\n1\n\n3\n\n10\n\n300\n\n핸드크림\n\n10\n\n1\n\n3\n\n3\n\n100\n\n얼굴크림 및 메이크업제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n메이크업리무버\n\n10\n\n1\n\n3\n\n3\n\n100\n\n입술 제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스타일링제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스프레이\n\n10\n\n1\n\n3\n\n1\n\n30\n\n샴푸\n\n10\n\n1\n\n3\n\n10\n\n300\n\n헤어컨디셔너\n\n10\n\n1\n\n3\n\n3\n\n100\n\n고체비누\n\n10\n\n1\n\n3\n\n10\n\n300\n\n액체비누\n\n10\n\n1\n\n3\n\n3\n\n100\n\n샤워젤, 목욕제품\n\n10\n\n1\n\n3\n\n10\n\n300\n\n참고 : 자외선차단제가 포함된 제품은 입술제품에 해당됨\n\n요인\n\nSAF\n\n내용\n\n개인 간\n\n10\n\n개인 간 차이 고려\n\n제품\n\n- 0.3, 1, 3\n- 0.3 : 직접 접촉하지 않는 불활성 물질\n1 : 대부분 제품\n\n3 : 실험 조건에서 예상한 것보다 더 큰 침투강화제인 경우\n\n빈도/제품사용기간\n\n1, 3\n\n제품의 장기간 사용 시 생체 축적 고려\n\n- - 51 -\n<!-- PAGE_57 -->\n###### ③ 노출평가\n\n<!-- PAGE_57 -->\n###### - 해당 유형에 따른 체표면적당 사용량(mg/cm2/day)을 고려하여 노출량(Consumer Exposure\n\n<!-- PAGE_57 -->\n###### Leve CEL, mg/cm2/day) 산출\n\nCEL = 0.03/100 × 11.65 mg/cm2 × 1000 ㎍/mg = 3.5 ㎍/cm2\n\n<!-- PAGE_57 -->\n###### - AEL/CEL이 1 이상이므로 위해 우려 가능성 낮음\n\n<!-- PAGE_57 -->\n###### ※ 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 체표면적을 고려한 사용량을 통합적\n\n<!-- PAGE_57 -->\n###### 으로 계산한 노출량을 이용할 경우, 51.67438 mg/cm2/day 사용(표3)\n\n- - 52 -\n<!-- PAGE_58 -->\n###### 표 3.  피부감작성 위해평가를 위한 화장품 통합 노출량\n\n**[표 시작]**\n\n| 적용되는 | 체표면적2 | 체표면적을 |\n| --- | --- | --- |\n| 노출유형 | 제품 | 노출량1 |\n| 선정 | (g/day) |\n**(cm2)**\n| 시험물질 | A | 시험방법 | 투여경로 | 시험대상 | 투여용량 | 무독성용량 | (mg/kg/day) |\n**참고 자료**\n**(mg/kg/day)**\n| 샤워 젤 | 0.10 | 17500 | 0.005714 |\n| 시험종 | 랫드 | 시험방법 | 투여경로 | 시험대상 | 투여용량 |\n**사용 후 씻어내지 않는**\n\n**[표 끝]**\n\n고려한 노출량\n\n(mg/cm2/day)\n\n사용 후 씻어내는 피부 및\n\n피부 및 모발 케어 제품\n\n1 2014∼2016 화장품 위해평가 선진화 연구\n\n2 체표면적 : Bremmer et al, 2005(RIVM) 자료 적용\n\n- - 53 -\n<!-- PAGE_59 -->\n###### 붙임 9.  화장품 유형별 위해평가 예시\n\n<!-- PAGE_59 -->\n###### 1. ",
        "original_sentence": "감작평가계수(Sensitisation Assessment Factors, SAF) 적용\n\n<!-- PAGE_56 -->\n###### 표 2. "
      }
    },
    {
      "chunk_id": "chunk_345",
      "text": "제품에 따른 SAF\n\n모든 타입의 데오도란트 및\n\n발한억제제\n\n10\n\n1\n\n3\n\n10\n\n300\n\n하이드로알코올 제품(향수 등)\n\n10\n\n1\n\n3\n\n3\n\n100\n\n바디 크림, 로션\n\n10\n\n1\n\n3\n\n10\n\n300\n\n핸드크림\n\n10\n\n1\n\n3\n\n3\n\n100\n\n얼굴크림 및 메이크업제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n메이크업리무버\n\n10\n\n1\n\n3\n\n3\n\n100\n\n입술 제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스타일링제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스프레이\n\n10\n\n1\n\n3\n\n1\n\n30\n\n샴푸\n\n10\n\n1\n\n3\n\n10\n\n300\n\n헤어컨디셔너\n\n10\n\n1\n\n3\n\n3\n\n100\n\n고체비누\n\n10\n\n1\n\n3\n\n10\n\n300\n\n액체비누\n\n10\n\n1\n\n3\n\n3\n\n100\n\n샤워젤, 목욕제품\n\n10\n\n1\n\n3\n\n10\n\n300\n\n참고 : 자외선차단제가 포함된 제품은 입술제품에 해당됨\n\n요인\n\nSAF\n\n내용\n\n개인 간\n\n10\n\n개인 간 차이 고려\n\n제품\n\n- 0.3, 1, 3\n- 0.3 : 직접 접촉하지 않는 불활성 물질\n1 : 대부분 제품\n\n3 : 실험 조건에서 예상한 것보다 더 큰 침투강화제인 경우\n\n빈도/제품사용기간\n\n1, 3\n\n제품의 장기간 사용 시 생체 축적 고려\n\n- - 51 -\n<!-- PAGE_57 -->\n###### ③ 노출평가\n\n<!-- PAGE_57 -->\n###### - 해당 유형에 따른 체표면적당 사용량(mg/cm2/day)을 고려하여 노출량(Consumer Exposure\n\n<!-- PAGE_57 -->\n###### Leve CEL, mg/cm2/day) 산출\n\nCEL = 0.03/100 × 11.65 mg/cm2 × 1000 ㎍/mg = 3.5 ㎍/cm2\n\n<!-- PAGE_57 -->\n###### - AEL/CEL이 1 이상이므로 위해 우려 가능성 낮음\n\n<!-- PAGE_57 -->\n###### ※ 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 체표면적을 고려한 사용량을 통합적\n\n<!-- PAGE_57 -->\n###### 으로 계산한 노출량을 이용할 경우, 51.67438 mg/cm2/day 사용(표3)\n\n- - 52 -\n<!-- PAGE_58 -->\n###### 표 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 344,
        "window_size": 3,
        "char_count": 1081,
        "word_count": 247,
        "page_number": 57,
        "window_text": "데오도란트에 함유된 물질 C에 대한 감작성 평가\n\n<!-- PAGE_55 -->\n###### - 기니피그에서 감작성 확인됨\n\nVNR: vehicle not reported\n\n<!-- PAGE_55 -->\n###### ② 위험성 결정\n\n<!-- PAGE_55 -->\n###### - 최대무감작성유도용량(No expected sensitization induced level, NESIL) 결정\n\n**[표 시작]**\n\n| 비밀보장, 불이익보호조치, 신변보호조치 등을 통하여 보호하는 제도 | - 52.2, 104.3 및 313 μg/mL 함유 |\n| --- | --- |\n**7.5% 함유**\n| 1414 | 1400 | NA | 3876 | 1400 |\n| in vivo | 경피 | 랫드 | 1, 2, 4, 8, 12 | 액상제형 | - 로션 : 1.2±0.7% | - 29.8, 38, 54.7% |\n| 보호조치 요구 방법 | (에멀젼, 로션 제형) |\n| in vitro | 피부 | 사람 | SCCP/1171/08 | (Munro et al, | Cosmos-TTC | Cosmos/Munro/ | RIFM/Munro/Cosmos/ |\n| 50 mg/kg × 3.25 g/day × kg/1000g = 0.16 mg/day | - 100 μg/mL 함유 샴푸, 바디로션, | - 29.5, 8.98, 19.6% |\n| [ 전화 : 043-719-4866, 팩스 043-719-4850 ] | (SEURAT-1; EC, | Federated DB | Federated DB |\n| 우편(30102) 세종특별자치시 도움5로 정부세종청사 7동 | NOAEL | = | 450 |\n| in vitro | 경피 | 사람 | 6 | 7.5% 함유 | 1996) | MOS | = | 2009) | (Yang et al,, 2017) | = 814 | (Patel et al., 2020) |\n| SED | NOAEL | = | 10 | 페이셜 크림 제형 | 1.1×10-7 mg/kg bw/day |\n| 국민권익위원회 공익보호지원과 / 전화 044-200-7773 / 팩스 044-200-7949 | - 1.6~9.3% |\n| LCR = | MOS | = | = | SED | 0.5525 | (에멀젼, 바세린 제형) | = 4762 | = 3.8 × 10-8 |\n| HT25/0.25 | 0.71 mg/kg bw/day / 0.25 | SED | 0.0021 |\n| 【공직자 부조리 및 공익신고안내】     ** 신고자 및 신고내용은 보호됩니다.  | 7.5% 함유 |\n| in vitro | 표피 | 사람 | 8 | - 7~16% |\n**(로션 제형)**\n**7.5% 함유**\n| in vitro | 경피 | 사람 | 18 | (에멀젼 제형) | - 10% |\n**BMDL10 (또는 T25)**\n**1400 ㎍/cm2**\n| WoE NESIL | 노출안전역(MOE) | = |\n| AEL  = | 1) 피부흡수율 = 평균 + (2 × 표준편차) | = |\n\n**[표 끝]**\n\n<!-- PAGE_55 -->\n###### - 허용 노출량(acceptable exposure level, AEL) 산출\n\n<!-- PAGE_55 -->\n###### - AEL을 도출하기 위해 개인간 민감도, 제품 구성 성분의 영향, 사용 기간, 신체 부위별 피부\n\n<!-- PAGE_55 -->\n###### 상태를 고려한 감작평가계수(Sensitisation Assessment Factors, SAF) 선택\n\n<!-- PAGE_55 -->\n###### =\n\n- 4.7 ㎍/cm2\n<!-- PAGE_55 -->\n###### SAF\n\n<!-- PAGE_55 -->\n###### 300\n\n- - 50 -\n<!-- PAGE_56 -->\n###### 표 1.  감작평가계수(Sensitisation Assessment Factors, SAF) 적용\n\n<!-- PAGE_56 -->\n###### 표 2.  제품에 따른 SAF\n\n모든 타입의 데오도란트 및\n\n발한억제제\n\n10\n\n1\n\n3\n\n10\n\n300\n\n하이드로알코올 제품(향수 등)\n\n10\n\n1\n\n3\n\n3\n\n100\n\n바디 크림, 로션\n\n10\n\n1\n\n3\n\n10\n\n300\n\n핸드크림\n\n10\n\n1\n\n3\n\n3\n\n100\n\n얼굴크림 및 메이크업제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n메이크업리무버\n\n10\n\n1\n\n3\n\n3\n\n100\n\n입술 제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스타일링제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스프레이\n\n10\n\n1\n\n3\n\n1\n\n30\n\n샴푸\n\n10\n\n1\n\n3\n\n10\n\n300\n\n헤어컨디셔너\n\n10\n\n1\n\n3\n\n3\n\n100\n\n고체비누\n\n10\n\n1\n\n3\n\n10\n\n300\n\n액체비누\n\n10\n\n1\n\n3\n\n3\n\n100\n\n샤워젤, 목욕제품\n\n10\n\n1\n\n3\n\n10\n\n300\n\n참고 : 자외선차단제가 포함된 제품은 입술제품에 해당됨\n\n요인\n\nSAF\n\n내용\n\n개인 간\n\n10\n\n개인 간 차이 고려\n\n제품\n\n- 0.3, 1, 3\n- 0.3 : 직접 접촉하지 않는 불활성 물질\n1 : 대부분 제품\n\n3 : 실험 조건에서 예상한 것보다 더 큰 침투강화제인 경우\n\n빈도/제품사용기간\n\n1, 3\n\n제품의 장기간 사용 시 생체 축적 고려\n\n- - 51 -\n<!-- PAGE_57 -->\n###### ③ 노출평가\n\n<!-- PAGE_57 -->\n###### - 해당 유형에 따른 체표면적당 사용량(mg/cm2/day)을 고려하여 노출량(Consumer Exposure\n\n<!-- PAGE_57 -->\n###### Leve CEL, mg/cm2/day) 산출\n\nCEL = 0.03/100 × 11.65 mg/cm2 × 1000 ㎍/mg = 3.5 ㎍/cm2\n\n<!-- PAGE_57 -->\n###### - AEL/CEL이 1 이상이므로 위해 우려 가능성 낮음\n\n<!-- PAGE_57 -->\n###### ※ 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 체표면적을 고려한 사용량을 통합적\n\n<!-- PAGE_57 -->\n###### 으로 계산한 노출량을 이용할 경우, 51.67438 mg/cm2/day 사용(표3)\n\n- - 52 -\n<!-- PAGE_58 -->\n###### 표 3.  피부감작성 위해평가를 위한 화장품 통합 노출량\n\n**[표 시작]**\n\n| 적용되는 | 체표면적2 | 체표면적을 |\n| --- | --- | --- |\n| 노출유형 | 제품 | 노출량1 |\n| 선정 | (g/day) |\n**(cm2)**\n| 시험물질 | A | 시험방법 | 투여경로 | 시험대상 | 투여용량 | 무독성용량 | (mg/kg/day) |\n**참고 자료**\n**(mg/kg/day)**\n| 샤워 젤 | 0.10 | 17500 | 0.005714 |\n| 시험종 | 랫드 | 시험방법 | 투여경로 | 시험대상 | 투여용량 |\n**사용 후 씻어내지 않는**\n\n**[표 끝]**\n\n고려한 노출량\n\n(mg/cm2/day)\n\n사용 후 씻어내는 피부 및\n\n피부 및 모발 케어 제품\n\n1 2014∼2016 화장품 위해평가 선진화 연구\n\n2 체표면적 : Bremmer et al, 2005(RIVM) 자료 적용\n\n- - 53 -\n<!-- PAGE_59 -->\n###### 붙임 9.  화장품 유형별 위해평가 예시\n\n<!-- PAGE_59 -->\n###### 1.  자외선차단 성분(에칠헥실메톡시신나메이트)에 대한 위해평가\n\n<!-- PAGE_59 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_59 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_59 -->\n###### ② 피부흡수율\n\n<!-- PAGE_59 -->\n###### - 랫드를 이용한 in vivo 시험결과인 피부흡수율 2.6%를 위해평가에 적용\n\n**[표 시작]**\n\n**- 피부흡수율 : 2.6%1)**\n\n**[표 끝]**\n\n- - 54 -\n<!-- PAGE_60 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_60 -->\n###### - 체중감소 및 간무게 증가를 근거로 NOAEL 450 mg/kg/day를 독성기준값으로 선정\n\n<!-- PAGE_60 -->\n###### - 자외선차단제 중 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 전신노출량\n\n<!-- PAGE_60 -->\n###### - 에칠헥실메톡시신나메이트 함유 농도 7.5%, 1일 1회 사용, 1일 사용량 17 g/day\n\n<!-- PAGE_60 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_60 -->\n###### - 자외선차단제에 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_60 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n- - 55 -\n<!-- PAGE_61 -->\n###### 2. ",
        "original_sentence": "제품에 따른 SAF\n\n모든 타입의 데오도란트 및\n\n발한억제제\n\n10\n\n1\n\n3\n\n10\n\n300\n\n하이드로알코올 제품(향수 등)\n\n10\n\n1\n\n3\n\n3\n\n100\n\n바디 크림, 로션\n\n10\n\n1\n\n3\n\n10\n\n300\n\n핸드크림\n\n10\n\n1\n\n3\n\n3\n\n100\n\n얼굴크림 및 메이크업제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n메이크업리무버\n\n10\n\n1\n\n3\n\n3\n\n100\n\n입술 제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스타일링제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스프레이\n\n10\n\n1\n\n3\n\n1\n\n30\n\n샴푸\n\n10\n\n1\n\n3\n\n10\n\n300\n\n헤어컨디셔너\n\n10\n\n1\n\n3\n\n3\n\n100\n\n고체비누\n\n10\n\n1\n\n3\n\n10\n\n300\n\n액체비누\n\n10\n\n1\n\n3\n\n3\n\n100\n\n샤워젤, 목욕제품\n\n10\n\n1\n\n3\n\n10\n\n300\n\n참고 : 자외선차단제가 포함된 제품은 입술제품에 해당됨\n\n요인\n\nSAF\n\n내용\n\n개인 간\n\n10\n\n개인 간 차이 고려\n\n제품\n\n- 0.3, 1, 3\n- 0.3 : 직접 접촉하지 않는 불활성 물질\n1 : 대부분 제품\n\n3 : 실험 조건에서 예상한 것보다 더 큰 침투강화제인 경우\n\n빈도/제품사용기간\n\n1, 3\n\n제품의 장기간 사용 시 생체 축적 고려\n\n- - 51 -\n<!-- PAGE_57 -->\n###### ③ 노출평가\n\n<!-- PAGE_57 -->\n###### - 해당 유형에 따른 체표면적당 사용량(mg/cm2/day)을 고려하여 노출량(Consumer Exposure\n\n<!-- PAGE_57 -->\n###### Leve CEL, mg/cm2/day) 산출\n\nCEL = 0.03/100 × 11.65 mg/cm2 × 1000 ㎍/mg = 3.5 ㎍/cm2\n\n<!-- PAGE_57 -->\n###### - AEL/CEL이 1 이상이므로 위해 우려 가능성 낮음\n\n<!-- PAGE_57 -->\n###### ※ 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 체표면적을 고려한 사용량을 통합적\n\n<!-- PAGE_57 -->\n###### 으로 계산한 노출량을 이용할 경우, 51.67438 mg/cm2/day 사용(표3)\n\n- - 52 -\n<!-- PAGE_58 -->\n###### 표 3. "
      }
    },
    {
      "chunk_id": "chunk_346",
      "text": "피부감작성 위해평가를 위한 화장품 통합 노출량\n\n**[표 시작]**\n\n| 적용되는 | 체표면적2 | 체표면적을 |\n| --- | --- | --- |\n| 노출유형 | 제품 | 노출량1 |\n| 선정 | (g/day) |\n**(cm2)**\n| 시험물질 | A | 시험방법 | 투여경로 | 시험대상 | 투여용량 | 무독성용량 | (mg/kg/day) |\n**참고 자료**\n**(mg/kg/day)**\n| 샤워 젤 | 0.10 | 17500 | 0.005714 |\n| 시험종 | 랫드 | 시험방법 | 투여경로 | 시험대상 | 투여용량 |\n**사용 후 씻어내지 않는**\n\n**[표 끝]**\n\n고려한 노출량\n\n(mg/cm2/day)\n\n사용 후 씻어내는 피부 및\n\n피부 및 모발 케어 제품\n\n1 2014∼2016 화장품 위해평가 선진화 연구\n\n2 체표면적 : Bremmer et al, 2005(RIVM) 자료 적용\n\n- - 53 -\n<!-- PAGE_59 -->\n###### 붙임 9. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 345,
        "window_size": 3,
        "char_count": 490,
        "word_count": 122,
        "page_number": 59,
        "window_text": "| 7.5% 함유 |\n| in vitro | 표피 | 사람 | 8 | - 7~16% |\n**(로션 제형)**\n**7.5% 함유**\n| in vitro | 경피 | 사람 | 18 | (에멀젼 제형) | - 10% |\n**BMDL10 (또는 T25)**\n**1400 ㎍/cm2**\n| WoE NESIL | 노출안전역(MOE) | = |\n| AEL  = | 1) 피부흡수율 = 평균 + (2 × 표준편차) | = |\n\n**[표 끝]**\n\n<!-- PAGE_55 -->\n###### - 허용 노출량(acceptable exposure level, AEL) 산출\n\n<!-- PAGE_55 -->\n###### - AEL을 도출하기 위해 개인간 민감도, 제품 구성 성분의 영향, 사용 기간, 신체 부위별 피부\n\n<!-- PAGE_55 -->\n###### 상태를 고려한 감작평가계수(Sensitisation Assessment Factors, SAF) 선택\n\n<!-- PAGE_55 -->\n###### =\n\n- 4.7 ㎍/cm2\n<!-- PAGE_55 -->\n###### SAF\n\n<!-- PAGE_55 -->\n###### 300\n\n- - 50 -\n<!-- PAGE_56 -->\n###### 표 1.  감작평가계수(Sensitisation Assessment Factors, SAF) 적용\n\n<!-- PAGE_56 -->\n###### 표 2.  제품에 따른 SAF\n\n모든 타입의 데오도란트 및\n\n발한억제제\n\n10\n\n1\n\n3\n\n10\n\n300\n\n하이드로알코올 제품(향수 등)\n\n10\n\n1\n\n3\n\n3\n\n100\n\n바디 크림, 로션\n\n10\n\n1\n\n3\n\n10\n\n300\n\n핸드크림\n\n10\n\n1\n\n3\n\n3\n\n100\n\n얼굴크림 및 메이크업제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n메이크업리무버\n\n10\n\n1\n\n3\n\n3\n\n100\n\n입술 제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스타일링제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스프레이\n\n10\n\n1\n\n3\n\n1\n\n30\n\n샴푸\n\n10\n\n1\n\n3\n\n10\n\n300\n\n헤어컨디셔너\n\n10\n\n1\n\n3\n\n3\n\n100\n\n고체비누\n\n10\n\n1\n\n3\n\n10\n\n300\n\n액체비누\n\n10\n\n1\n\n3\n\n3\n\n100\n\n샤워젤, 목욕제품\n\n10\n\n1\n\n3\n\n10\n\n300\n\n참고 : 자외선차단제가 포함된 제품은 입술제품에 해당됨\n\n요인\n\nSAF\n\n내용\n\n개인 간\n\n10\n\n개인 간 차이 고려\n\n제품\n\n- 0.3, 1, 3\n- 0.3 : 직접 접촉하지 않는 불활성 물질\n1 : 대부분 제품\n\n3 : 실험 조건에서 예상한 것보다 더 큰 침투강화제인 경우\n\n빈도/제품사용기간\n\n1, 3\n\n제품의 장기간 사용 시 생체 축적 고려\n\n- - 51 -\n<!-- PAGE_57 -->\n###### ③ 노출평가\n\n<!-- PAGE_57 -->\n###### - 해당 유형에 따른 체표면적당 사용량(mg/cm2/day)을 고려하여 노출량(Consumer Exposure\n\n<!-- PAGE_57 -->\n###### Leve CEL, mg/cm2/day) 산출\n\nCEL = 0.03/100 × 11.65 mg/cm2 × 1000 ㎍/mg = 3.5 ㎍/cm2\n\n<!-- PAGE_57 -->\n###### - AEL/CEL이 1 이상이므로 위해 우려 가능성 낮음\n\n<!-- PAGE_57 -->\n###### ※ 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 체표면적을 고려한 사용량을 통합적\n\n<!-- PAGE_57 -->\n###### 으로 계산한 노출량을 이용할 경우, 51.67438 mg/cm2/day 사용(표3)\n\n- - 52 -\n<!-- PAGE_58 -->\n###### 표 3.  피부감작성 위해평가를 위한 화장품 통합 노출량\n\n**[표 시작]**\n\n| 적용되는 | 체표면적2 | 체표면적을 |\n| --- | --- | --- |\n| 노출유형 | 제품 | 노출량1 |\n| 선정 | (g/day) |\n**(cm2)**\n| 시험물질 | A | 시험방법 | 투여경로 | 시험대상 | 투여용량 | 무독성용량 | (mg/kg/day) |\n**참고 자료**\n**(mg/kg/day)**\n| 샤워 젤 | 0.10 | 17500 | 0.005714 |\n| 시험종 | 랫드 | 시험방법 | 투여경로 | 시험대상 | 투여용량 |\n**사용 후 씻어내지 않는**\n\n**[표 끝]**\n\n고려한 노출량\n\n(mg/cm2/day)\n\n사용 후 씻어내는 피부 및\n\n피부 및 모발 케어 제품\n\n1 2014∼2016 화장품 위해평가 선진화 연구\n\n2 체표면적 : Bremmer et al, 2005(RIVM) 자료 적용\n\n- - 53 -\n<!-- PAGE_59 -->\n###### 붙임 9.  화장품 유형별 위해평가 예시\n\n<!-- PAGE_59 -->\n###### 1.  자외선차단 성분(에칠헥실메톡시신나메이트)에 대한 위해평가\n\n<!-- PAGE_59 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_59 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_59 -->\n###### ② 피부흡수율\n\n<!-- PAGE_59 -->\n###### - 랫드를 이용한 in vivo 시험결과인 피부흡수율 2.6%를 위해평가에 적용\n\n**[표 시작]**\n\n**- 피부흡수율 : 2.6%1)**\n\n**[표 끝]**\n\n- - 54 -\n<!-- PAGE_60 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_60 -->\n###### - 체중감소 및 간무게 증가를 근거로 NOAEL 450 mg/kg/day를 독성기준값으로 선정\n\n<!-- PAGE_60 -->\n###### - 자외선차단제 중 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 전신노출량\n\n<!-- PAGE_60 -->\n###### - 에칠헥실메톡시신나메이트 함유 농도 7.5%, 1일 1회 사용, 1일 사용량 17 g/day\n\n<!-- PAGE_60 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_60 -->\n###### - 자외선차단제에 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_60 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n- - 55 -\n<!-- PAGE_61 -->\n###### 2.  보존제(메칠이소치아졸리논)에 대한 위해평가\n\n<!-- PAGE_61 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_61 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_61 -->\n###### ② 피부흡수율\n\n<!-- PAGE_61 -->\n###### -  피부흡수율 실험자료가 높은 표준편차를 나타냄에 따라 피부흡수율을 계산할 수 없음.\n\n",
        "original_sentence": "피부감작성 위해평가를 위한 화장품 통합 노출량\n\n**[표 시작]**\n\n| 적용되는 | 체표면적2 | 체표면적을 |\n| --- | --- | --- |\n| 노출유형 | 제품 | 노출량1 |\n| 선정 | (g/day) |\n**(cm2)**\n| 시험물질 | A | 시험방법 | 투여경로 | 시험대상 | 투여용량 | 무독성용량 | (mg/kg/day) |\n**참고 자료**\n**(mg/kg/day)**\n| 샤워 젤 | 0.10 | 17500 | 0.005714 |\n| 시험종 | 랫드 | 시험방법 | 투여경로 | 시험대상 | 투여용량 |\n**사용 후 씻어내지 않는**\n\n**[표 끝]**\n\n고려한 노출량\n\n(mg/cm2/day)\n\n사용 후 씻어내는 피부 및\n\n피부 및 모발 케어 제품\n\n1 2014∼2016 화장품 위해평가 선진화 연구\n\n2 체표면적 : Bremmer et al, 2005(RIVM) 자료 적용\n\n- - 53 -\n<!-- PAGE_59 -->\n###### 붙임 9. "
      }
    },
    {
      "chunk_id": "chunk_347",
      "text": "화장품 유형별 위해평가 예시\n\n<!-- PAGE_59 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 346,
        "window_size": 3,
        "char_count": 44,
        "word_count": 9,
        "page_number": 59,
        "window_text": "감작평가계수(Sensitisation Assessment Factors, SAF) 적용\n\n<!-- PAGE_56 -->\n###### 표 2.  제품에 따른 SAF\n\n모든 타입의 데오도란트 및\n\n발한억제제\n\n10\n\n1\n\n3\n\n10\n\n300\n\n하이드로알코올 제품(향수 등)\n\n10\n\n1\n\n3\n\n3\n\n100\n\n바디 크림, 로션\n\n10\n\n1\n\n3\n\n10\n\n300\n\n핸드크림\n\n10\n\n1\n\n3\n\n3\n\n100\n\n얼굴크림 및 메이크업제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n메이크업리무버\n\n10\n\n1\n\n3\n\n3\n\n100\n\n입술 제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스타일링제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스프레이\n\n10\n\n1\n\n3\n\n1\n\n30\n\n샴푸\n\n10\n\n1\n\n3\n\n10\n\n300\n\n헤어컨디셔너\n\n10\n\n1\n\n3\n\n3\n\n100\n\n고체비누\n\n10\n\n1\n\n3\n\n10\n\n300\n\n액체비누\n\n10\n\n1\n\n3\n\n3\n\n100\n\n샤워젤, 목욕제품\n\n10\n\n1\n\n3\n\n10\n\n300\n\n참고 : 자외선차단제가 포함된 제품은 입술제품에 해당됨\n\n요인\n\nSAF\n\n내용\n\n개인 간\n\n10\n\n개인 간 차이 고려\n\n제품\n\n- 0.3, 1, 3\n- 0.3 : 직접 접촉하지 않는 불활성 물질\n1 : 대부분 제품\n\n3 : 실험 조건에서 예상한 것보다 더 큰 침투강화제인 경우\n\n빈도/제품사용기간\n\n1, 3\n\n제품의 장기간 사용 시 생체 축적 고려\n\n- - 51 -\n<!-- PAGE_57 -->\n###### ③ 노출평가\n\n<!-- PAGE_57 -->\n###### - 해당 유형에 따른 체표면적당 사용량(mg/cm2/day)을 고려하여 노출량(Consumer Exposure\n\n<!-- PAGE_57 -->\n###### Leve CEL, mg/cm2/day) 산출\n\nCEL = 0.03/100 × 11.65 mg/cm2 × 1000 ㎍/mg = 3.5 ㎍/cm2\n\n<!-- PAGE_57 -->\n###### - AEL/CEL이 1 이상이므로 위해 우려 가능성 낮음\n\n<!-- PAGE_57 -->\n###### ※ 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 체표면적을 고려한 사용량을 통합적\n\n<!-- PAGE_57 -->\n###### 으로 계산한 노출량을 이용할 경우, 51.67438 mg/cm2/day 사용(표3)\n\n- - 52 -\n<!-- PAGE_58 -->\n###### 표 3.  피부감작성 위해평가를 위한 화장품 통합 노출량\n\n**[표 시작]**\n\n| 적용되는 | 체표면적2 | 체표면적을 |\n| --- | --- | --- |\n| 노출유형 | 제품 | 노출량1 |\n| 선정 | (g/day) |\n**(cm2)**\n| 시험물질 | A | 시험방법 | 투여경로 | 시험대상 | 투여용량 | 무독성용량 | (mg/kg/day) |\n**참고 자료**\n**(mg/kg/day)**\n| 샤워 젤 | 0.10 | 17500 | 0.005714 |\n| 시험종 | 랫드 | 시험방법 | 투여경로 | 시험대상 | 투여용량 |\n**사용 후 씻어내지 않는**\n\n**[표 끝]**\n\n고려한 노출량\n\n(mg/cm2/day)\n\n사용 후 씻어내는 피부 및\n\n피부 및 모발 케어 제품\n\n1 2014∼2016 화장품 위해평가 선진화 연구\n\n2 체표면적 : Bremmer et al, 2005(RIVM) 자료 적용\n\n- - 53 -\n<!-- PAGE_59 -->\n###### 붙임 9.  화장품 유형별 위해평가 예시\n\n<!-- PAGE_59 -->\n###### 1.  자외선차단 성분(에칠헥실메톡시신나메이트)에 대한 위해평가\n\n<!-- PAGE_59 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_59 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_59 -->\n###### ② 피부흡수율\n\n<!-- PAGE_59 -->\n###### - 랫드를 이용한 in vivo 시험결과인 피부흡수율 2.6%를 위해평가에 적용\n\n**[표 시작]**\n\n**- 피부흡수율 : 2.6%1)**\n\n**[표 끝]**\n\n- - 54 -\n<!-- PAGE_60 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_60 -->\n###### - 체중감소 및 간무게 증가를 근거로 NOAEL 450 mg/kg/day를 독성기준값으로 선정\n\n<!-- PAGE_60 -->\n###### - 자외선차단제 중 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 전신노출량\n\n<!-- PAGE_60 -->\n###### - 에칠헥실메톡시신나메이트 함유 농도 7.5%, 1일 1회 사용, 1일 사용량 17 g/day\n\n<!-- PAGE_60 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_60 -->\n###### - 자외선차단제에 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_60 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n- - 55 -\n<!-- PAGE_61 -->\n###### 2.  보존제(메칠이소치아졸리논)에 대한 위해평가\n\n<!-- PAGE_61 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_61 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_61 -->\n###### ② 피부흡수율\n\n<!-- PAGE_61 -->\n###### -  피부흡수율 실험자료가 높은 표준편차를 나타냄에 따라 피부흡수율을 계산할 수 없음.\n\n - - 56 -\n<!-- PAGE_62 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_62 -->\n###### - 토끼에 대한 생식발생독성시험에서 얻어진 NOAEL 10 mg/kg bw/day를 독성기준값으로\n\n**[표 시작]**\n\n| 무독성용량 | (mg/kg/day) |\n| --- | --- |\n\n**[표 끝]**\n\n<!-- PAGE_62 -->\n###### - 대표유형 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 전신노출량(SED)\n\n<!-- PAGE_62 -->\n###### - 메칠이소치아졸리논 함유 농도 0.0015%, 1일 1회 사용, 1일 사용량 16.9 g/day\n\n<!-- PAGE_62 -->\n###### · SED = 16.9 (g/day) × 0.0015/100 × 50/100 ÷ 60 kg = 0.0021 mg/kg/day\n\n<!-- PAGE_62 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_62 -->\n###### - 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_62 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n<!-- PAGE_63 -->\n###### 붙임 10. ",
        "original_sentence": "화장품 유형별 위해평가 예시\n\n<!-- PAGE_59 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_348",
      "text": "자외선차단 성분(에칠헥실메톡시신나메이트)에 대한 위해평가\n\n<!-- PAGE_59 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_59 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_59 -->\n###### ② 피부흡수율\n\n<!-- PAGE_59 -->\n###### - 랫드를 이용한 in vivo 시험결과인 피부흡수율 2.6%를 위해평가에 적용\n\n**[표 시작]**\n\n**- 피부흡수율 : 2.6%1)**\n\n**[표 끝]**\n\n- - 54 -\n<!-- PAGE_60 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_60 -->\n###### - 체중감소 및 간무게 증가를 근거로 NOAEL 450 mg/kg/day를 독성기준값으로 선정\n\n<!-- PAGE_60 -->\n###### - 자외선차단제 중 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 전신노출량\n\n<!-- PAGE_60 -->\n###### - 에칠헥실메톡시신나메이트 함유 농도 7.5%, 1일 1회 사용, 1일 사용량 17 g/day\n\n<!-- PAGE_60 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_60 -->\n###### - 자외선차단제에 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_60 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n- - 55 -\n<!-- PAGE_61 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 347,
        "window_size": 3,
        "char_count": 753,
        "word_count": 146,
        "page_number": 59,
        "window_text": "제품에 따른 SAF\n\n모든 타입의 데오도란트 및\n\n발한억제제\n\n10\n\n1\n\n3\n\n10\n\n300\n\n하이드로알코올 제품(향수 등)\n\n10\n\n1\n\n3\n\n3\n\n100\n\n바디 크림, 로션\n\n10\n\n1\n\n3\n\n10\n\n300\n\n핸드크림\n\n10\n\n1\n\n3\n\n3\n\n100\n\n얼굴크림 및 메이크업제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n메이크업리무버\n\n10\n\n1\n\n3\n\n3\n\n100\n\n입술 제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스타일링제품\n\n10\n\n1\n\n3\n\n3\n\n100\n\n헤어스프레이\n\n10\n\n1\n\n3\n\n1\n\n30\n\n샴푸\n\n10\n\n1\n\n3\n\n10\n\n300\n\n헤어컨디셔너\n\n10\n\n1\n\n3\n\n3\n\n100\n\n고체비누\n\n10\n\n1\n\n3\n\n10\n\n300\n\n액체비누\n\n10\n\n1\n\n3\n\n3\n\n100\n\n샤워젤, 목욕제품\n\n10\n\n1\n\n3\n\n10\n\n300\n\n참고 : 자외선차단제가 포함된 제품은 입술제품에 해당됨\n\n요인\n\nSAF\n\n내용\n\n개인 간\n\n10\n\n개인 간 차이 고려\n\n제품\n\n- 0.3, 1, 3\n- 0.3 : 직접 접촉하지 않는 불활성 물질\n1 : 대부분 제품\n\n3 : 실험 조건에서 예상한 것보다 더 큰 침투강화제인 경우\n\n빈도/제품사용기간\n\n1, 3\n\n제품의 장기간 사용 시 생체 축적 고려\n\n- - 51 -\n<!-- PAGE_57 -->\n###### ③ 노출평가\n\n<!-- PAGE_57 -->\n###### - 해당 유형에 따른 체표면적당 사용량(mg/cm2/day)을 고려하여 노출량(Consumer Exposure\n\n<!-- PAGE_57 -->\n###### Leve CEL, mg/cm2/day) 산출\n\nCEL = 0.03/100 × 11.65 mg/cm2 × 1000 ㎍/mg = 3.5 ㎍/cm2\n\n<!-- PAGE_57 -->\n###### - AEL/CEL이 1 이상이므로 위해 우려 가능성 낮음\n\n<!-- PAGE_57 -->\n###### ※ 한 사람이 하루 동안 피부에 적용하는 모든 화장품의 체표면적을 고려한 사용량을 통합적\n\n<!-- PAGE_57 -->\n###### 으로 계산한 노출량을 이용할 경우, 51.67438 mg/cm2/day 사용(표3)\n\n- - 52 -\n<!-- PAGE_58 -->\n###### 표 3.  피부감작성 위해평가를 위한 화장품 통합 노출량\n\n**[표 시작]**\n\n| 적용되는 | 체표면적2 | 체표면적을 |\n| --- | --- | --- |\n| 노출유형 | 제품 | 노출량1 |\n| 선정 | (g/day) |\n**(cm2)**\n| 시험물질 | A | 시험방법 | 투여경로 | 시험대상 | 투여용량 | 무독성용량 | (mg/kg/day) |\n**참고 자료**\n**(mg/kg/day)**\n| 샤워 젤 | 0.10 | 17500 | 0.005714 |\n| 시험종 | 랫드 | 시험방법 | 투여경로 | 시험대상 | 투여용량 |\n**사용 후 씻어내지 않는**\n\n**[표 끝]**\n\n고려한 노출량\n\n(mg/cm2/day)\n\n사용 후 씻어내는 피부 및\n\n피부 및 모발 케어 제품\n\n1 2014∼2016 화장품 위해평가 선진화 연구\n\n2 체표면적 : Bremmer et al, 2005(RIVM) 자료 적용\n\n- - 53 -\n<!-- PAGE_59 -->\n###### 붙임 9.  화장품 유형별 위해평가 예시\n\n<!-- PAGE_59 -->\n###### 1.  자외선차단 성분(에칠헥실메톡시신나메이트)에 대한 위해평가\n\n<!-- PAGE_59 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_59 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_59 -->\n###### ② 피부흡수율\n\n<!-- PAGE_59 -->\n###### - 랫드를 이용한 in vivo 시험결과인 피부흡수율 2.6%를 위해평가에 적용\n\n**[표 시작]**\n\n**- 피부흡수율 : 2.6%1)**\n\n**[표 끝]**\n\n- - 54 -\n<!-- PAGE_60 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_60 -->\n###### - 체중감소 및 간무게 증가를 근거로 NOAEL 450 mg/kg/day를 독성기준값으로 선정\n\n<!-- PAGE_60 -->\n###### - 자외선차단제 중 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 전신노출량\n\n<!-- PAGE_60 -->\n###### - 에칠헥실메톡시신나메이트 함유 농도 7.5%, 1일 1회 사용, 1일 사용량 17 g/day\n\n<!-- PAGE_60 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_60 -->\n###### - 자외선차단제에 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_60 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n- - 55 -\n<!-- PAGE_61 -->\n###### 2.  보존제(메칠이소치아졸리논)에 대한 위해평가\n\n<!-- PAGE_61 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_61 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_61 -->\n###### ② 피부흡수율\n\n<!-- PAGE_61 -->\n###### -  피부흡수율 실험자료가 높은 표준편차를 나타냄에 따라 피부흡수율을 계산할 수 없음.\n\n - - 56 -\n<!-- PAGE_62 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_62 -->\n###### - 토끼에 대한 생식발생독성시험에서 얻어진 NOAEL 10 mg/kg bw/day를 독성기준값으로\n\n**[표 시작]**\n\n| 무독성용량 | (mg/kg/day) |\n| --- | --- |\n\n**[표 끝]**\n\n<!-- PAGE_62 -->\n###### - 대표유형 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 전신노출량(SED)\n\n<!-- PAGE_62 -->\n###### - 메칠이소치아졸리논 함유 농도 0.0015%, 1일 1회 사용, 1일 사용량 16.9 g/day\n\n<!-- PAGE_62 -->\n###### · SED = 16.9 (g/day) × 0.0015/100 × 50/100 ÷ 60 kg = 0.0021 mg/kg/day\n\n<!-- PAGE_62 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_62 -->\n###### - 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_62 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n<!-- PAGE_63 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집\n\n<!-- PAGE_63 -->\n###### 1. ",
        "original_sentence": "자외선차단 성분(에칠헥실메톡시신나메이트)에 대한 위해평가\n\n<!-- PAGE_59 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_59 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_59 -->\n###### ② 피부흡수율\n\n<!-- PAGE_59 -->\n###### - 랫드를 이용한 in vivo 시험결과인 피부흡수율 2.6%를 위해평가에 적용\n\n**[표 시작]**\n\n**- 피부흡수율 : 2.6%1)**\n\n**[표 끝]**\n\n- - 54 -\n<!-- PAGE_60 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_60 -->\n###### - 체중감소 및 간무게 증가를 근거로 NOAEL 450 mg/kg/day를 독성기준값으로 선정\n\n<!-- PAGE_60 -->\n###### - 자외선차단제 중 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 전신노출량\n\n<!-- PAGE_60 -->\n###### - 에칠헥실메톡시신나메이트 함유 농도 7.5%, 1일 1회 사용, 1일 사용량 17 g/day\n\n<!-- PAGE_60 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_60 -->\n###### - 자외선차단제에 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_60 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n- - 55 -\n<!-- PAGE_61 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_349",
      "text": "보존제(메칠이소치아졸리논)에 대한 위해평가\n\n<!-- PAGE_61 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_61 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_61 -->\n###### ② 피부흡수율\n\n<!-- PAGE_61 -->\n###### -  피부흡수율 실험자료가 높은 표준편차를 나타냄에 따라 피부흡수율을 계산할 수 없음.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 348,
        "window_size": 3,
        "char_count": 234,
        "word_count": 43,
        "page_number": 61,
        "window_text": "피부감작성 위해평가를 위한 화장품 통합 노출량\n\n**[표 시작]**\n\n| 적용되는 | 체표면적2 | 체표면적을 |\n| --- | --- | --- |\n| 노출유형 | 제품 | 노출량1 |\n| 선정 | (g/day) |\n**(cm2)**\n| 시험물질 | A | 시험방법 | 투여경로 | 시험대상 | 투여용량 | 무독성용량 | (mg/kg/day) |\n**참고 자료**\n**(mg/kg/day)**\n| 샤워 젤 | 0.10 | 17500 | 0.005714 |\n| 시험종 | 랫드 | 시험방법 | 투여경로 | 시험대상 | 투여용량 |\n**사용 후 씻어내지 않는**\n\n**[표 끝]**\n\n고려한 노출량\n\n(mg/cm2/day)\n\n사용 후 씻어내는 피부 및\n\n피부 및 모발 케어 제품\n\n1 2014∼2016 화장품 위해평가 선진화 연구\n\n2 체표면적 : Bremmer et al, 2005(RIVM) 자료 적용\n\n- - 53 -\n<!-- PAGE_59 -->\n###### 붙임 9.  화장품 유형별 위해평가 예시\n\n<!-- PAGE_59 -->\n###### 1.  자외선차단 성분(에칠헥실메톡시신나메이트)에 대한 위해평가\n\n<!-- PAGE_59 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_59 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_59 -->\n###### ② 피부흡수율\n\n<!-- PAGE_59 -->\n###### - 랫드를 이용한 in vivo 시험결과인 피부흡수율 2.6%를 위해평가에 적용\n\n**[표 시작]**\n\n**- 피부흡수율 : 2.6%1)**\n\n**[표 끝]**\n\n- - 54 -\n<!-- PAGE_60 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_60 -->\n###### - 체중감소 및 간무게 증가를 근거로 NOAEL 450 mg/kg/day를 독성기준값으로 선정\n\n<!-- PAGE_60 -->\n###### - 자외선차단제 중 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 전신노출량\n\n<!-- PAGE_60 -->\n###### - 에칠헥실메톡시신나메이트 함유 농도 7.5%, 1일 1회 사용, 1일 사용량 17 g/day\n\n<!-- PAGE_60 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_60 -->\n###### - 자외선차단제에 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_60 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n- - 55 -\n<!-- PAGE_61 -->\n###### 2.  보존제(메칠이소치아졸리논)에 대한 위해평가\n\n<!-- PAGE_61 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_61 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_61 -->\n###### ② 피부흡수율\n\n<!-- PAGE_61 -->\n###### -  피부흡수율 실험자료가 높은 표준편차를 나타냄에 따라 피부흡수율을 계산할 수 없음.\n\n - - 56 -\n<!-- PAGE_62 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_62 -->\n###### - 토끼에 대한 생식발생독성시험에서 얻어진 NOAEL 10 mg/kg bw/day를 독성기준값으로\n\n**[표 시작]**\n\n| 무독성용량 | (mg/kg/day) |\n| --- | --- |\n\n**[표 끝]**\n\n<!-- PAGE_62 -->\n###### - 대표유형 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 전신노출량(SED)\n\n<!-- PAGE_62 -->\n###### - 메칠이소치아졸리논 함유 농도 0.0015%, 1일 1회 사용, 1일 사용량 16.9 g/day\n\n<!-- PAGE_62 -->\n###### · SED = 16.9 (g/day) × 0.0015/100 × 50/100 ÷ 60 kg = 0.0021 mg/kg/day\n\n<!-- PAGE_62 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_62 -->\n###### - 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_62 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n<!-- PAGE_63 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집\n\n<!-- PAGE_63 -->\n###### 1.  성분 및 식별자료 검색\n\n사이트명\n\n홈페이지\n\n세부정보\n\n**[표 시작]**\n\n| CAS SciFindern | https://www.cas.org/solutions/cas-scifinder- | EU CosIng | 미국화학회(CAS)에서 구축하고 생화학, 의학, 화학공학 등에 특화된 |\n| --- | --- | --- | --- |\n| 결정할 수 있다. ",
        "original_sentence": "보존제(메칠이소치아졸리논)에 대한 위해평가\n\n<!-- PAGE_61 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_61 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_61 -->\n###### ② 피부흡수율\n\n<!-- PAGE_61 -->\n###### -  피부흡수율 실험자료가 높은 표준편차를 나타냄에 따라 피부흡수율을 계산할 수 없음.\n\n"
      }
    },
    {
      "chunk_id": "chunk_350",
      "text": "- - 56 -\n<!-- PAGE_62 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_62 -->\n###### - 토끼에 대한 생식발생독성시험에서 얻어진 NOAEL 10 mg/kg bw/day를 독성기준값으로\n\n**[표 시작]**\n\n| 무독성용량 | (mg/kg/day) |\n| --- | --- |\n\n**[표 끝]**\n\n<!-- PAGE_62 -->\n###### - 대표유형 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 전신노출량(SED)\n\n<!-- PAGE_62 -->\n###### - 메칠이소치아졸리논 함유 농도 0.0015%, 1일 1회 사용, 1일 사용량 16.9 g/day\n\n<!-- PAGE_62 -->\n###### · SED = 16.9 (g/day) × 0.0015/100 × 50/100 ÷ 60 kg = 0.0021 mg/kg/day\n\n<!-- PAGE_62 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_62 -->\n###### - 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_62 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n<!-- PAGE_63 -->\n###### 붙임 10. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 349,
        "window_size": 3,
        "char_count": 629,
        "word_count": 124,
        "page_number": 62,
        "window_text": "화장품 유형별 위해평가 예시\n\n<!-- PAGE_59 -->\n###### 1.  자외선차단 성분(에칠헥실메톡시신나메이트)에 대한 위해평가\n\n<!-- PAGE_59 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_59 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_59 -->\n###### ② 피부흡수율\n\n<!-- PAGE_59 -->\n###### - 랫드를 이용한 in vivo 시험결과인 피부흡수율 2.6%를 위해평가에 적용\n\n**[표 시작]**\n\n**- 피부흡수율 : 2.6%1)**\n\n**[표 끝]**\n\n- - 54 -\n<!-- PAGE_60 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_60 -->\n###### - 체중감소 및 간무게 증가를 근거로 NOAEL 450 mg/kg/day를 독성기준값으로 선정\n\n<!-- PAGE_60 -->\n###### - 자외선차단제 중 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 전신노출량\n\n<!-- PAGE_60 -->\n###### - 에칠헥실메톡시신나메이트 함유 농도 7.5%, 1일 1회 사용, 1일 사용량 17 g/day\n\n<!-- PAGE_60 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_60 -->\n###### - 자외선차단제에 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_60 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n- - 55 -\n<!-- PAGE_61 -->\n###### 2.  보존제(메칠이소치아졸리논)에 대한 위해평가\n\n<!-- PAGE_61 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_61 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_61 -->\n###### ② 피부흡수율\n\n<!-- PAGE_61 -->\n###### -  피부흡수율 실험자료가 높은 표준편차를 나타냄에 따라 피부흡수율을 계산할 수 없음.\n\n - - 56 -\n<!-- PAGE_62 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_62 -->\n###### - 토끼에 대한 생식발생독성시험에서 얻어진 NOAEL 10 mg/kg bw/day를 독성기준값으로\n\n**[표 시작]**\n\n| 무독성용량 | (mg/kg/day) |\n| --- | --- |\n\n**[표 끝]**\n\n<!-- PAGE_62 -->\n###### - 대표유형 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 전신노출량(SED)\n\n<!-- PAGE_62 -->\n###### - 메칠이소치아졸리논 함유 농도 0.0015%, 1일 1회 사용, 1일 사용량 16.9 g/day\n\n<!-- PAGE_62 -->\n###### · SED = 16.9 (g/day) × 0.0015/100 × 50/100 ÷ 60 kg = 0.0021 mg/kg/day\n\n<!-- PAGE_62 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_62 -->\n###### - 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_62 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n<!-- PAGE_63 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집\n\n<!-- PAGE_63 -->\n###### 1.  성분 및 식별자료 검색\n\n사이트명\n\n홈페이지\n\n세부정보\n\n**[표 시작]**\n\n| CAS SciFindern | https://www.cas.org/solutions/cas-scifinder- | EU CosIng | 미국화학회(CAS)에서 구축하고 생화학, 의학, 화학공학 등에 특화된 |\n| --- | --- | --- | --- |\n| 결정할 수 있다.  | 사이트명 | 홈페이지 | 세부정보 | https://ec.europa.eu/growth/tools-databases/cosing/ | EU의 화장품 규정 및 화장품 성분에 대한 정보 |\n**과학연구 DB로 유료로 운영됨**\n**(유럽 화장품 성분 정보 데이터베이스**\n**미국화학회(CAS)와 독일 연방과학기술센터(FIZ)rk 공동으로 구축한**\n**SCCS**\n| 을 발생시키는 체중 1 kg당 일일 용량을 의미한다. ",
        "original_sentence": "- - 56 -\n<!-- PAGE_62 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_62 -->\n###### - 토끼에 대한 생식발생독성시험에서 얻어진 NOAEL 10 mg/kg bw/day를 독성기준값으로\n\n**[표 시작]**\n\n| 무독성용량 | (mg/kg/day) |\n| --- | --- |\n\n**[표 끝]**\n\n<!-- PAGE_62 -->\n###### - 대표유형 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 전신노출량(SED)\n\n<!-- PAGE_62 -->\n###### - 메칠이소치아졸리논 함유 농도 0.0015%, 1일 1회 사용, 1일 사용량 16.9 g/day\n\n<!-- PAGE_62 -->\n###### · SED = 16.9 (g/day) × 0.0015/100 × 50/100 ÷ 60 kg = 0.0021 mg/kg/day\n\n<!-- PAGE_62 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_62 -->\n###### - 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_62 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n<!-- PAGE_63 -->\n###### 붙임 10. "
      }
    },
    {
      "chunk_id": "chunk_351",
      "text": "화장품 성분 위해평가를 위한 정보 수집\n\n<!-- PAGE_63 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 350,
        "window_size": 3,
        "char_count": 50,
        "word_count": 11,
        "page_number": 63,
        "window_text": "자외선차단 성분(에칠헥실메톡시신나메이트)에 대한 위해평가\n\n<!-- PAGE_59 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_59 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_59 -->\n###### ② 피부흡수율\n\n<!-- PAGE_59 -->\n###### - 랫드를 이용한 in vivo 시험결과인 피부흡수율 2.6%를 위해평가에 적용\n\n**[표 시작]**\n\n**- 피부흡수율 : 2.6%1)**\n\n**[표 끝]**\n\n- - 54 -\n<!-- PAGE_60 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_60 -->\n###### - 체중감소 및 간무게 증가를 근거로 NOAEL 450 mg/kg/day를 독성기준값으로 선정\n\n<!-- PAGE_60 -->\n###### - 자외선차단제 중 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 전신노출량\n\n<!-- PAGE_60 -->\n###### - 에칠헥실메톡시신나메이트 함유 농도 7.5%, 1일 1회 사용, 1일 사용량 17 g/day\n\n<!-- PAGE_60 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_60 -->\n###### - 자외선차단제에 에칠헥실메톡시신나메이트가 7.5% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_60 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n- - 55 -\n<!-- PAGE_61 -->\n###### 2.  보존제(메칠이소치아졸리논)에 대한 위해평가\n\n<!-- PAGE_61 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_61 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_61 -->\n###### ② 피부흡수율\n\n<!-- PAGE_61 -->\n###### -  피부흡수율 실험자료가 높은 표준편차를 나타냄에 따라 피부흡수율을 계산할 수 없음.\n\n - - 56 -\n<!-- PAGE_62 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_62 -->\n###### - 토끼에 대한 생식발생독성시험에서 얻어진 NOAEL 10 mg/kg bw/day를 독성기준값으로\n\n**[표 시작]**\n\n| 무독성용량 | (mg/kg/day) |\n| --- | --- |\n\n**[표 끝]**\n\n<!-- PAGE_62 -->\n###### - 대표유형 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 전신노출량(SED)\n\n<!-- PAGE_62 -->\n###### - 메칠이소치아졸리논 함유 농도 0.0015%, 1일 1회 사용, 1일 사용량 16.9 g/day\n\n<!-- PAGE_62 -->\n###### · SED = 16.9 (g/day) × 0.0015/100 × 50/100 ÷ 60 kg = 0.0021 mg/kg/day\n\n<!-- PAGE_62 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_62 -->\n###### - 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_62 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n<!-- PAGE_63 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집\n\n<!-- PAGE_63 -->\n###### 1.  성분 및 식별자료 검색\n\n사이트명\n\n홈페이지\n\n세부정보\n\n**[표 시작]**\n\n| CAS SciFindern | https://www.cas.org/solutions/cas-scifinder- | EU CosIng | 미국화학회(CAS)에서 구축하고 생화학, 의학, 화학공학 등에 특화된 |\n| --- | --- | --- | --- |\n| 결정할 수 있다.  | 사이트명 | 홈페이지 | 세부정보 | https://ec.europa.eu/growth/tools-databases/cosing/ | EU의 화장품 규정 및 화장품 성분에 대한 정보 |\n**과학연구 DB로 유료로 운영됨**\n**(유럽 화장품 성분 정보 데이터베이스**\n**미국화학회(CAS)와 독일 연방과학기술센터(FIZ)rk 공동으로 구축한**\n**SCCS**\n| 을 발생시키는 체중 1 kg당 일일 용량을 의미한다.  이것은 단일 관찰된 용량-반응으로부터 | 가정용 제품)의 건강 및 안전에 관한 위해성평 |\n| STN | https://www.stn-international.com/ | 데이터베이스로 구조식, CAS no, 분자식 등의 정보 및 구조식으로 |\n| (Science Committee on Consumer Safety) | 미국 화장품 가이드라인 및 규정 |\n**가 내용 제공**\n| 미국 FDA(식품의약품청) | 화합물 검색이 가능하며 유료로 운영됨 |\n**미국 화장품 착색제**\n**관련 전문가로 이루어진 비영리단체로 화장품에**\n**미국 국립보건원(NIH)의 미국의학도서관(NLM) 내 미국 국립생물공**\n**· AIC 낮은 값을 선택(BMDS)**\n| CIR(Cosmetic Ingredient Review) | https://www.cir-safety.org/ | 사용되는 성분에 대한 정성적 안전성 평가 |\n| PubChem | https://pubmed.ncbi.nlm.nih.gov/ | 학정보센터(NCIB)가 관리하는 화학분자 및 생물학 관련 논문 데이 |\n**로 독성에 대하여 대조군에 비해 10%의 반응이 나타나는 용량의 95% 신뢰구간의 하한값을**\n| 중국 NMPA(국가약품감독관리국) | https://www.nmpa.gov.cn/hzhp/index.html | 중국 화장품 관련 규제 | - 보수적 접근으로 p-value > 0.05 인 모델 중 가장 낮은 BMDL 값 | 보고서 제공 |\n| SED = 50 × 1/109 × 65/100 × 1.62 mg/kg bw/day = 5.3×10-8 mg/kg bw/day | 의미한다. ",
        "original_sentence": "화장품 성분 위해평가를 위한 정보 수집\n\n<!-- PAGE_63 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_352",
      "text": "성분 및 식별자료 검색\n\n사이트명\n\n홈페이지\n\n세부정보\n\n**[표 시작]**\n\n| CAS SciFindern | https://www.cas.org/solutions/cas-scifinder- | EU CosIng | 미국화학회(CAS)에서 구축하고 생화학, 의학, 화학공학 등에 특화된 |\n| --- | --- | --- | --- |\n| 결정할 수 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 351,
        "window_size": 3,
        "char_count": 201,
        "word_count": 39,
        "page_number": 17,
        "window_text": "보존제(메칠이소치아졸리논)에 대한 위해평가\n\n<!-- PAGE_61 -->\n###### 1) 위험성 확인\n\n<!-- PAGE_61 -->\n###### ① 단회투여독성, 반복투여독성, 생식·발생독성, 유전독성 등 독성자료 확인\n\n<!-- PAGE_61 -->\n###### ② 피부흡수율\n\n<!-- PAGE_61 -->\n###### -  피부흡수율 실험자료가 높은 표준편차를 나타냄에 따라 피부흡수율을 계산할 수 없음.\n\n - - 56 -\n<!-- PAGE_62 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_62 -->\n###### - 토끼에 대한 생식발생독성시험에서 얻어진 NOAEL 10 mg/kg bw/day를 독성기준값으로\n\n**[표 시작]**\n\n| 무독성용량 | (mg/kg/day) |\n| --- | --- |\n\n**[표 끝]**\n\n<!-- PAGE_62 -->\n###### - 대표유형 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 전신노출량(SED)\n\n<!-- PAGE_62 -->\n###### - 메칠이소치아졸리논 함유 농도 0.0015%, 1일 1회 사용, 1일 사용량 16.9 g/day\n\n<!-- PAGE_62 -->\n###### · SED = 16.9 (g/day) × 0.0015/100 × 50/100 ÷ 60 kg = 0.0021 mg/kg/day\n\n<!-- PAGE_62 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_62 -->\n###### - 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_62 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n<!-- PAGE_63 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집\n\n<!-- PAGE_63 -->\n###### 1.  성분 및 식별자료 검색\n\n사이트명\n\n홈페이지\n\n세부정보\n\n**[표 시작]**\n\n| CAS SciFindern | https://www.cas.org/solutions/cas-scifinder- | EU CosIng | 미국화학회(CAS)에서 구축하고 생화학, 의학, 화학공학 등에 특화된 |\n| --- | --- | --- | --- |\n| 결정할 수 있다.  | 사이트명 | 홈페이지 | 세부정보 | https://ec.europa.eu/growth/tools-databases/cosing/ | EU의 화장품 규정 및 화장품 성분에 대한 정보 |\n**과학연구 DB로 유료로 운영됨**\n**(유럽 화장품 성분 정보 데이터베이스**\n**미국화학회(CAS)와 독일 연방과학기술센터(FIZ)rk 공동으로 구축한**\n**SCCS**\n| 을 발생시키는 체중 1 kg당 일일 용량을 의미한다.  이것은 단일 관찰된 용량-반응으로부터 | 가정용 제품)의 건강 및 안전에 관한 위해성평 |\n| STN | https://www.stn-international.com/ | 데이터베이스로 구조식, CAS no, 분자식 등의 정보 및 구조식으로 |\n| (Science Committee on Consumer Safety) | 미국 화장품 가이드라인 및 규정 |\n**가 내용 제공**\n| 미국 FDA(식품의약품청) | 화합물 검색이 가능하며 유료로 운영됨 |\n**미국 화장품 착색제**\n**관련 전문가로 이루어진 비영리단체로 화장품에**\n**미국 국립보건원(NIH)의 미국의학도서관(NLM) 내 미국 국립생물공**\n**· AIC 낮은 값을 선택(BMDS)**\n| CIR(Cosmetic Ingredient Review) | https://www.cir-safety.org/ | 사용되는 성분에 대한 정성적 안전성 평가 |\n| PubChem | https://pubmed.ncbi.nlm.nih.gov/ | 학정보센터(NCIB)가 관리하는 화학분자 및 생물학 관련 논문 데이 |\n**로 독성에 대하여 대조군에 비해 10%의 반응이 나타나는 용량의 95% 신뢰구간의 하한값을**\n| 중국 NMPA(국가약품감독관리국) | https://www.nmpa.gov.cn/hzhp/index.html | 중국 화장품 관련 규제 | - 보수적 접근으로 p-value > 0.05 인 모델 중 가장 낮은 BMDL 값 | 보고서 제공 |\n| SED = 50 × 1/109 × 65/100 × 1.62 mg/kg bw/day = 5.3×10-8 mg/kg bw/day | 의미한다.  |\n**미국 국립보건원(NIH)의 생명과학 및 생물의**\n| - 그래프 확인 | 국제적으로 통용되는 화장품 성분의 명칭. ",
        "original_sentence": "성분 및 식별자료 검색\n\n사이트명\n\n홈페이지\n\n세부정보\n\n**[표 시작]**\n\n| CAS SciFindern | https://www.cas.org/solutions/cas-scifinder- | EU CosIng | 미국화학회(CAS)에서 구축하고 생화학, 의학, 화학공학 등에 특화된 |\n| --- | --- | --- | --- |\n| 결정할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_353",
      "text": "| 사이트명 | 홈페이지 | 세부정보 | https://ec.europa.eu/growth/tools-databases/cosing/ | EU의 화장품 규정 및 화장품 성분에 대한 정보 |\n**과학연구 DB로 유료로 운영됨**\n**(유럽 화장품 성분 정보 데이터베이스**\n**미국화학회(CAS)와 독일 연방과학기술센터(FIZ)rk 공동으로 구축한**\n**SCCS**\n| 을 발생시키는 체중 1 kg당 일일 용량을 의미한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 352,
        "window_size": 3,
        "char_count": 237,
        "word_count": 42,
        "page_number": 63,
        "window_text": "- - 56 -\n<!-- PAGE_62 -->\n###### 2) 위험성 결정\n\n<!-- PAGE_62 -->\n###### - 토끼에 대한 생식발생독성시험에서 얻어진 NOAEL 10 mg/kg bw/day를 독성기준값으로\n\n**[표 시작]**\n\n| 무독성용량 | (mg/kg/day) |\n| --- | --- |\n\n**[표 끝]**\n\n<!-- PAGE_62 -->\n###### - 대표유형 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 전신노출량(SED)\n\n<!-- PAGE_62 -->\n###### - 메칠이소치아졸리논 함유 농도 0.0015%, 1일 1회 사용, 1일 사용량 16.9 g/day\n\n<!-- PAGE_62 -->\n###### · SED = 16.9 (g/day) × 0.0015/100 × 50/100 ÷ 60 kg = 0.0021 mg/kg/day\n\n<!-- PAGE_62 -->\n###### 4) 위해도 평가\n\n<!-- PAGE_62 -->\n###### - 화장품에 메칠이소치아졸리논이 0.0015% 함유된 것을 가정하여 안전역 산출\n\n<!-- PAGE_62 -->\n###### - MOS 100 이상이므로 위해영향 가능성 낮음\n\n<!-- PAGE_63 -->\n###### 붙임 10.  화장품 성분 위해평가를 위한 정보 수집\n\n<!-- PAGE_63 -->\n###### 1.  성분 및 식별자료 검색\n\n사이트명\n\n홈페이지\n\n세부정보\n\n**[표 시작]**\n\n| CAS SciFindern | https://www.cas.org/solutions/cas-scifinder- | EU CosIng | 미국화학회(CAS)에서 구축하고 생화학, 의학, 화학공학 등에 특화된 |\n| --- | --- | --- | --- |\n| 결정할 수 있다.  | 사이트명 | 홈페이지 | 세부정보 | https://ec.europa.eu/growth/tools-databases/cosing/ | EU의 화장품 규정 및 화장품 성분에 대한 정보 |\n**과학연구 DB로 유료로 운영됨**\n**(유럽 화장품 성분 정보 데이터베이스**\n**미국화학회(CAS)와 독일 연방과학기술센터(FIZ)rk 공동으로 구축한**\n**SCCS**\n| 을 발생시키는 체중 1 kg당 일일 용량을 의미한다.  이것은 단일 관찰된 용량-반응으로부터 | 가정용 제품)의 건강 및 안전에 관한 위해성평 |\n| STN | https://www.stn-international.com/ | 데이터베이스로 구조식, CAS no, 분자식 등의 정보 및 구조식으로 |\n| (Science Committee on Consumer Safety) | 미국 화장품 가이드라인 및 규정 |\n**가 내용 제공**\n| 미국 FDA(식품의약품청) | 화합물 검색이 가능하며 유료로 운영됨 |\n**미국 화장품 착색제**\n**관련 전문가로 이루어진 비영리단체로 화장품에**\n**미국 국립보건원(NIH)의 미국의학도서관(NLM) 내 미국 국립생물공**\n**· AIC 낮은 값을 선택(BMDS)**\n| CIR(Cosmetic Ingredient Review) | https://www.cir-safety.org/ | 사용되는 성분에 대한 정성적 안전성 평가 |\n| PubChem | https://pubmed.ncbi.nlm.nih.gov/ | 학정보센터(NCIB)가 관리하는 화학분자 및 생물학 관련 논문 데이 |\n**로 독성에 대하여 대조군에 비해 10%의 반응이 나타나는 용량의 95% 신뢰구간의 하한값을**\n| 중국 NMPA(국가약품감독관리국) | https://www.nmpa.gov.cn/hzhp/index.html | 중국 화장품 관련 규제 | - 보수적 접근으로 p-value > 0.05 인 모델 중 가장 낮은 BMDL 값 | 보고서 제공 |\n| SED = 50 × 1/109 × 65/100 × 1.62 mg/kg bw/day = 5.3×10-8 mg/kg bw/day | 의미한다.  |\n**미국 국립보건원(NIH)의 생명과학 및 생물의**\n| - 그래프 확인 | 국제적으로 통용되는 화장품 성분의 명칭.  국제명칭위원회(INC)가 |\n| PubMed | https://pubmed.ncbi.nlm.nih.gov/ | 의약품, 의료기기 등의 품질, 유효성 및 안전 | 학에 관한 연구 및 최신동향 관련 논문을 확 |\n| wINCI | http://webdictionary.personalcarecouncil.org | 개발하고 PCPC(Personal Care Products Council)가 국제화장품성분 |\n| - BMD/BMDL 비율 : 낮은 값이 독성값에 대한 불확실성이 낮음 | 성 확보 등에 관한 법률 |\n**인할 수 있으며 일부 유료로 운영됨**\n| 일본 | 출할 수 있으며, 산출 방법은 다음과 같다. ",
        "original_sentence": "| 사이트명 | 홈페이지 | 세부정보 | https://ec.europa.eu/growth/tools-databases/cosing/ | EU의 화장품 규정 및 화장품 성분에 대한 정보 |\n**과학연구 DB로 유료로 운영됨**\n**(유럽 화장품 성분 정보 데이터베이스**\n**미국화학회(CAS)와 독일 연방과학기술센터(FIZ)rk 공동으로 구축한**\n**SCCS**\n| 을 발생시키는 체중 1 kg당 일일 용량을 의미한다. "
      }
    },
    {
      "chunk_id": "chunk_354",
      "text": "이것은 단일 관찰된 용량-반응으로부터 | 가정용 제품)의 건강 및 안전에 관한 위해성평 |\n| STN | https://www.stn-international.com/ | 데이터베이스로 구조식, CAS no, 분자식 등의 정보 및 구조식으로 |\n| (Science Committee on Consumer Safety) | 미국 화장품 가이드라인 및 규정 |\n**가 내용 제공**\n| 미국 FDA(식품의약품청) | 화합물 검색이 가능하며 유료로 운영됨 |\n**미국 화장품 착색제**\n**관련 전문가로 이루어진 비영리단체로 화장품에**\n**미국 국립보건원(NIH)의 미국의학도서관(NLM) 내 미국 국립생물공**\n**· AIC 낮은 값을 선택(BMDS)**\n| CIR(Cosmetic Ingredient Review) | https://www.cir-safety.org/ | 사용되는 성분에 대한 정성적 안전성 평가 |\n| PubChem | https://pubmed.ncbi.nlm.nih.gov/ | 학정보센터(NCIB)가 관리하는 화학분자 및 생물학 관련 논문 데이 |\n**로 독성에 대하여 대조군에 비해 10%의 반응이 나타나는 용량의 95% 신뢰구간의 하한값을**\n| 중국 NMPA(국가약품감독관리국) | https://www.nmpa.gov.cn/hzhp/index.html | 중국 화장품 관련 규제 | - 보수적 접근으로 p-value > 0.05 인 모델 중 가장 낮은 BMDL 값 | 보고서 제공 |\n| SED = 50 × 1/109 × 65/100 × 1.62 mg/kg bw/day = 5.3×10-8 mg/kg bw/day | 의미한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 353,
        "window_size": 3,
        "char_count": 816,
        "word_count": 159,
        "page_number": 37,
        "window_text": "화장품 성분 위해평가를 위한 정보 수집\n\n<!-- PAGE_63 -->\n###### 1.  성분 및 식별자료 검색\n\n사이트명\n\n홈페이지\n\n세부정보\n\n**[표 시작]**\n\n| CAS SciFindern | https://www.cas.org/solutions/cas-scifinder- | EU CosIng | 미국화학회(CAS)에서 구축하고 생화학, 의학, 화학공학 등에 특화된 |\n| --- | --- | --- | --- |\n| 결정할 수 있다.  | 사이트명 | 홈페이지 | 세부정보 | https://ec.europa.eu/growth/tools-databases/cosing/ | EU의 화장품 규정 및 화장품 성분에 대한 정보 |\n**과학연구 DB로 유료로 운영됨**\n**(유럽 화장품 성분 정보 데이터베이스**\n**미국화학회(CAS)와 독일 연방과학기술센터(FIZ)rk 공동으로 구축한**\n**SCCS**\n| 을 발생시키는 체중 1 kg당 일일 용량을 의미한다.  이것은 단일 관찰된 용량-반응으로부터 | 가정용 제품)의 건강 및 안전에 관한 위해성평 |\n| STN | https://www.stn-international.com/ | 데이터베이스로 구조식, CAS no, 분자식 등의 정보 및 구조식으로 |\n| (Science Committee on Consumer Safety) | 미국 화장품 가이드라인 및 규정 |\n**가 내용 제공**\n| 미국 FDA(식품의약품청) | 화합물 검색이 가능하며 유료로 운영됨 |\n**미국 화장품 착색제**\n**관련 전문가로 이루어진 비영리단체로 화장품에**\n**미국 국립보건원(NIH)의 미국의학도서관(NLM) 내 미국 국립생물공**\n**· AIC 낮은 값을 선택(BMDS)**\n| CIR(Cosmetic Ingredient Review) | https://www.cir-safety.org/ | 사용되는 성분에 대한 정성적 안전성 평가 |\n| PubChem | https://pubmed.ncbi.nlm.nih.gov/ | 학정보센터(NCIB)가 관리하는 화학분자 및 생물학 관련 논문 데이 |\n**로 독성에 대하여 대조군에 비해 10%의 반응이 나타나는 용량의 95% 신뢰구간의 하한값을**\n| 중국 NMPA(국가약품감독관리국) | https://www.nmpa.gov.cn/hzhp/index.html | 중국 화장품 관련 규제 | - 보수적 접근으로 p-value > 0.05 인 모델 중 가장 낮은 BMDL 값 | 보고서 제공 |\n| SED = 50 × 1/109 × 65/100 × 1.62 mg/kg bw/day = 5.3×10-8 mg/kg bw/day | 의미한다.  |\n**미국 국립보건원(NIH)의 생명과학 및 생물의**\n| - 그래프 확인 | 국제적으로 통용되는 화장품 성분의 명칭.  국제명칭위원회(INC)가 |\n| PubMed | https://pubmed.ncbi.nlm.nih.gov/ | 의약품, 의료기기 등의 품질, 유효성 및 안전 | 학에 관한 연구 및 최신동향 관련 논문을 확 |\n| wINCI | http://webdictionary.personalcarecouncil.org | 개발하고 PCPC(Personal Care Products Council)가 국제화장품성분 |\n| - BMD/BMDL 비율 : 낮은 값이 독성값에 대한 불확실성이 낮음 | 성 확보 등에 관한 법률 |\n**인할 수 있으며 일부 유료로 운영됨**\n| 일본 | 출할 수 있으며, 산출 방법은 다음과 같다.  | 사전(ICID) 및 핸드북에 게재하고 있음. ",
        "original_sentence": "이것은 단일 관찰된 용량-반응으로부터 | 가정용 제품)의 건강 및 안전에 관한 위해성평 |\n| STN | https://www.stn-international.com/ | 데이터베이스로 구조식, CAS no, 분자식 등의 정보 및 구조식으로 |\n| (Science Committee on Consumer Safety) | 미국 화장품 가이드라인 및 규정 |\n**가 내용 제공**\n| 미국 FDA(식품의약품청) | 화합물 검색이 가능하며 유료로 운영됨 |\n**미국 화장품 착색제**\n**관련 전문가로 이루어진 비영리단체로 화장품에**\n**미국 국립보건원(NIH)의 미국의학도서관(NLM) 내 미국 국립생물공**\n**· AIC 낮은 값을 선택(BMDS)**\n| CIR(Cosmetic Ingredient Review) | https://www.cir-safety.org/ | 사용되는 성분에 대한 정성적 안전성 평가 |\n| PubChem | https://pubmed.ncbi.nlm.nih.gov/ | 학정보센터(NCIB)가 관리하는 화학분자 및 생물학 관련 논문 데이 |\n**로 독성에 대하여 대조군에 비해 10%의 반응이 나타나는 용량의 95% 신뢰구간의 하한값을**\n| 중국 NMPA(국가약품감독관리국) | https://www.nmpa.gov.cn/hzhp/index.html | 중국 화장품 관련 규제 | - 보수적 접근으로 p-value > 0.05 인 모델 중 가장 낮은 BMDL 값 | 보고서 제공 |\n| SED = 50 × 1/109 × 65/100 × 1.62 mg/kg bw/day = 5.3×10-8 mg/kg bw/day | 의미한다. "
      }
    },
    {
      "chunk_id": "chunk_355",
      "text": "|\n**미국 국립보건원(NIH)의 생명과학 및 생물의**\n| - 그래프 확인 | 국제적으로 통용되는 화장품 성분의 명칭. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 354,
        "window_size": 3,
        "char_count": 68,
        "word_count": 16,
        "page_number": 37,
        "window_text": "성분 및 식별자료 검색\n\n사이트명\n\n홈페이지\n\n세부정보\n\n**[표 시작]**\n\n| CAS SciFindern | https://www.cas.org/solutions/cas-scifinder- | EU CosIng | 미국화학회(CAS)에서 구축하고 생화학, 의학, 화학공학 등에 특화된 |\n| --- | --- | --- | --- |\n| 결정할 수 있다.  | 사이트명 | 홈페이지 | 세부정보 | https://ec.europa.eu/growth/tools-databases/cosing/ | EU의 화장품 규정 및 화장품 성분에 대한 정보 |\n**과학연구 DB로 유료로 운영됨**\n**(유럽 화장품 성분 정보 데이터베이스**\n**미국화학회(CAS)와 독일 연방과학기술센터(FIZ)rk 공동으로 구축한**\n**SCCS**\n| 을 발생시키는 체중 1 kg당 일일 용량을 의미한다.  이것은 단일 관찰된 용량-반응으로부터 | 가정용 제품)의 건강 및 안전에 관한 위해성평 |\n| STN | https://www.stn-international.com/ | 데이터베이스로 구조식, CAS no, 분자식 등의 정보 및 구조식으로 |\n| (Science Committee on Consumer Safety) | 미국 화장품 가이드라인 및 규정 |\n**가 내용 제공**\n| 미국 FDA(식품의약품청) | 화합물 검색이 가능하며 유료로 운영됨 |\n**미국 화장품 착색제**\n**관련 전문가로 이루어진 비영리단체로 화장품에**\n**미국 국립보건원(NIH)의 미국의학도서관(NLM) 내 미국 국립생물공**\n**· AIC 낮은 값을 선택(BMDS)**\n| CIR(Cosmetic Ingredient Review) | https://www.cir-safety.org/ | 사용되는 성분에 대한 정성적 안전성 평가 |\n| PubChem | https://pubmed.ncbi.nlm.nih.gov/ | 학정보센터(NCIB)가 관리하는 화학분자 및 생물학 관련 논문 데이 |\n**로 독성에 대하여 대조군에 비해 10%의 반응이 나타나는 용량의 95% 신뢰구간의 하한값을**\n| 중국 NMPA(국가약품감독관리국) | https://www.nmpa.gov.cn/hzhp/index.html | 중국 화장품 관련 규제 | - 보수적 접근으로 p-value > 0.05 인 모델 중 가장 낮은 BMDL 값 | 보고서 제공 |\n| SED = 50 × 1/109 × 65/100 × 1.62 mg/kg bw/day = 5.3×10-8 mg/kg bw/day | 의미한다.  |\n**미국 국립보건원(NIH)의 생명과학 및 생물의**\n| - 그래프 확인 | 국제적으로 통용되는 화장품 성분의 명칭.  국제명칭위원회(INC)가 |\n| PubMed | https://pubmed.ncbi.nlm.nih.gov/ | 의약품, 의료기기 등의 품질, 유효성 및 안전 | 학에 관한 연구 및 최신동향 관련 논문을 확 |\n| wINCI | http://webdictionary.personalcarecouncil.org | 개발하고 PCPC(Personal Care Products Council)가 국제화장품성분 |\n| - BMD/BMDL 비율 : 낮은 값이 독성값에 대한 불확실성이 낮음 | 성 확보 등에 관한 법률 |\n**인할 수 있으며 일부 유료로 운영됨**\n| 일본 | 출할 수 있으며, 산출 방법은 다음과 같다.  | 사전(ICID) 및 핸드북에 게재하고 있음.  전자적으로 wINCI로 제공됨 |\n| ③ 위해도 결정 | 화장품 성분 관련 기준 |\n| - NOAEL(또는 LOAEL)/BMDL 비율 : 1에 가까울수록 불확실성이 낮음 | 세계보건기구 산하의 국제암연구기관으로 |\n| IARC | https://www.iarc.fr/ | 국내 화장품 성분명 표준화 위원회에서 「화장품법」에 따라 화장품 | 화장품 색소 관련 기준 |\n**1) 평생발암위해도(LCR) 산출**\n**발암물질에 대한 연구내용 및 분류 제공**\n| 대한화장품협회 성분사전 | https://kcia.or.kr/cid/search/ingd_list.php | 성분명을 표준화하여 제시하고 있음. ",
        "original_sentence": "|\n**미국 국립보건원(NIH)의 생명과학 및 생물의**\n| - 그래프 확인 | 국제적으로 통용되는 화장품 성분의 명칭. "
      }
    },
    {
      "chunk_id": "chunk_356",
      "text": "국제명칭위원회(INC)가 |\n| PubMed | https://pubmed.ncbi.nlm.nih.gov/ | 의약품, 의료기기 등의 품질, 유효성 및 안전 | 학에 관한 연구 및 최신동향 관련 논문을 확 |\n| wINCI | http://webdictionary.personalcarecouncil.org | 개발하고 PCPC(Personal Care Products Council)가 국제화장품성분 |\n| - BMD/BMDL 비율 : 낮은 값이 독성값에 대한 불확실성이 낮음 | 성 확보 등에 관한 법률 |\n**인할 수 있으며 일부 유료로 운영됨**\n| 일본 | 출할 수 있으며, 산출 방법은 다음과 같다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 355,
        "window_size": 3,
        "char_count": 342,
        "word_count": 70,
        "page_number": 2,
        "window_text": "| 사이트명 | 홈페이지 | 세부정보 | https://ec.europa.eu/growth/tools-databases/cosing/ | EU의 화장품 규정 및 화장품 성분에 대한 정보 |\n**과학연구 DB로 유료로 운영됨**\n**(유럽 화장품 성분 정보 데이터베이스**\n**미국화학회(CAS)와 독일 연방과학기술센터(FIZ)rk 공동으로 구축한**\n**SCCS**\n| 을 발생시키는 체중 1 kg당 일일 용량을 의미한다.  이것은 단일 관찰된 용량-반응으로부터 | 가정용 제품)의 건강 및 안전에 관한 위해성평 |\n| STN | https://www.stn-international.com/ | 데이터베이스로 구조식, CAS no, 분자식 등의 정보 및 구조식으로 |\n| (Science Committee on Consumer Safety) | 미국 화장품 가이드라인 및 규정 |\n**가 내용 제공**\n| 미국 FDA(식품의약품청) | 화합물 검색이 가능하며 유료로 운영됨 |\n**미국 화장품 착색제**\n**관련 전문가로 이루어진 비영리단체로 화장품에**\n**미국 국립보건원(NIH)의 미국의학도서관(NLM) 내 미국 국립생물공**\n**· AIC 낮은 값을 선택(BMDS)**\n| CIR(Cosmetic Ingredient Review) | https://www.cir-safety.org/ | 사용되는 성분에 대한 정성적 안전성 평가 |\n| PubChem | https://pubmed.ncbi.nlm.nih.gov/ | 학정보센터(NCIB)가 관리하는 화학분자 및 생물학 관련 논문 데이 |\n**로 독성에 대하여 대조군에 비해 10%의 반응이 나타나는 용량의 95% 신뢰구간의 하한값을**\n| 중국 NMPA(국가약품감독관리국) | https://www.nmpa.gov.cn/hzhp/index.html | 중국 화장품 관련 규제 | - 보수적 접근으로 p-value > 0.05 인 모델 중 가장 낮은 BMDL 값 | 보고서 제공 |\n| SED = 50 × 1/109 × 65/100 × 1.62 mg/kg bw/day = 5.3×10-8 mg/kg bw/day | 의미한다.  |\n**미국 국립보건원(NIH)의 생명과학 및 생물의**\n| - 그래프 확인 | 국제적으로 통용되는 화장품 성분의 명칭.  국제명칭위원회(INC)가 |\n| PubMed | https://pubmed.ncbi.nlm.nih.gov/ | 의약품, 의료기기 등의 품질, 유효성 및 안전 | 학에 관한 연구 및 최신동향 관련 논문을 확 |\n| wINCI | http://webdictionary.personalcarecouncil.org | 개발하고 PCPC(Personal Care Products Council)가 국제화장품성분 |\n| - BMD/BMDL 비율 : 낮은 값이 독성값에 대한 불확실성이 낮음 | 성 확보 등에 관한 법률 |\n**인할 수 있으며 일부 유료로 운영됨**\n| 일본 | 출할 수 있으며, 산출 방법은 다음과 같다.  | 사전(ICID) 및 핸드북에 게재하고 있음.  전자적으로 wINCI로 제공됨 |\n| ③ 위해도 결정 | 화장품 성분 관련 기준 |\n| - NOAEL(또는 LOAEL)/BMDL 비율 : 1에 가까울수록 불확실성이 낮음 | 세계보건기구 산하의 국제암연구기관으로 |\n| IARC | https://www.iarc.fr/ | 국내 화장품 성분명 표준화 위원회에서 「화장품법」에 따라 화장품 | 화장품 색소 관련 기준 |\n**1) 평생발암위해도(LCR) 산출**\n**발암물질에 대한 연구내용 및 분류 제공**\n| 대한화장품협회 성분사전 | https://kcia.or.kr/cid/search/ingd_list.php | 성분명을 표준화하여 제시하고 있음.  국문, 영문 성분명, CAS no, |\n\n**[표 끝]**\n\n구조식 등 확인 가능함. ",
        "original_sentence": "국제명칭위원회(INC)가 |\n| PubMed | https://pubmed.ncbi.nlm.nih.gov/ | 의약품, 의료기기 등의 품질, 유효성 및 안전 | 학에 관한 연구 및 최신동향 관련 논문을 확 |\n| wINCI | http://webdictionary.personalcarecouncil.org | 개발하고 PCPC(Personal Care Products Council)가 국제화장품성분 |\n| - BMD/BMDL 비율 : 낮은 값이 독성값에 대한 불확실성이 낮음 | 성 확보 등에 관한 법률 |\n**인할 수 있으며 일부 유료로 운영됨**\n| 일본 | 출할 수 있으며, 산출 방법은 다음과 같다. "
      }
    },
    {
      "chunk_id": "chunk_357",
      "text": "| 사전(ICID) 및 핸드북에 게재하고 있음. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 356,
        "window_size": 3,
        "char_count": 27,
        "word_count": 6,
        "page_number": 1,
        "window_text": "이것은 단일 관찰된 용량-반응으로부터 | 가정용 제품)의 건강 및 안전에 관한 위해성평 |\n| STN | https://www.stn-international.com/ | 데이터베이스로 구조식, CAS no, 분자식 등의 정보 및 구조식으로 |\n| (Science Committee on Consumer Safety) | 미국 화장품 가이드라인 및 규정 |\n**가 내용 제공**\n| 미국 FDA(식품의약품청) | 화합물 검색이 가능하며 유료로 운영됨 |\n**미국 화장품 착색제**\n**관련 전문가로 이루어진 비영리단체로 화장품에**\n**미국 국립보건원(NIH)의 미국의학도서관(NLM) 내 미국 국립생물공**\n**· AIC 낮은 값을 선택(BMDS)**\n| CIR(Cosmetic Ingredient Review) | https://www.cir-safety.org/ | 사용되는 성분에 대한 정성적 안전성 평가 |\n| PubChem | https://pubmed.ncbi.nlm.nih.gov/ | 학정보센터(NCIB)가 관리하는 화학분자 및 생물학 관련 논문 데이 |\n**로 독성에 대하여 대조군에 비해 10%의 반응이 나타나는 용량의 95% 신뢰구간의 하한값을**\n| 중국 NMPA(국가약품감독관리국) | https://www.nmpa.gov.cn/hzhp/index.html | 중국 화장품 관련 규제 | - 보수적 접근으로 p-value > 0.05 인 모델 중 가장 낮은 BMDL 값 | 보고서 제공 |\n| SED = 50 × 1/109 × 65/100 × 1.62 mg/kg bw/day = 5.3×10-8 mg/kg bw/day | 의미한다.  |\n**미국 국립보건원(NIH)의 생명과학 및 생물의**\n| - 그래프 확인 | 국제적으로 통용되는 화장품 성분의 명칭.  국제명칭위원회(INC)가 |\n| PubMed | https://pubmed.ncbi.nlm.nih.gov/ | 의약품, 의료기기 등의 품질, 유효성 및 안전 | 학에 관한 연구 및 최신동향 관련 논문을 확 |\n| wINCI | http://webdictionary.personalcarecouncil.org | 개발하고 PCPC(Personal Care Products Council)가 국제화장품성분 |\n| - BMD/BMDL 비율 : 낮은 값이 독성값에 대한 불확실성이 낮음 | 성 확보 등에 관한 법률 |\n**인할 수 있으며 일부 유료로 운영됨**\n| 일본 | 출할 수 있으며, 산출 방법은 다음과 같다.  | 사전(ICID) 및 핸드북에 게재하고 있음.  전자적으로 wINCI로 제공됨 |\n| ③ 위해도 결정 | 화장품 성분 관련 기준 |\n| - NOAEL(또는 LOAEL)/BMDL 비율 : 1에 가까울수록 불확실성이 낮음 | 세계보건기구 산하의 국제암연구기관으로 |\n| IARC | https://www.iarc.fr/ | 국내 화장품 성분명 표준화 위원회에서 「화장품법」에 따라 화장품 | 화장품 색소 관련 기준 |\n**1) 평생발암위해도(LCR) 산출**\n**발암물질에 대한 연구내용 및 분류 제공**\n| 대한화장품협회 성분사전 | https://kcia.or.kr/cid/search/ingd_list.php | 성분명을 표준화하여 제시하고 있음.  국문, 영문 성분명, CAS no, |\n\n**[표 끝]**\n\n구조식 등 확인 가능함.  일부 내용은 회원사에만 제공되고 있음\n\n<!-- PAGE_64 -->\n###### 2. ",
        "original_sentence": "| 사전(ICID) 및 핸드북에 게재하고 있음. "
      }
    },
    {
      "chunk_id": "chunk_358",
      "text": "전자적으로 wINCI로 제공됨 |\n| ③ 위해도 결정 | 화장품 성분 관련 기준 |\n| - NOAEL(또는 LOAEL)/BMDL 비율 : 1에 가까울수록 불확실성이 낮음 | 세계보건기구 산하의 국제암연구기관으로 |\n| IARC | https://www.iarc.fr/ | 국내 화장품 성분명 표준화 위원회에서 「화장품법」에 따라 화장품 | 화장품 색소 관련 기준 |\n**1) 평생발암위해도(LCR) 산출**\n**발암물질에 대한 연구내용 및 분류 제공**\n| 대한화장품협회 성분사전 | https://kcia.or.kr/cid/search/ingd_list.php | 성분명을 표준화하여 제시하고 있음. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 357,
        "window_size": 3,
        "char_count": 337,
        "word_count": 67,
        "page_number": 37,
        "window_text": "|\n**미국 국립보건원(NIH)의 생명과학 및 생물의**\n| - 그래프 확인 | 국제적으로 통용되는 화장품 성분의 명칭.  국제명칭위원회(INC)가 |\n| PubMed | https://pubmed.ncbi.nlm.nih.gov/ | 의약품, 의료기기 등의 품질, 유효성 및 안전 | 학에 관한 연구 및 최신동향 관련 논문을 확 |\n| wINCI | http://webdictionary.personalcarecouncil.org | 개발하고 PCPC(Personal Care Products Council)가 국제화장품성분 |\n| - BMD/BMDL 비율 : 낮은 값이 독성값에 대한 불확실성이 낮음 | 성 확보 등에 관한 법률 |\n**인할 수 있으며 일부 유료로 운영됨**\n| 일본 | 출할 수 있으며, 산출 방법은 다음과 같다.  | 사전(ICID) 및 핸드북에 게재하고 있음.  전자적으로 wINCI로 제공됨 |\n| ③ 위해도 결정 | 화장품 성분 관련 기준 |\n| - NOAEL(또는 LOAEL)/BMDL 비율 : 1에 가까울수록 불확실성이 낮음 | 세계보건기구 산하의 국제암연구기관으로 |\n| IARC | https://www.iarc.fr/ | 국내 화장품 성분명 표준화 위원회에서 「화장품법」에 따라 화장품 | 화장품 색소 관련 기준 |\n**1) 평생발암위해도(LCR) 산출**\n**발암물질에 대한 연구내용 및 분류 제공**\n| 대한화장품협회 성분사전 | https://kcia.or.kr/cid/search/ingd_list.php | 성분명을 표준화하여 제시하고 있음.  국문, 영문 성분명, CAS no, |\n\n**[표 끝]**\n\n구조식 등 확인 가능함.  일부 내용은 회원사에만 제공되고 있음\n\n<!-- PAGE_64 -->\n###### 2.  법률 규제 확인\n\n사이트명\n\n홈페이지\n\n세부정보\n\n한국 의약품안전나라 의약품통합정보시\n\n스템\n\nhttps://nedrug.mfds.go.kr/index\n\n국내 화장품원료 정보 및 규제정보\n\n**[표 시작]**\n\n**: 역학 자료가 있는 경우에는 우선적으로 고려하며, 동물 자료를 이용할 경우에는 사용할 동**\n**OECD(경제협력개발기구)의 후원으로 작성된**\n| OECD SIDS | https://hpvchemicals.oecd.org/ui/Default.aspx |\n| ASEAN Cosmetics Association | 물 데이터 세트와 고려할 종양 유형을 결정한다. ",
        "original_sentence": "전자적으로 wINCI로 제공됨 |\n| ③ 위해도 결정 | 화장품 성분 관련 기준 |\n| - NOAEL(또는 LOAEL)/BMDL 비율 : 1에 가까울수록 불확실성이 낮음 | 세계보건기구 산하의 국제암연구기관으로 |\n| IARC | https://www.iarc.fr/ | 국내 화장품 성분명 표준화 위원회에서 「화장품법」에 따라 화장품 | 화장품 색소 관련 기준 |\n**1) 평생발암위해도(LCR) 산출**\n**발암물질에 대한 연구내용 및 분류 제공**\n| 대한화장품협회 성분사전 | https://kcia.or.kr/cid/search/ingd_list.php | 성분명을 표준화하여 제시하고 있음. "
      }
    },
    {
      "chunk_id": "chunk_359",
      "text": "국문, 영문 성분명, CAS no, |\n\n**[표 끝]**\n\n구조식 등 확인 가능함. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 358,
        "window_size": 3,
        "char_count": 48,
        "word_count": 12,
        "page_number": 19,
        "window_text": "국제명칭위원회(INC)가 |\n| PubMed | https://pubmed.ncbi.nlm.nih.gov/ | 의약품, 의료기기 등의 품질, 유효성 및 안전 | 학에 관한 연구 및 최신동향 관련 논문을 확 |\n| wINCI | http://webdictionary.personalcarecouncil.org | 개발하고 PCPC(Personal Care Products Council)가 국제화장품성분 |\n| - BMD/BMDL 비율 : 낮은 값이 독성값에 대한 불확실성이 낮음 | 성 확보 등에 관한 법률 |\n**인할 수 있으며 일부 유료로 운영됨**\n| 일본 | 출할 수 있으며, 산출 방법은 다음과 같다.  | 사전(ICID) 및 핸드북에 게재하고 있음.  전자적으로 wINCI로 제공됨 |\n| ③ 위해도 결정 | 화장품 성분 관련 기준 |\n| - NOAEL(또는 LOAEL)/BMDL 비율 : 1에 가까울수록 불확실성이 낮음 | 세계보건기구 산하의 국제암연구기관으로 |\n| IARC | https://www.iarc.fr/ | 국내 화장품 성분명 표준화 위원회에서 「화장품법」에 따라 화장품 | 화장품 색소 관련 기준 |\n**1) 평생발암위해도(LCR) 산출**\n**발암물질에 대한 연구내용 및 분류 제공**\n| 대한화장품협회 성분사전 | https://kcia.or.kr/cid/search/ingd_list.php | 성분명을 표준화하여 제시하고 있음.  국문, 영문 성분명, CAS no, |\n\n**[표 끝]**\n\n구조식 등 확인 가능함.  일부 내용은 회원사에만 제공되고 있음\n\n<!-- PAGE_64 -->\n###### 2.  법률 규제 확인\n\n사이트명\n\n홈페이지\n\n세부정보\n\n한국 의약품안전나라 의약품통합정보시\n\n스템\n\nhttps://nedrug.mfds.go.kr/index\n\n국내 화장품원료 정보 및 규제정보\n\n**[표 시작]**\n\n**: 역학 자료가 있는 경우에는 우선적으로 고려하며, 동물 자료를 이용할 경우에는 사용할 동**\n**OECD(경제협력개발기구)의 후원으로 작성된**\n| OECD SIDS | https://hpvchemicals.oecd.org/ui/Default.aspx |\n| ASEAN Cosmetics Association | 물 데이터 세트와 고려할 종양 유형을 결정한다.  동물 용량 디스크립터(dose-descriptor, | 아세안 화장품협회 화장품 지침 |\n**화학물질 위험에 관한 연구 보고서 제공**\n| (아세안 화장품협회) | 아세안 화장품 성분 정보 |\n**T25)는 비교 대사율을 기반으로 인체 용량 디스크립터(HT25)로 변환된다. ",
        "original_sentence": "국문, 영문 성분명, CAS no, |\n\n**[표 끝]**\n\n구조식 등 확인 가능함. "
      }
    },
    {
      "chunk_id": "chunk_360",
      "text": "일부 내용은 회원사에만 제공되고 있음\n\n<!-- PAGE_64 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 359,
        "window_size": 3,
        "char_count": 49,
        "word_count": 10,
        "page_number": 64,
        "window_text": "| 사전(ICID) 및 핸드북에 게재하고 있음.  전자적으로 wINCI로 제공됨 |\n| ③ 위해도 결정 | 화장품 성분 관련 기준 |\n| - NOAEL(또는 LOAEL)/BMDL 비율 : 1에 가까울수록 불확실성이 낮음 | 세계보건기구 산하의 국제암연구기관으로 |\n| IARC | https://www.iarc.fr/ | 국내 화장품 성분명 표준화 위원회에서 「화장품법」에 따라 화장품 | 화장품 색소 관련 기준 |\n**1) 평생발암위해도(LCR) 산출**\n**발암물질에 대한 연구내용 및 분류 제공**\n| 대한화장품협회 성분사전 | https://kcia.or.kr/cid/search/ingd_list.php | 성분명을 표준화하여 제시하고 있음.  국문, 영문 성분명, CAS no, |\n\n**[표 끝]**\n\n구조식 등 확인 가능함.  일부 내용은 회원사에만 제공되고 있음\n\n<!-- PAGE_64 -->\n###### 2.  법률 규제 확인\n\n사이트명\n\n홈페이지\n\n세부정보\n\n한국 의약품안전나라 의약품통합정보시\n\n스템\n\nhttps://nedrug.mfds.go.kr/index\n\n국내 화장품원료 정보 및 규제정보\n\n**[표 시작]**\n\n**: 역학 자료가 있는 경우에는 우선적으로 고려하며, 동물 자료를 이용할 경우에는 사용할 동**\n**OECD(경제협력개발기구)의 후원으로 작성된**\n| OECD SIDS | https://hpvchemicals.oecd.org/ui/Default.aspx |\n| ASEAN Cosmetics Association | 물 데이터 세트와 고려할 종양 유형을 결정한다.  동물 용량 디스크립터(dose-descriptor, | 아세안 화장품협회 화장품 지침 |\n**화학물질 위험에 관한 연구 보고서 제공**\n| (아세안 화장품협회) | 아세안 화장품 성분 정보 |\n**T25)는 비교 대사율을 기반으로 인체 용량 디스크립터(HT25)로 변환된다.  또한, 평생발암**\n| OECD library | https://www.oecd-ilibrary.org/environment/oec |\n**OECD Guideline 시험 지침 제공**\n| - MOE가 104 이상이므로 위해 우려 가능성 낮음 | 위해도(LCR)는 EPA, IRIS 등 규제기관에서 산출된 값을 이용할 수 있으며, 10-5 미만이면 |\n**화장품 관련 규제 및 화학물질 관련 위해성평**\n**호주**\n**가 보고서 제공**\n\n**[표 끝]**\n\n<!-- PAGE_65 -->\n###### 3. ",
        "original_sentence": "일부 내용은 회원사에만 제공되고 있음\n\n<!-- PAGE_64 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_361",
      "text": "법률 규제 확인\n\n사이트명\n\n홈페이지\n\n세부정보\n\n한국 의약품안전나라 의약품통합정보시\n\n스템\n\nhttps://nedrug.mfds.go.kr/index\n\n국내 화장품원료 정보 및 규제정보\n\n**[표 시작]**\n\n**: 역학 자료가 있는 경우에는 우선적으로 고려하며, 동물 자료를 이용할 경우에는 사용할 동**\n**OECD(경제협력개발기구)의 후원으로 작성된**\n| OECD SIDS | https://hpvchemicals.oecd.org/ui/Default.aspx |\n| ASEAN Cosmetics Association | 물 데이터 세트와 고려할 종양 유형을 결정한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 360,
        "window_size": 3,
        "char_count": 323,
        "word_count": 52,
        "page_number": 63,
        "window_text": "전자적으로 wINCI로 제공됨 |\n| ③ 위해도 결정 | 화장품 성분 관련 기준 |\n| - NOAEL(또는 LOAEL)/BMDL 비율 : 1에 가까울수록 불확실성이 낮음 | 세계보건기구 산하의 국제암연구기관으로 |\n| IARC | https://www.iarc.fr/ | 국내 화장품 성분명 표준화 위원회에서 「화장품법」에 따라 화장품 | 화장품 색소 관련 기준 |\n**1) 평생발암위해도(LCR) 산출**\n**발암물질에 대한 연구내용 및 분류 제공**\n| 대한화장품협회 성분사전 | https://kcia.or.kr/cid/search/ingd_list.php | 성분명을 표준화하여 제시하고 있음.  국문, 영문 성분명, CAS no, |\n\n**[표 끝]**\n\n구조식 등 확인 가능함.  일부 내용은 회원사에만 제공되고 있음\n\n<!-- PAGE_64 -->\n###### 2.  법률 규제 확인\n\n사이트명\n\n홈페이지\n\n세부정보\n\n한국 의약품안전나라 의약품통합정보시\n\n스템\n\nhttps://nedrug.mfds.go.kr/index\n\n국내 화장품원료 정보 및 규제정보\n\n**[표 시작]**\n\n**: 역학 자료가 있는 경우에는 우선적으로 고려하며, 동물 자료를 이용할 경우에는 사용할 동**\n**OECD(경제협력개발기구)의 후원으로 작성된**\n| OECD SIDS | https://hpvchemicals.oecd.org/ui/Default.aspx |\n| ASEAN Cosmetics Association | 물 데이터 세트와 고려할 종양 유형을 결정한다.  동물 용량 디스크립터(dose-descriptor, | 아세안 화장품협회 화장품 지침 |\n**화학물질 위험에 관한 연구 보고서 제공**\n| (아세안 화장품협회) | 아세안 화장품 성분 정보 |\n**T25)는 비교 대사율을 기반으로 인체 용량 디스크립터(HT25)로 변환된다.  또한, 평생발암**\n| OECD library | https://www.oecd-ilibrary.org/environment/oec |\n**OECD Guideline 시험 지침 제공**\n| - MOE가 104 이상이므로 위해 우려 가능성 낮음 | 위해도(LCR)는 EPA, IRIS 등 규제기관에서 산출된 값을 이용할 수 있으며, 10-5 미만이면 |\n**화장품 관련 규제 및 화학물질 관련 위해성평**\n**호주**\n**가 보고서 제공**\n\n**[표 끝]**\n\n<!-- PAGE_65 -->\n###### 3.  독성 및 위해 정보\n\n**[표 시작]**\n\n| IFRA | https://ifrafragrance.org/ | 제한 금지에 대한 향료안전기준 및 제조법 |\n| --- | --- | --- |\n| 및 지침 등 제공 | CICADS, EHS, HSGs, ICSCs, JECFA, JMPR, |\n| 계산하기 위해, 생물학적으로 유의한 종양이 발생하는 최저용량의 종양 발생 비율(32%)과 최 | (Benchmark Dose Software)와 RIVM(https://www.rivm.nl/en/proast)에서 개발된 PROAST가 |\n**KemI-Riskline, PIMs , UKPID 등이 포함됨**\n| 저용량에서 노출기간 동안 노출된 체중 1 kg 당 1일 용량(6.4 mg/kg bw/day)를 고려하여 계산 | 있다. ",
        "original_sentence": "법률 규제 확인\n\n사이트명\n\n홈페이지\n\n세부정보\n\n한국 의약품안전나라 의약품통합정보시\n\n스템\n\nhttps://nedrug.mfds.go.kr/index\n\n국내 화장품원료 정보 및 규제정보\n\n**[표 시작]**\n\n**: 역학 자료가 있는 경우에는 우선적으로 고려하며, 동물 자료를 이용할 경우에는 사용할 동**\n**OECD(경제협력개발기구)의 후원으로 작성된**\n| OECD SIDS | https://hpvchemicals.oecd.org/ui/Default.aspx |\n| ASEAN Cosmetics Association | 물 데이터 세트와 고려할 종양 유형을 결정한다. "
      }
    },
    {
      "chunk_id": "chunk_362",
      "text": "동물 용량 디스크립터(dose-descriptor, | 아세안 화장품협회 화장품 지침 |\n**화학물질 위험에 관한 연구 보고서 제공**\n| (아세안 화장품협회) | 아세안 화장품 성분 정보 |\n**T25)는 비교 대사율을 기반으로 인체 용량 디스크립터(HT25)로 변환된다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 361,
        "window_size": 3,
        "char_count": 154,
        "word_count": 32,
        "page_number": 37,
        "window_text": "국문, 영문 성분명, CAS no, |\n\n**[표 끝]**\n\n구조식 등 확인 가능함.  일부 내용은 회원사에만 제공되고 있음\n\n<!-- PAGE_64 -->\n###### 2.  법률 규제 확인\n\n사이트명\n\n홈페이지\n\n세부정보\n\n한국 의약품안전나라 의약품통합정보시\n\n스템\n\nhttps://nedrug.mfds.go.kr/index\n\n국내 화장품원료 정보 및 규제정보\n\n**[표 시작]**\n\n**: 역학 자료가 있는 경우에는 우선적으로 고려하며, 동물 자료를 이용할 경우에는 사용할 동**\n**OECD(경제협력개발기구)의 후원으로 작성된**\n| OECD SIDS | https://hpvchemicals.oecd.org/ui/Default.aspx |\n| ASEAN Cosmetics Association | 물 데이터 세트와 고려할 종양 유형을 결정한다.  동물 용량 디스크립터(dose-descriptor, | 아세안 화장품협회 화장품 지침 |\n**화학물질 위험에 관한 연구 보고서 제공**\n| (아세안 화장품협회) | 아세안 화장품 성분 정보 |\n**T25)는 비교 대사율을 기반으로 인체 용량 디스크립터(HT25)로 변환된다.  또한, 평생발암**\n| OECD library | https://www.oecd-ilibrary.org/environment/oec |\n**OECD Guideline 시험 지침 제공**\n| - MOE가 104 이상이므로 위해 우려 가능성 낮음 | 위해도(LCR)는 EPA, IRIS 등 규제기관에서 산출된 값을 이용할 수 있으며, 10-5 미만이면 |\n**화장품 관련 규제 및 화학물질 관련 위해성평**\n**호주**\n**가 보고서 제공**\n\n**[표 끝]**\n\n<!-- PAGE_65 -->\n###### 3.  독성 및 위해 정보\n\n**[표 시작]**\n\n| IFRA | https://ifrafragrance.org/ | 제한 금지에 대한 향료안전기준 및 제조법 |\n| --- | --- | --- |\n| 및 지침 등 제공 | CICADS, EHS, HSGs, ICSCs, JECFA, JMPR, |\n| 계산하기 위해, 생물학적으로 유의한 종양이 발생하는 최저용량의 종양 발생 비율(32%)과 최 | (Benchmark Dose Software)와 RIVM(https://www.rivm.nl/en/proast)에서 개발된 PROAST가 |\n**KemI-Riskline, PIMs , UKPID 등이 포함됨**\n| 저용량에서 노출기간 동안 노출된 체중 1 kg 당 1일 용량(6.4 mg/kg bw/day)를 고려하여 계산 | 있다.  BMD 접근법은 여러 수학적 모델(probit, gamma, logist, weibull 등)을 활용하여 그 |\n| ① 물질 B의 용량-반응 연구에서 도출된 BMDL10 : 0.018 mg/kg bw/day | 이용하여 평생발암위해도(lifetime cancer risk, LCR)를 결정하거나 용량 디스크립터와 인체 | RIFM(향료물질연구소)에서 향료 물질에 대한 |\n| RIFM | https://rifm.org/ |\n| 적합도를 평가하여 최종 BMDL을 선택하게 된다. ",
        "original_sentence": "동물 용량 디스크립터(dose-descriptor, | 아세안 화장품협회 화장품 지침 |\n**화학물질 위험에 관한 연구 보고서 제공**\n| (아세안 화장품협회) | 아세안 화장품 성분 정보 |\n**T25)는 비교 대사율을 기반으로 인체 용량 디스크립터(HT25)로 변환된다. "
      }
    },
    {
      "chunk_id": "chunk_363",
      "text": "또한, 평생발암**\n| OECD library | https://www.oecd-ilibrary.org/environment/oec |\n**OECD Guideline 시험 지침 제공**\n| - MOE가 104 이상이므로 위해 우려 가능성 낮음 | 위해도(LCR)는 EPA, IRIS 등 규제기관에서 산출된 값을 이용할 수 있으며, 10-5 미만이면 |\n**화장품 관련 규제 및 화학물질 관련 위해성평**\n**호주**\n**가 보고서 제공**\n\n**[표 끝]**\n\n<!-- PAGE_65 -->\n###### 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 362,
        "window_size": 3,
        "char_count": 285,
        "word_count": 54,
        "page_number": 65,
        "window_text": "일부 내용은 회원사에만 제공되고 있음\n\n<!-- PAGE_64 -->\n###### 2.  법률 규제 확인\n\n사이트명\n\n홈페이지\n\n세부정보\n\n한국 의약품안전나라 의약품통합정보시\n\n스템\n\nhttps://nedrug.mfds.go.kr/index\n\n국내 화장품원료 정보 및 규제정보\n\n**[표 시작]**\n\n**: 역학 자료가 있는 경우에는 우선적으로 고려하며, 동물 자료를 이용할 경우에는 사용할 동**\n**OECD(경제협력개발기구)의 후원으로 작성된**\n| OECD SIDS | https://hpvchemicals.oecd.org/ui/Default.aspx |\n| ASEAN Cosmetics Association | 물 데이터 세트와 고려할 종양 유형을 결정한다.  동물 용량 디스크립터(dose-descriptor, | 아세안 화장품협회 화장품 지침 |\n**화학물질 위험에 관한 연구 보고서 제공**\n| (아세안 화장품협회) | 아세안 화장품 성분 정보 |\n**T25)는 비교 대사율을 기반으로 인체 용량 디스크립터(HT25)로 변환된다.  또한, 평생발암**\n| OECD library | https://www.oecd-ilibrary.org/environment/oec |\n**OECD Guideline 시험 지침 제공**\n| - MOE가 104 이상이므로 위해 우려 가능성 낮음 | 위해도(LCR)는 EPA, IRIS 등 규제기관에서 산출된 값을 이용할 수 있으며, 10-5 미만이면 |\n**화장품 관련 규제 및 화학물질 관련 위해성평**\n**호주**\n**가 보고서 제공**\n\n**[표 끝]**\n\n<!-- PAGE_65 -->\n###### 3.  독성 및 위해 정보\n\n**[표 시작]**\n\n| IFRA | https://ifrafragrance.org/ | 제한 금지에 대한 향료안전기준 및 제조법 |\n| --- | --- | --- |\n| 및 지침 등 제공 | CICADS, EHS, HSGs, ICSCs, JECFA, JMPR, |\n| 계산하기 위해, 생물학적으로 유의한 종양이 발생하는 최저용량의 종양 발생 비율(32%)과 최 | (Benchmark Dose Software)와 RIVM(https://www.rivm.nl/en/proast)에서 개발된 PROAST가 |\n**KemI-Riskline, PIMs , UKPID 등이 포함됨**\n| 저용량에서 노출기간 동안 노출된 체중 1 kg 당 1일 용량(6.4 mg/kg bw/day)를 고려하여 계산 | 있다.  BMD 접근법은 여러 수학적 모델(probit, gamma, logist, weibull 등)을 활용하여 그 |\n| ① 물질 B의 용량-반응 연구에서 도출된 BMDL10 : 0.018 mg/kg bw/day | 이용하여 평생발암위해도(lifetime cancer risk, LCR)를 결정하거나 용량 디스크립터와 인체 | RIFM(향료물질연구소)에서 향료 물질에 대한 |\n| RIFM | https://rifm.org/ |\n| 적합도를 평가하여 최종 BMDL을 선택하게 된다.  아래 사항은 기본적으로 모델 선택 판단 | 안전성 평가에 필요한 독성 관련 자료를 제공함 |\n**노출량 추정치 사이의 비율인 노출안전역(margin of exposure, MOE) 산출을 통해 위해도를**\n**비식품 소비자제품(화장품, 완구, 직물, 의류,**\n\n**[표 끝]**\n\nIFRA(국제향료협회)에서 제공하는 향료물질의\n\nIPCS INCHEM\n\nhttps://inchem.org/#/\n\nIPCS(국제화학물질안전프로그램) 및 CCOHS(캐\n\n나다 산업보건 및 안전센터)에서 운영하는 최\n\n신 화학물질 안전 관련 간행물 및 국제 기구\n\n의 데이터베이스 확인 가능\n\n<!-- PAGE_67 -->\n###### 참고 1. ",
        "original_sentence": "또한, 평생발암**\n| OECD library | https://www.oecd-ilibrary.org/environment/oec |\n**OECD Guideline 시험 지침 제공**\n| - MOE가 104 이상이므로 위해 우려 가능성 낮음 | 위해도(LCR)는 EPA, IRIS 등 규제기관에서 산출된 값을 이용할 수 있으며, 10-5 미만이면 |\n**화장품 관련 규제 및 화학물질 관련 위해성평**\n**호주**\n**가 보고서 제공**\n\n**[표 끝]**\n\n<!-- PAGE_65 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_364",
      "text": "독성 및 위해 정보\n\n**[표 시작]**\n\n| IFRA | https://ifrafragrance.org/ | 제한 금지에 대한 향료안전기준 및 제조법 |\n| --- | --- | --- |\n| 및 지침 등 제공 | CICADS, EHS, HSGs, ICSCs, JECFA, JMPR, |\n| 계산하기 위해, 생물학적으로 유의한 종양이 발생하는 최저용량의 종양 발생 비율(32%)과 최 | (Benchmark Dose Software)와 RIVM(https://www.rivm.nl/en/proast)에서 개발된 PROAST가 |\n**KemI-Riskline, PIMs , UKPID 등이 포함됨**\n| 저용량에서 노출기간 동안 노출된 체중 1 kg 당 1일 용량(6.4 mg/kg bw/day)를 고려하여 계산 | 있다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 363,
        "window_size": 3,
        "char_count": 405,
        "word_count": 81,
        "page_number": 37,
        "window_text": "법률 규제 확인\n\n사이트명\n\n홈페이지\n\n세부정보\n\n한국 의약품안전나라 의약품통합정보시\n\n스템\n\nhttps://nedrug.mfds.go.kr/index\n\n국내 화장품원료 정보 및 규제정보\n\n**[표 시작]**\n\n**: 역학 자료가 있는 경우에는 우선적으로 고려하며, 동물 자료를 이용할 경우에는 사용할 동**\n**OECD(경제협력개발기구)의 후원으로 작성된**\n| OECD SIDS | https://hpvchemicals.oecd.org/ui/Default.aspx |\n| ASEAN Cosmetics Association | 물 데이터 세트와 고려할 종양 유형을 결정한다.  동물 용량 디스크립터(dose-descriptor, | 아세안 화장품협회 화장품 지침 |\n**화학물질 위험에 관한 연구 보고서 제공**\n| (아세안 화장품협회) | 아세안 화장품 성분 정보 |\n**T25)는 비교 대사율을 기반으로 인체 용량 디스크립터(HT25)로 변환된다.  또한, 평생발암**\n| OECD library | https://www.oecd-ilibrary.org/environment/oec |\n**OECD Guideline 시험 지침 제공**\n| - MOE가 104 이상이므로 위해 우려 가능성 낮음 | 위해도(LCR)는 EPA, IRIS 등 규제기관에서 산출된 값을 이용할 수 있으며, 10-5 미만이면 |\n**화장품 관련 규제 및 화학물질 관련 위해성평**\n**호주**\n**가 보고서 제공**\n\n**[표 끝]**\n\n<!-- PAGE_65 -->\n###### 3.  독성 및 위해 정보\n\n**[표 시작]**\n\n| IFRA | https://ifrafragrance.org/ | 제한 금지에 대한 향료안전기준 및 제조법 |\n| --- | --- | --- |\n| 및 지침 등 제공 | CICADS, EHS, HSGs, ICSCs, JECFA, JMPR, |\n| 계산하기 위해, 생물학적으로 유의한 종양이 발생하는 최저용량의 종양 발생 비율(32%)과 최 | (Benchmark Dose Software)와 RIVM(https://www.rivm.nl/en/proast)에서 개발된 PROAST가 |\n**KemI-Riskline, PIMs , UKPID 등이 포함됨**\n| 저용량에서 노출기간 동안 노출된 체중 1 kg 당 1일 용량(6.4 mg/kg bw/day)를 고려하여 계산 | 있다.  BMD 접근법은 여러 수학적 모델(probit, gamma, logist, weibull 등)을 활용하여 그 |\n| ① 물질 B의 용량-반응 연구에서 도출된 BMDL10 : 0.018 mg/kg bw/day | 이용하여 평생발암위해도(lifetime cancer risk, LCR)를 결정하거나 용량 디스크립터와 인체 | RIFM(향료물질연구소)에서 향료 물질에 대한 |\n| RIFM | https://rifm.org/ |\n| 적합도를 평가하여 최종 BMDL을 선택하게 된다.  아래 사항은 기본적으로 모델 선택 판단 | 안전성 평가에 필요한 독성 관련 자료를 제공함 |\n**노출량 추정치 사이의 비율인 노출안전역(margin of exposure, MOE) 산출을 통해 위해도를**\n**비식품 소비자제품(화장품, 완구, 직물, 의류,**\n\n**[표 끝]**\n\nIFRA(국제향료협회)에서 제공하는 향료물질의\n\nIPCS INCHEM\n\nhttps://inchem.org/#/\n\nIPCS(국제화학물질안전프로그램) 및 CCOHS(캐\n\n나다 산업보건 및 안전센터)에서 운영하는 최\n\n신 화학물질 안전 관련 간행물 및 국제 기구\n\n의 데이터베이스 확인 가능\n\n<!-- PAGE_67 -->\n###### 참고 1.  발암물질 위해평가 및 예시\n\n<!-- PAGE_67 -->\n###### 참고 2. ",
        "original_sentence": "독성 및 위해 정보\n\n**[표 시작]**\n\n| IFRA | https://ifrafragrance.org/ | 제한 금지에 대한 향료안전기준 및 제조법 |\n| --- | --- | --- |\n| 및 지침 등 제공 | CICADS, EHS, HSGs, ICSCs, JECFA, JMPR, |\n| 계산하기 위해, 생물학적으로 유의한 종양이 발생하는 최저용량의 종양 발생 비율(32%)과 최 | (Benchmark Dose Software)와 RIVM(https://www.rivm.nl/en/proast)에서 개발된 PROAST가 |\n**KemI-Riskline, PIMs , UKPID 등이 포함됨**\n| 저용량에서 노출기간 동안 노출된 체중 1 kg 당 1일 용량(6.4 mg/kg bw/day)를 고려하여 계산 | 있다. "
      }
    },
    {
      "chunk_id": "chunk_365",
      "text": "BMD 접근법은 여러 수학적 모델(probit, gamma, logist, weibull 등)을 활용하여 그 |\n| ① 물질 B의 용량-반응 연구에서 도출된 BMDL10 : 0.018 mg/kg bw/day | 이용하여 평생발암위해도(lifetime cancer risk, LCR)를 결정하거나 용량 디스크립터와 인체 | RIFM(향료물질연구소)에서 향료 물질에 대한 |\n| RIFM | https://rifm.org/ |\n| 적합도를 평가하여 최종 BMDL을 선택하게 된다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 364,
        "window_size": 3,
        "char_count": 267,
        "word_count": 52,
        "page_number": 72,
        "window_text": "동물 용량 디스크립터(dose-descriptor, | 아세안 화장품협회 화장품 지침 |\n**화학물질 위험에 관한 연구 보고서 제공**\n| (아세안 화장품협회) | 아세안 화장품 성분 정보 |\n**T25)는 비교 대사율을 기반으로 인체 용량 디스크립터(HT25)로 변환된다.  또한, 평생발암**\n| OECD library | https://www.oecd-ilibrary.org/environment/oec |\n**OECD Guideline 시험 지침 제공**\n| - MOE가 104 이상이므로 위해 우려 가능성 낮음 | 위해도(LCR)는 EPA, IRIS 등 규제기관에서 산출된 값을 이용할 수 있으며, 10-5 미만이면 |\n**화장품 관련 규제 및 화학물질 관련 위해성평**\n**호주**\n**가 보고서 제공**\n\n**[표 끝]**\n\n<!-- PAGE_65 -->\n###### 3.  독성 및 위해 정보\n\n**[표 시작]**\n\n| IFRA | https://ifrafragrance.org/ | 제한 금지에 대한 향료안전기준 및 제조법 |\n| --- | --- | --- |\n| 및 지침 등 제공 | CICADS, EHS, HSGs, ICSCs, JECFA, JMPR, |\n| 계산하기 위해, 생물학적으로 유의한 종양이 발생하는 최저용량의 종양 발생 비율(32%)과 최 | (Benchmark Dose Software)와 RIVM(https://www.rivm.nl/en/proast)에서 개발된 PROAST가 |\n**KemI-Riskline, PIMs , UKPID 등이 포함됨**\n| 저용량에서 노출기간 동안 노출된 체중 1 kg 당 1일 용량(6.4 mg/kg bw/day)를 고려하여 계산 | 있다.  BMD 접근법은 여러 수학적 모델(probit, gamma, logist, weibull 등)을 활용하여 그 |\n| ① 물질 B의 용량-반응 연구에서 도출된 BMDL10 : 0.018 mg/kg bw/day | 이용하여 평생발암위해도(lifetime cancer risk, LCR)를 결정하거나 용량 디스크립터와 인체 | RIFM(향료물질연구소)에서 향료 물질에 대한 |\n| RIFM | https://rifm.org/ |\n| 적합도를 평가하여 최종 BMDL을 선택하게 된다.  아래 사항은 기본적으로 모델 선택 판단 | 안전성 평가에 필요한 독성 관련 자료를 제공함 |\n**노출량 추정치 사이의 비율인 노출안전역(margin of exposure, MOE) 산출을 통해 위해도를**\n**비식품 소비자제품(화장품, 완구, 직물, 의류,**\n\n**[표 끝]**\n\nIFRA(국제향료협회)에서 제공하는 향료물질의\n\nIPCS INCHEM\n\nhttps://inchem.org/#/\n\nIPCS(국제화학물질안전프로그램) 및 CCOHS(캐\n\n나다 산업보건 및 안전센터)에서 운영하는 최\n\n신 화학물질 안전 관련 간행물 및 국제 기구\n\n의 데이터베이스 확인 가능\n\n<!-- PAGE_67 -->\n###### 참고 1.  발암물질 위해평가 및 예시\n\n<!-- PAGE_67 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n- - 62 -\n<!-- PAGE_68 -->\n###### 참고 1. ",
        "original_sentence": "BMD 접근법은 여러 수학적 모델(probit, gamma, logist, weibull 등)을 활용하여 그 |\n| ① 물질 B의 용량-반응 연구에서 도출된 BMDL10 : 0.018 mg/kg bw/day | 이용하여 평생발암위해도(lifetime cancer risk, LCR)를 결정하거나 용량 디스크립터와 인체 | RIFM(향료물질연구소)에서 향료 물질에 대한 |\n| RIFM | https://rifm.org/ |\n| 적합도를 평가하여 최종 BMDL을 선택하게 된다. "
      }
    },
    {
      "chunk_id": "chunk_366",
      "text": "아래 사항은 기본적으로 모델 선택 판단 | 안전성 평가에 필요한 독성 관련 자료를 제공함 |\n**노출량 추정치 사이의 비율인 노출안전역(margin of exposure, MOE) 산출을 통해 위해도를**\n**비식품 소비자제품(화장품, 완구, 직물, 의류,**\n\n**[표 끝]**\n\nIFRA(국제향료협회)에서 제공하는 향료물질의\n\nIPCS INCHEM\n\nhttps://inchem.org/#/\n\nIPCS(국제화학물질안전프로그램) 및 CCOHS(캐\n\n나다 산업보건 및 안전센터)에서 운영하는 최\n\n신 화학물질 안전 관련 간행물 및 국제 기구\n\n의 데이터베이스 확인 가능\n\n<!-- PAGE_67 -->\n###### 참고 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 365,
        "window_size": 3,
        "char_count": 349,
        "word_count": 66,
        "page_number": 67,
        "window_text": "또한, 평생발암**\n| OECD library | https://www.oecd-ilibrary.org/environment/oec |\n**OECD Guideline 시험 지침 제공**\n| - MOE가 104 이상이므로 위해 우려 가능성 낮음 | 위해도(LCR)는 EPA, IRIS 등 규제기관에서 산출된 값을 이용할 수 있으며, 10-5 미만이면 |\n**화장품 관련 규제 및 화학물질 관련 위해성평**\n**호주**\n**가 보고서 제공**\n\n**[표 끝]**\n\n<!-- PAGE_65 -->\n###### 3.  독성 및 위해 정보\n\n**[표 시작]**\n\n| IFRA | https://ifrafragrance.org/ | 제한 금지에 대한 향료안전기준 및 제조법 |\n| --- | --- | --- |\n| 및 지침 등 제공 | CICADS, EHS, HSGs, ICSCs, JECFA, JMPR, |\n| 계산하기 위해, 생물학적으로 유의한 종양이 발생하는 최저용량의 종양 발생 비율(32%)과 최 | (Benchmark Dose Software)와 RIVM(https://www.rivm.nl/en/proast)에서 개발된 PROAST가 |\n**KemI-Riskline, PIMs , UKPID 등이 포함됨**\n| 저용량에서 노출기간 동안 노출된 체중 1 kg 당 1일 용량(6.4 mg/kg bw/day)를 고려하여 계산 | 있다.  BMD 접근법은 여러 수학적 모델(probit, gamma, logist, weibull 등)을 활용하여 그 |\n| ① 물질 B의 용량-반응 연구에서 도출된 BMDL10 : 0.018 mg/kg bw/day | 이용하여 평생발암위해도(lifetime cancer risk, LCR)를 결정하거나 용량 디스크립터와 인체 | RIFM(향료물질연구소)에서 향료 물질에 대한 |\n| RIFM | https://rifm.org/ |\n| 적합도를 평가하여 최종 BMDL을 선택하게 된다.  아래 사항은 기본적으로 모델 선택 판단 | 안전성 평가에 필요한 독성 관련 자료를 제공함 |\n**노출량 추정치 사이의 비율인 노출안전역(margin of exposure, MOE) 산출을 통해 위해도를**\n**비식품 소비자제품(화장품, 완구, 직물, 의류,**\n\n**[표 끝]**\n\nIFRA(국제향료협회)에서 제공하는 향료물질의\n\nIPCS INCHEM\n\nhttps://inchem.org/#/\n\nIPCS(국제화학물질안전프로그램) 및 CCOHS(캐\n\n나다 산업보건 및 안전센터)에서 운영하는 최\n\n신 화학물질 안전 관련 간행물 및 국제 기구\n\n의 데이터베이스 확인 가능\n\n<!-- PAGE_67 -->\n###### 참고 1.  발암물질 위해평가 및 예시\n\n<!-- PAGE_67 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n- - 62 -\n<!-- PAGE_68 -->\n###### 참고 1.  발암물질 위해평가 및 예시\n\n<!-- PAGE_68 -->\n###### 1. ",
        "original_sentence": "아래 사항은 기본적으로 모델 선택 판단 | 안전성 평가에 필요한 독성 관련 자료를 제공함 |\n**노출량 추정치 사이의 비율인 노출안전역(margin of exposure, MOE) 산출을 통해 위해도를**\n**비식품 소비자제품(화장품, 완구, 직물, 의류,**\n\n**[표 끝]**\n\nIFRA(국제향료협회)에서 제공하는 향료물질의\n\nIPCS INCHEM\n\nhttps://inchem.org/#/\n\nIPCS(국제화학물질안전프로그램) 및 CCOHS(캐\n\n나다 산업보건 및 안전센터)에서 운영하는 최\n\n신 화학물질 안전 관련 간행물 및 국제 기구\n\n의 데이터베이스 확인 가능\n\n<!-- PAGE_67 -->\n###### 참고 1. "
      }
    },
    {
      "chunk_id": "chunk_367",
      "text": "발암물질 위해평가 및 예시\n\n<!-- PAGE_67 -->\n###### 참고 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 366,
        "window_size": 3,
        "char_count": 46,
        "word_count": 10,
        "page_number": 67,
        "window_text": "독성 및 위해 정보\n\n**[표 시작]**\n\n| IFRA | https://ifrafragrance.org/ | 제한 금지에 대한 향료안전기준 및 제조법 |\n| --- | --- | --- |\n| 및 지침 등 제공 | CICADS, EHS, HSGs, ICSCs, JECFA, JMPR, |\n| 계산하기 위해, 생물학적으로 유의한 종양이 발생하는 최저용량의 종양 발생 비율(32%)과 최 | (Benchmark Dose Software)와 RIVM(https://www.rivm.nl/en/proast)에서 개발된 PROAST가 |\n**KemI-Riskline, PIMs , UKPID 등이 포함됨**\n| 저용량에서 노출기간 동안 노출된 체중 1 kg 당 1일 용량(6.4 mg/kg bw/day)를 고려하여 계산 | 있다.  BMD 접근법은 여러 수학적 모델(probit, gamma, logist, weibull 등)을 활용하여 그 |\n| ① 물질 B의 용량-반응 연구에서 도출된 BMDL10 : 0.018 mg/kg bw/day | 이용하여 평생발암위해도(lifetime cancer risk, LCR)를 결정하거나 용량 디스크립터와 인체 | RIFM(향료물질연구소)에서 향료 물질에 대한 |\n| RIFM | https://rifm.org/ |\n| 적합도를 평가하여 최종 BMDL을 선택하게 된다.  아래 사항은 기본적으로 모델 선택 판단 | 안전성 평가에 필요한 독성 관련 자료를 제공함 |\n**노출량 추정치 사이의 비율인 노출안전역(margin of exposure, MOE) 산출을 통해 위해도를**\n**비식품 소비자제품(화장품, 완구, 직물, 의류,**\n\n**[표 끝]**\n\nIFRA(국제향료협회)에서 제공하는 향료물질의\n\nIPCS INCHEM\n\nhttps://inchem.org/#/\n\nIPCS(국제화학물질안전프로그램) 및 CCOHS(캐\n\n나다 산업보건 및 안전센터)에서 운영하는 최\n\n신 화학물질 안전 관련 간행물 및 국제 기구\n\n의 데이터베이스 확인 가능\n\n<!-- PAGE_67 -->\n###### 참고 1.  발암물질 위해평가 및 예시\n\n<!-- PAGE_67 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n- - 62 -\n<!-- PAGE_68 -->\n###### 참고 1.  발암물질 위해평가 및 예시\n\n<!-- PAGE_68 -->\n###### 1.  발암물질의 위험성을 평가하는 경우에는 충분한 정보를 근거로 한 T25 또는 BMDL10 등을\n\n<!-- PAGE_68 -->\n###### - T25 : 시험종의 표준 수명 내에서 자연 발생을 보정한 후, 특정 조직 부위에서 25%의 종양\n\n<!-- PAGE_68 -->\n###### - BMDL10(Benchmark Dose Lower confidence limit) : 용량-반응 모델을 근거로 계산되는 값으\n\n<!-- PAGE_68 -->\n###### 2. ",
        "original_sentence": "발암물질 위해평가 및 예시\n\n<!-- PAGE_67 -->\n###### 참고 2. "
      }
    },
    {
      "chunk_id": "chunk_368",
      "text": "TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n- - 62 -\n<!-- PAGE_68 -->\n###### 참고 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 367,
        "window_size": 3,
        "char_count": 92,
        "word_count": 17,
        "page_number": 68,
        "window_text": "BMD 접근법은 여러 수학적 모델(probit, gamma, logist, weibull 등)을 활용하여 그 |\n| ① 물질 B의 용량-반응 연구에서 도출된 BMDL10 : 0.018 mg/kg bw/day | 이용하여 평생발암위해도(lifetime cancer risk, LCR)를 결정하거나 용량 디스크립터와 인체 | RIFM(향료물질연구소)에서 향료 물질에 대한 |\n| RIFM | https://rifm.org/ |\n| 적합도를 평가하여 최종 BMDL을 선택하게 된다.  아래 사항은 기본적으로 모델 선택 판단 | 안전성 평가에 필요한 독성 관련 자료를 제공함 |\n**노출량 추정치 사이의 비율인 노출안전역(margin of exposure, MOE) 산출을 통해 위해도를**\n**비식품 소비자제품(화장품, 완구, 직물, 의류,**\n\n**[표 끝]**\n\nIFRA(국제향료협회)에서 제공하는 향료물질의\n\nIPCS INCHEM\n\nhttps://inchem.org/#/\n\nIPCS(국제화학물질안전프로그램) 및 CCOHS(캐\n\n나다 산업보건 및 안전센터)에서 운영하는 최\n\n신 화학물질 안전 관련 간행물 및 국제 기구\n\n의 데이터베이스 확인 가능\n\n<!-- PAGE_67 -->\n###### 참고 1.  발암물질 위해평가 및 예시\n\n<!-- PAGE_67 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n- - 62 -\n<!-- PAGE_68 -->\n###### 참고 1.  발암물질 위해평가 및 예시\n\n<!-- PAGE_68 -->\n###### 1.  발암물질의 위험성을 평가하는 경우에는 충분한 정보를 근거로 한 T25 또는 BMDL10 등을\n\n<!-- PAGE_68 -->\n###### - T25 : 시험종의 표준 수명 내에서 자연 발생을 보정한 후, 특정 조직 부위에서 25%의 종양\n\n<!-- PAGE_68 -->\n###### - BMDL10(Benchmark Dose Lower confidence limit) : 용량-반응 모델을 근거로 계산되는 값으\n\n<!-- PAGE_68 -->\n###### 2.  평생발암 위험성의 판정을 위해서는 T25 또는 BMDL10 등을 이용하여 평생발암 위험률을 산\n\n<!-- PAGE_68 -->\n###### 2) BMDL10 또는 T25를 이용한 노출안전역(MOE) 산출\n\n<!-- PAGE_68 -->\n###### : 동물시험으로부터 BMDL10를 이용한 노출안전역(MOE)이 10,000 이상 또는 T25를 이용한\n\n<!-- PAGE_68 -->\n###### 노출안전역(MOE)이 25,000 이상인 경우, 위해 우려가 되지 않는다고 평가할 수 있다(EFSA,\n\n<!-- PAGE_68 -->\n###### 2005).\n\n",
        "original_sentence": "TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n- - 62 -\n<!-- PAGE_68 -->\n###### 참고 1. "
      }
    },
    {
      "chunk_id": "chunk_369",
      "text": "발암물질 위해평가 및 예시\n\n<!-- PAGE_68 -->\n###### 1. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 368,
        "window_size": 3,
        "char_count": 43,
        "word_count": 9,
        "page_number": 68,
        "window_text": "아래 사항은 기본적으로 모델 선택 판단 | 안전성 평가에 필요한 독성 관련 자료를 제공함 |\n**노출량 추정치 사이의 비율인 노출안전역(margin of exposure, MOE) 산출을 통해 위해도를**\n**비식품 소비자제품(화장품, 완구, 직물, 의류,**\n\n**[표 끝]**\n\nIFRA(국제향료협회)에서 제공하는 향료물질의\n\nIPCS INCHEM\n\nhttps://inchem.org/#/\n\nIPCS(국제화학물질안전프로그램) 및 CCOHS(캐\n\n나다 산업보건 및 안전센터)에서 운영하는 최\n\n신 화학물질 안전 관련 간행물 및 국제 기구\n\n의 데이터베이스 확인 가능\n\n<!-- PAGE_67 -->\n###### 참고 1.  발암물질 위해평가 및 예시\n\n<!-- PAGE_67 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n- - 62 -\n<!-- PAGE_68 -->\n###### 참고 1.  발암물질 위해평가 및 예시\n\n<!-- PAGE_68 -->\n###### 1.  발암물질의 위험성을 평가하는 경우에는 충분한 정보를 근거로 한 T25 또는 BMDL10 등을\n\n<!-- PAGE_68 -->\n###### - T25 : 시험종의 표준 수명 내에서 자연 발생을 보정한 후, 특정 조직 부위에서 25%의 종양\n\n<!-- PAGE_68 -->\n###### - BMDL10(Benchmark Dose Lower confidence limit) : 용량-반응 모델을 근거로 계산되는 값으\n\n<!-- PAGE_68 -->\n###### 2.  평생발암 위험성의 판정을 위해서는 T25 또는 BMDL10 등을 이용하여 평생발암 위험률을 산\n\n<!-- PAGE_68 -->\n###### 2) BMDL10 또는 T25를 이용한 노출안전역(MOE) 산출\n\n<!-- PAGE_68 -->\n###### : 동물시험으로부터 BMDL10를 이용한 노출안전역(MOE)이 10,000 이상 또는 T25를 이용한\n\n<!-- PAGE_68 -->\n###### 노출안전역(MOE)이 25,000 이상인 경우, 위해 우려가 되지 않는다고 평가할 수 있다(EFSA,\n\n<!-- PAGE_68 -->\n###### 2005).\n\n <!-- PAGE_68 -->\n###### SED\n\n- - 63 -\n<!-- PAGE_69 -->\n###### 3. ",
        "original_sentence": "발암물질 위해평가 및 예시\n\n<!-- PAGE_68 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_370",
      "text": "발암물질의 위험성을 평가하는 경우에는 충분한 정보를 근거로 한 T25 또는 BMDL10 등을\n\n<!-- PAGE_68 -->\n###### - T25 : 시험종의 표준 수명 내에서 자연 발생을 보정한 후, 특정 조직 부위에서 25%의 종양\n\n<!-- PAGE_68 -->\n###### - BMDL10(Benchmark Dose Lower confidence limit) : 용량-반응 모델을 근거로 계산되는 값으\n\n<!-- PAGE_68 -->\n###### 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 369,
        "window_size": 3,
        "char_count": 258,
        "word_count": 53,
        "page_number": 68,
        "window_text": "발암물질 위해평가 및 예시\n\n<!-- PAGE_67 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n- - 62 -\n<!-- PAGE_68 -->\n###### 참고 1.  발암물질 위해평가 및 예시\n\n<!-- PAGE_68 -->\n###### 1.  발암물질의 위험성을 평가하는 경우에는 충분한 정보를 근거로 한 T25 또는 BMDL10 등을\n\n<!-- PAGE_68 -->\n###### - T25 : 시험종의 표준 수명 내에서 자연 발생을 보정한 후, 특정 조직 부위에서 25%의 종양\n\n<!-- PAGE_68 -->\n###### - BMDL10(Benchmark Dose Lower confidence limit) : 용량-반응 모델을 근거로 계산되는 값으\n\n<!-- PAGE_68 -->\n###### 2.  평생발암 위험성의 판정을 위해서는 T25 또는 BMDL10 등을 이용하여 평생발암 위험률을 산\n\n<!-- PAGE_68 -->\n###### 2) BMDL10 또는 T25를 이용한 노출안전역(MOE) 산출\n\n<!-- PAGE_68 -->\n###### : 동물시험으로부터 BMDL10를 이용한 노출안전역(MOE)이 10,000 이상 또는 T25를 이용한\n\n<!-- PAGE_68 -->\n###### 노출안전역(MOE)이 25,000 이상인 경우, 위해 우려가 되지 않는다고 평가할 수 있다(EFSA,\n\n<!-- PAGE_68 -->\n###### 2005).\n\n <!-- PAGE_68 -->\n###### SED\n\n- - 63 -\n<!-- PAGE_69 -->\n###### 3.  T25를 활용한 평생발암위해도(LCR) 산출 예시\n\n<!-- PAGE_69 -->\n###### □ 물질 A에 대한 발암성 연구\n\n<!-- PAGE_69 -->\n###### ① 종양발생이 유의하게 증가하는 최저 용량\n\n<!-- PAGE_69 -->\n###### - 대조군 : 0/50 (0%)\n\n<!-- PAGE_69 -->\n###### - 사료 50 mg/kg에 노출된 암컷 마우스에서 악성림프종 발생 비율 : 16/50 (32%)\n\n<!-- PAGE_69 -->\n###### - net % : 32%\n\n<!-- PAGE_69 -->\n###### ② 노출기간 동안 마우스 한 마리당 1일 용량\n\n<!-- PAGE_69 -->\n###### - 마우스 1일 먹이 투여량 : 3.25 g/day(실험값)\n\n<!-- PAGE_69 -->\n###### ③ 노출기간 동안 마우스 체중 1 kg 당 물질 A의 1일 섭취량\n\n<!-- PAGE_69 -->\n###### - 시험자료를 통해 저용량 노출군의 암컷 마우스의 평균 체중은 25 g로 확인됨\n\n<!-- PAGE_69 -->\n###### 0.16 mg/day\n\n<!-- PAGE_69 -->\n###### ×\n\n<!-- PAGE_69 -->\n###### 1000 g\n\n<!-- PAGE_69 -->\n###### =\n\n<!-- PAGE_69 -->\n###### 6.4 mg/kg bw/day\n\n<!-- PAGE_69 -->\n###### 25 g bw/mouse\n\n<!-- PAGE_69 -->\n###### kg\n\n- - 64 -\n<!-- PAGE_70 -->\n###### ④ T25 산출\n\n<!-- PAGE_70 -->\n###### - 특정 조직에서 25% 종양을 일으킬 수 있는 용량 수준(악성림프종, 체중 1 kg 당 1일 용량)을\n\n<!-- PAGE_70 -->\n###### - 악성림프종 발생 용량인 50 mg/kg으로부터 T25 = 5.0 mg/kg bw/day을 산출함\n\n<!-- PAGE_70 -->\n###### ⑤ HT25 산출\n\n<!-- PAGE_70 -->\n###### ⑥ 노출평가\n\n<!-- PAGE_70 -->\n###### ⑦ 위해도 결정\n\n<!-- PAGE_70 -->\n###### - LCR이 10-5 이하이므로 위해 우려 가능성 낮음\n\n- - 65 -\n<!-- PAGE_71 -->\n###### 4. ",
        "original_sentence": "발암물질의 위험성을 평가하는 경우에는 충분한 정보를 근거로 한 T25 또는 BMDL10 등을\n\n<!-- PAGE_68 -->\n###### - T25 : 시험종의 표준 수명 내에서 자연 발생을 보정한 후, 특정 조직 부위에서 25%의 종양\n\n<!-- PAGE_68 -->\n###### - BMDL10(Benchmark Dose Lower confidence limit) : 용량-반응 모델을 근거로 계산되는 값으\n\n<!-- PAGE_68 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_371",
      "text": "평생발암 위험성의 판정을 위해서는 T25 또는 BMDL10 등을 이용하여 평생발암 위험률을 산\n\n<!-- PAGE_68 -->\n###### 2) BMDL10 또는 T25를 이용한 노출안전역(MOE) 산출\n\n<!-- PAGE_68 -->\n###### : 동물시험으로부터 BMDL10를 이용한 노출안전역(MOE)이 10,000 이상 또는 T25를 이용한\n\n<!-- PAGE_68 -->\n###### 노출안전역(MOE)이 25,000 이상인 경우, 위해 우려가 되지 않는다고 평가할 수 있다(EFSA,\n\n<!-- PAGE_68 -->\n###### 2005).\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 370,
        "window_size": 3,
        "char_count": 311,
        "word_count": 57,
        "page_number": 68,
        "window_text": "TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n- - 62 -\n<!-- PAGE_68 -->\n###### 참고 1.  발암물질 위해평가 및 예시\n\n<!-- PAGE_68 -->\n###### 1.  발암물질의 위험성을 평가하는 경우에는 충분한 정보를 근거로 한 T25 또는 BMDL10 등을\n\n<!-- PAGE_68 -->\n###### - T25 : 시험종의 표준 수명 내에서 자연 발생을 보정한 후, 특정 조직 부위에서 25%의 종양\n\n<!-- PAGE_68 -->\n###### - BMDL10(Benchmark Dose Lower confidence limit) : 용량-반응 모델을 근거로 계산되는 값으\n\n<!-- PAGE_68 -->\n###### 2.  평생발암 위험성의 판정을 위해서는 T25 또는 BMDL10 등을 이용하여 평생발암 위험률을 산\n\n<!-- PAGE_68 -->\n###### 2) BMDL10 또는 T25를 이용한 노출안전역(MOE) 산출\n\n<!-- PAGE_68 -->\n###### : 동물시험으로부터 BMDL10를 이용한 노출안전역(MOE)이 10,000 이상 또는 T25를 이용한\n\n<!-- PAGE_68 -->\n###### 노출안전역(MOE)이 25,000 이상인 경우, 위해 우려가 되지 않는다고 평가할 수 있다(EFSA,\n\n<!-- PAGE_68 -->\n###### 2005).\n\n <!-- PAGE_68 -->\n###### SED\n\n- - 63 -\n<!-- PAGE_69 -->\n###### 3.  T25를 활용한 평생발암위해도(LCR) 산출 예시\n\n<!-- PAGE_69 -->\n###### □ 물질 A에 대한 발암성 연구\n\n<!-- PAGE_69 -->\n###### ① 종양발생이 유의하게 증가하는 최저 용량\n\n<!-- PAGE_69 -->\n###### - 대조군 : 0/50 (0%)\n\n<!-- PAGE_69 -->\n###### - 사료 50 mg/kg에 노출된 암컷 마우스에서 악성림프종 발생 비율 : 16/50 (32%)\n\n<!-- PAGE_69 -->\n###### - net % : 32%\n\n<!-- PAGE_69 -->\n###### ② 노출기간 동안 마우스 한 마리당 1일 용량\n\n<!-- PAGE_69 -->\n###### - 마우스 1일 먹이 투여량 : 3.25 g/day(실험값)\n\n<!-- PAGE_69 -->\n###### ③ 노출기간 동안 마우스 체중 1 kg 당 물질 A의 1일 섭취량\n\n<!-- PAGE_69 -->\n###### - 시험자료를 통해 저용량 노출군의 암컷 마우스의 평균 체중은 25 g로 확인됨\n\n<!-- PAGE_69 -->\n###### 0.16 mg/day\n\n<!-- PAGE_69 -->\n###### ×\n\n<!-- PAGE_69 -->\n###### 1000 g\n\n<!-- PAGE_69 -->\n###### =\n\n<!-- PAGE_69 -->\n###### 6.4 mg/kg bw/day\n\n<!-- PAGE_69 -->\n###### 25 g bw/mouse\n\n<!-- PAGE_69 -->\n###### kg\n\n- - 64 -\n<!-- PAGE_70 -->\n###### ④ T25 산출\n\n<!-- PAGE_70 -->\n###### - 특정 조직에서 25% 종양을 일으킬 수 있는 용량 수준(악성림프종, 체중 1 kg 당 1일 용량)을\n\n<!-- PAGE_70 -->\n###### - 악성림프종 발생 용량인 50 mg/kg으로부터 T25 = 5.0 mg/kg bw/day을 산출함\n\n<!-- PAGE_70 -->\n###### ⑤ HT25 산출\n\n<!-- PAGE_70 -->\n###### ⑥ 노출평가\n\n<!-- PAGE_70 -->\n###### ⑦ 위해도 결정\n\n<!-- PAGE_70 -->\n###### - LCR이 10-5 이하이므로 위해 우려 가능성 낮음\n\n- - 65 -\n<!-- PAGE_71 -->\n###### 4.  BMDL10을 활용한 MOE 산출 예시\n\n<!-- PAGE_71 -->\n###### □ 물질 B에 대한 MOE 산출\n\n- - 66 -\n<!-- PAGE_72 -->\n###### 5. ",
        "original_sentence": "평생발암 위험성의 판정을 위해서는 T25 또는 BMDL10 등을 이용하여 평생발암 위험률을 산\n\n<!-- PAGE_68 -->\n###### 2) BMDL10 또는 T25를 이용한 노출안전역(MOE) 산출\n\n<!-- PAGE_68 -->\n###### : 동물시험으로부터 BMDL10를 이용한 노출안전역(MOE)이 10,000 이상 또는 T25를 이용한\n\n<!-- PAGE_68 -->\n###### 노출안전역(MOE)이 25,000 이상인 경우, 위해 우려가 되지 않는다고 평가할 수 있다(EFSA,\n\n<!-- PAGE_68 -->\n###### 2005).\n\n"
      }
    },
    {
      "chunk_id": "chunk_372",
      "text": "<!-- PAGE_68 -->\n###### SED\n\n- - 63 -\n<!-- PAGE_69 -->\n###### 3. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 371,
        "window_size": 3,
        "char_count": 65,
        "word_count": 14,
        "page_number": 68,
        "window_text": "발암물질 위해평가 및 예시\n\n<!-- PAGE_68 -->\n###### 1.  발암물질의 위험성을 평가하는 경우에는 충분한 정보를 근거로 한 T25 또는 BMDL10 등을\n\n<!-- PAGE_68 -->\n###### - T25 : 시험종의 표준 수명 내에서 자연 발생을 보정한 후, 특정 조직 부위에서 25%의 종양\n\n<!-- PAGE_68 -->\n###### - BMDL10(Benchmark Dose Lower confidence limit) : 용량-반응 모델을 근거로 계산되는 값으\n\n<!-- PAGE_68 -->\n###### 2.  평생발암 위험성의 판정을 위해서는 T25 또는 BMDL10 등을 이용하여 평생발암 위험률을 산\n\n<!-- PAGE_68 -->\n###### 2) BMDL10 또는 T25를 이용한 노출안전역(MOE) 산출\n\n<!-- PAGE_68 -->\n###### : 동물시험으로부터 BMDL10를 이용한 노출안전역(MOE)이 10,000 이상 또는 T25를 이용한\n\n<!-- PAGE_68 -->\n###### 노출안전역(MOE)이 25,000 이상인 경우, 위해 우려가 되지 않는다고 평가할 수 있다(EFSA,\n\n<!-- PAGE_68 -->\n###### 2005).\n\n <!-- PAGE_68 -->\n###### SED\n\n- - 63 -\n<!-- PAGE_69 -->\n###### 3.  T25를 활용한 평생발암위해도(LCR) 산출 예시\n\n<!-- PAGE_69 -->\n###### □ 물질 A에 대한 발암성 연구\n\n<!-- PAGE_69 -->\n###### ① 종양발생이 유의하게 증가하는 최저 용량\n\n<!-- PAGE_69 -->\n###### - 대조군 : 0/50 (0%)\n\n<!-- PAGE_69 -->\n###### - 사료 50 mg/kg에 노출된 암컷 마우스에서 악성림프종 발생 비율 : 16/50 (32%)\n\n<!-- PAGE_69 -->\n###### - net % : 32%\n\n<!-- PAGE_69 -->\n###### ② 노출기간 동안 마우스 한 마리당 1일 용량\n\n<!-- PAGE_69 -->\n###### - 마우스 1일 먹이 투여량 : 3.25 g/day(실험값)\n\n<!-- PAGE_69 -->\n###### ③ 노출기간 동안 마우스 체중 1 kg 당 물질 A의 1일 섭취량\n\n<!-- PAGE_69 -->\n###### - 시험자료를 통해 저용량 노출군의 암컷 마우스의 평균 체중은 25 g로 확인됨\n\n<!-- PAGE_69 -->\n###### 0.16 mg/day\n\n<!-- PAGE_69 -->\n###### ×\n\n<!-- PAGE_69 -->\n###### 1000 g\n\n<!-- PAGE_69 -->\n###### =\n\n<!-- PAGE_69 -->\n###### 6.4 mg/kg bw/day\n\n<!-- PAGE_69 -->\n###### 25 g bw/mouse\n\n<!-- PAGE_69 -->\n###### kg\n\n- - 64 -\n<!-- PAGE_70 -->\n###### ④ T25 산출\n\n<!-- PAGE_70 -->\n###### - 특정 조직에서 25% 종양을 일으킬 수 있는 용량 수준(악성림프종, 체중 1 kg 당 1일 용량)을\n\n<!-- PAGE_70 -->\n###### - 악성림프종 발생 용량인 50 mg/kg으로부터 T25 = 5.0 mg/kg bw/day을 산출함\n\n<!-- PAGE_70 -->\n###### ⑤ HT25 산출\n\n<!-- PAGE_70 -->\n###### ⑥ 노출평가\n\n<!-- PAGE_70 -->\n###### ⑦ 위해도 결정\n\n<!-- PAGE_70 -->\n###### - LCR이 10-5 이하이므로 위해 우려 가능성 낮음\n\n- - 65 -\n<!-- PAGE_71 -->\n###### 4.  BMDL10을 활용한 MOE 산출 예시\n\n<!-- PAGE_71 -->\n###### □ 물질 B에 대한 MOE 산출\n\n- - 66 -\n<!-- PAGE_72 -->\n###### 5.  프로그램을 활용한 BMDL10 산출 예시\n\n<!-- PAGE_72 -->\n###### 1) 가장 잘 알려진 BMD 소프트웨어는 미국 EPA(www.epa.gov/bmds)에서 개발된 BMDS\n\n<!-- PAGE_72 -->\n###### ※ [예시] Benzo(a)pyrene의 BMDS를 활용한 BMD 분석\n\n<!-- PAGE_72 -->\n###### - BMDL10 산출한 결과 5개의 모델이 통계적으로 수용 가능한 수준(p-value > 0.05)임\n\n<!-- PAGE_72 -->\n###### - BMDL10의 범위는 0.07∼0.20 mg/kg bw/day임\n\n<!-- PAGE_72 -->\n###### - 통계적 수용 가능 multi-stage 모델의 가장 낮은 BMDL10 0.07mg/kg bw/day 선택\n\nModel Name\n\nloglik\n\np-value\n\nAIC\n\nChi-square\n\nBMD10\n\ngamma\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.24\n- 0.09\nlogistic\n\n- -204.1\n- 0.105\n- 412.2\n- 10.1\n- 0.14\n- 0.12\nlog-logistic\n\n- -204.1\n- 0.061\n- 414.2\n- 9.9\n- 0.28\n- 0.18\nlog-probit\n\n- -204.3\n- 0.052\n- 414.6\n- 10.3\n- 0.29\n- 0.20\nmulti-stage\n\n- -204.3\n- 0.053\n- 414.6\n- 10.5\n- 0.14\n- 0.07\nprobit\n\n- -204.3\n- 0.092\n- 412.5\n- 10.4\n- 0.13\n- 0.12\nweibull\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.18\n- 0.08\nQuantal-linear\n\n- -204.4\n- 0.019\n- 416.8\n- 14.7\n- 0.07\n- 0.05\n유해물질의 인체안전기준 설정을 위한 용량-반응 평가 연구, 2016\n\n- - 67 -\n<!-- PAGE_73 -->\n###### 참고 2. ",
        "original_sentence": "<!-- PAGE_68 -->\n###### SED\n\n- - 63 -\n<!-- PAGE_69 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_373",
      "text": "T25를 활용한 평생발암위해도(LCR) 산출 예시\n\n<!-- PAGE_69 -->\n###### □ 물질 A에 대한 발암성 연구\n\n<!-- PAGE_69 -->\n###### ① 종양발생이 유의하게 증가하는 최저 용량\n\n<!-- PAGE_69 -->\n###### - 대조군 : 0/50 (0%)\n\n<!-- PAGE_69 -->\n###### - 사료 50 mg/kg에 노출된 암컷 마우스에서 악성림프종 발생 비율 : 16/50 (32%)\n\n<!-- PAGE_69 -->\n###### - net % : 32%\n\n<!-- PAGE_69 -->\n###### ② 노출기간 동안 마우스 한 마리당 1일 용량\n\n<!-- PAGE_69 -->\n###### - 마우스 1일 먹이 투여량 : 3.25 g/day(실험값)\n\n<!-- PAGE_69 -->\n###### ③ 노출기간 동안 마우스 체중 1 kg 당 물질 A의 1일 섭취량\n\n<!-- PAGE_69 -->\n###### - 시험자료를 통해 저용량 노출군의 암컷 마우스의 평균 체중은 25 g로 확인됨\n\n<!-- PAGE_69 -->\n###### 0.16 mg/day\n\n<!-- PAGE_69 -->\n###### ×\n\n<!-- PAGE_69 -->\n###### 1000 g\n\n<!-- PAGE_69 -->\n###### =\n\n<!-- PAGE_69 -->\n###### 6.4 mg/kg bw/day\n\n<!-- PAGE_69 -->\n###### 25 g bw/mouse\n\n<!-- PAGE_69 -->\n###### kg\n\n- - 64 -\n<!-- PAGE_70 -->\n###### ④ T25 산출\n\n<!-- PAGE_70 -->\n###### - 특정 조직에서 25% 종양을 일으킬 수 있는 용량 수준(악성림프종, 체중 1 kg 당 1일 용량)을\n\n<!-- PAGE_70 -->\n###### - 악성림프종 발생 용량인 50 mg/kg으로부터 T25 = 5.0 mg/kg bw/day을 산출함\n\n<!-- PAGE_70 -->\n###### ⑤ HT25 산출\n\n<!-- PAGE_70 -->\n###### ⑥ 노출평가\n\n<!-- PAGE_70 -->\n###### ⑦ 위해도 결정\n\n<!-- PAGE_70 -->\n###### - LCR이 10-5 이하이므로 위해 우려 가능성 낮음\n\n- - 65 -\n<!-- PAGE_71 -->\n###### 4. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 372,
        "window_size": 3,
        "char_count": 1156,
        "word_count": 245,
        "page_number": 69,
        "window_text": "발암물질의 위험성을 평가하는 경우에는 충분한 정보를 근거로 한 T25 또는 BMDL10 등을\n\n<!-- PAGE_68 -->\n###### - T25 : 시험종의 표준 수명 내에서 자연 발생을 보정한 후, 특정 조직 부위에서 25%의 종양\n\n<!-- PAGE_68 -->\n###### - BMDL10(Benchmark Dose Lower confidence limit) : 용량-반응 모델을 근거로 계산되는 값으\n\n<!-- PAGE_68 -->\n###### 2.  평생발암 위험성의 판정을 위해서는 T25 또는 BMDL10 등을 이용하여 평생발암 위험률을 산\n\n<!-- PAGE_68 -->\n###### 2) BMDL10 또는 T25를 이용한 노출안전역(MOE) 산출\n\n<!-- PAGE_68 -->\n###### : 동물시험으로부터 BMDL10를 이용한 노출안전역(MOE)이 10,000 이상 또는 T25를 이용한\n\n<!-- PAGE_68 -->\n###### 노출안전역(MOE)이 25,000 이상인 경우, 위해 우려가 되지 않는다고 평가할 수 있다(EFSA,\n\n<!-- PAGE_68 -->\n###### 2005).\n\n <!-- PAGE_68 -->\n###### SED\n\n- - 63 -\n<!-- PAGE_69 -->\n###### 3.  T25를 활용한 평생발암위해도(LCR) 산출 예시\n\n<!-- PAGE_69 -->\n###### □ 물질 A에 대한 발암성 연구\n\n<!-- PAGE_69 -->\n###### ① 종양발생이 유의하게 증가하는 최저 용량\n\n<!-- PAGE_69 -->\n###### - 대조군 : 0/50 (0%)\n\n<!-- PAGE_69 -->\n###### - 사료 50 mg/kg에 노출된 암컷 마우스에서 악성림프종 발생 비율 : 16/50 (32%)\n\n<!-- PAGE_69 -->\n###### - net % : 32%\n\n<!-- PAGE_69 -->\n###### ② 노출기간 동안 마우스 한 마리당 1일 용량\n\n<!-- PAGE_69 -->\n###### - 마우스 1일 먹이 투여량 : 3.25 g/day(실험값)\n\n<!-- PAGE_69 -->\n###### ③ 노출기간 동안 마우스 체중 1 kg 당 물질 A의 1일 섭취량\n\n<!-- PAGE_69 -->\n###### - 시험자료를 통해 저용량 노출군의 암컷 마우스의 평균 체중은 25 g로 확인됨\n\n<!-- PAGE_69 -->\n###### 0.16 mg/day\n\n<!-- PAGE_69 -->\n###### ×\n\n<!-- PAGE_69 -->\n###### 1000 g\n\n<!-- PAGE_69 -->\n###### =\n\n<!-- PAGE_69 -->\n###### 6.4 mg/kg bw/day\n\n<!-- PAGE_69 -->\n###### 25 g bw/mouse\n\n<!-- PAGE_69 -->\n###### kg\n\n- - 64 -\n<!-- PAGE_70 -->\n###### ④ T25 산출\n\n<!-- PAGE_70 -->\n###### - 특정 조직에서 25% 종양을 일으킬 수 있는 용량 수준(악성림프종, 체중 1 kg 당 1일 용량)을\n\n<!-- PAGE_70 -->\n###### - 악성림프종 발생 용량인 50 mg/kg으로부터 T25 = 5.0 mg/kg bw/day을 산출함\n\n<!-- PAGE_70 -->\n###### ⑤ HT25 산출\n\n<!-- PAGE_70 -->\n###### ⑥ 노출평가\n\n<!-- PAGE_70 -->\n###### ⑦ 위해도 결정\n\n<!-- PAGE_70 -->\n###### - LCR이 10-5 이하이므로 위해 우려 가능성 낮음\n\n- - 65 -\n<!-- PAGE_71 -->\n###### 4.  BMDL10을 활용한 MOE 산출 예시\n\n<!-- PAGE_71 -->\n###### □ 물질 B에 대한 MOE 산출\n\n- - 66 -\n<!-- PAGE_72 -->\n###### 5.  프로그램을 활용한 BMDL10 산출 예시\n\n<!-- PAGE_72 -->\n###### 1) 가장 잘 알려진 BMD 소프트웨어는 미국 EPA(www.epa.gov/bmds)에서 개발된 BMDS\n\n<!-- PAGE_72 -->\n###### ※ [예시] Benzo(a)pyrene의 BMDS를 활용한 BMD 분석\n\n<!-- PAGE_72 -->\n###### - BMDL10 산출한 결과 5개의 모델이 통계적으로 수용 가능한 수준(p-value > 0.05)임\n\n<!-- PAGE_72 -->\n###### - BMDL10의 범위는 0.07∼0.20 mg/kg bw/day임\n\n<!-- PAGE_72 -->\n###### - 통계적 수용 가능 multi-stage 모델의 가장 낮은 BMDL10 0.07mg/kg bw/day 선택\n\nModel Name\n\nloglik\n\np-value\n\nAIC\n\nChi-square\n\nBMD10\n\ngamma\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.24\n- 0.09\nlogistic\n\n- -204.1\n- 0.105\n- 412.2\n- 10.1\n- 0.14\n- 0.12\nlog-logistic\n\n- -204.1\n- 0.061\n- 414.2\n- 9.9\n- 0.28\n- 0.18\nlog-probit\n\n- -204.3\n- 0.052\n- 414.6\n- 10.3\n- 0.29\n- 0.20\nmulti-stage\n\n- -204.3\n- 0.053\n- 414.6\n- 10.5\n- 0.14\n- 0.07\nprobit\n\n- -204.3\n- 0.092\n- 412.5\n- 10.4\n- 0.13\n- 0.12\nweibull\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.18\n- 0.08\nQuantal-linear\n\n- -204.4\n- 0.019\n- 416.8\n- 14.7\n- 0.07\n- 0.05\n유해물질의 인체안전기준 설정을 위한 용량-반응 평가 연구, 2016\n\n- - 67 -\n<!-- PAGE_73 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n<!-- PAGE_73 -->\n###### 개별 화학물질의 인체 안전 노출량은 알려진 독성자료로부터 위해평가를 통해 구할 수 있다.\n\n",
        "original_sentence": "T25를 활용한 평생발암위해도(LCR) 산출 예시\n\n<!-- PAGE_69 -->\n###### □ 물질 A에 대한 발암성 연구\n\n<!-- PAGE_69 -->\n###### ① 종양발생이 유의하게 증가하는 최저 용량\n\n<!-- PAGE_69 -->\n###### - 대조군 : 0/50 (0%)\n\n<!-- PAGE_69 -->\n###### - 사료 50 mg/kg에 노출된 암컷 마우스에서 악성림프종 발생 비율 : 16/50 (32%)\n\n<!-- PAGE_69 -->\n###### - net % : 32%\n\n<!-- PAGE_69 -->\n###### ② 노출기간 동안 마우스 한 마리당 1일 용량\n\n<!-- PAGE_69 -->\n###### - 마우스 1일 먹이 투여량 : 3.25 g/day(실험값)\n\n<!-- PAGE_69 -->\n###### ③ 노출기간 동안 마우스 체중 1 kg 당 물질 A의 1일 섭취량\n\n<!-- PAGE_69 -->\n###### - 시험자료를 통해 저용량 노출군의 암컷 마우스의 평균 체중은 25 g로 확인됨\n\n<!-- PAGE_69 -->\n###### 0.16 mg/day\n\n<!-- PAGE_69 -->\n###### ×\n\n<!-- PAGE_69 -->\n###### 1000 g\n\n<!-- PAGE_69 -->\n###### =\n\n<!-- PAGE_69 -->\n###### 6.4 mg/kg bw/day\n\n<!-- PAGE_69 -->\n###### 25 g bw/mouse\n\n<!-- PAGE_69 -->\n###### kg\n\n- - 64 -\n<!-- PAGE_70 -->\n###### ④ T25 산출\n\n<!-- PAGE_70 -->\n###### - 특정 조직에서 25% 종양을 일으킬 수 있는 용량 수준(악성림프종, 체중 1 kg 당 1일 용량)을\n\n<!-- PAGE_70 -->\n###### - 악성림프종 발생 용량인 50 mg/kg으로부터 T25 = 5.0 mg/kg bw/day을 산출함\n\n<!-- PAGE_70 -->\n###### ⑤ HT25 산출\n\n<!-- PAGE_70 -->\n###### ⑥ 노출평가\n\n<!-- PAGE_70 -->\n###### ⑦ 위해도 결정\n\n<!-- PAGE_70 -->\n###### - LCR이 10-5 이하이므로 위해 우려 가능성 낮음\n\n- - 65 -\n<!-- PAGE_71 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_374",
      "text": "BMDL10을 활용한 MOE 산출 예시\n\n<!-- PAGE_71 -->\n###### □ 물질 B에 대한 MOE 산출\n\n- - 66 -\n<!-- PAGE_72 -->\n###### 5. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 373,
        "window_size": 3,
        "char_count": 102,
        "word_count": 24,
        "page_number": 71,
        "window_text": "평생발암 위험성의 판정을 위해서는 T25 또는 BMDL10 등을 이용하여 평생발암 위험률을 산\n\n<!-- PAGE_68 -->\n###### 2) BMDL10 또는 T25를 이용한 노출안전역(MOE) 산출\n\n<!-- PAGE_68 -->\n###### : 동물시험으로부터 BMDL10를 이용한 노출안전역(MOE)이 10,000 이상 또는 T25를 이용한\n\n<!-- PAGE_68 -->\n###### 노출안전역(MOE)이 25,000 이상인 경우, 위해 우려가 되지 않는다고 평가할 수 있다(EFSA,\n\n<!-- PAGE_68 -->\n###### 2005).\n\n <!-- PAGE_68 -->\n###### SED\n\n- - 63 -\n<!-- PAGE_69 -->\n###### 3.  T25를 활용한 평생발암위해도(LCR) 산출 예시\n\n<!-- PAGE_69 -->\n###### □ 물질 A에 대한 발암성 연구\n\n<!-- PAGE_69 -->\n###### ① 종양발생이 유의하게 증가하는 최저 용량\n\n<!-- PAGE_69 -->\n###### - 대조군 : 0/50 (0%)\n\n<!-- PAGE_69 -->\n###### - 사료 50 mg/kg에 노출된 암컷 마우스에서 악성림프종 발생 비율 : 16/50 (32%)\n\n<!-- PAGE_69 -->\n###### - net % : 32%\n\n<!-- PAGE_69 -->\n###### ② 노출기간 동안 마우스 한 마리당 1일 용량\n\n<!-- PAGE_69 -->\n###### - 마우스 1일 먹이 투여량 : 3.25 g/day(실험값)\n\n<!-- PAGE_69 -->\n###### ③ 노출기간 동안 마우스 체중 1 kg 당 물질 A의 1일 섭취량\n\n<!-- PAGE_69 -->\n###### - 시험자료를 통해 저용량 노출군의 암컷 마우스의 평균 체중은 25 g로 확인됨\n\n<!-- PAGE_69 -->\n###### 0.16 mg/day\n\n<!-- PAGE_69 -->\n###### ×\n\n<!-- PAGE_69 -->\n###### 1000 g\n\n<!-- PAGE_69 -->\n###### =\n\n<!-- PAGE_69 -->\n###### 6.4 mg/kg bw/day\n\n<!-- PAGE_69 -->\n###### 25 g bw/mouse\n\n<!-- PAGE_69 -->\n###### kg\n\n- - 64 -\n<!-- PAGE_70 -->\n###### ④ T25 산출\n\n<!-- PAGE_70 -->\n###### - 특정 조직에서 25% 종양을 일으킬 수 있는 용량 수준(악성림프종, 체중 1 kg 당 1일 용량)을\n\n<!-- PAGE_70 -->\n###### - 악성림프종 발생 용량인 50 mg/kg으로부터 T25 = 5.0 mg/kg bw/day을 산출함\n\n<!-- PAGE_70 -->\n###### ⑤ HT25 산출\n\n<!-- PAGE_70 -->\n###### ⑥ 노출평가\n\n<!-- PAGE_70 -->\n###### ⑦ 위해도 결정\n\n<!-- PAGE_70 -->\n###### - LCR이 10-5 이하이므로 위해 우려 가능성 낮음\n\n- - 65 -\n<!-- PAGE_71 -->\n###### 4.  BMDL10을 활용한 MOE 산출 예시\n\n<!-- PAGE_71 -->\n###### □ 물질 B에 대한 MOE 산출\n\n- - 66 -\n<!-- PAGE_72 -->\n###### 5.  프로그램을 활용한 BMDL10 산출 예시\n\n<!-- PAGE_72 -->\n###### 1) 가장 잘 알려진 BMD 소프트웨어는 미국 EPA(www.epa.gov/bmds)에서 개발된 BMDS\n\n<!-- PAGE_72 -->\n###### ※ [예시] Benzo(a)pyrene의 BMDS를 활용한 BMD 분석\n\n<!-- PAGE_72 -->\n###### - BMDL10 산출한 결과 5개의 모델이 통계적으로 수용 가능한 수준(p-value > 0.05)임\n\n<!-- PAGE_72 -->\n###### - BMDL10의 범위는 0.07∼0.20 mg/kg bw/day임\n\n<!-- PAGE_72 -->\n###### - 통계적 수용 가능 multi-stage 모델의 가장 낮은 BMDL10 0.07mg/kg bw/day 선택\n\nModel Name\n\nloglik\n\np-value\n\nAIC\n\nChi-square\n\nBMD10\n\ngamma\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.24\n- 0.09\nlogistic\n\n- -204.1\n- 0.105\n- 412.2\n- 10.1\n- 0.14\n- 0.12\nlog-logistic\n\n- -204.1\n- 0.061\n- 414.2\n- 9.9\n- 0.28\n- 0.18\nlog-probit\n\n- -204.3\n- 0.052\n- 414.6\n- 10.3\n- 0.29\n- 0.20\nmulti-stage\n\n- -204.3\n- 0.053\n- 414.6\n- 10.5\n- 0.14\n- 0.07\nprobit\n\n- -204.3\n- 0.092\n- 412.5\n- 10.4\n- 0.13\n- 0.12\nweibull\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.18\n- 0.08\nQuantal-linear\n\n- -204.4\n- 0.019\n- 416.8\n- 14.7\n- 0.07\n- 0.05\n유해물질의 인체안전기준 설정을 위한 용량-반응 평가 연구, 2016\n\n- - 67 -\n<!-- PAGE_73 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n<!-- PAGE_73 -->\n###### 개별 화학물질의 인체 안전 노출량은 알려진 독성자료로부터 위해평가를 통해 구할 수 있다.\n\n <!-- PAGE_73 -->\n###### TTC (Threshold of Toxicological Concern, 독성학적 우려 역치)는 화학물질별 독성자료가 없다\n\n<!-- PAGE_73 -->\n###### 하더라도 모든 화학물질에 대하여 인체 위해 영향이 없는(무시할만한) 노출량을 설정한다는 개\n\n<!-- PAGE_73 -->\n###### 념이다. ",
        "original_sentence": "BMDL10을 활용한 MOE 산출 예시\n\n<!-- PAGE_71 -->\n###### □ 물질 B에 대한 MOE 산출\n\n- - 66 -\n<!-- PAGE_72 -->\n###### 5. "
      }
    },
    {
      "chunk_id": "chunk_375",
      "text": "프로그램을 활용한 BMDL10 산출 예시\n\n<!-- PAGE_72 -->\n###### 1) 가장 잘 알려진 BMD 소프트웨어는 미국 EPA(www.epa.gov/bmds)에서 개발된 BMDS\n\n<!-- PAGE_72 -->\n###### ※ [예시] Benzo(a)pyrene의 BMDS를 활용한 BMD 분석\n\n<!-- PAGE_72 -->\n###### - BMDL10 산출한 결과 5개의 모델이 통계적으로 수용 가능한 수준(p-value > 0.05)임\n\n<!-- PAGE_72 -->\n###### - BMDL10의 범위는 0.07∼0.20 mg/kg bw/day임\n\n<!-- PAGE_72 -->\n###### - 통계적 수용 가능 multi-stage 모델의 가장 낮은 BMDL10 0.07mg/kg bw/day 선택\n\nModel Name\n\nloglik\n\np-value\n\nAIC\n\nChi-square\n\nBMD10\n\ngamma\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.24\n- 0.09\nlogistic\n\n- -204.1\n- 0.105\n- 412.2\n- 10.1\n- 0.14\n- 0.12\nlog-logistic\n\n- -204.1\n- 0.061\n- 414.2\n- 9.9\n- 0.28\n- 0.18\nlog-probit\n\n- -204.3\n- 0.052\n- 414.6\n- 10.3\n- 0.29\n- 0.20\nmulti-stage\n\n- -204.3\n- 0.053\n- 414.6\n- 10.5\n- 0.14\n- 0.07\nprobit\n\n- -204.3\n- 0.092\n- 412.5\n- 10.4\n- 0.13\n- 0.12\nweibull\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.18\n- 0.08\nQuantal-linear\n\n- -204.4\n- 0.019\n- 416.8\n- 14.7\n- 0.07\n- 0.05\n유해물질의 인체안전기준 설정을 위한 용량-반응 평가 연구, 2016\n\n- - 67 -\n<!-- PAGE_73 -->\n###### 참고 2. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 374,
        "window_size": 3,
        "char_count": 991,
        "word_count": 201,
        "page_number": 72,
        "window_text": "<!-- PAGE_68 -->\n###### SED\n\n- - 63 -\n<!-- PAGE_69 -->\n###### 3.  T25를 활용한 평생발암위해도(LCR) 산출 예시\n\n<!-- PAGE_69 -->\n###### □ 물질 A에 대한 발암성 연구\n\n<!-- PAGE_69 -->\n###### ① 종양발생이 유의하게 증가하는 최저 용량\n\n<!-- PAGE_69 -->\n###### - 대조군 : 0/50 (0%)\n\n<!-- PAGE_69 -->\n###### - 사료 50 mg/kg에 노출된 암컷 마우스에서 악성림프종 발생 비율 : 16/50 (32%)\n\n<!-- PAGE_69 -->\n###### - net % : 32%\n\n<!-- PAGE_69 -->\n###### ② 노출기간 동안 마우스 한 마리당 1일 용량\n\n<!-- PAGE_69 -->\n###### - 마우스 1일 먹이 투여량 : 3.25 g/day(실험값)\n\n<!-- PAGE_69 -->\n###### ③ 노출기간 동안 마우스 체중 1 kg 당 물질 A의 1일 섭취량\n\n<!-- PAGE_69 -->\n###### - 시험자료를 통해 저용량 노출군의 암컷 마우스의 평균 체중은 25 g로 확인됨\n\n<!-- PAGE_69 -->\n###### 0.16 mg/day\n\n<!-- PAGE_69 -->\n###### ×\n\n<!-- PAGE_69 -->\n###### 1000 g\n\n<!-- PAGE_69 -->\n###### =\n\n<!-- PAGE_69 -->\n###### 6.4 mg/kg bw/day\n\n<!-- PAGE_69 -->\n###### 25 g bw/mouse\n\n<!-- PAGE_69 -->\n###### kg\n\n- - 64 -\n<!-- PAGE_70 -->\n###### ④ T25 산출\n\n<!-- PAGE_70 -->\n###### - 특정 조직에서 25% 종양을 일으킬 수 있는 용량 수준(악성림프종, 체중 1 kg 당 1일 용량)을\n\n<!-- PAGE_70 -->\n###### - 악성림프종 발생 용량인 50 mg/kg으로부터 T25 = 5.0 mg/kg bw/day을 산출함\n\n<!-- PAGE_70 -->\n###### ⑤ HT25 산출\n\n<!-- PAGE_70 -->\n###### ⑥ 노출평가\n\n<!-- PAGE_70 -->\n###### ⑦ 위해도 결정\n\n<!-- PAGE_70 -->\n###### - LCR이 10-5 이하이므로 위해 우려 가능성 낮음\n\n- - 65 -\n<!-- PAGE_71 -->\n###### 4.  BMDL10을 활용한 MOE 산출 예시\n\n<!-- PAGE_71 -->\n###### □ 물질 B에 대한 MOE 산출\n\n- - 66 -\n<!-- PAGE_72 -->\n###### 5.  프로그램을 활용한 BMDL10 산출 예시\n\n<!-- PAGE_72 -->\n###### 1) 가장 잘 알려진 BMD 소프트웨어는 미국 EPA(www.epa.gov/bmds)에서 개발된 BMDS\n\n<!-- PAGE_72 -->\n###### ※ [예시] Benzo(a)pyrene의 BMDS를 활용한 BMD 분석\n\n<!-- PAGE_72 -->\n###### - BMDL10 산출한 결과 5개의 모델이 통계적으로 수용 가능한 수준(p-value > 0.05)임\n\n<!-- PAGE_72 -->\n###### - BMDL10의 범위는 0.07∼0.20 mg/kg bw/day임\n\n<!-- PAGE_72 -->\n###### - 통계적 수용 가능 multi-stage 모델의 가장 낮은 BMDL10 0.07mg/kg bw/day 선택\n\nModel Name\n\nloglik\n\np-value\n\nAIC\n\nChi-square\n\nBMD10\n\ngamma\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.24\n- 0.09\nlogistic\n\n- -204.1\n- 0.105\n- 412.2\n- 10.1\n- 0.14\n- 0.12\nlog-logistic\n\n- -204.1\n- 0.061\n- 414.2\n- 9.9\n- 0.28\n- 0.18\nlog-probit\n\n- -204.3\n- 0.052\n- 414.6\n- 10.3\n- 0.29\n- 0.20\nmulti-stage\n\n- -204.3\n- 0.053\n- 414.6\n- 10.5\n- 0.14\n- 0.07\nprobit\n\n- -204.3\n- 0.092\n- 412.5\n- 10.4\n- 0.13\n- 0.12\nweibull\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.18\n- 0.08\nQuantal-linear\n\n- -204.4\n- 0.019\n- 416.8\n- 14.7\n- 0.07\n- 0.05\n유해물질의 인체안전기준 설정을 위한 용량-반응 평가 연구, 2016\n\n- - 67 -\n<!-- PAGE_73 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n<!-- PAGE_73 -->\n###### 개별 화학물질의 인체 안전 노출량은 알려진 독성자료로부터 위해평가를 통해 구할 수 있다.\n\n <!-- PAGE_73 -->\n###### TTC (Threshold of Toxicological Concern, 독성학적 우려 역치)는 화학물질별 독성자료가 없다\n\n<!-- PAGE_73 -->\n###### 하더라도 모든 화학물질에 대하여 인체 위해 영향이 없는(무시할만한) 노출량을 설정한다는 개\n\n<!-- PAGE_73 -->\n###### 념이다.  이는 독성자료가 없거나 제한적일 때 화학구조에 대한 지식을 기반으로 독성 데이터베\n\n<!-- PAGE_73 -->\n###### 이스에서 유사 구조 화학물질의 독성자료와 비교하는 것으로 Cramer decision tree에 따라 세\n\n<!-- PAGE_73 -->\n###### 가지 등급으로 분류하여 TTC를 활용할 수 있다.\n\n",
        "original_sentence": "프로그램을 활용한 BMDL10 산출 예시\n\n<!-- PAGE_72 -->\n###### 1) 가장 잘 알려진 BMD 소프트웨어는 미국 EPA(www.epa.gov/bmds)에서 개발된 BMDS\n\n<!-- PAGE_72 -->\n###### ※ [예시] Benzo(a)pyrene의 BMDS를 활용한 BMD 분석\n\n<!-- PAGE_72 -->\n###### - BMDL10 산출한 결과 5개의 모델이 통계적으로 수용 가능한 수준(p-value > 0.05)임\n\n<!-- PAGE_72 -->\n###### - BMDL10의 범위는 0.07∼0.20 mg/kg bw/day임\n\n<!-- PAGE_72 -->\n###### - 통계적 수용 가능 multi-stage 모델의 가장 낮은 BMDL10 0.07mg/kg bw/day 선택\n\nModel Name\n\nloglik\n\np-value\n\nAIC\n\nChi-square\n\nBMD10\n\ngamma\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.24\n- 0.09\nlogistic\n\n- -204.1\n- 0.105\n- 412.2\n- 10.1\n- 0.14\n- 0.12\nlog-logistic\n\n- -204.1\n- 0.061\n- 414.2\n- 9.9\n- 0.28\n- 0.18\nlog-probit\n\n- -204.3\n- 0.052\n- 414.6\n- 10.3\n- 0.29\n- 0.20\nmulti-stage\n\n- -204.3\n- 0.053\n- 414.6\n- 10.5\n- 0.14\n- 0.07\nprobit\n\n- -204.3\n- 0.092\n- 412.5\n- 10.4\n- 0.13\n- 0.12\nweibull\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.18\n- 0.08\nQuantal-linear\n\n- -204.4\n- 0.019\n- 416.8\n- 14.7\n- 0.07\n- 0.05\n유해물질의 인체안전기준 설정을 위한 용량-반응 평가 연구, 2016\n\n- - 67 -\n<!-- PAGE_73 -->\n###### 참고 2. "
      }
    },
    {
      "chunk_id": "chunk_376",
      "text": "TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n<!-- PAGE_73 -->\n###### 개별 화학물질의 인체 안전 노출량은 알려진 독성자료로부터 위해평가를 통해 구할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 375,
        "window_size": 3,
        "char_count": 128,
        "word_count": 23,
        "page_number": 73,
        "window_text": "T25를 활용한 평생발암위해도(LCR) 산출 예시\n\n<!-- PAGE_69 -->\n###### □ 물질 A에 대한 발암성 연구\n\n<!-- PAGE_69 -->\n###### ① 종양발생이 유의하게 증가하는 최저 용량\n\n<!-- PAGE_69 -->\n###### - 대조군 : 0/50 (0%)\n\n<!-- PAGE_69 -->\n###### - 사료 50 mg/kg에 노출된 암컷 마우스에서 악성림프종 발생 비율 : 16/50 (32%)\n\n<!-- PAGE_69 -->\n###### - net % : 32%\n\n<!-- PAGE_69 -->\n###### ② 노출기간 동안 마우스 한 마리당 1일 용량\n\n<!-- PAGE_69 -->\n###### - 마우스 1일 먹이 투여량 : 3.25 g/day(실험값)\n\n<!-- PAGE_69 -->\n###### ③ 노출기간 동안 마우스 체중 1 kg 당 물질 A의 1일 섭취량\n\n<!-- PAGE_69 -->\n###### - 시험자료를 통해 저용량 노출군의 암컷 마우스의 평균 체중은 25 g로 확인됨\n\n<!-- PAGE_69 -->\n###### 0.16 mg/day\n\n<!-- PAGE_69 -->\n###### ×\n\n<!-- PAGE_69 -->\n###### 1000 g\n\n<!-- PAGE_69 -->\n###### =\n\n<!-- PAGE_69 -->\n###### 6.4 mg/kg bw/day\n\n<!-- PAGE_69 -->\n###### 25 g bw/mouse\n\n<!-- PAGE_69 -->\n###### kg\n\n- - 64 -\n<!-- PAGE_70 -->\n###### ④ T25 산출\n\n<!-- PAGE_70 -->\n###### - 특정 조직에서 25% 종양을 일으킬 수 있는 용량 수준(악성림프종, 체중 1 kg 당 1일 용량)을\n\n<!-- PAGE_70 -->\n###### - 악성림프종 발생 용량인 50 mg/kg으로부터 T25 = 5.0 mg/kg bw/day을 산출함\n\n<!-- PAGE_70 -->\n###### ⑤ HT25 산출\n\n<!-- PAGE_70 -->\n###### ⑥ 노출평가\n\n<!-- PAGE_70 -->\n###### ⑦ 위해도 결정\n\n<!-- PAGE_70 -->\n###### - LCR이 10-5 이하이므로 위해 우려 가능성 낮음\n\n- - 65 -\n<!-- PAGE_71 -->\n###### 4.  BMDL10을 활용한 MOE 산출 예시\n\n<!-- PAGE_71 -->\n###### □ 물질 B에 대한 MOE 산출\n\n- - 66 -\n<!-- PAGE_72 -->\n###### 5.  프로그램을 활용한 BMDL10 산출 예시\n\n<!-- PAGE_72 -->\n###### 1) 가장 잘 알려진 BMD 소프트웨어는 미국 EPA(www.epa.gov/bmds)에서 개발된 BMDS\n\n<!-- PAGE_72 -->\n###### ※ [예시] Benzo(a)pyrene의 BMDS를 활용한 BMD 분석\n\n<!-- PAGE_72 -->\n###### - BMDL10 산출한 결과 5개의 모델이 통계적으로 수용 가능한 수준(p-value > 0.05)임\n\n<!-- PAGE_72 -->\n###### - BMDL10의 범위는 0.07∼0.20 mg/kg bw/day임\n\n<!-- PAGE_72 -->\n###### - 통계적 수용 가능 multi-stage 모델의 가장 낮은 BMDL10 0.07mg/kg bw/day 선택\n\nModel Name\n\nloglik\n\np-value\n\nAIC\n\nChi-square\n\nBMD10\n\ngamma\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.24\n- 0.09\nlogistic\n\n- -204.1\n- 0.105\n- 412.2\n- 10.1\n- 0.14\n- 0.12\nlog-logistic\n\n- -204.1\n- 0.061\n- 414.2\n- 9.9\n- 0.28\n- 0.18\nlog-probit\n\n- -204.3\n- 0.052\n- 414.6\n- 10.3\n- 0.29\n- 0.20\nmulti-stage\n\n- -204.3\n- 0.053\n- 414.6\n- 10.5\n- 0.14\n- 0.07\nprobit\n\n- -204.3\n- 0.092\n- 412.5\n- 10.4\n- 0.13\n- 0.12\nweibull\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.18\n- 0.08\nQuantal-linear\n\n- -204.4\n- 0.019\n- 416.8\n- 14.7\n- 0.07\n- 0.05\n유해물질의 인체안전기준 설정을 위한 용량-반응 평가 연구, 2016\n\n- - 67 -\n<!-- PAGE_73 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n<!-- PAGE_73 -->\n###### 개별 화학물질의 인체 안전 노출량은 알려진 독성자료로부터 위해평가를 통해 구할 수 있다.\n\n <!-- PAGE_73 -->\n###### TTC (Threshold of Toxicological Concern, 독성학적 우려 역치)는 화학물질별 독성자료가 없다\n\n<!-- PAGE_73 -->\n###### 하더라도 모든 화학물질에 대하여 인체 위해 영향이 없는(무시할만한) 노출량을 설정한다는 개\n\n<!-- PAGE_73 -->\n###### 념이다.  이는 독성자료가 없거나 제한적일 때 화학구조에 대한 지식을 기반으로 독성 데이터베\n\n<!-- PAGE_73 -->\n###### 이스에서 유사 구조 화학물질의 독성자료와 비교하는 것으로 Cramer decision tree에 따라 세\n\n<!-- PAGE_73 -->\n###### 가지 등급으로 분류하여 TTC를 활용할 수 있다.\n\n <!-- PAGE_73 -->\n###### 발암 가능성이 높은 물질, 무기화학물질, 금속, 유기금속, 단백질, 스테로이드, 생물축적 혹은\n\n<!-- PAGE_73 -->\n###### 가능성이 있는 물질, 나노물질, 방사성물질 및 화학구조를 확인할 수 없는 물질이 포함된 혼합\n\n<!-- PAGE_73 -->\n###### 물에는 TTC 방법을 적용할 수 없다. ",
        "original_sentence": "TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n<!-- PAGE_73 -->\n###### 개별 화학물질의 인체 안전 노출량은 알려진 독성자료로부터 위해평가를 통해 구할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_377",
      "text": "<!-- PAGE_73 -->\n###### TTC (Threshold of Toxicological Concern, 독성학적 우려 역치)는 화학물질별 독성자료가 없다\n\n<!-- PAGE_73 -->\n###### 하더라도 모든 화학물질에 대하여 인체 위해 영향이 없는(무시할만한) 노출량을 설정한다는 개\n\n<!-- PAGE_73 -->\n###### 념이다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 376,
        "window_size": 3,
        "char_count": 199,
        "word_count": 35,
        "page_number": 73,
        "window_text": "BMDL10을 활용한 MOE 산출 예시\n\n<!-- PAGE_71 -->\n###### □ 물질 B에 대한 MOE 산출\n\n- - 66 -\n<!-- PAGE_72 -->\n###### 5.  프로그램을 활용한 BMDL10 산출 예시\n\n<!-- PAGE_72 -->\n###### 1) 가장 잘 알려진 BMD 소프트웨어는 미국 EPA(www.epa.gov/bmds)에서 개발된 BMDS\n\n<!-- PAGE_72 -->\n###### ※ [예시] Benzo(a)pyrene의 BMDS를 활용한 BMD 분석\n\n<!-- PAGE_72 -->\n###### - BMDL10 산출한 결과 5개의 모델이 통계적으로 수용 가능한 수준(p-value > 0.05)임\n\n<!-- PAGE_72 -->\n###### - BMDL10의 범위는 0.07∼0.20 mg/kg bw/day임\n\n<!-- PAGE_72 -->\n###### - 통계적 수용 가능 multi-stage 모델의 가장 낮은 BMDL10 0.07mg/kg bw/day 선택\n\nModel Name\n\nloglik\n\np-value\n\nAIC\n\nChi-square\n\nBMD10\n\ngamma\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.24\n- 0.09\nlogistic\n\n- -204.1\n- 0.105\n- 412.2\n- 10.1\n- 0.14\n- 0.12\nlog-logistic\n\n- -204.1\n- 0.061\n- 414.2\n- 9.9\n- 0.28\n- 0.18\nlog-probit\n\n- -204.3\n- 0.052\n- 414.6\n- 10.3\n- 0.29\n- 0.20\nmulti-stage\n\n- -204.3\n- 0.053\n- 414.6\n- 10.5\n- 0.14\n- 0.07\nprobit\n\n- -204.3\n- 0.092\n- 412.5\n- 10.4\n- 0.13\n- 0.12\nweibull\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.18\n- 0.08\nQuantal-linear\n\n- -204.4\n- 0.019\n- 416.8\n- 14.7\n- 0.07\n- 0.05\n유해물질의 인체안전기준 설정을 위한 용량-반응 평가 연구, 2016\n\n- - 67 -\n<!-- PAGE_73 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n<!-- PAGE_73 -->\n###### 개별 화학물질의 인체 안전 노출량은 알려진 독성자료로부터 위해평가를 통해 구할 수 있다.\n\n <!-- PAGE_73 -->\n###### TTC (Threshold of Toxicological Concern, 독성학적 우려 역치)는 화학물질별 독성자료가 없다\n\n<!-- PAGE_73 -->\n###### 하더라도 모든 화학물질에 대하여 인체 위해 영향이 없는(무시할만한) 노출량을 설정한다는 개\n\n<!-- PAGE_73 -->\n###### 념이다.  이는 독성자료가 없거나 제한적일 때 화학구조에 대한 지식을 기반으로 독성 데이터베\n\n<!-- PAGE_73 -->\n###### 이스에서 유사 구조 화학물질의 독성자료와 비교하는 것으로 Cramer decision tree에 따라 세\n\n<!-- PAGE_73 -->\n###### 가지 등급으로 분류하여 TTC를 활용할 수 있다.\n\n <!-- PAGE_73 -->\n###### 발암 가능성이 높은 물질, 무기화학물질, 금속, 유기금속, 단백질, 스테로이드, 생물축적 혹은\n\n<!-- PAGE_73 -->\n###### 가능성이 있는 물질, 나노물질, 방사성물질 및 화학구조를 확인할 수 없는 물질이 포함된 혼합\n\n<!-- PAGE_73 -->\n###### 물에는 TTC 방법을 적용할 수 없다.  유전독성 경고가 없는 화학물질에 대해 화학구조를 분석\n\n<!-- PAGE_73 -->\n###### 하고 전신독성 지표로 Cramer 분류를 사용하여 수행된다.\n\n",
        "original_sentence": "<!-- PAGE_73 -->\n###### TTC (Threshold of Toxicological Concern, 독성학적 우려 역치)는 화학물질별 독성자료가 없다\n\n<!-- PAGE_73 -->\n###### 하더라도 모든 화학물질에 대하여 인체 위해 영향이 없는(무시할만한) 노출량을 설정한다는 개\n\n<!-- PAGE_73 -->\n###### 념이다. "
      }
    },
    {
      "chunk_id": "chunk_378",
      "text": "이는 독성자료가 없거나 제한적일 때 화학구조에 대한 지식을 기반으로 독성 데이터베\n\n<!-- PAGE_73 -->\n###### 이스에서 유사 구조 화학물질의 독성자료와 비교하는 것으로 Cramer decision tree에 따라 세\n\n<!-- PAGE_73 -->\n###### 가지 등급으로 분류하여 TTC를 활용할 수 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 377,
        "window_size": 3,
        "char_count": 184,
        "word_count": 38,
        "page_number": 73,
        "window_text": "프로그램을 활용한 BMDL10 산출 예시\n\n<!-- PAGE_72 -->\n###### 1) 가장 잘 알려진 BMD 소프트웨어는 미국 EPA(www.epa.gov/bmds)에서 개발된 BMDS\n\n<!-- PAGE_72 -->\n###### ※ [예시] Benzo(a)pyrene의 BMDS를 활용한 BMD 분석\n\n<!-- PAGE_72 -->\n###### - BMDL10 산출한 결과 5개의 모델이 통계적으로 수용 가능한 수준(p-value > 0.05)임\n\n<!-- PAGE_72 -->\n###### - BMDL10의 범위는 0.07∼0.20 mg/kg bw/day임\n\n<!-- PAGE_72 -->\n###### - 통계적 수용 가능 multi-stage 모델의 가장 낮은 BMDL10 0.07mg/kg bw/day 선택\n\nModel Name\n\nloglik\n\np-value\n\nAIC\n\nChi-square\n\nBMD10\n\ngamma\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.24\n- 0.09\nlogistic\n\n- -204.1\n- 0.105\n- 412.2\n- 10.1\n- 0.14\n- 0.12\nlog-logistic\n\n- -204.1\n- 0.061\n- 414.2\n- 9.9\n- 0.28\n- 0.18\nlog-probit\n\n- -204.3\n- 0.052\n- 414.6\n- 10.3\n- 0.29\n- 0.20\nmulti-stage\n\n- -204.3\n- 0.053\n- 414.6\n- 10.5\n- 0.14\n- 0.07\nprobit\n\n- -204.3\n- 0.092\n- 412.5\n- 10.4\n- 0.13\n- 0.12\nweibull\n\n- -204.6\n- 0.041\n- 415.2\n- 11.0\n- 0.18\n- 0.08\nQuantal-linear\n\n- -204.4\n- 0.019\n- 416.8\n- 14.7\n- 0.07\n- 0.05\n유해물질의 인체안전기준 설정을 위한 용량-반응 평가 연구, 2016\n\n- - 67 -\n<!-- PAGE_73 -->\n###### 참고 2.  TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n<!-- PAGE_73 -->\n###### 개별 화학물질의 인체 안전 노출량은 알려진 독성자료로부터 위해평가를 통해 구할 수 있다.\n\n <!-- PAGE_73 -->\n###### TTC (Threshold of Toxicological Concern, 독성학적 우려 역치)는 화학물질별 독성자료가 없다\n\n<!-- PAGE_73 -->\n###### 하더라도 모든 화학물질에 대하여 인체 위해 영향이 없는(무시할만한) 노출량을 설정한다는 개\n\n<!-- PAGE_73 -->\n###### 념이다.  이는 독성자료가 없거나 제한적일 때 화학구조에 대한 지식을 기반으로 독성 데이터베\n\n<!-- PAGE_73 -->\n###### 이스에서 유사 구조 화학물질의 독성자료와 비교하는 것으로 Cramer decision tree에 따라 세\n\n<!-- PAGE_73 -->\n###### 가지 등급으로 분류하여 TTC를 활용할 수 있다.\n\n <!-- PAGE_73 -->\n###### 발암 가능성이 높은 물질, 무기화학물질, 금속, 유기금속, 단백질, 스테로이드, 생물축적 혹은\n\n<!-- PAGE_73 -->\n###### 가능성이 있는 물질, 나노물질, 방사성물질 및 화학구조를 확인할 수 없는 물질이 포함된 혼합\n\n<!-- PAGE_73 -->\n###### 물에는 TTC 방법을 적용할 수 없다.  유전독성 경고가 없는 화학물질에 대해 화학구조를 분석\n\n<!-- PAGE_73 -->\n###### 하고 전신독성 지표로 Cramer 분류를 사용하여 수행된다.\n\n <!-- PAGE_73 -->\n###### 원칙적으로 TTC 방법은 매우 낮은 양으로 존재하는 화학물질에 의해 발생하는 전신독성에\n\n<!-- PAGE_73 -->\n###### 대하여 인체 위해성을 평가하는 것으로, 화학물질별로 전문가의 판단하에 사례별로 수행되어야\n\n<!-- PAGE_73 -->\n###### 한다. ",
        "original_sentence": "이는 독성자료가 없거나 제한적일 때 화학구조에 대한 지식을 기반으로 독성 데이터베\n\n<!-- PAGE_73 -->\n###### 이스에서 유사 구조 화학물질의 독성자료와 비교하는 것으로 Cramer decision tree에 따라 세\n\n<!-- PAGE_73 -->\n###### 가지 등급으로 분류하여 TTC를 활용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_379",
      "text": "<!-- PAGE_73 -->\n###### 발암 가능성이 높은 물질, 무기화학물질, 금속, 유기금속, 단백질, 스테로이드, 생물축적 혹은\n\n<!-- PAGE_73 -->\n###### 가능성이 있는 물질, 나노물질, 방사성물질 및 화학구조를 확인할 수 없는 물질이 포함된 혼합\n\n<!-- PAGE_73 -->\n###### 물에는 TTC 방법을 적용할 수 없다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 378,
        "window_size": 3,
        "char_count": 201,
        "word_count": 42,
        "page_number": 73,
        "window_text": "TTC(Threshold of Toxicological Concern)를 활용한 위해도 결정\n\n<!-- PAGE_73 -->\n###### 개별 화학물질의 인체 안전 노출량은 알려진 독성자료로부터 위해평가를 통해 구할 수 있다.\n\n <!-- PAGE_73 -->\n###### TTC (Threshold of Toxicological Concern, 독성학적 우려 역치)는 화학물질별 독성자료가 없다\n\n<!-- PAGE_73 -->\n###### 하더라도 모든 화학물질에 대하여 인체 위해 영향이 없는(무시할만한) 노출량을 설정한다는 개\n\n<!-- PAGE_73 -->\n###### 념이다.  이는 독성자료가 없거나 제한적일 때 화학구조에 대한 지식을 기반으로 독성 데이터베\n\n<!-- PAGE_73 -->\n###### 이스에서 유사 구조 화학물질의 독성자료와 비교하는 것으로 Cramer decision tree에 따라 세\n\n<!-- PAGE_73 -->\n###### 가지 등급으로 분류하여 TTC를 활용할 수 있다.\n\n <!-- PAGE_73 -->\n###### 발암 가능성이 높은 물질, 무기화학물질, 금속, 유기금속, 단백질, 스테로이드, 생물축적 혹은\n\n<!-- PAGE_73 -->\n###### 가능성이 있는 물질, 나노물질, 방사성물질 및 화학구조를 확인할 수 없는 물질이 포함된 혼합\n\n<!-- PAGE_73 -->\n###### 물에는 TTC 방법을 적용할 수 없다.  유전독성 경고가 없는 화학물질에 대해 화학구조를 분석\n\n<!-- PAGE_73 -->\n###### 하고 전신독성 지표로 Cramer 분류를 사용하여 수행된다.\n\n <!-- PAGE_73 -->\n###### 원칙적으로 TTC 방법은 매우 낮은 양으로 존재하는 화학물질에 의해 발생하는 전신독성에\n\n<!-- PAGE_73 -->\n###### 대하여 인체 위해성을 평가하는 것으로, 화학물질별로 전문가의 판단하에 사례별로 수행되어야\n\n<!-- PAGE_73 -->\n###### 한다.  일반적으로 화장품에 사용되는 성분은 Cramer Class Ⅰ 또는 Ⅲ으로 분류하고, Class Ⅱ\n\n<!-- PAGE_73 -->\n###### 의 TTC 값에 대해서는 유효한 자료가 부족하기 때문에 이에 해당되는 물질은 Class Ⅲ으로 분\n\n<!-- PAGE_73 -->\n###### 류한다. ",
        "original_sentence": "<!-- PAGE_73 -->\n###### 발암 가능성이 높은 물질, 무기화학물질, 금속, 유기금속, 단백질, 스테로이드, 생물축적 혹은\n\n<!-- PAGE_73 -->\n###### 가능성이 있는 물질, 나노물질, 방사성물질 및 화학구조를 확인할 수 없는 물질이 포함된 혼합\n\n<!-- PAGE_73 -->\n###### 물에는 TTC 방법을 적용할 수 없다. "
      }
    },
    {
      "chunk_id": "chunk_380",
      "text": "유전독성 경고가 없는 화학물질에 대해 화학구조를 분석\n\n<!-- PAGE_73 -->\n###### 하고 전신독성 지표로 Cramer 분류를 사용하여 수행된다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 379,
        "window_size": 3,
        "char_count": 90,
        "word_count": 18,
        "page_number": 73,
        "window_text": "<!-- PAGE_73 -->\n###### TTC (Threshold of Toxicological Concern, 독성학적 우려 역치)는 화학물질별 독성자료가 없다\n\n<!-- PAGE_73 -->\n###### 하더라도 모든 화학물질에 대하여 인체 위해 영향이 없는(무시할만한) 노출량을 설정한다는 개\n\n<!-- PAGE_73 -->\n###### 념이다.  이는 독성자료가 없거나 제한적일 때 화학구조에 대한 지식을 기반으로 독성 데이터베\n\n<!-- PAGE_73 -->\n###### 이스에서 유사 구조 화학물질의 독성자료와 비교하는 것으로 Cramer decision tree에 따라 세\n\n<!-- PAGE_73 -->\n###### 가지 등급으로 분류하여 TTC를 활용할 수 있다.\n\n <!-- PAGE_73 -->\n###### 발암 가능성이 높은 물질, 무기화학물질, 금속, 유기금속, 단백질, 스테로이드, 생물축적 혹은\n\n<!-- PAGE_73 -->\n###### 가능성이 있는 물질, 나노물질, 방사성물질 및 화학구조를 확인할 수 없는 물질이 포함된 혼합\n\n<!-- PAGE_73 -->\n###### 물에는 TTC 방법을 적용할 수 없다.  유전독성 경고가 없는 화학물질에 대해 화학구조를 분석\n\n<!-- PAGE_73 -->\n###### 하고 전신독성 지표로 Cramer 분류를 사용하여 수행된다.\n\n <!-- PAGE_73 -->\n###### 원칙적으로 TTC 방법은 매우 낮은 양으로 존재하는 화학물질에 의해 발생하는 전신독성에\n\n<!-- PAGE_73 -->\n###### 대하여 인체 위해성을 평가하는 것으로, 화학물질별로 전문가의 판단하에 사례별로 수행되어야\n\n<!-- PAGE_73 -->\n###### 한다.  일반적으로 화장품에 사용되는 성분은 Cramer Class Ⅰ 또는 Ⅲ으로 분류하고, Class Ⅱ\n\n<!-- PAGE_73 -->\n###### 의 TTC 값에 대해서는 유효한 자료가 부족하기 때문에 이에 해당되는 물질은 Class Ⅲ으로 분\n\n<!-- PAGE_73 -->\n###### 류한다.  TTC 값은 모든 연령층을 포함한 전체 인구에 적용하기 위해서 일반적으로 1일 체중\n\n<!-- PAGE_73 -->\n###### kg당 양(amount)로 표시한다. ",
        "original_sentence": "유전독성 경고가 없는 화학물질에 대해 화학구조를 분석\n\n<!-- PAGE_73 -->\n###### 하고 전신독성 지표로 Cramer 분류를 사용하여 수행된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_381",
      "text": "<!-- PAGE_73 -->\n###### 원칙적으로 TTC 방법은 매우 낮은 양으로 존재하는 화학물질에 의해 발생하는 전신독성에\n\n<!-- PAGE_73 -->\n###### 대하여 인체 위해성을 평가하는 것으로, 화학물질별로 전문가의 판단하에 사례별로 수행되어야\n\n<!-- PAGE_73 -->\n###### 한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 380,
        "window_size": 3,
        "char_count": 177,
        "word_count": 34,
        "page_number": 73,
        "window_text": "이는 독성자료가 없거나 제한적일 때 화학구조에 대한 지식을 기반으로 독성 데이터베\n\n<!-- PAGE_73 -->\n###### 이스에서 유사 구조 화학물질의 독성자료와 비교하는 것으로 Cramer decision tree에 따라 세\n\n<!-- PAGE_73 -->\n###### 가지 등급으로 분류하여 TTC를 활용할 수 있다.\n\n <!-- PAGE_73 -->\n###### 발암 가능성이 높은 물질, 무기화학물질, 금속, 유기금속, 단백질, 스테로이드, 생물축적 혹은\n\n<!-- PAGE_73 -->\n###### 가능성이 있는 물질, 나노물질, 방사성물질 및 화학구조를 확인할 수 없는 물질이 포함된 혼합\n\n<!-- PAGE_73 -->\n###### 물에는 TTC 방법을 적용할 수 없다.  유전독성 경고가 없는 화학물질에 대해 화학구조를 분석\n\n<!-- PAGE_73 -->\n###### 하고 전신독성 지표로 Cramer 분류를 사용하여 수행된다.\n\n <!-- PAGE_73 -->\n###### 원칙적으로 TTC 방법은 매우 낮은 양으로 존재하는 화학물질에 의해 발생하는 전신독성에\n\n<!-- PAGE_73 -->\n###### 대하여 인체 위해성을 평가하는 것으로, 화학물질별로 전문가의 판단하에 사례별로 수행되어야\n\n<!-- PAGE_73 -->\n###### 한다.  일반적으로 화장품에 사용되는 성분은 Cramer Class Ⅰ 또는 Ⅲ으로 분류하고, Class Ⅱ\n\n<!-- PAGE_73 -->\n###### 의 TTC 값에 대해서는 유효한 자료가 부족하기 때문에 이에 해당되는 물질은 Class Ⅲ으로 분\n\n<!-- PAGE_73 -->\n###### 류한다.  TTC 값은 모든 연령층을 포함한 전체 인구에 적용하기 위해서 일반적으로 1일 체중\n\n<!-- PAGE_73 -->\n###### kg당 양(amount)로 표시한다.  특히, 일부 화학물질의 경우 미숙한 신진대사가 있을 수 있는 6\n\n<!-- PAGE_73 -->\n###### 개월 미만의 유아에 대하여 특별한 고려가 필요하다.\n\n",
        "original_sentence": "<!-- PAGE_73 -->\n###### 원칙적으로 TTC 방법은 매우 낮은 양으로 존재하는 화학물질에 의해 발생하는 전신독성에\n\n<!-- PAGE_73 -->\n###### 대하여 인체 위해성을 평가하는 것으로, 화학물질별로 전문가의 판단하에 사례별로 수행되어야\n\n<!-- PAGE_73 -->\n###### 한다. "
      }
    },
    {
      "chunk_id": "chunk_382",
      "text": "일반적으로 화장품에 사용되는 성분은 Cramer Class Ⅰ 또는 Ⅲ으로 분류하고, Class Ⅱ\n\n<!-- PAGE_73 -->\n###### 의 TTC 값에 대해서는 유효한 자료가 부족하기 때문에 이에 해당되는 물질은 Class Ⅲ으로 분\n\n<!-- PAGE_73 -->\n###### 류한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 381,
        "window_size": 3,
        "char_count": 166,
        "word_count": 35,
        "page_number": 73,
        "window_text": "<!-- PAGE_73 -->\n###### 발암 가능성이 높은 물질, 무기화학물질, 금속, 유기금속, 단백질, 스테로이드, 생물축적 혹은\n\n<!-- PAGE_73 -->\n###### 가능성이 있는 물질, 나노물질, 방사성물질 및 화학구조를 확인할 수 없는 물질이 포함된 혼합\n\n<!-- PAGE_73 -->\n###### 물에는 TTC 방법을 적용할 수 없다.  유전독성 경고가 없는 화학물질에 대해 화학구조를 분석\n\n<!-- PAGE_73 -->\n###### 하고 전신독성 지표로 Cramer 분류를 사용하여 수행된다.\n\n <!-- PAGE_73 -->\n###### 원칙적으로 TTC 방법은 매우 낮은 양으로 존재하는 화학물질에 의해 발생하는 전신독성에\n\n<!-- PAGE_73 -->\n###### 대하여 인체 위해성을 평가하는 것으로, 화학물질별로 전문가의 판단하에 사례별로 수행되어야\n\n<!-- PAGE_73 -->\n###### 한다.  일반적으로 화장품에 사용되는 성분은 Cramer Class Ⅰ 또는 Ⅲ으로 분류하고, Class Ⅱ\n\n<!-- PAGE_73 -->\n###### 의 TTC 값에 대해서는 유효한 자료가 부족하기 때문에 이에 해당되는 물질은 Class Ⅲ으로 분\n\n<!-- PAGE_73 -->\n###### 류한다.  TTC 값은 모든 연령층을 포함한 전체 인구에 적용하기 위해서 일반적으로 1일 체중\n\n<!-- PAGE_73 -->\n###### kg당 양(amount)로 표시한다.  특히, 일부 화학물질의 경우 미숙한 신진대사가 있을 수 있는 6\n\n<!-- PAGE_73 -->\n###### 개월 미만의 유아에 대하여 특별한 고려가 필요하다.\n\n <!-- PAGE_73 -->\n###### TTC는 경구 경로의 전신독성을 나타내는 외부용량 기반의 값이고, 화장품의 주요 노출 경로\n\n<!-- PAGE_73 -->\n###### 는 피부이기 때문에 피부 흡수에 대한 변수를 고려하여 내부 노출량으로 변환하여 TTC 값과\n\n<!-- PAGE_73 -->\n###### 비교하여야 한다.\n\n",
        "original_sentence": "일반적으로 화장품에 사용되는 성분은 Cramer Class Ⅰ 또는 Ⅲ으로 분류하고, Class Ⅱ\n\n<!-- PAGE_73 -->\n###### 의 TTC 값에 대해서는 유효한 자료가 부족하기 때문에 이에 해당되는 물질은 Class Ⅲ으로 분\n\n<!-- PAGE_73 -->\n###### 류한다. "
      }
    },
    {
      "chunk_id": "chunk_383",
      "text": "TTC 값은 모든 연령층을 포함한 전체 인구에 적용하기 위해서 일반적으로 1일 체중\n\n<!-- PAGE_73 -->\n###### kg당 양(amount)로 표시한다. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 382,
        "window_size": 3,
        "char_count": 93,
        "word_count": 19,
        "page_number": 73,
        "window_text": "유전독성 경고가 없는 화학물질에 대해 화학구조를 분석\n\n<!-- PAGE_73 -->\n###### 하고 전신독성 지표로 Cramer 분류를 사용하여 수행된다.\n\n <!-- PAGE_73 -->\n###### 원칙적으로 TTC 방법은 매우 낮은 양으로 존재하는 화학물질에 의해 발생하는 전신독성에\n\n<!-- PAGE_73 -->\n###### 대하여 인체 위해성을 평가하는 것으로, 화학물질별로 전문가의 판단하에 사례별로 수행되어야\n\n<!-- PAGE_73 -->\n###### 한다.  일반적으로 화장품에 사용되는 성분은 Cramer Class Ⅰ 또는 Ⅲ으로 분류하고, Class Ⅱ\n\n<!-- PAGE_73 -->\n###### 의 TTC 값에 대해서는 유효한 자료가 부족하기 때문에 이에 해당되는 물질은 Class Ⅲ으로 분\n\n<!-- PAGE_73 -->\n###### 류한다.  TTC 값은 모든 연령층을 포함한 전체 인구에 적용하기 위해서 일반적으로 1일 체중\n\n<!-- PAGE_73 -->\n###### kg당 양(amount)로 표시한다.  특히, 일부 화학물질의 경우 미숙한 신진대사가 있을 수 있는 6\n\n<!-- PAGE_73 -->\n###### 개월 미만의 유아에 대하여 특별한 고려가 필요하다.\n\n <!-- PAGE_73 -->\n###### TTC는 경구 경로의 전신독성을 나타내는 외부용량 기반의 값이고, 화장품의 주요 노출 경로\n\n<!-- PAGE_73 -->\n###### 는 피부이기 때문에 피부 흡수에 대한 변수를 고려하여 내부 노출량으로 변환하여 TTC 값과\n\n<!-- PAGE_73 -->\n###### 비교하여야 한다.\n\n <!-- PAGE_73 -->\n###### 유럽 SCCS에서는 Yang et al. ",
        "original_sentence": "TTC 값은 모든 연령층을 포함한 전체 인구에 적용하기 위해서 일반적으로 1일 체중\n\n<!-- PAGE_73 -->\n###### kg당 양(amount)로 표시한다. "
      }
    },
    {
      "chunk_id": "chunk_384",
      "text": "특히, 일부 화학물질의 경우 미숙한 신진대사가 있을 수 있는 6\n\n<!-- PAGE_73 -->\n###### 개월 미만의 유아에 대하여 특별한 고려가 필요하다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 383,
        "window_size": 3,
        "char_count": 91,
        "word_count": 21,
        "page_number": 73,
        "window_text": "<!-- PAGE_73 -->\n###### 원칙적으로 TTC 방법은 매우 낮은 양으로 존재하는 화학물질에 의해 발생하는 전신독성에\n\n<!-- PAGE_73 -->\n###### 대하여 인체 위해성을 평가하는 것으로, 화학물질별로 전문가의 판단하에 사례별로 수행되어야\n\n<!-- PAGE_73 -->\n###### 한다.  일반적으로 화장품에 사용되는 성분은 Cramer Class Ⅰ 또는 Ⅲ으로 분류하고, Class Ⅱ\n\n<!-- PAGE_73 -->\n###### 의 TTC 값에 대해서는 유효한 자료가 부족하기 때문에 이에 해당되는 물질은 Class Ⅲ으로 분\n\n<!-- PAGE_73 -->\n###### 류한다.  TTC 값은 모든 연령층을 포함한 전체 인구에 적용하기 위해서 일반적으로 1일 체중\n\n<!-- PAGE_73 -->\n###### kg당 양(amount)로 표시한다.  특히, 일부 화학물질의 경우 미숙한 신진대사가 있을 수 있는 6\n\n<!-- PAGE_73 -->\n###### 개월 미만의 유아에 대하여 특별한 고려가 필요하다.\n\n <!-- PAGE_73 -->\n###### TTC는 경구 경로의 전신독성을 나타내는 외부용량 기반의 값이고, 화장품의 주요 노출 경로\n\n<!-- PAGE_73 -->\n###### 는 피부이기 때문에 피부 흡수에 대한 변수를 고려하여 내부 노출량으로 변환하여 TTC 값과\n\n<!-- PAGE_73 -->\n###### 비교하여야 한다.\n\n <!-- PAGE_73 -->\n###### 유럽 SCCS에서는 Yang et al.  2017이 제안한 TTC 값 사용을 제안하고 있다.\n\n",
        "original_sentence": "특히, 일부 화학물질의 경우 미숙한 신진대사가 있을 수 있는 6\n\n<!-- PAGE_73 -->\n###### 개월 미만의 유아에 대하여 특별한 고려가 필요하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_385",
      "text": "<!-- PAGE_73 -->\n###### TTC는 경구 경로의 전신독성을 나타내는 외부용량 기반의 값이고, 화장품의 주요 노출 경로\n\n<!-- PAGE_73 -->\n###### 는 피부이기 때문에 피부 흡수에 대한 변수를 고려하여 내부 노출량으로 변환하여 TTC 값과\n\n<!-- PAGE_73 -->\n###### 비교하여야 한다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 384,
        "window_size": 3,
        "char_count": 187,
        "word_count": 39,
        "page_number": 73,
        "window_text": "일반적으로 화장품에 사용되는 성분은 Cramer Class Ⅰ 또는 Ⅲ으로 분류하고, Class Ⅱ\n\n<!-- PAGE_73 -->\n###### 의 TTC 값에 대해서는 유효한 자료가 부족하기 때문에 이에 해당되는 물질은 Class Ⅲ으로 분\n\n<!-- PAGE_73 -->\n###### 류한다.  TTC 값은 모든 연령층을 포함한 전체 인구에 적용하기 위해서 일반적으로 1일 체중\n\n<!-- PAGE_73 -->\n###### kg당 양(amount)로 표시한다.  특히, 일부 화학물질의 경우 미숙한 신진대사가 있을 수 있는 6\n\n<!-- PAGE_73 -->\n###### 개월 미만의 유아에 대하여 특별한 고려가 필요하다.\n\n <!-- PAGE_73 -->\n###### TTC는 경구 경로의 전신독성을 나타내는 외부용량 기반의 값이고, 화장품의 주요 노출 경로\n\n<!-- PAGE_73 -->\n###### 는 피부이기 때문에 피부 흡수에 대한 변수를 고려하여 내부 노출량으로 변환하여 TTC 값과\n\n<!-- PAGE_73 -->\n###### 비교하여야 한다.\n\n <!-- PAGE_73 -->\n###### 유럽 SCCS에서는 Yang et al.  2017이 제안한 TTC 값 사용을 제안하고 있다.\n\n <!-- PAGE_73 -->\n###### 표 1 . ",
        "original_sentence": "<!-- PAGE_73 -->\n###### TTC는 경구 경로의 전신독성을 나타내는 외부용량 기반의 값이고, 화장품의 주요 노출 경로\n\n<!-- PAGE_73 -->\n###### 는 피부이기 때문에 피부 흡수에 대한 변수를 고려하여 내부 노출량으로 변환하여 TTC 값과\n\n<!-- PAGE_73 -->\n###### 비교하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_386",
      "text": "<!-- PAGE_73 -->\n###### 유럽 SCCS에서는 Yang et al. ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 385,
        "window_size": 3,
        "char_count": 47,
        "word_count": 9,
        "page_number": 73,
        "window_text": "TTC 값은 모든 연령층을 포함한 전체 인구에 적용하기 위해서 일반적으로 1일 체중\n\n<!-- PAGE_73 -->\n###### kg당 양(amount)로 표시한다.  특히, 일부 화학물질의 경우 미숙한 신진대사가 있을 수 있는 6\n\n<!-- PAGE_73 -->\n###### 개월 미만의 유아에 대하여 특별한 고려가 필요하다.\n\n <!-- PAGE_73 -->\n###### TTC는 경구 경로의 전신독성을 나타내는 외부용량 기반의 값이고, 화장품의 주요 노출 경로\n\n<!-- PAGE_73 -->\n###### 는 피부이기 때문에 피부 흡수에 대한 변수를 고려하여 내부 노출량으로 변환하여 TTC 값과\n\n<!-- PAGE_73 -->\n###### 비교하여야 한다.\n\n <!-- PAGE_73 -->\n###### 유럽 SCCS에서는 Yang et al.  2017이 제안한 TTC 값 사용을 제안하고 있다.\n\n <!-- PAGE_73 -->\n###### 표 1 .  제안된 TTC 값 요약 (단위: μg/kg bw/day)\n\n**[표 시작]**\n\n**Cramer class**\n\n**[표 끝]**\n\nGenotoxic\n\ncompounds\n\n- 0.0025\nⅠ*\n\n30\n\n42\n\n46\n\n- 49.1\nⅡ*\n\nNot supported**\n\n- -\nNot supported**\n\n- 12.7\nⅢ*\n\n- 1.5\n- 7.9\n- 2.3\n- 2.9\n* Non-genotoxic componds\n\n** Chemicals of Cramer classⅡ should be treated as ClassⅢ substances.\n\n",
        "original_sentence": "<!-- PAGE_73 -->\n###### 유럽 SCCS에서는 Yang et al. "
      }
    },
    {
      "chunk_id": "chunk_387",
      "text": "2017이 제안한 TTC 값 사용을 제안하고 있다.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 386,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 2,
        "window_text": "특히, 일부 화학물질의 경우 미숙한 신진대사가 있을 수 있는 6\n\n<!-- PAGE_73 -->\n###### 개월 미만의 유아에 대하여 특별한 고려가 필요하다.\n\n <!-- PAGE_73 -->\n###### TTC는 경구 경로의 전신독성을 나타내는 외부용량 기반의 값이고, 화장품의 주요 노출 경로\n\n<!-- PAGE_73 -->\n###### 는 피부이기 때문에 피부 흡수에 대한 변수를 고려하여 내부 노출량으로 변환하여 TTC 값과\n\n<!-- PAGE_73 -->\n###### 비교하여야 한다.\n\n <!-- PAGE_73 -->\n###### 유럽 SCCS에서는 Yang et al.  2017이 제안한 TTC 값 사용을 제안하고 있다.\n\n <!-- PAGE_73 -->\n###### 표 1 .  제안된 TTC 값 요약 (단위: μg/kg bw/day)\n\n**[표 시작]**\n\n**Cramer class**\n\n**[표 끝]**\n\nGenotoxic\n\ncompounds\n\n- 0.0025\nⅠ*\n\n30\n\n42\n\n46\n\n- 49.1\nⅡ*\n\nNot supported**\n\n- -\nNot supported**\n\n- 12.7\nⅢ*\n\n- 1.5\n- 7.9\n- 2.3\n- 2.9\n* Non-genotoxic componds\n\n** Chemicals of Cramer classⅡ should be treated as ClassⅢ substances.\n\n Values in bold are those currently recommended by the SCCS for use for cosmetics-related substances\n\n**[표 시작]**\n\n| 발    행    처 | 식품의약품안전평가원 의료제품연구부 화장품연구과 |\n| --- | --- |\n\n**[표 끝]**\n\n공익신고자등(친족 또는 동거인 포함)이 공익신고등으로 인하여 피해를 받지 않도록\n\n“청렴한 식약처\n\n국민 안심의 시작“\n\n▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자   부조리 신고” 코너\n\n▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너\n",
        "original_sentence": "2017이 제안한 TTC 값 사용을 제안하고 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_388",
      "text": "<!-- PAGE_73 -->\n###### 표 1 . ",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 387,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 73,
        "window_text": "<!-- PAGE_73 -->\n###### TTC는 경구 경로의 전신독성을 나타내는 외부용량 기반의 값이고, 화장품의 주요 노출 경로\n\n<!-- PAGE_73 -->\n###### 는 피부이기 때문에 피부 흡수에 대한 변수를 고려하여 내부 노출량으로 변환하여 TTC 값과\n\n<!-- PAGE_73 -->\n###### 비교하여야 한다.\n\n <!-- PAGE_73 -->\n###### 유럽 SCCS에서는 Yang et al.  2017이 제안한 TTC 값 사용을 제안하고 있다.\n\n <!-- PAGE_73 -->\n###### 표 1 .  제안된 TTC 값 요약 (단위: μg/kg bw/day)\n\n**[표 시작]**\n\n**Cramer class**\n\n**[표 끝]**\n\nGenotoxic\n\ncompounds\n\n- 0.0025\nⅠ*\n\n30\n\n42\n\n46\n\n- 49.1\nⅡ*\n\nNot supported**\n\n- -\nNot supported**\n\n- 12.7\nⅢ*\n\n- 1.5\n- 7.9\n- 2.3\n- 2.9\n* Non-genotoxic componds\n\n** Chemicals of Cramer classⅡ should be treated as ClassⅢ substances.\n\n Values in bold are those currently recommended by the SCCS for use for cosmetics-related substances\n\n**[표 시작]**\n\n| 발    행    처 | 식품의약품안전평가원 의료제품연구부 화장품연구과 |\n| --- | --- |\n\n**[표 끝]**\n\n공익신고자등(친족 또는 동거인 포함)이 공익신고등으로 인하여 피해를 받지 않도록\n\n“청렴한 식약처\n\n국민 안심의 시작“\n\n▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자   부조리 신고” 코너\n\n▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너\n",
        "original_sentence": "<!-- PAGE_73 -->\n###### 표 1 . "
      }
    },
    {
      "chunk_id": "chunk_389",
      "text": "제안된 TTC 값 요약 (단위: μg/kg bw/day)\n\n**[표 시작]**\n\n**Cramer class**\n\n**[표 끝]**\n\nGenotoxic\n\ncompounds\n\n- 0.0025\nⅠ*\n\n30\n\n42\n\n46\n\n- 49.1\nⅡ*\n\nNot supported**\n\n- -\nNot supported**\n\n- 12.7\nⅢ*\n\n- 1.5\n- 7.9\n- 2.3\n- 2.9\n* Non-genotoxic componds\n\n** Chemicals of Cramer classⅡ should be treated as ClassⅢ substances.\n\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 388,
        "window_size": 3,
        "char_count": 302,
        "word_count": 55,
        "page_number": 43,
        "window_text": "<!-- PAGE_73 -->\n###### 유럽 SCCS에서는 Yang et al.  2017이 제안한 TTC 값 사용을 제안하고 있다.\n\n <!-- PAGE_73 -->\n###### 표 1 .  제안된 TTC 값 요약 (단위: μg/kg bw/day)\n\n**[표 시작]**\n\n**Cramer class**\n\n**[표 끝]**\n\nGenotoxic\n\ncompounds\n\n- 0.0025\nⅠ*\n\n30\n\n42\n\n46\n\n- 49.1\nⅡ*\n\nNot supported**\n\n- -\nNot supported**\n\n- 12.7\nⅢ*\n\n- 1.5\n- 7.9\n- 2.3\n- 2.9\n* Non-genotoxic componds\n\n** Chemicals of Cramer classⅡ should be treated as ClassⅢ substances.\n\n Values in bold are those currently recommended by the SCCS for use for cosmetics-related substances\n\n**[표 시작]**\n\n| 발    행    처 | 식품의약품안전평가원 의료제품연구부 화장품연구과 |\n| --- | --- |\n\n**[표 끝]**\n\n공익신고자등(친족 또는 동거인 포함)이 공익신고등으로 인하여 피해를 받지 않도록\n\n“청렴한 식약처\n\n국민 안심의 시작“\n\n▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자   부조리 신고” 코너\n\n▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너\n",
        "original_sentence": "제안된 TTC 값 요약 (단위: μg/kg bw/day)\n\n**[표 시작]**\n\n**Cramer class**\n\n**[표 끝]**\n\nGenotoxic\n\ncompounds\n\n- 0.0025\nⅠ*\n\n30\n\n42\n\n46\n\n- 49.1\nⅡ*\n\nNot supported**\n\n- -\nNot supported**\n\n- 12.7\nⅢ*\n\n- 1.5\n- 7.9\n- 2.3\n- 2.9\n* Non-genotoxic componds\n\n** Chemicals of Cramer classⅡ should be treated as ClassⅢ substances.\n\n"
      }
    },
    {
      "chunk_id": "chunk_390",
      "text": "Values in bold are those currently recommended by the SCCS for use for cosmetics-related substances\n\n**[표 시작]**\n\n| 발    행    처 | 식품의약품안전평가원 의료제품연구부 화장품연구과 |\n| --- | --- |\n\n**[표 끝]**\n\n공익신고자등(친족 또는 동거인 포함)이 공익신고등으로 인하여 피해를 받지 않도록\n\n“청렴한 식약처\n\n국민 안심의 시작“\n\n▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자   부조리 신고” 코너\n\n▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너\n",
      "metadata": {
        "source": "화장품+위해평가+가이드라인(민원인+안내서).pdf",
        "chunk_index": 389,
        "window_size": 3,
        "char_count": 347,
        "word_count": 72,
        "page_number": 48,
        "window_text": "2017이 제안한 TTC 값 사용을 제안하고 있다.\n\n <!-- PAGE_73 -->\n###### 표 1 .  제안된 TTC 값 요약 (단위: μg/kg bw/day)\n\n**[표 시작]**\n\n**Cramer class**\n\n**[표 끝]**\n\nGenotoxic\n\ncompounds\n\n- 0.0025\nⅠ*\n\n30\n\n42\n\n46\n\n- 49.1\nⅡ*\n\nNot supported**\n\n- -\nNot supported**\n\n- 12.7\nⅢ*\n\n- 1.5\n- 7.9\n- 2.3\n- 2.9\n* Non-genotoxic componds\n\n** Chemicals of Cramer classⅡ should be treated as ClassⅢ substances.\n\n Values in bold are those currently recommended by the SCCS for use for cosmetics-related substances\n\n**[표 시작]**\n\n| 발    행    처 | 식품의약품안전평가원 의료제품연구부 화장품연구과 |\n| --- | --- |\n\n**[표 끝]**\n\n공익신고자등(친족 또는 동거인 포함)이 공익신고등으로 인하여 피해를 받지 않도록\n\n“청렴한 식약처\n\n국민 안심의 시작“\n\n▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자   부조리 신고” 코너\n\n▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너\n",
        "original_sentence": "Values in bold are those currently recommended by the SCCS for use for cosmetics-related substances\n\n**[표 시작]**\n\n| 발    행    처 | 식품의약품안전평가원 의료제품연구부 화장품연구과 |\n| --- | --- |\n\n**[표 끝]**\n\n공익신고자등(친족 또는 동거인 포함)이 공익신고등으로 인하여 피해를 받지 않도록\n\n“청렴한 식약처\n\n국민 안심의 시작“\n\n▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자   부조리 신고” 코너\n\n▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너\n"
      }
    }
  ],
  "chunking_analysis": {
    "total_chunks": 390,
    "avg_chunk_length": 203.56666666666666,
    "min_chunk_length": 4,
    "max_chunk_length": 1706,
    "total_characters": 79391,
    "total_words": 16325,
    "window_size": 3
  },
  "statistics": {
    "total_text_blocks": 2810,
    "heading_count": 693,
    "paragraph_count": 445,
    "list_item_count": 186,
    "table_cell_count": 1486,
    "tables_detected": 15,
    "chunks_generated": 390
  }
}